date,form_type,accession_number,clean_text,word_count
1994-02-09,10-Q,0000080424-94-000002,"Net earnings for the October-December quarter increased 13% from the same quarter in the previous year. Earnings per share were up 14% from the Unit volume growth and lower costs were the major factors contributing to the increase in earnings. Unit volume was up 6%, excluding the discontinued pulp and juice operations. Less favorable exchange rates limited earnings growth. On a constant exchange rate basis, net earnings would have been up 17% from a Worldwide net sales for October-December decreased 1% from the same quarter last year. The decline reflects adverse foreign exchange rates. Excluding this effect, sales would have been up 3%. For July-December, net earnings and earnings per share were up 12% from the same six months in the previous year, excluding the prior years' effect of accounting changes and a restructuring provision. Net sales were down 2%. Excluding the impact of exchange rates, earnings would have increased 17% and sales would have been up 3% from a year ago. The U.S. consumer businesses continued to deliver strong unit volume gains during October-December, including record shipments in December. International achieved double-digit volume growth, despite difficult economic conditions in many major markets. Volume growth was particularly strong in the Far East, Latin America and Eastern Europe. Both the U.S. and International businesses showed good earnings growth, due in part to the restructuring program which is just beginning to contribute to earnings PART II. OTHER INFORMATION",236
1994-04-13,8-K,0000080424-94-000008,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 12, 1994 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State of Incorporation) (Commission File Number) (IRS Employer One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100",73
1994-05-13,10-Q,0000080424-94-000012,"Net earnings for the January-March quarter were $482 million, including a onetime charge of $102 million for the interest rate swaps announced in April. Excluding this charge, earnings increased 16% over earnings from the same period last year. Earnings per share excluding this onetime item were $.81, also up 16% from last year. The earnings improvement was largely due to lower costs and a 6% increase in worldwide unit volume. The $102 million after-tax charge was to close out the written option portion of two leveraged interest rate swaps, thus eliminating future A comprehensive review of all financial derivative contracts has been performed, and all outstanding derivative contracts are within our overall operating and financing policies. Based on this review, certain other derivative instruments are now being carried at market value for accounting purposes. The effect of this reclassification was not material to the Net sales for January-March were up 1% from the same period last year. Sales were adversely affected by exchange rates and would have been up 3% For the July-March period, net earnings were $1,907 million excluding the $102 million charge for the interest rate swaps. This represents a 13% increase from $1,688 million in the year ago period, excluding the prior years' effect of accounting changes and a restructuring provision. Comparable earnings per share were $2.68 per share, up 13% from $2.37 per share a year ago. Net sales for the first nine months of the fiscal year decreased 1% from the same period in the previous year. Excluding the impact of exchange rates, net sales would have been up 3% from last year. This was a strong quarter for the Company. Pre-tax operating profit was up 20% versus January-March a year ago. This improvement reflects the benefit of cost reduction programs, along with solid unit volume gains in the U.S. and continued double-digit volume growth in International operations. PART II. OTHER INFORMATION",317
1994-09-14,10-K,0000080424-94-000021,"and Analysis of Financial Condition and This information is incorporated by reference to the Analysis and Discussion and Financial Condition shown on pages 32-36 and the letter to shareholders on pages 1-5 of the Annual Report to Shareholders for the fiscal year ended June 30, 1994.",46
1994-11-10,10-Q,0000080424-94-000029,"Worldwide net earnings for the July-September quarter achieved a record level of $792 million, or $1.12 per share, an 18% increase over the same quarter in the prior year. First quarter earnings for the prior year were $670 million or $.95 per share. The earnings improvement reflects strong worldwide unit volume growth and good cost control throughout the Company. Worldwide net sales for the July-September quarter increased 8% from the same three months a year ago to a record level of $8.2 billion. This growth was driven by unit volume increases. Worldwide unit volume increased 10%, which compares to a 5% volume growth in fiscal year 1994. Acquisitions net of divestitures contributed 3 percentage points to the volume growth in this quarter. Net earnings in the United States increased 12% versus the first quarter last year, reflecting increases in Laundry & Cleaning, Paper and Food & Beverage sectors again due to volume growth and cost control. Sales in the United States increased 6% on an equal growth in unit volume. The Laundry & Cleaning sector increased unit volume by 10%, led by growth in the Laundry Detergent and Fabric Conditioners categories, reflecting the effect of new product initiatives. The Food & Beverage sector recorded a small unit volume decline, entirely due to the contraction of the coffee market resulting from sharp price increases following crop freezes in Brazil. On the balance of the Food & Beverage line there were broadly based volume gains. The Paper sector increased unit volume 12% on broadly based market share gains except for the Diaper category, where market share was flat. The Tissue/Towel category recorded significant gains due importantly to new product initiatives. The Beauty Care business also increased unit volume, while Health Care was about equal to year ago. Total International net earnings increased 23% over the first quarter a year ago, on a sales increase of 8% and a unit volume increase of 13%. The increase in earnings was driven by unit volume growth and continued cost reduction efforts. The lower rate of sales versus unit volume growth was in large part due to more competitive pricing across most regions. Exchange rates did not have a significant effect on sales or net earnings for the quarter. Europe's unit volume increased 13% led by broadly based gains in the Health & Beauty Care sector and Eastern European region. The European Laundry, Paper and Food & Beverage businesses did well, with volume up 12% overall. The balance of International unit volume also advanced by 13% with every region except Latin America growing at a double digit rate. The economic and political conditions in Mexico and Venezuela slowed volume advances in the region. Globally, there are signs of upward pressure on costs, not only for green coffee beans, but also for pulp and petrochemicals. Although the prices for many of these materials are up from unusually depressed levels, the increases may put pressure on pricing. Restructuring Reserve Status In the year ending June 30, 1993 a pre-tax reserve of $2,402 million was established to cover a worldwide restructuring effort to consolidate manufacturing systems and reduce overhead costs. The primary elements of this reserve were costs related to fixed asset disposals and separation- related activities (86% of the total). The following information relates to the 1993 reserve (in millions of Original Balance July-Sept. Balance Reserve 6/30/94 Charges 9/30/94 Separation-related costs $ 965 $ 596 $ 67 $ 529 Disposals of fixed assets 1,109 960 10 950 Includes separation allowances and related benefits, out placement services, and personnel relocation costs. Including closing, environmental remediation and contract termination costs for sites shut down or divested, offset by net proceeds from asset sales. No cost element within this category exceeds 5% of the total reserve. Execution of the restructuring program is on track and the cost of completing it is expected to approximate the original estimates. As anticipated, charges for the disposal of fixed assets will lag behind spending for separation-related programs. We have announced more than half of the sites and production modules to be closed in order to provide early notice to employees. However, relatively few of these facilities have been totally shut down at this time. Benefits continue to be obtained from the restructuring program. We estimate that incremental savings of about $60 million after-tax were achieved in the July-September 1994 quarter. This brings cumulative restructuring savings to about half of the $500 million after-tax objective established in June, 1993. These amounts reflect estimated gross savings, which may be offset to some degree by other actions, such as pricing or research and development spending. Additional Information responsive to this Item is incorporated by reference to the Report by Edwin L. Artzt, Chairman and Chief Executive, delivered on October 11, 1994, during the Company's Annual Meeting of Shareholders PART II. OTHER INFORMATION",804
1995-01-26,8-K,0000080424-95-000002,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 26, 1995 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State of Incorporation) (Commission File Number) (IRS Employer One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 5. OTHER EVENTS ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS (99) Press Release Issued by Registrant on January 26,",92
1995-02-14,10-Q,0000080424-95-000004,"Worldwide net earnings for the quarter ending December 31, 1994 were $750 million, a 15% increase over the same quarter of the prior year. Earnings per share for the quarter were $1.06 compared to $.92 per share for the second quarter of the prior year, also a 15% increase. Worldwide net sales for the quarter increased 9% over the same quarter of the prior year to $8.5 billion. Strong unit volume growth continued, with worldwide unit shipments increasing 9% over the same quarter in the prior year. Acquisitions contributed 3% of the quarter's volume growth. Favorable exchange rates contributed approximately 2% to the sales and earnings growth for the quarter. Results for the first six months of the fiscal year reflect continued volume growth and cost control efforts throughout the company. Worldwide net earnings for the July-December period were $1,542, or $2.18 per share, a 17% increase over the same period of the prior year. Year to date sales were $16.6 billion, up 8% compared to $15.4 billion for this period of the prior fiscal year. Year to date volume Net earnings in the United States increased 7% for the quarter, on a 6% sales growth versus the same period a year ago. The earnings increase reflects unit volume growth in all sectors, as well as benefits from restructuring actions begun in the prior year. Overall, unit volume increased 3%. The Laundry & Cleaning sector increased unit volume in spite of competitive pressure and responses to new initiatives in the Fabric Conditioners category. The Food & Beverage sector unit volume benefited from strong shipments in the Juice and Shortening & Oils categories. In the Paper sector, volume gains were driven by continued strength in the Tissue/Towel category. Diaper volume was down due, in part, to announced pricing reductions which will take effect in the January-March quarter. Driven by double-digit volume growth in the Hair Care category, the Beauty Care business also increased unit volume 2%, excluding the discontinued Clarion business. The Health Care business increased unit volume 2%. The primary driver of the growth was Aleve, offsetting lower volumes in respiratory attributable to a mild cough and cold season. Year to date earnings for the United States have increased 10% over the first half of the prior fiscal year. The earnings increase is attributable to a 6% increase in sales on a 5% unit volume growth, combined with the benefits of continued cost reduction efforts. Unit volume growth has been achieved by nearly all sectors. Food and Beverage year-to-date unit volume is down slightly due to the impact of the contraction of the coffee market following the crop freeze in Total international earnings increased 20% over the same quarter of the prior year on a sales increase of 8%. Unit volume increased 15%. The difference between sales and volume growth is largely due to competitive pricing in a number of markets. Favorable exchange rates contributed 4% to the sales growth and 5% to earnings growth. Europe posted strong net earnings gains, as broadly-based unit volume growth of 14% and continued cost reduction benefits offset the impact of reduced pricing. The European Laundry business continues to be strong, attaining record market share. The balance of international achieved 16% unit volume growth. Cost control efforts contributed to attaining double digit growth in quarterly earnings for this segment. The devaluation of the Mexican peso did not adversely impact the quarterly results. Translation of the net assets in Mexico resulted in a charge to the cumulative translation component of shareholders' equity, without significant impact to total equity. The devaluation of the Mexican peso is not expected to significantly impact results For the first half of the fiscal year, International earnings have increased 22% over the prior comparable period. Year to date sales growth was 8% on a 15% unit volume growth, reflecting pricing actions in a number of markets. International unit volume has increased at a double digit rate across all regions except Latin America where the economic conditions in Mexico and Venezuela have slowed volume growth. Favorable exchange rates contributed 3% to the sales and earnings growth for the first six months. Restructuring Reserve Status In the year ending June 30, 1993, a pre-tax reserve of $2,402 million was established to cover a worldwide restructuring effort to consolidate manufacturing systems and reduce overhead costs. The primary elements of this reserve were costs related to fixed asset disposals and separation-related costs (86% of the total). The following information relates to the June 1993 reserve (in millions of dollars pre-tax): Original Balance July-Dec Balance Reserve 6/30/94 Charges 12/31/94 Separation-related costs $ 965 $ 596 $134 $ 462 Disposals of Fixed Assets 1,109 960 116 844 Includes separation allowances and related benefits, out placement services, and personnel relocation costs. Includes closing, environmental remediation and contract termination costs for sites shut down or divested, offset by proceeds from asset sales. No cost element within this category exceeds 5% of the total reserve. Execution of the restructuring program is on track and the cost of completing it is expected to approximate the original estimates. As anticipated, charges for the disposal of fixed assets will lag behind spending for separation-related programs. We have announced more than half of the sites and production modules to be closed in order to provide advance notice to employees. However, relatively few of these facilities have been totally shut down at this time. Benefits continue to be obtained from the restructuring program. We estimate that incremental savings of almost $65 million after tax were achieved in the October-December quarter, bringing cumulative restructuring savings to approximately two-thirds of the $500 million after-tax objective established in June 1993. These amounts reflect estimated gross savings, which may be offset to some degree by other actions, such as pricing or research and development spending. Based on the information currently available, the recent earthquake in Kobe, Japan will result in a $50 million after-tax charge to earnings in the January-March quarter for employee assistance, clean-up and repair of facilities and other incremental expenses directly associated with the earthquake. Four of five plants in Japan were not affected by the earthquake. The Akashi plant, which produces paper products, suffered some damage and is being repaired currently. Customers are being supplied from existing inventory and another P&G plant in Japan. P&G's Japan headquarters and technical center on Rokko Island suffered some damage, but based on initial assessments, the basic structure appears sound. PART II. OTHER INFORMATION",1075
1995-05-11,10-Q,0000080424-95-000009,"Worldwide net earnings for the quarter ending March 31, 1995 were $631 million, 31% above the same quarter in the prior year, including a $50 million charge for incremental costs associated with the January earthquake in Japan. Net earnings for the same period of the prior fiscal year were $482 million, including a $102 million charge related to two interest rate swap contracts. Excluding the unusual items in both years, net earnings were $681 million, a 17% increase over the third quarter of the prior year, and earnings per share were $.95, Worldwide net sales for the quarter increased 12% over the same quarter of the prior year to $8,312 million. Strong unit volume growth continued, with a worldwide increase of 12% over the same quarter a year ago. Acquisitions contributed approximately 2% to the Year-to-date results reflect strong unit volume growth and cost containment efforts, despite upward pressure on raw material prices. Worldwide net earnings for the first nine months of the fiscal year were $2,173 million compared to $1,805 million in the prior year, a 20% increase, including the cost associated with the Japan earthquake and the $102 million charge related to two interest rate contracts, in the respective periods. Excluding the unusual items in both years, earnings and earnings per share increased 17% for the July-March period to $2,223 million and $3.13 per share, respectively. The United States achieved 10% sales growth in the quarter on a 9% unit volume increase, which is the largest year-to-year increase in unit volume in six years. Excellent unit volume growth was achieved by all sectors, with double-digit volume increases in the Health Care and Beauty Care businesses. The Diaper category unit volume continued to show a year-to-year volume decline in the current quarter, although volume increased over the prior quarter following the introduction of a new product and price reductions. In addition, competitive activity in the Shortenings & Oils and Hard Surface Cleaners categories negatively impacted unit volume growth. Strong growth in the Laundry, Fabric Conditioners and Tissue/Towel categories more than offset those impacts. Positive product mix impacts offset the effect of competitive pricing in several categories, primarily diapers. United States net earnings increased 8% in the third quarter. The benefit of cost containment efforts was impacted by higher raw material prices, primarily pulp, and continued research and development investment, primarily in pharmaceuticals. Selling price increases on tissue and towel products have recently been announced in response to increased pulp prices. Year-to-date earnings in the United States have increased 9% over the first nine months of the prior year. The earnings increase reflects a 7% increase in sales on a 6% unit volume increase. The benefits of continued cost containment efforts have been reduced by increased raw material prices. Unit volume growth increased across all sectors year to date, led by double-digit growth in the Beauty Care business. International volume increased 14% over the same quarter of the prior year. Continued competitive pricing in a number of markets limited sales growth to 11%. International earnings increased 23% for the quarter, reflecting aggressive cost reduction efforts. The impact of favorable exchange rates in Central Europe and Japan has offset the Mexican peso devaluation resulting in a small net positive impact on International sales and earnings. Europe continued to post strong net earnings gains, as unit volume growth of 15% and lower costs offset the impact of reduced pricing. The European Laundry business remains strong, supplemented by continued growth in the Health Care and Beauty Care businesses. The European Paper business continued to grow, with strength in both diapers and feminine hygiene products. The balance of International achieved 14% unit volume growth. Solid quarterly net earnings growth for this segment is attributable to aggressive cost increase recovery in Latin America. Unit volume in Japan was up, despite the temporary shut down of the Akashi paper plant due to the January earthquake. The impact of the delays is not expected to materially impact future results. For the first nine months of the fiscal year, International earnings have increased 22% over the prior period. Year-to-date sales growth of 9% was driven by 15% unit volume growth, reflecting continued competitive pricing in a number of markets. Unit volume growth and cost containment efforts continue to drive earnings growth in substantially all regions. On a year-to-date basis, countervailing exchange rate changes resulted in an immaterial impact on OTHER INCOME/(EXPENSE) - NET As discussed previously, the third quarter and year-to-date amounts of other income/(expense) - net include unusual items in both years. The current periods reflect a $77 million pre-tax charge for incremental costs associated with the January earthquake in Japan. This charge reflects the cost of employee assistance, cleanup and repair of facilities, and non-recurring expenses directly associated with the earthquake. The prior year periods include a $157 million pre-tax charge related to two interest rate swap contracts. RISK MANAGEMENT ACTIVITIES In response to currency exchange rate movements during the quarter, the Company expanded certain of its risk management activities. Certain foreign subsidiaries increased transactional hedging activities performed locally to manage the exposure related to commercial transactions and intercompany receivables and payables. Generally, any change in the market value of the financial instrument is offset by a corresponding change in the hedged exposure. In addition, the Company purchased additional foreign currency put options as a hedge against the effect of exchange rate fluctuations on income. These contracts give the Company the right, but not the obligation, to sell foreign currencies, primarily European currencies and the yen, in exchange for U.S. dollars at predetermined exchange rates. Those purchased options that do not qualify for hedge accounting are carried on a current market value basis. RESTRUCTURING RESERVE STATUS In the year ending June 30, 1993, a pre-tax reserve of $2,402 million was established to cover a worldwide restructuring effort to consolidate manufacturing systems and reduce overhead costs. The primary elements of this reserve were costs related to fixed asset disposals and separation-related costs (86% of the total). The following information relates to the June 1993 reserve (in millions of dollars pre-tax): Original Balance July-March Balance Reserve 6/30/94 Charges 3/31/95 Separation-related costs $ 965 $ 596 $ 162 $ 434 Desposals of Fixed Assets 1,109 960 272 688 Includes separation allowances and related benefits, out placement services, and personnel relocation costs. Includes closing, environmental remediation and contract termination costs for sites shut down or divested, offset by proceeds from asset sales. No cost element within this category exceeds 5% of the total reserve. The negative amount of charges represents proceeds received on asset sales, primarily during the Execution of the restructuring program continues to be on track, and the cost of completing it is expected to approximate the original estimates. As anticipated, charges for the disposal of fixed assets will lag behind spending for separation-related programs. We have announced more than half of the sites and production modules to be closed in order to provide advance notice to employees. Benefits continue to be obtained from the restructuring program. We estimate that incremental savings of almost $70 million after tax were achieved in the January-March quarter, bringing cumulative restructuring savings to approximately three-quarters of the $500 million after-tax objective established in June 1993. These amounts reflect estimated gross savings, which may be offset to some degree by other actions, such as lower pricing or increased research and PART II. OTHER INFORMATION",1231
1995-09-13,10-K,0000080424-95-000027,"THE PROCTER & GAMBLE COMPANY ANNUAL REPORT ON FORM 10-K SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION ANNUAL REPORT ON FORM 10-K PURSUANT TO SECTION 13 OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 1995 Commission File No. 1-434 THE PROCTER & GAMBLE COMPANY One Procter & Gamble Plaza, Cincinnati, Ohio 45202 IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each Exchange on which registered Common Stock, without Par Value New York, Cincinnati, Amsterdam, Paris, Basle, Geneva, Lausanne, Zurich, Frankfurt, Antwerp, Brussels, Tokyo Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes X No . Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ----------- There were 686,947,278 shares of Common Stock outstanding as of August 11, 1995. The aggregate market value of the voting stock held by non- affiliates amounted to $51 billion on August 11, 1995. Documents Incorporated By Reference Portions of the Annual Report to Shareholders for the fiscal year ended June 30, 1995 are incorporated by reference into Part I and Part II of this Portions of the Proxy Statement for the 1995 Annual Meeting of Shareholders are incorporated by reference into Part III of this report. General Development of Business The Procter & Gamble Company was incorporated in Ohio in 1905, having been built from a business founded in 1837 by William Procter and James Gamble. Today, the Company manufactures and markets a broad range of consumer products in many countries throughout the world. Unless the context indicates otherwise, the term the ""Company"" as used herein refers to The Procter & Gamble Company (the registrant) and its Additional information required by this item is",392
1995-11-13,10-Q,0000080424-95-000029,"Worldwide Results of Operations Worldwide net earnings for the quarter ending September 30, 1995 were $896 million or $1.27 per share. This represents a 13% increase over the same quarter of the prior year, when net earnings were $792 million or $1.12 per share. Worldwide net sales for the quarter were $9,027 million, a 10% increase from the prior year's $8,177 million. The sales increase reflects record shipments and unit volume growth of 9%. The effects of stronger European and Asian currencies on both sales and earnings were offset by the weaker Mexican peso. Gross margin was 42.3% for the current quarter versus 43.3% for the first quarter of the Gross margin for the prior fiscal year was 41.5%. These margin trends reflect higher raw material costs, primarily pulp. Operating margin for the quarter improved to 15.9%, compared to 15.5% for the same quarter of the prior year, as continued focus on cost control largely offset the effects of higher raw material prices and increased research and development costs. Net sales for the North American region increased 7% on a 6% unit volume increase. Earnings for the region increased 8%, as cost control actions largely offset increased raw material prices, primarily pulp, and continued investment in the health care business. The unit volume gains were driven by the Food and Beverage business which contributed nearly half of the region's unit volume growth. Solid progress in all categories of the Paper business also contributed to the unit volume growth, although related earnings were negatively affected by higher pulp prices that were not fully recovered through pricing. The Laundry and Cleaning business contributed approximately 25% of the region's unit volume growth. Beauty Care unit volume achieved solid growth, driven by hair care. Health Care unit volume declined slightly due to softness in the respiratory Europe, Middle East and Africa First quarter sales for the Europe, Middle East and Africa region increased 16%. Unit volume was up 12%, led by gains in Eastern Europe. The region's earnings grew 20% over the same quarter last year. Favorable exchange rates added 6% to sales, more than offsetting product mix impacts. Broad-based unit volume gains across the region's businesses drove the earnings growth, complemented by continuing cost control actions. Asia maintained its strong growth rate with a 22% increase in unit volume, led by China. The region delivered 12% sales and 9% earnings growth over the same quarter of the prior year. Favorable exchange rates increased sales by 6%, helping to mitigate the effects of lower pricing and product mix. Double-digit unit volume growth was achieved by the region's key businesses, with Laundry and Cleaning continuing to lead the growth. The results of the region reflect the continuing investment in this fast-growing market. Latin America delivered unit volume growth of 6%, despite a 3% decline in Mexico. Sales for the region were down 4%, as favorable pricing helped lessen the effect of unfavorable exchange rates. Earnings for the region were down 7%, primarily due to the continuing effects of the Mexican Peso devaluation. Excluding Mexico, net earnings for the region increased over the same quarter of the prior year. Unit volume growth in the region was led by the Paper business, driven by the success of Pampers Uni. Restructuring Reserve Status In the year ending June 30, 1993, a reserve of $2,402 million was established to cover a worldwide restructuring effort to consolidate manufacturing systems and reduce overhead costs. The primary elements of this reserve were costs related to fixed asset disposals and separation-related costs (86% of the total). The following information relates to the June 1993 reserve (in millions of dollars Original Balance July-September Balance Includes separation allowances and related benefits, out placement services, and personnel relocation costs. Includes closing, environmental remediation and contract termination costs for sites shut down or divested, offset by proceeds from asset sales. No cost element within this category exceeds 5% of the total Execution of the restructuring program continues to be on track, and the cost of completing it is expected to approximate the original estimates. As anticipated, charges for the disposal of fixed assets will lag behind spending for separation-related programs. About two-thirds of the sites and production modules to be closed have been announced in order to provide advance notice to Benefits continue to be obtained from the restructuring program. Incremental savings of almost $30 million after-tax are estimated for the July-September quarter, bringing cumulative restructuring savings to approximately 90% of the $500 million after-tax objective established in June 1993. Based on current projections, the Company believes cumulative restructuring savings ultimately will exceed the original estimate by approximately 20%. For this purpose, restructuring savings are estimated gross savings, which have been offset to some degree by lower pricing and other actions to build the business. PART II. OTHER INFORMATION",802
1996-02-13,10-Q,0000080424-96-000003,"WORLDWIDE RESULTS OF OPERATIONS Worldwide net earnings for the quarter ending December 31, 1995 were $836 million, an 11% increase over the same quarter of the prior year net earnings of $750 million. Earnings per share for the quarter were $1.18 compared to $1.06 per share in the second quarter of the prior year, also an 11% increase. Worldwide net sales were $9,090 million, representing an increase of 7% over the same quarter of the prior year, on 8% unit volume growth. For the first six months of the fiscal year, worldwide net earnings were $1,732 million or $2.45 per share, an increase of 12% over the same period of the prior year. Worldwide net sales increased 9% to $18,117 million, on comparable unit Gross margin was 42.1% for the current quarter versus 43.0% for the same quarter of the prior year. Raw material prices, primarily pulp, continued to affect margin trends. As a comparison, the prior full fiscal year gross margin was 41.5%. Operating margin for the quarter was 14.9%, an improvement over 14.2% for the same quarter of the prior year. The improvement reflects the effect of continued cost control efforts. Net sales and unit volume for the North American region grew 7% over the same quarter of the prior year. Earnings for the region increased 9%. The Laundry & Cleaning business led the region's growth, propelled by a significant unit volume increase. The Paper business also contributed to the unit volume growth, with particular strength in the tissue and towel and diaper categories. Margins continued to be affected by an increase in pulp prices over same quarter prior year. The Beauty Care and Food & Beverage businesses maintained strong unit volume growth, with double-digit growth in the hair care, coffee, juice and personal cleansing categories. The results of the Health Care business were affected by heavy competitive activity in the oral care and gastro-intestinal categories, which has hampered unit volume growth. For the July-December period, the North American region had unit volume and sales growth of 7%. Net earnings increased 8% over the prior year. Second quarter sales for the Europe, Middle East and Africa region increased 11% over the same quarter of the prior year. The increase was led by a 7% unit volume growth, complemented by favorable pricing and exchange rates. Central and Eastern Europe achieved volume growth of over 50% with increased expansion into these markets, contributing nearly half of the region's unit volume growth. Net earnings for the region were up 26%, as incremental restructuring savings and on-going cost control benefits were realized. A simplification of trade terms has recently been announced, which could negatively affect growth trends in the short-term. This move to value pricing eliminates inefficient promotion costs by rolling them into lower list prices. When implemented in the United States, this change led to improved results. Europe experienced 9% unit volume growth for the July-December period with a 14% increase in sales. Net earnings increased 23% over the same period of the prior Asia achieved unit volume growth of 16%, led primarily by record shipments in China. Sales for the region increased 6%, with a 7% net earnings increase. Unfavorable exchange rates, lower pricing and product mix limited the sales and earnings growth relative to the increased unit volume. Laundry and Beauty Care continued to lead growth within the region, experiencing double-digit volume For the first six months of the fiscal year, Asia had a 19% increase in unit volume and 9% sales growth. Net earnings increased by 8% over the prior period. Despite continuing economic difficulties in Latin America, the region delivered 8% unit volume growth in the quarter. Exchange effects, combined with higher costs, resulted in a sales and net earnings decline of 4% and 1%, respectively. Significant unit volume growth in Brazil and Venezuela compensated for flat unit volume in Mexico. Excluding Mexico, net earnings for the region increased For the July-December period, unit volume for the region grew 7%. Sales and net earnings both declined 4% from the prior year period. RESTRUCTURING RESERVE STATUS In the year ending June 30, 1993, a reserve of $2,402 million was established to cover a worldwide restructuring effort to consolidate manufacturing systems and reduce overhead costs. The primary elements of this reserve were costs related to fixed asset disposals and separation-related costs (86% of the total). The following information relates to the June 1993 reserve (in millions of Original Balance July-Dec. Balance Includes separation allowances and related benefits, out placement services, and personnel relocation costs. Includes closing, environmental remediation and contract termination costs for sites shut down or divested, offset by proceeds from asset sales. No cost element within this category exceeds 5% of the total Execution of the restructuring program continues to be on track, and the cost of completing it is expected to approximate the original estimates. As anticipated, charges for the disposal of fixed assets will lag behind spending for separation-related programs. Over 80% of the sites and production modules to be closed have been announced in order to provide advance notice to employees. Benefits continue to be obtained from the restructuring program. Incremental savings of approximately $25 million after-tax are estimated for the October-December quarter, bringing cumulative restructuring savings near the $500 million after-tax objective established in June 1993. Based on current projections, the Company believes cumulative restructuring savings ultimately may exceed the original estimate by approximately 20%. Restructuring savings are estimated gross savings, which have been offset to some degree by lower pricing and other actions to build the business. PART II. OTHER INFORMATION",929
1996-05-10,10-Q,0000080424-96-000006,"Worldwide Results of Operations Worldwide net earnings for the quarter ending March 31, 1996 were $760 million, a 20% increase over the same quarter of the prior year net earnings of $631 million. Earnings per share for the quarter were $1.07 compared to $0.88 in the third quarter of the prior year, a 22% increase. Net earnings for the same quarter of the prior year included a $50 million charge related to the earthquake in Kobe, Japan. Excluding that charge, quarterly net earnings and earnings per share increased 12% and 13%, respectively. Worldwide third quarter net sales were $8.59 billion for the quarter, a 3% increase over the same quarter of the prior year, on comparable unit volume Gross margin was 41.5% for the current quarter versus 41.2% for the same quarter of the prior year. Operating margin for the quarter was 13.9%, an improvement over 12.8% for the same quarter of the prior year. The improvement reflects continued efforts to improve efficiencies and simplify operations, resulting in lower costs to complement unit volume growth. For the nine months ended March 31, 1996, worldwide net earnings were $2.49 billion or $3.52 per share, an increase of 15% over the same period of the prior year. Worldwide net sales fiscal year-to-date increased 7% to $26.70 billion, on comparable unit volume growth. North America achieved 4% unit volume growth and 6% sales growth for the quarter versus a strong year-ago period. Positive pricing impacts and lower costs drove the region's 19% net earnings growth. The Laundry and Cleaning segment led the region's unit volume growth, with progress across substantially all categories. The Paper business achieved particularly strong net earnings results on important unit volume growth, with the diaper and feminine protection categories contributing double-digit unit volume increases. Food and Beverage contributed to the earnings growth with moderate volume increases and reduced green coffee bean prices. Despite flat volume, earnings in Beauty Care increased as a result of product mix and cost control efforts. The regional Health Care business was negatively impacted by competitive activity in the OTC health care categories, resulting in the segment's year-to-year decline in sales and net earnings. For the July-March period, the North America region increased sales 7%, on unit volume growth of 6%. Net earnings improved 12% over the prior year period. Third quarter unit volume for Europe, Middle East and Africa was flat, primarily due to the transition to value pricing in key Western European markets. This strategy to deliver better value to consumers was introduced several years ago in the United States and improved long-term results. Developing markets like Eastern Europe continued to generate excellent unit volume growth versus the same period of the prior year. The region's sales and earnings were at about the same level as the prior year due to the combined effects of pricing and a strong For the July-March period, unit volume in Europe, Middle East and Africa grew 6%, which, when combined with favorable exchange rates, drove 9% sales growth. Excellent cost reduction results helped the region achieve 15% net earnings growth for the nine months to date. Asia unit volume growth in the quarter remained strong, up 16% over the same period of the prior year. Sales growth was 4%, due primarily to lower pricing and unfavorable exchange rates in Japan. Exchange rates contributed a 5% decline across the region. Quarterly net earnings increased 11%, reflecting favorable mix effects and improved costs on certain key brands. China and the Philippines led the region with double-digit unit volume increases and improved earnings For the nine months ended March 31, 1996, Asia unit volume grew 18%, with a sales increase of 7%. Net earnings increased by 9% over the prior year. Unit volume for the Latin America region declined 5% in the quarter, as strong unit volume results in Brazil, Argentina and Venezuela were offset by market softening and an unusually strong year ago comparison in Mexico. Unfavorable exchange rate movements in the region contributed to a sales and net earnings decline of 4% for the quarter, despite continued cost control efforts in the For the July-March period, unit volume grew 3% in the Latin America region. Sales and net earnings were down 4%, as unfavorable exchange rates and the impact of the recession in Mexico affected results. Restructuring Reserve Status In the year ending June 30, 1993, a reserve of $2.40 billion was established to cover a worldwide restructuring effort to consolidate manufacturing systems and reduce overhead costs. The primary elements of this reserve were costs related to fixed asset disposals and separation-related costs (86% of the total). The following information relates to the June 1993 reserve (in million of Original Balance July-March Balance Includes separation allowances and related benefits, out placement services, and personnel relocation costs Including closing, environmental remediation and contract termination costs for sites shut down or divested, offset by proceeds from asset sales. No cost element within this category exceeds 5% of the total Execution of the restructuring program continues to be on track, and the cost of completing it is expected to approximate the original estimates. As anticipated, charges for the disposal of fixed assets will lag behind spending for separation related programs. Over 80% of the sites and production modules to be closed have been announced in order to provide advance notice to the employees. Benefits continue to be obtained from the restructuring program. With estimated incremental savings of approximately $30 million after-tax for the January-March quarter, cumulative restructuring savings have exceeded the $500 million after-tax objective established in June 1993. The Company continues to believe that cumulative restructuring savings will exceed the original estimate by approximately 20%. Restructuring savings are estimated gross savings, which have been offset to some degree by lower pricing and other actions to build the PART II. OTHER INFORMATION",971
1996-09-11,10-K,0000080424-96-000017,"THE PROCTER & GAMBLE COMPANY ANNUAL REPORT ON FORM 10-K SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION ANNUAL REPORT ON FORM 10-K PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 1996 Commission File No. 1-434 THE PROCTER & GAMBLE COMPANY One Procter & Gamble Plaza, Cincinnati, Ohio 45202 IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each Exchange on which registered Common Stock, without Par Value New York, Cincinnati, Amsterdam, Paris, Basle, Geneva, Lausanne, Zurich, Frankfurt, Antwerp, Brussels, Tokyo Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes X No . Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this There were 684,717,750 shares of Common Stock outstanding as of August 9, 1996. The aggregate market value of the voting stock held by non-affiliates amounted to $65 billion on August 9, 1996. Documents Incorporated By Reference Portions of the Annual Report to Shareholders for the fiscal year ended June 30, 1996 are incorporated by reference into Part I and Part II of this report. Portions of the Proxy Statement for the 1996 Annual Meeting of Shareholders are incorporated by reference into Part III of this report. General Development of Business The Procter & Gamble Company was incorporated in Ohio in 1905, having been built from a business founded in 1837 by William Procter and James Gamble. Today, the Company manufactures and markets a broad range of consumer products in many countries throughout the world. Unless the context indicates otherwise, the term the ""Company"" as used herein refers to The Procter & Gamble Company (the registrant) and its Additional information required by this item is",391
1996-11-13,10-Q,0000080424-96-000043,"and Analysis Results of Operations -- First Quarter Fiscal 1997 Compared with First Quarter Worldwide net earnings for the first quarter of fiscal year 1997 were $979 million or $1.39 per share. This represents a 9% increase over prior year first quarter earnings of $896 million or $1.27 per share. Sales for the quarter were $8.9 billion, down 1% compared to prior year first quarter sales of $9.0 billion. Worldwide unit volume grew 1% from the first quarter a year ago. The difference between the sales and unit volume trends was largely due to weaker currencies. Excluding the effect of unfavorable exchange rates, particularly in Japan and Germany, sales increased consistent with unit The company's results were affected by competitive pressures in Japan and difficult economic conditions in Latin America. In addition, the further roll-out of the Efficient Consumer Response program (ECR) within Europe and Asia impacted results. Specifically, the initial roll-out resulted in a reduction of trade inventories, slowing growth in the affected markets. When implemented several years ago in the United States, this program resulted in negative short-term business effects, but yielded stronger consumer loyalty and improved profit margins longer term. Gross margin was 43.8% for the current quarter, compared to 42.3% in the first quarter of the prior year and 41.2% for the full fiscal year ended June 30, 1996. Operating margin was 17.4% compared with 15.9% in the prior first quarter and 13.6% for the prior fiscal year, reflecting continued improvement in gross margin, efforts to improve efficiencies, and simplify operations, resulting in Net sales for the North America region increased 1% compared with the same quarter a year ago, on a 2% unit volume increase. The sales and volume growth in the quarter was affected by capacity constraints on certain key categories, such as tissue and towel. Earnings for the region grew 9%, reflecting broad-based margin growth from improved pricing and costs. The region's unit volume growth was led by the laundry and cleaning business, with particularly strong growth in the laundry and fabric conditioners categories. The paper business increased unit volume over a strong base period, despite capacity constraints in the tissue and towel category, where volume declined slightly due to reduced merchandising efforts pending planned capacity additions. This impact was offset primarily by the effect of acquisitions, as well as growth in the diapers and feminine hygiene categories. Importantly, earnings in this business led the region's growth, with improved pricing actions. The beauty care business also increased unit volume on the strength of the hair care category, as well as excellent growth in deodorants. Food and beverage increased unit volume, when adjusted for the effect of acquisitions and divestitures, as strength in the peanut butter and snack categories was moderated by softness in baking mixes and shortening and oils. Unit volume in the health care business was about flat, excluding the prior year divestiture of the Company's share of a joint venture. Oral care volume was up, but the effect was more than offset by the decline in respiratory care volume. The health care business also impacted the region's earnings growth, reflecting the volume softness in certain categories, as well as the increased investment to reestablish oral care growth. Europe, Middle East and Africa Sales in Europe, Middle East and Africa declined 1%, as unfavorable exchange rates, which reduced sales by 2%, combined with lower pricing related to ECR. Unit volume increased 5%, to a new record level. Net earnings increased 13% over the first quarter of last year, reflecting the solid volume progress and the margin improvement impact of lower costs. Central and Eastern Europe led the region's unit volume growth, increasing shipments by nearly 50%, primarily on the strength of the laundry and cleaning business. The Middle East and Africa region also had double-digit unit volume growth, while the remainder of the region was fairly flat, due to the impacts of First quarter results of the Asia region were impacted by the competitive environment in Japan and exchange rate effects. Sales declined 14%, including 9% related to unfavorable exchange rate movements. Unit volume was down 9%, largely due to the Japan situation and the impact of ECR-related trade inventory reductions. Additionally, China's unit volume growth was below recent levels, as trade inventories were adjusted in response to price increases taken earlier in the quarter. The Company's market share position remains strong, and unit volume in China is expected to rebound in the second quarter. Net earnings in Asia were down 10%, consistent with the sales trend in region. Sales in Latin America were down 1% in the first quarter, as pricing policies designed to address inflation and devaluation trends helped offset volume softness. Unit volume in the quarter was down 6%, reflecting declining markets due to slow economic recovery in key markets. Net earnings increased 11% on improved margins, largely reflecting the pricing actions. RESTRUCTURING RESERVE STATUS In the year ended June 30, 1993, a reserve of $2.4 billion was established to cover a worldwide restructuring effort to consolidate manufacturing systems and reduce overhead costs. The primary elements of this reserve were costs related to fixed asset disposals and separations. The balance of the reserve at September 30, 1996 was $610 million, with approximately half of the balance representing planned fixed asset disposals, all of which have been announced. The restructuring program is expected to be substantially completed during the current fiscal year. Based on current management estimates, the cost of the program is expected to approximate the original estimate, although certain immaterial reclassifications have been made within the elements of the reserve. PART II. OTHER INFORMATION Item 1.",938
1996-11-18,8-K,0000080424-96-000045,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) November 18, 1996 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On November 4, 5, 6 and 7, The Procter & Gamble Company (the ""Company"") sold approximately 7,000 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $717,920 in reliance No underwriter or placement agent was used.",127
1996-12-03,8-K,0000080424-96-000050,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) December 3, 1996 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On November 18 and 25, 1996 The Procter & Gamble Company (the ""Company"") sold 9,558 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $1,050,640 in reliance on No underwriter or placement agent was used.",126
1996-12-16,8-K,0000080424-96-000052,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) December 16, 1996 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On December 3, 5 and 6, 1996 The Procter & Gamble Company (the ""Company"") sold 6,877 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $731,577 in reliance on Regulation No underwriter or placement agent was used.",128
1996-12-20,8-K,0000080424-96-000054,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) December 20, 1996 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On December 18, 1996 The Procter & Gamble Company (the ""Company"") sold 23,479 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $2,493,329 in reliance on No underwriter or placement agent was used.",124
1997-01-07,8-K,0000080424-97-000001,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) January 7, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On December 20 and 25, 1996 The Procter & Gamble Company (the ""Company"") sold 4,759 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $521,595 in reliance on No underwriter or placement agent was used.",126
1997-01-17,8-K,0000080424-97-000002,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) January 17, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On January 3 and 9, 1997 The Procter & Gamble Company (the ""Company"") sold 7,250 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $785,467 in reliance on Regulation S. No underwriter or placement agent was used.",128
1997-01-28,8-K,0000080424-97-000003,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) January 28, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On January 20 and 21, 1997 The Procter & Gamble Company (the ""Company"") sold 6,154 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $700,209 in reliance on Regulation S. No underwriter or placement agent was used.",128
1997-02-11,10-Q,0000080424-97-000006,"and Analysis Worldwide net earnings for the second quarter of fiscal year 1997 were $944 million, a 13% increase over the same quarter of the prior year. Earnings per share for the quarter were $1.35 per share, a 14% increase over the same quarter of last year. The difference between the net earnings and earnings per share increases was primarily due to the company's stock repurchase program. Net sales for the quarter were $9.14 billion, up 1% compared to prior year second quarter sales of $9.09 billion. Worldwide unit volume grew 2% from the second quarter a year ago. The difference between the sales and unit volume trends was largely due to weaker currencies in Europe and Asia, primarily For the first six months of the fiscal year, worldwide net earnings were $1.92 billion, an 11% increase over the prior year. Earnings per share were $2.74 per share, a 12% increase over the prior year. Worldwide unit volume for the first six months was up 2% over the prior year, while net sales were stable, primarily reflecting unfavorable exchange rates. The company's results were impacted by competitive pressures in Japan and difficult economic conditions in Latin America. In addition, the continued roll-out of the Efficient Consumer Response program (ECR) within Europe and Asia has impacted results. Specifically, as ECR is rolled out in new markets, trade inventories are reduced, which negatively impacts short-term growth rate trends. When implemented several years ago in the United States, this program resulted in negative short-term business effects, but yielded stronger consumer loyalty and improved profit margins longer term. Gross margin was 44.6% for the current quarter, compared to 42.1% in the second quarter of the prior year and 41.2% for the full fiscal year ended June 30, 1996. The key driver of the gross margin improvement has been lower commodity prices, primarily pulp which declined in the latter part of the prior year, and cost reduction programs throughout the company. Operating margin was 16.6% compared to 14.9% in the prior second quarter and 13.6% for the prior fiscal year, reflecting the higher gross margins, partially offset by increased costs related to marketing, research and administrative activities. Net sales for the North America region increased 3% compared with the same quarter a year ago, on a 5% unit volume increase. The net sales and unit volume progress was achieved despite capacity constraints in certain key categories, particularly tissue and towel. Net earnings for the region increased 15%, benefiting from lower commodity prices and cost reductions. The region's volume growth was led by the laundry and cleaning business, specifically, strong growth in the laundry and fabric softener categories. Food and beverage also posted strong volume growth on the strength of the snacks category, which is benefiting from increased capacity, and the coffee category. The paper business also increased total unit volume, despite continued capacity constraints in the tissue and towel categories, due to growth generated from feminine hygiene products. The paper business led the region's earnings growth, primarily due to lower pulp prices, which declined in the latter part of the prior year. Beauty Care increased volumes, led by strong growth in the hair care and deodorants categories. Excluding the impacts of the prior year divestiture of the Company's share of a joint venture, unit volume in the health care business increased modestly due to increased volume in oral care. Importantly, despite the modest unit volume growth, health care's earnings showed significant improvement due to increased licensing activity. For the first six months of the fiscal year, the North American region had net sales and unit volume growth of 2% and 3%, respectively. Net earnings increased 12% over the same period in the prior year. Europe, Middle East and Africa Net sales in Europe, Middle East and Africa for the second quarter were stable, as unfavorable exchange rates and lower pricing offset a 4% increase in volume. Net earnings for the quarter grew 24% compared to the same period a year ago, reflecting the margin improvement impact of lower costs, led by pulp. Central and Eastern Europe led the region's volume growth, increasing shipments by nearly 40%, with strong gains in most core segments. Middle East and Africa also had double-digit volume growth. Western Europe's unit volume declined For the July-December period, the region's net sales declined 1%. Unit volume and net earnings increased 4% and 17% respectively, for the same period. Second quarter operations in Asia continue to be impacted by the competitive environment in Japan, the impact of the ECR roll-out and exchange rate effects. Sales for the region declined 8% compared to the same quarter of the prior year on a unit volume decline of 7%. Importantly, China's unit volume growth improved over the first quarter. A 5% decline in the region's sales attributable to unfavorable exchange rates was offset by more favorable pricing. Net earnings in Asia for the second quarter increased 12% on improved margins. Net sales and unit volume for the July-December period declined 10% and 8%, respectively. Net earnings increased 2% over the same period in the prior year. Net sales in Latin America increased 3% in the second quarter, despite a 3% decline in volume, due to pricing designed to address inflation and devaluation, particularly in Mexico. The unit volume decline was caused by the continued economic difficulties and slow economic recovery in certain key markets. Net earnings for the region increased 35% on improved margins, reflecting both pricing and cost reductions from standardization and simplification efforts. For the July-December period, net sales and net earnings were up 1% and 24%, respectively. Unit volume was down 5% compared to the same period in the prior Restructuring Reserve Status In the year ended June 30, 1993, a reserve of $2.4 billion was established to cover a worldwide restructuring effort to consolidate manufacturing systems and reduce overhead costs. The primary elements of this reserve were costs related to fixed asset disposals and separations. The balance of the reserve at December 31, 1996 was approximately $490 million, with approximately half of the balance representing planned fixed asset disposals, all of which have been announced. The restructuring program is expected to be substantially completed during the current fiscal year. Based on current management estimates, the cost of the program is expected to approximate the original estimate. PART II. OTHER INFORMATION",1058
1997-02-21,8-K,0000080424-97-000012,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) February 21, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On February 3, 6 and 19, 1997 The Procter & Gamble Company (the ""Company"") sold 7,064 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $828,350 in reliance on No underwriter or placement agent was used.",127
1997-03-04,8-K,0000080424-97-000013,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) March 4, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On February 18, 1997 The Procter & Gamble Company (the ""Company"") sold 4,872 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $616,021 in reliance on Regulation S. No underwriter or placement agent was used.",126
1997-03-24,8-K,0000080424-97-000014,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) March 21, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On March 3 and 6, 1997 The Procter & Gamble Company (the ""Company"") sold 6,243 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $755,910 in reliance on Regulation S. No underwriter or placement agent was used.",128
1997-04-07,8-K,0000080424-97-000015,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) April 7, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On January 25, February 25, March 18 and March 25, 1997 The Procter & Gamble Company (the ""Company"") sold 16,444 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $2,036,899 in reliance on Regulation S. No underwriter or placement agent was used.",133
1997-04-09,8-K,0000895345-97-000112,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) April 8, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File (IRS Employer jurisdiction of Number) Identification incorporation) Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, (513) 983-1100 On April 8, 1997, The Procter & Gamble Company (the ""Company"") entered into an Agreement and Plan of Merger between the Company, C.R. MacIntosh, Inc. and Tambrands Inc.",103
1997-04-23,8-K,0000080424-97-000019,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) April 22, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On April 3 and 4, 1997 The Procter & Gamble Company (the ""Company"") sold 7,804 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $896,568 in reliance on Regulation S. No underwriter or placement agent was used.",128
1997-04-25,8-K,0000080424-97-000020,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) April 25, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On April 18, 1997 The Procter & Gamble Company (the ""Company"") sold 6,444 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $783,416 in reliance on Regulation S. No underwriter or placement agent was used.",126
1997-05-02,8-K,0000080424-97-000021,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) May 2, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On April 25, 1997 The Procter & Gamble Company (the ""Company"") sold 2,792 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $343,458 in reliance on Regulation S. No underwriter or placement agent was used.",126
1997-05-09,10-Q,0000080424-97-000023,"Worldwide net earnings for the third quarter of fiscal year 1997 were $881 million, a 16% increase over the same quarter of the prior year. Earnings per share for the quarter were $1.26, an 18% increase over the same quarter of the prior year. The difference between the net earnings and earnings per share increases was primarily due to the company's share repurchase program. Net sales for the quarter were $8.77 billion, up 2% compared to the prior year third quarter sales of $8.59 billion. Worldwide unit volume grew 4% from the third quarter a year ago. Weaker currencies in Europe, Asia and Latin America negatively impacted sales, causing the difference between sales and volume In the first nine months of the fiscal year, worldwide net earnings were $2.80 billion, a 13% increase compared to the same prior year period. Year-to-date earnings per share were $4.00 per share, a 14% increase over the prior year. Worldwide unit volume for the first nine months was up 2% over the prior year, while sales were relatively stable at $26.8 billion, primarily reflecting unfavorable exchange rates. Gross margin was 43.9% for the current quarter, compared to 41.5% in the third quarter of the prior year and 41.2% for the full fiscal year ended June 30,1996. The key driver of the margin improvement has been cost reduction programs throughout the company and lower commodity prices, primarily pulp. Operating margin was 15.8% for the current quarter, an improvement over the 13.9% operating margin in the prior year third quarter and 13.6% for the prior fiscal year. This improvement was a reflection of higher gross margins, partially offset by increased costs related to marketing, research and administrative Net sales for the North America region remained relatively stable compared with the third quarter a year ago, on a 2% unit volume increase. The difference between sales and volume growth rates is primarily a reflection of lower pricing in the laundry category and commodity-based price reductions in the paper categories. Third quarter net earnings for the region increased 6% (compared to the same prior year period), as the region continued to benefit from simplification and standardization cost savings. The region's unit volume growth was led by the laundry, fabric conditioners and snacks categories. Importantly, laundry achieved volume growth over a very strong year ago base period and snacks continued to achieve double digit unit volume growth, benefitting from new production capacity. The paper business also increased unit volume led by strong growth in the feminine protection category and the Scott Baby Fresh acquisition in the diaper/wipes category. Beauty care volume declined in the current quarter due to softness in the hair care category, primarily reflecting trade inventory adjustments. Excluding the impacts of the prior year period divestiture of the Company's share of a joint venture, unit volume in the health care business improved over prior year period due to increased respiratory care volume. Health care's earnings also showed strong improvement due to increased licensing activity. For the first nine months of the fiscal year, the North American region had net sales and unit volume growth of 1% and 3%, respectively. Year to date net earnings increased 10% over the prior year. Europe, Middle East and Africa Third quarter net sales in Europe, Middle East and Africa increased by 3% compared to the prior year quarter, as unit volume growth of 9% was partially offset by unfavorable exchange rates. Net earnings for the quarter grew 20% compared to the same period a year ago, reflecting volume gains and cost savings as the region begins to benefit from Efficient Consumer Response (ECR). Central and Eastern Europe led the region's volume growth, increasing shipments by over 45%. The Middle East and Africa also had double digit increases. Market share for these two geographies continues to build across most core categories. Importantly, Western Europe, led by Germany, showed volume improvement over the comparable prior year period in which the Company began its transition to ECR. For the July-March period, the region's net sales remained stable on unit volume growth of 6%, reflecting unfavorable exchange rates and lower pricing. Year to date net earnings increased 18% over prior year. Asia continued to be impacted by the transition to ECR and competitive pressures in Japan. Third quarter sales for the region increased 1% over the same prior year period, as improved pricing and product mix offset continued softness in Japan and the impact of unfavorable exchange rates. Unit volume growth declined by 1% during the quarter, with the negative impacts of Japan largely offset by the acceleration of unit volume growth rates in the Philippines and the continued growth in China. Net earnings for the quarter grew by 37%, driven primarily by pricing actions and improved product mix. Net sales and unit volume for the July-March period declined 7% and 6%, respectively. Year-to-date net earnings for the period were up 12%. Net sales for the third quarter in Latin America grew 12% compared to the prior year quarter, on unit volume growth of 1%, as pricing designed to address inflation and devaluation was partially offset by unfavorable exchange rates. The region continues to be impacted by economic difficulties in certain key markets, as acquisitions in the laundry category were largely responsible for the unit volume increase. Net earnings for the quarter increased 53% on improved margins, primarily reflecting pricing, as well as the impact of divestitures of certain non-strategic brands. For the July-March period, net sales and net earnings were up 5% and 33%, respectively. The region's year-to-date unit volume was down 3% for the first Restructuring Reserve Status In the year ended June 30, 1993, a reserve of $2.4 billion was established to cover a worldwide restructuring effort to consolidate manufacturing systems and reduce overhead costs. The primary elements of this reserve were costs related to fixed asset disposals and separations. The balance of the reserve at March 31, 1997 was approximately $380 million, with approximately half of the balance representing planned fixed asset disposals, all of which have been announced. The restructuring program is expected to be substantially completed during the current fiscal year. Based on current management estimates, the cost of the program is expected to approximate the original estimate. In April 1997, the Company entered into an agreement to acquire Tambrands, Inc., a company in the feminine hygiene category, for approximately $2 billion. The acquisition is subject to approval by the shareholders of Tambrands, Inc., and regulatory clearance. It is expected to close in fiscal 1998. Pending Accounting Pronouncements In February 1997, the Financial Accounting Standards Board issued Statement No. 128, ""Earnings Per Share"", which revises the manner in which earnings per share is calculated. The statement is effective for our reporting period ending December 31, 1997 and is not expected to have a significant impact on the Company's earnings per share. PART II. OTHER INFORMATION",1146
1997-05-15,8-K,0000080424-97-000027,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) May 15, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On May 6, 1997 and May 12, 1997 The Procter & Gamble Company (the ""Company"") sold 5,641 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $741,096 in reliance on No underwriter or placement agent was used.",128
1997-05-29,8-K,0000080424-97-000030,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) May 29, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On May 20, 1997, May 21, 1997 and May 23, 1997 The Procter & Gamble Company (the ""Company"") sold 10,168 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $1,357,727 in reliance on Regulation S. No underwriter or placement agent was used.",133
1997-06-16,8-K,0000080424-97-000031,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 16, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On June 3, 1997 and June 6, 1997 The Procter & Gamble Company (the ""Company"") sold 4,897 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $663,080 in reliance on Regulation No underwriter or placement agent was used.",129
1997-06-18,8-K,0000080424-97-000032,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 18, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On June 6, 1997 The Procter & Gamble Company (the ""Company"") sold 8,410 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $1,181,941 in reliance on Regulation S. No underwriter or placement agent was used.",126
1997-06-27,8-K,0000080424-97-000047,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 27, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On June 18, 1997 The Procter & Gamble Company (the ""Company"") sold 5,018 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $700,312 in reliance on Regulation S. No underwriter or placement agent was used.",126
1997-07-08,8-K,0000080424-97-000050,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) July 8, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS (99) Press Release Issued by Registrant on July 8, 1997",92
1997-07-11,8-K,0000080424-97-000053,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) July 11, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On June 25, 1997 The Procter & Gamble Company (the ""Company"") sold 3,564 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $490,831 in reliance on Regulation S. No underwriter or placement agent was used.",126
1997-07-22,8-K,0000080424-97-000054,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) July 22, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On July 3, 1997 and July 17, 1997 The Procter & Gamble Company (the ""Company"") sold 4,367 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $631,739 in reliance on Regulation No underwriter or placement agent was used.",129
1997-08-27,8-K,0000080424-97-000057,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) August 27, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On July 25, 1997 and August 18, 1997 The Procter & Gamble Company (the ""Company"") sold 13,079 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $1,838,820 in reliance on No underwriter or placement agent was used.",128
1997-09-02,8-K,0000080424-97-000060,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 2, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On August 25, 1997 The Procter & Gamble Company (the ""Company"") sold 2,859 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $403,190 in reliance on Regulation S. No underwriter or placement agent was used.",126
1997-09-10,10-K,0000080424-97-000062,"THE PROCTER & GAMBLE COMPANY ANNUAL REPORT ON FORM 10-K SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION ANNUAL REPORT ON FORM 10-K PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 1997 Commission File No. 1-434 THE PROCTER & GAMBLE COMPANY One Procter & Gamble Plaza, Cincinnati, Ohio 45202 IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each Exchange on which registered Common Stock, without Par Value New York, Cincinnati, Amsterdam, Paris, Basle, Geneva, Lausanne, Zurich, Frankfurt, Antwerp, Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes X No . Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this There were 1,350,318,252 shares of Common Stock outstanding as of August 8, 1997 (restated for two-for-one stock split effective August 22, 1997). The aggregate market value of the voting stock held by non-affiliates amounted to $104 billion Documents Incorporated By Reference Portions of the Annual Report to Shareholders for the fiscal year ended June 30, 1997 are incorporated by reference into Part I and Part II of this report. Portions of the Proxy Statement for the 1997 Annual Meeting of Shareholders are incorporated by reference into Part III of this report. General Development of Business The Procter & Gamble Company was incorporated in Ohio in 1905, having been built from a business founded in 1837 by William Procter and James Gamble. Today, the Company manufactures and markets a broad range of consumer products in many countries throughout the world. Unless the context indicates otherwise, the term the ""Company"" as used herein refers to The Procter & Gamble Company (the registrant) and its Additional information required by this item is",394
1997-09-11,8-K,0000080424-97-000063,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 11, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On August 4, August 19, September 3 and September 4, 1997 The Procter & Gamble Company (the ""Company"") sold 10,552 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $1,503,051 in reliance on Regulation S. No underwriter or placement agent was used.",133
1997-09-29,8-K,0000080424-97-000065,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 29, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On September 18 and September 25, 1997 The Procter & Gamble Company (the ""Company"") sold 13,906 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $1,555,058 in reliance on No underwriter or placement agent was used.",127
1997-10-15,8-K,0000080424-97-000068,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) October 15, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS (4) Amended Articles of Incorporation Adopted by Registrant on",91
1997-10-27,8-K,0000080424-97-000070,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) October 27, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On October 2 and October 7, 1997 The Procter & Gamble Company (the ""Company"") sold 72,642 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $5,162,020 in reliance on No underwriter or placement agent was used.",127
1997-10-30,8-K,0000080424-97-000071,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) October 30, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On October 24, 1997 The Procter & Gamble Company (the ""Company"") sold 5,699 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $415,058 in reliance on Regulation S. No underwriter or placement agent was used.",126
1997-11-05,8-K,0000080424-97-000072,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) November 5, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On October 20, 1997 The Procter & Gamble Company (the ""Company"") sold 14,615 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $1,029,232 in reliance on Regulation S. No underwriter or placement agent was used.",126
1997-11-10,8-K,0000080424-97-000073,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) November 10, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On November 4 and November 5, 1997 The Procter & Gamble Company (the ""Company"") sold 11,301 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $802,297 in reliance on Regulation No underwriter or placement agent was used.",128
1997-11-14,10-Q,0000080424-97-000075,"and Analysis RESULTS OF OPERATIONS -- FIRST QUARTER FISCAL 1997 COMPARED WITH FIRST QUARTER Net earnings for the July-September quarter were $ .79 per share, a 13 percent increase over the same quarter of the prior year. Worldwide net earnings for the quarter were $1,085 million, an 11 percent increase. The differential between the earnings per share and net earnings increases was primarily due to the company's stock repurchase program. Worldwide net sales for the quarter were $9.4 billion, a five percent increase over the same quarter of the prior year, on eight percent unit volume growth. The difference between the sales and volume growth rates was largely due to weaker currencies in Western Europe and Asia. Net acquisitions and divestitures, led by the July 1997 addition of Tambrands, contributed one percent to the unit The Company's ongoing program of simplification and standardization did not have a significant impact on earnings in the current quarter. This program includes re-engineering of the manufacturing and distribution processes, organization design projects, consolidation of selected manufacturing facilities, simplified product line-ups and sales of non-strategic brands. Gross margin was 44.3 percent for the quarter compared to 43.3 percent in the same quarter of the prior year and 42.7 percent for the full fiscal year ended June 30, 1997. The key driver of the margin improvement has been a continuation of the effective focus on cost control through simplification and standardization efforts throughout the company. Operating margin was 18.6 percent for the quarter compared to 17.4 percent in the same quarter year ago and 15.3 percent for the prior fiscal year. This improvement was a reflection of the higher volumes and gross margins, partially offset by higher costs related to marketing, research, and administrative activities. Net sales for the North America region were up six percent, on equal volume growth. Net earnings grew five percent as the impact of volume growth was partially offset by increased spending on new product initiatives and provisions for simplification and standardization projects. The region's six percent unit volume growth was broad based with contributions from all segments and was led by the laundry, tissue and towel, and snacks categories. The tissue and towel and snacks growth was achieved behind increases in productive capacity. The laundry category continued strong shipments behind product initiatives. Feminine protection also achieved significant growth driven primarily by the acquired Tambrands business. Unit volume growth within the Beauty Care segment was achieved behind new product initiatives in hair care and deodorants. Health Care achieved unit volume increase in both over the counter medicines and pharmaceuticals, while continuing to invest in new brand EUROPE, MIDDLE EAST, AND AFRICA Net sales in Europe, Middle East, and Africa were flat on a 10 percent unit volume increase, as the favorable impact of volume growth was offset by unfavorable exchange rates, primarily in Germany, France and Italy. The region's net earnings grew six percent as the favorable impacts of volume and higher gross margins were partially offset by higher new brand initiative spending and unfavorable exchange rates. The region's unit volume growth was led by continued double digit growth in Central and Eastern Europe and the Middle East and Africa. Western Europe also achieved solid unit volume growth led by continued growth in laundry and the Net sales in Asia grew four percent for the quarter on unit volume growth of eight percent, as pricing actions in China and other southeast Asia countries were offset by weaker currencies throughout the region. The region's net earnings increased 35 percent as the favorable impacts of volume growth and pricing were partially offset by increased spending on product initiatives and unfavorable exchange rates. Asia unit volume growth was led by double digit growth in China, the Philippines and Indonesia. Importantly, Japan's volume increased behind new brand initiatives, despite the continuing weakness in consumer demand in the overall market. Net sales in Latin America were up 15 percent driven by improved pricing in key countries. Net earnings increased 112 percent, which included the gain on the sale of a non-strategic brand. Unit volume for the region was up four percent, driven by double digit gains in Brazil, which benefited from an acquisition in the laundry category, and Venezuela. Mexico's unit volume was down, primarily due to the divestiture of the non-strategic brand. PART II. OTHER INFORMATION Item 2. Changes in Securities and Use of Proceeds: (a) On October 15, 1997, the Company amended its Amended Articles of Incorporation (see 8-K filed October 15, 1997) to increase the number of authorized shares of Common Stock from 2,000,000,000 to 5,000,000,000. (b) On October 15, 1997, the Company amended its Amended Articles of Incorporation to change the dividend rate for its Series A ESOP Convertible Class A Preferred Stock (the ""Series A Preferred Stock""), so that such dividend rate would equal the higher of the existing dividend rate on the Series A Preferred Stock or the then current dividend on the Company's Common Stock. This change will result in the conversion of Series A Preferred Stock gradually into shares of Common Stock, rather than being converted all at once at such time as the dividend rate on the Common Stock exceeds the dividend rate on the Series A Preferred Stock. A corresponding change was made to the dividend rate on the Series B ESOP Convertible Class A Preferred Stock.",891
1997-12-02,8-K,0000080424-97-000076,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) December 2, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATIONS On November 18, 1997 The Procter & Gamble Company (the ""Company"") sold 23,160 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $1,714,929 in reliance on Regulation S. No underwriter or placement agent was used.",126
1997-12-03,8-K,0000080424-97-000078,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) December 3, 1997 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATION S On November 25, 1997 The Procter & Gamble Company (the ""Company"") sold 6,423 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $496,626 in reliance on Regulation S. No underwriter or placement agent was used.",127
1998-01-05,8-K,0000080424-98-000001,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) January 5, 1998 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATION S On December 18, 1997 The Procter & Gamble Company (the ""Company"") sold 9,256 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $755,142 in reliance on Regulation S. No underwriter or placement agent was used.",127
1998-01-06,8-K,0000080424-98-000002,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) January 6, 1998 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATION S On December 25, 1997 The Procter & Gamble Company (the ""Company"") sold 20,814 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $1,655,650 in reliance on Regulation S. No underwriter or placement agent was used.",127
1998-01-08,8-K,0000080424-98-000003,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) January 8, 1998 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATION S On December 8, 1997 The Procter & Gamble Company (the ""Company"") sold 7,574 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $609,293 in reliance on Regulation S. No underwriter or placement agent was used.",127
1998-01-23,8-K,0000080424-98-000004,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) January 23, 1998 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATION S On January 23, 1998 The Procter & Gamble Company (the ""Company"") sold 5,121 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $419,359 in reliance on Regulation S. No underwriter or placement agent was used.",127
1998-01-30,8-K,0000080424-98-000005,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) January 30, 1998 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATION S On January 20, 1998 The Procter & Gamble Company (the ""Company"") sold 2,572 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $206,794 in reliance on Regulation S. No underwriter or placement agent was used.",127
1998-02-13,10-Q,0000080424-98-000008,"and Analysis Basic net earnings for the October-December quarter of fiscal year 1998 were $.76 per share, a 13 percent increase over the same quarter of the prior year. Worldwide net earnings for the quarter were $1,046 million, an 11 percent increase. The differential between the earnings per share and net earnings increases was primarily due to the company's stock repurchase program. Worldwide net sales for the quarter were $9.6 billion, a five percent increase over the same quarter of the prior year, on eight percent unit volume growth. Acquisitions, primarily Tambrands, net of divestitures, contributed two percent to the unit volume growth rate. The difference between the sales and volume growth rates was largely due to weaker currencies in Asia and western Europe. Basic earnings per share for the first six months of the fiscal year were $1.55, a 13 percent increase over the prior year. Worldwide net earnings were $2,133 million, an 11 percent increase over the prior year. Worldwide net sales for the first six months were $19.0 billion, up five percent over the prior year, on eight percent unit volume growth. Unfavorable exchange rates caused the difference between sales and volume growth rates. Gross margin was 44.8 percent for the current quarter compared to 44.3 percent in the same quarter of the prior year and 42.7 percent for the full fiscal year ended June 30, 1997. The key driver of the margin improvement has been a continuation of the effective focus on cost control through simplification and standardization efforts throughout the company. Operating margin was 17.5 percent for the current quarter compared to 16.6 percent in the same quarter year ago and 15.3 percent for the prior fiscal year. This improvement was a reflection of the higher gross margins and lower administrative and other costs relative to sales, partially offset by higher marketing and research costs. Second quarter net sales for the North America region were up seven percent versus the same quarter of the prior year, on six percent volume growth. Net earnings grew 15 percent behind volume growth and continued savings from simplification and standardization projects partially reduced by increased investment in product initiatives. The region's six percent unit volume growth was led by the Paper, Food and Beverage, and Laundry and Cleaning segments. The growth was driven primarily by feminine protection, which benefited from the Tambrands acquisition, and by tissue and towel and snacks, which benefited from increases in production capacity. The laundry category continued strong shipments behind product initiatives. Unit volume growth within the Beauty Care segment was achieved behind new product initiatives in hair care and deodorants. Health Care unit volume was down due to competitive pressure in oral care. For the first six months of the fiscal year, net sales for the North America region were up six percent on equal unit volume growth. Net earnings increased nine percent over the same period in the prior year, and included the impact of provisions for simplification and standardization projects in the first quarter. EUROPE, MIDDLE EAST, AND AFRICA Second quarter net sales in Europe, Middle East, and Africa were up four percent on a 12 percent unit volume increase, as the favorable impact of volume growth was partially offset by unfavorable exchange rates across Europe. The region's net earnings grew 17 percent as the favorable impacts of volume and higher gross margins were partially offset by higher new brand initiative spending and unfavorable exchange rates. The region's unit volume growth was led by continued double digit growth in Central and Eastern Europe and the Middle East and Africa. Western Europe also achieved solid unit volume growth led by continued strength in laundry and the For the first six months of the fiscal year, the region's net sales and unit volume grew two percent and 11 percent respectively. Net earnings increased 11 percent over the same period in the prior year. Asia unit volume for the second quarter was flat due to market contraction caused by economic troubles which have impacted most Asian countries. Net sales were down five percent versus the same quarter year ago, with the impact of weaker currencies across the region partially offset by price increases. The region's net earnings were down four percent due to unfavorable exchange rates and higher investment in product initiatives. On a year to date basis, sales were down one percent while unit volume increased four percent. Net earnings increased 12 percent reflecting the favorable impact of volume growth and pricing partially offset by product initiative spending and unfavorable exchange rates. Earnings in Asia over the balance of the current fiscal year are expected to be well below year ago as the full effect of the economic crisis in that region is felt. However, this is not expected to be significant to the Company's overall earnings growth rate for the current fiscal year. While the region is expected to recover from these difficulties, the depth and duration of the economic effects are still uncertain. Net sales in Latin America were up 18 percent for the quarter on 15 percent volume growth. Net earnings increased 10 percent, with the favorable impact of volume growth partially offset by increased marketing support to counter competitive pressure in Brazil. Unit volume growth for the region was broad based with almost all countries recording increases. Mexico led this growth behind the acquisition of a paper business and volume growth in the base business. Brazil benefited from prior year acquisitions in the laundry category. On a year to date basis, sales increased 17 percent with unit volume up 10 percent. Net earnings increased 53 percent, benefiting from the first quarter sale of a non-strategic brand. ADOPTION OF NEW ACCOUNTING STANDARD Effective with the quarter ended December 31, 1997 the Company adopted FAS 128 Earnings Per Share. The impact is not material. PART II. OTHER INFORMATION",976
1998-03-05,8-K,0000080424-98-000009,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) March 5, 1998 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATION S On February 25, 1998 The Procter & Gamble Company (the ""Company"") sold 5,857 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $498,073 in reliance on Regulation S. No underwriter or placement agent was used.",127
1998-03-16,8-K,0000080424-98-000010,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) March 16, 1998 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATION S On February 18, 1998 The Procter & Gamble Company (the ""Company"") sold 3,761 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $314,747 in reliance on Regulation S. No underwriter or placement agent was used.",127
1998-03-27,8-K,0000080424-98-000011,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) March 27, 1998 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATION S On March 25, 1998 The Procter & Gamble Company (the ""Company"") sold 6,796 shares of the Company's common stock to employees of subsidiaries of the Company for approximately $606,815 in reliance on Regulation S. No underwriter or placement agent was used.",127
1998-05-14,10-Q,0000080424-98-000024,"and Analysis Basic net earnings for the January-March quarter of fiscal year 1998 were $.69 per share, a 10 percent increase over the same quarter of the prior year. Worldwide net earnings for the quarter were $961 million, a nine percent increase. The difference between the earnings per share and the net earnings increases was primarily due to the Company's share repurchase program. Worldwide net sales for the quarter were $8.9 billion, a one percent increase over the same quarter of the prior year. Excluding the effect of weaker currencies, primarily in Asia and Western Europe, sales increased by six percent. Unit volume increased three percent, with the difference in sales and volume growth caused primarily by price increases in all regions. For the first nine months of the fiscal year, basic net earnings per share were $2.24, a 12 percent increase versus a year ago. Worldwide net earnings were $3.093 billion, a 10 percent increase over the prior year. Worldwide sales for the nine month period grew four percent to $27.9 billion on six percent unit volume growth. Operating margin was 17.1 percent for the quarter compared to 15.8 percent in the same quarter a year ago and 15.3 percent for the prior fiscal year. The improvement in operating margin reflected the reduction of manufacturing expenses, partially offset by higher selling, research and administrative expenses. The Company's ongoing program of simplification and standardization did not have a significant impact on operating margin, since gains on sales of non-strategic brands were reinvested in other projects. Gross margin was 41.1 percent for the current quarter compared to 43.2 percent in the same quarter of the prior year and 42.7 percent for the full fiscal year ended June 30, 1997. Gross margin was negatively impacted this quarter by provisions for shutdown costs of a laundry site, a pulp mill, and other simplification and standardization projects, partially offset by lower Net sales in North America were up two percent versus the same quarter in the prior year on one percent unit volume growth. Net sales growth outpaced volume due to pricing. The region achieved a 10 percent net earnings increase due to pricing and lower costs. A $200 million after tax gain on the sale of the Duncan Hines business was reinvested in simplification and standardization projects, including the closing of a laundry plant, a pulp mill, and other The region's unit volume softness was caused by a number of factors, most notably pricing, as competition has lagged behind the Company in the implementation of price increases in tissue and towel and laundry. In addition, the growth rate in snacks was reduced due to competitive pressure. Volume softness in these categories and the impact of the sale of the Duncan Hines business were partially offset by volume strength in beauty care, led by hair care and deodorants, feminine protection, which benefited from the Tambrands acquisition, and pharmaceuticals. For the first nine months of the fiscal year, net sales for the North America region were up five percent on four percent unit volume growth. Net earnings EUROPE, MIDDLE EAST, AND AFRICA Third quarter net sales in Europe, Middle East, and Africa increased one percent on a five percent unit volume increase. Excluding the effects of unfavorable exchange rates, net sales increased eight percent. The region's sales were positively impacted by increased pricing, primarily in laundry, paper, and beverage. Net earnings grew 36 percent behind volume gains, higher gross margins, and the sale of minor brands. Unit volume growth in the region was led by continued double digit growth in Central and Eastern Europe and the Middle East and Africa. Western Europe's volume was flat behind the short-term softness related to pricing and competitive activity in the laundry category, which offset favorable impacts of the Tambrands acquisition. For the first nine months of the fiscal year, sales increased two percent on nine percent unit volume growth. Net earnings increased 18 percent, reflecting the favorable impact of volume growth and pricing, offset by higher initiative spending and unfavorable exchange rates. Third quarter net sales in Asia fell seven percent versus the same quarter of the prior year, on three percent volume growth. Excluding the effects of unfavorable exchange rates, sales increased by 11 percent, primarily due to higher volume and price increases designed to recover currency devaluation. Net earnings were down 81 percent due to unfavorable exchange rates and higher investment in product initiatives. Asia third quarter unit volume gains from the acquisition of the Ssangyong Paper Company in Korea and increased ownership of China ventures were partially offset by lower consumption, reflecting the economic difficulties in the region, and in particular the worsening climate in Japan. The business climate in Asia is expected to remain difficult for at least the remainder of On a year to date basis, sales were down three percent while unit volume increased four percent. Net earnings decreased 20 percent. Third quarter net sales in Latin America were up 11 percent on unit volume growth of 14 percent, as the positive impact of higher pricing was offset by unfavorable exchange rates. Net earnings decreased two percent. The prior year's earnings benefited from the divestiture of certain non-strategic brands. Excluding that effect, the region's net earnings would have increased approximately in line with sales growth. Earnings for the current period were also depressed by increased marketing support to counter competitive pressure The volume growth was led by Mexico, which benefited from the acquisition of the Loreto y Pena paper business and growth in its base business, and On a year to date basis, sales were up 15 percent on 11 percent unit volume growth. Net earnings increased 32 percent, benefiting from the first quarter sale of a non-strategic brand. Effective with the quarter ended March 31, 1998, Brazil and Peru no longer report results on a hyper-inflationary basis. This change had no material effect on the quarter's results, or the results for the nine month period. During the nine months ended March 31, 1998, the Company acquired Tambrands, Inc., the Loreto y Pena paper business in Mexico, and Ssangyong Paper Company in Korea, and increased its interest in ventures in China, Argentina, and Chile. Long-term debt and debt due within one year increased from June 30, 1997, to March 31, 1998, to finance the bulk of these acquisitions. PART II. OTHER INFORMATION",1060
1998-09-09,10-K,0000080424-98-000039,"THE PROCTER & GAMBLE COMPANY ANNUAL REPORT ON FORM 10-K SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION ANNUAL REPORT ON FORM 10-K PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 1998 Commission File No. 1-434 COMPANY One Procter & Gamble Plaza, IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio Securities registered pursuant to Section Title of each class Name of each Exchange on which registered Common Stock, without Par Value New York, Cincinnati, Amsterdam, Paris, Basle, Geneva, Lausanne, Zurich, Frankfurt, Brussels, Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes X No . Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this There were 1,337,755,222 shares of Common Stock outstanding as of July 31, 1998. The aggregate market value of the voting stock held by non-affiliates amounted to $106 billion on July 31, 1998. Documents Incorporated By Reference Portions of the Annual Report to Shareholders for the fiscal year ended June 30, 1998 are incorporated by reference into Part I, Part II and Part IV of this Portions of the Proxy Statement for the 1998 Annual Meeting of Shareholders are incorporated by reference into Part III of this report. General Development of Business The Procter & Gamble Company was incorporated in Ohio in 1905, having been built from a business founded in 1837 by William Procter and James Gamble. Today, the Company manufactures and markets a broad range of consumer products in many countries throughout the world. Unless the context indicates otherwise, the term the ""Company"" as used herein refers to The Procter & Gamble Company (the registrant) and its Additional information required by this item is",379
1998-11-05,10-Q,0000080424-98-000043,"and Analysis Basic net earnings for the July-September quarter of fiscal year 1999 were $ .86 per share, a nine percent increase over the same quarter of the prior year. Worldwide net earnings for the quarter were $1.17 billion, a seven percent increase. The difference between the earnings per share and the net earnings increases was primarily due to the Company's share repurchase program. Worldwide net sales for the quarter were $9.5 billion, a two percent increase over the same quarter of the prior year. Weaker currencies, primarily in Asia and Latin America, reduced sales by three percent. Unit volume was flat, with the difference in sales and volume growth caused primarily by price increases and favorable product mix. Gross margin was 45.5 percent for the current quarter compared to 44.3 percent in the same quarter of the prior year and 43.3 percent for the full fiscal year ended June 30, 1998. Gross margin was positively impacted this quarter by improved pricing, product mix, and lower manufacturing expenses. Operating margin was 19.7 percent for the quarter compared to 18.6 percent in the same quarter a year ago and 16.3 percent for the prior fiscal year, largely reflecting the improvement in gross margin. Net sales in North America were up one percent versus the same quarter in the prior year on a one percent unit volume decline. Sales growth was driven by improved pricing in laundry and cleaning and paper products. The region achieved an 11 percent net earnings increase due primarily to improved pricing in laundry and paper products. The decline in volume was due to the prior year divestiture of Duncan Hines and increased competition in the hair care and oral care markets. Importantly, the laundry & cleaning business benefited from strength in fabric care behind the launch of Febreze, and the paper business achieved gains behind growth in diapers. In addition, excluding the impact of the divestiture of Duncan Hines, food & beverage unit volume grew behind a broad recovery in coffee driven by EUROPE, MIDDLE EAST, AND AFRICA Net sales for Europe, Middle East, and Africa increased four percent on a two percent decline in unit volume. Sales outpaced volume behind increased pricing, primarily in laundry and paper products. The region's net earnings grew eight percent, primarily behind pricing-driven improvements in gross margins and cost The region's unit volume was negatively impacted by Central and Eastern Europe, as a result of the economic crisis in Russia. Volumes were also soft in laundry & cleaning, due to increased competitive initiatives. Food & beverage achieved strong volume gains behind the strength of Pringles in Western Europe and the launch of Sunny Delight in the United Kingdom. The paper products business was up slightly behind continued growth in Bounty and Baby Wipes. Net sales in Asia fell seven percent versus the same quarter of the prior year, on two percent unit volume growth, due to the effects of unfavorable exchange rates. Net earnings increased 11 percent versus the same quarter last year, as improved pricing, cost reduction and the favorable settlement of a patent litigation dispute offset the continuing impact of economic difficulties in the The region grew volume behind the prior year acquisition of the Ssangyong Paper Company in Korea and improvement in the base business in Japan, which advanced despite the country's economic difficulties, and increased market share behind product initiatives, primarily in beauty care and laundry and cleaning. Volume continues to be ngatively impacted by the recession and lower consumption in Latin America net sales were up 13 percent, on 15 percent unit volume growth, as increased pricing largely offset the effects of unfavorable exchange rates. Earnings for the region were up 21 percent, reflecting effective balance sheet management in the face of the peso devaluation in Mexico Unit volume growth for the quarter was led by Mexico, which benefited from the prior year acquisition of the Loreto y Pena paper business and growth in its base business. Importantly, the region's laundry and cleaning business strengthened behind accelerated product innovation. Total debt increased $1.6 billion since June 30, 1998. The incremental debt was used to finance working capital, ongoing operations and the previously announced accelerated share repurchase program. In September, 1998, the Company announced plans for Organization 2005, a realignment of the organizational structure, work processes, and culture to accelerate growth and innovation. Details regarding the nature, timing, and implications related to the design change are currently being determined. Financial impacts are not yet known. PART II. OTHER INFORMATION",752
1999-02-05,10-Q,0000080424-99-000002,"and Analysis Basic net earnings for the three months ended December 31, 1998 were $ .84 per share, an 11 percent increase over the same quarter of the prior year. Worldwide net earnings for the quarter were $1.14 billion, a nine percent increase. The difference between the earnings per share and the net earnings increases was primarily due to the Company's share repurchase program. Worldwide net sales for the quarter were $9.9 billion, a three percent increase over the same quarter of the prior year. Weaker currencies, primarily in Asia and Latin America, reduced sales by one percent. Unit volume was flat, with the difference in sales and volume growth caused by favorable pricing and mix Basic net earnings for the six months ended December 31, 1998 were $1.70 per share, a 10 percent increase versus a year ago. Net earnings for the same period were $2.31 billion, an eight percent increase over the prior year. Worldwide sales for the six-month period grew two percent to $19.4 billion, ahead of flat unit volume, due largely to favorable pricing impacts. Unfavorable exchange rates reduced sales by two percent year-to-date. Gross margin was 45.9 percent for the quarter ended December 31, 1998 compared to 44.8 percent in the same quarter of the prior year and 43.3 percent for the full fiscal year ended June 30, 1998. Gross margin was positively impacted this quarter by improved pricing, product mix, and lower manufacturing expenses. Operating margin was 18.5 percent for the quarter compared to 17.5 percent in the same quarter a year ago and 16.3 percent for the prior fiscal year. The improvement in operating margin reflected pricing-driven improvements in gross margin, which were partially offset by higher marketing, research and administrative expenditures behind product innovations, and the negative impact of unfavorable exchange rates. Net sales in North America for the quarter ended December 31, 1998 were up two percent versus the same quarter in the prior year on a one percent unit volume increase. Sales growth was primarily driven by improved pricing in Laundry and Cleaning, Beauty Care, and Paper. The region achieved a 12 percent net earnings increase due primarily to pricing and cost improvements. The pace of the business in North America is improving, with volume up three percent excluding the sale of Duncan Hines. The Region's overall unit volume improvement was driven by Laundry and Cleaning, which enjoyed continued success from improved market shares across all laundry brands and from the launch of Febreze in the fabric care category, and Paper, behind additional tissue capacity. In addition, strong coffee results partially offset unit volume losses resulting from the prior year divestiture of Duncan Hines in the Food and For the six months ended December 31, 1998, net sales were up two percent on flat unit volume. Net earnings increased 12 percent. EUROPE, MIDDLE EAST, AND AFRICA Net sales for Europe, Middle East, and Africa for the three months ended December 31, 1998 increased three percent over the same quarter in the prior year on a four percent decline in unit volume. Sales outpaced volume behind improved pricing, primarily in laundry and paper products, and favorable exchange effects in Western Europe. The Region's results were negatively impacted by the economic crisis and currency devaluation in Russia. Despite the impact of Russia and Central and Eastern Europe, the Region's net earnings grew 12 percent, primarily behind improved pricing. Volume softness was largely attributable to the economic crisis in Russia and continued competitive pressures in laundry & cleaning, primarily related to laundry tablet initiatives in Western Europe. However, a number of new brand expansions in the Region are beginning to produce positive results. Food & beverage achieved considerable volume gains behind the strength of Pringles, as well as the successful launch of Sunny Delight in the United Kingdom. In paper, Bounty continues to exceed objectives in Germany and has now assumed market For the six months ended December 31, 1998, sales were up three percent while unit volume declined three percent. Net earnings increased 10 percent. Net sales in Asia for the three months ended December 31, 1998 increased five percent versus the same quarter of the prior year, on five percent unit volume growth, as positive pricing offset the effects of unfavorable exchange rates. Net earnings increased two percent versus the same quarter last year, as sales increases were partially offset by increased investment in new initiatives and economic conditions in the ASEAN region. The region grew volume behind the strengthening of the business in Japan and China and the prior year acquisition of the Ssangyong Paper Company in Korea. Importantly, Japan was able to build market share in a difficult economy through laundry and cleaning initiatives and Pringles. China's unit volume grew behind the national expansion of Vidal Sassoon, improved Whisper Ultra, and advance buying in anticipation of a consumption tax increase. Volume in the remainder of Asia continues to be negatively impacted by the recession and market For the six months ended December 31, 1998, sales decreased one percent and unit volume increased four percent. Sales did not keep pace with unit volume growth due to the effects of unfavorable exchange rates. Net earnings increased seven Latin America net sales for the three months ended December 31, 1998 were up seven percent versus the same quarter of the prior year, on five percent unit volume growth, as improved pricing more than offset the effects of unfavorable exchange rates. Earnings for the Region were up nine percent, as the improvement in sales and pricing exceeded the investment in product upgrades and new Unit volume growth for the quarter was led by the strengthening of the business in Mexico and the prior year buy-out of a paper joint venture in Chile and For the six months ended December 31, 1998, sales increased 10 percent on a nine percent increase in unit volume. Net earnings increased 14 percent. Total debt increased $1.3 billion since June 30, 1998. The incremental debt was used primarily to finance the previously announced share repurchase program. As outlined in the 10-K for the year ended June 30, 1998, the Company has developed plans to address the possible exposures related to the impact on its computer systems of the Year 2000. These plans have not changed materially in terms of scope or estimated costs to complete, and are progressing according to previously identified time schedules. Implementation of required changes to critical systems is expected to be completed during fiscal 1999. Testing and certification of critical systems, which includes review of documented remediation work and test results by technical experts, key users, and a central project team, is expected to be successfully completed by December 31, 1999. Critical systems compliance has % of Applications Year 2000 Compliant Actual Planned December 1998 June 1999 Critical plant-based manufacturing, operating, and control systems 95% 100% Incremental costs, which include contractor costs to modify existing systems and costs of internal resources dedicated to achieving Year 2000 compliance, are charged to expense as incurred. Costs are expected to total approximately $100 million, of which 60% has been spent to date. PART II. OTHER INFORMATION",1189
1999-04-23,10-Q,0000080424-99-000004,"and Analysis Basic net earnings for the three months ended March 31, 1999 were $ .76 per share, a 10 percent increase over the same quarter of the prior year. Worldwide net earnings for the quarter were $1.04 billion, an eight percent increase. The difference between the earnings per share and the net earnings increases was primarily due to the Company's share repurchase program. Worldwide net sales for the quarter were $9.2 billion, a four percent increase over the same quarter of the prior year. Unit volume was flat, with the difference in sales and volume growth caused by premium-priced initiatives and Basic net earnings for the nine months ended March 31, 1999 were $2.46 per share, a 10 percent increase versus a year ago. Net earnings for the same period were $3.35 billion, an eight percent increase over the prior year. Worldwide sales for the nine-month period grew three percent to $28.7 billion, ahead of flat unit volume, due largely to favorable pricing impacts. Unfavorable exchange rates reduced sales by two percent year-to-date. Gross margin was 46.4 percent for the quarter ended March 31, 1999 compared to 41.1 percent in the same quarter of the prior year and 43.3 percent for the full fiscal year ended June 30, 1998. Gross margin was positively impacted this quarter by improved pricing, product mix, and lower manufacturing expenses. In addition, the year ago quarter's gross margin was negatively impacted by provisions for shutdown costs of a laundry site, a pulp mill, and other simplification and standardization projects. Operating margin was 18.0 percent for the quarter compared to 17.1 percent in the same quarter a year ago and 16.3 percent for the prior fiscal year. The improvement in operating margin reflected improvements in gross margin, partially offset by higher marketing, research and administrative expenditures behind product innovations. Net sales in North America for the quarter ended March 31, 1999 increased seven percent versus the same quarter in the prior year, outpacing a five percent unit volume growth, primarily as a result of the successful launches of premium-priced initiatives in paper and beauty care and improved pricing in the paper and laundry and cleaning businesses. The region's net earnings were up 16 percent due primarily to increased unit volume, pricing, and effective control of manufacturing costs, partially offset by increased investment in initiatives. The business in North America continues to strengthen, with volume up six percent excluding the sale of Duncan Hines. The region's overall unit volume growth was driven by the laundry and cleaning business, behind the continued success of the launch of Febreze, the recent launch of Tide with Bleach that sanitizes laundry and share growth behind Cascade Plus. Shares are also growing in fabric conditioners behind new initiatives. In addition, the Oil of Olay Cosmetics and Rash-Guard Diaper initiatives are contributing to stronger volumes in the beauty care and paper businesses. For the nine months ended March 31, 1999, net sales were up three percent on a two percent improvement in unit volume. Net earnings increased 13 percent. EUROPE, MIDDLE EAST, AND AFRICA Net sales for Europe, Middle East, and Africa for the three months ended March 31, 1999, were flat versus the same quarter of the prior year, on a five percent decline in unit volume, as the region's results continue to be negatively impacted by the economic crisis and currency devaluation in Russia. Sales outperformed volume due to favorable pricing, primarily in laundry and paper products, and favorable exchange effects in Western Europe. The region's net earnings declined two percent due to the impact of the economic crisis in Russia. Excluding Russia, earnings in the region increased by double digits. The decline in unit volume caused by the economic crisis in Russia was partially offset by the launch of initiatives in the region. The beverage business showed significant improvement behind the continued success of the Sunny Delight launch in the United Kingdom, where results are nearly double our initial objectives. The region also benefited from the expansion of Pringles into multiple countries and the continued tissue/towel regional expansion. For the nine months ended March 31, 1999, sales increased two percent on a three percent decline in unit volume. Net earnings increased six percent. Net sales in Asia for the three months ended March 31, 1999 increased eight percent versus the same quarter of the prior year, on a six percent decline in unit volume. The increase in sales was driven by improved pricing throughout the region and strengthening exchange rates in Japan and Korea. Net earnings for the quarter increased 117 percent versus a weak year ago base period, as improved pricing more than offset increased investment on new brand initiatives. The region's volumes continue to be impacted by recession and market contraction in several of the developing markets. However, Japan continues to grow unit volume and market share in its base businesses behind the successful launch of several initiatives in paper, laundry and cleaning and beauty care. For the nine months ended March 31, 1999, sales increased two percent on flat unit volume. Net earnings increased 21 percent. Net sales in Latin America for the three months ended March 31, 1999 were flat versus the same quarter of the prior year, on six percent decline in unit volume. Improved pricing across the region offset unfavorable exchange rates. Volume was negatively impacted by continued competitive pressures in laundry & cleaning, primarily in the Southern Cone, and a reduction in trade inventory levels in Mexico. Earnings for the region were down 16 percent, as the improved pricing was more than offset by unfavorable exchange rates and increased investment in initiatives, particularly the expansion of Ariel into the Southern For the nine months ended March 31, 1999, sales increased seven percent on a four percent increase in unit volume. Net earnings increased four percent. Total debt increased $1.4 billion since June 30, 1998. The incremental debt was used primarily to finance the previously announced share repurchase program. As outlined in the 10-K for the year ended June 30, 1998, the Company has developed plans to address the possible exposures related to the impact on its computer systems of the Year 2000. These plans have not changed materially in terms of scope or estimated costs to complete, and are progressing according to previously identified time schedules. Implementation of required changes to critical systems is expected to be completed by June 1999. Testing and certification of critical systems, which includes review of documented remediation work and test results by technical experts, key users, and a central project team, is expected to be successfully completed by December 31, 1999. Critical systems compliance has progressed as % of Applications Year 2000 Compliant Actual Planned Critical plant-based manufacturing, operating, and control systems 96% 100% Incremental costs, which include contractor costs to modify existing systems and costs of internal resources dedicated to achieving Year 2000 compliance, are charged to expense as incurred. Costs are expected to total approximately $100 million, of which 75% has been spent to date. As previously announced, the Company is currently designing Organization 2005, a realignment of the organization structure, work processes and culture to accelerate growth. We anticipate there will be significant costs associated with this reorganization that are beyond our current ongoing program of simplification and standardization. These costs, which will commence in the final quarter of the current fiscal year, involve the costs to transition from a geographic basis of management to product-based Global Business Units, standardize and streamline our selling, administrative, and product supply organizations and transition to our Global Business Services organization. We are still completing the design work which will enable us to determine the specific nature, amount and timing of these costs, and we'll provide more information late this fiscal year. Still, we would expect to commit to an increase in our earnings growth rate that is commensurate with the magnitude of PART II. OTHER INFORMATION",1320
1999-08-11,8-K,0000080424-99-000025,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) August 11, 1999 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 On August 2, 1999, The Procter & Gamble Company (the ""Company"") entered into a Share Purchase Agreement between the Company, The Iams Company, and Certain of its Affiliates and The Shareholders of The Iams Company and Certain",113
1999-09-15,10-K,0000080424-99-000027,"THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES ANNUAL REPORT ON FORM 10-K SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION ANNUAL REPORT ON FORM 10-K PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 1999 Commission File No. 1-434 COMPANY One Procter & Gamble Plaza, IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each Exchange on which registered Common Stock, without Par Value New York, Cincinnati, Amsterdam, Paris, Basle, Geneva, Lausanne, Zurich, Frankfurt, Brussels, Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes X No . Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this There were 1,315,149,346 shares of Common Stock outstanding as of July 30, 1999. The aggregate market value of the voting stock held by non-affiliates amounted to $119 billion on July 30, 1999. Documents Incorporated By Reference Portions of the Annual Report to Shareholders for the fiscal year ended June 30, 1999 are incorporated by reference into Part I, Part II and Part IV of this Portions of the Proxy Statement for the 1999 Annual Meeting of Shareholders are incorporated by reference into Part III of this report. General Development of Business The Procter & Gamble Company was incorporated in Ohio in 1905, having been built from a business founded in 1837 by William Procter and James Gamble. Today, the Company manufactures and markets a broad range of consumer products in many countries throughout the world. Unless the context indicates otherwise, the term the ""Company"" as used herein refers to The Procter & Gamble Company (the registrant) and its Additional information required by this item is",385
1999-11-05,10-Q,0000080424-99-000033,"and Analysis The Company reported net earnings of $1.15 billion or $0.80 per diluted share for the quarter ended September 30, 1999. These results include charges related to the Company's Organization 2005 program, which was announced last June. This multi-year program is associated with the Company's reorganization to product-based Global Business Units, as described more fully below. Core net earnings per diluted share, which exclude the Organization 2005 costs, were $0.88, a ten percent increase over the first quarter of last year. Core net earnings were $1.27 billion, excluding $120 million after tax in charges related to Organization 2005. This solid progress reflects a continued cost-containment focus in the face of significant initiative investments that yielded initial results in the first quarter and laid the foundation for future growth. Reported net sales for the first quarter were a record $9.92 billion, up four percent. Net sales grew five percent, excluding a one percent impact of negative exchange rates, primarily the euro and the Brazilian real. Unit volume grew two percent. New premium-priced initiatives and product upgrades boosted sales ahead Gross margin was 47.5 percent for the current quarter compared to 45.9 percent in the same quarter of the prior year and 44.8 percent for the full fiscal year ended June 30, 1999. Included in Cost of Product Sold is $105 million before tax related to Organization 2005. Gross margin was positively impacted this quarter by improved pricing, product mix, and lower manufacturing expenses. Operating margin was 18.6 percent for the quarter compared to 19.7 percent in the same quarter a year ago and 16.4 percent for the prior fiscal year. Excluding $160 million before tax in Organization 2005 charges, operating margin was 20.2 percent, primarily due to gross margin improvement. Following are highlights by business segment: As the Company's biggest and fastest-growing business unit, Fabric and Home Care set the pace for the Company's results. Net sales grew eight percent to $3.16 billion on four percent unit volume growth supplemented by the launch of higher-margin initiatives and product upgrades. Currency impacts depressed sales by one percent. The recent launches of Swiffer and Dryel in North America and strong base business results drove volume gains. Share-building initiative activity in Northeast Asia spurred double-digit volume growth in the geography. Ariel tablets performed well after their spring launch in the United Kingdom and are currently being expanded in Western Europe. Net earnings grew ten percent to $484 million, reflecting volume growth and improved pricing, despite continued initiative investment and the impact of unfavorable currency movements, The Paper business demonstrated strong volume gains on certain key brands, behind an upgrade on Charmin and increased capacity on Bounty and Charmin. These results were mitigated by significant competitive activity, particularly in diapers and feminine care products. Excluding a two percent impact from the Attends divestiture, volume and net sales were stable for the quarter, with net sales at $3.01 billion. On the base business, successful pricing measures on certain brands and markets were offset by negative currency impacts. Despite the improved pricing, chiefly behind product upgrades in diapers, increased spending in a difficult competitive environment resulted in net earnings of $343 million, Food and Beverage posted a strong first quarter. Geographical expansion in both snacks and juice helped push sales up five percent to $1.21 billion, on comparable unit volume growth. A slate of new initiatives in North America, including Folgers Whole Bean, Pringles Twin Pack, Sunny Delight Eclipse, and Jif Smooth Sensations, along with the expansion of Pringles and Sunny Delight across Western Europe, drove the volume growth. Earnings grew 35 percent to $106 million, behind the volume gains on the base business, higher-margin initiatives, and improved gross margin. During the first quarter, Beauty Care continued to see benefits from the launch of Oil of Olay Cosmetics, as well as a number of other premium initiatives. Premium initiatives, as well as favorable currency impacts in Northeast Asia, helped offset a three percent unit volume decline to maintain sales in line with year-ago levels at $1.82 billion. Currency effects contributed one percent to the sales increase. Volume comparisons reflect strong year-ago results and the current competitive environment, primarily for hair care in key European markets. Western Europe results were negatively impacted by the recent introduction of new trade terms in France and the prior year divestiture of certain minor brands. Volume also was impacted by economic sluggishness in China that dampened consumption and certain trade inventory adjustments in advance of current quarter pricing actions. Net earnings were $225 million, down four percent as volume declines and initiative spending offset pricing improvements. Health Care segment results included the integration of the newly acquired pet health and nutrition business, The Iams Company, in September, 1999. Net sales increased 16 percent to $799 million on seven percent unit volume growth, primarily reflecting the Iams acquisition. Negative exchange impacts reduced sales by one percent for the quarter. Net earnings were $91 million, a 29 percent increase over the prior year. The overall segment earnings reflect the benefits of favorable pricing and increased licensing and divestiture activity, which more than offset continued investment behind future initiatives and The Corporate segment includes certain financing and investing activities, other general corporate income and expense items, segment eliminations, and Organization 2005 costs which amounted to $120 million after tax for the July-September, 1999 quarter. Total debt increased $2.7 billion since June 30, 1999. The incremental debt was used primarily to fund the previously announced share repurchase program and the acquisition of The Iams Company, which was completed August 31, 1999. As outlined in the 10-K for the year ended June 30, 1999, the Company has substantially completed its program to address the possible exposures related to the impact on its computer systems of the Year 2000. These plans have not changed materially in terms of scope or estimated costs to complete, and have progressed according to previously identified time schedules. Implementation of required changes to critical systems is complete. Testing and certification of critical systems, which includes review of documented remediation work and test results by technical experts, key users, and a central project team, was successfully completed by September 30, 1999. The focus in this area is now on maintaining Year 2000 readiness. The Company's risk management program, which was expanded to include the Year 2000 Business Continuity Plan (BCP), was completed by October 31, 1999, consistent with previously identified time schedules. The objectives of the BCP are twofold: 1) to ensure business-critical processes are protected from disruption and will continue to function during and after the year 2000; and, 2) to ensure the Company's ability to produce an acceptable level of products and services is safeguarded in the event of failures of external systems and services. The BCP includes, for example, identification of alternative suppliers or customers, possible increases in safety inventory levels and other backup procedures. Businesses and assets acquired by the Company after June 30, 1999 but prior to the end of 1999 are subjected by the Company to a Year 2000 assessment process and, where feasible, representations as to Year 2000 readiness are obtained from the seller. Post-closing, the Company will take such actions as it considers necessary regarding Year 2000 readiness, including modification or remediation Incremental costs related to Year 2000 efforts, which include contractor costs to modify existing systems and costs of internal resources dedicated to achieving and maintaining Year 2000 compliance, are charged to expense as incurred. Costs are expected to total approximately $90 million, of which over 90% has been spent through September 30, 1999. The Company is taking all reasonable steps to prevent major interruptions in the business due to Year 2000 issues. The effect, if any, on the Company's financial statements if the Company, its customers, its suppliers, or the public sector are not fully Year 2000 compliant is not reasonably estimable. The Company believes, however, that the successful completion of its Year 2000 project will significantly reduce the risk of a major business interruption due to Year 2000 failures. Additionally, the Company's broad base of customers and suppliers and the worldwide nature of its operations is expected to mitigate any Year 2000 On June 9, 1999, the Company announced an Organization 2005 program that is an integral part of the broader 2005 initiative, which includes a realignment of the organization structure, work processes and culture designed to accelerate growth by streamlining management decision-making, manufacturing and other work processes. These changes are intended to increase the Company's ability to innovate and bring initiatives to global markets more quickly. In order to implement the program's structural changes and achieve the benefits of faster growth, the Company needs to make a number of structural changes to both its administrative and manufacturing operations. Charges related to Organization 2005 consist primarily of costs related to the consolidation of manufacturing facilities (including accelerated depreciation, asset writedowns and contract termination costs) and employee separation costs. During the quarter ended September 30, 1999, the Company recorded expenses totaling $160 million before tax related to Organization 2005, as detailed in ORGANIZATION 2005 JULY-SEPTEMBER, 1999 CHARGES (BEFORE TAX) Total Spent Charged Beginning New During Against Ending Reserves Charges Period Assets Reserves Organization 2005 charges are included in the Company's cost of products sold ($105 million) and in marketing, research and administrative expenses ($55 million), and are included in Corporate & Other in the Company's segment reporting disclosure. The underlying plant closures and consolidations will impact all regions and product segments. The planned plant closures and consolidations will not all be executed immediately due to either capacity or Employee separation charges in July-September, 1999 relate to severance packages for approximately 700 people, representing primarily administrative employees in North America, Asia, Europe, Middle East and Africa. The predominantly voluntary packages are formula-driven, based on salary levels and past service. Severance costs related to voluntary separations are charged to earnings when the employee accepts the offer in accordance with P&G policy for such programs. On average, net enrollment is expected to decline by approximately 75% of total separations, as some terminations will be partially offset through increased enrollment at remaining sites. Of total separations expected through fiscal 2001, approximately half will take place in manufacturing with the balance in administrative functions. Separation costs related to manufacturing employees are included in cost of products sold, while those for administrative employees are reported in marketing, research and administrative expenses. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period due to manufacturing consolidations, technology standardization and closures that will occur primarily over the next three years as a result of the Organization 2005 program. The Company has changed the estimated useful lives of such assets, resulting in an acceleration of depreciation. The majority of accelerated depreciation recorded in the July-September, 1999 quarter is concentrated in the Paper segment and reflects the standardization of manufacturing and other work processes being undertaken in that segment. Other costs include primarily relocation and training costs, as well as other Organization 2005-related expenses. Such costs are expensed as incurred. PART II. OTHER INFORMATION",1855
2000-01-27,10-Q,0000080424-00-000003,"and Analysis The Company reported net earnings of $1.1 billion or $0.78 per diluted share for the quarter ended December 31, 1999, including charges of $137 million related to its Organization 2005 program. Organization 2005 is the Company's multi-year initiative designed to accelerate growth by increasing innovation and speed to market. The objective of the program is to increase long-term sales growth to six-to-eight percent annually and increase growth in core net earnings per share to 13 to 15 percent over a five year period. Core net earnings per diluted share, which exclude Organization 2005 costs, were $0.88, a 13 percent increase over the second quarter of last year. Net sales increased seven percent to a record $10.6 billion. Sales growth, resulting from faster speed to market with initiatives and a greater strategic focus from the Organization 2005 program, represented the largest quarterly increase since 1997. Exchange rates, primarily Western Europe and Brazil partially offset by Japan, negatively impacted sales by two percentage points. Unit volume grew six percent, reflecting continued initiative activity around the world, base business growth and acquisitions. For the first six months, reported net earnings were $2.3 billion, or $1.58 per diluted share. Worldwide sales grew five percent to $20.5 billion, including a two percent impact from unfavorable exchange rates on four percent unit volume growth. Core net earnings were $2.5 billion, while core diluted net earnings per share grew 11 percent to $1.76. Gross margin was 47.5 percent for the current quarter compared to 46.3 percent in the same quarter of the prior year and 44.8 percent for the full fiscal year ended June 30, 1999. Included in Cost of Products Sold is $110 million before tax related to Organization 2005. Excluding Organization 2005 costs, core gross margin reached 48.5 percent. Gross margin improvement this quarter reflected continued focus on cost control, improved pricing and shifts towards premium Operating margin was 17.4 percent for the quarter compared to 18.5 percent in the same quarter a year ago and 16.4 percent for the prior fiscal year. Excluding $183 million before tax in Organization 2005 charges, operating margin was 19.1 percent, primarily driven by gross margin improvement. For the six-month period, gross margin was 47.5 percent, versus 46.1 percent in the same period a year ago. Excluding $215 million in costs related to Organization 2005, gross margin was 48.5 percent. For the current six-month period, operating margin fell to 18 percent versus 19.1 percent in the July-December, 1998 period. Excluding $343 million before tax in Organization 2005 costs, operating margin increased to 19.7 percent. Following are highlights by business segment: Fabric and home care continued to deliver strong results. Sales increased 10 percent to $3.17 billion, or 12 percent excluding unfavorable currency impacts, primarily from euro-denominated countries and Brazil. Base business strength and initiatives combined to ignite top-line growth. Febreze, Swiffer and Dryel sales continued to grow strongly from global expansion and the introduction of new line extensions. Unit volume grew eight percent, double the growth rate posted in the September quarter this year. Volume gains were broad-based across major markets in North America and Western Europe. Both volume and share growth were particularly strong in Northeast Asia and the Southern Cone (Brazil, Argentina, Chile). Net earnings grew seven percent to $405 million, on improved gross margin, partially offset by increased costs related to initiatives and negative exchange rate impacts. The Company also announced plans to introduce Ariel liquid in Japan and to launch another innovative new product, Fit Fruit and Vegetable Wash, in the United States this For the first six months of the fiscal year, a six percent unit volume increase and higher-value initiatives drove sales up nine percent. Net earnings increased Paper results improved during the second quarter, with net sales up one percent to $3.18 billion. Excluding negative exchange rate impacts, largely due to the euro, net sales grew three percent. Unit volume grew three percent behind strong increases on Charmin and Bounty and improved performance in diapers, despite continuing competitive issues in feminine care. The divestiture of the Attends adult incontinence business weakened comparisons, negatively impacting volume and sales by two percent versus the same quarter last year. Earnings declined 15 percent to $293 million, behind continued investment in new initiatives, geographic expansion and rising pulp prices. The effect of prior pricing actions, primarily in baby care, were offset by price reductions in earlier quarters taken on tissue/towel in reaction to competitive activities and negative mix effects in diapers. An upgraded Tampax product based on closed-end satin technology was introduced in Ireland and Switzerland, as part of the Company's focus to build the business through product innovation. On a year-to-date basis, sales were down one percent on flat unit volume. Net earnings fell eight percent. Beauty care was impacted by a difficult competitive environment, especially in Greater China and Western Europe, and the double impact of declining consumption and price deflation in China, where the hair care market has been especially hard hit by the weakened economy. Sales fell three percent to $1.90 billion on a five percent volume decline. Net earnings were equal to year ago at $273 million, as pricing programs and progress on cost control offset incremental spending and costs related to initiatives. The Company's response to the situation in China, which is focused on stimulating consumption through price reductions on specific hair care brands and complemented by a strong sachet drive, is beginning to rebuild the business in that country. The Company also continues to emphasize long-term value creation through investment in premium initiatives, such as Secret Platinum and Oil of Olay Cosmetics. Several new product upgrades and launches, including the U.S. launch of the Physique styling-led hair care brand, are planned for the back half of the year. For the first six months of the year, unit volume fell four percent. Sales and net earnings fell two percent. The health care segment, which includes new venture activities, delivered strong results this quarter behind the acquisitions of Iams and Recovery Engineering, with its water filtration brand, PuR. Net sales increased 35 percent to $1.07 billion on 33 percent unit volume growth. Net earnings were up 57 percent to $125 million, driven by outstanding progress by Iams that supplemented solid base business earnings. The Company recently announced that Iams pet food products will be expanded to new retail channels in the coming quarter, only a few months after the integration of the acquisition. Health care also introduced ThermaCare portable heat wraps, which are intended to change the way consumers think about pain relief, and announced further progress with Actonel, the Company's new osteoporosis drug. The Swedish government approved Actonel for use with Corticosteroid-Induced Osteoporosis and Post-Menopausal Osteoporosis in October, 1999, while FDA approval is expected in the near future. On a year-to-date basis, net sales increased 26 percent with unit volume up 21 percent. Net earnings increased 44 percent. Improvements were driven by the newly acquired businesses, as well as strong growth in leading respiratory Continued expansion of snacks across geographies, mainly in Western Europe, drove strong quarterly results, with sales increasing four percent to $1.32 billion on comparable unit volume growth. Recent launches of Pringles in Spain and Italy and the introduction of the Pringles Pizzalicious flavor in Japan are yielding great results. Excluding the effects of the Hawaiian Punch divestiture, volume grew nine percent, boosted by recent initiative launches of Folgers Whole Bean, Pringles Twin Pack, Sunny Delight Eclipse, and Jif Smooth Sensations. Significant improvements in gross margin, behind a sharpened focus on cost control, boosted earnings 23 percent to $137 million, despite investments in new For the first half of the year, sales increased five percent on four percent unit volume growth. Net earnings climbed 28 percent, reflecting cost The Company confirmed that it was comfortable with the current range of analyst estimates for fiscal year earnings. However, earnings growth may be more concentrated in the April-June quarter, given heavy initiative spending planned for the January-March quarter. Volume and sales increases through the remainder of the year are expected to be above the growth achieved in the July-December period. For fiscal year 2001 and beyond, the Company has raised its internal expectations and is targeting for earnings growth near the top of its 13 to 15 percent target range, as it continues to see increased financial benefits flowing from Organization 2005. Total debt increased $4.1 billion since June 30, 1999. The incremental debt was used primarily to fund the previously announced share repurchase program and the acquisitions of the Iams Company and Recovery Engineering. For the six-month period ended December 31, 1999, cash generated from operating activities totaled $1.5 billion, down from $2.0 billion in the same prior year period. Most of the decrease resulted from increased investment in working capital, driven by lower accrual balances and inventory accumulation in advance Capital spending increased $322 million versus the year ago period, including Organization 2005-driven spending. Investment in acquisitions totaled $3.1 billion, compared to $0.1 billion in the prior period. As described in the Form 10-K for the year ended June 30, 1999, the Company had developed plans to address the possible exposures related to the impact on its computer systems of the Year 2000. Since entering the year 2000, the Company has not experienced any major disruptions to its business nor is it aware of any significant Year 2000-related disruptions impacting its customers and suppliers. Furthermore, the Company did not experience any material impact on inventories at calendar year end. The Company will continue to monitor its critical systems over the next several months but does not anticipate any significant impacts due to Year 2000 exposures from its internal systems as well as from the activities of its suppliers and customers. Costs incurred to achieve Year 2000 readiness, which include contractor costs to modify existing systems and costs of internal resources dedicated to achieving Year 2000 compliance, were charged to expense as incurred. Such costs totaled approximately $90 million and were largely incurred prior to the current fiscal On June 9, 1999, the Company announced an Organization 2005 program that is an integral part of the broader 2005 initiative, which includes a realignment of the organization structure, work processes and culture designed to accelerate growth by streamlining management decision-making, manufacturing and other work processes. These changes are intended to increase the Company's ability to innovate and bring initiatives to global markets more quickly. In order to implement the program's structural changes and achieve the benefits of faster growth, the Company needs to make a number of structural changes to both its administrative and manufacturing operations. Charges related to Organization 2005 consist primarily of costs related to the consolidation of manufacturing facilities (including accelerated depreciation, asset writedowns and contract termination costs) and employee separation costs. During the quarter ended December 31, 1999, the Company recorded expenses totaling $183 million before tax related to Organization 2005, as detailed in Organization 2005 July-December, 1999 Charges (before tax) For the July-December Period Beginning Quarter Quarter Total Charged Ending Reserves Charges New Charges Cash Against Reserve at 6/30/99 Jul-Sep 99 Charges Jul-Dec Spent Assets 12/31/99 During October-December, 1999, Organization 2005 costs charged against the Company's cost of products sold amounted to $110 million, while charges included in marketing, research and administrative expenses amounted to $73 million. Charges related to Organization 2005 are included in Corporate & Other in the Company's segment reporting disclosure. The underlying plant closures and consolidations will impact all regions and product segments. Planned plant closures and consolidations will not all be executed immediately due to either capacity or logistics constraints. For the July-December, 1999 period, total charges related to Organization 2005 amounted to $343 million before tax. Employee separation charges in October-December, 1999 are associated with severance packages for approximately 310 people, representing primarily administrative employees in North America, Asia, and Europe. For the fiscal year-to-date period, separation charges related to Organization 2005 totaled $72 million, and relate to approximately 1,010 terminations. The predominantly voluntary packages are formula-driven, based on salary levels and past service. Severance costs related to voluntary separations are charged to earnings when the employee accepts the offer in accordance with P&G policy for such programs. On average, net enrollment is expected to decline by approximately 75% of total separations, as some terminations will be partially offset through increased enrollment at remaining sites. Of total separations expected through fiscal 2001, approximately half will take place in manufacturing with the balance in administrative functions. Separation costs related to manufacturing employees are included in cost of products sold, while those for administrative employees are reported in marketing, research and administrative expenses. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period due to manufacturing consolidations, technology standardization and closures that will occur primarily over the next three years as a result of the Organization 2005 program. The Company has changed the estimated useful lives of such assets, resulting in an acceleration of depreciation. Approximately 60% of the $99 million of accelerated depreciation recorded in the October-December, 1999 quarter is concentrated in the paper segment and reflects the standardization of manufacturing and other work processes being undertaken in that segment. Most of the balance is concentrated in the beauty care and fabric and home care segments. For the six month period ended December, 1999, total charges related to accelerated depreciation amounted to $199 million before tax. Charges for other costs related to Organization 2005 amounted to $52 million during the October-December, 1999 quarter, and consisted primarily of costs associated with the restructuring of certain beauty care categories, as well as relocation, training costs and other Organization 2005-related expenses. For the fiscal year-to-date period, other costs totaled $63 million. PART II. OTHER INFORMATION",2299
2000-03-07,8-K,0000080424-00-000005,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) March 7, 2000 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 On March 7, 2000, The Procter & Gamble Company (the ""Company"") issued a news release with respect to its expected financial results.",98
2000-04-28,10-Q,0000080424-00-000009,"and Analysis The Company reported net earnings of $753 million or $0.52 per diluted share for the quarter ended March 31, 2000, including charges of $170 million related to its Organization 2005 program. Core net earnings per diluted share, which exclude the Organization 2005 costs, were $0.64. This 11 percent decline over the third quarter of last year is primarily due to higher costs, including increased investments behind consumer and customer initiatives and a slight Net sales grew six percent to $9.78 billion. Exchange rates, primarily the euro, depressed sales by about two percent. A strong Japanese yen and Mexican peso partially offset the weaker currencies in Western Europe. Unit volume grew seven percent, reflecting stepped-up initiative activity across geographies, base business strength, and acquisition effects, primarily Iams. For the first nine months, reported net earnings were $3.03 billion, or $2.10 per diluted share. Worldwide net sales grew six percent to $30.29 billion on five percent unit volume growth, despite a one percent impact of unfavorable exchange rates. Core net earnings were $3.45 billion, generating core diluted net earnings per share of $2.40, a four percent increase. Gross margin was 45.5 percent for the current quarter compared to 46.9 percent in the same quarter of the prior year and 44.8 percent for the fiscal year ended June 30, 1999. Impacting gross margin is a before-tax charge of $107 million related to the Organization 2005 restructuring project. Excluding this charge, core gross margin was 46.6 percent, down from the prior year behind commodity-related cost increases and exchange impacts. Operating margin was 13.5 percent for the January-March quarter versus 18.0 percent in the same quarter a year ago and 16.4 percent for the prior fiscal year. Excluding $184 million before tax in Organization 2005 charges, operating margin was 15.4 percent. The decline in operating margin was driven by the gross margin decrease, as well as heavy initiative investments. The initiative investments most negatively affected marketing, research, and administrative expenses, which increased considerably versus the same quarter in the prior For the nine-month period, gross margin was 46.9 percent, an increase versus 46.4 percent reported in the same period a year ago. Excluding Organization 2005 charges of $322 million before tax, gross margin was 47.9 percent. Operating margin on a year-to-date basis was 16.5 percent compared to 18.7 percent for the same period last year. Without Organization 2005 charges of $527 million before tax, operating margin was 18.3 percent. Fabric and home care continued to deliver strong top-line results, with unit volume growth of eight percent behind global initiative activity and solid base business performance in North America. Sales increased seven percent, to $2.94 billion, including a two percent negative currency impact. Importantly, overall global market share grew, with Latin America delivering substantial share progress and top-line growth in the face of heavy competitive activity. Net earnings were $283 million, a decline of 26 percent. These results reflect the significant investments behind new initiatives including Mr. Clean Wipes and Fit Fruit and Vegetable Wash, the expansion of Dryel, Swiffer, and Mr. Proper Wipes, innovative customer marketing programs and increases in petroleum-related costs. Western European earnings were significantly impacted by initiative investment and response to heavy competitive activity. For the first nine months of the fiscal year, higher value initiatives drove sales up eight percent and unit volume up seven percent. Net earnings decreased Paper continues to face significant challenges including unfavorable cost trends and a difficult competitive environment. Volume was up one percent on the quarter, as solid volume progress in the tissue and towel business offset weakness in diapers and the prior year divestiture of Attends in feminine care products. Sales of $2.93 billion were down three percent, driven by a three percent negative currency impact. Rising pulp prices, capacity expansion and initiative investments depressed earnings, bringing them down 27 percent to $218 million. Charmin and Bounty posted solid gains behind product upgrades and geographical expansion. The segment announced pricing plans to counter rising commodity-related raw material increases, effective for the April-June quarter. On a year-to-date basis, sales were down one percent on flat unit volume. Net earnings fell 14 percent. Beauty care posted solid growth in the January-March quarter, reflecting an improving business trend. Sales grew well ahead of volume, and the business generated earnings growth despite heavy initiative investments. Sales grew seven percent to $1.90 billion on a four percent unit volume increase fueled by premium initiatives in hair care, including the Physique styling-led hair care line. Earnings increased 13 percent to $231 million, bolstered by premium-priced For the first nine months of the fiscal year, sales grew one percent, despite a two percent unit volume decline. Net earnings were up two percent. Health care results highlight the benefits of acquisitions, as Iams drove volume and sales growth. Sales were up 52 percent to $1.08 billion, on 59 percent volume growth. Excluding acquisitions and divestitures, volume was down one percent, as a slower cold and flu season offset strong gains in oral care. Earnings were up 74 percent to $101 million. Earnings excluding Iams were down, as the business continued to invest in its portfolio of new products. As expected, the regulatory approval of Actonel for the prevention and treatment of osteoporosis was recently obtained, with marketing efforts and shipments to Year-to-date, volume increased 33 percent with net sales up 34 percent. Net earnings increased 52 percent. Results in food and beverage were negatively impacted by a divestiture in the prior year and commodity-related pricing actions. Sales declined 11 percent to $976 million on an eight percent unit volume decline. Excluding the divestiture impacts, unit volume was down three percent. Pricing actions affected both market size and timing of shipments in the segment, primarily in coffee. Volume was also negatively impacted by softness in Sunny Delight in Western Europe and snacks in the United States. Earnings were down 32 percent to $50 million, reflecting the Hawaiian Punch divestiture last year and initiative-related cost increases, particularly in Western Europe, where we are launching Sunny Delight For the first nine months of the fiscal year, unit volume was up one percent on flat net sales. Net earnings increased 11 percent. The corporate segment includes certain financing and employee benefit costs, goodwill amortization, other general corporate income and expense items, segment eliminations and Organization 2005 charges. Due to the nature of its components, results can vary significantly by quarter and year. In the January-March quarter, earnings declined sharply due to the Organization 2005 charges. Excluding Organization 2005, gains on the settlement of a patent dispute with Paragon Trade Brands and the divestiture of the Chloraseptic brand were offset by higher costs associated with certain employee benefit programs, higher interest expense, goodwill amortization and corporate innovation investments. Total debt increased $4.1 billion since June 30, 1999. The incremental debt was used primarily to fund the previously announced share repurchase program and the acquisitions of the Iams Company and Recovery Engineering. During its March, 2000 meeting, the Board of Directors approved increasing the Company's authorization to repurchase its shares to 56 million, up from 40 million. For the nine-month period ended March 31, 2000, cash generated from operating activities totaled $2.9 billion, down from $3.6 billion in the same period in the prior year. The decrease resulted primarily from incremental investments in working capital and lower earnings versus a year ago. Acquisitions were up $2.8 billion versus the year ago period. Capital spending grew $152 million, versus the year ago period, including capital projects related to Organization 2005. The Company confirmed that it is comfortable with the current range of analysts' earnings estimates. April-June volume growth currently is estimated at five to seven percent. The Company also noted that the increase in net income for the April-June quarter will result from an increase in income from the corporate segment. Business units will be negatively impacted by continued investment in new initiatives, and they will likely report profit results which are flat or down versus fourth quarter a year ago. On June 9, 1999, the Company announced an Organization 2005 program that is an integral part of the broader 2005 initiative, which includes a realignment of the organization structure, work processes and culture designed to accelerate growth by streamlining management decision-making, manufacturing and other work processes. These changes are intended to increase the Company's ability to innovate and bring initiatives to global markets more quickly. In order to implement the program's structural changes and achieve the benefits of faster growth, the Company will make a number of structural changes to both its administrative and manufacturing operations. Charges related to Organization 2005 consist primarily of costs related to the consolidation of manufacturing facilities (including accelerated depreciation, asset writedowns and contract termination costs) and employee separation costs. During the quarter ended March 31, 2000, the Company recorded expenses totaling $184 million before tax related to Organization 2005, as detailed in the Organization 2005 July-March, 2000 Charges (before tax) For the July-March Period Beginning Current Charged Ending Reserves Charges Quarter Total Cash Against Reserves at 6/30/99 Jul-Dec 99 Charges Charges Spent Assets 3/31/00 During January-March, 2000, Organization 2005 costs charged against the Company's cost of products sold amounted to $107 million, while charges included in marketing, research and administrative expenses amounted to $77 million. Charges related to Organization 2005 are included in Corporate & Other in the Company's segment disclosures. The underlying plant closures and consolidations will impact all regions and product segments. Planned plant closures and consolidations will not all be executed immediately due to either capacity or logistics constraints. For the July-March, 2000 period, total charges related to Organization 2005 amounted to $527 million before tax. Employee separation charges in January-March, 2000 are associated with severance packages for approximately 300 people, representing primarily administrative employees in North America, Asia, and Europe, along with production employees in Latin America. For the fiscal year-to-date period, separation charges related to Organization 2005 totaled $110 million, and relate to approximately 1,310 terminations. The predominantly voluntary packages are formula-driven, based on salary levels and past service. Severance costs related to voluntary separations are charged to earnings when the employee accepts the offer in accordance with P&G policy for such programs. On average, net enrollment is expected to decline by approximately 75% of total separations, as some terminations will be partially offset through increased enrollment at remaining sites. Of total separations expected through fiscal 2001, approximately half will take place in manufacturing with the balance in administrative functions. Separation costs related to manufacturing employees are included in cost of products sold, while those for administrative employees are reported in marketing, research and Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period due to manufacturing consolidations, technology standardization and closures that will occur primarily over the next three years as a result of the Organization 2005 program. The Company has changed the estimated useful lives of such assets, resulting in an acceleration of depreciation. Approximately 50% of the $100 million of accelerated depreciation recorded in the January-March, 2000 quarter is concentrated in the paper segment and reflects the standardization of manufacturing and other work processes being undertaken in that segment. Most of the remaining balance is concentrated in the beauty care and fabric and home care segments. For the nine month period ended March 31, 2000, total charges related to accelerated depreciation amounted to $299 million before tax. Charges for other costs related to Organization 2005 amounted to $42 million during the January-March, 2000 quarter, and consisted primarily of costs associated with the restructuring of certain beauty care categories, as well as relocation, training costs and other Organization 2005-related expenses. For the fiscal year-to-date period, other costs totaled $105 million. PART II. OTHER INFORMATION",1965
2000-05-15,8-K,0000080424-00-000011,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) May 15, 2000 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 As of May 15, 2000, six lawsuits have been filed against The Procter & Gamble Company (the ""Company"") in response to its March 7, 2000 earnings press release. In each of these cases, the plaintiffs have filed class action lawsuits purportedly pursuant to the Federal Rules of Civil Procedure 23(a) and 23(b)(3) on behalf of all persons who purchased the Company's common stock on the open market during the period January 25, 2000 through March 6, 2000 (the ""Class Period""). Each of these cases is pending before the United States District Court, Southern District of Ohio. Plaintiffs assert Section 10(b) and 20(a) and Rule 10b-5 claims under the Securities Exchange Act of 1934, asserting the Company and certain named officers violated federal securities laws through the preparation and dissemination to the investing public of materially false and misleading information about the Company's financial condition and prospects. Plaintiffs also assert the Company had a duty to disclose certain financial information during such Class Period. The plaintiffs are currently seeking unspecified While the effect of future results of these suits is not currently subject to reasonable estimation, management presently believes that the ultimate liability arising from such claims will not materially affect the Company's",278
2000-06-08,8-K,0000080424-00-000013,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 8, 2000 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 On June 8, 2000 The Procter & Gamble Company (the ""Company"") issued a news release with respect to its revised financial outlook and changes in its Senior",103
2000-09-06,8-K,0000080424-00-000036,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 6, 2000 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 Procter & Gamble today stated that it continues to be comfortable with its prior guidance on the September quarter and for Fiscal Year 2001. On August 1, 2000, Procter & Gamble estimated that July-September earnings per share would be about flat compared to the same period last year. Additionally, Procter & Gamble indicated that it was comfortable with the then current range of investment analyst earnings estimates for fiscal 2001.",146
2000-09-13,10-K,0000080424-00-000040,"THE PROCTER & GAMBLE COMPANY ANNUAL REPORT ON FORM 10-K SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION ANNUAL REPORT ON FORM 10-K PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2000 Commission File No. 1-434 THE PROCTER & GAMBLE COMPANY One Procter & Gamble Plaza, Cincinnati, Ohio 45202 IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each Exchange on which registered Common Stock, without Par Value New York, Cincinnati, Amsterdam, Paris, Basle, Geneva, Lausanne, Zurich, Frankfurt, Brussels, Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes X No . Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this There were 1,306,135,586 shares of Common Stock outstanding as of July 31, 2000. The aggregate market value of the voting stock held by non-affiliates amounted to $74 billion on July 31, 2000. Documents Incorporated By Reference Portions of the Annual Report to Shareholders for the fiscal year ended June 30, 2000 are incorporated by reference into Part I, Part II and Part IV of this Portions of the Proxy Statement for the 2000 Annual Meeting of Shareholders are incorporated by reference into Part III of this report. General Development of Business The Procter & Gamble Company was incorporated in Ohio in 1905, having been built from a business founded in 1837 by William Procter and James Gamble. Today, the Company manufactures and markets a broad range of consumer products in many countries throughout the world. Unless the context indicates otherwise, the term the ""Company"" as used herein refers to The Procter & Gamble Company (the registrant) and its Additional information required by this item is",390
2000-09-28,8-K,0000080424-00-000045,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 28, 2000 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 On September 28, 2000 The Procter & Gamble Company (the ""Company"") issued a news release with respect to its business plan. P&G is filing this 8-K pursuant to the SEC's proposed Regulation FD.",109
2000-10-31,8-K,0000950152-00-007494,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) October 31, 2000 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 On October 31, 2000 The Procter & Gamble Company (the ""Company"") issued a news release with respect to first quarter earnings. P&G is filing this 8-K pursuant to the SEC's proposed Regulation FD.",109
2000-11-02,10-Q,0000080424-00-000053,"and Analysis The Company reported net earnings of $1.16 billion or $0.82 per share for the quarter ended September 30, 2000. Results include an $85 million after-tax charge related to the Organization 2005 restructuring program. Core net earnings, which exclude the Organization 2005 charges, were $1.24 billion for the quarter. Core net earnings per share were equal to the prior year at $0.88. Earnings results were influenced by significant commodity-related cost increases and negative exchange impacts, which more than offset the benefits of pricing and a focus on growth of premium-priced products. Net sales grew one percent, consistent with unit volume, reaching $9.97 billion. Gains from improved pricing and higher volume were partially offset by the negative impact of exchange rates. Excluding currency effects, primarily from the euro, sales grew four percent. Gross margin was 46.8 percent for the current quarter compared to 47.5 percent in the same quarter of the prior year and 46.1 percent for the full fiscal year ended June 30, 2000. Included in cost of products sold is a before-tax charge of $63 million related to Organization 2005. Excluding Organization 2005 costs, core gross margin reached 47.4 percent, down from the prior year as improved pricing and premium products were more than offset by commodity-cost increases. Operating margin was 17.8 percent for the quarter compared to 18.6 percent in the same quarter a year ago and 14.9 percent for the prior fiscal year. Excluding $105 million before tax in Organization 2005 charges, operating margin was 18.9 percent. Operating margin declined primarily due to the gross margin Unit volume was flat, as gains in North America laundry ahead of the price increase were offset by softness in Western Europe. Net sales declined three percent to $3.08 billion, primarily reflecting a three percent unfavorable foreign exchange impact, driven by Western European currencies. Net earnings were $498 million, up three percent. Earnings progress was due to lower costs in developing markets, minor brand divestitures and lower taxes. Comparisons were impacted by strong results in the prior year, when significant initiative activity, including sell-in of Swiffer and Dryel, fueled eight percent sales and 10 percent earnings growth. The business continued to invest in new initiatives in the current quarter, with recent launches of Downy Wrinkle Releaser and Tide Tablets in North America. Unit volume was up one percent behind improved performance in diapers, notably in Latin America, and growth in Western Europe and China. Net sales also increased one percent to $3.04 billion, as pricing mitigated a four percent unfavorable exchange impact. Volume and sales growth reflected the successful introductions of new products in baby care and feminine care. Net earnings declined four percent to $329 million as progress in marketing, research and administrative spending was offset by unfavorable exchange rates. Significant commodity-related cost increases were countered by pricing actions, primarily in tissues/towel and feminine care. Unit volume was flat versus year ago as strong growth in hair care was offset by significant competitive activity in personal cleansing and deodorants in North America and by Western Europe business softness. Net sales grew two percent to $1.87 billion, including a three percent unfavorable exchange impact. Sales were ahead of volume due to pricing and the continued focus on high-performance, premium-priced initiatives. Net earnings were $267 million, a 19 percent increase, reflecting the benefit of improved pricing, lower taxes and comparison to a weak year ago base period. Double-digit volume and sales growth in health care was led by continued outstanding progress on Iams pet health and nutrition business which was acquired in September 1999. Unit volume climbed 34 percent versus the prior year and sales grew 24 percent to $990 million, including a two percent negative impact from weaker currencies. Net earnings were $81 million, an 11 percent decline, as growth from acquisitions was outweighed by last year's high level of licensing and divestiture activity. Base business net earnings grew by double-digits, excluding the impact of acquisitions, divestitures and licensing Unit volume and sales declined 11 percent and 13 percent respectively, reflecting softness in both the snacks and beverage businesses. Pringles volume was down in part due to trade inventory builds in advance of an announced June price increase. The beverage business declined as a result of a heavy competitive climate in juice. Net sales were $1.05 billion, including a two percent negative impact from currency rate changes. Net earnings decreased 29 percent to $75 million, due to lower volume and the associated cost impact. Total debt increased $535 million since June 30, 2000. The incremental debt was used primarily to fund the Company's ongoing share repurchase program. The Company confirmed its prior guidance of core earnings per share growth in the mid-single-digits, or a range of $0.91 to $0.93 per share. October-December sales, excluding the impact of foreign exchange, are expected to be up slightly with volume down in the low-single-digits. The second quarter results will benefit from the Company's ongoing minor brand divestiture program, including the divestiture of Clearasil. These results are against a particularly strong year ago base period, where volume increased six percent and core earnings grew 11 percent, driven by a strong new brand launch program. On June 9, 1999, the Company announced an Organization 2005 restructuring program that is an integral part of the broader 2005 initiative, which includes a realignment of the organization structure, work processes and culture designed to accelerate growth by streamlining management decision-making, manufacturing and other work processes. These changes are intended to increase the Company's ability to innovate and bring initiatives to global markets more quickly. In order to implement the program's structural changes and achieve the benefits of faster growth, the Company will make a number of structural changes to both its administrative and manufacturing operations. Charges related to Organization 2005 consist primarily of costs related to the consolidation of manufacturing facilities (including accelerated depreciation, asset writedowns and contract termination costs) and employee separation costs. During the quarter ended September 30, 2000, the Company recorded expenses totaling $107 million before tax related to Organization 2005, as detailed in Organization 2005 July-September, 2000 Charges (before tax) Beginning Charged Ending Reserves Total Cash Against Reserves at 6/30/00 Charges Spent Assets 9/30/00 During July-September, 2000, Organization 2005 costs charged against the Company's cost of products sold amounted to $63 million, while charges included in marketing, research and administrative expenses and other expenses amounted to $44 million. Charges related to Organization 2005 are included in Corporate in the Company's segment disclosures. The underlying plant closures and consolidations will impact all regions and product segments. Planned plant closures and consolidations will not all be executed immediately due to either capacity or logistics constraints. Employee separation charges in July-September, 2000 are associated with severance packages for approximately 430 people, representing primarily administrative employees in North America, Asia, and Europe, along with production employees in Asia. The predominantly voluntary packages are formula-driven, based on salary levels and past service. Severance costs related to voluntary separations are charged to earnings when the employee accepts the offer in accordance with P&G policy for such programs. On average, net enrollment is expected to decline by approximately 85% of total separations, as some terminations will be partially offset through increased enrollment at remaining sites. Of total separations expected through fiscal 2001, approximately half will take place in manufacturing with the balance in administrative functions. Separation costs related to manufacturing employees are included in cost of products sold, while those for administrative employees are reported in marketing, research and administrative expenses. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period due to manufacturing consolidations, technology standardization and closures that will occur primarily over the next two years as a result of the Organization 2005 program. The Company has changed the estimated useful lives of such assets, resulting in an acceleration of depreciation. Approximately 60% of the $52 million of accelerated depreciation recorded in the July-September, 2000 quarter is concentrated in the paper segment and reflects the standardization of manufacturing and other work processes being undertaken in that segment. Most of the remaining balance is concentrated in the beauty care and fabric and home Charges for other costs related to Organization 2005 amounted to $22 million during the July-September, 2000 quarter, and consisted primarily of costs associated with relocation, training and other Organization 2005-related expenses. These costs are expensed as incurred. In December, 1999, the Securities and Exchange Commission issued Staff Accounting Bulletin 101, ""Revenue Recognition in Financial Statements."" The effective date has been deferred pending additional interpretive guidance. Based on current interpretations, no material impact on the Company's financial statements is anticipated. PART II. OTHER INFORMATION",1450
2000-11-20,8-K,0000080424-00-000056,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) November 20, 2000 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE On November 20, 2000 The Procter & Gamble Company (""P&G"") issued the Bristol-Myers Squibb announced in September its intention to sell its hair care business, including the Clairol line. No offering memorandum has yet been issued. P&G plans to review the offering memorandum once it is issued, but has made no commitments. P&G presently is not considering a swap of its pharmaceutical or OTC business as part of future discussions with",155
2000-12-12,8-K,0000080424-00-000057,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) December 12, 2000 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE This disclosure is being made pursuant to Regulation FD. The Procter & Gamble Company (the ""Company"") today stated that it continues to be comfortable with its prior guidance on the December quarter and for Fiscal Year 2001. On October 31, 2000, the Company estimated that October-December earnings per share would be in the range of $0.91 to $0.93, up mid-single digits vs. the prior year's December quarter. Additionally, The Company estimated that Fiscal 2001 earnings per share would increase +7 to +10%. This disclosure contains forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995. There are certain factors that could cause results to differ materially from those anticipated by some of the statements made. These include achievement of the business unit volume and income growth projections, the achievement of the company's cost containment goals, and the timely divestiture of assets within the company's ongoing minor brand divestiture program, as well as factors listed in Management's Discussion and Analysis of Financial Condition and Results of Operations in the company's most recently filed",262
2001-01-30,8-K,0000080424-01-000002,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) January 30, 2001 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE On January 30, 2001 The Procter & Gamble Company (the ""Company"") issued a news release with respect to second quarter earnings. P&G is filing this 8-K pursuant to the SEC's proposed Regulation FD.",117
2001-02-01,10-Q,0000080424-01-000004,"and Analysis The Company reported net earnings of $1.19 billion or $0.84 per share for the quarter ended December 31, 2000. Results included a $120 million after-tax charge related to the Organization 2005 restructuring program. Core net earnings, which exclude the Organization 2005 charges, were $1.31 billion for the quarter. Core net earnings per share were $0.93, a six percent increase Net sales were $10.18 billion for the quarter. This is equal to year ago record levels, after adjusting for a four percent unfavorable currency impact, primarily the euro. Unit volume was down two percent against an all-time record quarter last year, when new brand introductions, strong initiative activity and marketing support, and geographic expansions of established brands fueled Business segment after-tax earnings were up two percent as pricing and tax savings offset the impact of foreign exchange and increased product costs, driven by higher commodity-based prices. The sale of Clearasil added approximately $146 million after tax to the corporate segment, and was an important factor in delivering the six percent core net earnings per share For the first six months, reported net earnings were $2.35 billion, or $1.66 per share. Results included a charge of $205 million after-tax related to the Organization 2005 program. Excluding Organization 2005 charges, core net earnings were $2.55 billion, while core net earnings per share grew three percent to $1.81. Worldwide sales were down two percent to $20.15 billion, including a four percent effect due to unfavorable exchange rates, on flat unit Gross margin was 46.8 percent for the current quarter compared to 47.5 percent in the same quarter of the prior year, and 46.1 percent for the full fiscal year ended June 30, 2000. Included in cost of products sold is a before-tax charge of $81 million related to Organization 2005. Excluding Organization 2005 costs, gross margin was 47.6 percent, down from the year ago quarter as commodity-related cost increases and unfavorable exchange impacts were not fully offset by pricing actions. Operating margin was 16.8 percent for the quarter compared to 17.4 percent in the same quarter a year ago and 14.9 percent for the prior fiscal year. Excluding $154 million before tax in Organization 2005 charges, operating margin was 18.3 percent. The decline in operating margin was primarily driven by the For the six-month period, gross margin was 46.8 percent, comparable to the quarter results, and below the 47.5 percent reported in the same period a year The following provides additional perspective on the Company's results by The Company's largest segment, fabric and home care, began to show signs of share improvement, despite a continued difficult competitive environment. Net earnings were $390 million, down four percent against particularly strong growth in the prior year. Net sales were $2.93 billion, with a four percent volume decline exacerbated by a five percent unfavorable exchange impact. The unit volume trend reflects the strength of the year-ago base period, which included the initial shipments of Swiffer, Febreze and Dryel, as well as the impact of inventory builds in advance of last quarter's North America laundry price increase. Recent pricing actions in Western Europe and laundry product improvements in North America are designed to improve the value equation with consumers to support achievement of our future growth objectives. For the first six months of the fiscal year, unit volume was down two percent. Sales fell five percent while earnings were equal to year-ago levels. The paper segment posted a one percent growth in net earnings as pricing and a disciplined focus on controllable costs countered exchange impacts and higher raw material prices. Net earnings for the quarter were $295 million. Excluding a five percent unfavorable exchange impact, net sales grew one percent to $3.05 billion. Pricing benefits, primarily in North America tissues and towel and baby care, mitigated a slight decrease in unit volume. Growth in Latin America volume, primarily in baby care, was offset by a decline in North America, following particularly strong results in the prior year. This segment continues to face competitive challenges and is focused on the best approaches to deliver a winning consumer value equation in the future. For the first half of the year, unit volume was flat while net sales and net earnings were down two percent. Beauty care also delivered net earnings growth, as the segment continues to focus on premium products. Net earnings grew five percent to $286 million. The business supported continued investment in business-building initiatives by managing costs, primarily lower taxes. Share progress on key brands was not directly reflected in top-line results due to trade inventory adjustments, primarily related to the Pantene relaunch. Net sales were $1.86 billion, down two percent driven entirely by a five percent negative impact of currency. Excluding exchange, the net sales growth in the face of a two percent decline in unit volume reflects the benefit of pricing as the business extends its hair and skin care product lines. Notable progress was achieved in the hair care business in Latin America, and earnings progress in China following challenges in the On a year-to-date basis, unit volume was down one percent while sales were flat. Net earnings grew 11 percent driven by higher value initiatives. On top of record results in the year ago quarter, the health care segment again delivered excellent growth, reflecting strong execution of initiative plans. Net earnings grew 31 percent to $164 million. Disciplined focus on costs complemented top-line growth, particularly in Iams, North America pharmaceuticals, and oral care. Net sales were up seven percent to $1.15 billion, including a three percent negative impact from weaker currencies. Excluding this effect, the double-digit sales growth was driven by an 11 percent increase in unit volume. Iams continues to exceed expectations, as the expansion into new retail channels has delivered substantial growth, while it continues to be number one in pet specialty outlets. For the first six months of the year, unit volume increased 21 percent with net sales and net earnings up 14 percent. The food and beverage segment remained below the record level of a year ago, reflecting the continued impacts of the competitive environment and transition impacts of a re-sizing initiative on Pringles. Net earnings were $124 million, down nine percent, due to lower volume versus record shipments in the year ago quarter. Net sales were $1.18 billion, down 11 percent due to a seven percent decline in unit volume and a three percent impact of unfavorable exchange rates. Year-to-date, unit volume reflected a nine percent decline while net sales declined 12 percent. Net earnings were 18 percent below a year ago. Total debt increased $2.1 billion since June 30, 2000, as the Company increased its foreign currency debt exposure to obtain favorable interest rates and to fund the Company's ongoing share repurchase program. For the six-month period ended December 31, 2000, cash generated from operating activities totaled $2.3 billion, up from $1.5 billion in the same period in the prior year. The increase resulted primarily from improvements in working Acquisitions were down $3.1 billion versus the year ago period, which included the Iams Company and Recovery Engineering. Capital spending declined $201 million versus the year ago period, reflecting slowing spending patterns while continuing Organization 2005-related capital projects. FISCAL YEAR AND THIRD QUARTER ESTIMATES The Company confirmed that it is comfortable with the high end of the current range of analysts' estimates for core net earnings per share growth for the year. Based on current trends and expectations, the Company now expects unit volume to be about flat for the year, and net sales, excluding exchange effects, to be up two to four percent. Unit volume for January - March is forecasted to be flat or down two percent versus a strong prior year base period. Net sales excluding exchange effects are expected to grow in the low single digits. Double-digit earnings per share growth is expected for the quarter, with core net earnings per share in the On June 9, 1999, the Company announced an Organization 2005 restructuring program that is an integral part of the broader 2005 initiative, which includes a realignment of the organization structure, work processes and culture designed to accelerate growth by streamlining management decision-making, manufacturing and other work processes. These changes are intended to increase the Company's ability to innovate and bring initiatives to global markets more quickly. In order to implement the program's structural changes and achieve the benefits of faster growth, the Company will make a number of structural changes to both its administrative and manufacturing operations. Charges related to Organization 2005 consist primarily of costs related to the consolidation of manufacturing facilities (including accelerated depreciation, asset write-downs and contract termination costs) and employee separation costs. During the quarter ended December 31, 2000, the Company recorded expenses totaling $152 million before tax related to Organization 2005, as detailed in Organization 2005 July-December, 2000 Charges (before tax) For the July-December Period Beginning Quarter Quarter Charged Ending Reserves Charges New Total Cash Against Reserves at 6/30/00 Jul-Sep 00 Charges Charges Spent Assets 12/31/00 During October-December, 2000, Organization 2005 costs charged against the Company's cost of products sold amounted to $81 million, while charges included in marketing, research and administrative expenses and other expenses amounted to $71 million. Charges related to Organization 2005 are included in Corporate in the Company's segment disclosures. The underlying plant closures and consolidations will impact all regions and product segments. Planned plant closures and consolidations will not all be executed immediately due to either capacity or logistics constraints. Employee separation charges in October-December, 2000 are associated with severance packages for approximately 440 people, representing primarily administrative employees in North America, Asia, and Europe. The predominantly voluntary packages are formula-driven, based on salary levels and past service. Severance costs related to voluntary separations are charged to earnings when the employee accepts the offer in accordance with P&G policy for such programs. On average, net enrollment is expected to decline by approximately 85% of total separations, as some terminations will be partially offset through increased enrollment at remaining sites. Of total separations expected through fiscal 2001, approximately half will take place in manufacturing with the balance in administrative functions. Separation costs related to manufacturing employees are included in cost of products sold, while those for administrative employees are reported in marketing, research and administrative expenses. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period due to manufacturing consolidations, technology standardization and closures that will occur primarily over the next two years as a result of the Organization 2005 program. The Company has changed the estimated useful lives of such assets, resulting in an acceleration of depreciation. Approximately 70% of the $66 million of accelerated depreciation recorded in the October-December, 2000 quarter is concentrated in the paper segment and reflects the standardization of manufacturing and other work processes being undertaken in that segment. Most of the remaining balance is concentrated in the fabric and home care, food and beverage and beauty care segments. Charges for other costs related to Organization 2005 amounted to $46 million during the October-December, 2000 quarter, and consisted primarily of costs associated with relocation, training and other Organization 2005-related PART II. OTHER INFORMATION",1873
2001-02-21,8-K,0000080424-01-000009,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) February 21, 2001 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE On February 21, 2000 The Procter & Gamble Company (""P&G"") and The Coca-Cola Company (""KO"") issued a joint news release with respect to the mutual intentions of KO and P&G with respect to the proposed acquisition of P&G's Juice Beverages and Salted Snack Products businesses by a wholly owned entity of KO that owns KO's Juice Beverages business in exchange for a 50% equity and voting interest in such entity.",154
2001-02-26,8-K,0000080424-01-000011,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) February 26, 2001 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE This disclosure is being made pursuant to Regulation FD. The Procter & Gamble Company issued the attached press release today regarding the outlook for the second half of its fiscal year.",115
2001-03-22,8-K,0000080424-01-000015,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) March 22, 2001 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE This disclosure is being made pursuant to Regulation FD. The Procter & Gamble Company issued the attached press release today regarding staffing and overhead costs.",109
2001-05-01,8-K,0000080424-01-500006,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) May 1, 2001 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE On May 1, 2001 The Procter & Gamble Company (the ""Company"") issued a news release with respect to third quarter earnings. P&G is filing this 8-K pursuant to the SEC's proposed Regulation FD.",117
2001-05-09,10-Q,0000080424-01-500008,"and Analysis The Company reported net earnings of $893 million or $0.63 per diluted share for the quarter ended March 31, 2001. Results included a $113 million after-tax charge related to the Organization 2005 restructuring program. Core net earnings, excluding Organization 2005 charges, were $1.01 billion for the quarter or $0.71 per diluted share. Core net earnings per diluted share increased 11 percent, primarily driven by pricing benefits and tax savings in the business units and divestiture gains. Net sales for the quarter were $9.51 billion, down three percent. Excluding a three percent unfavorable impact of exchange, due primarily to the euro and British pound, net sales were equal to year ago. Favorable pricing and mix effects offset a unit volume decline of three percent due to major new brand introductions in the base period. For the first nine months, reported net earnings were $3.24 billion, or $2.29 per diluted share. Results included charges of $318 million after-tax related to the Organization 2005 program. Excluding Organization 2005 charges, core net earnings were $3.56 billion, while core net earnings per diluted share were $2.52, five percent above the prior year. Net sales were up one percent to $29.66 billion, excluding a three percent unfavorable exchange rate effect. Unit volume decreased one percent. Gross margin was 45.6 percent for the current quarter compared to 45.5 percent in the same quarter of the prior year, and 46.1 percent for the full fiscal year ended June 30, 2000. Included in cost of products sold is a before-tax charge of $102 million related to Organization 2005. Excluding Organization 2005 costs, gross margin was 46.7 percent, slightly up versus the year ago quarter due to Operating margin was 13.7 percent for the quarter compared to 13.5 percent in the same quarter a year ago and 14.9 percent for the prior fiscal year. Excluding $152 million before tax in Organization 2005 charges, operating margin was 15.3 percent, down slightly from the year ago period. The decline in operating margin was primarily due to the impact of the devaluation of Turkish lira assets, mitigated by a combination of pricing benefits and marketing For the nine-month period, gross margin was 46.4 percent, below the 46.9 percent reported in the same period a year ago. Excluding Organization 2005 charges of $246 million before tax, gross margin was 47.2 percent. Operating margin on a year-to-date basis was 16.2 percent compared to 16.5 percent for the same period last year. Without Organization 2005 charges of $411 million before tax, operating margin was 17.5 percent. The decline in operating margin was primarily driven by the gross margin decrease. The following provides additional perspective on the company's results by Fabric and home care delivered double-digit earnings growth. Net sales of $2.77 billion were down three percent excluding negative exchange of three percent. Volume declined three percent, due to heavy new brand activity in the base period. Net earnings grew 23 percent to $348 million, including the benefit of lower taxes, gains from divestitures and pricing in North America laundry. Western Europe laundry continues to face strong competition, although shares have begun to improve indicating progress in restoring price competitiveness. For the first nine months of the year, net sales decreased five percent on a two percent volume decline. Net earnings increased five percent, reflecting factors similar to those for the quarter. The paper segment achieved solid earnings progress during the quarter. The competitive environment kept volume flat, despite growth in baby care and in Latin America and Europe. Pricing actions and improved mix offset unfavorable exchange impacts. Net sales of $2.94 billion were up three percent, excluding an unfavorable foreign exchange impact of three percent. Net earnings for the quarter grew eight percent to $236 million, as pricing actions particularly in tissues and towel and lower investment spending offset commodity-related cost On a year-to-date basis, net sales were down one percent on flat unit volume. Net earnings were up one percent. Beauty care net sales were $1.78 billion, down six percent. Excluding the four percent impact of unfavorable currencies, and the impact of divestitures, net sales were down one percent. Innovation on core brands - Pantene, Head & Shoulders and Olay - is growing share in the U.S., and beginning to expand to international markets. Volume was down two percent, excluding divestitures, due to the launch of Physique in the base period. Gross margin improvements and marketing cost efficiency helped deliver $243 million in net earnings, five percent growth over the prior year. For the first nine months of the year, net sales were down two percent, consistent with unit volume. Net earnings grew nine percent. Health care delivered net sales growth of two percent to $1.10 billion, despite flat unit volume, on a stronger mix of new oral care and pharmaceutical products, notably Actonel. Excluding the impact of foreign exchange, net sales grew five percent. Net earnings declined 10 percent to $91 million. Excluding the benefit of the Iams sell-in in the base period, health care earnings grew Year-to-date, volume increased 13 percent while net sales rose 10 percent, primarily from Iams growth and new products in oral care and pharmaceuticals. Net earnings increased six percent as growth from new products was partially offset by the high level of licensing and divestiture activity in the prior In food and beverage, net earnings grew to $67 million, a 34 percent increase due to global snacks price increases and heavy new initiative spending in the base period, primarily in coffee. Net sales of $938 million were down four percent. Excluding one percent unfavorable foreign exchange, and the divestiture of institutional shortening and oils in the quarter, net sales were flat. A favorable mix impact partially offset the eight percent volume decline. For the first nine months of the year, net sales decreased 10 percent with unit volume down nine percent. Net earnings were down nine percent primarily due to The Company has announced possible transactions that could materially affect future results of the food and beverage segment. The intended formation of a new entity to combine the snacks and juice business with the juice business of The Coca-Cola Company is expected to provide the strategic focus and capability to deliver future growth for these businesses. Additionally, the Company recently announced plans to explore strategic alternatives with respect to its retail shortening and oils and peanut butter businesses, including outright sale, joint venture or a swap for other consumer brands. The corporate segment includes both operating and non-operating items such as financing and investing activities, goodwill amortization, employee benefit costs, charges related to restructuring (including the Organization 2005 program), segment eliminations and other general corporate items. Based on the nature of the items, corporate results can vary significantly from period to period. Net earnings for the corporate segment declined nearly 50 percent in the quarter, excluding Organization 2005 charges, reflecting divestiture gains in the current year which were more than offset by increased interest expense and certain non-recurring items in the prior year. Net debt (total debt less cash) decreased $201 million since June 30, 2000, as increases in debt, primarily to fund the Company's ongoing share repurchase program, were more than offset by increases in operating cash flow. For the nine-month period ended March 31, 2001, cash generated from operating activities totaled $3.8 billion, up from $2.9 billion in the same period in the prior year. The increase resulted primarily from improvements in working Acquisitions were down $2.8 billion versus the year ago period, which included the Iams Company and Recovery Engineering. Capital spending declined $165 million versus the year ago period, reflecting the Company's focus on improved The Company confirmed that it is comfortable with the range of analysts' estimates for core earnings per share growth for the quarter. Unit volume for April-June is forecasted to be flat to up two percent while net sales excluding exchange effects are expected to grow in the low single digits. On June 9, 1999, the Company announced an Organization 2005 restructuring program that is an integral part of the broader 2005 initiative, which includes a realignment of the organization structure, work processes and culture designed to accelerate growth by streamlining management decision-making, manufacturing and other work processes. These changes are intended to increase the Company's ability to innovate and bring initiatives to global markets more quickly. In order to implement the program's structural changes and achieve the benefits of faster growth, the Company is making a number of structural changes to both its administrative and manufacturing operations. During the quarter, the Company announced an acceleration and expansion of the Organization 2005 restructuring program designed to ensure competitive costs and enable accelerated growth. These actions will streamline the Company's cost structure by reducing overhead costs and by extending plans to reduce manufacturing costs. This is expected to be achieved by reducing staffing by an additional 9,600 jobs worldwide, or nine percent of the Company's workforce. About 40 percent will be in the U.S. and about 60 percent outside the U.S. Two-thirds of the reductions will come from non-manufacturing roles across all levels in the company; one-third will come from manufacturing projects. Manufacturing reductions will include both plant closures and further consolidation of production modules. Although the plans are not finalized, the Company expects the cost of this aspect of the program to be $1.4 billion after-tax, with the bulk of these costs to be incurred by June 30, 2002. The savings are expected to be $600-700 million after-tax annually by 2004, and will be incremental to the original Organization 2005 restructuring program. Additionally, the Company is continuing to review its business and new investments with the goal of more tightly focusing on its core business. While no decisions have been reached, it is possible that such additional costs could be $400-800 million after-tax. A final decision on this component of the Organization 2005 restructuring program is expected before the end of the fiscal Charges related to Organization 2005 are related to the initial program and consist primarily of costs related to the consolidation of manufacturing facilities (including accelerated depreciation, asset write-downs and contract termination costs) and employee separation costs. During the quarter ended March 31, 2001, the Company recorded expenses totaling $152 million before tax related to Organization 2005, as detailed in the following table: Organization 2005 July, 2000-March, 2001 Charges (before tax) For the July-March Period Beginning Quarter Charged Ending Reserves Charges New Total Cash Against Reserves at 6/30/00 Jul-Dec 00 Charges Charges Spent Assets 3/31/01 During January-March, 2001, Organization 2005 costs charged against the Company's cost of products sold amounted to $102 million, while charges included in marketing, research and administrative expenses amounted to $50 million. Charges related to Organization 2005 are included in Corporate in the Company's segment disclosures. The underlying plant closures and consolidations will impact all regions and product segments. Planned plant closures and consolidations will not all be executed immediately due to either capacity or Employee separation charges in January-March, 2001 are associated with severance packages for approximately 550 people, representing primarily administrative employees in North America, Asia, and Europe. The predominantly voluntary packages are formula-driven, based on salary levels and past service. Severance costs related to voluntary separations are charged to earnings when the employee accepts the offer in accordance with Company policy for such programs. On average, net enrollment is expected to decline by approximately 85% of total separations, as some terminations will be partially offset through increased enrollment at remaining sites. Of total separations expected through fiscal 2001, approximately half will take place in manufacturing with the balance in administrative functions. Separation costs related to manufacturing employees are included in cost of products sold, while those for administrative employees are reported in marketing, research and administrative expenses. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period due to manufacturing consolidations, technology standardization and closures that will occur primarily over the next two years as a result of the Organization 2005 program. The Company has changed the estimated useful lives of such assets, resulting in an acceleration of depreciation. Approximately 70% of the $68 million of accelerated depreciation recorded in the January-March, 2001 quarter is concentrated in the paper segment and reflects the standardization of manufacturing and other work processes being undertaken in that segment. Most of the remaining balance is concentrated in the fabric and home care and beauty Charges for other costs related to Organization 2005 amounted to $31 million during the January-March, 2001 quarter, and consisted primarily of costs associated with relocation, training and other Organization 2005-related PART II. OTHER INFORMATION",2109
2001-05-21,8-K,0000080424-01-500014,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) May 21, 2001 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 On May 21, 2001 The Procter & Gamble Company (the ""Company"") issued a news release announcing that the Company will purchase the Clairol business from Bristol-Myers Squibb Company.",104
2001-06-08,8-K,0000080424-01-500018,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 8, 2001 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 On June 8, 2001, The Procter & Gamble Company (the ""Company"") issued a news release announcing that the Company has reached an agreement in principle to settle the securities class action litigation filed against it in connection with the Company's March 2000 earnings announcement.",120
2001-06-15,8-K,0000080424-01-500020,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 15, 2001 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE The Procter & Gamble Company (""P&G"") issued the attached press release today summarizing comments made by A. G. Lafley, president and chief executive, at a securities analysts meeting in New York.",115
2001-08-07,8-K,0000080424-01-500034,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) August 7, 2001 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE On August 7, 2001 The Procter & Gamble Company (the ""Company"") issued a news release with respect to fourth quarter earnings. P&G is filing this 8-K pursuant to the SEC's proposed Regulation FD.",117
2001-08-15,8-K,0000080424-01-500038,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) August 15, 2001 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 August 15, 2001 -- The Procter & Gamble Company (the ""Company"") is issuing this 8-K with respect to a potential transaction with The Coca-Cola Company.",101
2001-09-05,8-K,0000080424-01-500040,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 5, 2001 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 Procter & Gamble today stated that it continues to be comfortable with its prior guidance on the September quarter and for Fiscal Year 2002. On August 7, 2001, the Company estimated that July-September core earnings per share would be up low-to-mid single digits vs. the prior year's September quarter. Additionally, the Company estimated that core earnings per share for Fiscal 2002 were expected to grow at a rate that equals or exceeds the prior year's growth, but not yet at the Company's double-digit earnings growth target.",162
2001-09-12,10-K,0000950152-01-504449,"THE PROCTER & GAMBLE COMPANY FORM 10-K THE PROCTER & GAMBLE COMPANY ANNUAL REPORT ON FORM 10-K SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION ANNUAL REPORT ON FORM 10-K PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2001 Commission File No. 1-434 THE PROCTER & GAMBLE COMPANY One Procter & Gamble Plaza, Cincinnati, Ohio 45202 IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio Securities registered pursuant to Section 12(b) of the Act: Name of each Exchange on which registered Common Stock, without Par Value New York, Cincinnati, Amsterdam, Paris, Basle, Geneva, Lausanne, Zurich, Frankfurt, Brussels, Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes X No . Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 S-K is not contained herein, and will not be contained, to the best of in definitive proxy or information statements incorporated by reference in Part Form 10-K or any amendment to this Form 10-K. There were 1,296,093,087 shares of Common Stock outstanding as of July 31, 2001. The aggregate market value of the voting stock held by non-affiliates amounted to $92 billion on July 31, 2001. Documents Incorporated By Reference Portions of the Annual Report to Shareholders for the fiscal year ended June 30, 2001 are incorporated by reference into Part I, Part II and Part IV of this Portions of the Proxy Statement for the 2001 Annual Meeting of Shareholders are incorporated by reference into Part III of this report. General Development of Business The Procter & Gamble Company was incorporated in Ohio in 1905, having been built from a business founded in 1837 by William Procter and James Gamble. Today, the Company manufactures and markets a broad range of consumer products in many countries throughout the world. Unless the context indicates otherwise, the term the Company as used herein refers to The Procter & Gamble Company (the registrant) and its In 1999, the Company announced its intention to transition from its previous geographic-based structure to a product-based global business unit structure. Concurrent with that change, the Company initiated its Organization 2005 restructuring program, a discussion of which is",419
2001-10-30,8-K,0000080424-01-500072,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) October 30, 2001 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE On October 30, 2001, The Procter & Gamble Company (the ""Company"") issued a news release with respect to first quarter earnings. P&G is filing this 8-K pursuant to the SEC's Regulation FD.",116
2001-10-30,10-Q,0000080424-01-500074,"and Analysis The Company reported earnings of $1.10 billion or $0.79 per share for the quarter ended September 30, 2001. Results included a $238 million after-tax restructuring charge related to the Company's restructuring initiative to streamline its organization structure and business portfolio. Net earnings in the year ago quarter were $1.16 billion, including a $85 million after-tax Core net earnings were $1.34 billion for the quarter or $0.96 per diluted share. Core results exclude restructuring charges in both periods and $53 million after-tax or $0.04 per share of goodwill and intangible asset amortization in the prior period. In the first quarter, the Company adopted the new accounting rules for goodwill and other intangible assets, which prospectively eliminates a significant portion of amortization expense beginning July 1, 2001. Gross margin was 47.7 percent for the current quarter compared to 46.8 percent in the same quarter of the prior year, and 43.7 percent for the full fiscal year ended June 30, 2001. Included in cost of products sold is a $120 million before-tax restructuring charge. Excluding restructuring, gross margin was 48.8 percent, up from 47.4 percent in the year ago quarter due to lower material costs and other cost savings programs. Operating margin was 18.0 percent for the current quarter compared to 17.8 percent in the same quarter a year ago and 12.1 for the prior fiscal year. Excluding $310 million before tax in restructuring charges and the prior year impact of goodwill amortization, operating margin was 21.3 percent, up from 19.5 percent in the year ago period. Operating margin progress was driven by gross margin improvement, overhead cost reductions and marketing support efficiencies. The following provides additional perspective on the Company's results by Fabric and home care's focus on leadership brands and improved fundamentals is beginning to show promising results in key markets. However, prior year comparisons are difficult due to a very high base that included significant customer buying in advance of a price increase in North America laundry. Unit volume decreased two percent versus the prior year comparison, despite growth in Western Europe and developing markets. Excluding two percent negative foreign exchange and a one percent impact of divestitures in the prior year, net sales of $2.88 billion were down three percent. Net earnings were down 10 percent to $450 million versus year ago, primarily due to lower sales and minor brand divestitures in the prior year. BABY, FEMININE AND FAMILY CARE The baby, feminine and family care segment generated earnings growth as the business responds to improved consumer value propositions. Unit volume grew four percent, driven by family care. Net sales of $3.00 billion were up two percent excluding a three percent unfavorable exchange impact. Net earnings for the quarter increased four percent to $342 million due to lower commodity costs and other cost structure improvements. In baby care, net sales were up behind strength in Baby Wipes and double-digit growth in Central and Eastern Europe, the Middle East and Africa, and in China. In family care, sales were up strongly as the North American business continues to respond to an improved value Beauty care results demonstrate the benefit of portfolio shifts into higher margin products behind leadership innovation. Unit volume was down slightly due to Clearasil divestiture impacts; however, earnings growth was outstanding. Net sales were $1.77 billion, comparable to the prior year after excluding a three percent impact of unfavorable currencies and a two percent impact of divestitures. Net earnings grew 22 percent to $326 million, primarily due to marketing support efficiencies behind growing businesses and lower launch expenditure, coupled with disciplined cost management. Additionally, the majority of key markets achieved double-digit earnings progress, with Latin America providing the strongest growth behind the successful restages of Pantene Health care delivered double-digit growth behind the sustained development of initiative programs on leading brands. Unit volume was up 19 percent driven by excellent results in oral care, Iams pet health and nutrition, and pharmaceuticals. Net sales grew 21 percent to $1.18 billion, excluding a two percent unfavorable exchange impact. Net earnings increased 73 percent to $140 million, reflecting the benefit of high margin brands driving growth. In oral care, Spinbrush is vying for value share leadership in the U.S. electric toothbrush market, while Whitestrips achieved $100 million in net sales since its launch in May 2001. Iams continues to grow behind initiatives and channel expansion. Pharmaceuticals continued growth was driven by Actonel, which built prescription share in the United States, Canada and key European markets. Food and beverage achieved solid earnings progress during the quarter. Excluding divestitures, unit volume declined two percent. Net sales were $955 million, down from the prior year level of $1.05 billion. The decrease is attributable to divestitures, unfavorable foreign exchange impact and commodity-related pricing actions in coffee. Importantly, net earnings grew to $99 million, a 32 percent increase, behind heightened cost savings efforts in juice and coffee. The corporate segment, which contains both operating and non-operating items is not included in the business results. The change in net earnings for the corporate segment was driven by increased restructuring charges due to the expansion of the program announced last fiscal year. Net debt (total debt less cash) increased $32.3 million since June 30, 2001, as increases in debt, primarily to fund the Company's ongoing share repurchase program, were partially offset by increases in operating cash flow. For the three-month period ended September 30, 2001, cash generated from operating activities totaled $1.3 billion, slightly up from $1.1 billion in the same period in the prior year. The increase resulted primarily from improvements RESTRUCTURING PROGRAM UPDATE Beginning in 1999 - concurrent with the Company's reorganization into product-based global business units - the Company initiated its Organization 2005 restructuring program. The program was expanded in March, 2001 to deliver further cost reductions through reduced overhead, further manufacturing consolidations, and discontinuation of under-performing businesses and Costs to be incurred include separation related expenses, asset write-downs or accelerated depreciation, results of certain initiatives being discontinued and other costs directly related to the restructuring effort. These costs are reported in the corporate segment for management and external reporting. During the quarter ended September 30, 2001, the Company recorded charges totaling $310 million before tax ($238 million after tax) related to restructuring. The charges to cost of products sold amounted to $120 million before tax and charges included in marketing, research and administrative expenses amounted to $214 million before tax. Business results from certain initiatives being discontinued included $24 million before tax of net sales which are nearly offset by related costs in the current period restructuring charges. Further details are shown in the following table: Restructuring Program July-September, 2001 Charges (before tax) Beginning Current Charged Ending Reserves Quarter Cash Against Reserves at 6/30/01 Charges Spent Assets 9/30/01 Employee separation charges of $212 million before tax in July - September, 2001 are associated with severance packages for approximately 3,000 people. The packages are predominantly voluntary and are formula driven based on salary levels and past service. Severance costs related to voluntary separations are charged to earnings when the employee accepts the offer. The current and planned separations span the entire organization, including manufacturing, selling, research and administrative positions. The charges for accelerated depreciation and asset write-downs, which totaled $63 million before tax in the first quarter, are primarily related to manufacturing operations. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period due to manufacturing consolidations, technology standardization, plant closures or strategic choices to discontinue initiatives. The Company has shortened the estimated useful lives of such assets, resulting in incremental depreciation expense. Charges for asset write-downs relate to the establishment of new fair value bases for assets held for sale or disposal that represent excess capacity in the process of being removed from service or disposed and businesses held for sale in the next 12 months. Other costs incurred as a direct result of the restructuring program amounted to $35 million before tax during the July - September, 2001 quarter. These were primarily for relocation, training, establishment of global business services and results from discontinued initiatives. There are two additional areas for which additional discussion is provided: accounting for goodwill and intangible amortization, and disclosure of Effective July 1, 2001, the Company adopted FASB Statement Nos. 141 and 142, Business Combinations and Accounting for Goodwill and Other Intangible Assets. FASB Statement No. 141 requires a fundamentally different approach to accounting for business combinations, requiring that virtually all business combinations be accounted for as acquisitions at fair value. The former pooling of interests method has been eliminated. These rules will be applicable to all subsequent acquisitions, including the planned acquisition of Clairol. FASB Statement No. 142 eliminates the amortization of goodwill and certain intangible assets. Rather, goodwill and intangibles not subject to amortization will be tested for impairment at least annually by comparing their fair values with their recorded amounts. The impact of adopting these new requirements is discussed further in Footnote 4. Annually the Company discloses advertising expense, which is a component of its marketing, research and administrative expense. This amount reflects primarily media and media-related costs. In the prior year disclosure a misclassification occurred. For the years ended June 30, 2001, 2000 and 1999 the correct amounts of advertising expense were: $3,612, $3,793, and $3,639, respectively. As a percent of net sales, this would be 9.2%, 9.5% and 9.6% for 2001, 2000, and 1999. This reclassification only affects the advertising expense disclosure and has no effect on total marketing, research and administrative expense, operating PART II. OTHER INFORMATION",1602
2001-11-16,8-K,0000080424-01-500080,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) November 16, 2001 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 2. ACQUISITION OR DISPOSITION OF ASSETS On November 15, 2001, The Procter & Gamble Company (""P&G"") completed the purchase of the Clairol hair care business of Bristol-Byers Squibb (""BMS"") for $4.95 billion in cash. The Clairol acquisition includes the acquisition of Clairol's hair colorant brands, including Nice 'n Easy, Natural Instincts, Miss Clairol and Hydrience, and Clairol's hair care brands, including Herbal Essences, Aussie and Infusium. This acquisition included the purchase of all of the capital stock of Clairol, Inc. held by BMS and additional assets used by BMS in the worldwide Clairol business. P&G intends to use such assets for the same purpose following the acquisition. The purchase price of $4.95 billion was determined by arm's length negotiations between P&G and BMS. The acquisition was financed with approximately $500 million in current cash and $4.5 billion in debt raised by the issuance of commercial paper immediately prior to the closing of the The Stock and Asset Purchase Agreement dated May 20, 2001 between P&G and BMS was filed as Exhibit 2-1 to P&G's Annual Report on Form 10-K for the fiscal year ended June 30, 2001, and is",266
2001-12-11,8-K,0000080424-01-500083,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) December 11, 2001 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE On December 11, 2001 The Procter & Gamble Company (the ""Company"") issued a news release with respect to second quarter earnings. P&G is filing this 8-K pursuant to the SEC's Regulation FD.",116
2002-01-31,8-K,0000080424-02-000002,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) January 31, 2002 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE On January 31, 2002, The Procter & Gamble Company (the ""Company"") issued a news release with respect to second quarter earnings. P&G is filing this 8-K pursuant to the SEC's Regulation FD.",116
2002-02-05,10-Q,0000080424-02-000004,"and Analysis The Company reported net earnings of $1.30 billion or $0.93 per share for the quarter ended December 31, 2001. Results included a $146 million after-tax restructuring charge related to the Company's streamlining of operations and business portfolio. Net earnings in the year ago quarter were $1.19 billion, including a $120 million after-tax restructuring charge. Core net earnings were $1.03 per share or $1.45 billion for the current quarter, compared to $0.97 per share or $1.37 billion in the year ago quarter. These results exclude restructuring charges in both periods. Additionally, the year ago quarter excludes $55 million after-tax, or $0.04 per share, for amortization of goodwill and certain intangible assets that are not required in the current Net sales were $10.40 billion, up two percent versus year-ago. Unit volume grew five percent versus the prior year, led by double-digit growth in the health and beauty care businesses. Excluding acquisitions and divestitures, unit volume increased four percent. Pricing had a two percent negative impact on sales in the quarter, consistent with plans to achieve more competitive levels and address the impacts of commodity prices. Foreign exchange had a negative one percent impact on net sales. Business segment after tax earnings were up 12 percent, reflecting increased volume and improved manufacturing costs. Beauty care and fabric and home care generated two-thirds of the net earnings growth. For the first six months, reported net earnings were $2.40 billion, or $1.71 per share. Results included a $384 million after-tax charge related to the restructuring program. Excluding restructuring charges and the prior year amortization of goodwill and certain intangibles, core net earnings were $2.79 billion in 2001 and $2.66 billion in 2000. Core net earnings per share grew five percent to $1.99 in the current year. Net sales were up two percent, excluding a two percent negative foreign exchange impact. Gross margin was 48.7 percent for the current quarter, compared to 46.8 percent in the same quarter of the prior year, and 43.7 percent for the full fiscal year ended June 30, 2001. This margin progress reflects lower manufacturing costs and the benefits of previous restructuring actions. Cost of products sold includes an $82 million before-tax restructuring charge. Excluding restructuring costs, gross margin was 49.4 percent, compared to 47.6 percent in the year ago quarter. Operating margin was 17.9 percent for the quarter, compared to 16.8 percent in the same quarter year ago, and 12.1 percent for the prior fiscal year. Excluding restructuring charges and amortization of goodwill and certain intangible assets in the year ago quarter, operating margin grew to 19.8 percent from 18.9 percent. Operating margin progress was driven by gross margin improvement. Marketing, research and administrative costs reflect good progress on base savings programs, but increased due to costs associated with the integration of Clairol and increased investments in health care. Fabric and home care results improved during the second quarter, with four percent volume growth behind strength in Europe fabric care and improved performance in North America home care. Net sales were $2.97 billion, up one percent, as minor pricing and mix impacts in Western Europe and Asia partially offset increased volume. Net earnings were $437 million, up 12 percent, due to disciplined cost management led by North America and Western Europe and increased marketing support efficiencies. Year-to-date, unit volume reflected a one percent increase while net sales declined three percent. Net earnings were flat versus year ago. BABY, FEMININE & FAMILY CARE Baby, feminine and family care reflected solid results. Unit volume increased three percent behind strong family care volume, particularly on Bounty(R) in North America and baby care's Pamper's Wipes(R). Net sales were $3.03 billion, down one percent, as commodity-driven price moves in family care and targeted pricing actions in baby care more than offset volume growth. Earnings were $335 million, up 14 percent, behind a strong focus on cost efficiencies including For the first six months of the year, unit volume increased three percent. Net sales declined one percent while earnings grew eight percent. Beauty care continued to deliver strong results led by progress in hair care across all regions. Unit volume increased 15 percent driven by the Clairol acquisition. Excluding the impact of acquisitions and divestitures, volume was up three percent. Net sales were $2.06 billion, up 13 percent, excluding a two percent negative exchange impact, as strength in hair care - driven by Pantene(R), Head & Shoulders(R) and Clairol - was partially offset by price adjustments in North America's personal cleansing category. Excluding acquisitions and divestitures, net sales were up two percent. Net earnings were $334 million, up 17 percent versus last year despite increased costs associated with the integration of Clairol. This earnings increase was driven by a continued focus on cost control and higher launch costs in the base period. For the first six months of the fiscal year, unit volume was up seven percent. Net sales increased three percent while net earnings grew 19 percent. Excluding the impact of acquisitions and divestitures, volume increased two percent and net sales declined one percent during this six month period. Health care posted strong results, with double-digit volume and sales growth, led by oral care and pharmaceuticals. Unit volume increased 15 percent driven by strong sales of Actonel(R) and Crest(R) (particularly White Strips(R) and Spinbrush(R)). Net sales grew 17 percent to $1.34 billion behind volume growth and positive mix effects. Crest joined the ranks of P&G's billion dollar brands, achieving $1.0 billion in sales in calendar year 2001. Net earnings were $172 million, up five percent, as investments behind oral care initiatives and pharmaceutical development partially offset gains due to volume. On a year-to-date basis, unit volume was up 17 percent and net sales were up 18 percent. Net earnings grew 27 percent behind these strong volume and net sales Net earnings in food and beverage increased despite a divestiture in the prior year and commodity-related pricing actions. Net sales declined 11 percent to $1.05 billion on a nine percent unit volume decline. Excluding the divestiture impacts, unit volume was down five percent reflecting an increased competitive merchandising environment. Pricing also contributed to decreased sales as we continued to reflect lower green coffee costs into Folgers(R) pricing. Net earnings were $126 million, up two percent, behind restructuring savings in juice and coffee and other cost savings efforts offset by lower volumes. For the first half of the year, unit volume was down eight percent while net sales were down ten percent and net earnings grew 13 percent. The corporate segment contains both operating and non-operating items that are not included in the business results. The comparability of corporate results is affected by a reduction in divestiture gains and higher restructuring costs in the current year. These more than offset the benefit from the accounting change to no longer amortize goodwill and certain intangibles, effective in the current FINANCIAL CONDITION & LIQUIDITY For the six-month period ended December 31, 2001, cash generated from operating activities totaled $3.2 billion, up $0.9 billion from the same period in the prior year. The increase in operating cash flow was primarily due to changes in working capital levels. Progress on accounts receivable continues while inventory levels are up slightly, primarily in food and beverage and baby, feminine and family care. This reflects both volume trends and initiative activity. Accounts payable and accruals delivered a significant amount of cash flow improvement, reflecting the timing of payments for accruals. Accounts payable were relatively stable. Investing activities and financing activities reflect the impacts of the Clairol acquisition and associated financing. Initial funding for the acquisition was primarily achieved with short-term debt. Importantly, capital spending declined $583 million, reflecting increased efficiencies across multiple business units primarily in North America. The decline in proceeds from asset sales is consistent with reduced divestitures gains. COMMITMENTS AND CONTINGENCIES On January 22, 2002, the Securities and Exchange Commission issued an interpretive release on disclosures related to liquidity and capital resources, including off-balance sheet arrangements. The Company does not have material off-balance sheet arrangements or related party transactions. The Company is not aware of factors that are reasonably likely to adversely affect liquidity trends, other than the",1359
2002-03-19,8-K,0000080424-02-000011,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) March 19, 2002 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE On March 19, 2002, The Procter & Gamble Company (the ""Company"") issued a news release with respect to an update on anticipated third quarter earnings. P&G is filing this 8-K pursuant to the SEC's Regulation FD.",120
2002-04-30,8-K,0000080424-02-000018,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) April 30, 2002 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE On April 30, 2002, The Procter & Gamble Company (the ""Company"") issued a news release with respect to third quarter earnings. P&G is filing this 8-K pursuant to the SEC's Regulation FD.",116
2002-05-02,10-Q,0000080424-02-000020,"and Analysis The Company reported net earnings of $1.04 billion or $0.74 per share for the quarter ended March 31, 2002. Results included a $147 million after-tax restructuring charge related to the Company's streamlining of operations and business portfolio. This restructuring charge included employee separation costs of $51 million before tax and asset-related charges of $83 million before tax. Net earnings in the year ago quarter were $893 million, including a $113 million after-tax restructuring charge. Core net earnings were $0.84 per share or $1.19 billion for the current quarter, compared to $0.75 per share or $1.06 billion in the year ago quarter. These results exclude restructuring charges in both periods. Additionally, the year ago quarter excludes $56 million after-tax, or $0.04 per share, for amortization of goodwill and certain intangible assets that are not required in the current Net sales were $9.90 billion, up four percent versus year ago. Unit volume grew ten percent versus the prior year, led by double-digit growth in the health and beauty care businesses and strong progress in fabric and home care. Excluding acquisitions and divestitures, unit volume increased six percent. Pricing and mix had a three percent negative impact on sales in the quarter, due to the pass through of lower commodity costs, structural price adjustments in fabric and baby care and mix effects. Foreign exchange had a negative three percent impact For the first nine months, reported net earnings were $3.44 billion, or $2.45 per share. Results included a $531 million after-tax charge related to the restructuring program. This restructuring charge includes employee separation costs of $348 million before tax and asset-related charges of $224 million before tax. Excluding restructuring charges and the prior year amortization of goodwill and certain intangibles, core net earnings were $3.97 billion in 2002 and $3.72 billion in 2001. Core net earnings per share grew seven percent to $2.83 in the current year. Net sales for the first nine months were $30.1 billion, up three percent, excluding a two percent negative foreign exchange Gross margin was 48.8 percent for the quarter ended March 31, 2002, compared to 45.6 percent in the same quarter of the prior year. Excluding restructuring costs, gross margin was 49.8 percent, compared to 46.7 percent in the year ago quarter. This margin progress reflects the benefits of restructuring actions, lower material costs and benefits from improved corporate portfolio mix. Cost of products sold includes a $107 million before-tax restructuring charge. Operating margin was 16.7 percent for the quarter, compared to 13.7 percent in the same quarter year ago, and 12.1 percent for the prior fiscal year. Excluding restructuring charges and amortization of goodwill and certain intangible assets in the year ago quarter, operating margin grew to 18.7 percent from 15.9 percent. Operating margin progress was driven by gross margin improvement. Marketing, research and administrative costs reflect continued progress from restructuring, but increased due to costs associated with the integration of Clairol and increased marketing investments. Fabric and home care delivered excellent results, with six percent volume growth behind strength in North America. Net sales were $2.84 billion, up two percent, as pricing adjustments in Western Europe and Latin America partially offset increased volume. Net earnings were $472 million, up 36 percent, due to a continued focus on disciplined cost management led by North America and Western Year-to-date, unit volume reflected a two percent increase while net sales declined one percent. Net earnings increased 10 percent versus year ago. BABY, FEMININE & FAMILY CARE Baby, feminine and family care reflected solid earnings growth. Unit volume increased four percent behind strong North America family care volume and strong Pamper's(R) growth. Net sales were $2.90 billion, down one percent, as volume growth partially offset the negative impact of foreign exchange and pricing adjustments to improve consumer value, including commodity-driven price moves. Earnings were $263 million, up 11 percent, including a non-operating gain from a licensing transaction with an unconsolidated joint venture. Excluding this one-time gain, earnings would have been up four percent, reflecting gross margin improvement from manufacturing projects and commodity price reductions that funded increased marketing investment. For the first nine months of the year, unit volume increased four percent. Net sales declined one percent while earnings grew nine percent. Beauty care posted strong results with double-digit volume, sales and earnings growth led by hair care and fine fragrances. Unit volume increased 28 percent driven by the Clairol acquisition. Excluding the impact of acquisitions and divestitures, volume was up four percent behind hair care. Net sales were $2.11 billion, up 18 percent. Volume growth was partially offset by mix impacts driven by the Clairol acquisition and negative foreign exchange. Excluding acquisitions and divestitures, net sales were up one percent versus year ago. Net earnings were $269 million, up 11 percent versus last year. The relationship between earnings and top-line growth reflects mix effects from the Clairol acquisition. For the first nine months of the fiscal year, unit volume was up 14 percent (up three percent excluding acquisitions and divestitures). Net sales increased eight percent while net earnings grew 17 percent. Health care continued to deliver strong results, as unit volume increased 16 percent, driven by strength in oral care, pharmaceuticals and pet health and nutrition. Net sales grew 11 percent to $1.22 billion behind strength in Crest Whitestrips and Spinbrush. Net earnings were $124 million, up 36 percent, reflecting volume and sales growth of high margin items, which has funded increased marketing investments. On a year-to-date basis, unit volume was up 17 percent and net sales were up 15 percent. Net earnings grew 30 percent behind these strong volume and net sales Net earnings in food and beverage increased behind broad-based cost reductions. Unit volume is showing improvement after a slow start to the fiscal year but was down one percent. Net sales declined six percent to $879 million as Folgers(R) pricing continued to reflect lower green coffee costs. Net earnings were $79 For the first nine months of the year, unit volume was down six percent (down three percent excluding acquisitions and divestitures) while net sales were down nine percent and net earnings grew 14 percent. The corporate segment contains both operating and non-operating items that are not included in the business results. The comparability of corporate results is affected by a reduction in divestiture gains and higher restructuring costs in the current year. These more than offset the benefit from the accounting change to no longer amortize goodwill and certain intangibles, effective in the current For the nine-month period ended March 31, 2002, cash generated from operating activities totaled $5.4 billion, up $1.6 billion from the same period in the prior year. Combined with earnings growth, this year-over-year increase reflects the benefit of a non-recurring shift in payment timing on certain operating accruals. Capital expenditures are down significantly versus prior year ($0.7 billion) achieving our long-term six percent of sales target several quarters ahead of expectations. This reflects increased efficiencies across multiple business units, primarily in North America. Asset sale proceeds from divestitures are down from the prior year due to larger divestitures last year (Clearasil, Spic & Span, Brooklands), generating a year- over-year cash decrease of $0.6 billion. Acquisitions in the current year reflect primarily the purchase of Clairol, which resulted in a year-over-year decline in cash partially offset by an increase in short-term debt. The Company maintains share repurchase programs, which authorize the purchase of shares on the open market to mitigate the dilutive impact of employee compensation programs. For the nine months ended March 31, 2002, the purchase of treasury shares was $0.4 billion compared to $1.2 billion in the same period in the prior year. This temporary decline was primarily driven by cash requirements for the Clairol acquisition. RESTRUCTURING PROGRAM UPDATE Concurrent with the Company's reorganization into product-based global business units, a multi-year restructuring program was initiated in 1999. The program will deliver cost reductions through reduced overhead, manufacturing consolidations, operational streamlining and discontinuation of under-performing businesses and initiatives. Restructuring charges include separation-related expenses, asset write-downs or accelerated depreciation, costs relating to certain discontinued initiatives and other costs directly related to the restructuring effort. These costs are reported in the corporate segment for management and external reporting. During the quarter ended March 31, 2002, the Company recorded charges totaling $191 million before tax ($147 million after tax) related to restructuring, as detailed in the following table: RESTRUCTURING PROGRAM JULY, 2001 - MARCH, 2002 CHARGES (BEFORE TAX) Beginning Quarters Current Applied Ending Reserves Charges Quarter Total Cash Against Reserves At 6/30/01 Jul-Dec 01 Charges Charges Spent Assets 3/31/02 During January - March 2002, restructuring charges against the Company's cost of products sold amounted to $107 million before tax and charges included in marketing, research and administrative expenses amounted to $99 million before tax. In addition, the Company had $15 million of net sales from initiatives being discontinued, which are reflected in corporate. Employee separation charges in January - March 2002 are associated with severance packages for approximately 1,000 people. The packages are predominantly voluntary and are formula driven based on salary levels and past service. Severance costs related to voluntary separations are charged to earnings when the employee accepts the offer. The current and planned separations span the entire organization, including manufacturing, selling, research and administrative positions. The charges for accelerated depreciation and asset write-downs, which totaled $76 million before tax in the quarter ended March 31, 2002, are primarily related to manufacturing operations. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period due to manufacturing consolidations, technology standardization, plant closures or strategic choices to discontinue initiatives. The Company has shortened the estimated useful lives of such assets, resulting in incremental depreciation expense. Charges for asset write-downs relate to the establishment of new fair value bases for assets held for sale or disposal that represent excess capacity in the process of being removed from service or disposed and businesses held for sale in the next 12 months. Additionally, asset write-downs include certain manufacturing assets that are expected to operate at levels significantly below their planned capacity. The projected cash flows from such assets over their remaining useful lives were no longer estimated to be greater than their current carrying values; therefore, they were written down to estimated fair value, generally determined by reference to discounted expected future cash flows. Such charges represented $15 million before tax in this quarter. Other costs incurred as a direct result of the restructuring program amounted to $64 million before tax during January - March, 2002. These were primarily for relocation, training, establishment of global business services and results from discontinued initiatives. PART II. OTHER INFORMATION",1786
2002-06-12,8-K,0000080424-02-000026,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 12, 2002 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE On June 12, 2002, The Procter & Gamble Company (the ""Company"") issued a news release with respect to an update on anticipated fourth quarter earnings. P&G is filing this 8-K pursuant to the SEC's Regulation FD.",120
2002-08-05,8-K,0000080424-02-000035,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) August 5, 2002 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On August 5, 2002, The Procter & Gamble Company (the ""Company"") issued a news release with respect to fourth quarter earnings and guidance for the upcoming fiscal year. P&G is filing this 8-K pursuant to the SEC's Regulation",119
2002-09-05,8-K,0000080424-02-000042,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 5, 2002 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 On Septemer 5, 2002, The Procter & Gamble Company (the ""Company"") issued a news release with respect to sales and earnings per share growth guidance for the September 2002 quarter. P&G is filing this 8-K pursuant to",113
2002-09-12,8-K,0000080424-02-000050,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) September 12, 2002 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE. On September 12, 2002, the Chief Executive Officer, A.G. Lafley, and Chief Financial Officer, Clayton C. Daley, Jr., of the Registrant delivered to the Secretary of the Securities and Exchange Commission in accordance with SEC Order No. 4-460 statements under oath regarding facts and circumstances relating to the Annual Report of the Registrant on Form 10-K for the fiscal year ended June 30, 2002. Copies of the statements are attached as Exhibits 99.1 and 99.2.",158
2002-09-12,10-K,0000950152-02-006968,"The Procter & Gamble Company 10-K/FYE 6-30-02 ANNUAL REPORT ON FORM 10-K SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION ANNUAL REPORT ON FORM 10-K PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2002 Commission File No. 1-434 THE PROCTER & GAMBLE COMPANY One Procter & Gamble Plaza, Cincinnati, Ohio 45202 IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio Securities registered pursuant to Section 12(b) of the Act: Name of each Exchange on which registered Common Stock, without Par Value New York, Cincinnati, Amsterdam, Paris, Basle, Geneva, Lausanne, Zurich, Frankfurt, Brussels, Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 S-K is not contained herein, and will not be contained, to the best of in definitive proxy or information statements incorporated by reference in Part Form 10-K or any amendment to this Form 10-K. o There were 1,300,493,412 shares of Common Stock outstanding as of July 31, 2002. The aggregate market value of the voting stock held by non-affiliates amounted to $116 billion on July 31, 2002. Item 3. Legal Proceedings. Item 4. Submission of Matters to a Vote of Security Holders. Item 5. Market for the Common Stock and Related Stockholder Matters Item 6. Selected Financial Data Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations Item 7A. Quantitative and Qualitative Disclosures About Market Risk Item 8. Financial Statements and Supplemental Data Item 9. Disagreements on Accounting and Financial Disclosure Item 10. Directors and Executive Officers Item 11. Executive Compensation Item 12. Security Ownership of Certain Beneficial Owners and Management Item 13. Certain Relationships and Related Transactions Item 14. Exhibits, Financial Statements, Schedules and Reports on Form 8-K EX. 10-8 The P&G 1992 Stock Plan (Belgian Version) EX. 10-9 The Procter & Gamble Future Shares Plan EX. 11 Computation of Earnings Per Share EX.12 Comput. of Ratio of Earnings to Fixed Chrgs EX. 21 The Procter & Gamble Company Subsidiaries EX. 23 Independent Auditors Consent EX. 99-1 Certification of Periodic Financial Rprts EX. 99-3 Dir. & Off. 1st & 6th Excess Liab. Binder EX. 99-4 Dir. & Off. 2nd Excess Liability Binder EX. 99-5 Dir. & Off. 3rd Excess Liability Binder EX. 99-6 Dir. & Off. 4th Excess Liability Binder EX. 99-7 Dir. & Off. 5th Excess Liability Binder EX. 99-8 Dir. & Off. 7th Excess Liability Binder Documents Incorporated By Portions of the Annual Report to Shareholders for the fiscal year ended June 30, 2002 are incorporated by reference into Part I, Part II and Part IV of this Portions of the Proxy Statement for the 2002 Annual Meeting of Shareholders are incorporated by reference into Part III of this report. The Procter & Gamble Company was incorporated in Ohio in 1905, having been built from a business founded in 1837 by William Procter and James Gamble. Today, the Company manufactures and markets a broad range of consumer products in many countries throughout the world. Unless the context indicates otherwise, the term the Company as used herein refers to The Procter & Gamble Company (the registrant) and its In 1999, the Company announced its intention to transition from its previous geographic-based structure to a product-based global business unit structure. Concurrent with that change, the Company initiated a multi-year restructuring program, a discussion of which is",620
2002-09-27,8-K,0000080424-02-000141,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 27, 2002 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 On Septemer 27, 2002, The Procter & Gamble Company (the ""Company"") issued a news release with respect to volume, sales and earnings per share growth guidance for both the September 2002 quarter and the fiscal year. P&G is filing this 8-K pursuant to the SEC's Regulation FD.",123
2002-10-24,8-K,0000080424-02-000162,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) October 24, 2002 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 As disclosed in its Annual Report on Form 10-K, on May 31, 2002, The Procter & Gamble Company (the ""Company"") completed its spin-off of the Jif and Crisco brands. In addition, effective July 1, 2002, the Company realigned the management of its feminine care business from Baby, Feminine & Family Care to Beauty Care. To reflect these management and business changes, the Company has realigned its internal and external reporting segments. Beginning in the first quarter of fiscal year 2003 (July - September 2002), the feminine care business will be included in the Beauty Care segment, and the former Baby, Feminine & Family Care segment will become Baby & Family Care. The former Food & Beverage segment will be renamed Snacks & Beverages, reflecting the remaining As required by FASB Statement No. 131, DISCLOSURES ABOUT SEGMENTS OF AN ENTERPRISE AND RELATED INFORMATION, prior year segment results have been reclassified to reflect these changes and provide comparable current and historical results. The elements of the former Food & Beverage segment that were spun off or divested, including Jif, Crisco and commercial shortening and oils, are now presented as part of Corporate. This change affects only the presentation of segment results and does not affect the consolidated results of The Procter & Gamble Company. For information, selected interim segment information is provided in this 8-K filing. Full segment information will be presented in the Company's P&G is filing this 8-K pursuant to the SEC's Regulation FD.",320
2002-10-29,8-K,0000080424-02-000163,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) October 29, 2002 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 On October 29, 2002, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended September 30, 2002. P&G is filing this 8-K pursuant to the SEC's Regulation FD.",113
2002-10-29,8-K,0000080424-02-000165,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) October 29, 2002 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 On October 29, 2002, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended September 30, 2002. P&G is filing this 8-K pursuant to the SEC's Regulation FD.",113
2002-10-31,10-Q,0000080424-02-000168,"and Analysis Despite continuing softness in the global economy, and in particular in the Latin American region, the Company delivered double-digit volume, sales and earnings growth for the quarter ended September 30, 2002. For a discussion of key factors that could impact and must be managed by the Company, refer to the Management Discussion and Analysis section in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2002. The Company reported net earnings of $1.46 billion or $1.04 diluted net earnings per share for the quarter ended September 30, 2002. Results included a $113 million after-tax restructuring charge related to the program to streamline the Company's operations and business portfolio. This restructuring program charge included employee separation costs of $52 million before tax and asset-related charges of $62 million before tax. Net earnings in the year ago quarter were $1.10 billion or $0.79 diluted net earnings per share, including a $238 million after-tax restructuring charge. The restructuring charge for the year ago quarter include employee separation costs of $212 million before tax and asset-related charges of $69 million before tax. Core net earnings were $1.58 billion or $1.12 diluted net earnings per share for the current quarter, compared to $1.34 billion or $0.96 core diluted net earnings per share in the year ago quarter. These results exclude restructuring program charges in both periods. Net sales were $10.80 billion, up eleven percent versus the year ago quarter. Unit volume grew thirteen percent versus the prior year, led by double-digit growth in the fabric and home care, health care and beauty care businesses. Excluding acquisitions and divestitures, unit volume increased ten percent. Sales trailed volume growth as a three-percent negative pricing and mix impact was partially offset by a positive foreign exchange impact of one percent. The pricing and mix impact was a function of the following primary effects: the pass through of lower commodity costs to consumers in coffee and tissue and structural price adjustments in baby care; negative mix impacts in beauty care, primarily related to Clairol; and continuing strong growth of the Company's developing market businesses which typically have a lower sales rate per unit and growth in mid-tier laundry brands. Gross margin was 49.2 percent for the quarter ended September 30, 2002, compared to 47.7 percent in the same quarter of the prior year. Cost of products sold includes a $83 million before-tax charge related to the restructuring program. Excluding restructuring costs, gross margin was 50.0 percent, compared to 48.8 percent in the year ago quarter. This gross margin progress reflects the benefits from improved corporate portfolio mix, ongoing base business and restructuring savings and lower material costs. Operating margin was 20.2 percent for the quarter, compared to 18.0 percent in the same quarter a year ago. Excluding restructuring charges, core operating margin increased to 21.6 percent from 21.3 percent, as gross margin improvement was offset by increased core marketing, research, administrative and other (MRA&O) costs. Core MRA&O as a percent of sales increased to 28.4 percent from 27.5 percent in the same quarter a year ago, reflecting increased marketing investments and investments in pharmaceuticals for clinical trials for our ongoing feminine testosterone research and milestone payments for our diabetes product research per our contractual agreements, partially offset by continued progress from the Company's restructuring program. Non-operating income increased $81 million, which includes the gain from the divestiture of the non strategic elements of the Company's Vicks business in As discussed in Note 3, segments have been restated for recent management and Fabric and home care delivered eleven percent volume growth reflecting innovation across all brands. Net sales were $3.13 billion, up nine percent, including a positive one percent foreign exchange impact. Sales trailed volume growth primarily due to strong performance on mid-tier brands and in developing markets, which resulted in a negative sales mix impact. Net earnings were $547 million, up 22 percent, reflecting higher volumes and a strong cost management focus. Operating margin expansion was achieved through lower material prices and a continued focus on base business savings projects, which funded increased All regions posted double-digit volume increases in fabric care except Latin America, where markets are contracting reflecting the tough economic environment and sharp currency erosion. However, the Company maintained laundry category share leadership in Latin America and shares are up versus prior year. Baby and family care delivered unit volume growth of six percent behind strength in baby care in North America and Western Europe. Net sales were $2.43 billion, up five percent, as pricing adjustments to reflect lower commodity costs and improved consumer value on Luvs were partially offset by a positive one percent foreign exchange impact and product mix toward premium tier diapers and pants. Earnings were $241 million, up eight percent, reflecting sales growth, particularly in premium tier diapers, and manufacturing and restructuring cost Despite four percent volume growth in family care, shares were down slightly due to aggressive competitive promotional spending - well beyond levels associated with passing on lower pulp prices to consumers. The Company has responded to these actions, but is anticipating a reversal of the spending trends as pulp costs start to increase. Baby care volume grew double-digits in both North America and Western Europe, leading to strong share growth in the quarter driven by the Pampers Baby Stages initiative. Beauty care posted double-digit volume, sales and earnings growth. Unit volume increased 32 percent led by the Clairol acquisition. Excluding the impact of acquisitions and divestitures, volume was up ten percent behind strength in hair care and fine fragrances. The hair care business was particularly strong, with North America delivering broad-based volume progress across the hair care portfolio. Western Europe and China hair care were also notably strong, where both Pantene and Head & Shoulders delivered excellent volume growth. Feminine care volume grew in the high single digits after several quarters of declines, with the U.S. delivering double-digit volume growth. Net sales were $3.12 billion, up 27 percent including a two percent positive foreign exchange impact. Volume growth was partially offset by mix impacts driven by the Clairol business. Net earnings were $548 million, up 23 percent versus last year as manufacturing cost reductions were partially offset by increased marketing investments, primarily in advertising. Health care continued to deliver strong results. Unit volume increased 19 percent, driven by strength in pharmaceuticals, behind strong Actonel once-a-week results, and oral care. Net sales grew 20 percent to $1.41 billion, including a positive one percent foreign exchange impact. Net earnings for health care were $196 million, up 40 percent, reflecting volume and sales growth of high margin items, such as Crest Whitestrips and Actonel. This growth is after the funding of increased clinical and milestone costs in pharmaceuticals. The oral care business continued to grow strongly in all major tooth care segments: dentifrice, toothbrushes and whitening systems. Crest Whitestrips results have been very strong, with volume double the prior year. Recently, the Company has responded to a competitive entry into the tooth whitening category by announcing a price decline, of approximately 30%, effective in October 2002. Additionally, the expected FDA approval timing on Prilosec OTC has moved to the fall of 2003. This new timeline has no material impact to the Company's expected results for the current fiscal year. Snacks and beverages delivered good results as unit volume increased four percent behind strength in the snacks businesses offset by softness in beverages. Net sales grew three percent to $822 million, including a two percent positive foreign exchange impact. Results reflect the Folgers' pricing response to aggressive competitive pricing activity in the marketplace and continued lower green coffee costs. Snacks delivered double-digit volume growth, with progress in both Pringles and Torengos. Net earnings grew strongly, up 23 percent to $91 million, driven by volume growth and a continued focus on cost The corporate segment contains both operating and non-operating items that are not included in the business results. Current year results reflect increased divestiture gains and lower restructuring costs. For the quarter ended September 30, 2002, cash generated from operating activities totaled $2.01 billion. Earnings, adjusted for non-cash charges, are the primary driver of operating cash flow and the $0.68 billion increase from the first quarter of last year. Working capital increased slightly from June 30. Days sales outstanding improved two days for receivables and seven days for inventory days on hand versus the first quarter of last year. Accounts payable and other accruals decreased, reflecting a reduction in days outstanding for trade payables and normal timing differences for other accruals. The remaining increase versus the prior year was driven by changes in other operating assets and liabilities, including deferred taxes, and a reduction in equity investments Free cash flow, defined as cash flow from operations less capital expenditures, for the first quarter was $1.73 billion, representing a $0.76 billion increase over the same period last year. In addition to earnings growth, this increase reflects reduced capital spending levels in the quarter. The Company anticipates that this capital spending rate will increase through the year, but the fiscal year average will be in line with the revised target of below five percent of Investing activities used $195 million of cash in the current year compared to $362 million in the previous year. This generated a $167 million net cash increase versus the prior year, primarily attributable to $53 million higher divestiture proceeds, reduced capital spending of $71 million and the absence of acquisition activity in the quarter. Divestiture proceeds in the quarter were from the Vicks throat drop business in Japan. The prior year acquisition activity relates primarily to Jean Patou. Financing activities used $524 million of cash for the current fiscal year versus a net use of $389 million in the prior year quarter. The largest driver of this $135 million difference is increased purchase of treasury shares, reflecting a return of the share repurchase program to historical levels. We continue negotiations regarding the potential outsourcing of certain administrative and other business support services. At this time, no final decisions have been made. RESTRUCTURING PROGRAM UPDATE In 1999, concurrent with a reorganization of its operations into product-based global business units, the Company initiated a multi-year restructuring program. The program is designed to accelerate growth and deliver cost reductions by streamlining management decision-making, manufacturing and other work processes and discontinuing under-performing businesses and initiatives. Technology improvements as well as standardization of manufacturing and other work processes allow the Company to streamline operations, resulting in the consolidation of manufacturing activity and various business processes. Costs to be incurred include separation related costs, asset write-downs, accelerated depreciation and other costs directly related to the restructuring During the quarter ended September 30, 2002, the Company recorded charges totaling $151 million before tax ($113 million after tax) related to its restructuring program, as detailed in the following table. In addition, the Company continues to execute similar projects as part of ongoing operations. Costs for these projects are included in core earnings. Restructuring Program July - September, 2002 Charges (before tax) Beginning Current Applied Ending Reserves Quarter Cash Against Reserves 6/30/02 Charges Spent Assets 9/30/02 Accelerated depreciation - 33 - 33 - During July - September 2002, restructuring charges against the Company's cost of products sold amounted to $83 million before tax and charges included in marketing, research and administrative expenses amounted to $63 million before tax. In addition, the Company had $5 million of net sales reductions from initiatives being discontinued, which are reflected in corporate. Employee separation charges in July - September 2002 are associated with severance packages for approximately 900 people. The packages are predominantly voluntary and are formula driven based on salary levels and past service. Severance costs related to voluntary separations are charged to earnings when the employee accepts the offer. The current and planned separations span the entire organization, including manufacturing, selling, research and administrative positions. The charges for accelerated depreciation and asset write-downs, which totaled $58 million before tax in the quarter ended September 30, 2002, are primarily related to manufacturing operations. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period due to manufacturing consolidations, technology standardization, plant closures or strategic choices to discontinue initiatives. The Company has shortened the estimated useful lives of such assets, resulting in incremental depreciation expense. Charges for asset write-downs relate to the establishment of new fair value bases for assets held for sale or disposal that represent excess capacity in the process of being removed from service or disposed and businesses held for sale in the next 12 months. Other costs incurred as a direct result of the restructuring program amounted to $41 million before tax during July - September 2002. These were primarily for relocation, training, establishment of global business services and results from discontinued initiatives.",2144
2002-11-26,8-K,0000080424-02-000172,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) November 25, 2002 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 The Procter & Gamble Company (the ""Company"") has been advised that A.G. Lafley, Chairman of the Board, President and Chief Executive of the Company, entered into a stock trading plan on November 25, 2002, designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Under Rule 10b5-1, directors and officers may adopt a prearranged plan or contract for the sale of Company securities under specified conditions and at specified times. Mr. Lafley's plan allows for the sale of a total of 32,000 shares of the Company's common stock over a one year period, and provides for sales of specified share amounts at specified market prices, subject to specified limitations. Sales pursuant to this plan may begin in August 2003 and will terminate on May 30, 2004, unless terminated sooner in accordance with the plan's terms. This plan was established during the Company's trading ""window."" In addition, Mr. Lafley has informed the Company that he will publicly disclose any stock sales made under the Rule 10b5-1 plan as required by the securities laws. Except as may be required by law, the Company does not undertake to report plans by other Company officers or directors, nor to report modifications, terminations, transactions or other activities under Mr. Lafley's plan or the plan of any other officer or director.",296
2002-11-26,8-K,0000080424-02-000174,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) November 26, 2002 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 As disclosed in its Annual Report on Form 10-K, on May 31, 2002, The Procter & Gamble Company (the ""Company"") completed its spin-off of the Jif and Crisco brands. In addition, effective July 1, 2002, the Company realigned the management of its feminine care business from Baby, Feminine & Family Care to Beauty Care. To reflect these management and business changes, the Company has realigned its internal and external reporting segments. Beginning in the first quarter of fiscal year 2003 (July - September 2002), the feminine care business will be included in the Beauty Care segment, and the former Baby, Feminine & Family Care segment will become Baby & Family Care. The former Food & Beverage segment will be renamed Snacks & Beverages, reflecting the remaining As required by FASB Statement No. 131, DISCLOSURES ABOUT SEGMENTS OF AN ENTERPRISE AND RELATED INFORMATION, prior year segment results have been reclassified to reflect these changes and provide comparable current and historical results. The elements of the former Food & Beverage segment that were spun off or divested, including Jif, Crisco and commercial shortening and oils, are now presented as part of Corporate. This change affects only the presentation of segment results and does not affect the consolidated results of The Procter & Gamble Company. In the Company's Form 8-K filed on October 24, 2002, selected interim segment information for 2002 was presented. In this 8-K filing, additional interim segment information is provided for fiscal 2002 and selected interim segment information is provided for fiscal 2001. Full segment information will be presented in the Company's next annual filing. P&G is filing this 8-K pursuant to the SEC's Regulation FD.",352
2002-12-11,8-K,0000080424-02-000176,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) December 11, 2002 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On December 11, 2002, The Procter & Gamble Company (the ""Company"") issued a news release with respect to estimated earnings per share for the",105
2003-01-28,8-K,0000080424-03-000002,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) January 28, 2003 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 On January 28, 2003, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended December 31, 2002. P&G is filing this 8-K pursuant to the SEC's Regulation FD.",113
2003-01-29,10-Q,0000080424-03-000004,"and Analysis Despite continuing softness in the global economy the Company delivered sales and earnings growth for the quarter ended December 31, 2002. Most businesses in Latin America suffered declines in volume, sales and earnings, which had a modest dampening effect on the Company. Going forward, economic and political uncertainties in markets such as Latin America and the Middle East could affect results. For a discussion of key factors that could impact and must be managed by the Company, refer to the Management Discussion and Analysis section in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2002. The Company reported net earnings of $1.49 billion or $1.06 diluted net earnings per share for the quarter ended December 31, 2002. Results included a $98 million ($0.07 per share) after-tax restructuring charge related to the Company's program to streamline operations and its business portfolio. Net earnings in the year ago quarter were $1.30 billion or $0.93 per share, including a $146 million ($0.10 per share) after-tax restructuring charge. Core net earnings, which exclude restructuring charges, grew ten percent to $1.59 billion or $1.13 per share for the quarter. On a per share basis, core earnings grew ten percent to $1.13. In the year ago period, core net earnings were $1.45 billion or $1.03 per share. Net sales were $11.01 billion, up six percent versus the year ago quarter. Unit volume grew eight percent versus the prior year, including double-digit growth in the health care and beauty care businesses and eight percent growth in fabric and home care and baby and family care. Excluding acquisitions and divestitures, unit volume increased seven percent. Sales trailed volume growth as strategic pricing investments and a negative mix impact were partially offset by a positive foreign exchange impact of one percent. The foreign exchange impact represents the benefit of the Euro offset by Latin American devaluations. The pricing and mix impacts were a function of the following primary effects: promotional investments on baby and family care in the U.S., the pricing adjustments taken on Crest Whitestrips following competitive entries and portfolio extension strategies in the hair care business. Gross margin was 50.1 percent for the quarter ended December 31, 2002, compared to 48.7 percent in the same quarter of the prior year, an increase of 140 basis points. Core gross margin also increased 140 basis points to 50.8 percent from 49.4 percent in the prior year. Core gross margin excludes before-tax charges in cost of products sold related to the restructuring program of $84 million in the current year and $82 million in the prior year. Core gross margin has expanded by over 100 basis points in each of the last six quarters creating a challenging base for future period growth comparisons. The current quarter improvement was primarily driven by base business savings, which includes both systemic material price improvements and volume benefits. Restructuring program savings and improved margin mix also contributed. Marketing, Research, Administrative, and Other costs (MRA&O), as a percent of sales, decreased from 30.8 percent in the prior year to 29.7 percent in the current year, an improvement of 110 basis points. Core MRA&O, which excludes restructuring costs of $57 million in the current year and $121 million in the prior year, decreased from 29.6 percent of sales in the prior year to 29.2 percent in the current year. These trends reflect reductions in overhead costs, partially offset by increased marketing spending, primarily in beauty care. Operating margin was 20.4 percent for the quarter, compared to 17.9 percent in the same quarter a year ago. Excluding before tax net restructuring charges in the current and prior year of $132 million and $189 million, core operating margin increased to 21.6 percent from 19.8 percent, due to the gross margin and MRA&O improvements discussed in the preceding paragraphs. Non-operating income decreased $126 million, primarily due to the prior year gain from the divestiture of the Comet business. Fabric and home care delivered eight percent unit volume growth. This was broad-based, with strong growth across most regions - lead by double-digit growth in the developing markets. Net sales were $3.10 billion, up five percent. Sales trailed volume growth due to pricing and mix impacts. The pricing actions included the restage of certain mid-tier brands and certain targeted actions to sharpen consumer value in key markets. Mix impacts in laundry were driven by the growth of mid-tier brands in Western Europe and North America, larger sizes in Western Europe and growth in developing markets. Net earnings were $514 million, up 18 percent, behind volume growth and gross margin expansion. Gross margin expansion was achieved through lower material prices and a continued focus on base business savings projects, which funded increased Baby and family care delivered unit volume growth of eight percent behind strength in both family care and baby care, driven primarily by the Baby Stages of Development initiative, Charmin in the U.S., Western Europe and Mexico and U.S. Bounty. Net sales were $2.53 billion, up seven percent, including a one percent positive impact from foreign exchange. Sales trailed volume due primarily to pricing adjustments in response to competitive activity in both the baby and family care segments, which more than offset positive mix behind growth in premium tier diapers. Earnings were $276 million, up twenty-one percent, reflecting volume growth and cost savings, including benefits from previous Beauty care posted double-digit volume, sales and earnings growth, led by hair care and fine fragrances. Unit volume increased 14 percent driven by the Clairol acquisition, which was annualized in mid-November. Excluding the impact of acquisitions and divestitures, volume was up six percent behind hair care, as Pantene, Head & Shoulders, Pert and Rejoice all posted volume gains on a global basis. Additionally, the fine fragrances business increased volume 30 percent. Feminine care volume was up two percent, which follows last quarter's strong shipments that included pipeline fill for the Tampax Pearl initiative. Beauty care net sales were $3.00 billion, up 10 percent, including a one percent positive foreign exchange impact. Volume growth was partially offset by mix impacts driven by the Clairol business and value driven pricing investments behind the repositioning of the hair care portfolio into mid-tier brands, which more than offset devaluation driven pricing actions in Latin America. Net earnings were $507 million, up 15 percent versus last year driven primarily by volume growth and reduced overheads, partially offset by increased marketing Health care delivered double-digit unit volume, sales and earnings growth. Unit volume increased 18 percent, driven by results in oral care, pharmaceuticals and pet health and nutrition. Net sales grew 17 percent to $1.57 billion, including a positive one percent foreign exchange impact, which partially offset pricing investments. Despite an October pricing adjustment, Crest Whitestrips still delivered volume and sales growth relative to the prior year. Actonel, the Company's drug for treatment and prevention of osteoporosis, surpassed $500 million in annual sales in calendar year 2002. Net earnings for health care were $253 million, up 47 percent, reflecting volume growth and improved mix, driven by the continued trend toward high-margin products, partially offset by the funding of increased marketing investments. Snacks and beverages delivered mixed results. Unit volume declined one percent, as an increase in coffee was offset by declines in the snacks and juice businesses. Net sales grew one percent to $881 million, including a two percent positive foreign exchange impact. Net earnings grew 15 percent to $110 million, behind positive mix and cost savings from operating efficiencies and restructuring, which more than offset increased marketing investments. The corporate segment contains both operating and non-operating items that are not included in the business results. Current quarter results reflect decreased divestiture gains and lower restructuring costs. For the six months ended December 31, 2002, cash generated from operating activities totaled $4.33 billion. Earnings, adjusted for non-cash charges, increased $555 million and are a key driver of operating cash flow and the $1.15 billion increase from the first half of last year. Working capital increased slightly from June 30. Receivables days sales outstanding and inventory days on hand both improved versus the same period last year. Accounts payable and other accruals decreased cash year-over-year, reflecting a decrease in taxes payable that reflects a return to historical levels, a reduction in days outstanding for trade payables and normal timing differences for other accruals. The remaining increase in operating cash flow versus the prior year was driven by changes in other operating assets and liabilities, including deferred taxes, and a reduction in investments in non-consolidated entities for dividends received. Free cash flow for the first half of the year, defined as cash flow from operations less capital expenditures, was $3.71 billion, representing a $1.20 billion increase over the same period last year. This increase reflects the increase in operating cash flow discussed in the preceding paragraph and reduced capital spending levels in the quarter. The Company anticipates that this capital spending rate may increase through the year, but the fiscal year average will be below the Company's revised target of below five percent of sales. Investing activities used $507 million of cash year to date compared to $5.48 billion in the comparable prior year period, which included the Clairol acquisition during the October-December quarter. There has been no significant acquisition activity in the current year. This generated a $4.98 billion net cash increase versus the prior year. Divestiture proceeds in the current year include the Vicks throat drop business in Japan, certain Clairol small brands and a paper divestiture in China. Prior year divestitures included Comet and PUR Financing activities used $2.15 billion of cash for the current fiscal year versus a source of $3.19 billion in the first half of the prior year. The largest driver of this $5.34 billion difference is the prior year issuance of short-term debt to finance the Clairol acquisition. Treasury share purchases used more cash in the current year, reflecting lower repurchase activity in the prior year base period driven by cash needs for the Clairol acquisition. Share repurchase in the current year reflects a return to historical levels. RESTRUCTURING PROGRAM UPDATE In 1999, concurrent with a reorganization of its operations into product-based global business units, the Company initiated a multi-year restructuring program. The program was designed to accelerate growth and deliver cost reductions by streamlining management decision-making, manufacturing and other work processes and discontinuing under-performing businesses and initiatives. Technology improvements as well as standardization of manufacturing and other work processes allow the Company to streamline operations, resulting in the consolidation of manufacturing activity and various business processes. Costs to be incurred include separation related costs, asset write-downs, accelerated depreciation and other costs directly related to the restructuring During the quarter ended December 31, 2002, the Company recorded charges totaling $132 million before tax ($98 million after tax) related to its restructuring program, as detailed in the following table. In addition, the Company continues to execute similar projects as part of ongoing operations. Costs for these projects are included in core earnings. RESTRUCTURING PROGRAM JULY - DECEMBER, 2002 CHARGES (BEFORE TAX) Beginning Quarter Current Applied Ending Reserves Charges Quarter Total Cash Against Reserves 6/30/02 Jul-Sep 02 Charges Charges Spent Assets 12/31/02 During October - December 2002, restructuring charges included in the Company's cost of products sold amounted to $84 million before tax and charges included in MRA&O amounted to $57 million before tax. In addition, the Company had $9 million of net sales from discontinued initiatives, which are reflected in Employee separation charges in October - December 2002 are associated with severance packages for approximately 1,150 people. The packages are predominantly voluntary and are formula driven based on salary levels and past service. Severance costs related to voluntary separations are charged to earnings when the employee accepts the offer. The current and planned separations span the entire organization, including manufacturing, selling, research and administrative positions. The charges for accelerated depreciation and asset write-downs, which totaled $64 million before tax in the quarter ended December 31, 2002, are primarily related to manufacturing operations. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period due to manufacturing consolidations, technology standardization, plant closures or strategic choices to discontinue initiatives. The Company has shortened the estimated useful lives of such assets, resulting in incremental depreciation expense. Charges for asset write-downs relate to the establishment of new fair value bases for assets held for sale or disposal that represent excess capacity in the process of being removed from service or disposed and businesses held for sale in the next 12 months. Asset write-downs also include certain manufacturing assets that are expected to operate at levels significantly below their planned capacity. The projected cash flows from such assets over their remaining useful lives were no longer estimated to be greater than their current carrying values; therefore, they are written down to estimated fair value, generally determined by reference to discounted expected future cash flows. Such charges represented $23 million before tax in this quarter. Other costs incurred as a direct result of the restructuring program amounted to $14 million before tax during October - December 2002. These were primarily for relocation, training, establishment of global business services and results from discontinued initiatives. The Company recently announced its intent to discontinue separate reporting of its current Restructuring Program at the conclusion of the current fiscal year. The Company will continue to undertake projects in future periods to maintain a competitive cost structure, including manufacturing consolidation and work force rationalization. The costs of such activities will be reported as part of core",2271
2003-03-17,8-K,0000080424-03-000008,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) March 17, 2003 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On March 17, 2003, The Procter & Gamble Company (the ""Company"") issued a news release with respect to its earnings guidance for the January to March 2003 quarter.",109
2003-03-18,8-K,0000080424-03-000009,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) March 18, 2003 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On March 18, 2003, The Procter & Gamble Company (the ""Company"") issued a news release announcing that the Company has signed an agreement to purchase a controlling interest from the majority shareholders of Wella AG, headquartered",117
2003-03-20,8-K,0000080424-03-000010,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) March 20, 2003 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On March 20, 2003, The Procter & Gamble Company posted the attached Questions and Answers on its website. This 8-K is being filed pursuant to",106
2003-03-27,8-K,0000080424-03-000011,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) March 27, 2003 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) ONE PROCTER & GAMBLE PLAZA, CINCINNATI, OHIO 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (513) 983-1100 ITEM 5. OTHER EVENTS. As disclosed in its Annual Report on Form 10-K for the year ended June 30, 2002, on May 31, 2002, The Procter & Gamble Company (the ""Company"") completed its spin-off of the Jif and Crisco brands. In addition, effective July 1, 2002, the Company realigned the management of its feminine care business from Baby, Feminine & Family Care to Beauty Care. To reflect these management and business changes, the Company has realigned its internal and external reporting segments. Beginning with the first quarter of fiscal year 2003 (July - September 2002), the feminine care business has been included in the Beauty Care segment, and the former Baby, Feminine & Family Care segment has become Baby & Family Care. The former Food & Beverage segment was renamed Snacks & Beverages, reflecting the remaining businesses. As required by FASB Statement No. 131, DISCLOSURES ABOUT SEGMENTS OF AN ENTERPRISE AND RELATED INFORMATION, prior year segment results have been reclassified to reflect these changes and provide comparable current and historical results. The elements of the former Food & Beverage segment that were spun off or divested, including Jif, Crisco and commercial shortening and oils, are now presented as part of Corporate. This change affects only the presentation of segment results and does not affect the consolidated results of The Procter & Gamble Company. In this form 8-K filing, segment information for the Company reflecting the new structure is presented for the fiscal years 2000 through 2002. The segment results that are affected by the management realignment in the Company's management discussion and analysis of financial condition and results of operations section of its Annual Report on Form 10-K for fiscal year 2002 is The Company is filing this form 8-K pursuant to the SEC's",372
2003-04-07,8-K,0000080424-03-000014,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) April 7, 2003 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On April 7, 2003, The Procter & Gamble Company issued a news release with respect to declaration of a quarterly dividend. This 8-K is being filed pursuant to Regulation FD.",111
2003-04-08,8-K,0000080424-03-000016,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) April 8, 2003 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On April 8, 2003, The Procter & Gamble Company issued a news release announcing that it intends to make a cash only tender offer of (euro) 61.50 per share for Wella AG preference shares. This 8-K is being filed pursuant to",122
2003-04-28,8-K,0000080424-03-000018,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) April 28, 2003 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On April 28, 2003, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended March 31, 2003. The Company is furnishing this 8-K pursuant to Item 12, ""Results of Operations and Financial Condition.""",126
2003-04-28,8-K,0000080424-03-000020,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) April 28, 2003 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On April 28, 2003, The Procter & Gamble Company (the ""Company"") issued a news release with respect to the launching of a tender offer for the shares of Wella AG. The Company is furnishing this 8-K pursuant to Item 9, ""Regulaton FD Disclosure."" A copy of the English Translation of the Offer Document is attached",136
2003-04-29,10-Q,0000080424-03-000021,"and Analysis Despite continuing softness in the global economy and competitive activity within certain of the Company's core categories, the Company delivered strong sales and earnings growth for the quarter ended March 31, 2003. Businesses in Latin America continue to suffer declines in sales and earnings from the economic and political situation in the region, which had a modest dampening effect on the Company. Going forward, uncertainties in markets such as Latin America and the Middle East could affect results. For a discussion of key factors that could impact and must be managed by the Company, refer to the Management Discussion and Analysis section in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2002. The Company reported net earnings of $1.27 billion or $0.91 diluted net earnings per share for the quarter ended March 31, 2003. Results included a $66 million after-tax restructuring charge related to the Company's program to streamline operations and its business portfolio. Net earnings in the year ago quarter were $1.04 billion or $0.74 per share, including a $147 million after-tax Net sales were $10.66 billion, up eight percent versus the year-ago quarter. Unit volume grew seven percent versus the prior year quarter behind double-digit growth in the health care business and nine percent growth in both the fabric and home care and the beauty care businesses. Double-digit volume increases in Asia and Central and Eastern Europe helped drive the volume growth. Excluding acquisitions and divestitures, unit volume increased eight percent. Sales growth included a positive foreign exchange impact of three percent, which was partially offset by pricing. Acquisitions and divestitures had a negative two percent impact on sales. The foreign exchange impact represents the benefits of the Euro and British Pound, partially offset by Latin American devaluations. The pricing impacts were directed towards activities to drive top line growth, including expanding the Company's mid-tier and developing market businesses, improving in-store presence and merchandising activities in Western Europe and to achieve competitive pricing on shelf. Examples include the following: the re-launch of a number of beauty and fabric care brands into mid-tier product positionings, pricing adjustments on Crest Whitestrips following competitive entry, price adjustments on baby care to maintain shelf parity versus a key competitor, and promotional investments on coffee and family care to match key competitors' levels of merchandising and remain competitive on shelf. Gross margin was 49.4 percent for the quarter ended March 31, 2003, compared to 48.8 percent in the same quarter of the prior year. This represents an increase of 60 basis points versus a base period that delivered a 320 basis point improvement. The current year increase was driven by a reduction in cost of products sold for charges related to the restructuring program, which totaled $46 million before tax in the current quarter and $107 million in the prior year quarter. Other base business and restructuring savings in the current quarter were reinvested in pricing activities to stimulate growth as discussed in the preceding paragraph, leading to lower margin expansion. Marketing, Research, Administrative, and Other costs (MRA&O), as a percent of sales, decreased from 32.1 percent in the prior year quarter to 31.0 percent in the current year quarter, an improvement of 110 basis points. This improvement was caused by a reduction in restructuring costs, from $99 million in the prior year to $41 million in the current year, a base period that included Clairol transition costs, and lower overhead spending which more than offset increased marketing investments, particularly in fabric and home care, health care and Operating margin increased 170 basis points to 18.4 percent for the quarter, compared to 16.7 percent in the same quarter a year ago. This improvement was caused by lower restructuring charges, which declined from $191 million in the prior year quarter to $87 million in the current quarter, along with the other MRA&O improvements discussed in the preceding paragraph. Fabric and home care unit volume grew nine percent and was broad-based, led by North America home care and Asia and Central and Eastern Europe. Net sales were up eight percent to $3.06 billion. This includes a positive two percent foreign exchange impact partially offset by mix impacts from growth in mid-tier brands and developing markets. Additionally, pricing investments behind mid-tier growth in North America and increased spending to improve in store presence and merchandising activities in Western Europe contributed to sales growth lagging volume growth. Net earnings increased six percent to $499 million, as volume growth was partially offset by the funding of increased initiative spending and in-store marketing investments, including the launch of Mr. Proper in Germany Baby and family care delivered unit volume growth of seven percent behind continued strength in baby care, driven primarily by Pampers Baby Stages of Development, and solid results in North America and Western Europe family care. Net sales increased nine percent to $2.47 billion, including a positive four percent foreign exchange impact. Positive mix behind growth in premium tier diapers was more than offset by temporary pricing adjustments in North America to reach shelf unit price parity with key competition in baby care and retain competitive pricing in family care. Earnings increased 39 percent to $200 million reflecting volume growth, cost reductions and lower promotional marketing investment versus the base period. Beauty care unit volume was up nine percent driven by hair care, including continued strength behind Pantene and Head & Shoulders, and feminine care. Sales grew 10 percent, including a positive four percent foreign exchange impact, reaching $3.03 billion. Negative pricing and mix impacts, driven by the repositioning of the Company's portfolio of hair care brands such as Pert, Aussie and Renewal 5x into multiple price tiers, partially offset foreign exchange impacts. Net earnings were $463 million, up 19 percent driven by volume and continued reductions in cost of products sold, partially offset by increased Health care delivered double-digit unit volume, sales and earnings growth this quarter. Unit volume increased 18 percent driven by strong results in oral care and continued strength in pharmaceuticals. Net sales were $1.43 billion, up 18 percent, including a three percent positive foreign exchange impact that was offset by lower Crest Whitestrips pricing versus year ago. Crest and Actonel led the volume and sales growth. Health care's net earnings increased 19 percent to $147 million primarily behind volume. Progress in health care's gross margin was re-invested in marketing, primarily in oral care. Snacks and beverages unit volume was down one percent as improved snacks results in North America and Western Europe were offset by soft beverage results. Sales grew one percent to $756 million, including a positive four percent foreign exchange impact. Net earnings declined 22 percent to $50 million. This partly reflects the response to competitive promotional spending in the U.S. coffee market, which has escalated at a rate in excess of that justified by commodity price declines, resulting in increased promotional spending to defend share. The corporate segment contains both operating and non-operating items that are not included in the business results. Current quarter results primarily reflect lower restructuring costs. For the nine months ended March 31, 2003, cash generated from operating activities totaled $6.74 billion, compared to $5.43 billion in the prior year. Earnings adjusted for non-cash items including depreciation, amortization and deferred income taxes accounted for $5.7 billion of the current year cash flow and $0.9 billion of the $1.31 billion current year improvement. The inventory, accounts receivable and accounts payable and accruals components of working capital changed slightly from June 30, providing $0.4 billion of operating cash flow. Inventories increased as compared to June 30, 2002, while receivables declined. However, both receivables days sales outstanding and inventory days on hand improved versus the year ago period. Accounts payable and other accruals increased as compared to June 30, providing operating cash flows, due to timing differences for payments of other accruals, primarily taxes. Working capital changes during the nine months ended March 31, 2002 provided a higher amount of operating cash flows than the current year due to abnormally low tax payments in the year ago period. Current year activity reflects a return to historical Investing activities used $989 million of cash year to date, compared to $6.61 billion used in the comparable prior year period, which included the Clairol acquisition during the October-December quarter. There has been no significant acquisition activity in the current year. This difference in acquisition activity generated $5.35 billion of the year over year change in investing cash flows. Divestiture proceeds in the current year include the Vicks throat drop business in Japan, certain Clairol small brands and a family care divestiture in China. Prior year divestitures included Comet and PUR Outdoor. Capital spending was also reduced in the current year as compared to the prior year. The Company anticipates that this capital spending rate may increase through the year, but the fiscal year average will be below the Company's revised target of less than five percent of sales. The Company's pending acquisition of Wella AG is discussed in Note 4 to the Consolidated Financial Statements. Financing activities used $3.66 billion of cash for the current fiscal year versus a source of $1.94 billion in the first nine months of the prior year. The largest driver of this $5.6 billion difference is the prior year issuance of short-term debt to finance the Clairol acquisition. In addition, treasury share purchases used more cash in the current year, reflecting lower repurchase activity in the prior year base period driven by cash needs for the Clairol RESTRUCTURING PROGRAM UPDATE In 1999, concurrent with a reorganization of its operations into product-based global business units, the Company initiated a multi-year restructuring program. The program was designed to accelerate growth and deliver cost reductions by streamlining management decision-making, manufacturing and other work processes and discontinuing under-performing businesses and initiatives. Technology improvements as well as standardization of manufacturing and other work processes allow the Company to streamline operations, resulting in the consolidation of manufacturing activity and various business processes. Costs to be incurred include separation related costs, asset write-downs, accelerated depreciation and other costs directly related to the restructuring During the quarter ended March 31, 2003, the Company recorded charges totaling $87 million before tax ($66 million after tax) related to its restructuring program, as detailed in the following table. In addition, the Company continues to execute similar projects as part of ongoing operations. Restructuring Program July, 2002 - March, 2003 Charges (before tax) Beginning Quarter Current Applied Ending Reserves Charges Quarter Total Cash Against Reserves 6/30/02 Jul-Dec 02 Charges Charges Spent Assets 3/31/03 During January-March 2003, restructuring charges included in the Company's cost of products sold amounted to $46 million before tax and charges included in MRA&O amounted to $41 million before tax. Employee separation charges in January-March 2003 are associated with severance packages for approximately 250 people. The packages are predominantly voluntary and are formula driven based on salary levels and past service. Severance costs related to voluntary separations are charged to earnings when the employee accepts the offer. The current and planned separations span the entire organization, including manufacturing, selling, research and administrative positions. The charges for accelerated depreciation and asset write-downs, which totaled $47 million before tax in the quarter ended March 31, 2003, are primarily related to manufacturing operations. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period due to manufacturing consolidations, technology standardization, plant closures or strategic choices to discontinue initiatives. The Company has shortened the estimated useful lives of such assets, resulting in incremental depreciation expense. Charges for asset write-downs relate to the establishment of new fair value bases for assets held for sale or disposal that represent excess capacity in the process of being removed from service or disposed and businesses held for sale in the next 12 months. Asset write-downs also include certain manufacturing assets that are expected to operate at levels significantly below their planned capacity. The projected cash flows from such assets over their remaining useful lives were no longer estimated to be greater than their current carrying values; therefore, they are written down to estimated fair value, generally determined by reference to discounted expected future cash flows. Other costs incurred as a direct result of the restructuring program amounted to $11 million before tax during January-March 2003. These were primarily for relocation, training, establishment of global business services and results from discontinued initiatives. The Company recently announced its intent to discontinue separate reporting of its current Restructuring Program at the conclusion of the current fiscal year. The Company anticipates an increase in the quarterly restructuring charges in April-June 2003, as many enrollment reductions and consolidation projects are completed. The Company, as part of its on-going operations, will continue to undertake similar projects in future periods to maintain a competitive cost structure, including manufacturing consolidation and work force rationalization.",2154
2003-05-08,8-K,0000080424-03-000022,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) May 8, 2003 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On May 8, 2003, The Procter & Gamble Company (the ""Company"") issued a news release with respect to restoring capability at the Company's Jackson, Tennessee plant that was hit by tornados earlier in the week. The Company is filing this 8-K pursuant to Regulation FD.",126
2003-05-09,8-K,0000080424-03-000023,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) May 9, 2003 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On May 9, 2003, The Procter & Gamble Company (the ""Company"") issued a news release with respect to the Wella Management Board's acceptance of the Company's offer for ordinary and voting shares. The Company is filing this 8-K pursuant to Regulation FD.",123
2003-05-29,8-K,0000950152-03-005854,"Procter & Gamble 8-K SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) Registrants telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On May 29, 2003, The Procter & Gamble Company (the Company) issued a news release with respect to the closing of the initial acceptance period of the Companys tender offer for the voting and preference shares of Wella, A.G. The Company is filing this 8-K pursuant to Item 9, Regulation FD Disclosure.",119
2003-06-05,8-K,0000080424-03-000030,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 5, 2003 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On June 5, 2003, The Procter & Gamble Company (the ""Company"") issued a news release with respect to its earnings guidance for the April to June 2003 quarter. The Company is filing this 8-K pursuant to Regulation FD.",119
2003-06-05,8-K,0000080424-03-000031,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 5, 2003 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On June 5, 2003, The Procter & Gamble Company (the ""Company"") issued a news release with respect to initial Wella tender offer results and the launching of mandatory extension period. The Company is filing this 8-K pursuant",118
2003-06-06,8-K,0000080424-03-000032,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 6, 2003 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On June 6, 2003, The Procter & Gamble Company (the ""Company"") issued a news release correcting the timing of the additional acceptance period for the Wella tender offer. The Company is filing this 8-K pursuant to Regulation FD.",119
2003-06-26,8-K,0000080424-03-000052,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 26, 2003 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On June 26, 2003, The Procter & Gamble Company (the ""Company"") issued a news release announcing the Wella tender offer final results. The Company is filing this 8-K pursuant to Regulation FD.",113
2003-07-16,8-K,0000080424-03-000055,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) July 16, 2003 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On July 16, 2003, The Procter & Gamble Company (the ""Company"") issued a news release announcing that the Company is exploring strategic alternatives with respect to its Sunny Delight(R) and Punica(R) juice drink brands. The Company is filing this 8-K pursuant to Item 9, Regulation FD Disclosure.",128
2003-07-31,8-K,0000080424-03-000059,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) July 31, 2003 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On July 31, 2003, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter and fiscal year ended June 30, 2003. The Company is furnishing this 8-K pursuant to Item 12, ""Results of Operations and Financial Condition.""",129
2003-09-04,8-K,0000950152-03-008056,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) Registrants telephone number, including area code ITEM 9. REGULATION FD DISCLOSURE On September 4, 2003, The Procter & Gamble Company (the Company) issued a news release with respect to its earnings guidance for the July to September 2003 quarter. The Company is filing this 8-K pursuant to Regulation FD.",104
2003-09-11,10-K,0000950152-03-008195,"The Procter & Gamble Company 10-K/FYE 6-30-2003 THE PROCTER & GAMBLE COMPANY ANNUAL REPORT ON FORM 10-K SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION ANNUAL REPORT ON FORM 10-K PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2003 Commission File No. 1-434 THE PROCTER & GAMBLE COMPANY One Procter & Gamble Plaza, Cincinnati, Ohio 45202 IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio Securities registered pursuant to Section 12(b) of the Act: Name of each Exchange on which registered Common Stock, without Par Value New York, Cincinnati, Amsterdam, Paris, Basle, Geneva, Lausanne, Zurich, Frankfurt, Brussels, Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 S-K is not contained herein, and will not be contained, to the best of in definitive proxy or information statements incorporated by reference in Part Form 10-K or any amendment to this Form 10-K. [ ] Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act). Yes [X] No [ ] There were 1,296,560,113 shares of Common Stock outstanding as of July 31, 2003. The aggregate market value of the voting stock held by non-affiliates amounted to $111 billion on December 31, 2002. Documents Incorporated By Reference Portions of the Annual Report to Shareholders for the fiscal year ended June 30, 2003 are incorporated by reference into Part I, Part II and Part IV of this report to the extent described herein. Portions of the Proxy Statement for the 2003 Annual Meeting of Shareholders are incorporated by reference into Part III of this report to the extent described Item 3. Legal Proceedings Item 4. Submission of Matters to a Vote of Security Holders Item 5. Market for the Common Stock and Related Stockholder Matters Item 6. Selected Financial Data Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations Item 7A. Quantitative and Qualitative Disclosures About Market Risk Item 8. Financial Statements and Supplemental Data Item 9. Disagreements on Accounting and Financial Disclosure Item 9A. Controls and Procedures Item 10. Directors and Executive Officers Item 11. Executive Compensation Item 12. Security Ownership of Certain Beneficial Owners and Management Item 13. Certain Relationships and Related Transactions Item 14. Exhibits, Financial Statements, Schedules and Reports on Form 8-K EX-10.1 2001 Stock and Incentive Compensation Plan EX-10.3 Executive Life Insurance Policy EX-10.6 1993 Non-Employee Directors' Stock Plan EX-10.7 1992 Stock Option Plan EX-10.8 Future Shares Plan EX-12 Computation of Ratio EX-21 Subsidiaries of Reg EX-23 Independent Auditors' Consent General Development of Business The Procter & Gamble Company was incorporated in Ohio in 1905, having been built from a business founded in 1837 by William Procter and James Gamble. Today, the Company manufactures and markets a broad range of consumer products in many countries throughout the world. Unless the context indicates otherwise, the term the Company as used herein refers to The Procter & Gamble Company (the registrant) and its In March, 2003, the Company entered into an agreement to acquire a controlling interest in Wella AG from the majority shareholders and, in June, 2003, the Company completed a tender offer for the remaining outstanding voting class shares and preference shares. On September 2, 2003, the Company completed the previously announced purchase of the shares of Wella AG held by the majority shareholders for 3.16 billion Euros (approximately based on spot exchange rates on that date). On September 10, 2003, the Company purchased the shares secured through the tender offer for 1.49 billion Euros (approximately $1.67 billion based on spot exchange rates on that date). As a result of these purchases, the Company acquired approximately 81% of the outstanding Wella shares (99% of the voting class shares and 45% of the preference shares). The acquisition was financed by a mixture of available cash balances and debt. Wella AG is a leading beauty care company selling its products in more than 150 countries, focused on professional hair care, retail hair care and cosmetics and fragrances. November 16, 2001, the Company completed the acquisition of the Clairol business from Bristol-Myers Squibb Company and, on May 31, 2002, the Company completed the spin-off of the Jif peanut butter and Crisco shortening brands to the Companys shareholders and their subsequent merger into the J.M. Smucker In 1999, the Company announced its intention to transition from its previous geographic-based structure to a product-based global business unit structure. Concurrent with that change, the Company initiated a multi-year restructuring program, a discussion of which is",820
2003-10-14,8-K,0000080424-03-000164,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) October 14, 2003 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE. On October 14, 2003, The Procter & Gamble Company (the ""Company"") issued a news release with respect to Chairman, President and Chief Executive A.G. Lafley's address to the shareholders at the Company's annual meeting. The Company is furnishing this 8-K pursuant to Item 9, ""Regulation FD Disclosure.""",128
2003-10-27,8-K,0000080424-03-000166,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) October 27, 2003 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION On October 27, 2003, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended September 30, 2003. The Company is furnishing this 8-K pursuant to Item 12, ""Results of Operations and Financial Condition.""",126
2003-10-28,10-Q,0000080424-03-000167,"and Analysis For the quarter ended September 30, 2003, the Company had double-digit volume, sales and earnings growth despite strong base period comparisons and heavy competitive activity in certain of the Company's core categories. Going forward, business and market uncertainties could affect results. For a discussion of key factors that could impact and must be managed by the Company, please refer to the Management Discussion and Analysis section in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2003. Unit volume increased 12 percent, with all business segments and all geographic regions reporting unit volume growth. Double-digit increases in Health Care, Beauty Care and developing regions helped drive the volume growth. Excluding acquisitions and divestitures, primarily the recently completed acquisition of Wella AG, unit volume increased nine percent. Net sales increased 13 percent to $12.20 billion. Foreign exchange had a positive impact of three percent, partially offset by mix of one percent and pricing investments of one percent. The foreign exchange impact reflects the strengthening of the Euro, Canadian Dollar and British Pound partially offset by weakening of the Venezuelan Bolivar and the Mexican Peso. Mix was driven, in part, by higher than expected growth in developing markets, including strong growth in China, and the continued portfolio expansion into mid-tier brands. Pricing investments were directed toward activities to drive top line growth in multiple businesses and to respond to competitive activity on Crest Whitestrips and continued high competitive promotion levels in the bath tissue and kitchen The Company reported net earnings of $1.76 billion, an increase of 20 percent versus the prior year quarter. Earnings growth was primarily driven by volume impacts, the completion of the prior year restructuring program, which had $113 million of after-tax charges in the base period, and lower manufacturing costs, despite inclusion of ongoing costs for restructuring-type activities to maintain a competitive cost structure. These improvements were partially offset by marketing investments to support base business and new product growth. Net earnings per share were $1.26, an increase of 21 percent. Net earnings in the prior year quarter were $1.46 billion or $1.04 per share. Wella did not have a significant impact on net earnings. Gross margin was 51.8 percent for the quarter compared to 49.2 percent for the same quarter of the prior year, an increase of 260 basis points. The increase in gross margin was primarily driven by lower cost of products sold due to the scale effect of volume, the reduction of before-tax charges related to the completed restructuring program of $88 million in the prior year quarter and material cost savings, which more than offset certain commodity price increases. Other base business and restructuring savings in the quarter more than offset the pricing investments discussed previously. Marketing, Research, Administration and Other Costs (MRA&O) for the quarter increased to 30.1 percent versus 29.0 percent in the prior year quarter. The increase was driven by marketing spending and the impact of the Wella acquisition, which more than offset the reduction in prior year restructuring program charges. Marketing investments were made to drive growth on the base business and in support of initiatives such as Crest Whitestrips and Night Effects, Olay Regenerist, Swiffer and Prilosec OTC. The addition of Wella contributed approximately one third of the basis point increase due to higher MRA&O spending as a percent of sales and initial post-acquisition costs. Operating margin increased 150 basis points to 21.7 percent for the quarter, compared to 20.2 percent in the same quarter year ago. The improvement was driven by the reduction in prior year restructuring program charges and lower cost of products sold, partially offset by the impact of higher MRA&O spending discussed in the previous paragraph. The Company entered into several multi-year service contracts for services estimated at $3.6 billion. The biggest of these went into effect during the quarter ended September 30, 2003, while the remainder will go into effect in The following provides supplemental information on the underlying drivers of net JULY-SEPTEMBER NET SALES INFORMATION (Percent Change vs. Year Ago) ** Acquisitions/ Acquisitions/ Total Total Impact Divestitures Divestitures FX Price Mix/Other Impact Ex-FX ** These sales percentage changes are approximations based on quantitative formulas that are consistently applied. Fabric & Home Care volume was up eight percent behind strong growth in global fabric care led by the developing regions and double-digit growth in global home care, with the continued success of the Swiffer WetJet and Duster, Dawn Power Dissolver and Dawn Complete and Febreze Anti-Allergen initiatives. Net sales increased eight percent to $3.39 billion. A three percent positive foreign exchange impact was offset by pricing and mix effects. Pricing reflects the continuation of pricing investments taken on select fabric care segments in North America, markets in Western Europe and on the Swiffer brand. Mix reduced sales by two percent driven by double-digit growth in developing geographies, including the expansion of Tide in China, and the expansion of mid-tier brands, including the growth of Bold in Japan. Net earnings increased to $562 million, or three percent versus a strong base period of 22 percent growth. Earnings were impacted by mix effects and increased marketing spending to support product initiatives. Fabric & Home Care earnings growth is expected to improve over the remainder of the fiscal year. Beauty Care volume increased 21 percent, including the benefit from acquisitions and divestitures, primarily Wella. Excluding acquisitions and divestitures, Beauty Care volume increased eight percent despite heavy competitive activity in North America. Net sales increased 20 percent to $3.75 billion, including a positive foreign exchange impact of three percent. Negative mix of three percent was driven by the impact of Wella and developing market growth. The solid base business results were driven by continued global strength of the Pantene, Head & Shoulders, Always/Whisper and Olay brands. Net earnings for Beauty Care increased 12 percent to $616 million driven by volume growth and lower manufacturing costs, partially offset by increased marketing spending to defend against competitive entries in the hair care and skin care categories. Marketing spending also increased to support initiatives, including Pantene Daily Moisture Renewal in Japan, the expansion of Olay Regenerist and continued support of Baby and Family Care unit volume increased six percent. Baby care volume growth was primarily driven by continued momentum in the Baby Stages of Development line in Western Europe and North America, growth in Japan and the broadening of the diaper product line in Latin America. Net sales grew seven percent to $2.61 billion, including a positive foreign exchange impact of three percent, partially offset by pricing investments of one percent and mix of one percent. Pricing was driven by continued high competitive promotional activity in North America family care. Earnings increased 22 percent to $295 million, due to strong volume growth and lower costs including the scale effects of volume. Health Care delivered volume growth of 23 percent driven by the Prilosec OTC launch in September, the continued success of Actonel, Crest Whitestrips and Night Effects tooth whitening products and base business strength. Net sales increased 23 percent to $1.73 billion, as a positive three percent foreign exchange impact was offset by mix and pricing, primarily the actions on Crest Whitestrips taken in November 2002. Although Prilosec OTC was an important contributor to the quarter results, even without the launch, Health Care delivered double-digit volume, sales and earnings growth. Net earnings increased 41 percent to $276 million as strong volume, sales and lower product costs funded marketing investments behind base business growth and new product introductions. While double-digit top line growth is expected for the fiscal year, results in the remaining quarters are expected to return to consumption levels following the one-time pipeline impact from Prilosec OTC. Additionally, although Prilosec OTC volume was particularly strong with the launch, associated marketing expenses will continue throughout the year. Snacks & Beverages volume was up three percent reflecting growth in the Pringles and Folgers brands, partially offset by volume declines in the juice category. Net sales were $896 million, an increase of nine percent, reflecting the benefits of a three percent impact from foreign exchange and three percent from price and mix impacts. Positive pricing includes a partial pass-through of higher commodity costs. For the balance of the fiscal year, the Company expects pricing will have a neutral or slightly negative impact on sales based on the aggressive pricing environment of the coffee category. Net earnings increased 20 percent to $109 million behind volume and sales growth and margin expansion due to base business savings. Corporate includes certain operating and non-operating activities, as well as eliminations to adjust management reporting principles to United States Generally Accepted Accounting Principles (U.S. GAAP). Current quarter results primarily reflect lower restructuring program charges partially offset by one-time items in the prior year quarter, including the impact of the Vicks For the three months ended September 30, 2003, cash generated from operating activities totaled $1.61 billion compared to $2.01 billion in the comparable prior year period. The decrease in cash from operations is due to increases in working capital, as well as base period impacts due to dividends received from a joint venture. Accounts receivable grew slightly ahead of sales since June 30, 2003. The year-over-year accounts receivable increase of $0.3 billion is attributed to sales growth, particularly the timing of the Prilosec OTC launch in September, offset to some extent by an underlying improvement in days sales outstanding. These trends follow a two-day improvement in receivables days outstanding in the prior year period. Inventory increased primarily due to initiative-related activity, shipment trends and capacity utilization planning. The slight increase in inventory days on hand (approximately two days, excluding inventory acquired from Wella) compares to a seven day decrease in the prior Investing activities used $5.30 billion of cash year-to-date compared to $0.20 billion used in the prior year period. The acquisition of Wella is the key driver accounting for approximately $5.10 billion. The Company's acquisition of Wella is discussed in Note 4 of the financial statements. There was no acquisition activity in the comparable prior year period. Capital spending increased to $364 million in the current year versus $281 million in the comparable prior year period. Capital spending as a percent of net sales was three percent, one percentage point below target. Financing activities provided $1.96 billion in cash for the current fiscal year versus using $0.52 billion in the comparable prior year period. This generated a net cash increase of $2.48 billion driven primarily by short-term debt to support the Wella acquisition, partially offset by a decrease in long-term debt. RESTRUCTURING PROGRAM UPDATE In 1999, concurrent with a reorganization of its operations into product-based global business units, the Company initiated a multi-year restructuring program. This program was substantially complete at the end of 2003. At June 30, 2003, there was a reserve liability balance remaining of $335 million for the program. This liability is expected to be settled by the end of 2004 through cash payments primarily for separations. The Company continues to undertake projects to maintain a competitive cost structure, including manufacturing consolidations and work force rationalization, as part of its normal operations.",1856
2003-12-11,8-K,0000080424-03-000209,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) December 11, 2003 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On December 11, 2003, The Procter & Gamble Company (the ""Company"") issued a news release with respect to confirming prior earnings guidance for 2003/04 second quarter and fiscal year. The Company is furnishing this 8-K pursuant to Item 9, ""Regulation FD Disclosure"".",125
2004-01-07,8-K,0000950152-04-000060,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) January 7, 2004 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On January 7, 2004, The Procter & Gamble Company (the ""Company"") issued a news release (i) updating earnings per share guidance for the 2003/04 second quarter, and (ii) providing certain unit volume growth information for the 2003/04 second quarter. The Company is furnishing this 8-K pursuant to Item 9, ""Regulation FD Disclosure"", with the exception of the first sentence of the second paragraph, which is furnished pursuant to Item 12, ""Results of Operations and Financial Condition.""",159
2004-01-28,8-K,0000080424-04-000018,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) January 28, 2004 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 28, 2004, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended December 31, 2003. The Company is furnishing this 8-K pursuant to Item 12, ""Results of Operations and Financial Condition.""",126
2004-02-03,10-Q,0000080424-04-000025,"and Analysis of Financial Condition and Results The Company markets approximately 300 products in more than 160 countries around the world in five distinct business segments: Fabric and Home Care, Beauty Care, Baby and Family Care, Health Care and Snacks and Beverages. During the first six months of the fiscal year through December 31, 2003, the Company delivered strong top line results and double-digit earnings growth, despite widespread competitive activity. All business segments posted volume and earnings growth. Results include the impact of the Wella acquisition which was completed in September 2003. Sales grew ahead of volume due to positive foreign exchange impacts, partially offset by mix (driven by high growth in developing markets) and pricing activity. Earnings increased due to the scale benefit of volume, the completion of the Company's restructuring program which had $211 million of after tax charges in the base period, and lower manufacturing costs. Earnings growth was partially offset by continued marketing investments in the base business and in support of product initiatives. Going forward, business and market uncertainties may affect results. For a discussion of key factors that could impact and must be managed by the Company, please refer to Management's Discussion and Analysis in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2003. RESULTS OF OPERATIONS - Three Months Ended December 31, 2003 THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information MARKETING, RESEARCH, ADMINISTRATIVE & OTHER 4,155 3,267 27 % OTHER NON-OPERATING INCOME, NET 29 74 EARNINGS BEFORE INCOME TAXES 2,622 2,179 20 % AVERAGE DILUTED SHARES OUTSTANDING 1,400.4 1,402.6 COMPARISONS AS A % OF NET SALES Chg MARKETING, RESEARCH, ADMINISTRATIVE & OTHER 31.4% 29.7% EARNINGS BEFORE INCOME TAXES 19.8% 19.8% Unit volume for the quarter increased 19 percent, with all business segments and geographic regions reporting unit volume growth. Excluding the impact of acquisitions and divestitures, primarily Wella, unit volume increased nine percent. Beauty Care led the business segments with unit volume growth of 45 percent. Excluding acquisitions and divestitures, Beauty Care volume increased 10 percent. Health Care and Fabric and Home Care volume increased 17 and nine percent, respectively. Developing markets delivered strong, double-digit unit Net sales increased 20 percent to $13.22 billion. Foreign exchange had a positive impact of four percent due primarily to the strengthening of the Euro, Canadian dollar, British pound and Japanese yen, offset by weakening of the Mexican Peso and Venezuelan Bolivar. Mix was driven primarily by continued high growth in developing markets, including China and Latin America. Pricing activity, largely in response to competition, reduced sales by one percent. Pricing includes responses to competitive actions across multiple categories including family care in North America and Fabric and Home Care in Europe and the Middle East. The table below identifies the drivers to net sales changes versus the prior year quarter by business segment: Acquisitions/ Acquisitions/ Total Impact Divestitures Divestitures FX Price Mix/Other Impact Ex-FX Note: These sales percentage changes are approximations based on quantitative formulas that are consistently applied. Net earnings increased 22 percent to $1.82 billion. Earnings growth was primarily driven by volume benefits, the completion of the prior year restructuring program (which included $98 million after tax in the base period) and lower manufacturing costs. These improvements were partially offset by marketing investments to support base business growth and new initiatives. Net earnings per share were $1.30, an increase of 23 percent, including a slightly accretive effect from Wella. Gross margin expanded 210 basis points. Of this, 70 basis points ($75 million before tax) relates to restructuring charges in the prior period. Of the remaining 140 basis points of expansion, approximately half was driven by the addition of Wella, which has a higher gross margin than the base business. The remaining half was driven by the scale benefit of volume growth, the mix impact of higher volume in the Health and Beauty Care businesses, and product cost Marketing, Research, Administrative and Other Costs (MRA&O) as a percentage of net sales increased 170 basis points. The large majority of this basis point increase is due to Wella, reflecting a higher ratio of marketing expenses to sales than the base business and initial post-acquisition costs. The remaining increase in spending reflects investments behind the base business and support for initiatives. The addition of Wella and increased marketing investments more than offset the basis point improvement due to the non-recurrence of restructuring program charges ($57 million before tax) in the base period. RESULTS OF OPERATIONS - Six Months Ended December 31, 2003 THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information MARKETING, RESEARCH, ADMINISTRATIVE & OTHER 7,828 6,395 22 % OTHER NON-OPERATING INCOME, NET 69 177 EARNINGS BEFORE INCOME TAXES 5,164 4,317 20 % AVERAGE DILUTED SHARES OUTSTANDING 1,399.6 1,404.9 COMPARISONS AS A % OF NET SALES Chg MARKETING, RESEARCH, ADMINISTRATIVE & OTHER 30.8% 29.3% EARNINGS BEFORE INCOME TAXES 20.3% 19.8% Fiscal year to date, unit volume increased 16 percent. All business segments and geographic regions delivered unit volume growth. The lower growth rate year to date versus the October - December quarter reflects the acquisition of Wella in September. Excluding acquisitions and divestitures, unit volume increased nine percent through the first six months of the fiscal year. Volume growth was led by Beauty Care, up 33 percent, and Health Care, up 20 percent. Developing markets delivered double-digit volume growth with strong results in China and Central and Eastern Europe. For the first six months of the fiscal year, net sales increased 17 percent to $25.42 billion. Foreign exchange contributed three percent to sales growth. Pricing and mix combined for a negative two percent impact on sales growth. Pricing investments include activities to drive top line growth in multiple businesses and to respond to competition. Mix was driven primarily by strong growth in developing markets. The table below identifies the drivers to net sales changes fiscal year to date versus the prior year by business segment: Acquisitions/ Acquisitions/ Total Impact Divestitures Divestitures FX Price Mix/Other Impact Ex-FX Note: These sales percentage changes are approximations based on quantitative formulas that are consistently applied. Fiscal year to date earnings increased 21 percent to $3.58 billion. Earnings growth was driven by volume benefits, the completion of the restructuring program (which included $211 million of after tax charges in the prior year period) and product cost savings. Earnings growth was partially offset by continued marketing investments in the base business and in support of initiatives. Net earnings per share increased 22 percent to $2.56 compared to $2.10 in the base period. Gross margin fiscal year to date was 52.0 percent compared to 49.6 percent in the prior year, an increase of 240 basis points. The gross margin improvement was driven by the scale benefit of volume, the reduction of before tax charges related to the completed restructuring program of $163 million, the addition of Wella which has a higher gross margin than the base business, the mix shift to the Health and Beauty Care segments (which have higher gross margins than the Company average) and base business product cost savings. These improvements were partially offset by the impact of pricing and higher commodity Marketing, Research, Administrative and Other Costs (MRA&O) fiscal year to date increased to 30.8 percent from 29.3 percent of net sales in the comparable base period, an increase of 150 basis points. The majority of the increase is due to Wella, reflecting a higher ratio of marketing expenses to sales than the base business and initial post-acquisition costs. Marketing investments were made to drive growth on the base business and in support of initiatives. The spending increases associated with Wella and marketing investments more than offset the reduction in prior year restructuring program charges of $120 million before BUSINESS SEGMENT DISCUSSION The following tables provide supplemental information on net earnings and the underlying drivers of net sales changes by business segment for the quarter ended December 31, 2003 and fiscal year to date: THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended December 31, 2003 % Change Earnings % Change % Change Versus Before Versus Net Versus Net Sales Year Ago Income Taxes Year Ago Earnings Year Ago Six Months Ended December 31, 2003 % Change Earnings % Change % Change Versus Before Versus Net Versus Net Sales Year Ago Income Taxes Year Ago Earnings Year Ago For the quarter, volume was up nine percent behind Tide, Gain, Era and the continued success of initiatives including Mr. Clean Magic Eraser and Swiffer Duster. Net sales increased 10 percent to $3.41 billion. Sales growth includes a positive four percent foreign exchange impact that was partially offset by negative pricing and mix. Mix was driven by continued strong growth in developing markets, particularly China and Central and Eastern Europe. Pricing had a one percent impact on sales and represents primarily the continuation of prior period actions to maintain competitiveness. Net earnings increased 11 percent to $570 million driven primarily by volume, as lower manufacturing costs were offset by the profit impact of continued pricing actions. For the first six months of the fiscal year, Fabric and Home Care volume increased nine percent. Net sales increased nine percent, including a positive foreign exchange impact of three percent. Mix and pricing impacts combined for a negative three percent impact on sales. Net earnings increased seven percent. Earnings growth lags sales growth for the first six months of the fiscal year due to a high base period comparison in the July - September quarter. Total volume in the October - December quarter increased 45 percent including acquisitions and divestitures, primarily Wella. Excluding acquisitions and divestitures, Beauty Care volume increased 10 percent. Strong base business results were led by double-digit growth by the Pantene, Head & Shoulders and Herbal Essences hair care brands, Olay skin care and the Always feminine care brand. Net sales increased 50 percent to $4.49 billion, including a positive five percent foreign exchange impact. Net earnings were $681 million, an increase of 34 percent, due to strong top line growth, including Wella. Gross margin expansion was partially offset by the higher ratio of marketing expenses to sales for the Wella business, increased marketing investments in the North America hair care and skin care businesses and in support of initiatives (including Boss Intense, Lacoste Pour Femme, Rejoice in Greater China, Always/Alldays upgrades, Herbal Essences and Pantene in Western Europe and the geographic expansion of Olay Regenerist and Total Effects). The Wella acquisition was accretive to Beauty Care earnings. Interest and amortization expenses associated with Wella are included in Corporate. For the six months ended December 31, Beauty Care volume increased 33 percent. Volume growth fiscal year to date reflects the Wella acquisition, completed in September, and double-digit increases in developing markets. Net sales increased 35 percent to $8.25 billion. A positive foreign exchange impact of four percent was partially offset by pricing and mix. Net earnings increased 23 percent to $1.30 billion. Volume benefits and lower product costs were partially offset by additional marketing investments to support the base business and initiatives. For the quarter ended December 31, volume increased four percent behind strong growth in baby care - primarily in Western Europe and developing markets. Family care volume was flat due, in part, to high promotional spending levels by key competitors. Net sales increased six percent to $2.67 billion. Foreign exchange was a positive impact of five percent; the impact of volume on sales was partially offset by pricing and mix. Mix was primarily driven by strong growth in mid-tier diaper products in developing markets. Pricing had a negative one percent effect on sales in response to increased competitive promotional activity in North America family care. Earnings grew two percent against strong base period results (21 percent increase) to $281 million. Earnings in baby care increased due to volume and cost savings, largely offset by the aforementioned pricing investments and rising commodity costs in family care. Fiscal year to date, Baby and Family Care volume increased five percent. Baby care volume increased high single-digits, while family care volume increased low single-digits. Net sales increased seven percent to $5.28 billion, including a positive foreign exchange impact of four percent. Price and mix combined for a negative two percent impact. Earnings were $576 million, an increase of 11 percent, as profit growth behind volume and product cost savings was partially offset by pricing investments and increased commodity costs. Health Care unit volume increased 17 percent during the October - December quarter driven by the continued success of Actonel, Prilosec OTC and oral care. Vicks also posted strong unit volume growth due to the early cough/cold season in North America. Net sales increased 22 percent to $1.91 billion aided by a positive four percent foreign exchange impact and one percent for pricing. Net earnings were $333 million, an increase of 32 percent, on strong volume, lower manufacturing costs and margin expansion due to product mix. Marketing spending increased versus the base period primarily behind continued support of Prilosec OTC, Crest Whitestrips and Crest Night Effects. While double-digit top line growth is expected for the fiscal year, Prilosec OTC volume in the remaining quarters is expected to reflect consumption levels following the successful launch in September and continued strong results in October - December quarter. Fiscal year to date, Health Care volume increased 20 percent. Net sales were $3.64 billion, an increase of 22 percent. Sales growth was impacted by a positive three percent for foreign exchange. Mix was a negative one percent impact driven primarily by developing market growth. Net earnings increased 36 percent to $609 million. Earnings increased behind sales growth and margin expansion, including the impact of product cost savings. Snacks and Beverages unit volume increased one percent. Beverages volume increased two percent driven primarily by the Folgers AromaSeal initiative. Net sales increased six percent to $931 million driven primarily by a foreign exchange benefit of four percent. Volume and mix gains were partially offset by increased merchandising costs to support the continued high level of promotional activity in the coffee category. Manufacturing costs increased behind initiative start-up expenses. Net earnings increased 11 percent to $122 million behind sales growth and lower marketing and administrative spending. For the first six months of the fiscal year, Snacks and Beverages volume increased two percent. Net sales increased seven percent to $1.83 billion, reflecting volume growth, a positive foreign exchange impact of four percent and combined mix and pricing of one percent. Net earnings in Snacks and Beverages increased 15 percent to $231 million. Corporate includes certain operating and non-operating activities, as well as eliminations to adjust management reporting principles to United States Generally Accepted Accounting Principles (U.S. GAAP). For the quarter, net sales were -$190 million compared to -$68 million in the prior period, primarily driven by eliminations due to stronger joint venture sales. Net earnings for the quarter were -$169 million compared to -$166 million in the comparable prior period. Results primarily reflect lower costs from the restructuring program offset by charges associated with Wella and hedging impacts. For the first six months of the fiscal year, Corporate net sales were -$372 million compared to - -$185 million in the prior period. Net earnings for the six month period were - -$266 million versus -$325 million in the same period year ago. Cash generated from operating activities for the six months ended December 31, 2003 was $3.96 billion compared to $4.33 billion in the comparable prior period. Strong earnings, adjusted for non-cash items (depreciation, amortization and deferred income taxes) generated $4.67 billion of cash flow and were partially offset by increases in working capital. Working capital increased by $0.9 billion during the period. Accounts receivable increased by $0.5 billion due mainly to strong December shipments. Accounts payable decreased reflecting the Company's continued effort to accelerate payments to suppliers in order to maximize efficiencies and capture all Cash generated from operating activities is down $0.4 billion versus the comparable prior year period. The impact of increased earnings in the current period were offset by a larger increase in working capital and the impact of dividends received from a joint venture in the base period. Investing activities in the current year decreased cash by $6.11 billion compared to a decrease of $0.5 billion in prior year period. The primary driver was the acquisition of Wella for approximately $5.10 billion. Additional current year acquisitions include Glide Dental Floss and fabric care brands in Western Europe and the Middle East. There was no acquisition activity in the comparable Capital spending increased to $810 million versus $616 million in the comparable prior period. Capital spending as a percent of sales increased slightly versus the comparable period, but was still below the Company's target of four percent. Financing activities in the current fiscal year to date increased cash by $1.14 billion, representing a year-over-year cash increase of $3.29 billion. Cash from financing includes an increase in short and long-term debt to support the Wella acquisition. The Company issued $1.38 billion aggregate principal amount of notes with varying maturity dates. Additionally, two bonds matured reducing long-term debt $993 million. The net change in long-term debt is an increase of $412 million versus June 30. Treasury share repurchases were roughly in line with the comparable base period. Treasury share repurchases through the remainder of the fiscal year are expected to be higher than the prior year. The Company purchased approximately $200 million of stock in the January - June 2003 Current assets net of current liabilities declined by approximately $3.3 billion during the six months ended December 31, 2003. This decline was primarily caused by the issuance of commercial paper to partially fund the acquisition of Wella AG. The Company anticipates being able to support its short-term liquidity through cash generated from operations. The Company also has very strong long and short-term credit ratings which will enable it to refinance this debt at favorable rates in the commercial paper and bond markets. In addition, the Company has agreements with a diverse group of creditworthy financial institutions that, should they be needed, would provide sufficient credit funding to meet short-term financing requirements.",3046
2004-03-09,8-K,0000080424-04-000059,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) March 9, 2004 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) ONE PROCTER & GAMBLE PLAZA, CINCINNATI, OHIO 45202 (Address of principal executiveoffices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On March 9, 2003, The Procter & Gamble Company (the ""Company"") issued a news release with respect to (i) a 2-1 split of the Company's stock, (ii) an increase in the Company's quarterly dividend, and (iii) updating the Company's guidance for the 2003/04 third quarter and full fiscal year. The Company is furnishing this 8-K pursuant to Item 9, ""Regulation FD Disclosure"".",144
2004-04-01,8-K,0000080424-04-000071,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) April 1, 2004 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) ONE PROCTER & GAMBLE PLAZA, CINCINNATI, OHIO 45202 (Address of principal executiveoffices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On April 1, 2004, The Procter & Gamble Company (the ""Company"") issued a news release announcing the sale of its Sunny Delight and Punica juice-based drink businesses. The Company is furnishing this 8-K pursuant to Item 9, ""Regulation FD Disclosure"".",122
2004-04-26,8-K,0000950152-04-003185,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) April 26, 2004 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On April 26, 2004, The Procter & Gamble Company (the ""Company"") issued a news release announcing the Company has entered into a Domination and Profit Transfer Agreement with Wella AG. The Company is furnishing this 8-K pursuant to Item 9, ""Regulation FD Disclosure"".",126
2004-04-26,8-K,0000950152-04-003176,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) April 26, 2004 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On April 26, 2004, The Procter & Gamble Company (the ""Company"") issued a news release announcing an alternative to the Wella Dividend Proposal. The Company is furnishing this 8-K pursuant to Item 9, ""Regulation FD",118
2004-04-30,8-K,0000080424-04-000074,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) April 30, 2004 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) ONE PROCTER & GAMBLE PLAZA, CINCINNATI, OHIO 45202 (Address of principal executiveoffices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On April 30, 2004, The Procter & Gamble Company (""P&G"") issued a news release announcing that court appointed independent auditor, Ernst & Young, has confirmed the cash offer and annual compensation payment to be offered by P&G as part of its domination and profit transfer agreement with Wella AG. P&G is furnishing this 8-K pursuant to Item 9, ""Regulation FD Disclosure"".",143
2004-04-30,8-K,0000080424-04-000073,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) April 30, 2004 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION On April 30, 2004, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended March 31, 2004. P&G is furnishing this 8-K pursuant to Item 12, ""Results of Operations and Financial Condition"".",125
2004-04-30,10-Q,0000080424-04-000075,"and Analysis of Financial Condition and Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is organized in the following sections: Results of Operations - Three Months Ended March 31, 2004 Results of Operations - Nine Months Ended March 31, 2004 Business Segment Discussion (for the three and nine months ended The Company markets approximately 300 consumer products in more than 160 countries around the world in five distinct business segments: Fabric and Home Care, Beauty Care, Baby and Family Care, Health Care and Snacks and Beverages. The following table provides the percentage of net sales and net earnings by business segment for the nine months ended March 31, 2004 (excludes net sales and net earnings in Corporate): NET SALES NET EARNINGS The Company has expressed its intent to focus on strategies that are right for the long term health of the business as measured by shareholder return. Long term targets include: sales growth of 4% to 6% excluding the impact of changes in foreign exchange rates from year-over-year comparisons, double-digit earnings per share growth, and greater than 90 percent free cash flow productivity (defined as the ratio of net earnings divided by the difference of operating cash flow less capital expenditures). MD&A will reference results for the quarter and fiscal year to date against these targets. For the nine months ended March 31, 2004, the Company delivered sales and earnings growth above long-term targets. Net sales increased 18 percent (14% excluding foreign exchange impacts) while net earnings increased 21 percent, with all business segments posting sales and earnings growth. Results of the Beauty Care segment include the impact of the Wella acquisition which was completed in September 2003. Sales grew ahead of volume due to positive foreign exchange impacts, partially offset by mix (driven by high growth in developing markets) and pricing activity. Earnings increased due to the scale benefit of volume, the completion of the Company's restructuring program which had $277 million of after tax charges in the base period, and lower manufacturing costs, partially offset by increased marketing investments in the base business and in support of product initiatives. The markets in which the Company sells its products are highly competitive and comprised of both global and local competitors. Going forward, business and market uncertainties may affect results. Among the key factors that could impact results and must be managed by the Company are: (1) the ability to achieve business plans, including growing existing sales and volume profitably despite high levels of competitive activity, especially with respect to the product categories and geographical markets (including developing markets) in which the Company has chosen to focus; (2) successfully executing, managing and integrating key acquisitions (including the Domination and Profit Transfer Agreement with Wella) and completing planned divestitures (including the divestiture of the Company's juice business); (3) the ability to manage and maintain key customer relationships; (4) the ability to maintain key manufacturing and supply sources (including sole supplier and plant manufacturing sources); (5) the ability to successfully manage regulatory, tax and legal matters (including product liability matters), and to resolve pending matters within current estimates; (6) the ability to successfully implement, achieve and sustain cost improvement plans in manufacturing and overhead areas, including the success of the Company's outsourcing projects; (7) the ability to successfully manage currency (including currency issues in volatile countries), interest rate and certain commodity cost (8) the ability to manage the continued global political and/or economic uncertainty, especially in the Company's significant geographical markets, as well as any political and/or economic uncertainty due to terrorist activities; and (9) the ability to successfully manage increases in the prices of raw materials used to make the Company's products. If the Company's assumptions and estimates are incorrect or do not come to fruition, or if the Company does not achieve all of these key factors, then the Company's actual results could vary materially from the forward-looking RESULTS OF OPERATIONS - THREE MONTHS ENDED MARCH 31, 2004 The following discussion provides a review of results for the three months ended March 31, 2004 versus the three months ended March 31, 2003. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended March 31 OTHER NON-OPERATING INCOME, NET 67 37 AVERAGE DILUTED SHARES OUTSTANDING 1,395.0 1,395.8 COMPARISONS AS A % OF NET SALES Unit volume for the quarter increased 20 percent, with all business segments and geographic regions reporting unit volume growth. Excluding the impact of acquisitions and divestitures, primarily Wella, unit volume increased 12 percent. Volume growth was led by Beauty Care, up 41 percent, and Health Care, up 19 percent. Developing markets delivered double-digit volume growth led by China and Central and Eastern Europe. Net sales increased 22 percent to $13.03 billion. Net sales increased behind volume growth, the addition of Wella and a positive foreign exchange impact of five percent due primarily to the strengthening of the Euro, British Pound and Canadian dollar. Product mix reduced sales growth by two percent reflecting higher growth in developing markets, including China and Latin America. Developing markets generally have an average unit sales price lower than the Company average. Pricing activity reduced sales growth by one percent largely in response to competition in multiple categories including coffee and family care in the United States and Beauty Care and Fabric and Home Care in North America and Europe. The table below identifies the drivers to net sales changes versus the prior year quarter by business segment: Acquisitions/ Acquisitions/ Total Impact Divestitures Divestitures FX Price Mix/Other Impact Ex-FX Note: These sales percentage changes are approximations based on quantitative formulas that are consistently applied. Net earnings increased 20 percent to $1.53 billion. Earnings growth was primarily driven by volume benefits and the completion of the prior year restructuring program (which included $66 million after tax in the base period). These improvements were partially offset by marketing investments to support base business growth and new initiatives, as well as current period charges to maintain a competitive cost structure. Diluted net earnings per share were $1.09, an increase of 20 percent. The acquisition of Wella had a slightly dilutive effect on total Company earnings. Gross margin expanded 150 basis points, with 40 basis points of the improvement ($46MM before tax) related to restructuring program charges in the prior year. The remaining 110 basis points of gross margin expansion were predominately driven by the scale benefit of volume. Base business savings and the addition of Wella, which has a higher gross margin than the consolidated Company average, also contributed to margin expansion. These items were partially offset by the impact of pricing, higher commodity costs, increased mix of developing markets (which have lower average margins) and current year charges for actions associated with organizational streamlining and other projects to maintain a competitive cost structure. Marketing, Research, Administrative and Other Costs (MRA&O) as a percentage of net sales increased 220 basis points. The prior year period includes $41 million before tax of restructuring program charges. The majority of the basis point increase was due to the Wella acquisition reflecting a higher ratio of MRA&O expenses to sales than the base business. The remaining increase reflects marketing investments to sustain growth behind the base business and initiatives, partially offset by the non-recurrence of prior year restructuring costs, which represented a 40 basis point improvement year-over-year. RESULTS OF OPERATIONS - NINE MONTHS ENDED MARCH 31, 2004 The following discussion provides a review of results for the nine months ended March 31, 2004 versus the nine months ended March 31, 2003. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Nine Months Ended March 31 MARKETING, RESEARCH, ADMINISTRATIVE & OTHER 12,160 9,700 25 % OTHER NON-OPERATING INCOME, NET 136 214 AVERAGE DILUTED SHARES OUTSTANDING 1,398.1 1,401.9 COMPARISONS AS A % OF NET SALES MARKETING, RESEARCH, ADMINISTRATIVE & OTHER 31.6 % 29.9 % 170 Fiscal year to date, unit volume increased 17 percent with all business segments and geographic regions delivering unit volume growth. Excluding acquisitions and divestitures, unit volume increased 10 percent through the first nine months of the fiscal year. Volume growth was led by Beauty Care, up 35 percent, and Health Care, up 20 percent. Developing markets delivered double-digit volume growth led by China and Central and Eastern Europe. For the first nine months of the fiscal year, net sales increased 18 percent to $38.45 billion. Foreign exchange contributed four percent to sales growth behind the strengthening of the Euro, British Pound and Canadian Dollar. Product mix reduced sales growth by two percent reflecting higher growth in developing markets, including China and Latin America. Developing markets generally have an average unit sales price lower than the Company average. Pricing investments include activities to drive top line growth in multiple businesses and to respond to competitors' actions. The table below identifies the drivers to changes in net sales fiscal year to date versus the prior year by business Acquisitions/ Acquisitions/ Total Total Impact Divestitures Divestitures FX Price Mix/Other Impact Ex-FX Note: These sales percentage changes are approximations based on quantitative formulas that are consistently applied. Fiscal year to date earnings increased 21 percent to $5.11 billion. Earnings growth was driven by volume benefits, the completion of the restructuring program (which included $277 million of after tax charges in the prior year period) and product cost savings. Earnings growth was partially offset by increased marketing investments in the base business and in support of initiatives. Diluted net earnings per share increased 21 percent to $3.65 compared to $3.01 in the base period. Gross margin expanded 200 basis points, with 60 basis points of the improvement related to restructuring program charges in the base period of $209 million. The remaining gross margin improvement was driven by the scale benefit of volume, base business savings and the addition of Wella which has a higher gross margin than the base business. These improvements were partially offset by the impact of higher commodity costs and the pricing actions mentioned above, as well as current year restructuring activity. Marketing, Research, Administrative and Other Costs (MRA&O) as a percentage of net sales increased 170 basis points. The prior year period includes $161 million of restructuring program charges. The majority of the increase is due to Wella, reflecting a higher ratio of marketing expenses to sales than the base business. The balance was due to marketing investments made to drive growth on the base business and in support of initiatives, partially offset by the non-recurrence of prior year restructuring charges which resulted in a 50 basis point improvement year-over-year. BUSINESS SEGMENT DISCUSSION The following discussion provides a review of results by business segment. An analysis of the results for the three and nine months ended March 31, 2004 are compared to the same periods ended March 31, 2003. The table below provides supplemental information on net earnings by business segment for the three and nine months ended March 31, 2004 versus the comparable THREE MONTHS ENDED MARCH 31, 2004 % Change Earnings % Change % Change Versus Before Versus Net Versus Net Sales Year Ago Income Taxes Year Ago Earnings Year Ago NINE MONTHS ENDED MARCH 31, 2004 % Change Earnings % Change % Change Versus Before Versus Net Versus Net Sales Year Ago Income Taxes Year Ago Earnings Year Ago For the quarter, Fabric and Home Care unit volume was up 12 percent behind growth on established brands such as Tide, Ariel and Gain and the continued success of initiatives including Mr. Clean Magic Eraser, Mr. Clean AutoDry, Swiffer Duster, Gain Fabric Enhancer, and the expansion of Lenor in Japan. Net sales increased 17 percent to $3.58 billion. Sales growth includes a positive five percent foreign exchange impact. Pricing of negative one percent was primarily driven by the continuation of prior period actions to maintain competitive shelf pricing. Positive mix of one percent was due to the higher growth in the home care business which has a higher sales per unit rate than the segment average, which was partially offset by developing market growth. Net earnings increased 10 percent to $548 million. Earnings margin was impacted by the mix effect of strong developing market growth which has a lower gross margin than the segment average, marketing investments and startup costs to support initiative activity, and startup costs for manufacturing optimization. For the nine months ended March 31, 2004, Fabric and Home Care volume increased 10 percent. Volume was driven by growth in the fabric care business, particularly in developing regions, and growth in the home care business behind initiatives. Net sales increased 12 percent to $10.38 billion, including a positive foreign exchange impact of four percent. Mix reduced sales by one percent driven primarily by double-digit growth in developing markets. Net earnings were $1.68 billion, an increase of eight percent, due to volume growth and base business cost savings, partially offset by the mix effect of strong developing market growth which has a lower gross margin than the segment average, the aforementioned pricing actions and higher costs, including marketing support for initiatives. Beauty Care unit volume in the January - March quarter increased 41 percent. Excluding the impact of Wella, unit volume increased 13 percent. Global hair care volume grew in all regions with particular progress in the Head & Shoulders, Pantene, and Herbal Essences brands. In feminine care, volume growth was driven by Always/Alldays and Naturella in Latin America. Olay delivered double-digit growth. Net sales increased 48 percent to $4.47 billion, including a positive foreign exchange impact of six percent. Positive mix contributed two percent to sales growth due to higher growth rates in premium priced products with a higher sales per unit rate than the segment average, including Wella, Olay Regenerist and fine fragrances. Net earnings increased 28 percent to $593 million. While the higher marketing and administrative expense ratio for Wella impacts margins, earnings growth reflects volume and continued marketing investments to support the base businesses and initiatives. Key initiatives include the geographic expansion of Herbal Essences and Head & Shoulders, as well as support for Lacoste Red and Olay Regenerist. The Wella acquisition was accretive to Beauty Care earnings in the quarter, but slightly dilutive to the Company as the interest and amortization expenses related to Wella are included For the nine months ended March 31, 2004, Beauty Care volume increased 35 percent versus the comparable prior year period. Excluding acquisitions and divestitures from year-over-year comparisons, Beauty Care volume increased 10 percent. Volume growth was broad-based behind hair care, feminine care, personal beauty and in developing markets. Net sales increased 39% to $12.71 billion. Sales growth includes a positive foreign exchange impact of five percent, partially offset by negative pricing of one percent. Pricing includes actions to support the North American hair, colorants and cosmetics and Western European feminine care businesses. Net earnings increased 25 percent to $1.89 billion. Volume benefits and lower product costs were partially offset by marketing investments to support product initiatives and the base business. Earnings margin was also negatively impacted by the higher expense ratios of Wella. Fiscal year to date, the Wella acquisition was accretive to Beauty Care earnings and a slight gain on Company earnings after including the impacts of interest and amortization expense. Baby and Family Care volume increased seven percent for the quarter ended March 31. Volume was driven by double-digit growth in Pampers diaper, particularly in Western Europe and developing markets, and Bounty paper towel brands. Net sales increased nine percent to $2.71 billion, including a positive foreign exchange impact of five percent. Sales were reduced by two percent from mix driven primarily by growth of diapers in developing markets and baby wipes, which have a lower average revenue per unit than the segment average. Promotional activity, primarily in North America family care to match higher levels of competitive spending, resulted in a one percent pricing impact. Net earnings grew 10 percent to $219 million. Earnings improved behind volume strength and cost savings, partly offset by the aforementioned pricing investments and higher commodity For the nine months ended March 31, Baby and Family Care volume increased six percent driven primarily by double-digit growth in baby care, including gains in Western Europe and developing markets, and low single-digit growth in family care. Family care volume growth fiscal year to date reflects a difficult competitive environment, particularly in North America, as competitors increased promotional spending. Net sales increased eight percent to $7.99 billion versus the comparable prior year period, including a positive foreign exchange impact of five percent. Sales were negatively impacted by pricing of two percent primarily due to increased competitive promotional activity in North America family care. Net earnings increased 11 percent to $795 million as profit growth from volume and product cost savings was partially offset by pricing and increases in commodity costs. The Company recently announced North America family care will increase prices six percent effective in July to partially recover increases in commodity costs. For the quarter, Health Care unit volume increased 19 percent driven by pharmaceuticals, Prilosec OTC, oral care and developing markets. Net sales increased 20 percent to $1.72 billion including a positive four percent foreign exchange impact. Developing market growth in oral care and pipeline shipments for generic Macrobid, which have a lower average revenue per unit than the segment average, resulted in a negative three percent mix impact on sales. Net earnings were $215 million, an increase of 46 percent. Operating margin expansion due to volume, product mix (including the increase in pharmaceutical sales), manufacturing cost savings and lower overhead spending as a percentage of sales were the key drivers behind earnings growth versus the base period. Margin expansion was partially offset by marketing spending versus the comparable prior year period in support of Prilosec OTC and Crest whitening Through the first nine months of the fiscal year ended March 31, Health Care volume increased 20 percent behind initiatives. Sales increased 22 percent to $5.36 billion, and included a positive four percent impact from foreign exchange. Mix had a negative two percent impact on sales due to strong growth in developing markets and the aforementioned pipeline impact of generic Macrobid. Net earnings increased 38 percent to $824 million. Earnings growth was primarily driven by sales growth behind initiatives and margin expansion due to product mix, manufacturing cost savings and lower overhead spending as a percentage of sales. Margin expansion was negatively impacted by increased Snacks and Beverages unit volume increased two percent, with progress on Pringles and Folgers. Net sales increased six percent to $800 million, including a positive foreign exchange impact of five percent. Pricing, primarily coffee promotional spending, negatively impacted sales by three percent. Positive mix of two percent was due to growth in Folgers which has a higher average sales per unit rate than the segment. Net earnings were $55 million, an For the first nine months of the fiscal year, Snacks and Beverages volume increased two percent driven by mid-single digit volume growth on the Pringles and Folgers brands. Net sales were $2.63 billion, representing an increase of seven percent versus the comparable prior period. Sales growth includes a positive four percent impact from foreign exchange. Price and mix combined for a one percent positive impact to sales growth. Net earnings increased 14 percent to $286 million as volume and base business savings were partially offset by higher commodity costs. In April, the Company announced an agreement to sell the juice business. The transaction is expected to be completed during the July - Corporate includes certain operating and non-operating activities, as well as eliminations to adjust management reporting principles to United States Generally Accepted Accounting Principles (U.S. GAAP). For the quarter, net sales were -$243 million compared to -$88 million in the prior period. For the first nine months of the fiscal year, net sales held in Corporate were -$615 million compared to -$273 million in the base period. For both the quarter and fiscal year to date, the change in net sales in Corporate was primarily driven by eliminations due to stronger joint venture sales. Net earnings for the quarter were -$102 million compared to -$86 million in the prior year. For the first nine months of the fiscal year, net earnings were - -$368 million compared to -$411 million in the prior year. Results for the quarter and fiscal year to date reflect lower charges versus the base period due to the completion of the restructuring program offset by higher interest and intangible asset amortization charges associated with Wella, hedging impacts and current year charges for activities to maintain a competitive cost structure. Cash generated from operating activities for the nine months ended March 31, 2004 was $6.94 billion compared to $6.74 billion in the prior year period. Strong earnings, adjusted for non-cash items (depreciation, amortization and deferred income taxes) generated $6.74 billion of cash. Cash generated from operating activities is up $200 million versus the prior year period as the impact of increased earnings was partially offset by an increase in working capital, the impact of dividends received from a joint venture in the base period and the impact of the timing of certain tax payments related to the prior year. Working capital increased by $154 million year-over-year due to the impact of business growth partially offset by strong working capital performance as a result of the Company's focus on cash management. Both accounts receivable days' outstanding and inventory days improved excluding the impact of Wella. Investing activities in the current year used $6.67 billion compared to $989 million in the prior year period. The primary driver was the acquisition of Wella for approximately $5.10 billion, as well as certain smaller acquisitions such as Glide Dental Floss and fabric care brands in Western Europe and the Capital spending was $1.33 billion versus $967 million in the prior year period. Capital spending as a percent of sales increased versus the prior year but was still below the Company's target of four percent. On April 26, 2004, the Company announced it had concluded a domination and profit transfer agreement with Wella AG's Supervisory Board. The agreement is subject to approval by Wella's shareholders at their annual general meeting in June. As required by German law, the Company will make a cash offer of EUR 72.86 per share to Wella AG minority shareholders for all outstanding ordinary and preference shares. As an alternative to the cash offer, minority shareholders in Wella AG have the option to receive a fixed annual payment of EUR 3.81 per ordinary share and EUR 3.83 per preference share. Assuming all remaining minority shareholders tender their shares under the offer, the total consideration paid will be approximately EUR 1.1 billion (approximately $1.3 billion based on current exchange rates). Financing activities used net cash of $828 million for the period compared to $3.66 billion in the prior year period. Financing activities in the current year include an increase in the Company's debt position primarily to support the acquisition of Wella AG. Short term debt increased by $2.07 billion and the Company has issued $1.96 billion aggregate principal amount of notes with varying maturity dates. Additionally, long term debt reduced by $1.10 billion primarily due to the maturing of two bonds. The net change in long term debt is an increase of $859 million versus June 30, Treasury share purchases were $2.33 billion for the nine months ended March 31, 2004, an increase of $1.09 billion versus the prior year period. Treasury share purchases for the remainder of the fiscal are expected to continue at an accelerated rate versus the prior year. Actual purchases will depend on available cash balances, consistent with the Company's cash utilization Current assets net of current liabilities declined by approximately $2.7 billion during the nine months ended March 31, 2004. This decline was primarily caused by the issuance of commercial paper to partially fund the acquisition of Wella AG. The Company anticipates being able to support its short-term liquidity through cash generated from operations. The Company also has very strong long and short-term ratings which will enable it to refinance this debt at favorable rates in commercial paper and bond markets. In addition, the Company has agreements with a diverse group of creditworthy financial institutions that, if needed, would provide sufficient credit funding to meet short-term financing",4065
2004-05-11,8-K,0000080424-04-000085,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) May 11, 2004 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) ONE PROCTER & GAMBLE PLAZA, CINCINNATI, OHIO 45202 (Address of principal executiveoffices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On May 11, 2004, The Procter & Gamble Company (""P&G"") issued a news release announcing that it purchased remaining stake in China joint venture. P&G is furnishing this 8-K pursuant to Item 9, ""Regulation FD Disclosure"".",118
2004-05-19,8-K,0000080424-04-000088,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) May 19, 2004 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) ONE PROCTER & GAMBLE PLAZA, CINCINNATI, OHIO 45202 (Address of principal executiveoffices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On May 19, 2004, The Procter & Gamble Company (the ""Company"") issued a news release announcing some business unit realignments and associated management changes. The Company is furnishing this 8-K pursuant to Item 9, ""Regulation FD Disclosure"".",119
2004-06-10,8-K,0000080424-04-000094,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) June 10, 2004 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) ONE PROCTER & GAMBLE PLAZA, CINCINNATI, OHIO 45202 (Address of principal executiveoffices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On June 10, 2004, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended June 2004. The Company is furnishing this 8-K pursuant to Item 9, ""Regulation FD Disclosure"".",120
2004-06-14,8-K,0000080424-04-000105,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) June 11, 2004 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) ONE PROCTER & GAMBLE PLAZA, CINCINNATI, OHIO 45202 (Address of principal executiveoffices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On June 11, 2004, The Procter & Gamble Company (the ""Company"") issued a news release announcing that the Domination and Profit Transfer Agreement between the Company and Wella AG has become effective. The Company is furnishing this 8-K pursuant to Item 9, ""Regulation FD Disclosure"".",127
2004-07-14,8-K,0000080424-04-000114,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) July 14, 2004 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) ONE PROCTER & GAMBLE PLAZA, CINCINNATI, OHIO 45202 (Address of principal executiveoffices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 9. REGULATION FD DISCLOSURE On July 14, 2004, The Procter & Gamble Company (the ""Company"") issued a news release announcing that the Company declared a quarterly dividend of twenty-five cents ($.25) per share on the Common Stock and on the Series A ESOP Convertible Class A Preferred Stock, payable on or after August 16, 2004 to shareholders of record at the close of business on July 23, 2004. The Company is furnishing this 8-K pursuant to Item 9, ""Regulation FD Disclosure"".",159
2004-08-02,8-K,0000080424-04-000115,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) August 2, 2004 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION On August 2, 2004, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter and fiscal year ended June 30, 2004. The Company is furnishing this 8-K pursuant to Item 12, ""Results of Operations and Financial Condition.""",129
2004-09-01,8-K,0000080424-04-000147,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 1, 2004 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 The Procter & Gamble Company (the ""Company"") has been advised that A.G. Lafley, Chairman of the Board, President and Chief Executive of the Company, extended his stock trading plan first entered on November 25, 2002, designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Under Rule 10b5-1, directors and officers may adopt a prearranged plan or contract for the sale of Company securities under specified conditions and at Mr. Lafley's plan allows for the sale of a total of 64,000 shares of the Company's common stock over a one year period, and provides for sales of specified share amounts at specified market prices, subject to specified limitations. Sales pursuant to this plan may begin in August 2005 and will terminate on May 30, 2006, unless terminated sooner in accordance with the In addition, Mr. Lafley has informed the Company that he will publicly disclose any stock sales made under the Rule 10b5-1 plan as required by the securities laws. Except as may be required by law, the Company does not undertake to report plans by other Company officers or directors, nor to report modifications, terminations, transactions or other activities under Mr. Lafley's plan or the plan of any other officer or director.",284
2004-09-09,10-K,0000950152-04-006777,"Procter & Gamble 10-K THE PROCTER & GAMBLE COMPANY ANNUAL REPORT ON FORM 10-K SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION ANNUAL REPORT ON FORM 10-K PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2004 Commission File No. 1-434 One Procter & Gamble Plaza, Cincinnati, Ohio 45202 IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio Securities registered pursuant to Section 12(b) of the Act: Name of each Exchange on which registered Common Stock, without Par Value New York, National, Amsterdam, Paris, Basle, Geneva, Lausanne, Zurich, Frankfurt, Brussels Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 S-K is not contained herein, and will not be contained, to the best of in definitive proxy or information statements incorporated by reference in Part Form 10-K or any amendment to this Form Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes x No o There were 2,542,231,468 shares of Common Stock outstanding as of July 31, 2004. The aggregate market value of the voting stock held by non-affiliates amounted to $129 billion on December 31, 2003. Documents Incorporated By Reference Portions of the Annual Report to Shareholders for the fiscal year ended June 30, 2004 are incorporated by reference into Part I, Part II and Part IV of this report to the extent described herein. Portions of the Proxy Statement for the 2004 Annual Meeting of Shareholders are incorporated by reference into Part III of this report to the extent described Item 3. Legal Proceedings Item 4. Submission of Matters to a Vote of Security Holders Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities Item 6. Selected Financial Data Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations Item 7A. Quantitative and Qualitative Disclosures About Market Risk Item 8. Financial Statements and Supplementary Data Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure Item 9A. Controls and Procedures Item 10. Directors and Executive Officers of the Registrant Item 11. Executive Compensation Item 12. Security Ownership of Certain Beneficial Owners and Management Item 13. Certain Relationships and Related Transactions Item 14. Principal Accounting Fees and Services Item 15. Exhibits, Financial Statement Schedules and Reports on Form 8-K Additional information required by this item is",473
2004-09-09,8-K,0000080424-04-000148,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 9, 2004 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 7.01 REGULATION FD DISCLOSURE On September 9, 2004, The Procter & Gamble Company (the ""Company"") issued a news release confirming previously announced guidance for the July to September quarter in line with analysts' current consensus estimate.",113
2004-10-13,8-K,0000080424-04-000179,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) October 13, 2004 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 7.01 REGULATION FD DISCLOSURE On October 12, 2004, the Board of Directors of The Procter & Gamble Company (the ""Company"")declared a quarterly dividend of $0.25 per share on the Common Stock and on the Series A ESOP Convertible Class A Preferred Stock of the Company, payable on or after November 15, 2004 to shareholders of record at the close of business on October 22, 2004. The Company is furnishing this 8-K pursuant to Item, 7.01, ""Regulation FD Disclosure"".",155
2004-10-22,8-K,0000950152-04-007572,"THE PROCTER & GAMBLE COMPANY SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) Registrants telephone number, including area code EX-99.1 FISCAL YEAR 2004 BUSINESS SEGMENT INFORMATION EX-99.2 FISCAL YEAR 2003 BUSINESS SEGMENT INFORMATION EX-99.3 EXCERPTED PART I AND PART II OF PROCTER & GAMBLE'S ANNUAL REPORT ON FORM 10-K FOR THE FISCAL YEAR ENDED JUNE 30, 2004 EX-99.4 MANAGEMENT'S DISCUSSION AND ANALYSIS UNDER ITEMS 1 AND 7 OF PROCTER & GAMBLE'S ANNUAL REPORT ON FORM 10-K EX-99.5 FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA UNDER ITEMS 1, 6, 7 AND 8 OF PROCTER & GAMBLE'S ANNUAL REPORT ON FORM 10-K FOR THE FISCAL YEAR ENDED JUNE 30, 2004 EX-99.6 CONSENT OF DELOITTE AND TOUCHE LLP The information included in this Form 8-K affects the disclosure of segment results only and in no way revises or restates the Consolidated Statements of Earnings, Consolidated Balance Sheets, Consolidated Statements of Shareholders Equity or Consolidated Statements of Cash Flows for the Procter & Gamble Company and consolidated subsidiaries. As disclosed in its Annual Report on Form 10-K, the Company made the following management and business changes: (1) Effective July 1, 2004, the Company realigned some of its business units and associated management responsibilities. Effective July 1, 2004, the Company realigned to three global business units: Beauty Care; Health, Baby and Family Care; and Household Care, which will include the Fabric and Home Care business and the Snacks and Beverages business. Snacks and Beverages is renamed Snacks and Coffee to reflect the remaining businesses. (2) In August 2004, the Company completed the divestiture of its Juice business. Historical results of the Juice business will be included in Corporate to provide segment results on a comparable basis. In addition to these management and business changes, the Company made adjustments to the basis of measurement for segment performance effective July 1, 2004. These adjustments reflect recent changes in the measures used to evaluate the performance of senior management, consistent with the Companys increased acquisition and licensing activity. The most significant of these adjustments is the amortization of identifiable intangible assets with determinable lives, which will now be included in segment results rather than held in Corporate. The amortization of identifiable intangible assets for the three years ended June 30, 2004, 2003 and 2002 was $165 million, $100 million and $97 million, respectively. Other changes made to the basis of measurement of segment performance are the allocation methodologies of certain overhead items managed by the Companys Global Business Services organization. Certain other immaterial changes were made to cost allocations from Corporate to the As required by Statement of Financial Accounting Standards (SFAS) No. 131, consolidated financial statements issued by the Company in the future will reflect these modifications, including reclassification of all comparative prior period segment information. The attached exhibits provide information about segment performance taking into account the management, business and reclassification changes as they relate to prior periods. Exhibits 99-1 and 99-2 provide a summary of segment results, including interim periods, for fiscal years 2004 and 2003, respectively. Exhibit 99-3 contains parts I and II of Procter & Gambles Form 10-K for fiscal year 2004. Exhibits 99-4 and 99-5 contain the complete Managements Discussion and Analysis and consolidated financial statements, respectively, for the recently completed fiscal year for which the segment information has been reclassified to conform to the new segment presentation. These financial statements, conformed for the changes, will become the historical financial statements of The Procter & Gamble Company and consolidated subsidiaries for currently open and future filings with the Securities and Exchange Commission.",635
2004-10-27,8-K,0000080424-04-000194,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) October 27, 2004 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On October 27, 2004, The Procter & Gamble Company (the ""Company"") issued a press release with respect to earnings for the quarter ended September 30, 2004. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition"".",126
2004-10-28,10-Q,0000080424-04-000195,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2004 Commission file number 1-434 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State of incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [ X ] No [ ] Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes [ X ] No [ ] There were 2,536,682,989 shares of Common Stock outstanding as of September 30, PART I. FINANCIAL INFORMATION Item 1. Financial Statements The Consolidated Statements of Earnings of The Procter & Gamble Company and subsidiaries for the three months ended September 30, 2004 and 2003, the Consolidated Balance Sheets as of September 30, 2004 and June 30, 2004, and the Consolidated Statements of Cash Flows for the three months ended September 30, 2004 and 2003 follow. In the opinion of management, these unaudited consolidated financial statements contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, such financial statements may not be indicative necessarily THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS Amounts in millions except per share amounts Other non-operating income, net 182 40 EARNINGS BEFORE INCOME TAXES 2,871 2,542 COMMON SHARES OUTSTANDING 2,756.0 2,797.7 See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS September 30 June 30 Prepaid expenses and other receivables 1,835 1,803 PROPERTY, PLANT AND EQUIPMENT NET PROPERTY, PLANT AND EQUIPMENT 13,984 14,108 GOODWILL AND OTHER INTANGIBLE ASSETS Trademarks and other intangible assets, net 4,521 4,290 NET GOODWILL AND OTHER INTANGIBLE ASSETS 24,410 23,900 LIABILITIES AND SHAREHOLDERS' EQUITY Common stock - shares outstanding - Sept 30 2,536.7 2,537 Reserve for ESOP debt retirement (1,267) (1,283) Accumulated other comprehensive income (1,328) (1,545) TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 59,203 $ 57,048 See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS Amounts in millions September 30 CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD $ 5,469 $ 5,912 Depreciation and amortization 480 407 Accounts payable, accrued and other liabilities 65 (76) Other operating assets & liabilities (112) (57) Acquisitions, net of cash acquired (335) (5,035) Change in investment securities (31) 11 Proceeds from the exercise of stock options and other 99 89 EFFECT OF EXCHANGE RATE CHANGES ON CASH CHANGE IN CASH AND CASH EQUIVALENTS 793 (1,863) CASH AND CASH EQUIVALENTS, END OF PERIOD $ 6,262 $ 4,049 See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 1. These statements should be read in conjunction with the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2004 and the Form 8-K filed on October 22, 2004 reflecting certain changes to the Company's segment information. The results of operations for the three-month period ended September 30, 2004 are not indicative necessarily of annual results. 2. Comprehensive Income - Total comprehensive income is comprised primarily of net earnings, net currency translation gains and losses, impacts of net investment and cash flow hedges and net unrealized gains and losses on securities. Total comprehensive income for the three months ended September 30, 2004 and 2003 was $2,218 million and $1,937 million, respectively. 3. Segment Information - Following is a summary of segment results, including supplemental data on the Fabric and Home Care, Snacks and Coffee, Health Care and Baby and Family Care businesses. Three Months Ended September 30 Net Sales Income Taxes Net Earnings Total Health, Baby & Family Care 2004 $ 4,694 $ 891 $ 575 4. Goodwill and Other Intangible Assets - Goodwill as of September 30, 2004 is allocated by reportable segment as follows (amounts in millions): Total Beauty Care, beginning of year $ 14,457 Acquistions & divestiture 109 Translation & other 141 Goodwill, September 30, 2004 $ 14,707 Health Care, beginning of year $ 3,315 Acquistions & divestiture 11 Translation & other 7 Goodwill, September 30, 2004 $ 3,333 Baby & Family Care, beginning of year $ 941 Acquistions & divestiture -- Translation & other 8 Goodwill, September 30, 2004 $ 949 Total Health, Baby & Family Care, beginning of year $ 4,256 Acquistions & divestiture 11 Translation & other 15 Goodwill, September 30, 2004 $ 4,282 Fabric & Home Care, beginning of year $ 614 Acquistions & divestiture 27 Translation & other -- Goodwill, September 30, 2004 $ 641 Snacks & Coffee, beginning of year $ 283 Acquistions & divestiture (25) Translation & other 1 Goodwill, September 30, 2004 $ 259 Total Household Care, beginning of year $ 897 Acquistions & divestiture 2 Translation & other 1 Goodwill, September 30, 2004 $ 900 Goodwill, Net, beginning of year $ 19,610 Acquistions & divestiture 122 Translation & other 157 Goodwill, September 30, 2004 $ 19,889 The increase in goodwill is due to the completed allocation of the purchase price relating to the September 2003 acquisition of Wella AG. The Company finalized the allocation of Wella purchase price to the individual assets acquired and liabilities assumed. In addition, the Company completed its analysis of collaboration plans. Identifiable intangible assets as of September 30, 2004 are comprised of: Gross Carrying Accumulated Amount Amortization Amortizable intangible assets with determinable lives 2,283 622 Intangible assets with indefinite lives 3,029 169 Total identifiable intangible assets 5,312 791 Amortizable intangible assets consist principally of patents, technology and trademarks. The intangible assets with indefinite lives consist primarily of certain trademarks. The amortization of intangible assets for the three months ended September 30, 2004 was $48 million. 5. Pro Forma Stock-Based Compensation - The Company has a primary stock-based compensation plan under which stock options are granted annually to key managers and directors with exercise prices equal to the market price of the underlying shares on the date of grant. Grants were made under plans approved by shareholders in 1992, 2001 and 2003. Grants issued since September 2002 are vested after three years and have a ten-year life. Grants issued from July 1998 through August 2002 are vested after three years and have a fifteen-year life, while grants issued prior to July 1998 are vested after one year and have a ten-year life. The Company also makes other minor grants to employees, for which vesting terms and option lives are not substantially different. Pursuant to SFAS No. 123, ""Accounting for Stock-Based Compensation,"" the Company has elected to account for its employee stock option plans under APB Opinion No. 25, ""Accounting for Stock Issued to Employees,"" which recognizes expense based on the intrinsic value at date of grant. As stock options have been issued with exercise prices equal to the market value of the underlying shares on the grant date, no compensation cost has resulted. Had compensation cost for all options granted been determined based on the fair value at grant date consistent with SFAS No. 123, the Company's net earnings and earnings per share would Net earnings per common share The assumptions used to calculate the fair value of options granted are evaluated and revised, as necessary, to reflect market conditions and 6. Postretirement Benefits - The Company offers various postretirement benefits to its employees. Additional information about these benefits is",1311
2004-12-08,8-K,0000080424-04-000204,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) December 8, 2004 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 7.01 REGULATION FD DISCLOSURE On December 8, 2004, The Procter & Gamble Company (the ""Company"") issued a news release announcing that it expects stronger volume growth for second quarter and fiscal year 2004/05 and that it remains comfortable with the current range of analysts' earnings estimates for the October to December quarter. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD",141
2004-12-15,8-K,0000950152-04-008964,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) Registrants telephone number, including area code (513) 983-1100 Item 8.01 OTHER EVENTS On December 14, 2004, the Board of Directors of The Procter & Gamble Company (the Company) approved a resolution to delist the Companys common stock from the National Stock Exchange in Chicago as well as exchanges in Amsterdam, Brussels, Frankfurt, and Switzerland. Pursuant to this resolution, the Company will initiate the voluntary delistings. The effective dates depend on the application process and the internal rules of each exchange. The Company will remain listed on the New York Stock Exchange, its principal listing. The Company is also listed on the Paris exchange.",158
2005-01-11,8-K,0000080424-05-000002,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) January 11, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 7.01 REGULATION FD DISCLOSURE On January 11, 2005, the Board of Directors of The Procter & Gamble Company (the ""Company"")declared a quarterly dividend of $0.25 per share on the Common Stock and on the Series A ESOP Convertible Class A Preferred Stock of the Company, payable on or after February 15, 2005 to shareholders of record at the close of business on January 21, 2005. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure"".",155
2005-01-28,8-K,0000080424-05-000003,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) January 28, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 27, 2005, The Procter & Gamble Company (the ""Company"") issued a press release with respect to earnings for the quarter ended December 31, 2004. The Company is filing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition"".",126
2005-01-28,8-K,0000914121-05-000257,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 27, 2005 The Procter & Gamble Company (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) File Number) Identification No.) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: (513) 983-1100 (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): [X] Written communications pursuant to Rule 425 under the Securities Act (17 [X] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR [_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Item 1.01 Entry into a Material Definitive Agreement On January 27, 2005, The Procter & Gamble Company, an Ohio corporation (""Procter & Gamble""), entered into a definitive Agreement and Plan of Merger (the ""Merger Agreement"") with Aquarium Acquisition Corp., a direct wholly-owned subsidiary of Procter & Gamble (the ""Merger Sub"") and The Gillette Company, a Delaware corporation (""Gillette""). The Merger Agreement provides that, upon the terms and subject to the conditions set forth in the Merger Agreement, Merger Sub will merge with and into Gillette, with Gillette continuing as the surviving corporation and a wholly-owned subsidiary of Procter & Gamble (the ""Merger""). At the effective time and as a result of the Merger, each share of Gillette common stock issued and outstanding immediately prior to the effective time of the Merger will be converted automatically into and become exchangeable for 0.975 shares of Procter & Gamble common stock. Following the effective time of the Merger, James M. Kilts, the Chairman, Chief Executive Officer and President of Gillette, will become a member of Procter & Gamble's board of directors. Procter & Gamble and Gillette have made customary representations, warranties and covenants in the Merger Agreement, including, among others, covenants (i) to conduct their respective businesses in the ordinary course consistent with past practice during the interim period between the execution of the Merger Agreement and consummation of the Merger, (ii) not to engage in certain kinds of transactions during such period, (iii) subject to certain exceptions, to cause stockholder meetings to be held to consider approval of the Merger and the other transactions contemplated by the Merger Agreement and (iv) subject to certain exceptions, for their respective boards of directors to recommend adoption and approval by its stockholders of the Merger Agreement and the transactions contemplated by the Merger Agreement. In addition, Gillette made certain additional customary covenants, including among others, covenants not to: (i) solicit proposals relating to alternative business combination transactions or (ii) subject to certain exceptions, enter into discussions concerning or provide confidential information in connection with alternative business combination Consummation of the Merger is subject to customary conditions, including (i) approval of the holders of Procter & Gamble common stock, (ii) approval of the holders of Gillette common stock, (iii) absence of any law or order prohibiting the closing, (iv) expiration or termination of the applicable Hart-Scott-Rodino waiting period and certain other regulatory approvals, (v) subject to certain exceptions, the accuracy of representations and warranties, (vi) the absence of any material adverse effect with respect to each party's business and (vii) the delivery of customary opinions from counsel to Procter & Gamble and counsel to Gillette that the Merger will qualify as a tax-free reorganization for federal The Merger Agreement contains certain termination rights for both Procter & Gamble and Gillette, and further provides that, upon termination of the Merger Agreement under specified circumstances, Gillette may be required to pay Procter & Gamble a termination fee of $1.92 billion. The foregoing description of the Merger and the Merger Agreement does not purport to be complete and is qualified in its entirety by reference to the Merger Agreement, which is filed as Exhibit 2.1 hereto, and is incorporated into this report by reference. On January 28, 2005, Procter & Gamble and Gillette issued a joint press release announcing the execution of the Merger Agreement and Procter & Gamble's plan to repurchase $18 to $22 billion of its common stock over the next 12 to 18 months. The press release is attached as Exhibit 99.1 and is incorporated herein by Stockholders are urged to read the joint proxy statement/prospectus and Procter & Gamble registration statement regarding the proposed transaction, when they become available, because they will contain important information. Stockholders will be able to obtain free copies of the joint proxy statement/prospectus and Procter & Gamble registration statement, as well as other filings containing information about Procter & Gamble and Gillette, without charge, at the SEC's Internet site ( These documents may also be obtained for free from Procter & Gamble by directing a request to The Procter & Gamble Company, Investor Relations, P.O. Box 599, Cincinnati, Ohio 45201-0599. Free copies of Gillette's filings may be obtained by directing a request to The Gillette Company, Office of the Secretary, Prudential Tower, Boston, Massachusetts, 02199- 8004. Procter & Gamble, Gillette and their respective directors and executive officers and other members of management and employees may be deemed to be participants in the solicitation of proxies from their respective shareholders in respect of the proposed transactions. Information regarding Procter & Gamble's directors and executive officers is available in Procter & Gamble's proxy statement for its 2004 annual meeting of shareholders, which was filed with the SEC on August 27, 2004, and information regarding Gillette's directors and executive officers is available in Gillette's proxy statement for its 2004 annual meeting of shareholders, which was filed with the SEC on April 12, 2004. Additional information regarding the interests of such potential participants will be included in the joint proxy statement/prospectus and the other relevant documents filed with the SEC when they become available. Item 9.01 Financial Statements and Exhibits Exhibit No. Description 2.1 Agreement and Plan of Merger dated as of January 27, 2005 among The Procter & Gamble Company, Aquarium Acquisition Corp. and The Gillette Company (the schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K). 99.1 Press release issued jointly by The Procter & Gamble Company and The Gillette Company, dated as of January 28, 2005.",1092
2005-01-31,10-Q,0000080424-05-000005,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 31, 2004 Commission file number 1-434 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State of incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [ X ] No [ ] Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes [ X ] No [ ] There were 2,522,583,573 shares of Common Stock outstanding as of December 31, Item 1. Financial Statements The Consolidated Statements of Earnings of The Procter & Gamble Company and subsidiaries (the Company) for the three and six months ended December 31, 2004 and 2003, the Consolidated Balance Sheets as of December 31, 2004 and June 30, 2004, and the Consolidated Statements of Cash Flows for the six months ended December 31, 2004 and 2003 follow. In the opinion of management, these unaudited consolidated financial statements contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, such financial statements may not be indicative necessarily of annual results. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS Amounts in millions except per share amounts Three Months Ended Six Months Ended December 31 December 31 THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS December 31 June 30 Prepaid expenses and other receivables 1,944 1,803 PROPERTY, PLANT AND EQUIPMENT NET PROPERTY, PLANT AND EQUIPMENT 14,502 14,108 GOODWILL AND OTHER INTANGIBLE ASSETS Trademarks and other intangible assets, net 4,655 4,290 NET GOODWILL AND OTHER INTANGIBLE ASSETS 25,306 23,900 LIABILITIES AND SHAREHOLDERS' EQUITY Common stock - shares outstanding Dec 31 2,522.6 2,523 Reserve for ESOP debt retirement (1,271) (1,283) Accumulated other comprehensive income (366) (1,545) TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 63,032 $ 57,048 See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS Amounts in millions December 31 CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD $ 5,469 $ 5,912 Depreciation and amortization 928 857 Accounts payable, accrued and other liabilities (518) (183) Other operating assets & liabilities (171) (144) Acquisitions, net of cash acquired (351) (5,358) Change in investment securities (73) (69) Additions to long-term debt 3,041 1,405 Reductions of long-term debt (1,565) (993) Proceeds from the exercise of stock options and other 201 233 EFFECT OF EXCHANGE RATE CHANGES ON CASH CHANGE IN CASH AND CASH EQUIVALENTS 2,207 (969) CASH AND CASH EQUIVALENTS, END OF PERIOD $ 7,676 $ 4,943 See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 1. These statements should be read in conjunction with the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2004 and the Form 8-K filed on October 22, 2004 reflecting certain changes to the Company's segment information. The results of operations for the three-month and six-month periods ended December 31, 2004 are not indicative necessarily of 2. Comprehensive Income - Total comprehensive income is composed primarily of net earnings, net currency translation gains and losses, impacts of net investment and cash flow hedges and net unrealized gains and losses on securities. Total comprehensive income for the three months ended December 31, 2004 and 2003 was $3,001 million and $2,429 million, respectively. For the six months ended December 31, 2004 and 2003, total comprehensive income was $5,219 million and $4,366 million, respectively. 3. Segment Information - Following is a summary of segment results, including supplemental data on the Fabric and Home Care, Snacks and Coffee, Health Care and Baby and Family Care businesses. Three Months Ended December 31 Six Months Ended December 31 Earnings Before Earnings Before Net Sales Income Taxes Net Earnings Net Sales Income Taxes Net Earnings 4. Goodwill and Other Intangible Assets - Goodwill as of December 31, 2004 is allocated by reportable segment as follows (amounts in millions): Total Beauty Care, beginning of year $ 14,457 Acquistions & divestiture 132 Health Care, beginning of year $ 3,315 Acquistions & divestiture 27 Baby & Family Care, beginning of year $ 941 Acquistions & divestiture -- Total Health, Baby & Family Care, beginning of year $ 4,256 Acquistions & divestiture 27 Fabric & Home Care, beginning of year $ 614 Acquistions & divestiture 27 Snacks & Coffee, beginning of year $ 283 Acquistions & divestiture (25) Total Household Care, beginning of year $ 897 Acquistions & divestiture 2 Goodwill, Net, beginning of year $ 19,610 Acquistions & divestiture 161 The increase in goodwill from June 30, 2004 is primarily due to the completed allocation of the purchase price relating to the September 2003 acquisition of Wella AG and translation impacts. The Company finalized the allocation of Wella purchase price to the individual assets acquired and liabilities assumed. In addition, the Company completed its analysis of Identifiable intangible assets as of December 31, 2004 are comprised of Gross Carrying Accumulated Amortizable intangible assets with 2,362 687 Intangible assets with indefinite lives 2,980 - Total identifiable intangible assets 5,342 687 Amortizable intangible assets consist principally of patents, technology and trademarks. The non-amortizable intangible assets consist primarily of The amortization of intangible assets for the three and six months ended December 31, 2004 is $51 million and $99 million, respectively. 5. Pro Forma Stock-Based Compensation - The Company has a primary stock-based compensation plan under which stock options are granted annually to key managers and directors with exercise prices equal to the market price of the underlying shares on the date of grant. Grants were made under plans approved by shareholders in 1992, 2001 and 2003. Grants issued since September 2002 are vested after three years and have a ten-year life. Grants issued from July 1998 through August 2002 are vested after three years and have a fifteen-year life, while grants issued prior to July 1998 are vested after one year and have a ten-year life. The Company also makes other minor grants to employees, for which vesting terms and option lives are not substantially different. Pursuant to SFAS No. 123, ""Accounting for Stock-Based Compensation,"" the Company has elected to account for its employee stock option plans under APB Opinion No. 25, ""Accounting for Stock Issued to Employees,"" which recognizes expense based on the intrinsic value at date of grant. As stock options have been issued with exercise prices equal to the market value of the underlying shares on the grant date, no compensation cost has resulted. Had compensation cost for all options granted been determined based on the fair value at grant date consistent with SFAS No. 123, the Company's net earnings and earnings per share would have been as follows: Amounts in millions except per share data Three Months Ended Six Months Ended December 31 December 31 Net earnings per common share The assumptions used to calculate the fair value of options granted are evaluated and revised, as necessary, to reflect market conditions and In December 2004, the Financial Accounting Standards Board (FASB) issued SFAS No. 123 (Revised 2004), ""Share-Based Payment"" (SFAS 123(R)). This Statement revises SFAS No. 123 by eliminating the option to account for employee stock options under APB No. 25 and generally requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of those awards (the ""fair-value-based"" method). The Company plans to adopt SFAS 123(R) on July 1, 2005 using the modified retrospective method, whereby all prior periods will be adjusted to give effect to the fair-value-based method of accounting for awards granted in fiscal years beginning on or after July 1, 1995. The impact of adopting SFAS 123 (R) will be consistent with the impact previously disclosed pursuant to the pro forma disclosure requirements of SFAS No. 123. 6. Postretirement Benefits - The Company offers various postretirement benefits to its employees. Additional information about these benefits is",1419
2005-03-14,8-K,0000950152-05-002093,"THE PROCTER & GAMBLE COMPANY 8-K SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) number, including area code (513) 983-1100 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) contained in this Form 8-K revises the classification of certain investments, along with the cash flow impacts, on the Consolidated Balance Sheets and Consolidated Statements of Cash Flows for The Procter & Gamble Company and consolidated subsidiaries (the Company). The Company believes this change in classification, which reflects the converging interpretations of the accounting treatment of auction rate securities, is not material to its financial condition and cash flows. In addition, it has no effect on the amounts of total current assets, total assets, or operating cash flows of the Company. The reclassification in no way revises or restates the Companys Consolidated Statements of reclassified its investments in auction rate securities as current investment securities. These auction rate securities, which have interest rate reset dates every less but maturity dates greater than 90 days, were included in cash and cash equivalents previous periods in the following amounts: June 30, 2003  $484 million June 30, 2004  $1,237 million September 30, 2004  $1,422 million December 31, 2004  $1,275 million contains the financial statements for the year ended June 30, 2004 conformed for the reclassification of auction rate securities as short-term investments. The financial statements, conformed for the change, will become the historical financial statements of The Procter & Company and consolidated subsidiaries for currently open and future filings with the Securities contains Item 1 of Procter & Gambles Quarterly Report on Form 10-Q for the period ended September 30, 2004 conformed for the reclassification of auction rate short-term investments. The financial statements, conformed for the change, will become the historical financial statements of The Procter & Gamble Company and consolidated currently open and future filings with the Securities and Exchange Commission. contains Item 1 of Procter & Gambles Quarterly Report on Form 10-Q for the period ended December 31, 2004 conformed for the reclassification of auction rate short-term investments. The financial statements, conformed for the change, will become the historical financial statements of The Procter & Gamble Company and consolidated currently open and future filings with the Securities and Exchange Commission.",483
2005-03-15,8-K,0000080424-05-000043,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) March 15, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 7.01 REGULATION FD DISCLOSURE On March 15, 2005, The Procter & Gamble Company (the ""Company"") issued a press release announcing that it confirms prior earnings guidance for third quarter 2004/05. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure"".",120
2005-03-22,8-K,0000080424-05-000044,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) March 22, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [X] Written communications pursuant to Rule 425 under the Securities Act [X] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01. REGULATION FD DISCLOSURE On March 22, 2005, The Procter & Gamble Company (""P&G"") and The Gillette Company issued a news release announcing that the Federal Trade Commission had issued a request for additional information in connection with its review of the proposed merger between the two companies. A request of this nature is typical in a transaction of this size, and was expected. The companies plan to respond promptly and continue to believe that the transaction will close in the Fall of 2005. P&G is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",225
2005-04-11,8-K,0000080424-05-000047,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) April 11, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On April 11, 2005, The Procter & Gamble Company (the ""Company"") issued a news release announcing that the Board of Directors of the Company declared an increase in the quarterly dividend on its Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock from $0.25 to $0.28 per share, payable on or after May 16, 2005 to shareholders of record at the close of business on April 22, 2005. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",223
2005-04-12,8-K,0000080424-05-000048,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) April 12, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On April 12, 2005, The Procter & Gamble Company (the ""Company"") announced that the Board of Directors of the Company has unanimously agreed to submit and support a proposal at the annual meeting of shareholders in October 2005, to declassify its board structure and move to annual elections of directors. The Board said it was guided by shareholder opinion on this important issue of If approved by more than 50% of the shares outstanding, annual elections will be phased in during the next three years so that by the annual meeting in 2008, all directors will be elected annually for one-year terms. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD",249
2005-04-15,8-K,0000080424-05-000053,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) April 15, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 5.02(b) DEPARTURE OF DIRECTOR On April 15, 2005, The Procter & Gamble Company (the ""Company"") issued a press release announcing the resignation of Domenico De Sole as a director of the Company, effective immediately. The press release is attached hereto as Exhibit 99 and is",176
2005-04-28,8-K,0000080424-05-000054,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) April 28, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On April 28, 2005, The Procter & Gamble Company (the ""Company"") issued a press release with respect to earnings for the quarter ended March 31, 2005. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",180
2005-05-09,10-Q,0000950152-05-004141,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION [x] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2005 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___ to ___ Commission file number 1-434 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State of incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ] Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes [X] No[ ] There were 2,494,479,366 shares of Common Stock outstanding as of March 31, PART I. FINANCIAL INFORMATION Item 1. Financial Statements The Consolidated Statements of Earnings of The Procter & Gamble Company and subsidiaries (the Company) for the three and nine months ended March 31, 2005 and 2004, the Consolidated Balance Sheets as of March 31, 2005 and June 30, 2004, and the Consolidated Statements of Cash Flows for the nine months ended March 31, 2005 and 2004 follow. In the opinion of management, these unaudited consolidated financial statements contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, such financial statements may not be indicative necessarily of annual results. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS Amounts in millions except per share amounts Three Months Ended Nine Months Ended See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS Prepaid expenses and other receivables 1,843 1,803 PROPERTY, PLANT AND EQUIPMENT GOODWILL AND OTHER INTANGIBLE ASSETS Trademarks and other intangible assets, net 4,616 4,290 NET GOODWILL AND OTHER INTANGIBLE ASSETS 24,902 23,900 LIABILITIES AND SHAREHOLDERS' EQUITY Common stock - shares outstanding - Mar 31 2,494.4 2,494 Accumulated other comprehensive income (838) (1,545) TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 63,076 $ 57,048 See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD (1) $ 4,232 $ 5,428 Depreciation and amortization 1,403 1,279 Accounts payable, accrued and other liabilities (143) 213 Other operating assets & liabilities (221) 23 Acquisitions, net of cash acquired (528) (5,398) Change in investment securities (56) (801) Proceeds from the exercise of stock options and other 371 437 EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS 243 9 CHANGE IN CASH AND CASH EQUIVALENTS 2,840 (1,254) CASH AND CASH EQUIVALENTS, END OF PERIOD $ 7,072 $ 4,174 (1) The Company reclassified its investments in auction rate securities as current investment securities. These auction rate securities, for which interest rates reset in less than 90 days, but the maturity date is greater than 90 days, were included in cash and cash equivalents before the See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 1. These statements should be read in conjunction with the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2004, the Form 8-K filed on October 22, 2004 reflecting certain changes to the Company's segment information and the Form 8-K filed on March 14, 2005, reflecting the reclassification of certain investments from cash and cash equivalents to investment securities. The results of operations for the three-month and nine-month periods ended March 31, 2005 are not indicative necessarily 2. Comprehensive Income - Total comprehensive income is composed primarily of net earnings, net currency translation gains and losses, impacts of net investment and cash flow hedges and net unrealized gains and losses on securities. Total comprehensive income for the three months ended March 31, 2005 and 2004 was $1,248 million and $1,373 million, respectively. For the nine months ended March 31, 2005 and 2004, total comprehensive income was $6,467 million and $5,739 million, respectively. 3. Segment Information - Following is a summary of segment results, including supplemental data on the Fabric Care and Home Care, Snacks and Coffee, Health Care, and Baby Care and Family Care businesses. Three Months Ended March 31 Nine Months Ended March 31 Net Earnings Before Net Net Earnings Before Net Sales Income Taxes Earnings Sales Income Taxes Earnings 4. Goodwill and Other Intangible Assets - Goodwill as of March 31, 2005 is allocated by reportable segment as follows (amounts in millions): TOTAL BEAUTY CARE, BEGINNING OF YEAR $ 14,457 Acquistions & divestiture 122 HEALTH CARE, BEGINNING OF YEAR 3,315 Acquistions & divestiture 54 BABY CARE & FAMILY CARE, BEGINNING OF YEAR 941 Acquistions & divestiture - TOTAL HEALTH, BABY & FAMILY CARE, BEGINNING OF YEAR 4,256 Acquistions & divestiture 54 FABRIC CARE & HOME CARE, BEGINNING OF YEAR 614 Acquistions & divestiture 27 SNACKS & COFFEE, BEGINNING OF YEAR 283 Acquistions & divestiture (25) TOTAL HOUSEHOLD CARE, BEGINNING OF YEAR 897 Acquistions & divestiture 2 GOODWILL, NET, BEGINNING OF YEAR 19,610 Acquistions & divestiture 178 The increase in goodwill from June 30, 2004 is primarily due to the completed allocation of the purchase price relating to the September 2003 acquisition of Wella AG and translation impacts. The Company finalized the allocation of Wella purchase price to the individual assets acquired and liabilities assumed. In addition, the Company completed its analysis of collaboration plans. Identifiable intangible assets as of March 31, 2005 are comprised of Gross Carrying Accumulated Amortizable intangible assets with determinable lives $ 2,312 $ 723 Intangible assets with indefinite lives 3,027 - Total identifiable intangible assets $ 5,339 $ 723 Amortizable intangible assets consist principally of patents, technology and trademarks. The non-amortizable intangible assets consist primarily of The amortization of intangible assets for the three and nine months ended March 31, 2005 is $51 million and $149 million, respectively. 5. Pro Forma Stock-Based Compensation - The Company has a primary stock-based compensation plan under which stock options are granted annually to key managers and directors with exercise prices equal to the market price of the underlying shares on the date of grant. Grants were made under plans approved by shareholders in 1992, 2001 and 2003. Grants issued since September 2002 are vested after three years and have a ten-year life. Grants issued from July 1998 through August 2002 are vested after three years and have a fifteen-year life, while grants issued prior to July 1998 are vested after one year and have a ten-year life. The Company also makes other minor grants to employees, for which vesting terms and option lives are not substantially different. Pursuant to SFAS No. 123, ""Accounting for Stock-Based Compensation,"" the Company has elected to account for its employee stock option plans under APB Opinion No. 25, ""Accounting for Stock Issued to Employees,"" which recognizes expense based on the intrinsic value at date of grant. As stock options have been issued with exercise prices equal to the market value of the underlying shares on the grant date, no compensation cost has resulted. Had compensation cost for all options granted been determined based on the fair value at grant date consistent with SFAS No. 123, the Company's net earnings and earnings per share would have been as follows: Amounts in millions except per share data THREE MONTHS ENDED NINE MONTHS ENDED Net earnings per common share The assumptions used to calculate the fair value of options granted are evaluated and revised, as necessary, to reflect market conditions and experience. The Company has estimated the fair value of stock option grants after January 1, 2005 using a lattice-based model. In December 2004, the Financial Accounting Standards Board (FASB) issued SFAS No. 123 (Revised 2004), ""Share-Based Payment"" (SFAS 123(R)). This Statement revises SFAS No. 123 by eliminating the option to account for employee stock options under APB No. 25 and generally requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of those awards (the ""fair-value-based"" method). The Company plans to adopt SFAS 123(R) on July 1, 2005 using the modified retrospective method, whereby all prior periods will be adjusted to give effect to the fair-value-based method of accounting for awards granted in fiscal years beginning on or after July 1, 1995. The impact of adopting SFAS 123(R) will be consistent with the impact previously disclosed pursuant to the pro forma disclosure requirements of SFAS No. 123. 6. Postretirement Benefits - The Company offers various postretirement benefits to its employees. Additional information about these benefits is",1507
2005-05-26,8-K,0000080424-05-000066,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) May 26, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [X] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01. REGULATION FD DISCLOSURE On May 26, 2005, The Procter & Gamble Company (the ""Company"") issued a news release concerning the date of the special shareholder meeting to approve its proposed merger with The Gillette Company. P&G is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",178
2005-06-06,8-K,0000080424-05-000072,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 6, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On June 6, 2005, The Procter & Gamble Company (the ""Company"") issued a news release confirming previously announced earnings guidance for the April to June quarter and fiscal year 2004/05. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure"".",178
2005-06-15,8-K,0000080424-05-000076,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 15, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 5.02 (b) DEPARTURE OF A PRINCIPAL OFFICER On June 15, 2005, The Procter & Gamble Company (the ""Company"") issued a press release announcing the retirement of John K. Jensen as Comptroller (Principal Accounting Officer) of the Company. Mr. Jensen will cease serving as Comptroller effective August 1, 2005, and will serve as Vice President on special assignment until his retirement on October 1, 2005. ITEM 5.02 (c) APPOINTMENT OF A PRINCIPAL OFFICER On June 15, 2005, the Company issued a press release announcing the appointment of Valarie L. Sheppard as Vice President and Comptroller (Principal Accounting Officer) of the Company, effective August 1, 2005, to serve at the pleasure of the Company's Board of Directors and until her successor is elected Ms. Sheppard, 41, joined the Company in 1986. For the previous five years, she has held the positions of Manager of Finance and Accounting (F&A) for Global Household Care, Manager of F&A for Global Fabric and Home Care, and Finance Director for the Northeast Asia Market Development Organization. The press release concerning these personnel announcements is attached hereto as Exhibit 99 and",314
2005-06-20,8-K,0000080424-05-000089,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 14, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [X] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 1.01 ENTRY TO A MATERIAL DEFINITIVE AGREEMENT On January 28, 2005, The Procter & Gamble Company (""Company"" or ""P&G"") announced its proposed merger with The Gillette Company (""Gillette""). The closing of the transaction, which is subject to shareholder and regulatory approval and other conditions, is expected to occur in fall, 2005. P&G's Board of Directors and management are confident that combining P&G and Gillette will create substantial and sustainable shareholder value over the long term. Near term, the Company must focus on the successful integration of the Gillette business and delivery of growth and cost synergies, while maintaining momentum in the core businesses. The dilutive impact of the acquisition is expected to reduce P&G earnings by 25 to 35 cents per share in the first year following closing, and 5 to 10 cents per share in the second year following closing. In the third year following closing, the acquisition is expected to add 1 to 5 The near term impacts of the proposed transaction caused the Board's Compensation & Leadership Development Committee (""Committee"") to re-consider certain aspects of P&G's incentive compensation programs, during meetings on May 19, 2005 and June 14, 2005. Subject to closing of the transaction, the Committee approved at its June 14, 2005, meeting modifications to the Company's Short Term Achievement Reward Program (""STAR"") and Business Growth Program (""BGP"") as described below and in the documents attached hereto. STAR is the Company's annual incentive program. Awards are made within the authority of the Additional Remuneration Plan, which dates back to 1949, and the 2001 Stock and Incentive Compensation Plan (""2001 Stock Plan). Historically, STAR awards have been based on two factors -- overall Company results and specific business unit results. In view of the importance of successfully integrating the Gillette acquisition, an additional factor will be used in determining STAR awards beginning fiscal year 2005/06. This 'Gillette Factor' will be determined by assessing performance during the fiscal year on various metrics related to integration goals including: sustaining the overall health of both the P&G and Gillette businesses during this period (based on market share and earnings progress); achieving sales, research and administrative budget and synergy objectives; meeting enrollment reduction targets; and staying within integration cost and restructuring estimates. This will put payments for all STAR participants at risk based on the achievement of integration goals. Under the revised STAR plan, participants may end up earning more or less than they would have without this change. BGP is a three-year performance program under the authority of the Additional Remuneration Plan and the 2001 Stock Plan. Approximately 35 senior executive officers were included in BGP for the period from July 1, 2004 through June 30, 2007. Each was assigned a target amount for the performance period. Taken together, stock options at target and BGP at target represent total long-term incentive compensation equal to the median long-term incentive of P&G's compensation survey group for comparable positions. The Committee determines actual BGP awards based on an assessment of Company performance versus pre-established financial measures for diluted earnings per share (""EPS"") growth and operating total shareholder return (""OTSR""). The Committee believes P&G's compensation programs should continue to be directly linked to business results and remain consistent with shareholder interests following the Gillette merger. Accordingly, the Committee will discontinue the current three-year BGP cycle at the end of its first year (June 30, 2005). In its place, the Committee will establish a new three-year cycle, beginning July 1, 2005. The Committee will restart the program cycle so that senior management compensation for the combined company is linked more directly to the success of the Gillette integration. By starting a new BGP cycle, the Committee will ensure that management compensation reflects results of all the Company's businesses, including those acquired from Gillette. More specifically, management will be incented to minimize the dilution of EPS in the first two years following closing and deliver accretive EPS in the third year following closing. The program will pay out at target compensation levels for the full three-year period only if, by the third year following closing, the Company achieves its Operating Total Shareholder Return goal and delivers three-year 10% compound EPS growth for P&G's current business, while also achieving its accretion goal for Gillette. Consequently, management compensation will be at risk to achieve the profitable growth objectives of both Gillette and current P&G. Depending on actual results, participants may earn more or less than The Committee has approved funding formulas covering STAR and BGP awards to named executive officers. These formulas qualify the payments as performance-based compensation under Section 162(m) of the Internal Revenue Code, thereby preserving tax deductibility. More detailed descriptions of STAR and BGP, as modified, are attached as Exhibit 10-1 hereto, together with related correspondence and grant ADDITIONAL INFORMATION AND WHERE TO FIND IT In connection with the proposed merger, The Procter & Gamble Company (""P&G"") has filed a registration statement on Form S-4 on May 26, 2005 with the Securities and Exchange Commission (Registration No. 333-123309), containing a definitive joint proxy statement/prospectus. INVESTORS AND SECURITY HOLDERS ARE ADVISED TO READ THE DEFINITIVE JOINT PROXY STATEMENT/PROSPECTUS BECAUSE IT CONTAINS IMPORTANT INFORMATION. Investors and security holders may obtain a free copy of the definitive joint proxy statement/prospectus and other documents filed by P&G and The Gillette Company (""Gillette"") with the Commission at the Commission's web site at Free copies of the definitive joint proxy statement/prospectus and each company's other filings with the Commission may also be obtained from the respective companies. Free copies of P&G's filings may be obtained by directing a request to P&G Investor Relations at 513-983-2415. Free copies of Gillette's filings may be obtained by directing a request to Gillette Investor Relations at 617-421-8172. This communication shall not constitute an offer to sell or the solicitation of an offer to buy securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of PARTICIPANTS IN THE SOLICITATION P&G, Gillette and their respective directors, executive officers and other members of their management and employees may be soliciting proxies from their respective stockholders in favor of the merger. Information concerning persons who may be considered participants in the solicitation of P&G's stockholders under the rules of the Commission is set forth in the Proxy Statement filed by P&G with the Commission on August 27, 2004, and information concerning persons who may be considered participants in the solicitation of Gillette's stockholders under the rules of the Commission is set forth in the Proxy Statement filed by Gillette with the Commission on March 30, 2005. FORWARD-LOOKING STATEMENTS All statements, other than statements of historical fact included in this release, are forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995. In addition to the risks and uncertainties noted in this release, there are certain factors that could cause actual results to differ materially from those anticipated by some of the statements made. These include: (1) the ability to achieve business plans, including with respect to lower income consumers and growing existing sales and volume profitably despite high levels of competitive activity, especially with respect to the product categories and geographical markets (including developing markets) in which the Company has chosen to focus; (2) the ability to successfully execute, manage and integrate key acquisitions and mergers, including (i) the Domination and Profit Transfer Agreement with Wella, and (ii) the Company's agreement to merge with The Gillette Company, including obtaining the related required shareholder and regulatory approvals; (3) the ability to manage and maintain key customer relationships; (4) the ability to maintain key manufacturing and supply sources (including sole supplier and plant manufacturing sources); (5) the ability to successfully manage regulatory, tax and legal matters (including product liability, patent, and other intellectual property matters), and to resolve pending matters within current estimates; (6) the ability to successfully implement, achieve and sustain cost improvement plans in manufacturing and overhead areas, including the Company's outsourcing projects; (7) the ability to successfully manage currency (including currency issues in volatile countries), debt (including debt related to the Company's announced plan to repurchase shares of the Company's stock), interest rate and certain commodity cost exposures; (8) the ability to manage the continued global political and/or economic uncertainty and disruptions, especially in the Company's significant geographical markets, as well as any political and/or economic uncertainty and disruptions due to terrorist activities; (9) the ability to successfully manage the pattern of sales, including the variation in sales volume within periods; (10) the ability to successfully manage competitive factors, including prices, promotional incentives and trade terms for products; (11) the ability to obtain patents and respond to technological advances attained by competitors and patents granted to competitors; (12) the ability to successfully manage increases in the prices of raw materials used to make the Company's products; (13) the ability to stay close to consumers in an era of increased media fragmentation; and (14) the ability to stay on the leading edge of innovation. For additional information concerning factors that could cause actual results to materially differ from those projected herein, please refer to our most recent 10-K, 10-Q and 8-K reports.",1671
2005-07-12,8-K,0000080424-05-000099,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) July 12, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [X] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01. REGULATION FD DISCLOSURE On July 12, 2005, The Procter & Gamble Company (the ""Company"") issued a news release announcing that the Company's shareholders had approved the planned merger with The Gillette Company. Details of the approval and the merger are set forth in Exhibit 99, which is incorporated by reference. In a separate action, the Company also announced that its Board of Directors declared a quarterly dividend of $0.28 per share on its Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after Aug. 15, 2005 to shareholders of record at the close of business on July 22, 2005. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD",255
2005-07-15,8-K,0000080424-05-000100,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) July 15, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On July 15, 2005, The Procter & Gamble Company (the ""Company"") issued a news release announcing that the European Commission has cleared the proposed merger with The Gillette Company. A copy of the Company's news release is attached hereto as Exhibit 99 and",178
2005-08-01,8-K,0000080424-05-000101,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) August 1, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT On July 27, 2005, Procter & Gamble International S.a.r.l. (""P&G International""), a wholly-owned subsidiary of The Procter & Gamble Company (the ""Company""), signed a 3-year credit facility of $24 billion with a syndicate of banks led by Citigroup. The cost of the facility is a variable interest rate of 10 basis points over LIBOR on a fully drawn basis. Proceeds will be used for general corporate purposes with the expectation that the majority of the funds will be used as part of the share repurchase program of up to $22 billion that the Company and its subsidiaries announced on January 28, 2005. At its discretion and dependent upon market conditions and regulatory approvals, P&G International may also, as part of this share repurchase program, purchase shares of the Gillette Company to be exchanged for shares of the Company upon the closing of the merger of the Company and Gillette. P&G International expects to pay down the $24 billion facility with a combination of cash, commercial paper and term debt, beginning in fiscal year 2006/07. The current bridge facility between P&G International and Merrill Lynch will be replaced by this new facility, in which Merrill Lynch will also participate.",336
2005-08-01,8-K,0000080424-05-000102,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) August 1, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On August 1, 2005, The Procter & Gamble Company (the ""Company"") issued a press release with respect to earnings for the quarter and fiscal year ended June 30, 2005. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",183
2005-08-11,8-K,0000080424-05-000127,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) August 11, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) The Procter & Gamble Company (the ""Company"") has been advised that A.G. Lafley, Chairman of the Board, President and Chief Executive of the Company, has terminated his stock trading plan, which was entered pursuant to Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. Under Rule 10b5-1(c), directors and officers may adopt a prearranged plan or contract for the sale of company securities under specified conditions and at specified times. As described in the Company's 2004 Proxy Statement, the Board of Directors implemented a mandatory holding period for stock option gains which now requires Mr. Lafley to hold for at least two years the net shares received from stock option exercises, after paying the exercise price and taxes. In accordance with the commitment, Mr. Lafley will retain shares for the required period rather than sell them under his stock trading plan. Mr. Lafley also wishes to retain a higher level of his stock during the initial stages of the integration of The Gillette Company as a sign of confidence in the transaction. Accordingly, Mr. Lafley has terminated his stock trading plan in accordance with its terms, effective August 8, 2005.",322
2005-08-29,10-K,0000950152-05-007351,"The Procter & Gamble Company 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION ANNUAL REPORT ON FORM 10-K PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended June 30, 2005 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___to ___ Commission File No. 1-434 THE PROCTER & GAMBLE COMPANY One Procter & Gamble Plaza, Cincinnati, Ohio 45202 IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio Securities registered pursuant to Section 12(b) of the Act: Name of each Exchange on which registered Common Stock, without Par Value Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No o Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrants knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes  No o Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No market value of the voting stock held by non-affiliates amounted to $139 billion on December 31, There were 2,461,253,748 shares of Common Stock outstanding as of July 31, 2005. Documents Incorporated By Reference Portions of the Annual Report to Shareholders for the fiscal year ended June 30, 2005 are incorporated by reference into Part I, Part II and Part IV of this report to the extent described Portions of the Proxy Statement for the 2005 Annual Meeting of Shareholders are incorporated by reference into Part III of this report to the extent described herein. Item 3. Legal Proceedings Item 4. Submission of Matters to a Vote of Security Holders Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities Item 6. Selected Financial Data Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations Item 7A. Quantitative and Qualitative Disclosures About Market Risk Item 8. Financial Statements and Supplementary Data Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure Item 9A. Controls and Procedures Item 9B.Other Information Item 10. Directors and Executive Officers of the Registrant Item 11. Executive Compensation Item 12. Security Ownership of Certain Beneficial Owners and Management Item 13. Certain Relationships and Related Transactions Item 14. Principal Accounting Fees and Services Item 15. Exhibits and Financial Statement Schedules Additional information required by this item is",505
2005-08-29,8-K,0000950152-05-007349,"The Procter & Gamble Company 8-K SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) number, including area code (513) 983-1100 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) On August 26, 2005 the Federal Trade Commission (FTC) granted early termination of the Hart-Scott-Rodino waiting period for the proposed acquisition by The Procter & Gamble Company (P&G) of up to $500,000,000 of voting securities of The Gillette Company (Gillette). This early termination is separate from the FTC approval which is required to close the merger between P&G and Gillette. That merger is still under FTC review and P&G expects it will be completed in the Fall. P&G is furnishing this 8-K pursuant to Item 7.01 Regulation FD Disclosure.",229
2005-09-08,8-K,0000080424-05-000144,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 8, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On September 8, 2005, The Procter & Gamble Company (the ""Company"") issued a news release announcing that the Company has increased its ownership in Wella AG above 95% of Wella's outstanding shares and is initiating a process to acquire the remaining shares. A copy of the Company's news release is attached hereto as Exhibit 99 and",191
2005-09-08,8-K,0000080424-05-000145,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 8, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 5.04 TEMPORARY SUSPENSION OF TRADING UNDER CERTAIN EMPLOYEE BENEFIT PLANS On September 8, 2005, The Procter & Gamble Company (""P&G"") sent a notice to its directors and executive officers informing them that the Gillette Employees' Savings Plan, the Gillette Employee Stock Ownership Plan, and the Gillette Supplemental Savings Plan (collectively, the ""Plans"") will be closed for participant transactions around the closing of the proposed merger between P&G and The Gillette Company (""Gillette""), which is expected in fall 2005. The blackout period is contingent on the consummation of the merger. The blackout is expected to last approximately three business days around the closing date, which is not yet known. Because P&G will assume the Plans at closing, P&G's directors and executive officers were notified that they would be restricted from trading in P&G and Gillette securities during the anticipated blackout period, according to applicable regulations. Steven W. Jemison, P&G Secretary, was designated as the officer to respond to questions by directors and officers about the proposed blackout period. The blackout period is necessary for the Plans' administrator--Fidelity Investments--to clear all pending trades, determine final share balances, and process the exchange of Gillette securities for P&G securities pursuant to the Agreement and Plan of Merger dated January 27, 2005.",338
2005-09-14,8-K,0000080424-05-000146,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 14, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On September 14, 2005, The Procter & Gamble Company (""Company"") issued a news release announcing that it has entered into a definitive agreement to sell the SpinBrush(R) toothbrush business to Church & Dwight Co., Inc. A copy of the Company's news release is attached hereto as Exhibit 99 and",184
2005-09-19,8-K,0000080424-05-000157,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 19, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On September 19, 2005, The Procter & Gamble Company (the ""Company"") issued a news release confirming previously announced earnings guidance for the July to September quarter. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure"".",174
2005-09-23,8-K,0000080424-05-000179,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 23, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) As disclosed in its Annual Report on Form 10-K for the year ended June 30, 2005, the Company adopted SFAS 123(R) effective July 1, 2005 which requires that all stock-based compensation, including grants of employee stock options, be accounted for using a fair-value-based method. The Company has elected to adopt SFAS 123(R) using the modified retrospective method under which prior years' results will be revised to give effect to the value of options granted in fiscal years beginning on or after July 1, 1995. The recognized compensation expense will be consistent with the amounts previously reported in the Company's pro forma footnote disclosure for stock-based compensation on Form 10-K for the year ended June 30, 2005. Consistent with the Company's basis of measurement for segment performance, the additional expense associated with stock-based compensation under SFAS 123(R) will be also reflected in segment results. The attached exhibits are intended to provide investors more insight into the impact of SFAS 123(R) on the Company's 2005 results by quarter and for the full year. Exhibits 99-1 and 99-2 provide consolidated earnings information both as reported and reflecting the retrospective impact of SFAS 123(R) for the fiscal years ended June 30, 2005 and 2004, respectively. Exhibits 99-3 and 99-4 provide business segment information both as reported and reflecting the retrospective impact of SFAS 123(R) for the fiscal years ended June 30, 2005 and As required by Statement of Financial Accounting Standards (SFAS) No. 131, consolidated financial statements issued by the Company in the future will reflect these modifications, including reclassification of all comparative prior period segment information. These financial statements, conformed for the changes, will become the historical financial statements of The Procter & Gamble Company and consolidated subsidiaries for currently open and future filings with the Securities and",425
2005-09-30,8-K,0000080424-05-000185,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 30, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On September 30, 2005, The Procter & Gamble Company (the ""Company"") issued a news release announcing that the Company was informed that the Federal Trade Commission has cleared the proposed acquisition of The Gillette Company. A copy of the Company's news release is attached hereto as Exhibit 99 and",184
2005-09-30,8-K,0000080424-05-000186,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 30, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 5.04 TEMPORARY SUSPENSION OF TRADING UNDER CERTAIN EMPLOYEE BENEFIT PLANS On September 8, 2005, The Procter & Gamble Company (""P&G"") sent a notice to its directors and executive officers informing them that the Gillette Employees' Savings Plan, the Gillette Employee Stock Ownership Plan, and the Gillette Supplemental Savings Plan (collectively, the ""Plans"") would be closed for participant transactions around the closing of the merger between P&G and The As a result, according to applicable regulations, P&G directors and executive officers were notified that they would be prohibited from trading in Gillette and P&G securities during this blackout period. At that time, the effective date of the merger was not known. On September 8, 2005, P&G filed a Form 8-K further describing this notice, which is incorporated herein by Following its announcement of the anticipated effective date of the merger, P&G today notified its directors and executive officers of the anticipated blackout dates. The blackout period will start on September 30, 2005, and is expected to end at the close of business on Wednesday, October 5, 2005.",307
2005-10-03,8-K,0000950152-05-007960,"The Procter & Gamble Company 8-K SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) October 3, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) Registrants telephone number, including area code (513) 983-1100 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE ITEM 7.01 REGULATION FD DISCLOSURE On October 3, 2005, The Procter & Gamble Company (the Company) issued a news release announcing that it remained comfortable with the previously stated earnings per share dilution range following the closing of the Gillette acquisition on October 1, after adjusting for actual deal closing timing. A copy of the Companys news release is attached hereto as Exhibit 99.1 and",193
2005-10-04,8-K,0000080424-05-000187,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) October 4, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 2.01 COMPLETION OF ACQUISITION OF ASSETS On October 1, 2005, The Procter & Gamble Company's (the ""Company"") previously announced acquisition of The Gillette Company (""Gillette"") became effective. Pursuant to the terms of the Agreement and Plan of Merger signed on January 27, 2005, Aquarium Acquisition Corp., a direct wholly-owned subsidiary of the Company, merged with and into Gillette, with Gillette continuing as the surviving corporation and a wholly-owned subsidiary of The Procter & Gamble Gillette is the market leader in nearly a dozen global product categories including blades and razors, oral care and alkaline batteries. Following the closing of the transaction, the Company began the exchange of 0.975 shares of the Company common stock for each share of The Gillette Company. Under the purchase method of accounting, the total consideration will be approximately $54 billion, determined using the average Company stock prices two days before and ending two days after January 28, 2005, the date the acquisition was announced. Unaudited Pro Forma Condensed Combined Financial Statements are attached hereto at Exhibit 99.1 and incorporate herein by reference. For reference, The Procter & Gamble Company has also prepared unaudited Pro Forma Segment Financial Information coverning the Gillette global business unit. This Pro Forma is attached hereto a Exhibit 99.3 and incorporated herein",342
2005-10-11,8-K,0000080424-05-000199,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) October 11, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 7.01 REGULATION FD DISCLOSURE On October 11, 2005, the Board of Directors of The Procter & Gamble Company (the ""Company"")declared a quarterly dividend of $0.28 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after November 15, 2005 to shareholders of record at the close of business on October 21, 2005. Former Gillette shareholders who continue to hold Gillette or P&G shares on the P&G dividend record date will be entitled to the dividend. The Company is furnishing this 8-K pursuant to Item, 7.01, ""Regulation FD Disclosure"".",181
2005-10-13,8-K,0000080424-05-000219,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) October 13, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEMS 5.02(c) and 5.02(d) APPOINTMENT OF A PRINCIPAL OFFICER AND ELECTION OF A NEW DIRECTOR. On October 11, 2005, the Board of Directors of The Procter & Gamble Company (the ""Company"") approved a resolution appointing James M. Kilts as Vice Chairman of the Board-Gillette, effective October 11, 2005. During the previous five years, Mr. Kilts was the Chairman of the Board (January 2001-October 2005), Chief Executive Officer (February 2001-October 2005) and President (November 2003-October 2005) of The Gillette Company, and President and Chief Executive Officer, Nabisco Group Holdings Corporation (December 1999-December 2000). Mr. Kilts, 57, is a member of several community and corporate boards, including the Board of Directors of MetLife Inc., the National Association of Manufacturers, and The New York Times Company. Mr. Kilts also serves on Citigroup's International Advisory Board. On October 1, 2005, the merger between the Company and The Gillette Company became effective, pursuant to which The Gillette Company became a wholly-owned subsidiary of the Company. As a result of that transaction, the Company holds an employment agreement with Mr. Kilts. The material terms of that employment agreement and a description of Mr. Kilts' interests in that transaction are set forth on pages I-65 through I-68 of the Company's registration statement on Form S-4/A, which was filed with the Securities and Exchange Commission on May 26, 2005 (Registration No. 333-123309). The information on the referenced pages, up to but not including the section entitled ""Employment Agreements with Other Key Employees,"" is",375
2005-11-01,8-K,0000080424-05-000223,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) November 1, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On November 1, 2005, The Procter & Gamble Company (the ""Company"") issued a press release with respect to earnings for the quarter and fiscal year ended September 30, 2005. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",183
2005-11-02,10-Q,0000080424-05-000224,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2005 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to _____ Commission file number 1-434 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State of incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [ X ] No [ ] Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes [ X ] No [ ] Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [ X ] There were 2,377,658,052 shares of Common Stock outstanding as of September 30, PART I. FINANCIAL INFORMATION Item 1. Financial Statements The Consolidated Statements of Earnings of The Procter & Gamble Company and subsidiaries (the ""Company"", ""we"" or ""our"") for the three months ended September 30, 2005 and 2004, the Consolidated Balance Sheets as of September 30, 2005 and June 30, 2005, and the Consolidated Statements of Cash Flows for the three months ended September 30, 2005 and 2004 follow. In the opinion of management, these unaudited consolidated financial statements contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, such financial statements may not be indicative necessarily of annual results. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS Amounts in millions except per share amounts Other non-operating income, net 74 182 EARNINGS BEFORE INCOME TAXES 2,912 2,790 COMMON SHARES OUTSTANDING 2,649.7 2,766.1 See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS September 30 June 30 Prepaid expenses and other current assets 1,805 1,924 PROPERTY, PLANT AND EQUIPMENT NET PROPERTY, PLANT AND EQUIPMENT 14,256 14,332 GOODWILL AND OTHER INTANGIBLE ASSETS Trademarks and other intangible assets, net 4,435 4,347 NET GOODWILL AND OTHER INTANGIBLE ASSETS 24,228 24,163 LIABILITIES AND SHAREHOLDERS' EQUITY Accrued and other liabilities 6,247 7,531 OTHER NON-CURRENT LIABILITIES 3,266 3,230 Common stock - shares issued - Sept 30 2,976.6 2,977 Reserve for ESOP debt retirement (1,269) (1,259) Accumulated other comprehensive income (1,485) (1,566) TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 61,906 $ 61,527 See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS Amounts in millions September 30 CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD $ 6,389 $ 4,232 Depreciation and amortization 448 480 Share based compensation expense 95 122 Accounts payable, accrued and other liabilities (243) 57 Other operating assets & liabilities 175 (112) TOTAL OPERATING ACTIVITIES 2,171 1,912 Proceeds from asset sales 26 366 Change in investment securities (17) (216) TOTAL INVESTING ACTIVITIES (1,570) (598) Dividends to shareholders (727) (685) Additions to long-term debt 8,612 2,996 Reductions of long-term debt (1,858) (130) Impact of stock options and other 142 105 TOTAL FINANCING ACTIVITIES (616) (765) EFFECT OF EXCHANGE RATE CHANGES ON CASH CHANGE IN CASH AND CASH EQUIVALENTS (79) 608 CASH AND CASH EQUIVALENTS, END OF PERIOD $ 6,310 $ 4,840 See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 1. These statements should be read in conjunction with the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2005 and Form 8-Ks filed on September 23, 2005, and November 2, 2005 reflecting the Company's historical results as conformed for the adoption of SFAS 123 (Revised 2004), ""Share-Based Payment"" (SFAS 123(R)) and the change in our method of accounting for Treasury Stock. The results of operations for the three-month period ended September 30, 2005 are not indicative necessarily 2. Comprehensive Income - Total comprehensive income is composed primarily of net earnings, net currency translation gains and losses, impacts of net investment and cash flow hedges and net unrealized gains and losses on securities. Total comprehensive income for the three months ended September 30, 2005 and 2004 was $2,110 million and $2,159 million, respectively. 3. Segment Information - Following is a summary of segment results. Amounts in millions Three Months Ended September 30 Net Sales Income Taxes Net Earnings 4. Goodwill and Other Intangible Assets - Goodwill as of September 30, 2005 is allocated by reportable segment and global business unit as follows Total Beauty, beginning of year $ 14,580 Acquistions & divestiture (19) Translation & other 8 Goodwill, September 30, 2005 14,569 Health Care, beginning of year 3,378 Acquistions & divestiture -- Translation & other (2) Goodwill, September 30, 2005 3,376 Baby Care & Family Care, beginning of year 955 Acquistions & divestiture (23) Translation & other 12 Goodwill, September 30, 2005 944 Total Family Health, beginning of year 4,333 Acquistions & divestiture (23) Translation & other 10 Goodwill, September 30, 2005 4,320 Fabric Care & Home Care, beginning of year 644 Acquistions & divestiture -- Translation & other -- Goodwill, September 30, 2005 644 Snacks & Coffee, beginning of year 259 Acquistions & divestiture -- Translation & other 1 Goodwill, September 30, 2005 260 Total Household Care, beginning of year 903 Acquistions & divestiture -- Translation & other 1 Goodwill, September 30, 2005 904 Goodwill, Net, beginning of year 19,816 Acquistions & divestiture (42) Translation & other 19 Goodwill, September 30, 2005 $ 19,793 Identifiable intangible assets as of September 30, 2005 are comprised of Gross Carrying Accumulated Amortizable intangible assets with Intangible assets with indefinite lives 2,933 - Total identifiable intangible assets $ 5,190 $ 755 Amortizable intangible assets consist principally of patents, technology and trademarks. The non-amortizable intangible assets consist primarily of The amortization of intangible assets for the three months ended September 30, 2005 was $49 million. 5. In December 2004, the Financial Accounting Standards Board (FASB) issued (SFAS 123(R)). This Statement revises SFAS No. 123 by eliminating the option to account for employee stock options under APB No. 25 and requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of those awards (the ""fair-value-based"" method). We adopted SFAS 123(R) effective July 1, 2005 using the modified retrospective method. All prior periods were adjusted to give effect to the fair-value-based method of accounting for awards granted in fiscal years beginning on or after July 1, 1995. We provided revised Consolidated Financial Statements for the years ended June 30, 2005, 2004 and 2003 reflecting the adoption of SFAS 123(R) under the modified retrospective method in a Form 8-K dated November 2, 2005. The impact to the Company's net earnings of adopting SFAS 123(R) is consistent with the pro forma disclosures provided in previous financial statements. The impact of adopting SFAS 123(R) on Shareholders' Equity as of September 30, 2005, June 30, 2005 and June 30, 2004 is shown in Note 8. For the three months ended September 30, 2005 and 2004, we recognized total share-based compensation of $95 million and $122 million, respectively, of which $73 million and $82 million relate to additional compensation recognized under SFAS 123(R) for stock options, and $22 million and $40 million relate to compensation for other share-based awards, primarily restricted stock and restricted stock units. These amounts are reflected in Cost of Products Sold and Selling, General and Administrative Expense and have been allocated to the reportable segments. The fair value of each grant issued since January 1, 2005 was estimated using a binomial lattice-based model. The fair value of options granted prior to January 1, 2005 was estimated using the Black-Scholes option-pricing model. The utilization of the binomial lattice-based model did not have a significant impact on the valuation of stock options as compared to the Black-Scholes model. Assumptions utilized in the model are evaluated and revised, as necessary, to reflect market conditions and 6. Postretirement Benefits - The Company offers various postretirement benefits to its employees. Additional information about these benefits is",1431
2005-11-02,8-K,0000950152-05-008662,"The Procter & Gamble Company 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) Registrants telephone number, including area code (513) 983-1100 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) disclosed in its Annual Report on Form 10-K for the year ended June 30, 2005, The Procter and Gamble Company (the Company, we) adopted the Financial Accounting Standards Board (FASB) SFAS 123 (Revised 2004), Share-Based Payment (SFAS 123 (R)) effective July 1, 2005 which requires that all stock-based compensation, including grants of employee stock options, be accounted for using a fair-value-based method. The Company has elected to adopt SFAS 123(R) using the modified retrospective method under which prior years results will be revised to give effect to the value of options granted in fiscal years beginning on or after July 1, 1995. In addition, the Company elected to change its method of accounting for Treasury Stock. The Company previously accounted for share repurchases as if the Treasury retired by reducing Common Stock and Retained Earnings within Shareholders Equity. Our new method of accounting will present Treasury Stock as a separate component of Shareholders Equity. We believe that our new accounting method is preferable as it more closely depicts the underlying intent of the share repurchases. The Company is providing this Form 8-K to present only those sections in its Form 10-K filing for the fiscal year ended June 30, 2005, that are conformed for the adoption of the accounting changes described above. For reference, the Company has included the entire text of the affected sections. Other than as presented here, the sections of the Form 10-K for year ended June 30, 2005 remain as previously filed. This Form 8-K does not purport to provide an update or a discussion of any other developments at the Company subsequent to the original Form 10-K filing. These financial statements, conformed for the changes, will become the historical financial statements of The Procter & Gamble Company and consolidated subsidiaries for currently open and future filings with the Securities and Exchange Commission.",430
2005-11-22,8-K,0000080424-05-000251,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) November 22, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE As disclosed in its Form 8-K furnished on October 3, 2005, The Procter & Gamble Company (the ""Company"") completed its acquisition of The Gillette Company (""Gillette"") on October 1, 2005. The Gillette Company has historically operated in five operating business segments: Blades & Razors; Duracell; Oral Care; Braun; and Personal Care. Gillette's Oral Care and Personal Care segments will be subsumed within the Company's Health Care and Beauty Care segments, respectively. Blades & Razors and Duracell & Braun, which together will be managed as a separate Gillette Global Business Unit (GBU) under the direction of a Vice Chair, will be presented as two reportable segments in future filings. Blades & Razors will constitute a separate reportable segment and the combined Duracell and Braun businesses will constitute the second separate reportable Exhibit 99-1 provides net sales and earnings data on a pro forma basis for the Gillette Global Business Unit for the three months ended September 30, 2005 along with a discussion of the results. With respect to the earnings data, the exhibit reconciles ""Profit from Operations,"" the measure used by Gillette in its historical filings, to Earnings before Income Taxes, the comparable measure used by the Company. The net sales and earnings data for the two separate reportable segments will be utilized in the Management Discussion and Analysis section of future filings as the base period for discussing the performance of the Because Gillette's Oral Care and Personal Care businesses will be subsumed within the Company's existing segments and will therefore not be reported separately in the future, pro forma net sales and earnings data are not provided for these businesses in Exhibit 99-1. For perspective, for the three months ended September 30, 2005, Gillette Oral Care and Personal Care businesses both delivered sales growth in the mid single-digits versus the prior year period. Sales growth came behind solid volume growth on Oral-B and in shave preps as well as the ongoing success of TAG body sprays.",462
2005-12-13,8-K,0000080424-05-000259,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) December 13, 2005 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On December 13, 2005, The Procter & Gamble Company (the ""Company"") issued a news release updating previously announced sales and earnings per share guidance for the October to December quarter. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure"".",178
2006-01-10,8-K,0000080424-06-000001,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) January 10, 2006 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 ITEM 7.01 REGULATION FD DISCLOSURE On January 10, 2006, the Board of Directors of The Procter & Gamble Company (the ""Company"") declared a quarterly dividend of twenty-eight cents ($0.28) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after February 15, 2006 to shareholders of record at the close of business on January 20, 2006. The Company is furnishing this 8-K pursuant to Item, 7.01, ""Regulation FD Disclosure"".",161
2006-01-19,8-K,0000080424-06-000002,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) January 19, 2006 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 4.01 CHANGE IN CERTIFYING ACCOUNTANT FOR CERTAIN GILLETTE PLANS Effective January 19, 2006, Plante & Moran PLLC (""Plante & Moran"") was engaged as the new independent registered public accounting firm for The Gillette Company Global Employee Stock Ownership Plan and The Gillette Company Employees' Savings Plan (the ""Gillette Plans""), which file Annual Reports on Form 11-K pursuant to Section 15(d) of the Securities Act of 1934. Previously, KPMG LLP (""KPMG"") served as the independent registered public accounting firm for the Gillette Plans. On January 19, 2006, KPMG declined to stand for reelection in connection with an audit of the Gillette Plans starting with the annual audit of such plans for the fiscal year ended December 31, 2005. This change follows the merger between The Procter & Gamble Company (the ""Company"") and The Gillette Company. The Procter & Gamble Master Savings Plan Committee for The Gillette Company Employees' Savings Plan and the Gillette Employee Stock Ownership Plan Committee for The Gillette Company Global Employee Stock Ownership Plan each approved the appointment of Plante & Moran as the new independent registered public accounting firm to replace KPMG. Neither the Board of Directors of the Company nor its Audit Committee was involved in this decision as it does not change the principal independent registered public accounting firm responsible for auditing the financial statements of The Procter & Gamble Company. In connection with the audits of the Gillette Plans for the two fiscal years ended December 31, 2004, and the subsequent interim period through January 19, 2006, there were no disagreements with KPMG concerning accounting principles or practices, financial statement disclosure, or auditing scope or procedures, which disagreements if not resolved to their satisfaction would have caused them to make reference in connection with their opinion to the subject matter of the disagreement. The Company is not aware of any ""reportable events,"" as defined in Item 304(a)(1)(v) of Regulation S-K, during the two fiscal years ended December 31, 2004 in connection with the Gillette Plans. The audit reports of KPMG contained in the Annual Report on Form 11-K filed in connection with the Gillette Plans for the years ended December 31, 2004 and 2003 did not contain any adverse opinion or disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope, or accounting principles. The Company has requested that KPMG furnish it with a letter addressed to the United States Securities and Exchange Commission stating whether or not it agrees with the statements in this paragraph. A copy of such letter dated January 19, 2006, is attached hereto as Exhibit 99. During the fiscal years ended December 31, 2004 and 2003, neither the Company, The Gillette Company Employees' Savings Plan, nor The Gillette Company Global Employee Stock Ownership Plan consulted with Plante & Moran regarding either (i) the application of accounting principles to a specified transaction, either completed or proposed; or the type of audit opinion that might be rendered on the Company's financial statements or on those of the Gillette Plans, and neither a written report was provided to the Company or the Gillette Plans nor oral advice was provided that Plante & Moran concluded was an important factor considered by the Company or the Gillette Plans in reaching a decision as to the accounting, auditing or financial reporting issue; or (ii) any manner that was either the subject of a disagreement, as that term is defined in Item 304(a)(1)(v) of Regulation S-K and the related instructions to Item 304 of Regulation S-K, or a reportable event, as that term is defined in Item 304(a)(1)(v) of Regulation S-K.",730
2006-01-27,8-K,0000080424-06-000003,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) January 27, 2006 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 27, 2006, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended December 31, 2005. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and",178
2006-01-30,10-Q,0000080424-06-000004,"and Analysis of Financial Condition and Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is organized in the following sections: Results of Operations - Three Months Ended December 31, 2005 Results of Operations - Six Months Ended December 31, 2005 Business Segment Discussion (three and six months ended December 31, 2005) Throughout MD&A, we refer to several measures used by management to evaluate performance including unit volume growth, net sales and after-tax profit. We also refer to organic sales growth (net sales excluding the impacts of acquisitions, divestitures and foreign exchange), free cash flow and free cash flow productivity, which are not defined under accounting principles generally accepted in the United States of America (U.S. GAAP). The explanation of these measures at the end of MD&A provides more details. Effective July 1, 2005, Procter & Gamble adopted SFAS 123(R) which requires that all stock-based compensation, including grants of employee stock options, be accounted for using a fair value-based method. We have elected to adopt SFAS 123(R) using the modified retrospective method. As a result, we have revised our historical results to include the effect of stock-based compensation. Therefore, all financial data provided in this Form 10-Q filing, including prior year data, have been revised to include the impact of stock option compensation expense. Our business is focused on providing branded products of superior quality and value to improve the lives of the world's consumers. We believe this will lead to leadership sales, profits and value creation, allowing employees, shareholders and the communities in which we operate to prosper. On October 1, 2005, we completed the acquisition of The Gillette Company (""Gillette""), a leading consumer products company that had $10.5 billion of sales in its most recent year ended December 31, 2004. The results of Gillette are included in the Financial Statements and Management's Discussion and Analysis for the three months ended December 31, 2005. In order to provide our investors with more insight into the results of the Blades & Razors and Duracell & Braun reporting segments, we have previously provided supplemental pro forma net sales and earnings data for these segments for each of the quarters in the Gillette Company's year ended June 30, 2005 (as presented in our Form 8-K released October 4, 2005). Management's discussion of the current quarter results of these two segments is in relation to such comparable prior year pro forma net sales and earnings data. Procter & Gamble markets approximately 300 consumer products in more than 160 countries. Our products are sold primarily through mass merchandisers, grocery stores, membership club stores and drug stores. We compete in multiple product categories and have four global business units: P&G Beauty, P&G Family Health, P&G Household Care, and Gillette. Under U.S. Generally Accepted Accounting Principles, we have seven reportable segments: Beauty, Health Care, Baby Care & Family Care, Fabric Care & Home Care, Snacks & Coffee, Blades & Razors, and Duracell & Braun. We have operations in over 80 countries through our Market Development Organization, which leads country business teams to build our brands in local markets and is organized along seven geographic areas: North America, Western Europe, Northeast Asia, Latin America, Central and Eastern Europe/Middle East/Africa, Greater China and ASEAN/Australasia/India. The following table provides the percentage of net sales and net earnings by business segment for the six months ended December 31, 2005 (excludes net sales and net earnings in Corporate): Net Sales Net Earnings Baby Care and Family Care 18% 13% Fabric Care and Home Care 25% 25% Note: Calculations above are based on only 3 months of Gillette results The following table provides the percentage of net sales and net earnings by business segment for the three months ended December 31, 2005 (excludes net sales and net earnings in Corporate): Net Sales Net Earnings Baby Care and Family Care 17% 12% SUMMARY OF RESULTS. Following are highlights of results for the six months o Unit volume increased 17 percent. Organic volume, which excludes the impact of acquisitions and divestitures, increased seven percent. Growth was broad-based with every business unit and every geographic region delivering organic volume increases. o Net sales increased 17 percent to $33.13 billion. Organic sales, which exclude the impacts of foreign exchange, acquisitions, and divestitures, increased seven percent. o Net earnings increased 17 percent to $4.58 billion behind strong organic growth and the addition of the Gillette business, partially offset by increased commodity costs and acquisition-related expenses. o Diluted net earnings per share were $1.48, an increase of four percent versus the comparable prior year period. o Operating cash flow was $4.75 billion, an increase of 20 percent versus the prior year period. Free cash flow productivity was 81 percent. FORWARD LOOKING STATEMENTS. The markets in which the Company sells its products are highly competitive and comprised of both global and local competitors. Going forward, business and market uncertainties may affect results. Among the key factors that could impact results and must be managed by the Company are: (1) the ability to achieve business plans, including with respect to lower income consumers and growing existing sales and volume profitably despite high levels of competitive activity, especially with respect to the product categories and geographical markets (including developing markets) in which the Company has chosen to (2) the ability to successfully execute, manage and integrate key acquisitions and mergers, including (i) the Company's acquisition of The Gillette Company, including the ability to achieve the cost and growth synergies in accordance with the stated goals of the transaction and (ii), the Domination and Profit Transfer Agreement (3) the ability to manage and maintain key customer relationships; (4) the ability to maintain key manufacturing and supply sources (including sole supplier and plant manufacturing sources); (5) the ability to successfully manage regulatory, tax and legal matters (including product liability, patent, and other intellectual property matters), and to resolve pending matters within current estimates; (6) the ability to successfully implement, achieve and sustain cost improvement plans in manufacturing and overhead areas, including the Company's outsourcing projects; (7) the ability to successfully manage currency (including currency issues in volatile countries), debt (including debt related to the Company's announced plan to repurchase shares of the Company's stock), interest rate and certain commodity cost exposures; (8) the ability to manage the continued global political and/or economic uncertainty and disruptions, especially in the Company's significant geographical markets, as well as any political and/or economic uncertainty and disruptions due to terrorist activities; (9) the ability to successfully manage competitive factors, including prices, promotional incentives and trade terms for products; (10) the ability to obtain patents and respond to technological advances attained by competitors and patents granted to competitors; (11) the ability to successfully manage increases in the prices of raw materials used to make the Company's products; (12) the ability to stay close to consumers in an era of increased media (13) the ability to stay on the leading edge of innovation. If the Company's assumptions and estimates are incorrect or do not come to fruition, or if the Company does not achieve all of these key factors, then the Company's actual results could vary materially from the forward-looking statements made herein, as that term is defined in the Private Securities Litigation Reform Act of 1995. RESULTS OF OPERATIONS - THREE MONTHS ENDED DECEMBER 31, 2005 The following discussion provides a review of results for the three months ended December 31, 2005 versus the three months ended December 31, 2004. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information SELLING, GENERAL & ADMINISTRATIVE EXPENSE 5,713 4,585 25 % OTHER NON-OPERATING INCOME, NET 68 55 AVERAGE DILUTED SHARES OUTSTANDING 3,547.0 2,752.1 COMPARISONS AS A % OF NET SALES SELLING, GENERAL & ADMINISTRATIVE EXPENSE 31.2 % 31.7 % (50) Unit volume increased 27 percent during the December quarter driven by the addition of the Gillette business as well as organic volume growth. Organic volume, which excludes the impact of acquisitions and divestitures from year-over-year comparisons, increased six percent. Every business segment except Snacks and Coffee, which was impacted by Hurricane Katrina, delivered mid-single digit or higher organic volume growth. In addition, each of the Company's geographic regions delivered organic growth, with developing regions growing organic volume in the mid-teens. Net sales for the quarter increased 27 percent to $18.34 billion. Organic sales, which exclude acquisitions, divestitures and foreign exchange impacts, grew eight percent. Foreign exchange had a negative two percent impact on sales growth. Pricing and mix each had a positive one percent impact on sales growth. Volume Net Sales Acquisitions Acquisitions Total Divestitures Divestitures FX Price Other Impact Ex-FX DURACELL AND BRAUN N/A N/A N/A N/A N/A N/A N/A Note: Sales percentage changes are approximations based on quantitative formulas that are consistently applied * Figures include Gillette results for the October - December quarter only Gross margin was 52.4 percent, flat versus the prior year period. The addition of the Gillette business added approximately 75 basis points to gross margin due to higher margins in the Blades and Razors segment, net of approximately 35 basis points of increased product costs from revaluing Gillette's opening inventory balances to fair value as of the acquisition date. The gross margin decline in our other businesses was caused primarily by higher commodity costs, which hurt gross margin by about 150 basis points in the quarter. Scale leverage, costs savings initiatives and pricing partially offset the increase in Total Selling, general, and administrative expenses (SG&A) increased 25%, or $1.13 billion, during the quarter versus the prior year period. The addition of Gillette drove approximately $1.0 billion of the total increase in the quarter, including approximately $200 million of acquisition related expenses. The acquisition related expenses were comprised of $135 million due to increased intangible asset amortization resulting from revaluing intangible assets in the opening balance sheet of the acquired Gillette business. The balance of the acquisition related expenses was due to incremental integration and overhead expenses such as legal and consulting fees. Total SG&A also increased due to higher marketing and overhead spending on our base businesses (total company excluding Gillette and acquisition related expenses), although both were lower as a percentage of sales. Marketing spending increased in support of new initiatives across key brands including Tide, Crest, Olay, Pantene, Naturella, and LaCoste. SG&A decreased as percentage of sales by 50 basis points. Sales growth and the mix benefits of adding the Gillette businesses more than offset the impact of acquisition related expenses. Interest expense for the quarter increased $99 million versus the prior year period driven by the financing cost of the previously announced share repurchase program associated with the Gillette acquisition. We repurchased $3.5 billion of P&G stock during the quarter as part of this program. This brings the cumulative value of shares purchased under the program to $12.0 billion. Net earnings increased 29 percent to $2.55 billion. Earnings growth was driven by organic growth, the addition of Gillette, and an improvement in SG&A as a percentage of sales, partially offset by commodity-driven increases in product costs. The contribution from Gillette was net of increased interest expense, higher costs from revaluing Gillette's opening asset balances to fair value as of the acquisition date and other one-time integration costs. Diluted net earnings per share were $0.72, in-line with comparable prior year period results. Earnings per share included an estimated $0.06-$0.07 cents per share of dilution related to the Gillette acquisition. The dilution estimate includes $0.03 of one-time charges, including costs from revaluing Gillette's opening inventory balances to fair value as of the acquisition date. RESULTS OF OPERATIONS - Six Months Ended December 31, 2005 The following discussion provides a review of results for the six months ended December 31, 2005 versus the six months ended December 31, 2004. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information SELLING, GENERAL & ADMINISTRATIVE EXPENSE 10,290 8,917 15% OTHER NON-OPERATING INCOME, NET 142 237 AVERAGE DILUTED SHARES OUTSTANDING 3,098.0 2,759.1 COMPARISONS AS A % OF NET SALES SELLING, GENERAL & ADMINISTRATIVE EXPENSE 31.1 % 31.6 % (50) Fiscal year to date, unit volume increased 17 percent. Organic volume, which excludes the impact of acquisitions and divestitures, increased seven percent. Growth was broad-based across businesses and geographies. Every business segment except Snacks and Coffee, which was impacted by Hurricane Katrina, delivered mid-single digit or higher organic volume growth. In addition, each of the Company's regions delivered organic growth led by double-digit growth in For the first six months of the fiscal year, net sales increased 17 percent to $33.13 billion driven by the addition of the Gillette business as well as growth on the base P&G businesses. Organic sales, which exclude the impact of acquisitions and divestitures, increased seven percent. Favorable product mix, resulting largely from the addition of the Gillette business offset the mix impact of disproportionate growth in developing regions where average selling price is lower than the global average. Pricing activity in Health Care, Baby and Family Care, Fabric and Home Care, and Snacks and Coffee had a positive one percent impact on sales growth. Foreign exchange was neutral during the period. Volume Net Sales Acquisitions Acquisitions Total Divestitures Divestitures FX Price Other Impact Ex-FX DURACELL AND BRAUN N/A N/A N/A N/A N/A N/A N/A Note: Sales percentage changes are approximations based on quantitative formulas that are consistently applied * Figures include Gillette results for the October - December quarter only Gross margin was 52.0 percent fiscal year to date, a 10 basis point decrease versus the comparable base period. Adding the Gillette business added approximately 40 basis points to gross margin due to higher margins in the Blades and Razors segment, net of approximately 20 basis points of increased product costs from revaluing Gillette's opening inventory balances to fair value as of the acquisition date. Gross margin on the Company's base businesses declined by approximately 50 basis points driven by higher commodity costs, which negatively impacted gross margin by about 130 basis points. Scale benefits of volume growth, price increases and cost savings programs partially offset the increase in commodity costs. Total Selling, general, and administrative expenses (SG&A) increased 15%, or $1.37 billion, fiscal year to date versus the prior year period. The addition of Gillette drove approximately $1.0 billion of the total increase in the period, including approximately $200 million of acquisition related expenses. The acquisition related expenses were comprised of $135 million due to increased intangible asset amortization resulting from revaluing intangible assets in the opening balance sheet of the acquired Gillette business. The balance of the acquisition related expenses was due to incremental integration and overhead expenses such as legal and consulting fees. Total SG&A also increased due to higher marketing and overhead spending on our base businesses (total company excluding Gillette and acquisition related expenses), although both were lower as a percentage of sales. SG&A decreased as percentage of sales by 50 basis points. Sales growth and the mix benefits of adding the Gillette businesses more than offset the impact of acquisition related expenses. Interest expense increased fiscal year to date by $137 million versus the prior year period driven by the financing cost of the previously announced share repurchase program associated with the Gillette acquisition. The Company repurchased $9.0 billion of P&G stock fiscal year to date under this program, bringing cumulative repurchases under the program to $12.0 billion since January Net earnings increased 17 percent to $4.58 billion behind organic growth, the impact of adding the Gillette business, and improved SG&A as a percentage of sales, partially offset by increased commodity costs. Diluted net earnings per share increased four percent to $1.48 compared during BUSINESS SEGMENT DISCUSSION The following discussion provides a review of results by business segment. An analysis of the results for the three and six months ended December 31, 2005 is provided compared to the same three and six month periods ended December 31, 2004. The primary financial measures used to evaluate segment performance are net sales and net earnings. The table below provides supplemental information on net earnings by business segment for the three and six months ended December 31, 2005 versus the comparable prior year period: Three Months Ended December 31, 2005 % Change Before % Change % Change Net Versus Income Versus Net Versus Sales Year Ago Taxes Year Ago Earnings Year Ago Six Months Ended December 31, 2005 % Change Before % Change % Change Net Versus Income Versus Net Versus Sales Year Ago Taxes Year Ago Earnings Year Ago * Figures include Gillette results for the October - December quarter only Beauty volume increased nine percent during the quarter, including the addition of Gillette Personal Care. Organic volume, which excludes the impact of acquisitions and divestitures, increased five percent. Skin Care delivered double digit volume growth behind product innovations including Olay Regenerist and Total Effects Cleansing. The Feminine Care business delivered volume growth in the upper-single digits behind Always softness innovations, scent line extensions, Naturella expansion, and continued growth of Tampax Pearl. Retail Hair Care volume was up mid-single digits. Growth in developing regions and in hair colorants behind innovations on Koleston, Wellaton, and Nice n' Easy was partially offset by a volume decrease in developed regions resulting primarily from the discontinuation of minor shampoo brands in the US. Cosmetics volume declined in the mid-single digits versus a base period that included pipeline shipments ahead of a major initiative launch. Net sales increased seven percent to $5.37 billion, including a negative two percent foreign exchange impact. Net earnings increased seven percent to $848 million. Volume growth was partially offset by higher commodity costs and increased marketing investments to support initiative programs, primarily in developing regions. Beauty volume increased eight percent fiscal year to date, including three months of results of Gillette Personal Care. Organic volume, which excludes acquisitions and divestitures, increased six percent, led by double digit organic growth in developing regions. Volume growth was driven by initiative activity on Pantene, Head & Shoulders, Rejoice, Olay, Always, and Naturella. Net sales increased seven percent to $10.36 billion including a negative one percent foreign exchange impact. Net earnings increased 11 percent to $1.63 billion. Volume growth was partially offset by higher commodity costs and increased marketing investments to support initiative programs, primarily in developing Health Care delivered 31 percent volume growth in the quarter, including the addition of Gillette Oral Care. Organic volume, which excludes acquisitions and divestitures, increased eight percent. Volume increases on our base business were driven by Pharmaceuticals and Personal Health behind continued growth on Actonel and Prilosec OTC. Oral Care also grew behind Crest, which delivered double-digit organic volume growth, net of the impact of the Spinbrush divestiture required in order to obtain regulatory approval of the Gillette acquisition. Growth on Crest was driven by share increases in North America and continued strength in developing markets. Net sales increased 29 percent to $2.64 billion behind organic volume growth as well as the addition of Gillette Oral Care. Pricing had a positive one percent impact on sales growth from prior period increases on Actonel and Prilosec OTC. Foreign exchange had a negative one percent impact on sales growth. Product mix reduced sales by two percent due primarily to the impact of adding Gillette Oral Care, which has a lower average selling price than the balance of the segment, and the impact of disproportionate growth in developing regions, where average selling prices are lower than the balance of the segment. Net earnings increased 41 percent to $427 million behind volume growth, including the addition of Gillette Oral Care, and margin expansion on P&G's base business. Margins expanded primarily due to scale benefits of volume growth, favorable product mix and pricing. Fiscal year to date, Health Care volume increased 21 percent, including three months of Gillette Oral Care results. Organic volume, which excludes the impact of acquisitions and divestitures, increased 10 percent behind double digit growth in Pharmaceuticals and Personal Health and upper-single digit organic growth in Oral Care. Net sales grew 21 percent to $4.72 billion. Pricing on Actonel and Prilosec OTC had a positive one percent impact on sales. This was offset by a negative one percent mix impact due to adding Gillette Oral Care, which has a lower average selling price than the segment average, and the impact of disproportionate growth in developing regions, where average selling prices are lower than the balance of the segment. Organic sales, which exclude the impact of acquisitions and divestitures, increased 11 percent. Net earnings increased 40 percent to $763 million behind organic volume growth, the addition of Gillette Oral Care, and margin expansion on the base P&G business. Margins expanded primarily due to scale benefits of volume growth, favorable product mix Baby Care and Family Care delivered volume growth of five percent during the quarter. Volume increased behind product initiatives such as Pampers Full Motion in Western Europe and Bounty and Charmin ""Basic,"" as well as double digit growth in developing markets. Baby Care volume declined in developed regions due to high levels of competitive pricing activity in North America. Net sales increased two percent to $3.04 billion, including a negative two percent foreign exchange impact. Pricing added one percent to sales growth, but was offset by a negative two percent product mix impact from growth in developing markets and Bounty and Charmin ""Basic,"" both of which have lower relative sales prices than the segment average. Net earnings declined five percent to $330 million versus the base period. Earnings in the quarter were negatively impacted by the increase in energy costs that followed the hurricanes last September and reduced volume in North America Baby Care, both of which also contributed to the decline in the segment's earnings margin. Baby Care and Family Care volume increased five percent fiscal year to date. Organic volume, which excludes the impact of acquisitions and divestitures, increased six percent. Volume increased in both Baby Care and Family Care behind product initiatives and double digit growth in developing regions. Net sales increased four percent to $6.04 billion. Pricing had a positive one percent impact on sales but was offset by a negative two percent mix impact due to growth in mid-tier Basic products and disproportionate growth in developing regions. Net earnings declined one percent to $650 million as volume growth and pricing were offset by increased energy costs and unfavorable product mix. Fabric Care and Home Care delivered volume growth of seven percent for the quarter. Volume was driven by innovations such as Tide with Febreze, Tide Coldwater, Ariel Ion Power Gels, Cascade Action Packs, Febreze Air Effects and the expansion of Bold in Japan coupled with very strong customer support behind key initiatives. Fabric Care grew volume in the upper-single digits behind double digit global growth on Tide. Net sales increased eight percent to $4.08 billion, including a negative two percent foreign exchange impact. Pricing in the Fabric Care and Home Care businesses added two points to sales growth. Favorable product mix, primarily due to disproportionate growth on Tide, added an additional one point to sales growth. Net earnings increased eight percent to $593 million. Earnings growth reflects top line progress, as well as cost savings and pricing to mitigate commodity price increases. Fiscal year to date, Fabric Care and Home Care volume increased seven percent behind innovations on Tide, Ariel, Dawn, Febreze, Downy, and Cascade. Net sales increased nine percent to $8.30 billion. Pricing, primarily in North America and Latin America, added two points to sales growth. Net earnings increased nine percent to $1.23 billion. Volume growth, pricing, and cost savings programs more than offset increased commodity costs. Snacks and Coffee results were impacted by Hurricane Katrina, which occurred in August 2005. The business experienced significant disruption and damages to our manufacturing facilities in New Orleans. Beginning in December, these facilities were fully operational. Snacks and Coffee volume grew three percent in the quarter, as a mid-single digit decline in Coffee volume partially offset growth in other businesses. Snacks volume was up mid-single digits. Sales were $927 million, an increase of 10 percent. Pricing actions taken in the prior year in response to rising coffee prices added 9 percent to sales, which was partially offset by 1 percent each from negative product mix and foreign exchange. Earnings declined 20% to $95 million, as sales growth was offset by increased costs related to Hurricane Katrina and negative product mix. Fiscal year to date, Snacks and Coffee volume declined one percent. Lower Coffee shipments following the hurricane more than offset growth in other businesses. Snacks volume was up mid-single digits in the period. Net sales increased three percent to $1.63 billion, including a negative one percent foreign exchange impact. Pricing in Coffee added seven percent to sales. The mix effect of lower Coffee shipments had a negative two percent impact on sales. Earnings declined 15 percent to $168 million as sales growth was offset by negative product mix and increased costs, primarily related to Hurricane Katrina. ACQUIRED GILLETTE REPORTED SEGMENTS As disclosed in note 4 to the consolidated financial statements, we completed the acquisition of The Gillette Company on October 1, 2005. This acquisition resulted in two new reportable segments for the Company: Blades and Razors and Duracell and Braun. The Gillette Oral Care and Personal Care businesses were subsumed within the Health Care and Beauty reportable segments, respectively. Because the acquisition was completed in the current period, there are no results for these segments in our prior year period. In order to provide our investors with more insight into the results of the Blades & Razors and Duracell & Braun reporting segments, we have previously provided supplemental pro forma net sales and earnings data for these segments for each of the quarters in the Gillette Company's year ended June 30, 2005 (as presented in our Form 8-K released October 4, 2005). Management's discussion of the current quarter results of these two segments is in relation to such comparable prior year pro forma net sales and earnings data. With respect to the earnings data, this analysis is based on Earnings before Income Taxes. The previously disclosed Blades & Razors and Duracell & Braun pro forma information reconciled ""Profit from Operations,"" the measure used by Gillette in its historical filings, to Earnings before Income Taxes, the comparable measure used by the Company. Gillette did not allocate income tax expense to its reporting Blades and Razors sales increased six percent to $1.15 billion over the pro forma prior year quarter. Positive pricing of two percent offset a negative two percent foreign exchange impact. Sales growth was driven by M3Power, Venus Vibrance, and Venus Disposables as well as continued consumer trade-up in developing markets. Earnings before income taxes increased 11 percent to $375 million versus previously published pro forma prior year results. Earnings increased behind sales, a more profitable product mix of replacement blades versus razors, price increases and lower overhead and manufacturing expenses, primarily as a result of savings realized from Gillette's Functional Excellence program. Earnings growth was also favorably impacted by base period charges for severance and other exit charges associated with Gillette's Functional Excellence program, the European Manufacturing Realignment program, and other asset write-downs. These earnings drivers were partially offset by acquisition-related expenses in the current period of $116 million (before-tax), including increased amortization expense from revaluing acquired fixed and intangible assets and increased product costs from revaluing opening inventory balances at fair value. Reported net earnings for the segment were $272 million. Duracell and Braun delivered one percent sales growth to $1.28 billion during the quarter. Volume growth was offset by a negative two percent impact from foreign exchange. A price increase on Duracell had a positive impact on segment sales, but was more than offset by a year-on-year increase in total promotion expenses in the segment; the net impact of pricing on segment sales was negative one percent. Duracell pricing in the U.S. continues to trend upwards following the list price increase taken in August 2005 and the roll-out across trade accounts. Duracell sales increased behind share growth, while Braun sales were driven by new product initiatives such as 360 Complete, Tassimo, and Contour. Earnings before income taxes increased 46 percent to $243 million versus previously published pro forma prior year results. Earnings growth was driven primarily by volume as well as lower overhead and manufacturing costs, primarily resulting from the Functional Excellence program. Earnings growth was also favorably impacted by base period charges for severance and other exit charges associated with Gillette's Functional Excellence program as well as other asset write-downs. These earnings drivers were partially offset by acquisition-related expenses in the current period of $43 million (before tax), including increased amortization expense from revaluing acquired fixed and intangible assets and increased product costs from revaluing opening inventory balances at fair value. Reported net earnings for the segment were $165 million. We expect earnings before income taxes growth indices to moderate in the second half of the fiscal year versus the quarter ended December 31, 2005. This is primarily due to the lapping of the Functional Excellence program benefits coupled with increased investments behind the Fusion blade system launch. Corporate includes certain operating and non-operating activities not allocated to specific business units. These include: the incidental businesses managed at the corporate level, financing and investing activities, certain restructuring charges, other general corporate items and the historical results of certain divested categories, including the juice business that was divested in August of 2004 and the Gillette brands (primarily Rembrandt and Right Guard) that will be divested as required by the Gillette acquisition. Corporate also includes reconciling items to adjust the accounting policies used in the segments to U.S. GAAP. The most significant reconciling items include income taxes (to adjust from statutory rates that are reflected in the segments to the overall Company effective tax rate), adjustments for unconsolidated entities (to eliminate sales, cost of products sold and SG&A for entities that are consolidated in the segments but accounted for using the equity method for U.S. GAAP) and minority interest adjustments for subsidiaries where we do not have 100% ownership. Because both unconsolidated entities and less than 100 percent owned subsidiaries are managed as integral parts of the Company, they are accounted for similar to a wholly-owned subsidiary for management and segment purposes. This means our segment results recognize 100 percent of each income statement component through before-tax earnings in the segments, with eliminations in Corporate. In determining segment net earnings, we apply the statutory tax rates (with adjustments to arrive at the Company's effective tax rate in Corporate) and eliminate the share of earnings applicable to other ownership interests, in a manner similar to minority interest. The decline in net earnings for the quarter and year to date is primarily driven by the impact of the base period gain on the sale of the juice business and a current period increase in net interest expense due to the financing cost of the share repurchase program announced in connection with the Gillette acquisitions. Cash generated from operating activities for the six months ended December 31, 2005 was $4.75 billion versus $3.96 billion in the comparable prior period. Strong earnings, adjusted for non-cash items (primarily depreciation, amortization, stock-based compensation, and deferred income taxes) generated $6.46 billion. This was partially offset by an increase in working capital items, primarily accounts receivable and accounts payable. Accounts receivable increased to support business growth. Days sales in receivables were flat versus the comparable prior year period. Accounts payable, accrued, and other liabilities days were down largely due to our continued efforts to accelerate payments to suppliers in order to maximize payment discounts. Inventory days on hand were down marginally resulting in a slight improvement to cash flow. Investing activities in the current year decreased cash by $402 million, compared to the prior year period when investing activities reduced cash by $1.01 billion. Acquisitions provided a net source of cash. A cash balance of $1.60 billion received in the Gillette acquisition, representing Gillette's cash balances at the acquisition date, was partially offset by cash used for other acquisitions, including settlement of a major portion of the Wella domination liability. Capital expenditures as a percentage of sales were 3.1 percent, in-line with the comparable prior year period. Total cash used by financing activities was $2.87 billion versus $1.23 billion in the comparable base period. Our net debt position increased by $7.34 billion, primarily to fund the share repurchase program associated with the acquisition of Gillette. This was offset by $9.03 billion of treasury purchases during the Our discussion of financial results includes several measures not defined by U.S. GAAP. We believe these measures provide our investors with additional information about the underlying results and trends of the Company, as well as insight to some of the metrics used to evaluate management. When used in MD&A, we have provided the comparable GAAP measure in the discussion. ORGANIC SALES GROWTH. Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions, divestitures and foreign exchange from year-over-year comparisons. We believe this provides investors with a more complete understanding of underlying sales trends by providing sales growth on a consistent basis. The reconciliation of reported sales growth to organic sales for the October - December 2005 quarter: Total Sales Growth 27% Foreign Exchange Impact 2% Acquisition/Divestiture Impact -21% Organic Sales Growth 8% The reconciliation of reported sales growth to organic sales for the fiscal year to date period ended December 31, 2005: Total Sales Growth 17% Foreign Exchange Impact 0% Acquisition/Divestiture Impact -10% Organic Sales Growth 7% FREE CASH FLOW. Free cash flow is defined as operating cash flow less capital spending. We view free cash flow as an important measure because it is one factor in determining the amount of cash available for dividends and discretionary investment. Free cash flow is also one of the measures used to evaluate senior management and is a factor in determining their at-risk FREE CASH FLOW PRODUCTIVITY. Free cash flow productivity is defined as the ratio of free cash flow to net earnings. The Company's long-term target is to generate free cash at or above 90 percent of net earnings. Free cash flow is also one of the measures used to evaluate senior management. The reconciliation of free cash flow and free cash flow productivity is provided below: Operating Capital Free Net Free Cash ($MM) Cash Flow Spending Cash Flow Earnings Flow Productivity",5748
2006-02-23,8-K,0000950152-06-001403,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) February 23, 2006 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) Registrants telephone number, including area code ( 513) 983-1100 o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR ITEM 7.01 REGULATION FD DISCLOSURE On February 23, 2006, The Procter & Gamble Company (the Company) provided a presentation at the Consumer Analyst Group of New York 2006 Conference, which was previously announced and webcast. Certain presentation materials concerning the Gillette integration and Company financial measures are attached hereto as Exhibit 99.1 and the accompanying reconciliation pursuant to Regulation G is attached hereto as Exhibit 99.2. The Company is furnishing this 8-K pursuant to Item 7.01, Regulation FD Disclosure.",200
2006-03-13,8-K,0000080424-06-000052,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) March 13, 2006 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On March 13, 2006, The Procter & Gamble Company (the ""Company"") issued a news release concerning an increase in its quarterly dividend and concerning previously announced sales and earnings per share guidance for the January to March quarter. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure"".",186
2006-04-17,8-K,0000080424-06-000062,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) April 17, 2006 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 5.02(b) DEPARTURE OF DIRECTOR Effective today, April 17, 2006, R. Kerry Clark (53), vice chair of the Board-P&G Family Health, will retire after 32 years of service. This 8-K is being filed pursuant to Item 5.02(b), ""Departure of Directors or Principal",172
2006-05-01,8-K,0000080424-06-000064,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) May 1, 2006 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 5.02(b) DEPARTURE OF DIRECTOR The Procter & Gamble Company (the ""Company"") announced today that Robert D. Storey is retiring from the Company's board of directors effective immediately. Mr. Storey has reached the customary age (70) for retirement from the board. The Company is filing this 8-K pursuant to Item 5.02(b), ""Departure of Directors or",185
2006-05-03,8-K,0000080424-06-000065,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) May 3, 2006 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On May 3, 2006, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended March 31, 2006. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations",177
2006-05-04,10-Q,0000080424-06-000067,"and Analysis of Financial Condition and Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is organized in the following sections: o Results of Operations - Three Months Ended March 31, 2006 o Results of Operations - Nine Months Ended March 31, 2006 o Business Segment Discussion (three and nine months ended March 31, 2006) Throughout MD&A, we refer to several measures used by management to evaluate performance including unit volume growth, net sales and after-tax profit. We also refer to organic sales growth (net sales excluding the impacts of acquisitions, divestitures and foreign exchange), free cash flow and free cash flow productivity, which are not defined under accounting principles generally accepted in the United States of America (U.S. GAAP). The explanation of these measures at the end of MD&A provides more details. Effective July 1, 2005, Procter & Gamble adopted SFAS 123(R) which requires that all stock-based compensation, including grants of employee stock options, be accounted for using a fair value-based method. We have elected to adopt SFAS 123(R) using the modified retrospective method. As a result, we have revised our historical results to include the effect of stock-based compensation. Therefore, all financial data provided in this Form 10-Q filing, including prior year data, have been revised to include the impact of all stock-based compensation expense. Our business is focused on providing branded products of superior quality and value to improve the lives of the world's consumers. We believe this will lead to leadership sales, profits and value creation, allowing employees, shareholders and the communities in which we operate to prosper. On October 1, 2005, we completed the acquisition of The Gillette Company (""Gillette""), a leading consumer products company that had $10.5 billion of sales in its most recent year ended December 31, 2004. The results of Gillette are included in the Financial Statements and Management's Discussion and Analysis as of October 1, 2005. In order to provide our investors with more insight into the results of the Blades and Razors and Duracell and Braun reporting segments, we have previously provided supplemental pro forma net sales and earnings data for these segments for each of the four quarters in the year ended June 30, 2005 (as presented in our Form 8-K released October 4, 2005). Management's discussion of the current quarter results of these two reporting segments is in relation to such comparable prior year pro forma net sales and Procter & Gamble markets approximately 300 consumer products in more than 160 countries. Our products are sold primarily through mass merchandisers, grocery stores, membership club stores and drug stores. We compete in multiple product categories and have four global business units: P&G Beauty, P&G Family Health, P&G Household Care and Gillette. Under U.S. Generally Accepted Accounting Principles, we have seven reportable segments: Beauty, Health Care, Baby Care & Family Care, Fabric Care & Home Care, Snacks & Coffee, Blades & Razors and Duracell & Braun. We have operations in over 80 countries through our Market Development Organization, which leads country business teams to build our brands in local markets and is organized along seven geographic areas: North America, Western Europe, Northeast Asia, Latin America, Central and Eastern Europe/Middle East/Africa, Greater China and ASEAN/Australasia/India. On April 17, 2006, we announced a number of changes to certain of our key leadership positions, which also involved changes to our organization structure. These changes will impact our segment reporting. Specifically, Pet Health & Nutrition, which is part of our Health Care reporting segment, will become part of our Snacks & Coffee reporting segment. In addition, our commercial products organization, which primarily sells cleaning products directly to commercial end users, will be moved from Snacks & Coffee to our Fabric Care & Home Care segment. Our segment reporting will be revised to reflect these changes during the upcoming quarter ended June 30, 2006, at which time we will also revise our historical financial statements to reflect these changes. The accompanying financial statements and management discussion of operating results reflect the management and organization structure that existed prior to the changes The following table provides the percentage of net sales and net earnings by business segment for the nine months ended March 31, 2006 (excludes net sales and net earnings in Corporate): NET SALES NET EARNINGS Baby Care and Family Care 18% 13% Fabric Care and Home Care 24% 25% NOTE: CALCULATIONS ABOVE INCLUDE 6 MONTHS OF GILLETTE RESULTS (OCTOBER 1, 2005 - MARCH 31, 2006) The following table provides the percentage of net sales and net earnings by business segment for the three months ended March 31, 2006 (excludes net sales and net earnings in Corporate): NET SALES NET EARNINGS Baby Care and Family Care 17% 14% SUMMARY OF RESULTS. Following are highlights of results for the nine months o Unit volume increased 18 percent fiscal year to date. Organic volume, which excludes the impacts of acquisitions and divestitures, increased six percent. Growth was broad-based with every segment delivering volume growth, except Snacks and Coffee which was impacted by business disruptions due to Hurricane Katrina. Every region delivered organic volume growth, with double digit growth in developing regions. o Net sales increased 19 percent to $50.38 billion fiscal year to date, including Gillette results since October 1, 2005. Organic sales, which exclude the impact of acquisitions, divestitures and foreign exchange, o Net earnings increased 23 percent to $6.79 billion fiscal year to date. Net earnings increased behind the addition of Gillette and sales growth on our base business. o Diluted net earnings per share were $2.10 through the first nine months of the fiscal year, an increase of four percent versus the comparable prior year period, including $0.15 - $0.17 of dilution from o Operating cash flow was $8.19 billion, an increase of 24 percent versus the prior year period. Free cash flow productivity fiscal year FORWARD LOOKING STATEMENTS. The markets in which the Company sells its products are highly competitive and comprised of both global and local competitors. Going forward, business and market uncertainties may affect results. Among the key factors that could impact results and must be managed by the Company are: (1) the ability to achieve business plans, including with respect to lower income consumers and growing existing sales and volume profitably despite high levels of competitive activity, especially with respect to the product categories and geographical markets (including developing markets) in which the Company has chosen to focus; (2) the ability to successfully execute, manage and integrate key acquisitions and mergers, including (i) the Company's acquisition of The Gillette Company, including the ability to achieve the cost and growth synergies in accordance with the stated goals of the transaction and (ii), the Domination and Profit Transfer Agreement (3) the ability to manage and maintain key customer relationships; (4) the ability to maintain key manufacturing and supply sources (including sole supplier and plant manufacturing sources); (5) the ability to successfully manage regulatory, tax and legal matters (including product liability, patent, and other intellectual property matters), and to resolve pending matters within current estimates; (6) the ability to successfully implement, achieve and sustain cost improvement plans in manufacturing and overhead areas, including the Company's outsourcing projects; (7) the ability to successfully manage currency (including currency issues in volatile countries), debt (including debt related to the Company's plan to repurchase shares of the Company's stock), interest rate and certain commodity cost exposures; (8) the ability to manage the continued global political and/or economic uncertainty and disruptions, especially in the Company's significant geographical markets, as well as any political and/or economic uncertainty and disruptions due to terrorist activities; (9) the ability to successfully manage competitive factors, including prices, promotional incentives and trade terms for products; (10) the ability to obtain patents and respond to technological advances attained by competitors and patents granted to competitors; (11) the ability to successfully manage increases in the prices of raw materials used to make the Company's products; (12) the ability to stay close to consumers in an era of increased media (13) the ability to stay on the leading edge of innovation. If the Company's assumptions and estimates are incorrect or do not come to fruition, or if the Company does not achieve all of these key factors, then the Company's actual results could vary materially from the forward-looking statements made herein, as that term is defined in the Private Securities Litigation Reform Act of 1995. RESULTS OF OPERATIONS - THREE MONTHS ENDED MARCH 31, 2006 The following discussion provides a review of results for the three months ended March 31, 2006 versus the three months ended March 31, 2005. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (AMOUNTS IN MILLIONS EXCEPT PER SHARE AMOUNTS) Consolidated Earnings Information SELLING, GENERAL & ADMINISTRATIVE EXPENSE 5,559 4,690 19 % OTHER NON-OPERATING INCOME, NET 79 60 AVERAGE DILUTED SHARES OUTSTANDING 3,510.5 2,730.3 COMPARISONS AS A % OF NET SALES SELLING, GENERAL & ADMINISTRATIVE EXPENSE 32.2 % 32.8 % (60) Unit volume increased 22 percent during the March quarter driven by the addition of the Gillette business and organic volume growth. Organic volume, which excludes the impacts of acquisitions and divestitures, increased five percent, largely behind product innovations that drove broad-based market share growth. Net sales for the quarter increased 21 percent to $17.25 billion. Organic sales, which exclude the impact of acquisitions, divestitures and foreign exchange, grew six percent. Sales growth was broad-based across both developed and developing regions. Developing markets led sales growth, driven by increases in Central and Eastern Europe/Middle East/Africa behind market share improvements and new initiative introductions. China sales growth moderated versus prior periods' growth rates, but was still up mid to high-single digits excluding the impact of Gillette. Foreign exchange trends had a negative three percent impact on the Company's sales growth due primarily to the strengthening of the US dollar versus the euro, the British pound and the Japanese yen. Pricing and mix each had a positive one percent impact on sales growth. Acquisitions Acquisitions Total Divestitures Divestitures FX Price Other Impact Ex-FX NOTE: Sales percentage changes are approximations based on quantitative formulas that are consistently applied Gross margin expanded by 110 basis points in the quarter to 51.7%. Commodity cost increases had a negative impact on gross margin of approximately 100 basis points. Scale leverage from volume growth, along with pricing and cost savings projects, offset the majority of the commodity cost increases. The mix benefit of adding the Gillette business drove approximately 125 basis points of gross margin expansion due to above company average margins in the Blades and Razors Total selling, general and administrative expenses (SG&A) increased 19%, or $869 million, during the quarter versus the prior year period. The increase was driven by the addition of Gillette, which added approximately $900 million to SG&A in the period, including approximately $150 million of acquisition-related expenses. The acquisition-related expenses included $108 million of increased intangible asset amortization resulting from revaluing intangible assets in the opening balance sheet of the acquired Gillette business. The balance of the acquisition-related expenses was due to incremental integration and overhead expenses such as legal and consulting fees. Marketing spending on our base business (total Company excluding Gillette) increased behind investments in Fabric Care and Home Care and in Beauty to support initiative activity, but was down as a percentage of sales versus the comparable prior year period. Overhead spending on our base business also decreased as a percentage of sales driven largely by reduced Wella integration costs versus the base period. Overall, SG&A decreased as a percentage of sales by 60 basis points as sales growth, overhead cost control and the mix benefits of adding the Gillette business more than offset the increase in SG&A expense. Interest expense for the quarter increased by $79 million versus the prior year period driven by the financing cost of the previously announced share repurchase program associated with the Gillette acquisition. We repurchased $3.7 billion of P&G stock during the quarter as part of this program, including $2.2 billion of shares repurchased under a forward purchase agreement that settled in April 2006. This brings the cumulative value of shares repurchased under the program to $15.8 billion since January 2005. We expect to repurchase about $20 billion in total under the program and to complete the program by mid-calendar 2006. Net earnings increased 37 percent to $2.21 billion behind organic sales growth, the addition of Gillette, improvement in gross margin and SG&A as a percentage of sales and a reduced tax rate versus the comparable base period. The contribution from Gillette was net of increased interest expense, higher costs from revaluing Gillette's intangible assets to fair value as of the acquisition date and one-time integration costs. Net earnings also benefited from a lower effective tax rate in the quarter. The Company's effective tax rate in the quarter was 29.3% compared to a rate of 32.2% in the comparable prior year period. The comparable prior year tax rate was negatively impacted by a provision for tax costs on anticipated dividends originating from foreign subsidiaries. The tax rate in the current quarter benefited from the favorable settlement of a tax audit in a foreign jurisdiction. Diluted net earnings per share were $0.63, up seven percent versus the prior year, including an estimated $0.07-$0.08 per share of dilution from the Gillette acquisition. Net earnings per share benefited by about $0.01 per share due to the favorable tax settlement. RESULTS OF OPERATIONS - NINE MONTHS ENDED MARCH 31, 2006 The following discussion provides a review of results for the nine months ended March 31, 2006 versus the nine months ended March 31, 2005. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (AMOUNTS IN MILLIONS EXCEPT PER SHARE AMOUNTS) Consolidated Earnings Information SELLING, GENERAL & ADMINISTRATIVE EXPENSE 15,849 13,607 16 % OTHER NON-OPERATING INCOME, NET 221 297 AVERAGE DILUTED SHARES OUTSTANDING 3,235.4 2,749.4 COMPARISONS AS A % OF NET SALES SELLING, GENERAL & ADMINISTRATIVE EXPENSE 31.5 % 32.0 % (50) Fiscal year to date, unit volume increased 18 percent. Organic volume, which excludes the impact of acquisitions and divestitures, increased six percent behind broad-based growth across segments and geographies. Every business segment except Snacks and Coffee, which was impacted by Hurricane Katrina, delivered mid-single digit or higher organic volume growth. In addition, each of the Company's regions delivered organic volume growth, led by double digit growth in developing regions. Net sales increased 19 percent to $50.38 billion in the first nine months of the fiscal year driven by the addition of the Gillette business in October, 2005, as well as growth on the base P&G businesses. Organic sales, which exclude the impact of acquisitions, divestitures and foreign exchange, increased seven percent during the period. Favorable product mix, resulting from the addition of the Gillette business which has a unit selling price that is higher than the Company average, along with more favorable product mix in Beauty and in Health Care, added one percent to sales growth. Pricing increases, taken across most segments, also had a positive one percent impact on sales growth, but were offset by a negative one percent unfavorable foreign exchange trend. Acquisitions Acquisitions Total Divestitures Divestitures FX Price Other Impact Ex-FX NOTE: Sales percentage changes are approximations based on quantitative formulas that are consistently applied. * Figures include only six months of Gillette results (October 1, 2005 - March 31, 2006) Gross margin was 51.9 percent fiscal year to date, an increase of 30 basis points versus the comparable base period. Adding the Gillette business added approximately 70 basis points to gross margin due to higher margins in the Blades and Razors segment, net of approximately 15 basis points due to increased product costs from revaluing Gillette's opening inventory balances to fair value as of the acquisition date. Gross margin on the Company's base businesses declined approximately 40 basis points during the period. Higher commodity costs, which negatively impacted gross margin by about 120 basis points, were partially offset by the scale benefit from sales growth and cost savings Total selling, general and administrative expenses (SG&A) increased 16 percent, or $2.2 billion fiscal year to date versus the prior year period. The addition of Gillette drove approximately $2.0 billion of the total increase in the period, including approximately $350 million of acquisition-related expenses. The acquisition-related expenses included $243 million of increased intangible asset amortization resulting from revaluing intangible assets in the opening balance sheet of the acquired Gillette business. The balance of the acquisition-related expenses was due to incremental integration and overhead expenses such as legal and consulting fees. Marketing spending on our base business (total Company excluding Gillette) increased behind investments in Fabric Care and Home Care and in Beauty to support initiative activity, but was down as a percentage of sales versus the comparable prior year period. Overhead spending on our base business also decreased as a percentage of sales driven largely by reduced Wella integration costs versus the base period. Overall, SG&A decreased as a percentage of sales by 50 basis points as sales growth, overhead cost control and the mix benefits of adding the Gillette businesses more than offset the increase in SG&A expense. Interest expense increased fiscal year to date by $216 million versus the prior year period driven by the financing cost of the previously announced share repurchase program associated with the Gillette acquisition. The Company repurchased $12.8 billion of P&G stock fiscal year to date under this program, including $2.2 billion of shares repurchased under a forward purchase agreement that settled in April 2006. This brings the cumulative value of shares repurchased under the program to $15.8 billion since January 2005. We expect to repurchase about $20 billion in total under the program and to complete the program by mid-calendar 2006. Net earnings increased 23 percent to $6.79 billion fiscal year to date behind the impact of adding the Gillette business, organic sales growth and improved SG&A as a percentage of sales, partially offset by increased commodity costs. Net earnings also benefited from a lower fiscal year to date effective tax rate as a result of a favorable resolution of a tax audit in a foreign jurisdiction during the current March quarter, coupled with a tax provision in the comparable base period related to a planned repatriation of dividends from foreign subsidiaries. Diluted net earnings per share increased four percent to $2.10 during the period, including $0.15 - $0.17 of Gillette dilution. BUSINESS SEGMENT DISCUSSION The following discussion provides a review of results by business segment. An analysis of the results for the three and nine months ended March 31, 2006 is provided compared to the same three and nine month periods ended March 31, 2005. The primary financial measures used to evaluate segment performance are net sales and net earnings. The table below provides supplemental information on net sales and net earnings by business segment for the three and nine months ended March 31, 2006 versus the comparable prior year period: Three Months Ended March 31, 2006 % Change Before % Change % Change Net Versus Income Versus Net Versus Sales Year Ago Taxes Year Ago Earnings Year Ago Nine Months Ended March 31, 2006* % Change Before % Change % Change Net Versus Income Versus Net Versus Sales Year Ago Taxes Year Ago Earnings Year Ago * Figures shown include six months of Gillette results only (October 1, 2005 - March 31, 2006) Beauty volume increased eight percent during the quarter behind organic volume growth and the addition of Gillette Personal Care. Organic volume, which excludes the impact of acquisitions and divestitures, increased four percent with growth across multiple categories and double digit developing region growth. Skin Care volume increased double digits behind growth on Olay. Cosmetics volume decreased versus last year due to declines on Max Factor in North America resulting from reduced distribution. Retail Hair Care volume increased mid-single digits behind Head & Shoulders, Pantene and Rejoice. Beauty net sales increased six percent to $5.16 billion driven by volume growth and a favorable one percent product mix impact resulting from higher sales of premium Hair Care and Feminine Care products, partially offset by three percent of unfavorable foreign exchange trends. Net earnings in Beauty increased 10 percent to $738 million behind the addition of Gillette Personal Care, organic sales growth, reduced Wella integration costs and a more profitable product mix. These were partially offset by higher commodity costs and an increase in marketing investments behind initiative activity, primarily in developing regions. Beauty volume increased eight percent fiscal year to date, including six months of Gillette Personal Care results. Organic volume increased five percent, led by double digit growth in developing regions. Volume growth was driven by initiative activity across categories and brands including Pantene, Head & Shoulders, Rejoice, Olay, Always and Naturella. Net sales increased seven percent to $15.51 billion including a negative two percent foreign exchange impact. Net earnings increased 11 percent to $2.37 billion. Sales growth and lower Wella integration costs were partially offset by higher commodity costs and increased marketing investments behind initiative activity, primarily in Health Care delivered 18 percent volume growth in the quarter, including the addition of the Gillette business. Organic volume, which excludes the impact of acquisitions and divestitures, declined one percent despite market share increases across most businesses and regions. Year-on-year comparisons were negatively impacted by a base period in which volume grew 14 percent behind the rebuild of Prilosec OTC trade inventory following an allocation period. The prior year also benefited from a late flu season in North America and Western Europe. Despite volume declines, market shares grew in Oral Care, Respiratory and on Prilosec OTC. Net sales in Health Care grew 21 percent to $2.43 billion due primarily to the addition of Gillette Oral Care. Favorable product mix in Pharmaceuticals and Personal Health and within the base Oral Care business increased sales by three percent. In addition, previously announced price increases on Actonel and Prilosec OTC added one percent to sales growth, but were offset by one percent from unfavorable foreign exchange trends. Health Care net earnings increased 28 percent to $298 million primarily behind the addition of the Gillette Oral Care business and a 100 basis point operating margin expansion. Operating margin increased as a result of adding Gillette Oral Care coupled with pricing activity and lower marketing expenses as a percentage of Fiscal year to date, Health Care volume increased 20 percent, including six months of Gillette Oral Care results. Organic volume increased six percent behind upper-single digit growth in Pharmaceuticals and Personal Health and mid-single digit growth in Oral Care. Additionally, volume increased due to a suppressed July-December base period when Prilosec OTC was on shipment allocations. Net sales increased 21 percent to $7.15 billion including a negative one percent foreign exchange impact. Pricing on Actonel and Prilosec OTC had a positive one percent impact on sales. Favorable product mix due to disproportionate growth in Pharmaceuticals and Personal Health added an additional one percent to sales. Net earnings increased 36 percent to $1.06 billion behind organic volume growth, the addition of Gillette Oral Care and margin expansion on the base P&G business. Operating margin in Health Care expanded by 220 basis points versus the comparable prior year period primarily due to scale benefits of sales growth, favorable product mix and a reduction in marketing expenses as percentage of sales versus the base period. Baby Care and Family Care volume increased two percent during the quarter, with organic volume up three percent. Baby Care volume increased in the low-single digits with developing regions up double digits behind market share growth in China and in Central and Eastern Europe. In developed regions, market share on Pampers in North America was in-line with the prior year period while continued pricing pressure from private label competitors drove share softness on the Luvs brand. Family Care organic volume grew in the mid-single digits, largely behind growth on Bounty and on the Charmin Basic initiative. Net sales in the Baby Care and Family Care segment were $3.03 billion, down one percent versus the prior year including a negative three percent foreign exchange impact. Previously announced price increases in North America Baby Care, coupled with a late January increase in North America Family Care, added two percent to sales. Disproportionate growth in mid-tier products and in developing regions, where average unit selling price is below the segment average, resulted in a negative two percent mix impact. Baby Care and Family Care net earnings increased two percent to $326 million. Operating margin increased 90 basis points as cost savings projects and lower marketing expenses as a percentage of sales offset higher commodity and energy costs. Baby Care and Family Care volume increased four percent fiscal year to date. Organic volume increased five percent behind product initiatives and double digit growth in developing regions. Net sales increased two percent to $9.07 billion, including a negative one percent foreign exchange impact. Pricing had a positive one percent impact on sales. Product mix and higher growth rates in developing markets reduced sales by two percent. Net earnings were unchanged at $976 million as volume growth and price increases in the second and third quarter were offset by increased energy costs and unfavorable product mix. Fabric Care and Home Care volume grew seven percent during the quarter. Growth was broad-based across regions and across both Fabric Care and Home Care. Volume was driven by innovations such as Tide with Febreze, Febreze Noticeables, Gain Joyful Expressions, Bounce with Febreze and Bold Liquid Tabs. Net sales increased seven percent to $4.08 billion, including a negative two percent foreign exchange impact. Pricing activity, primarily in Latin America Fabric Care and North America Dish Care, added two percent to sales growth. Net earnings increased thirteen percent to $545 million behind sales growth and margin expansion. Operating margin expanded by 100 basis points as volume growth, cost savings initiatives and pricing activity offset commodity cost increases and increased marketing investments behind initiative activity. Fiscal year to date, Fabric Care and Home Care volume increased seven percent driven by initiative activity across the segment. Net sales increased eight percent to $12.38 billion, including a negative one percent foreign exchange impact. Pricing activity added two percent to sales growth. Net earnings increased 10 percent to $1.78 billion. Volume growth, pricing and cost savings programs more than offset increased commodity costs and increased marketing spending behind initiative activity. Snacks and Coffee volume grew three percent in the quarter. Coffee volume increased mid-single digits as Folgers market share, which was impacted by disruptions related to Hurricane Katrina, returned to pre-hurricane levels during the quarter. Snacks volume was flat versus the prior year. Net sales for the segment were $796 million, an increase of four percent including a negative two percent impact from unfavorable foreign exchange trends. Previously announced price increases in Coffee added three percent to sales growth. Earnings were up 12 percent to $109 million driven by sales growth and an insurance recovery from Hurricane Katrina, which more than offset current quarter hurricane-related costs. Fiscal year to date, Snacks and Coffee volume was flat, primarily due to Coffee shipment disruptions following Hurricane Katrina. Coffee volume was down double digits while Snacks volume was up in the low-single digits during the period. Net sales increased three percent to $2.43 billion, including a negative one percent foreign exchange impact. Pricing in Coffee added six percent to sales while the mix effect of lower Coffee shipments had a negative two percent impact on sales. Earnings declined six percent to $277 million as sales growth was offset by increased costs related to Hurricane Katrina (net of the insurance recovery), negative product mix and higher green coffee prices. ACQUIRED GILLETTE REPORTED SEGMENTS As disclosed in Note 4 to the consolidated financial statements, we completed the acquisition of The Gillette Company on October 1, 2005. This acquisition resulted in two new reportable segments for the Company: Blades and Razors and Duracell and Braun. The Gillette Oral Care and Personal Care businesses were subsumed within the Health Care and Beauty reportable segments, respectively. Because the acquisition was completed during the current fiscal year period, there are no results for these segments in our prior year period. In order to provide our investors with more insight into the results of the Blades and Razors and Duracell and Braun reporting segments, we have previously provided supplemental pro forma net sales and earnings data for these segments for each of the quarters in the Gillette Company's year ended June 30, 2005 (as presented in our Form 8-K released October 4, 2005). Management's discussion of the current quarter results of these two segments is in relation to such comparable prior year pro forma net sales and earnings data. With respect to the earnings data, this analysis is based on Earnings before Income Taxes. The previously disclosed Blades and Razors and Duracell and Braun pro forma information reconciled ""Profit from Operations,"" the measure used by Gillette in its historical filings, to Earnings before Income Taxes, the comparable measure used by the Company. Gillette did not allocate income tax expense to its Blades and Razors sales increased one percent during the quarter to $1.19 billion versus prior year pro forma results, including a negative two percent foreign exchange impact. The launch of Fusion in North America led to an increase in sales in the region but was partially offset by a decline in Western Europe. In Western Europe, sales were down versus the prior year period despite market share growth. This was due to a base period in which sales grew in the mid-teens behind the launch of M3Power and Venus Disposables. Sales in the current quarter were also negatively impacted by a reduction in distributor inventory levels in several developing countries in Asia where the Gillette business was integrated into existing P&G distributors. Sales in Latin America increased behind continued growth on Mach3 Turbo and Prestobarba Excel. Overall, volume/mix increased sales by two percent and previously announced pricing activity added one percent to sales growth. Earnings before income taxes were $361 million, down 17 percent versus the published prior year pro forma results due primarily to $87 million of acquisition-related charges that negatively impacted earnings by 20 percent. The acquisition-related charges primarily represented increased amortization charges from revaluing intangible assets in the opening balance sheet. Earnings benefited from sales growth in North America and synergy savings from overhead cost reductions, largely offset by increased marketing investment behind the Fusion launch and the sales declines in Western Europe and Asia. Net earnings for the segment were $265 million in the quarter. Sales for Blades and Razors since the acquisition closed on October 1, 2005 have increased 4% to $2.34 billion versus the comparable prior year period pro forma results, including negative two percent of unfavorable foreign exchange trends. Sales grew behind the launch of Fusion in North America and growth in Latin America and Central and Eastern Europe/Middle East/Africa, but were partially offset by a decline in Western Europe due to a base period that included the launch of M3Power and Venus Disposables. Sales were also impacted by a reduction in distributor inventory levels in several developing Asian countries where the Gillette business was integrated into existing P&G distributors. Earnings before income tax declined by 5 percent to $736 million, including $203 million of acquisition-related charges that negatively impacted earnings by 26 percent during the period. The acquisition-related charges primarily represented increased amortization charges as a result of revaluing Gillette's opening balance sheet to fair market value and increased product costs from revaluing opening inventory balances at fair value. Earnings were also impacted by an increase in the current year marketing investment behind the launch of Fusion offset by synergy savings from overhead cost reductions and base period charges for severance and other exit charges associated with Gillette's Functional Excellence program, the European Manufacturing Realignment program and other asset write downs. Fiscal year to date, net earnings were $537 million (since the acquisition closed on October 1, 2005). Duracell and Braun sales were $763 million in the quarter, down one percent versus the prior year pro forma results including three percent of unfavorable foreign exchange impact. In the Duracell business, market share growth and price increases taken in North America to compensate for rising commodity costs were more than offset by unfavorable foreign exchange trends, competitive activity in Western Europe and unfavorable mix due to a trend toward larger pack sizes. Braun sales increased in North America behind Tassimo, but were partially offset by competitive activity in Germany and unfavorable foreign exchange trends. Overall, volume/mix and pricing each contributed one percent to segment sales growth, but were offset by negative three percent of unfavorable foreign exchange trends. Earnings before income taxes increased one percent to $76 million, including acquisition-related charges of $10 million that negatively impacted earnings by 13 percent. The acquisition-related charges primarily represented increased amortization charges for revaluing intangible assets in the opening balance sheet. Earnings grew ahead of sales primarily because of base period charges for the shutdown of a manufacturing facility and synergy savings from overhead cost reductions. In addition, current period cost savings resulting largely from the Gillette Functional Excellence program more than offset the effect of increased commodity costs. Net earnings for the segment were $54 million in the quarter. Sales for Duracell and Braun since the acquisition closed on October 1, 2005 have increased one percent to $2.04 billion versus the comparable prior year period pro forma results, including negative two percent of unfavorable foreign exchange trends. Market share growth and pricing activity on Duracell, coupled with successful growth on Braun behind initiative launches, were largely offset by unfavorable foreign exchange trends and declines in Western Europe due to competitive activity. Earnings before income tax increased 32 percent to $319 million, including acquisition-related charges of $53 million that negatively impacted earnings by 23 percent in the period. The acquisition-related charges primarily represented increased amortization charges as a result of revaluing Gillette's opening balance sheet to fair market value and increased product costs for revaluing opening inventory balances at fair value. Earnings growth was favorably impacted by base period charges for severance and other exit costs associated with Gillette's Functional Excellence program, including charges related to the shutdown of a manufacturing facility, as well as current-year synergy savings from overhead cost reductions. Fiscal year to date, net earnings were $219 million (since the acquisition closed on October 1, 2005). Corporate includes certain operating and non-operating activities not allocated to specific business units. These include: the incidental businesses managed at the corporate level, financing and investing activities, certain restructuring charges, other general corporate items and the historical results of certain divested categories, including the Juice business that was divested in August of 2004 and any Gillette brands that were divested as required by the Gillette acquisition. Corporate also includes reconciling items to adjust the accounting policies used in the segments to U.S. GAAP. The most significant reconciling items include income taxes (to adjust from statutory rates that are reflected in the segments to the overall Company effective tax rate), adjustments for unconsolidated entities (to eliminate sales, cost of products sold and SG&A for entities that are consolidated in the segments but accounted for using the equity method for U.S. GAAP) and minority interest adjustments for subsidiaries where we do not have 100% ownership. Because both unconsolidated entities and less than 100 percent owned subsidiaries are managed as integral parts of the Company, they are accounted for similar to a wholly-owned subsidiary for management and segment purposes. This means our segment results recognize 100 percent of each income statement component through before-tax earnings in the segments, with eliminations in Corporate. In determining segment net earnings, we apply the statutory tax rates (with adjustments to arrive at the Company's effective tax rate in Corporate) and eliminate the share of earnings applicable to other ownership interests, in a manner similar to minority interest. Net losses in the Corporate segment improved from -$185 million to -$124 million in the quarter due primarily to lower income taxes and a favorable legal settlement reached during the quarter. Income taxes benefited from the favorable resolution of a foreign tax audit in the current quarter, coupled with a provision taken in the comparable prior year period for tax costs on anticipated dividends originating from foreign subsidiaries. These benefits were partially offset by an increase in net interest expense due to the financing cost of the share repurchase program announced in connection with the Gillette acquisition. Fiscal year to date earnings in the Corporate segment declined by $160 million primarily due to impact of the base period gain on the sale of the Juice business and a current period increase in net interest expense, partially offset by the favorable tax settlement in the current quarter. Cash generated from operating activities for the nine months ended March 31, 2006 was $8.19 billion versus $6.59 billion in the comparable prior year period, an increase of $1.60 billion. Cash increased behind earnings adjusted for non-cash items (primarily depreciation, amortization, share based compensation and deferred income taxes), partially offset by working capital items. Changes in accounts payable, accrued and other liabilities used $582 million of cash due primarily to spending against Gillette accruals. Inventory and accounts receivable increases in support of business growth were both net uses of cash. Both inventory and receivable days on hand were roughly flat over the fiscal year to date period, excluding the impact of Gillette. Investing activities in the current year decreased cash by $607 million, compared to the prior year period when investing activities reduced cash by $1.60 billion. Acquisitions provided a net source of cash. A cash balance of $1.60 billion received in the Gillette acquisition, representing Gillette's cash balances at the acquisition date, was partially offset by cash used for other acquisitions, including settlement of a major portion of the Wella domination liability. Capital expenditures as a percentage of sales were 3.3 percent, in-line with the comparable prior year period. Total cash used by financing activities was $5.36 billion versus $2.39 billion in the comparable base period. Our net debt position increased by $6.76 billion, primarily to fund the share repurchase program associated with the acquisition of Gillette. This was offset by $10.60 billion of treasury purchases during the Our discussion of financial results includes several measures not defined by U.S. GAAP. We believe these measures provide our investors with additional information about the underlying results and trends of the Company, as well as insight to some of the metrics used to evaluate management. When used in MD&A, we have provided the comparable GAAP measure in the discussion. ORGANIC SALES GROWTH. Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions, divestitures and foreign exchange from year-over-year comparisons. We believe this provides investors with a more complete understanding of underlying sales trends by providing sales growth on a consistent basis. The reconciliation of reported sales growth to organic sales for the January - March 2006 quarter and for the fiscal year to date: Acquisition/Divestiture Impact (18)% (13)% FREE CASH FLOW. Free cash flow is defined as operating cash flow less capital spending. We view free cash flow as an important measure because it is one factor in determining the amount of cash available for dividends and discretionary investment. Free cash flow is also one of the measures used to evaluate senior management and is a factor in determining their at-risk FREE CASH FLOW PRODUCTIVITY. Free cash flow productivity is defined as the ratio of free cash flow to net earnings. The Company's long-term target is to generate free cash at or above 90 percent of net earnings. Free cash flow is also one of the measures used to evaluate senior management. The reconciliation of free cash flow and free cash flow productivity is provided below: Operating Capital Free Cash Net Free Cash Flow Cash Flow Spending Flow Earnings Productivity",6662
2006-05-23,8-K,0000080424-06-000074,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) May 23, 2006 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 8.01 OTHER EVENTS The Procter & Gamble Company (the ""Company"") has been advised that A.G. Lafley, Chairman of the Board, President and Chief Executive of the Company, has entered into a stock trading plan designed to comply with Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. Under Rule 10b5-1(c), directors and officers may adopt a prearranged plan or contract for the sale of Company securities under specified conditions and at specified times. Mr. Lafley's plan allows for the sale of a maximum of 80,000 shares of the Company's common stock over a one-year period during the Company's trading ""windows,"" and provides for sales of specified share amounts at specified market prices, subject to specified limitations. Sales pursuant to this plan may begin in February 2007 and will terminate on November 30, 2007, unless terminated sooner in accordance with the plan's terms. This plan was established during the Company's current trading window. Any sales under the plan will comply with the holding period requirement for stock option gains as implemented by the Company's Board of Directors and described in the Company's 2005 Proxy Statement. In addition, Mr. Lafley and the Company will publicly disclose any of his stock sales made under the Rule 10b5-1(c) plan. Except as may be required by law, the Company does not undertake to report stock trading plans by other Company officers or directors, nor to report modifications, transactions or other activities under Mr. Lafley's plan or the plan of any other officer or director.",382
2006-05-24,8-K,0000080424-06-000075,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) May 24, 2006 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On May 24, 2006, The Procter & Gamble Company (the ""Company"") issued a news release concerning certain management changes. A copy of the Company's news release is attached hereto as Exhibit 99 and",168
2006-06-02,8-K,0000080424-06-000081,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 2, 2006 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) On March 11, 2004, The Procter & Gamble Company (the ""Company"") filed a Registration Statement on Form S-3 (Registration No. 333-113515), as amended May 5, 2004 (the ""Registration Statement""). Exhibit 1 of the Registration Statement contained a form of Underwriting Agreement (including form of Delayed Delivery Contract) (the ""Form of Underwriting Agreement""). The Company has now amended the Form of Underwriting Agreement pursuant to the Registration Statement, which is attached hereto as Exhibit 1.1 and",205
2006-06-08,8-K,0000950152-06-004995,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 7, 2006 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification incorporation) Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On June 7, 2006, The Procter & Gamble Company (the ""Company"") confirmed previously announced sales and earnings guidance for the April to June quarter of fiscal year 2005/06. The Company stated that it continued to expect sales growth for the quarter of 20 percent to 24 percent and diluted earnings per share of $0.52 to $0.54. The Company also expects the components of guidance to remain in line with the previously disclosed ranges for the quarter. The Company announced that the release date of final results for the April to June quarter and for fiscal year 2005/06 is scheduled for August 2, The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FORWARD LOOKING STATEMENTS All statements, other than statements of historical fact included in this release, are forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995. In addition to the risks and uncertainties noted in this release, there are certain factors that could cause actual results to differ materially from those anticipated by some of the statements made. These include: (1) the ability to achieve business plans, including with respect to lower income consumers and growing existing sales and volume profitably despite high levels of competitive activity, especially with respect to the product categories and geographical markets (including developing markets) in which the Company has chosen to focus; (2) the ability to successfully execute, manage and integrate key acquisitions and mergers, including (i) the Domination and Profit Transfer Agreement with Wella, and (ii) the Company's merger with The Gillette Company, and to achieve the cost and growth synergies in accordance with the stated goals of the Gillette transaction; (3) the ability to manage and maintain key customer relationships; (4) the ability to maintain key manufacturing and supply sources (including sole supplier and plant manufacturing sources); (5) the ability to successfully manage regulatory, tax and legal matters (including product liability, patent, and other intellectual property matters), and to resolve pending matters within current estimates; (6) the ability to successfully implement, achieve and sustain cost improvement plans in manufacturing and overhead areas, including the Company's outsourcing projects; (7) the ability to successfully manage currency (including currency issues in volatile countries), debt (including debt related to the Company's announced plan to repurchase shares of the Company's stock), interest rate and certain commodity cost exposures; (8) the ability to manage the continued global political and/or economic uncertainty and disruptions, especially in the Company's significant geographical markets, as well as any political and/or economic uncertainty and disruptions due to terrorist activities; (9) the ability to successfully manage competitive factors, including prices, promotional incentives and trade terms for products; (10) the ability to obtain patents and respond to technological advances attained by competitors and patents granted to competitors; (11) the ability to successfully manage increases in the prices of raw materials used to make the Company's products; (12) the ability to stay close to consumers in an era of increased media fragmentation; and (13) the ability to stay on the leading edge of innovation. For additional information concerning factors that could cause actual results to materially differ from those projected herein, please refer to our most recent 10-K, 10-Q and 8-K reports.",673
2006-07-11,8-K,0000080424-06-000094,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) July 11, 2006 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On July 11, 2006, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of thirty-one cents ($0.31) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after August 15, 2006 to shareholders of record at the close of business on July 21, 2006.",203
2006-07-14,8-K,0000080424-06-000095,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) July 14, 2006 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) This Form 8-K provides information on the change in the reporting structure of The Procter & Gamble Company (the ""Company"") and the effects of this change on the Company's historical segment results. The change in segment reporting will be reflected retrospectively but in no way revises or restates the Consolidated Statements of Earnings, Consolidated Balance Sheets, Consolidated Statements of Shareholders' Equity or Consolidated Statements of Cash Flows for the Company and consolidated subsidiaries for any period. In April 2006, the Company announced a number of changes to certain key leadership positions, which resulted in changes to its organization structure and segment reporting. Specifically, Pet Health & Nutrition, which was formerly part of the Health Care segment, became part of the Snacks and Coffee segment. The balance of the Health Care segment was moved under the P&G Beauty Global Business Unit (GBU), but will continue to be reported as a separate segment. In addition, the commercial products group, which primarily sells products to commercial end users, was moved from Snacks and Coffee to the Fabric Care and Home Care segment. Finally, the Adult Incontinence business was moved from Baby Care and Family Care to P&G Beauty. The balance of the Baby Care and Family Care reporting segment was moved from the P&G Family Health GBU to the P&G Household Care GBU and will continue to be reported as a separate reporting segment. In conjunction with these changes, the P&G Beauty GBU was renamed ""Beauty and Health"", the Snacks and Coffee reporting segment was renamed ""Pet Health, Snacks and Coffee"", the P&G Household Care GBU was renamed ""Household Care"" and the Family Health GBU was eliminated. The Company now operates with three Global Business Units and seven reportable segments as summarized in the following GBU REPORTABLE SEGMENT Beauty and Health Beauty Household Care Fabric Care and Home Care Pet Health, Snacks and Coffee Baby Care and Family Care Gillette GBU Blades and Razors All financial statements, beginning in the quarter ending June 30, 2006, will reflect the new segment reporting structure. This change in segment reporting will be reflected on a retrospective basis, with prior years also adjusted to reflect the new segment reporting structure. The Company is issuing this Form 8-K in order to provide investors with historical data that is on a basis consistent with the Company's new segment reporting structure. Exhibits 99-1 and 99-2 provide quarterly business segment information for the nine months ended March 31, 2006 and the fiscal year ended June 30, 2005, respectively. Exhibit 99-3 provides fiscal year financial summary data by reportable segment for the 2003, 2004 and 2005 fiscal years.",566
2006-08-02,8-K,0000080424-06-000096,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) August 2, 2006 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On August 2, 2006, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter and fiscal year ended June 30, 2006. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",183
2006-08-29,10-K,0000950152-06-007291,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION ANNUAL REPORT ON FORM 10-K PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended June 30, 2006 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 the transition period from to Commission File No. 1-434 THE PROCTER & GAMBLE COMPANY One Procter & Gamble Plaza, Cincinnati, Ohio 45202 IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio Securities registered pursuant to Section 12(b) of the Act: of each Exchange on which registered Common Stock, without Par Value Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrants knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Large accelerated filer  Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No  The aggregate market value of the voting stock held by non-affiliates amounted to $190 billion on There were 3,175,086,100 shares of Common Stock outstanding as of July 31, 2006. Documents Incorporated By Reference Portions of the Annual Report to Shareholders for the fiscal year ended June 30, 2006 are incorporated by reference into Part I, Part II and Part IV of this report to the extent described Portions of the Proxy Statement for the 2006 Annual Meeting of Shareholders are incorporated by reference into Part III of this report to the extent described herein. Item 1B. Unresolved Staff Comments. Item 3. Legal Proceedings. Item 4. Submission of Matters to a Vote of Security Holders. Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. Item 6. Selected Financial Data. Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations. Item 7A. Quantitative and Qualitative Disclosures About Market Risk. Item 8. Financial Statements and Supplementary Data. Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure. Item 9A. Controls and Procedures. Item 9B. Other Information Item 10. Directors and Executive Officers of the Registrant. Item 11. Executive Compensation. Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. Item 13. Certain Relationships and Related Transactions. Item 14. Principal Accounting Fees and Services. Additional information required by this item is",538
2006-09-05,8-K,0000080424-06-000133,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 5, 2006 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On September 5, 2006, The Procter & Gamble Company (the ""Company"") issued a news release confirming previously announced sales and earnings guidance for the July to September quarter. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure"".",176
2006-10-10,8-K,0000080424-06-000164,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) October 10, 2006 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On October 10, 2006, The Procter & Gamble Company (the ""Company"") issued a news release with respect to Chairman of the Board, President and Chief Executive A.G. Lafley's address to the shareholders at the Company's annual meeting. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation",183
2006-10-10,8-K,0000080424-06-000165,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) October 10, 2006 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other (Commission File Number) (IRS Employer jurisdiction of Identification One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (513) 983-1100 [ ] Written communications pursuant to Rule 425 under the Securities Act [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On October 10, 2006, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of thirty-one cents ($0.31) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after November 15, 2006 to shareholders of record at the close of business on October 20, 2006. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD",215
2006-10-27,8-K,0000080424-06-000178,"8-K - Commercial Paper Program - 10/27/2006 to Section 13 OR 15(d) of The Securities Exchange Act Of of Report (Date of earliest event reported) name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) material pursuant to Rule 14a-12 under the Exchange communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) into a Material Definitive October 25, 2006, Procter & Gamble International Funding S.C.A. (P&G International Funding), a wholly owned indirect subsidiary of The Procter & Gamble Company (the Company), initiated a commercial paper program under which it may from time to time issue short-term unsecured notes with maturities up to 397 days in an aggregate amount not to exceed $10 billion (the Program). Initial proceeds from the Program will be used to repay a portion of the debt associated with the previously announced $24 billion facility entered on July 27, 2005. The Company has provided an irrevocable unconditional guarantee for notes issued as part of the Program. October 23, 2006, P&G International Funding and the Company entered into (i) an Issuing and Paying Agent Agreement with Citibank, N.A. facilitate the Program and (ii) Commercial Paper Dealer Agreements with each Goldman, Sachs & Co., J.P. Morgan Securities Inc., Merrill Lynch Money Markets Inc. (for notes with maturities up to 270 days), Merrill Lynch, Pierce, Fenner & Smith Incorporated (for notes with maturities from 270 to 397 days), and The Williams Capital Group, L.P, under which each of these banks act as dealer of the commercial paper issued under the Program. time to time, one or more of these banks and/or their affiliates have provided, and may in the future provide, investment banking services to the Company and its subsidiaries or may act as lenders or members a syndicate of lenders to the Company and its subsidiaries. notes have not been and will not be registered under the Securities Act or state securities laws, and may not be offered or sold in United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state laws. information contained in this Current Report on Form 8-K is neither an offer sell nor a solicitation of an offer to buy any securities. of a Direct Financial Obligation or an Obligation under an OffBalance Sheet Arrangement of a information disclosed above under Item 1.01 is incorporated herein by to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf the undersigned hereunto duly authorized. THE PROCTER & GAMBLE COMPANY",463
2006-10-31,8-K,0000080424-06-000180,"8-K - JAS 2006 Earnings Release to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 of Report (Date of earliest event reported) name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area code ) communications pursuant to Rule 425 under the Securities Act (17 material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange OF OPERATIONS AND FINANCIAL CONDITION October 31, 2006, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended September 30, 2006. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Release by The Procter & Gamble Company dated October 31,",169
2006-11-01,10-Q,0000080424-06-000184,"REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES Quarterly Period Ended September 30, 2006 REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES transition period from ___ to ___ name of registrant as specified in its charter) Employer Identification No.) of principal executive offices) telephone number, including area code (513) 983-1100 by check mark whether the registrant (1) has filed all reports filed by Section 13 or 15(d) of the Securities Exchange Act of preceding 12 months (or for such shorter period that the registrant to file such reports), and (2) has been subject to such filing the past 90 days. Yes x No  by check mark whether the registrant is a large accelerated filer, accelerated filer, or a non-accelerated filer (as defined in Rule accelerated filer x Accelerated filer  Non-accelerated by check mark whether the registrant is a shell company (as defined 12b-2 of the Exchange Act). Yes  No x were 3,168,754,493 shares of Common Stock outstanding as of September Consolidated Statements of Earnings of The Procter & Gamble Company and subsidiaries (the Company, we or our) for the three months ended September 30, 2006 and 2005, the Consolidated Balance Sheets as of September June 30, 2006, and the Consolidated Statements of Cash Flows for months ended September 30, 2006 and 2005 follow. In the opinion of these unaudited consolidated financial statements contain all adjustments necessary to present fairly the financial position, results of oprations cash flows for the interim periods reported. However, such financial may not necessarily be indicative of annual results. PROCTER & GAMBLE COMPANY AND in millions except per share amounts non-operating income, net accompanying Notes to Consolidated Financial PROCTER & GAMBLE COMPANY AND SUBSIDIARIES BALANCE SHEETS Amounts in Millions expenses and other current assets PROPERTY, PLANT AND EQUIPMENT AND OTHER INTANGIBLE ASSETS and other intangible assets, net GOODWILL AND OTHER INTANGIBLE ASSETS other comprehensive income LIABILITIES AND SHAREHOLDERS' EQUITY accompanying Notes to Consolidated Financial Statements PROCTER & GAMBLE COMPANY AND SUBSIDIARIES AND CASH EQUIVALENTS, BEGINNING OF PERIOD payable, accrued and other liabilities operating assets and liabilities of stock options and other OF EXCHANGE RATE CHANGES ON CASH IN CASH AND CASH EQUIVALENTS AND CASH EQUIVALENTS, END OF PERIOD accompanying Notes to Consolidated Financial Statements PROCTER & GAMBLE COMPANY AND SUBSIDIARIES TO CONSOLIDATED FINANCIAL STATEMENTS statements should be read in conjunction with the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2006. The operations for the three-month period ended September 30, necessarily indicative of annual Income - Total comprehensive income is composed primarily net currency translation gains and losses, impacts of net cash flow hedges and net unrealized gains and losses on comprehensive income for the three months ended September 2005 was $2,663 million and $2,110 million, Information - Following is a summary of segment results. 4, the Company acquired The Gillette Company on October Accordingly, results of the acquired Gillette businesses in segment results for the three months ended September Months Ended September 30 Health, Snacks and Coffee completed our acquisition of The Gillette Company 1, 2005. Accordingly, the operating results of the Gillette reported in our financial statements beginning October following table provides pro forma results of operations months ended September 30, 2005, as if Gillette had been the beginning of the fiscal year presented. The pro forma certain purchase accounting adjustments such as the changes depreciation and amortization expense on acquired tangible assets. However, pro forma results do not include any anticipated savings or other effects of the planned integration of Accordingly, such amounts are not necessarily indicative the acquisition had occurred on the dates indicated or Net Earnings per Common Share the current period, we completed the allocation of the purchase price individual assets acquired and liabilities assumed. To assist management allocation, we engaged valuation specialists to prepare independent The following table presents the completed allocation of purchase to the Gillette business as of the date of the acquisition. Gillette acquisition resulted in $35.30 billion in goodwill, allocated to the segments comprising the Gillette businesses (Blades and Razors; and Braun; Health Care and Beauty). A of the goodwill has also been allocated to the other segments on certain cost synergies will benefit these businesses. purchase price allocation to the identifiable intangible assets included these financial statements is as follows: Assets with Determinable Lives majority of the intangible asset valuation relates to brands. Our to brands that have an indefinite life and those that have a definite based on a number of factors, including the competitive environment, share, brand history, product life cycles, operating plan and macroeconomic environment of the countries in which the brands are sold. The indefinite-lived brands include Gillette, Venus, Duracell, Oral-B and Braun. The definite-lived brands include certain brand sub-names, such as MACH 3 and Sensor Gillette Blades and Razors business, and other regional or local definite-lived brands have asset lives ranging from 10 to 40 years. and technology intangibles are concentrated in the Blades and Razors Care businesses and have asset lives ranging from 5 to 20 years. customer relationship intangible asset useful lives ranging from reflect the very low historical and projected customer attrition Gillettes major retailer and distributor customers. the current period, we also completed our analysis of integration pursuant to which the Company will incur costs primarily related elimination of selling, general and administrative overlap between companies in areas like Global Business Services, corporate staff go-to-market support, as well as redundant manufacturing capacity. as an assumed liability for Gillette exit costs of $1.23 billion, million in separations related to approximately 5,500 people, $55 employee relocation costs and $320 million in other exit costs. We activities to be substantially complete by June 30, 2008. and Other Intangible Assets - Goodwill as of September allocated by reportable segment and global business unit Months Ended September 30, 2006 Beauty & Health Care, beginning of year Care and Family Care, beginning of year Care and Home Care, beginning of year Health, Snacks and Coffee, beginning of year Household Care, beginning of year and Razors, beginning of year and Braun, beginning of year Gillette Business Unit, beginning of year increase in goodwill from June 30, 2006 is primarily due to the finalization the allocation of the purchase price relating to the acquisition intangible assets as of September 30, 2006 are comprised of (amounts intangible assets with determinable lives assets with indefinite lives identifiable intangible assets intangible assets consist principally of brands, patents, technology, customer relationships. The non-amortizable intangible assets consist amortization expense of intangible assets for the three months ended 30, 2006 and 2005 was $163 million and $49 million, respectively. to SFAS 123(R) Share-Based Payment, companies must recognize the cost of employee services received in exchange for awards of based on the grant-date fair value of those awards (the share-based compensation for the three months ended September 30, are summarized in the following table (amounts in millions): utilized in the model are evaluated and revised, as necessary, to conditions and experience. Benefits - The Company offers various postretirement employees. Additional information about these benefits Note 9, Postretirement Benefits and Employee Stock appears on pages 55-59 of the Annual Report to Shareholders year ended June 30, 2006, which can be found by reference the Company's Annual Report on Form 10-K for the fiscal components of net periodic benefit cost are as follows: of Prior Service Cost and Prior Transition Amount Periodic Benefit Cost (Credit) year ending June 30, 2007, the expected return on plan assets is for defined benefit and other retiree benefit plans, respectively. July 2006, the FASB issued FIN 48, Accounting for Uncertainty in Income Taxes. FIN 48 addresses the accounting and disclosure of uncertain tax positions. We will adopt 2007. We are evaluating the impact, if any, that FIN September 2006, the FASB issued SFAS 157, Fair Value Measurements, which established a framework for measuring fair value and will be effective July 1, 2008. We are evaluating the impact, if any, that SFAS 157 our financial statements. September 2006, the FASB issued SFAS 158, Employers Accounting for Defined Benefit Pension and Other Postretirement Plans. SFAS 158 requires companies to recognize the over-funded and under-funded status of defined benefit other postretirement plans as assets or liabilities on their balance to recognize changes in that funded status, in the year in which through other comprehensive income in shareholders equity As of June 30, 2006, our unrecognized defined benefit pension and other postretirement liabilities, consisting primarily of unrecognized actuarial losses service costs totaled $880 million. We will adopt SFAS 158 as of new accounting pronouncement issued or effective during the fiscal is expected to have a material impact on the consolidated financial Discussion and Analysis of Financial Condition and Results purpose of this discussion is to provide an understanding of P&G's financial results and condition by focusing on changes in certain key measures to year. Managements Discussion and Analysis (MD&A) is organized in of Operations - Three Months Ended September 30, 2006 Segment Discussion - Three Months Ended September 30, 2006 MD&A, we refer to measures used by management to evaluate performance including unit volume growth, net outside sales and after-tax profit. refer to organic sales growth (net sales growth excluding the impacts acquisitions, divestitures and foreign exchange), free cash flow flow productivity. These financial measures are not defined under principles generally accepted in the United States of America (U.S. explanation of these measures at the end of MD&A provides more details on the use and the derivation of these measures. Management also uses market share and market consumption estimates to evaluate performance to competition despite some limitations on the availability and comparability share information. References to market share and market consumption are based on a combination of vendor-reported consumption and market as well as internal estimates. October 1, 2005, we completed the acquisition of The Gillette Company billion. Gillette is a leading consumer products company that had of sales in its most recent pre-acquisition year ended December to provide our investors with more insight into the results of Razors and the Duracell and Braun reporting segments, we have previously provided supplemental pro forma net sales and earnings data for for the quarter ended September 30, 2005 (as presented in our Form November 22, 2005). Managements discussion of the current year results of these two reportable segments is in relation to such comparable prior net sales and earnings data. Results of Gillettes personal care and oral care businesses were subsumed within the Beauty and the Health Care business is focused on providing branded consumer products. Our goal is to provide products of superior quality and improve the lives of the world's consumers. We believe this will leadership sales, profits and value creation, allowing employees, and the communities in which we operate to prosper. products are sold in more than 180 countries primarily through merchandisers, grocery stores, membership club stores and drug also expanded our presence in ""high frequency stores,"" the neighborhood which serve many consumers in developing markets. We compete in multiple product categories and have three global business (GBUs): Beauty and Health, Household Care and Gillette GBU. Under Accepted Accounting Principles, the business units comprising the aggregated into seven reportable segments: Beauty; Health Care; Home Care; Baby Care and Family Care; Pet Health, Snacks and Coffee; Razors; and Duracell and Braun. We have on-the-ground operations countries through our Market Development Organization, which leads business teams to build our brands in local markets and is organized geographic areas: North America, Western Europe, Northeast Asia, Central and Eastern Europe/Middle East/Africa, Greater China and following table provides the percentage of net sales and net earnings reportable business segment for the three months ended September (excludes net sales and net earnings in Corporate): Health, Snacks and Coffee are highlights of results for the three months ended September volume increased 23 percent during the quarter. Organic excludes the impacts of acquisitions and divestitures, percent. Growth was broad-based with every reportable segment sales grew 27 percent to $18.79 billion, including the Gillette. Organic sales, which exclude the impacts of acquisitions, divestitures and foreign exchange, increased six earnings increased 33 percent to $2.70 billion for the earnings increased behind the addition of Gillette, sales base business and profit margin net earnings per share were $0.79, an increase of three comparable prior year period, including an estimated $0.05 dilution impact from the Gillette cash flow was $2.95 billion, an increase of 36 percent year period. Free cash flow productivity was 88 percent, year level. Free cash flow productivity is defined as the operating cash flow less capital expenditures to net discuss expectations regarding future performance, events and outcomes, our business outlook and objectives, in annual and quarterly reports, releases and other written and oral communications. All such statements, for historical and present factual information, are ""forward-looking statements,"" and are based on financial data and our business plans only as of the time the statements are made, which may become out-of-date incomplete. We assume no obligation to update any forward-looking a result of new information, future events or other factors. Forward-looking statements are inherently uncertain, and investors must recognize could be significantly different from our expectations. to Achieve Business Plans. consumer products company and rely on continued demand for our products. To achieve business goals, we must develop and sell products appeal to consumers and retail trade customers. Our continued success dependent on leading-edge innovation, with respect to both products operations. This means we must be able to obtain patents and respond technological advances and patents granted to competition. Our dependent on effective sales, advertising and marketing programs increasingly fragmented media environment. Our ability to innovate in these areas will determine the extent to which we are able to sales and volume profitably, especially with respect to the product and geographic markets (including developing markets) in which focus. There are high levels of competitive activity in the environments which we operate. To address these challenges, we must respond factors, including pricing, promotional incentives and trade terms. manage each of these factors, as well as maintain mutually beneficial relationships with our key customers, in order to effectively compete achieve our business plans. Since our goals include a growth component acquisitions, we must manage and integrate key acquisitions, such Gillette and Wella acquisitions, including achieving the cost and synergies in accordance with stated goals. costs are subject to fluctuations, particularly due to changes prices, raw materials, cost of labor, foreign exchange and interest Therefore, our success is dependent, in part, on our continued these fluctuations through pricing actions, cost savings projects, decisions and certain hedging transactions. We also must manage currency exposure, especially in volatile countries. We need to manufacturing and supply arrangements, including sole supplier manufacturing plant arrangements. We must implement, achieve and improvement plans, including our outsourcing projects and those general overhead and work force rationalization. changes, terrorist activity and political unrest may result in interruption, inflation, deflation or decreased demand for our success will depend in part on our ability to manage continued and/or economic uncertainty, especially in our significant geographic as well as any political or economic disruption due to terrorist in laws, regulations and the related interpretations may alter in which we do business. This includes changes in environmental, product-related laws, as well as changes in accounting standards requirements. Accordingly, our ability to manage regulatory, tax matters (including product liability, patent and intellectual property as well as those related to the integration of Gillette and its resolve pending matters within current estimates may impact our OF OPERATIONS - Three Months Ended September 30, 2006 following discussion provides a review of results for the three September 30, 2006 versus the three months ended September 30, PROCTER & GAMBLE COMPANY AND SUBSIDIARIES in Millions Except Per Share Amounts) GENERAL & ADMINISTRATIVE EXPENSE NON-OPERATING INCOME, NET DILUTED SHARES OUTSTANDING GENERAL & ADMINISTRATIVE EXPENSE for the quarter increased 27 percent to $18.79 billion behind 23 percent volume growth. Organic sales increased six percent, at the top-end of the Companys long-term organic sales growth target range of four to six percent. Price increases taken across several segments added one sales growth. Mix added two percent to sales growth. Growth behind premium-priced product initiatives and the addition of Gillette, higher average unit selling prices than the Company average, more growth in developing regions, where average unit selling prices Company average. Foreign exchange had a positive one percent impact increased 23 percent globally during the quarter behind base business the addition of Gillette, which benefited from the launch of Fusion markets around the globe. Organic volume was up five percent. Each segment delivered year-on-year organic volume growth led by successful initiatives including Olay Definity, Crest Pro Health, Tide Simple Febreze Noticeables, Pantene Color Expressions, Head & Shoulders and Herbal Essences restages, and Folgers Gourmet Selections and Simply Sales Change Drivers vs. Year Ago (July-September Quarter with Acquisitions & Divestitures excluding Acquisitions & Divestitures Health, Snacks and Coffee percentage changes are approximations based on quantitative formulas consistently applied. Total Company mix impact driven largely by the addition of Gillette. margin expanded 120-basis points in the quarter to 52.8% of net and energy cost increases had a negative impact on gross margin 100-basis points. Scale leverage from organic volume growth, price cost savings projects more than offset the commodity cost increases. benefit of adding the Gillette business added approximately 115-basis gross margin due to above Company average margins in the Blades selling, general and administrative expenses (SG&A) increased 28%, or $1.29 billion, during the quarter primarily due to the addition of Gillette. addition of Gillette accounted for approximately $1.08 billion increase in the period, including approximately $160 million of acquisition-related expenses. The acquisition-related expenses million of increased intangible asset amortization resulting from intangible assets in the opening balance sheet of the acquired business. The balance of the acquisition-related expenses was comprised primarily of integration costs, legal and consulting fees. Total percentage of net sales increased by 30-basis points during the by a 100-basis point increase from the Gillette impacts. Overhead percentage of net sales was down on our base business, but increased to the addition of Gillette (including acquisition-related expenses). spending was down 20-basis points during the quarter driven largely impact of adding the Gillette business, which benefited from significant purchasing synergies during the quarter. expense for the quarter increased by $139 million versus the prior The increase was driven by the financing cost of the previously repurchase program associated with the Gillette acquisition. We repurchased $0.3 billion of P&G stock under the program during the quarter to complete the program, bringing cumulative shares repurchased program since its inception to $20.1 billion. non-operating income increased during the quarter by $106 million base year period primarily as a result of the gains of the sale America and Sure and higher interest income during the quarter. earnings increased 33 percent to $2.70 billion behind organic sales impacts from the addition of Gillette, including financing and acquisition-related expenses, and profit margin expansion. net earnings per share were $0.79, up three percent versus the including an estimated $0.05-$0.06 per share of dilution from the SEGMENT DISCUSSION- Three Months Ended September 30, following discussion provides a review of results by business segment. analysis of the results for the three months ended September 30, provided compared to the same three month period ended September primary financial measures used to evaluate segment performance and net earnings. The table below provides supplemental information and net earnings by business segment for the three months ended 2006 versus the comparable prior year period: Months Ended September 30, 2006 net sales grew 11 percent during the quarter to $5.60 billion. up eight percent behind growth across most categories as well as Gillette personal care. Organic volume increased five percent behind double-digit growth on Pantene, Head & Shoulders and Olay and high-single digit growth on Always. Skin care volume was up double-digits behind initiatives on the Olay brand including the launch of Olay Definity continued growth on Olay Regenerist. Feminine care volume increased digits due to market share growth on Always and Tampax behind the and Fresh initiatives and product upgrades on Tampax Pearl. Retail organic volume increased high-single digits behind product initiatives the globe on Pantene, Head & Shoulders and Herbal Essences. Cosmetics volume was in-line with the base year period as more focused distribution in North America was offset by growth in the remaining regions. hair care volume declined as growth in North America and Latin than offset by softness in Europe. Price increases, primarily in feminine care added one percent to sales growth, while favorable exchange had a two percent impact. Beauty organic sales were up during the quarter. Net earnings increased 11 percent to $872 million sales growth. Net earnings margin was in-line with the prior year benefits of sales growth were largely offset by the impact of the temporary suspension of SK-II in mainland China. The Company expects shipments of SK-II in China in the near future. Care net sales increased 32 percent to $2.23 billion. Volume grew 28 percent behind the addition of Gillette oral care and organic growth care and Vicks. Organic sales increased four percent during the care organic sales grew double-digits behind the launch of Crest toothpaste. Pharmaceuticals and personal health organic sales were digits due primarily to a base period trade inventory build on which was largely offset by current-year market share growth on Vicks. Pricing on Actonel, Prilosec OTC and Vicks added two percent to sales growth while favorable product mix and foreign exchange each percent to sales growth. Net earnings grew 23 percent to $385 million organic sales growth and the addition of Gillette oral care. Net increased on the base P&G business, but was down 120-basis points overall primarily due to the mix impact of adding Gillette oral care. Care and Home Care net sales increased nine percent during the billion. Net sales increased behind eight percent volume growth. was broad-based across regions with mid-single digit increases regions and double-digit growth across each developing region. and home care grew volume high-single digits behind product initiatives Tide Simple Pleasures, Gain Joyful Expressions, Febreze Noticeables, Swiffer and the launch of Fairy auto-dishwashing in the U.K. and impact of previously executed price increases, primarily in Latin care and in North America dish care, added one percent to sales. negative one percent impact as growth on premium-priced initiatives than offset by disproportionately higher growth in developing regions, have a lower average selling price than the balance of the segment. foreign exchange added one percent to sales growth. Net earnings percent to $754 million behind sales growth and a 65-basis point net earnings margin. Margin improved as the scale benefits of volume cost savings programs on manufacturing and overhead costs more commodity cost increases and higher marketing investments to support and Family Care net sales increased five percent to $3.10 billion volume growth of four percent during the quarter. Baby care volume mid-single digits with developing regions up double-digits behind growth in Greater China and in Central and Eastern Europe. In developed growth on Pampers Baby Stages of Development in North America and was offset by softness on Luvs in North America and Pampers Pants Europe. Family care volume increased low-single digits behind product initiatives on Puffs and Charmin and continued growth on Bounty Basics. Price increases taken since the year ago period in North care added one percent to sales growth while disproportionate growth developing regions led to a negative one percent mix impact. Favorable exchange added one percent to sales growth. Net earnings in Baby Care increased 20 percent during the quarter to $383 million. Earnings behind sales growth and a 150-basis point improvement in earnings Earnings margin expansion was driven by improved gross margins pricing and cost savings projects more than offset increased commodity Health, Snacks and Coffee Health, Snacks and Coffee net sales increased 10 percent during $1.06 billion. Volume grew five percent following a base period significant reduction in the coffee business from Hurricane Katrina. volume increased more than 50 percent during the quarter as a result of the base period impact of Katrina coupled with the recent launches Smooth and Gourmet Selections. Volume growth on coffee was partially volume decline in snacks due to customer inventory adjustments following the World Cup soccer merchandising events and competitive the U.K. and North America. Pet health delivered low-single digit behind the Iams brand. Disproportionately high coffee growth drove five percent mix impact on sales while favorable foreign exchange percent to sales. These were partially offset by a negative one impact on coffee. Net earnings increased 14 percent to $87 million quarter. Earnings increased year-on-year primarily due to sales base period impacts related to Hurricane Katrina. disclosed in Note 4 to the consolidated financial statements, we acquisition of The Gillette Company on October 1, 2005. This acquisition resulted in two new reportable segments for the Company: Blades Duracell and Braun. The Gillette oral care and personal care businesses subsumed within the Health Care and Beauty reportable segments, Because the acquisition was completed in October 2005, there are these segments in our base July-September 2005 period. to provide our investors with more insight into the results of Razors and Duracell and Braun reporting segments, we have previously supplemental pro forma net sales and earnings data for these segments quarter ended September 30, 2005 (as presented in our Form 8-K 22, 2005). Managements discussion of the current quarter results of these two segments is in relation to such comparable prior year pro forma earnings data. With respect to the earnings data, this analysis earnings before income taxes. The previously disclosed Blades and Duracell and Braun pro forma information reconciled Profit from Operations, the measure used by Gillette in its historical filings, to Earnings Income Taxes, the comparable measure used by the Company. Gillette did not expense to its reporting segments. in Blades and Razors increased 12 percent to $1.30 billion versus forma results, largely behind the launch of Fusion in certain key the globe. Global consumption for Gillette Blades and Razors was during the quarter. Net sales also increased behind pipeline customer builds to support the Fusion launch in the U.K, Germany and Japan. volume/mix increased ten percent during the quarter, including shipments. Promotion pricing activity to support the Fusion launch growth by one percent. Favorable foreign exchange added three percent growth. Earnings before income taxes increased 18 percent to $450 the published prior year pro forma results, including $88 million acquisition-related charges that negatively impacted earnings before taxes by 23 percent. The acquisition-related charges primarily increased amortization charges from revaluing intangible assets balance sheet. Earnings grew as a result of sales growth, synergy base period asset write-offs, partially offset by the purchase adjustments. Net earnings were $337 million for the quarter. in Duracell and Braun increased seven percent to $976 million versus pro forma results. In Duracell, sales increased mid-single digits Sales growth in Latin America resulting from successful expansion customer channels more than offset a slight decline in Western competitive activity from both private label and branded competitors. sales increased double-digits behind new product launches in certain across the globe. The launch of 360 Complete and Contour razors and Pulsonic razors in Germany more than offset softness in Western household appliances. Overall, volume/mix in the Duracell and Braun increased five percent. Favorable foreign exchange added two percent growth. Earnings before income taxes were down one percent to $151 versus the published prior year pro forma results, primarily due of acquisition-related charges that negatively impacted earnings taxes by five percent. The acquisition-related charges primarily increased amortization charges from revaluing intangible assets balance sheet. The earnings impact from strong sales growth was by the negative impact of higher commodity and energy costs. Net $95 million for the quarter. includes certain operating and non-operating activities not allocated specific business units. These include: the incidental businesses corporate level, financing and investing activities, certain restructuring charges, other general corporate items including the historical certain divested categories, including certain Gillette brands divested in fiscal 2006 as required by the regulatory authorities the Gillette acquisition. Corporate also includes reconciling items the accounting policies used in the segments to U.S. GAAP. The reconciling items include income taxes (to adjust from statutory reflected in the segments to the overall Company effective tax adjustments for unconsolidated entities (to eliminate sales, cost sold and SG&A for entities that are consolidated in the segments but accounted for using the equity method for U.S. GAAP) and minority adjustments for subsidiaries where we do not have 100% ownership. unconsolidated entities and less than 100% owned subsidiaries are integral parts of the Company, they are accounted for similar to subsidiary for management and segment purposes. This means our recognize 100% of each income statement component through before-tax the segments, with eliminations for unconsolidated entities in determining segment net earnings, we apply the statutory tax rates adjustments to arrive at the Companys effective tax rate in Corporate) and eliminate the share of earnings applicable to other ownership interests, manner similar to minority interest. decline in net earnings for the quarter was primarily driven by interest expenses and higher restructuring and integration costs, offset by the gain on the sale of Pert in North America and Sure. expense was up due to the financing costs of the share repurchase announced in connection with the Gillette acquisition. The increase restructuring and integration expense is related to costs incurred the Gillette integration. generated from operating activities for the three months ended 2006 was $2.95 billion versus $2.17 billion in the comparable prior an increase of $780 million. Cash increased behind earnings, adjusted non-cash items (primarily depreciation, amortization, share based and deferred income taxes), offset by working capital increases business growth. Inventory increased to support business growth launches. Accounts receivable was up largely due to a high level shipments in several key markets, including shipments related to Fusion. The inventory and accounts receivable increases were partially the cash flow impacts from an increase in accounts payable, accrued liabilities driven primarily by the timing of tax payments in the and accounts receivable days on hand increased by four days and respectively, versus the base year period due the mix impact of Gillette business, which carries higher inventory and accounts activities in the current year used $448 million, compared to the period cash use of $1.57 billion that included $1.18 billion in funding related primarily to the settling of a major portion of Domination liability. Capital expenditures were $570 million during or 3.0 percent of net sales. cash used by financing activities was $2.51 billion during the purchased $1.36 billion of treasury shares during the period and debt position by $550 million. discussion of financial results includes several measures not defined GAAP. We believe these measures provide our investors with additional information about the underlying results and trends of the Company, insight to some of the metrics used to evaluate management. When MD&A, we have provided the comparable GAAP measure in the discussion. sales growth is a non-GAAP measure of sales growth excluding the acquisitions, divestitures and foreign exchange from year-over-year We believe this provides investors with a more complete understanding underlying sales trends by providing sales growth on a consistent reconciliation of reported sales growth to organic sales for the cash flow is defined as operating cash flow less capital spending. cash flow as an important measure because it is one factor in determining amount of cash available for dividends and discretionary investment. flow is also one of the measures used to evaluate senior management factor in determining their at-risk compensation. cash flow productivity is defined as the ratio of free cash flow earnings. The Companys long-term target is to generate free cash at or above 90 percent of net earnings. Free cash flow is also one of the measures evaluate senior management. The reconciliation of free cash flow flow productivity is provided below: and Qualitative Disclosures about Market Risk. have been no material changes in the Companys exposure to market risk since June 30, 2006. Additional information can be found in section entitled Other Information, which appears on pages 39-40, Risk Management Activities, which appears on pages 52-53 of the Annual Shareholders for the fiscal year ended June 30, 2006 which can be reference to Exhibit 13 of the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2006. of Disclosure Controls and Procedures. Companys Chairman of the Board, President and Chief Executive, A. G. Lafley, and the Companys Chief Financial Officer, Clayton C. Daley, Jr., performed an evaluation of the Companys disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 Act)) as of the end of the period covered by this report. Messrs. Lafley Daley have concluded that the Companys disclosure controls and procedures were in Internal Control Over Financial Reporting. were no changes in our internal control over financial reporting during the Companys fiscal quarter ended September 30, 2006 that have materially affected, or are reasonably likely to materially affect, Companys internal control over financial reporting. Company is subject, from time to time, to certain legal proceedings arising out of our business, which cover a wide range of matters, antitrust and trade regulation, product liability, advertising, contracts, environmental issues, patent and trademark matters, and taxes. In French authorities, in connection with an inquiry into potential violations in France, entered the premises of a number of consumer companies operating there, including two of the Companys French subsidiaries, and seized a variety of documents. No formal claim has been made Company or our French subsidiaries in connection with the seizure documents. The Company cannot predict what, if any, financial impact from this situation. The Companys policy is to comply with all laws and regulations, including all antitrust and competition laws. discussion of the Companys risk factors, please refer to Part 1, Item 1A. Risk Factors in the Company's Annual Report on Form 10-K for the fiscal year ended Sales of Equity Securities and Use of Proceeds. PURCHASES OF EQUITY SECURITIES Number of Shares Purchased (1) Number of Shares Purchased as Part of Publicly Announced The number of shares purchased other than through a publicly repurchase plan were 21,576,233 for the quarter. This includes 3,844,253 shares acquired by the Company under compensation and benefit plans, including those purchased by P&G's Profit Sharing Trust. The Company administers cashless exercises through an independent, third party broker repurchase stock in connection with cashless Average price paid per share is calculated on a settlement July 21, 2006, the Company completed its share buyback announced on January 28, 2005 in connection with the Gillette acquisition. Total shares repurchased under to $20.1 billion which was consistent with our stated estimate of about $20 billion. The Company expects repurchase of shares will be made on a discretionary basis as part of the Company's overall strategy, which also includes capital expenditures, dividends, debt service, and strategic of Matters to a Vote of Security Holders. Company's 2006 Annual Meeting of Shareholders held on October 10, following actions were taken: following Directors were elected for terms of office expiring in to the terms of the Notice of Annual Meeting and Proxy received were voted, unless authority was withheld, in the election of the five nominees addition, the following Directors continued to serve as Directors proposal by the Board of Directors to ratify the appointment of Deloitte Touche LLP as the Company's independent registered public accounting conduct the annual audit of the financial statements of the Company subsidiaries for the fiscal year ending June 30, 2007, was approved shareholders. The shareholders cast 2,683,028,940 votes in favor proposal and 55,871,866 votes against. There were 28,931,061 proposal by the Board of Directors to approve an amendment to the of Regulations to decrease the authorized number of Directors on approved by the shareholders. The shareholders cast 2,718,179,781 of this proposal and 20,264,184 votes against. There were 29,387,902 proposal by the Board of Directors to reapprove and amend the materials the performance criteria under The Procter & Gamble 2001 Stock and Incentive Compensation Plan was approved by the shareholders. The shareholders 2,595,364,099 votes in favor of this proposal and 129,128,198 votes There were 43,339,570 abstentions. shareholder resolution proposed by Mrs. Evelyn Y. Davis was defeated shareholders. The proposal requested that the Board of Directors necessary steps to award no new stock options. The Board opposed The shareholders cast 107,539,196 votes in favor of the resolution 2,106,098,156 against. There were 49,934,848 abstentions and 504,259,667 broker non-votes. these actions occurred following the first quarter, the Company is including this information here. Articles of Incorporation (Incorporated by reference the Companys Form 10-Q for the quarter ended September 30, (as amended by shareholders at the annual meeting on Procter & Gamble 2001 Stock and Incentive Compensation Plan (as amended on October 10, 2006) which was adopted by shareholders annual meeting on October 9, 2001.* Short Term Achievement Reward Program and Business Growth related correspondence and terms and conditions.* Revolving Credit Agreement among Procter & Gamble International S.a.r.l and a syndicate of banks led by Citigroup. Gillette Company Executive Life Insurance Program.* Gillette Company Personal Financial Planning Reimbursement Gillette Company Senior Executive Financial Planning Gillette Company Estate Preservation Plan.* Gillette Company Deferred Compensation Plan.* of Commercial Paper Dealer Agreement in connection with commercial paper program initiated by Procter & Gamble International of Issuing and Paying Agent Agreement in connection with commercial paper program initiated by Procter & Gamble International of Ratio of Earnings to Fixed Charges. 13a-14(a)/15d-14(a) Certifications. * Compensatory plan or arrangement to the requirements of the Securities Exchange Act of 1934, the Registrant duly caused this Report to be signed on its behalf by the undersigned VALARIE L. SHEPPARD_____________ President and Comptroller Articles of Incorporation (Incorporated by reference the Companys Form 10-Q for the quarter ended September 30, (as amended by shareholders at the annual meeting on Procter & Gamble 2001 Stock and Incentive Compensation Plan (as amended on October 10, 2006) which was adopted by shareholders annual meeting on October 9, 2001. Short Term Achievement Reward Program and Business Growth related correspondence and terms and conditions. Revolving Credit Agreement among Procter & Gamble International S.a.r.l and a syndicate of banks led by Citigroup. Gillette Company Executive Life Insurance Program. Gillette Company Personal Financial Planning Reimbursement Gillette Company Senior Executive Financial Planning Gillette Company Estate Preservation Plan. Gillette Company Deferred Compensation Plan. of Commercial Paper Dealer Agreement in connection with commercial paper program initiated by Procter & Gamble International of Issuing and Paying Agent Agreement in connection with commercial paper program initiated by Procter & Gamble International of Ratio of Earnings to Fixed Charges. 13a-14(a)/15d-14(a) Certifications.",6436
2006-12-14,8-K,0000080424-06-000204,"8-K - Mid-Qtr Update OND 2006 13 OR 15(d) of The Securities Exchange Act Of 1934 Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act communications pursuant to Rule 13e-4(c) under the Exchange Act 7.01 REGULATION FD DISCLOSURE 2006, The Procter & Gamble Company (the ""Company"") issueda news release confirming previously announced sales and earnings guidance for the October December quarter. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure"". requirements of the Securities Exchange Act of 1934, the Registrant has caused this Report to be signed on its behalf by the undersigned hereunto Release by The Procter & Gamble Company dated December 14,",153
2006-12-15,8-K,0000080424-06-000208,"8-K - Senior Executive Officer Recoupment Policy 13 OR 15(d) of The Securities Exchange Act Of 1934 Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act material pursuant to Rule 14a-12 under the Exchange Act communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange 5.02(e) COMPENSATORY ARRANGEMENT OF CERTAIN OFFICERS 2006, the Compensation and Leadership Development Committee of Directors of The Procter & Gamble Company (the Company) adopted a Senior Executive Recoupment Policy (the Recoupment Policy) to be effective January 1, 2007. A copy of the Recoupment Policy is attached hereto as Exhibit",125
2007-01-09,8-K,0000080424-07-000002,"8-K - Dividend Announcement on 01/09/2007 to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 of Report (Date of earliest event reported) name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area code ) communications pursuant to Rule 425 under the Securities Act material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange ITEM 7.01 REGULATION January 9, 2007, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of thirty-one cents ($0.31) per share on the Common the Series A and Series B ESOP Convertible Class A Preferred Company, payable on or after February 15, 2007 to shareholders at the close of business on January 19, 2007. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD to the requirements of the Securities Exchange Act of 1934, the has duly caused this Report to be signed on its behalf by the hereunto duly authorized. Release by The Procter & Gamble Company dated January 9,",194
2007-01-10,8-K,0000080424-07-000004,"8-K - Realignment of Gillette GBUs to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 of Report (Date of earliest event reported) name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area code ) communications pursuant to Rule 425 under the Securities material pursuant to Rule 14a-12 under the Exchange Act (17 communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange ITEM 7.01 REGULATION January 10, 2007, The Procter & Gamble Company (the ""Company"") announced an internal realignment involving the Gillette Unit (GBU) and associated management changes. Effective July Company is combining its Gillette blades and razors and Braun and realigning them with the Beauty and Health GBU. The Company realign its Duracell business with the Household Care GBU. Company also announced certain management changes in connection currently presidentglobal grooming, will be elected to group president, continuing to lead Gillette global grooming and reporting Arnold, vice chairmanBeauty and Health. will continue as president of Braun, reporting to Mr. Bergh. F. Dooley will continue as president of Duracell, reporting to Bruce L. Byrnes, vice impacts of this realignment on segment reporting will be disclosed at a later date. Company is furnishing this 8-K pursuant to Item 7.01, Regulation FD Disclosure. statements, other than statements of historical fact included in this release, are forward-looking statements, defined in the Private Securities Litigation Reform Act statements are based on financial data, market assumptions plans available only as of the time the statements are become out of date or incomplete. We assume no obligation forward-looking statement as a result of new information, other factors. Forward-looking statements are inherently investors must recognize that events could differ significantly expectations. In addition to the risks and uncertainties release, there are certain factors that could cause actual differ materially from those anticipated by some of the These include: (1) the ability to achieve business plans, respect to lower income consumers and growing existing profitably despite high levels of competitive activity, respect to the product categories and geographical markets developing markets) in which the Company has chosen to ability to successfully execute, manage and integrate key mergers, including (i) the Domination and Profit Transfer Wella, and (ii) the Companys merger with The Gillette Company, and to achieve the cost and growth synergies in accordance with of these transactions; (3) the ability to manage and maintain relationships; (4) the ability to maintain key manufacturing sources (including sole supplier and plant manufacturing ability to successfully manage regulatory, tax and legal (including product liability, patent, and intellectual well as those related to the integration of Gillette and subsidiaries), and to resolve pending matters within current (6) the ability to successfully implement, achieve and improvement plans in manufacturing and overhead areas, Company's outsourcing projects; (7) the ability to successfully currency (including currency issues in volatile countries), rate and commodity cost exposures; (8) the ability to manage global political and/or economic uncertainty and disruptions, in the Company's significant geographical markets, as well political and/or economic uncertainty and disruptions due activities; (9) the ability to successfully manage competitive including prices, promotional incentives and trade terms (10) the ability to obtain patents and respond to technological attained by competitors and patents granted to competitors; ability to successfully manage increases in the prices used to make the Company's products; (12) the ability to consumers in an era of increased media fragmentation; and to stay on the leading edge of innovation. For additional concerning factors that could cause actual results to materially from those projected herein, please refer to our most recent to the requirements of the Securities Exchange Act of 1934, has duly caused this Report to be signed on its behalf by hereunto duly authorized.",629
2007-01-30,8-K,0000080424-07-000008,"8-K - Earnings Release - OND 2006 to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 of Report (Date of earliest event reported) name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area code ) communications pursuant to Rule 425 under the Securities Act material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange OF OPERATIONS AND FINANCIAL CONDITION January 30, 2007, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended 2006. The Company is furnishing this 8-K pursuant to Item 2.02, of Operations and Financial to the requirements of the Securities Exchange Act of 1934, the has duly caused this Report to be signed on its behalf by the hereunto duly authorized. Release by The Procter & Gamble Company dated January 30,",164
2007-01-31,10-Q,0000080424-07-000010,"(MD&A) is organized in of Operations - Three Months Ended December 31, of Operations ---- Six Months Ended December Segment Discussion - Three and Six Months Ended MD&A, we refer to measures used by management to including unit volume growth, net sales and net earnings. We also refer to organic sales growth (net sales growth excluding the impacts of acquisitions, divestitures and foreign exchange), free cash productivity. These financial measures are not defined under principles generally accepted in the United States The explanation of these measures at the end of MD&A provides more details on the use and the derivation of these measures. Management also uses certain market share and market consumption estimates relative to competition despite some limitations comparability of share information. References to market share and market consumption in MD&A are based on a combination of vendor-reported consumption and market size data, as well as October 1, 2005, we completed the acquisition of The Gillette Company for $53.43 billion. Gillette is a leading consumer products company billion of sales in its most recent pre-acquisition to provide our investors with more insight into the results of the Blades and Razors and the Duracell and Braun reporting segments, provided supplemental pro forma net sales and earnings data for these segments for the quarter ended September 30, 2005 (as presented in our Form 8-K released November 22, 2005). Managements discussion of the current year to date results of these two reportable segments is in relation to the comparable prior year results, including pro forma net sales and earnings data for the July - September 2005 period and reported results for the October - December 2005 period. Results of Gillettes personal care and oral care businesses were subsumed within the Beauty and the Health Care business is focused on providing branded consumer products. Our goal is to provide products of superior quality improve the lives of the world's consumers. We believe this will result in leadership sales, profits and value creation, allowing employees, shareholders and the communities in which we operate to prosper. products are sold in more than 180 countries merchandisers, grocery stores, membership club stores and drug stores. We have also expanded our presence in ""high frequency stores,"" the neighborhood stores which serve many consumers in developing compete in multiple product categories and have three global business units (GBUs): Beauty and Health; Household Care; and Gillette Generally Accepted Accounting Principles, the business units comprising the GBUs are aggregated into seven reportable segments: Beauty; Health Care; Fabric Care and Home Care; Baby Care and Family Care; Snacks, Coffee and Pet Care; Blades and Razors; and Duracell and Braun. We recently changed the name of the Pet Health, Snacks and Coffee reportable segment to Snacks, Coffee and Pet Care. This is a name change only and does not change financial results of the segment. We have on-the-ground operations in over 80 countries through our Market Development Organization, business teams to build our brands in local markets and is organized along seven geographic areas: North America, Western Europe, Northeast Asia, Latin America, Central and Eastern Europe/Middle East/Africa, following table provides the percentage of net sales and net earnings by reportable business segment for the three months (excludes net sales and net earnings in Corporate): following table provides the percentage of net sales and net earnings by reportable business segment for the six months ended December 31, 2006 (excludes net sales and net earnings in Corporate): are highlights of results for the six months grew 16 percent to $38.51 billion. Organic sales, which exclude the impacts of acquisitions, divestitures and foreign increased 13 percent fiscal year to date including an additional three months of Gillette results in the current fiscal year period. Organic volume, which excludes the impacts of acquisitions and divestitures, percent. Growth was broad-based with every reportable increased 22 percent to $5.56 billion. Net earnings increased behind sales growth, the addition of Gillette and profit margin net earnings per share were $1.63, an increase of 10% versus the comparable cash flow was $5.40 billion, an increase of 14 percent versus the prior year period. Free cash flow productivity was 75 percent. Free cash flow productivity is defined as the ratio of operating expenditures to net earnings. discuss expectations regarding future performance, events and outcomes, such as our business outlook and objectives, in annual and quarterly reports, press releases and other written and oral communications. All such statements, except for historical and present factual information, statements,"" and are based on financial data and our business plans available only as of the time the statements are made, which may become out-of-date or incomplete. We assume no obligation to update any forward-looking statements as a result of new information, future Forward-looking statements are inherently uncertain, recognize that events could be significantly to Achieve Business Plans. consumer products company and rely on continued demand for our brands and products. To achieve business goals, we must develop and that appeal to consumers and retail trade customers. is dependent on leading-edge innovation, with respect to both products and operations. This means we must be able to obtain technological advances and patents granted to competition. Our success is also dependent on effective sales, advertising and increasingly fragmented media environment. Our ability to innovate and execute in these areas will determine the extent to which we are able to grow existing sales and volume profitably, especially with respect to the product categories and geographic markets (including developing markets) in which we have chosen to focus. There are high levels of competitive activity which we operate. To address these challenges, we must respond to competitive factors, including pricing, promotional incentives manage each of these factors, as well as maintain relationships with our key customers, in order to effectively compete and achieve our business plans. Since our goals include a growth component tied to acquisitions, we must manage and integrate key acquisitions, such as the Gillette and Wella acquisitions, including achieving synergies in accordance with stated goals. costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, cost of labor, foreign exchange and interest rates. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects, sourcing decisions and certain hedging transactions. We also must manage our debt and currency exposure, especially in volatile countries. manufacturing and supply arrangements, including manufacturing plant arrangements. We must implement, improvement plans, including our outsourcing projects and those related to general overhead and work force rationalization. changes, terrorist activity and political unrest interruption, inflation, deflation or decreased demand for our products. Our success will depend in part on our ability to manage continued global political and/or economic uncertainty, especially in our significant geographic markets, as well as any political or economic disruption due to terrorist and other in laws, regulations and the related interpretations may alter the environment in which we do business. This includes changes in environmental, competitive and product-related laws, as well as changes in accounting requirements. Accordingly, our ability to manage regulatory, tax and legal matters (including product liability, patent and intellectual property matters as well as those related to the integration of resolve pending matters within current estimates OF OPERATIONS - Three Months Ended December 31, following discussion provides a review of results for the three months ended December 31, 2006 versus the three months ended PROCTER & GAMBLE COMPANY AND SUBSIDIARIES in Millions Except Per Share Amounts) SELLING, GENERAL & ADMINISTRATIVE EXPENSE OTHER NON-OPERATING INCOME, NET AVERAGE DILUTED SHARES OUTSTANDING SELLING, GENERAL & ADMINISTRATIVE EXPENSE EARNINGS BEFORE INCOME TAXES for the quarter increased eight percent to $19.73 billion. Every reportable segment grew sales during the quarter, led by double-digit increases in the Blades and Razors and the Fabric Care and Home increased behind product initiatives including Gillette Fusion, Tide Simple Pleasures, Febreze Noticeables, Olay Definity, Pantene Color Expressions, Head & Shoulders restage, and Crest Pro Health. Unit percent during the quarter. Every geographic region grew volume, led by double-digit growth in developing regions. Organic volume, which excludes the impacts of acquisitions and divestitures, was up five percent. Price increases across several segments added one percent to sales growth and favorable foreign currency trends added an additional three percent sales, which exclude the impacts of acquisitions, exchange, grew five percent during the quarter. Sales Change Drivers 2006 vs. 2005 (Three Months Ended December with Acquisitions & Divestitures excluding Acquisitions & Divestitures percentage changes are approximations based on quantitative formulas that are consistently applied. Total Company Mix/Other excluding A&D is -1% leading to 5% total Company organic sales growth. margin expanded 50-basis points in the quarter to 52.9% of net sales. Commodity cost increases had a negative impact on gross margin of approximately 80-basis points. Scale leverage from volume growth, price increases and cost savings projects more than offset the commodity cost increases. Gross margin also improved due to costs in the base period from revaluing Gillettes opening inventory balances to fair value as of the acquisition selling, general and administrative expenses (SG&A) increased 7%, or $375 million during the quarter. Total SG&A as a percentage of net sales was down 30-basis points, primarily behind improved overhead spending during the quarter. Overhead spending as a percentage of net sales decreased by 30-basis points largely as a result of Gillette synergies, which benefited overhead spending across all business segments during the quarter. expense for the quarter increased by $40 million versus the prior year period due to higher interest rates. Other non-operating income was roughly in-line with the prior year period. earnings increased 12 percent to $2.86 billion behind sales growth and profit margin expansion. Our effective tax rate was down 50-basis points to 30.0% primarily due to country mix impacts. Diluted net earnings per share were $0.84, up 17 percent versus the prior year. Earnings per share growth exceeded net earnings growth due to share repurchases, primarily share buyback program in connection with the Gillette acquisition, which was OF OPERATIONS - Six Months Ended December 31, following discussion provides a review of results December 31, 2006 versus the six months ended PROCTER & GAMBLE COMPANY AND SUBSIDIARIES in Millions Except Per Share Amounts) SELLING, GENERAL & ADMINISTRATIVE EXPENSE OTHER NON-OPERATING INCOME, NET AVERAGE DILUTED SHARES OUTSTANDING SELLING, GENERAL & ADMINISTRATIVE EXPENSE EARNINGS BEFORE INCOME TAXES fiscal year to date increased 16 percent to $38.51 billion primarily behind 13 percent volume growth, including an additional three months of Gillette results during the current fiscal year to date period versus the comparable year ago period. Organic volume grew five percent with broad-based growth across the business. Every reportable segment delivered year-on-year growth driven by successful product initiatives including Tide Simple Pleasures, Febreze Noticeables, Pantene Color Expressions, Olay Regenerist and Definity and the Head & Shoulders and Herbal Essences restages. Price increases taken across several segments added one percent to sales growth while favorable foreign exchange trends had a positive two percent no net impact on sales growth as the favorable mix impact from the additional period of Gillette results was offset by disproportionate regions, where unit selling prices are below the Company average. Organic sales, which exclude the impacts of acquisitions, divestitures increased five percent fiscal year to date. Sales Change Drivers 2006 vs. 2005 (Six Months Ended December with Acquisitions & Divestitures excluding Acquisitions & Divestitures percentage changes are approximations based on quantitative formulas that are consistently applied. Total Company Mix/Other excluding A&D impacts is -1% leading to 5% total Company organic sales growth. margin expanded 90-basis points fiscal year to date to 52.9% of net sales. Commodity cost increases had a negative impact on gross margin of approximately 90-basis points. Scale leverage from organic volume growth, price increases and cost savings projects more than offset the commodity benefit of an additional three months of Gillette in the current fiscal year to date period added approximately 50-basis points to gross margin due to higher average margins in the Blades and Razors segment. selling, general and administrative expenses (SG&A) increased 16%, or $1.66 billion fiscal year to date. The additional three months of Gillette in the current fiscal year to date period accounted for approximately $1.08 billion of the SG&A increase, including approximately $160 million acquisition-related expenses. The acquisition-related comprised of increased intangible asset amortization intangible assets in the opening balance sheet of the acquired Gillette business and integration-related expenses. Total SG&A as a percentage of net sales decreased by 10-basis points as lower overhead spending as a percentage of net sales on our base business (excluding Gillette) and synergies from the Gillette integration activities more than offset the impact of higher acquisition-related expense fiscal year to date increased by $179 million versus the prior year period. The increase was driven by the financing cost of debt issued to fund the share repurchase program associated with the Gillette acquisition. The repurchase program was completed during the first quarter of the fiscal year. We repurchased $20.1 billion of shares under the program since its inception. non-operating income increased during the fiscal year to date period by $117 million versus the base year period primarily as a result of the gains of the sale of Pert in North America and Sure and higher earnings increased 22 percent to $5.56 billion behind organic sales growth, the impacts from the addition of Gillette, including acquisition-related expenses, and profit margin expansion. Diluted net earnings per share were $1.63, up 10 percent versus the prior year. Earnings per share growth lagged net earnings growth due to a net outstanding (incremental shares issued in conjunction acquisition on October 1, 2005, net of share repurchases, primarily under the Gillette repurchase program). SEGMENT DISCUSSION- Three and Six Months Ended following discussion provides a review of results by business segment. Analyses of the results for the three and six months ended December 31, 2006 are provided compared to the same three and six month period ended December 31, 2005. The primary financial measures used to evaluate segment performance are net sales and net earnings. The table below provides supplemental and net earnings by business segment for the three and six months ended December 31, 2006 versus the comparable prior year period PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Months Ended December 31, 2006 Months Ended December 31, 2006 net sales increased eight percent during the quarter to $5.88 billion. Organic sales increased five percent, despite a negative impact from sales disruptions on the SK-II franchise in Asia. Unit volume was up four percent and organic volume increased five percent behind mid-single digit organic volume growth in hair care, skin care and feminine care and high-single fragrances. Volume increased behind initiative activity including Pantene Color Expressions, Head & Shoulders and Herbal Essences restages, Olay and Regenerist, Always Clean, Tampax Pearl product upgrades, and the Dolce & Gabbana The One launch. A more premium product mix drove a positive percent impact on sales while favorable foreign additional three percent to sales growth. Net earnings grew 19 percent to $1.01 billion driven by sales growth and profit margin improvement. Net earnings margin increased 150-basis points behind a more profitable product mix and lower overhead expenses as a percentage of net sales. percentage of net sales benefited primarily from fiscal year to date net sales increased 10% to $11.49 billion behind six percent volume growth. Volume was up behind five percent organic volume growth and the addition of Gillette personal care. Hair care volume increased mid-single digits driven by product initiatives on Pantene, Head Essences. Skin care volume was up high-single digits behind Olay Definity and Regenerist. Feminine care volume increased mid-single digits due to market share growth on Always and Tampax behind the Always Clean and Fresh initiatives and product upgrades increases, primarily in North America feminine care added one percent to sales growth while favorable foreign exchange had a three percent impact. Beauty organic sales were up five fiscal year to date, including a negative impact from the sales disruption in Asia resulting from the temporary suspension of SK-II shipments in China. earnings increased 15 percent to $1.88 billion. Net earnings margin increased 80-basis points as the scale benefits of volume growth and lower overhead spending as a percentage of net sales more than offset the impact of the SK-II Care net sales increased seven percent to $2.36 billion during the quarter. Unit volume grew two percent while organic volume Pharmaceuticals and personal health volume increased double-digit growth on Prilosec OTC as a result of market share growth and a low base period. In the year ago period, Prilosec OTC shipments were reduced as a result of a customer inventory build in the preceding increase. Oral care volume was flat globally as double-digit growth in developing regions behind market share gains was offset by a decline in developed regions. Developed region oral care volume was impacted by heavy competitive promotional activity, trade inventory adjustments in North America due to the August 2006 launch of Crest Pro Health and the base period launch of Crest Whitestrips Renewal and the divestiture of Spinbrush. Pricing taken in prior periods in pharmaceuticals and personal health contributed a positive two percent to segment sales growth while a more premium product mix added one percent. Foreign exchange had a positive two percent impact on sales growth. Net earnings grew 22 percent to $472 million during the quarter behind sales growth and a 250-basis point earnings margin improvement. Earnings margin increased behind volume scale leverage, lower product costs year-on-year Gillette acquisition-related expenses and Gillette synergy savings, which drove a reduction in overhead spending Care net sales were $4.58 billion fiscal year to date, up 18% versus the comparable prior year period. Sales increased as a result of three additional months of Gillette oral care results in the current growth on the base P&G business. Health Care organic sales increased percent fiscal year to date. Health Care volume grew 13% with organic volume up 2%. Oral care organic volume grew low-single digits as the first quarter launch of Crest Pro Health in North America was partially promotional activity. Pharmaceuticals and personal health volume increased low single-digits primarily behind growth on Prilosec OTC and Vicks. Pricing in pharmaceuticals and personal health added two percent to segment sales growth while a more premium product mix added one percent. Foreign exchange added two percent to sales growth. Net earnings grew 23 percent fiscal year to date to $857 million behind organic sales growth, the addition of Gillette oral care and a 70-basis point profit margin expansion. Earnings volume scale leverage, lower year-on-year Gillette acquisition-related expenses, lower product costs in personal health care and Gillette synergy savings, which more than offset the negative mix impact on gross margin from the addition of the Gillette oral care business. Care and Home Care net sales increased 11 percent during the quarter to $4.68 billion behind eight percent volume growth. Volume was up double-digits in home care and high-single digits in fabric care behind recently launched initiatives including Tide Simple Pleasures, Gain Joyful Expressions, several Swiffer restages, Febreze Noticeables, Cascade Action Pacs and the Fairy Auto Dish expansion in Western Europe. Previously executed price increases contributed one percent to sales growth while favorable foreign exchange had a two percent positive impact. Net earnings increased nine percent to $673 million. Profit margin was down 20-basis points due to reduced gross margins as scale benefits of volume growth and manufacturing cost savings projects were offset by higher commodity costs. The gross margin decline was partially offset by lower overhead costs as a percentage of sales. Care and Home Care fiscal year to date net sales increased 10 percent to $9.43 billion behind eight percent volume growth. Volume growth was broad-based across regions with mid-single digit increases in developed growth in developing regions. Both fabric care and home care grew volume high-single digits behind product initiatives such as Tide Simple Pleasures, Gain Joyful Expressions, Febreze Noticeables, upgrades on Swiffer and the launch of Fairy auto-dishwashing in Western Europe. The impact of previously executed price increases, primarily in Latin America fabric care and in North America dish care, added one percent to sales while disproportionate developing regions drove a negative one percent mix impact. Foreign exchange had a positive two percent impact on sales growth. Net earnings increased 12 percent to $1.43 billion behind sales growth and a 20-basis earnings margin. Margin improved as the scale benefits of volume growth, cost savings programs and lower overhead expenses as a percentage of net sales more than offset higher commodity costs. and Family Care net sales increased five percent to $3.12 billion during the quarter. Unit volume grew two percent behind mid-single digit growth in baby care. Baby care volume increased high-single digits in developing regions behind market share growth in Greater China and in Central developed regions, baby care volume was up low-single increased in North America behind growth on Baby Stages of Development and the Caterpillar stretch initiative on Pampers Baby Dry. This growth was partially offset by soft results on Pampers in Western Europe and Luvs in North America caused by low pricing of both branded and private label competitors. Family care organic volume was up low-single digits, led by growth on Charmin Basics and Bounty Basics. Pricing in North America family care added one point to segment sales growth and favorable foreign exchange had a positive two percent impact. Net earnings in Baby Care and Family Care increased quarter to $341 million as topline growth and lower overhead expenses as a percentage of net sales more than offset higher and Family Care net sales increased five percent fiscal year to date to $6.22 billion behind three percent volume growth. Baby mid-single digits with developing regions up double-digits. In developed regions, growth on Pampers Baby Stages of Development and Caterpillar stretch in North America was offset by softness caused by low pricing of both branded and private label competitors that impacted Pampers in Western Europe and Luvs in North America. Family care volume increased low-single growth on Bounty Basics and Charmin Basics. Price increases taken since the year ago period in North America family care added one percent to sales growth while disproportionate growth in developing regions led to a negative one percent mix impact. Favorable foreign exchange added two percent to sales growth. Net earnings in Baby Care and Family Care increased 11 percent fiscal year to date to $724 million. Earnings increased behind sales growth and a 60-basis point improvement in net earnings margin. Earnings margin expansion was driven by both improved gross margins and lower SG&A as a percentage of net sales. SG&A improved as a result of lower overhead and marketing expenses as a percentage of Coffee and Pet Care net sales increased three percent during the quarter to $1.25 billion. Volume was up one percent behind mid-single digit growth on coffee, partially offset by a decline on pet care. Coffee volume grew over a base period that included reduced shipments due to Hurricane Katrina and behind Folgers Simply Smooth and Gourmet Selections. Snacks volume was in-line with the prior year period as growth behind the Pringles Minis and Gourmet initiatives was offset by a four percent contraction in the North America chips market and heavy competitive merchandising activity. Disproportionate more premium product mix in snacks drove a positive one percent mix impact while favorable foreign exchange added one percent to sales. Net earnings increased 34 percent to $150 million during the quarter. Earnings increased as a result of sales growth and incremental base period costs Coffee and Pet Care net sales increased six percent fiscal year to date to $2.32 billion behind three percent volume growth. Coffee volume increased more than 20 percent during the period due to a base period that included a significant reduction in the coffee business from the impact of Hurricane Katrina and the recent launches of Folgers Simply Smooth and Gourmet Selections. Volume growth on coffee was partially offset by a decline in snacks due to customer inventory adjustments in Western Europe following the World events, market contraction in the U.S. and strong competitive activity. Pet care volume was in-line with the year ago period. Disproportionately high growth in coffee drove a positive two percent mix impact on sales while favorable foreign exchange added one percent to sales. Net earnings increased 26 percent to $237 million fiscal year to date. Earnings increased primarily due to base period impacts related to Hurricane Katrina. disclosed in Note 4 to the consolidated financial statements, we completed the acquisition of The Gillette Company on October 1, 2005. This acquisition resulted in two new reportable segments for the Company: Blades and Razors and Duracell and Braun. The Gillette oral care and personal care businesses were subsumed within the Health Care and Beauty reportable Because the acquisition was completed in October 2005, there are no results for these segments in our base July-September 2005 to provide our investors with more insight into the results of the Blades and Razors and Duracell and Braun reporting segments, we have previously provided supplemental pro forma net sales and earnings data for these segments for the quarter ended September 30, 2005 (as presented in our Form 8-K released November 22, 2005). Managements discussion of the current quarter results is to the comparable prior year reported net sales and net earnings results. The fiscal year to date results of these two segments is in relation to comparable prior year results including pro forma net sales and earnings data for the July - September 2005 period and reported results for the October - December 2005 period. With respect to the earnings data, the fiscal year to date analysis is based on earnings before income taxes. The previously Razors and Duracell and Braun pro forma information Operations, the measure used by Gillette in its historical before Income Taxes, the comparable measure used by the Company. Gillette did not allocate income tax expense to its reporting segments. in Blades and Razors increased 11 percent to $1.28 billion during the quarter. Sales grew primarily behind the Fusion launch in developed regions and on Mach 3 in developing regions. Unit volume increased four percent during the quarter, led by double-digit growth in developing regions. Price increases and a more premium product mix each added two percent to sales growth while favorable foreign exchange added three percent. Net earnings increased 11 percent during the quarter to $301 million. Net earnings grew behind higher sales and lower acquisition-related expenses partially offset by higher marketing investment behind Fusion and higher year-on-year overhead expenses driven by a low level of base period overhead expenses. Acquisition-related expenses decreased primarily due to base period product costs resulting from revaluing Gillettes opening balance sheet inventory balance. in Blades and Razors increased 11 percent fiscal year to date to $2.58 billion versus the comparable pro forma prior year period. Net sales increased behind higher consumption of Gillette blades and razors and pipeline inventory builds to support the Fusion launch. Overall, volume/mix increased eight percent during the period and favorable foreign exchange added three percent to sales growth. Earnings before income taxes increased 15 percent to $867 million versus the comparable prior year pro forma results, including $63 million of incremental acquisition-related charges in the current fiscal year period that negatively impacted earnings before income taxes by eight acquisition-related charges are comprised of amortization charges from revaluing intangible assets in the opening balance sheet, partially offset by base period product costs related to revaluing Gillettes opening balance sheet inventory balance. Amortization charges are higher in the current fiscal year to date period due to the extra three months of Gillette post-acquisition results in the current period. Earnings grew as a result of sales growth, synergy savings and base period asset write-offs, partially offset marketing investment behind Fusion and acquisition-related were $638 million fiscal year to date. in Duracell and Braun increased five percent to $1.35 billion. Unit volume was flat with organic volume up one percent. Duracell low-single digits as growth in developing regions softness in North America and Western Europe from strong competitive activity. Braun volume was down slightly due to the divestiture pressure devices, a lower level of category promotion activity in North America during the 2006 holiday period versus the prior year period and a strong base period in Western Europe that included the launch of Tassimo in Germany. The Duracell and Braun business was impacted by one-time supply disruptions during systems cutover at a warehousing facility in the United States during a key holiday shipment period. The issue was completely resolved during the quarter and shipments capabilities returned to full capacity. A more premium product mix contributed two percent to segment sales growth while favorable foreign exchange had a positive three percent impact. Net earnings increased 32 percent during the quarter to $218 million. Earnings growth was driven by the increase in net sales and lower acquisition-related expenses Acquisition-related expenses decreased primarily due to base period product costs resulting from revaluing Gillettes opening balance sheet in Duracell and Braun increased six percent fiscal year to date to $2.32 billion versus the comparable prior year pro forma results. In Duracell, sales increased mid-single digits globally behind double-digit growth in developing regions partially offset by reduced sales in developed regions which were impacted by strong competitive activity from both private label and branded competitors. In Braun, sales increased mid-single digits as the launch of 360 Complete and Contour razors in North America and Pulsonic razors in Germany and Japan more than offset softness in Western Europe household appliances, lower year-on-year holiday promotion activity in North America and the divestiture of thermometer and blood pressure devices. Overall, volume/mix in the Duracell and Braun segment increased four percent. Favorable foreign exchange added two percent to sales growth. Earnings before income taxes increased 17 percent fiscal year to date to $463 million versus the comparable prior year period pro forma results. Earnings grew behind sales growth and lower year-on-year expenses. Acquisition-related charges were down primarily due to base period product costs related to revaluing Gillette opening level, which more than offset the impact of an additional three months of amortization charges in current year period from revaluing intangible assets in the opening balance sheet. Net earnings were $313 million fiscal year to includes certain operating and non-operating activities not allocated to specific business units. These include: the incidental businesses managed at the corporate level, financing and investing activities, charges, other general corporate items and the historical results of certain divested categories, including certain Gillette brands that were divested in fiscal 2006 as required by the regulatory authorities Gillette acquisition. Corporate also includes reconciling items to adjust the accounting policies used in the segments to U.S. GAAP. The most significant reconciling items include income taxes (to adjust from statutory rates that are reflected in the segments to the overall Company adjustments for unconsolidated entities (to eliminate sold and SG&A for entities that are consolidated in the segments accounted for using the equity method for U.S. GAAP) and minority interest adjustments for subsidiaries where we do not have 100% ownership. Because both unconsolidated entities and less than 100% owned subsidiaries are managed as integral parts of the Company, they are accounted for similar to a wholly owned subsidiary for management and segment purposes. This means our segment results recognize 100% of each income statement component through before-tax earnings in the segments, with eliminations for unconsolidated entities in Corporate. In determining segment net earnings, we apply the statutory tax rates (with adjustments to arrive at the Companys effective tax rate in Corporate) and eliminate the share of earnings applicable to other ownership interests, in a manner similar to minority interest. decline in net earnings for the quarter and the fiscal year to date period was primarily driven by increased interest expenses and higher restructuring and integration costs. Interest expense was up due to the financing costs of the share repurchase program announced in connection with the Gillette acquisition. The increase in restructuring expense is primarily related to costs incurred as part of the Gillette integration. These fiscal year to date cost increases were partially offset by the first quarter gains on the sale of Pert in North America generated fiscal year to date from operating activities was $5.40 billion versus $4.75 billion in the comparable prior year period. Net earnings, adjusted for non-cash items (primarily depreciation, amortization, and deferred income taxes) were partially offset by an increase in working capital. Accounts receivable increased due to seasonality primarily behind our Prestige fragrance impacts related to the Gillette integration. Inventory increased primarily to support business growth and upcoming initiative activities in the current year used $623 million, compared to the prior year period cash use of $402 million. Acquisitions used $139 million of cash behind several small acquisitions versus a net source of cash of $249 million in the prior year period from receiving Gillettes cash balance, which more than offset funding related to the settlement of a major portion of the Wella Domination liability. Investment securities generated $620 million due to an investment shift from auction rate securities to cash equivalent expenditures were $1.24 billion, or 3.2 percent of net sales during the fiscal cash used by financing activities was $6.64 billion fiscal year to date versus $2.87 billion in the comparable prior year period. We repurchased $2.71 billion of treasury shares and reduced our debt position by $2.61 billion in the current year period. In the prior year period, we repurchased $9.03 billion of treasury shares funded in part by increases in our debt position of $7.34 billion. Companys current liabilities exceeded current assets by $6.61 billion. The key driver was the refinancing of a portion of our long-term credit facility with commercial paper. The Company anticipates being able to support its short-term liquidity through cash generated from operations. The Company also has very strong long- and short-term ratings which will refinance this debt at favorable rates in commercial paper and bond markets. In addition, the Company has agreements with a diverse financial institutions that, if needed, would provide sufficient credit funding to meet short-term financing requirements. discussion of financial results includes several measures not defined by U.S. GAAP. We believe these measures provide our investors information about the underlying results and trends of the Company, as well as insight to some of the metrics used to evaluate MD&A, we have provided the comparable GAAP measure sales growth is a non-GAAP measure of sales growth acquisitions, divestitures and foreign exchange from year-over-year comparisons. We believe this provides investors with a more complete understanding of underlying sales trends by providing sales growth on a consistent basis. The reconciliation of reported sales growth to organic Acquisition/Divestiture Impact reconciliation of reported sales growth to organic sales for the fiscal year to Acquisition/Divestiture Impact cash flow is defined as operating cash flow less capital spending. We view free cash flow as an important measure because it is one factor in determining the amount of cash available for dividends and discretionary flow is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation. cash flow productivity is defined as the ratio earnings. The Companys long-term target is to generate free cash at percent of net earnings. Free cash flow is also one of the measures used to evaluate senior management. The reconciliation of free cash flow and free cash flow productivity is provided below (amounts 3.",5909
2007-03-09,8-K,0000080424-07-000052,"9-K -- Mid-Qtr Update (AMJ 2007) 13 OR 15(d) of The Securities Exchange Act Of 1934 Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act material pursuant to Rule 14a-12 under the Exchange Act (17 communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange 7.01 REGULATION FD DISCLOSURE The Procter & Gamble Company (the ""Company"") issued a news release confirming previously announced sales and earnings guidance for the January March quarter. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure"". requirements of the Securities Exchange Act of 1934, the Registrant has caused this Report to be signed on its behalf by the undersigned hereunto News Release by The Procter & Gamble Company dated March 9,",151
2007-04-16,8-K,0000080424-07-000071,"13 OR 15(d) of The Securities Exchange Act Of 1934 of Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange 2007, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared an increase in the quarterly dividend from thirty-one cents ($0.31) to thirty-five cents ($0.35) per share on its Common Stock and on the Series A and Series Convertible Class A Preferred Stock of the Company, payable on after May 15, 2007 to shareholders of record at the close of business on April 27, 2007. This represents a 13% increase compared to the prior quarterly dividend. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD the requirements of the Securities Exchange Act of 1934, the has duly caused this Report to be signed on its behalf by the hereunto duly authorized.",189
2007-05-01,8-K,0000080424-07-000075,"8-K - Earnings Release - JFM 2007 to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 of Report (Date of earliest event reported) name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area code ) communications pursuant to Rule 425 under the Securities Act (17 material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange OF OPERATIONS AND FINANCIAL CONDITION May 1, 2007, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended March 2007. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Release by The Procter & Gamble Company dated May 1,",169
2007-05-02,10-Q,0000080424-07-000078,"(MD&A) is organized in the following Operations - Three Months Ended March 31, 2007 Operations - Nine Months Ended March 31, 2007 Discussion - Three and Nine Months Ended March 31, 2007 MD&A, we refer to measures used by management to evaluate performance including unit volume growth, net sales and net earnings. We organic sales growth (net sales growth excluding the impacts divestitures and foreign exchange), free cash flow and free productivity. These financial measures are not defined under principles generally accepted in the United States of America explanation of these measures at the end of MD&A provides more details on the use and the derivation of these measures. Management also market share and market consumption estimates to evaluate performance to competition despite some limitations on the availability share information. References to market share and market consumption are based on a combination of vendor-reported consumption and as well as internal estimates. we completed the acquisition of The Gillette Company for $53.43 Gillette is a leading consumer products company that had $10.48 in its most recent pre-acquisition year ended December 31, our investors with more insight into the results of the Blades the Duracell and Braun reporting segments, we have previously supplemental pro forma net sales and earnings data for these quarter ended September 30, 2005 (as presented in our Form 22, 2005). Managements discussion of the current year to date results of these two reportable segments is in relation to the comparable prior including pro forma net sales and earnings data for the July period and reported results for the October 2005 - March 2006 Gillettes personal care and oral care businesses were subsumed within Beauty and the Health Care reportable segments, respectively. is focused on providing branded consumer products. Our goal is to provide products of superior quality improve the lives of the world's consumers. We believe this leadership sales, profits and value creation, allowing employees, and the communities in which we operate to prosper. sold in more than 180 countries primarily through mass merchandisers, stores, membership club stores and drug stores. We have also presence in ""high frequency stores,"" the neighborhood stores consumers in developing markets. We multiple product categories and have three global business and Health; Household Care; and Gillette GBU. Under U.S. Generally Accounting Principles, the business units comprising the GBUs into seven reportable segments: Beauty; Health Care; Fabric Baby Care and Family Care; Snacks, Coffee and Pet Care; Blades Duracell and Braun. We have on-the-ground operations in over through our Market Development Organization, which leads country to build our brands in local markets and is organized along areas comprised of three developed regions (North America, Northeast Asia) and four developing regions (Latin America, Europe/Middle East/Africa, Greater China and ASEAN/Australasia/India). provides the percentage of net sales and net earnings by reportable segment for the three months ended March 31, 2007 (excludes provides the percentage of net sales and net earnings by reportable segment for the nine months ended March 31, 2007 (excludes highlights of results for the nine months ended March 31, 2007: percent to $57.20 billion. Organic sales, which exclude the acquisitions, divestitures and foreign exchange, increased increased 11 percent fiscal year to date including an additional Gillette results in the current fiscal year period. Organic excludes the impacts of acquisitions and divestitures, was every reportable segment delivering year-on-year organic volume increased 19 percent to $8.07 billion. Net earnings increased growth, the addition of Gillette and operating profit margin earnings per share were $2.37, an increase of 13 percent versus was $9.85 billion, an increase of 20 percent versus the prior cash flow productivity was 97 percent. Free cash flow productivity the ratio of operating cash flow less capital expenditures expectations regarding future performance, events and outcomes, business outlook and objectives, in annual and quarterly reports, and other written and oral communications. All such statements, historical and present factual information, are ""forward-looking and are based on financial data and our business plans available time the statements are made, which may become out-of-date assume no obligation to update any forward-looking statements information, future events or other factors. Forward-looking inherently uncertain, and investors must recognize that events significantly different from our expectations. products company and rely on continued demand for our brands achieve business goals, we must develop and sell products that consumers and retail trade customers. Our continued success leading-edge innovation, with respect to both products and means we must be able to obtain patents and respond to technological and patents granted to competition. Our success is also dependent sales, advertising and marketing programs in an increasingly environment. Our ability to innovate and execute in these areas the extent to which we are able to grow existing sales and especially with respect to the product categories and geographic (including developing markets) in which we have chosen to focus. levels of competitive activity in the environments in which address these challenges, we must respond to competitive factors, pricing, promotional incentives and trade terms. We must manage factors, as well as maintain mutually beneficial relationships customers, in order to effectively compete and achieve our our goals include a growth component tied to acquisitions, integrate key acquisitions, such as the Gillette and Wella including achieving the cost and growth synergies in accordance subject to fluctuations, particularly due to changes in commodity materials, cost of labor, foreign exchange and interest rates. success is dependent, in part, on our continued ability to fluctuations through pricing actions, cost savings projects, and certain hedging transactions. We also must manage our debt and currency exposure, especially in volatile countries. We need to maintain manufacturing and supply arrangements, including sole supplier manufacturing plant arrangements. We must implement, achieve improvement plans, including our outsourcing projects and those general overhead and work force rationalization. terrorist activity and political unrest may result in business inflation, deflation or decreased demand for our products. depend in part on our ability to manage continued global political economic uncertainty, especially in our significant geographic as any political or economic disruption due to terrorist and regulations and the related interpretations may alter the environment we do business. This includes changes in environmental, competitive product-related laws, as well as changes in accounting standards requirements. Accordingly, our ability to manage regulatory, matters (including product liability, patent and intellectual as well as those related to the integration of Gillette and pending matters within current estimates may impact our results. OF OPERATIONS - Three Months Ended March 31, 2007 discussion provides a review of results for the three months 2007 versus the three months ended March 31, 2006. PROCTER & GAMBLE COMPANY AND SUBSIDIARIES in Millions Except Per Share Amounts) NON-OPERATING INCOME, NET quarter were up eight percent to $18.69 billion. All reportable the Snacks, Coffee and Pet Care segment grew sales in the quarter, double-digit growth in Fabric Care and Home Care, Health Care Family Care. Volume increased six percent with each geographic year-on-year growth, led by double-digit growth in developing Organic volume also increased six percent behind high single-digit Fabric Care and Home Care and Baby Care and Family Care, with in Snacks, Coffee and Pet Care. Tide, Ariel, Downy, Charmin, Shoulders, Olay, Always and Prilosec OTC each posted double-digit in the quarter. Price increases across most of our reportable contributed one percent to sales growth but were offset by percent mix impact from a less premium product mix across several disproportionate growth in developing regions, where selling the Company average. Foreign exchange added an additional two growth. Organic sales increased six percent during the quarter. Sales Change Drivers 2007 vs. 2006 (Three Months Acquisitions & Divestitures excluding Acquisitions & Divestitures Sales percentage changes are approximations based on quantitative are consistently applied. down 10-basis points in the quarter to 51.6% of net sales. increases had a negative impact on gross margin of approximately but were more than offset by scale leverage from volume growth, and cost savings projects. A number of one-time items during including net charges related to the integration of Gillette, restructuring projects and the impacts of a pet food recall, margin versus the prior year period by approximately 50-basis general and administrative expenses (SG&A) increased eight percent, or $432 million, during the quarter. Total SG&A as a percentage of net sales was down 20-basis points, primarily behind overhead spending during partially offset by the impact of a favorable legal settlement period. Overhead spending as a percentage of net sales was volume scale leverage, overhead cost controls and Gillette for the quarter decreased by $22 million versus the year-ago due to lower gross debt. Other non-operating income was up year-on-year. The increase was primarily due to the gains on Beauty brand divestitures which closed during the quarter. increased 14 percent to $2.51 billion behind sales growth and expansion. Diluted net earnings per share were $0.74, up 17 prior year. Earnings per share growth exceeded net earnings repurchases, primarily under the $20.1 billion share buyback connection with the Gillette acquisition, which was completed OF OPERATIONS - Nine Months Ended March 31, 2007 discussion provides a review of results for the nine months versus the nine months ended March 31, 2006. PROCTER & GAMBLE COMPANY AND SUBSIDIARIES in Millions Except Per Share Amounts) GENERAL & ADMINISTRATIVE EXPENSE NON-OPERATING INCOME, NET year to date increased 14 percent to $57.20 billion behind growth, including an additional three months of Gillette results current fiscal year to date period versus the comparable year Organic volume grew five percent with broad-based growth across Every reportable segment delivered year-on-year organic volume product initiatives including Tide Simple Pleasures, Febreze Pantene Color Expressions, Olay Regenerist and Definity and Shoulders and Herbal Essences restages. Price increases taken segments added one percent to sales growth while favorable trends had a positive two percent impact. Product mix had no growth as the favorable mix impact from the additional period results was offset by disproportionate growth in developing selling prices are below the Company average. Organic sales percent fiscal year to date. Sales Change Drivers 2007 vs. 2006 (Nine Months Ended Acquisitions & Divestitures excluding Acquisitions & Divestitures Sales percentage changes are approximations based on quantitative are consistently applied. increased 50-basis points for the fiscal year to date period sales. Higher commodity costs had a negative gross margin impact approximately 80-basis points. Scale leverage from organic increases and cost savings projects more than offset the commodity increase. The mix benefit of an additional three months of current fiscal year to date period added approximately 40-basis higher average margins in the Blades and Razors segment. general and administrative expenses (SG&A) increased 13%, or $2.10 billion fiscal year to date. The additional three months of Gillette fiscal year to date period accounted for approximately $1.08 SG&A increase, including approximately $160 million of incremental acquisition-related expenses. The acquisition-related expenses comprised of increased intangible asset amortization resulting intangible assets in the opening balance sheet of the acquired and integration-related expenses. Total SG&A as a percentage of net sales decreased by 10-basis points as lower overhead spending as sales on our base business (excluding Gillette) driven by volume overhead cost control and synergies from the Gillette integration more than offset the impact of higher acquisition-related expenses. fiscal year to date increased by $157 million versus the prior increase was driven by the financing cost of debt issued to repurchase program associated with the Gillette acquisition. The repurchase program was completed during the first quarter of repurchased $20.1 billion of shares under the program since income increased during the fiscal year to date period by $208 the base year period primarily as a result of the gains on divestitures including Pert in North America and Sure, as well increased 19 percent to $8.07 billion behind organic sales from the addition of Gillette, including financing and other expenses, and profit margin expansion. Diluted net earnings $2.37, up 13 percent versus the prior year. Earnings per share earnings growth due to a net increase in the weighted average in the current year to date period (incremental shares issued with the Gillette acquisition on October 1, 2005, net of share primarily under the Gillette repurchase program). SEGMENT DISCUSSION- Three and Nine Months Ended March 31, discussion provides a review of results by business segment. results for the three and nine months ended March 31, 2007 to the same three and nine month period ended March 31, 2006. financial measures used to evaluate segment performance are earnings. The table below provides supplemental information earnings by business segment for the three and nine months versus the comparable prior year period (Amounts in millions): were up eight percent during the quarter to $5.62 billion. three percent with organic volume up four percent. Volume growth double-digit growth in skin care and prestige fragrances and growth in feminine care behind Olay Regenerist, Olay Definity, Gabbana and Hugo Boss and Always. Hair care organic volume digits behind Head & Shoulders and Herbal Essences growth. Volume growth in these categories was partially offset by softness in the balance categories and the impact of the divestiture of several minor Pert in North America and Sure. Volume and sales growth were impacted by lower sales on SK-II as the brand continues to period business disruptions in Asia. Carryover price increases, primarily in feminine care, contributed one percent to sales growth. from disproportionate prestige fragrance growth added an additional to sales growth. Foreign exchange had a positive three percent sales. Organic sales increased five percent. Net earnings in percent to $805 million behind sales growth. Earnings margin was roughly in-line with the prior year period as higher marketing spending of net sales was largely offset by the impact of divestiture to date net sales increased nine percent to $17.11 billion. organic volume increased five percent for the period. Skin high-single digits behind Olay Definity and Regenerist. Hair increased mid-single digits driven by product initiatives on Shoulders and Herbal Essences. Feminine care volume increased due to market share growth on Always and Tampax behind the Fresh initiatives and product upgrades on Tampax Pearl . fragrances volume increased double-digits behind the Dolce launch. Disproportionate growth in prestige fragrances had impact of one percent on sales growth while favorable foreign three percent impact. Beauty organic sales were up five year to date, including a negative impact from the sales disruption resulting from the temporary suspension of SK-II shipments earnings increased 13 percent to $2.69 billion behind sales margin improvement. Earnings margin increased 60-basis points due to divestiture gains on minor Beauty brands and lower SG&A as a percent of sales, partially offset by the impact of the SK-II disruption. percent of sales improved as the scale benefits of volume growth overhead spending as a percentage of net sales more than offset spending as a percentage of net sales. sales increased 10 percent to $2.19 billion during the quarter percent volume growth. Oral care volume was up mid-single digits, double-digit growth in developing regions behind market share Pharmaceuticals and personal health care volume was up mid-single growth on Prilosec OTC and Vicks more than offset softness Prilosec OTC volume increased double-digits behind a two point market share and a base period that was depressed due to customer builds ahead of a prior period price increase. Price increases, pharmaceuticals and personal health care, added one percent while a more premium product mix added an additional one percent. foreign exchange had a two percent impact on net sales. Health grew 31 percent to $347 million during the quarter behind sales higher earnings margin. Earnings margin improved 260-basis quarter behind volume scale leverage, lower product costs, savings and lower research and development costs in our pharmaceuticals driven by the timing of clinical milestone payments. sales were $6.77 billion fiscal year to date, up 15 percent comparable prior year period on 10 percent volume growth. Sales increased as a result of three additional months of Gillette in the current fiscal year period and growth on the base P&G business. Health Care organic sales increased six percent fiscal year percent organic volume growth. Oral care organic volume grew driven by high-single digit growth in developing regions behind gains. Pharmaceuticals and personal health volume increased behind growth on Prilosec OTC and Vicks. Pricing, primarily and personal health, contributed two percent to segment sales more premium product mix added an additional one percent. Foreign positive two percent impact on net sales. Net earnings grew year to date to $1.20 billion behind organic sales growth, Gillette oral care and earnings margin expansion. Earnings 140-basis points as lower SG&A as a percent of sales and lower product costs more than offset the negative mix impact on gross margin from the Gillette oral care business. SG&A improved as a percentage of net sales due to volume scale leverage, lower research and development in our pharmaceuticals business driven by the timing of clinical payments and Gillette synergy savings. Home Care net sales increased 12 percent during the quarter driven by a 10 percent increase in unit volume. Volume growth across both the fabric care and the home care businesses and Each geographic region delivered high-single digit or above brands drove the growth with Tide, Ariel, Downy, Swiffer and posting double-digit volume growth for the quarter. Favorable added two percent to sales growth. Net earnings increased 21 quarter to $685 million behind sales growth and a 110-basis margin expansion from lower SG&A as a percentage of net sales. SG&A benefited from lower overhead and marketing spending as a percentage sales. Manufacturing cost savings, volume scale leverage and cost savings initiatives offset higher commodity costs. Home Care fiscal year to date net sales increased 11 percent behind eight percent volume growth. Volume growth was broad-based with mid-single digit increases in developed regions and double-digit developing regions. Both fabric care and home care grew volume digits behind product initiatives such as Tide Simple Pleasures, Expressions, Febreze Noticeables, upgrades on Swiffer and the auto-dishwashing in Western Europe. The impact of previously increases added one percent to sales growth while favorable a positive two percent impact. Net earnings increased 14 percent billion behind sales growth and a 50-basis point improvement margin. Earnings margin improved behind lower overhead expenses of net sales. Scale benefits of volume growth and cost savings Family Care net sales increased 10 percent to $3.27 billion behind eight percent unit volume growth. Baby care volume was digits, led by double-digit growth in developing regions behind growth. In developed regions, baby care volume increased mid-single driven largely by the Caterpillar stretch initiative on Pampers North America and Western Europe. Family care volume increased digits behind product performance improvements on Bounty and Bounty Basics and Charmin Basics. Pricing in North America percent to segment sales growth. Disproportionate growth in and on the Basics products, which have lower average selling negative two percent mix impact. Favorable foreign exchange to sales. Net earnings in Baby Care and Family Care increased the quarter to $382 million behind sales growth and a 70-basis earnings margin. The earnings margin expansion was driven by lower SG&A from reduced marketing and overhead spending as a percentage Volume scale leverage and manufacturing cost savings projects impact of higher pulp costs. Family Care net sales increased seven percent fiscal year to billion behind five percent volume growth. Baby care volume digits with developing regions up double-digits. In developed volume was up low-single digits as growth on Pampers Baby Stages and Caterpillar stretch more than offset softness on Pampers and Luvs in North America from lower competitor pricing of private label products. Family care volume increased low-single Family care organic volume was up mid-single digits behind improvements on Bounty and continued growth on Bounty Basics Price increases in North America family care added one percent while disproportionate growth in developing regions and on led to a negative one percent mix impact. Favorable foreign percent to sales growth. Net earnings in Baby Care and Family percent fiscal year to date to $1.11 billion behind sales growth point improvement in net earnings margin. Earnings margin expansion by lower overhead and marketing expenses as a percentage of Manufacturing cost savings and volume scale leverage offset Pet Care net sales were in-line with the prior year period Volume was down two percent during the quarter as high-single snacks was more than offset by the impacts of a reduction in inventory and a pet food recall. In coffee, U.S. market share one point versus the prior year period. However, volume was to lower year-on-year trade inventory levels. Trade inventory during the current quarter due to the impact of a January price Folgers coupled with heavy competitive promotion activity. declined due to strong competitive activity and the impacts food recall of some Iams and Eukanuba wet pet foods in March. increased behind the Pringles Select and Minis initiatives. three percent to segment net sales growth following a January Folgers. Disproportionate growth in snacks, which has a lower the segment average, resulted in a negative two percent mix foreign exchange added one percent to sales. Net earnings were percent to $116 million during the quarter as higher commodity segment and expenses associated with the pet food recall more base period impacts related to Hurricane Katrina and an additional recovery from Katrina in the current period. Pet Care net sales increased four percent fiscal year to date Volume was up one percent as growth in coffee was largely offset pet care and flat volume in snacks. Coffee volume was up high-single digits primarily due to a weak base period that included a coffee business from Hurricane Katrina and current period volume launches of Folgers Simply Smooth and Gourmet Selections. Pet down versus the year-ago period due to strong competitive activity impacts of a voluntary pet food recall of the Iams and Eukanuba March 2007. Price increases in coffee, product mix from disproportionate growth and foreign exchange each had a positive one percent earnings increased 15 percent to $353 million fiscal year to increased primarily due to base period impacts related to Hurricane which more than offset the impacts of higher commodity costs associated with the pet food recall in the current period. Note 4 to the consolidated financial statements, we completed The Gillette Company on October 1, 2005. This acquisition resulted reportable segments for the Company: Blades and Razors and The Gillette oral care and personal care businesses were subsumed Health Care and Beauty reportable segments, respectively. Because acquisition was completed in October 2005, there are no results segments in our base July-September 2005 period. our investors with more insight into the results of the Blades Duracell and Braun reporting segments, we have previously provided pro forma net sales and earnings data for these segments for September 30, 2005 (as presented in our Form 8-K released November Managements discussion of the current quarter results is in relation comparable prior year reported net sales and net earnings results. year to date results of these two segments is in relation to year results including pro forma net sales and earnings data September 2005 period and reported results for the October period. With respect to the earnings data, the fiscal year based on earnings before income taxes. The previously disclosed Razors and Duracell and Braun pro forma information reconciled Operations, the measure used by Gillette in its historical filings, to before Income Taxes, the comparable measure used by the Company. not allocate income tax and Razors increased eight percent to $1.28 billion behind growth. In developing regions, volume increased high-teens growth on Mach 3. Volume in developed regions was down due launch of Fusion in North America, the segments largest region. Current period volume did benefit from continued expansion of Fusion with launches in several European countries and in Australia. Pricing shaving systems contributed two percent to sales growth, while growth in developing regions resulted in a negative two percent Foreign exchange added four percent to sales growth. Net earnings percent during the quarter to $294 million behind sales growth point increase in earnings margin. Earnings margin was up as gross margin expansion from a more favorable product mix driven by Fusion higher marketing and overhead expenses as a percentage of net Overhead expenses increased year-on-year due to the inclusion P&Gs corporate allocations systems. This had no net impact on the Companys total overhead expense as the offsetting reductions are spread the Beauty and Health and the Household Care GBUs. and Razors increased 10 percent fiscal year to date to $3.87 comparable pro forma prior year period. Net sales increased growth on Fusion in developed regions and on Mach 3 in developing Overall, volume/mix contributed six percent to sales growth increases taken across most shaving systems added one percent. exchange had a three percent impact on net sales. Earnings increased 14 percent to $1.27 billion versus the comparable results, including $65 million of incremental acquisition-related current fiscal year period. The incremental acquisition-related comprised of amortization charges from revaluing intangible opening balance sheet, partially offset by base period product revaluing Gillettes opening balance sheet inventory balance. Amortization charges are higher in the current fiscal year to date period three months of Gillette post-acquisition results in the current Earnings growth was driven by sales growth and synergy savings, by higher marketing investment behind Fusion, higher overhead acquisition-related charges. Overhead expenses are up year-on-year integration of the Gillette GBU into the Companys corporate allocations systems in the current period. Net earnings were $932 million fiscal Duracell and Braun increased three percent to $789 million. segment was flat globally with organic volume up three percent. volume increased low-single digits driven by developing market market volumes were negatively impacted by high levels of competitive from both branded and private label competitors in North America Europe. In Braun, unit volume was down globally as mid-single developing regions was more than offset by the impact of the thermometer and blood pressure devices. Braun organic volume mid-single digits behind the 360 Complete, Pulsonic and Contour Price increases on Duracell contributed two percent to segment were offset by a negative two percent mix impact driven in disproportionate growth in developing regions. Favorable foreign three percent to sales growth. Net earnings declined $36 million quarter to $18 million. Earnings were down primarily due to and higher overheads resulting from the inclusion of Gillette corporate allocations systems. This had no net impact on the Companys total overhead expense as the offsetting reductions are spread and Health and the Household Care GBUs. Duracell and Braun increased five percent fiscal year to date versus the comparable prior year pro forma results. In Duracell, mid-single digits globally, led by double-digit growth in developing developed regions, Duracell organic sales were in-line with period due to high levels of competitive activity from both branded competitors. In Braun, sales increased mid-single digits of 360 Complete and Contour razors in North America and Pulsonic Germany and Japan more than offset softness in Western Europe appliances, lower year-on-year winter holiday promotion activity America and the divestiture of thermometer and blood pressure volume/mix in the Duracell and Braun segment contributed two growth while favorable foreign exchange added three percent. income taxes increased four percent fiscal year to date to the comparable prior year period pro forma results. Earnings sales growth and lower year-on-year acquisition-related expenses, offset by higher overhead expenses. Acquisition-related charges were down primarily due to base period product costs related to revaluing balance sheet inventory level, which more than offset the impact additional three months of amortization charges in current revaluing intangible assets in the opening balance sheet. Overhead expenses as a percentage of net sales increased year-on-year integration of the Gillette GBU into the Company's corporate in the current period. Net earnings were $331 million fiscal year to certain operating and non-operating activities not allocated business units. These include: the incidental businesses managed corporate level, financing and investing activities, certain charges, other general corporate items and the historical results divested brands, including certain Gillette brands that were 2006 as required by the regulatory authorities in relation acquisition. Corporate also includes reconciling items to adjust policies used in the segments to U.S. GAAP. The most significant items include income taxes (to adjust from statutory rates the segments to the overall Company effective tax rate), adjustments unconsolidated entities (to eliminate sales, cost of products for entities that are consolidated in the segments but accounted equity method for U.S. GAAP) and minority interest adjustments where we do not have 100% ownership. Because both unconsolidated less than 100% owned subsidiaries are managed as integral parts they are accounted for similar to a wholly owned subsidiary segment purposes. This means our segment results recognize statement component through before-tax earnings in the segments, eliminations for unconsolidated entities in Corporate. In determining net earnings, we apply the statutory tax rates (with adjustments the Companys effective tax rate in Corporate) and eliminate the share earnings applicable to other ownership interests, in a manner the quarter were roughly in-line versus the prior year period. gain resulting from the harmonization of U.S. postretirement between Gillette and P&G and lower interest expense were offset by the write-down of certain overhead-related manufacturing assets legal settlement in the base period. the fiscal year to date period were down $219 million primarily increased interest expenses and higher restructuring and integration Interest expense was up due to the financing costs of the share program announced in connection with the Gillette acquisition. restructuring expense is primarily related to costs incurred Gillette integration. These fiscal year to date cost increases offset by the gains on the sale of certain minor brands including fiscal year to date from operating activities was $9.85 billion billion in the comparable prior year period. Net earnings, items (primarily depreciation, amortization, share based compensation deferred income taxes) provided $11.39 billion of operating partially offset by an increase in working capital. Inventory to support business growth and upcoming initiative launches. increased due to business growth and continued temporary impacts Gillette integration. Accounts payable was down as the Company efforts to accelerate payments to suppliers in order to maximize activities in the current year used $1.18 billion, compared period cash use of $607 million. Acquisitions used $167 million of cash behind several small acquisitions versus a net source of cash the prior year period from net cash received in the Gillette more than offset funding related to the settlement of a major Wella Domination liability. Investment securities generated a shift from auction rate securities to cash equivalent securities. expenditures were $2.00 billion, or 3.5 percent of net sales financing activities was $11.53 billion fiscal year to date in the comparable prior year period. We repurchased $4.06 billion shares and reduced our debt position by $5.61 billion in the to date period. In the prior year period, we repurchased $10.60 treasury shares funded in part by increases in our debt position billion during the period. 2007 the Companys current liabilities exceeded current assets by $8.21 billion. The key driver was the refinancing of a portion of our long-term with commercial paper. The Company anticipates being able to short-term liquidity through cash generated from operations. has very strong long- and short-term debt ratings which will continue to refinance this debt at favorable rates in commercial markets. In addition, the Company has agreements with a diverse creditworthy financial institutions that, if needed, would credit funding to meet short-term financing requirements. financial results includes several measures not defined by these measures provide our investors with additional information underlying results and trends of the Company, as well as insight metrics used to evaluate management. When used in MD&A, we have provided the comparable GAAP measure in the discussion. growth is a non-GAAP measure of sales growth excluding the acquisitions, divestitures and foreign exchange from year-over-year We believe this provides investors with a more complete understanding underlying sales trends by providing sales growth on a consistent reconciliation of reported sales growth to organic sales for Acquisition/Divestiture Impact of reported sales growth to organic sales for the fiscal year Acquisition/Divestiture Impact defined as operating cash flow less capital spending. We view an important measure because it is one factor in determining available for dividends and discretionary investment. Free of the measures used to evaluate senior management and is a determining their at-risk compensation. productivity is defined as the ratio of free cash flow to net Companys long-term target is to generate free cash at or above 90 net earnings. Free cash flow is also one of the measures used management. The reconciliation of free cash flow and free cash is provided below (amounts in millions): Qualitative Disclosures About",5403
2007-05-14,8-K,0000080424-07-000083,"8-K - Business Unit Realignment - 05/14/2007 to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 of Report (Date of earliest event reported) name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area code ) communications pursuant to Rule 425 under the Securities Act material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS May 14, 2007, the Board of Directors of The Procter & Gamble Company (the Company) elected Susan E. Arnold (53), currently Vice Chair - P&G Beauty & Health, to the position of President - Global Business Units. In addition, the Board of Directors elected McDonald (53), currently Vice Chair - Global Operations, of Chief Operating Officer. These changes will be effective and both principal officers will serve at the pleasure of the past five years, Ms. Arnold held the following positions Company: President - Global Personal Beauty Care & Global Feminine Care (7/1/02 - 6/30/04), Vice Chair - P&G Beauty (7/1/04 - 4/16/06) and Vice Chair - P&G Beauty & Health (4/17/06 - the past five years, Mr. McDonald held the following positions Company: President - Global Fabric & Home Care (7/12/01 - 6/30/04) and Vice Chair - Global Operations (7/1/04 - present). May 14, 2007, the Board of Directors of The Procter & Gamble Company (the Company) announced some business unit realignments and associated changes to its executive management structure effective July copy of the Companys press release announcing these changes I attached Company is furnishing the items in this section pursuant Regulation FD Disclosure. to the requirements of the Securities Exchange Act of 1934, the has duly caused this Report to be signed on its behalf by the hereunto duly authorized. Release by The Procter & Gamble Company dated May 14,",329
2007-05-31,8-K,0000080424-07-000095,"13 OR 15(d) of The Securities Exchange Act Of 1934 of Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act material pursuant to Rule 14a-12 under the Exchange Act (17 communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange & Gamble Company (the Company) has been advised that A.G. Lafley, Chairman of the Board, President and Chief Executive of the entered into a stock trading plan designed to comply with Rule of the Securities Exchange Act of 1934, as amended. Under Rule 10b5-1(c), directors and officers may adopt a prearranged plan for the sale of Company securities under specified conditions plan allows for the sale of a maximum of 160,000 shares of common stock over a two-year period during the Companys trading windows, and provides for sales of specified share amounts at specified market prices, subject to specified limitations. Sales pursuant to this plan may begin in February 2008 and will terminate on 2009, unless terminated sooner in accordance with the plan's This plan was established during the Company's current trading is merely an extension of Mr. Lafleys current plan. Any sales under the plan will comply with the holding period requirement gains as implemented by the Companys Board of Directors and described in the Companys Proxy Statement. In addition, Mr. Lafley and the Company will publicly disclose any of his stock sales made be required by law, the Company does not undertake to report plans by other Company officers or directors, nor to report transactions or other activities under Mr. Lafley's plan any other officer or director. The Company is furnishing this 8-K pursuant to Item 7.01, Regulation FD requirements of the Securities Exchange Act of 1934, the Registrant duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.",328
2007-06-05,8-K,0000080424-07-000098,"8-K - Mid-Quarter Update - AMJ 2007 13 OR 15(d) of The Securities Exchange Act Of 1934 Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act material pursuant to Rule 14a-12 under the Exchange Act (17 communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange 7.01 REGULATION FD DISCLOSURE The Procter & Gamble Company (the ""Company"") issued a news release confirming previously announced sales and earnings guidance for the April June quarter. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure"". requirements of the Securities Exchange Act of 1934, the Registrant has caused this Report to be signed on its behalf by the undersigned hereunto Release by The Procter & Gamble Company dated June 5,",151
2007-06-12,8-K,0000950152-07-005078,"THE PROCTER & GAMBLE COMPANY 8-K Pursuant to Section 13 OR 15(d) of the Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) June 12, 2007 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) Registrants telephone number, including area code Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR ITEM 5.02(b) and ITEM 5.02(d) DEPARTURE OF DIRECTOR and ELECTION OF A NEW DIRECTOR The Procter & Gamble Company (the Company) announced today that Norman R. Augustine will retire following P&Gs August board meeting. The Company also announced today that Rajat K. Gupta was appointed to the Board of Directors, effective immediately. Mr. Guptas committee assignments have The Company is filing this 8-K pursuant to Item 5.02 (b), Departure of Directors and Item 5.02(d), Election of Directors. A copy of the Companys press release relating to these announcements is being furnished as Exhibit ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS The following exhibit is furnished as part of this Form 8-K: News Release by The Procter & Gamble Company dated June 12, 2007.",238
2007-07-10,8-K,0000080424-07-000114,"8-K - Declare August 2007 Dividend 13 OR 15(d) of The Securities Exchange Act Of 1934 of Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act material pursuant to Rule 14a-12 under the Exchange Act (17 communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange 2007, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of thirty-five ($0.35) per share on the Common Stock and on the Series A and ESOP Convertible Class A Preferred Stock of the Company, payable after August 15, 2007 to shareholders of record at the close of business on July 20, 2007. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD the requirements of the Securities Exchange Act of 1934, the has duly caused this Report to be signed on its behalf by the hereunto duly authorized.",174
2007-08-03,8-K,0000080424-07-000131,"8-K - Earnings Release AMJ 2007 13 OR 15(d) of The Securities Exchange Act Of 1934 Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities material pursuant to Rule 14a-12 under the Exchange Act communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange 2.02 RESULTS OF OPERATIONS AND FINANCIAL The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended June 30, 2007. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations requirements of the Securities Exchange Act of 1934, the Registrant caused this Report to be signed on its behalf by the undersigned Procter & Gamble Company dated August 3, 2007.",145
2007-08-15,8-K,0000080424-07-000160,"8-K - Gorman Retires from BOD 13 OR 15(d) of The Securities Exchange Act Of 1934 Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act communications pursuant to Rule 13e-4(c) under the Exchange Act 5.02(b) DEPARTURE OF DIRECTOR; The Procter & Gamble Company (the ""Company"") issued a news release announcing that in accordance with the Companys customary retirement age for directors, Joseph T. Gorman has announced his intention to retire effective the October 2007 P&G Board of Directors meeting. Mr. Gorman, who has been a director since 1993, will turn 70 on October 1. The Company is filing this 8-K pursuant to Item 5.02(b), ""Departure of Directors or Principal requirements of the Securities Exchange Act of 1934, the Registrant has caused this Report to be signed on its behalf by the undersigned hereunto Procter & Gamble Company dated August 15, 2007.",186
2007-08-23,8-K,0000080424-07-000171,"13 OR 15(d) of The Securities Exchange Act Of 1934 Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act communications pursuant to Rule 13e-4(c) under the Exchange Act Material Definitive Agreement The Procter & Gamble Company (the Company) and Procter & Gamble International S.a.r.l., Procter & Gamble Holding (HK) Limited and Procter & Gamble International Operations, each Named Borrowers and wholly-owned subsidiaries of the Company, entered into an amendment and restatement existing $24 billion 3-year credit facility that was entered into on July 2005, (as previously amended, the Credit Facility), with a syndicate of banks led by Citigroup and JP Morgan. The amendment resulted in two new credit facilities: (i) a $17 billion 364-day credit facility, the cost of which variable interest rate of 8.5 basis points over LIBOR for drawn balances; (ii) a $6 billion 5-year credit facility, the cost of which is 8.5 basis over LIBOR for drawn balances until August 2008, when it increases to 15 points over LIBOR. Proceeds from each of these facilities will be used commercial paper backstop and general corporate purposes. The Company and other Named Borrowers expects to pay down these two new facilities from combination of operating cash flow, commercial paper and term debt beginning one or more of banks in the syndicate (including Citigroup and JP Morgan), and/or their affiliates have provided, and may in the future provide, banking services to the Company and its subsidiaries. Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. disclosed above under Item 1.01 is incorporated herein by requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto",330
2007-08-28,10-K,0000950152-07-007152,"PROCTER & GAMBLE COMPANY 10-K THE PROCTER & GAMBLE COMPANY ANNUAL REPORT ON FORM 10-K SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION ANNUAL REPORT ON FORM 10-K PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended June 30, 2007 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-434 THE PROCTER & GAMBLE COMPANY One Procter & Gamble Plaza, Cincinnati, Ohio 45202 IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio Securities registered pursuant to Section 12(b) of the Act: Name of each Exchange on which registered Common Stock, without Par Value Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  No o Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes o No  Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No o Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrants knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Large accelerated filer  Accelerated filer o Non-accelerated filer o Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No  The aggregate market value of the voting stock held by non-affiliates amounted to $203 billion on There were 3,120,750,759 shares of Common Stock outstanding as of July 31, 2007. Documents Incorporated By Reference Portions of the Annual Report to Shareholders for the fiscal year ended June 30, 2007 are incorporated by reference into Part I, Part II and Part IV of this report to the extent described Portions of the Proxy Statement for the 2007 Annual Meeting of Shareholders are incorporated by reference into Part III of this report to the extent described herein. Item 1B. Unresolved Staff Comments Item 3. Legal Proceedings Item 4. Submission of Matters to a Vote of Security Holders Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities Item 6. Selected Financial Data Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations Item 7A. Quantitative and Qualitative Disclosures About Market Risk Item 8. Financial Statements and Supplementary Data Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure Item 9A. Controls and Procedures Item 9B. Other Information Item 10. Directors and Executive Officers of the Registrant Item 11. Executive Compensation Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters Item 13. Certain Relationships and Related Transactions Item 14. Principal Accounting Fees and Services Item 15. Exhibits and Financial Statement Schedules Additional information required by this item is",593
2007-09-18,8-K,0000080424-07-000190,"13 OR 15(d) of The Securities Exchange Act Of 1934 Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act communications pursuant to Rule 13e-4(c) under the Exchange Act 2007, The Procter & Gamble Company (the ""Company"") issued a news release confirming previously announced sales and earnings guidance for the July September quarter. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure"". requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto Procter & Gamble Company dated September 18, 2007.",144
2007-09-25,8-K,0000080424-07-000214,"13 OR 15(d) of The Securities Exchange Act Of 1934 Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act communications pursuant to Rule 13e-4(c) under the Exchange Act provides information on the change in the reporting structure of The & Gamble Company (the Company) and a summary of the effects of this change on the Companys historical segment results. The change in segment reporting will be reflected retrospectively, but in no way revises or restates Consolidated Statements of Earnings, Consolidated Balance Sheets, Consolidated Statements of Shareholders Equity or Consolidated Statements of Cash Flows for the Company and consolidated subsidiaries for any period. 2008 Changes to Global Business Unit (GBU) Structure May 2007, the Company announced a number of changes to our organization structure and certain of our key leadership positions that became effective July 1, 2007. These resulted in changes to our GBU and segment structure. Specifically, our new structure is comprised of three GBUs with a total 2007, the Company consisted of three Global Business Units: Beauty and Household Care; and Gillette GBU. The businesses that previously comprised Gillette GBU are now included within the Beauty and Household Care GBUs. result of these moves, the Duracell and Braun business will no longer separate reportable segment. The Braun business has been combined and managed with the Blades and Razors business to form the Grooming reportable segment within the Beauty GBU. The Grooming reportable segment also includes face and shave prep products, previously reported within the Beauty reportable segment. The Duracell business has been moved to our Household Care GBU be reported as part of our Fabric Care and Home Care reportable segment. Finally, our feminine care business, which previously was part of our and reportable segment, is now being managed within our Health and Well-Being GBU and will be reported as part of the Health Care reportable segment. effective as of July 1, 2007. All financial statements, beginning in ending September 30, 2007, will reflect the new segment reporting structure. This change in segment reporting will be reflected on a retrospective with prior years also adjusted to reflect the new segment reporting structure. The Company is issuing this Form 8-K in order to provide investors with financial information and historical data that is on a basis consistent Companys new segment reporting structure. Exhibit 99.1 provides quarterly financial summary information by reportable segment for the fiscal year June 30, 2007. Exhibit 99.2 provides fiscal year financial summary information by reportable segment for the fiscal years ended June 30, 2005, 2006 requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto Segment Financial Summary Information- Fiscal Year Ended June 30, Segment Financial Summary Information (Fiscal Years Ended June 30, 2005 -",510
2007-10-09,8-K,0000950152-07-007930,"THE PROCTER & GAMBLE CO. 8-K Shareholder Meeting SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) October 9, 2007 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) Registrants telephone number, including area code (513) 983-1100 o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On October 9, 2007, The Procter & Gamble Company (the Company) issued a news release with respect to Chairman of the Board and Chief Executive Officer A.G. Lafleys address to the shareholders at the Companys annual meeting. The Company is furnishing this 8-K pursuant to Item 7.01, Regulation FD Disclosure.",185
2007-10-09,8-K,0000950152-07-007949,"THE PROCTER & GAMBLE CO. 8-K Dividend Declaration SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) October 9, 2007 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) Registrants telephone number, including area code (513) 983-1100 o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On October 9, 2007, The Procter & Gamble Company (the Company) announced that its Board of Directors declared a quarterly dividend of thirty-five cents ($0.35) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after November 15, 2007 to shareholders of record at the close of business on October 19, 2006. The Company is furnishing this 8-K pursuant to Item 7.01, Regulation FD Disclosure.",216
2007-10-10,8-K,0000080424-07-000216,"13 OR 15(d) of The Securities Exchange Act Of 1934 Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act communications pursuant to Rule 13e-4(c) under the Exchange Act 5.02(b) DEPARTURE OF CERTAIN OFFICERS; APPOINTMENT OF 2007, The Procter & Gamble Company [NYSE:PG] announced that Richard L. Antoine, global human resources officer, will retire effective March 31, The Company also announced that Moheet Nagrath, currently vice president-corporate human resources, has been elected global human resources officer effective January 1, 2008. The Company is filing this 8-K pursuant to Item 5.02(b), ""Departure of Certain Officers; Appointment of Certain requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto Procter & Gamble Company dated October 10, 2007.",175
2007-10-12,8-K,0000080424-07-000233,"Committee Assignment Changes 13 OR 15(d) of The Securities Exchange Act Of 1934 Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act communications pursuant to Rule 13e-4(c) under the Exchange Act 5.02(d) ELECTION OF DIRECTORS Directors of The Procter & Gamble Company (the ""Board"") announced today that Rajat K. Gupta, who was appointed to the Board on June 12, 2007, and elected the Companys shareholders at its annual meeting on October 9, 2007, has been named to the Board's Audit and Innovation & Technology announced that it has dissolved the standing Finance Committee and decided Committee assignments for the Board's four remaining standing Committees, requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto",174
2007-10-30,8-K,0000080424-07-000235,"8-K JAS 2007 EARNINGS RELEASE to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 of Report (Date of earliest event reported) name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area code ) communications pursuant to Rule 425 under the Securities Act (17 material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange OF OPERATIONS AND FINANCIAL CONDITION 30, 2007, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended September The Company is furnishing this 8-K pursuant to Item 2.02, ""Results to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Release by The Procter & Gamble Company dated October 30,",161
2007-10-31,10-Q,0000950152-07-008417,"PROCTER & GAMBLE COMPANY 10-Q SECURITIES AND EXCHANGE COMMISSION QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES For the Quarterly Period Ended September 30, 2007 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES For the transition period from to Commission file number 1-434 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Large accelerated filer  Accelerated filer o Non-accelerated filer o Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No  There were 3,105,639,235 shares of Common Stock outstanding as of September 30, 2007. PART I. FINANCIAL INFORMATION Item 1. Financial Statements. Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations. Item 3. Quantitative and Qualitative Disclosures About Market Risk. Item 4. Controls and Procedures. PART II. OTHER INFORMATION Item 1. Legal Proceedings. Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. Item 4. Submission of Matters to a Vote of Security Holders. PART I. FINANCIAL INFORMATION Item 1. Financial Statements. The Consolidated Statements of Earnings of The Procter & Gamble Company and subsidiaries (the Company, we or our) for the three months ended September 30, 2007 and 2006, the Consolidated Balance Sheets as of September 30, 2007 and June 30, 2007, and the Consolidated Statements of Cash Flows for the three months ended September 30, 2007 and 2006 follow. In the opinion of management, these unaudited consolidated financial statements contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, such financial statements may not necessarily be indicative of annual results. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS Amounts in millions except per share amounts EARNINGS BEFORE INCOME TAXES See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS Cash and cash equivalents Prepaid expenses and other current assets PROPERTY, PLANT AND EQUIPMENT NET PROPERTY, PLANT AND EQUIPMENT GOODWILL AND OTHER INTANGIBLE ASSETS Trademarks and other intangible assets, net NET GOODWILL AND OTHER INTANGIBLE ASSETS LIABILITIES AND SHAREHOLDERS EQUITY Accrued and other liabilities TOTAL CURRENT LIABILITIES OTHER NON-CURRENT LIABILITIES Common stock  shares issued  Additional paid-in capital Reserve for ESOP debt retirement Accumulated other comprehensive income TOTAL SHAREHOLDERS EQUITY TOTAL LIABILITIES AND SHAREHOLDERS EQUITY See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD Depreciation and amortization Share-based compensation expense Accounts payable, accrued and other liabilities Other operating assets and liabilities TOTAL OPERATING ACTIVITIES Proceeds from asset sales Change in investment securities TOTAL INVESTING ACTIVITIES Dividends to shareholders Change in short-term debt Additions to long-term debt Reductions of long-term debt Impact of stock options and other TOTAL FINANCING ACTIVITIES EFFECT OF EXCHANGE RATE CHANGES ON CASH CHANGE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, END OF PERIOD See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS These statements should be read in conjunction with the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2007. The results of operations for the three-month period ended September 30, 2007 are not necessarily indicative of annual Comprehensive Income  Total comprehensive income is composed primarily of net earnings, net currency translation gains and losses, impacts of net investment and cash flow hedges and net unrealized gains and losses on investment securities. Total comprehensive income for the three months ended September 30, 2007 and 2006 was $4,113 million and $2,663 million, respectively. Segment Information  Following is a summary of segment results. In May 2007, we announced a number of changes to our organization structure and certain of our key leadership positions. The changes became effective on July 1, 2007 and resulted in changes to our GBU and reporting segment structure. The businesses that previously comprised the Gillette GBU are now included within the Beauty and Household Care GBUs. The Braun business has been combined with the Blades & Razors business to form the Grooming reportable segment within the Beauty GBU. The Grooming reportable segment also includes all face and shave prep products which were previously reported within the Beauty reportable segment. Duracell was moved to our Household Care GBU and will be reported as part of our Fabric Care and Home Care reportable segment. Finally, our feminine care business, which previously was part of our Beauty GBU and reportable segment, is now part of our Health and Well-Being GBU and will be reported as part of the Health Care reportable segment. The following segment information reflects the new segment reporting structure. Three Months Ended September 30 The Company acquired the Gillette Company in October 2005. At that time, we recognized an assumed liability for Gillette exit costs of $1.23 billion, including $854 million in separations related to approximately 5,500 people, $55 million in employee relocation costs and $320 million in other exit costs. These costs are primarily related to the elimination of selling, general and administrative overlap between the two companies in areas like Global Business Services, corporate staff and go-to-market support, as well as redundant manufacturing capacity. As of September 30, 2007, the remaining liability was $548 million. Total integration plan charges against the assumed liability were $68 million for the three months ended September 30, 2007. We expect such activities to be substantially complete by June 30, 2008. Goodwill and Other Intangible Assets  Goodwill as of September 30, 2007 is allocated by reportable segment and global business unit as follows (amounts in millions): Beauty, beginning of year Acquisitions and divestitures Goodwill, September 30, 2007 Grooming, beginning of year Acquisitions and divestitures Goodwill, September 30, 2007 Health Care, beginning of year Acquisitions and divestitures Goodwill, September 30, 2007 Snacks, Coffee and Pet Care, beginning of year Acquisitions and divestitures Goodwill, September 30, 2007 Fabric Care and Home Care, beginning of year Acquisitions and divestitures Goodwill, September 30, 2007 Baby Care and Family Care, beginning of year Acquisitions and divestitures Goodwill, September 30, 2007 GOODWILL, NET, beginning of year Acquisitions and divestitures Goodwill, September 30, 2007 The increase in goodwill from June 30, 2007 is primarily due to currency translation. Identifiable intangible assets as of September 30, 2007 are comprised of (amounts in Amortizable intangible assets with Intangible assets with indefinite Total identifiable intangible assets Amortizable intangible assets consist principally of brands, patents, technology, and customer relationships. The non-amortizable intangible assets consist primarily of The amortization expense of intangible assets for the three months ended September 30, 2007 and 2006 was $157 million and $163 million, respectively. Pursuant to SFAS 123(R) Share-Based Payment, companies must recognize the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of those awards (the fair-value-based method). Total share-based compensation for the three months ended September 30, 2007 and 2006 are summarized in the following table (amounts in millions): Total Share-Based Compensation Assumptions utilized in the model are evaluated and revised, as necessary, to reflect market conditions and experience. Postretirement Benefits  The Company offers various postretirement benefits to its The components of net periodic benefit cost are as follows: Expected Return on Plan Assets Amortization of Deferred Amounts Recognized Net Actuarial Loss Gross Benefit Cost (Credit) Dividends on ESOP Preferred Stock Net Periodic Benefit Cost (Credit) For the year ending June 30, 2008, the expected return on plan assets is 7.4% and 9.3% for defined benefit and other retiree benefit plans, respectively. On July 1, 2007, we adopted FASB Interpretation 48, Accounting for Uncertainty in Income Taxes (FIN 48). FIN 48 addresses the accounting and disclosure of uncertain tax positions. FIN 48 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The difference between the tax benefit recognized in the financial statements for a position in accordance with FIN 48 and the tax benefit claimed in the tax return is referred to as an unrecognized tax benefit. The adoption of FIN 48 resulted in a decrease to retained earnings as of July 1, 2007 of $232 million, which was reflected as a cumulative effect of a change in accounting principle, with a corresponding increase to the net liability for unrecognized tax benefits. The impact primarily reflects the accrual of additional statutory interest and penalties as required by FIN 48, partially offset by adjustments to existing unrecognized tax benefits to comply with FIN 48 measurement principles. The implementation of FIN 48 also resulted in a reduction in our net tax liabilities for uncertain tax positions related to prior acquisitions accounted for under purchase accounting, resulting in an $80 million decrease to goodwill. Additionally, the Company historically classified unrecognized tax benefits in current taxes payable. As a result of the adoption of FIN 48, unrecognized tax benefits not expected to be paid in the next 12 months were reclassified to other non-current liabilities. The total amount of unrecognized tax benefits at July 1, 2007 is $2,971 million, excluding any related accruals for interest and penalties. Included in the total unrecognized tax benefits is $1,893 million that, if recognized, would impact the effective tax rate in future periods. We recognize accrued interest and penalties related to unrecognized tax benefits in income tax expense. interest and penalties as of July 1, 2007 were $589 million and $128 million, respectively, on an after tax basis. The amount of unrecognized tax benefits and related interests and penalties that are expected to be paid in the next 12 months are not P&G files income tax returns in multiple federal, state and local US and foreign jurisdictions. The Company is subject to examination by the taxing authorities in these jurisdictions, with open tax years generally ranging from 1997 and forward. The Company has on-going audits in various stages of completion in several jurisdictions, one or more of which might conclude within the next 12 months. Audit outcomes and the timing of audit settlements are subject to significant uncertainty at this time. Such settlements will involve some or all of the following: the payment of additional taxes, the adjustment of certain deferred taxes and/or the recognition of unrecognized tax benefits. It is possible that the amount of unrecognized benefit with respect to certain of our uncertain tax positions will significantly increase or decrease within the next twelve months related to the audits described above. At this time, we are not able to make a reasonable estimate of the range of impact on the balance of unrecognized tax benefits or the impact on the effective tax rate related to these items. The unrecognized tax benefits described above will be included in the Companys annual Form 10-K contractual obligations table to the extent the Company is able to make reliable estimates of the timing of cash settlements with the respective taxing authorities. If not, the total amount of unrecognized tax benefits will be disclosed in a footnote to the contractual obligations table. At this time, the Company can not make a reliable estimate as to the timing of cash settlements. No other new accounting pronouncement issued or effective during the fiscal year had or is expected to have a material impact on the consolidated financial statements. Item 2. Managements Discussion and Analysis of Financial Condition and Results of The purpose of this discussion is to provide an understanding of P&Gs financial results and condition by focusing on changes in certain key measures from year to year. Managements Discussion and Analysis (MD&A) is organized in the following sections: Forward-Looking Statements Results of Operations  Three Months Ended September 30, 2007 Business Segment Discussion  Three Months Ended September 30, 2007 Reconciliation of Non-GAAP Measures Throughout MD&A, we refer to measures used by management to evaluate performance, including unit volume growth, net outside sales and after-tax profit. We also refer to organic sales growth, free cash flow and free cash flow productivity. These financial measures are not defined under accounting principles generally accepted in the United States of America (U.S. GAAP). The explanation of these measures at the end of MD&A provides more details on the use and the derivation of these measures. Management also uses certain market share and market consumption estimates to evaluate performance relative to competition despite some limitations on the availability and comparability of share information. References to market share and market consumption in MD&A are based on a combination of vendor-reported consumption and market size data, as well as internal estimates. P&Gs business is focused on providing branded consumer goods products. Our goal is to provide products of superior quality and value to improve the lives of the worlds consumers. We believe this will result in leadership sales, profits and value creation, allowing employees, shareholders and the communities in which we operate to prosper. Our products are sold in more than 180 countries primarily through mass merchandisers, grocery stores, membership club stores and drug stores. We have also expanded our presence in high frequency stores, the neighborhood stores which serve many consumers in developing markets. We compete in multiple product categories and have three global business units (GBUs): Beauty; Health and Well-Being; and Household Care. Under U.S. Generally Accepted Accounting Principles, the business units comprising the GBUs are aggregated into six reportable segments: Beauty; Grooming; Health Care; Snacks, Coffee and Pet Care; Fabric Care and Home Care; and Baby Care and Family Care. We have on-the-ground operations in over 80 countries through our Market Development Organization, which leads country business teams to build our brands in local markets and is organized along seven geographic areas comprised of three developed regions (North America, Western Europe and Northeast Asia) and four developing regions (Latin America, Central and Eastern Europe/Middle East/Africa, Greater China and ASEAN/Australasia/India). The following table provides the percentage of net sales and net earnings by reportable business segment for the three months ended September 30, 2007 (excludes net sales and net earnings in Health and Well-Being GBU Snacks, Coffee and Pet Care Fabric Care and Home Care Baby Care and Family Care Following are highlights of results for the three months ended September 30, 2007: Net sales grew eight percent to $20.2 billion. Organic sales, which exclude the impacts of acquisitions, divestitures and foreign exchange, increased five percent. Unit volume increased five percent. Every reportable segment and each of our geographic regions delivered year-on-year volume growth. Net earnings increased 14 percent to $3.1 billion. Net earnings increased behind sales growth, operating profit margin improvement and a one-time tax benefit. Diluted net earnings per share were $0.92, an increase of 16 percent versus the comparable prior year period. This included a $0.02 per share, or two percent, benefit from a one-time tax benefit incurred during the quarter. Operating cash flow was $3.2 billion, an increase of nine percent versus the prior year period. Free cash flow productivity was 87 percent for the quarter, roughly in-line with the year-ago period. Free cash flow productivity is defined as the ratio of operating cash flow less capital expenditures to net earnings. FORWARD-LOOKING STATEMENTS We discuss expectations regarding future performance, events and outcomes, such as our business outlook and objectives, in annual and quarterly reports, press releases and other written and oral communications. All such statements, except for historical and present factual information, are forward-looking statements, and are based on financial data and our business plans available only as of the time the statements are made, which may become out-of-date or incomplete. We assume no obligation to update any forward-looking statements as a result of new information, future events or other factors. Forward-looking statements are inherently uncertain, and investors must recognize that events could be significantly different from our expectations. Ability to Achieve Business Plans. We are a consumer products company and rely on continued demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers and retail trade customers. Our continued success is dependent on leading-edge innovation with respect to both products and operations and on the continued positive reputations of our brands. This means we must be able to obtain patents and respond to technological advances and patents granted to competition. Our success is also dependent on effective sales, advertising and marketing programs in an increasingly fragmented media environment. Our ability to innovate and execute in these areas will determine the extent to which we are able to grow existing sales and volume profitably, especially with respect to the product categories and geographic markets (including developing markets) in which we have chosen to focus. There are high levels of competitive activity in the environments in which we operate. To address these challenges, we must respond to competitive factors, including pricing, promotional incentives and trade terms. We must manage each of these factors, as well as maintain mutually beneficial relationships with our key customers, in order to effectively compete and achieve our business plans. Since our goals include a growth component tied to acquisitions, we must manage and integrate key acquisitions, such as the Gillette and Wella acquisitions, including achieving the cost and growth synergies in accordance with stated goals. Cost Pressures. Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, cost of labor, foreign exchange and interest rates. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects, sourcing decisions and certain hedging transactions. We also must manage our debt and currency exposure, especially in volatile countries. We need to maintain key manufacturing and supply arrangements, including sole supplier and sole manufacturing plant arrangements. We must implement, achieve and sustain cost improvement plans, including our outsourcing projects and those related to general overhead and workforce rationalization. Global Economic Conditions. Economic changes, terrorist activity and political unrest may result in business interruption, inflation, deflation or decreased demand for our products. Our success will depend in part on our ability to manage continued global political and/or economic uncertainty, especially in our significant geographic markets, as well as any political or economic disruption due to terrorist and other hostile activities. Regulatory Environment. Changes in laws, regulations and the related interpretations may alter the environment in which we do business. This includes changes in environmental, competitive and product-related laws, as well as changes in accounting standards and taxation requirements. Accordingly, our ability to manage regulatory, tax and legal matters (including product liability, patent and intellectual property matters, as well as those related to the integration of Gillette and its subsidiaries) and to resolve pending matters within current estimates may impact our RESULTS OF OPERATIONS  Three Months Ended September 30, 2007 The following discussion provides a review of results for the three months ended September 30, 2007 versus the three months ended September 30, 2006. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information SELLING, GENERAL & ADMINISTRATIVE OTHER NON-OPERATING INCOME, NET EARNINGS BEFORE INCOME TAXES AVERAGE DILUTED SHARES OUTSTANDING COMPARISONS AS A % OF NET SALES SELLING, GENERAL & ADMINISTRATIVE EARNINGS BEFORE INCOME TAXES Net sales for the quarter were up eight percent to $20.2 billion. Sales growth was broad-based with all reportable segments delivering six percent or higher sales growth. Unit volume increased five percent for the quarter led by high single-digit growth in Fabric Care and Home Care and in Baby Care and Family Care. Each geographic region posted year-on-year volume growth, led by double-digit growth in developing regions. Volume grew behind initiative activity, led by Tide, Downy, Febreze, Fusion, Head & Shoulders, Boss, Dolce & Gabbana, Naturella, Pampers, Charmin and Pringles, all of which posted high-single digit or higher volume growth to offset softness in Braun and pet care. There was no net mix impact for the quarter as positive product mix resulting from a continued shift towards premium products was offset by disproportionate growth in developing regions, where average unit selling prices are below the Company average. Foreign exchange had a positive three percent impact on sales growth. Organic sales increased five percent for the Net Sales Change Drivers 2007 vs. 2006 (Three Months Ended Sept. 30) Health and Well-Being GBU Snacks, Coffee and Pet Care Fabric Care and Home Care Baby Care and Fabric Care Sales percentage changes are approximations based on quantitative formulas that are consistently Gross margin was up 10-basis points for the quarter to 52.9% of net sales. Commodity cost increases had a negative impact on gross margin of approximately 80-basis points but were more than offset by scale leverage from volume growth and cost savings projects. Total selling, general and administrative expenses (SG&A) increased seven percent to $6.3 billion. SG&A as a percentage of net sales was down 20-basis points as lower overhead spending as a percentage of net sales more than offset higher marketing spending as a percentage of net sales. Overhead spending as a percentage of net sales was down primarily due to volume scale leverage, overhead cost controls and Gillette synergy savings. Interest expense for the quarter was roughly in-line with the year-ago period. Other non-operating income was also roughly in-line with the prior year. The base period included a gain on the sale of Pert in North America and Sure, while the current period includes a gain on the sale of our adult incontinence business in Japan. Net earnings increased 14 percent to $3.1 billion behind sales growth, operating profit margin expansion and a reduction in our tax rate. Our tax rate was down from 30.4% to 27.6% due to a reduction in our going rate from a shift in the mix of earnings to lower tax rate countries and a one-time tax benefit resulting from a reduction in the German statutory tax rate, which reduced our deferred tax liabilities related to acquired intangible assets. Diluted net earnings per share were $0.92, up 16 percent versus the prior year. Diluted earnings per share included a $0.02 per share, or two percent impact, from the one-time tax benefit. BUSINESS SEGMENT DISCUSSION  Three Months Ended September 30, 2007 The following discussion provides a review of results by business segment. Analyses of the results for the three months ended September 30, 2007 are provided compared to the same three month period ended September 30, 2006. The primary financial measures used to evaluate segment performance are net sales and net earnings. The table below provides supplemental information on net sales and net earnings by business segment for the three months ended September 30, 2007 versus the comparable prior year period (amounts in millions): Three Months Ended September 30, 2007 Health and Well-Being GBU Snacks, Coffee and Pet Care Fabric Care and Home Care Baby Care and Family Care Beauty net sales increased six percent during the quarter to $4.6 billion. Sales increased behind two percent volume growth, a one percent positive product mix impact from disproportionate growth in prestige fragrances and three points of favorable foreign exchange. Prestige Fragrances volume was up high-single digits behind growth on Dolce & Gabbana, Hugo Boss and Lacoste. In skin care, volume was up low-single digits as high-single digit growth in developing regions more than offset lower developed market volumes from the impact of a base period in North America that included the launch of Olay Definity. Olay market share in the US increased more than one point versus the year-ago period. Hair care volume was also up low-single digits as high-single digit growth in developing regions more than offset a low-single digit volume decline in developed regions due to the timing of promotion and initiative activity in North America. Hair care market share in the U.S. increased by nearly two points during the quarter. The SK-II brand continues to recover from prior period business disruptions in Asia and had a negative impact of roughly one percent on Beauty sales. Net earnings in Beauty increased nine percent to $689 million primarily behind higher sales growth. Before-tax profit margin was roughly in-line with the year-ago period as volume scale leverage and cost savings projects in manufacturing and overheads offset the impact of higher commodity costs and increased marketing investment. Grooming net sales increased nine percent to $2.0 billion during the quarter. Sales were up behind five percent volume growth, a positive one percent pricing impact and a four percent favorable foreign exchange impact. These were partially offset by a negative one percent mix impact as positive product mix from growth on the premium-priced Fusion brand was more than offset by disproportionate growth in developing regions, where average selling prices are below the segment average. Blades and razors volume increased high-single digits behind growth in developing regions exceeding 20%. In developed regions, blades and razors volume was down due to a base period that included significant pipeline shipments related to the Fusion launch in Western Europe and Japan. Fusion delivered double-digit volume growth in every geographic region where it has launched. Market share in the U.S. was up four points on Fusion and two points on Venus behind the Venus Breeze launch. Braun volume was down mid-single digits for the quarter primarily due to lower home appliances shipments resulting from shipment constraints in Western Europe and a de-emphasis of the home appliances business in the U.S. Net earnings in Grooming were up 17% for the quarter to $451 million behind sales growth and a 150-basis point earnings margin expansion. Earnings margin improved behind lower overhead spending from volume scale leverage and Gillette synergies, partially offset by higher marketing investment levels as a percentage of net sales. HEALTH AND WELL-BEING GBU Health Care net sales increased seven percent during the quarter to $3.6 billion behind a four percent increase in volume. Pricing added one percent and foreign exchange had a positive three percent impact on net sales. Disproportionate growth in developing regions on feminine care and oral care resulted in a negative one percent mix impact. Feminine care volume increased mid-single digits behind double-digit growth in developing regions. Oral care volume was up low-single digits behind high-single digit growth in developing regions. Oral care volume in developed regions grew slightly over a base period that included the launch of Crest Pro Health paste in North America. Crest toothpaste market share in the U.S. increased more than one point versus the year-ago period behind continued growth on Pro Health. Volume in pharmaceuticals and personal health was in-line with the year-ago period as the impact of adding the Swiss Precision Diagnostics business was offset by lower bas business shipments on the remaining categories. Net earnings in Health Care were up nine percent to $648 million behind sales growth and gross margin improvement. Gross margin was up behind volume scale leverage, pricing and lower product costs. SG&A was roughly in-line with the year-ago period as higher marketing spending was offset by lower overheads as a Snacks, Coffee and Pet Care Snacks, Coffee and Pet Care net sales increased six percent to $1.1 billion during the quarter. Volume increased two percent while product mix from the launch of premium-priced coffee products and favorable foreign exchange each had a positive two percent impact. Snacks volume was up double-digits behind the launch of Rice Infusion in Western Europe. Coffee volume increased mid-single digits behind the launch of Folgers Black Silk, Folgers House Blend and Dunkin Donuts coffee. In pet care, volume was down due to continued negative impacts from the voluntary wet pet food recall in the U.S. last fiscal year. Net earnings in Snacks, Coffee and Pet Care increased 30% to $113 million as a result of sales growth, an insurance recovery related to Hurricane Katrina and lower overhead and marketing spending as a percentage of net sales. Fabric Care and Home Care Fabric Care and Home Care net sales increased 10 percent to $5.9 billion. Volume was up eight percent and favorable foreign exchange added three percent to sales growth. This was partially offset by a negative one percent mix impact primarily from disproportionate growth in developing regions and on large pack sizes in fabric care. Fabric care volume increased high-single digits behind the initial wave of the liquid laundry detergent compaction launch in North America and the launch of Tide Pure Essentials. Home care volume was up double-digits for the quarter behind the Dawn restage in North America, the launch of Febreze candles and continued expansion of auto-dishwashing products in Western Europe. Batteries volume was up mid-single digits behind double-digit volume growth in developing regions. Net earnings in Fabric Care and Home Care increased 10 percent to $916 million. Earnings margin was in-line with the year-ago level as a slight reduction in gross margin was offset by an improvement SG&A. Gross margin was down slightly as volume scale leverage and manufacturing cost savings projects largely offset higher commodity costs. SG&A improved as a percentage of net sales as higher marketing spending was more than offset by lower overheads as a percentage of net sales. Baby Care and Family Care Baby Care and Family Care net sales increased 10 percent to $3.4 billion behind eight percent volume growth and a three percent favorable foreign exchange impact, partially offset by a negative one percent mix impact from disproportionate growth on large pack sizes and on the lower-priced Basic product tier. Volume growth was balanced across the segment with high-single digit growth in both baby care and family care. Baby care volume in developed regions was up mid-single digits behind growth on Pampers Baby Stages of Development and on the Baby Dry caterpillar flex initiative. In developing regions, baby care volume was up double-digits, led by growth on Pampers across regions. Family care volume was up behind the Charmin product restage and continued growth on the Basic product tier. Net earnings in Baby Care and Family Care were up 12 percent to $430 million behind sales growth and a 50-basis point improvement in before-tax profit margin. Gross margin declined from the impact of higher pulp and commodity costs, but was more than offset by lower SG&A as a percentage of sales resulting from lower overhead and marketing as a percentage of Corporate includes certain operating and non-operating activities not allocated to specific business units. These include: the incidental businesses managed at the corporate level, financing and investing activities, certain restructuring charges, other general corporate items and the historical results of certain divested brands and categories, including certain Gillette brands that were divested as required by the regulatory authorities in relation to the Gillette acquisition. Corporate also includes reconciling items to adjust the accounting policies used in the segments to U.S. GAAP. The most significant reconciling items include income taxes (to adjust from statutory rates that are reflected in the segments to the overall Company effective tax rate), adjustments for unconsolidated entities (to eliminate sales, cost of products sold and SG&A for entities that are consolidated in the segments but accounted for using the equity method for U.S. GAAP) and minority interest adjustments for subsidiaries where we do not have 100% ownership. Since both unconsolidated entities and less than 100% owned subsidiaries are managed as integral parts of the Company, they are accounted for similar to a wholly owned subsidiary for management and segment purposes. This means our segment results recognize 100% of each income statement component through before-tax earnings in the segments, with eliminations for unconsolidated entities in Corporate. In determining segment net earnings, we apply the statutory tax rates (with adjustments to arrive at the Companys effective tax rate in Corporate) and eliminate the share of earnings applicable to other ownership interests, in a manner similar to minority Net earnings in Corporate increased $47 million versus the year-ago period. The increase was driven primarily by the aforementioned one-time tax benefit resulting from a change in the statutory tax rate in Germany, partially offset by higher restructuring spending. Cash generated from operating activities was $3.2 billion, an increase of nine percent versus the comparable prior year period. Net earnings, adjusted for non-cash items (primarily depreciation, amortization, share based compensation and deferred income taxes) provided $4.2 billion of operating cash. This was partially offset by an increase in working capital driven by higher inventory and accounts receivable levels. Investing activities in the current year used $419 million, compared to the prior year period cash use of $448 million. Capital expenditures were $540 million, or 2.7 percent of net sales for the quarter. Proceeds from asset sales generated $274 million in cash from the sale of our adult incontinence business in Japan and cash received during the current quarter for minor Beauty divestitures that closed last fiscal year. Total cash used by financing activities was $3.6 billion versus $2.5 billion in the comparable prior year period. We repurchased $2.6 billion of treasury shares under a previously announced share buyback program that started in July 2007. We reduced our debt position by $385 million during the quarter. In the prior year period, we repurchased $1.4 billion of treasury shares funded in part by increases in our debt position of $550 million during the period. As of September 30, 2007 the Companys current liabilities exceeded current assets by $5.7 billion, driven by our short-term debt position. The Company anticipates being able to support its short-term liquidity through cash generated from operations. The Company also has very strong long- and short-term debt ratings which will enable it to continue to refinance this debt at favorable rates in commercial paper and bond markets. In addition, the Company has agreements with a diverse group of creditworthy financial institutions that, if needed, would provide sufficient credit funding to meet short-term financing requirements. RECONCILIATION OF NON-GAAP MEASURES Our discussion of financial results includes several measures not defined by U.S. GAAP. We believe these measures provide our investors with additional information about the underlying results and trends of the Company, as well as insight to some of the metrics used to evaluate management. When used in MD&A, we have provided the comparable GAAP measure in the discussion. Organic Sales Growth . Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions, divestitures and foreign exchange from year-over-year comparisons. We believe this provides investors with a more complete understanding of underlying sales trends by providing sales growth on a consistent basis. The reconciliation of reported sales growth to organic sales for the July-September quarter: Less: Foreign Exchange Impact Less: Acquisition/Divestiture Impact Free Cash Flow . Free cash flow is defined as operating cash flow less capital spending. We view free cash flow as an important measure because it is one factor in determining the amount of cash available for dividends and discretionary investment. Free cash flow is also one of the measures used to evaluate senior management and is a factor in determining their at-risk Free Cash Flow Productivity . Free cash flow productivity is defined as the ratio of free cash flow to net earnings. The Companys long-term target is to generate free cash at or above 90 percent of net earnings. Free cash flow is also one of the measures used to evaluate senior management. The reconciliation of free cash flow and free cash flow productivity is provided below (amounts in millions): Item 3. Quantitative and Qualitative Disclosures About Market Risk. There have been no material changes in the Companys exposure to market risk since June 30, 2007. Additional information can be found in the section entitled Other Information, which appears on page 47, and Note 6, Risk Management Activities, which appears on pages 59-60 of the Annual Report to Shareholders for the fiscal year ended June 30, 2007 which can be found by reference to Exhibit 13 of the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2007. Item 4. Controls and Procedures. Evaluation of Disclosure Controls and Procedures. The Companys Chairman of the Board and Chief Executive Officer, A. G. Lafley, and the Companys Chief Financial Officer, Clayton C. Daley, Jr., performed an evaluation of the Companys disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (Exchange Act)) as of the end of the period covered by this report. Messrs. Lafley and Daley have concluded that the Companys disclosure controls and procedures were effective to ensure that information required to be disclosed in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) accumulated and communicated to our management, including Messrs. Lafley and Daley, to allow their timely decisions regarding required disclosure. Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting that occurred during the Companys fiscal quarter ended September 30, 2007 that have materially affected, or are reasonably likely to materially affect, the Companys internal control over financial reporting. PART II. OTHER INFORMATION Item 1. Legal Proceedings. In August 2007, The Procter & Gamble Manufacturing Company, a subsidiary of the Company, received and subsequently accepted an offer of settlement from the Sacramento Metropolitan Air Quality Management District to resolve notices of violation alleging noncompliance with certain air emission permit requirements at the subsidiarys Sacramento, California plant. The subsidiary paid $42,720 to settle one notice and $60,660 to settle two other notices. These issues were resolved through the Districts Mutual Settlement Program and no judicial proceeding was involved. For a discussion of the Companys risk factors, please refer to Part 1, Item 1A. Risk Factors in the Companys Annual Report on Form 10-K for the fiscal year ended June 30, Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. ISSUER PURCHASES OF EQUITY SECURITIES Approximate dollar value of purchased under our share The number of shares purchased other than through a publicly announced repurchase plan were 3,695,396. All transactions were made in the open market. This includes 70,821 shares acquired by the Company under various compensation and benefit plans and 3,624,575 shares acquired by the Profit Sharing Trust. This table excludes shares withheld from employees to satisfy minimum tax withholding requirements on option exercises and other equity-based transactions. The Company administers cashless exercises through an independent, third party broker and does not repurchase stock in connection with cashless exercise. Average price paid per share is calculated on a settlement basis and excludes commission. On August 3, 2007, the Company announced a share repurchase plan authorized by the Companys Board of Directors. Pursuant to the share repurchase plan, the Company announced its intention to acquire in open market and/or private transactions $24 to $30 billion of Company common stock over the next three fiscal years to be financed with cash generated from operations and by issuing a combination of long-term and short-term debt. Certain purchases accounted for in Column 4 of this table were made prior to the announcement of the program but are considered purchases against the program. The numbers listed in Column 5 include commissions paid to brokers to execute the transactions. Item 4. Submission of Matters to a Vote of Security Holders. At the Companys 2007 Annual Meeting of Shareholders held on October 9, 2007, the following actions were taken: The following Directors were elected for terms of office expiring in 2008: Pursuant to the terms of the Notice of Annual Meeting and Proxy Statements, proxies received were voted, unless authority was withheld, in favor of the election of the seven In addition, the following Directors continued to serve as Directors after the meeting: A proposal by the Board of Directors to ratify the appointment of Deloitte & Touche LLP as the Companys independent registered public accounting firm to conduct the annual audit of the financial statements of the Company and its subsidiaries for the fiscal year ending June 30, 2008, was approved by the shareholders. The shareholders cast 2,609,051,396 votes in favor of this proposal and 26,049,138 votes against. There were A shareholder resolution proposed by Mrs. Evelyn Y. Davis was defeated by the shareholders. The proposal requested that the Board of Directors take the necessary steps to award no new stock options. The Board opposed the resolution. The shareholders cast 81,497,637 votes in favor of the resolution and 2,046,486,408 against. There were 41,993,765 abstentions and 493,491,471 broker non-votes. A shareholder resolution proposed by The Free Enterprise Action Fund was defeated by the shareholders. The proposal requested that the Board of Directors report on company policies intended to promote free enterprise, improve the general business environment and to prevent anti-business activists from harming shareholder value. The Board opposed the resolution. The shareholders cast 94,056,423 votes in favor of the resolution and 1,853,046,023 against. There were 222,875,364 abstentions and 493,491,471 broker A shareholder resolution proposed by People for the Ethical Treatment of Animals was defeated by the shareholders. The proposal requested that the Board of Directors report phasing out Iams funding for and use of laboratory tests on animals and replacing these tests with methods offered by PetSci, LLC. The Board opposed the resolution. The shareholders cast 76,836,000 votes in favor of the resolution and 1,778,800,507 against. There were 314,341,303 abstentions and 493,491,471 broker non-votes. Although these actions occurred following the first quarter, the Company is voluntarily including this information here. Amended Articles of Incorporation (Incorporated by reference to Exhibit (3-1) of the Companys Form 10-Q for the quarter ended September 30, 2005). Regulations (as amended by shareholders at the annual meeting on October 10, 2006) (Incorporated by reference to Exhibit (3-2) of the Companys Form 10-Q for the quarter ended September 30, 2006). Summary of the Companys Short Term Achievement Reward Program, and related correspondence and terms and conditions.* The Procter & Gamble 2001 Stock and Incentive Compensation Plan (as amended on August 14, 2007) which was adopted by shareholders at the annual meeting on October 9, 2001, and related correspondence and terms and conditions.* The Procter & Gamble 2003 Non-Employee Directors Stock Plan (as adjusted for the stock split effective May 21, 2004) which was adopted by the shareholders at the annual meeting on October 14, 2003, and related correspondence and terms and conditions.* The Gillette Company 2004 Long-Term Incentive Plan.* Amended Revolving Credit Agreement among Procter & Gamble International S.a.r.l and a syndicate of banks led by Citigroup. Computation of Earnings per Share. Computation of Ratio of Earnings to Fixed Charges.",7203
2007-10-31,8-K,0000950152-07-008431,"The Procter & Gamble Company 8-K SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) October 31, 2007 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) Registrants telephone number, including area code (513) 983-1100 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) As disclosed in its most recent Form 10-K for the year ended June 30, 2007, the Procter & Gamble Company (the Company) announced changes to its segment reporting structure that were effective July 1, 2007. Such changes are discussed below in Fiscal Year 2008 Changes to Global Business Unit (GBU) Structure. This Form 8-K provides revised (1) Managements Discussion and Analysis (MD&A) and (2) Consolidated Financial Statements and accompanying footnotes that reflect the impact of this new reporting structure. The change in the reporting structure, as reflected in the information included in this Form 8-K, only affects the manner in which segment results were previously reported. It in no way revises or restates the Companys Consolidated Statements of Earnings, Consolidated Balance Sheets, Consolidated Statements of Shareholders Equity or Consolidated Statements of Cash Flows for any period. The only changes to the information disclosed in the Companys original Form 10-K filing are to the segment discussion within the MD&A and to Footnotes 2, 3 and 12, as these were the only sections impacted by the change in the Companys segment reporting structure. Fiscal Year 2008 Changes to Global Business Unit (GBU) Structure In May 2007, the Company announced a number of changes to our organization structure and certain of our key leadership positions that became effective on July 1, 2007. These resulted in changes to our GBU and segment structure. Specifically, our new structure is comprised of three GBUs with a total of six reportable segments: Global Business Unit (GBU)  Snacks, Coffee and Pet Care  Fabric Care and Home Care  Baby Care and Family Care Prior to July 1, 2007, the Company consisted of three Global Business Units: Beauty and Health; Household Care; and Gillette GBU. The businesses that previously comprised the Gillette GBU are now included within the Beauty and Household Care GBUs. As a result of these moves, the Duracell and Braun business no longer comprise a separate reportable segment. The Braun business has been combined and is being managed with the Blades and Razors business to form the Grooming reportable segment within the Beauty GBU. The Grooming reportable segment also includes all face and shave prep products, which were previously reported within the Beauty reportable segment. The Duracell business has been moved to our Household Care GBU and is now be reported as part of our Fabric Care and Home Care reportable segment. Finally, our feminine care business, which previously was part of our Beauty GBU and reportable segment, is now being managed within our Health and Well-Being GBU and is now reported as part of the Health Care reportable segment. These changes were effective as of July 1, 2007. All financial statements, beginning in the quarter ended September 30, 2007, reflect the new segment reporting structure. This change in segment reporting was reflected on a retrospective basis, with prior years also revised to reflect the new segment reporting structure. The Company is issuing this Form 8-K in order to provide revised financial information that is on a basis consistent with the Companys new segment reporting structure. provides a revised Managements Discussion and Analysis (MD&A); Exhibit 99-2 provides a revised Consolidated Financial Statements and accompanying footnotes; Exhibit 99-3 provides the updated report of the independent registered public accountant; and Exhibit 99-4 provides the Consent of Deloitte & Touche, LLP.",709
2008-01-08,8-K,0000080424-08-000022,"13 OR 15(d) of The Securities Exchange Act Of 1934 Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act communications pursuant to Rule 13e-4(c) under the Exchange Act 5.02(d) ELECTION OF DIRECTORS 2008, The Procter & Gamble Company (the ""Company"") issued a news release announcing that Patricia A. Woertz was appointed to the Board of Directors, effective immediately. Ms. Woertz will serve on the Audit Committee and the Governance & Public Responsibility Committee. filing this 8-K pursuant to Item 5.02(d), ""Election of Directors."" copy of the Company's press release relating to these announcements is being furnished as Exhibit 99 requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto Procter & Gamble Company dated January 8, 2008.",178
2008-01-08,8-K,0000080424-08-000023,"13 OR 15(d) of The Securities Exchange Act Of 1934 of Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange 2008, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of thirty-five cents ($0.35) per share on the Common Stock and on the Series A and Series ESOP Convertible Class A Preferred Stock of the Company, payable after February 15, 2008 to shareholders of record at the close of business on January 18, 2008. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Release by The Procter & Gamble Company dated January 8,",184
2008-02-01,8-K,0000080424-08-000033,"to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area code ) communications pursuant to Rule 425 under the Securities Act (17 material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange OF OPERATIONS AND FINANCIAL CONDITION January 31, 2008, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended December 2007 and announcing the Company's intention to separate its coffee business through a spin-off or a split-off transaction. The Company furnishing this 8-K pursuant to Item 2.02, ""Results of Operations Financial Condition"" and Item 7.01, ""Regulation FD Disclosure."" to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Release by The Procter & Gamble Company dated January 31, 2008.",178
2008-02-01,10-Q,0000080424-08-000035,"of Financial Condition and Results purpose of this discussion is to provide an understanding of P&Gs financial results and condition by focusing on changes in certain key measures from year to year. Management's Discussion and Analysis (MD&A) is organized in of Operations  Three Months Ended December 31, of Operations  Six Months Ended December 31, Segment Discussion  Three Months Ended December 31, Segment Discussion  Six Months Ended December 31, measures used by management to evaluate performance , including outside sales and after-tax profit. We also refer to financial defined under accounting principles generally accepted in the United States of America GAAP) , including organic sales growth, free cash flow and free cash flow productivity. The explanation of these measures at the end of MD&A provides more details on the use and the derivation of these measures. Management also uses certain market share and market consumption estimates to evaluate performance relative to competition despite some limitations on the availability and comparability of share information. References to market share and market consumption in MD&A are based on a combination of vendor-reported consumption and market size data, as well as internal estimates. providing branded consumer goods products. Our goal is to provide products of superior quality and value to improve the lives of the world's consumers. We believe this will result in leadership sales, profits and value creation, allowing employees, shareholders and the communities in which we operate to prosper. products are sold in more than 180 countries primarily through mass merchandisers, grocery stores, membership stores and drug stores. We have also expanded our presence in ""high frequency stores,"" the neighborhood stores which serve many consumers in developing markets. We compete in multiple product categories and have three global business units (GBUs): Beauty; Health and Well-Being; Household Care. Under U.S. Generally Accepted Accounting Principles, the business units comprising the GBUs are aggregated into six reportable segments: Beauty; Grooming; Health Care; Snacks, Coffee and Pet Care; Fabric Care and Home Care; and Baby Care and Family Care. We have on-the-ground operations in over 80 countries through our Market Development Organization, which leads country business teams to build our brands in local markets and is organized along seven geographic areas comprised of three developed regions (North America, Western Europe and Northeast Asia) and developing regions (Latin America, Central and Eastern Europe/Middle East/Africa, Greater China and ASEAN/Australasia/India). following table provides the percentage of net sales and net earnings by reportable business segment for the three months ended December 31, 2007 (excludes net sales and net earnings in Corporate): following table provides the percentage of net sales and net earnings by reportable business segment for the six months ended December 31, 2007 (excludes net sales and net earnings in Corporate): are highlights of results for the six months ended December 31, sales grew eight percent to $41.8 billion. Organic sales, which exclude the impacts of acquisitions, divestitures and foreign exchange, volume increased five percent and organic volume grew six percent. Every reportable segment and geographic region posted year-on-year organic volume growth. earnings increased 14 percent to $6.3 billion. Net earnings increased behind sales growth, higher operating profit, a lower and favorable foreign exchange. net earnings per share were $1.90, an increase of 17 percent versus comparable prior year period. cash flow was $7.4 billion, an increase of 36 percent versus the year period. Free cash flow productivity was 97 percent for the fiscal year to date period. Free cash flow productivity is defined as the ratio of operating cash flow less capital expenditures discuss expectations regarding future performance, events and outcomes, such as our business outlook and objectives, in annual and quarterly reports, press releases and other written and oral communications. All such statements, except for historical and present factual information, are ""forward-looking statements,"" and are based financial data and our business plans available only as of the time the statements are made, which may become out-of-date or incomplete. We assume no obligation to update any forward-looking statements as a result information, future events or other factors. Forward-looking statements are inherently uncertain, and investors must recognize that events could be significantly different from our expectations. Plans. We are a consumer products company and rely on continued demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers and retail trade customers. Our continued success is dependent on leading-edge innovation with respect to both products and operations and on the continued positive reputations of our brands. This means we must be able to obtain patents and respond to technological advances and patents granted competition. Our success is also dependent on effective sales, advertising and marketing programs in an increasingly fragmented media environment. Our ability to innovate and execute in these areas will determine the extent to which we are able to grow existing sales and volume profitably, especially with respect to the product categories and geographic markets (including developing markets) in which we have chosen to focus. There are high levels of competitive activity in the environments in which we operate. To address these challenges, we must respond to competitive factors, including pricing, promotional incentives and trade terms. We must manage each of these factors, as well as maintain mutually beneficial relationships with our key customers, in order effectively compete and achieve our business plans. Since our goals include a growth component which can be affected by acquisitions and divestitures, we must manage and integrate key company transactions, such Gillette and Wella acquisitions, including achieving the cost and growth synergies for those transactions in accordance with stated goals, and the successful separation of the Companys coffee business while continuing to deliver the Companys goals. Pressures. Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, cost of labor, foreign exchange and interest rates. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects, sourcing decisions and certain hedging transactions. We also must manage our debt and currency exposure, especially in volatile countries. We need to maintain key manufacturing and supply arrangements, including sole supplier and sole manufacturing plant arrangements. We must implement, achieve and sustain cost improvement plans, including our outsourcing projects and those related to general overhead and workforce rationalization. Conditions. Economic changes, terrorist activity and political unrest may result in business interruption, inflation, deflation or decreased demand for our products. Our success will depend in part on our ability to manage continued global political and/or economic uncertainty, especially in our significant geographic markets, as well as any political economic disruption due to terrorist and other hostile activities. Environment. Changes in laws, regulations and the related interpretations may alter the environment in which we do business. This includes changes in environmental, competitive and product-related laws, as well as changes in accounting standards and taxation requirements. Accordingly, our ability to manage regulatory, tax and legal matters (including product liability, patent and intellectual property matters, as well as those related to the integration of Gillette and its subsidiaries) and to resolve pending matters within current estimates may Three Months Ended December 31, 2007 following discussion provides a review of results for the three months ended December 31, 2007 versus the three months ended December 31, 2006. PROCTER & GAMBLE COMPANY AND SUBSIDIARIES in Millions Except Per Share Amounts) GENERAL & ADMINISTRATIVE EXPENSE NON-OPERATING INCOME, NET DILUTED SHARES OUTSTANDING GENERAL & ADMINISTRATIVE EXPENSE increased nine percent for the quarter to $21.6 billion. Sales were up behind a five percent increase in unit volume and a five percent favorable foreign exchange impact. These were partially offset by a negative one percent mix impact resulting from disproportionate double-digit volume growth in developing regions, where average selling price is below the company average. Volume growth was broad-based across geographies with each geographic region posting year-on-year organic volume growth. All reportable segments except Snacks, Coffee and Pet Care grew both total and organic volume, led by Fabric Care and Home Care, Baby Care and Family Care, Grooming. Volume grew primarily behind initiative activity on our key brands and continued developing region expansion. Duracell, Febreze, Fusion, Head & Shoulders, Nice N Easy, Pampers, Prilosec and Tide each delivered double-digit volume growth for the quarter. Organic sales were up five percent for the quarter behind six percent organic volume Sales Change Drivers 2007 vs. 2006 (Three Months Ended Dec. with Acquisitions & Divestitures excluding Acquisitions & Divestitures percentage changes are approximations based on quantitative formulas that are margin was down 110-basis points for the quarter to 51.8% of net sales. Commodity and energy cost increases had a negative impact on gross margin of over 150-basis points. These were partially offset by scale leverage from volume growth and cost savings projects. selling, general and administrative expenses (SG&A) increased six percent to $6.5 billion. SG&A as a percentage of net sales was down 90-basis points as lower overhead spending as a percentage of net sales more than higher marketing spending as a percentage of net sales. Overhead spending as a percentage of net sales was down primarily due to scale leverage, overhead cost controls and Gillette synergy savings. expense for the quarter was up $50 million versus the year-ago period due higher interest rate driven by the geographic mix of our short-term borrowings. Other non-operating income increased $113 million versus the prior year period primarily due to the gain on the sale of our Western European family care business, which closed on October 1, 2007. earnings increased 14 percent for the quarter to $3.3 billion behind sales growth, higher operating profit, a lower tax rate and favorable foreign exchange. Our tax rate declined from 30.0% to 27.6% primarily due to the favorable settlement of tax audits and a more favorable geographic mix earnings. Diluted net earnings per share were $0.98, up 17 percent versus the prior year. Diluted net earnings per share growth exceeded net earnings growth due to share repurchase activity. Months Ended December 31, 2007 following discussion provides a review of results for the six months ended December 31, 2007 versus the six months ended December 31, 2006. PROCTER & GAMBLE COMPANY AND SUBSIDIARIES in Millions Except Per Share Amounts) GENERAL & ADMINISTRATIVE EXPENSE NON-OPERATING INCOME, NET DILUTED SHARES OUTSTANDING GENERAL & ADMINISTRATIVE EXPENSE for fiscal year to date period were up eight percent to $41.8 billion behind five percent volume growth and a favorable four percent foreign exchange impact. This was partially offset by a negative one percent mix impact primarily due to disproportionate double-digit growth in developing regions. Volume growth was broad-based across segments and geographic regions. Each reportable segment and geographic region as well as 15 of our top 16 countries delivered year-on-year organic volume growth for fiscal year to date period. Volume grew behind initiative activity, led by Tide, Downy, Febreze, Fusion, Head & Shoulders, Hugo Boss, Dolce & Gabbana, Naturella, Pampers, Charmin and Pringles, all of which posted high-single digit or higher volume growth to offset declines on Braun, Actonel and in pet care. Organic sales increased five percent for the fiscal year to date period behind six percent organic volume Sales Change Drivers 2007 vs. 2006 (Six Months Ended Dec. with Acquisitions & Divestitures excluding Acquisitions & Divestitures percentage changes are approximations based on quantitative formulas that margin was down 60-basis points fiscal year to date to 52.3% of net sales. Commodity and energy cost increases had a negative impact on gross margin of over 120-basis points. These were largely offset by scale leverage from volume growth and cost savings selling, general and administrative expenses (SG&A) increased six percent to $12.7 billion for the fiscal year to date period. SG&A as a percentage of net sales was down 50-basis points primarily behind lower overhead spending as a percentage of net sales. Overhead spending as a percentage of net sales was down primarily due to scale leverage, overhead controls and Gillette synergy savings. Marketing spending as a percentage of net sales increased slightly versus the year ago period to initiative activity on key brands. expense for the fiscal year to date period was up $51 million versus the year-ago period due to a higher interest rate driven by the geographic mix our short-term borrowings. Other non-operating income increased $126 million primarily due to higher current year divestiture gains, including on the sale of our Western European family care business and our Japanese incontinence business. The base period included gains on the sale of Pert in North America and Sure. earnings increased 14 percent to $6.3 billion behind sales growth, higher operating profit, a lower tax rate and favorable foreign exchange. Our tax rate declined from 30.2% to 27.6% due to a one-time tax benefit resulting from a reduction in the German statutory tax rate, reduced our deferred tax liabilities related to acquired intangible assets, favorable settlement of tax audits and a more favorable geographic mix of earnings. Diluted net earnings per share were up 17 percent versus the prior year to $1.90 per share. Three and Six Months Ended December 31, 2007 following discussion provides a review of results by business segment. Analyses of the results for the three and six months ended December 31, 2007 are provided compared to the same three and six month period ended December 31, 2006. The primary financial measures used to evaluate segment performance are net sales and net earnings. The table below provides supplemental information on net sales and net earnings business segment for the three and six months ended December 31, 2007 versus comparable prior year period (Amounts in millions): Months Ended December 31, 2007 Months Ended December 31, 2007 net sales increased 10 percent during the quarter to $5.1 billion. Net sales were up behind percent foreign exchange impact. Disproportionate growth priced Prestige fragrances and on skin care products drove a favorable one percent mix impact on net sales. Organic sales increased five volume increased high-single digits Regenerist. Volume in Prestige Fragrances was up mid-single digits with continued growth on volume was up low-single digits as professional hair care and flat volume on earnings margin was down 10-basis points as a reduction in gross margin was largely offset by an improvement SG&A. Gross margin was down primarily due to higher commodity costs. SG&A as a percentage of net sales was down as higher marketing spending was more than offset by lower overhead spending as a net sales increased eight percent fiscal behind two percent volume growth, a one percent positive product mix impact growth in prestige fragrances and five points exchange. Prestige Fragrances volume was up mid-single digits behind growth on Dolce & Gabbana, Hugo digits behind growth on Olay care volume was up low-single developing markets was partially offset by a volume decline in North America . Head was up double-digits globally. Pantene volume grew low-single digits globally as high-single digits growth in developing markets was largely offset earnings in Beauty increased nine percent to $1.6 billion primarily behind higher sales gross margin was more than offset by improved SG&A as a percentage of net sales and a lower tax rate. Gross margin was down due to higher commodity costs. SG&A improved as lower overhead a percentage of net sales was partially offset by increased marketing investment. net sales increased nine percent for the quarter to $2.2 billion behind seven percent volume growth. Net sales benefited from a favorable seven percent foreign exchange impact, partially offset by a negative five percent mix impact primarily due to disproportionate double-digit growth developing regions, where average selling prices are below the segment average. Blades and razors volume was up double-digits behind developing region volume growth of approximately 20% driven by the expansion Fusion. In developed regions, high-single digit growth in North America driven by Fusion and Venus Breeze more than offset reductions in Western European markets from the impact of pipeline volume in the base period related to the Fusion launch. In Braun, mid-single digit volume growth in male and female hair removers was more than offset by reductions home appliances resulting from supply constraints at our contract manufacturer, a de-emphasis of the home appliances business in the U.S. and the divestiture thermometer and blood pressure devices. Net earnings in Grooming were up 11 percent for the quarter to $429 million. Net earnings margin improved 30-basis points for the quarter as lower gross margins were more offset by lower SG&A as a percentage of net sales. Gross margin declined primarily due to higher costs incurred at our contract manufacturer the Braun home appliance business. SG&A improved as higher marketing spending as a percentage of net sales was more than offset by lower net sales increased nine percent to $4.2 billion fiscal year to date. Sales were up behind six percent volume growth, a six percent favorable foreign exchange impact and a one percent positive pricing impact carryover price increases. These were partially offset by a negative four percent mix impact as positive product mix from growth on the premium-priced Fusion brand was more than offset by disproportionate growth developing regions. Blades and razors volume increased high-single digits behind volume growth of over 20% in developing regions driven primarily by Fusion expansion. In developed regions, blades and razors volume was down low-single digits due to a base period that included significant pipeline shipments related to the Fusion launch in Western Europe and Japan. Braun volume was down mid-single digits fiscal year to date primarily due to lower home appliances shipments resulting from supply constraints at our contract manufacturer, a de-emphasis of the home appliances business in the U.S. and the divestiture of thermometer and blood pressure devices. Net earnings in Grooming were up 14% fiscal year to date to $880 million behind sales growth and a 90-basis point earnings margin expansion. Earnings margin improved as a reduction in gross margin was more than offset by improved SG&A as a percentage of net sales. Gross margin declined primarily due to higher costs incurred at our contract manufacturer on the Braun home appliance business. SG&A was down due to lower overhead spending, partially offset by higher marketing investment levels as a percentage of net Care net sales were up 11 percent during the quarter to $3.8 billion. Sales grew behind a five percent increase in volume and a six percent favorable foreign exchange impact. Oral care volume was up high-single digits driven by double-digit growth in developing regions Crest toothpaste. Oral care volume grew mid-single digits in developed regions behind Oral-B brushes and Crest toothpaste and oral rinse. Feminine care volume was up mid-single digits behind double-digit growth in developing regions, partially offset by the impact divestiture of our Japanese adult incontinence business. Volume in pharmaceuticals and personal health was in-line with the year ago period double-digit growth on Prilosec OTC and the addition of the Swiss Precision Diagnostics joint venture were offset by lower shipment levels on Actonel Vicks. Net earnings in Health Care were up 10 percent to $715 million. Net earnings margin was down 10-basis points as reduced gross margin from a less profitable geographic and product mix and higher commodity costs was partially offset by lower overhead and marketing spending a percentage of net sales. Care net sales increased nine percent fiscal year to date to $7.3 billion a five percent increase in volume. Foreign exchange had a positive five percent impact on net sales. Disproportionate growth in developing regions on feminine care and oral care resulted in a negative percent mix impact. Oral care volume was up mid-single digits behind initiative-driven growth on Oral-B brushes and Crest toothpaste. Feminine care volume increased mid-single digits behind double-digit growth in developing regions. Volume in pharmaceuticals and personal health was up low-single digits as the impact of adding the Precision Diagnostics business and mid-single digit growth on Prilosec OTC largely offset by lower shipments on Actonel and Vicks. Net earnings in Health Care were up 10 percent to $1.4 billion behind sales growth and 20-basis point improvement in net earnings margin. Net earnings margin increased behind lower SG&A as a percentage of net sales, partially offset by lower gross margin. Gross margin was down due to a less profitable geographic and product mix and higher commodity costs. SG&A improved primarily behind lower overhead spending as a percentage of net sales. Coffee and Pet Care net sales increased four percent for the quarter to $1.3 billion. Sales benefited from a positive one percent pricing impact from the carryover effect of price increases in coffee and pet care and a percent favorable foreign exchange impact. Volume for the segment was in-line with the year-ago level as growth in snacks and coffee was offset decline in pet care. Snacks volume increased mid-single digits behind the Pringles Minis and Selects initiatives. Coffee volume was up low-single digits behind the recent launches of Dunkin Donuts, Folgers Black Silk and Folgers House Blend. In pet care, volume was down high-single digits primarily due to continued negative impacts from the voluntary wet pet food recall in the U.S. in March 2007. Net earnings in Snacks, Coffee and Pet Care were down 15 percent to $127 million for the quarter. Higher sales were more than offset by a 220-basis point decline in net earnings margin. Net earnings margin was down due to a reduction in gross margin partially offset by lower overhead spending as percentage of net sales. Gross margin was down primarily due to Coffee and Pet Care net sales increased five percent to $2.4 billion fiscal to date. Sales grew behind a one percent volume increase and a three percent favorable foreign exchange impact. Favorable product mix, primarily from growth in premium priced coffee, added one percent to net sales. Snacks volume was up high-single digits behind the launch of Rice Infusion in Western Europe and continued growth on Pringles Minis and Selects. Coffee volume increased mid-single digits behind the launch of Folgers Black Silk, Folgers House Blend and Dunkin Donuts coffee. In pet care, volume was down mid-single digits due to continued negative impacts from the voluntary wet pet food recall in the March 2007. Net earnings in Snacks, Coffee and Pet Care increased one percent to $240 million. Net earnings margin was down 30-basis points as a first-quarter insurance recovery related to Hurricane Katrina and lower overhead and marketing spending as a percentage of net sales were more than offset by a reduction in gross margin driven by higher commodity January 2008, P&G announced plans to separate its coffee business and create an independent company. The coffee business had net sales of approximately $1.6 billion and operating income of about $350 million in year 2007. Although no decision has been made on the form of the separation, P&G expects to do a spin-off or split-off Care and Home Care net sales increased 10 percent for the quarter to $6.1 billion behind seven percent volume growth. Favorable foreign exchange added five percent to net sales, but was partially offset by a negative two percent mix impact resulting from disproportionate double-digit growth developing regions. Fabric Care volume was up high-single digits behind double-digit volume growth in developing regions and initiative activity on Tide, Ariel, Downy and Gain, including continued growth from the expansion the liquid laundry detergent compaction project in North America. Home Care volume was up low-single digits as growth on initiative activity, including Febreze Candles and the Western Europe Air launch, was partially offset by market softness in North America. In batteries, volume was up double-digits in both developed and developing regions behind promotion programs during the holiday period. Net earnings in Fabric Care and Home Care increased six percent to $882 million for the quarter. Net earnings margin was down 60-basis points primarily due to lower gross margin from increased commodity costs. SG&A was roughly in-line with the year ago period as lower overhead spending as a percentage of net sales was largely offset by higher marketing spending as Care and Home Care net sales increased 10 percent to $12.0 billion fiscal to date. Volume was up eight percent and favorable foreign exchange added four percent to sales growth. This was partially offset by a negative two percent mix impact primarily from disproportionate double-digit growth in developing regions and on large pack sizes in fabric care. Fabric care volume increased high-single digits behind double-digit developing region growth, the liquid laundry detergent compaction launch in North America and initiative activity on Tide, Gain, Ariel and Downy. Home care volume was up high-single digits behind the Dawn restage in North America, the launch of Febreze Candles and continued expansion of auto-dishwashing products in Western Europe. Batteries volume was up high-single digits behind double-digit growth in developing regions and high-single digit growth in North America behind promotional activity. Net earnings in Fabric Care and Home Care increased eight percent to $1.8 billion. Earnings margin was down 30-basis points primarily due to lower gross margin. Gross margin was down as volume scale leverage and manufacturing cost savings projects were more than offset higher commodity costs. SG&A improved as a percentage of net sales as higher marketing spending was more than offset by lower overheads and Family Care net sales increased eight percent for the quarter to $3.4 billion, including the impact of the Western European family care divestiture. Sales were up behind two percent volume growth, five points of favorable foreign exchange and a one percent favorable mix impact. Organic volume and organic sales, which exclude the impacts of foreign exchange and the Western European family care divestiture, grew percent. Baby care volume increased double-digits behind double-digit growth in developing regions, driven by the expansion of Pampers, and mid-single digit growth in developed regions, driven by Baby Dry, Swaddlers and Luvs. Family care volume was down high-single digits due to the sale of the Western European business. Family care organic volume was up mid-single digits behind growth on both Charmin and Bounty from recently launched product restages. Net earnings in Baby Care and Family Care were up 23 percent to $418 million behind sales growth and net earnings margin expansion. Net earnings margin was up 150-basis points behind higher gross margin and lower overhead spending as a percentage of net sales. Gross margin improved due to a more profitable product mix following the Western Europe family care divestiture, volume scale leverage cost savings projects, partially offset by higher commodity costs. and Family Care net sales increased nine percent fiscal year to date to $6.8 billion, including the impact of the Western European family care divestiture. Sales grew behind five percent volume growth and a four percent favorable foreign exchange impact. Organic sales, which exclude the impacts of foreign exchange and the Western European family care divestiture, grew eight percent behind nine percent organic volume growth. Organic volume growth was balanced across the segment with high-single digit growth in both baby care and family care. Baby care volume in developed regions was up mid-single digits behind growth on Pampers Baby Stages of Development and on the Baby Dry caterpillar flex initiative. In developing regions, baby care volume was up double-digits, led by growth on Pampers across regions. Family care organic volume was up high-single digits behind the Bounty and Charmin product restages and continued growth on the Basic product tier. Net earnings in Baby Care and Family Care were up 17 percent to $848 million. Net earnings margin improved 80-basis points primarily behind lower SG&A costs due to lower overhead and marketing as a percentage of net sales. Gross margin was up slightly as a more profitable product mix following the Western Europe family care divestiture, volume scale leverage cost savings projects were largely offset by higher commodity includes certain operating and non-operating activities not allocated to specific business units. These include: the incidental businesses managed at the corporate level, financing and investing activities, certain restructuring charges, other general corporate items and the historical results of certain divested brands and categories, including certain Gillette brands that were divested as required by the regulatory authorities in relation to the Gillette acquisition. Corporate also includes reconciling items to adjust the accounting policies used in the segments to U.S. GAAP. The most significant reconciling items include income taxes (to adjust from statutory rates that are reflected in the segments to the overall Company effective tax rate), adjustments for unconsolidated entities (to eliminate sales, cost of products sold and SG&A for entities that are consolidated in the segments but accounted for using the equity method for GAAP) and minority interest adjustments for subsidiaries where we do not 100% ownership. Since both unconsolidated entities and less than 100% owned subsidiaries are managed as integral parts of the Company, they are accounted for similar to a wholly owned subsidiary for management and segment purposes. This means our segment results recognize 100% of each income statement component through before-tax earnings in the segments, with eliminations for unconsolidated entities in Corporate. In determining segment net earnings, we apply the statutory tax rates (with adjustments arrive at the Companys effective tax rate in Corporate) and eliminate the share of earnings applicable to other ownership interests, in a manner similar earnings in Corporate increased $117 million for the quarter primarily due the gain on the sale of our Western European family care business and a lower tax rate, partially offset by higher interest expense. Our tax rate was down 240-basis points in the current quarter due to favorable settlements tax audits and a more favorable geographic mix of earnings. Fiscal year to date, net earnings in Corporate increased $166 million versus the year-ago period. The increase was driven primarily by higher divestiture gains and a lower tax rate, partially offset by higher interest expense. Divestiture gains in the current year period include our Western European family care business and our adult incontinence business Japan. Our fiscal year to date tax rate was down 260-basis points due to a one-time tax benefit in the first quarter resulting from a change in statutory tax rate in Germany, tax audit settlements and a more favorable generated from operating activities for the fiscal year to date period was billion, an increase of 36 percent versus the comparable prior year period. Operating cash increased due to higher net earnings and an improvement in working capital days versus the base period. Accounts receivable days improved by two days versus the prior year level due to Gillette integration benefits including a temporary increase in the base period due Gillette integration impacts. Inventory days increased one day and accounts payable days were down one day. activities in the current year used $915 million, compared to the prior year period cash use of $623 million. Capital expenditures were $1.2 billion, or 2.8 percent of net sales. Proceeds from asset sales generated $747 million in cash primarily from the sale of our Western European family care business and our adult incontinence business in Japan. cash used by financing activities was $6.7 billion this fiscal year to date, versus $6.6 billion in the comparable prior year period. We repurchased $5.5 billion of treasury shares under a previously announced buyback program that started in July 2007. We reduced our debt position by $72 million during the fiscal year. In the prior year period, we repurchased $2.7 billion of treasury shares and reduced our debt position by $2.6 billion. December 31, 2007 the Companys current liabilities exceeded current assets by $4.5 billion, driven by our short-term debt position. The Company anticipates being able to support its short-term liquidity through cash generated from operations. The Company also has very strong long- and short-term debt ratings which will enable it to continue to refinance this at favorable rates in commercial paper and bond markets. In addition, the Company has agreements with a diverse group of creditworthy financial institutions that, if needed, would provide sufficient credit funding to short-term financing requirements. discussion of financial results includes several measures not defined by GAAP. We believe these measures provide our investors with additional information about the underlying results and trends of the Company, as well insight to some of the metrics used to evaluate management. When used in MD&A, we have provided the comparable GAAP measure in the Growth . Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions, divestitures and foreign exchange from year-over-year comparisons. We believe this provides investors with a more complete understanding of underlying sales trends by providing growth on a consistent basis. reconciliation of reported sales growth to organic sales for the October Acquisition/Divestiture Impact reconciliation of reported sales growth to organic sales for the fiscal Acquisition/Divestiture Impact Flow . Free cash flow is defined as operating cash flow less capital spending. We view free cash flow as an important measure because it is one factor in determining the amount of cash available for dividends and discretionary investment. Free cash flow is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation. Productivity . Free cash flow productivity is defined as the ratio of free cash flow to net earnings. The Companys long-term target is to generate free cash at or above 90 percent of net earnings. Free cash flow is also one of the measures used to evaluate senior management. The reconciliation of free cash flow and free cash flow productivity is provided below (amounts in millions):",5565
2008-02-14,8-K,0000080424-08-000037,"to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 of Report (Date of earliest event reported) name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 5.02(b) & (c) DEPARTURE OF CERTAIN OFFICERS; APPOINTMENT OF February 13, 2008, The Procter & Gamble Company (the Company) announced that James J. Johnson, Chief Legal Officer and Secretary, will retire effective June 1, 2008. The Company also announced that Steven W. Jemison (56), currently Deputy General Counsel, has been elected to succeed Mr. Johnson as Chief Legal Officer and Secretary effective March 1, 2008. the past five years, Mr. Jemison held the following positions at the Company: Deputy General Counsel (July 2006 - present), Secretary & Associate General Counsel (July 2005- June 2006), and General Counsel  Central & Eastern Europe, Middle East and Africa (February 2003- June Company is filing this 8-K pursuant to Item 5.02(b) and (c), ""Departure of Certain Officers; Appointment of Certain Officers."" to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto BY : \ s\ E. J. Wunsch Release by The Procter & Gamble Company dated February 13,",256
2008-04-08,8-K,0000080424-08-000043,"13 OR 15(d) of The Securities Exchange Act Of 1934 of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange ITEM 7.01 REGULATION FD 2008, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of forty cents ($0.40) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after May 15, 2008 to shareholders of record at the close of business on April 18, 2008. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Release by The Procter & Gamble Company dated April 8,",186
2008-04-21,8-K,0000080424-08-000047,"13 OR 15(d) of The Securities Exchange Act Of 1934 Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act communications pursuant to Rule 13e-4(c) under the Exchange Act 5.02(d) DEPARTURE OF DIRECTOR and ELECTION OF DIRECTOR 2008, The Procter & Gamble Company (the ""Company"") issued a news release announcing that in accordance with the Company's customary retirement age for directors, John F. Smith, Jr. has announced his intention to retire effective at the April 2008 P&G Board of Directors meeting. Mr. Smith, who has been a director since 1995, turned 70 on April 6th. announced that Kenneth I. Chenault was appointed to the Board of Directors effective immediately. Mr. Chenault will serve on the Audit Committee and the Compensation & Leadership Development The Company is filing this 8-K pursuant to Item 5.02 (b), ""Departure of Directors"" and Item 5.02(d), ""Election of Directors."" Company's press release relating to these announcements is being furnished as requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly 99. News Release by The Procter & Gamble Company dated April 21, 2008.",239
2008-04-30,8-K,0000080424-08-000049,"to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area code ) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange OF OPERATIONS AND FINANCIAL CONDITION April 30, 2008, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended March 31, 2008. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Release by The Procter & Gamble Company dated April 30,",158
2008-05-01,10-Q,0000950152-08-003318,"Procter & Gamble Company 10-Q SECURITIES AND EXCHANGE COMMISSION QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2008 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___ to ___ Commission file number 1-434 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one): Large accelerated filer  Smaller reporting company o (Do not check if a smaller reporting company) Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No  There were 3,052,985,133 shares of Common Stock outstanding as of March 31, 2008. PART I. FINANCIAL INFORMATION Item 1. Financial Statements. Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations. Item 3. Quantitative and Qualitative Disclosures About Market Risk Item 4. Controls and Procedures. PART II. OTHER INFORMATION Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. The Consolidated Statements of Earnings of The Procter & Gamble Company and subsidiaries (the Company, we or our) for the three months and nine months ended March 31, 2008 and 2007, the Consolidated Balance Sheets as of March 31, 2008 and June 30, 2007, and the Consolidated Statements of Cash Flows for the nine months ended March 31, 2008 and 2007 follow. In the opinion of management, these unaudited consolidated financial statements contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, such financial statements may not necessarily be indicative of annual results. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS Amounts in millions except per share amounts Other non-operating income, net EARNINGS BEFORE INCOME TAXES COMMON SHARES OUTSTANDING See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS Cash and cash equivalents Prepaid expenses and other current assets PROPERTY, PLANT AND EQUIPMENT NET PROPERTY, PLANT AND EQUIPMENT GOODWILL AND OTHER INTANGIBLE ASSETS Trademarks and other intangible assets, net NET GOODWILL AND OTHER INTANGIBLE ASSETS LIABILITIES AND SHAREHOLDERS EQUITY Accrued and other liabilities TOTAL CURRENT LIABILITIES OTHER NON-CURRENT LIABILITIES Common stock  shares issued  Additional paid-in capital Reserve for ESOP debt retirement Accumulated other comprehensive income TOTAL SHAREHOLDERS EQUITY TOTAL LIABILITIES AND SHAREHOLDERS EQUITY See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD Depreciation and amortization Share-based compensation expense Accounts payable, accrued and other liabilities Other operating assets and liabilities TOTAL OPERATING ACTIVITIES Proceeds from asset sales Change in investment securities TOTAL INVESTING ACTIVITIES Dividends to shareholders Change in short-term debt Additions to long-term debt Reductions of long-term debt Impact of stock options and other TOTAL FINANCING ACTIVITIES EFFECT OF EXCHANGE RATE CHANGES ON CASH CHANGE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, END OF PERIOD See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS These statements should be read in conjunction with the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2007. The results of operations for the three-month and nine-month period ended March 31, 2008 are not necessarily indicative Comprehensive Income  Total comprehensive income is composed primarily of net earnings, net currency translation gains and losses, impacts of net investment and cash flow hedges and net unrealized gains and losses on investment securities. Total comprehensive income for the three months ended March 31, 2008 and 2007 was $4,389 million and $2,800 million, respectively. For the nine months ended March 31, 2008 and 2007, total comprehensive income was $12,588 million and $8,976 million, respectively. Segment Information  Following is a summary of segment results. In May 2007, we announced a number of changes to our organization structure and certain of our key leadership positions. The changes became effective on July 1, 2007 and resulted in changes to our GBU and reporting segment structure. The businesses that previously comprised the Gillette GBU are now included within the Beauty and Household Care GBUs. The Braun business has been combined with the Blades and Razors business to form the Grooming reportable segment within the Beauty GBU. The Grooming reportable segment also includes all face and shave prep products which were previously reported within the Beauty reportable segment. Duracell was moved to our Household Care GBU and will be reported as part of our Fabric Care and Home Care reportable segment. Finally, our feminine care business, which previously was part of our Beauty GBU and reportable segment, is now part of our Health and Well-Being GBU and will be reported as part of the Health Care reportable segment. The following segment information reflects the new segment reporting structure. Three Months Ended March 31 Nine Months Ended March 31 Snacks, Coffee and Pet Care Fabric Care and Home Care Baby Care and Family Care The Company acquired the Gillette Company in October 2005. At that time, we recognized an assumed liability for Gillette exit costs of $1.23 billion, including $854 million in separations related to approximately 5,500 people, $55 million in employee relocation costs and $320 million in other exit costs. These costs are primarily related to the elimination of selling, general and administrative overlap between the two companies in areas like Global Business Services, corporate staff and go-to-market support, as well as redundant manufacturing capacity. As of March 31, 2008, the remaining liability was $322 million. Total integration plan charges against the assumed liability were $94 million for the three months ended March 31, 2008 and $243 million for the nine months ended March 31, 2008. A total of $109 million of the liability was reversed to goodwill during the three months ended March 31, 2008 related to underspending on a number of projects that were concluded during the period. We expect such activities to be substantially complete by June 30, 2008. Goodwill and Other Intangible Assets  Goodwill as of March 31, 2008 is allocated by reportable segment and global business unit as follows (amounts in millions): Beauty, beginning of year Acquisitions and divestitures Grooming, beginning of year Acquisitions and divestitures Health Care, beginning of year Acquisitions and divestitures Snacks, Coffee and Pet Care, beginning of year Acquisitions and divestitures Fabric Care and Home Care, beginning of year Acquisitions and divestitures Baby Care and Family Care, beginning of year Acquisitions and divestitures GOODWILL, Net, beginning of year Acquisitions and divestitures The increase in goodwill from June 30, 2007 is primarily due to currency translation. Identifiable intangible assets as of March 31, 2008 are comprised of (amounts in Amortizable intangible assets with Intangible assets with indefinite lives Total identifiable intangible assets Amortizable intangible assets consist principally of brands, patents, technology and customer relationships. The non-amortizable intangible assets consist primarily of The amortization expense of intangible assets for the three months ended March 31, 2008 and 2007 was $156 million and $153 million, respectively. For the nine months ended March 31, 2008 and 2007, the amortization expense of intangible assets was $468 million and $484 million respectively. Pursuant to SFAS 123(R) Share-Based Payment, companies must recognize the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of those awards (the fair-value-based method). Total share-based compensation for the three months and nine months ended March 31, 2008 and 2007 are summarized in the following table (amounts in millions): SFAS 123(R) Stock Options Total Share-Based Compensation Assumptions utilized in the model are evaluated and revised, as necessary, to reflect market conditions and experience. Postretirement Benefits  The Company offers various postretirement benefits to its The components of net periodic benefit cost are as follows: Expected Return on Plan Assets Amortization of Deferred Amounts Recognized Net Actuarial Loss Gross Benefit Cost (Credit) Dividends on ESOP Preferred Stock Net Periodic Benefit Cost (Credit) Expected Return on Plan Assets Amortization of Deferred Amounts Recognized Net Actuarial Loss Gross Benefit Cost (Credit) Dividends on ESOP Preferred Stock Net Periodic Benefit Cost (Credit) For the year ending June 30, 2008, the expected return on plan assets is 7.4% and 9.3% for defined benefit and other retiree benefit plans, respectively. On July 1, 2007, we adopted FASB Interpretation 48, Accounting for Uncertainty in Income Taxes (FIN 48). FIN 48 addresses the accounting and disclosure of uncertain tax positions. FIN 48 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The difference between the tax benefit recognized in the financial statements for a position in accordance with FIN 48 and the tax benefit claimed in the tax return is referred to as an unrecognized tax benefit. The adoption of FIN 48 resulted in a decrease to retained earnings as of July 1, 2007 of $232 million, which was reflected as a cumulative effect of a change in accounting principle, with a corresponding increase to the net liability for unrecognized tax benefits. The impact primarily reflects the accrual of additional statutory interest and penalties as required by FIN 48, partially offset by adjustments to existing unrecognized tax benefits to comply with FIN 48 measurement principles. The implementation of FIN 48 also resulted in a reduction in our net tax liabilities for uncertain tax positions related to prior acquisitions accounted for under purchase accounting, resulting in an $80 million decrease to goodwill. Additionally, the Company historically classified unrecognized tax benefits in current taxes payable. As a result of the adoption of FIN 48, unrecognized tax benefits not expected to be paid in the next 12 months were reclassified to other non-current liabilities. The total amount of unrecognized tax benefits at July 1, 2007 was $2,971 million, excluding any related accruals for interest and penalties. Included in this total was $1,893 million that, if recognized, would impact the effective tax rate in future periods. We recognize accrued interest and penalties related to unrecognized tax benefits in income tax expense. Accrued interest and penalties as of July 1, 2007 were $589 million and $128 million, respectively, on an after tax basis. P&G is present in over 140 taxable jurisdictions, and at any point in time, has 30-40 audits underway at various stages of completion. We have tax years open ranging from 1997 and forward. P&G has made a concerted effort to bring its audit inventory to a more current position. We have done this by working with tax authorities to conduct audits for several open years at once. While we may be able to estimate the timing of the resolution we are generally not able to reliably estimate the ultimate settlement amounts until the close of the audit. Based on information currently available we anticipate that over the next 12 month period net audit activity could favorably impact earnings by a range of up to $150 million to $250 million. On an ongoing basis, adjustments will be made to the liability for unrecognized tax benefits to reflect the impact of audit developments, tax law changes, statute expirations, as well as for the accrual of additional current year tax exposures and for interest and penalties on existing The unrecognized tax benefits described above will be included in the Companys annual Form 10-K contractual obligations table to the extent the Company is able to make reliable estimates of the timing of cash settlements with the respective taxing authorities. If not, the total amount of unrecognized tax benefits will be disclosed in a footnote to the contractual obligations table. At this time, the Company can not make a reliable estimate as to the timing of cash settlements. In December 2007, the FASB issued SFAS 141 (Revised), Business Combinations (SFAS 141R) and SFAS 160, Noncontrolling Interests in Consolidated Financial Statements (SFAS 160). SFAS 141(R) and SFAS 160 revise the method of accounting for a number of aspects of business combinations and non-controlling interests, including acquisition costs, contingencies (including contingent assets, contingent liabilities and contingent purchase price), the impacts of partial and step-acquisitions (including the valuation of net assets attributable to non-acquired minority interests), and post acquisition exit activities of acquired businesses. SFAS 141(R) and SFAS 160 will be effective for the company during our fiscal year beginning In March 2008, the FASB issued SFAS No. 161, Disclosures about Derivative Instruments and Hedging Activities (SFAS 161). SFAS 161 amends and expands the disclosure requirements of SFAS No. 133 with the intent to provide users of financial statements with an enhanced understanding of 1) how and why an entity uses derivative instruments; 2) how derivative instruments and related hedged items are accounted for under Statement 133 and its related interpretations; and 3) how derivative instruments and related hedged items affect an entitys financial position, financial performance, and cash flows. SFAS 161 is effective for the Company beginning July 1, 2009. The Company is currently evaluating the provisions of SFAS 161 to determine the impact on its consolidated financial statements. No other new accounting pronouncement issued or effective during the fiscal year had or is expected to have a material impact on the consolidated financial statements. Item 2. Managements Discussion and Analysis of Financial Condition and Results of The purpose of this discussion is to provide an understanding of P&Gs financial results and condition by focusing on changes in certain key measures from year to year. Managements Discussion and Analysis (MD&A) is organized in the following sections: Forward-Looking Statements Results of Operations  Three Months Ended March 31, 2008 Results of Operations  Nine months Ended March 31, 2008 Business Segment Discussion  Three and Nine Months Ended March 31, 2008 Reconciliation of Non-GAAP Measures Throughout MD&A, we refer to measures used by management to evaluate performance, including unit volume growth, net outside sales and after-tax profit. We also refer to financial measures that are not defined under accounting principles generally accepted in the United States of America (U.S. GAAP), including organic sales growth, free cash flow and free cash flow productivity. The explanation of these measures at the end of MD&A provides more details on the use and the derivation of these measures. Management also uses certain market share and market consumption estimates to evaluate performance relative to competition despite some limitations on the availability and comparability of market share information. References to market share and market consumption in MD&A are based on a combination of vendor-reported consumption and market size data, as well as internal estimates. P&Gs business is focused on providing branded consumer goods products. Our goal is to provide products of superior quality and value to improve the lives of the worlds consumers. We believe this will result in leadership sales, profits and value creation, allowing employees, shareholders and the communities in which we operate to prosper. Our products are sold in more than 180 countries primarily through mass merchandisers, grocery stores, membership club stores and drug stores. We have also expanded our presence in high frequency stores, the neighborhood stores which serve many consumers in developing markets. We compete in multiple product categories and have three global business units (GBUs): Beauty; Health and Well-Being; and Household Care. Under U.S. Generally Accepted Accounting Principles, the business units comprising the GBUs are aggregated into six reportable segments: Beauty; Grooming; Health Care; Snacks, Coffee and Pet Care; Fabric Care and Home Care; and Baby Care and Family Care. We have on-the-ground operations in over 80 countries through our Market Development Organization, which leads country business teams to build our brands in local markets and is organized along seven geographic areas comprised of three developed regions (North America, Western Europe and Northeast Asia) and four developing regions (Latin America, Central and Eastern Europe/Middle East/Africa, Greater China and ASEAN/Australasia/India). The following table provides the percentage of net sales and net earnings by reportable business segment for the three months ended March 31, 2008 (excludes net sales and net earnings in Health and Well-Being GBU Snacks, Coffee and Pet Care Fabric Care and Home Care Baby Care and Family Care The following table provides the percentage of net sales and net earnings by reportable business segment for the nine months ended March 31, 2008 (excludes net sales and net earnings in Health and Well-Being GBU Snacks, Coffee and Pet Care Fabric Care and Home Care Baby Care and Family Care Following are highlights of results for the nine months ended March 31, 2008: Net sales grew nine percent to $62.2 billion. Organic sales, which exclude the impacts of acquisitions, divestitures and foreign exchange, increased five percent. Unit volume increased five percent and organic volume, which excludes acquisitions and divestitures, grew six percent. Every reportable segment posted year-on-year volume growth and each geographic region delivered year-on-year organic volume growth. Net earnings increased 12 percent to $9.1 billion. Net earnings increased behind higher operating profit, a lower tax rate and favorable foreign exchange. Diluted net earnings per share were $2.72, an increase of 15 percent versus the comparable prior year period. Operating cash flow was $11.7 billion, an increase of 19 percent versus the prior year period. Free cash flow productivity was 109 percent for the fiscal year to date period. Free cash flow productivity is defined as the ratio of operating cash flow less capital expenditures to net earnings. FORWARD-LOOKING STATEMENTS We discuss expectations regarding future performance, events and outcomes, such as our business outlook and objectives, in annual and quarterly reports, press releases and other written and oral communications. All such statements, except for historical and present factual information, are forward-looking statements, and are based on financial data and our business plans available only as of the time the statements are made, which may become out-of-date or incomplete. We assume no obligation to update any forward-looking statements as a result of new information, future events or other factors. Forward-looking statements are inherently uncertain, and investors must recognize that events could be significantly different from our expectations. Ability to Achieve Business Plans. We are a consumer products company and rely on continued demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers and retail trade customers. Our continued success is dependent on leading-edge innovation with respect to both products and operations and on the continued positive reputations of our brands. This means we must be able to obtain patents and respond to technological advances and patents granted to competition. Our success is also dependent on effective sales, advertising and marketing programs in an increasingly fragmented media environment. Our ability to innovate and execute in these areas will determine the extent to which we are able to grow existing net sales and volume profitably, especially with respect to the product categories and geographic markets (including developing markets) in which we have chosen to focus. There are high levels of competitive activity in the environments in which we operate. To address these challenges, we must respond to competitive factors, including pricing, promotional incentives and trade terms. We must manage each of these factors, as well as maintain mutually beneficial relationships with our key customers, in order to effectively compete and achieve our business plans. Since our goals include a growth component which can be affected by acquisitions and divestitures, we must manage and integrate key company transactions, such as the Gillette and Wella acquisitions, including achieving the cost and growth synergies for those transactions in accordance with stated goals, and the successful separation of the Companys coffee business while continuing to deliver the Companys goals. Cost Pressures. Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, cost of labor, foreign exchange and interest rates. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects, sourcing decisions and certain hedging transactions. We also must manage our debt and currency exposure, especially in volatile countries. We need to maintain key manufacturing and supply arrangements, including sole supplier and sole manufacturing plant arrangements. We must implement, achieve and sustain cost improvement plans, including our outsourcing projects and those related to general overhead and workforce rationalization. Global Economic Conditions. Economic changes, terrorist activity and political unrest may result in business interruption, inflation, deflation or decreased demand for our products. Our success will depend in part on our ability to manage continued global political and/or economic uncertainty, especially in our significant geographic markets, as well as any political or economic disruption due to terrorist and other hostile activities. Regulatory Environment. Changes in laws, regulations and the related interpretations may alter the environment in which we do business. This includes changes in environmental, competitive and product-related laws, as well as changes in accounting standards and taxation requirements. Accordingly, our ability to manage regulatory, tax and legal matters (including product liability, patent and intellectual property matters, as well as those related to the integration of Gillette and its subsidiaries) and to resolve pending matters within current estimates may impact our RESULTS OF OPERATIONS  Three Months Ended March 31, 2008 The following discussion provides a review of results for the three months ended March 31, 2008 versus the three months ended March 31, 2007. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information SELLING, GENERAL & ADMINISTRATIVE OTHER NON-OPERATING INCOME, NET EARNINGS BEFORE INCOME TAXES AVERAGE DILUTED SHARES OUTSTANDING COMPARISONS AS A % OF NET SALES SELLING, GENERAL & ADMINISTRATIVE EARNINGS BEFORE INCOME TAXES Net sales increased nine percent for the quarter to $20.5 billion. Volume was up four percent, including a negative one percent impact from the divestiture of our Western European family care business. Price increases, taken primarily to offset higher commodity costs, contributed one percent to net sales growth. These were partially offset by a negative one percent mix impact resulting from disproportionate double-digit volume growth in developing regions, where average selling price is below the company average. Favorable foreign exchange added five percent to net sales. Every reportable segment, except Beauty, posted mid-single digit or higher organic volume growth. Volume grew primarily behind initiative activity on our key brands and continued developing region expansion. The Company delivered high-single digit or higher volume growth on Always, Ariel, Dolce & Gabbana, Febreze, Fusion, Gain, Head & Shoulders, Naturella, Pampers, Pringles, Rejoice, Venus and Vicks for the quarter, partially offset by declines on Braun, Folgers and Mach3. Organic volume and sales were both up five percent for the quarter. Net Sales Change Drivers 2008 vs. 2007 (Three Months Ended Mar. 31) Health and Well-Being GBU Snacks, Coffee and Pet Care Fabric Care and Home Care Baby Care and Family Care Net sales percentage changes are approximations based on quantitative formulas that are Gross margin was down 30-basis points for the quarter to 51.3% of net sales. Commodity and energy cost increases had a negative impact on gross margin of over 220-basis points. These were largely offset by scale leverage from volume growth, pricing and cost savings projects resulting from manufacturing efficiency improvements and product reformulations. The year over year gross margin change was also impacted by a number of base period charges, including net charges related to the integration of Gillette, supply chain restructuring projects and the impacts of the pet food recall, that reduced the base period gross margin approximately 50-basis points. Total selling, general and administrative expenses (SG&A) increased six percent to $6.4 billion. SG&A as a percentage of net sales was down 80-basis points as a result of lower overhead spending as a percentage of net sales. Total overhead spending increased, but was down as a percentage of net sales for the total Company and in each reportable segment primarily due to scale leverage, a focus on overhead productivity and Gillette synergy savings. Marketing spending as a percentage of net sales was in-line with the prior year period. Interest expense for the quarter was up $85 million versus the year-ago period due to a higher debt level and a higher interest rate driven by the geographic mix of our short-term borrowings. Other non-operating income decreased $159 million versus the prior year period primarily due to lower current period interest income and base period gains on the sale of minor beauty and feminine care brands. Interest income declined primarily due to lower interest rates. Net earnings increased eight percent for the quarter to $2.7 billion behind a 13 percent increase in operating profit and a lower tax rate, partially offset by lower other non-operating income. Our effective tax rate was down 110-basis points primarily due to a more favorable geographic mix of earnings. There is a possibility of favorable tax audit activity in the April - June quarter that could impact the Companys fourth quarter and fiscal year effective tax rate. However, given the uncertainty around such items, we cannot quantify the potential impact at this time. Diluted net earnings per share were up 11 percent to $0.82. Diluted net earnings per share growth exceeded net earnings growth due to share repurchase activity. We repurchased $2.6 billion of treasury shares during the quarter under a previously announced share buyback program that started in July 2007. RESULTS OF OPERATIONS  Nine months Ended March 31, 2008 The following discussion provides a review of results for the nine months ended March 31, 2008 versus the nine months ended March 31, 2007. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information SELLING, GENERAL & ADMINISTRATIVE OTHER NON-OPERATING INCOME, NET EARNINGS BEFORE INCOME TAXES AVERAGE DILUTED SHARES OUTSTANDING COMPARISONS AS A % OF NET SALES SELLING, GENERAL & ADMINISTRATIVE EARNINGS BEFORE INCOME TAXES Net sales for the fiscal year to date period were up nine percent to $62.2 billion behind five percent volume growth and a favorable five percent foreign exchange impact. This was partially offset by a negative one percent mix impact primarily due to disproportionate double-digit growth in developing regions. Volume growth was broad-based across segments and geographic regions. Each reportable segment posted year-on-year volume growth and each geographic region delivered year-on-year organic volume growth for the fiscal year to date period. Volume grew primarily behind initiative activity on key brands and continued expansion in developing regions. A number of the companys key brands, including Always, Ariel, Dolce & Gabbana, Downy, Febreze, Fusion, Gain, Head & Shoulders, Hugo Boss, Naturella, Pampers, Pringles, Oral-B, Tide and Venus, posted high-single digit or higher volume growth to offset declines on Actonel, Braun, Iams and Mach3. Organic sales increased five percent for the fiscal year to date period behind six percent organic Net Sales Change Drivers 2008 vs. 2007 (Nine months Ended Mar. 31) Health and Well-Being GBU Snacks, Coffee and Pet Care Fabric Care and Home Care Baby Care and Family Care Net sales percentage changes are approximations based on quantitative formulas that are Gross margin was down 40-basis points fiscal year to date to 52.0% of net sales. Commodity and energy cost increases had a negative impact on gross margin of over 150-basis points. These were largely offset by scale leverage from volume growth and cost savings projects resulting from manufacturing efficiency improvements and product reformulations. Total selling, general and administrative expenses (SG&A) increased six percent to $19.1 billion for the fiscal year to date period. SG&A as a percentage of net sales was down 70-basis points primarily behind lower overhead spending as a percentage of net sales, partially offset by higher marketing spending as a percentage of net sales. Total overhead spending increased, but was down as a percentage of net sales for the total Company and for each reportable segment primarily due to scale leverage, a focus on overhead productivity and Gillette synergy savings. Interest expense for the fiscal year to date period was up $136 million versus the year-ago period due to a higher interest rate driven by the geographic mix of our short-term borrowings. Other non-operating income was down $34 million primarily due to lower interest income, which more than offset higher current period divestiture gains. Current year gains included a gain on the sale of our Western Europe family care business and our Japanese adult incontinence business. The base period included gains on the sale of Pert in North America, Sure and minor beauty and feminine Net earnings increased 12 percent to $9.1 billion behind higher operating profit, a lower tax rate and favorable foreign exchange. Our tax rate declined from 29.8% to 27.7% due to a one-time tax benefit resulting from a reduction in the German statutory tax rate, which reduced our deferred tax liabilities related to acquired intangible assets, the favorable settlement of tax audits and a more favorable geographic mix of earnings. Diluted net earnings per share were up 15 percent versus the prior year to $2.72 per share. Diluted net earnings per share growth exceeded net earnings growth due to share repurchase activity. We repurchased $8.0 billion of treasury shares during the fiscal year to date period under a previously announced share buyback program that BUSINESS SEGMENT DISCUSSION Three and Nine months Ended March 31, 2008 The following discussion provides a review of results by business segment. Analyses of the results for the three and nine months ended March 31, 2008 are provided compared to the same three and nine month period ended March 31, 2007. The primary financial measures used to evaluate segment performance are net sales and net earnings. The table below provides supplemental information on net sales and net earnings by business segment for the three and nine months ended March 31, 2008 versus the comparable prior year period (Amounts in millions): Three Months Ended March 31, 2008 Health and Well-Being GBU Snacks, Coffee and Pet Care Fabric Care and Home Care Baby Care and Family Care Nine months Ended March 31, 2008 Health and Well-Being GBU Snacks, Coffee and Pet Care Fabric Care and Home Care Baby Care and Family Care Beauty net sales increased nine percent for the quarter to $4.7 billion. Net sales were up on three percent volume growth and a six percent favorable foreign exchange impact. Volume was up mid-single digits in both hair color, behind the Nice N Easy Perfect 10 launch, and in cosmetics, behind the Cover Girl Lash Blast mascara initiative. Retail hair care volume was also up mid-single digits as high-teens growth on Head & Shoulders, double-digit growth on Rejoice and high-single digit growth on Pantene outside of North America more than offset an 11 percent decline on Pantene in North America. Prestige fragrances volume was up low-single digits and organic volume was up mid-single digits as a result of new product launches on Gucci, Hugo Boss and Dolce & Gabbana. Skin care volume was flat versus a base period that grew double-digits behind initiative pipeline volume builds in developing regions and mid-teens growth in North America. Professional hair care volume was in-line with the prior year period as mid-single digit growth in developing regions was offset by a low-single digit decline in developed regions. Volume in deodorants was due to a double-digit decline in Western Europe resulting primarily from market softness. Net earnings in Beauty declined two percent to $589 million. Net earnings margin was down 140-basis points as lower gross margin and the impact of base period minor brand divestiture gains more than offset lower SG&A as a percentage of net sales. Gross margin declined due to higher commodity costs, which more than offset benefits from volume scale leverage and cost savings projects. SG&A improved as a percentage of net sales as lower overhead spending as a percentage of net sales more than offset increased marketing spending as a percentage of net sales. Beauty net sales increased eight percent fiscal year to date to $14.5 billion. Net sales increased behind three percent volume growth and five points of favorable foreign exchange. Product mix was neutral as the favorable impacts of disproportionate growth in prestige fragrances and the launch of premium-priced clinical strength deodorants were offset by the impact of disproportionate growth in developing regions, where selling prices are below the segment average. Skin care volume was up mid-single digits driven by growth on Olay behind the Definity and Regenerist initiatives. Prestige fragrances volume was up mid-single digits and organic volume was up high-single digits behind new product launches on Dolce & Gabbana and Hugo Boss. Retail hair care volume was up mid-single digits, led by high-single digit growth in developing markets. Retail hair care volume in developed regions was flat as a 20% volume increase on Head & Shoulders was offset by a double-digit volume decline on Pantene in North America. Hair color volume increased low-single digits as growth on Nice N Easy behind the Perfect 10 launch more than offset declines on minor color brands. Volume in deodorants was down mid-single digits primarily due to competitive activity and market softness in Western Europe. Net earnings in Beauty increased six percent to $2.2 billion. Net earnings margin was down 40-basis points as lower gross margin and base period divestiture gains on minor brands more than offset improved SG&A as a percentage of net sales. Gross margin was down due to higher commodity costs, which more than offset volume scale leverage and cost savings projects. SG&A improved behind lower overhead spending as a percentage of net sales, which more than offset higher marketing spending as a Grooming net sales increased 13 percent for the quarter to $2.0 billion behind six percent volume growth and a seven percent favorable foreign exchange impact. Price increases taken across premium shaving systems added two percent to net sales. Product mix had a negative two percent mix impact on net sales as the positive mix impact from growth on the premium-priced Fusion brand was more than offset by disproportionate growth in developing regions, where selling prices are below the segment average. Blades and razors volume was up high-single digits behind double-digit volume growth in developing regions on the expansion of Fusion and the launch of Venus Embrace in North America. These gains were partially offset by a mid-single digit volume decline in Western Europe, due primarily to base period pipeline volume related to the Fusion launch in several Western European markets, and lower Mach3 shipments resulting from the business trade-up strategy to the Fusion line. Braun volume was down mid-single digits globally. High-single digit volume growth in developing regions was more than offset by overall softness in Western Europe, lower volume in home appliances resulting primarily from supply constraints at our contract manufacturer and the previously announced exit of the U.S. home appliance business. Net earnings in Grooming were up 30 percent for the quarter to $403 million behind higher net sales and a 270-basis point increase in net earnings margin. Net earnings margin was up primarily behind lower overhead expenses as a percentage of net sales. Gross margin was up slightly as benefits of volume scale leverage, pricing and a more profitable product mix were largely offset by higher costs incurred at our contract manufacturer on the Braun home appliance business. Grooming net sales increased 11 percent to $6.2 billion fiscal year to date. Net sales were up behind six percent volume growth, a seven percent favorable foreign exchange impact and a one percent positive pricing impact. Product mix had a negative three percent impact on net sales as positive product mix from growth on the premium-priced Fusion brand was more than offset by the impact of disproportionate growth in developing regions. Blades and razors volume increased high-single digits behind volume growth of over 20% in developing regions driven primarily by Fusion expansion. In developed regions, blades and razors volume was down low-single digits due to a base period that included significant pipeline shipments related to the Fusion launch in Western Europe and Japan and lower current period Mach3 shipments resulting from the business trade-up strategy to the Fusion line. Braun volume was down mid-single digits fiscal year to date primarily due to lower home appliance shipments resulting from supply constraints at our contract manufacturer, the previously announced exit of the home appliance business in the U.S. and the divestiture of thermometer and blood pressure devices. Net earnings in Grooming were up 19% fiscal year to date to $1.3 billion behind net sales growth and a 150-basis point earnings margin expansion. Earnings margin improved behind lower SG&A as a percentage of net sales, partially offset by a reduction in gross margin. Gross margin declined due to higher costs incurred at our contract manufacturer on the Braun home appliance business, which more than offset higher pricing, benefits from volume scale leverage and a more profitable product mix. SG&A as a percentage of net sales was down due to lower overhead spending, partially offset by higher marketing spending as a percentage of net sales. HEALTH AND WELL-BEING GBU Health Care net sales were up 11 percent for the quarter to $3.7 billion. Net sales growth was driven by a six percent increase in volume and a six percent favorable foreign exchange impact. Disproportionate growth in feminine care in developing regions, where selling prices are below the segment average, drove a negative one percent mix impact. Feminine care volume was up high-single digits behind double-digit growth on Naturella and high-single digit growth on Always, partially offset by a low-single digit decline on Tampax. Oral care volume increased mid-single digits with both Crest and Oral-B posting mid-single digit growth. Volume in pharmaceuticals and personal health was up mid-single digits as the addition of the Swiss Precision Diagnostics joint venture and high-single digit growth on Vicks, driven by high cold and flu incidence in North America during the quarter, more than offset low-single digit volume growth in pharmaceuticals and on Prilosec OTC. Prilosec OTC volume is expected to decline significantly starting in the fourth fiscal quarter due to the recent loss of marketplace exclusivity and the entry of competing products into the market. This is expected to have an adverse effect on the results of the Health Care segment in future periods. Net earnings in Health Care were up 15 percent to $617 million. Net earnings margin was up 60-basis points primarily due to lower overhead expenses as a percent of net sales, which more than offset lower gross margin. Gross margin was down due to higher commodity costs and a less profitable product mix, primarily from disproportionate growth in developing regions in feminine care and oral care (which have lower gross margin than the segment Health Care net sales increased nine percent fiscal year to date to $11.0 billion behind a five percent increase in volume. Foreign exchange had a positive five percent impact on net sales. Disproportionate growth in developing regions on feminine care and oral care resulted in a negative one percent mix impact. Feminine care volume increased mid-single digits and organic volume was up high-single digits behind double-digit growth on Naturella and high-single digit growth on Always, which more than offset a low-single digit decline on Tampax. Oral care volume was up mid-single digits behind initiative-driven growth on Oral-B toothbrushes and Crest. Volume in pharmaceuticals and personal health was up low-single digits as the impact of adding the Swiss Precision Diagnostics business and mid-single digit growth on Prilosec OTC was largely offset by lower shipments on Actonel. Prilosec OTC volume is expected to decline significantly starting in the fourth fiscal quarter due to the recent loss of marketplace exclusivity and the entry of competing products into the market. This is expected to have an adverse effect on the results of the Health Care segment in future periods. Net earnings in Health Care were up 11 percent to $2.0 billion behind net sales growth and a 30-basis point improvement in net earnings margin. Net earnings margin increased as reduced SG&A as a percentage of net sales more than offset lower gross margin. Gross margin was down as higher commodity costs and a less profitable mix primarily from disproportionate growth in developing regions in feminine care and oral care more than offset volume scale leverage. SG&A improved primarily behind lower overhead spending as a Snacks, Coffee and Pet Care Snacks, Coffee and Pet Care net sales increased 11 percent for the quarter to $1.2 billion on four percent volume growth. Increased pricing in coffee and pet care added five percent to net sales. Favorable foreign exchange added three percent, partially offset by a negative one percent product mix impact from disproportionate growth in Snacks. Snacks volume increased double-digits driven by the Pringles Rice Infusion and Pringles Extreme Flavors initiatives. Coffee volume was up low-single digits behind the Dunkin Donuts  license agreement, which was not in the prior year period. Pet care volume was down low-single digits due to continued negative impacts from the voluntary wet pet food recall in the U.S. in March 2007. Net earnings in Snacks, Coffee and Pet Care were $105 million, down nine percent due to the receipt in the base period of a Hurricane Katrina insurance payment. Net earnings margin was down 200-basis points due to lower gross margin and an increase in SG&A as a percentage of net sales. Gross margin was down as higher commodity costs more than offset higher pricing and base period impacts related to the pet care recall. SG&A as a percentage of net sales increased significantly, despite lower current period overhead spending as a percentage of net sales, due to the Hurricane Katrina insurance receipt in Snacks, Coffee and Pet Care net sales increased seven percent to $3.6 billion fiscal year to date. Net sales grew behind a two percent volume increase, a positive two percent price impact resulting from price increases in coffee and pet care and a three percent favorable foreign exchange impact. Snacks volume was up high-single digits behind the launch of Rice Infusion in Western Europe, Extreme Flavors in North America and continued growth on Pringles Minis and Selects. Coffee volume increased low-single digits primarily behind the Dunkin Donuts  license agreement. In pet care, volume was down mid-single digits due to continued negative impacts from the voluntary wet pet food recall in the U.S. in March 2007. Net earnings in Snacks, Coffee and Pet Care were down two percent to $345 million. Net earnings margin was down 90-basis points as lower gross margin was partially offset by improved SG&A expenses as a percentage of net sales. Gross margin was down as higher commodity costs more than offset price increases and base period pet recall impacts. SG&A decreased as a percentage of net sales due to lower overhead and marketing spending as a percentage of net sales. Hurricane Katrina insurance payments were received in both the current and the base period and, therefore, had minimal impact on the segments year-on-year net In January 2008, P&G announced plans to separate its coffee business and create an independent company. The coffee business had net sales of approximately $1.6 billion and operating income of about $350 million in fiscal 2007. Although no decision has been made on the form of the separation, P&G expects to do a spin-off or split-off transaction in the first half of fiscal 2009. Fabric Care and Home Care Fabric Care and Home Care net sales increased 10 percent to $5.8 billion for the quarter on six percent volume growth. Favorable foreign exchange added five percent to net sales, but was partially offset by a negative one percent mix impact resulting from disproportionate growth in developing regions and on large pack sizes in fabric care, both of which have selling prices below the segment average. Fabric care volume was up high-single digits behind double-digit developing region growth and initiative activity on Ariel, Downy, Gain and Tide, including continued growth behind the liquid laundry detergent compaction expansion in North America. Home care volume was up mid-single digits behind growth on Febreze Candles, the expansion of Fairy auto-dishwashing in Western Europe and high-single digit growth on Cascade resulting from high levels of customer orders in advance of a March price increase. Batteries volume was up mid-single digits as high-single digit growth in developing regions more than offset a mid-single digit decline in North America resulting from market softness. Net earnings in Fabric Care and Home Care increased 12 percent to $781 million. Net earnings margin was up 20-basis points behind a lower tax rate resulting from disproportionate growth in developing regions, where tax rates are below the segment average. Lower SG&A as a percentage of net sales offset lower gross margin. Gross margin was down due to higher commodity costs, which more than offset the benefits of volume scale leverage and cost savings projects. SG&A as percentage of net sales improved due to lower overhead expenses as a percentage of net sales. Fabric Care and Home Care net sales increased 10 percent to $17.7 billion fiscal year to date. Volume was up seven percent and favorable foreign exchange added five percent to net sales growth. This was partially offset by a negative two percent mix impact primarily from disproportionate double-digit growth in developing regions and on large pack sizes in fabric care. Fabric care volume increased high-single digits behind double-digit growth in developing regions, the liquid laundry detergent compaction launch in North America and initiative activity on Tide, Gain, Ariel and Downy. Home care volume was up mid-single digits behind the Dawn restage in North America, the launch of Febreze Candles and continued expansion of auto-dishwashing products in Western Europe. Batteries volume was up high-single digits behind double-digit growth in developing regions and mid-single digit growth in North America. Net earnings in Fabric Care and Home Care increased nine percent to $2.6 billion. Earnings margin was down 20-basis points primarily due to lower gross margin, partially offset by a reduction in SG&A as a percentage of net sales. Gross margin was down due to higher commodity costs, which more than offset benefits from volume scale leverage and manufacturing cost savings projects. SG&A improved as a percentage of net sales as lower overhead spending as a percentage of net sales more than offset higher marketing spending as a percentage of Baby Care and Family Care Baby Care and Family Care net sales increased eight percent to $3.5 billion for the quarter. Volume was up one percent, including the impact of the Western European Family Care divestiture in October 2007. Price increases in both Baby Care and Family Care and favorable product mix each contributed one percent to net sales and favorable foreign exchange added five percent. Organic sales, which exclude the impacts of the Western European family care divestiture and foreign exchange, were up eight percent behind a seven percent increase in organic volume. Baby care volume was up high-single digits behind double-digit growth in developing regions on Pampers and continued growth on Baby Dry and Swaddlers in developed regions. Family care volume was down mid-single digits due to the divestiture of the Western European family care business but was up high-single digits on an organic basis behind growth on both Charmin and Bounty. Net earnings in Baby Care and Family Care were up 23 percent to $471 million. Net earnings margin was up 170-basis point behind higher gross margin and improved SG&A costs. Gross margin was up behind a more profitable product mix following the Western Europe family care divestiture, volume scale leverage, increased pricing and cost savings projects, which more than offset higher commodity and energy costs. SG&A improved as a percentage of net sales due to lower overhead spending as a percentage of net sales and the receipt of payments for transitional services performed by P&G for the divested Western European family care business, partially offset by higher marketing spending as a percentage of net Baby Care and Family Care net sales increased nine percent fiscal year to date to $10.3 billion. Volume was up four percent, including the impact of the Western European family care divestiture. Foreign exchange had a positive five percent impact in net sales. Organic volume and organic sales, which exclude the impacts of the Western European family care divestiture and foreign exchange, both grew eight percent. Organic volume growth was balanced across the segment with high-single digit growth in both baby care and family care. Baby care volume in developed regions was up mid-single digits behind growth on Pampers Baby Stages of Development and on the Baby Dry caterpillar flex initiative. In developing regions, baby care volume was up double-digits behind continued growth on Pampers. Family care volume was down low-single digits due to the divestiture of the Western European family care business. Family care organic volume was up high-single digits behind the Bounty and Charmin product restages. Net earnings in Baby Care and Family Care were up 19 percent to $1.3 billion. Net earnings margin improved 110-basis points behind higher gross lower SG&A as a percentage of net sales. Gross margin was up as a more profitable product mix following the Western Europe family care divestiture, volume scale leverage and cost savings projects more than offset higher commodity and energy costs. SG&A improved as a percentage of net sales due to lower overhead spending as a percentage of net sales and the receipt of payments for transitional services performed by P&G for the divested Western European family care business. Corporate includes certain operating and non-operating activities not allocated to specific business units. These include: the incidental businesses managed at the corporate level, financing and investing activities, certain restructuring charges, other general corporate items and the historical results of certain divested brands and categories, including certain Gillette brands that were divested as required by the regulatory authorities in relation to the Gillette acquisition. Corporate also includes reconciling items to adjust the accounting policies used in the segments to U.S. GAAP. The most significant reconciling items include income taxes (to adjust from statutory rates that are reflected in the segments to the overall Company effective tax rate), adjustments for unconsolidated entities (to eliminate sales, cost of products sold and SG&A for entities that are consolidated in the segments but accounted for using the equity method for U.S. GAAP) and minority interest adjustments for subsidiaries where we do not have 100% ownership. Since both unconsolidated entities and less than 100% owned subsidiaries are managed as integral parts of the Company, they are accounted for similar to a wholly owned subsidiary for management and segment purposes. This means our segment results recognize 100% of each income statement component through before-tax earnings in the segments, with eliminations for unconsolidated entities in Corporate. In determining segment net earnings, we apply the statutory tax rates (with adjustments to arrive at the Companys effective tax rate in Corporate) and eliminate the share of earnings applicable to other ownership interests, in a manner similar to minority Net earnings in Corporate decreased $121 million for the quarter primarily due to higher interest expense, lower interest income and base period divestiture gains. Fiscal year to date, net earnings in Corporate increased $43 million versus the year-ago period. The increase was driven primarily by a lower tax rate partially offset by higher interest expense. Our fiscal year to date tax rate was down 210-basis points primarily due to a one-time tax benefit in the first quarter resulting from a change in the statutory tax rate in Germany and the favorable settlement Cash generated from operating activities for the fiscal year to date period was $11.7 billion, an increase of 19 percent versus the comparable prior year period. Operating cash flow, and the increase in operating cash flow versus the prior year period, resulted primarily from increased net earnings and non-cash charges (depreciation and amortization, share-based compensation and deferred income tax expense). Working capital balances increased, resulting in a net use of cash, primarily to support business growth. Inventory days increased 10 days during the fiscal year to date period due to foreign exchange, softer than expected shipments in Beauty and higher inventory in fabric care to support the liquid laundry detergent compaction expansion in North America. Accounts payable days were down six days during the fiscal year to date period, but increased six days versus the comparable prior-year period largely due to foreign exchange. Accounts receivable days were down one day during the fiscal year to date period due to Gillette integration benefits, which more than offset foreign exchange impacts. Operating cash flow also benefitted from an income tax benefit associated with net investment hedges that matured or were terminated in the Investing activities in both the current and prior fiscal year to date periods used $1.2 billion in cash. Capital expenditures in the current fiscal year to date period were $1.9 billion, or 3.0 percent of net sales. Proceeds from asset sales in the current period generated $759 million in cash primarily from the sale of our Western European family care business and our adult incontinence business in Japan. Total cash used by financing activities was $12.5 billion this fiscal year to date, versus $11.5 billion in the comparable prior year period. We repurchased $8.0 billion of treasury shares under a previously announced share buyback program that started in July 2007. Net changes in the Companys short and long-term debt balances due to borrowings, maturities and other payments used $2.5 billion of cash during the fiscal year, primarily due to the maturity and termination of instruments designated as net investment hedges. In the prior year period, we repurchased $4.1 billion of treasury shares and reduced our debt position by $5.6 billion. As of March 31, 2008 the Companys current liabilities exceeded current assets by $5.5 billion, driven by our short-term debt position. The Company anticipates being able to support its short-term liquidity through cash generated from operations. The Company also has very strong long- and short-term debt ratings which will enable it to continue to refinance this debt at favorable rates in commercial paper and bond markets. In addition, the Company has agreements with a diverse group of creditworthy financial institutions that, if needed, would provide sufficient credit funding to meet short-term financing requirements. RECONCILIATION OF NON-GAAP MEASURES Our discussion of financial results includes several measures not defined by U.S. GAAP. We believe these measures provide our investors with additional information about the underlying results and trends of the Company, as well as insight to some of the metrics used to evaluate management. When used in MD&A, we have provided the comparable GAAP measure in the discussion. Organic Sales Growth . Organic sales growth is a non-GAAP measure of net sales growth excluding the impacts of acquisitions, divestitures and foreign exchange from year-over-year comparisons. We believe this provides investors with a more complete understanding of underlying sales trends by providing sales growth on a consistent basis. The reconciliation of reported net sales growth to organic sales for the January  March quarter: Less: Foreign Exchange Impact Less: Acquisition/Divestiture Impact The reconciliation of reported net sales growth to organic sales for the fiscal year to date Less: Foreign Exchange Impact Less: Acquisition/Divestiture Impact Free Cash Flow . Free cash flow is defined as operating cash flow less capital spending. We view free cash flow as an important measure because it is one factor in determining the amount of cash available for dividends and discretionary investment. Free cash flow is also one of the measures used to evaluate senior management and is a factor in determining their at-risk Free Cash Flow Productivity . Free cash flow productivity is defined as the ratio of free cash flow to net earnings. The Companys long-term target is to generate free cash at or above 90 percent of net earnings. Free cash flow is also one of the measures used to evaluate senior management. The reconciliation of free cash flow and free cash flow productivity is provided below (amounts in millions): Item 3. Quantitative and Qualitative Disclosures About Market Risk. There have been no material changes in the Companys exposure to market risk since June 30, 2007. Additional information can be found in the section entitled Other Information, which appears on page 47, and Note 6, Risk Management Activities, which appears on pages 59-60 of the Annual Report to Shareholders for the fiscal year ended June 30, 2007 which can be found by reference to Exhibit 13 of the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2007. Item 4. Controls and Procedures. Evaluation of Disclosure Controls and Procedures. The Companys Chairman of the Board and Chief Executive Officer, A. G. Lafley, and the Companys Chief Financial Officer, Clayton C. Daley, Jr., performed an evaluation of the Companys disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (Exchange Act)) as of the end of the period covered by this report. Messrs. Lafley and Daley have concluded that the Companys disclosure controls and procedures were effective to ensure that information required to be disclosed in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) accumulated and communicated to our management, including Messrs. Lafley and Daley, to allow their timely decisions regarding required disclosure. Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting that occurred during the Companys fiscal quarter ended March 31, 2008 that have materially affected, or are reasonably likely to materially affect, the Companys internal control over financial reporting. PART II. OTHER INFORMATION For a discussion of the Companys risk factors, please refer to Part 1, Item 1A. Risk Factors in the Companys Annual Report on Form 10-K for the fiscal year ended June 30, Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. ISSUER PURCHASES OF EQUITY SECURITIES The total number of shares purchased was 37,523,400 for the quarter. All transactions were made in the open market or pursuant to prepaid forward agreements with large financial institutions. Under these agreements, the Company prepaid large financial institutions to deliver shares at a future date in exchange for a discount. The number of shares purchased other than through a publicly announced repurchase plan was 213,388 for the quarter. These shares were acquired by the Company under various compensation and benefit plans. This table excludes shares withheld from employees to satisfy minimum tax withholding requirements on option exercises and other equity-based transactions. The Company administers cashless exercises through an independent, third party broker and does not repurchase stock in connection with cashless exercise. Average price paid per share is calculated on a settlement basis and excludes commission. On August 3, 2007, the Company announced a share repurchase plan. Pursuant to the share repurchase plan, the Board of Directors authorized the Company and its subsidiaries to acquire in open market and/or private transactions $24 to $30 billion of shares of Company common stock over the subsequent three years to be financed by issuing a combination of long-term and short-term debt. Certain purchases were made prior to announcement of program but are considered purchases against the program. The dollar values listed in this column include commissions to be paid to brokers to execute Amended Articles of Incorporation (Incorporated by reference to Exhibit (3-1) of the Companys Form 10-Q for the quarter ended September 30, 2005). Regulations (as amended by shareholders at the annual meeting on October 10, 2006) (Incorporated by reference to Exhibit (3-2) of the Companys Form 10-Q for the quarter ended September 30, 2006). The Procter & Gamble 2001 Stock and Incentive Compensation Plan (as amended on August 14, 2007) which was adopted by shareholders at the annual meeting on October 9, 2001, and related correspondence and terms and conditions.* Computation of Earnings per Share. Computation of Ratio of Earnings to Fixed Charges.",10122
2008-06-04,8-K,0000080424-08-000056,"to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 of Report (Date of earliest event name of registrant as specified in its charter) Number) Identification Procter & Gamble Plaza, Cincinnati, number, including area code (513) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 7.01 REGULATION FD DISCLOSURE 2008, The Procter & Gamble Company (Company) and The J. M. Smucker Company (Smucker) issued a news release announcing that the companies have agreed to merge the Companys coffee business into Smucker in an all-stock reverse Morris Trust transaction. Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto J. Wunsch, Assistant Secretary Release by The Procter & Gamble Company dated June 4,",177
2008-06-13,8-K,0000080424-08-000060,"to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 of Report (Date of earliest event reported) name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 5.02(b) DEPARTURE OF CERTAIN OFFICERS AND Byrnes, Vice Chairman of the Board  Global Brand Building Training for The Procter & Gamble Company (the Company), retired from the Companys Board of Directors following its June 10, 2008 meeting and announced that he will retire from the Company on June 30, 2008. Company is filing this 8-K pursuant to Item 5.02(b), ""Departure of Certain to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto",174
2008-07-08,8-K,0000080424-08-000068,"13 OR 15(d) of The Securities Exchange Act Of 1934 of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange ITEM 7.01 REGULATION FD 2008, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of forty cents ($0.40) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after August 15, 2008 to shareholders of record at the close of business on July 18, 2008. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Release by The Procter & Gamble Company dated July 8,",185
2008-07-15,8-K,0000080424-08-000070,"13 OR 15(d) of The Securities Exchange Act Of 1934 Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act communications pursuant to Rule 13e-4(c) under the Exchange Act The Procter & Gamble Company (the ""Company"") issued a news release confirming previously announced sales and earnings guidance for the April to June quarter. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure"". requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly Release by The Procter & Gamble Company dated July 15, 2008.",149
2008-08-05,8-K,0000080424-08-000072,"to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area code ) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange OF OPERATIONS AND FINANCIAL CONDITION August 5, 2008, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended June 30, 2008. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Release by The Procter & Gamble Company dated August 5,",158
2008-08-14,8-K,0000080424-08-000075,"13 OR 15(d) of The Securities Exchange Act Of 1934 Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act communications pursuant to Rule 13e-4(c) under the Exchange Act 5.02(e) COMPENSATORY ARRANGEMENTS OF CERTAIN August 12, 2008, the Compensation & Leadership Development Committee (the Committee) of the Board of Directors of The Procter & Gamble Company (P&G) granted Clayton C. Daley, Jr., Vice-Chairman and Chief Financial Officer, a special equity award of $1,500,000 in recognition of Mr. Daleys integral role in the valuation, negotiation and acquisition of The Gillette Company (Gillette) and his successful leadership of the integration of Gillette into P&G. This grant reflects Mr. Daleys involvement and oversight of all aspects of the transaction, which was the largest and one of the most successful in the Companys history. The grant will be made in the form of restricted stock units granted under the Companys 2001 Stock and Incentive Compensation Plan using the closing price for the Companys Common Stock on the New York Stock Exchange on August 12, 2008. addition, the Committee approved a change to the Companys Short Term Achievement Reward Program (STAR). STAR Awards were previously based on three components: a Total Company Factor, a Business Unit Factor and a Gillette Integration Factor. Because the Company has now successfully completed the Gillette integration, the Committee approved the removal of the Gillette Integration Factor from the STAR calculation formula. A summary of the revised STAR Program is attached as Exhibit 99. requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly STAR Program Summary dated August 12, 2008.",323
2008-08-28,10-K,0000950152-08-006832,"The Procter & Gamble Company 10-K THE PROCTER & GAMBLE COMPANY ANNUAL REPORT ON FORM 10-K SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION ANNUAL REPORT ON FORM 10-K PURSUANT TO SECTION 13 or 15(d) SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended June 30, 2008 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-434 THE PROCTER & GAMBLE COMPANY One Procter & Gamble Plaza, Cincinnati, Ohio 45202 IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio Securities registered pursuant to Section 12(b) of the Act: Name of each Exchange on which registered Common Stock, without Par Value Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  No o Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes o No  Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No o Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrants knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o large accelerated filer, an accelerated filer, a non-accelerated smaller reporting company. See the definitions of large accelerated and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one): (Do not check if a smaller reporting company) Smaller reporting company Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No  The aggregate market value of the voting stock held by non-affiliates amounted to $226 billion on There were 3,034,310,829 shares of Common Stock outstanding as of July 31, 2008. Documents Incorporated By Reference Portions of the Annual Report to Shareholders for the fiscal year ended June 30, 2008 are incorporated by reference into Part I, Part II and Part IV of this report to the extent described Portions of the Proxy Statement for the 2008 Annual Meeting of Shareholders are incorporated by reference into Part III of this report to the extent described herein. Item 1B. Unresolved Staff Comments Item 3. Legal Proceedings Item 4. Submission of Matters to a Vote of Security Holders Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities Item 6. Selected Financial Data Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations Item 7A. Quantitative and Qualitative Disclosures About Market Risk Item 8. Financial Statements and Supplementary Data Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure Item 9A. Controls and Procedures Item 9B. Other Information Item 10. Directors and Executive Officers of the Registrant Item 11. Executive Compensation Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters Item 13. Certain Relationships and Related Transactions Item 14. Principal Accounting Fees and Services Item 15. Exhibits and Financial Statement Schedules Additional information required by this item is",595
2008-09-26,8-K,0000080424-08-000081,"to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 of Report (Date of earliest event reported) name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act communications pursuant to Rule 13e-4(c) under the Exchange Act 5.02(e) COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS June 30, 2008, The Procter & Gamble Company's (the ""Company"") current long-term incentive program for its most senior executives expired on its own terms. Accordingly, on September 22, 2008, the Compensation & Leadership Development Committee (the Committee"") of the Board of Directors of the Company renewed and approved the Company's Business Growth Program (""BGP"") with the material modifications described below. is a three-year performance program for approximately 40 of the Companys most senior executive officers. Under the previous BGP for the period from July 1, 2005 to June 30, 2008, awards were based on the Companys performance versus pre-established financial measures in two areas: (1) diluted earnings per share (""EPS"") growth and (2) operating total shareholder return (""OTSR""). The previous BGP also allowed for interim payments to be made based on performance metrics between 100 and 200% of target and provided payments in the form of cash and three year restricted stock units. BGP recently approved by the Committee covers the period from July 1, 2008 to June 30, 2011 and sets awards based on the Companys performance versus pre-established financial measures in four areas: (1) earnings per share growth; (2) organic sales growth; (3) before-tax operating profit growth; and (4) free cash flow efficiency. This BGP also prohibits Interim Payments exceeding 100% of target and provides for payment in the form of cash and restricted stock units that deliver in shares at the conclusion of the three year Performance Period. The BGP pays out at target compensation levels for the three year Performance Period only if the Company achieves the Performance Goals on each of the four measures described above. summary of the new BGP approved by the Committee is attached as Exhibit to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto 99: BGP Program Summary dated September 22, 2008.",406
2008-10-08,8-K,0000080424-08-000097,"& GAMBLE COMMENCES FOLGERS EXCHANGE OFFER 2008 - The Procter & Gamble Company (NYSE:PG) today announced that it has commenced an exchange offer for P&G common stock in connection with the previously announced merger of P&Gs Folgers coffee subsidiary with The J. M. Smucker Company (NYSE: SJM). In the exchange offer, P&G shareholders have the option to exchange some, none or all of their shares of P&G common stock for shares of Folgers common stock. Following the merger, each share of Folgers common stock will automatically convert into the right to receive one Smucker common share. The Smucker common shares issued in the Folgers merger are expected to represent approximately 53.5 percent of the Smucker common shares that will be outstanding after the merger. is designed to permit P&G shareholders to exchange their shares of P&G common stock for shares of Folgers common stock at a discount of 12 percent, with the price of Folgers common stock established by P&G as described below, subject to a limit of 1.7213 shares of Folgers common stock per share of P&G common stock. P&G will determine the prices at which shares of P&G common stock and shares of Folgers common stock will be exchanged by reference to the simple arithmetic average of the daily volume-weighted average prices of shares of P&G common stock and Smucker common shares, respectively, on the New York Stock Exchange during a period of three consecutive trading days ending on and including the second trading day preceding the last day of the exchange offer. The final exchange ratio showing the number of shares of Folgers common stock (which will immediately be converted, on a one for one basis, into the right to receive Smucker common shares) that P&G shareholders participating in the exchange offer will receive for each share of P&G common stock accepted for exchange will be announced by news release no later than 9:00 a.m., New York City time, on November 4, 2008 (unless the exchange offer is extended). expected to be tax-advantaged to P&G and P&G shareholders for U.S. federal income tax purposes. The exchange offer will expire at 12:00 midnight, New York City time, on November 5, 2008, unless extended, and will immediately be followed by the closing of the merger of Folgers and the Smucker subsidiary. The transactions are subject to customary closing conditions, including Smucker shareholder approval and a minimum tender condition. As a result of the exchange offer, the number of outstanding shares of P&G common stock will be reduced. that approximately 63.1 million shares of Folgers common stock will be offered in exchange for shares of P&G common stock. The exchange offer will be subject to proration if it is over-subscribed, and the number of shares of P&G common stock accepted in the exchange offer may be less than the number of shares of P&G common stock tendered. offer is consummated but not fully subscribed, P&G will distribute all of the shares of Folgers common stock it continues to own as a pro rata dividend to all P&G shareholders whose shares of P&G common stock remain outstanding and have not been accepted for exchange in the exchange offer. & Co. Incorporated will serve as the dealer manager for the exchange a day, P&G brands touch the lives of people around the world. The company has one of the strongest portfolios of trusted, quality, leadership brands, including Pampers, Tide, Ariel, Always, Whisper, Pantene, Mach3, Bounty, Dawn, Gain, Pringles, Folgers, Charmin, Downy, Lenor, Iams, Crest, Oral-B, Actonel, Duracell, Olay, Head & Shoulders, Wella, Gillette, Braun and Fusion. The P&G community includes approximately 138,000 employees working in over 80 countries worldwide. Please visit for the latest news and in-depth information about P&G and its other than statements of historical fact included in this release, are forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on financial data, market assumptions and business plans available only as of the time the statements are made, which may become out of date or incomplete. P&G assumes no obligation to update any forward-looking statement as a result of new information, future events or other factors. Forward-looking statements are inherently uncertain, and investors must recognize that events could differ significantly from P&Gs expectations. In addition to the risks and uncertainties noted in this release, there are certain factors that could cause actual results to differ materially from those anticipated by some of the statements made. These include: (1) the ability to achieve business plans, including with respect to lower income consumers and growing existing sales and volume profitably despite high levels of competitive activity, especially with respect to the product categories and geographical markets (including developing markets) in which P&G has chosen to focus; (2) the ability to successfully execute, manage and integrate key acquisitions and mergers, including (i) the Domination and Profit Transfer Agreement with Wella, and (ii) P&Gs merger with The Gillette Company, and to achieve the cost and growth synergies in accordance with the stated goals of these transactions; (3) the ability to manage and maintain key customer relationships; (4) the ability to maintain key manufacturing and supply sources (including sole supplier and plant manufacturing sources); (5) the ability to successfully manage regulatory, tax and legal matters (including product liability, patent, intellectual property, and competition law matters), and to resolve pending matters within current estimates; (6) the ability to successfully implement, achieve and sustain cost improvement plans in manufacturing and overhead areas, including P&Gs outsourcing projects; (7) the ability to successfully manage currency (including currency issues in volatile countries), debt, interest rate and commodity cost exposures; (8) the ability to manage continued global political and/or economic uncertainty and disruptions, especially in P&Gs significant geographical markets, as well as any political and/or economic uncertainty and disruptions due to terrorist activities; (9) the ability to successfully manage competitive factors, including prices, promotional incentives and trade terms for products; (10) the ability to obtain patents and respond to technological advances attained by competitors and patents granted to competitors; (11) the ability to successfully manage increases in the prices of raw materials used to make P&Gs products; (12) the ability to stay close to consumers in an era of increased media fragmentation; (13) the ability to stay on the leading edge of innovation and maintain a positive reputation on our brands; and (14) the ability to successfully separate P&Gs coffee business. For additional information concerning factors that could cause actual results to materially differ from those projected herein, please refer to P&Gs most recent 10-K, 10-Q and 8-K reports. have filed registration statements with the U. S. Securities and Exchange Commission (SEC) registering the shares of Folgers common stock and Smucker common shares to be issued to P&G shareholders in connection with the Folgers transaction. Smucker has also filed a definitive proxy statement with the SEC that has been sent to the shareholders of Smucker. In connection with the exchange offer for the shares of common stock of Folgers, P&G filed on October 8, 2008 a tender offer statement with the SEC. P&G shareholders are urged to read the prospectus included in the registration statements, the tender offer statement and any other relevant documents, because they contain important information about Smucker, Folgers and the proposed transaction. The proxy statement, prospectus, tender offer statement and other documents relating to the proposed transaction can be obtained free of charge from the SECs website at www.sec.gov. The documents can also be obtained free of charge from P&G upon written request to The Procter and Gamble Company, Shareholder Services Department, P.O. Box 5572, Cincinnati, Ohio 45201-5572 or by calling (800) 742-6253, or from Smucker upon written request to The J. M. Smucker Company, Shareholder Relations, Strawberry Lane, Orrville, Ohio 44667 or by calling (330) 684-3838. is not a solicitation of a proxy from any security holder of Smucker and shall not constitute an offer to sell or the solicitation of an offer to buy securities, nor shall there be any sale of securities in any jurisdiction in which such solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. However, P&G, Smucker and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from shareholders in connection with the proposed transaction under the rules of the SEC. Information about the directors and executive officers of The J. M. Smucker Company may be found in its 2008 Annual Report on Form 10-K filed with the SEC on June 27, 2008, and its definitive proxy statement relating to its 2008 Annual Meeting of Shareholders filed with the SEC on July 14, 2008. Information about the directors and executive officers of The Procter & Gamble Company may be found in its 2008 Annual Report on Form 10-K filed with the SEC on August 29, 2008, and its definitive proxy statement relating to its 2008 Annual Meeting of Shareholders filed with the SEC on August 28, 2008. Investor Relations Contacts :",1537
2008-10-14,8-K,0000080424-08-000103,"13 OR 15(d) of The Securities Exchange Act Of 1934 of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange ITEM 7.01 REGULATION FD 14, 2008, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of forty cents ($0.40) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after November 14, 2008 to shareholders of record at the close of business on October 24, 2008. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Release by The Procter & Gamble Company dated October 14,",186
2008-10-14,8-K,0000080424-08-000101,"13 OR 15(d) of The Securities Exchange Act Of 1934 & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange ITEM 7.01 REGULATION FD 14, 2008, The Procter & Gamble Company (the ""Company"") issued a news release with respect to Chairman of the Board and Chief Executive Officer A.G. Lafley's address to the shareholders at the Company's annual meeting. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Release by The Procter & Gamble Company dated October 14,",151
2008-10-29,8-K,0000080424-08-000106,"to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area code ) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange OF OPERATIONS AND FINANCIAL CONDITION October 29, 2008, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended September 30, 2008. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Release by The Procter & Gamble Company dated October 29,",158
2008-10-30,10-Q,0001193125-08-219742,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2008 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-434 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (513) 983-1100 (Registrants telephone number, including area code) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No  Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Large accelerated filer x Accelerated filer  Non-accelerated filer  Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No x There were 2,985,705,141 shares of Common Stock outstanding as of September 30, 2008. PART I. FINANCIAL INFORMATION Financial Statements. The Consolidated Statements of Earnings of The Procter & Gamble Company and subsidiaries (the Company, we or our) for the three months ended September 30, 2008 and 2007, the Consolidated Balance Sheets as of September 30, 2008 and June 30, 2008, and the Consolidated Statements of Cash Flows for the three months ended September 30, 2008 and 2007 follow. In the opinion of management, these unaudited consolidated financial statements contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, such financial statements may not necessarily be indicative of annual results. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS Amounts in millions except per share amounts Three Months Ended September 30 Selling, general and administrative expense Other non-operating income, net EARNINGS BEFORE INCOME TAXES DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS Cash and cash equivalents Prepaid expenses and other current assets PROPERTY, PLANT AND EQUIPMENT NET PROPERTY, PLANT AND EQUIPMENT GOODWILL AND OTHER INTANGIBLE ASSETS Trademarks and other intangible assets, net NET GOODWILL AND OTHER INTANGIBLE ASSETS LIABILITIES AND SHAREHOLDERS EQUITY Accrued and other liabilities TOTAL CURRENT LIABILITIES OTHER NON-CURRENT LIABILITIES Common stock - shares issued - Additional paid-in capital Reserve for ESOP debt retirement Accumulated other comprehensive income TOTAL SHAREHOLDERS EQUITY TOTAL LIABILITIES AND SHAREHOLDERS EQUITY See accompanying Notes to Consolidated Financial Statements Certain amounts for prior periods were reclassified to conform with the fiscal 2009 presentation THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS Three Months Ended September 30 CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD Depreciation and amortization Share-based compensation expense Gain on sale of businesses and fixed assets Accounts payable, accrued and other liabilities Other operating assets and liabilities TOTAL OPERATING ACTIVITIES Proceeds from asset sales Acquisitions, net of cash acquired TOTAL INVESTING ACTIVITIES Dividends to shareholders Change in short-term debt Additions to long-term debt Reductions of long-term debt Impact of stock options and other TOTAL FINANCING ACTIVITIES EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS CHANGE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, END OF PERIOD See accompanying Notes to Consolidated Financial Statements Certain amounts for prior periods were reclassified to conform with the fiscal 2009 presentation THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS These statements should be read in conjunction with the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2008. The results of operations for the three-month period ended September 30, 2008 are not necessarily indicative of annual results. Comprehensive Income - Total comprehensive income is comprised primarily of net earnings, net currency translation gains and losses, impacts of net investment and cash flow hedges and net unrealized gains and losses on investment securities. Total comprehensive income for the three months ended September 30, 2008 and 2007 was -$252 million and $4,113 million, respectively. Segment Information - Following is a summary of segment results. SEGMENT INFORMATION Amounts in millions Three Months Ended September 30 Earnings Before Income Taxes Snacks, Coffee and Pet Care Fabric Care and Home Care Baby Care and Family Care Goodwill and Other Intangible Assets  Goodwill as of September 30, 2008 is allocated by reportable segment and global business unit as follows (amounts in millions): Three Months Ended September 30, 2008 Beauty, beginning of year Acquisitions and divestitures Goodwill, September 30, 2008 Grooming, beginning of year Acquisitions and divestitures Goodwill, September 30, 2008 Health Care, beginning of year Acquisitions and divestitures Goodwill, September 30, 2008 Snacks, Coffee and Pet Care, beginning of year Acquisitions and divestitures Goodwill, September 30, 2008 Fabric Care and Home Care, beginning of year Acquisitions and divestitures Goodwill, September 30, 2008 Baby Care and Family Care, beginning of year Acquisitions and divestitures Goodwill, September 30, 2008 GOODWILL, NET, beginning of year Acquisitions and divestitures Goodwill, September 30, 2008 The decrease in goodwill from June 30, 2008 is primarily due to currency translation. Identifiable intangible assets as of September 30, 2008 are comprised of (amounts in millions): Amortizable intangible assets with determinable lives Intangible assets with indefinite lives Total identifiable intangible assets Amortizable intangible assets consist principally of brands, patents, technology, and customer relationships. The non-amortizable intangible assets consist primarily of brands. The amortization expense of intangible assets for the three months ended September 30, 2008, and 2007 was $160 million and $157 million, respectively. Pursuant to SFAS 123(R) Share-Based Payment, companies must recognize the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of those awards (the fair-value based method). Total share-based compensation for the three months ended September 30, 2008 and 2007 are summarized in the following table (amounts in millions): Three Months Ended September 30 SFAS 123(R) Stock Options Total Share-Based Compensation Assumptions utilized in the model are evaluated and revised, as necessary, to reflect market conditions and experience. Postretirement Benefits - The Company offers various postretirement benefits to its employees. The components of net periodic benefit cost are as follows: Amounts in millions Three Months Ended September 30 Three Months Ended September 30 Expected Return on Plan Assets Amortization of Deferred Amounts Recognized Net Actuarial Loss/(Gain) Gross Benefit Cost (Credit) Dividends on ESOP Preferred Stock Net Periodic Benefit Cost (Credit) For the year ending June 30, 2009, the expected return on plan assets is 7.4% and 9.3% for defined benefit and other retiree benefit plans, respectively. Fair Value Measurements On July 1, 2008, the Company adopted SFAS No. 157, Fair Value Measurements (SFAS 157) for certain financial assets and liabilities. This standard defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. SFAS 157 also establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The statement requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories. Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs reflecting the reporting entitys own assumptions or external inputs from inactive markets. Fair Value Hierarchy Under the SFAS 157 hierarchy, an entity is required to maximize the use of quoted market prices and minimize the use of unobservable inputs. The following table sets forth the Companys financial assets and liabilities as of September 30, 2008 that are measured on a recurring basis during the period, segregated by level within the fair value hierarchy: Investment securities (1) Total assets at fair value Liabilities at fair value: Total Liabilities at fair value Investment securities consist primarily of non-qualified retirement plan assets. These securities are generally valued using observable market prices in active markets, with some securities valued using unobservable market prices in inactive markets. These investment securities are included within Other non-current assets in our Consolidated Balance Sheets for each period presented. Derivatives consist of foreign currency, interest rate and commodity derivative instruments. Foreign currency derivatives consist primarily of forward contracts with maturities of less than 18 months and currency swaps with maturities up to 5 years. The Company can use such instruments to offset the effect of exchange rate fluctuations on forecasted sales, inventory purchases, intercompany royalties, intercompany and external loans and its investment in certain foreign subsidiaries. These contracts are generally valued using observable forward rates in commonly quoted intervals for the full term of the contracts. Interest rate derivatives consist of interest rate swaps. Our policy is to manage interest cost using a mixture of fixed-rate and variable-rate debt. To manage this risk in a cost efficient manner, we enter into interest rate swaps in which we agree to exchange with the counterparty, at specified intervals, the difference between fixed and variable interest amounts calculated by reference to an agreed-upon notional principal amount. These interest rate derivatives are valued using observable benchmark rates at commonly quoted intervals for the full term of the swaps. Commodity derivatives consist of futures, swaps and options with maturities up to 5 years. We use these derivatives to manage a portion of the volatility in the cost of raw materials utilized in our products or production processes resulting from weather, supply conditions, political and economic variables and other unpredictable factors. These market instruments generally are designated as cash flow hedges under SFAS 133. They are generally measured using quoted commodity exchange prices in active markets and quoted commodity exchange prices for identical commodities. A small portion of these instruments are also valued using unobservable market prices in inactive markets. There were no gains, losses or settlements of Level 3 investment securities for the three months ended September 30, 2008. For Level 3 derivative securities we had $3 million of gains recorded in other non-operating income, net, $14 million of losses recorded in OCI and total settlements of $4 million for the three months ended September 30, 2008. No transfers in and/or out of Level 3 occurred during the three months ended September 30, 2008. In February 2008, the FASB issued Staff Position No. 157-2, which delays the effective date of SFAS 157 for one year for all nonfinancial assets and liabilities, except those that are recognized or disclosed at fair value in the financial statements on a recurring basis. Based on this guidance, the Company will adopt the provisions of SFAS 157 as they relate to long-lived assets effective July 1, 2009, which it is not expected to have a material impact on the Companys financial New Accounting Pronouncements and Policies In December 2007, the FASB issued SFAS 141 (Revised), Business Combinations (SFAS 141R) and SFAS 160, Noncontrolling Interests in Consolidated Financial Statements (SFAS 160). SFAS 141(R) and SFAS 160 revise the method of accounting for a number of aspects of business combinations and non-controlling interests, including acquisition costs, contingencies (including contingent assets, contingent liabilities and contingent purchase price), the impacts of partial and step-acquisitions (including the valuation of net assets attributable to non-acquired minority interests), and post acquisition exit activities of acquired businesses. SFAS 141(R) and SFAS 160 will be effective for the company during our fiscal year beginning July 1, 2009. In March 2008, the FASB issued SFAS No. 161, Disclosures about Derivative Instruments and Hedging Activities (SFAS 161). SFAS 161 amends and expands the disclosure requirements of SFAS No. 133 with the intent to provide users of financial statements with an enhanced understanding of 1) how and why an entity uses derivative instruments; 2) how derivative instruments and related hedged items are accounted for under Statement 133 and its related interpretations; and 3) how derivative instruments and related hedged items affect an entitys financial position, financial performance, and cash flows. SFAS 161 is effective for the Company beginning January 1, 2009. The Company is currently evaluating the provisions of SFAS 161 to determine the impact on its consolidated financial statements. No other new accounting pronouncement issued or effective during the fiscal year had or is expected to have a material impact on the consolidated Commitments and Contingencies  Litigation As previously disclosed, the Company recently became subject to a variety of investigations into potential competition law violations in the European Union, including investigations initiated in the fourth quarter of fiscal 2008 by the European Commission with the assistance of the national authorities from a variety of countries. We believe these matters involve a number of other consumer products companies and/or retail customers. The Companys policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with investigations by relevant regulatory authorities, which the Company is doing. Competition and antitrust law inquiries often continue for several years and, if violations are found, can result in substantial fines. In other industries, fines have amounted to hundreds of millions of dollars. At this point, no significant formal claims have been made against the Company or any of our subsidiaries in connection with any of the above inquiries. In response to the actions of the Commission and national authorities, the Company has launched its own internal investigations into potential violations of competition laws, which are ongoing. The Company has identified some violations in certain European countries and appropriate actions are being taken. It is still too early for us to reasonably estimate the fines to which the Company will be subject as a result of these competition law issues. However, the ultimate resolution of these matters will likely result in fines or other costs that could materially impact our income statement and cash flows in the period in which they are accrued and paid, respectively. As these matters evolve the Company will, if necessary, recognize the appropriate reserves. Additional information on the Commitments and Contingencies of the Company can be found in Note 11, Commitments and Contingencies, which appears on pages 73-74 of the Annual Report to Shareholders for the fiscal year ended June 30, 2008, which can be found by reference to Exhibit 13 of the Companys Form 10-K/A Amendment No. 1 for the fiscal year ended June 30, 2008 which was filed on October 3, 2008. Managements Discussion and Analysis of Financial Condition and Results of Operations. The purpose of this discussion is to provide an understanding of P&Gs financial results and condition by focusing on changes in certain key measures from year to year. Managements Discussion and Analysis (MD&A) is organized in the following sections: Forward-Looking Statements Results of Operations  Three Months Ended September 30, 2008 Business Segment Discussion  Three Months Ended September 30, 2008 Reconciliation of Non-GAAP Measures Throughout MD&A, we refer to measures used by management to evaluate performance, including unit volume growth, net outside sales and after-tax profit. We also refer to organic sales growth, free cash flow and free cash flow productivity. These financial measures are not defined under accounting principles generally accepted in the United States of America (U.S. GAAP). The explanation of these measures at the end of MD&A provides more details on the use and the derivation of these measures. Management also uses certain market share and market consumption estimates to evaluate performance relative to competition despite some limitations on the availability and comparability of share information. References to market share and market consumption in MD&A are based on a combination of vendor-reported consumption and market size data, as well as internal estimates. OVERVIEW P&Gs business is focused on providing branded consumer goods products. Our goal is to provide products of superior quality and value to improve the lives of the worlds consumers. We believe this will result in leadership sales, profits and value creation, allowing employees, shareholders and the communities in which we operate to prosper. Our products are sold in more than 180 countries primarily through mass merchandisers, grocery stores, membership club stores and drug stores. We have also expanded our presence in high frequency stores, the neighborhood stores which serve many consumers in developing markets. We compete in multiple product categories and have three global business units (GBUs): Beauty; Health and Well-Being; and Household Care. Under U.S. Generally Accepted Accounting Principles, the business units comprising the GBUs are aggregated into six reportable segments: Beauty; Grooming; Health Care; Snacks, Coffee and Pet Care; Fabric Care and Home Care; and Baby Care and Family Care. We have on-the-ground operations in approximately 80 countries through our Market Development Organization, which leads country business teams to build our brands in local markets and is organized along seven geographic areas comprised of three developed regions (North America, Western Europe and Japan) and four developing regions (Latin America, Central and Eastern Europe/Middle East/Africa, Greater China and ASEAN/Australasia/India/Korea). The following table provides the percentage of net sales and net earnings by reportable business segment for the three months ended September 30, 2008 (excludes net sales and net earnings in Corporate): Health and Well-Being GBU Snacks, Coffee and Pet Care Fabric Care and Home Care Baby Care and Family Care SUMMARY OF RESULTS Following are highlights of results for the three months ended September 30, 2008: Net sales grew 9% to $22.0 billion. Organic sales, which exclude the impacts of acquisitions, divestitures and foreign exchange, increased 5%. Unit volume increased 2% and organic volume increased 3% led by growth in the Beauty segment. Net earnings increased 9% to $3.3 billion. Net earnings increased due to sales growth and higher divestiture gains partially offset by lower operating margin. Diluted net earnings per share were $1.03, an increase of 12% versus the comparable prior year period. Operating cash flow was $3.3 billion, an increase of 1% versus the prior year period. Free cash flow productivity was 76% for the quarter. Free cash flow productivity is defined as the ratio of operating cash flow less capital expenditures to net earnings. FORWARD-LOOKING STATEMENTS We discuss expectations regarding future performance, events and outcomes, such as our business outlook and objectives, in annual and quarterly reports, press releases and other written and oral communications. All such statements, except for historical and present factual information, are forward-looking statements, and are based on financial data and our business plans available only as of the time the statements are made, which may become out-of-date or incomplete. We assume no obligation to update any forward-looking statements as a result of new information, future events or other factors. Forward-looking statements are inherently uncertain and investors must recognize that events could be significantly different from our expectations. The following details a number of circumstances which could impact our ability to successfully achieve our business objectives. For additional information concerning factors that could cause actual results to differ from those projected herein, please refer to Part II, Item 1A of this for 10-Q and our recent 10-K and 8-K reports. Ability to Achieve Business Plans: We are a consumer products company and rely on continued demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers and retail trade customers. Our continued success is dependent on leading-edge innovation with respect to both products and operations and on the continued positive reputations of our brands. This means we must be able to obtain patents and respond to technological advances and patents granted to competition. Our success is also dependent on effective sales, advertising and marketing programs in an increasingly fragmented media environment. Our ability to innovate and execute in these areas will determine the extent to which we are able to grow existing sales and volume profitably, especially with respect to the product categories and geographic markets (including developing markets) in which we have chosen to focus. There are high levels of competitive activity in the environments in which we operate. To address these challenges, we must respond to competitive factors, including pricing, promotional incentives, trade terms and product initiatives. We must manage each of these factors, as well as maintain mutually beneficial relationships with our key customers, in order to effectively compete and achieve our business plans. Since our goals include a growth component tied to acquisitions, we must manage and integrate key acquisitions including achieving the cost and growth synergies in accordance with stated goals. Cost Pressures: Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, cost of labor, foreign exchange and interest rates. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects, sourcing decisions and certain hedging transactions. We also must manage our debt and currency exposure, especially in volatile countries. We need to maintain key manufacturing and supply arrangements, including sole supplier and sole manufacturing plant arrangements. We must implement, achieve and sustain cost improvement plans, including our outsourcing projects and those related to general overhead and workforce rationalization. Global Economic Conditions: Economic changes, terrorist activity and political unrest may result in business interruption, significant credit or liquidity issues, inflation, deflation or decreased demand for our products. Our success will depend, in part, on our ability to manage continued global political and/or economic uncertainty, especially in our significant geographic markets, as well as any political or economic disruption due to a global or regional credit crisis or terrorist and other hostile activities. Regulatory Environment: Changes in laws, regulations and the related interpretations may alter the environment in which we do business. This includes changes in environmental, competition and product-related laws, as well as changes in accounting standards and taxation requirements. Our ability to manage regulatory, tax and legal matters (including product liability, patent, intellectual property and competition law matters) and to resolve pending legal matters within current estimates may impact our results. RESULTS OF OPERATIONS  Three Months Ended September 30, 2008 The following discussion provides a review of results for the three months ended September 30, 2008 versus the three months ended September 30, 2007. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended September 30 SELLING, GENERAL & ADMINISTRATIVE EXPENSE OTHER NON-OPERATING INCOME, NET EARNINGS BEFORE INCOME TAXES AVERAGE DILUTED SHARES OUTSTANDING COMPARISONS AS A % OF NET SALES SELLING, GENERAL & ADMINISTRATIVE EXPENSE EARNINGS BEFORE INCOME TAXES Net sales for the quarter were up 9% to $22.0 billion. Sales growth was led by double-digit growth in the Beauty, the Fabric Care and Home Care and the Family Care and Baby Care segments. Unit volume increased 2% for the quarter led by mid-single digit growth in Beauty and in developing regions. Volume in developed regions declined low-single digits but grew low-single digits on an organic basis due to the net impact of acquisitions and divestitures. Volume growth was led by Head & Shoulders, Gain, Gillette Fusion, Cover Girl, Rejoice and SK-II, all of which posted double-digit volume growth to offset double-digit declines in Braun, Eukanuba, Febreze, Hugo Boss and Prilosec OTC. Foreign exchange had a positive 5% impact on sales growth. Price increases implemented to offset commodity-driven cost increases contributed 3% to net sales. These were partially offset by a negative 1% mix impact due to disproportionate growth in developing regions and a shift toward mid-tier brands, where average unit selling prices are below the Company average. Organic sales, which exclude the impacts of acquisitions, divestitures and foreign exchange, increased 5% for the quarter. Net Sales Change Drivers 2008 vs. 2007 (Three Months Ended Sept. 30) Volume with Acquisitions & Divestitures Volume excluding Acquisitions & Divestitures Health and Well-Being GBU Snacks, Coffee and Pet Care Fabric Care and Home Care Baby Care and Family Care Sales percentage changes are approximations based on quantitative formulas that are consistently applied. Gross margin was down 240 basis points for the quarter to 50.5% of net sales. Commodity-driven cost impacts reduced gross margin by approximately 400 basis points. This was partially offset by the impact of price increases and manufacturing cost savings projects. Total selling, general and administrative expenses (SG&A) increased 3% to $6.4 billion. SG&A as a percentage of net sales was down 180 basis points. Both overhead and marketing spending were down as a percentage of net sales primarily due to scale leverage, overhead productivity improvements, marketing spending efficiencies and the impact of foreign currency transaction gains on working capital balances caused by strengthening of the U.S. dollar late in the quarter. Interest expense declined 6% for the quarter to $339 million driven mainly by a reduction in U.S. interest rates. Other non-operating income increased $144 million to $337 million primarily due to divestiture gains. The base period included a gain on the sale of our adult incontinence business in Japan, while the current period included gains on the sale of ThermaCare, Dantrium and Dryel. Net earnings increased 9% to $3.3 billion as sales growth, increased divestiture gains and favorable foreign exchange were partially offset by a lower operating margin resulting from a commodity-driven decline in gross margin. Our tax rate was up from 27.6% to 28.5% primarily due to the impact of a reduction in the German statutory tax rate in the year-ago period. Diluted net earnings per share were $1.03, up 12% versus the prior year. Earnings per share growth exceeded net earnings growth due to the impact of our share repurchase program. BUSINESS SEGMENT DISCUSSION Three Months Ended September 30, 2008 The following discussion provides a review of results by business segment. Analyses of the results for the three months ended September 30, 2008 are provided compared to the same three month period ended September 30, 2007. The primary financial measures used to evaluate segment performance are net sales and net earnings. The table below provides supplemental information on net sales and net earnings by business segment for the three months ended September 30, 2008 versus the comparable prior year period (amounts in millions): Three Months Ended September 30, 2008 Earnings Before Income Taxes Health and Well-Being GBU Snacks, Coffee and Pet Care Fabric Care and Home Care Baby Care and Family Care BEAUTY GBU Beauty Beauty net sales increased 12% during the quarter to $5.1 billion. Net sales were up due to a 4% increase in volume, a 2% pricing impact and a 6% favorable foreign exchange impact. Hair Care volume grew mid-single digits behind growth in developing regions. Globally, all major hair care brands contributed to volume growth led by mid-single digit growth of Pantene and double-digit growth of Head & Shoulders and Rejoice. This was partially offset by a low-single digit volume decline in Professional Hair Care. Cosmetics volume grew double digits behind continued growth of Cover Girl. Skin Care volume grew low-single digits due to double-digit growth of SK-II following a base period that was impacted by business disruptions in Asia. Global market share of facial skin care declined slightly on a decline in U.S. market share promotional activity by competitors. Prestige Fragrances volume declined low-single digits as double-digit increases of Dolce & Gabbana and Gucci were more than offset by lower shipments of Lacoste and Hugo Boss. Initiative launches in Prestige Fragrances are skewed toward the second half of fiscal 2009 and will continue to impact year-on-year results through the second quarter. Earnings grew 9% during the quarter to $754 million as higher net sales and lower overhead and marketing spending as a percentage of net sales were partially offset by reduced gross margin from higher commodity costs. Grooming Grooming net sales were up 6% to $2.1 billion for the quarter. Volume declined 1% due to a double-digit decline of Braun. Blades & Razors volume grew low-single digits behind growth in developing regions. Double-digit growth of Gillette Fusion and high-single digit growth of Venus were mostly offset by declines in legacy shaving systems. Volume of Blades & Razors declined mid-single digits in developed regions primarily due to trade inventory reductions in North America and market softness in Western Europe. Global market share of the blades and razors category increased slightly for the quarter. Braun volume was down due to a double-digit decline of male hair removers, the exits of the U.S. home appliance and Tassimo coffee appliance businesses and the continued impact of supply constraints in Western Europe. Global market share of the dry shaving category increased 1 point for the quarter due to a 4 point increase in share of leg epilators. Favorable foreign exchange contributed 6% to net sales growth. Price increases taken across premium shaving systems added 3% to net sales. Product mix had a negative 2% impact on net sales as favorable product mix from growth on Gillette Fusion was more than offset by disproportionate growth in developing regions, which have lower than segment average selling prices. Net earnings increased 6% to $478 million for the quarter on sales growth. Net earnings margin declined slightly as lower gross margin was largely offset by lower SG&A expenses as a percentage of net sales. HEALTH AND WELL-BEING GBU Health Care Health Care net sales were up 4% during the quarter to $3.7 billion. Sales growth was driven by 5% favorable foreign exchange and a 2% increase in pricing. This was partially offset by a negative 3% product mix impact driven primarily by lower volume on Prilosec OTC and growth in developing regions. Segment volume was flat for the quarter including a negative 1% impact from divestitures. High-single digit growth in developing regions was offset by a mid-single digit decline in developed regions. Oral Care volume increased mid-single digits primarily behind double-digit growth of Crest in developing regions. Globally, Crest grew mid-single digits. Feminine Care volume was up low-single digits as high-single digit growth of Always in developing regions was partially offset by a high-single digit decline of Tampax globally and the divestiture of the Adult Incontinence business in Japan. Pharmaceuticals and Personal Health volume declined high-single digits due to a double-digit decline of Prilosec OTC from the loss of marketplace exclusivity and the divestitures of ThermaCare, Eneas and Dantrium. U.S. market share of the personal health category declined nearly 4 points for the quarter. Net earnings increased 2% for the quarter to $658 million as sales growth was partially offset by reduced operating margin. Reduced gross margin from higher commodity costs and unfavorable product mix were partially offset by lower overhead spending as a percentage of net sales. Snacks, Coffee and Pet Care Snacks, Coffee and Pet Care net sales increased 9% to $1.2 billion for the quarter on a 2% volume increase. Snacks volume increased mid-single digits due to double-digit growth in North America behind base business growth of Pringles and continued growth from Pringles Extreme Flavors and Stix initiatives. Coffee volume grew low-single digits behind the Folgers Roast & Ground restage and continued expansion of the Dunkin Donuts  line. Pet Care volume declined low-single digits as initiative driven growth of Iams was more than offset by a double-digit decline of Eukanuba. Pricing contributed 7% to net sales due to multiple price increases in Coffee and Pet Care which helped grow sales double digits and high-single digits, respectively. Favorable foreign exchange added 2% to net sales. Product mix had a negative 2% impact on sales due to the disproportionate growth of Snacks, which has lower selling prices than the segment average. Net earnings increased 6% to $120 million for the quarter as sales growth was partially offset by lower operating margin. Lower corporate overhead allocations to Coffee in advance of separating from the Company and lower marketing spending as a percentage of net sales were more than offset by higher commodity costs in the current period and Katrina insurance claim receipts in the base period. HOUSEHOLD CARE GBU Fabric Care and Home Care Fabric Care and Home Care net sales increased 10% during the quarter to $6.5 billion. Volume grew 2% behind mid-single digit growth of Fabric Care from the launch of Tide and Downy Total Care, trade inventory increases prior to announced price increases in North America and innovation in developing regions. Market share of the global fabric care category was down slightly to about 32%. Volume in Home Care declined low-single digits due to Febreze Candles and Mr. Clean Wipes initiatives in the base period and a decrease in trade inventory following price increases on Dawn and Swiffer in North America. Volume in Batteries was flat. Global market share of general purpose batteries declined about 1 point in the quarter. Foreign exchange contributed 4% to net sales and price increases added 4% to sales growth. Net earnings decreased 9% to $831 million as sales growth and lower marketing spending as a percentage of net sales were more than offset by lower gross margin from significantly higher commodity costs. Baby Care and Family Care Baby Care and Family Care net sales increased 10% during the quarter to $3.8 billion. Volume grew 1%, including a negative 6% impact from the Western European Tissue divestiture. Baby Care volume grew high-single digits due to growth of Pampers in developing regions and double-digit growth of Luvs partially offset by a mid-single digit decline of Pampers in North America. Global market share of the baby care category was up slightly to approximately 35%. Family Care volume declined mid-single digits due to the Western European Tissue divestiture. Organic volume for Family Care was up high-single digits behind growth of Charmin Basic and Bounty Basic. Family Care U.S. market share was up over 1 point to about 33%. Favorable foreign exchange added 4% to net sales. Price increases contributed 5% to sales growth. Mix was flat as the negative impacts of disproportionate growth in developing regions and growth of mid-tier brands were offset by the positive impact from the Western European Tissue divestiture. Organic sales were up 10% behind a 7% increase in organic volume. Net earnings increased 20% for the quarter to $514 million. Earnings increased due to sales growth, higher gross margin from a combination of manufacturing cost savings projects and positive mix impact due to the Western Europe Tissue divestiture and lower marketing spending as a percentage of net sales. CORPORATE Corporate includes certain operating and non-operating activities not allocated to specific business units. These include: the incidental businesses managed at the corporate level; financing and investing activities; other general corporate items; the historical results of certain divested brands and categories; and certain restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce rationalization. Corporate also includes reconciling items to adjust the accounting policies used in the segments to U.S. GAAP. The most significant reconciling items include income taxes (to adjust from statutory rates that are reflected in the segments to the overall Company effective tax rate), adjustments for unconsolidated entities (to eliminate sales, cost of products sold and SG&A for entities that are consolidated in the segments but accounted for using the equity method for U.S. GAAP) and minority interest adjustments for subsidiaries where we do not have 100% ownership. Since both unconsolidated entities and less than 100% owned subsidiaries are managed as integral parts of the Company, they are accounted for similar to a wholly owned subsidiary for management and segment purposes. This means our segment results recognize 100% of each income statement component through before-tax earnings, with eliminations for unconsolidated entities in Corporate. In determining segment after-tax net earnings, we apply the statutory tax rates (with adjustments to arrive at the Companys effective tax rate in Corporate) and eliminate the share of earnings applicable to other ownership interests, in a manner similar to minority interest. Net earnings in Corporate increased $161 million versus the year-ago period. The increase was driven primarily by corporate hedging impacts and higher current period divestiture gains primarily from the sale of ThermaCare, partially offset by higher restructuring spending. FINANCIAL CONDITION Operating Activities Cash generated from operating activities was $3.3 billion, an increase of 1% versus the comparable prior year period. Net earnings, adjusted for non-cash items (primarily depreciation, amortization, share based compensation, deferred income taxes and gains on the sale of businesses) provided $4.2 billion of operating cash. This was partially offset by an increase in working capital due to higher levels of accounts receivable and inventory to support business growth. Investing Activities Investing activities in the current year used $412 million, compared to the prior year period cash use of $419 million. Capital expenditures were $699 million or 3.2% of net sales for the quarter. Proceeds from asset sales generated $545 million in cash primarily from the sale of ThermaCare and the Western European Tissue business. Acquisitions, net of cash acquired, consumed $292 million of cash. Financing Activities Total cash used by financing activities was $1.5 billion versus $3.6 billion in the comparable prior year period. We repurchased $3.9 billion of treasury shares under a previously announced share buyback program that started in July 2007. We increased our debt position by $3.2 billion during the quarter primarily to fund share repurchases. In the prior year period, we repurchased $2.6 billion of treasury shares and reduced our debt position by $385 million. As of September 30, 2008, our current liabilities exceeded current assets by $13.2 billion, driven by our short-term debt position. We have short- and long-term debt to fund discretionary items such as acquisitions and share buyback programs. We anticipate being able to support our short-term liquidity and operating needs largely through cash generated from operations. We have strong short- and long-term debt ratings which despite the current credit crisis have and should enable us to continue to refinance our debt as it becomes due at favorable rates in commercial paper and bond markets. In addition, we have agreements with a diverse group of financial institutions that, if needed, should provide sufficient credit funding to meet short-term financing requirements. However, if the current credit crisis were to continue to worsen such that we were unable to access the credit market, it could impair our ability to fund discretionary spending such as the previously announced share buyback program. RECONCILIATION OF NON-GAAP MEASURES Our discussion of financial results includes several measures not defined by U.S. GAAP. We believe these measures provide our investors with additional information about the underlying results and trends of the Company, as well as insight to some of the metrics used to evaluate management. When used in MD&A, we have provided the comparable GAAP measure in the discussion. Organic Sales Growth ; Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions, divestitures and foreign exchange from year-over-year comparisons. We believe this provides investors with a more complete understanding of underlying sales trends by providing sales growth on a consistent basis. The reconciliation of reported sales growth to organic sales for the July-September quarter: Less: Foreign Exchange Impact Less: Acquisition/Divestiture Impact Free Cash Flow; Free cash flow is defined as operating cash flow less capital spending. We view free cash flow as an important measure because it is one factor in determining the amount of cash available for dividends and discretionary investment. Free cash flow is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation. Free Cash Flow Productivity: Free cash flow productivity is defined as the ratio of free cash flow to net earnings. The Companys long-term target is to generate free cash at or above 90 percent of net earnings. Free cash flow is also one of the measures used to evaluate senior management. The reconciliation of free cash flow and free cash flow productivity is provided below (amounts in millions): Free Cash Flow Productivity Quantitative and Qualitative Disclosures About Market Risk. There have been no material changes in the Companys exposure to market risk since June 30, 2008. Additional information can be found in the section entitled Other Information, which appears on page 54, and Note 6, Risk Management Activities, which appears on pages 65-66 of the Annual Report to Shareholders for the fiscal year ended June 30, 2008 which can be found by reference to Exhibit 13 of the Companys Annual Report on Form 10-K for the fiscal year ended Controls and Procedures. Evaluation of Disclosure Controls and Procedures. The Companys Chairman of the Board and Chief Executive Officer, A. G. Lafley, and the Companys Chief Financial Officer, Clayton C. Daley, Jr., performed an evaluation of the Companys disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (Exchange Act)) as of the end of the period covered by this report. Messrs. Lafley and Daley have concluded that the Companys disclosure controls and procedures were effective to ensure that information required to be disclosed in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) accumulated and communicated to our management, including Messrs. Lafley and Daley, to allow their timely decisions regarding required disclosure. Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting that occurred during the Companys fiscal quarter ended September 30, 2008 that have materially affected, or are reasonably likely to materially affect, the Companys internal control over financial reporting. PART II. OTHER INFORMATION Legal Proceedings. The Company is subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental issues, patent and trademark matters, and taxes. Recently, the Company has become subject to a variety of investigations into potential competition law violations in the European Union. In July 2006, French authorities, in connection with an inquiry into potential competition law violations in France, entered the premises of two of the Companys French subsidiaries and seized a variety of documents. In April 2008, UK authorities initiated an investigation concerning potential antitrust violations in the UK involving one of the Companys subsidiaries. In June 2008, European Commission officials, with the assistance of the national authorities from a variety of countries, started an investigation into potential competition law violations in a variety of countries across the European Union. Around the same time, the national authorities in Spain, Italy and the Czech Republic initiated additional investigations into potential antitrust concerns within those countries. In connection with these investigations, a number of the Companys subsidiaries were visited and documents seized. The Company or its subsidiaries are also involved in other competition law investigations in Belgium, Romania and Greece. We believe that all of the above matters involve a number of other consumer products companies and/or retail customers. The Companys policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with investigations by relevant regulatory authorities, which the Company is doing. Competition and antitrust law investigations often continue for several years and, if violations are found, can result in substantial fines. In other industries, fines have amounted to hundreds of millions of dollars. At this point, no formal claims have been made against the Company or any of our subsidiaries in connection with any of the above inquiries. During the fiscal year ended June 30, 2008, certain of the Companys subsidiaries in Germany received a formal complaint alleging violations of the antitrust laws. We are now discussing the situation with the German authorities. In response to the actions of the Commission and national authorities, the Company has launched its own internal investigations into potential violations of competition laws, which are ongoing. The Company has identified some violations in certain European countries and appropriate actions are being taken. It is still too early for us to reasonably estimate the fines to which the Company will be subject as a result of these competition law issues. However, we have taken and will take reserves as appropriate. Please refer to the Companys Risk Factors in Item 1A below for additional information. Risk Factors. We discuss our expectations regarding future performance, events and outcomes, such as our business outlook and objectives in this Form 10-Q, the Annual Report to Shareholders, quarterly reports, press releases and other written and oral communications. All statements, except for historical and present factual information, are forward-looking statements and are based on financial data and business plans available only as of the time the statements are made, which may become out of date or incomplete. We assume no obligation to update any forward-looking statements as a result of new information, future events, or other factors. Forward-looking statements are inherently uncertain, and investors must recognize that events could significantly differ from our The following discussion of risk factors identifies the most significant factors that may adversely affect our business, operations, financial position or future financial performance. This information should be read in conjunction with Managements Discussion and Analysis (MD&A) and the consolidated financial statements and related notes incorporated by reference into this report. The following discussion of risks is not all inclusive but is designed to highlight what we believe are important factors to consider when evaluating our expectations. These factors could cause our future results to differ from those in the forward-looking statements and from historical trends. A material change in consumer demand for our products could have a significant impact on our business. We are a consumer products company and rely on continued global demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers. This is dependent on a number of factors including our ability to develop effective sales, advertising and marketing programs in an increasingly fragmented media environment. We expect to achieve our financial targets, in part, by shifting our portfolio towards faster growing, higher margin businesses. If demand and growth rates fall substantially below expected levels or our market share declines significantly in these businesses, our results could be negatively impacted. This could occur due to unforeseen negative economic or political events or to changes in consumer trends and habits. In addition, our continued success is dependent on leading-edge innovation, with respect to both products and operations. This means we must be able to obtain patents that lead to the development of products that appeal to our consumers across the world. The ability to achieve our business objectives is dependent on how well we can respond to our local and global competitors. Across all of our categories, we compete against a wide variety of global and local competitors. As a result, there are ongoing competitive product and pricing pressures in the environments in which we operate, as well as challenges in maintaining profit margins. To address these challenges, we must be able to successfully respond to competitive factors, including pricing, promotional incentives and trade terms, as well as technological advances and patents granted to competition. Our ability to successfully integrate key acquisitions, such as Gillette, could impact our business results. Since our goals include a growth component tied to acquisitions, we must be able to successfully manage and integrate key acquisitions, such as the acquisition of The Gillette Company. Specifically, we must be able to integrate acquisitions without any significant disruption to our ability to manage and execute business plans on our base businesses. In addition, our financial results could be adversely impacted if we are not able to deliver the expected cost and growth synergies associated with our acquisitions. Our businesses face cost pressures which could affect our business results. Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, cost of labor, foreign exchange and interest rates. Our costs in 2008 were impacted by higher commodity costs. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects (including outsourcing projects), sourcing decisions and certain hedging transactions. In the manufacturing and general overhead areas, we need to maintain key manufacturing and supply arrangements, including any key sole supplier and sole manufacturing plant arrangements. We face risks associated with significant international operations. We conduct business across the globe with a significant portion of our sales outside the United States. We expect to achieve our financial targets, in part, by achieving disproportionate growth in developing regions. Should growth rates or our market share fall substantially below expected levels in these regions, our results could be negatively impacted. In addition, economic changes, terrorist activity and political unrest may result in business interruption, inflation, deflation or decreased demand for our products. Our success will depend, in part, on our ability to manage continued global political and/or economic uncertainty, especially in our significant geographical markets, as well as any political or economic disruption due to terrorist and other hostile activities. Our business is subject to regulation in the U.S. and abroad. Changes in laws, regulations and the related interpretations may alter the environment in which we do business. This includes changes in environmental, competitive and product-related laws, as well as changes in accounting standards and taxation requirements. Accordingly, our ability to manage regulatory, tax and legal matters (including product liability, patent, and intellectual property matters), and to resolve pending legal matters without significant liability, including the competition law and antitrust investigations described in Part II, Item 1 of this Form 10-Q, which could require the Company to take significant reserves or pay significant fines during a reporting period, may materially impact our results. If the reputation of one or more of our leading brands erodes significantly, it could have a material impact on our financial results. Our Companys financial success is directly dependent on the success of our brands, particularly our billion-dollar brands. The success of these brands can suffer if our marketing plans or product initiatives do not have the desired impact on a brands image or its ability to attract consumers. Further, our Companys results could be negatively impacted if one of our leading brands suffers a substantial impediment to its reputation due to real or perceived quality issues. A material change in customer relationships or in customer demand for our products could have a significant impact on our business. Our success is dependent on our ability to successfully manage relationships with our retail trade customers. This includes our ability to offer trade terms that are acceptable to our customers and are aligned with our pricing and profitability targets. Our business could suffer if we cannot reach agreement with a key customer based on our trade terms and principles. Further, there is a continuing trend towards retail trade consolidation and this leads to more complex work across broader geographic boundaries for both us and key retailers. This can be particularly difficult when major customers are addressing local trade pressures or local law and regulation changes. Further, our business would be negatively impacted if a key customer were to significantly reduce the range or inventory level of our products. We face risks related to the current credit crisis. The company currently generates significant operating cash flows, which combined with access to the credit markets provides us with significant discretionary funding capacity. However, current uncertainty in the global economic conditions resulting from the recent disruption in credit markets pose a risk to the overall economy that could impact consumer and customer demand for our products, as well as our ability to manage normal commercial relationships with our customers, suppliers and creditors. If the current situation deteriorates significantly, our business could be negatively impacted, including such areas as reduced demand for our products from a slow-down in the general economy, or supplier or customer disruptions resulting from tighter credit markets. Unregistered Sales of Equity Securities and Use of Proceeds. ISSUER PURCHASES OF EQUITY SECURITIES Total Number of Shares Purchased (1) Average Price Paid per Share (2) Total Number of Shares Purchased as Part of Publicly Announced Plans Approximate dollar value of shares that may yet be purchased under our share repurchase program ($ in Billions) (3) (4) The total number of shares purchased was 63,024,552 for the quarter. All transactions were made in the open market or pursuant to prepaid forward agreements with large financial institutions. Under these agreements, the Company prepaid large financial institutions to deliver shares at future dates in exchange for a discount. The number of shares purchased other than through a publicly announced repurchase plan was 4,159,846 for the quarter. This includes 34,006 shares acquired by the Company under various compensation and benefit plans and 4,125,840 shares acquired by the Profit Sharing Trust. This table excludes shares withheld from employees to satisfy minimum tax withholding requirements on option exercises and other equity-based transactions. The Company administers cashless exercises through an independent, third party broker and does not repurchase stock in connection with cashless exercise. Average price paid per share is calculated on a settlement basis and excludes commission. On August 3, 2007, the Company announced a share repurchase plan. Pursuant to the share repurchase plan, the Board of Directors authorized the Company and its subsidiaries to acquire in open market and/or private transactions $24 to $30 billion of shares of Company common stock over the subsequent three years to be financed by issuing a combination of long-term and short-term debt. Certain purchases were made prior to announcement of the program but are considered purchases against the program. The dollar values listed in this column include commissions to be paid to brokers to execute the transactions. Submission of Matters to a Vote of Security Holders. At the Companys 2008 Annual Meeting of Shareholders held on October 14, 2008, the following actions were taken: The following Directors were elected for terms of office expiring in 2009: Pursuant to the terms of the Notice of Annual Meeting and Proxy Statements, proxies received were voted, unless authority was withheld, in favor of the election of the twelve A proposal by the Board of Directors to ratify the appointment of Deloitte & Touche LLP as the Companys independent registered public accounting firm to conduct the annual audit of the financial statements of the Company and its subsidiaries for the fiscal year ending June 30, 2009, was approved by the shareholders. The shareholders cast 2,405,033,875 votes in favor of this proposal and 30,504,273 votes against. There were 33,405,797 abstentions. A proposal by the Board of Directors to amend the Amended Articles of Incorporation to adopt majority voting was approved by the shareholders. 76.35% of the issued and outstanding shares were voted in favor of the resolution. The shareholders cast 2,398,583,979 in favor of the resolution and 34,149,764 votes against. A shareholder resolution proposed by Mrs. Evelyn Y. Davis was defeated by the shareholders. The proposal requested that the Board of Directors rotate the site of the annual meeting to other major cities. The Board opposed the resolution. The shareholders cast 36,210,019 votes in favor of the resolution and 1,827,400,036 against. There were 54,283,693 abstentions and 551,050,197 broker non-votes. A shareholder resolution proposed by Mr. Peter Flaherty of the National Legal and Policy Center was defeated by the shareholders. The proposal requested shareholders be given an advisory vote on executive compensation. The Board opposed the resolution. The shareholders cast 751,316,440 votes in favor of the resolution and 1,050,432,793 against. There were 116,144,515 abstentions and 551,050,197 broker non-votes. Although these actions occurred following the first quarter, the Company is voluntarily including this information here. Amended Articles of Incorporation. Regulations (as amended by shareholders at the annual meeting on October 10, 2006) (Incorporated by reference to Exhibit (3-2) of the Companys Form 10-Q for the quarter ended September Summary of the Companys Short Term Achievement Reward Program, and related correspondence and terms and conditions (Incorporated by reference to Exhibit 99 of the Companys Form 8-K filed on August 14, 2008).* Summary of the Companys Business Growth Program and related correspondence and terms and conditions (Incorporated by reference to Exhibit 99 of the Companys Form 8-K filed on Summary of personal benefits available to certain officers and non-employee directors.* Computation of Earnings per Share. Computation of Ratio of Earnings to Fixed Charges.",9413
2008-10-30,8-K,0001193125-08-219236,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 29, 2008 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified (State or Other Jurisdiction of Incorporation) (IRS Employer Identification No.) One Procter & Gamble Plaza, Cincinnati, Ohio (Address of Principal Executive Offices) Registrants telephone number, including area code: (513) 983-1100 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Other Events. On October 29, 2008, The Procter & Gamble Company (P&G), an Ohio corporation, issued a news release announcing the commencement of the averaging period and clarifying the conditions for its exchange offer related to the separation of P&Gs coffee business and the previously announced merger of The Folgers Coffee Company (Folgers) and The J. M. Smucker Company (Smucker), pursuant to which a Smucker subsidiary will merge with and into Folgers, with Folgers surviving as a wholly owned subsidiary of Smucker. A copy of the news release is filed as Exhibit 99.1 to this Current Report on Form 8-K. In addition, on October 29, 2008, P&G also announced the following information regarding Folgers performance in the first quarter of fiscal 2009: As previously disclosed, the company plans to separate the Folgers business in the October  December quarter. This business is comprised of P&Gs coffee category, a component of P&Gs Snacks, Coffee and Pet Health reportable segment, as well as the coffee portion of the P&G Professional (PGP) business. The company provided a brief summary of results for the Folgers business for the July  September quarter. These results represent the business as currently operated as a component of P&G, including PGP, and are not directly comparable to the historical results of Folgers as a stand alone entity as presented in its recently filed registration statement related to the transaction with The J. M. Smucker Company. The differences are primarily related to P&G management reporting conventions and do not have a material impact on the underlying business trends. Folgers net sales for July-September quarter were up 11 percent to $445 million primarily due to the benefit of pricing actions in prior periods to recover higher green coffee bean costs. Volume increased one percent as gains in retail channels were offset by a decline in PGP volume. Market share was flat period over period. After tax earnings for the Folgers business for the July-September quarter were $67.4 million, an increase of 10 percent versus the prior year period. Earnings increased behind the benefit of higher unit volume, cost savings, and favorable green coffee bean market conditions. Results for the quarter also included the benefit of $13 million in reduced overhead costs, primarily as the result of reduced current period overhead allocations from P&G in preparation for the planned separation. These benefits were offset by $17 million in insurance proceeds in the base period related to Hurricane Katrina. Consistent with Folgers pricing policy, Folgers recently announced a list price decrease across the majority of its product offering in response to declining green coffee bean prices. ADDITIONAL INFORMATION Smucker and Folgers have filed registration statements with the U. S. Securities and Exchange Commission (SEC) registering the shares of Folgers common stock and Smucker common shares to be issued to P&G shareholders in connection with the Folgers transaction. In connection with the exchange offer for the shares of common stock of Folgers, P&G filed on October 8, 2008 a tender offer statement with the SEC. P&G shareholders are urged to read the prospectus included in the registration statements, the tender offer statement and any other relevant documents, because they contain important information about Smucker, Folgers and the proposed transaction. The prospectus, tender offer statement and other documents relating to the proposed transaction can be obtained free of charge from the SECs website at www.sec.gov. The documents can also be obtained free of charge from P&G upon written request to The Procter and Gamble Company, Shareholder Services Department, P.O. Box 5572, Cincinnati, Ohio 45201-5572 or by calling (800) 742-6253, or from Smucker upon written request to The J. M. Smucker Company, Shareholder Relations, Strawberry Lane, Orrville, Ohio 44667 or by calling (330) 684-3838 This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy securities, nor shall there be any sale of securities in any jurisdiction in which such solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. Financial Statements and Exhibits. The following exhibit is being filed with this Current Report on Form 8-K. News Release by The Procter & Gamble Company dated October 29, 2008.",897
2008-10-31,8-K,0000080424-08-000108,"to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 of Report (Date of earliest event reported) name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 5.02 (b) & (c) DEPARTURE OF CERTAIN OFFICERS; APPOINTMENT OF CERTAIN OFFICERS October 28, 2008, The Procter & Gamble Company (the Company) announced that Clayton C. Daley, Jr., Vice Chairman and Chief Financial Officer, will retire effective September 16, 2009. The Company also announced that Jon R. Moeller (44), currently Vice President & Treasurer, has been elected to succeed Mr. Daley as Chief Financial Officer effective January 1, the past five years, Mr. Moeller held the following positions at the Company: Vice President & Treasurer (July 2007-present), Vice President  Finance & Accounting, P&G Beauty & Health (June 2006-June 2007), Vice President  Finance & Accounting, P&G Beauty (June 2005-June 2006), Manager  Finance, Global Beauty Care (July 2004-June 2005), and Manager  Finance & Accounting, Global Beauty & Feminine Care and Global Health Care (February 2003-June 2004). addition, Mr. Moellers wife, Lisa Sauer, is a long-tenured employee of the Company who currently holds the position of Manager in our Oral Care business. Her total compensation in the last year was approximately $750,000, consisting of salary, bonus, equity grants and retirement benefits. Her compensation is consistent with the Companys overall compensation principles based on her years of experience and position within the Company is filing this 8-K pursuant to Item 5.02(b) and (c), ""Departure of Certain Officers; Appointment of Certain Officers."" to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto Release by The Procter & Gamble Company dated October 28,",342
2008-11-04,8-K,0001193125-08-223138,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 3, 2008 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (IRS Employer Identification No.) One Procter & Gamble Plaza, Cincinnati, Ohio (Address of Principal Executive Offices) Registrants telephone number, including area code: (513) 983-1100 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Other Events. On November 3, 2008, The Procter & Gamble Company (P&G), an Ohio corporation, issued a news release announcing the exchange ratio for its exchange offer related to the separation of P&Gs coffee business and the previously announced merger of The Folgers Coffee Company (Folgers) and The J. M. Smucker Company (Smucker), pursuant to which a Smucker subsidiary will merge with and into Folgers, with Folgers surviving as a wholly owned subsidiary of Smucker. A copy of the news release is filed as Exhibit 99.1 to this Current Report on Form 8-K. Financial Statements and Exhibits. The following exhibit is being filed with this Current Report on Form 8-K. News Release by The Procter & Gamble Company dated November 3, 2008.",292
2008-11-06,8-K,0001193125-08-227073,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 6, 2008 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (IRS Employer Identification No.) One Procter & Gamble Plaza, Cincinnati, Ohio (Address of Principal Executive Offices) Registrants telephone number, including area code: (513) 983-1100 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Other Events. On November 6, 2008, The Procter & Gamble Company (P&G), an Ohio corporation, issued a news release announcing the preliminary results of its exchange offer related to the separation of P&Gs coffee business and the closing of the previously announced merger of The Folgers Coffee Company (Folgers) and The J. M. Smucker Company (Smucker), pursuant to which a Smucker subsidiary merged with and into Folgers, with Folgers surviving as a wholly owned subsidiary of Smucker. A copy of the news release is filed as Exhibit 99.1 to this Current Report on Form 8-K. Financial Statements and Exhibits. (d) The following exhibit is being filed with this Current Report on Form 8-K. News Release by The Procter & Gamble Company dated November 6, 2008.",295
2008-11-12,8-K,0001193125-08-232224,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 10, 2008 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (IRS Employer Identification No.) One Procter & Gamble Plaza, Cincinnati, Ohio (Address of Principal Executive Offices) Registrants telephone number, including area code: (513) 983-1100 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Regulation FD Disclosure. On November 10, 2008, The Procter & Gamble Company (P&G), an Ohio corporation, in connection with announcing the final results of its exchange offer related to the separation of P&Gs coffee business, announced the amount of the after-tax gain from the transaction as follows: Based on actual proceeds from the transaction, P&G now expects the gain from the Folgers transaction to be approximately $0.63 per share, an increase of $0.13 per share from the previous estimate of $0.50 per share. Based on the new estimate, the company now expects earnings per share of $1.58 to $1.63 for the October  December quarter and $4.28 to $4.38 for the 2009 fiscal year. P&G plans to announce the final gain on the transaction as part of its report of December quarter results, which is currently scheduled for January 30, 2009. The foregoing information is being furnished under Item 7.01 Regulation FD Disclosure. Such information shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.",376
2008-12-11,8-K,0000080424-08-000120,"13 OR 15(d) of The Securities Exchange Act Of 1934 of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange ITEM 7.01 REGULATION FD 11, 2008, The Procter & Gamble Company (the ""Company"") issued the attached news release. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Release by The Procter & Gamble Company dated December 11,",135
2009-01-06,8-K,0000080424-09-000002,"to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 of Report (Date of earliest event reported) name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 5.02 (b) DEPARTURE OF December 31, 2008, Margaret C. Whitman resigned from The Procter & Gamble Companys Board of Directors. Company is filing this 8-K pursuant to Item 5.02(b), ""Departure of Certain to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto",143
2009-01-13,8-K,0000080424-09-000006,"13 OR 15(d) of The Securities Exchange Act Of 1934 of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange ITEM 7.01 REGULATION FD 13, 2009, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of forty cents ($0.40) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after February 17, 2009 to shareholders of record at the close of business on January 23, 2009. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Release by The Procter & Gamble Company dated January 13,",186
2009-01-30,8-K,0000080424-09-000008,"to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area code ) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange OF OPERATIONS AND FINANCIAL CONDITION January 30, 2009, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended December 31, 2008. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Release by The Procter & Gamble Company dated January 30,",158
2009-02-02,10-Q,0001193125-09-016473,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 31, 2008 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-434 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (513) 983-1100 (Registrants telephone number, including area code) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No  Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Large accelerated filer x Accelerated filer  Non-accelerated filer  Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No x There were 2,930,826,562 shares of Common Stock outstanding as of December 31, 2008. PART I. FINANCIAL INFORMATION Financial Statements. The Consolidated Statements of Earnings of The Procter & Gamble Company and subsidiaries (the Company, we or our) for the three months and six months ended December 31, 2008 and 2007, the Consolidated Balance Sheets as of December 31, 2008 and June 30, 2008, and the Consolidated Statements of Cash Flows for the six months ended December 31, 2008 and 2007 follow. In the opinion of management, these unaudited consolidated financial statements contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, such financial statements may not necessarily be indicative of annual results. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS Amounts in millions except per share amounts Three Months Ended December 31 Six Months Ended December 31 Selling, general and administrative expense Other non-operating income, net Earnings from Continuing Operations Before Income taxes Net Earnings from Continuing Operations Net Earnings from Discontinued Operations Basic net earnings from continuing operations Basic net earnings from discontinued operations Diluted net earnings from continuing operations Diluted net earnings from discontinued operations Diluted Weighted Average Common Shares Outstanding See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS Cash and cash equivalents Prepaid expenses and other current assets PROPERTY, PLANT AND EQUIPMENT NET PROPERTY, PLANT AND EQUIPMENT GOODWILL AND OTHER INTANGIBLE ASSETS Trademarks and other intangible assets, net NET GOODWILL AND OTHER INTANGIBLE ASSETS LIABILITIES AND SHAREHOLDERS EQUITY Accrued and other liabilities TOTAL CURRENT LIABILITIES OTHER NON-CURRENT LIABILITIES Common stock - shares issued - Additional paid-in capital Reserve for ESOP debt retirement Accumulated other comprehensive income TOTAL SHAREHOLDERS EQUITY TOTAL LIABILITIES AND SHAREHOLDERS EQUITY See accompanying Notes to Consolidated Financial Statements Certain amounts for prior periods were reclassified to conform with the fiscal 2009 presentation THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS Six Months Ended December 31 CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD Depreciation and amortization Share-based compensation expense Gain on sale of businesses and fixed assets Accounts payable, accrued and other liabilities Other operating assets and liabilities TOTAL OPERATING ACTIVITIES Proceeds from asset sales Acquisitions, net of cash acquired TOTAL INVESTING ACTIVITIES Dividends to shareholders Change in short-term debt Additions to long-term debt Reductions of long-term debt Impact of stock options and other TOTAL FINANCING ACTIVITIES EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS CHANGE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, END OF PERIOD See accompanying Notes to Consolidated Financial Statements Certain amounts for prior periods were reclassified to conform with the fiscal 2009 presentation THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS These statements should be read in conjunction with the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2008. The results of operations for the three-month and six-month period ended December 31, 2008 are not necessarily indicative of annual results. Comprehensive Income  Total comprehensive income is comprised primarily of net earnings, net currency translation gains and losses, impacts of net investment and cash flow hedges and net unrealized gains and losses on investment securities. Total comprehensive income for the three months ended December 31, 2008 and 2007 was $2,644 million and $4,086 million, respectively. For the six months ended December 31, 2008 and 2007, total comprehensive income was $2,392 million and $8,199 million, respectively. Segment Information  Following is a summary of segment results. SEGMENT INFORMATION Three Months Ended December 31 Six Months Ended December 31 Earnings from Continuing Operations Before Income Taxes Net Earnings from Continuing Operations Earnings from Continuing Operations Before Income Taxes Net Earnings from Continuing Operations Fabric Care and Home Care Baby Care and Family Care Goodwill and Other Intangible Assets  Goodwill as of December 31, 2008 is allocated by reportable segment and global business unit as follows (amounts in millions): Six Months Ended December 31, 2008 Beauty, beginning of year Acquisitions and divestitures Goodwill, December 31, 2008 Grooming, beginning of year Acquisitions and divestitures Goodwill, December 31, 2008 Health Care, beginning of year Acquisitions and divestitures Goodwill, December 31, 2008 Snacks and Pet Care, beginning of year Acquisitions and divestitures Goodwill, December 31, 2008 Fabric Care and Home Care, beginning of year Acquisitions and divestitures Goodwill, December 31, 2008 Baby Care and Family Care, beginning of year Acquisitions and divestitures Goodwill, December 31, 2008 GOODWILL, Net, beginning of year Acquisitions and divestitures Goodwill, December 31, 2008 $357 million of the decrease in goodwill from June 30, 2008 in Snacks and Pet Care is due to the divestiture of the Coffee business. Identifiable intangible assets as of December 31, 2008 are comprised of (amounts in millions): Amortizable intangible assets with determinable lives Intangible assets with indefinite lives Total identifiable intangible assets Amortizable intangible assets consist principally of brands, patents, technology and customer relationships. The non-amortizable intangible assets consist primarily of brands. The amortization expense of intangible assets for the three months ended December 31, 2008 and 2007 was $150 million and $155 million, respectively. For the six months ended December 31, 2008 and 2007 the amortization expense of intangible assets was $310 million and $312 million, Pursuant to SFAS 123(R) Share-Based Payment, companies must recognize the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of those awards (the fair-value based method). Total share-based compensation for the three months and six months ended December 31, 2008 and 2007 are summarized in the following table (amounts in millions): Three Months Ended December 31 Six Months Ended December 31 SFAS 123(R) Stock Options Total Share-Based Compensation Assumptions utilized in the model are evaluated and revised, as necessary, to reflect market conditions and experience. Postretirement Benefits  The Company offers various postretirement benefits to its employees. The components of net periodic benefit cost are as follows: Three Months Ended December 31 Three Months Ended December 31 Expected Return on Plan Assets Amortization of Deferred Amounts Recognized Net Actuarial Loss/ (Gain) Gross Benefit Cost (Credit) Dividends on ESOP Preferred Stock Net Periodic Benefit Cost (Credit) Six Months Ended December 31 Six Months Ended December 31 Expected Return on Plan Assets Amortization of Deferred Amounts Recognized Net Actuarial Loss/ (Gain) Gross Benefit Cost (Credit) Dividends on ESOP Preferred Stock Net Periodic Benefit Cost (Credit) For the year ending June 30, 2009, the expected return on plan assets is 7.4% and 9.3% for pension and other retiree benefit plans, respectively. Fair Value Measurements On July 1, 2008 the Company adopted SFAS No. 157, Fair Value Measurements (SFAS 157) for certain financial assets and liabilities. This standard defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosures about fair value measurements. SFAS 157 also establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The statement requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs reflecting the reporting entitys own assumptions or external inputs from inactive markets. Fair Value Hierarchy Under the SFAS 157 hierarchy, an entity is required to maximize the use of quoted market prices and minimize the use of unobservable inputs. The following table sets forth the Companys financial assets and liabilities as of December 31, 2008 that are measured on a recurring basis during the period, segregated by level within the fair value hierarchy: Investment securities (1) Total assets at fair value Liabilities at fair value: Total liabilities at fair value Investment securities consist primarily of non-qualified retirement plan assets. These securities are generally valued using observable market prices in active markets, with some securities valued using unobservable market prices in inactive markets. These investment securities are included within Other non-current assets in our Consolidated Balance Sheets for each period presented. Derivatives consist of foreign currency, interest rate and commodity derivative instruments. Foreign currency derivatives consist primarily of forward contracts with maturities of less than 18 months and currency swaps with maturities up to 5 years. The Company can use such instruments to offset the effect of exchange rate fluctuations on forecasted sales, inventory purchases, intercompany royalties, intercompany and external loans and its investment in certain foreign subsidiaries. These contracts are generally valued using observable forward rates in commonly quoted intervals for the full term of the contracts. Interest rate derivatives consist of interest rate swaps. Our policy is to manage interest cost using a mixture of fixed-rate and variable-rate debt. To manage this risk in a cost efficient manner, we enter into interest rate swaps in which we agree to exchange with the counterparty, at specified intervals, the difference between fixed and variable interest amounts calculated by reference to an agreed-upon notional principal amount. These interest rate derivatives are valued using observable benchmark rates at commonly quoted intervals for the full term of the swaps. Commodity derivatives consist of futures, swaps and options with maturities up to 5 years. We use these derivatives to manage a portion of the volatility in the cost of raw materials utilized in our products or production processes resulting from weather, supply conditions, political and economic variables and other unpredictable factors. These market instruments generally are designated as cash flow hedges under SFAS 133. These contracts are generally measured using quoted commodity exchange prices in active markets and quoted commodity exchange prices for identical commodities. A small portion of these instruments are also valued using unobservable market prices in inactive markets. The table below sets forth a reconciliation of the Companys beginning and ending Level 3 financial assets and liabilities balances for the six months ended December 31, 2008. Total gains or (losses) (realized/unrealized) included in earnings (or changes in net assets) Total gains or (losses) (realized/unrealized) included in OCI Net purchases, issuances and settlements Transfers in and/or out of Level 3 December 31, 2008 Balance In February 2008, the FASB issued Staff Position No. 157-2, which delays the effective date of SFAS 157 for one year for all nonfinancial assets and liabilities, except those that are recognized or disclosed at fair value in the financial statements on a recurring basis. Based on this guidance, the Company will adopt the provisions of SFAS 157 as they relate to long-lived assets effective July 1, 2009. The adoption is not expected to have a material impact on the Companys financial statements. New Accounting Pronouncements and Policies In December 2007, the FASB issued SFAS 141 (Revised), Business Combinations (SFAS 141R) and SFAS 160, Noncontrolling Interests in Consolidated Financial Statements (SFAS 160). SFAS 141(R) and SFAS 160 revise the method of accounting for a number of aspects of business combinations and non-controlling interests, including acquisition costs, contingencies (including contingent assets, contingent liabilities and contingent purchase price), the impacts of partial and step-acquisitions (including the valuation of net assets attributable to non-acquired minority interests) and post acquisition exit activities of acquired businesses. SFAS 141(R) and SFAS 160 will be effective for the company during our fiscal year beginning July 1, 2009. In March 2008, the FASB issued SFAS No. 161, Disclosures about Derivative Instruments and Hedging Activities (SFAS 161). SFAS 161 amends and expands the disclosure requirements of SFAS No. 133 with the intent to provide users of financial statements with an enhanced understanding of 1) how and why an entity uses derivative instruments; 2) how derivative instruments and related hedged items are accounted for under Statement 133 and its related interpretations; and 3) how derivative instruments and related hedged items affect an entitys financial position, financial performance and cash flows. SFAS 161 is effective for the Company beginning January 1, 2009. The Company is currently evaluating the provisions of SFAS 161 to determine the impact on its consolidated financial statements. No other new accounting pronouncement issued or effective during the fiscal year had or is expected to have a material impact on the consolidated financial statements. Commitments and Contingencies  Litigation As previously disclosed, the Company is subject to a variety of investigations into potential competition law violations in Europe, including investigations initiated in the fourth quarter of fiscal 2008 by the European Commission with the assistance of the national authorities from a variety of countries. We believe these matters involve a number of other consumer products companies and/or retail customers. The Companys policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with investigations by relevant regulatory authorities, which the Company is doing. Competition and antitrust law inquiries often continue for several years and, if violations are found, can result in substantial fines. In other industries, fines have amounted to hundreds of millions of dollars. At this point, no significant formal claims have been made against the Company or any of our subsidiaries in connection with any of the above inquiries. In response to the actions of the European Commission and national authorities, the Company has launched its own internal investigations into potential violations of competition laws, which are ongoing. The Company has identified violations in certain European countries and appropriate actions are being taken. It is still too early for us to reasonably estimate the fines to which the Company will be subject as a result of these competition law issues. However, the ultimate resolution of these matters will likely result in fines or other costs that could materially impact our income statement and cash flows in the period in which they are accrued and paid, respectively. As these matters evolve the Company will, if necessary, recognize the appropriate reserves. Additional information on the Commitments and Contingencies of the Company can be found in Note 11, Commitments and Contingencies, which appears on pages 73-74 of the Annual Report to Shareholders for the fiscal year ended June 30, 2008, which can be found by reference to Exhibit 13 of the Companys Form 10-K/A Amendment No. 1 for the fiscal year ended June 30, 2008 which was filed on October 3, 2008. Discontinued Operations In November 2008, the Company completed the divestiture of its Coffee business through the merger of its Folgers coffee subsidiary into The J.M. Smucker Company (Smucker) in an all-stock reverse Morris Trust transaction. In connection with the merger, 38.7 million shares of common stock of the Company were tendered by shareholders and exchanged for all shares of Folgers common stock, resulting in an increase of treasury stock of $2,466 million. Pursuant to the merger, a Smucker subsidiary merged with and into Folgers and Folgers became a wholly owned subsidiary of Smucker. The Company recorded an after tax gain on the transaction of $2,011, or $0.63 per share, which is included in Net Earnings from Discontinued Operations in the Consolidated Statement of Earnings for the three-month and six-month periods ended December 31, 2008. The Coffee business had historically been part of the Companys Snacks, Coffee and Pet Care reporting segment, as well as the coffee portion of the P&G Professional (PGP) business which is included in the Fabric Care and Home Care segment. In accordance with the provisions of SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, the results of Folgers are presented as discontinued operations and, as such, have been excluded from both continuing operations and segment results for all periods presented. Following is selected financial information included in net earnings from discontinued operations for the Coffee business: Three Months Ended December 31 Six Months Ended December 31 Earnings from discontinued operations Gain on sale of discontinued operations Deferred tax benefit on gain Net earnings from discontinued operations Reclassification The Company has reclassified certain amounts in the prior period Statements of Cash Flows to be consistent with the current period presentation. Realized gains and losses from non-qualifying derivative instruments used to hedge currency exposures resulting from intercompany financing transactions were reclassified from operating activities to financing activities, which is consistent with the use of the instruments and their related cash flows. Managements Discussion and Analysis of Financial Condition and Results of Operations The purpose of this discussion is to provide an understanding of P&Gs financial results and condition by focusing on changes in certain key measures from year to year. Managements Discussion and Analysis (MD&A) is organized in the following sections: Forward-Looking Statements Results of Operations  Three Months Ended December 31, 2008 Results of Operations  Six Months Ended December 31, 2008 Business Segment Discussion  Three and Six Months Ended December 31, 2008 Reconciliation of Non-GAAP Measures Throughout MD&A, we refer to measures used by management to evaluate performance, including unit volume growth, net outside sales and after-tax profit. We also refer to organic sales growth, free cash flow and free cash flow productivity. These financial measures are not defined under accounting principles generally accepted in the United States of America (U.S. GAAP). The explanation of these measures at the end of MD&A provides more details on the use and the derivation of these measures. Management also uses certain market share and market consumption estimates to evaluate performance relative to competition despite some limitations on the availability and comparability of share information. References to market share and market consumption in MD&A are based on a combination of vendor-reported consumption and market size data, as well as internal estimates. OVERVIEW P&Gs business is focused on providing branded consumer goods products. Our goal is to provide products of superior quality and value to improve the lives of the worlds consumers. We believe this will result in leadership sales, profits and value creation, allowing employees, shareholders and the communities in which we operate to prosper. Our products are sold in more than 180 countries primarily through mass merchandisers, grocery stores, membership club stores and drug stores. We continue to expand our presence in high frequency stores, the neighborhood stores which serve many consumers in developing markets. We compete in multiple product categories and have three global business units (GBUs): Beauty; Health and Well-Being; and Household Care. Under U.S. Generally Accepted Accounting Principles, the business units comprising the GBUs are aggregated into six reportable segments: Beauty; Grooming; Health Care; Snacks and Pet Care; Fabric Care and Home Care; and Baby Care and Family Care. We have on-the-ground operations in approximately 80 countries through our Market Development Organization, which leads country business teams to build our brands in local markets and is organized along seven geographic areas comprised of three developed regions (North America, Western Europe and Japan) and four developing regions (Latin America, Central and Eastern Europe/Middle East/Africa, Greater China and ASEAN/Australasia/India/Korea). In November 2008, the Company completed the divestiture of its Coffee business through the merger of its Folgers coffee subsidiary into The J.M. Smucker Company (Smucker) in an all-stock reverse Morris Trust transaction. In connection with the merger, 38.7 million shares of common stock of the Company were tendered by shareholders and exchanged for all the common shares of Folgers, which became a wholly owned subsidiary of Smucker. The Company recorded an after tax gain on the transaction of $2.0 billion, or $0.63 per share, which is included in Net Earnings from Discontinued Operations in the Consolidated Statement of Earnings for the period ended December 2008. The Coffee business had historically been part of the Companys Snacks, Coffee and Pet Care reporting segment, as well as the coffee portion of the P&G Professional (PGP) business which is included in the Fabric Care and Home Care segment. In accordance with the provisions of SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, the results of Folgers are presented as discontinued operations and, as such, have been excluded from continuing operations and from segment results for all periods presented. The following table provides the percentage of net sales and net earnings from continuing operations by reportable business segment for the three months ended December 31, 2008 (excludes net sales and net earnings in Corporate): Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care The following table provides the percentage of net sales and net earnings from continuing operations by reportable business segment for the six months ended December 31, 2008 (excludes net sales and net earnings in Corporate): Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care SUMMARY OF RESULTS Following are highlights of results for the six months ended December 31, 2008: Net sales grew 3% to $42.0 billion. Organic sales, which exclude the impacts of acquisitions, divestitures and foreign exchange, also increased 3%. Unit volume decreased 1%, and organic volume was in line with the prior year period. Net earnings increased 32% to $8.4 billion. Net earnings increased primarily due to the gain on the Folgers transaction, as the benefit from increased net sales on the continuing operations was largely offset by a decline in operating margin. Diluted net earnings per share were $2.61, an increase of 37% versus the comparable prior year period. Operating cash flow was $5.6 billion, a decrease of 20% versus the prior year period. Free cash flow productivity, defined as the ratio of operating cash flow less capital expenditures to net earnings, was 51%. FORWARD-LOOKING STATEMENTS We discuss expectations regarding future performance, events and outcomes, such as our business outlook and objectives, in annual and quarterly reports, press releases and other written and oral communications. All such statements, except for historical and present factual information, are forward-looking statements, and are based on financial data and our business plans available only as of the time the statements are made, which may become out-of-date or incomplete. We assume no obligation to update any forward-looking statements as a result of new information, future events or other factors. Forward-looking statements are inherently uncertain and investors must recognize that events could be significantly different from our expectations. The following details a number of circumstances which could impact our ability to successfully achieve our business objectives. For additional information concerning factors that could cause actual results to differ from those projected herein, please refer to our recent reports on Forms 10-K, 10-Q and 8-K. Ability to Achieve Business Plans: We are a consumer products company and rely on continued demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers and retail trade customers. Our continued success is dependent on leading-edge innovation with respect to both products and operations and on the continued positive reputations of our brands. This means we must be able to obtain patents and respond to technological advances and patents granted to competition. Our success is also dependent on effective sales, advertising and marketing programs in an increasingly fragmented media environment. Our ability to innovate and execute in these areas will determine the extent to which we are able to grow existing sales and volume profitably, especially with respect to the product categories and geographic markets (including developing markets) in which we have chosen to focus. There are high levels of competitive activity in the environments in which we operate. To address these challenges, we must respond to competitive factors, including pricing, promotional incentives, trade terms and product initiatives. We must manage each of these factors, as well as maintain mutually beneficial relationships with our key customers, in order to effectively compete and achieve our business plans. Since our goals include a growth component tied to acquisitions, we must manage and integrate key acquisitions including achieving the cost and growth synergies in accordance with stated goals. Cost Pressures: Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, cost of labor, foreign exchange and interest rates. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects, sourcing decisions and certain hedging transactions. We also must manage our debt and currency exposure, especially in volatile countries. We need to maintain key manufacturing and supply arrangements, including sole supplier and sole manufacturing plant arrangements. We must implement, achieve and sustain cost improvement plans, including our outsourcing projects and those related to general overhead and workforce rationalization. Global Economic Conditions: Economic changes, terrorist activity and political unrest may result in business interruption, significant credit or liquidity issues, inflation, deflation or decreased demand for our products. Our success will depend, in part, on our ability to manage continued global political and/or economic uncertainty, especially in our significant geographic markets, as well as any political or economic disruption due to a global or regional credit crisis or terrorist and other hostile activities. Regulatory Environment: Changes in laws, regulations and the related interpretations may alter the environment in which we do business. This includes changes in environmental, competition and product-related laws, as well as changes in accounting standards and taxation requirements. Our ability to manage regulatory, tax and legal matters (including product liability, patent, intellectual property and competition law matters) and to resolve pending legal matters within current estimates may impact our results. RESULTS OF OPERATIONS  Three Months Ended December 31, 2008 The following discussion provides a review of results for the three months ended December 31, 2008 versus the three months ended December 31, 2007. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended December 31 Selling, General & Administrative Expense Other Non-operating Income, Net Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Net Earnings From Discontinued Operations Effective Tax Rate  Continuing Operations Basic Net Earnings  Continuing Operations Basic Net Earnings  Discontinued Operations Diluted Net Earnings  Continuing Operations Diluted Net Earnings  Discontinued Operations Average Diluted Shares Outstanding Comparisons as a % of Net Sales Selling, General & Administrative Expense Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Net sales for the quarter were down 3% to $20.4 billion on a 3% decline in unit volume. The Companys net sales were negatively impacted by the global economic downturn, credit crisis and associated currency market volatility. These factors are expected to continue and negatively impact net sales for the remainder of the fiscal year. Unfavorable foreign exchange reduced net sales by 5% as the U.S. Dollar appreciated versus the Euro, British Pound and Canadian Dollar. Price increases to recover rising commodity costs and product mix added 4% and 1%, respectively, to net sales. The unit volume decline was driven by trade inventory reductions, market contractions and market share declines. Unit volume declined in every reportable segment except Baby Care and Family Care, and was down in both developed and developing markets. Organic sales increased 2% for the quarter led by the Baby Care and Family Care segment and the Snacks and Pet Care segment. Net Sales Change Drivers 2008 vs. 2007 (Three Months Ended Dec. 31) Volume with Acquisitions & Divestitures Volume excluding Acquisitions & Divestitures Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Sales percentage changes are approximations based on quantitative formulas that are consistently applied. Gross margin was down 70 basis points for the quarter to 51.6% of net sales. Higher commodity and energy costs reduced gross margin by approximately 300 basis points. This was partially offset by the impact of price increases and manufacturing cost savings projects. Total selling, general and administrative expenses (SG&A) decreased 2% to $6.3 billion. Both overhead and marketing spending declined for the quarter. SG&A as a percentage of net sales increased 20 basis points largely due to cost for incremental restructuring activities undertaken to offset dilution from the divestiture of Folgers. The impact of overhead productivity programs and marketing spending efficiencies offset the negative scale impact of lower net sales. Interest expense declined 9% for the quarter to $354 million driven mainly by a reduction in U.S. interest rates. Other non-operating income decreased $102 million to $91 million primarily due to lower interest income. Interest income declined as a result of lower U.S. dollar interest rates and a reduction of cash balances. The effective tax rate on continuing operations declined 160 basis points to 25.7% reflecting the net effect of foreign mix, audit settlements and the effects of foreign repatriations. Net earnings from continuing operations decreased 7% to $3.0 billion primarily due to lower net sales and reduced operating margin. Diluted net earnings per share from continuing operations were $0.94, down 2% versus the prior year. Net earnings from discontinued operations increased $2.0 billion for the quarter primarily due to the $2.0 billion after tax gain on the divestiture of Folgers. Net earnings during the quarter increased 53% to $5.0 billion. Diluted net earnings per share were $1.58, up 61% versus the prior year. Earnings per share growth exceeded net earnings growth due to the impact of our share repurchase program and shares tendered for the Folgers transaction. RESULTS OF OPERATIONS  Six Months Ended December 31, 2008 The following discussion provides a review of results for the six months ended December 31, 2008 versus the six months ended December 31, 2007. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Six Months Ended December 31 Selling, General & Administrative Expense Other Non-operating Income, Net Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Net Earnings From Discontinued Operations Effective Tax Rate  Continuing Operations Basic Net Earnings  Continuing Operations Basic Net Earnings  Discontinued Operations Diluted Net Earnings  Continuing Operations Diluted Net Earnings  Discontinued Operations Average Diluted Shares Outstanding Comparisons as a % of Net Sales Selling, General & Administrative Expense Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Net sales for the fiscal year to date increased 3% to $42.0 billion. Unit volume declined 1%, while price increases across all segments to offset commodity-driven cost increases added 4% to net sales. Baby Care and Family Care, Beauty and developing market unit volume each increased low-single-digits; while the remaining reportable segments and developed markets all had low-single-digit volume declines. Net sales increased in the Baby Care and Family Care; Snacks and Pet Care; Beauty; and Fabric Care and Home Care segments, partially offset by declines in the Grooming and Health Care Net Sales Change Drivers 2008 vs. 2007 (Six Months Ended Dec. 31) Volume with Acquisitions & Divestitures Volume excluding Acquisitions & Divestitures Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Sales percentage changes are approximations based on quantitative formulas that are consistently applied. Gross margin was down 160 basis points to 51.2% of net sales fiscal year to date. Commodity-driven cost impacts reduced gross margin by over 300 basis points. This was partially offset by the impact of price increases and manufacturing cost savings projects. Total selling, general and administrative expenses (SG&A) were in line with the prior year period at $12.7 billion. SG&A as a percentage of net sales was down 80 basis points. Both overhead and marketing spending were down as a percentage of net sales primarily due to scale leverage, overhead productivity improvements and marketing spending efficiencies, partially offset by cost for incremental restructuring activities undertaken to offset dilution from the divestiture of Folgers. The net impact of foreign exchange transactional gains and losses on working capital balances contributed half of the decline in SG&A as a percentage of net sales. Interest expense declined 7% to $693 million fiscal year to date driven mainly by a reduction in U.S. interest rates. Other non-operating income increased $41 million to $427 million as higher divestiture gains were partially offset by lower interest income. The base period included a gain on the sale of our adult incontinence business in Japan and tissue business in Western Europe, while the current period included gains on the sale of Thermacare, Dantrium and Dryel. Interest income declined as a result of lower U.S. dollar interest rates and a reduction of cash balances. The effective tax rate on continuing operations was down to 27.1% from 27.3%. Net earnings from continuing operations increased 1% to $6.2 billion. Net earnings increased primarily due to higher net sales, lower interest expense and higher non-operating income, partially offset by reduced operating margin. Diluted net earnings per share from continuing operations were $1.95, up 5% versus the prior year. Net earnings for discontinued operations increased $2.0 billion fiscal year to date mainly due to the after tax gain on the divestiture of Folgers. Net earnings increased 32% fiscal year to date to $8.4 billion largely as a result of the Folgers transaction gain. Diluted net earnings per share were $2.61, up 37% versus the prior year. Earnings per share growth exceeded net earnings growth due to the impact of our share repurchase program and shares tendered for the Folgers transaction. BUSINESS SEGMENT DISCUSSION  Three and Six Months Ended December 31, 2008 The following discussion provides a review of results by business segment. Analyses of the results for the three and six months ended December 31, 2008 are provided compared to the same three and six month periods ended December 31, 2007. The primary financial measures used to evaluate segment performance are net sales and net earnings from continuing operations. The table below provides supplemental information on net sales and net earnings from continuing operations by business segment for the three and six months ended December 31, 2008 versus the comparable prior year period (amounts in millions): Three Months Ended December 31, 2008 Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Six Months Ended December 31, 2008 Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Beauty net sales decreased 4% to $4.9 billion for the quarter. Net sales were down due to a 1% decline in volume and a 4% unfavorable foreign exchange impact, partially offset by a 1% positive pricing impact. Organic sales were in line with the previous year. Retail Hair Care volume grew low-single digits behind growth in developing regions and mid-single-digit or higher global growth of Head & Shoulders, Herbal Essences, Rejoice and Nice N Easy. Professional Hair Care volume declined mid-single-digits primarily due to market contractions. Personal Cleansing volume decreased high-single-digits due to trade inventory reductions and market contractions. Volume in Skin Care decreased mid-single-digits mainly due to the divestiture of Noxzema. Cosmetics volume was down mid-single-digits due to trade inventory reductions. Prestige Fragrances volume decreased high-single-digits due mainly to market contractions and a shift in initiative timings to the second half of fiscal 2009. Net earnings declined 10% during the quarter to $799 million primarily due to lower operating margin and a reduction in net sales. Operating margin declined as lower marketing spending as a percentage of net sales was more than offset by the impact of higher commodity costs. Beauty net sales increased 3% fiscal year to date to $10.1 billion. Volume increases, positive pricing, and favorable foreign exchange each contributed 1% to net sales growth. Organic sales increased 3%. Retail Hair Care volume grew mid-single-digits behind growth in developing regions. Professional Hair Care volume declined mid-single-digits due to market contractions. Cosmetics volume grew low-single-digits behind mid-single-digit growth of Cover Girl. Volume in Skin Care declined low-single-digits due to the divestiture of Noxzema. Personal Cleansing volume was down low-single-digits behind trade inventory reductions and market contractions. Prestige Fragrances volume declined mid-single-digits due to market contractions and a shift in initiative timings to the second half of fiscal 2009. Net earnings decreased 1% fiscal year to date to $1.6 billion as sales growth and lower overhead and marketing spending as a percentage of net sales were more than offset by reduced gross margin from the impact of higher commodity costs. Grooming Grooming net sales declined 7% during the quarter to $2.0 billion on a 6% decline in unit volume. Price increases taken across premium shaving systems added 4% to net sales. Product mix contributed 1% to net sales behind continued growth of premium innovations such as Gillette Fusion. Unfavorable foreign exchange reduced net sales by 6%. Organic sales increased 1% for the quarter. Unit volume declined primarily due to a double-digit decline of Braun. Blades and Razors volume decreased low-single-digits driven primarily by trade inventory reductions and market contractions in North America and Western Europe. Double-digit growth of Gillette Fusion was offset by a high-single-digit decline of Mach3. Global value share of the blades and razors category increased by 1 percent. Braun volume declined behind market contractions, the exits of the U.S. home appliance and Tassimo coffee appliance businesses and trade inventory reductions. Global value share of the dry shaving category increased half of a point to nearly 35%. Net earnings decreased 3% to $416 million for the quarter primarily due to lower net sales, partially offset by higher operating margin. Operating margins increased due to lower overhead spending as a percentage of net sales and the positive gross margin impact of price increases and improved mix, partially offset by higher marketing spending as a percentage of net sales. Grooming net sales were down 1% to $4.2 billion fiscal year to date on a 3% decline in unit volume. Price increases taken across premium shaving systems added 3% to net sales. Product mix had a negative 1% impact on net sales as favorable product mix from growth on Gillette Fusion was more than offset by disproportionate growth in developing regions, which have lower than segment average selling prices. Organic sales were consistent with the prior year to date period. Volume in Blades and Razors was consistent with previous year as growth in developing regions was offset by trade inventory reductions and market contractions in North America and Western Europe. Double-digit growth of Gillette Fusion and mid-single-digit growth of Venus were offset by declines in Mach3 and disposables. Global value share of the blades and razors category increased over half a point to about 70%. Volume in Braun was down due to market contractions, the exits of the U.S. home appliance and Tassimo coffee appliance businesses and trade inventory reductions. Global value share of the dry shaving category increased over 1 point to about 36%. Net earnings increased 2% to $894 million on higher operating margin. Operating margin increased behind lower overhead spending as a percentage of net sales and the positive gross margin impact of price increases and improved mix, partially offset by higher marketing spending as a percentage of net sales. HEALTH AND WELL-BEING GBU Health Care Health Care net sales were down 6% during the quarter to $3.5 billion on a 3% volume decline. Unfavorable foreign exchange and negative product mix reduced net sales by 5% and 1%, respectively. These impacts were partially offset by a positive pricing impact of 3%. Organic sales were in line with the prior year as positive pricing offset declining volume and negative product mix. Personal Health Care volume decreased double-digits due to a double-digit decline of Prilosec OTC from the loss of marketplace exclusivity in North America and the ThermaCare divestiture. P&Gs all-outlet value share of the U.S. stomach remedies market has declined about nine points to about 29 percent. Pharmaceuticals volume declined mid-single-digits primarily as a result of minor brand divestitures. Feminine Care volume was flat as double-digit growth of Naturella was offset by a mid-single-digit decline of Tampax. Oral Care volume decreased low-single-digits behind lower shipments of Crest primarily in China from trade inventory reductions and transition issues while implementing a new mid-tier brand restage. For the quarter, net earnings decreased 10% to $647 million primarily due to the decline of net sales and lower operating margin driven primarily by higher commodity costs. Health Care net sales declined 1% fiscal year to date to $7.2 billion on a 2% decline in unit volume. Price increases added 3% to net sales, while negative product mix reduced net sales by 2% resulting primarily from lower shipments of Prilosec OTC. Organic sales were in line with the prior year period. Personal Health Care volume was down low-double-digits due to a double-digit decline of Prilosec OTC from the loss of marketplace exclusivity in North America and the divestiture of ThermaCare. Pharmaceuticals volume decreased mid-single-digits due to minor brand divestitures. Oral Care volume was consistent with previous year results as low-single-digit growth of Oral B was offset by a low-single-digit decline of Crest. Feminine Care volume grew low-single-digits due to growth in developing regions behind Always and Naturella. Net earnings declined 4% to $1.3 billion due to lower net sales and a commodity cost-driven decline in gross margin, partially offset by lower overhead spending as a percentage of sales. Snacks and Pet Care Snacks and Pet Care net sales decreased 1% to $791 million for the quarter on a unit volume decline of 5%. Net sales were negatively impacted by unfavorable foreign exchange of 5% and negative product mix of 1%. Price increases to recover higher commodity costs contributed 10% to net sales. Volume in Snacks declined mid-single-digits due to supply constraints in North America. Volume in Pet Care was down mid-single-digits due to declining shipments to the pet specialty channel in response to multiple price increases. Net earnings declined 6% to $63 million for the quarter primarily due to lower gross margin from higher commodity costs, partially offset by lower overhead and marketing expenses as a percentage of net sales. Snacks and Pet Care net sales increased 4% fiscal year to date to $1.6 billion behind positive pricing impacts of 8%. Lower volume and unfavorable foreign exchange each reduced net sales by 1%. Product mix negatively impacted net sales by 2% due to lower shipments of Eukanuba and premium snack products, which have higher than segment average selling prices. Volume in Snacks increased low-single-digits behind mid-single-digit growth in North America. Pet Care volume declined mid-single-digits due to consumption declines following multiple price increases, which resulted in overall pet care sales increasing mid-single-digits. Net earnings were consistent with previous year results at $118 million as higher net sales and lower overhead and marketing spending as a percentage of net sales were offset by lower gross margin from higher commodity costs and a higher effective tax rate. HOUSEHOLD CARE GBU Fabric Care and Home Care Fabric Care and Home Care net sales decreased 4% to $5.8 billion for the quarter on a 6% decline in unit volume. Unfavorable foreign exchange reduced net sales by 5% during the quarter. Price increases to offset commodity costs had a positive impact of 6% on net sales and positive mix added an additional 1%. Organic sales grew 1%. Fabric Care volume decreased mid-single-digits primarily due to a double-digit reduction of Tide shipments from trade inventory reductions and market share declines. U.S. all-outlet value share of the detergents category was down over two points as lower shares on Tide and minor brands were partially offset by increases on the Gain brand. Home Care volume was down low-single digits as growth of Air Care was more than offset by declines of Dish Care and Surface Care following price increases. Batteries volume was down low-double-digits behind market contractions, trade inventory reductions and market share declines. Global value share of general purpose batteries was down slightly to about 28%. Net earnings declined 25% to $658 million primarily due to a decline in net sales and lower gross margin from higher commodity costs. Higher overhead spending as a percentage of net sales was partially offset by lower marketing spending as a percentage of net sales. Fabric Care and Home Care net sales increased 3% to $12.3 billion fiscal year to date. Price increases contributed 5% to net sales and more than offset a 2% decline in unit volume. Fabric Care volume declined low-single-digits as lower shipments of Tide due to trade inventory reductions and market share declines were mostly offset by growth of Gain and Downy. U.S. all-outlet value share of the detergents category was down over two points as lower shares on Tide and minor brands were partially offset by increases on the Gain brand. Home Care volume declined low-single-digits due to the Febreze Candles initiatives in the base period and volume softness following price increases on Dish Care and Surface Care. Batteries volume was down mid-single-digits due to market contractions, trade inventory reductions and market share declines. Net earnings declined 17% to $1.5 billion as increased net sales were more than offset by reduced operating margin. Operating margin declined primarily due to reduced gross margin, driven by higher commodity costs. Higher overhead spending as a percentage of net sales was more than offset by lower marketing spending as a percentage of net sales. Baby Care and Family Care Baby Care and Family Care net sales increased 3% during the quarter to $3.5 billion on 1% unit volume growth. Price increases to recover higher commodity and energy costs contributed 7% to sales growth. Unfavorable foreign exchange reduced net sales by 4%. Product mix from the disproportionate growth in developing regions and a shift toward larger pack counts, which have lower than segment average selling prices, negatively impacted net sales by 1%. Volume in Baby Care increased low-single-digits due to growth of Pampers in developing regions. Volume in Family Care decreased low-single-digits as lower shipments of Charmin more than offset growth of Bounty. Net earnings were consistent with previous year results at $418 million as higher net sales were offset by lower operating margins and a higher effective tax rate. Baby Care and Family Care net sales increased 7% to $7.2 billion fiscal year to date on 1% volume growth. Pricing to help recover higher commodity and energy costs contributed 6% to net sales growth. Volume in Baby Care increased mid-single-digits due to growth of Pampers in developing regions and double-digit growth of Luvs in North America. Family Care volume declined low-single-digits due to the Western European Tissue divestiture. Organic volume for Family Care was up low-single-digits behind double-digit growth of Charmin Basic and Bounty Basic. Family Care U.S. value share was up nearly one point to over 32%. Organic sales were up 9% year to date behind a 4% increase in organic volume. Net earnings increased 10% to $932 million due to sales growth and higher gross margin. Fiscal year to date gross margin increased as the impact of price increases, manufacturing cost savings and the positive mix impact of the Western European Tissue and Towel divestiture more than offset higher commodity and energy costs. CORPORATE Corporate includes certain operating and non-operating activities not allocated to specific business units. These include: the incidental businesses managed at the corporate level; financing and investing activities; other general corporate items; the historical results of certain divested brands and categories; and certain restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce rationalization. Corporate also includes reconciling items to adjust the accounting policies used in the segments to U.S. GAAP. The most significant reconciling items include income taxes (to adjust from statutory rates that are reflected in the segments to the overall Company effective tax rate), adjustments for unconsolidated entities (to eliminate sales, cost of products sold and SG&A for entities that are consolidated in the segments but accounted for using the equity method for U.S. GAAP) and minority interest adjustments for subsidiaries where we do not have 100% ownership. Since both unconsolidated entities and less than 100% owned subsidiaries are managed as integral parts of the Company, they are accounted for similar to a wholly owned subsidiary for management and segment purposes. This means our segment results recognize 100% of each income statement component through before-tax earnings, with eliminations for unconsolidated entities in Corporate. In determining segment after-tax net earnings, we apply the statutory tax rates (with adjustments to arrive at the Companys effective tax rate in Corporate) and eliminate the share of earnings applicable to other ownership interests, in a manner similar to minority interest. For the Corporate segment, net expenses from continuing operations decreased $157 million to $39 million for the quarter. The decrease was driven primarily by corporate hedging impacts and lower net interest expense, partially offset by higher restructuring spending. Fiscal year to date, net expenses from continuing operations decreased $330 million. The decrease was primarily due to corporate hedging impacts, higher current period divestiture gains and lower interest expense, partially offset by higher restructuring spending. FINANCIAL CONDITION Operating Activities Cash generated from operating activities for the fiscal year to date period was $5.6 billion, a decrease of 20% versus the comparable prior year period. Net earnings, adjusted for non-cash items (primarily depreciation, amortization, share based compensation, deferred income taxes and gains on the sale of businesses) provided $8.0 billion of operating cash. This was partially offset by an increase in working capital, driven primarily by inventory, accounts receivable and accounts payable, accrued and other liabilities. Inventory increased primarily due to higher input costs and the decline in unit volume, which drove a 2 day increase in the amount of inventory on hand. Accounts receivable increased primarily due to seasonality of certain business categories such as prestige fragrances, batteries and appliances, which have higher relative sales leading up to the holiday season. Accounts payable, accrued and other liabilities levels declined due to earlier relative payment timing for marketing and other operating expenses, along with the timing of interest payments on debt. Cash flow from discontinued operations contributed $96 million to operating cash flow. Investing Activities Investing activities in the current year used $675 million. Capital expenditures were $1,421 million fiscal year to date or 3.4% of net sales. Proceeds from asset sales generated $1,017 million in cash primarily from the Noxzema, Coffee and Western European Tissue divestitures. Acquisitions, net of cash acquired, consumed $323 million of cash mainly due to the Nioxin acquisition. Cash flow from discontinued operations consumed $3 million of investing cash flow. Financing Activities Total cash used by financing activities was $2.4 billion fiscal year to date. Treasury shares in the amount of $5.2 billion were repurchased under a previously announced share buyback program that started in July 2007. Dividends to shareholders used $2.5 billion. These uses of cash were partially funded by an increase in the Companys debt position of $4.8 billion. As of December 31, 2008, our current liabilities exceeded current assets by $11.7 billion, driven by our short-term debt position. We have short- and long-term debt to fund discretionary items such as acquisitions and share buyback programs. We anticipate being able to support our short-term liquidity and operating needs largely through cash generated from operations. We have strong short- and long-term debt ratings which despite the current credit crisis have enabled and should continue to enable us to refinance our debt as it becomes due at favorable rates in commercial paper and bond markets. In addition, we have agreements with a diverse group of financial institutions that, if needed, should provide sufficient credit funding to meet short-term financing requirements. However, if the current credit crisis were to continue to worsen such that we were unable to access the credit market, it could impair our ability to fund discretionary spending such as the previously announced share buyback program. RECONCILIATION OF NON-GAAP MEASURES Our discussion of financial results includes several measures not defined by U.S. GAAP. We believe these measures provide our investors with additional information about the underlying results and trends of the Company, as well as insight to some of the metrics used to evaluate management. When used in MD&A, we have provided the comparable GAAP measure in the discussion. Organic Sales Growth: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions, divestitures and foreign exchange from year-over-year comparisons. We believe this provides investors with a more complete understanding of underlying sales trends by providing sales growth on a consistent basis. The reconciliation of reported sales growth to organic sales for the October - December quarter: Acquisition/ Divestiture Impact Fabric Care and Home Care The reconciliation of reported sales growth to organic sales for the fiscal year to date period: Acquisition/ Divestiture Impact Baby Care and Family Care Free Cash Flow: Free cash flow is defined as operating cash flow less capital spending. We view free cash flow as an important measure because it is one factor in determining the amount of cash available for dividends and discretionary investment. Free cash flow is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation. Free Cash Flow Productivity: Free cash flow productivity is defined as the ratio of free cash flow to net earnings. The Companys long-term target is to generate free cash at or above 90 percent of net earnings. Free cash flow is also one of the measures used to evaluate senior management. The reconciliation of free cash flow and free cash flow productivity is provided below (amounts in millions): Free Cash Flow Productivity Quantitative and Qualitative Disclosures About Market Risk. There have been no material changes in the Companys exposure to market risk since June 30, 2008. Additional information can be found in the section entitled Other Information, which appears on page 54, and Note 6, Risk Management Activities, which appears on pages 65-66 of the Annual Report to Shareholders for the fiscal year ended June 30, 2008 which can be found by reference to Exhibit 13 of the Companys Annual Report on Form 10-K/A Amendment No. 1 for the fiscal year ended June 30, 2008 which was filed on October 3, 2008. Controls and Procedures. Evaluation of Disclosure Controls and Procedures. The Companys Chairman of the Board and Chief Executive Officer, A. G. Lafley, and the Companys Chief Financial Officer, Jon R. Moeller, performed an evaluation of the Companys disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (Exchange Act)) as of the end of the period covered by this report. Messrs. Lafley and Moeller have concluded that the Companys disclosure controls and procedures were effective to ensure that information required to be disclosed in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) accumulated and communicated to our management, including Messrs. Lafley and Moeller, to allow their timely decisions regarding required disclosure. Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting that occurred during the Companys fiscal quarter ended December 31, 2008 that have materially affected, or are reasonably likely to materially affect, the Companys internal control over financial reporting. PART II. OTHER INFORMATION Legal Proceedings. The Company is subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental issues, patent and trademark matters and taxes. The Company is subject to a variety of investigations into potential competition law violations in Europe. In July 2006, French authorities, in connection with an inquiry into potential competition law violations in France, entered the premises of two of the Companys French subsidiaries and seized a variety of documents. In April 2008, UK authorities initiated an investigation concerning potential antitrust violations in the UK involving one of the Companys subsidiaries. In June 2008, European Commission officials, with the assistance of the national authorities from a variety of countries, started an investigation into potential competition law violations in a variety of countries across the European Union. Around the same time, the national authorities in Spain, Italy and the Czech Republic initiated additional investigations into potential antitrust concerns within those countries. In connection with these investigations, a number of the Companys subsidiaries were visited and documents seized. The Company or its subsidiaries are also involved in other competition law investigations in Belgium, Romania, Switzerland, France and Greece. We believe that all of the above matters involve a number of other consumer products companies and/or retail customers. The Companys policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with investigations by relevant regulatory authorities, which the Company is doing. Competition and antitrust law investigations often continue for several years and, if violations are found, can result in substantial fines. In other industries, fines have amounted to hundreds of millions of dollars. At this point, no formal claims have been made against the Company or any of our subsidiaries in connection with any of the above inquiries. During the fiscal year ended June 30, 2008, certain of the Companys subsidiaries in Germany received a formal complaint alleging violations of the antitrust laws. We are now discussing the situation with the German authorities. In response to the actions of the Commission and national authorities, the Company has launched its own internal investigations into potential violations of competition laws, which are ongoing. The Company has identified violations in certain European countries and appropriate actions are being taken. It is still too early for us to reasonably estimate the fines to which the Company will be subject as a result of these competition law issues. However, we have taken and will take reserves as appropriate. Please refer to the Companys Risk Factors in Item 1A below for additional information. In December 2008, the Company became aware of an investigation by Italian authorities into an environmental accident at the site of a contractor which provides services to one or more of the Companys European affiliates. The accident involved the explosion of certain pressurized cans and resulted in the death of one worker and serious injuries to another. Italian authorities are currently investigating whether the Companys affiliates complied with Italian laws related to the proper classification and disposal of their products. While no judicial proceeding has been initiated, the Italian authorities could levy fines in excess of $100,000 against the Companys European affiliate(s), should they find that these entities violated the law. Risk Factors. We discuss our expectations regarding future performance, events and outcomes, such as our business outlook and objectives in this Form 10-Q, the Annual Report to Shareholders, quarterly reports, press releases and other written and oral communications. All statements, except for historical and present factual information, are forward-looking statements and are based on financial data and business plans available only as of the time the statements are made, which may become out of date or incomplete. We assume no obligation to update any forward-looking statements as a result of new information, future events, or other factors. Forward-looking statements are inherently uncertain, and investors must recognize that events could significantly differ from our expectations. The following discussion of risk factors identifies the most significant factors that may adversely affect our business, operations, financial position or future financial performance. This information should be read in conjunction with Managements Discussion and Analysis (MD&A) and the consolidated financial statements and related notes incorporated by reference into this report. The following discussion of risks is not all inclusive but is designed to highlight what we believe are important factors to consider when evaluating our expectations. These factors could cause our future results to differ from those in the forward-looking statements and from historical trends. A material change in consumer demand for our products could have a significant impact on our business. We are a consumer products company and rely on continued global demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers. This is dependent on a number of factors including our ability to develop effective sales, advertising and marketing programs in an increasingly fragmented media environment. We expect to achieve our financial targets, in part, by shifting our portfolio towards faster growing, higher margin businesses. If demand and growth rates fall substantially below expected levels or our market share declines significantly in these businesses, our results could be negatively impacted. This could occur due to unforeseen negative economic or political events or to changes in consumer trends and habits. In addition, our continued success is dependent on leading-edge innovation, with respect to both products and operations. This means we must be able to obtain patents that lead to the development of products that appeal to our consumers across the world. The ability to achieve our business objectives is dependent on how well we can respond to our local and global competitors. Across all of our categories, we compete against a wide variety of global and local competitors. As a result, there are ongoing competitive product and pricing pressures in the environments in which we operate, as well as challenges in maintaining profit margins. To address these challenges, we must be able to successfully respond to competitive factors, including pricing, promotional incentives and trade terms, as well as technological advances and patents granted to competition. Our ability to successfully integrate key acquisitions, such as Gillette, could impact our business results. Since our goals include a growth component tied to acquisitions, we must be able to successfully manage and integrate key acquisitions, such as the acquisition of The Gillette Company. Specifically, we must be able to integrate acquisitions without any significant disruption to our ability to manage and execute business plans on our base businesses. In addition, our financial results could be adversely impacted if we are not able to deliver the expected cost and growth synergies associated with our acquisitions. Our businesses face cost pressures which could affect our business results. Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, cost of labor, foreign exchange and interest rates. Our costs in 2008 were impacted by higher commodity costs and this trend is likely to continue in 2009. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects (including outsourcing projects), sourcing decisions and certain hedging transactions. In the manufacturing and general overhead areas, we need to maintain key manufacturing and supply arrangements, including any key sole supplier and sole manufacturing plant arrangements. We face risks associated with significant international operations. We conduct business across the globe with a significant portion of our sales outside the United States. We expect to achieve our financial targets, in part, by achieving disproportionate growth in developing regions. Should growth rates or our market share fall substantially below expected levels in these regions, our results could be negatively impacted. In addition, economic changes, terrorist activity and political unrest may result in business interruption, inflation, deflation or decreased demand for our products. Our success will depend, in part, on our ability to manage continued global political and/or economic uncertainty, especially in our significant geographical markets, as well as any political or economic disruption due to terrorist and other hostile activities. Our business is subject to regulation in the U.S. and abroad. Changes in laws, regulations and the related interpretations may alter the environment in which we do business. This includes changes in environmental, competitive and product-related laws, as well as changes in accounting standards and taxation requirements. Accordingly, our ability to manage regulatory, tax and legal matters (including product liability, patent, and intellectual property matters), and to resolve pending legal matters without significant liability, including the competition law and antitrust investigations described in Part II, Item 1 of this Form 10-Q, which could require the Company to take significant reserves or pay significant fines during a reporting period, may materially impact our results. If the reputation of one or more of our leading brands erodes significantly, it could have a material impact on our financial results. Our Companys financial success is directly dependent on the success of our brands, particularly our billion-dollar brands. The success of these brands can suffer if our marketing plans or product initiatives do not have the desired impact on a brands image or its ability to attract consumers. Further, our Companys results could be negatively impacted if one of our leading brands suffers a substantial impediment to its reputation due to real or perceived quality issues. A material change in customer relationships or in customer demand for our products could have a significant impact on our business. Our success is dependent on our ability to successfully manage relationships with our retail trade customers. This includes our ability to offer trade terms that are acceptable to our customers and are aligned with our pricing and profitability targets. Our business could suffer if we cannot reach agreement with a key customer based on our trade terms and principles. Further, there is a continuing trend towards retail trade consolidation and this leads to more complex work across broader geographic boundaries for both us and key retailers. This can be particularly difficult when major customers are addressing local trade pressures or local law and regulation changes. Further, our business would be negatively impacted if a key customer were to significantly reduce the range or inventory level of our products. We face risks related to the current credit crisis. The Company currently generates significant operating cash flows, which combined with access to the credit markets provides us with significant discretionary funding capacity. However, current uncertainty in the global economic conditions resulting from the recent disruption in credit markets pose a risk to the overall economy that could impact consumer and customer demand for our products, as well as our ability to manage normal commercial relationships with our customers, suppliers and creditors, including financial institutions. If the current situation deteriorates significantly, our business could be negatively impacted, including such areas as reduced demand for our products from a slow-down in the general economy, supplier or customer disruptions resulting from tighter credit markets and/or temporary interruptions in our ability to conduct day-to-day transactions through our financial intermediaries involving the payment to or collection of funds from our customers, vendors and suppliers. Unregistered Sales of Equity Securities and Use of Proceeds. ISSUER PURCHASES OF EQUITY SECURITIES Total Number of Shares Purchased (1) Average Price Paid per Share (2) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (3) Approximate dollar value of shares that may yet be purchased under our share repurchase program ($ in Billions) (3) (4) The total number of shares purchased was 59,242,766 for the quarter. Except for those shares described in footnote 5 below, all transactions were made in the open market or pursuant to prepaid forward agreements with large financial institutions. Under the prepaid forward agreements, the Company prepaid large financial institutions to deliver shares at future dates in exchange for a discount. The number of shares purchased other than through a publicly announced repurchase plan was 21,913 for the quarter. This number excludes the 38,652,878 shares described in footnote 5 below but includes shares acquired by the Company under various compensation and benefit plans. This table excludes shares withheld from employees to satisfy minimum tax withholding requirements on option exercises and other equity-based transactions. The Company administers cashless exercises through an independent, third party broker and does not repurchase stock in connection with cashless exercise. Average price paid per share is calculated on a settlement basis and excludes commission. On August 3, 2007, the Company announced a share repurchase plan. Pursuant to the share repurchase plan, the Board of Directors authorized the Company and its subsidiaries to acquire in open market and/or private transactions $24 to $30 billion of shares of Company common stock over the subsequent three years to be financed by issuing a combination of long-term and short-term debt. Certain purchases were made prior to announcement of the program but are considered purchases against the program. The dollar values listed in this column include commissions to be paid to brokers to execute the transactions. This includes 38,652,878 shares acquired in November 2008 in exchange for 63,166,532 shares of The Folgers Coffee Company as part of the previously disclosed reverse Morris Trust transaction with The J. M. Smucker Company. This does not apply to the 38,652,878 shares described in footnote 5 above. Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October 14, 2008). Regulations (as amended by shareholders at the annual meeting on October 10, 2006) (Incorporated by reference to Exhibit (3-2) of the Companys Form 10-Q for the quarter ended September 30, The Procter & Gamble 2001 Stock and Incentive Compensation Plan (as amended on August 14, 2007) (Incorporated by reference to Exhibit (10-1) of the Companys Form 10-Q for the quarter ended March 31, 2008) and related correspondence and terms and conditions.* The Procter & Gamble Company Executive Deferred Compensation Plan.* Computation of Earnings per Share. Computation of Ratio of Earnings to Fixed Charges.",11738
2009-02-06,8-K,0000950123-09-002159,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Soliciting material pursuant to Rule 14a-12 under the Exchange Act Pre-commencement communications pursuant to Rule 14d-2(b) under Pre-commencement communications pursuant to Rule 13e-4(c) under Item 9.01 Financial Statements and Exhibits EX-5.A: OPINION OF SUSAN S. WHALEY EX-5.B: OPINION OF ARENDT & MEDERNACH EX-5.C: OPINION OF FRIED, FRANK, HARRIS, SHRIVER & JACOBSON LLP Item 8.01 Other Events. On February 6, 2009, The Procter & Gamble Company (the Company) closed an underwritten public offering of $750,000,000 aggregate principal amount of 3.500% Notes due 2015 and $1,250,000,000 aggregate principal amount of 4.700% Notes due 2019 under the Companys Registration Statement on Form S-3 (Registration No. 333-145938) (the Registration Statement). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are",192
2009-02-10,8-K,0001193125-09-024142,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) February 10, 2009 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation) (IRS Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (513) 983-1100 (Registrants telephone number, including area code) Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) OTHER EVENTS As disclosed in its most recent Form 10-Q for the quarter ended December 31, 2008, The Procter & Gamble Company (the Company) completed the divestiture of its coffee business in November 2008 through the merger of its Folgers coffee subsidiary into The J.M. Smucker Company (Smucker) in an all-stock reverse Morris Trust transaction. In connection with the merger, 38.7 million shares of P&G common stock were tendered by the Companys shareholders and exchanged for all shares of Folgers common stock. Pursuant to the merger, a Smucker subsidiary merged with and into Folgers, and Folgers became a wholly owned subsidiary of Smucker. Historically, the Companys coffee business was part of its Snacks, Coffee and Pet Care reportable segment, as well as the coffee portion of the P&G Professional (PGP) business which is included in the Fabric Care and Home Care reportable segment. In accordance with the provisions of SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, the Company is now required to present the results of Folgers as discontinued operations. As such, the Company has amended its previously filed Consolidated Financial Statements and accompanying footnotes to exclude the results of Folgers from both continuing operations and segment results for the years ended June 30, 2008, 2007 and 2006. This Form 8-K provides revised (1) Managements Discussion and Analysis (MD&A) and (2) Consolidated Financial Statements and accompanying footnotes. Exhibit 99.1 provides a revised Managements Discussion and Analysis (MD&A); Exhibit 99.2 provides revised Consolidated Financial Statements and accompanying footnotes; Exhibit 99.3 provides an updated report of the independent registered public accountant; and Exhibit 23 provides the Consent of Deloitte & Touche LLP.",434
2009-02-17,8-K,0000080424-09-000010,"13 OR 15(d) of The Securities Exchange Act Of 1934 Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 C F R 240.14a-12) communications pursuant to Rule 14d-2(b) under the Exchange Act communications pursuant to Rule 13e-4(c) under the Exchange Act 5.02(e) COMPENSATORY ARRANGEMENTS OF CERTAIN February 10, 2009, the Compensation & Leadership Development Committee (the Committee) of the Board of Directors of The Procter & Gamble Company (P&G) granted A.G. Lafley, Chairman of the Board and Chief Executive Officer, a special equity award of $3,500,000 in recognition of Mr. Lafleys foresight for initiating the acquisition of The Gillette Company (Gillette) and his leadership throughout the acquisition and integration processes. The acquisition and integration of Gillette was the largest and most successful in the Companys history. Through this grant, the Committee rewards Mr. Lafleys strategic vision to combine two world-class consumer products companies into the largest consumer products company in the world, his understanding of the transactions benefits for shareholders and his successful leadership through the complexities of integrating Gillette into P&G. grant will be made in the form of restricted stock units granted under the Companys 2001 Stock and Incentive Compensation Plan using the closing price for the Companys Common Stock on the New York Stock Exchange on February 27, requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly",274
2009-03-09,8-K,0000080424-09-000012,"13 OR 15(d) of The Securities Exchange Act Of 1934 Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act communications pursuant to Rule 13e-4(c) under the Exchange Act March 9, 2009, The Procter & Gamble Company (the Company) announced that Susan E. Arnold will leave her current position as President  Global Business Units effective March 9, 2009, in anticipation of retiring from the Company on Company is filing this 8-K pursuant to Item 5.02(b), ""Departure of Certain requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. 99. News Release by The Procter & Gamble Company dated March 9,",164
2009-04-14,8-K,0000080424-09-000020,"13 OR 15(d) of The Securities Exchange Act Of 1934 of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange ITEM 7.01 REGULATION FD 2009, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of forty-four cents ($0.44) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after May 15, 2009 to shareholders of record at the close of business on April 24, 2009. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Release by The Procter & Gamble Company dated April 14,",186
2009-04-30,8-K,0000080424-09-000022,"to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area code ) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange OF OPERATIONS AND FINANCIAL CONDITION April 30, 2009, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended March 31, 2009. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Release by The Procter & Gamble Company dated April 30,",158
2009-05-01,10-Q,0001193125-09-096244,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2009 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-434 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (513) 983-1100 (Registrants telephone number, including area code) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No  Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No  Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer (as defined in Rule 12b-2 of the Exchange Act).  (Do not check if a smaller reporting company) Smaller reporting company Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No x There were 2,914,701,790 shares of Common Stock outstanding as of March 31, 2009. PART I. FINANCIAL INFORMATION Financial Statements. The Consolidated Statements of Earnings of The Procter & Gamble Company and subsidiaries (the Company, we or our) for the three months and nine months ended March 31, 2009 and 2008, the Consolidated Balance Sheets as of March 31, 2009 and June 30, 2008, and the Consolidated Statements of Cash Flows for the nine months ended March 31, 2009 and 2008 follow. In the opinion of management, these unaudited consolidated financial statements contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, such financial statements may not necessarily be indicative of annual results. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS Amounts in millions except per share amounts Three Months Ended March 31 Nine Months Ended March 31 Selling, general and administrative expense Other non-operating income, net Earnings from Continuing Operations Before Income taxes Net Earnings from Continuing Operations Net Earnings from Discontinued Operations Basic net earnings from continuing operations Basic net earnings from discontinued operations Diluted net earnings from continuing operations Diluted net earnings from discontinued operations Diluted Weighted Average Common Shares Outstanding See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS Cash and cash equivalents Prepaid expenses and other current assets PROPERTY, PLANT AND EQUIPMENT NET PROPERTY, PLANT AND EQUIPMENT GOODWILL AND OTHER INTANGIBLE ASSETS Trademarks and other intangible assets, net NET GOODWILL AND OTHER INTANGIBLE ASSETS LIABILITIES AND SHAREHOLDERS EQUITY Accrued and other liabilities TOTAL CURRENT LIABILITIES OTHER NON-CURRENT LIABILITIES Common stock - shares issued - Additional paid-in capital Reserve for ESOP debt retirement Accumulated other comprehensive income TOTAL SHAREHOLDERS EQUITY TOTAL LIABILITIES AND SHAREHOLDERS EQUITY See accompanying Notes to Consolidated Financial Statements Certain amounts for prior periods were reclassified to conform with the fiscal 2009 presentation THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS Nine Months Ended March 31 CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD Depreciation and amortization Share-based compensation expense Gain on sale of businesses Accounts payable, accrued and other liabilities Other operating assets and liabilities TOTAL OPERATING ACTIVITIES Proceeds from asset sales Acquisitions, net of cash acquired TOTAL INVESTING ACTIVITIES Dividends to shareholders Change in short-term debt Additions to long-term debt Reductions of long-term debt Impact of stock options and other TOTAL FINANCING ACTIVITIES EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS CHANGE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, END OF PERIOD See accompanying Notes to Consolidated Financial Statements Certain amounts for prior periods were reclassified to conform with the fiscal 2009 presentation THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS These statements should be read in conjunction with the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2008, as updated by the Companys Form 8-K filed on February 10, 2009. The results of operations for the three-month and nine-month period ended March 31, 2009 are not necessarily indicative of annual results. Comprehensive IncomeTotal comprehensive income is comprised primarily of net earnings, net currency translation gains and losses, impacts of net investment and cash flow hedges and net unrealized gains and losses on investment securities. Total comprehensive income for the three months ended March 31, 2009 and 2008 was $504 million and $4,389 million, respectively. For the nine months ended March 31, 2009 and 2008, total comprehensive income was $2,896 million and $12,588 million, respectively. Segment Information  Following is a summary of segment results. SEGMENT INFORMATION Three Months Ended March 31 Nine Months Ended March 31 Earnings from Continuing Operations Before Income Taxes Net Earnings from Continuing Operations Earnings from Continuing Operations Before Income Taxes Net Earnings from Continuing Operations Fabric Care and Home Care Baby Care and Family Care Goodwill and Other Intangible Assets  Goodwill as of March 31, 2009 is allocated by reportable segment and global business unit as follows (amounts in millions): Nine Months Ended March 31, 2009 Beauty, beginning of year Acquisitions and divestitures Grooming, beginning of year Acquisitions and divestitures Health Care, beginning of year Acquisitions and divestitures Snacks and Pet Care, beginning of year Acquisitions and divestitures Fabric Care and Home Care, beginning of year Acquisitions and divestitures Baby Care and Family Care, beginning of year Acquisitions and divestitures GOODWILL, Net, beginning of year Acquisitions and divestitures $357 million of the decrease in goodwill from June 30, 2008 in Snacks and Pet Care is due to the divestiture of the Coffee business. The remaining decrease in goodwill from June 30, 2008 is primarily due to currency translation. Identifiable intangible assets as of March 31, 2009 are comprised of (amounts in millions): Amortizable intangible assets with determinable lives Intangible assets with indefinite lives Total identifiable intangible assets Amortizable intangible assets consist principally of brands, patents, technology and customer relationships. The non-amortizable intangible assets consist primarily of brands. The amortization expense of intangible assets for the three months ended March 31, 2009 and 2008 was $149 million and $156 million, respectively. For the nine months ended March 31, 2009 and 2008 the amortization expense of intangible assets was $459 million and $468 million, respectively. Pursuant to SFAS 123(R) Share-Based Payment, companies must recognize the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of those awards (the fair-value based method). Total share-based compensation for the three months and nine months ended March 31, 2009 and 2008 are summarized in the following table (amounts in millions): Three Months Ended March 31 Nine Months Ended March 31 SFAS 123(R) Stock Options Total Share-Based Compensation Assumptions utilized in the model are evaluated and revised, as necessary, to reflect market conditions and experience. Postretirement BenefitsThe Company offers various postretirement benefits to its employees. The components of net periodic benefit cost are as follows: Three Months Ended March 31 Three Months Ended March 31 Expected Return on Plan Assets Amortization of Deferred Amounts Recognized Net Actuarial Loss/ (Gain) Gross Benefit Cost (Credit) Dividends on ESOP Preferred Stock Net Periodic Benefit Cost (Credit) Nine Months Ended March 31 Nine Months Ended March 31 Expected Return on Plan Assets Amortization of Deferred Amounts Recognized Net Actuarial Loss/ (Gain) Gross Benefit Cost (Credit) Dividends on ESOP Preferred Stock Net Periodic Benefit Cost (Credit) For the year ending June 30, 2009, the expected return on plan assets is 7.4% and 9.3% for pension and other retiree benefit plans, respectively. Fair Value Measurements On July 1, 2008 the Company adopted SFAS No. 157, Fair Value Measurements (SFAS 157) for certain financial assets and liabilities. This standard defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosures about fair value measurements. SFAS 157 also establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The statement requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs reflecting the reporting entitys own assumptions or external inputs from inactive markets. Fair Value Hierarchy Under the SFAS 157 hierarchy, an entity is required to maximize the use of quoted market prices and minimize the use of unobservable inputs. The following table sets forth the Companys financial assets and liabilities as of March 31, 2009 that are measured on a recurring basis during the period, segregated by level within the fair value hierarchy: Investment securities (1) Total assets at fair value Liabilities at fair value: Total liabilities at fair value Investment securities consist primarily of non-qualified retirement plan assets. These securities are generally valued using observable market prices in active markets, with some securities valued using unobservable market prices in inactive markets. These investment securities are included within Other non-current assets in our Consolidated Balance Sheets for each period presented. Derivatives consist of foreign currency, interest rate and commodity financial instruments. See Note 8 for additional details on our risk management activities. The table below sets forth a reconciliation of the Companys beginning and ending Level 3 financial assets and liabilities balances for the nine months ended March 31, 2009. Total gains or (losses) (realized/unrealized) included in earnings (or changes in net assets) Total gains or (losses) (realized/unrealized) included in OCI Net purchases, issuances and settlements Transfers in and/or (out) of Level 3 In February 2008, the FASB issued Staff Position No. 157-2, which delays the effective date of SFAS 157 for one year for all nonfinancial assets and liabilities, except those that are recognized or disclosed at fair value in the financial statements on a recurring basis. Based on this guidance, the Company will adopt the provisions of SFAS 157 as they relate to long-lived assets effective July 1, 2009. The adoption is not expected to have a material impact on the Companys financial statements. Risk Management Activities As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. We evaluate exposures on a consolidated basis to take advantage of logical exposure netting and correlation. To the extent we choose to manage volatility associated with the remaining net exposures, we enter into various financial transactions, which we account for under SFAS 133, Accounting for Derivative Instruments and Hedging Activities, as amended and interpreted. These financial transactions are governed by our policies covering acceptable counterparty exposure, instrument types and other hedging practices. At inception, we formally designate and document qualifying instruments as hedges of underlying exposures. We formally assess, both at inception and at least quarterly, whether the financial instruments used in hedging transactions are effective at offsetting changes in either the fair value or cash flows of the related underlying exposure. Fluctuations in the value of these instruments generally are offset by changes in the fair value or cash flows of the underlying exposures being hedged. This offset is driven by the high degree of effectiveness between the exposure being hedged and the hedging instrument. Any ineffective portion of a change in the fair value of a qualifying instrument, which is immaterial for all periods presented, is immediately recognized in earnings. For additional details on the Companys risk management activities, refer to the Companys annual financial statements and footnotes in the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2008, as updated by the Companys Form 8-K filed on February 10, 2009. The location, fair value and fair value hierarchy level of the Companys financial instruments used in hedging transactions at March 31, 2009 are as follows: Prepaid expenses & Other noncurrent assets Total assets at fair value Liabilities at fair value: Accrued liabilities & Other noncurrent liabilities Total liabilities at fair value Certain of the Companys financial instruments used in hedging transactions are governed by industry standard netting agreements with counterparties. If the Companys credit rating were to fall below the levels stipulated in the agreements, the counterparties could demand either collateralization or termination of the deal. The aggregate fair value of the instruments covered by these contractual features that are in a net liability position as of March 31, 2009 was $712 million. The Company has never been required to post any collateral as a result of these The locations and amounts of gains and losses on qualifying and non-qualifying financial instruments used in hedging transactions for the three and nine months ended March 31, 2009 are as follows: Derivatives in Cash Flow Hedging Relationships Notional Amount (Ending Balance) Fair Value Asset (Liability) Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Location of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Three Months Ended March 31 Nine Months Ended March 31 Foreign currency contracts (1) Selling, general and administrative expense Derivatives in Net Investment Hedging Relationships Notional Amount (Ending Balance) Fair Value Asset (Liability) Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) Location of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion and Amount Excluded from Effectiveness Testing) Amount of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion and Amount Excluded from Three Months Ended March 31 Nine Months Ended March 31 Net investment hedges (3) Derivatives Not Designated as Hedging Instruments Notional Amount (Ending Balance) Fair Value Asset (Liability) Location of Gain or (Loss) Recognized in Income on Derivative Amount of Gain or (Loss) Recognized in Income on Derivative Three Months Ended March 31 Nine Months Ended March 31 Foreign currency contracts (4) (5) Selling, general and administrative expense Foreign currency cash flow hedges consist of currency swaps with maturities of up to 5 years. The fair value of these instruments offsets the effect of exchange rate fluctuations on intercompany loans denominated in foreign currencies. Commodity hedges consist of futures and options with maturities generally less than 1 year and swap contracts with maturities up to 5 years. We use these instruments to manage a portion of the volatility in the cost of raw materials used in our products or production processes resulting from weather, supply conditions, political and economic variables and other unpredictable factors. The change in fair value of these instruments offsets the effect of fluctuations in costs for forecasted purchases of commodities used in the manufacturing process. Net investment hedges consist of both direct borrowings in foreign currencies and foreign currency swaps which are designated as hedges of our net investments in certain foreign subsidiaries. Changes to the fair value of these instruments are immediately recognized in OCI to offset the change in the value of the net investment being hedged. Certain of our foreign currency instruments used to manage foreign exchange exposure of intercompany financing transactions and other balance sheet items are not designated as hedges. In these cases, the change in the fair value of the instruments is designed to substantially offset the foreign currency mark-to-market impact of the related exposure. Total fair value of derivatives not designated as hedging instruments included $367 million of foreign currency contracts in a liability position and $161 million of foreign currency contracts in an asset position. The total notional amount of contracts outstanding at the end of the period is indicative of the level of the Companys derivative activity during the period. New Accounting Pronouncements and Policies In December 2007, the FASB issued SFAS 141 (Revised), Business Combinations (SFAS 141R) and SFAS 160, Noncontrolling Interests in Consolidated Financial Statements (SFAS 160). SFAS 141(R) and SFAS 160 revise the method of accounting for a number of aspects of business combinations and non-controlling interests, including acquisition costs, contingencies (including contingent assets, contingent liabilities and contingent purchase price), the impacts of partial and step-acquisitions (including the valuation of net assets attributable to non-acquired minority interests) and post acquisition exit activities of acquired businesses. SFAS 141(R) and SFAS 160 will be effective for the Company during our fiscal year beginning July 1, 2009. In March 2008, the FASB issued SFAS No. 161, Disclosures about Derivative Instruments and Hedging Activities (SFAS 161). SFAS 161 amends and expands the disclosure requirements of SFAS No. 133 with the intent to provide users of financial statements with an enhanced understanding of 1) how and why an entity uses derivative instruments; 2) how derivative instruments and related hedged items are accounted for under Statement 133 and its related interpretations; and 3) how derivative instruments and related hedged items affect an entitys financial position, financial performance and cash flows. SFAS 161 was adopted by the Company on January 1, 2009. The adoption of SFAS 161 did not have any impact on our consolidated net earnings, cash flows or financial position. No other new accounting pronouncement issued or effective during the fiscal year had or is expected to have a material impact on the consolidated financial statements. Commitments and Contingencies  Litigation As previously disclosed, the Company is subject to a variety of investigations into potential competition law violations in Europe, including investigations initiated in the fourth quarter of fiscal 2008 by the European Commission with the assistance of the national authorities from a variety of countries. We believe these matters involve a number of other consumer products companies and/or retail customers. The Companys policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with investigations by relevant regulatory authorities, which the Company is doing. Competition and antitrust law inquiries often continue for several years and, if violations are found, can result in substantial fines. In other industries, fines have amounted to hundreds of millions of dollars. At this point, no significant formal claims have been made against the Company or any of our subsidiaries in connection with any of the above inquiries. In response to the actions of the European Commission and national authorities, the Company has launched its own internal investigations into potential violations of competition laws, some of which are ongoing. The Company has identified violations in certain European countries and appropriate actions are being taken. It is still too early for us to reasonably estimate the fines to which the Company will be subject as a result of these competition law issues. However, the ultimate resolution of these matters will likely result in fines or other costs that could materially impact our income statement and cash flows in the period in which they are accrued and paid, respectively. As these matters evolve the Company will, if necessary, recognize the appropriate reserves. Additional information on the Commitments and Contingencies of the Company can be found in Note 11, Commitments and Contingencies, which appears in Exhibit 99.2 to the Companys Form 8-K filed February 10, Discontinued Operations In November 2008, the Company completed the divestiture of its Coffee business through the merger of its Folgers coffee subsidiary into The J.M. Smucker Company (Smucker) in an all-stock reverse Morris Trust transaction. In connection with the merger, 38.7 million shares of common stock of the Company were tendered by shareholders and exchanged for all shares of Folgers common stock, resulting in an increase of treasury stock of $2,466 million. Pursuant to the merger, a Smucker subsidiary merged with and into Folgers and Folgers became a wholly owned subsidiary of Smucker. The Company recorded an after tax gain on the transaction of $2,011, or $0.63 per share, which is included in Net Earnings from Discontinued Operations in the Consolidated Statement of Earnings for the nine-month period ended March 31, 2009. The Coffee business had historically been part of the Companys Snacks, Coffee and Pet Care reportable segment, as well as the coffee portion of the P&G Professional (PGP) business which is included in the Fabric and Home Care reportable segment. In accordance with the provisions of SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, the results of Folgers are presented as discontinued operations and, as such, have been excluded from both continuing operations and segment results for all periods presented. Following is selected financial information included in Net Earnings from Discontinued Operations for the Coffee business: Three Months Ended March 31 Nine Months Ended March 31 Earnings from discontinued operations Gain on sale of discontinued operations Deferred tax benefit on gain Net earnings from discontinued operations The $28 million of Net Earnings from Discontinued Operations for the three-month period ended March 31, 2009 consist primarily of a gain on the settlement of a patent infringement lawsuit. Reclassification The Company has reclassified certain amounts in the prior period Statements of Cash Flows to be consistent with the current period presentation. Realized gains and losses from non-qualifying derivative instruments used to hedge currency exposures resulting from intercompany financing transactions were reclassified from operating activities to financing activities, which is consistent with the use of the instruments and their related cash flows. Managements Discussion and Analysis of Financial Condition and Results of Operations The purpose of this discussion is to provide an understanding of P&Gs financial results and condition by focusing on changes in certain key measures from year to year. Managements Discussion and Analysis (MD&A) is organized in the following sections: Forward-Looking Statements Results of Operations  Three Months Ended March 31, 2009 Results of Operations  Nine Months Ended March 31, 2009 Business Segment Discussion  Three and Nine Months Ended March 31, 2009 Reconciliation of Non-GAAP Measures Throughout MD&A, we refer to measures used by management to evaluate performance, including unit volume growth, net outside sales and after-tax profit. We also refer to organic sales growth, free cash flow and free cash flow productivity. These financial measures are not defined under accounting principles generally accepted in the United States of America (U.S. GAAP). The explanation at the end of MD&A provides more details on the use and the derivation of these measures. Management also uses certain market share and market consumption estimates to evaluate performance relative to competition despite some limitations on the availability and comparability of such information. References to market share and market consumption in MD&A are based on a combination of vendor-reported consumption and market size data, as well as internal estimates. OVERVIEW P&Gs business is focused on providing branded consumer goods products. Our goal is to provide products of superior quality and value to improve the lives of the worlds consumers. We believe this will result in leadership sales, profits and value creation, allowing employees, shareholders and the communities in which we operate to prosper. Our products are sold in more than 180 countries primarily through mass merchandisers, grocery stores, membership club stores and drug stores. We continue to expand our presence in high frequency stores, the neighborhood stores which serve many consumers in developing markets. We compete in multiple product categories and have three global business units (GBUs): Beauty; Health and Well-Being; and Household Care. Under U.S. Generally Accepted Accounting Principles, the business units comprising the GBUs are aggregated into six reportable segments: Beauty; Grooming; Health Care; Snacks and Pet Care; Fabric Care and Home Care; and Baby Care and Family Care. We have on-the-ground operations in approximately 80 countries through our Market Development Organization, which leads country business teams to build our brands in local markets and is organized along seven geographic areas comprised of three developed regions (North America, Western Europe and Japan) and four developing regions (Latin America, Central and Eastern Europe/Middle East/Africa, Greater China and ASEAN/Australasia/India/Korea). In November 2008, the Company completed the divestiture of its Coffee business through the merger of its Folgers coffee subsidiary into The J.M. Smucker Company (Smucker) in an all-stock reverse Morris Trust transaction. In connection with the merger, 38.7 million shares of common stock of the Company were tendered by shareholders and exchanged for all the common shares of Folgers, which became a wholly owned subsidiary of Smucker. The Company recorded an after tax gain on the transaction of $2.0 billion, or $0.63 per share, which is included in Net Earnings from Discontinued Operations in the Consolidated Statement of Earnings for the nine month period ended March 31, 2009. The Coffee business had historically been part of the Companys Snacks, Coffee and Pet Care reportable segment, as well as the coffee portion of the P&G Professional (PGP) business which is included in the Fabric Care and Home Care reportable segment. In accordance with the provisions of SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, the results of Folgers are presented as discontinued operations and, as such, have been excluded from continuing operations and from segment results for all periods presented. The following table provides the percentage of net sales and net earnings from continuing operations by reportable business segment for the three months ended March 31, 2009 (excludes net sales and net earnings in Corporate): Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care The following table provides the percentage of net sales and net earnings from continuing operations by reportable business segment for the nine months ended March 31, 2009 (excludes net sales and net earnings in Corporate): Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care SUMMARY OF RESULTS Following are highlights of results for the nine months ended March 31, 2009: Net sales declined 1% to $60.4 billion. Organic sales, which exclude the impacts of acquisitions, divestitures and foreign exchange, grew 3%. Unit and organic volume, which excludes the impact of acquisitions and divestitures, both decreased 2% versus the prior-year period. Net earnings increased 21% to $11.0 billion. Net earnings increased due to the gain on the Folgers transaction. Net earnings from continuing operations were flat versus the prior year period as lower net sales and a decline in operating margin were offset by lower interest expense, higher gains from divestitures and a lower tax rate. Diluted net earnings per share were $3.46, an increase of 27% versus the comparable prior-year period. Operating cash flow was $9.9 billion, a decrease of 11% versus the prior year period. Free cash flow productivity, defined as the ratio of operating cash flow less capital expenditures to net earnings, was 71%. FORWARD-LOOKING STATEMENTS We discuss expectations regarding future performance, events and outcomes, such as our business outlook and objectives, in annual and quarterly reports, press releases and other written and oral communications. All such statements, except for historical and present factual information, are forward-looking statements, and are based on financial data and our business plans available only as of the time the statements are made, which may become out-of-date or incomplete. We assume no obligation to update any forward-looking statements as a result of new information, future events or other factors. Forward-looking statements are inherently uncertain and investors must recognize that events could be significantly different from our expectations. The following details a number of circumstances which could impact our ability to successfully achieve our business objectives. For additional information concerning factors that could cause actual results to differ from those projected herein, please refer to our recent reports on Forms 10-K, 10-Q and 8-K. Ability to Achieve Business Plans: We are a consumer products company and rely on continued demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers and retail trade customers. Our continued success is dependent on leading-edge innovation with respect to both products and operations and on the continued positive reputations of our brands. This means we must be able to obtain patents and respond to technological advances and patents granted to competition. Our success is also dependent on effective sales, advertising and marketing programs in an increasingly fragmented media environment. Our ability to innovate and execute in these areas will determine the extent to which we are able to grow existing sales and volume profitably, especially with respect to the product categories and geographic markets (including developing markets) in which we have chosen to focus. There are high levels of competitive activity in the environments in which we operate. To address these challenges, we must respond to competitive factors, including pricing, promotional incentives, trade terms and product initiatives. We must manage each of these factors, as well as maintain mutually beneficial relationships with our key customers, in order to effectively compete and achieve our business plans. Since our goals include a growth component tied to acquisitions, we must manage and integrate key acquisitions including achieving the cost and growth synergies in accordance with stated goals. Cost Pressures: Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, cost of labor, foreign exchange and interest rates. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects, sourcing decisions and certain hedging transactions. We also must manage our debt and currency exposure, especially in volatile countries. We need to maintain key manufacturing and supply arrangements, including sole supplier and sole manufacturing plant arrangements. We must implement, achieve and sustain cost improvement plans, including our outsourcing projects and those related to general overhead and workforce rationalization. Global Economic Conditions: Economic changes, terrorist activity and political unrest may result in business interruption, significant credit or liquidity issues, inflation, deflation or decreased demand for our products. Our success will depend, in part, on our ability to manage continued global political and/or economic uncertainty, especially in our significant geographic markets, as well as any political or economic disruption due to a global or regional credit crisis or terrorist and other hostile activities. Regulatory Environment: Changes in laws, regulations and the related interpretations may alter the environment in which we do business. This includes changes in environmental, competition and product-related laws, as well as changes in accounting standards and taxation requirements. Our ability to manage regulatory, tax and legal matters (including product liability, patent, intellectual property and competition law matters) and to resolve pending legal matters within current estimates may impact our results. RESULTS OF OPERATIONS  Three Months Ended March 31, 2009 The following discussion provides a review of results for the three months ended March 31, 2009 versus the three months ended March 31, 2008. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended March 31 Selling, General & Administrative Expense Other Non-operating Income, Net Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Net Earnings From Discontinued Operations Effective Tax Rate  Continuing Operations Basic Net Earnings  Continuing Operations Basic Net Earnings  Discontinued Operations Diluted Net Earnings  Continuing Operations Diluted Net Earnings  Discontinued Operations Average Diluted Shares Outstanding Comparisons as a % of Net Sales Selling, General & Administrative Expense Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Net sales for the quarter decreased 8% to $18.4 billion on a 5% decline in unit volume. Unfavorable foreign exchange reduced net sales by 9% as many foreign currencies weakened versus the U.S. dollar. Price increases added 7% to net sales, while product mix had a negative 1% impact on net sales. All reportable segments except Baby Care and Family Care experienced volume declines. Both developed and developing markets declined mid-single digits driven primarily by market contractions and continued trade inventory reductions. These impacts were most acute across the Central & Eastern Europe/Middle East/Africa (CEEMEA) region, where more pronounced price increases were necessary to maintain the structural economics of businesses as the devaluation of local currencies increased the local cost of dollar-denominated inputs costs. Organic sales increased 1% with growth in the Baby Care and Family Care, the Fabric Care and Home Care and the Snacks and Pet Care segments. The Companys net sales were negatively impacted by the global economic downturn, credit crisis and associated currency market volatility. These factors are expected to continue and negatively impact net sales for the remainder of the fiscal year and beginning of next fiscal year. Net Sales Change Drivers 2009 vs. 2008 (Three Months Ended Mar. 31) Volume with Acquisitions & Divestitures Volume excluding Acquisitions & Divestitures Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Sales percentage changes are approximations based on quantitative formulas that are consistently applied. Gross margin for the quarter was 50.3% of net sales, a decline of 140 basis points versus the prior-year period. Higher commodity and energy costs lowered gross margin by about 200 basis points. Unfavorable foreign exchange impacts, negative product mix and incremental restructuring charges also reduced gross margin for the quarter. These were largely offset by the impact of price increases and manufacturing cost savings projects. Total selling, general and administrative expenses (SG&A) decreased 13% to $5.5 billion for the quarter due to currency impacts and cost reduction efforts. SG&A as a percentage of net sales decreased 170 basis points primarily due to lower marketing spending and the impact of foreign currency transaction gains on working capital balances caused by strengthening of the U.S. dollar. These impacts were partially offset by increased overhead costs as a percentage of net sales as the impact of overhead productivity programs was more than offset by the negative scale impact of lower net sales and the cost of incremental restructuring activities. Incremental restructuring activities undertaken to offset dilution from the Folgers divestiture reduced operating margins by approximately 60 basis points for the quarter. Interest expense declined 8% for the quarter to $336 million driven mainly by a reduction in U.S. interest rates. Other non-operating income increased $83 million to $93 million primarily due to gains on the divestiture of minor brands. The effective tax rate on continuing operations declined 170 basis points to 25.9% primarily due to audit settlements in a number of countries. Net earnings from continuing operations decreased 2% to $2.6 billion primarily due to reduced net sales and operating income, partially offset by a lower tax rate. The overall decline in operating income was driven primarily by foreign-exchange impacts, as most major currencies weakened against the U.S. dollar. Diluted net earnings per share from continuing operations were $0.83, an increase of 4% versus the prior year. Net earnings from discontinued operations were $28 million consisting primarily of a gain on the settlement of a patent infringement lawsuit. This represents a decline of 53% versus the prior-year period caused by the loss of contribution from the Folgers business divested in the December quarter. Net earnings were down 4% to $2.6 billion during the quarter. Diluted net earnings per share increased 2% to $0.84. Earnings per share growth exceeded net earnings growth due to the impact of our share repurchase program and shares tendered for the Folgers transaction. RESULTS OF OPERATIONS  Nine Months Ended March 31, 2009 The following discussion provides a review of results for the nine months ended March 31, 2009 versus the nine months ended March 31, 2008. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amount in Millions Except Per Share Amounts) Consolidated Earnings Information Nine Months Ended March 31 Selling, General & Administrative Expense Other Non-operating Income, Net Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Net Earnings From Discontinued Operations Effective Tax Rate  Continuing Operations Basic Net Earnings  Continuing Operations Basic Net Earnings  Discontinued Operations Diluted Net Earnings  Continuing Operations Diluted Net Earnings  Discontinued Operations Average Diluted Shares Outstanding Comparisons as a % of Net Sales Selling, General & Administrative Expense Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Net sales decreased 1% to $60.4 billion fiscal year to date on a 2% decline in unit volume. Unfavorable foreign exchange reduced net sales by 3% as many foreign currencies weakened versus the U.S. dollar. Negative product mix lowered net sales by 1%. Price increases across all segments to offset commodity-driven cost increases added 5% to net sales. Every reportable segment, except Baby Care and Family Care, reported volume declines led by a high single-digit decline of Grooming and mid-single-digit decline in Health Care. Developed market volume declined low single-digits and developing market volume was in line with prior-year results. Organic sales increased 3% versus the prior year period driven by growth of the Baby Care and Family Care, Snacks and Pet Care, Beauty and Fabric Care and Home Care segments. The global economic downturn, credit crisis and price increases have contributed to market contractions, trade inventory reductions and share declines in certain businesses, resulting in organic sales below the Companys long-term financial target range. Net Sales Change Drivers 2009 vs. 2008 (Nine Months Ended Mar. 31) Volume with Acquisitions & Divestitures Volume excluding Acquisitions Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Sales percentage changes are approximations based on quantitative formulas that are consistently applied. Gross margin was down 150 basis points to 50.9% of net sales fiscal year to date. Commodity-driven cost impacts reduced gross margin by about 300 basis points. Unfavorable foreign exchange impacts, negative product mix and incremental restructuring charges also negatively impacted gross margin. These impacts were partially offset by price increases and manufacturing cost savings projects. Total selling, general and administrative expenses (SG&A) were down 4% versus the prior-year period to $18.2 billion primarily due to foreign currency impacts and cost reduction efforts. SG&A as a percentage of net sales declined 110 basis points due to lower marketing spending and the net impact of foreign exchange transactional gains and losses on working capital balances, partially offset by cost for incremental restructuring activities undertaken to offset dilution from the divestiture of Folgers. Incremental restructuring activities undertaken to offset dilution from the Folgers divestiture reduced operating margins by approximately 40 basis points fiscal year to date. Interest expense declined 7% to $1.0 billion fiscal year to date driven mainly by a reduction in U.S. interest rates. Other non-operating income increased $124 million to $520 million as higher divestiture gains were partially offset by lower interest income. The base period divestiture gains resulted primarily from the sale of our adult incontinence business in Japan and tissue business in Western Europe, while the current period gains resulted primarily from the sale of Thermacare, Dantrium, Infusium and other minor brands. Interest income declined as a result of lower U.S. dollar interest rates and a reduction of cash balances. The effective tax rate on continuing operations was down to 26.7% from 27.4% due to the net effect of foreign mix, audit settlements and the effects of foreign repatriations. Net earnings from continuing operations were in line with the prior-year period at $8.8 billion as lower net sales and reduced operating margin were offset by lower interest expense, higher divestiture gains and a lower tax rate. Diluted net earnings per share from continuing operations were $2.78, up 5% versus the prior year. Net earnings for discontinued operations increased $1.9 billion fiscal year to date mainly due to the after tax gain on the divestiture of Folgers. Net earnings increased 21% to $11.0 billion fiscal year to date as a result of the Folgers transaction gain. Diluted net earnings per share were $3.46, up 27% versus the prior year. Earnings per share growth exceeded net earnings growth due to the impact of our share repurchase program and shares tendered for the Folgers transaction. BUSINESS SEGMENT DISCUSSION Three and Nine Months Ended March 31, 2009 The following discussion provides a review of results by business segment. Analyses of the results for the three and nine months ended March 31, 2009 are provided compared to the same three and nine month periods ended March 31, 2008. The primary financial measures used to evaluate segment performance are net sales and net earnings from continuing operations. The table below provides supplemental information on net sales and net earnings from continuing operations by business segment for the three and nine months ended March 31, 2009 versus the comparable prior year period (amounts in millions): Three Months Ended March 31, 2009 Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Nine Months Ended March 31, 2009 Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care BEAUTY GBU Beauty Beauty net sales declined 9% during the quarter to $4.3 billion. Organic sales were in line with the previous year period. A 5% decline in unit volume primarily due to soft shipments in Prestige Fragrances and across the CEEMEA region was offset by positive pricing of 5% to offset higher commodity costs. Unfavorable foreign exchange reduced net sales by 9%. Prestige Fragrances volume declined double-digits as markets contracted and trade customers reduced inventory levels. Retail Hair Care volume was down low single-digits as a double-digit decline in CEEMEA resulting from market contractions, trade inventory reductions and share declines was partially offset by growth in most of the other regions. Volume in Professional Hair Care decreased double- digits primarily due to market contractions and trade inventory reductions. Skin Care volume declined high single-digits mainly due to trade inventory reductions and the divestiture of Noxzema. Volume in Personal Cleansing decreased mid-single-digits primarily due to trade inventory reductions and share declines, particularly in CEEMEA and Greater China. Net earnings declined 14% during the quarter to $504 million behind lower net sales, a decline in operating margin driven by reduced gross margin and a higher tax rate, partially offset by divestiture gains. Beauty net sales decreased 1% fiscal year to date to $14.4 billion on a 1% decline in unit volume. Organic volume was in line with the prior year. Price increases to offset higher commodity costs added 2% to net sales and resulted in 2% organic sales growth. Unfavorable foreign exchange reduced net sales by 2%. Retail Hair Care volume grew low single-digits behind growth of Pantene, Head & Shoulders and Rejoice. Prestige Fragrances volume declined double-digits and Professional Hair Care volume declined mid-single-digits due to market contractions and trade inventory reductions. Volume in Skin Care declined mid-single-digits primarily due to lower shipments of Olay and the divestiture of Noxzema. Personal Cleansing volume was down mid-single-digits behind trade inventory reductions, market contractions and divestiture activity. Net earnings decreased 5% fiscal year to date to $2.1 billion mainly due to lower net sales and reduced operating margins. A reduction in gross margin from higher commodity costs was partially offset by lower marketing spending as a percentage of net sales. Grooming Grooming net sales were down 16% to $1.7 billion for the quarter. Organic sales decreased 4% versus the prior year period. Volume declined 9% primarily due to market contractions and trade inventory reductions. Unfavorable foreign exchange reduced net sales by 12%. Unfavorable product mix due to growth of disposables, which have lower than segment average selling prices, reduced net sales by 2%. These impacts were partially offset by positive pricing impacts of 7% mainly due to price increases taken across premium systems and to offset foreign exchange impacts. Blades and Razors volume decreased high single-digits as growth of Gillette Fusion was more than offset by declines of Mach3 and Venus. Global value share of the Blades and Razors category was flat versus the prior-year period at about 71%. Braun volume was down double-digits due to market contractions, trade inventory reductions and share softness in home appliances, particularly in developing regions. Globally, Brauns value share of the dry shaving market was down less than half a point. For the quarter, net earnings decreased 24% to $306 million primarily due to lower net sales and a decline in operating margin. Within operating margin, a decline in gross margin from sales de-leveraging and unfavorable foreign-exchange impacts were partially offset by lower marketing spending as a percentage of net sales. Grooming net sales declined 6% fiscal year to date to $5.8 billion on a 5% decline in unit volume. Organic sales decreased 1% versus the prior year to date period. Unfavorable foreign exchange reduced net sales by 4% as the U.S. dollar strengthened against key foreign currencies. Product mix had a negative 1% impact on net sales as favorable product mix from growth on Gillette Fusion was more than offset by a disproportionate decline in developed regions, which have higher than segment average selling prices. Price increases taken primarily across premium shaving systems added 4% to net sales. Blades and Razors volume declined low single-digits primarily driven by market contractions in developed regions. Growth of Gillette Fusion and Venus was more than offset by declines in legacy systems. Global value share of Blades and Razors was up less than half a point and remains above 70%. Volume in Braun was down double-digits due to market contractions, the exits of the U.S. home appliance and Tassimo coffee appliance businesses and trade inventory reductions. Global value share of the Dry Shaving market was up about half a point to approximately 35%. Net earnings were down 6% versus the prior year period to $1.2 billion primarily on a decline in net sales. Reduced gross margin was partially offset by lower overhead spending as a HEALTH AND WELL-BEING GBU Health Care Net sales in Health Care decreased 12% for the quarter to $3.2 billion on a 6% decline in unit volume. Net sales were negatively impacted by unfavorable foreign exchange of 8%. Negative product mix reduced net sales by 3% due to disproportionately higher volume declines in Personal Health Care and Pharmaceuticals, primarily in North America, which have higher than segment average selling prices. These impacts were partially offset by a positive pricing impact of 5% resulting from price increases to recover higher commodity costs. Organic sales declined 2% for the quarter. Volume in Personal Health Care was down double-digits due to a double-digit decline of Prilosec OTC from the loss of marketplace exclusivity in North America, the impact of a mild cold and flu season on Vicks and the ThermaCare divestiture. U.S. all outlet value share of the personal health care market has declined over two points including a double-digit share decline of Prilosec OTC. Pharmaceuticals volume declined high single-digits primarily as a result of minor brand divestitures and generic competition in the U.S. weekly osteoporosis market. Feminine Care volume was down low single-digits behind market contractions and trade inventory reductions, mainly in CEEMEA. Volume in Oral Care decreased low single-digits primarily due to lower shipments of Crest in developing markets from trade inventory reductions and market contractions. Net earnings for the quarter declined 9% to $564 million mainly due to the decline in net sales. A lower gross margin from higher commodity costs was more than offset by lower marketing and overhead spending as a percentage of net sales and minor brand divestiture gains. Health Care net sales were down 5% to $10.5 billion fiscal year to date on a 3% decline in unit volume. Unfavorable foreign exchange reduced net sales by 3%. Negative product mix from disproportionately higher volume declines of Personal Health Care and Pharmaceuticals, primarily in North America, also reduced net sales by 3%. These negative impacts were partially offset by positive pricing impacts of 4%. Personal Health Care volume was down double-digits due to the loss of marketplace exclusivity of Prilosec in North America, the impact of a mild cold and flu season on Vicks and the divestiture of ThermaCare. All outlet value share of the U.S. personal health care market has declined nearly three points including a double-digit share decline of Prilosec OTC. Pharmaceuticals volume decreased mid-single-digits mainly due to minor brand divestitures. Oral Care volume declined low single-digits as growth of Oral B was more than offset by a decline of Crest. Feminine Care volume was consistent with the prior year period as low single-digit growth of Always was offset by a high single-digit decline of Tampax. Organic volume was down 2% and organic sales were down 1% versus prior year period. Net earnings declined 6% to $1.9 billion fiscal year to date. Lower net sales and reduced gross margin from higher commodity costs were partially offset by lower marketing spending as a percentage of net sales and higher divestiture gains. Snacks and Pet Care Snacks and Pet Care net sales declined 4% to $764 million during the quarter on a 6% decline in unit volume. Price increases to offset higher commodity costs added 10% to net sales. Product mix negatively impacted net sales by 2% due to lower shipments of Eukanuba and premium snack products, which have higher than segment average selling prices. Unfavorable foreign exchange reduced net sales by 6%. Organic sales increased 2%. Volume in Snacks was down mid-single-digits due primarily to a high base period which included the Rice Infusion initiative in Western Europe, the Extreme Flavors initiative in North America, market share declines following price increase and trade inventory reductions. Pet Care volume declined mid-single-digits behind consumption declines in response to price increases. For the quarter, net earnings decreased 14% to $51 million as a commodity cost-driven decline in gross margin, lower net sales and a higher tax rate were partially offset by lower overhead and marketing spending as a percentage of net sales. Snacks and Pet Care net sales increased 1% fiscal year to date to $2.4 billion behind positive pricing impacts of 9%. Lower volume and unfavorable foreign exchange each reduced net sales by 3%. Product mix negatively impacted net sales by 2% due to lower shipments of Eukanuba and premium snack products, which have higher than segment average selling prices. Organic sales grew 4%. Snacks volume decreased low single-digits primarily due to a high base period which included the Rice Infusion initiative in Western Europe, the Extreme Flavors initiative in North America, market share declines following price increase and trade inventory reductions. Volume in Pet Care declined mid-single-digits mainly due to consumption declines following multiple price increases. Fiscal year to date, net earnings were down 5% to $169 million as higher net sales and lower overhead and marketing spending as a percentage of net sales were more than offset by a commodity cost-driven reduction in gross margin and a higher effective tax rate. HOUSEHOLD CARE GBU Fabric Care and Home Care Net sales in Fabric Care and Home Care were down 6% to $5.4 billion on a 5% decline in unit volume. Price increases mainly to offset higher commodity costs in developing regions added 9% to net sales. Unfavorable foreign exchange of 9% and negative product mix of 1% each reduced net sales. Organic sales increased 3% for the quarter. Volume in Fabric Care declined mid-single-digits and was down in both developed and developing markets. Share declines and market contractions in key regions following price increases on Tide and Ariel more than offset an increase in Gain and Downy shipments. Value share of global fabric care was down less than half a point and remained over 31%. Home Care volume decreased low single-digits as declines of Cascade, Dawn and Mr. Clean, following price increases, were partially offset by growth of Febreze and Swiffer. Batteries volume was down high single-digits due to market contractions, share declines and lower demand from equipment manufacturers. Global value share of general purpose batteries declined over one point to about 29%. Net earnings decreased 7% to $726 million primarily due to a decline in net sales. The impact of a higher tax rate was largely offset by higher operating margin driven by lower marketing spending as a percentage of net sales. Fiscal year to date, Fabric Care and Home Care net sales were consistent with the prior-year period at $17.7 billion on a 3% decline in unit volume. Unfavorable foreign exchange reduced net sales by 3%. Price increases taken to offset higher commodity costs added 6% to net sales. Organic sales increased 3% fiscal year to date. Fabric Care, Home Care and Batteries unit volume were each down in both developed and developing markets. Fabric Care volume declined low single-digits as lower shipments of Tide and Ariel due to trade inventory reductions and market share declines were only partially offset by growth of Gain and Downy. Global value share of the fabric care market was down about half a point behind declines in U.S. all outlet shares of Tide and Downy, partially offset by share growth of Gain. Home Care volume was down low single-digits due to market contractions and share declines in Dish Care and Hard Surface Cleaners following price increases. Batteries volume declined mid-single-digits due to market contractions, trade inventory reductions and market share declines. Global value share of general purpose batteries declined one point to about 28%. Net earnings declined 14% to $2.2 billion primarily due to a commodity-driven decline in gross margin and higher overhead spending as a percentage of net sales, partially offset by lower marketing spending as a percentage of net sales. Baby Care and Family Care Baby Care and Family Care net sales decreased 2% during the quarter to $3.5 billion on flat volume versus the prior-year period. Organic sales grew 6% behind positive pricing impacts of 6% implemented to recover higher commodity and energy costs. Unfavorable foreign exchange reduced net sales by 8%. Baby Care volume increased low single-digits behind growth in developed regions driven by the UNICEF Vaccine Partnership initiative in Western Europe and a double-digit increase in Luvs shipments. Family Care volume decreased low single-digits as lower shipments of Charmin were partially offset by higher shipments of Bounty. Net earnings declined 10% to $423 million primarily due to foreign exchange impacts and lower gross margin from higher commodity costs. Baby Care and Family Care net sales increased 4% to $10.7 billion fiscal year to date on 1% volume growth. Pricing to help recover higher commodity and energy costs contributed 6% to net sales growth. Unfavorable foreign exchange and negative product mix reduced net sales by 2% and 1%, respectively. Baby Care volume increased mid-single-digits due to growth of Pampers primarily in developing regions and double-digit growth of Luvs in North America. The growth in Baby Care was mostly offset by a low single-digit decline of Family Care due to the Western European Tissue divestiture. Organic volume for Family Care was up low single-digits behind double-digit growth of Charmin Basic and Bounty Basic. Organic sales were up 8% year to date behind a 3% increase in organic volume. Net earnings increased 3% to $1.4 billion primarily due to sales growth and higher gross margin. Fiscal year to date gross margin increased as the impact of price increases, manufacturing cost savings and the positive mix impact of the Western European Tissue divestiture more than offset higher commodity and energy costs. These impacts were partially offset by an increase in overhead as a percentage of net sales. CORPORATE Corporate includes certain operating and non-operating activities not allocated to specific business units. These include: the incidental businesses managed at the corporate level; financing and investing activities; other general corporate items; the historical results of certain divested brands and categories; and certain restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce rationalization. Corporate also includes reconciling items to adjust the accounting policies used in the segments to U.S. GAAP. The most significant reconciling items include income taxes (to adjust from statutory rates that are reflected in the segments to the overall Company effective tax rate), adjustments for unconsolidated entities (to eliminate sales, cost of products sold and SG&A for entities that are consolidated in the segments but accounted for using the equity method for U.S. GAAP) and minority interest adjustments for subsidiaries where we do not have 100% ownership. Since both unconsolidated entities and less than 100% owned subsidiaries are managed as integral parts of the Company, they are accounted for similar to a wholly owned subsidiary for management and segment purposes. This means our segment results recognize 100% of each income statement component through before-tax earnings, with eliminations for unconsolidated entities in Corporate. In determining segment after-tax net earnings, we apply the statutory tax rates (with adjustments to arrive at the Companys effective tax rate in Corporate) and eliminate the share of earnings applicable to other ownership interests, in a manner similar to minority interest. For the Corporate segment, net earnings from continuing operations increased $279 million to $11 million for the quarter. The increase was driven primarily by corporate hedging impacts and tax impacts from adjusting segment results to the total company effective tax rate, partially offset by higher restructuring charges. Fiscal year to date, net expenses from continuing operations decreased $609 million to $36 million. The decrease was primarily due to corporate hedging impacts, higher current period divestiture gains and lower interest expense, partially offset by higher restructuring spending. FINANCIAL CONDITION Operating Activities Cash generated from operating activities for the fiscal year to date period was $9.9 billion, a decrease of 11% versus the comparable prior year period. The combination of net earnings and non-cash items (primarily depreciation, amortization, share based compensation, deferred income taxes and gains on the sale of businesses) provided $11.3 billion of operating cash as compared to $12.6 billion in the prior year period. This was partially offset by an increase in working capital, driven primarily by inventory and accounts payable, accrued and other liabilities. Inventory increased primarily due to the decline in unit volume. Accounts payable, accrued and other liabilities levels declined primarily due to lower spending levels and a quicker payment cycle. Cash flow from discontinued operations contributed $124 million to operating cash flow. Investing Activities Investing activities in the current year used $1.3 billion. Capital expenditures were $2.2 billion fiscal year to date or 3.6% of net sales. Proceeds from asset sales generated $1.1 billion in cash primarily from the Coffee, Thermacare and Western European Tissue divestitures. Acquisitions, net of cash acquired, consumed $315 million of cash mainly due to the Nioxin acquisition. Cash flow from discontinued operations consumed $3 million of investing cash flow. Financing Activities Total cash used by financing activities was $7.2 billion fiscal year to date. Treasury shares in the amount of $6.4 billion were repurchased under a previously announced share buyback program that started in July 2007. Dividends to shareholders used $3.7 billion. These uses of cash were partially funded by an increase in the Companys debt position of $2.3 billion. As of March 31, 2009, our current liabilities exceeded current assets by $10.8 billion, driven by our short-term debt position. We have short- and long-term debt to fund discretionary items such as acquisitions and share buyback programs. We anticipate being able to support our short-term liquidity and operating needs largely through cash generated from operations. We have strong short- and long-term debt ratings which despite the current credit crisis have enabled and should continue to enable us to refinance our debt as it becomes due at favorable rates in commercial paper and bond markets. In addition, we have agreements with a diverse group of financial institutions that, if needed, should provide sufficient credit funding to meet short-term financing requirements. However, if the current credit crisis were to continue to worsen such that we were unable to access the credit market, it could impair our ability to fund discretionary spending such as the previously announced share buyback program. RECONCILIATION OF NON-GAAP MEASURES Our discussion of financial results includes several measures not defined by U.S. GAAP. We believe these measures provide our investors with additional information about the underlying results and trends of the Company, as well as insight to some of the metrics used to evaluate management. When used in MD&A, we have provided the comparable GAAP measure in the discussion. Organic Sales Growth: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions, divestitures and foreign exchange from year-over-year comparisons. We believe this provides investors with a more complete understanding of underlying sales trends by providing sales growth on a consistent basis. The reconciliation of reported sales growth to organic sales for the JanuaryMarch quarter: Acquisition/ Divestiture Impact Fabric Care and Home Care Baby Care and Family Care The reconciliation of reported sales growth to organic sales for the fiscal year to date period: Acquisition/ Divestiture Impact Fabric Care and Home Care Baby Care and Family Care Free Cash Flow: Free cash flow is defined as operating cash flow less capital spending. We view free cash flow as an important measure because it is one factor in determining the amount of cash available for dividends and discretionary investment. Free cash flow is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation. Free Cash Flow Productivity: Free cash flow productivity is defined as the ratio of free cash flow to net earnings. The Companys long-term target is to generate free cash at or above 90 percent of net earnings. Free cash flow is also one of the measures used to evaluate senior management. The reconciliation of free cash flow and free cash flow productivity is provided below (amounts in millions): Free Cash Flow Productivity Quantitative and Qualitative Disclosures About Market Risk. There have been no material changes in the Companys exposure to market risk since June 30, 2008. Additional information can be found in the section entitled Other Information in Exhibit 99.1 and Note 6, Risk Management Activities, in Exhibit 99.2 to the Companys Form 8-K filed on February 10, 2009. Controls and Procedures. Evaluation of Disclosure Controls and Procedures. The Companys Chairman of the Board and Chief Executive Officer, A. G. Lafley, and the Companys Chief Financial Officer, Jon R. Moeller, performed an evaluation of the Companys disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (Exchange Act)) as of the end of the period covered by this report. Messrs. Lafley and Moeller have concluded that the Companys disclosure controls and procedures were effective to ensure that information required to be disclosed in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) accumulated and communicated to our management, including Messrs. Lafley and Moeller, to allow their timely decisions regarding required disclosure. Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting that occurred during the Companys fiscal quarter ended March 31, 2009 that have materially affected, or are reasonably likely to materially affect, the Companys internal control over financial reporting. PART II. OTHER INFORMATION Legal Proceedings. The Company is subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental issues, patent and trademark matters and taxes. The Company is subject to a variety of investigations into potential competition law violations in Europe. In July 2006, French authorities, in connection with an inquiry into potential competition law violations in France, entered the premises of two of the Companys French subsidiaries and seized a variety of documents. In April 2008, UK authorities initiated an investigation concerning potential antitrust violations in the UK involving one of the Companys subsidiaries. In June 2008, European Commission officials, with the assistance of the national authorities from a variety of countries, started an investigation into potential competition law violations in a variety of countries across the European Union. Around the same time, the national authorities in Spain, Italy and the Czech Republic initiated additional investigations into potential antitrust concerns within those countries. In connection with these investigations, a number of the Companys subsidiaries were visited and documents seized. The Company or its subsidiaries are also involved in other competition law investigations in Belgium, Romania, Switzerland, France and Greece, as well as some other countries. We believe that all of the above matters involve a number of other consumer products companies and/or retail customers. The Companys policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with investigations by relevant regulatory authorities, which the Company is doing. Competition and antitrust law investigations often continue for several years and, if violations are found, can result in substantial fines. In other industries, fines have amounted to hundreds of millions of dollars. During the fiscal year ended June 30, 2008, certain of the Companys subsidiaries in Germany received a formal complaint alleging violations of the antitrust laws. We are now discussing the situation with the German authorities. At this point, no other formal claims have been made against the Company or any of our subsidiaries in connection with any of the above inquiries. In response to the actions of the Commission and national authorities, the Company has launched its own internal investigations into potential violations of competition laws, some of which are ongoing. The Company has identified violations in certain European countries and appropriate actions are being taken. It is still too early for us to reasonably estimate the fines to which the Company will be subject as a result of these competition law issues. However, we have taken and will take reserves as appropriate. Please refer to the Companys Risk Factors in Item 1A below for additional information. In December 2008, the Company became aware of an investigation by Italian authorities into an environmental accident at the site of a contractor which provides services to one or more of the Companys European affiliates. The accident involved the explosion of certain pressurized cans and resulted in the death of one worker and serious injuries to another. Italian authorities are formally investigating whether the Companys affiliates complied with Italian laws related to the proper classification and disposal of their products. Should they find that these entities violated the law, the Italian authorities could levy fines in excess of $100 thousand against the Companys European affiliate(s). Risk Factors. We discuss our expectations regarding future performance, events and outcomes, such as our business outlook and objectives in this Form 10-Q, the Annual Report to Shareholders, quarterly reports, press releases and other written and oral communications. All statements, except for historical and present factual information, are forward-looking statements and are based on financial data and business plans available only as of the time the statements are made, which may become out of date or incomplete. We assume no obligation to update any forward-looking statements as a result of new information, future events, or other factors. Forward-looking statements are inherently uncertain, and investors must recognize that events could significantly differ from our expectations. The following discussion of risk factors identifies the most significant factors that may adversely affect our business, operations, financial position or future financial performance. This information should be read in conjunction with Managements Discussion and Analysis (MD&A) and the consolidated financial statements and related notes incorporated by reference into this report. The following discussion of risks is not all inclusive but is designed to highlight what we believe are important factors to consider when evaluating our expectations. These factors could cause our future results to differ from those in the forward-looking statements and from historical trends. A material change in consumer demand for our products could have a significant impact on our business. We are a consumer products company and rely on continued global demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers. This is dependent on a number of factors including our ability to develop effective sales, advertising and marketing programs in an increasingly fragmented media environment. We expect to achieve our financial targets, in part, by shifting our portfolio towards faster growing, higher margin businesses. If demand and growth rates fall substantially below expected levels or our market share declines significantly in these businesses, our results could be negatively impacted. This could occur due to unforeseen negative economic or political events or to changes in consumer trends and habits. In addition, our continued success is dependent on leading-edge innovation, with respect to both products and operations. This means we must be able to obtain patents that lead to the development of products that appeal to our consumers across the world. The ability to achieve our business objectives is dependent on how well we can respond to our local and global competitors. Across all of our categories, we compete against a wide variety of global and local competitors. As a result, there are ongoing competitive product and pricing pressures in the environments in which we operate, as well as challenges in maintaining profit margins. To address these challenges, we must be able to successfully respond to competitive factors, including pricing, promotional incentives and trade terms, as well as technological advances and patents granted to competition. Our ability to successfully integrate key acquisitions could impact our business results. Since our goals include a growth component tied to acquisitions, we must be able to successfully manage and integrate key acquisitions. Specifically, we must be able to integrate acquisitions without any significant disruption to our ability to manage and execute business plans on our base businesses. In addition, our financial results could be adversely impacted if we are not able to deliver the expected cost and growth synergies associated with our acquisitions or if changes in the cash flows or other market-based assumptions cause the value of acquired assets to fall below book value. Our businesses face cost pressures which could affect our business results. Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, cost of labor, foreign exchange and interest rates. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects (including outsourcing projects), sourcing decisions and certain hedging transactions. In the manufacturing and general overhead areas, we need to maintain key manufacturing and supply arrangements, including any key sole supplier and sole manufacturing plant arrangements. We face risks associated with significant international operations. We conduct business across the globe with a significant portion of our sales outside the United States. We expect to achieve our financial targets, in part, by achieving disproportionate growth in developing regions. Should growth rates or our market share fall substantially below expected levels in these regions, our results could be negatively impacted. In addition, economic changes, terrorist activity and political unrest may result in business interruption, inflation, deflation or decreased demand for our products. Our success will depend, in part, on our ability to manage continued global political and/or economic uncertainty, especially in our significant geographical markets, as well as any political or economic disruption due to terrorist and other hostile activities. Our business is subject to regulation in the U.S. and abroad. Changes in laws, regulations and the related interpretations may alter the environment in which we do business. This includes changes in environmental, competitive and product-related laws, as well as changes in accounting standards and taxation requirements. Accordingly, our ability to manage regulatory, tax and legal matters (including product liability, patent, and intellectual property matters), and to resolve pending legal matters without significant liability, including the competition law and antitrust investigations described in Part II, Item 1 of this Form 10-Q, which could require the Company to take significant reserves or pay significant fines during a reporting period, may materially impact our results. In addition, as a U.S. based multinational company we are also subject to tax regulations in the U.S. and multiple foreign jurisdictions, some of which are interdependent. For example, certain income that is earned and taxed in countries outside the U.S. is not taxed in the U.S. provided those earnings are indefinitely reinvested outside the U.S. If these or other tax regulations should change, our financial results could be impacted. If the reputation of one or more of our leading brands erodes significantly, it could have a material impact on our financial results. Our Companys financial success is directly dependent on the success of our brands, particularly our billion-dollar brands. The success of these brands can suffer if our marketing plans or product initiatives do not have the desired impact on a brands image or its ability to attract consumers. Further, our Companys results could be negatively impacted if one of our leading brands suffers a substantial impediment to its reputation due to real or perceived quality issues. A material change in customer relationships or in customer demand for our products could have a significant impact on our business. Our success is dependent on our ability to successfully manage relationships with our retail trade customers. This includes our ability to offer trade terms that are acceptable to our customers and are aligned with our pricing and profitability targets. Our business could suffer if we cannot reach agreement with a key customer based on our trade terms and principles. Further, there is a continuing trend towards retail trade consolidation and this leads to more complex work across broader geographic boundaries for both us and key retailers. This can be particularly difficult when major customers are addressing local trade pressures or local law and regulation changes. Further, our business would be negatively impacted if a key customer were to significantly reduce the range or inventory level of our products. We face risks related to the current credit crisis. The Company currently generates significant operating cash flows, which combined with access to the credit markets provides us with significant discretionary funding capacity. However, current uncertainty in the global economic conditions resulting from the recent disruption in credit markets poses a risk to the overall economy that could impact consumer and customer demand for our products, as well as our ability to manage normal commercial relationships with our customers, suppliers and creditors, including financial institutions. If the current situation deteriorates significantly, our business could be negatively impacted, including such areas as reduced demand for our products from a slow-down in the general economy, supplier or customer disruptions resulting from tighter credit markets and/or temporary interruptions in our ability to conduct day-to-day transactions through our financial intermediaries involving the payment to or collection of funds from our customers, vendors and suppliers. Unregistered Sales of Equity Securities and Use of Proceeds. ISSUER PURCHASES OF EQUITY SECURITIES Total Number of Shares Purchased (1) Average Price Paid per Share (2) Total Number of Shares Purchased as Part of Publicly Announced Plans Approximate dollar value of shares that may yet be purchased under our share repurchase program ($ in Billions) (3) (4) The total number of shares purchased was 19,064,332 for the quarter. All transactions were made in the open market or pursuant to prepaid forward agreements with large financial institutions. Under these agreements, the Company prepaid large financial institutions to deliver shares at future dates in exchange for a discount. The number of shares purchased other than through a publicly announced repurchase plan was 27,062 for the quarter. This includes shares acquired by the Company under various compensation and benefit plans. This table excludes shares withheld from employees to satisfy minimum tax withholding requirements on option exercises and other equity-based transactions. The Company administers cashless exercises through an independent, third party broker and does not repurchase stock in connection with cashless exercise. Average price paid per share is calculated on a settlement basis and excludes commission. On August 3, 2007, the Company announced a share repurchase plan. Pursuant to the share repurchase plan, the Board of Directors authorized the Company and its subsidiaries to acquire in open market and/or private transactions $24 to $30 billion of shares of Company common stock over the subsequent three years to be financed by issuing a combination of long-term and short-term debt. Certain purchases were made prior to announcement of the program but are considered purchases against the program. The dollar values listed in this column include commissions to be paid to brokers to execute the transactions. Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October 14, 2008) (Incorporated by reference to Exhibit (3-1) of the Companys Form 10-Q for the quarter ended December 31, 2008). Regulations (as amended by shareholders at the annual meeting on October 10, 2006) (Incorporated by reference to Exhibit (3-2) of the Companys Form 10-Q for the quarter ended Computation of Earnings per Share. Computation of Ratio of Earnings to Fixed Charges.",12896
2009-05-07,8-K,0000080424-09-000024,"to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 of Report (Date of earliest event reported) name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange 2009, Procter & Gamble International Funding SCA (PGIF), a wholly owned finance subsidiary of The Procter & Gamble Company (the Company), closed an underwritten public offering of $2,000,000,000 aggregate principal amount of Floating Rate Notes due 2010 under the Companys Registration Statement on Form S-3 (Registration No. 333-145938) (the Registration Statement), which are fully and unconditionally guaranteed by the Company. Legal opinions related to these notes and the guarantee are attached hereto as Exhibits (5)(a), (5)(b) and (5)(c) and are",159
2009-05-28,8-K,0000080424-09-000026,"13 OR 15(d) of The Securities Exchange Act Of 1934 of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange ITEM 7.01 REGULATION FD 2009, The Procter & Gamble Company (the ""Company"") issued the attached news release. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Release by The Procter & Gamble Company dated May 28,",135
2009-06-10,8-K,0000080424-09-000029,"to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 of Report (Date of earliest event reported) name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 5.02 (b), (c) & (d) DEPARTURE OF CERTAIN OFFICERS; APPOINTMENT OF 10, 2009, The Procter & Gamble Company (the Company) announced that A.G. Lafley, Chairman of the Board and Chief Executive Officer, will move full-time into the role of Chairman of the Board, effective July 1, 2009. Company also announced that Robert A. McDonald (55), currently Chief Operating Officer, has been elected President and Chief Executive, effective July 1, 2009, to serve at the pleasure of the Board of Directors. Mr. McDonald has also been appointed as a member of the Companys Board of Directors. As an employee of the Company, he will not serve on any Board Committees. the past five years, Mr. McDonald held the following positions at the Company: Chief Operating Officer (July 1, 2007  present); Vice Chairman, Global Operations (July, 1, 2004 through June 30, 2007) and President  Global Fabric & Home Care (July 12, 2001 through June 30, Company issued a news release on June 10, 2009 announcing the appointment and election of Mr. McDonald and the changes to Mr. Lafleys role. A copy of this news release is furnished as Exhibit 99 to this report. Company is filing this 8-K pursuant to Item 5.02(b), (c) & (d), ""Departure of Directors or Certain Officers; Appointment of Certain Officers; Appointment to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto Release by The Procter & Gamble Company dated June 10,",337
2009-07-13,8-K,0000080424-09-000035,"13 OR 15(d) of The Securities Exchange Act Of 1934 of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange ITEM 7.01 REGULATION FD 13, 2009, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of forty-four cents ($0.44) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after August 17, 2009 to shareholders of record at the close of business on July 24, 2009. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Release by The Procter & Gamble Company dated July 13,",186
2009-08-05,8-K,0000080424-09-000038,"to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area code ) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange OF OPERATIONS AND FINANCIAL CONDITION 5, 2009, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended June 30, 2009. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Release by The Procter & Gamble Company dated August 5,",157
2009-08-12,8-K,0000080424-09-000040,"to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 of Report (Date of earliest event reported) name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 5.02(d) ELECTION OF DIRECTORS 12, 2009, The Procter & Gamble Company (the ""Company"") issued a news release announcing that Mary A. Wilderotter was appointed to the Board of Directors, effective August 11, 2009. Ms. Wilderotter will serve on the Compensation & Leadership Development and Governance and Public Responsibility is filing this 8-K pursuant to Item 5.02(d), ""Election of the Company's press release relating to this announcement is being furnished as to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto Release by The Procter & Gamble Company dated August 12, 2009.",193
2009-08-14,10-K,0001193125-09-175986,"THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES ANNUAL REPORT ON FORM 10-K TO THE SECURITIES AND EXCHANGE COMMISSION FOR THE YEAR ENDED UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark one) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended June 30, 2009 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-434 THE PROCTER & GAMBLE COMPANY One Procter & Gamble Plaza, Cincinnati, Ohio 45202 Telephone (513) 983-1100 IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value New York Stock Exchange, NYSE Euronext-Paris Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  No  Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes  No  Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No  Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No  Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrants knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act). Smaller reporting company Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No  The aggregate market value of the voting stock held by non-affiliates amounted to $181 billion on December 31, 2008. There were 2,918,890,075 shares of Common Stock outstanding as of July 31, 2009. Documents Incorporated by Reference Portions of the Annual Report to Shareholders for the fiscal year ended June 30, 2009, (2009 Annual Report) are incorporated by reference into Part I, Part II and Part IV of this report to the extent described herein. Portions of the Proxy Statement for the 2009 Annual Meeting of Shareholders which will be filed within one hundred and twenty days of the fiscal year ended June 30, 2009, (2009 Proxy Statement) are incorporated by reference into Part III of this report to the extent described herein. PART I Item 1. Business . Additional information required by this item is",566
2009-08-24,8-K,0000080424-09-000043,"13 OR 15(d) of The Securities Exchange Act Of 1934 Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act communications pursuant to Rule 13e-4(c) under the The Procter & Gamble Company (Company) and Warner Chilcott plc (Warner Chilcott) issued a news release announcing that the companies have reached an agreement for the sale of P&Gs global pharmaceuticals business to Warner furnishing this 8-K pursuant to Item 7.01, ""Regulation FD",116
2009-08-28,8-K,0000080424-09-000044,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Item 8.01 Other Events. On August 28, 2009, The Procter & Gamble Company (the Company) closed an underwritten public offering of $500,000,000 aggregate principal amount of 3.150% Notes due 2015 under the Companys Registration Statement on Form S-3 (Registration No. 333-145938) (the Registration Statement). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are",165
2009-09-10,8-K,0000080424-09-000049,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 7.01 REGULATION On September 10, 2009, The Procter & Gamble Company (the ""Company"") issued the attached news release. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",139
2009-10-13,8-K,0000080424-09-000070,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 7.01 REGULATION On October 13, 2009, The Procter & Gamble Company (the ""Company"") issued a news release with respect to President and Chief Executive Officer Robert A. McDonald's address to the shareholders at the Company's annual meeting. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",144
2009-10-13,8-K,0000080424-09-000074,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 7.01 REGULATION On October 13, 2009, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of forty-four cents ($0.44) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after November 16, 2009 to shareholders of record at the close of business on October 23, 2009. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",190
2009-10-15,8-K,0000080424-09-000077,"bgstructurepharmachange.htm SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE As disclosed in its most recent Form 10-K for the year ended June 30, 2009, The Procter & Gamble Company (the Company) announced changes to its segment reporting structure that were effective July 1, 2009. Also, as disclosed in a Form 8-K dated August 24, 2009, the Company announced an agreement for the sale of its global pharmaceuticals business to Warner Chilcott. This Form 8-K provides pro forma historical total company and segment results for the three months ended September 30, 2008 reflecting the change in the reporting structure of the Company and the presentation of the Companys pharmaceuticals business as discontinued operations. This information in no way revises or restates the Consolidated Statement of Earnings, Consolidated Balance Sheet, Consolidated Statement of Shareholders Equity or Consolidated Statements of Cash Flows for the Company and consolidated subsidiaries for any period. Fiscal Year 2010 Changes to Global Business Unit (GBU) Structure Effective July 1, 2009, the Company implemented a number of changes to the organization structure of the Beauty GBU, which resulted in changes to the components of its reportable segment structure. Female blades and razors were formerly included in the Grooming reportable segment and are now included in the Beauty reportable segment. Certain male-focused brands and businesses, such as Old Spice and Gillette personal care, moved from the Beauty reportable segment to the Grooming reportable segment. In addition, the Beauty GBU was renamed the Beauty and Grooming GBU. Presentation of the Global Pharmaceuticals Business as Discontinued Operations Separately, on August 24, 2009, the Company announced an agreement for the sale of its global pharmaceuticals business to Warner Chilcott which will be completed at a later date. The pharmaceuticals business has historically been part of the Health Care reportable segment. In accordance with applicable accounting guidance for the disposal of long-lived assets, the results of the pharmaceuticals business will be presented as discontinued operations and, as such, will be excluded from continuing operations and from segment results. The above changes will be reflected in the consolidated financial statements and segment reporting beginning in fiscal year 2010, starting with the Form 10-Q for the three months ended September 30, 2009. In advance of the Form 10-Q filing, this document provides pro forma consolidated earnings information and quarterly sales and profit information for the affected segments for the three months ended September 30, 2008. CONSOLIDATED EARNINGS INFORMATION THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information SELLING, GENERAL & ADMINISTRATIVE EXPENSE OTHER NON-OPERATING INCOME, NET EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES NET EARNINGS FROM CONTINUING OPERATIONS NET EARNINGS FROM DISCONTINUED OPERATIONS EFFECTIVE TAX RATE FROM CONTINUING OPERATIONS BASIC NET EARNINGS - CONTINUING OPERATIONS BASIC NET EARNINGS - DISCONTINUED OPERATIONS DILUTED NET EARNINGS - CONTINUING OPERATIONS DILUTED NET EARNINGS - DISCONTINUED OPERATIONS AVERAGE DILUTED SHARES OUTSTANDING SEGMENT REPORTING INFORMATION Three Months Ended September 30, 2008 Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care This 8-K is furnished pursuant to Item 7.01 Regulation FD Disclosure. Pursuant",624
2009-10-29,8-K,0000080424-09-000080,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) ( Registrant's telephone number, including area code ) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On October 29, 2009, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended September 30, 2009. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",159
2009-10-29,10-Q,0001193125-09-217067,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2009 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-434 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (513) 983-1100 (Registrants telephone number, including area code) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No  Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No  Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No x There were 2,921,734,338 shares of Common Stock outstanding as of September 30, 2009. PART I. FINANCIAL INFORMATION Financial Statements. The Consolidated Statements of Earnings of The Procter & Gamble Company and subsidiaries (the Company, we or our) for the three months ended September 30, 2009 and 2008, the Consolidated Balance Sheets as of September 30, 2009 and June 30, 2009, and the Consolidated Statements of Cash Flows for the three months ended September 30, 2009 and 2008 follow. In the opinion of management, these unaudited Consolidated Financial Statements contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, such financial statements may not necessarily be indicative of annual results. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS Amounts in millions except per share amounts Three Months Ended September 30 Selling, general and administrative expense Other non-operating income, net Earnings from Continuing Operations Before Income Taxes Net Earnings from Continuing Operations Net Earnings from Discontinued Operations Basic net earnings from continuing operations Basic net earnings from discontinued operations Diluted net earnings from continuing operations Diluted net earnings from discontinued operations Diluted Weighted Average Common Shares Outstanding See accompanying Notes to Consolidated Financial Statements Certain amounts for prior periods were reclassified to conform with the fiscal 2010 presentation THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS Cash and cash equivalents Prepaid expenses and other current assets PROPERTY, PLANT AND EQUIPMENT Total property, plant and equipment NET PROPERTY, PLANT AND EQUIPMENT GOODWILL AND OTHER INTANGIBLE ASSETS Trademarks and other intangible assets, net NET GOODWILL AND OTHER INTANGIBLE ASSETS LIABILITIES AND SHAREHOLDERS EQUITY Accrued and other liabilities Liabilities held for sale TOTAL CURRENT LIABILITIES OTHER NON-CURRENT LIABILITIES Common stock - shares issued - Additional paid-in capital Reserve for ESOP debt retirement Accumulated other comprehensive income (loss) TOTAL SHAREHOLDERS EQUITY TOTAL LIABILITIES AND SHAREHOLDERS EQUITY See accompanying Notes to Consolidated Financial Statements Certain amounts for prior periods were reclassified to conform with the fiscal 2010 presentation THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS Three Months Ended September 30 CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD Depreciation and amortization Share-based compensation expense Gain on sale of businesses Accounts payable, accrued and other liabilities Other operating assets and liabilities TOTAL OPERATING ACTIVITIES Proceeds from asset sales Acquisitions, net of cash acquired TOTAL INVESTING ACTIVITIES Dividends to shareholders Change in short-term debt Additions to long-term debt Reductions of long-term debt Impact of stock options and other TOTAL FINANCING ACTIVITIES EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS CHANGE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, END OF PERIOD See accompanying Notes to Consolidated Financial Statements Certain amounts for prior periods were reclassified to conform with the fiscal 2010 presentation THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS These statements should be read in conjunction with the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2009. The results of operations for the three-month period ended September 30, 2009 are not necessarily indicative of annual results. For the three months ended September 30, 2009, the Company has evaluated subsequent events for potential recognition and disclosure through October 29, 2009, the date of financial statement issuance. Comprehensive IncomeTotal comprehensive income is comprised primarily of net earnings, net currency translation gains and losses, impacts of net investment and cash flow hedges, net unrealized gains and losses on investment securities and defined benefit and other retiree benefit plan activities. Total comprehensive income (loss) for the three months ended September 30, 2009 and 2008 was $4,702 million and $(252) million, respectively. Segment Information  Effective July 1, 2009, we implemented a number of changes to the organization structure of the Beauty GBU, which resulted in changes to the components of our reportable segment structure. Female blades and razors were formerly included in the Grooming reportable segment and are now included in the Beauty reportable segment. Certain male-focused brands and businesses, such as Old Spice and Gillette personal care, moved from the Beauty reportable segment to the Grooming reportable segment. In addition, the Beauty GBU was renamed the Beauty and Grooming GBU. These changes have been reflected in our segment reporting for all periods presented. Following is a summary of segment results. Three Months Ended September 30 Earnings from Continuing Operations Before Income Taxes Net Earnings from Continuing Operations Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Goodwill and Other Intangible Assets  Goodwill as of September 30, 2009 is allocated by reportable segment and global business unit as follows (amounts in Three Months Ended September 30, 2009 Beauty, beginning of year Acquisitions and divestitures Goodwill, September 30, 2009 Grooming, beginning of year Acquisitions and divestitures Goodwill, September 30, 2009 Health Care, beginning of year Acquisitions and divestitures Reclassification to held for sale (1) Goodwill, September 30, 2009 Snacks and Pet Care, beginning of year Acquisitions and divestitures Goodwill, September 30, 2009 Fabric Care and Home Care, beginning of year Acquisitions and divestitures Goodwill, September 30, 2009 Baby Care and Family Care, beginning of year Acquisitions and divestitures Goodwill, September 30, 2009 GOODWILL, beginning of year Acquisitions and divestitures Reclassification to held for sale (1) Goodwill, September 30, 2009 See Note 10 for further details on goodwill reclassification to held for sale. The increase in goodwill from June 30, 2009 is primarily due to currency translation, partially offset by the reclassification of goodwill related to the pharmaceuticals business to assets held for sale. Identifiable intangible assets as of September 30, 2009 are comprised of (amounts in Amortizable intangible assets with determinable lives Intangible assets with indefinite lives Total identifiable intangible assets Amortizable intangible assets consist principally of brands, patents, technology and customer relationships. The non-amortizable intangible assets consist primarily of brands. The amortization of intangible assets for the three months ended September 30, 2009, and 2008 was $145 million and $153 million, respectively. Pursuant to applicable accounting guidance for share-based payments, companies must recognize the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of those awards. Total share-based compensation for the three months ended September 30, 2009 and 2008 are summarized in the following table (amounts in millions): Three Months Ended September 30 Total share-based compensation Assumptions utilized in the model are evaluated and revised, as necessary, to reflect market conditions and experience. Postretirement BenefitsThe Company offers various postretirement benefits to its employees. The components of net periodic benefit cost are as follows: Three Months Ended September 30 Three Months Ended September 30 Expected return on plan assets Amortization of deferred amounts Recognized net actuarial loss Gross benefit cost (credit) Dividends on ESOP preferred stock Net periodic benefit cost (credit) For the year ending June 30, 2010, the expected return on plan assets is 7.1% and 9.3% for pension and other retiree benefit plans, respectively. Risk Management Activities and Fair Value Measurements As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. We evaluate exposures on a centralized basis to take advantage of natural exposure netting and correlation. To the extent we choose to manage volatility associated with the net exposures, we enter into various financial transactions which we account for using the applicable accounting guidance for derivative instruments and hedging activities. These financial transactions are governed by our policies covering acceptable counterparty exposure, instrument types and other hedging practices. At inception, we formally designate and document qualifying instruments as hedges of underlying exposures. We formally assess, both at inception and at least quarterly, whether the financial instruments used in hedging transactions are effective at offsetting changes in either the fair value or cash flows of the related underlying exposure. Fluctuations in the value of these instruments generally are offset by changes in the fair value or cash flows of the underlying exposures being hedged. This offset is driven by the high degree of effectiveness between the exposure being hedged and the hedging instrument. The ineffective portion of a change in the fair value of a qualifying instrument is immediately recognized in earnings. The amount of ineffectiveness recognized is immaterial for all periods presented. For additional details on the Companys risk management activities, refer to the Companys annual financial statements and footnotes in the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2009. Fair Value Hierarchy Accounting guidance on fair value measurement for certain financial assets and liabilities requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs reflecting the reporting entitys own assumptions or external inputs from inactive markets. In valuing assets and liabilities, we are required to maximize the use of quoted market prices and minimize the use of unobservable inputs. We calculate the fair value of our Level 1 and Level 2 instruments based on the exchange traded price of similar or identical instruments where available or based on other observable instruments. The fair value of our Level 3 instruments is calculated as the net present value of expected cash flows based on externally provided inputs. These calculations take into consideration the credit risk of both the Company and our counterparties. The Company has not changed its valuation techniques in measuring the fair value of any financial assets and liabilities during the period. The following table sets forth the Companys financial assets and liabilities as of September 30 and June 30, 2009 that are measured at fair value on a recurring basis during the period, segregated by level within the fair value hierarchy: Other foreign currency instruments (1) Total assets at fair value (2) Liabilities at fair value: Other foreign currency instruments (1) Total liabilities at fair value (3) The other foreign currency instruments are comprised of foreign currency financial instruments that do not qualify as hedges. All assets are presented in prepaid expenses and other current assets or other noncurrent assets with the exception of investment securities which are only presented in All liabilities are presented in accrued and other liabilities or other noncurrent liabilities. The table below sets forth a reconciliation of the Companys beginning and ending Level 3 financial assets and liabilities balances for the period June 30 to September 30, 2009. Total gains or (losses) (realized/unrealized) included in earnings (or changes in net assets) Total gains or (losses) (realized/unrealized) included in OCI Net purchases, issuances and settlements Transfers in/(out) of Level 3 On July 1, 2009, we adopted the provisions of the fair value measurement accounting and disclosure guidance related to non-financial assets and liabilities recognized or disclosed at fair value on a nonrecurring basis. Assets and liabilities subject to this new guidance primarily include goodwill and indefinite-lived intangible assets measured at fair value for impairment assessments, long-lived assets measured at fair value for impairment assessments and non-financial assets and liabilities measured at fair value in business combinations. The adoption of this new guidance did not affect our financial position, results of operations or cash flows for the periods presented. Certain of the Companys financial instruments used in hedging transactions are governed by industry standard netting agreements with counterparties. If the Companys credit rating were to fall below the levels stipulated in the agreements, the counterparties could demand either collateralization or termination of the arrangement. The aggregate fair value of the instruments covered by these contractual features that are in a net liability position as of September 30, 2009 was $289 million. The Company has never been required to post any collateral as a result of these contractual features. Fair Values of Other Financial Instruments Other financial instruments, including cash equivalents, other investments and short-term debt, are recorded at cost, which approximates fair value. The fair value of the long-term debt was $23,880 million and $21,514 million at September 30 and June 30, 2009, respectively. Disclosures about Derivative Instruments The fair values and amounts of gains and losses on qualifying and non-qualifying financial instruments used in hedging transactions as of, and for the three months ended, September 30, 2009 are as follows: Derivatives in Cash Flow Hedging Relationships Notional Amount (Ending Balance) Fair Value Asset (Liability) Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) (1) Three Months Ended September 30 Foreign currency contracts Derivatives in Fair Value Hedging Relationships Notional Amount (Ending Balance) Fair Value Asset (Liability) Amount of Gain or (Loss) Recognized in Debt on Derivative (Effective Portion) Amount of Gain or (Loss) Recognized in Income (Ineffective Portion) (2) Three Months Ended September Derivatives in Net Investment Hedging Relationships Notional Amount (Ending Balance) Fair Value Asset (Liability) Amount of Gain or (Loss) Recognized in OCI on Derivative (Effective Portion) Amount of Gain or (Loss) Recognized in Income (Ineffective Portion) (2) Three Months Ended September Derivatives Not Designated as Hedging Instruments Notional Amount (Ending Balance) Fair Value Asset (Liability) Amount of Gain or (Loss) Recognized Three Months Ended September Foreign currency contracts The gain or loss reclassified from accumulated OCI into income is included in the Consolidated Statements of Earnings as follows: interest rate contracts in interest expense, foreign currency contracts in selling, general and administrative expense and interest expense and commodity contracts in cost of products sold. The gain or loss on the ineffective portion of interest rate contracts and net investment hedges, if any, is included in the Consolidated Statements of Earnings in The gain or loss on foreign currency contracts not designated as hedging instruments is included in the Consolidated Statements of Earnings in selling, general and administrative expense. During the next 12 months, the amount of the September 30, 2009 OCI balance that will be reclassified to earnings is expected to be immaterial. In addition, the total notional amount of contracts outstanding at the end of the period is indicative of the level of the Companys derivative activity during the period. New Accounting Pronouncements and Policies In December 2007, the Financial Accounting Standards Board (FASB) issued new accounting guidance on business combinations. The new guidance revises the method of accounting for a number of aspects of business combinations including acquisition costs, contingencies (including contingent assets, contingent liabilities and contingent purchase price), and post-acquisition exit activities of acquired businesses. The Company adopted the new guidance beginning July 1, 2009, and the adoption of the new guidance did not have a material effect on our financial position, results of operations or cash flows. In December 2007, the FASB also issued new accounting guidance on noncontrolling interests in consolidated financial statements. The new accounting guidance requires that a noncontrolling interest in the equity of a subsidiary be accounted for and reported as equity, provides revised guidance on the treatment of net income and losses attributable to the noncontrolling interest and changes in ownership interests in a subsidiary, and requires additional disclosures that identify and distinguish between the interests of the controlling and noncontrolling owners. The Company retrospectively adopted the presentation and disclosure requirements of the new guidance on July 1, 2009. The adoption of the new guidance did not have a material effect on our financial position, results of operations or cash flows. Noncontrolling interests of $283 million at June 30, 2009 were reclassified from liabilities to shareholders equity in the Consolidated Balance Sheet. Net expense for income attributable to the noncontrolling interest totaling $28 million and $21 million for the three months ended September 30, 2009 and 2008, respectively, are not presented separately in the Consolidated Statements of Earnings due to immateriality, but are reflected within other non-operating income, net. Net earnings represents net income attributable to the Companys common shareholders. No other new accounting pronouncement issued or effective during the fiscal year had or is expected to have a material impact on the Consolidated Financial Statements. Commitments and Contingencies Litigation We are subject to various legal proceedings and claims arising out of our business which cover a wide range of matters such as governmental regulations, antitrust and trade regulations, product liability, patent and trademark matters, income taxes and other actions. As previously disclosed, the Company is subject to a variety of investigations into potential competition law violations in Europe, as detailed in Part 2, Item 1, Legal Proceedings of this 10-Q. We believe these matters involve a number of other consumer products companies and/or retail customers. The Companys policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with investigations by relevant regulatory authorities, which the Company is doing. Competition and antitrust law inquiries often continue for several years and, if violations are found, can result in substantial fines. In other industries, fines have amounted to hundreds of millions of dollars. At this point, no significant formal claims have been made against the Company or any of our subsidiaries in connection with any of the above inquiries. In response to the actions of the European Commission and national authorities, the Company launched its own internal investigations into potential violations of competition laws. The Company has identified violations in certain European countries and appropriate actions have been taken. It is still too early for us to reasonably estimate the total amount of fines to which the Company will be subject as a result of these competition law issues. However, the ultimate resolution of these matters will likely result in fines or other costs that could materially impact our income statement and cash flows in the period in which they accrued and paid, respectively. As these matters evolve, the Company will recognize the appropriate reserves. With respect to other litigation and claims, while considerable uncertainty exists, in the opinion of management and our counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows. We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will have a material adverse effect on our financial position, results of operations or cash flows. Income Tax Uncertainties P&G is present in over 150 taxable jurisdictions, and at any point in time has 50-60 audits underway at various stages of completion. We have tax years open ranging from 1997 and forward. We are generally not able to reliably estimate the ultimate settlement amounts or timing until the close of the audit. However, we evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Unrecognized tax benefits are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law, and closing of statute of limitations. Based on information currently available, we anticipate that over the next 12 month period, audit activity could be completed related to existing unrecognized tax benefits of approximately $400 million. Additional information on the Commitments and Contingencies of the Company can be found in Note 10, Commitments and Contingencies, which appears in the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2009. Discontinued Operations In August 2009, the Company announced an agreement to sell our global pharmaceuticals business to Warner Chilcott plc (Warner Chilcott) for $3.1 billion of cash. Under the terms of the agreement, Warner Chilcott will acquire our portfolio of branded pharmaceutical products, our prescription drug product pipeline and manufacturing facilities in Puerto Rico and Germany. In addition, the majority of the 2,300 employees working on the pharmaceuticals business are expected to transfer to Warner Chilcott. The Company expects the transaction to close by the end of the 2009 calendar year, pending necessary regulatory approvals. The pharmaceuticals business had historically been part of the Companys Health Care reportable segment. In accordance with the applicable accounting guidance for the disposal of long-lived assets, the results of the pharmaceuticals business are presented as discontinued operations and, as such, have been excluded from both continuing operations and segment results for all periods presented. Additionally, the assets and liabilities of the pharmaceuticals business at September 30, 2009 are presented as held for sale in the Consolidated Balance Sheet. In November 2008, the Company completed the divestiture of our coffee business through the merger of its Folgers coffee subsidiary into The J.M. Smucker Company (Smucker) in an all-stock reverse Morris Trust transaction. In connection with the merger, 38.7 million shares of common stock of the Company were tendered by shareholders and exchanged for all shares of Folgers common stock, resulting in an increase of treasury stock of $2,466 million. Pursuant to the merger, a Smucker subsidiary Folgers and Folgers became a wholly owned subsidiary of Smucker. The Company recorded an after-tax gain on the transaction of $2,011 million, which is included in net earnings from discontinued operations in the Consolidated Statement of Earnings for the year ended June 30, 2009. The coffee business had historically been part of the Companys Snacks, Coffee and Pet Care reportable segment, as well as the coffee portion of our away-from-home business, which is included in the Fabric Care and Home Care reportable segment. In accordance with the applicable accounting guidance for the disposal of long-lived assets, the results of Folgers are presented as discontinued operations and, as such, have been excluded from both continuing operations and segment results for all periods presented. Following is selected financial information included in net earnings from discontinued operations for the pharmaceuticals and Three months ended September 30 Earnings from discontinued operations Net earnings from discontinued operations Net earnings from discontinued operations of the pharmaceuticals business for the three months ended September 30, 2009 include an after-tax gain of $121 million on the sale of the Actonel brand in Japan. At September 30, 2009, the major components of assets and liabilities held for sale from the pharmaceuticals business were as follows: Prepaid expenses and other assets Property, plant and equipment, net Trademarks and other intangible assets, net Total current assets held for sale Accrued and other liabilities Total current liabilities held for sale Reclassification The Company has reclassified certain amounts in the prior period Consolidated Balance Sheet and Consolidated Statement of Earnings in accordance with our July 1, 2009 retrospective adoption of new accounting guidance on noncontrolling interests in consolidated financial statements. See Note 8 for further details. The Company has reclassified certain amounts in the prior period Consolidated Statement of Cash Flows to be consistent with the current period presentation. Realized gains and losses from non-qualifying derivative instruments used to hedge currency exposures resulting from intercompany financing transactions were reclassified from operating activities to financing activities, which is consistent with the use of the instruments and their related cash flows. Managements Discussion and Analysis of Financial Condition and Results of Operations The purpose of this discussion is to provide an understanding of P&Gs financial results and condition by focusing on changes in certain key measures from year to year. Managements Discussion and Analysis (MD&A) is organized in the following sections: Forward-Looking Statements Results of Operations  Three Months Ended September 30, 2009 Business Segment Discussion  Three Months Ended September 30, 2009 Reconciliation of Non-GAAP Measures Throughout MD&A, we refer to measures used by management to evaluate performance, including unit volume growth, net outside sales and after-tax profit. We also refer to organic sales growth, free cash flow and free cash flow productivity. These financial measures are not defined under accounting principles generally accepted in the United States of America (U.S. GAAP). The explanation at the end of MD&A provides more details on the use and the derivation of these measures. Management also uses certain market share and market consumption estimates to evaluate performance relative to competition despite some limitations on the availability and comparability of such information. References to market share and market consumption in MD&A are based on a combination of vendor-reported consumption and market size data, as well as internal estimates. OVERVIEW P&Gs business is focused on providing branded consumer goods products. Our purpose is to provide products and services of superior quality and value that improve the lives of the worlds consumers, now and for generations to come. We believe this will result in leadership sales, profits and value creation, allowing employees, shareholders and the communities in which we operate to prosper. Our products are sold in more than 180 countries primarily through mass merchandisers, grocery stores, membership club stores, drug stores and high frequency stores, the neighborhood stores which serve many consumers in developing markets. We continue to expand our presence in other channels including department stores, perfumeries, pharmacies, salons and e-commerce. We compete in multiple product categories and have three global business units (GBUs): Beauty and Grooming; Health and Well-Being; and Household Care. Under U.S. GAAP, the business units comprising the GBUs are aggregated into six reportable segments: Beauty; Grooming; Health Care; Snacks and Pet Care; Fabric Care and Home Care; and Baby Care and Family Care. We have on-the-ground operations in approximately 80 countries through our Market Development Organization, which leads country business teams to build our brands in local markets and is organized along five geographic units: North America, Western Europe, Central & Eastern Europe/Middle East/Africa (CEEMEA), Latin America and Asia, which is comprised of Japan, Greater China and ASEAN/Australia/India/Korea (AAIK). Throughout MD&A, we reference business results in developing markets, which we define as the aggregate of CEEMEA, Latin America, AAIK and Greater China, and developed markets, which are comprised of North America, Western Europe and Japan. Effective July 1, 2009, we implemented a number of changes to the organization structure of the Beauty GBU, which resulted in changes to the components of our reportable segment structure. Female blades and razors were formerly included in the Grooming reportable segment and are now included in the Beauty reportable segment. Certain male-focused brands and businesses, such as Old Spice and Gillette personal care, moved from the Beauty reportable segment to the Grooming reportable segment. In addition, the Beauty GBU was renamed the Beauty and Grooming GBU. These changes have been reflected in our segment reporting for all periods presented. On August 24, 2009, we announced an agreement for the sale of our global pharmaceuticals business to Warner Chilcott which we expect to complete by the end of calendar 2009. The pharmaceuticals business had historically been part of the Health Care reportable segment. In accordance with applicable accounting guidance for the disposal of long-lived assets, the results of the pharmaceuticals business are presented as discontinued operations and, as such, have been excluded from continuing operations and from segment results for all periods presented. The table below provides more information about the components of our GBU structure. Hair Colorants, Shampoos and Conditioners Head & Shoulders, Pantene Hair Colorants, Shampoos and Conditioners Cosmetics, Deodorants, Female Blades and Razors, Personal Cleansing and Skin Care Fine Fragrances and Prestige Skin Care (SK II) Male Blades & Razors and Male Personal Care Products (Deodorants, Face and Shave Products, Hair Care, Personal Cleansing) Electric Hair Removal Devices and Home Appliances Feminine Pads and Tampons Personal Diagnostics, Digestive and Respiratory Health Products Oral Rinses, Toothbrushes and Toothpastes Wet and Dry Pet Food Potato Fabric Care and Home Care Laundry Detergents and Fabric Softeners Air and Fabric Fresheners, Dishwashing Detergents, Hard Surface Cleaners Batteries and Personal Power Devices Baby Care and Family Care Baby Wipes and Diapers Bath Tissue, Facial Tissue and Paper Towels The following table provides the percentage of net sales and net earnings from continuing operations by reportable business segment for the three months ended September 30, 2009 (excludes net sales and net earnings in Corporate): Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care SUMMARY OF RESULTS Following are highlights of results for the three months ended September 30, 2009: Net sales declined 6% to $19.8 billion. Organic sales, which exclude the impacts of acquisitions, divestitures and foreign exchange, grew 2%. Unit volume declined 3% and organic volume, which excludes the impact of acquisitions and divestitures, decreased 2% versus the comparable prior-year Net earnings from continuing operations declined 3% versus the prior year period as lower net sales and lower levels of minor brand divestiture gains were mostly offset by an increase in operating margin and lower interest expense. Net earnings declined 1% to $3.3 billion for the quarter as the reduction in net earnings from continuing operations was partially offset by earnings from discontinued operations, which included the current period gain on the sale of the Actonel brand in Japan. Diluted net earnings per share were $1.06, an increase of 3% versus the prior-year period. Diluted net earnings per share growth exceeded net earnings growth due to share repurchase activity in the prior fiscal year. Operating cash flow was $4.6 billion, an increase of 32% versus the prior year period. Free cash flow productivity, defined as the ratio of operating cash flow less capital expenditures to net earnings, was 121%. FORWARD-LOOKING STATEMENTS We discuss expectations regarding future performance, events and outcomes, such as our business outlook and objectives, in annual and quarterly reports, press releases and other written and oral communications. All such statements, except for historical and present factual information, are forward-looking statements, and are based on financial data and our business plans available only as of the time the statements are made, which may become out-of-date or incomplete. We assume no obligation to update any forward-looking statements as a result of new information, future events or other factors. Forward-looking statements are inherently uncertain and investors must recognize that events could be significantly different from our expectations. For more information on risks that could impact our results, refer to Item 1A Risk Factors in our most recent 10-Q, 10-K and 8-K filings. Ability to Achieve Business Plans: We are a consumer products company and rely on continued demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers and retail trade customers. Our continued success is dependent on leading-edge innovation with respect to both products and operations and on the continued positive reputations of our brands. This means we must be able to obtain patents and respond to technological advances and patents granted to competition. Our success is also dependent on effective sales, advertising and marketing programs in an increasingly fragmented media environment. Our ability to innovate and execute in these areas will determine the extent to which we are able to grow existing sales and volume profitably, especially with respect to the product categories and geographic markets (including developing markets) in which we have chosen to focus. There are high levels of competitive activity in the environments in which we operate. To address these challenges, we must respond to competitive factors, including pricing, promotional incentives, trade terms and product initiatives. We must manage each of these factors, as well as maintain mutually beneficial relationships with our key customers, in order to effectively compete and achieve our business plans. As a company that manages a portfolio of consumer brands, our ongoing business model involves a certain level of ongoing acquisition and divestiture activities. We must be able to successfully manage the impacts of these activities, while at the same time delivering against base business objectives. Our success will also depend on our ability to maintain key information technology systems. Cost Pressures: Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, cost of labor, foreign exchange and interest rates. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects, sourcing decisions and certain hedging transactions. We also must manage our debt and currency exposure, especially in certain countries, such as Venezuela, China and India. We need to maintain key manufacturing and supply arrangements, including sole supplier and sole manufacturing plant arrangements. We must implement, achieve and sustain cost improvement plans, including our outsourcing projects and those related to general overhead and workforce optimization. Successfully managing these changes, including identifying, developing and retaining key employees, is critical to our success. Global Economic Conditions: Economic changes, terrorist activity and political unrest may result in business interruption, inflation, deflation or decreased demand for our products. Our success will depend, in part, on our ability to manage continued global political and/or economic uncertainty, especially in our significant geographic markets, as well as any political or economic disruption due to terrorist and other hostile activities. Regulatory Environment: Changes in laws, regulations and the related interpretations may alter the environment in which we do business. This includes changes in environmental, competitive and product-related laws, as well as changes in accounting standards and taxation requirements. Our ability to manage regulatory, tax and legal matters (including product liability, patent, intellectual property, competition law matters and tax policy) and to resolve pending legal matters within current estimates may impact our results. RESULTS OF OPERATIONS  Three Months Ended September 30, 2009 The following discussion provides a review of results for the three months ended September 30, 2009 versus the three months ended September 30, 2008. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended September 30 Selling, General & Administrative Expense Other Non-operating Income, Net Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Net Earnings From Discontinued Operations Effective Tax Rate  Continuing Operations Basic Net Earnings  Continuing Operations Basic Net Earnings  Discontinued Operations Diluted Net Earnings  Continuing Operations Diluted Net Earnings  Discontinued Operations Average Diluted Shares Outstanding Comparisons as a % of Net Sales Selling, General & Administrative Expense Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Net sales decreased 6% for the quarter to $19.8 billion on a 3% decline in unit volume. Unfavorable foreign exchange reduced net sales by 7% as many foreign currencies weakened versus the U.S. dollar. Price increases, taken primarily in developing regions to offset local currency devaluations, added 3% to net sales. Positive product mix from disproportionate volume declines in developing regions, which have lower than company average selling prices, contributed 1% to net sales. Volume in developed regions declined low single digits while developing markets were down mid-single digits driven primarily by market contractions in CEEMEA. All reportable segments except Health Care experienced volume declines, led by a double-digit decline in Snacks and Pet Care and a high single-digit decline in Grooming. Organic sales increased 2% led by sequentially improving growth in the Beauty Care and Health Care segments. Net Sales Change Drivers 2009 vs. 2008 (Three Months Ended Sep. 30) Volume with Acquisitions & Divestitures Volume excluding Acquisitions & Divestitures Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Sales percentage changes are approximations based on quantitative formulas that are consistently applied. Gross margin increased 290 basis points for the quarter to 52.6% of net sales. Price increases, lower commodity and energy costs and manufacturing cost savings added approximately 450 basis points to gross margin and were partially offset by unfavorable foreign exchange impacts, negative product mix and the negative impacts of volume scale deleveraging. Total selling, general and administrative expenses (SG&A) decreased 1% to $6.0 billion due to lower overhead and marketing spending, partially offset by an increase in other operating expenses due to higher foreign currency exchange costs. SG&A as a percentage of net sales was up 130 basis points primarily due to the negative scale leveraging impact of reduced sales and an increase in other operating expenses, partially offset by lower marketing spending as a percent of net sales. Other operating expenses as a percentage of net sales increased behind the higher foreign currency exchange costs. Marketing spending as a percentage of net sales decreased behind media rate savings and a shift in timing of expenditures to later in the fiscal year. Overhead spending as a percentage of net sales increased slightly as productivity improvements and lower restructuring charges were more than offset by sales deleveraging. The higher foreign exchange costs result primarily from our operations in Venezuela. Because of currency restrictions in Venezuela, payments for certain imported goods and services need to be satisfied by exchanging Bolivares Fuertes for U.S. dollars through a parallel exchange mechanism rather than at the more favorable official exchange rate. A reduction in the availability of foreign currency at the official exchange rate resulted in increased costs for exchange transactions executed using the parallel mechanism. Unless official foreign exchange is made more available, we expect these exchange controls to continue negatively impacting our results of operations. In addition, if Venezuela is designated as a high inflation economy and/or there is a devaluation of the official exchange rate, results of operations will be negatively impacted. Interest expense was $287 million for the quarter, a decline of 15% due primarily to lower U.S. interest rates. Other non-operating income was down $257 million to $23 million mainly due to gains on the sale of minor brands in the prior year period. The effective tax rate on continuing operations declined 30 basis points to 27.7% primarily due to audit settlements, partially offset by changes in the geographic mix of earnings. Net earnings from continuing operations declined 3% to $3.0 billion mainly due to reduced net sales and lower levels of minor brand divestiture gains, partially offset by an increase in operating margin and lower interest expense. Operating margin expanded primarily due to an increase in gross margin, increase in SG&A as a percentage of net sales mainly resulting from higher foreign currency exchange costs. Diluted net earnings per share from continuing operations increased 1% versus the prior year to $0.97. Net earnings from discontinued operations increased $47 million for the quarter to $280 million primarily due to a gain on the sale of the Actonel brand in Japan, partially offset by the loss of contribution from the Folgers business divested in fiscal 2009. Net earnings from discontinued operations also include the results of operations from the global pharmaceuticals business. Net earnings were down 1% to $3.3 billion during the quarter. Diluted net earnings per share increased 3% to $1.06. Earnings per share growth exceeded net earnings growth due to the impact of share repurchases in fiscal 2009. BUSINESS SEGMENT DISCUSSION  Three Months Ended September 30, 2009 The following discussion provides a review of results by business segment. Analyses of the results for the three months ended September 30, 2009 are provided compared to the same three month period ended September 30, 2008. The primary financial measures used to evaluate segment performance are net sales and net earnings from continuing operations. The table below provides supplemental information on net sales and net earnings from continuing operations by business segment for the three months ended September 30, 2009 versus the comparable prior year period (amounts in millions): Three Months Ended September 30, 2009 Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care BEAUTY AND GROOMING GBU Beauty Beauty net sales were down 5% for the quarter to $4.9 billion on a 2% decline in unit volume. Unfavorable foreign exchange impacted net sales by 7%. Price increases, mainly in developing regions to offset local currency devaluations, and positive product mix added 3% and 1% to net sales, respectively. Organic sales grew 2%. Organic volume, which excludes acquisitions and divestitures, was down 1% mainly due to volume declines in the CEEMEA region and in the more discretionary businesses of Professional Salon and Prestige. Hair Care volume grew low single digits behind initiative-driven growth of Pantene, Head & Shoulders and Rejoice and delivered growth in every region except CEEMEA. Professional Salon volume declined double digits due to the exit of non-strategic businesses and continued market contractions. Prestige volume decreased high single digits primarily due to the continued contraction of the fragrance market, partially offset by double- digit growth of SK II. Female Beauty volume was down mid-single digits primarily due to lower shipments in CEEMEA, share losses on non-strategic personal cleansing brands, lower merchandising and initiative activity in cosmetics and the fiscal 2009 divestiture of Noxzema. Net earnings decreased 1% for the quarter to $777 million as lower net sales and a higher effective tax rate were mostly offset by operating margin expansion. Operating margin increased primarily due to higher gross margin, driven primarily by increased pricing and manufacturing cost savings, and a reduction in marketing spending as a percentage of net sales, partially offset by higher foreign currency exchange costs. Grooming Grooming net sales in the first fiscal quarter decreased 11% to $1.9 billion on an 8% decline in unit volume. Unfavorable foreign exchange reduced net sales by 9%. These impacts were partially offset by positive pricing impacts of 6%. Organic sales declined 2%. Volume in Male Blades and Razors declined high single digits behind market contractions and market share declines. Gillette Fusion volume continued to grow but was more than offset by volume declines in legacy shaving systems. Global market share of male blades and razors declined about half a point. Volume in Male Personal Care declined high single digits behind lower shipments of shave preparation products due to market share declines driven by increased competitive promotional activity. Volume in Braun was down double digits mainly due to market contractions, particularly in home and hair care appliances, and market share declines. Net earnings declined 21% versus the prior year period to $351 million primarily driven by lower net sales and reduced operating margin. The contraction of operating margin resulted from higher foreign currency exchange costs, lower gross margin and higher overhead spending as a percentage of net sales, both driven by the negative impacts of scale deleveraging, partially offset by lower marketing spending as a percentage of net sales. HEALTH AND WELL-BEING GBU Health Care Health Care net sales declined 4% to $3.0 billion for the quarter. Unit volume was consistent with the prior year period as growth in developed regions was offset by a decline in developing regions, primarily CEEMEA. Unfavorable foreign exchange reduced net sales by 8%, partially offset by positive pricing impacts of 3% and improved product mix of 1%. Organic sales increased 4%. Personal Health Care volume was in line with the prior year period as growth in diagnostics products was offset by lower shipments of digestive health products in North America and shipment delays in CEEMEA due to a distributor transition. Feminine Care volume declined low single digits mainly due to increased competitive activity in CEEMEA, partially offset by growth in Asia. Global market share of feminine care was down nearly 1 point to about 36%. Oral Care volume was in line with the prior year period as initiative-driven growth in Western Europe and Latin America was offset by market contractions in Asia and CEEMEA. Net earnings increased 9% to $550 million for the first fiscal quarter. The decline in net sales and higher foreign currency exchange costs were more than offset by lower marketing spending as a percentage of net sales, a pricing-driven expansion of gross margin and a receipt from a favorable settlement of a legal dispute. Snacks and Pet Care Snacks and Pet Care net sales were down 6% for the quarter to $755 million on a 10% decline in unit volume. Unfavorable foreign exchange reduced net sales by 3%. Price increases to offset increased commodity costs and currency devaluations contributed 6% to net sales. Improved product mix added 1% to net sales due to relatively better volume results in Pet Care, which has higher than segment average selling prices. Organic sales declined 3% due to a decline in Snacks, partially offset by growth in Pet Care. Volume in Snacks decreased double digits due to lower merchandising activity in North America following the Super Stacks initiative and market contractions in CEEMEA. Volume in Pet Care was down low single digits mainly due to the contraction of the premium nutrition category following price increases, partially offset by the impact of new product initiatives launched in previous quarters. Net earnings were up 35% in the first quarter to $74 million behind gross margin expansion and a lower tax rate, partially offset by higher marketing and overhead spending as a percentage of net sales. Gross margin increased mainly due to price increases, formulation and packaging cost savings and commodity cost reductions in Pet Care. HOUSEHOLD CARE GBU Fabric Care and Home Care Fabric Care and Home Care net sales decreased 5% to $6.1 billion for the quarter on a 2% decline in unit volume. Unfavorable foreign exchange reduced net sales by 7%, while positive pricing and product mix improved net sales by 3% and 1%, respectively. Organic sales grew 2%. Fabric Care volume was down low single digits due to trade inventory reductions in North America and global market share declines, partially offset by the new product launches and growth in Western Europe behind incremental merchandising activities. Global market share of fabric care declined less than 1 point. Home Care volume grew mid-single digits primarily due to new initiative launches in North America and Western Europe. Global market share of home care increased over half a point. Batteries volume declined mid-single digits due to market contractions, market share declines and trade inventory reductions. Global market share of general purpose batteries declined about 1 point. Net earnings grew 22% to $1.0 billion behind gross margin expansion and a lower tax rate, partially offset by lower net sales and higher SG&A as a percentage of net sales. Gross margin increased primarily due to the impact of price increases taken in the previous fiscal year, lower commodity costs and manufacturing and formulation cost savings. SG&A as a percentage of net sales was up due to an increase in currency exchange costs and higher overhead and marketing spending as a percentage of net sales. Baby Care and Family Care Baby Care and Family Care net sales declined 5% in the first fiscal quarter to $3.6 billion on a 1% decline in unit volume. Price increases, primarily taken in developing regions to offset local currency devaluations, added 2% to net sales. Unfavorable foreign exchange reduced net sales by 6%. Organic sales grew 1%. Baby Care volume increased low single digits behind new initiative launches in Western Europe including the expansion of Pampers Simply Dry and market growth in Asia and Western Europe. Family Care volume was down mid-single digits due to lower shipments of Charmin primarily driven by trade inventory reductions and market share losses due to a shift in timing of merchandising activity. Net earnings increased 8% to $557 million as gross margin expansion more than offset lower net sales, higher SG&A as a percentage of net sales and a higher tax rate. Gross margin increased mainly behind the impact of price increases taken in previous periods, lower commodity costs and manufacturing cost savings. SG&A as a percentage of net sales increased primarily due to higher foreign currency exchange costs and higher overhead spending. CORPORATE Corporate includes certain operating and non-operating activities not allocated to specific business units. These include: the incidental businesses managed at the corporate level; financing and investing activities; other general corporate items; the historical results of certain divested brands and categories; and certain restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce rationalization. Corporate also includes reconciling items to adjust the accounting policies used in the segments to U.S. GAAP. The most significant reconciling items include income taxes (to adjust from statutory rates that are reflected in the segments to the overall Company effective tax rate), adjustments for unconsolidated entities (to eliminate sales, cost of products sold and SG&A for entities that are consolidated in the segments but accounted for using the equity method for U.S. GAAP) and noncontrolling interest adjustments for subsidiaries where we do not have 100% ownership. Since both unconsolidated entities and less than 100% owned subsidiaries are managed as integral parts of the Company, they are accounted for similar to a wholly owned subsidiary for management and segment purposes. This means our segment results recognize 100% of each income statement component through before-tax earnings, with eliminations for unconsolidated entities in Corporate. In determining segment after-tax net earnings, we apply the statutory tax rates (with adjustments to arrive at the Companys effective tax rate in Corporate) and eliminate the share of earnings applicable to other ownership interests, in a manner similar to For the Corporate segment, net expenses from continuing operations increased $277 million to $291 million for the quarter. The increase in net expenses was driven primarily by higher divestiture gains and hedging impacts in the prior year period and foreign currency transaction losses in the current period. These were partially offset by lower current period net interest expense and a decrease in overhead spending which includes a reduction in restructuring charges. FINANCIAL CONDITION Operating Activities Cash generated from operating activities for the quarter increased 32% versus the comparable prior year period to $4.6 billion. The combination of net earnings and non-cash items (primarily depreciation, amortization, share based compensation, deferred income taxes and gains on the sale of businesses) provided $3.9 billion of operating cash compared to $4.2 billion in the prior year period. A decrease in working capital contributed $209 million to operating cash flow primarily due to an increase in accounts payable, accrued and other liabilities behind higher taxes payable, partially offset by increased accounts receivable. Accounts receivable levels increased during the fiscal first quarter primarily due to higher net sales versus the June quarter but declined versus the comparable prior year period mainly due to lower net sales versus the prior year period and improved collection efforts. Inventory balances consumed less cash in the current period due to improving commodity costs trends and better matching of production to shipment volume. Investing Activities Investing activities in the first fiscal quarter used $378 million. Cash consumed by investing activities decreased 8% versus the prior year period mainly due to lower capital spending, partially offset by lower net cash from acquisition and divestiture activities. Capital expenditures were $552 million for the quarter or 2.8% of net sales. Proceeds from asset sales generated $209 million in cash primarily from the sale of the Actonel brand in Japan. Financing Activities Cash used to fund financing activities was up 62% versus the prior year period to $2.8 billion for the quarter. The increase versus the prior year resulted mainly from the retirement of debt, partially offset by a reduction in treasury stock purchases. Current year net repayments of debt used $1.6 billion, while dividends to shareholders used $1.3 billion. As of September 30, 2009, our current liabilities exceeded current assets by $4.2 billion, driven by our short-term debt position. We have short- and long-term debt to fund discretionary items such as acquisitions and share buyback programs. We anticipate being able to support our short-term liquidity and operating needs largely through cash generated from operations. We have strong short- and long-term debt ratings which despite the credit crisis have enabled and should continue to enable us to refinance our debt as it becomes due at favorable rates in commercial paper and bond markets. In addition, we have agreements with a diverse group of financial institutions that, if needed, should provide sufficient credit funding to meet short-term financing requirements. RECONCILIATION OF NON-GAAP MEASURES Our discussion of financial results includes several measures not defined by U.S. GAAP. We believe these measures provide our investors with additional information about the underlying results and trends of the Company, as well as insight to some of the metrics used to evaluate management. When used in MD&A, we have provided the comparable GAAP measure in the discussion. Organic Sales Growth: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions, divestitures and foreign exchange from year-over-year comparisons. We believe this provides investors with a more complete understanding of underlying sales trends by providing sales growth on a consistent basis. The reconciliation of reported sales growth to organic sales for the JulySeptember quarter: Acquisition/ Divestiture Impact Fabric Care and Home Care Baby Care and Family Care Free Cash Flow: Free cash flow is defined as operating cash flow less capital spending. We view free cash flow as an important measure because it is one factor in determining the amount of cash available for dividends and discretionary investment. Free cash flow is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation. Free Cash Flow Productivity: Free cash flow productivity is defined as the ratio of free cash flow to net earnings. The Companys long-term target is to generate free cash at or above 90 percent of net earnings. Free cash flow is also one of the measures used to evaluate senior management. The reconciliation of free cash flow and free cash flow productivity is provided below (amounts in millions): Free Cash Flow Productivity Quantitative and Qualitative Disclosures About Market Risk. There have been no material changes in the Companys exposure to market risk since June 30, 2009. Additional information can be found in the section entitled Other Information, which appears on pages 47-48, and Note 5, Risk Management Activities and Fair Value Measurements, which appears on pages 58-61 of the Annual Report to Shareholders for the fiscal year ended June 30, 2009 which can be found by reference to Exhibit 13 of the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2009. Controls and Procedures. Evaluation of Disclosure Controls and Procedures. The Companys President and Chief Executive Officer, Robert A. McDonald, and the Companys Chief Financial Officer, Jon R. Moeller, performed an evaluation of the Companys disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (Exchange Act)) as of the end of the period covered by this report. Messrs. McDonald and Moeller have concluded that the Companys disclosure controls and procedures were effective to ensure that information required to be disclosed in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) accumulated and communicated to our management, including Messrs. McDonald and Moeller, to allow their timely decisions regarding required disclosure. Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting that occurred during the Companys fiscal quarter ended September 30, 2009 that have materially affected, or are reasonably likely to materially affect, the Companys internal control over financial reporting. PART II. OTHER INFORMATION Legal Proceedings. The Company is subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental issues, patent and trademark matters and taxes. The Company is subject to a variety of investigations into potential competition law violations in Europe. In 2006, French authorities, in connection with an inquiry into potential competition law violations in France, entered the premises of two of the Companys French subsidiaries and seized a variety of documents. In 2008, European Commission officials, with the assistance of the national authorities from a variety of countries, started an investigation into potential competition law violations in a variety of countries across the European Union. Around the same time, the national authorities in Spain, Italy and the Czech Republic initiated additional investigations into potential antitrust concerns within those countries. In connection with these investigations, a number of the Companys subsidiaries were visited and documents seized. Also in 2008, authorities in the United Kingdom (UK) initiated an investigation concerning potential antitrust violations in the UK involving one of the Companys subsidiaries. The Company or its subsidiaries are also involved in other competition law investigations in Germany, Belgium, Romania, Switzerland, France and Greece, as well as some other countries. We believe that all of the above matters involve a number of other consumer products companies and/or retail customers. The Companys policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with investigations by relevant regulatory authorities, which the Company is doing. Competition and antitrust law investigations often continue for several years and, if violations are found, can result in substantial fines. In other industries, fines have amounted to hundreds of millions of dollars. At this point, no formal claims have been made against the Company or any of our subsidiaries in connection with the French, European Commission or UK inquiries. The remaining matters also are in various stages of the investigatory process. In response to the actions of the European Commission and national authorities, the Company launched its own internal investigations into potential violations of competition laws. The Company has identified violations in certain European countries and appropriate actions have been taken. It is still too early for us to reasonably estimate the total amount of fines to which the Company will be subject as a result of these competition law issues. However, we have taken and will take reserves as appropriate. Please refer to the Companys Risk Factors in Item 1A of this Form 10-Q for additional information. In December 2008, the Company became aware of an investigation by Italian authorities into an environmental accident at the site of a contractor which provides services to one or more of the Companys European affiliates. The accident involved the explosion of certain pressurized cans and resulted in the death of one worker and serious injuries to another. Italian authorities are formally investigating whether the Companys affiliates complied with Italian laws related to the proper classification and disposal of their products. Should they find that these entities violated the law, the Italian authorities could levy fines in excess of $100 thousand against the Companys European affiliate(s). For a discussion of the Companys risk factors, please refer to Part 1, Item 1A. Risk Factors in the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2009. Unregistered Sales of Equity Securities and Use of Proceeds. ISSUER PURCHASES OF EQUITY SECURITIES Total Number of Shares Purchased (1) Average Price Paid per Share (2) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (3) Approximate Dollar Value of Shares That May Yet Be Purchased Under our Share Repurchase Program ($ in of shares purchased was 6,030,211 for the quarter. All transactions were made in the open market or pursuant to prepaid forward agreements with large financial institutions. Under these agreements, the Company prepays large financial institutions to deliver shares at future dates in exchange for a discount. The number of shares purchased other than through a publicly announced repurchase plan was 6,030,211 for the quarter. This includes 13,051 shares acquired by the Company under various compensation and benefit plans and 6,017,160 shares acquired by the Profit Sharing Trust. This table excludes shares withheld from employees to satisfy minimum tax withholding requirements on option exercises and other equity-based transactions. The Company administers cashless exercises through an independent, third party broker and does not repurchase stock in connection with cashless exercise. per share is calculated on a settlement basis and excludes commission. 2007, the Company announced a share repurchase plan. Pursuant to the share repurchase plan, the Board of Directors authorized the Company and its subsidiaries to acquire in open market and/or private transactions $24 to $30 billion of shares of Company common stock over the subsequent three years (through June 30, 2010) to be financed by issuing a combination of long-term and short-term debt. Certain purchases were made prior to announcement of the program but are considered purchases listed in this column include commissions to be paid to brokers to execute the transactions. Submission of Matters to a Vote of Security Holders. At the Companys 2009 Annual Meeting of Shareholders held on October 13, 2009, the following actions were taken: The following Directors were elected for terms of office expiring in 2010: Pursuant to the terms of the Notice of Annual Meeting and Proxy Statements, proxies received were voted, unless authority was withheld, in favor of the election of the thirteen nominees named. A proposal by the Board of Directors to ratify the appointment of Deloitte & Touche LLP as the Companys independent registered public accounting firm to conduct the annual audit of the financial statements of the Company and its subsidiaries for the fiscal year ending June 30, 2010, was approved by the shareholders. The shareholders cast 2,370,909,650 votes in favor of this resolution and 23,326,560 votes against. There were 6,672,105 abstentions. A proposal by the Board of Directors to amend the Companys Regulations to authorize the Board of Directors to amend the Companys Regulations to the extent permitted by the Ohio General Corporation Law was approved by the shareholders. 76.34% of the issued and outstanding shares were voted in favor of the resolution. The shareholders cast 2,332,823,944 votes in favor of the resolution and 65,510,450 votes against. There were 2,573,921 abstentions. A proposal by the Board of Directors to approve and authorize The Procter & Gamble 2009 Stock and Incentive Compensation Plan was approved by the shareholders. The shareholders cast 1,475,251,662 votes in favor of the resolution and 371,542,034 votes against. There were 12,333,145 abstentions and 541,781,474 broker non-votes. A shareholder resolution proposed by Mrs. Evelyn Y. Davis was defeated by the shareholders. The proposal requested that the Board of Directors provide for cumulative voting in the election of directors. The Board opposed the resolution. The shareholders cast 558,974,175 votes in favor of the resolution and 1,290,224,761 votes against. There were 9,927,905 abstentions and 541,781,474 broker non-votes. A shareholder resolution proposed by Walden Asset Management was defeated by the shareholders. The proposal requested shareholders be given an advisory vote on the compensation of certain executive officers. The Board opposed the resolution. The shareholders cast 826,408,834 votes in favor of the resolution and 965,702,952 votes against. There were 67,015,055 abstentions and 541,781,474 broker non-votes. Although these actions occurred following the first quarter, the Company is voluntarily including this information here. Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October 14, 2008) (Incorporated by reference to Exhibit (3-1) of the Companys Form 10-Q for the quarter ended December 31, 2008). Regulations (as amended by shareholders at the annual meeting on October 13, 2009). Computation of Earnings per Share. Computation of Ratio of Earnings to Fixed Charges.",10811
2009-12-08,8-K,0000080424-09-000082,"13 OR 15(d) of The Securities Exchange Act Of 1934 Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act communications pursuant to Rule 13e-4(c) under the Exchange Act OF DIRECTORS OR CERTAIN OFFICERS; APPOINTMENT OF CERTAIN OFFICERS On December 8, 2009, The Procter & Gamble Company (the Company) announced that Alan G. Lafley, Chairman of the Board and former President and Chief Executive Officer, will retire from his position as Chairman of the Board effective January 1, 2010. The Company also announced that Robert A. McDonald (56), currently President and Chief Executive Officer, has been elected Chairman of the Board, in addition to his other responsibilities, effective filing this 8-K pursuant to Item 5.02(b) and (c), ""Departure of Directors or Certain Officers; Appointment of Certain Officers."" requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly Release by The Procter & Gamble Company dated December 8,",208
2009-12-08,8-K,0000080424-09-000084,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 5.02(d) ELECTION OF DIRECTORS On December 8, 2009, The Procter & Gamble Company (the ""Company"") issued a news release announcing that Angela F. Braly was appointed to the Board of Directors, effective December 8, 2009. Ms. Braly will serve on the Audit and Governance & Public Responsibility Committees. The Company is filing this 8-K pursuant to Item 5.02(d), ""Election of Directors."" A copy of the Company's press release relating to this announcement is being furnished as Exhibit 99 to this 8-K.",195
2009-12-11,8-K,0000080424-09-000086,"13 OR 15(d) of The Securities Exchange Act Of 1934 Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act communications pursuant to Rule 13e-4(c) under the Exchange Act 2009, The Procter & Gamble Company (Company) and the Sara Lee Corporation (Sara Lee) issued a news release announcing that the companies have reached an agreement for the purchase of Sara Lee's Ambi Pur brand by the furnishing this 8-K pursuant to Item 7.01, ""Regulation FD",121
2010-01-08,8-K,0001193125-10-003501,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) January 08, 2010 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (513) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Regulation FD Disclosure As disclosed in its most recent Form 10-K for the year ended June 30, 2009, The Procter & Gamble Company (the Company) announced changes to its segment reporting structure that were effective July 1, 2009. Also, as disclosed in a Form 8-K dated August 24, 2009, the Company announced an agreement for the sale of its global pharmaceuticals business to Warner Chilcott plc (Warner Chilcott). This Form 8-K provides pro forma historical total company and segment results for the three months ended December 31, 2008, reflecting the change in the reporting structure of the Company and the presentation of the Companys pharmaceuticals business as discontinued operations. This information in no way revises or restates the Consolidated Statement of Earnings, Consolidated Balance Sheet, Consolidated Statement of Shareholders Equity or Consolidated Statements of Cash Flows for the Company and consolidated subsidiaries for any period. Fiscal Year 2010 Changes to Global Business Unit (GBU) Structure Effective July 1, 2009, the Company implemented a number of changes to the organization structure of the Beauty GBU, which resulted in changes to the components of its reportable segment structure. Female blades and razors were formerly included in the Grooming reportable segment and are now included in the Beauty reportable segment. Certain male-focused brands and businesses, such as Old Spice and Gillette personal care, moved from the Beauty reportable segment to the Grooming reportable segment. In addition, the Beauty GBU was renamed the Beauty and Grooming GBU. Presentation of the Global Pharmaceuticals Business as Discontinued Operations On October 30, 2009, the Company sold its global pharmaceuticals business to Warner Chilcott for $2.9 billion. Under the terms of the agreement, Warner Chilcott acquired the Companys portfolio of branded pharmaceuticals products, prescription drug product pipeline and manufacturing facilities in Puerto Rico and Germany. The pharmaceuticals business has historically been part of the Health Care reportable segment. In accordance with applicable accounting guidance for the disposal of long-lived assets, the results of the pharmaceuticals business are presented as discontinued operations and, as such, are excluded from continuing operations and from segment results. The above changes are being reflected in the consolidated financial statements and segment reporting beginning in fiscal year 2010, starting with the Form 10-Q for the three months ended September 30, 2009. This document provides pro forma consolidated earnings information and quarterly sales and profit information for the affected segments for the three months ended December 31, 2008. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended December 31, 2008 SELLING, GENERAL & ADMINISTRATIVE EXPENSE OTHER NON-OPERATING INCOME, NET EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES NET EARNINGS FROM CONTINUING OPERATIONS NET EARNINGS FROM DISCONTINUED OPERATIONS EFFECTIVE TAX RATE FROM CONTINUING OPERATIONS BASIC NET EARNINGS - CONTINUING OPERATIONS BASIC NET EARNINGS - DISCONTINUED OPERATIONS DILUTED NET EARNINGS - CONTINUING OPERATIONS DILUTED NET EARNINGS - DISCONTINUED OPERATIONS AVERAGE DILUTED SHARES OUTSTANDING Three Months Ended December 31, 2008 Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care This 8-K is furnished pursuant to Item 7.01 Regulation FD Disclosure.",704
2010-01-12,8-K,0000080424-10-000002,"to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 of Report (Date of earliest event reported) name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act communications pursuant to Rule 13e-4(c) under the Exchange Act 12, 2010, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of forty-four cents ($0.44) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after February 16, 2010 to shareholders of record at the close of business on January 22, 2010. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Release by The Procter & Gamble Company dated January 12,",197
2010-01-15,8-K,0000080424-10-000003,"13 OR 15(d) of The Securities Exchange Act Of 1934 Report (Date of earliest event reported) of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act communications pursuant to Rule 13e-4(c) under the Exchange Act 5.02(b) DEPARTURE OF DIRECTOR; 2010, Lynn M. Martin retired from The Procter & Gamble Company (the ""Company"") Board of Directors (the ""Board"") in accordance with the Board's customary retirement age for directors as set forth in the Board's Corporate Governance Guidelines. The Company is filing this 8-K pursuant to Item 5.02(b), ""Departure of Directors or Principal Officers."" requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly 99. News Release by The Procter & Gamble Company dated January 15, 2010.",171
2010-01-28,8-K,0000080424-10-000007,"to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area code ) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act communications pursuant to Rule 13e-4(c) under the Exchange Act OF OPERATIONS AND FINANCIAL CONDITION January 28, 2010, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended December 31, 2009. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Release by The Procter & Gamble Company dated January 28,",160
2010-01-28,10-Q,0001193125-10-014865,". Going forward, the devaluation of the official rate has reduced the differential between the official and parallel exchange rate and is therefore expected to reduce the incremental cost of exchanging currencies through securities transactions in the parallel market. However, at this time, we are not able to reasonably estimate the future state of exchange controls in Venezuela and the availability of official foreign exchange rate U.S. dollars. RESULTS OF OPERATIONS  Six Months Ended December 31, 2009 The following discussion provides a review of results for the six months ended December 31, 2009 versus the six months ended December 31, 2008. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Six Months Ended December 31 Selling, General & Administrative Expense Other Non-operating Income, Net Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Net Earnings From Discontinued Operations Effective Tax Rate  Continuing Operations Basic Net Earnings  Continuing Operations Basic Net Earnings  Discontinued Operations Diluted Net Earnings  Continuing Operations Diluted Net Earnings  Discontinued Operations Average Diluted Shares Outstanding Comparisons as a % of Net Sales Selling, General & Administrative Expense Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Net sales were in line with the prior year period at $40.8 billion on a 1% increase in unit volume. Price increases, taken primarily in developing regions to offset local currency devaluations, added 2% to net sales. Unfavorable foreign exchange reduced net sales by 3% as many foreign currencies weakened versus the U.S. dollar, primarily in the first fiscal quarter. Volume was up low single digits in both developed and developing regions, led by mid-singledigits growth in Asia. Volume growth for the reportable segments was mixed, with low to mid-single-digit increases in the Fabric Care and Home Care, Baby Care and Family Care and Health Care segments, partially offset by mid-single-digit declines in the Grooming and Snacks and Pet Care segments. Organic sales increased 3% led by mid-single-digits growth in the Household Care GBU. Net Sales Change Drivers 2009 vs. 2008 (Six Months Ended Dec. 31) Volume with Acquisitions & Divestitures Volume excluding Acquisitions & Divestitures Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Sales percentage changes are approximations based on quantitative formulas that are consistently applied. Gross margin increased 310 basis points versus the comparable prior year period to 53.1% of net sales. Lower commodity and energy costs increased gross margin by approximately 170 basis points. Gross margin also benefited from manufacturing cost savings and price increases, partially offset by unfavorable foreign exchange impacts and negative product and geographic mix. Total SG&A increased 5% to $12.6 billion due to higher other operating expenses, partially offset by lower overhead spending. Other operating expenses increased mainly due to Venezuela-related foreign currency exchange costs of $546 million and a charge for potential competition law fines of $267 million. SG&A as a percentage of net sales increased 150 basis points to 30.8% behind a 180 basis point increase in other operating expenses as a percentage of sales, driven by the aforementioned currency exchange costs and charges for competition law fines, partially offset by a decrease in overhead spending as a percentage of net sales, driven by productivity improvements and lower restructuring spending. Marketing spending as a percentage of net sales was consistent with the prior year period as additional marketing investments were offset by media rate savings. Interest expense was down $182 million versus the comparable prior year period, a decrease of 26% due primarily to lower interest rates on floating rate debt and a reduction in debt outstanding. Other non-operating income declined $271 million to $76 million mainly due to gains on the sale of minor brands in the prior year period. The effective tax rate on continuing operations increased 190 basis points to 28.7% primarily due to lower audit settlements and foreign tax credits and the non-deductibility of the charge for potential competition law fines. Net earnings from continuing operations increased 4% to $6.2 billion mainly due to an increase in operating margin, partially offset by an increase in the effective tax rate. Operating margin expanded primarily due to an increase in gross margin, partially offset by an increase in SG&A as a percentage of net sales. Diluted net earnings per share from continuing operations increased 7% versus the prior year period to $1.98. Net earnings from discontinued operations decreased $634 million to $1.8 billion primarily due to lower gains on the sale of discontinued operations. In the current year, we had a gain of $1.5 billion from the sale of the global pharmaceuticals business, as compared to the $2.0 billion prior year gain on the sale of the Folgers coffee business. In addition, earnings were negatively impacted by the loss of contribution from the global pharmaceuticals business which was divested at the end of October 2009. Net earnings declined 5% versus the prior year period to $8.0 billion behind a decrease in net earnings from discontinued operations, partially offset by an increase in net earnings from continuing operations. Diluted net earnings per share were down 2% to $2.56. Earnings per share growth rates differed from net earnings growth rates due to a reduction in the number of shares outstanding resulting from share repurchases. BUSINESS SEGMENT DISCUSSION  Three and Six Months Ended December 31, 2009 The following discussion provides a review of results by business segment. Analyses of the results for the three and six months ended December 31, 2009 are provided compared to the same three and six month period ended December 31, 2008. The primary financial measures used to evaluate segment performance are net sales and net earnings from continuing operations. The table below provides supplemental information on net sales and net earnings from continuing operations by business segment for the three and six months ended December 31, 2009 versus the comparable prior year periods (amounts in millions): Three Months Ended December 31, 2009 Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Six Months Ended December 31, 2009 Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care BEAUTY AND GROOMING GBU Beauty Beauty net sales increased 7% in the second fiscal quarter to $5.2 billion on a 2% increase in unit volume. Organic sales increased 4% versus the prior year period. Price increases, primarily in developing regions to offset currency impacts, and favorable foreign exchange added 2% and 3%, respectively, to net sales growth. Organic volume, which excludes acquisitions and divestitures, was up 3% behind mid-single-digit growth in developing regions, partially offset by a low single-digit decline in developed regions. Volume in Hair Care increased low single digits mainly due to double-digit growth in Asia driven by both market and share growth. Volume in Female Beauty increased low single digits primarily due to higher shipments of female skin care and personal cleansing products in developing regions. Volume in Salon Professional was down double digits due to the exit of non-strategic businesses and continued market contractions. Volume in Prestige decreased low single digits as continued contraction of the fragrance market was mostly offset by trade inventory reductions in the prior year period. Net earnings were up 7% versus the prior year period to $876 million on higher net sales and operating margin expansion, partially offset by a higher tax rate. Gross margin expansion, primarily due to price increases and manufacturing cost savings, was partially offset by higher SG&A as a percentage of sales behind increased marketing spending and higher foreign currency exchange costs. Beauty net sales increased 1% fiscal year to date to $10.1 billion. Organic sales increased 3%. Unit volume was consistent with the prior year period, while organic volume, which excludes acquisitions and divestitures, increased 1% driven by growth in Hair Care. Pricing increases, primarily taken in developing regions to offset currency devaluations, added 3% to net sales growth. Unfavorable foreign exchange reduced net sales by 2%. Hair Care volume grew low single digits behind growth of Pantene, Head & Shoulders and Rejoice primarily in Asia and Latin America. Female Beauty volume was down low single digits due to lower shipments of cosmetics behind the discontinuation of Max Factor in North America and lower merchandising and initiative activity, the fiscal 2009 divestiture of Noxzema and market share losses on non-strategic personal cleansing brands. Salon Professional volume declined double digits mainly due to the exit of non-strategic businesses and continued market contractions. Prestige volume declined mid-single digits due to continued contraction of the fragrance market. Net earnings grew 3% fiscal year to date to $1.7 billion behind operating margin expansion and net sales growth, partially offset by a higher tax rate. Operating margin increased due to higher gross margin driven by price increases and manufacturing costs savings. Gross margin expansion was partially offset by higher SG&A as a percentage of net sales due to higher foreign currency exchange costs and increased marketing spending. Grooming Grooming net sales grew 3% to $2.1 billion for the quarter on a 2% decline in unit volume. Organic sales were consistent with the prior year period. Favorable foreign exchange contributed 3% to net sales. Price increases, taken mainly in developing regions to offset currency impacts, added 4% to net sales for the quarter. Negative mix impacts reduced net sales by 2% as volume declines disproportionately affected developed regions and premium shaving systems, both of which have higher than segment average selling prices. Male Blades and Razors volume was down low single digits as market contractions and market share losses in developed regions were partially offset by initiative-driven growth in developing regions. Volume declines in premium shaving systems were mostly offset by growth in lower priced systems and disposables. Global market share of the blades and razors category was down nearly 2 points to about 70%. Male Personal Care volume declined high single digits behind increased competitive promotional activity on shave preparation products and distribution declines on Tag deodorants. Braun volume decreased low single digits behind a double-digit decline in developing regions mainly due to market contractions. Global market share of the dry shaving category was up about half a point to 33%. Net earnings increased 10% to $433 million for the quarter due to net sales growth and operating margin expansion, partially offset by a higher tax rate. Gross margin increased mainly due to price increases and lower commodity costs. SG&A as a percentage of net sales was up mainly due to higher foreign currency exchange costs, mostly offset by overhead spending reductions and marketing spending efficiencies. Grooming net sales were down 4% to $4.0 billion fiscal year to date on a 5% decline in unit volume. Organic sales declined 1%. Price increases, taken primarily in developing regions to offset currency devaluations and across premium shaving systems, added 5% to net sales. Product mix had a negative 1% impact on net sales due to disproportionate volume decline of premium shaving systems, which have higher than segment average selling prices. Unfavorable foreign exchange reduced net sales by 3%. Volume in Blades and Razors was down mid-single digits mainly due to market contractions and market share losses in developed regions. A mid-single-digits increase of Gillette Fusion volume was more than offset by the continued double-digit decline of Mach3 volume. Global market share of the blades and razors category was down nearly 2 points to 70%. Volume in Male Personal Care declined high single digits primarily behind increased competitive promotional activity on shave preparation products and distribution declines on Tag deodorants. Volume in Braun was down high single digits due mostly to market contractions, particularly in home and hair care appliances. Global market share of the dry shaving category was down about half a point to approximately 34%. Net earnings were $784 million fiscal year to date, a decrease of 6% versus the comparable prior year period behind operating margin contraction and net sales decline. Operating margin decreased due to higher SG&A as a percentage of net sales, partially offset by an increase in gross margin due to price increases and lower commodity costs. The increase in SG&A as a percentage of net sales was driven by higher foreign currency exchange costs, partially offset by lower marketing and overhead spending as a percentage of net sales. HEALTH AND WELL-BEING GBU Health Care Health Care net sales were up 5% for the quarter to $3.1 billion on a 3% increase in unit volume. Organic sales grew 2%. Favorable foreign exchange and positive pricing impacts added 3% and 1%, respectively to net sales growth. These impacts were partially offset by a 2% negative mix impact resulting from disproportionate growth in developing regions and unfavorable product mix. Volume in developing regions grew high single digits, while developed regions grew low single digits. Personal Health Care volume increased mid-single digits behind double-digit growth of Vicks due to higher cold and flu levels and double-digit growth of diagnostics products, partially offset by a double-digit decline of Prilosec OTC in North America due to increased competitive activity. Feminine Care volume was up low single digits due mainly to growth in the CEEMEA and Asia regions, partially offset by market share losses in Latin America following price increases. Global market share of the feminine care category was down about 1 point to 35%. Oral Care volume grew mid-single digits behind initiative-driven growth in Western Europe, Latin America and Asia and trade inventory reductions in the base period, partially offset by a decline in North America. Net earnings grew 8% in the quarter to $534 million on higher net sales and operating margin expansion. Gross margin increased mainly due to price increases, lower commodity costs and manufacturing cost savings. SG&A as a percentage of net sales increased primarily due to higher foreign currency exchange costs and higher overhead and marketing spending to fund investments in business growth. Health Care net sales fiscal year to date were consistent with the prior year period at $6.1 billion. Organic sales increased 3%. Unit volume increased 1% driven by growth of Personal Health Care and Oral Care. Price increases, taken mainly in developing regions to offset currency devaluations, added 2% to net sales. Unfavorable foreign exchange reduced net sales by 3%. Personal Health Care volume was up low singles digits driven by mid-single-digit growth of Vicks due to higher cold and flu levels and double-digit growth of diagnostic products, partially offset by a high-single-digit decline of Prilosec OTC in North America due to increased competitive activity. Oral Care volume increased low single digits behind initiative activity in Western Europe, Latin America and Asia. Feminine Care volume was in line with the prior year period as growth of Always and Naturella was offset by lower shipments of Tampax. Global market share of the feminine care category was down about 1 point to 35%. Net earnings were $1.1 billion fiscal year to date, an increase of 9% versus the prior year period behind operating margin expansion. Operating margin was up due to higher gross margin and lower SG&A as a percentage of net sales. Gross margin expanded behind price increases, lower commodity costs and manufacturing cost savings. SG&A as a percentage of net sales declined mainly due to lower marketing spending, partially offset by higher foreign currency exchange costs and overhead spending. Snacks and Pet Care Snacks and Pet Care net sales increased 6% to $835 million for the quarter on a 1% increase in unit volume. Organic sales increased 3%. The carryover impact of pricing to recover higher commodity costs added 5% to net sales. This was partially offset by negative mix impacts of 2% driven by the discontinuation of premium snack products which had higher than segment average selling prices. Favorable foreign exchange contributed 2% to net sales growth. Volume in Snacks declined low single digits driven by lower merchandising activity in North America and the discontinuation of some premium snack products. Volume in Pet Care increased mid-single digits behind continued success of product initiatives and increased promotional activity. Net earnings increased 56% versus the prior year period to $98 million behind gross margin expansion, net sales growth and a lower tax rate due to geographic mix of earnings, partially offset by higher SG&A as a percentage of net sales. Gross margin increased due to price increases, lower commodity costs and manufacturing cost savings. SG&A as a percentage of net sales increased mainly due to higher marketing spending. Snacks and Pet Care net sales decreased 1% fiscal year to date to $1.6 billion on a 5% decline in unit volume. Organic sales were consistent with the prior year period. Price increases, taken primarily to offset high commodity costs, added 5% to net sales. Unfavorable foreign exchange reduced net sales by 1%. Volume in Snacks was down double-digits behind share losses and market contractions. Global market share of the snacks category was down about 1 point to approximately 9%. Share losses were driven primarily by lower merchandising activity in North America following the Super Stacks initiative and the discontinuation of some premium snack products. Volume in Pet Care increased low single digits due to continued success of product initiatives and increased promotional activity. Net earnings increased 46% to $172 million fiscal year to date behind higher operating margins and a lower tax rate. Operating margin expanded mainly due to higher gross margin driven by price increases, commodity cost declines and manufacturing cost savings, partially offset by higher SG&A as a percentage of net sales due to increased marketing and HOUSEHOLD CARE GBU Fabric Care and Home Care Fabric Care and Home Care net sales grew 9% in the second fiscal quarter to $6.3 billion on an 8% increase in unit volume. Organic sales increased 7%. Price declines to improve consumer value reduced net sales by 1%. Favorable foreign exchange added 2% to net sales growth. All major brands contributed to volume growth for the segment. Fabric Care volume increased high single digits mainly due to a low base period, which included trade inventory reductions, and initiative-driven growth in the current period. Volume growth was broad-based in Fabric Care with growth in all regions. Home Care volume grew double digits due to initiative activity in all regions, market growth in North America and CEEMEA and trade inventory reductions in the prior year period. Batteries volume increased low single digits due to market growth in developing regions and trade inventory reductions in the prior year period. Net earnings grew 47% to $965 million primarily due to operating margin expansion, net sales growth and lower tax rate. Operating margin expanded behind improved gross margins, partially offset by higher SG&A as a percentage of net sales. Gross margin increased behind manufacturing cost savings and lower commodity costs. SG&A as a percentage of net sales was up due to an increase in marketing spending, partially offset by lower overhead spending as a percentage of net sales driven by scale leverage. Fabric Care and Home Care net sales increased 1% to $12.4 billion fiscal year to date on a 3% increase in unit volume. Organic sales grew 4%. Price increases added 1% to net sales growth as the carry over impact of prior period price increases taken primarily in developing regions to offset currency devaluations was partially offset by more recent price reductions to improve consumer value. Unfavorable foreign exchange reduced net sales by 3%. Fabric Care volume increased low single digits behind new product launches and growth in Western Europe from incremental merchandising activity, partially offset by market share loss. Global market share of the fabric care category was down about 1 point. Home Care volume increased high single digits mainly due to new product launches and market growth. Global market share of the home care category was up half a point to 17%. Batteries volume was down low single digits primarily due to market share losses in North America and Western Europe. Global market share of the general purpose batteries category was down over half a point to about 27%. Net earnings increased 33% to $2.0 billion due to increased operating margin, a lower tax rate and higher net sales. Operating margin expanded due to higher gross margin, partially offset by higher SG&A as a percentage of net sales. Gross margin increased due to lower commodity costs, price increases and manufacturing cost savings. SG&A as a percentage of net sales increased due to higher marketing spending and increased foreign currency exchange costs, partially offset by lower overhead spending. Baby Care and Family Care Baby Care and Family Care net sales increased 10% to $3.8 billion for the quarter on 10% volume growth. Organic sales grew 8%. Negative mix impacts due to a shift toward larger count packages, which have lower than segment average selling prices, reduced net sales by 2%. Favorable foreign exchange added 2% to net sales growth. Baby Care volume was up high single digits behind incremental initiative activity and merchandising support, as well as market growth. Family Care volume grew double digits due to initiatives launched in the previous quarter and incremental merchandising activity. U.S. all-outlet value share of the family care category increased over 1%. Net earnings were up 39% for the quarter to $579 million on gross margin expansion and net sales growth, partially offset by higher SG&A as a percentage of net sales. Gross margin increased behind lower commodity costs and manufacturing cost savings. SG&A as a percentage of net sales were up due to higher foreign currency exchange costs and higher marketing spending as a percentage of net sales. Baby Care and Family Care net sales grew 2% to $7.4 billion fiscal year to date on 4% volume growth. Organic sales increased 5%. Price increases added 1% to net sales growth as the carryover impact of price increases taken primarily in developing regions to offset currency devaluations was partially offset by more recent price reductions to improve consumer value. Negative product mix reduced net sales by 1%. Unfavorable foreign exchange reduced net sales by 2%. Volume in Baby Care increased mid-single digits behind incremental initiative activity and merchandising support, as well as market growth. Volume in Family Care grew mid-single digits due to market growth and volume share gains driven by increased merchandising and initiative activity. Family Care U.S. value share was up nearly half a point to about 33%. Net earnings increased 22% to $1.1 billion behind operating margin expansion and net sales growth. Operating margin expansion was driven by higher gross margin, partially offset by higher SG&A as a percentage of net sales. Gross margin increased behind lower commodity costs, price increases and manufacturing cost savings. SG&A as a percentage of net sales was up due to higher foreign currency exchange costs, increased overhead spending and incremental marketing investments. CORPORATE Corporate includes certain operating and non-operating activities not allocated to specific business units. These include: the incidental businesses managed at the corporate level; financing and investing activities; other general corporate items; the historical results of certain divested brands and categories; and certain restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce rationalization. Corporate also includes reconciling items to adjust the accounting policies used in the segments to U.S. GAAP. The most significant reconciling items include income taxes (to adjust from statutory rates that are reflected in the segments to the overall Company effective tax rate), adjustments for unconsolidated entities (to eliminate sales, cost of products sold and SG&A for entities that are consolidated in the segments but accounted for using the equity method for U.S. GAAP) and noncontrolling interest adjustments for subsidiaries where we do not have 100% ownership. Since both unconsolidated entities and less than 100% owned subsidiaries are managed as integral parts of the Company, they are accounted for similar to a wholly owned subsidiary for management and segment purposes. This means our segment results recognize 100% of each income statement component through before-tax earnings, with eliminations for unconsolidated entities in Corporate. In determining segment after-tax net earnings, we apply the statutory tax rates (with adjustments to arrive at the Companys effective tax rate in Corporate) and eliminate the share of earnings applicable to other ownership interests, in a manner similar to noncontrolling interest. For the Corporate segment, net expenses from continuing operations increased $300 million to $336 million for the quarter. The increase in net expenses was driven primarily by the $267 million charge for potential competition law fines, higher foreign currency exchange costs and higher net tax costs due to the impacts of tax adjustments required to reconcile the statutory rates reflected in the business segments to the overall Company effective tax rate, partially offset by lower interest expense. Fiscal year to date, net expenses from continuing operations increased $577 million. The increase was primarily due to the charge for potential competition law fines, higher foreign currency exchange costs, higher net tax costs due to the impact of tax adjustments required to reconcile the statutory rates reflected in the business segments to the overall Company effective tax rate and higher prior period divestiture gains, partially offset by lower interest expense. FINANCIAL CONDITION Operating Activities We generated $7.8 billion of cash from operating activities for the fiscal year to date period, an increase of 39% versus the comparable prior year period mainly due to changes in working capital required to support the business, partially offset by lower net earnings. Working capital reductions versus June contributed $847 million to operating cash flow primarily due to an increase in accounts payable, accrued and other liabilities behind higher current period accruals and an increase in taxes payable, partially offset by increased accounts receivable. Accounts receivable levels increased primarily due to higher net sales versus the June quarter. Cash flow from discontinued operations contributed $285 million to operating cash flow. Investing Activities Our investing activities generated cash of $1.6 billion fiscal year to date, an increase of $2.3 billion versus the prior year period mainly due to higher proceeds from divestitures. Proceeds from asset sales increased $2.0 billion due to receipts from the sales of the global pharmaceuticals business, including Actonel in Japan, partially offset by receipts in the prior year period related to the Folgers, Thermacare and other minor brand divestitures. Capital expenditures were $1.3 billion fiscal year to date or 3.1% of net sales. Acquisitions consumed $70 million of cash primarily to fund the purchase of MDVIP, a physicians network focused on preventative medicine. Financing Activities We used $10.3 billion fiscal year to date to fund financing activities. This represents an increase of $8.0 billion versus the prior year period driven mainly by the retirement of debt, partially offset by a reduction in treasury stock purchases. Current year net repayments of debt used $6.6 billion, while dividends to shareholders increased to $2.7 billion. We resumed our share repurchase program during the second fiscal quarter and expect to repurchase about $5 billion during fiscal 2010. As of December 31, 2009, our current liabilities exceeded current assets by $1.9 billion. We have short- and long-term debt to fund discretionary items such as acquisitions and share repurchase programs. We anticipate being able to support our short-term liquidity and operating needs largely through cash generated from operations. We have strong short- and long-term debt ratings which have enabled and should continue to enable us to refinance our debt as it becomes due at favorable rates in commercial paper and bond markets. In addition, we have agreements with a diverse group of financial institutions that, if needed, should provide sufficient credit funding to meet short-term financing requirements. RECONCILIATION OF NON-GAAP MEASURES Our discussion of financial results includes several measures not defined by U.S. GAAP. We believe these measures provide our investors with additional information about the underlying results and trends of the Company, as well as insight to some of the metrics used to evaluate management. When used in MD&A, we have provided the comparable GAAP measure in the discussion. Organic Sales Growth: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions, divestitures and foreign exchange from year-over-year comparisons. We believe this provides investors with a more complete understanding of underlying sales trends by providing sales growth on a consistent basis. The reconciliation of reported sales growth to organic sales for the October - December quarter: Acquisition/ Divestiture Impact* Fabric Care and Home Care Baby Care and Family Care The reconciliation of reported sales growth to organic sales for the fiscal year to date period: Acquisition/ Divestiture Impact* Fabric Care and Home Care Baby Care and Family Care Acquisition/Divestiture Impacts includes rounding impacts necessary to reconcile net sales to organic sales. Free Cash Flow: Free cash flow is defined as operating cash flow less capital spending. We view free cash flow as an important measure because it is one factor in determining the amount of cash available for dividends and discretionary investment. Free cash flow is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation. Free Cash Flow Productivity: Free cash flow productivity is defined as the ratio of free cash flow to net earnings. The Companys long-term target is to generate free cash at or above 90 percent of net earnings. Free cash flow is also one of the measures used to evaluate senior management. The reconciliation of free cash flow and free cash flow productivity is provided below (amounts in Free Cash Flow Productivity",4936
2010-01-29,8-K,0001193125-10-017029,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) January 29, 2010 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (513) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) TABLE OF CONTENTS ITEM 8.01 OTHER EVENTS SIGNATURE",171
2010-02-08,8-K,0000080424-10-000012,"to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 of Report (Date of earliest event reported) name of registrant as specified in its Procter & Gamble Plaza, Cincinnati, Ohio of principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR February 8, 2010, The Procter & Gamble Company (the Company) closed an underwritten public offering of $1,250,000,000 aggregate principal amount of 1.375% Notes due 2012 under the Companys Registration Statement on Form S-3 (Registration No. 333-161767) (the Registration Statement). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are",140
2010-02-18,8-K,0000080424-10-000014,"13 OR 15(d) of The Securities Exchange Act Of 1934 of registrant as specified in its & Gamble Plaza, Cincinnati, Ohio principal executive offices) telephone number, including area code) communications pursuant to Rule 425 under the Securities Act (17 CFR material pursuant to Rule 14a-12 under the Exchange Act (17 CFR communications pursuant to Rule 14d-2(b) under the Exchange communications pursuant to Rule 13e-4(c) under the Exchange ITEM 7.01 REGULATION FD 18, 2010 The Procter & Gamble Company (the ""Company"") issued a news release with regard to the Company's remarks made at the Consumer Analyst Group of New York annual conference today. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. Release by The Procter & Gamble Company dated February 18,",152
2010-04-19,8-K,0000080424-10-000023,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On April 18, 2010, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of $0.4818 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after May 17, 2010 to shareholders of record at the close of business on April 30, 2010. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",196
2010-04-20,8-K,0000080424-10-000024,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 5.02(b) DEPARTURE OF DIRECTORS On April 19, 2010, Charles R. Lee and Ralph Snyderman retired from The Procter & Gamble Company (the ""Company"") Board of Directors (the ""Board"") in accordance with the Board's customary retirement age for directors as set forth in the Board's Corporate Governance Guidelines. As a result of these retirements, the Board has designated Patricia A. Woertz as the new Chair of the Audit Committee and Scott D. Cook as the new Chair of the Innovation & Technology Committee. The Company is filing this 8-K pursuant to Item 5.02(b), ""Departure of Directors.""",209
2010-04-22,8-K,0000080424-10-000026,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGES IN FISCAL YEAR. On April 18, 2010, the Board of Directors of The Procter & Gamble Company (the Company) approved and adopted a series of amendments to the Companys Code of Regulations (the Regulations) effective immediately. The Board approved these amendments pursuant to authority granted by shareholders at the Annual Meeting of Shareholders held on October 13, 2009. The Board amended Article II, Section 8 of the Regulations to add an advance notice provision. Pursuant to this amendment, if a shareholder wishes to present either (1) a proposal relating to director nominations or (2) a proposal relating to a matter other than director nominations, other than a proposal offered pursuant to Rule 14a-8 of the Securities Exchange Act of 1934, the shareholder must comply with the procedures contained in Article II, Section 8 of the amended Regulations. These procedures include timely notice to the Company Secretary of such proposal, specific requirements as to the form of notice and content of the proposal, and detailed disclosures regarding the shareholders ownership and voting interests in Company securities as well as descriptions of all agreements, arrangements and understandings betwe en the proposing shareholder and other shareholders. For a notice to be timely with respect to shareholder nominations of directors, a proposal must be received by the Company Secretary no later than 140 days prior to the one year anniversary of the preceding years annual meeting and no earlier than 240 days prior to that date. For a notice to be timely with respect to any other business, a proposal must be received by the Company Secretary no later than 90 days prior to the one year anniversary of the preceding years annual meeting and no earlier than 240 days prior to that date. The advance notice provision sets different deadlines if an annual meeting is scheduled for more than 30 days before or more than 60 days after the one year anniversary date of the previous years annual meeting. The amended Regulations also establish procedures for special meetings of shareholders. Indemnification Provision The Board amended Article III, Section 8 to address Company indemnification of all employees. In addition, the Board revised the standards for Company indemnification to be more consistent with Ohio General Corporation Law. Administrative / Ministerial Provisions The Board approved and adopted amendments to a number of other provisions to update and modernize the Regulations, including: Article I  Eliminated reference to Company seal Article II  Authorized virtual shareholder meetings, and enhanced flexibility for setting the date for the annual meeting, providing notice to shareholders and establishing the order of business for meetings Article III  Increased flexibility for setting and providing notice for regular Board meetings Article IV  Updated officer titles and procedures for officer elections, terms and removals Article V  Updated officer titles and duties The foregoing descriptions of the Regulations are qualified in their entirety by reference to the actual Code of Regulations of The Procter & Gamble Company, which is filed as Exhibit 3.ii to this Form 8-K and is hereby incorporate by reference. The Company is filing this 8-K pursuant to Item 5.03, "" Amendments to Articles of Incorporation or Bylaws; Changes in Fiscal Year .""",654
2010-04-29,8-K,0000080424-10-000028,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) ( Registrant's telephone number, including area code ) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On April 29, 2010, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended March 31, 2010. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",165
2010-04-30,10-Q,0001193125-10-101892,"SECURITIES AND EXCHANGE COMMISSION QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2010 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission file number 1-434 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No  Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No  Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Large accelerated filer  Accelerated filer  Non-accelerated filer  Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No  There were 2,879,904,226 shares of Common Stock outstanding as of March 31, 2010. PART I. FINANCIAL INFORMATION Financial Statements. The Consolidated Statements of Earnings of The Procter & Gamble Company and subsidiaries (the Company, we or our) for the three months and nine months ended March 31, 2010 and 2009, the Consolidated Balance Sheets as of March 31, 2010 and June 30, 2009, and the Consolidated Statements of Cash Flows for the nine months ended March 31, 2010 and 2009 follow. In the opinion of management, these unaudited Consolidated Financial Statements contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, such financial statements may not necessarily be indicative of annual results. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS Three Months Ended March 31 Amounts in millions except per share amounts Selling, general and administrative expense Other non-operating income, net Earnings from Continuing Operations Before Income Taxes Net Earnings from Continuing Operations Net Earnings from Discontinued Operations Basic net earnings from continuing operations Basic net earnings from discontinued operations Diluted net earnings from continuing operations Diluted net earnings from discontinued operations Diluted Weighted Average Common Shares Outstanding 3,172.9 See accompanying Notes to Consolidated Financial Statements Certain amounts for prior periods were reclassified to conform with the fiscal 2010 THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS Cash and cash equivalents Prepaid expenses and other current assets PROPERTY, PLANT AND EQUIPMENT Total property, plant and equipment NET PROPERTY, PLANT AND EQUIPMENT GOODWILL AND OTHER INTANGIBLE ASSETS Trademarks and other intangible assets, net NET GOODWILL AND OTHER INTANGIBLE ASSETS LIABILITIES AND SHAREHOLDERS EQUITY Accrued and other liabilities TOTAL CURRENT LIABILITIES OTHER NON-CURRENT LIABILITIES Common stock - shares issued - Additional paid-in capital Reserve for ESOP debt retirement Accumulated other comprehensive income (loss) TOTAL SHAREHOLDERS EQUITY TOTAL LIABILITIES AND SHAREHOLDERS EQUITY See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD Depreciation and amortization Share-based compensation expense Gain on sale of businesses Accounts payable, accrued and other liabilities Other operating assets and liabilities TOTAL OPERATING ACTIVITIES Proceeds from asset sales Acquisitions, net of cash acquired TOTAL INVESTING ACTIVITIES Dividends to shareholders Change in short-term debt Additions to long-term debt Reductions of long-term debt Impact of stock options and other TOTAL FINANCING ACTIVITIES EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS CHANGE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, END OF PERIOD See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS These statements should be read in conjunction with the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2009, as updated by the Companys Form 8-K filed on January 29, 2010. The results of operations for the three-month and nine-month periods ended March 31, 2010 are not necessarily indicative of annual results. Comprehensive Income - Total comprehensive income is comprised primarily of net earnings, net currency translation gains and losses, impacts of net investment and cash flow hedges, net unrealized gains and losses on investment securities and defined benefit and other retiree benefit plan activities. Total comprehensive income for the three months ended March 31, 2010 and 2009 was $772 million and $504 million, respectively. For the nine months ended March 31, 2010 and 2009, total comprehensive income was $9,860 million and $2,896 million, respectively. Segment Information - Effective July 1, 2009, we implemented a number of changes to the organization structure of the Beauty GBU, which resulted in changes to the components of our reportable segment structure. Female blades and razors were formerly included in the Grooming reportable segment and are now included in the Beauty reportable segment. Certain male-focused brands and businesses, such as Old Spice and Gillette personal care, moved from the Beauty reportable segment to the Grooming reportable segment. In addition, the Beauty GBU was renamed the Beauty and Grooming GBU. These changes have been reflected in our segment reporting for all periods presented. As discussed in Note 10, certain divested businesses are presented as discontinued operations and are excluded from segment results for all periods presented. Following is a summary of segment results. Three Months Ended March 31 Nine Months Ended March 31 from Continuing Operations Before Earnings from Continuing Operations from Continuing Operations Before Earnings from Continuing Operations Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Goodwill and Other Intangible Assets - Goodwill as of March 31, 2010 is allocated by reportable segment and global business unit as follows (amounts in millions): Beauty, beginning of year Acquisitions and divestitures Grooming, beginning of year Acquisitions and divestitures Health Care, beginning of year Acquisitions and divestitures Snacks and Pet Care, beginning of year Acquisitions and divestitures Fabric Care and Home Care, beginning of year Acquisitions and divestitures Baby Care and Family Care, beginning of year Acquisitions and divestitures Corporate, beginning of year Acquisitions and divestitures GOODWILL, beginning of year Acquisitions and divestitures The decrease in goodwill from June 30, 2009 is primarily due to the divestiture of the Pharmaceuticals business and currency translation, partially offset by the acquisition of MDVIP, a physicians network focused on preventative medicine. Identifiable intangible assets as of March 31, 2010 are comprised of (amounts in millions): Amortizable intangible assets with determinable lives Intangible assets with indefinite lives Total identifiable intangible assets Amortizable intangible assets consist principally of brands, patents, technology and customer relationships. The non-amortizable intangible assets consist primarily of brands. The amortization of intangible assets for the three months ended March 31, 2010, and 2009 was $147 million and $149 million, respectively. For the nine months ended March 31, 2010 and 2009 the amortization of intangible assets was $435 million and $459 million, respectively. The Company provides awards of equity instruments in exchange for employee services provided. Total share-based compensation for the three months and nine months ended March 31, 2010 and 2009 are summarized in the following table (amounts in millions): Total share-based compensation Assumptions utilized in the model are evaluated and revised, as necessary, to reflect market conditions and experience. Postretirement Benefits - The Company offers various postretirement benefits to its employees. The components of net periodic benefit cost are as follows: Expected return on plan assets Amortization of deferred amounts Recognized net actuarial loss Gross benefit cost (credit) Dividends on ESOP preferred stock Net periodic benefit cost (credit) Expected return on plan assets Amortization of deferred amounts Recognized net actuarial loss Gross benefit cost (credit) Dividends on ESOP preferred stock Net periodic benefit cost (credit) For the year ending June 30, 2010, the expected return on plan assets is 7.1% and 9.3% for pension and other retiree benefit plans, respectively. Risk Management Activities and Fair Value Measurements As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. We evaluate exposures on a centralized basis to take advantage of natural exposure netting and correlation. To the extent we choose to manage volatility associated with the net exposures, we enter into various financial transactions which we account for using the applicable accounting guidance for derivative instruments and hedging activities. These financial transactions are governed by our policies covering acceptable counterparty exposure, instrument types and other hedging practices. At inception, we formally designate and document qualifying instruments as hedges of underlying exposures. We formally assess, both at inception and at least quarterly, whether the financial instruments used in hedging transactions are effective at offsetting changes in either the fair value or cash flows of the related underlying exposure. Fluctuations in the value of these instruments generally are offset by changes in the fair value or cash flows of the underlying exposures being hedged. This offset is driven by the high degree of effectiveness between the exposure being hedged and the hedging instrument. The ineffective portion of a change in the fair value of a qualifying instrument is immediately recognized in earnings. The amount of ineffectiveness recognized is immaterial for all periods presented. For additional details on the Companys risk management activities, refer to the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2009, as updated by the Companys Form 8-K filed on January 29, 2010. Fair Value Hierarchy Accounting guidance on fair value measurement for certain financial assets and liabilities requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs reflecting the reporting entitys own assumptions or external inputs from inactive markets. In valuing assets and liabilities, we are required to maximize the use of quoted market prices and minimize the use of unobservable inputs. We calculate the fair value of our Level 1 and Level 2 instruments based on the exchange traded price of similar or identical instruments where available or based on other observable instruments. The fair value of our Level 3 instruments is calculated as the net present value of expected cash flows based on externally provided inputs. These calculations take into consideration the credit risk of both the Company and our counterparties. The Company has not changed its valuation techniques in measuring the fair value of any financial assets and liabilities during the period. The following table sets forth the Companys financial assets and liabilities as of March 31, 2010 and June 30, 2009 that are measured at fair value on a recurring basis during the period, segregated by level within the fair value hierarchy: Other foreign currency instruments Total assets at fair value Liabilities at fair value: Other foreign currency instruments Total liabilities at fair value The other foreign currency instruments are comprised of foreign currency financial instruments that do not qualify as hedges. All derivative assets are presented in prepaid expenses and other current assets or other non-current assets, and investment securities are presented in other All liabilities are presented in accrued and other liabilities or other non-current liabilities. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each quarter. The table below sets forth a reconciliation of the Companys beginning and ending Level 3 financial assets and liabilities balances for the period June 30, 2009 to March 31, 2010. Total gains or (losses) (realized/unrealized) included in earnings (or changes in net assets) Total gains or (losses) (realized/unrealized) included in OCI Net purchases, issuances and settlements Transfers in/(out) of Level 3 Certain of the Companys financial instruments used in hedging transactions are governed by industry standard netting agreements with counterparties. If the Companys credit rating were to fall below the levels stipulated in the agreements, the counterparties could demand either collateralization or termination of the arrangements. The aggregate fair value of the instruments covered by these contractual features that are in a net liability position as of March 31, 2010 was $270 million. The Company has never been required to post any collateral as a result of these contractual features. On July 1, 2009, we adopted the provisions of the fair value measurement accounting and disclosure guidance related to non-financial assets and liabilities recognized or disclosed at fair value on a nonrecurring basis. Assets and liabilities subject to this new guidance primarily include goodwill and indefinite-lived intangible assets measured at fair value for impairment assessments, long-lived assets measured at fair value for impairment assessments and non-financial assets and liabilities measured at fair value in business combinations. The adoption of this new guidance did not have a material effect on our financial position, results of operations or cash flows for the periods presented. There were no significant assets or liabilities that were measured at fair value on a non-recurring basis during the nine months ended March 31, 2010. Fair Values of Other Financial Instruments Other financial instruments, including cash equivalents, other investments and short-term debt, are recorded at cost, which approximates fair value. The fair value of the long-term debt was $24,309 million and $21,514 million at March 31, 2010 and June 30, 2009, respectively. Disclosures about Derivative Instruments The fair values and amounts of gains and losses on qualifying and non-qualifying financial instruments used in hedging transactions as of, and for the three and nine-month periods ended, March 31, 2010 are as follows: Fair Value Asset (Liability) Derivatives in Cash Flow Hedging Relationships Foreign currency contracts Derivatives in Fair Value Hedging Relationships Derivatives in Net Investment Hedging Relationships Derivatives Not Designated as Hedging Instruments Foreign currency contracts Amount of Gain (Loss) Recognized in OCI on Derivatives (Effective Portion) Derivatives in Cash Flow Hedging Relationships Foreign currency contracts Derivatives in Net Investment Hedging Relationships Gain (Loss) Recognized in Debt on Derivatives (Effective Portion) Derivatives in Fair Value Hedging Relationships Amount of Gain (Loss) Reclassified from Accumulated OCI into Derivatives in Cash Flow Hedging Relationships Foreign currency contracts Amount of Gain (Loss) Recognized in Income Derivatives in Fair Value Hedging Relationships Derivatives in Net Investment Hedging Relationships Derivatives Not Designated as Hedging Instruments Foreign currency contracts The gain or loss on the effective portion of cash flow hedging relationships that is reclassified from accumulated OCI into income is included in the Consolidated Statements of Earnings as follows: interest rate contracts in interest expense, foreign currency contracts in selling, general and administrative expense and interest expense and commodity contracts in cost of products sold. The gain or loss on the ineffective portion of interest rate contracts and net investment hedges, if any, is included in the Consolidated Statements of Earnings in The gain or loss on foreign currency contracts not designated as hedging instruments is included in the Consolidated Statements of Earnings in selling, general and administrative expense. During the next 12 months, the amount of the March 31, 2010 OCI balance that will be reclassified to earnings is expected to be immaterial. In addition, the total notional amount of contracts outstanding at the end of the period is indicative of the level of the Companys derivative activity during the period. New Accounting Pronouncements and Policies In December 2007, the Financial Accounting Standards Board (FASB) issued new accounting guidance on business combinations. The new guidance revises the method of accounting for a number of aspects of business combinations including acquisition costs, contingencies (including contingent assets, contingent liabilities and contingent purchase price) and post-acquisition exit activities of acquired businesses. The Company adopted the new guidance beginning July 1, 2009, and the adoption of the new guidance did not have a material effect on our financial position, results of operations or cash flows. In December 2007, the FASB also issued new accounting guidance on noncontrolling interests in consolidated financial statements. The new accounting guidance requires that a noncontrolling interest in the equity of a subsidiary be accounted for and reported as equity, provides revised guidance on the treatment of net income and losses attributable to the noncontrolling interest and changes in ownership interests in a subsidiary and requires additional disclosures that identify and distinguish between the interests of the controlling and noncontrolling owners. The Company retrospectively adopted the presentation and disclosure requirements of the new guidance on July 1, 2009. The adoption of the new guidance did not have a material effect on our financial position, results of operations or cash flows. Noncontrolling interests of $283 million at June 30, 2009 were reclassified from non-current liabilities to shareholders equity in the Consolidated Balance Sheet. Net expense for income attributable to the noncontrolling interest totaling $32 million and $29 million for the three months ended March 31, 2010 and 2009, respectively, and $93 million and $61 million for the nine months ended March 31, 2010 and 2009, respectively, are not presented separately in the Consolidated Statements of Earnings due to immateriality, but are reflected within other non-operating income, net. Net earnings represent net income attributable to the Companys common shareholders. No other new accounting pronouncement issued or effective during the fiscal year had or is expected to have a material impact on the Consolidated Financial Statements. Commitments and Contingencies We are subject to various legal proceedings and claims arising out of our business which cover a wide range of matters such as governmental regulations, antitrust and trade regulations, product liability, patent and trademark matters, income taxes and other actions. As previously disclosed, the Company is subject to a variety of investigations into potential competition law violations in Europe, as detailed in Part 2, Item 1, Legal Proceedings of this 10-Q. We believe these matters involve a number of other consumer products companies and/or retail customers. The Companys policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with investigations by relevant regulatory authorities, which the Company is doing. Competition and antitrust law inquiries often continue for several years and, if violations are found, can result in substantial fines. In response to the actions of the European Commission and national authorities, the Company launched its own internal investigations into potential violations of competition laws. The Company has identified violations in certain European countries and appropriate actions were taken. Three countries in Europe have issued separate complaints pursuant to their investigations alleging that the Company, along with several other companies, engaged in violations of competition laws in those countries. The Company will have the opportunity to respond to these complaints. As a result of our initial and on-going analyses of these complaints, the Company has taken appropriate reserves totaling $279 million fiscal year to date for potential fines for competition law violations. The remaining matters are in various stages of the investigatory process. It is still too early for us to reasonably estimate the total amount of fines to which the Company will be subject as a result of these various competition law issues. However, the ultimate resolution of these matters will likely result in fines or other costs in excess of amounts accrued to date that could materially impact our income statement and cash flows in the period in which they are accrued and paid, respectively. In other industries, these fines have amounted to hundreds of millions of dollars. We will continue to monitor developments for all of these investigations, and will record additional charges as appropriate. With respect to other litigation and claims, while considerable uncertainty exists, in the opinion of management and our counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows. We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will have a material adverse effect on our financial position, results of operations or cash flows. Income Tax Uncertainties P&G is present in over 150 taxable jurisdictions, and at any point in time has 50  60 audits underway at various stages of completion. We have tax years open ranging from 1997 and forward. We are generally not able to reliably estimate the ultimate settlement amounts or timing until the close of the audit. However, we evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and related reserves are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law, and closing of statute of limitations. Based on information currently available, we anticipate that over the next 12 month period, audit activity could be completed related to uncertain tax positions for which we have accrued existing liabilities of approximately $500 million. Additional information on the Commitments and Contingencies of the Company can be found in Note 10, Commitments and Contingencies, which appears in the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2009. Discontinued Operations In October 2009, the Company completed the divestiture of our global pharmaceuticals business to Warner Chilcott plc (Warner Chilcott) for $2.8 billion of cash, net of assumed and transferred liabilities. Under the terms of the agreement, Warner Chilcott acquired our portfolio of branded pharmaceutical products, our prescription drug product pipeline and manufacturing facilities in Puerto Rico and Germany. In addition, the majority of the employees working on the pharmaceuticals business were transferred to Warner Chilcott. The Company recorded an after-tax gain on the transaction of $1,464 million in the quarter ended December 31, 2009, which is included in net earnings from discontinued operations in the Consolidated Statements of Earnings for the nine-month period ended March 31, 2010. The pharmaceuticals business had historically been part of the Companys Health Care reportable segment. In accordance with the applicable accounting guidance for the disposal of long-lived assets, the results of the pharmaceuticals business are presented as discontinued operations and, as such, have been excluded from both continuing operations and segment results for all periods presented. In November 2008, the Company completed the divestiture of our coffee business through the merger of its Folgers coffee subsidiary into The J.M. Smucker Company (Smucker) in an all-stock reverse Morris Trust transaction. In connection with the merger, 38.7 million shares of common stock of the Company were tendered by shareholders and exchanged for all shares of Folgers common stock, resulting in an increase of treasury stock of $2,466 million. Pursuant to the merger, a Smucker subsidiary merged with and into Folgers and Folgers became a wholly owned subsidiary of Smucker. The Company recorded an after-tax gain on the transaction of $2,011 million in the quarter ended December 31, 2008, which is included in net earnings from discontinued operations in the Consolidated Statements of Earnings for the nine-month period ended March 31, 2009. The coffee business had historically been part of the Companys Snacks, Coffee and Pet Care reportable segment, as well as the coffee portion of our away-from-home business, which was included in the Fabric Care and Home Care reportable segment. In accordance with the applicable accounting guidance for the disposal of long-lived assets, the results of Folgers are presented as discontinued operations and, as such, have been excluded from both continuing operations and segment results for all periods presented. Following is selected financial information included in net earnings from discontinued operations for the pharmaceuticals and coffee businesses: Three months ended March 31 Earnings from discontinued operations Net earnings from discontinued operations Nine months ended March 31 Earnings from discontinued operations Gain on sale of discontinued operations Income tax benefit (expense) on sale Net earnings from discontinued operations The net gain on the sale of the pharmaceuticals business for the nine-month period ended March 31, 2010 includes an after-tax gain of $121 million on the sale of the Actonel brand in Japan. Managements Discussion and Analysis of Financial Condition and Results of Operations The purpose of this discussion is to provide an understanding of P&Gs financial results and condition by focusing on changes in certain key measures from year to year. Managements Discussion and Analysis (MD&A) is organized in the following sections: Forward-Looking Statements Results of Operations  Three Months Ended March 31, 2010 Results of Operations  Nine Months Ended March 31, 2010 Business Segment Discussion  Three and Nine Months Ended March 31, 2010 Reconciliation of Non-GAAP Measures Throughout MD&A, we refer to measures used by management to evaluate performance, including unit volume growth, net outside sales and after-tax profit. We also refer to organic sales growth, core EPS (earnings per share), free cash flow and free cash flow productivity. These financial measures are not defined under accounting principles generally accepted in the United States of America (U.S. GAAP). The explanation at the end of MD&A provides more details on the use and the derivation of these measures. Management also uses certain market share and market consumption estimates to evaluate performance relative to competition despite some limitations on the availability and comparability of such information. References to market share and market consumption in MD&A are based on a combination of vendor-reported consumption and market size data, as well as internal P&Gs business is focused on providing branded consumer goods products. Our purpose is to provide products and services of superior quality and value that improve the lives of the worlds consumers, now and for generations to come. We believe this will result in leadership sales, profits and value creation, allowing employees, shareholders and the communities in which we operate to prosper. Our products are sold in more than 180 countries primarily through mass merchandisers, grocery stores, membership club stores, drug stores and high frequency stores, the neighborhood stores which serve many consumers in developing markets. We continue to expand our presence in other channels including department stores, perfumeries, pharmacies, salons and e-commerce. We compete in multiple product categories and have three global business units (GBUs): Beauty and Grooming; Health and Well-Being; and Household Care. Under U.S. GAAP, the business units comprising the GBUs are aggregated into six reportable segments: Beauty; Grooming; Health Care; Snacks and Pet Care; Fabric Care and Home Care; and Baby Care and Family Care. We have on-the-ground operations in approximately 80 countries through our Market Development Organization, which leads country business teams to build our brands in local markets and is organized along five geographic units: North America, Western Europe, Central & Eastern Europe/Middle East/Africa (CEEMEA), Latin America and Asia, which is comprised of Japan, Greater China and ASEAN/Australia/India/Korea (AAIK). Throughout MD&A, we reference business results in developing markets, which we define as the aggregate of CEEMEA, Latin America, AAIK and Greater China, and developed markets, which are comprised of North America, Western Europe and Japan. Effective July 1, 2009, we implemented a number of changes to the organization structure of the Beauty GBU, which resulted in changes to the components of our reportable segment structure. Female blades and razors were formerly included in the Grooming reportable segment and are now included in the Beauty reportable segment. Certain male-focused brands and businesses, such as Old Spice and Gillette personal care, moved from the Beauty reportable segment to the Grooming reportable segment. In addition, the Beauty GBU was renamed the Beauty and Grooming GBU. These changes have been reflected in our segment reporting for all periods presented. On October 30, 2009, we sold our global pharmaceuticals business to Warner Chilcott plc (Warner Chilcott) for $2.8 billion. Under the terms of the agreement, Warner Chilcott acquired our portfolio of branded pharmaceuticals products, prescription drug product pipeline and manufacturing facilities in Puerto Rico and Germany. The pharmaceuticals business had historically been part of the Health Care reportable segment. In accordance with applicable accounting guidance for the disposal of long-lived assets, the results of the pharmaceuticals business are presented as discontinued operations and, as such, are excluded from continuing operations and from segment results. The table below provides more information about the components of our GBU structure. Hair Colorants, Shampoos and Conditioners Head & Shoulders, Pantene Hair Colorants, Shampoos and Conditioners Cosmetics, Deodorants, Female Blades and Razors, Personal Cleansing and Skin Care Fine Fragrances and Prestige Skin Care (SK II) Male Blades & Razors and Male Personal Care Products (Deodorants, Face and Shave Products, Hair Care, Personal Cleansing) Electric Hair Removal Devices and Home Appliances Feminine Pads and Tampons Personal Diagnostics, Digestive and Respiratory Health Products Oral Rinses, Toothbrushes and Toothpastes Fabric Care and Home Care Laundry Detergents and Fabric Softeners Air and Fabric Fresheners, Dishwashing Detergents, Hard Surface Cleaners Batteries and Personal Power Devices Baby Care and Family Care Bath Tissue, Facial Tissue and Paper Towels The following table provides the percentage of net sales and net earnings from continuing operations by reportable business segment for the three months ended March 31, 2010 (excludes net sales and net earnings in Corporate): Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care provides the percentage of net sales and net earnings from continuing operations by reportable business segment for the nine months ended March 31, 2010 (excludes net sales and net earnings in Corporate): Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Following are highlights of results for the nine months ended March 31, 2010: Net sales increased 2% versus the comparable prior year period to $60.0 billion. Organic sales, which exclude the impacts of acquisitions, divestitures and foreign exchange, grew 3%. Unit volume was up 3% versus the prior year period primarily behind growth in the Household Care GBU. Net earnings from continuing operations were $8.8 billion, an increase of 5% versus the prior year period due to net sales growth and operating margin expansion, partially offset by a higher effective tax rate. Net earnings were $10.6 billion, a decrease of 4% compared to the prior year period due to lower current period gains on the sale of discontinued operations. Diluted net earnings per share declined 2% versus the prior year period to $3.39, while diluted net earnings per share from continuing operations increased 7% to $2.82. Growth rates on a per share basis differ from those of net earnings due to share repurchase activity. Core EPS, which excludes certain tax, legal and restructuring charges, was $2.96, up 10%. Operating cash flow increased $2.8 billion versus the prior year period to $12.8 billion. Free cash flow, which is operating cash flow less capital expenditures, was $10.8 billion fiscal year to date. Free cash flow productivity, which is the ratio of free cash flow to net earnings, was 102%. FORWARD-LOOKING STATEMENTS We discuss expectations regarding future performance, events and outcomes, such as our business outlook and objectives, in annual and quarterly reports, press releases and other written and oral communications. All such statements, except for historical and present factual information, are forward-looking statements, and are based on financial data and our business plans available only as of the time the statements are made, which may become out-of-date or incomplete. We assume no obligation to update any forward-looking statements as a result of new information, future events or other factors. Forward-looking statements are inherently uncertain and investors must recognize that events could be significantly different from our expectations. For more information on risks that could impact our results, refer to Item 1A Risk Factors in our most recent 10-Q, 10-K and 8-K filings. Ability to Achieve Business Plans: We are a consumer products company and rely on continued demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers and retail trade customers. Our continued success is dependent on leading-edge innovation with respect to both products and operations and on the continued positive reputations of our brands. This means we must be able to obtain patents and respond to technological advances and patents granted to competition. Our success is also dependent on effective sales, advertising and marketing programs in an increasingly fragmented media environment. Our ability to innovate and execute in these areas will determine the extent to which we are able to grow existing sales and volume profitably, especially with respect to the product categories and geographic markets (including developing markets) in which we have chosen to focus. There are high levels of competitive activity in the environments in which we operate. To address these challenges, we must respond to competitive factors, including pricing, promotional incentives, trade terms and product initiatives. We must manage each of these factors, as well as maintain mutually beneficial relationships with our key customers, in order to effectively compete and achieve our business plans. As a company that manages a portfolio of consumer brands, our ongoing business model involves a certain level of ongoing acquisition and divestiture activities. We must be able to successfully manage the impacts of these activities, while at the same time delivering against base business objectives. Our success will also depend on our ability to maintain key information technology systems. Cost Pressures: Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, cost of labor, foreign exchange and interest rates. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects, sourcing decisions and certain hedging transactions. We also must manage our debt and currency exposure, especially in certain countries, such as Venezuela, China and India. We need to maintain key manufacturing and supply arrangements, including sole supplier and sole manufacturing plant arrangements. We must implement, achieve and sustain cost improvement plans, including our outsourcing projects and those related to general overhead and workforce optimization. Successfully managing these changes, including identifying, developing and retaining key employees, is critical to our success. Global Economic Conditions: Economic changes, terrorist activity and political unrest may result in business interruption, inflation, deflation or decreased demand for our products. Our success will depend, in part, on our ability to manage continued global political and/or economic uncertainty, especially in our significant geographic markets, as well as any political or economic disruption due to terrorist and other hostile activities. Regulatory Environment: Changes in laws, regulations and the related interpretations may alter the environment in which we do business. This includes changes in environmental, competitive and product-related laws, as well as changes in accounting standards and taxation requirements. Our ability to manage regulatory, tax and legal matters (including product liability, patent, intellectual property, competition law matters and tax policy) and to resolve pending legal matters within current estimates may impact our results. RESULTS OF OPERATIONS  Three Months Ended March 31, 2010 The following discussion provides a review of results for the three months ended March 31, 2010 versus the three months ended March 31, 2009. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended March 31 Selling, General & Administrative Expense Other Non-operating Income, Net Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Net Earnings From Discontinued Operations Effective Tax Rate  Continuing Operations Basic Net Earnings  Continuing Operations Basic Net Earnings  Discontinued Operations Diluted Net Earnings  Continuing Operations Diluted Net Earnings  Discontinued Operations Average Diluted Shares Outstanding Comparisons as a % of Net Sales Selling, General & Administrative Expense Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations ) Net sales increased 7% to $19.2 billion for the January - March quarter on a 7% increase in unit volume. Volume growth was broad-based with growth in all geographic regions, led by double-digit growth in developing regions. Five of the six business segments contributed to volume growth, led by double-digit growth in the Fabric Care and Home Care and the Baby Care and Family Care segments. Volume in the Beauty, Grooming and Health Care segments was up mid-single digits, while volume in the Snacks and Pet Care segment declined mid-single digits. Price decreases lowered net sales by 1% behind current period pricing investments to improve consumer value, partially offset by the impact of prior period increases taken in developing regions to offset currency devaluations. Negative mix reduced net sales by 2% due mainly to disproportionate growth in developing regions and mid-tier value products, both of which have lower than Company average selling prices. Favorable foreign exchange added 3% to net sales growth as key foreign currencies strengthened versus the U.S. dollar. Organic sales growth was 4% driven by a unit volume growth, partially offset by the impact of price decreases and negative mix. Net Sales Change Drivers 2010 vs. 2009 (Three Months with Acquisitions & Divestitures Volume excluding Acquisitions Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Sales percentage changes are approximations based on quantitative formulas that are consistently applied. Gross margin increased 290 basis points to 51.9% of net sales for the quarter. Manufacturing cost savings increased gross margin by approximately 190 basis points. Gross margin was also positively impacted by lower commodity and energy costs which contributed approximately 90 basis points of improvement. The benefit of volume scale leverage was offset by unfavorable product mix and lower pricing. Total selling, general and administrative expenses (SG&A) were $6.0 billion, up 15% versus the prior year period due to higher marketing and overhead spending. SG&A as a percentage of net sales increased 210 basis points due primarily to higher marketing spending as a percentage of net sales. Marketing spending as a percentage of net sales increased across all reportable segments behind additional investments to support business growth, partially offset by media rate savings. Interest expense was $223 million for the quarter, down $114 million versus the prior year period primarily due to a reduction in debt outstanding and lower interest rates on floating rate debt. Other non-operating income declined $17 million mainly due to gains on the sale of minor brands in the prior year period. The effective tax rate on continuing operations increased 600 basis points to 31.3% primarily due to a $152 million charge for recently enacted legislation which changed the taxation of certain future retiree prescription drug subsidy payments in the United States. Net earnings from continuing operations increased 6% for the quarter to $2.6 billion driven by margin expansion and net sales growth, partially offset by a higher tax rate. Operating margin expanded primarily due to an increase in gross margin, partially offset by an increase in SG&A as a percentage of net sales driven by increased marketing spending. Diluted net earnings per share from continuing operations were $0.83, up 6% versus the comparable prior year period. Net earnings from discontinued operations declined $184 million for the quarter primarily due to the loss of contribution from the global pharmaceuticals business which was divested at the end of October 2009. Net earnings decreased 1% for the quarter to $2.6 billion behind a decrease in net earnings from discontinued operations, partially offset by an increase in net earnings from continuing operations. Diluted net earnings per share were down 1% to $0.83. Core EPS, which is diluted net earnings per share from continuing operations excluding current period charges for pending European legal matters and recently enacted legislation which changed the taxation of certain future retiree prescription drug subsidy payments in the United States and incremental restructuring charges incurred in the prior period to offset the dilutive impact of the Folgers divestiture, was up 10% to $0.89 for the quarter. RESULTS OF OPERATIONS  Nine Months Ended March 31, 2010 The following discussion provides a review of results for the nine months ended March 31, 2010 versus the nine months ended March 31, 2009. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Nine Months Ended March 31 Selling, General & Administrative Expense Other Non-operating Income, Net Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Net Earnings From Discontinued Operations Effective Tax Rate  Continuing Operations Basic Net Earnings  Continuing Operations Basic Net Earnings  Discontinued Operations Diluted Net Earnings  Continuing Operations Diluted Net Earnings  Discontinued Operations Average Diluted Shares Outstanding Comparisons as a % of Net Sales Selling, General & Administrative Expense Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Net sales increased 2% versus the prior year period to $60.0 billion on a 3% increase in unit volume. Volume increased low single digits in developed regions and mid-single digits in developing regions. All geographic regions contributed to volume growth, led by mid-singledigits growth in Asia. Volume growth for the reportable segments was mixed, with low to mid-single-digit increases in the Fabric Care and Home Care, Baby Care and Family Care, Beauty and Health Care segments, partially offset by a mid-single-digit decline in the Snacks and Pet Care segment and a low single-digit decline in the Grooming segment. Price increases added 1% to net sales as increases taken primarily in developing regions to offset local currency devaluations were partially offset by more recent price reductions to improve consumer value. Unfavorable foreign exchange reduced net sales by 1% as many foreign currencies weakened versus the U.S. dollar, primarily in the first fiscal quarter. Mix reduced net sales by 1% behind disproportionate growth in developing regions, which have lower than Company average selling prices, and relatively weaker shipments of Professional Salon, Prestige, Personal Health Care and Pet Care, which have higher than Company average selling prices. Organic sales were up 3% led by mid-single-digits growth across the Net Sales Change Drivers 2010 vs. 2009 (Nine Months Ended Volume excluding Acquisitions Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Sales percentage changes are approximations based on quantitative formulas that are consistently applied. Gross margin increased 310 basis points versus the comparable prior year period to 52.8% of net sales. The combination of manufacturing cost savings and lower commodity and energy costs delivered approximately 300 basis points of the gross margin expansion. Gross margin also benefited from price increases and volume scale leverage, partially offset by unfavorable foreign exchange impacts and negative product and geographic mix. Total SG&A increased 8% to $18.6 billion due primarily to higher marketing and other operating expenses. SG&A as a percentage of net sales increased 180 basis points to 31.0% behind a 120 basis point increase in other operating expenses as a percentage of net sales and higher marketing spending as a percentage of net sales. Other operating expenses increased mainly due to Venezuela-related foreign currency exchange costs of $541 million (see further discussion in the following paragraph) and charges for potential competition law fines of $279 million. Marketing spending as a percentage of net sales was up as additional marketing investments were partially offset by media rate savings. Because of currency restrictions in Venezuela, payments for certain imported goods and services are satisfied by exchanging Bolivares fuertes for U.S. dollars through securities transactions in the parallel market rather than at the more favorable official exchange rate. At the discretion of management, these securities transactions can be utilized to manage exposure to currency movements on local cash balances. A reduction in the availability of foreign currency at the official exchange rate resulted in increased costs for exchange transactions executed using securities transactions in the parallel market during the current year. Interest expense was down $296 million versus the comparable prior year period, a decrease of 29% due primarily to lower interest rates on floating rate debt and a reduction in debt outstanding. Other non-operating income declined $288 million to $93 million mainly due to the impact of prior year gains on the sale of minor brands. The effective tax rate on continuing operations increased 320 basis points to 29.5% primarily due to a charge for recently enacted legislation which changed the taxation of certain future retiree prescription drug subsidy payments in the United States, lower current period audit settlements and foreign tax credits and the non-deductibility of the aforementioned charge for potential competition law fines. Net earnings from continuing operations were $8.8 billion, an increase of 5% versus the prior year period due mainly to operating margin expansion and net sales growth, partially offset by a tax rate increase. Operating margin was up due to an increase in gross margin, partially offset by an increase in SG&A as a percentage of net sales. Diluted net earnings per share from continuing operations increased 7% to $2.82. Net earnings from discontinued operations decreased $818 million to $1.8 billion due to lower gains on the sale of discontinued operations and a loss of contribution from the global pharmaceuticals business divested in October 2009. In the current year, we had a gain of $1.5 billion from the sale of the global pharmaceuticals business, as compared to the $2.0 billion prior year gain on the sale of the Folgers coffee business. Net earnings were down 4% versus the prior year period to $10.6 billion due to the decline in net earnings from discontinued operations, partially offset by an increase in net earnings from continuing operations. Diluted net earnings per share were down 2% to $3.39. Earnings per share growth rates differed from net earnings growth rates due to a reduction in the number of shares outstanding resulting from share repurchases. Core EPS, which is diluted net earnings per share from continuing operations excluding current period charges for pending European legal matters and recently enacted legislation which changed the taxation of certain future retiree prescription drug subsidy payments in the United States and the impact of incremental restructuring charges incurred in the prior period to offset the dilutive impact of the Folgers divestiture, was up 10% to $2.96 fiscal year to date. Foreign Currency Translation  Venezuela Impacts As of January 1, 2010, Venezuela has been designated as a highly inflationary economy under U.S. GAAP. As a result, beginning January 1, 2010, the U.S. dollar is the functional currency for our subsidiaries in Venezuela. Beginning in our third fiscal quarter, currency remeasurement adjustments for these subsidiaries financial statements and other transactional foreign exchange gains and losses will be reflected in earnings. Through December 31, 2009 (prior to being designated as highly inflationary), translation adjustments were reflected in Shareholders Equity as part of other comprehensive income. On January 8, 2010, the Venezuelan government announced its intention to devalue its currency (Bolivar fuerte) relative to the U.S. dollar. The official exchange rate for imported goods classified as essential, such as food and medicine, changed from 2.15 to 2.6, while payments for other non-essential goods moved to an exchange rate of 4.3. Some of our imported products fall into the essential classification and qualify for the 2.6 rate. However, our overall results in Venezuela are reflected in our consolidated financial statements at the 4.3 rate expected to be applicable to dividend repatriations. The remeasurement of our local balance sheets in the third fiscal quarter to reflect the impact of the devaluation did not materially impact our results. There will also be an ongoing impact related to measuring our income statement at the new exchange rates. Moving from the 2.15 rate to 4.3 will reduce future total company reported sales by less than 2% on a going basis. For the quarter ended March 31, 2010, the impact was approximately 1%. This does not impact our organic sales growth rate, which excludes the impact of foreign currency changes. Versus our existing business plans, the exchange rate change reduced our reported earnings per share by approximately $0.05 in the third fiscal quarter and is expected to reduce fourth quarter results by about $0.03 per share. This impact is net of the impact of devaluation on Venezuela-related foreign currency exchange costs. Going forward, the devaluation of the official rate has reduced the differential between the official and parallel exchange rate and is therefore expected to reduce the incremental cost of exchanging currencies through securities transactions in the parallel market. Over time, we intend to restore the sales and profit levels achieved prior to the devaluation. However, our ability to do so will be impacted by several factors, including the companys ability to take actions to mitigate the effect of the devaluation, further actions of the Venezuelan government, economic conditions in Venezuela such as inflation and consumer spending, the availability of raw materials, utilities and energy and the future state of exchange controls in Venezuela including the availability of U.S. dollars at the official foreign exchange rate. BUSINESS SEGMENT DISCUSSION  Three and Nine Months Ended March 31, 2010 The following discussion provides a review of results by business segment. Analyses of the results for the three and nine months ended March 31, 2010 are provided compared to the same three and nine month period ended March 31, 2009. The primary financial measures used to evaluate segment performance are net sales and net earnings from continuing operations. The table below provides supplemental information on net sales and net earnings from continuing operations by business segment for the three and nine months ended March 31, 2010 versus the comparable prior year periods (amounts in millions): Three Months Ended March 31, 2010 Earnings From Continuing Operations Before Income Taxes From Continuing Operations Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Nine Months Ended March 31, 2010 Earnings From Continuing Operations Before Income Taxes From Continuing Operations Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Beauty Beauty net sales increased 6% to $4.6 billion for the quarter on unit volume growth of 4%. Organic sales increased 2%. Price reductions, due mainly to strengthened trade programs in the CEEMEA region and in North American Hair Care to support innovation and maintain competitive consumer value, lowered net sales growth by 1%. Negative geographic mix reduced net sales by 1% due mainly to the disproportionate growth in developing regions where selling prices are below the segment average. Favorable foreign exchange contributed 4% to net sales growth. Volume growth was driven by double-digit growth in developing regions. Developed region volume was down low single digits. Hair Care volume was up mid-single digits driven by double-digit growth in developing regions, partially offset by low- single digit decline in developed regions. Overall hair care growth was driven by initiative activity and market size expansion with all major Hair Care brands contributing to volume growth. Market share of the global hair care category declined about half a point. Female Beauty volume grew mid-single digits primarily due to a double-digit increase in shipments of female skin care products driven by the Olay Natural White initiative in Asia. Salon Professional volume declined high single digits mainly due to the exit of non-strategic businesses, while organic volume declined mid-single digits primarily due to continued market contractions. Prestige volume increased mid-single digits as the impact of trade inventory reductions in the prior year period were partially offset by continued contraction of the fragrance market in the current year. Net earnings were $562 million, up 2% behind higher net sales and a lower tax rate, partially offset by lower operating margin and a minor brand divestiture gain in the prior year period. Operating margin contracted as a higher gross margin behind lower commodity costs and manufacturing cost savings was more than offset by an increase in SG&A as a percentage of net sales due to increased marketing investments. Beauty net sales increased 2% fiscal year to date to $14.8 billion on unit volume growth of 1%. Organic sales were up 3% on a 2% increase in organic volume. Pricing increases added 1% to net sales growth as price increases taken early in the fiscal year in developing regions to offset currency devaluations more than offset the more recent price reductions in Hair Care. Hair Care volume grew low single digits, while organic volume grew mid-single digits behind growth of Pantene, Head & Shoulders and Rejoice primarily in Asia and Latin America. Global share of the hair care market was down less than half a point to 22%. Female Beauty volume was in line with the prior year period as higher shipments of female skin care and personal cleansing products in developing regions were offset by the discontinuation of Max Factor in North America, the fiscal 2009 divestiture of Noxzema and market share losses on non-strategic personal cleansing brands in developed regions. Salon Professional volume was down double digits mainly due to the exit of non-strategic businesses and continued market contractions. Prestige volume declined low single digits due to continued contraction of the fragrance market. Net earnings grew 3% fiscal year to date to $2.2 billion driven by net sales growth and operating margin expansion, partially offset by divestiture gains in the prior period and a higher tax rate. Operating margin increased due to higher gross margin driven primarily by price increases and manufacturing costs savings. Gross margin expansion was partially offset by higher SG&A as a percentage of net sales due to increased marketing spending and higher foreign currency exchange costs. Grooming Grooming net sales grew 11% for the quarter to $1.8 billion on a 6% increase in unit volume. Organic sales were up 4%. Price increases contributed 2% to net sales growth mainly due to price increases taken in Latin America to offset currency devaluations. Negative product mix reduced net sales by 3% due mainly to disproportionate growth of disposable razors in developing regions and entry level shaving systems, both of which have lower than segment average selling prices. Favorable foreign exchange added 6% to net sales growth for the quarter. Segment volume grew mid single digits in developed regions and high single digits in developing regions. Volume in Male Blades and Razors increased high single digits due to market growth mainly in developing regions and the impact of trade inventory reductions in the prior year period. Gillette Fusion continued to lead volume gains delivering double-digit growth for the quarter. Global market share of the blades and razors category was up less than half a point to 72%. Volume in Male Personal Care grew low single digits due to the Zirh acquisition, while organic volume was down low single digits behind market contractions and share losses in Western Europe. Volume in Braun was up mid-single digits behind market growth, particularly in CEEMEA, which was disproportionately impacted by the economic crisis in the prior year period. Global share of the dry shaving market was up about two and a half points to about 33%. Net earnings increased 46% to $377 million for the quarter due to higher net sales, increased operating margin and a lower tax rate. The expansion of operating margin was due to higher gross margin driven by price increases, manufacturing cost savings and volume scale leverage, partially offset by an increase in SG&A as a percentage on net sales driven by marketing investments. Grooming net sales were in line with the prior year period at $5.7 billion fiscal year to date on a 2% decline in unit volume. Organic sales were in line with the comparable prior year period. Price increases, taken primarily in developing regions to offset currency devaluations and across Blades and Razors, added 4% to net sales. Product mix had a negative 2% impact on net sales due mainly to disproportionate growth in developing regions and of disposable razors, both of which have lower than segment average selling prices. Volume in Blades and Razors was in line with the prior year period as low single-digit growth in developing regions was offset by a low-single-digit decline in developed regions. Mach3 shipments declined double digits, while Gillette Fusion shipments increased high single digits. Global market share of the blades and razors category was down less than 1 point. Volume in Male Personal Care declined mid-single digits primarily due to share losses resulting from increased competitive promotional activity on shave preparation products in Western Europe and distribution declines on Tag deodorants. Volume in Braun was down mid-single digits due mostly to market contractions, particularly in home and hair care appliances. Net earnings fiscal year to date were up 6% versus the comparable prior year period to $1.2 billion behind a lower tax rate and operating margin expansion. Operating margin increased behind improved gross margin from price increases and lower commodity costs, partially offset by higher SG&A as a percentage of net sales driven by higher foreign currency exchange costs. HEALTH AND WELL-BEING GBU Health Care Health Care net sales were up 5% to $2.8 billion during the third fiscal quarter on a 5% increase in unit volume. Organic sales grew 1%. Mix impacts reduced net sales by 3% mainly as a result of the disproportionate growth of developing regions, which have lower than segment average selling prices. Price decreases to improve consumer value lowered net sales by 1%. Favorable foreign exchange added 4% to net sales growth. Volume was strongest in developing regions, up double digits, while volume in developed regions was up low single digits. Oral Care volume increased high single digits driven mainly by increased initiative activity, including Crest 3D White in North America, Oral-B toothpaste expansion in Latin America, Oral-B Pro Health whitespace expansion in Western Europe and Dare to Try commercial innovation in Greater China. Personal Health Care volume declined mid-single digits primarily due to increased competitive activity on Prilosec OTC in North America and the impact of a mild cold and flu season on Vicks shipments. Feminine Care volume grew mid-single digits behind reduced pricing to improve consumer value in CEEMEA, the launch of Naturella in Greater China and the impact of trade inventory reductions in the prior year period. Global market share of the feminine care category was down about half a point. Net earnings increased 5% to $435 million during the quarter mainly due to net sales growth, partially offset by operating margin contraction. Operating margin declined due to higher SG&A as a percentage of net sales, partially offset by higher gross margin. SG&A as a percentage of net sales increased primarily due to higher marketing, overhead and foreign currency exchange costs. Gross margin improved behind manufacturing cost savings and improved volume scale leverage. Health Care net sales increased 2% fiscal year to date to $8.9 billion on unit volume growth of 2%. Organic sales also increased 2%. Price increases, taken mainly in developing regions to offset currency devaluations, added 1% to net sales. Negative product mix reduced net sales by 1% due to disproportionate growth of developing regions, which have lower than segment average selling prices. Oral Care volume grew mid-single digits behind initiative activity in Western Europe, Latin America and Asia. Personal Health Care volume was in line with the prior year period as growth of diagnostic products and higher shipments of Vicks in developing regions was offset by a continued decline of Prilosec OTC in North America due to increased competitive activity and the prior period divestiture of Thermacare. Feminine Care volume increased low single digits behind initiative-driven growth of Always and Naturella, partially offset by lower shipments of Tampax. Global market share of the feminine care category was down about 1 point. Net earnings were $1.5 billion fiscal year to date, an increase of 8% versus the prior year period behind operating margin expansion and net sales growth. Operating margin increased due to higher gross margin, partially offset by higher SG&A as a percentage of net sales. Gross margin grew behind price increases, lower commodity costs and manufacturing cost savings. SG&A as a percentage of net sales increased due mainly to higher foreign currency exchange costs and overhead spending, partially offset by lower marketing spending. Snacks and Pet Care Snacks and Pet Care net sales were $747 million, down 2% for the quarter driven by a unit volume decline of 6%. Organic sales decreased 6%. Favorable foreign exchange added 4% to net sales. Volume in Snacks decreased high single digits primarily due to lower levels of merchandising activity in North America and the discontinuation of some premium snack products. Global market share of the snacks category was in line with the prior year period. Volume in Pet Care was down low single digits mainly due to market contractions in the premium nutrition category. Net earnings increased 51% versus the prior year period to $77 million driven by higher operating margin and a lower tax rate. Operating margin was up behind higher gross margin, partially offset by higher SG&A as a percentage of net sales. Gross margin expanded behind mix from more profitable initiative launches, such as Pringles Super Stack and Iams Prebiotics, as well as lower commodity costs. SG&A as a percentage of net sales increased due to higher marketing and overhead spending. Snacks and Pet Care net sales decreased 1% fiscal year to date to $2.3 billion on a 5% decline in unit volume. Organic sales declined 2%. Price increases, taken primarily to offset high commodity costs, added 4% to net sales. Favorable foreign exchange added 1% to net sales. Mix reduced net sales by 1% due to the discontinuation of certain premium snack product, which have higher than segment average selling prices. Volume in Snacks was down double-digits behind share losses and market contractions. Global market share of the snacks category was down 1 point. Share losses were driven primarily by lower merchandising activity in North America following the Super Stacks initiative and the discontinuation of some premium snack products. Volume in Pet Care was in line with the prior year period as the continued success of product initiatives was offset by market contraction in the premium nutrition category. Net earnings increased 47% to $249 million fiscal year to date behind higher operating margins and a lower tax rate. Operating margin expanded due to higher gross margin driven by price increases, commodity cost declines and manufacturing cost savings, partially offset by higher SG&A as a percentage of net sales due to increased marketing and overhead spending. HOUSEHOLD CARE GBU Fabric Care and Home Care Fabric Care and Home Care net sales increased 8% to $5.8 billion for the quarter on a 10% increase in unit volume. Organic sales grew 5%. Mix reduced net sales by 2% due to unfavorable geographic mix and disproportionate growth of laundry powder and mid-tier brands, both of which have lower than segment average selling prices. Pricing investments to improve consumer value lowered net sales by 3%. Favorable foreign exchange contributed 3% to net sales growth. Each billion dollar brand delivered high single digits or better volume growth for the segment. Fabric Care volume increased high single digits behind targeted price reductions to improve consumer value, higher media weights and trade inventory increases to support merchandising activity in North America. Global market share of the fabric care category was down 1 point to about 29%. Home Care volume was up double digits due to market size expansion, the continued success of new products launched in prior quarters, increased merchandising activity and higher media weights. Batteries volume increased double digits mainly due to reduced pricing to improve consumer value in North America and higher demand from business customers. Net earnings were up 4% for the quarter to $752 million due primarily to net sales growth, partially offset by operating margin contraction. Operating margin declined due to higher SG&A as a percentage of net sales, partially offset by higher gross margin. Gross margin improved behind manufacturing cost savings and volume scale leverage, partially offset by lower pricing. SG&A as a percentage of net sales was up due to higher marketing spending to support business growth, partially offset by lower overhead spending as a percentage of net sales. Fabric Care and Home Care net sales increased 3% to $18.3 billion fiscal year to date on a 5% increase in unit volume. Organic sales grew 5%. Pricing was in line with the prior year period as the impact of prior period price increases taken primarily in developing regions to offset currency devaluations was offset by more recent price reductions to improve consumer value. Mix lowered net sales by 1% due mainly to unfavorable geographic mix. Unfavorable foreign exchange reduced net sales by 1%. Fabric Care volume grew low single digits behind new product launches and growth in Western Europe from incremental merchandising activity, partially offset by market share loss. Global market share of the fabric care category was down about 1 point to about 29%. Home Care volume was up high single digits mainly due to market size expansion and share growth behind new product launches. Global market share of the home care category was up less than half a point to 17%. Batteries volume increased mid-single digits primarily due to growth in Greater China, price reductions to improve consumer value in North America, and higher demand from business customers. Net earnings increased 23% to $2.7 billion due to higher net sales, increased operating margin and a lower tax rate. Operating margin expanded due to higher gross margin, partially offset by an increase in SG&A as a percentage of net sales. Gross margin increased mainly due to lower commodity costs and manufacturing cost savings, while SG&A as a percentage of net sales increased due to higher marketing spending. Baby Care and Family Care Baby Care and Family Care net sales increased 9% to $3.8 billion for the quarter on 10% volume growth. Organic sales grew 7%. Mix lowered net sales growth by 2% due to disproportionate growth of mid-tier products, larger pack counts and developing regions, all of which have lower than segment average selling prices. Price decreases to improve consumer value reduced net sales by 1%. Favorable foreign exchange added 2% to net sales growth. Volume growth was broad-based with all major geographic regions contributing mid-single digits or higher to volume growth, led by double-digit growth in developing regions. Volume in Baby Care grew double digits primarily due to share growth, market size expansion and trade inventory increases to support the launch of Dry Max in North America. Global market share of the baby care category increased over half a point to over 34% driven by price reductions to improve consumer value, increased marketing spending and the continued success of initiatives launched in prior periods. Volume in Family Care was up double digits behind incremental merchandising activity, price reductions to improve consumer value, primarily executed in prior periods, and double-digit growth of Basic product lines. Net earnings grew 32% to $558 million for the quarter driven by net sales growth and operating margin expansion. Operating margin grew behind higher gross margin, partially offset by an increase in SG&A as a percentage of net sales. Gross margin improved primarily due to lower commodity costs and manufacturing cost savings, while SG&A as a percentage of net sales increased due to higher marketing investments. Baby Care and Family Care net sales grew 4% to $11.2 billion fiscal year to date on 6% volume growth. Organic sales increased 5%. Pricing was in line with the prior year period as the impact of price increases taken primarily in developing regions to offset currency devaluations was offset by more recent price reductions to improve consumer value. Negative product mix reduced net sales by 1% driven mainly by disproportionate growth of mid-tier product lines and large count packs, both of which have lower than segment average selling prices. Unfavorable foreign exchange reduced net sales by 1%. Volume in Baby Care increased mid-single digits behind market size expansion and share growth due to incremental initiative activity and price reductions to improve consumer value. Global share of the baby care market was up about half a point. Volume in Family Care grew mid-single digits due to market growth and volume share gains driven by increased merchandising and initiative activity and price reductions to improve consumer value. Net earnings increased 25% to $1.7 billion behind net sales growth and operating margin expansion. Operating margin expansion was driven by higher gross margin, partially offset by higher SG&A as a percentage of net sales. Gross margin increased mainly due to lower commodity costs and manufacturing cost savings. SG&A as a percentage of net sales increased behind higher foreign currency exchange costs, incremental marketing investments and additional overhead spending. CORPORATE Corporate includes certain operating and non-operating activities not allocated to specific business units. These include: the incidental businesses managed at the corporate level; financing and investing activities; other general corporate items; the historical results of certain divested brands and categories; and certain restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce rationalization. Corporate also includes reconciling items to adjust the accounting policies used in the segments to U.S. GAAP. The most significant reconciling items include income taxes (to adjust from statutory rates that are reflected in the segments to the overall Company effective tax rate), adjustments for unconsolidated entities (to eliminate sales, cost of products sold and SG&A for entities that are consolidated in the segments but accounted for using the equity method for U.S. GAAP) and noncontrolling interest adjustments for subsidiaries where we do not have 100% ownership. Since both unconsolidated entities and less than 100% owned subsidiaries are managed as integral parts of the Company, they are accounted for similar to a wholly owned subsidiary for management and segment purposes. This means our segment results recognize 100% of each income statement component through before-tax earnings, with eliminations for unconsolidated entities and noncontrolling interests in Corporate. In determining segment after-tax net earnings, we apply the statutory tax rates (with adjustments to arrive at the Companys effective tax rate in Corporate) and eliminate the share of earnings applicable to other ownership interests, in a manner similar to noncontrolling interest. For the Corporate segment, net expenses from continuing operations increased $180 million to $176 million for the quarter. The increase in net expenses was driven primarily by a $152 million charge for a change in legislation which changed the taxation of certain future retiree prescription drug subsidy payments and tax adjustments required to reconcile the statutory rates reflected in the business segments to the overall Company effective tax rate. These impacts were partially offset by lower interest expense, restructuring charges and foreign currency exchange costs. Fiscal year to date, net expenses from continuing operations increased $757 million. The increase was primarily due to current period charges for potential competition law fines and for recently enacted legislation impacting the taxation of certain future retiree prescription drug subsidy payments and the impact of prior period divestiture gains and tax audit settlements, partially offset by lower interest expense and restructuring charges. Operating Activities We generated $12.8 billion of cash from operating activities for the fiscal year to date period, an increase of 29% versus the comparable prior year period mainly due to changes in working capital, partially offset by lower net earnings. On a year-to-date basis, working capital reductions contributed $1.8 billion to operating cash flow primarily due to an increase in accounts payable, accrued and other liabilities, partially offset by increased accounts receivable. Accounts payable, accrued and other liabilities increased primarily due to increased taxes payable, due to the timing of tax payments, and increased expenditures to support business growth, primarily related to the increased marketing investments. Accounts receivable levels increased primarily due to disproportionately higher sales growth in the last month of the quarter. Cash flow from discontinued operations contributed $285 million to operating cash flow. Investing Activities Our investing activities generated cash of $970 million fiscal year to date, an increase of $2.2 billion versus the prior year period mainly due to higher proceeds from divestitures. Current year proceeds from asset sales were $3.0 billion due to receipts from the sales of the global pharmaceuticals business, including Actonel in Japan. Prior year period proceeds related to the Folgers, Thermacare and other minor brand divestitures. Capital expenditures were $2.0 billion fiscal year to date or 3.3% of net sales. Acquisitions consumed $65 million of cash primarily to purchase the remaining shares of MDVIP, a physicians network focused on preventative medicine. Financing Activities We used $13.5 billion fiscal year to date to fund financing activities. This represents an increase of $6.3 billion versus the prior year period due to increased levels of debt retirement, partially offset by a reduction in treasury stock purchases. Current year net repayments of debt used $6.7 billion, while dividends to shareholders increased to $4.0 billion. Fiscal year to date, we have made $3.4 billion of treasury stock purchases through our share repurchase program and expect to repurchase about $6 billion during fiscal 2010. As of March 31, 2010, our current liabilities exceeded current assets by $1.8 billion. We have short- and long-term debt to fund discretionary items such as acquisitions and share repurchase programs. We anticipate being able to support our short-term liquidity and operating needs largely through cash generated from operations. We have strong short- and long-term debt ratings which have enabled and should continue to enable us to refinance our debt as it becomes due at favorable rates in commercial paper and bond markets. In addition, we have agreements with a diverse group of financial institutions that, if needed, should provide sufficient credit funding to meet short-term financing requirements. RECONCILIATION OF NON-GAAP MEASURES Our discussion of financial results includes several measures not defined by U.S. GAAP. We believe these measures provide our investors with additional information about the underlying results and trends of the Company, as well as insight to some of the metrics used to evaluate management. When used in MD&A, we have provided the comparable GAAP measure in the discussion. Organic Sales Growth: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions, divestitures and foreign exchange from year-over-year comparisons. We believe this provides investors with a more complete understanding of underlying sales trends by providing sales growth on a consistent basis. The reconciliation of reported sales growth to organic sales for the January - March quarter: Acquisition/ Divestiture Impact* Fabric Care and Home Care Baby Care and Family Care The reconciliation of reported sales growth to organic sales for the fiscal year to date period: Acquisition/ Divestiture Impact* Fabric Care and Home Care Baby Care and Family Care Acquisition/Divestiture Impacts includes rounding impacts necessary to reconcile net sales to organic sales. Core EPS : Core EPS is a measure of the Companys diluted net earnings per share growth from continuing operations excluding charges for pending European legal matters, a charge related to recently enacted legislation which changed the taxation of certain future retiree prescription drug subsidy payments in the United States and the impact of incremental Corporate restructuring charges incurred in fiscal 2009 versus 2008 to offset the dilutive impact of the Folgers divestiture in the prior period. We do not view these items to be part of our sustainable results. We believe the core EPS measure provides an important perspective of underlying business trends and results and provides a more comparable measure of year-on-year earnings per share growth. Core EPS is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation. The tables below provide reconciliations of reported diluted net earnings per share from continuing operations to core earnings per share: Diluted Net Earnings Per Share - Continuing Operations Incremental Folgers-related Restructuring Charges Charge for Taxation of Retiree Healthcare Subsidy Charges for Pending European Legal Matters Note  All reconciling items are presented net of tax. Tax effects are calculated consistent with the nature of the underlying transaction. The tax impacts on the incremental Folgers-related restructuring charges are ($0.00) for JFM 2009 and ($0.01) for FYTD 2009. The entire amount of the charge for taxation of retiree healthcare subsidy is tax expense. There is no tax impact on the charges for pending European legal matters. Free Cash Flow: Free cash flow is defined as operating cash flow less capital spending. We view free cash flow as an important measure because it is one factor in determining the amount of cash available for dividends and discretionary investment. Free cash flow is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation. Free Cash Flow Productivity: Free cash flow productivity is defined as the ratio of free cash flow to net earnings. The Companys long-term target is to generate free cash at or above 90 percent of net earnings. Free cash flow is also one of the measures used to evaluate senior management. The reconciliation of free cash flow and free cash flow productivity is provided below (amounts in millions): Free Cash Flow Productivity Quantitative and Qualitative Disclosures About Market Risk. There have been no material changes in the Companys exposure to market risk since June 30, 2009. Additional information can be found in the section entitled Other Information, which appears on pages 47-48, and Note 5, Risk Management Activities and Fair Value Measurements, which appears on pages 58-61 of the Annual Report to Shareholders for the fiscal year ended June 30, 2009 which can be found by reference to Exhibit 13 of the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2009, as updated by the Companys Form 8-K filed on January 29, 2010. Controls and Procedures. Evaluation of Disclosure Controls and Procedures. The Companys Chairman of the Board, President and Chief Executive Officer, Robert A. McDonald, and the Companys Chief Financial Officer, Jon R. Moeller, performed an evaluation of the Companys disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (Exchange Act)) as of the end of the period covered by this report. Messrs. McDonald and Moeller have concluded that the Companys disclosure controls and procedures were effective to ensure that information required to be disclosed in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) accumulated and communicated to our management, including Messrs. McDonald and Moeller, to allow their timely decisions regarding required disclosure. Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting that occurred during the Companys fiscal quarter ended March 31, 2010 that have materially affected, or are reasonably likely to materially affect, the Companys internal control over financial reporting. PART II. OTHER INFORMATION Legal Proceedings. The Company is subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental issues, patent and trademark matters and taxes. The Company is subject to a variety of investigations into potential competition law violations in Europe. The Companys policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with investigations by relevant regulatory authorities, which the Company is doing. The Company is subject to a number of antitrust investigations in Europe. In 2006, French authorities, in connection with an inquiry into potential competition law violations in France, entered the premises of two of the Companys French subsidiaries and seized a variety of documents. In 2008, European Commission officials, with the assistance of the national authorities from a variety of countries, started an investigation into potential competition law violations in a variety of countries across the European Union. Around the same time, the national authorities in Spain, Italy and the Czech Republic initiated additional investigations into potential antitrust concerns within those countries. In connection with these investigations, a number of the Companys subsidiaries were visited and documents seized. Also in 2008, authorities in the United Kingdom (UK) initiated an investigation concerning potential antitrust violations in the UK involving one of the Companys subsidiaries. The Company or its subsidiaries are also involved in other competition law investigations in Germany, Belgium, Romania, Switzerland, France and Greece, as well as some other countries. We believe that all of the above matters involve a number of other consumer products companies and/or retail customers. Competition and antitrust law investigations often continue for several years and, if violations are found, can result in substantial fines. In other industries, fines have amounted to hundreds of millions of dollars. In response to the actions of the European Commission and national authorities, the Company launched its own internal investigations into potential violations of competition laws. The Company identified violations in certain European countries and appropriate actions were taken. In addition to the complaints issued by France and Italy in a prior quarter, the authorities in Spain have issued a complaint alleging that the Company, along with several other companies, engaged in violations of competition laws in Spain. The Company will have the opportunity to respond to these complaints. The remaining matters discussed above are in various stages of the investigatory process. It is still too early for us to reasonably estimate the total amount of fines to which the Company will be subject as a result of these various competition law issues. However, we have taken and will take reserves as appropriate. Please refer to the Companys Risk Factors in Item 1A of this Form 10-Q for additional information. In December 2008, the Company became aware of an investigation by Italian authorities into an environmental accident at the site of a contractor which provides services to one or more of the Companys European affiliates. The accident involved the explosion of certain pressurized cans and resulted in the death of one worker and serious injuries to another. Italian authorities have commenced a formal criminal proceeding regarding whether the Companys local affiliate and certain of its employees complied with Italian laws related to the proper classification and disposal of their products. Should they find that these entities violated the law, the Italian authorities could levy fines in excess of $100 thousand against the Companys European affiliate(s). Risk Factors. We discuss our expectations regarding future performance, events and outcomes, such as our business outlook and objectives in this Form 10-Q, the Annual Report to Shareholders, quarterly reports, press releases and other written and oral communications. All statements, except for historical and present factual information, are forward-looking statements and are based on financial data and business plans available only as of the time the statements are made, which may become out of date or incomplete. We assume no obligation to update any forward-looking statements as a result of new information, future events, or other factors. Forward-looking statements are inherently uncertain, and investors must recognize that events could significantly differ from our expectations. The following discussion of risk factors identifies the most significant factors that may adversely affect our business, operations, financial position or future financial performance. This information should be read in conjunction with MD&A and the consolidated financial statements and related notes incorporated by reference into this report. The following discussion of risks is not all inclusive but is designed to highlight what we believe are important factors to consider when evaluating our expectations. These factors could cause our future results to differ from those in the forward-looking statements and from historical trends. A material change in consumer demand for our products could have a significant impact on our business. We are a consumer products company and rely on continued global demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers. This is dependent on a number of factors including our ability to develop effective sales, advertising and marketing programs in an increasingly fragmented media environment. We expect to achieve our financial targets, in part, by shifting our portfolio towards faster growing, higher margin businesses. If demand and growth rates fall substantially below expected levels or our market share declines significantly in these businesses, our results could be negatively impacted. This could occur due to unforeseen negative economic or political events or to changes in consumer trends and habits. In addition, our continued success is dependent on leading-edge innovation, with respect to both products and operations. This means we must be able to obtain patents that lead to the development of products that appeal to our consumers across the world. The ability to achieve our business objectives is dependent on how well we can respond to our local and global competitors. Across all of our categories, we compete against a wide variety of global and local competitors. As a result, there are ongoing competitive product and pricing pressures in the environments in which we operate, as well as challenges in maintaining profit margins. To address these challenges, we must be able to successfully respond to competitive factors, including pricing, promotional incentives and trade terms, as well as technological advances and patents granted to competition. Our businesses face cost pressures which could affect our business results. Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, cost of labor, foreign exchange and interest rates. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects (including outsourcing projects), sourcing decisions and certain hedging transactions. In the manufacturing and general overhead areas, we need to maintain key manufacturing and supply arrangements, including any key sole supplier and sole manufacturing plant arrangements. We face risks associated with significant international operations. We conduct business across the globe with a significant portion of our sales outside the United States. As a result, we are subject to a number of risks, including, but not limited to, changes in exchange rates for foreign currencies, which may reduce the U.S. dollar value of revenues and earnings received and/or balances held by or invested in our foreign subsidiaries, as well as exchange controls and other limits on our ability to repatriate earnings from outside the U.S. that can increase our exposure. We have sizable businesses and maintain local currency cash balances in a number of foreign countries with exchange controls, including, but not limited to, Venezuela, China and India. Our results of operations and/or financial condition could be adversely impacted if we are unable to successfully manage these risks. Further, we expect to achieve our financial targets, in part, by achieving disproportionate growth in developing regions. Should growth rates or our market share fall substantially below expected levels in these regions, our results could be negatively impacted. In addition, economic changes, terrorist activity and political unrest may result in business interruption, inflation, deflation or decreased demand for our products. Our success will depend, in part, on our ability to manage continued global political and/or economic uncertainty, especially in our significant geographical markets, as well as any political or economic disruption due to terrorist and other hostile activities. If the reputation of one or more of our leading brands erodes significantly, it could have a material impact on our financial results. Our financial success is directly dependent on the success of our brands, particularly our billion-dollar brands. The success of these brands can suffer if our marketing plans or product initiatives do not have the desired impact on a brands image or its ability to attract consumers. Further, our results could be negatively impacted if one of our leading brands suffers a substantial impediment to its reputation due to real or perceived quality issues. Our ability to successfully adapt to ongoing organizational change could impact our business results. We have executed a number of significant business and organizational changes including acquisitions, divestitures and workforce optimization projects to support our growth strategies. We expect these types of changes to continue for the foreseeable future. Successfully managing these changes, including retention of key employees, is critical to our business success. In addition, we are generally a build-from-within company, and our success is dependent on identifying, developing and retaining key employees to provide uninterrupted leadership and direction for our business. Further, our financial targets assume a consistent level of productivity improvement. If we are unable to deliver expected productivity improvements, while continuing to invest in business growth, our financial results could be adversely impacted. Our ability to successfully manage ongoing acquisition and divestiture activities could impact our business results. As a company that manages a portfolio of consumer brands, our ongoing business model involves a certain level of acquisition and divestiture activities. We must be able to successfully manage the impacts of these activities, while at the same time delivering against base business objectives. Specifically, our financial results could be adversely impacted if: 1) we are not able to deliver the expected cost and growth synergies associated with our acquisitions, 2) changes in the cash flows or other market-based assumptions cause the value of acquired assets to fall below book value or 3) we are unable to offset the dilutive impacts from the loss of revenue streams associated with divested brands. Our business is subject to regulation in the U.S. and abroad. Changes in laws, regulations and the related interpretations may alter the environment in which we do business. This includes changes in competitive, product-related and environmental laws, including actions in response to global climate change concerns, as well as changes in accounting standards and taxation requirements. Accordingly, our ability to manage regulatory, tax and legal matters (including product liability, patent, and intellectual property matters), and to resolve pending legal matters without significant liability, including the competition law and antitrust investigations described in Part II, Item 1 of this Form 10-Q, which could require us to take significant reserves in excess of amounts accrued to date or pay significant fines during a reporting period, may materially impact our results. In addition, as a U.S. based multinational company we are also subject to tax regulations in the U.S. and multiple foreign jurisdictions, some of which are interdependent. For example, certain income that is earned and taxed in countries outside the U.S. is not taxed in the U.S., provided those earnings are indefinitely reinvested outside the U.S. If these or other tax regulations should change, our financial results could be impacted. A material change in customer relationships or in customer demand for our products could have a significant impact on our business. Our success is dependent on our ability to successfully manage relationships with our retail trade customers. This includes our ability to offer trade terms that are acceptable to our customers and are aligned with our pricing and profitability targets. Our business could suffer if we cannot reach agreement with a key customer based on our trade terms and principles. Further, there is a continuing trend towards retail trade consolidation, which can create significant cost and margin pressure and could lead to more complex work across broader geographic boundaries for both us and key retailers. This can be particularly difficult when major customers are addressing local trade pressures or local law and regulation changes. In addition, our business would be negatively impacted if a key customer were to significantly reduce the range or inventory level of our products. We face risks related to changes in the global economic environment. Our business is impacted by global economic conditions. If the global economy experiences significant disruptions, our business could be negatively impacted, including such areas as reduced demand for our products from a slow-down in the general economy, supplier or customer disruptions resulting from tighter credit markets and/or temporary interruptions in our ability to conduct day-to-day transactions through our financial intermediaries involving the payment to or collection of funds from our customers, vendors and suppliers. A failure of a key information technology system, process or site could have a material adverse impact on our ability to conduct business. We rely extensively on information technology systems, some of which are managed by third-party service providers, to interact with internal and external stakeholders. These interactions include, but are not limited to, ordering and managing materials from suppliers, converting materials to finished products, shipping product to customers, processing transactions, summarizing and reporting results of operations, complying with regulatory, legal or tax requirements, and other processes necessary to manage the business. If our systems are damaged or cease to function properly due to any number of causes, ranging from catastrophic events to power outages to security breaches, and our business continuity plans do not effectively compensate on a timely basis, we may suffer interruptions in our ability to manage operations which may adversely impact our results of operations and/or financial condition. Unregistered Sales of Equity Securities and Use of Proceeds. ISSUER PURCHASES OF EQUITY SECURITIES Total Number of Shares Purchased Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs Approximate Dollar Value of Shares That May Yet Be Purchased Under our Share Repurchase Program ($ in billions) (3) (4) The total number of shares purchased was 31,965,526 for the quarter. All transactions were made in the open market or pursuant to prepaid forward agreements with large financial institutions. Under these agreements, the Company prepays large financial institutions to deliver shares at future dates in exchange for a discount. The number of shares purchased other than through a publicly announced repurchase plan was 30,241 for the quarter. The 30,241 shares were acquired by the Company under various compensation and benefit plans. This table excludes shares withheld from employees to satisfy minimum tax withholding requirements on option exercises and other equity-based transactions. The Company administers cashless exercises through an independent, third party broker and does not repurchase stock in connection with cashless exercise. Average price paid per share is calculated on a settlement basis and excludes commission. On August 3, 2007, the Company announced a share repurchase plan. Pursuant to the share repurchase plan, the Board of Directors authorized the Company and its subsidiaries to acquire in open market and/or private transactions $24 to $30 billion of shares of Company common stock over the subsequent three years (through June 30, 2010) to be financed by issuing a combination of long-term and short-term debt. Certain purchases were made prior to announcement of the program but are considered purchases against the program. We expect to repurchase about $6 billion during fiscal 2010. The dollar values listed in this column include commissions to be paid to brokers to execute the transactions. Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October 14, 2008) (Incorporated by reference to Exhibit (3-1) of the Companys Form 10-Q for the quarter ended December 31, 2008). Regulations (as amended by shareholders at the annual meeting on October 13, 2009). (Incorporated by reference to Exhibit (3-2) of the Companys Form 10-Q for the quarter ended Computation of Earnings per Share. Computation of Ratio of Earnings to Fixed Charges.",15936
2010-05-19,8-K,0000950123-10-051262,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) May 19, 2010 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) On May 19, 2010, The Procter & Gamble Company (the Company) closed an underwritten public offering of 100,000,000,000 aggregate principal amount of 0.95% Notes due 2015 under the Companys Registration Statement on Form S-3 (Registration No. 333-161767) (the Registration Statement). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are",176
2010-07-13,8-K,0000080424-10-000034,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On July 13, 2010, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of $0.4818 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after August 16, 2010 to shareholders of record at the close of business on July 23, 2010. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",196
2010-08-03,8-K,0000080424-10-000036,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) ( Registrant's telephone number, including area code ) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On August 3, 2010, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended June 30, 2010. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",165
2010-08-13,10-K,0001193125-10-188769,"THE PROCTER & GAMBLE COMPANY SECURITIES AND EXCHANGE COMMISSION SECURITIES AND EXCHANGE COMMISSION ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended June 30, 2010 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-434 THE PROCTER & GAMBLE COMPANY One Procter & Gamble Plaza, Cincinnati, Ohio 45202 IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value New York Stock Exchange, NYSE Euronext-Paris Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  No  Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes  No  Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No  Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No  Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrants knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act). Smaller reporting company Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No  The aggregate market value of the voting stock held by non-affiliates amounted to $176 billion on December 31, 2009. There were 2,838,474,868 shares of Common Stock outstanding as of July 31, 2010. Documents Incorporated by Reference Portions of the Annual Report to Shareholders for the fiscal year ended June 30, 2010, (2010 Annual Report) are incorporated by reference into Part I, Part II and Part IV of this report to the extent described herein. Portions of the Proxy Statement for the 2010 Annual Meeting of Shareholders which will be filed within one hundred and twenty days of the fiscal year ended June 30, 2010, (2010 Proxy Statement) are incorporated by reference into Part III of this report to the extent described herein. Additional information required by this item is",532
2010-08-13,8-K,0000080424-10-000038,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 5.02(e) COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS On August 10, 2010, The Procter & Gamble Companys (Company) Compensation & Leadership Development Committee (Committee) of the Board of Directors terminated its long-term incentive compensation plan for its senior executives and adopted a new long-term incentive compensation plan. The Committee adopted its current long-term incentive compensation plan, a three-year plan called the Business Growth Plan (BGP), on September 22, 2008. The Committee determined that it was in the best interests of the Company and its shareholders to terminate BGP one year early and adopt a new long-term incentive program that better supports the Companys business strategies and reinforces the principle of paying for performance. The new plan, called the Performance Stock Program (PSP), will continue to focus on the four performance categories that were included in BGP and that the Committee believes are the most critical for creating long-term shareholder value (organic sales, core earnings per share growth, before tax operating profit growth and free cash flow productivity). It also ;includes several new features that are more consistent with the Committees principles and objectives of paying for performance, supporting the business strategy and driving superior business results. These new features include: annual grants with overlapping performance periods, the elimination of interim payments, payment entirely in performance-vested equity rather than cash, and more precise performance goals tied to our performance versus peer companies. The PSP is also better aligned with the best practices of our peer companies as most have similar long-term incentive programs. Under the PSP, the Committee will grant each participant performance share units (PSUs) that will be earned over a three-year performance period which begins each year on July 1 st , with the first period beginning July 1 st 2010. The number of PSUs granted to each participant will be based on the target long-term incentive compensation for individuals in similar positions at peer group companies after adjusting for the Companys other long-term incentive programs. The PSUs will vest at the end of the performance period, and the number of PSUs that vest will range from 0-200% of the initial PSU grant based on the Companys results against performance goals in each of the four categories listed above. Once vested, PSUs will be paid in shares of the Companys common stock distributed to participants following the performance period. A summary of the PSP approved by the Committee is attached as Exhibit 99. In conjunction with the termination of BGP, the Committee approved the final payment under that program based upon the shortened performance period ending on June 30, 2010. Since the program was terminated one year early, the Committee calculated the final payment by (1) reducing each participants BGP target award by 1/3 rd ; (2) applying the previously approved BGP sliding scale to establish a payout factor for each performance category based on results achieved as of June 30, 2010; and (3) subtracting the value of any interim payments received. This compensates participants consistent with the orig inal objectives of BGP while avoiding any possibility of double payment under BGP and PSP for the current fiscal year. The final payment will be made in RSUs that will be paid in shares of the Companys common stock in September 2011, the same date on which each participant would have received the final BGP payment had the Committee not elected to change the plan. The total payout under BGP was 42% of the reduced target, more than half of which had already been paid to executives pursuant to interim payments. The final payment received by each named executive officer will be as follows: Mr. McDonald - $646,000, Mr. Moeller  $204,000, Mr. Geissler  $295,800, Mr. Panayotopoulos - $309,400, Mr. Shirley - $251,600, and Mr. Steele - $295,800.",741
2010-10-12,8-K,0000735244-10-000003,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On October 12, 2010, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of forty-eight point eighteen cents ($0.4818) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after November 15, 2010 to Common Stock shareholders of record at the close of business on October 22, 2010, and payable on the dividend payment date for the Common Stock to Series A and Series B Preferred Stock shareholders of record at the start of business on that date. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",232
2010-10-12,8-K,0000080424-10-000055,"shareholdermeeting2010.htm SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 7.01 REGULATION FD DISCLOSURE On October 12, 2010, The Procter & Gamble Company (the ""Company"") issued a news release with respect to Chairman of the Board, President and Chief Executive Officer Robert A. McDonald's address to the shareholders at the Company's annual meeting. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",151
2010-10-14,8-K,0000735244-10-000004,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act Submission of Matters to a Vote of Security Holders The Procter & Gamble Company (the Company) held its Annual Meeting of Shareholders on October 12, 2010. Set forth below are the final voting results for each of the proposals submitted to a vote of the shareholders. Ratify Appointment of Independent Registered Public Accounting Firm Shareholder Proposal - Adopt Cumulative Voting in the Election of Directors",158
2010-10-27,8-K,0000735244-10-000006,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) ( Registrant's telephone number, including area code ) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On October 27, 2010, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended September 30, 2010. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",159
2010-10-28,10-Q,0001193125-10-238937,"SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2010 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission file number 1-434 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (513) 983-1100 (Registrants telephone number, including area code) check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No  Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No  Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Large accelerated filer  Accelerated filer  Non-accelerated filer  Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No  There were 2,799,193,095 shares of Common Stock outstanding as of September 30, 2010. PART I. FINANCIAL INFORMATION Financial Statements. The Consolidated Statements of Earnings of The Procter & Gamble Company and subsidiaries (the Company, we or our) for the three months ended September 30, 2010 and 2009, the Consolidated Balance Sheets as of September 30, 2010 and June 30, 2010, and the Consolidated Statements of Cash Flows for the three months ended September 30, 2010 and 2009 follow. In the opinion of management, these unaudited Consolidated Financial Statements contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, such financial statements may not necessarily be indicative of annual results. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS Three Months Ended September 30 Amounts in millions except per share amounts Selling, general and administrative expense Other non-operating income/(expense), net Earnings from Continuing Operations Before Income Taxes Income taxes on continuing operations Net Earnings from Continuing Operations Net Earnings from Discontinued Operations Basic net earnings from continuing operations Basic net earnings from discontinued operations Diluted net earnings from continuing operations Diluted net earnings from discontinued operations Diluted Weighted Average Common Shares Outstanding to Consolidated Financial Statements PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS Cash and cash equivalents Prepaid expenses and other current assets PROPERTY, PLANT AND EQUIPMENT Total property, plant and equipment NET PROPERTY, PLANT AND EQUIPMENT GOODWILL AND OTHER INTANGIBLE ASSETS Trademarks and other intangible assets, net NET GOODWILL AND OTHER INTANGIBLE ASSETS LIABILITIES AND SHAREHOLDERS EQUITY Accrued and other liabilities TOTAL CURRENT LIABILITIES OTHER NONCURRENT LIABILITIES Common stock  shares issued  Additional paid-in capital Reserve for ESOP debt retirement Accumulated other comprehensive income (loss) TOTAL SHAREHOLDERS EQUITY TOTAL LIABILITIES AND SHAREHOLDERS EQUITY See accompanying Notes to Consolidated Financial Statements PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS Three Months Ended September 30 CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD Depreciation and amortization Share-based compensation expense (Gain)/loss on sale of businesses Accounts payable, accrued and other liabilities Other operating assets and liabilities TOTAL OPERATING ACTIVITIES Proceeds from asset sales Acquisitions, net of cash acquired TOTAL INVESTING ACTIVITIES Dividends to shareholders Change in short-term debt Additions to long-term debt Reductions of long-term debt Impact of stock options and other TOTAL FINANCING ACTIVITIES EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS CHANGE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, END OF PERIOD See accompanying Notes to Consolidated Financial Statements PROCTER & GAMBLE COMPANY AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS These statements should be read in conjunction with the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2010. The results of operations for the three-month period ended September 30, 2010 are not necessarily indicative of annual results. Comprehensive Income - Total comprehensive income is comprised primarily of net earnings, net currency translation gains and losses, impacts of net investment and cash flow hedges, net unrealized gains and losses on investment securities and defined benefit and other retiree benefit plan activities. Total comprehensive income for the three months ended September 30, 2010 and 2009 was $5,896 million and $4,702 Segment Information - Following is a summary of segment results. As discussed in Note 10, a certain divested business is presented as discontinued operations and is excluded from segment results for all periods presented. Following is a summary of segment results. Three Months Ended September 30 from Continuing Operations Before Net Earnings from Continuing Operations Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Goodwill and Other Intangible Assets - Goodwill as of September 30, 2010 is allocated by reportable segment and global business unit as follows (amounts in Beauty, beginning of year Acquisitions and divestitures Goodwill, September 30, 2010 Grooming, beginning of year Acquisitions and divestitures Goodwill, September 30, 2010 Health Care, beginning of year Acquisitions and divestitures Goodwill, September 30, 2010 Snacks and Pet Care, beginning of year Acquisitions and divestitures Goodwill, September 30, 2010 Fabric Care and Home Care, beginning of year Acquisitions and divestitures Goodwill, September 30, 2010 Baby Care and Family Care, beginning of year Acquisitions and divestitures Goodwill, September 30, 2010 Corporate, beginning of year Acquisitions and divestitures Goodwill, September 30, 2010 GOODWILL, beginning of year Acquisitions and divestitures Goodwill, September 30, 2010 The increase in goodwill from June 30, 2010 is primarily due to currency translation across all GBUs and the acquisition of Ambi Pur. assets as of September 30, 2010 are comprised of (amounts in millions): Amortizable intangible assets with determinable lives Intangible assets with indefinite lives Total identifiable intangible assets Amortizable intangible assets consist principally of brands, patents, technology and customer relationships. The non-amortizable intangible assets consist primarily of brands. The amortization of intangible assets for the three months ended September 30, 2010 and 2009 was $140 million and $145 million, respectively. Pursuant to applicable accounting guidance for share-based payments, companies must recognize the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of those awards. Total share-based compensation for the three months ended September 30, 2010 and 2009 are summarized in the following table (amounts in millions): Three Months Ended September 30 Total share-based compensation Assumptions utilized in the model are evaluated and revised, as necessary, to reflect market conditions and Postretirement Benefits - The Company offers various postretirement benefits to its employees. The components of net periodic benefit cost for defined benefit plans are as follows: Three Months Ended September 30 Three Months Ended September 30 Expected return on plan assets Amortization of deferred amounts Recognized net actuarial loss Gross benefit cost (credit) Dividends on ESOP preferred stock Net periodic benefit cost (credit) June 30, 2011, the expected return on plan assets is 7.0% and 9.2% for defined benefit and other retiree benefit plans, respectively. Risk Management Activities and Fair Value Measurements As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. For details on the Companys risk management activities, refer to the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2010. Fair Value Hierarchy For a discussion of the Companys fair value measurement policies under the fair value hierarchy, refer to the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2010. The Company has not changed its valuation techniques in measuring the fair value of any financial assets and liabilities during the period. The following table sets forth the Companys financial assets and liabilities as of September 30 and June 30, 2010 that are measured at fair value on a recurring basis during the period, segregated by level within the fair value hierarchy: Other foreign currency instruments (1) Total assets at fair value (2) Liabilities at fair value: Other foreign currency instruments (1) Total liabilities at fair value (3) Other foreign currency instruments are comprised of foreign currency financial instruments that do not qualify as hedges. Investment securities are presented in other noncurrent assets and all derivative assets are presented in prepaid expenses and other current assets or other noncurrent All liabilities are presented in accrued and other liabilities or other noncurrent liabilities. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each quarter. There was no significant activity within the Level 3 assets and liabilities during the periods presented. There were no significant assets or liabilities that were re-measured at fair value on a non-recurring basis during the periods presented. Companys financial instruments used in hedging transactions are governed by industry standard netting agreements with counterparties. If the Companys credit rating were to fall below the levels stipulated in the agreements, the counterparties could demand either collateralization or termination of the arrangement. The aggregate fair value of the instruments covered by these contractual features that are in a net liability position as of September 30, 2010 was $177 million. The Company has never been required to post any collateral as a result of these contractual features. Fair Values of Other Financial Instruments Other financial instruments, including cash equivalents, other investments and short-term debt, are recorded at cost, which approximates fair value. The fair value of the long-term debt was $23,707 million and $23,072 million at September 30 and June 30, 2010, respectively. Disclosures about Derivative Instruments The notional amounts and fair values of qualifying and non-qualifying financial instruments used in hedging transactions as of September 30 and June 30, 2010 are as follows: Fair Value Asset (Liability) Derivatives in Cash Flow Hedging Relationships Foreign currency contracts Derivatives in Fair Value Hedging Relationships Derivatives in Net Investment Hedging Relationships Derivatives Not Designated as Hedging Instruments Foreign currency contracts The total notional amount of contracts outstanding at the end of the period is indicative of the level of the Companys derivative activity during the period. Amount of Gain (Loss) Recognized in Accumulated OCI on Derivatives (Effective Portion) Derivatives in Cash Flow Hedging Relationships Foreign currency contracts Derivatives in Net Investment Hedging Relationships During the next 12 months, the amount of the September 30, 2010 accumulated other comprehensive income (OCI) balance that will be reclassified to earnings is expected to be immaterial. The amounts of gains and losses on qualifying and non-qualifying financial instruments used in hedging transactions for the three months ended September 30, 2010 and 2009 are as follows: Amount of Gain (Loss) Reclassified from Accumulated OCI into Three Months Ended September 30 Derivatives in Cash Flow Hedging Relationships Foreign currency contracts Amount of Gain (Loss) Recognized in Income Three Months Ended September 30 Derivatives in Fair Value Hedging Relationships (2) Derivatives in Net Investment Hedging Relationships (2) Derivatives Not Designated as Hedging Instruments (3) Foreign currency contracts The gain or loss on the effective portion of cash flow hedging relationships is reclassified from accumulated OCI into net income in the same period during which the related item affects earnings. Such amounts are included in the Consolidated Statements of Earnings as follows: interest rate contracts in interest expense, foreign currency contracts in selling, general and administrative expense and interest expense and commodity contracts in cost of products sold. The gain or loss on the ineffective portion of interest rate contracts and net investment hedges, if any, is included in the Consolidated Statements of Earnings in The gain or loss on contracts not designated as hedging instruments is included in the Consolidated Statements of Earnings as follows: foreign currency contracts in selling, general and administrative expense and commodity contracts in cost of products sold. New Accounting Pronouncements and Policies No new accounting pronouncement issued or effective during the fiscal year has had or is expected to have a material impact on the Consolidated Financial Statements. Commitments and Contingencies We are subject to various legal proceedings and claims arising out of our business which cover a wide range of matters such as governmental regulations, antitrust and trade regulations, product liability, patent and trademark matters, income taxes and other actions. As previously disclosed, the Company is subject to a variety of investigations into potential competition law violations in Europe by the European Commission and national authorities from a number of countries, as detailed in Part 2, Item 1, Legal Proceedings of this 10-Q. These matters involve a number of consumer products companies and/or retail customers. The Companys policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with investigations by relevant regulatory authorities, which the Company is doing. Competition and antitrust law inquiries often continue for several years and, if violations are found, can result in substantial fines. In response to the actions of the European Commission and national authorities, the Company launched its own internal investigations into potential violations of competition laws. The Company has identified violations in certain European countries and appropriate actions were taken. Several countries in Europe have issued separate complaints pursuant to their investigations alleging that the Company, along with several other companies, engaged in violations of competition laws in those countries. The Company either has, or will have, the opportunity to respond to these complaints. As a result of our initial and on-going analyses of these complaints, the Company has reserves totaling $275 million as of September 30, 2010 for potential fines for competition law violations. The ultimate resolution of these matters could result in fines or costs significantly in excess of the amounts reserved. The remaining matters involving the European Commission and various other countries are in various stages of the investigatory process. It is still too early for us to reasonably estimate the total amount of fines to which the Company will be subject as a result of these competition law issues. The ultimate resolution of these matters will likely result in fines or other costs that could materially impact our income statement and cash flows in the period in which they are accrued and paid, respectively. In other industries, these fines have amounted to hundreds of millions of dollars. We will continue to monitor developments for all of these investigations and will record additional charges as appropriate. With respect to other litigation and claims, while considerable uncertainty exists, in the opinion of management and our counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows. We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will have a material adverse effect on our financial position, results of operations or cash flows. Income Tax Uncertainties The Company is present in over 150 taxable jurisdictions and, at any point in time, has 50  60 audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law and closing of statute of limitations. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 1997 and forward. We are generally not able to reliably estimate the ultimate settlement amounts or timing until the close of the audit. At this time, we are not able to make a reasonable estimate of the range of impact on the balance of uncertain tax positions or the impact on the effective tax rate related to these items. Additional information on the Commitments and Contingencies of the Company can be found in Note 10, Commitments and Contingencies, which appears in the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2010. Discontinued Operations In October 2009, the Company completed the divestiture of our global pharmaceuticals business to Warner Chilcott plc (Warner Chilcott) for $2.8 billion of cash, net of assumed and transferred liabilities. Under the terms of the agreement, Warner Chilcott acquired our portfolio of branded pharmaceutical products, our prescription drug product pipeline and manufacturing facilities in Puerto Rico and Germany. In addition, the majority of the employees working on the pharmaceuticals business were transferred to Warner Chilcott. The Company recorded an after-tax gain on the transaction of $1,464 million in the quarter ended December 31, 2009. In accordance with the applicable accounting guidance for the disposal of long-lived assets, the results of the pharmaceuticals business are presented as discontinued operations and, as such, have been excluded from continuing operations for all periods presented. Following is selected financial information included in net earnings from discontinued operations for the pharmaceuticals business: Three months ended September 30 Earnings from discontinued operation Net earnings from discontinued operations Managements Discussion and Analysis of Financial Condition and Results of Operations The purpose of this discussion is to provide an understanding of P&Gs financial results and condition by focusing on changes in certain key measures from year to year. Managements Discussion and Analysis (MD&A) is organized in the following sections: Forward-Looking Statements Results of Operations  Three Months Ended September 30, 2010 Business Segment Discussion  Three Months Ended September 30, 2010 Reconciliation of Non-GAAP Measures Throughout MD&A, we refer to measures used by management to evaluate performance, including unit volume growth, net outside sales and after-tax profit. We also refer to organic sales growth, free cash flow and free cash flow productivity. These financial measures are not defined under accounting principles generally accepted in the United States of America (U.S. GAAP). The explanation at the end of MD&A provides more details on the use and the derivation of these measures. Management also uses certain market share and market consumption estimates to evaluate performance relative to competition despite some limitations on the availability and comparability of such information. References to market share and market consumption in MD&A are based on a combination of vendor-reported consumption and market size data, as well as internal estimates. OVERVIEW P&Gs business is focused on providing branded consumer goods products. Our purpose is to provide products and services of superior quality and value that improve the lives of the worlds consumers, now and for generations to come. We believe this will result in leadership sales, profits and value creation, allowing employees, shareholders and the communities in which we operate to prosper. Our products are sold in more than 180 countries primarily through mass merchandisers, grocery stores, membership club stores, drug stores and high frequency stores, the neighborhood stores which serve many consumers in developing markets. We continue to expand our presence in other channels including department stores, perfumeries, pharmacies, salons and e-commerce. We compete in multiple product categories and have three global business units (GBUs): Beauty and Grooming; Health and Well-Being; and Household Care. Under U.S. GAAP, the business units comprising the GBUs are aggregated into six reportable segments: Beauty; Grooming; Health Care; Snacks and Pet Care; Fabric Care and Home Care; and Baby Care and Family Care. We have on-the-ground operations in approximately 80 countries through our Market Development Organization, which leads country business teams to build our brands in local markets and is organized along five geographic units: North America, Western Europe, Central & Eastern Europe/Middle East/Africa (CEEMEA), Latin America and Asia, which is comprised of Japan, Greater China and ASEAN/Australia/India/Korea (AAIK). Throughout MD&A, we reference business results in developing markets, which we define as the aggregate of CEEMEA, Latin America, AAIK and Greater China, and developed markets, which are comprised of North America, Western Europe and Japan. On October 30, 2009, we sold our global pharmaceuticals business to Warner Chilcott plc (Warner Chilcott) for $2.8 billion. Under the terms of the agreement, Warner Chilcott acquired our portfolio of branded pharmaceuticals products, prescription drug product pipeline and manufacturing facilities in Puerto Rico and Germany. The pharmaceuticals business had historically been part of the Health Care reportable segment. In accordance with applicable accounting guidance for the disposal of long-lived assets, the results of the pharmaceuticals business are presented as discontinued operations and, as such, are excluded from continuing operations and from segment results. The table below provides more information about the components of our GBU structure. Cosmetics, Female Antiperspirant and Deodorant, Female Personal Cleansing, Female Shave Care, Hair Care, Hair Color, Hair Styling, Pharmacy Channel, Prestige Products, Salon Head & Shoulders, Olay, Pantene, Wella Beauty Electronics, Home Small Appliances, Male Blades and Razors, Male Personal Care Braun, Fusion, Gillette, Mach3 Feminine Care, Gastrointestinal, Incontinence, Rapid Diagnostics, Respiratory, Toothbrush, Toothpaste, Water Filtration, Other Oral Care Fabric Care and Home Care Additives, Air Care, Batteries, Dish Care, Fabric Enhancers, Laundry, Surface Care Ace, Ariel, Dawn, Downy, Duracell, Gain, Tide Baby Care and Family Care Baby Wipes, Diapers, Paper Towels, Tissues, Toilet Paper Bounty, Charmin, Pampers The following table provides the percentage of net sales and net earnings from continuing operations by reportable business segment for the three months ended September 30, 2010 (excludes net sales and net earnings in Corporate): Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Following are highlights of results for the three months ended September 30, 2010: Net sales increased 2% to $20.1 billion. Organic sales, which exclude the impacts of acquisitions, divestitures and foreign exchange, were up 4%. Unit volume grew 8%, led by double-digit growth in the Fabric Care and Home Care and Baby Care and Family Care segments. Net earnings from continuing operations were $3.1 billion, an increase of 2% versus the prior year period mainly due to net sales growth. Net earnings declined 7% to $3.1 billion due to the lost contribution from the discontinued pharmaceuticals business. Diluted net earnings per share from continuing operations increased 5% to $1.02. Earnings per share growth exceeded net earnings growth due to the impact of share repurchase activity. Diluted net earnings per share decreased 4% versus the prior year period to $1.02 as the loss of contribution from discontinued operations was only partially offset by increased earnings from continuing operations. Operating cash flow decreased $2.1 billion versus the prior year period to $2.5 billion mainly due to an increase in working capital. Free cash flow, which is operating cash flow less capital expenditures, was $1.9 billion. Free cash flow productivity, which is the ratio of free cash flow to net earnings, was 63%. FORWARD-LOOKING STATEMENTS We discuss expectations regarding future performance, events and outcomes, such as our business outlook and objectives, in annual and quarterly reports, press releases and other written and oral communications. All such statements, except for historical and present factual information, are forward-looking statements, and are based on financial data and our business plans available only as of the time the statements are made, which may become out-of-date or incomplete. We assume no obligation to update any forward-looking statements as a result of new information, future events or other factors. Forward-looking statements are inherently uncertain and investors must recognize that events could be significantly different from our expectations. For more information on risks that could impact our results, refer to Item 1A Risk Factors in our most recent 10-K filing. Ability to Achieve Business Plans: We are a consumer products company and rely on continued demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers and retail trade customers. Our continued success is dependent on leading-edge innovation with respect to both products and operations and on the continued positive reputations of our brands. This means we must be able to obtain patents and respond to technological advances and patents granted to competition. Our success is also dependent on effective sales, advertising and marketing programs in an increasingly fragmented media environment. Our ability to innovate and execute in these areas will determine the extent to which we are able to grow existing sales and volume profitably, especially with respect to the product categories and geographic markets (including developing markets) in which we have chosen to focus. There are high levels of competitive activity in the environments in which we operate. To address these challenges, we must respond to competitive factors, including pricing, promotional incentives, trade terms and product initiatives. We must manage each of these factors, as well as maintain mutually beneficial relationships with our key customers, in order to effectively compete and achieve our business plans. As a company that manages a portfolio of consumer brands, our ongoing business model involves a certain level of ongoing acquisition and divestiture activities. We must be able to successfully manage the impacts of these activities, while at the same time delivering against base business objectives. Our success will also depend on our ability to maintain key information technology systems. Cost Pressures: Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, cost of labor, foreign exchange and interest rates. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects, sourcing decisions and certain hedging transactions. We also must manage our debt and currency exposure, especially in certain countries, such as Venezuela, China and India. We need to maintain key manufacturing and supply arrangements, including sole supplier and sole manufacturing plant arrangements. We must implement, achieve and sustain cost improvement plans, including our outsourcing projects and those related to general overhead and workforce optimization. Successfully managing these changes, including identifying, developing and retaining key employees, is critical to our success. Global Economic Conditions: Economic changes, terrorist activity and political unrest may result in business interruption, inflation, deflation or decreased demand for our products. Our success will depend, in part, on our ability to manage continued global political and/or economic uncertainty, especially in our significant geographic markets, as well as any political or economic disruption due to terrorist and other hostile activities. Regulatory Environment: Changes in laws, regulations and the related interpretations may alter the environment in which we do business. This includes changes in environmental, competitive and product-related laws, as well as changes in accounting standards and taxation requirements. Our ability to manage regulatory, tax and legal matters (including product liability, patent, intellectual property, competition law matters and tax policy) and to resolve pending legal matters within current estimates may impact our results. RESULTS OF OPERATIONS  Three Months Ended September 30, 2010 The following discussion provides a review of results for the three months ended September 30, 2010 versus the three months ended September 30, 2009. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended September 30 SELLING GENERAL & ADMINISTRATIVE EXPENSE OTHER NON-OPERATING INCOME/(EXPENSE), NET EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES NET EARNINGS FROM CONTINUING OPERATIONS NET EARNINGS FROM DISCONTINUED OPERATIONS EFFECTIVE TAX RATE FROM CONTINUING OPERATIONS BASIC NET EARNINGS  CONTINUING OPERATIONS BASIC NET EARNINGS  DISCONTINUED OPERATIONS DILUTED NET EARNINGS  CONTINUING OPERATIONS DILUTED NET EARNINGS  DISCONTINUED OPERATIONS AVERAGE DILUTED SHARES OUTSTANDING COMPARISONS AS A % OF NET SALES SELLING, GENERAL & ADMINISTRATIVE EXPENSE EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES NET EARNINGS FROM CONTINUING OPERATIONS Net sales increased 2% to $20.1 billion for the July - September quarter on an 8% increase in unit volume. Volume growth was broad based with growth in all geographic regions, led by double-digit growth in developing regions. Five of the six business segments contributed to volume growth, led by double-digit growth in the Fabric Care and Home Care and the Baby Care and Family Care segments. Volume in the Beauty, Grooming and Health Care segments was up mid-single digits, while volume in the Snacks and Pet Care segment declined low single digits. Organic volume, which excludes acquisitions and divestitures, increased 7%. Price reductions lowered net sales by 1% mainly due to pricing adjustments executed in previous periods, partially offset by price increases taken in developing regions to offset currency devaluations. Negative mix reduced net sales by 2% due mainly to disproportionate growth in developing regions and mid-tier value products, both of which have lower than Company average selling prices. Unfavorable foreign exchange lowered net sales by 3% as key foreign currencies weakened versus the U.S. dollar. Organic sales growth was 4% driven by unit volume growth, partially offset by the impact of price reductions and unfavorable mix. Net Sales Change Drivers 2010 vs. 2009 (Three Months Ended Sep. 30) Volume with Acquisitions & Divestitures Volume excluding Acquisitions & Divestitures Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Sales percentage changes are approximations based on quantitative formulas that are consistently applied. Gross margin contracted 70 basis points to 51.9% of net sales in the first fiscal quarter. The reduction in gross margin was driven mainly by higher commodity and energy costs and unfavorable product mix, partially offset by the impact of volume scale leverage and manufacturing cost savings. Total selling, general and administrative expenses (SG&A) were in line with the prior year period at $5.9 billion as higher marketing spending was offset by reduced overhead spending and the impact of higher base period foreign currency exchange costs primarily related to our operations in Venezuela. In the prior year period, foreign currency exchange costs related to our operations in Venezuela were approximately $320 million versus approximately $10 million in the current period. These costs included losses incurred to swap bolivars for U.S. dollars in the parallel market and the remeasurement of a portion of our net monetary assets denominated in bolivars at the parallel market exchange rate. See the section titled Foreign Currency Translation  Venezuela Impacts below for additional discussion. SG&A as a percentage of net sales declined 60 basis points due mainly to scale leverage from an increase in net sales. Interest expense was $208 million for the quarter, down $79 million versus the prior year period primarily due to a reduction in debt outstanding and lower interest rates on floating rate debt. Other non-operating income/(expense), net declined $34 million mainly behind lower interest and investment income and higher provisions for noncontrolling interests due to increased earnings in less than fully-owned subsidiaries. The effective tax rate on continuing operations increased 30 basis points to 28.0% primarily due to audit settlements in the prior year period. Net earnings from continuing operations increased 2% to $3.1 billion for the quarter, in line with net sales growth. Operating margin declined 10 basis points as lower gross margin was largely offset by a reduction in SG&A as a percentage of net sales. The impact of lower interest expense was largely offset by lower other non-operating income/(expense), net and a higher effective tax rate. Diluted net earnings per share from continuing operations increased 5% to $1.02. Earnings per share growth exceeded net earnings growth due to the impact of share repurchase activity. Net earnings from discontinued operations declined $280 million for the quarter due to the loss of contribution from the global pharmaceuticals business which was divested at the end of October 2009. Net earnings declined 7% for the quarter to $3.1 billion behind a decrease in net earnings from discontinued operations, partially offset by an increase in net earnings from continuing operations. Diluted net earnings per share were down 4% to $1.02. The decline in earnings per share was less than the decline in net earnings due to the impact of share repurchases. Foreign Currency Translation  Venezuela Impacts Venezuela is a highly inflationary economy under U.S. GAAP. As a result, the U.S. dollar is the functional currency for our subsidiaries in Venezuela. Any currency remeasurement adjustments for non-dollar denominated monetary assets and liabilities held by these subsidiaries and other transactional foreign exchange gains and losses are reflected in earnings. The Venezuelan government has introduced a number of currency controls for companies operating in Venezuela. Under these controls, there are two official exchange rates for imported goods. Those goods classified as essential, such as food, medicine and capital investments, have an exchange rate of 2.6 bolivars to the U.S. dollar, while payments for other non-essential goods have an exchange rate of 4.3. Many of our imported products fall into the essential classification and qualify for the 2.6 rate. However, our overall results in Venezuela are reflected in our Consolidated Financial Statements at the 4.3 rate expected to be applicable to dividend repatriations. There are also exchange controls over securities transactions in the parallel market, which has historically been used to pay for imported goods and services that do not qualify for exchange in the official market. The Central Bank of Venezuela is the only legal intermediary through which parallel market transactions can be executed. The government controls the underlying parallel exchange rate which was approximately 5.3 at September 30, 2010. The notional amount of transactions that run through this parallel market mechanism is very restricted, which has eliminated our ability to access the parallel market to pay for imported goods and/or manage our local monetary asset balances. As of September 30, 2010, we had net monetary assets denominated in local currency of approximately $490 million. Approximately $260 million of this balance has been remeasured using the parallel rate because we plan to use that amount of the net assets (largely cash) to satisfy U.S. dollar denominated liabilities that do not qualify for official rate dollars. The availability of the parallel market to settle these transactions is uncertain. The remaining net monetary asset balances are currently reflected within our Consolidated Financial Statements at the 4.3 official exchange rate. Depending on the future availability of U.S. dollars at the official rate, our local U.S. dollar needs and our overall repatriation plans, we have exposure for the differential between the official and parallel exchange rates on this portion of our local monetary assets. Our ability to effectively manage sales and profit levels in Venezuela will be impacted by several factors, including the Companys ability to mitigate the effect of the potential future devaluation, further actions of the Venezuelan government, economic conditions in Venezuela, such as inflation and consumer spending, the availability of raw materials, utilities and energy and the future state of exchange controls in Venezuela including the availability of U.S. dollars at the official foreign exchange rate. BUSINESS SEGMENT DISCUSSION  Three Months Ended September 30, 2010 The following discussion provides a review of results by business segment. Analyses of the results for the three months ended September 30, 2010 are provided compared to the same three month period ended September 30, 2009. The primary financial measures used to evaluate segment performance are net sales and net earnings from continuing operations. The table below provides supplemental information on net sales and net earnings from continuing operations by business segment for the three months ended September 30, 2010 versus the comparable prior year period (amounts in millions): Three Months Ended September 30, 2010 Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care BEAUTY AND GROOMING GBU Beauty Beauty net sales were in line with the prior year period at $4.9 billion on unit volume growth of 4%. Organic sales grew 3%. Volume in developing regions increased double digits, while volume in developed regions declined low single digits. Mix reduced net sales by 2% behind disproportionate growth in developing regions, which have lower than segment average selling prices, and declines in the premium-priced categories of Prestige Products and Salon Professional. Unfavorable foreign exchange lowered net sales growth by 2%. Volume in Retail Hair Care increased mid-single digits due to double-digit growth in developing regions behind initiative activity and market growth. Volume in Female Beauty grew mid-single digits primarily behind double-digit growth of Olay, Safeguard and Venus. Volume in Salon Professional declined high single digits mainly due to the exit of non-strategic businesses. Volume in Prestige Products was down high single digits behind lower shipments in Western Europe and the divestiture of minor brands. Net earnings increased 7% to $829 million driven by higher operating margin due to higher gross margin and lower SG&A as a percentage of net sales. Gross margin expanded behind manufacturing cost savings. SG&A as a percentage of net sales declined due to lower overhead spending and reduced foreign currency exchange costs, partially offset by higher marketing spending. Grooming Grooming net sales increased 2% to $1.9 billion on a 5% increase in unit volume. Organic sales were up 6%. Price increases, taken primarily across blades and razors, added 1% to net sales growth. Unfavorable foreign exchange reduced net sales growth by 4%. Volume grew double digits in developing regions and low single digits in developed regions. Male Grooming volume grew mid-single digits due to higher shipments of blades and razors, mainly in developing regions, and deodorants in North America and Latin America. Appliances volume increased high single digits behind increased shipments of beauty electronics, which includes shavers, epilators and hair care appliances. Global market share of the dry shave category increased over 2 points. Net earnings increased 13% to $398 million driven by higher net sales, increased operating margin and a lower tax rate. Operating margin increased behind higher gross margin and lower SG&A as a percentage of net sales. Gross margin increased due to improved product mix. SG&A as a percentage of net sales declined as lower foreign currency exchange costs and reduced overhead spending were only partially offset by higher marketing spending. HEALTH AND WELL-BEING GBU Health Care Health Care net sales were in line with the prior year period at $3.0 billion on unit volume growth of 6%. Organic sales grew 4%. Pricing reduced net sales by 2%. Unfavorable foreign exchange reduced net sales by 4%. Volume increased double digits in developing regions and low single digits in developed regions. Oral Care volume was up high single digits behind the launch of Crest ProHealth Clinical and ProHealth For Me in North America, expansion of Oral-B toothpaste and success of ProHealth and Complete in Latin America and continued success of Crest ProHealth in Asia. Global market share of the oral care category was up half a point. Personal Health Care volume increased low single digits behind higher shipments of Vicks and PuR, mainly in CEEMEA, partially offset by a continued decline of Prilosec OTC in North America due to increased competitive activity. Feminine Care volume grew mid-single digits due to higher shipments of Naturella behind expansion into China and growth of Always mainly in CEEMEA. Global market share of the feminine care category was down half a point. Net earnings declined 10% to $495 million driven by lower operating margin. Operating margin contracted mainly due to a marketing-spending driven increase in SG&A as a percentage of net sales. Snacks and Pet Care Snacks and Pet Care net sales decreased 6% to $709 million on a 1% decline in unit volume. Organic sales were down 9%. Pricing reduced net sales by 2%. Product mix reduced net sales by 2% due to the disproportionate growth of Snacks, which have lower than segment average selling prices. Unfavorable foreign exchange lowered net sales by 1%. Organic volume, which excludes the impact of acquisitions and divestitures, declined 4%. Volume in Snacks increased high single digits mainly due to increased distribution in CEEMEA and Latin America and X-treme and multigrain initiatives in North America and Western Europe. Volume in Pet Care was down high single digits due mainly to supply constraints resulting from a restructuring of the supply chain and following the recall of select dry pet food products, partially offset by the impact of the Natura Pet Products acquisition in June 2010. Net earnings declined 27% to $54 million mainly due to lower net sales and incremental costs related to the pet food recall and supply chain restructuring efforts. HOUSEHOLD CARE GBU Fabric Care and Home Care Fabric Care and Home Care net sales increased 3% to $6.3 billion on 10% unit volume growth. Organic sales were up 5% on 9% organic volume growth. Pricing lowered net sales by 2%. Negative product mix reduced net sales by 2% mainly due to disproportionate growth of mid-tier product lines and powdered laundry detergents, which have lower than segment average selling prices. Unfavorable foreign exchange reduced net sales by 3%. Volume in developing regions grew double digits, while volume in developed regions was up high single digits. Volume in Fabric Care increased high single digits mainly due to initiative activity and increased distribution in developing regions. Global market share of the fabric care category increased less than half a point. Volume in Home Care was up double digits driven mainly by initiative launches, market growth and the Ambi Pur acquisition. Global market share of the home care category was up over one point. Volume in Batteries grew high single digits primarily due to price reductions executed through pack count increases in North America, higher demand from business customers and market growth and distribution expansion in developing regions. Global market share of the batteries category increased over half a point. Net earnings decreased 7% to $937 million as sales growth was more than offset by operating margin contraction. Operating margin declined due to lower gross margin and higher SG&A as a percentage of net sales. Gross margin contracted due mainly to lower pricing, unfavorable product mix and higher commodity costs. SG&A as a percentage of net sales increased behind higher marketing spending. Baby Care and Family Care Baby Care and Family Care net sales increased 2% to $3.7 billion on volume growth of 10%. Organic sales grew 5%. Pricing lowered net sales by 2%. Mix reduced net sales by 3% driven mainly by disproportionate growth of mid-tier product lines, larger package sizes and developing regions, all of which have lower than segment average selling prices. Unfavorable foreign exchange reduced net sales by 3%. Volume increased double digits in developing regions and high single digits in developed regions. Baby Care volume was up high single digits behind initiative activity, market size growth and distribution expansion, primarily in developing regions. Global market share of the baby care category increased over 1 point. Family Care volume grew double digits behind initiative activity, increased merchandising and additional distribution of Charmin in Latin America. U.S. all outlet share of the family care category increased half a point. Net earnings declined 16% to $470 million as sales growth was more than offset by lower operating margin. Operating margin declined mainly due to lower gross margin driven by higher commodity costs, lower pricing and unfavorable product mix. SG&A as a percentage of net sales declined due to lower foreign currency exchange costs and overhead spending, partially offset by higher marketing spending. CORPORATE Corporate includes certain operating and non-operating activities not allocated to specific business units. These include: the incidental businesses managed at the corporate level; financing and investing activities; other general corporate items; the historical results of certain divested brands and categories; and certain restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization. Corporate also includes reconciling items to adjust the accounting policies used in the segments to U.S. GAAP. The most significant reconciling items include income taxes (to adjust from statutory rates that are reflected in the segments to the overall Company effective tax rate), adjustments for unconsolidated entities (to eliminate net sales, cost of products sold and SG&A for entities that are consolidated in the segments but accounted for using the equity method for U.S. GAAP) and noncontrolling interest adjustments for subsidiaries where we do not have 100% ownership. Since certain unconsolidated entities and less than 100%-owned subsidiaries are managed as integral parts of the Company, they are accounted for similar to a wholly-owned subsidiary for management and segment purposes. This means our segment results recognize 100% of each income statement component through before-tax earnings in the segments, with eliminations for unconsolidated entities and noncontrolling interests in Corporate. In determining segment after-tax net earnings, we apply the statutory tax rates (with adjustments to arrive at the Companys effective tax rate in Corporate) and eliminate the share of earnings applicable to other ownership interests, in a manner similar to noncontrolling interest. Corporate net sales primarily reflect the adjustment to eliminate the sales of unconsolidated entities included in business segment results. Accordingly, Corporate net sales is generally a negative balance. Negative net sales in Corporate were down 18% primarily due to currency impacts on adjustments required to eliminate the sales of unconsolidated entities. Net expenses from continuing operations decreased $189 million to $102 million. The decline in net expenses was driven by prior year costs for remeasuring a portion of our local currency denominated net monetary assets in Venezuela and lower current period restructuring-type spending and interest expense. We generated $2.5 billion of cash from operating activities in our first fiscal quarter. This represents a decline of 46% versus the prior year period primarily due to lower net earnings and higher levels of working capital. On a year-to-date basis, working capital consumed $1.3 billion of cash. Accounts receivable used $434 million of cash primarily due to increased sales later in the quarter, growth in categories, such as Respiratory, which have longer average payment terms and to support overall business growth. Inventory consumed $604 million of cash, mainly to support product initiatives and holiday-related shipments in some of our seasonal businesses. Accounts payable, accrued and other liabilities used $303 million of cash, primarily related to the payment of prior-year marketing accruals, which were unusually high due to several large initiative launches late in fiscal 2010. Investing Activities Our investing activities consumed cash of $928 million mainly to fund capital expenditures and acquisition activity. Acquisitions consumed $398 million due to the purchase of Ambi Pur, while proceeds from asset sales were minimal. Capital expenditures were $519 million or 2.6% of net sales. We expect capital expenditures of approximately 4% of net sales for the fiscal year. Cash used for investing activities increased $550 million versus the prior year period mainly due to net cash used for acquisitions and lower proceeds from divestitures. Financing Activities Our financing activities consumed net cash of $1.9 billion. We used $3.0 billion for treasury stock purchases and $1.4 billion for dividends and partially funded these cash outlays through the issuance of $2.4 billion of short-term debt. We expect to repurchase a total of $6 - $8 billion of treasury stock during fiscal 2011. Cash consumed by financing activities declined $902 million versus the prior year period due to increased levels of debt, partially offset by an increase in treasury stock purchases. As of September 30, 2010, our current liabilities exceeded current assets by $7.1 billion. We have short- and long-term debt to fund discretionary items such as acquisitions and share repurchase programs. We anticipate being able to support our short-term liquidity and operating needs largely through cash generated from operations. We have strong short- and long-term debt ratings which have enabled and should continue to enable us to refinance our debt as it becomes due at favorable rates in commercial paper and bond markets. In addition, we have agreements with a diverse group of financial institutions that, if needed, should provide sufficient credit funding to meet short-term financing requirements. RECONCILIATION OF NON-GAAP MEASURES Our discussion of financial results includes several measures not defined by U.S. GAAP. We believe these measures provide our investors with additional information about the underlying results and trends of the Company, as well as insight to some of the metrics used to evaluate management. When used in MD&A, we have provided the comparable GAAP measure in the discussion. Organic Sales Growth: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions, divestitures and foreign exchange from year-over-year comparisons. We believe this provides investors with a more complete understanding of underlying sales trends by providing sales growth on a consistent basis. The reconciliation of reported sales growth to organic sales for the July - September quarter: Acquisition/ Divestiture Impact* Fabric Care and Home Care Baby Care and Family Care Acquisition/Divestiture Impacts includes rounding impacts necessary to reconcile net sales to organic sales. Free Cash Flow: Free cash flow is defined as operating cash flow less capital spending. We view free cash flow as an important measure because it is one factor in determining the amount of cash available for dividends and discretionary investment. Free cash flow is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation. Free Cash Flow Productivity: Free cash flow productivity is defined as the ratio of free cash flow to net earnings. The Companys long-term target is to generate free cash at or above 90% of net earnings. Free cash flow is also one of the measures used to evaluate senior management. The reconciliation of free cash flow and free cash flow productivity is provided below (amounts Free Cash Flow Productivity Quantitative and Qualitative Disclosures About Market Risk. There have been no material changes in the Companys exposure to market risk since June 30, 2010. Additional information can be found in the section entitled Other Information, which appears on pages 48-49, and Note 5, Risk Management Activities and Fair Value Measurements, which appears on pages 59-62 of the Annual Report to Shareholders for the fiscal year ended June 30, 2010 which can be found by reference to Exhibit 13 of the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2010. Controls and Procedures. Evaluation of Disclosure Controls and Procedures. The Companys Chairman of the Board, President and Chief Executive Officer, Robert A. McDonald, and the Companys Chief Financial Officer, Jon R. Moeller, performed an evaluation of the Companys disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (Exchange Act)) as of the end of the period covered by this report. Messrs. McDonald and Moeller have concluded that the Companys disclosure controls and procedures were effective to ensure that information required to be disclosed in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) accumulated and communicated to our management, including Messrs. McDonald and Moeller, to allow their timely decisions regarding required disclosure. Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting that occurred during the Companys fiscal quarter ended September 30, 2010 that have materially affected, or are reasonably likely to materially affect, the Companys internal control over financial reporting. PART II. OTHER INFORMATION Legal Proceedings. The Company is subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental issues, patent and trademark matters, labor and employment matters and taxes. As previously reported, the Company is subject to a number of investigations into potential competition law violations in Europe. These investigations involve the European Commission, which is investigating potential competition law violations in a variety of countries across the European Union, as well as individual investigations by national authorities in Belgium, the Czech Republic, France, Germany, Greece, Italy, Romania, Spain, Switzerland and the United Kingdom. We believe that all of these matters involve a number of other consumer products companies and/or retail customers. Although non-monetary sanctions are not being sought in any of these matters, competition and antitrust law investigations often continue for several years and, if violations are found, can result in substantial fines. In other industries, fines have amounted to hundreds of millions of dollars. The Companys policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with investigations by relevant regulatory authorities, which the Company is doing. In response to the actions of the European Commission and national authorities, the Company launched its own internal investigations into potential violations of competition laws. The Company identified violations in certain European countries and appropriate actions were taken. To date, authorities in the Czech Republic, France, Germany, Italy, Spain and Switzerland have issued separate complaints alleging that the Company, along with several other companies, engaged in violations of competition laws. The Company either has, or will have, the opportunity to respond to these complaints. The remaining matters discussed above are in various stages of the investigatory process. The Company has taken, and will continue to take, reserves as appropriate. However, it is still too early for us to reasonably estimate the total amount of fines to which the Company will be subject as a result of these various competition law issues. Please refer to the Companys Risk Factors in Item 1A of this Form 10-Q for additional information. In December 2008, the Company became aware of an investigation by Italian authorities into an environmental accident at the site of a contractor which provides services to one or more of the Companys European affiliates. The accident involved the explosion of certain pressurized cans and resulted in the death of one worker and serious injuries to another. Italian authorities have commenced a formal criminal proceeding regarding whether the Companys local affiliate and certain of its employees complied with Italian laws related to the proper classification and disposal of their products. Should they find that these entities violated the law, the Italian authorities could levy fines in excess of $100 thousand against the Companys European affiliate(s). discussion of the Companys risk factors, please refer to Part 1, Item 1A. Risk Factors in the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2010. Unregistered Sales of Equity Securities and Use of Proceeds. ISSUER PURCHASES OF EQUITY SECURITIES Total Number of Shares Purchased (1) Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Plans Approximate Dollar Value of Shares That May Yet Be Purchased Under our Share Repurchase Program ($ in billions) (3) (4) The total number of shares purchased was 54,687,581 for the quarter. This includes 1,347 shares acquired by the Company under various compensation and benefit plans and 4,869,267 shares acquired by the Profit Sharing Trust. All transactions were made in the open market or pursuant to prepaid forward agreements with large financial institutions. Under these agreements, the Company prepays large financial institutions to deliver shares at future dates in exchange for a discount. This table excludes shares withheld from employees to satisfy minimum tax withholding requirements on option exercises and other equity-based transactions. The Company administers cashless exercises through an independent, third party and does not repurchase stock in connection with cashless exercise. Average price paid per share is calculated on a settlement basis and excludes commission. On August 3, 2010, the Company announced a share repurchase plan to acquire $6 to $8 billion of Company common stock during the fiscal year ending June 30, 2011 in open market and/or private transactions. This repurchase plan was authorized pursuant to a resolution issued by the Companys Board of Directors and is expected to be financed by issuing a combination of long-term and short-term debt. Certain purchases were made prior to the announcement of the plan but are considered purchases against the plan. The dollar values listed in this column include commissions to be paid to brokers to execute the transactions. Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October 14, 2008) (Incorporated by reference to Exhibit (3-1) of the Companys Form 10-Q for the quarter ended December 31, 2008). Regulations (as amended by the Board of Directors on April 18, 2010 pursuant to authority granted by shareholders at the annual meeting on October 13, 2009). (Incorporated by reference to Exhibit 3.ii of the Companys Form 8-K filed on April 18, 2010). Summary of Performance Stock Program Summary (Incorporated by reference to Exhibit 99 of the Companys Form 8-K filed on August 10, 2010). * Computation of Earnings per Share. Computation of Ratio of Earnings to Fixed Charges.",9516
2010-11-18,8-K,0000950123-10-107034,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) November 18, 2010 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) On November 18, 2010, The Procter & Gamble Company (the Company) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.800% Notes due 2015 and $500,000,000 aggregate principal amount of Floating Rate Notes due 2012 under the Companys Registration Statement on Form S-3 (Registration No. 333-161767) (the Registration Statement). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are incorporated Financial Statements and Exhibits. (d) The following exhibits are being filed with this Current Report on Form 8-K. Opinion of Jason P. Muncy, Esq., Associate Director & Associate General Counsel of the Company. Opinion of Fried, Frank, Harris, Shriver & Jacobson LLP, which is referred to in the opinion Consent of Jason P. Muncy, Esq., which is contained in his opinion filed as Exhibit (5)(a).",249
2010-12-14,8-K,0000735244-10-000018,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 5.02(d) ELECTION OF DIRECTORS On December 14, 2010, The Procter & Gamble Company (the ""Company"") issued a news release announcing that Susan Desmond-Hellmann, MD was appointed to the Board of Directors on December 13, 2010. Dr. Hellmann will serve on the Audit and Innovation & Technology Committees. The Company is filing this 8-K pursuant to Item 5.02(d), ""Election of Directors."" A copy of the Company's press release relating to this announcement is being furnished as Exhibit 99 to this 8-K.",194
2011-01-11,8-K,0000735244-11-000002,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On January 11, 2011, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of forty-eight point eighteen cents ($0.4818) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after February 15, 2011 to Common Stock shareholders of record at the close of business on January 21, 2011, and payable on the dividend payment date for the Common Stock to Series A and Series B Preferred Stock shareholders of record at the start of business on that date. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",232
2011-01-27,8-K,0000735244-11-000007,"ond2010earningsrelease.htm SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) ( Registrant's telephone number, including area code ) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 27, 2011, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended December 31, 2010. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",160
2011-01-28,10-Q,0001193125-11-017328,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 31, 2010 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission file number 1-434 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (513) 983-1100 (Registrants telephone number, including area code) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No  Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No  Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Large accelerated filer  Accelerated filer  Non-accelerated filer  Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No  There were 2,800,783,600 shares of Common Stock outstanding as of December 31, 2010. PART I. FINANCIAL INFORMATION Financial Statements. The Consolidated Statements of Earnings of The Procter & Gamble Company and subsidiaries (the Company, we or our) for the three months and six months ended December 31, 2010 and 2009, the Consolidated Balance Sheets as of December 31, 2010 and June 30, 2010, and the Consolidated Statements of Cash Flows for the six months ended December 31, 2010 and 2009 follow. In the opinion of management, these unaudited Consolidated Financial Statements contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, such financial statements may not necessarily be indicative of annual results. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS Three Months Ended December 31 Six Months Ended December 31 Amounts in millions except per share amounts Selling, general and administrative expense Other non-operating income/(expense), net Earnings from Continuing Operations Before Income Taxes Income taxes on continuing operations Net Earnings from Continuing Operations Net Earnings from Discontinued Operations Basic net earnings from continuing operations Basic net earnings from discontinued operations Diluted net earnings from continuing operations Diluted net earnings from discontinued operations Diluted Weighted Average Common Shares Outstanding to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS Cash and cash equivalents Prepaid expenses and other current assets PROPERTY, PLANT AND EQUIPMENT Total property, plant and equipment NET PROPERTY, PLANT AND EQUIPMENT GOODWILL AND OTHER INTANGIBLE ASSETS Trademarks and other intangible assets, net NET GOODWILL AND OTHER INTANGIBLE ASSETS LIABILITIES AND SHAREHOLDERS EQUITY Accrued and other liabilities TOTAL CURRENT LIABILITIES OTHER NONCURRENT LIABILITIES Common stock  shares issued  Additional paid-in capital Reserve for ESOP debt retirement Accumulated other comprehensive income (loss) TOTAL SHAREHOLDERS EQUITY TOTAL LIABILITIES AND SHAREHOLDERS EQUITY See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS Six Months Ended December 31 CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD Depreciation and amortization Share-based compensation expense Gain on sale of businesses Accounts payable, accrued and other liabilities Other operating assets and liabilities TOTAL OPERATING ACTIVITIES Proceeds from asset sales Acquisitions, net of cash acquired TOTAL INVESTING ACTIVITIES Dividends to shareholders Change in short-term debt Additions to long-term debt Reductions of long-term debt Impact of stock options and other TOTAL FINANCING ACTIVITIES EFFECT OF EXCHANGE RATE CHANGES ON CASH CHANGE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, END OF PERIOD See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS These statements should be read in conjunction with the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2010. The results of operations for the three-month and six-month periods ended December 31, 2010 are not necessarily indicative of annual results. Comprehensive Income - Total comprehensive income is comprised primarily of net earnings, net currency translation gains and losses, impacts of net investment and cash flow hedges, net unrealized gains and losses on investment securities and defined benefit and other retiree benefit plan activities. Total comprehensive income for the three months ended December 31, 2010 and 2009 was $2,984 million and $4,386 million, respectively. For the six months ended December 31, 2010 and 2009, total comprehensive income was $8,880 million and $9,088 million, respectively. Segment Information - Following is a summary of segment results. As discussed in Note 10, our divested global pharmaceutical business is presented as discontinued operations and is excluded from segment results for all periods presented. Following is a summary of segment Three Months Ended December 31 Six Months Ended December 31 from Continuing Operations Before Net Earnings from Continuing Operations from Continuing Operations Before Net Earnings from Continuing Operations Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Goodwill and Other Intangible Assets  Goodwill as of December 31, 2010 is allocated by reportable segment and global business unit as follows (amounts in Six Months Ended December Beauty, beginning of year Acquisitions and divestitures Goodwill, December 31, 2010 Grooming, beginning of year Acquisitions and divestitures Goodwill, December 31, 2010 Health Care, beginning of year Acquisitions and divestitures Goodwill, December 31, 2010 Snacks and Pet Care, beginning of year Acquisitions and divestitures Goodwill, December 31, 2010 Fabric Care and Home Care, beginning of year Acquisitions and divestitures Goodwill, December 31, 2010 Baby Care and Family Care, beginning of year Acquisitions and divestitures Goodwill, December 31, 2010 Corporate, beginning of year Acquisitions and divestitures Goodwill, December 31, 2010 GOODWILL, beginning of year Acquisitions and divestitures Goodwill, December 31, 2010 The increase in goodwill from June 30, 2010 is primarily due to currency translation across all GBUs and the acquisition of Ambi Pur in our Fabric Care and Home Care reportable segment. Identifiable intangible assets as of December 31, 2010 are comprised of (amounts in Amortizable intangible assets with determinable lives Intangible assets with indefinite lives Total identifiable intangible assets Defined life intangible assets consist principally of brands, patents, technology and customer relationships. Indefinite lived intangible assets consist primarily of brands. The amortization of intangible assets for the three months ended December 31, 2010, and 2009 was $132 million and $143 million, respectively. For the six months ended December 31, 2010 and 2009, the amortization of intangible assets was $272 million and $288 million, respectively. Pursuant to applicable accounting guidance for share-based payments, companies must recognize the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of those awards. Total share-based compensation for the three months and six months ended December 31, 2010 and 2009 are summarized in the following table (amounts in millions): Three Months Ended December Six Months Ended December Total share-based compensation Assumptions utilized in the model are evaluated and revised, as necessary, to reflect market conditions and Postretirement Benefits - The Company offers various postretirement benefits to its employees. The components of net periodic benefit cost for defined benefit plans are as follows: Three Months Ended December 31 Three Months Ended December 31 Expected Return on Plan Assets Amortization of Deferred Amounts Recognized Net Actuarial Loss Gross Benefit Cost (Credit) Dividends on ESOP Preferred Stock Net Periodic Benefit Cost (Credit) Six Months Ended December 31 Six Months Ended December 31 Expected Return on Plan Assets Amortization of Deferred Amounts Recognized Net Actuarial Loss Gross Benefit Cost (Credit) Dividends on ESOP Preferred Stock Net Periodic Benefit Cost (Credit) For the year ending June 30, 2011, the expected return on plan assets is 7.0% and 9.2% for defined benefit and other retiree benefit plans, respectively. Risk Management Activities and Fair Value Measurements As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. For details on the Companys risk management activities, refer to the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2010. Fair Value Hierarchy For a discussion of the Companys fair value measurement policies under the fair value hierarchy, refer to the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2010. The Company has not changed its valuation techniques for measuring the fair value of any financial assets and liabilities during the period. The following table sets forth the Companys financial assets and liabilities as of December 31 and June 30, 2010 that are measured at fair value on a recurring basis during the period, segregated by level within the fair value hierarchy: Other foreign currency instruments (1) Total assets at fair value (2) Liabilities at fair value: Other foreign currency instruments (1) Total liabilities at fair value (3) Other foreign currency instruments are comprised of non-qualifying foreign currency financial instruments. Investment securities are presented in other noncurrent assets and all derivative assets are presented in prepaid expenses and other current assets or other noncurrent All derivative liabilities are presented in accrued and other liabilities or other noncurrent liabilities. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each quarter. There was no significant activity within the Level 3 assets and liabilities during the periods presented. There were no significant assets or liabilities that were re-measured at fair value on a non-recurring basis during the periods presented. Certain of the Companys financial instruments used in hedging transactions are governed by industry standard netting agreements with counterparties. If the Companys credit rating were to fall below the levels stipulated in the agreements, the counterparties could demand either collateralization or termination of the arrangement. The aggregate fair value of the instruments covered by these contractual features that are in a net liability position as of December 31, 2010 was $138 million. The Company has not been required to post any collateral as a result of these contractual features. Fair Values of Other Financial Instruments Other financial instruments, including cash equivalents, other investments and short-term debt, are recorded at cost, which approximates fair value. The fair value of the long-term debt was $22,743 million and $23,072 million at December 31 and June 30, 2010, respectively. Disclosures about Derivative Instruments The notional amounts and fair values of qualifying and non-qualifying financial instruments used in hedging transactions as of December 31 and June 30, 2010 are as follows: Fair Value Asset (Liability) Derivatives in Cash Flow Hedging Relationships Foreign currency contracts Derivatives in Fair Value Hedging Relationships Derivatives in Net Investment Hedging Relationships Derivatives Not Designated as Hedging Instruments Foreign currency contracts The total notional amount of contracts outstanding at the end of the period is indicative of the level of the Companys derivative activity during the period. Amount of Gain (Loss) Recognized in Accumulated OCI on Derivatives (Effective Portion) Derivatives in Cash Flow Hedging Relationships Foreign currency contracts Derivatives in Net Investment Hedging Relationships During the next 12 months, the amount of the December 31, 2010 accumulated other comprehensive income (OCI) balance that will be reclassified to earnings is expected to be immaterial. The amounts of gains and losses on qualifying and non-qualifying financial instruments used in hedging transactions for the three-month and six-month periods ended December 31, 2010 and 2009 are as follows: Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (1) Three Months Ended December 31 Six Months Ended December 31 Derivatives in Cash Flow Hedging Relationships Foreign currency contracts Amount of Gain(Loss) Recognized in Income Three Months Ended December 31 Six Months Ended December 31 Derivatives in Fair Value Hedging Relationships (2) Derivatives in Net Investment Hedging Relationships (2) Derivatives Not Designated as Hedging Instruments (3) Foreign currency contracts The gain or loss on the effective portion of cash flow hedging relationships is reclassified from accumulated OCI into net income in the same period during which the related item affects earnings. Such amounts are included in the Consolidated Statements of Earnings as follows: interest rate contracts in interest expense, foreign currency contracts in selling, general and administrative expense and interest expense and commodity contracts in cost of products sold. The gain or loss on the ineffective portion of interest rate contracts and net investment hedges, if any, is included in the Consolidated Statements of Earnings in The gain or loss on contracts not designated as hedging instruments is included in the Consolidated Statements of Earnings as follows: foreign currency contracts in selling, general and administrative expense and commodity contracts in cost of products sold. New Accounting Pronouncements and Policies No new accounting pronouncement issued or effective during the fiscal year has had or is expected to have a material impact on the Consolidated Financial Statements. Commitments and Contingencies We are subject to various legal proceedings and claims arising out of our business which cover a wide range of matters such as governmental regulations, antitrust and trade regulations, product liability, patent and trademark matters, income taxes and other actions. As previously disclosed, the Company is subject to a variety of investigations into potential competition law violations in Europe by the European Commission and national authorities from a number of countries, as detailed in Part II, Item 1, Legal Proceedings of this 10-Q. These matters involve a number of consumer products companies and/or retail customers. The Companys policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with investigations by relevant regulatory authorities, which the Company is doing. Competition and antitrust law inquiries often continue for several years and, if violations are found, can result in substantial fines. In response to the actions of the European Commission and national authorities, the Company launched its own internal investigations into potential violations of competition laws. The Company has identified violations in certain European countries and appropriate actions were taken. Several countries in Europe have issued separate complaints pursuant to their investigations alleging that the Company, along with several other companies, engaged in violations of competition laws in those countries. The remaining matters involving the European Commission and several other countries are in various stages of the regulatory process. As a result of our initial and on-going analyses of the complaints, as well as a final decision issued by the authorities in Italy and additional information disclosed by the authorities in France, the Czech Republic and the European Commission during the quarter ended December 31, 2010, the Company has reserves totaling $574 million as of December 31, 2010 for potential fines for competition law violations. In accordance with US GAAP, certain of the reserves included in this amount represent the low end of a range of potential outcomes. Accordingly, the ultimate resolution of these matters may result in fines or costs in excess of the amounts reserved that could materially impact our income statement and cash flows in the period in which they are accrued and paid, respectively. We will continue to monitor developments for all of these investigations and will record additional charges as appropriate. With respect to other litigation and claims, while considerable uncertainty exists in the opinion of management and our counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows. We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will have a material adverse effect on our financial position, results of operations or cash flows. Income Tax Uncertainties The Company is present in over 150 taxable jurisdictions and, at any point in time, has 50  60 audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law and closing of statute of limitations. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 2001 and forward. Net adjustments to prior-year tax balances for uncertain tax positions resulted in a tax benefit of approximately $380 million in the current year. We are generally not able to reliably estimate the ultimate settlement amounts or timing until the close of the audit. At this time, we are not able to make a reasonable estimate of the range of potential changes to the balance of uncertain tax positions over the next 12 months or the impact of any such changes on the effective tax rate. Additional information on the Commitments and Contingencies of the Company can be found in Note 10, Commitments and Contingencies, which appears in the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2010. Discontinued Operations In October 2009, the Company completed the divestiture of our global pharmaceuticals business to Warner Chilcott plc (Warner Chilcott) for $2.8 billion of cash, net of assumed and transferred liabilities. Under the terms of the agreement, Warner Chilcott acquired our portfolio of branded pharmaceutical products, our prescription drug product pipeline and manufacturing facilities in Puerto Rico and Germany. In addition, the majority of the employees working on the pharmaceuticals business were transferred to Warner Chilcott. The Company recorded an after-tax gain on the transaction of $1,464 million in the quarter ended December 31, 2009, which is included in net earnings from discontinued operations in the Consolidated Statement of Earnings for the three-month and six-month periods ended December 31, 2009. In accordance with the applicable accounting guidance for the disposal of long-lived assets, the results of the pharmaceuticals business are presented as discontinued operations and, as such, have been excluded from continuing operations and segment results for all periods presented. Following is selected financial information included in net earnings from discontinued operations for the pharmaceuticals business: Six months ended December Earnings from discontinued operations Gain on sale of discontinued operations Income tax benefit (expense) on sale Net earnings from discontinued operations The net gain on the sale of the pharmaceuticals business for the six-month period ended December 31, 2009 also includes an after-tax gain on the sale of the Actonel brand in Japan, which occurred prior to the divestiture to Warner Chilcott. Managements Discussion and Analysis of Financial Condition and Results of Operations The purpose of this discussion is to provide an understanding of P&Gs financial results and condition by focusing on changes in certain key measures from year to year. Managements Discussion and Analysis (MD&A) is organized in the following sections: Forward-Looking Statements Results of Operations  Three Months Ended December 31, 2010 Results of Operations  Six Months Ended December 31, 2010 Business Segment Discussion  Three and Six Months Ended December 31, 2010 Reconciliation of Non-GAAP Measures Throughout MD&A, we refer to measures used by management to evaluate performance, including unit volume growth, net outside sales and after-tax profit. We also refer to organic sales growth, core earnings per share growth, free cash flow and free cash flow productivity. These financial measures are not defined under accounting principles generally accepted in the United States of America (U.S. GAAP). The explanation at the end of MD&A provides more details on the use and the derivation of these measures. Management also uses certain market share and market consumption estimates to evaluate performance relative to competition despite some limitations on the availability and comparability of such information. References to market share and market consumption in MD&A are based on a combination of vendor-reported consumption and market size data, as well as internal estimates. OVERVIEW P&Gs business is focused on providing branded consumer goods products. Our purpose is to provide products and services of superior quality and value that improve the lives of the worlds consumers, now and for generations to come. We believe this will result in leadership sales, profits and value creation, allowing employees, shareholders and the communities in which we operate to prosper. Our products are sold in more than 180 countries primarily through mass merchandisers, grocery stores, membership club stores, drug stores and high frequency stores, the neighborhood stores which serve many consumers in developing markets. We continue to expand our presence in other channels including department stores, perfumeries, pharmacies, salons and e-commerce. We compete in multiple product categories and have three global business units (GBUs): Beauty and Grooming; Health and Well-Being; and Household Care. Under U.S. GAAP, the business units comprising the GBUs are aggregated into six reportable segments: Beauty; Grooming; Health Care; Snacks and Pet Care; Fabric Care and Home Care; and Baby Care and Family Care. We have on-the-ground operations in approximately 80 countries through our Market Development Organization, which leads country business teams to build our brands in local markets and is organized along five geographic units: North America, Western Europe, Central & Eastern Europe/Middle East/Africa (CEEMEA), Latin America and Asia, which is comprised of Japan, Greater China and ASEAN/Australia/India/Korea (AAIK). Throughout MD&A, we reference business results in developing markets, which we define as the aggregate of CEEMEA, Latin America, AAIK and Greater China, and developed markets, which are comprised of North America, Western Europe and Japan. On October 30, 2009, we sold our global pharmaceuticals business to Warner Chilcott plc (Warner Chilcott) for $2.8 billion. Under the terms of the agreement, Warner Chilcott acquired our portfolio of branded pharmaceuticals products, prescription drug product pipeline and manufacturing facilities in Puerto Rico and Germany. The pharmaceuticals business had historically been part of the Health Care reportable segment. In accordance with applicable accounting guidance for the disposal of long-lived assets, the results of the pharmaceuticals business are presented as discontinued operations and, as such, are excluded from continuing operations and from segment results. The table below provides more information about the components of our GBU structure. Cosmetics, Female Antiperspirant and Deodorant, Female Personal Cleansing, Female Shave Care, Hair Care, Hair Color, Hair Styling, Pharmacy Channel, Prestige Products, Salon Head & Shoulders, Olay, Pantene, Wella Beauty Electronics, Home Small Appliances, Male Blades and Razors, Male Personal Care Braun, Fusion, Gillette, Mach3 Feminine Care, Gastrointestinal, Incontinence, Rapid Diagnostics, Respiratory, Toothbrush, Toothpaste, Water Filtration, Other Oral Care Fabric Care and Home Care Additives, Air Care, Batteries, Dish Care, Fabric Enhancers, Laundry, Surface Care Ace, Ariel, Dawn, Downy, Duracell, Gain, Tide Baby Care and Family Care Baby Wipes, Diapers, Paper Towels, Tissues, Toilet Paper Bounty, Charmin, Pampers The following table provides the percentage of net sales and net earnings from continuing operations by reportable business segment for the three months ended December 31, 2010 (excludes net sales and net earnings in Corporate): Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care The following table provides the percentage of net sales and net earnings from continuing operations by reportable business segment for the six months ended December 31, 2010 (excludes net sales and net earnings in Corporate): Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Following are highlights of results for the six months ended December 31, 2010 versus the six months ended December 31, Net sales increased 2% to $41.5 billion as 7% volume growth was mostly offset by unfavorable foreign exchange, mix impacts and lower pricing. Organic sales, which exclude the impacts of acquisitions, divestitures and foreign exchange, were up 4%. Operating margin declined 120 basis points behind a commodity-cost driven reduction in gross margin and increased marketing investments, partially offset by reduced foreign currency exchange costs. Net earnings from continuing operations increased 4% to $6.4 billion mainly due to a lower effective tax rate and higher net sales, partially offset by operating margin contraction. Net earnings were $6.4 billion, a decrease of 19% due to the divestiture of the discontinued pharmaceuticals business in the prior year period. Diluted net earnings per share were $2.13, a decline of 17%. Diluted net earnings per share from continuing operations increased 8% to $2.13. Earnings per share growth exceeded net earnings growth due to the impact of share repurchase activity. Core EPS, which is diluted net earnings per share from continuing operations excluding charges for pending European legal matters and a significant adjustment to an income tax reserve, increased 4% to $2.15. Operating cash flow decreased $2.5 billion to $5.3 billion mainly due to an increase in working capital. Free cash flow, which is operating cash flow less capital expenditures, was $4.1 billion. Free cash flow productivity, which is the ratio of free cash flow to net earnings, was 64%. FORWARD-LOOKING STATEMENTS We discuss expectations regarding future performance, events and outcomes, such as our business outlook and objectives, in annual and quarterly reports, press releases and other written and oral communications. All such statements, except for historical and present factual information, are forward-looking statements, and are based on financial data and our business plans available only as of the time the statements are made, which may become out-of-date or incomplete. We assume no obligation to update any forward-looking statements as a result of new information, future events or other factors. Forward-looking statements are inherently uncertain and investors must recognize that events could be significantly different from our expectations. For more information on risks that could impact our results, refer to Part II Item 1A Risk Factors in this 10-Q filing. Ability to Achieve Business Plans: We are a consumer products company and rely on continued demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers and retail trade customers. Our continued success is dependent on leading-edge innovation with respect to both products and operations and on the continued positive reputations of our brands. This means we must be able to obtain patents and respond to technological advances and patents granted to competition. Our success is also dependent on effective sales, advertising and marketing programs in an increasingly fragmented media environment. Our ability to innovate and execute in these areas will determine the extent to which we are able to grow existing sales and volume profitably, especially with respect to the product categories and geographic markets (including developing markets) in which we have chosen to focus. There are high levels of competitive activity in the environments in which we operate. To address these challenges, we must respond to competitive factors, including pricing, promotional incentives, trade terms and product initiatives. We must manage each of these factors, as well as maintain mutually beneficial relationships with our key customers, in order to effectively compete and achieve our business plans. As a company that manages a portfolio of consumer brands, our ongoing business model involves a certain level of ongoing acquisition and divestiture activities. We must be able to successfully manage the impacts of these activities, while at the same time delivering against base business objectives. Our success will also depend on our ability to maintain key information technology systems. Cost Pressures: Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, cost of labor, foreign exchange and interest rates. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects, sourcing decisions and certain hedging transactions. We also must manage our debt and currency exposure, especially in certain countries, such as Venezuela, China and India. We need to maintain key manufacturing and supply arrangements, including sole supplier and sole manufacturing plant arrangements. We must implement, achieve and sustain cost improvement plans, including our outsourcing projects and those related to general overhead and workforce optimization. Successfully managing these changes, including identifying, developing and retaining key employees, is critical to our success. Global Economic Conditions: Economic changes, terrorist activity and political unrest may result in business interruption, inflation, deflation or decreased demand for our products. Our success will depend, in part, on our ability to manage continued global political and/or economic uncertainty, especially in our significant geographic markets, as well as any political or economic disruption due to terrorist and other hostile activities. Regulatory Environment: Changes in laws, regulations and the related interpretations may alter the environment in which we do business. This includes changes in environmental, competitive and product-related laws, as well as changes in accounting standards and taxation requirements. Our ability to manage regulatory, tax and legal matters (including product liability, patent, intellectual property, competition law matters and tax policy) and to resolve pending legal matters within current estimates may impact our results. RESULTS OF OPERATIONS  Three Months Ended December 31, 2010 The following discussion provides a review of results for the three months ended December 31, 2010 versus the three months ended December 31, 2009. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended December 31 SELLING, GENERAL & ADMINISTRATIVE EXPENSE OTHER NON-OPERATING INCOME/(EXPENSE), NET EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES NET EARNINGS FROM CONTINUING OPERATIONS NET EARNINGS FROM DISCONTINUED OPERATIONS EFFECTIVE TAX RATE FROM CONTINUING OPERATIONS BASIC NET EARNINGS  CONTINUING OPERATIONS BASIC NET EARNINGS  DISCONTINUED OPERATIONS DILUTED NET EARNINGS  CONTINUING OPERATIONS DILUTED NET EARNINGS  DISCONTINUED OPERATIONS AVERAGE DILUTED SHARES OUTSTANDING COMPARISONS AS A % OF NET SALES SELLING, GENERAL & ADMINISTRATIVE EXPENSE EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES NET EARNINGS FROM CONTINUING OPERATIONS Net sales increased 2% to $21.3 billion on 6% unit volume growth. Volume growth was broad based with growth in all major geographic regions. Volume increased double digits in developing regions and low single digits in developed regions. Five of the six business segments grew volume, led by high single-digit growth in the Fabric Care and Home Care and Baby Care and Family Care segments. Volume was up mid-single digits in the Beauty, Grooming and Health Care segments, and declined low single digits in the Snacks and Pet Care segment. Negative mix reduced net sales by 2% due mainly to disproportionate growth in developing regions and mid-tier value products, both of which have lower than Company average selling prices. Unfavorable foreign exchange lowered net sales by 2% as key foreign currencies weakened versus the U.S. dollar. Organic sales were up 3%. Net Sales Change Drivers 2010 vs. 2009 (Three Months Volume excluding Acquisitions Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Sales percentage changes are approximations based on quantitative formulas that are consistently applied. Gross margin declined 190 basis points to 51.8% of net sales for the quarter. The decline was mainly due to 160-basis point increase in commodity and energy costs and unfavorable product mix from disproportionate growth in developing regions and mid-tier value product. These were partially offset by the favorable impact of volume scale leverage and manufacturing cost savings. Total selling, general and administrative expenses (SG&A) increased 2% driven by higher marketing and overhead spending, which were mostly offset by the impact of higher foreign currency exchange costs in the base period. Marketing spending increased primarily due to increased investments to support innovation and expansion plans. Overhead spending was up behind investments to support business growth and charges for potential competition law fines (see note 9 to the Consolidated Financial Statements), which totaled approximately $305 million in the current period and $267 million in the prior year period. We incurred approximately $226 million of foreign currency exchange costs in the base period primarily to swap Venezuelan bolivars for U.S. dollars in the parallel market and to remeasure a portion of our net monetary assets denominated in bolivars at the parallel market exchange rate. These costs were nominal in the current period. See the section titled Foreign Currency Translation  Venezuela Impacts below for additional discussion. SG&A as a percentage of net sales increased 20 basis points as higher spending was only partially offset by scale leverage from an increase in net sales. Interest expense declined $15 million versus the prior year period primarily due to lower interest rates on floating rate debt, partially offset by an increase in debt outstanding. Other non-operating income/(expense), net decreased $43 million primarily due to the impact of a prior-year gain on the acquisition of MDVIP, a physicians network focused on preventative medicine. The effective tax rate on continuing operations decreased from 29.8% in the prior year to 17.9% primarily due to 930 basis points of net favorable discrete adjustments to income tax reserves in a number of jurisdictions. Net adjustments to tax balances for uncertain tax positions resulted in a benefit of approximately $378 million in the quarter, including a $252 million benefit related to the pending settlement of tax litigation primarily related to the deductibility of technology donations. We do not expect the magnitude of recent benefits from these adjustments to be sustainable. The current-quarter tax rate also benefited from the geographic mix of earnings, as an increased proportion of earnings were generated in lower tax jurisdictions during the quarter. Net earnings from continuing operations increased 6% to $3.3 billion driven primarily by a lower effective tax rate and higher net sales, partially offset by a 210-basis point reduction in operating margin. The decline in operating margin resulted largely from a lower gross margin. Diluted net earnings per share from continuing operations increased 10% to $1.11. Earnings per share growth exceeded net earnings growth due to the impact of share repurchase activity. Net earnings from discontinued operations decreased $1.5 billion mainly due to the impact of a gain on the divestiture of the global pharmaceuticals business in the prior year period. Net earnings decreased 28% to $3.3 billion driven by the decrease in net earnings from discontinued operations, partially offset by an increase in net earnings from continuing operations. Diluted net earnings per share declined 26% to $1.11. The decline in earnings per share was less than the decline in net earnings due to the impact of share repurchases. Foreign Currency Translation  Venezuela Impacts Venezuela is a highly inflationary economy under U.S. GAAP. As a result, the U.S. dollar is the functional currency for our subsidiaries in Venezuela. Any currency remeasurement adjustments for non-dollar denominated monetary assets and liabilities held by these subsidiaries and other transactional foreign exchange gains and losses are reflected in earnings. The Venezuelan government has introduced a number of currency controls for companies operating in Venezuela. During calendar year 2010, there were two official exchange rates for imported goods. Those goods classified as essential, such as food, medicine and capital investments, had an exchange rate of 2.6 bolivars to the U.S. dollar, while payments for other non-essential goods had an exchange rate of 4.3. Many of our imported products fell into the essential classification and qualified for the 2.6 rate. In January 2011, the Venezuelan government announced the elimination of the 2.6 exchange rate on essential goods. Our overall results in Venezuela are reflected in our Consolidated Financial Statements at the 4.3 rate expected to be applicable to dividend repatriations. There are also exchange controls over securities transactions in the parallel market, which has historically been used to pay for imported goods and services that do not qualify for exchange in the official market. The Central Bank of Venezuela is the only legal intermediary through which parallel market transactions can be executed. The government controls the underlying parallel exchange rate which was approximately 5.3 as of December 31, 2010. The notional amount of transactions that run through this parallel market mechanism is very restricted, which has eliminated our ability to access the parallel market to pay for imported goods and/or manage our local monetary asset balances. As of December 31, 2010, we had net monetary assets denominated in local currency of approximately $590 million. Approximately $280 million of this balance has been remeasured using the parallel rate because we plan to use that amount of the net assets (largely cash) to satisfy U.S. dollar denominated liabilities that do not qualify for official rate dollars. The availability of the parallel market to settle these transactions is uncertain. The remaining net monetary asset balances are currently reflected within our Consolidated Financial Statements at the 4.3 official exchange rate. Depending on the future availability of U.S. dollars at the official rate, our local U.S. dollar needs and our overall repatriation plans, we have exposure for the differential between the official and parallel exchange rates on this portion of our local monetary assets. Our ability to effectively manage sales and profit levels in Venezuela will be impacted by several factors, including the Companys ability to mitigate the effect of any potential future devaluation, further actions of the Venezuelan government, economic conditions in Venezuela, such as inflation and consumer spending, the availability of raw materials, utilities and energy and the future state of exchange controls in Venezuela including the availability of U.S. dollars at the official foreign exchange rate. RESULTS OF OPERATIONS  Six Months Ended December 31, 2010 The following discussion provides a review of results for the six months ended December 31, 2010 versus the six months ended December 31, 2009. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Six Months Ended December 31 SELLING, GENERAL & ADMINISTRATIVE EXPENSE OTHER NON-OPERATING INCOME/(EXPENSE), NET EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES NET EARNINGS FROM CONTINUING OPERATIONS NET EARNINGS FROM DISCONTINUED OPERATIONS EFFECTIVE TAX RATE FROM CONTINUING OPERATIONS BASIC NET EARNINGS - CONTINUING OPERATIONS BASIC NET EARNINGS - DISCONTINUED OPERATIONS DILUTED NET EARNINGS - CONTINUING OPERATIONS DILUTED NET EARNINGS - DISCONTINUED OPERATIONS AVERAGE DILUTED SHARES OUTSTANDING COMPARISONS AS A % OF NET SALES SELLING, GENERAL & ADMINISTRATIVE EXPENSE EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES NET EARNINGS FROM CONTINUING OPERATIONS Net sales increased 2% to $41.5 billion fiscal year to date on a 7% increase in unit volume. Volume growth was broad based with growth in all geographic regions, led by double-digit growth in Asia and CEEMEA. Five of the six business segments contributed to volume growth, with high single-digit growth in the Fabric Care and Home Care and the Baby Care and Family Care segments, mid-single-digit growth in the Beauty, Grooming and Health Care segments, and a low single-digit decline in the Snacks and Pet Care segment. which excludes acquisitions and divestitures, was up 6%. Pricing reduced net sales by 1% mainly due to pricing adjustments executed in previous periods, partially offset by price increases taken in developing regions to offset currency devaluations. Mix reduced net sales by 2% due mainly to disproportionate growth in developing regions and mid-tier value products, both of which have lower than Company average selling prices. Unfavorable foreign exchange lowered net sales by 2% as key foreign currencies weakened versus the U.S. dollar. Organic sales were up 4% driven by unit volume growth, partially offset by lower pricing and unfavorable mix. Net Sales Change Drivers 2010 vs. 2009 (Six Months Ended Dec. 31) Volume excluding Acquisitions Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Sales percentage changes are approximations based on quantitative formulas that are consistently applied. Gross margin contracted 130 basis points to 51.8% of net sales. The reduction in gross margin was driven mainly by a 160-basis point increase in commodity and energy costs and unfavorable product mix from disproportionate growth in developing regions and mid-tier value product. These impacts were partially offset by the favorable impact of volume scale leverage and manufacturing cost savings. Total SG&A expense was up 1% to $12.7 billion as higher marketing spending was mostly offset by lower overhead spending and the impact of higher foreign currency exchange costs in the base period. Marketing spending increased behind continued investments in our innovation and expansion plans. Overhead spending declined behind productivity improvements and lower restructuring spending, partially offset by net charges for potential competition law fines (see note 9 to the Consolidated Financial Statements), which totaled approximately $306 million in the current year and $267 million in the prior year period. We incurred approximately $546 million of foreign currency exchange costs in the base period primarily to swap Venezuelan bolivars for U.S. dollars in the parallel market and to remeasure a portion of our net monetary assets denominated in bolivars at the parallel market exchange rate. These costs were nominal in the current period. See the section titled Foreign Currency Translation  Venezuela Impacts above for additional discussion. SG&A as a percentage of net sales declined 10 basis points due to scale leverage from an increase in net sales. Interest expense declined $94 million mainly due to lower interest rates on floating rate debt. Other non-operating income/(expense), net declined $77 million primarily due to the impact of a gain on the acquisition of MDVIP in the prior year period. The effective tax rate on continuing operations decreased from 28.7% in the prior year to 23.1% primarily due to 460 basis points of net favorable discrete adjustments to income tax reserves in a number of jurisdictions. Net adjustments to tax balances for uncertain tax positions resulted in a benefit of approximately $380 million fiscal year to date, including a $252 million benefit related to the pending settlement of tax litigation primarily related to the deductibility of technology donations. We do not expect the magnitude of recent benefits from these adjustments to be sustainable. The tax rate also benefited from the geographic mix of earnings, as an increased proportion of earnings were generated in lower tax jurisdictions during the current year. Net earnings from continuing operations increased 4% to $6.4 billion driven primarily by a lower effective tax rate and higher net sales, partially offset by a 120-basis point reduction in operating margin. The decline in operating margin resulted largely from lower gross margin. Diluted net earnings per share from continuing operations increased 8% to $2.13. Earnings per share growth exceeded net earnings growth due to the impact of share repurchase activity. Net earnings from discontinued operations decreased $1.8 billion mainly due to the impact of the gain on the divestiture of the global pharmaceuticals business in the prior year period. Net earnings declined 19% to $6.4 billion due to a reduction in net earnings from discontinued operations, partially offset by an increase in net earnings from continuing operations. Diluted net earnings per share declined 17% to $2.13. The decline in earnings per share was less than the decline in net earnings due to the impact of share repurchases. BUSINESS SEGMENT DISCUSSION  Three and Six Months Ended December 31, 2010 The following discussion provides a review of results by business segment. Analyses of the results for the three and six months ended December 31, 2010 are provided compared to the same three and six month periods ended December 31, 2009. The primary financial measures used to evaluate segment performance are net sales and net earnings from continuing operations. The table below provides supplemental information on net sales and net earnings from continuing operations by business segment for the three and six months ended December 31, 2010 versus the comparable prior year period (amounts in millions): Three Months Ended December 31, 2010 Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care Six Months Ended December 31, 2010 Operations Before Income Taxes Net Earnings From Continuing Operations Health and Well-Being GBU Fabric Care and Home Care Baby Care and Family Care BEAUTY AND GROOMING GBU Beauty Net sales increased 1% to $5.3 billion during the second fiscal quarter. Organic sales grew 3%. Volume grew 5%, while organic volume, which excludes the net impact of acquisitions and divestitures, increased 6%. Volume growth was driven entirely by double-digit growth in developing regions. Lower pricing in developing regions on Retail Hair Care and Female Beauty reduced net sales by 1%. Mix negatively impacted net sales by 2% due to disproportionate growth in developing regions and Retail Hair Care, both of which have lower than segment average selling prices. Unfavorable foreign exchange lowered net sales by 1%. Volume in Retail Hair Care grew high single digits behind double-digit growth in developing regions primarily due to initiative activity, lower pricing and distribution expansions in Asia and Latin America. Volume in Female Beauty was up mid-single digits mainly due to skin care initiatives and market growth in Asia and the continued success of female blades and razors initiatives in North America and Western Europe. Volume in Salon Professional declined double digits due to the exit of non-strategic businesses and lower shipments in developed markets. Volume in Prestige Products was down low single digits due to the divestiture of minor brands, while organic volume was up low single digits behind market growth in Asia and the continued success of new fragrance launches in the prior quarter. Net earnings increased 2% to $896 million driven by higher net sales and a lower effective tax rate, partially offset by lower operating margin. Operating margin contracted behind lower gross margin, partially offset by lower SG&A as a percentage of net sales. Gross margin declined primarily due to higher commodity costs. SG&A as a percentage of net sales decreased mainly due to lower foreign currency exchange costs and reduced overhead spending, mostly offset by increased marketing spending. The effective tax rate was down due to favorable geographic mix of earnings. Net sales increased 1% to $10.2 billion fiscal year to date on unit volume growth of 5%. Organic sales grew 3%. Mix negatively impacted net sales growth by 2% behind disproportionate growth in developing regions, which have lower than segment average selling prices, and declines in the premium-priced categories of Prestige Products and Salon Professional. Unfavorable foreign exchange reduced net sales by 2%. Volume in developing regions increased double digits, while volume in developed regions declined low single digits. Volume in Retail Hair Care grew high single digits due to double-digit growth in developing regions behind initiative activity, price reductions, distribution expansions and market growth. Volume in Female Beauty was up mid-single digits primarily due to higher shipments of Olay, Safeguard and Venus behind initiative activity, distribution expansion and market growth. Volume in Salon Professional was down high single digits mainly due to the exit of non-strategic businesses and lower shipments in developed markets. Volume in Prestige Products declined mid-single digits primarily due the divestiture of minor brands and lower shipments in Western Europe. Net earnings increased 4% to $1.7 billion due to higher net sales, operating margin expansion and a lower effective tax rate. Operating margin increased due to lower SG&A as a percentage of net sales. SG&A as a percentage of net sales declined behind lower overhead spending and reduced foreign currency exchange costs, partially offset by higher marketing spending. The effective tax rate decreased due to favorable geographic mix of earnings. Grooming Net sales increased 3% to $2.2 billion for the quarter on a 5% increase in unit volume. Organic sales were up 6%. Price increases, taken primarily across blades and razors, added 1% to net sales growth. Unfavorable foreign exchange reduced net sales growth by 3%. Volume growth was led by high single-digits growth in developing regions, while developed regions delivered low single-digit growth. Volume in Male Grooming increased mid-single digits primarily due to growth of blades and razors in developing regions and deodorants in North America. Global market share of the blades and razors category was down nearly 1 point. Volume in Appliances declined low single digits due to lower shipments of epilators and hair care appliances, primarily in CEEMEA. Global market share of the dry shaving category was down about 1 point. Net earnings increased 11% to $482 million driven by net sales growth and a lower effective tax rate. Operating margin increased slightly, as a higher gross margin was mostly offset by higher SG&A as a percentage of net sales. Gross margin expanded primarily behind the favorable impact of volume scale leverage and manufacturing cost savings. SG&A as a percentage of net sales increased due to higher marketing spending, partially offset by lower foreign currency exchange costs. The effective tax rate was down due to favorable geographic mix of earnings. Net sales increased 3% to $4.1 billion fiscal year to date on volume growth of 5%. Organic sales were up 6%. Price increases, taken primarily across blades and razors, contributed 1% to net sales growth. Unfavorable foreign exchange reduced net sales by 3%. Volume grew high single digits in developing regions and low single digits in developed regions. Volume in Male Grooming was up mid-single digits due to higher shipments of blades and razors, mainly in developing regions driven by market growth, and deodorants in North America. Global market share of the blades and razors category was down about half a point. Volume in Appliances increased low single digits behind higher shipments of male shavers and hair care appliances in Western Europe. Global market share of the dry shave category was up less than half a point. Net earnings increased 12% to $880 million behind higher net sales, increased operating margin and a lower effective tax rate. Operating margin expanded due to higher gross margin and lower SG&A as a percentage of net sales. Gross margin increased primarily due to the favorable impact of volume scale leverage. SG&A as a percentage of net sales were down due to lower foreign currency exchange costs and reduced overhead spending, partially offset by higher marketing spending. The effective tax rate decreased due to favorable geographic mix of earnings. HEALTH AND WELL-BEING GBU Health Care Net sales increased 2% during the second fiscal quarter to $3.1 billion on unit volume growth of 5%. Organic sales grew 5%. Unfavorable foreign exchange reduced net sales by 3%. Volume was up high single digits in developing regions and mid-single digits in developed regions. Oral Care volume increased high single digits behind initiative activity and incremental merchandising support behind Crest 3D White in North America, Oral-B toothpaste in Brazil, Belgium and Holland and the Pro-Health innovation in multiple markets around the world. Global market share of the oral care category was up over half a point. Personal Health Care volume was up low single digits mainly due to higher shipments of Vicks in Latin America and Asia and increased distribution of PuR in CEEMEA, partially offset by lower shipments of diagnostics products. Feminine Care volume grew mid-single digits due to the expansion of Naturella into China and Brazil and Always initiatives in China and India. Net earnings declined 1% to $531 million, as higher net sales were more than offset by lower operating margin. Operating margin declined due to lower gross margin and higher SG&A as a percentage of net sales. Gross margin contracted mainly due to higher commodity costs. SG&A as a percentage of net sales increased mainly due to higher marketing spending, mostly offset by lower foreign currency exchange costs. Net sales increased 1% to $6.1 billion fiscal year to date on 5% growth in unit volume. Organic sales were up 4%. Lower pricing, primarily in developed regions, reduced net sales growth by 1%. Unfavorable foreign exchange negatively impacted net sales growth by 3%. Volume increased high single digits in developing regions and low single digits in developed regions. Oral Care volume grew high single digits behind initiative activity and incremental merchandising support of Crest and Oral-B. Global market share of the oral care category was up about half a point. Personal Health Care volume grew low single digits behind higher shipments of Vicks in developing regions and increased distribution of PuR in CEEMEA, partially offset by lower shipments of Prilosec OTC in North America and diagnostics products. Feminine Care volume was up mid-single digits mainly due to higher shipments of Naturella, behind expansion into China and Brazil, and Always, behind initiative activity in developing regions. Global market share of the feminine care category was down less than half a point. Net earnings decreased 5% to $1.0 billion driven by lower operating margin, partially offset by higher net sales. Operating margin contracted due to lower gross margin and higher SG&A as a percentage of net sales. Gross margin declined mainly due to higher commodity costs. SG&A as a percentage of net sales increased behind higher marketing spending, partially offset by lower foreign currency exchange costs. Snacks and Pet Care Net sales decreased 4% to $798 million for the quarter on a 2% decline in unit volume. Organic sales, which exclude the impacts of foreign exchange and the Natura Pet Products acquisition, were down 8% on a 6% decline in organic volume. Mix lowered net sales by 1% primarily due to the disproportionate growth of Snacks, which have lower than segment average selling prices. Unfavorable foreign exchange reduced net sales by 1%. Snacks volume increased mid-single digits mainly due to double-digit growth in developing regions behind increased distribution and incremental merchandising activity. Pet Care volume was down double digits due mainly to supply constraints resulting from a restructuring of the supply chain and following the recall of select dry pet food products, partially offset by the impact of the Natura acquisition in June 2010. Net earnings decreased 32% to $67 million due to lower net sales and a reduced operating margin driven by incremental costs and reduced scale leverage resulting from the pet food recalls and related supply constraints. Net sales decreased 5% to $1.5 billion fiscal year to date on a 1% decline in unit volume. Organic sales, which exclude the impacts of foreign exchange and the Natura acquisition, were down 9% on a 5% decline in organic volume. Lower pricing in developed regions reduced net sales by 1%. Product mix reduced net sales by 2% due to the disproportionate growth of Snacks and developing regions, both of which have lower than segment average selling prices. Unfavorable foreign exchange negatively impacted net sales by 1%. Snacks volume increased mid-single digits mainly due to increased distribution in CEEMEA and Latin America and X-treme and multigrain initiatives in North America and Western Europe. Pet Care volume was down double digits due mainly to the impacts of the voluntary pet food recalls and associated supply constraints resulting from a restructuring of the supply chain, partially offset by the impact of the Natura acquisition in June 2010. Net earnings decreased 30% to $121 million mainly due to lower net sales and a reduced operating margin driven by incremental costs and reduced scale leverage related to the pet food recall and supply chain restructuring efforts. HOUSEHOLD CARE GBU Fabric Care and Home Care Net sales during the quarter were in-line with the prior year period at $6.3 billion. Organic sales increased 2%. Volume grew 7%, while organic volume, which excludes the impact of the Ambi Pur acquisition, was up 5%. Pricing reductions, mainly in developed regions, lowered net sales by 1%. Mix negatively impacted net sales by 3% primarily due to disproportionate growth of mid-tier product lines, which have lower than segment average selling prices. Unfavorable foreign exchange reduced net sales by 3%. Volume increased double digits in developing regions and mid-single digits in developed regions. Fabric Care volume was up mid-single digits mainly due to initiative activity and market growth in developing regions. Global market share of the fabric care category increased half a point. Home Care volume increased double digits due in part to the Ambi Pur acquisition. Organic volume in Home Care was up high single digits driven mainly by initiative activity, including the prior-period launches of Gain hand dishwashing liquid and Febreze Set & Refresh in North America, higher marketing spending and increased merchandising support. Global market share of the home care category was up over 1 point. Batteries volume grew high single digits primarily due to market share gains behind incremental holiday merchandising in North America, initiative activity in Western Europe and market growth and distribution expansion in Asia. Net earnings declined 21% to $758 million mainly due to operating margin contraction. Operating margin declined behind a lower gross margin and higher SG&A as a percentage of net sales. Gross margin contracted primarily due to unfavorable product mix, behind disproportionate growth of developing regions and mid-tier value products, and higher commodity costs. SG&A as a percentage of net sales increased due to higher marketing and overhead spending. Net sales increased 1% to $12.6 billion fiscal year to date. Organic sales were up 3%. Volume grew 8%, while organic volume, which excludes the impact of the Ambi Pur acquisition, increased 7%. Lower pricing, mainly in developed regions, reduced net sales by 1%. Mix negatively impacted net sales growth by 3% mainly due to disproportionate growth of mid-tier product lines and powdered laundry detergents, which have lower than segment average selling prices. Unfavorable foreign exchange reduced net sales growth by 3%. Volume in developing regions was up double digits, while volume in developed regions grew mid-single digits. Fabric Care volume increased mid-single digits mainly due to growth in developing regions behind initiative activity, increased distribution and market growth. Global market share of the fabric care category increased half a point. Home Care volume increased double digits due in part to the Ambi Pur acquisition. Organic volume in Home Care was up double digits driven mainly by initiative activity, including the prior-period launches of Gain hand dishwashing liquid and Febreze Set & Refresh in North America, higher marketing spending and increased merchandising support. Global market share of the home care category was up over 1 point. Batteries volume grew high single digits primarily due to price reductions executed through pack count increases in North America, which were implemented in January 2010, initiative activity in Western Europe and market growth and distribution expansion in Asia. Global market share of the batteries category increased about half a point. Net earnings decreased 14% to $1.7 billion as net sales growth was more than offset by operating margin contraction. Operating margin declined due to a lower gross margin and higher SG&A as a percentage of net sales. Gross margin contracted due mainly to higher commodity costs and unfavorable product mix behind disproportionate growth of developing regions and mid-tier value products. SG&A as a percentage of net sales increased behind higher marketing spending. Baby Care and Family Care Net sales increased 3% to $3.9 billion for the quarter on 8% volume growth. Organic sales were up 6%. Mix reduced net sales by 2% driven mainly by disproportionate growth of mid-tier product lines, larger package sizes and developing regions, all of which have lower than segment average selling prices. Unfavorable foreign exchange reduced net sales by 3%. Volume in developing regions was up double digits, while volume in developed regions increased mid-single digits. Volume in Baby Care grew high single digits mainly due to growth in developing regions behind initiative activity, distribution expansion and market growth. Global market share of the baby care category increased over 1 point. Volume in Family Care was up high single digits behind the continued impact of prior-period initiative launches, growth of Charmin Basic in North America and lower price gaps versus competition in Latin America. Net earnings declined 13% to $502 million as sales growth was more than offset by a lower operating margin. Operating margin decreased mainly due to a lower gross margin driven by higher commodity costs and unfavorable product mix due to disproportionate growth of mid-tier product lines, larger package sizes and developing regions. Net sales increased 2% to $7.6 billion fiscal year to date on 9% volume growth. Organic sales were up 5%. Price reductions initiated in prior periods lowered net sales growth by 1%. Mix reduced net sales by 3% driven mainly by disproportionate growth of mid-tier product lines, larger package sizes and developing regions, all of which have lower than segment average selling prices. Unfavorable foreign exchange negatively impacted net sales growth by 3%. Volume grew double digits in developing regions and mid-single digits in developed regions. Volume in Baby Care was up high single digits primarily due to growth in developing regions behind initiative activity, market size growth and distribution expansion. Global market share of the baby care category increased over 1 point. Volume in Family Care increased double digits driven by the continued impact of initiative launches from prior periods, growth of Charmin Basic in North America and lower price gaps versus competition in Latin America. U.S. all outlet share of the family care category increased about half a point. Net earnings decreased 14% to $972 million driven by operating margin contraction, partially offset by sales growth. Operating margin declined mainly due to a lower gross margin as higher commodity costs and unfavorable product mix, behind disproportionate growth of mid-tier product lines, larger package sizes and developing regions, were only partially offset by the favorable impact of volume scale leverage and manufacturing cost savings. SG&A as a percentage of net sales decreased slightly due to lower foreign currency exchange costs and overhead spending, mostly offset by higher marketing spending. CORPORATE Corporate includes certain operating and non-operating activities not allocated to specific business units. These include: the incidental businesses managed at the corporate level; financing and investing activities; other general corporate items; the historical results of certain divested brands and categories; and certain restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization. Corporate also includes reconciling items to adjust the accounting policies used in the segments to U.S. GAAP. The most significant reconciling items include income taxes (to adjust from statutory rates that are reflected in the segments to the overall Company effective tax rate), adjustments for unconsolidated entities (to eliminate net sales, cost of products sold and SG&A for entities that are consolidated in the segments but accounted for using the equity method for U.S. GAAP) and noncontrolling interest adjustments for subsidiaries where we do not have 100% ownership. Since certain unconsolidated entities and less than 100%-owned subsidiaries are managed as integral parts of the Company, they are accounted for similar to a wholly-owned subsidiary for management and segment purposes. This means our segment results recognize 100% of each income statement component through before-tax earnings in the segments, with eliminations for unconsolidated entities and noncontrolling interests in Corporate. In determining segment after-tax net earnings, we apply the statutory tax rates (with adjustments to arrive at the Companys effective tax rate in Corporate) and eliminate the share of earnings applicable to other ownership interests, in a manner similar to noncontrolling interest. Net sales in the Corporate segment primarily reflect the adjustment to eliminate the sales of unconsolidated entities included in business segment results. Accordingly, Corporate net sales are generally a negative balance. Negative net sales were down $38 million in the second fiscal quarter and down $116 million fiscal year to date primarily due to adjustments required to eliminate the sales of unconsolidated entities. Corporate had net earnings of $97 million in the quarter versus net expenses of $336 million in the prior year period mainly due to the net benefit of discrete tax adjustments to income tax reserves and the favorable settlement of a value added tax audit. Net expenses declined $622 million fiscal year to date driven by the aforementioned benefits from discrete tax adjustments, higher base period foreign currency exchange costs and lower current period restructuring-type spending. FINANCIAL CONDITION Operating Activities We generated $5.3 billion from operating activities during the fiscal year to date period. This represents a 32% decline versus the prior year period primarily due to higher levels of cash invested in working capital. On a year-to-date basis, working capital consumed $2.1 billion primarily behind higher accounts receivable and inventory balances. Accounts receivable used $931 million mainly due to higher sales in December relative to June and growth in regions and categories with longer average payment terms. Inventory consumed $779 million driven by initiative activity, business growth, higher commodity costs and increased safety stock levels behind customer service improvement efforts. Accounts payable, accrued and other liabilities used $377 million primarily to satisfy marketing and capital commitments accrued for at the end of the 2010 fiscal year. Other operating assets and liabilities consumed $650 million mainly due to lower net liabilities for unrecognized tax positions. Investing Activities We consumed $1.5 billion to fund investing activities primarily to support capital expenditures and acquisitions in the current period. Capital expenditures were $1.3 billion or 3.0 % of net sales. We expect capital expenditures of approximately 4% of net sales for the fiscal year. Acquisitions consumed $435 million mainly due to the purchase of Ambi Pur, while proceeds from asset sales were minimal. Prior-year cash generated from investing activities was $1.6 billion, as normal ongoing capital investments was more than offset by proceeds from divestitures driven by the sale of the global pharmaceuticals business in October 2009. Financing Activities We utilized $3.5 billion for financing activities. We continued to return cash to shareholders by purchasing $3.5 billion of treasury stock and paying $2.8 billion in dividends. We received $2.3 billion primarily behind the proceeds from additional debt issuances. We expect to repurchase a total of $6 - $8 billion of treasury stock during fiscal 2011. In the prior year period, we consumed $10.3 billion to fund financing activities, primarily due to debt repayments. As of December 31, 2010, our current liabilities exceeded current assets by $5.4 billion. We have short- and long-term debt to fund discretionary items such as acquisitions and share repurchase programs. We anticipate being able to support our short-term liquidity and operating needs largely through cash generated from operations. We have strong short- and long-term debt ratings which have enabled and should continue to enable us to refinance our debt as it becomes due at favorable rates in commercial paper and bond markets. In addition, we have agreements with a diverse group of financial institutions that, if needed, should provide sufficient credit funding to meet short-term financing requirements. RECONCILIATION OF NON-GAAP MEASURES Our discussion of financial results includes several measures not defined by U.S. GAAP. We believe these measures provide our investors with additional information about the underlying results and trends of the Company, as well as insight to some of the metrics used to evaluate management. When used in MD&A, we have provided the comparable GAAP measure in the discussion. Organic Sales Growth: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions, divestitures and foreign exchange from year-over-year comparisons. We believe this provides investors with a more complete understanding of underlying sales trends by providing sales growth on a consistent basis. The reconciliation of reported sales growth to organic sales for the October - December quarter: Acquisition/ Divestiture Impact* Fabric Care and Home Care Baby Care and Family Care Acquisition/Divestiture Impacts includes rounding impacts necessary to reconcile net sales to organic sales. The reconciliation of reported sales growth to organic sales for the fiscal year to date period: Acquisition/ Divestiture Impact* Fabric Care and Home Care Baby Care and Family Care Acquisition/Divestiture Impacts includes rounding impacts necessary to reconcile net sales to organic sales. Core EPS: This is a measure of the Companys diluted net earnings per share from continuing operations excluding charges for pending European legal matters and a significant adjustment to an income tax reserve related to the deductibility of technology donations in prior years. We do not view these items to be part of our sustainable results. We believe the Core EPS measure provides an important perspective of underlying business trends and results and provides a more comparable measure of year-on-year earnings per share growth. Core EPS is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation. The table below provides a reconciliation of reported diluted net earnings per share from continuing operations to Core EPS: Diluted Net Earnings Per Share - Continuing Operations Significant Adjustment to Income Tax Reserve Charges for Pending European Legal Matters Diluted Net Earnings Per Share - Continuing Operations Significant Adjustment to Income Tax Reserve Charges for Pending European Legal Matters Note  All reconciling items are presented net of tax. Tax effects are calculated consistent with the nature of the underlying transaction. The significant adjustment to an income tax reserve was tax expense. There was no tax impact on EPS due to the charges for pending European legal matters. Free Cash Flow: Free cash flow is defined as operating cash flow less capital spending. We view free cash flow as an important measure because it is one factor in determining the amount of cash available for dividends and discretionary investment. Free cash flow is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation. Free Cash Flow Productivity: Free cash flow productivity is defined as the ratio of free cash flow to net earnings. The Companys long-term target is to generate free cash at or above 90 percent of net earnings. Free cash flow is also one of the measures used to evaluate senior management. The reconciliation of free cash flow and free cash flow productivity is provided below (amounts in millions): Free Cash Flow Productivity Quantitative and Qualitative Disclosures About Market Risk. There have been no material changes in the Companys exposure to market risk since June 30, 2010. Additional information can be found in the section entitled Other Information, which appears on pages 48-49, and Note 5, Risk Management Activities and Fair Value Measurements, which appears on pages 59-62 of the Annual Report to Shareholders for the fiscal year ended June 30, 2010 which can be found by reference to Exhibit 13 of the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2010. Controls and Procedures. Evaluation of Disclosure Controls and Procedures. The Companys Chairman of the Board, President and Chief Executive Officer, Robert A. McDonald, and the Companys Chief Financial Officer, Jon R. Moeller, performed an evaluation of the Companys disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (Exchange Act)) as of the end of the period covered by this report. Messrs. McDonald and Moeller have concluded that the Companys disclosure controls and procedures were effective to ensure that information required to be disclosed in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) accumulated and communicated to our management, including Messrs. McDonald and Moeller, to allow their timely decisions regarding required disclosure. Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting that occurred during the Companys fiscal quarter ended December 31, 2010 that have materially affected, or are reasonably likely to materially affect, the Companys internal control over financial reporting. PART II. OTHER INFORMATION Legal Proceedings. The Company is subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental issues, patent and trademark matters, labor and employment matters and taxes. As previously reported, the Company has been subject to a number of investigations into potential competition law violations in Europe. These investigations involve the European Commission, which is investigating potential competition law violations in a variety of countries across the European Union, as well as individual investigations by national authorities in Belgium, the Czech Republic, France, Germany, Greece, Italy, Romania, Spain, Switzerland and the United Kingdom. We believe that all of these matters involve a number of other consumer products companies and/or retail customers. Although non-monetary sanctions are not being sought in any of these matters, competition and antitrust law investigations often continue for several years and, if violations are found, can result in substantial fines. In other industries, fines have amounted to hundreds of millions of dollars. The Companys policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with investigations by relevant regulatory authorities, which the Company is doing. In response to the actions of the European Commission and national authorities, the Company launched its own internal investigations into potential violations of competition laws. The Company identified violations in certain European countries and appropriate actions were taken. As previously disclosed, as a result of the investigations discussed above, authorities in several countries have issued separate complaints alleging that the Company, along with several other companies, engaged in violations of competition laws in the past. During the most recent quarter, there were further developments. The United Kingdom authority closed its investigation without issuing any penalty to the Company. Authorities in Italy issued a final decision resulting in monetary damages and authorities in France, the Czech Republic and the European Commission disclosed additional information to the Company regarding their respective investigations. Pursuant to these activities, the Company took additional reserves for potential fines. The remaining matters are in various stages of the regulatory process. The Company will continue to take reserves as appropriate. The ultimate resolution of these matters may result in fines or costs in excess of the amounts reserved that could materially impact our income statement and cash flows in the period in which they are accrued and paid, respectively. Please refer to the Companys Risk Factors in Item 1A of this Form 10-Q for additional information. In December 2008, the Company became aware of an investigation by Italian authorities into an environmental accident at the site of a contractor which provides services to one or more of the Companys European affiliates. The accident involved the explosion of certain pressurized cans and resulted in the death of one worker and serious injuries to another. Italian authorities have commenced a formal criminal proceeding regarding whether the Companys local affiliate and certain of its employees complied with Italian laws related to the proper classification and disposal of their products. Should they find that these entities violated the law, the Italian authorities could levy fines in excess of $100 thousand against the Companys European affiliate(s). discuss our expectations regarding future performance, events and outcomes, such as our business outlook and objectives in this Form 10-Q, the Annual Report to Shareholders, quarterly reports, press releases and other written and oral communications. All statements, except for historical and present factual information, are forward-looking statements and are based on financial data and business plans available only as of the time the statements are made, which may become out of date or incomplete. We assume no obligation to update any forward-looking statements as a result of new information, future events, or other factors. Forward-looking statements are inherently uncertain, and investors must recognize that events could significantly differ from our expectations. The following discussion of risk factors identifies the most significant factors that may adversely affect our business, operations, financial position or future financial performance. This information should be read in conjunction with MD&A and the consolidated financial statements and related notes incorporated by reference into this report. The following discussion of risks is not all inclusive but is designed to highlight what we believe are important factors to consider when evaluating our expectations. These factors could cause our future results to differ from those in the forward-looking statements and from historical trends. A material change in consumer demand for our products could have a significant impact on our business. We are a consumer products company and rely on continued global demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers. This is dependent on a number of factors including our ability to develop effective sales, advertising and marketing programs in an increasingly fragmented media environment. We expect to achieve our financial targets, in part, by shifting our portfolio towards faster growing, higher margin businesses. If demand and growth rates fall substantially below expected levels or our market share declines significantly in these businesses, our results could be negatively impacted. This could occur due to unforeseen negative economic or political events or to changes in consumer trends and habits. In addition, our continued success is dependent on leading-edge innovation, with respect to both products and operations. This means we must be able to obtain patents that lead to the development of products that appeal to our consumers across the world. The ability to achieve our business objectives is dependent on how well we can respond to our local and global competitors. Across all of our categories, we compete against a wide variety of global and local competitors. As a result, there are ongoing competitive product and pricing pressures in the environments in which we operate, as well as challenges in maintaining profit margins. To address these challenges, we must be able to successfully respond to competitive factors, including pricing, promotional incentives and trade terms, as well as technological advances and patents granted to competition. Our businesses face cost pressures which could affect our business results. Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, cost of labor, foreign exchange and interest rates. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects (including outsourcing projects), sourcing decisions and certain hedging transactions. In the manufacturing and general overhead areas, we need to maintain key manufacturing and supply arrangements, including any key sole supplier and sole manufacturing plant arrangements. We face risks associated with significant international operations. We conduct business across the globe with a significant portion of our sales outside the United States. As a result, we are subject to a number of risks, including, but not limited to, changes in exchange rates for foreign currencies, which may reduce the U.S. dollar value of revenues and earnings received and/or balances held by or invested in our foreign subsidiaries, as well as exchange controls and other limits on our ability to repatriate earnings from outside the U.S. that can increase our exposure. We have sizable businesses and maintain local currency cash balances in a number of foreign countries with exchange controls, including, but not limited to, Venezuela, China and India. Our results of operations and/or financial condition could be adversely impacted if we are unable to successfully manage these risks in an increasingly volatile environment. Further, we expect to achieve our financial targets, in part, by achieving disproportionate growth in developing regions. Should growth rates or our market share fall substantially below expected levels in these regions, our results could be negatively impacted. In addition, economic changes, terrorist activity and political unrest may result in business interruption, inflation, deflation or decreased demand for our products. Our success will depend, in part, on our ability to manage continued global political and/or economic uncertainty, especially in our significant geographical markets, as well as any political or economic disruption due to terrorist and other hostile activities. If the reputation of the Company or one or more of our leading brands erodes significantly, it could have a material impact on our financial results. The Companys reputation is the foundation of our relationships with key stakeholders and other constituencies. If we are unable to effectively manage real or perceived issues, which could negatively impact sentiments toward the Company, our ability to operate freely could be impaired and our financial results could suffer. Our financial success is directly dependent on the success of our brands, particularly our billion-dollar brands. The success of these brands can suffer if our marketing plans or product initiatives do not have the desired impact on a brands image or its ability to attract consumers. Further, our results could be negatively impacted if one of our leading brands suffers a substantial impediment to its reputation due to real or perceived quality issues or the distribution and sale of counterfeit products. Our ability to successfully adapt to ongoing organizational change could impact our business results. We have executed a number of significant business and organizational changes including acquisitions, divestitures and workforce optimization projects to support our growth strategies. We expect these types of changes to continue for the foreseeable future. Successfully managing these changes, including retention of key employees, is critical to our business success. In addition, we are generally a build-from-within company, and our success is dependent on identifying, developing and retaining key employees to provide uninterrupted leadership and direction for our business. This includes developing organization capabilities in key growth markets where the depth of skilled employees is limited and competition for these resources is intense. Further, business and organizational changes may result in more reliance on third parties for various services, and that reliance may increase compliance risks, including anti-corruption. Finally, our financial targets assume a consistent level of productivity improvement. If we are unable to deliver expected productivity improvements, while continuing to invest in business growth, our financial results could be adversely impacted. Our ability to successfully manage ongoing acquisition and divestiture activities could impact our business results. As a company that manages a portfolio of consumer brands, our ongoing business model involves a certain level of acquisition and divestiture activities. We must be able to successfully manage the impacts of these activities, while at the same time delivering against base business objectives. Specifically, our financial results could be adversely impacted if: 1) we are not able to deliver the expected cost and growth synergies associated with our acquisitions, 2) changes in the cash flows or other market-based assumptions cause the value of acquired assets to fall below book value or 3) we are unable to offset the dilutive impacts from the loss of revenue streams associated with divested brands. Our business is subject to legislation, regulation and enforcement in the U.S. and abroad. Changes in laws, regulations and the related interpretations and increased enforcement actions may alter the environment in which we do business. This includes changes in competition, product-related, privacy and environmental laws, including actions in response to global climate change concerns, increased enforcement as well as changes in accounting standards, taxation requirements and enforcement penalties. Accordingly, our ability to manage regulatory, tax and legal matters (including product liability, patent, and other intellectual property matters), and to resolve pending legal matters without significant liability may materially impact our results of operations and financial position. Furthermore, the competition law and antitrust investigations described in Part II, Item 1 of this Form 10-Q, may result in fines or costs in excess of the amounts accrued to date that could materially impact our results of operations and financial position. In addition, as a U.S. based multinational company we are also subject to tax regulations in the U.S. and multiple foreign jurisdictions, some of which are interdependent. For example, certain income that is earned and taxed in countries outside the U.S. is not taxed in the U.S., provided those earnings are indefinitely reinvested outside the U.S. If these or other tax regulations should change, our financial results could be impacted. A material change in customer relationships or in customer demand for our products could have a significant impact on our business. Our success is dependent on our ability to successfully manage relationships with our retail trade customers. This includes our ability to offer trade terms that are acceptable to our customers and are aligned with our pricing and profitability targets. Our business could suffer if we cannot reach agreement with a key customer based on our trade terms and principles. Further, there is a continuing trend towards retail trade consolidation, which can create significant cost and margin pressure and could lead to more complex work across broader geographic boundaries for both us and key retailers. This can be particularly difficult when major customers are addressing local trade pressures or local law and regulation changes. In addition, our business would be negatively impacted if a key customer were to significantly reduce the range or inventory level of our products. We face risks related to changes in the global economic environment. Our business is impacted by global economic conditions, which are increasingly volatile. If the global economy experiences significant disruptions, our business could be negatively impacted, including such areas as reduced demand for our products from a slow-down in the general economy, supplier or customer disruptions resulting from tighter credit markets and/or temporary interruptions in our ability to conduct day-to-day transactions through our financial intermediaries involving the payment to or collection of funds from our customers, vendors and suppliers. A failure of a key information technology system, process or site could have a material adverse impact on our ability to conduct business. We rely extensively on information technology systems, some of which are managed by third-party service providers, to interact with internal and external stakeholders. These interactions include, but are not limited to, ordering and managing materials from suppliers, converting materials to finished products, shipping product to customers, processing transactions, summarizing and reporting results of operations, complying with regulatory, legal or tax requirements, and other processes necessary to manage the business. If our systems are damaged or cease to function properly due to any number of causes, ranging from catastrophic events to power outages to security breaches, and our business continuity plans do not effectively compensate on a timely basis, we may suffer interruptions in our ability to manage operations which may adversely impact our results of operations and/or financial condition. In addition, we are transitioning our ordering, shipping and billing systems in North America and Western Europe to a new system during fiscal 2011. If the new system does not function properly upon implementation, our ability to process and deliver customer orders in our two largest regions could be limited and could negatively impact our results of operations during the period(s) of transition. Also, we may be unable to process and receive payments for products sold which could negatively impact our cash flow results during those periods. Unregistered Sales of Equity Securities and Use of Proceeds. ISSUER PURCHASES OF EQUITY SECURITIES Total Number of Shares Purchased (1) Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Plans Value of Shares That May Yet Be Purchased Under our Share Repurchase Program ($ in billions) (3) (4) The total number of shares purchased was 8,234,139 for the quarter. This includes 176,365 shares acquired by the Company under various compensation and benefit plans. All transactions were made in the open market or pursuant to prepaid forward agreements with large financial institutions. Under these agreements, the Company prepays large financial institutions to deliver shares at future dates in exchange for a discount. This table excludes shares withheld from employees to satisfy minimum tax withholding requirements on option exercises and other equity-based transactions. The Company administers cashless exercises through an independent, third party and does not repurchase stock in connection with a cashless exercise. Average price paid per share is calculated on a settlement basis and excludes commission. On August 3, 2010, the Company announced a share repurchase plan to acquire $6 to $8 billion of Company common stock during the fiscal year ending June 30, 2011 in open market and/or private transactions. This repurchase plan was authorized pursuant to a resolution issued by the Companys Board of Directors and is expected to be financed by issuing a combination of long-term and short-term debt. Certain purchases were made prior to the announcement of the plan but are considered purchases against the plan. The dollar values listed in this column include commissions to be paid to brokers to execute the transactions. Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October 14, 2008) (Incorporated by reference to Exhibit (3-1) of the Companys Form 10-Q for the quarter ended December 31, 2008). Regulations (as amended by the Board of Directors on April 18, 2010 pursuant to authority granted by shareholders at the annual meeting on October 13, 2009). (Incorporated by reference to Exhibit 3.ii of the Companys Form 8-K filed on April 18, 2010). Computation of Earnings per Share. Computation of Ratio of Earnings to Fixed Charges.",14820
2011-02-01,8-K,0000080424-11-000002,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) DEPARTURE OF CERTAIN OFFICERS On February 1, 2011, The Procter & Gamble Company (the Company) announced that Robert A. Steele will leave his current position as Vice Chairman-Global Health and Well-Being effective February 1, 2011, in anticipation of retiring from the Company on September 1, 2011. The Company is filing this 8-K pursuant to Item 5.02(b), ""Departure of Certain Officers.""",173
2011-02-11,8-K,0000080424-11-000003,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 5.02(d) ELECTION OF DIRECTORS On February 11, 2011, The Procter & Gamble Company (the ""Company"") issued a news release announcing that Margaret C. Whitman was appointed to the Board of Directors, effective February 8, 2011. Ms. Whitman's committee assignments will be determined at a later date. The Company is filing this 8-K pursuant to Item 5.02(d), ""Election of Directors."" A copy of the Company's press release relating to this announcement is being furnished as Exhibit 99 to this 8-K.",193
2011-03-01,8-K,0000735244-11-000010,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 5.02 (b) DEPARTURE OF DIRECTOR On March 1, 2011, Rajat K. Gupta voluntarily resigned from The Procter & Gamble Companys Board of Directors. The Company is filing this 8-K pursuant to Item 5.02(b), ""Departure of Certain Officers and Directors.""",153
2011-03-24,8-K,0000735244-11-000012,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On March 24, 2011, The Procter & Gamble Company (Company) and Teva Pharmaceutical Industries Ltd. issued a news release announcing that the companies have reached an agreement to created a partnership in consumer health care by bringing together both companies' existing over-the-counter medicines and complementary capabilities. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",177
2011-04-05,8-K,0000080424-11-000005,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On April 5, 2011, The Procter & Gamble Company (""Company"") and Diamond Foods, Inc. (""Diamond"") issued a news release announcing that the companies have agree to merge the Company's Pringles business into Diamond in an all-stock reverse Morris Trust transaction. Details of the transaction will be finalized and announced publicly in the coming months. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",185
2011-04-11,8-K,0000080424-11-000006,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On April 11, 2011, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of fifty two point five cents ($0.525) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after May 16, 2011 to Common Stock shareholders of record at the close of business on April 29, 2011, and payable on the dividend payment date for the Common Stock to Series A and Series B Preferred Stock shareholders of record at the start of business on that date. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",233
2011-04-28,8-K,0000735244-11-000020,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) ( Registrant's telephone number, including area code ) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On April 28, 2011, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended March 31, 2011. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",165
2011-04-29,10-Q,0001193125-11-116981,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2011 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission file number 1-434 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (513) 983-1100 (Registrants telephone number, including area code) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No  Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No  Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Large accelerated filer  Accelerated filer  Non-accelerated filer  Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No  There were 2,791,293,888 shares of Common Stock outstanding as of March 31, 2011. PART I. FINANCIAL INFORMATION Financial Statements. The Consolidated Statements of Earnings of The Procter & Gamble Company and subsidiaries (the Company, we or our) for the three months and nine months ended March 31, 2011 and 2010, the Consolidated Balance Sheets as of March 31, 2011 and June 30, 2010, and the Consolidated Statements of Cash Flows for the nine months ended March 31, 2011 and 2010 follow. In the opinion of management, these unaudited Consolidated Financial Statements contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, such financial statements may not necessarily be indicative of annual results. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS Three Months Ended March 31 Nine Months Ended March 31 Amounts in millions except per share amounts Selling, general and administrative expense Other non-operating income/(expense), net Earnings from Continuing Operations Before Income Taxes Income taxes on continuing operations Net Earnings from Continuing Operations Net Earnings from Discontinued Operations Basic net earnings from continuing operations Basic net earnings from discontinued operations Diluted net earnings from continuing operations Diluted net earnings from discontinued operations Diluted Weighted Average Common Shares Outstanding to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS Cash and cash equivalents Prepaid expenses and other current assets PROPERTY, PLANT AND EQUIPMENT Total property, plant and equipment NET PROPERTY, PLANT AND EQUIPMENT GOODWILL AND OTHER INTANGIBLE ASSETS Trademarks and other intangible assets, net NET GOODWILL AND OTHER INTANGIBLE ASSETS LIABILITIES AND SHAREHOLDERS EQUITY Accrued and other liabilities TOTAL CURRENT LIABILITIES OTHER NONCURRENT LIABILITIES Common stock  shares issued  Additional paid-in capital Reserve for ESOP debt retirement Accumulated other comprehensive income (loss) TOTAL SHAREHOLDERS EQUITY TOTAL LIABILITIES AND SHAREHOLDERS EQUITY See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS Nine Months Ended March 31 CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD Depreciation and amortization Share-based compensation expense Gain on sale of businesses Accounts payable, accrued and other liabilities Other operating assets and liabilities TOTAL OPERATING ACTIVITIES Proceeds from asset sales Acquisitions, net of cash acquired TOTAL INVESTING ACTIVITIES Dividends to shareholders Change in short-term debt Additions to long-term debt Reductions of long-term debt Impact of stock options and other TOTAL FINANCING ACTIVITIES EFFECT OF EXCHANGE RATE CHANGES ON CASH CHANGE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, END OF PERIOD See accompanying Notes to Consolidated Financial Statements THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS These statements should be read in conjunction with the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2010. The results of operations for the three-month and nine-month periods ended March 31, 2011 are not necessarily indicative of annual results. Comprehensive Income - Total comprehensive income is comprised primarily of net earnings, net currency translation gains and losses, impacts of net investment and cash flow hedges, net unrealized gains and losses on investment securities and defined benefit and other retiree benefit plan activities. Total comprehensive income for the three months ended March 31, 2011 and 2010 was $4,734 million and $772 million, respectively. For the nine months ended March 31, 2011 and 2010, total comprehensive income was $13,614 million and $9,860 million, respectively. Segment Information - Following is a summary of segment results. As discussed in Note 10, our divested global pharmaceutical business is presented as discontinued operations and is excluded from segment results for all periods presented. Following is a summary of segment Three Months Ended March 31 Nine Months Ended March 31 Earnings from Continuing Operations Before Income Taxes Net Earnings from Continuing Operations Earnings from Continuing Operations Before Income Taxes Net Earnings from Continuing Operations Fabric Care and Home Care Baby Care and Family Care Goodwill and Other Intangible Assets - Goodwill as of March 31, 2011 is allocated by reportable segment as follows (amounts in millions): Nine Months Ended March 31, 2011 Beauty, beginning of year Acquisitions and divestitures Grooming, beginning of year Acquisitions and divestitures Health Care, beginning of year Acquisitions and divestitures Snacks and Pet Care, beginning of year Acquisitions and divestitures Fabric Care and Home Care, beginning of year Acquisitions and divestitures Baby Care and Family Care, beginning of year Acquisitions and divestitures Corporate, beginning of year Acquisitions and divestitures GOODWILL, beginning of year Acquisitions and divestitures The increase in goodwill from June 30, 2010 is primarily due to currency translation across all reportable segments and the acquisition of Ambi Pur in our Fabric Care and Home Care reportable segment. Identifiable intangible assets as of March 31, 2011 are comprised of (amounts in Amortizable intangible assets with determinable lives Intangible assets with indefinite lives Total identifiable intangible assets Defined life intangible assets consist principally of brands, patents, technology and customer relationships. Indefinite lived intangible assets consist primarily of brands. The amortization of intangible assets for the three months ended March 31, 2011, and 2010 was $128 million and $147 million, respectively. For the nine months ended March 31, 2011 and 2010, the amortization of intangible assets was $399 million and $435 million, respectively. Pursuant to applicable accounting guidance for share-based payments, companies must recognize the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of those awards. Total share-based compensation for the three months and nine months ended March 31, 2011 and 2010 are summarized in the following table (amounts in millions): Three Months Ended March 31 Nine Months Ended March 31 Total share-based compensation Assumptions utilized in the model are evaluated and revised, as necessary, to reflect market conditions and Postretirement Benefits - The Company offers various postretirement benefits to its employees. The components of net periodic benefit cost for defined benefit plans are as follows: Three Months Ended March 31 Three Months Ended March 31 Expected Return on Plan Assets Amortization of Deferred Amounts Recognized Net Actuarial Loss Gross Benefit Cost (Credit) Dividends on ESOP Preferred Stock Net Periodic Benefit Cost (Credit) Nine Months Ended March 31 Nine Months Ended March 31 Expected Return on Plan Assets Amortization of Deferred Amounts Recognized Net Actuarial Loss Gross Benefit Cost (Credit) Dividends on ESOP Preferred Stock Net Periodic Benefit Cost (Credit) For the year ending June 30, 2011, the expected return on plan assets is 7.2% and 9.2% for defined benefit and other retiree benefit plans, respectively. Risk Management Activities and Fair Value Measurements As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. For details on the Companys risk management activities, refer to the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2010. Fair Value Hierarchy For a discussion of the Companys fair value measurement policies under the fair value hierarchy, refer to the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2010. The Company has not changed its valuation techniques for measuring the fair value of any financial assets and liabilities during the period. The following table sets forth the Companys financial assets and liabilities as of March 31, 2011 and June 30, 2010 that are measured at fair value on a recurring basis during the period, segregated by level within the fair value hierarchy: Other foreign currency instruments (1) Total assets at fair value (2) Liabilities at fair value: Other foreign currency instruments (1) Total liabilities at fair value (3) Other foreign currency instruments are comprised of non-qualifying foreign currency financial instruments. Investment securities are presented in other noncurrent assets and all derivative assets are presented in prepaid expenses and other current assets or other noncurrent All derivative liabilities are presented in accrued and other liabilities or other noncurrent liabilities. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each quarter. There was no significant activity within the Level 3 assets and liabilities during the periods presented. There were no significant assets or liabilities that were re-measured at fair value on a non-recurring basis during the periods presented. Certain of the Companys financial instruments used in hedging transactions are governed by industry standard netting agreements with counterparties. If the Companys credit rating were to fall below the levels stipulated in the agreements, the counterparties could demand either collateralization or termination of the arrangement. The aggregate fair value of the instruments covered by these contractual features that are in a net liability position as of March 31, 2011 was $146 million. The Company has not been required to post any collateral as a result of these contractual features. Fair Values of Other Financial Instruments Other financial instruments, including cash equivalents, other investments and short-term debt, are recorded at cost, which approximates fair value. The fair value of the long-term debt was $22,996 million and $23,072 million at March 31, 2011 and June 30, 2010, respectively. Disclosures about Derivative Instruments The notional amounts and fair values of qualifying and non-qualifying financial instruments used in hedging transactions as of March 31, 2011 and June 30, 2010 are as follows: Fair Value Asset (Liability) Derivatives in Cash Flow Hedging Relationships Foreign currency contracts Derivatives in Fair Value Hedging Relationships Derivatives in Net Investment Hedging Relationships Derivatives Not Designated as Hedging Instruments Foreign currency contracts The total notional amount of contracts outstanding at the end of the period is indicative of the level of the Companys derivative activity during the period. Amount of Gain (Loss) Recognized in Accumulated OCI on Derivatives (Effective Portion) Derivatives in Cash Flow Hedging Relationships Foreign currency contracts Derivatives in Net Investment Hedging Relationships During the next 12 months, the amount of the March 31, 2011 accumulated other comprehensive income (OCI) balance that will be reclassified to earnings is expected to be immaterial. The amounts of gains and losses on qualifying and non-qualifying financial instruments used in hedging transactions for the three-month and nine-month periods ended March 31, 2011 and 2010 are as follows: Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (1) Three Months Ended March 31 Nine Months Ended March 31 Derivatives in Cash Flow Hedging Relationships Foreign currency contracts Amount of Gain(Loss) Recognized in Income Three Months Ended March 31 Nine Months Ended March 31 Derivatives in Fair Value Hedging Relationships (2) Derivatives in Net Investment Hedging Relationships (2) Derivatives Not Designated as Hedging Instruments (3) Foreign currency contracts The gain or loss on the effective portion of cash flow hedging relationships is reclassified from accumulated OCI into net income in the same period during which the related item affects earnings. Such amounts are included in the Consolidated Statements of Earnings as follows: interest rate contracts in interest expense, foreign currency contracts in selling, general and administrative expense and commodity contracts in cost of products sold. The gain or loss on the ineffective portion of interest rate contracts and net investment hedges, if any, is included in the Consolidated Statements of Earnings in The gain or loss on contracts not designated as hedging instruments is included in the Consolidated Statements of Earnings as follows: foreign currency contracts in selling, general and administrative expense and commodity contracts in cost of products sold. New Accounting Pronouncements and Policies No new accounting pronouncement issued or effective during the fiscal year has had or is expected to have a material impact on the Consolidated Financial Statements. Commitments and Contingencies We are subject to various legal proceedings and claims arising out of our business which cover a wide range of matters such as governmental regulations, antitrust and trade regulations, product liability, patent and trademark matters, income taxes and other actions. As previously disclosed, the Company is and has been subject to a variety of investigations into potential competition law violations in Europe by the European Commission and national authorities from a number of countries. These matters involve a number of consumer products companies and/or retail customers. The Companys policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with investigations by relevant regulatory authorities, which the Company is doing. Competition and antitrust law inquiries often continue for several years and, if violations are found, can result in substantial fines. In response to the actions of the European Commission and national authorities, the Company launched its own internal investigations into potential violations of competition laws. The Company identified violations in certain European countries and appropriate actions were taken. Several regulatory authorities in Europe have issued separate complaints pursuant to their investigations alleging that the Company, along with several other companies, engaged in violations of competition laws in those countries. The remaining authorities investigations are in various stages of the regulatory process. As a result of our initial and on-going analyses of the complaints, as well as final decisions issued by the authorities in Spain and Czech Republic during the quarter ended March 31, 2011 and by the European Commission in April 2011, the Company has reserves totaling $606 million as of March 31, 2011 for potential fines for competition law violations. In accordance with US GAAP, certain of the reserves included in this amount represent the low end of a range of potential outcomes. Accordingly, the ultimate resolution of these matters may result in fines or costs in excess of the amounts reserved that could materially impact our income statement and cash flows in the period in which they are accrued and paid, respectively. We will continue to monitor developments for all of these investigations and will record additional charges as appropriate. With respect to other litigation and claims, while considerable uncertainty exists in the opinion of management and our counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows. We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will have a material adverse effect on our financial position, results of operations or cash flows. Income Tax Uncertainties The Company is present in over 150 taxable jurisdictions and, at any point in time, has 50 - 60 audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law and closing of statute of limitations. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 2001 and forward. Net adjustments to prior-year tax balances for uncertain tax positions resulted in a tax benefit of approximately $424 million in the current year. We are generally not able to reliably estimate the ultimate settlement amounts or timing until the close of the audit. At this time, we are not able to make a reasonable estimate of the range of potential changes to the balance of uncertain tax positions over the next 12 months or the impact of any such changes on the effective tax rate. Additional information on the Commitments and Contingencies of the Company can be found in Note 10, Commitments and Contingencies, which appears in the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2010. Discontinued Operations In October 2009, the Company completed the divestiture of our global pharmaceuticals business to Warner Chilcott plc (Warner Chilcott) for $2.8 billion of cash, net of assumed and transferred liabilities. Under the terms of the agreement, Warner Chilcott acquired our portfolio of branded pharmaceutical products, our prescription drug product pipeline and manufacturing facilities in Puerto Rico and Germany. In addition, the majority of the employees working on the pharmaceuticals business were transferred to Warner Chilcott. The Company recorded an after-tax gain on the transaction of $1,464 million in the quarter ended December 31, 2009, which is included in net earnings from discontinued operations in the Consolidated Statement of Earnings for the nine-month period ended March 31, 2010. In accordance with the applicable accounting guidance for the disposal of long-lived assets, the results of the pharmaceuticals business are presented as discontinued operations and, as such, have been excluded from continuing operations and segment results for all periods presented. Following is selected financial information included in net earnings from discontinued operations for the pharmaceuticals business: Earnings from discontinued operations Gain on sale of discontinued operations Income tax benefit (expense) on sale Net earnings from discontinued operations The net gain on the sale of the pharmaceuticals business for the nine-month period ended March 31, 2010 also includes an after-tax gain on the sale of the Actonel brand in Japan, which occurred prior to the divestiture to Warner Chilcott. Managements Discussion and Analysis of Financial Condition and Results of Operations The purpose of this discussion is to provide an understanding of P&Gs financial results and condition by focusing on changes in certain key measures from year to year. Managements Discussion and Analysis (MD&A) is organized in the following sections: Forward-Looking Statements Results of Operations - Three Months Ended March 31, 2011 Results of Operations - Nine Months Ended March 31, 2011 Business Segment Discussion - Three and Nine Months Ended March 31, 2011 Reconciliation of Non-GAAP Measures Throughout MD&A, we refer to measures used by management to evaluate performance, including unit volume growth, net outside sales and after-tax profit. We also refer to organic sales growth, core earnings per share growth, free cash flow and free cash flow productivity. These financial measures are not defined under accounting principles generally accepted in the United States of America (U.S. GAAP). The explanation at the end of MD&A provides more details on the use and the derivation of these measures. Management also uses certain market share and market consumption estimates to evaluate performance relative to competition despite some limitations on the availability and comparability of such information. References to market share and market consumption in MD&A are based on a combination of vendor-reported consumption and market size data, as well as internal estimates. OVERVIEW P&Gs business is focused on providing branded consumer goods products. Our purpose is to provide products and services of superior quality and value that improve the lives of the worlds consumers, now and for generations to come. We believe this will result in leadership sales, profits and value creation, allowing employees, shareholders and the communities in which we operate to prosper. Our products are sold in more than 180 countries primarily through mass merchandisers, grocery stores, membership club stores, drug stores and high frequency stores, the neighborhood stores which serve many consumers in developing markets. We continue to expand our presence in other channels including department stores, perfumeries, pharmacies, salons and e-commerce. We compete in multiple product categories and have two global business units (GBUs): the Beauty and Grooming GBU and the Household Care GBU. Under U.S. GAAP, the business units comprising the GBUs are aggregated into six reportable segments: Beauty; Grooming; Health Care; Snacks and Pet Care; Fabric Care and Home Care; and Baby Care and Family Care. We have on-the-ground operations in approximately 80 countries through our Market Development Organization, which leads country business teams to build our brands in local markets and is organized along five geographic units: North America, Western Europe, Central & Eastern Europe/Middle East/Africa (CEEMEA), Latin America and Asia, which is comprised of Japan, Greater China and ASEAN/Australia/India/Korea (AAIK). Throughout MD&A, we reference business results in developing markets, which we define as the aggregate of CEEMEA, Latin America, AAIK and Greater China, and developed markets, which are comprised of North America, Western Europe and Japan. On October 30, 2009, we sold our global pharmaceuticals business to Warner Chilcott plc (Warner Chilcott) for $2.8 billion. Under the terms of the agreement, Warner Chilcott acquired our portfolio of branded pharmaceuticals products, prescription drug product pipeline and manufacturing facilities in Puerto Rico and Germany. The pharmaceuticals business had historically been part of the Health Care reportable segment. In accordance with applicable accounting guidance for the disposal of long-lived assets, the results of the pharmaceuticals business are presented as discontinued operations and, as such, are excluded from continuing operations and from segment results. The table below provides more information about the components of our reportable business segment structure. Cosmetics, Female Antiperspirant and Deodorant, Female Personal Cleansing, Female Shave Care, Hair Care, Hair Color, Hair Styling, Pharmacy Channel, Prestige Products, Salon Head & Shoulders, Olay, Pantene, Wella Beauty Electronics, Home Small Appliances, Male Blades and Razors, Male Personal Care Braun, Fusion, Gillette, Mach3 Feminine Care, Gastrointestinal, Incontinence, Rapid Diagnostics, Respiratory, Toothbrush, Toothpaste, Water Filtration, Other Oral Care Fabric Care and Home Care Laundry Additives, Air Care, Batteries, Dish Care, Fabric Enhancers, Laundry Detergents, Surface Care Ace, Ariel, Dawn, Downy, Duracell, Gain, Tide, Febreze Baby Care and Family Care Baby Wipes, Diapers, Paper Towels, Tissues, Toilet Paper Bounty, Charmin, Pampers The following table provides the percentage of net sales and net earnings from continuing operations by reportable business segment for the three and nine months ended March 31, 2011 (excludes net sales and net earnings in Corporate): Three Months Ended March 31 Nine Months Ended March 31 Fabric Care and Home Care Baby Care and Family Care Following are highlights of results for the nine months ended March 31, 2011 versus the nine months ended March 31, 2010: Net sales increased 3% to $61.7 billion as 6% volume growth was partially offset by 2 points from negative mix and 1 point from unfavorable foreign exchange. Organic sales, which exclude the impacts of acquisitions, divestitures and foreign exchange, were up 4%. Operating margin declined 150 basis points behind a commodity-cost driven reduction in gross margin and increased marketing investments, partially offset by reduced foreign currency exchange costs. Net earnings from continuing operations increased 6% to $9.3 billion mainly due to a lower effective tax rate and higher net sales, partially offset by operating margin contraction. Diluted net earnings per share from continuing operations increased 10% to $3.09. Earnings per share growth exceeded net earnings growth due to the impact of share repurchase activity. Net earnings were $9.3 billion, a decrease of 12% due to the divestiture of the pharmaceuticals business in the prior year period. Diluted net earnings per share were $3.09, a decrease of 9%. Core EPS, which is diluted net earnings per share from continuing operations excluding US healthcare reform legislation costs in the base period, pending European legal matters and a significant adjustment to an income tax reserve, increased 5% to $3.10. Operating cash flow decreased $3.4 billion to $9.4 billion mainly due to an increase in working capital. Free cash flow, which is operating cash flow less capital expenditures, was $7.3 billion. Free cash flow productivity, which is the ratio of free cash flow to net earnings, was 79%. FORWARD-LOOKING STATEMENTS We discuss expectations regarding future performance, events and outcomes, such as our business outlook and objectives, in annual and quarterly reports, press releases and other written and oral communications. All such statements, except for historical and present factual information, are forward-looking statements, and are based on financial data and our business plans available only as of the time the statements are made, which may become out-of-date or incomplete. We assume no obligation to update any forward-looking statements as a result of new information, future events or other factors. Forward-looking statements are inherently uncertain and investors must recognize that events could be significantly different from our expectations. For more information on risks that could impact our results, refer to Part II Item 1A Risk Factors in this 10-Q filing. Ability to Achieve Business Plans: We are a consumer products company and rely on continued demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers and retail trade customers. Our continued success is dependent on leading-edge innovation with respect to both products and operations and on the continued positive reputations of our brands. This means we must be able to obtain patents and respond to technological advances and patents granted to competition. Our success is also dependent on effective sales, advertising and marketing programs in an increasingly fragmented media environment. Our ability to innovate and execute in these areas will determine the extent to which we are able to grow existing sales and volume profitably, especially with respect to the product categories and geographic markets (including developing markets) in which we have chosen to focus. There are high levels of competitive activity in the environments in which we operate. To address these challenges, we must respond to competitive factors, including pricing, promotional incentives, trade terms and product initiatives. We must manage each of these factors, as well as maintain mutually beneficial relationships with our key customers, in order to effectively compete and achieve our business plans. As a company that manages a portfolio of consumer brands, our ongoing business model involves a certain level of ongoing acquisition and divestiture activities. We must be able to successfully manage the impacts of these activities, while at the same time delivering against base business objectives. Our success will also depend on our ability to maintain key information technology systems. Cost Pressures: Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, cost of labor, foreign exchange and interest rates. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects, sourcing decisions and certain hedging transactions. We also must manage our debt and currency exposure, especially in certain countries, such as Venezuela, China and India. We need to maintain key manufacturing and supply arrangements, including sole supplier and sole manufacturing plant arrangements. We must implement, achieve and sustain cost improvement plans, including our outsourcing projects and those related to general overhead and workforce optimization. Successfully managing these changes, including identifying, developing and retaining key employees, is critical to our success. Global Economic Conditions: Economic changes, terrorist activity, political unrest and natural disasters, such as the civil unrest in the Middle East and the Japan crisis, may result in business interruption, inflation, deflation or decreased demand for our products. Our success will depend, in part, on our ability to manage continued global political and/or economic uncertainty, especially in our significant geographic markets, as well as any political or economic disruption due to terrorist and other hostile activities or natural disasters. Regulatory Environment: Changes in laws, regulations and the related interpretations may alter the environment in which we do business. This includes changes in environmental, competitive and product-related laws, as well as changes in accounting standards and taxation requirements. Our ability to manage regulatory, tax and legal matters (including product liability, patent, intellectual property, competition law matters and tax policy) and to resolve pending legal matters within current estimates may impact our results. RESULTS OF OPERATIONS  Three Months Ended March 31, 2011 The following discussion provides a review of results for the three months ended March 31, 2011 versus the three months ended March 31, 2010. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended March 31 SELLING, GENERAL & ADMINISTRATIVE EXPENSE OTHER NON-OPERATING INCOME/(EXPENSE), NET EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES NET EARNINGS FROM CONTINUING OPERATIONS NET EARNINGS FROM DISCONTINUED OPERATIONS EFFECTIVE TAX RATE FROM CONTINUING OPERATIONS BASIC NET EARNINGS  CONTINUING OPERATIONS BASIC NET EARNINGS  DISCONTINUED OPERATIONS DILUTED NET EARNINGS  CONTINUING OPERATIONS DILUTED NET EARNINGS  DISCONTINUED OPERATIONS AVERAGE DILUTED SHARES OUTSTANDING COMPARISONS AS A % OF NET SALES SELLING, GENERAL & ADMINISTRATIVE EXPENSE EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES NET EARNINGS FROM CONTINUING OPERATIONS Net sales increased 5% to $20.2 billion on 5% unit volume growth. Volume growth was broad based with growth in all major geographic regions. Volume increased high single digits in developing regions and low single digits in developed regions. All six of the business segments grew volume, led by high single-digit growth in the Baby Care and Family Care, and Snacks and Pet Care segments. Volume was up mid-single digits in the Fabric Care and Home Care, Beauty, and Health Care segments, and increased low single digits in the Grooming segment. Increased volume in advance of planned customer order system conversion in North America and Western Europe was largely offset by volume reductions from political disruptions in the Middle East. Higher prices increased net sales by 1%. Favorable foreign exchange increased net sales by 1% as key foreign currencies strengthened versus the U.S. dollar. Negative mix reduced net sales by 2% due mainly to disproportionate growth in developing regions and low and mid-tier value products, both of which have lower than Company average selling prices. Organic sales were up 4% on organic volume growth of 5%. Net Sales Change Drivers 2011 vs. 2010 (Three Months Volume with Acquisitions & Divestitures Volume excluding Acquisitions & Divestitures Fabric Care and Home Care Baby Care and Family Care Sales percentage changes are approximations based on quantitative formulas that are consistently applied. Gross margin declined 140 basis points to 50.5% of net sales for the quarter. The decline was mainly due to a 200-basis point increase in commodity and energy costs and unfavorable product mix from disproportionate growth in developing regions and low and mid-tier value product. These were partially offset by the favorable impact of manufacturing cost savings and pricing. Total selling, general and administrative expenses (SG&A) increased 8% driven by higher marketing and overhead spending and foreign currency impacts. Marketing and overhead spending increased primarily due to increased investments to support innovation and expansion plans. SG&A as a percentage of net sales increased 70 basis points due to higher marketing spending and foreign exchange costs as a percentage of net sales, partially offset by a reduction in overhead spending as a percentage of net sales. Interest expense declined $21 million versus the prior year period primarily due to lower interest rates on floating rate debt, partially offset by an increase in debt outstanding. Other non-operating income/(expense), increased $54 million primarily due to a gain on the divestiture of the Zest brand in North America. The effective tax rate on continuing operations decreased from 31.3% in the prior year to 21.1%. Approximately 530 basis points of this decline is due to the impact of discrete tax adjustments in both periods, including a $152 million base period charge for legislation that changed the taxation of certain future retiree prescription subsidy payments in the United States and a current period benefit for a number of minor adjustments to tax balances for uncertain tax positions. The remaining decline relates primarily to more favorable mix of earnings in the current year as an increased proportion of earnings were generated in lower tax jurisdictions during the current year. Net earnings from continuing operations increased 11% to $2.9 billion driven primarily by a lower effective tax rate. The impact of higher net sales was largely offset by a 210-basis point reduction in operating margin. The decline in operating margin resulted largely from a lower gross margin and higher SG&A as a percentage of net sales. SG&A as a percentage of net sales increased due to higher marketing spending and foreign exchange impacts as a percentage of net sales, partially offset by a reduction in overhead as a percentage of net sales. Diluted net earnings per share from continuing operations increased 16% to $0.96. Earnings per share growth exceeded net earnings growth due to the impact of share repurchase activity. RESULTS OF OPERATIONS  Nine Months Ended March 31, 2011 The following discussion provides a review of results for the nine months ended March 31, 2011 versus the nine months ended March 31, 2010. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Nine Months Ended March 31 SELLING, GENERAL & ADMINISTRATIVE EXPENSE OTHER NON-OPERATING INCOME/(EXPENSE), NET EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES NET EARNINGS FROM CONTINUING OPERATIONS NET EARNINGS FROM DISCONTINUED OPERATIONS EFFECTIVE TAX RATE FROM CONTINUING OPERATIONS BASIC NET EARNINGS - CONTINUING OPERATIONS BASIC NET EARNINGS - DISCONTINUED OPERATIONS DILUTED NET EARNINGS - CONTINUING OPERATIONS DILUTED NET EARNINGS - DISCONTINUED OPERATIONS AVERAGE DILUTED SHARES OUTSTANDING COMPARISONS AS A % OF NET SALES SELLING, GENERAL & ADMINISTRATIVE EXPENSE EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES NET EARNINGS FROM CONTINUING OPERATIONS Net sales increased 3% to $61.7 billion fiscal year to date on a 6% increase in unit volume. Volume growth was broad based with growth in all geographic regions, led by double-digit growth in Asia and high single digit growth in Latin America and CEEMEA. All six of the business segments contributed to volume growth, with high single-digit growth in the Baby Care and Family Care and Fabric Care and Home Care segments, mid-single-digit growth in the Beauty, Grooming and Health Care segments, and a low single-digit increase in the Snacks and Pet Care segment. Organic volume, which excludes acquisitions and divestitures, was up 6%. Mix reduced net sales by 2% due mainly to disproportionate growth in developing regions and low and mid-tier value products, both of which have lower than Company average selling prices. Unfavorable foreign exchange lowered net sales by 1% as key foreign currencies weakened versus the U.S. dollar. Organic sales were up 4% driven by unit volume growth, partially offset by unfavorable mix. Net Sales Change Drivers 2011 vs. 2010 (Nine Months Ended Mar. 31) Volume with Acquisitions & Divestitures Volume excluding Acquisitions & Divestitures Fabric Care and Home Care Baby Care and Family Care Sales percentage changes are approximations based on quantitative formulas that are consistently applied. Gross margin contracted 140 basis points to 51.4% of net sales. The reduction in gross margin was driven mainly by a 180-basis point increase in commodity and energy costs and unfavorable product mix from disproportionate growth in developing regions and low and mid-tier value product. These impacts were partially offset by manufacturing cost savings and the favorable impact of volume scale leverage. Total SG&A expense was up 3% to $19.2 billion, primarily due to higher marketing spending which was partially offset by the impact of higher foreign currency exchange costs in the base period. Marketing spending increased behind continued investments in our innovation and expansion plans. We incurred approximately $530 million of foreign currency exchange costs in the base period primarily to swap Venezuelan bolivars for U.S. dollars in the parallel market and to remeasure a portion of our net monetary assets denominated in bolivars at the parallel market exchange rate. These costs were nominal in the current period. See the section titled Foreign Currency Translation  Venezuela Impacts below for additional discussion. SG&A as a percentage of net sales increased marginally as increased marketing as a percentage of net sales was mostly offset by a reduction in foreign exchange costs and reduced overhead as a percentage of net sales. Interest expense declined $115 million mainly due to lower interest rates on floating rate debt. Other non-operating income/(expense), net declined $23 million primarily due to the impact of a gain on the acquisition of MDVIP in the prior year period, partially offset a gain on the divestiture of the Zest brand in North America in the current year. The effective tax rate on continuing operations decreased from 29.5% in the prior year to 22.5%. Net favorable discrete adjustments to income tax reserves in a number of jurisdictions in the current year, as compared to unfavorable adjustments in the prior year resulted in a 420 basis points reduction in the effective tax rate. Net adjustments to tax balances for uncertain tax positions resulted in a benefit of approximately $424 million fiscal year to date, including a $252 million benefit related to the pending settlement of tax litigation primarily related to the deductibility of technology donations. We do not expect the magnitude of recent benefits from these adjustments to be sustainable. The tax rate also benefited from the geographic mix of earnings, as an increased proportion of earnings were generated in lower tax jurisdictions during the current year. Net earnings from continuing operations increased 6% to $9.3 billion driven primarily by a lower effective tax rate and higher net sales, partially offset by a 150-basis point reduction in operating margin. The decline in operating margin resulted largely from lower gross margin. Diluted net earnings per share from continuing operations increased 10% to $3.09. Earnings per share growth exceeded net earnings growth due to the impact of share repurchase activity. Net earnings from discontinued operations decreased $1.8 billion mainly due to the impact of the gain on the divestiture of the global pharmaceuticals business in the prior year period. Net earnings declined 12% to $9.3 billion due to a reduction in net earnings from discontinued operations, partially offset by an increase in net earnings from continuing operations. Diluted net earnings per share declined 9% to $3.09. The decline in earnings per share was less than the decline in net earnings due to the impact of share repurchases. Foreign Currency Translation - Venezuela Impacts Venezuela is a highly inflationary economy under U.S. GAAP. As a result, the U.S. dollar is the functional currency for our subsidiaries in Venezuela. Any currency remeasurement adjustments for non-dollar denominated monetary assets and liabilities held by these subsidiaries and other transactional foreign exchange gains and losses are reflected in earnings. The Venezuelan government has introduced a number of currency controls for companies operating in Venezuela. During calendar year 2010, there were two official exchange rates for imported goods. Those goods classified as essential, such as food, medicine and capital investments, had an exchange rate of 2.6 bolivars to the U.S. dollar, while payments for other non-essential goods had an exchange rate of 4.3. Many of our imported products fell into the essential classification and qualified for the 2.6 rate. In January 2011, the Venezuelan government announced the elimination of the 2.6 exchange rate on essential goods. Our overall results in Venezuela are reflected in our Consolidated Financial Statements at the 4.3 rate expected to be applicable to dividend repatriations. There are also exchange controls over securities transactions in the parallel market, which has historically been used to pay for imported goods and services that do not qualify for exchange in the official market. The Central Bank of Venezuela is the only legal intermediary through which parallel market transactions can be executed. The government controls the underlying parallel exchange rate which was approximately 5.3 as of March 31, 2011. The notional amount of transactions that run through this parallel market mechanism is very restricted, which has eliminated our ability to access the parallel market to pay for imported goods and/or manage our local monetary asset balances. As of March 31, 2011, we had net monetary assets denominated in local currency of approximately $709 million. Approximately $251 million of this balance has been remeasured using the parallel rate because we plan to use that amount of the net assets (largely cash) to satisfy U.S. dollar denominated liabilities that do not qualify for official rate dollars. The availability of the parallel market to settle these transactions is uncertain. The remaining net monetary asset balances are currently reflected within our Consolidated Financial Statements at the 4.3 official exchange rate. Depending on the future availability of U.S. dollars at the official rate, our local U.S. dollar needs and our overall repatriation plans, we have exposure for the differential between the official and parallel exchange rates on this portion of our local monetary assets. Our ability to effectively manage sales and profit levels in Venezuela will be impacted by several factors, including the Companys ability to mitigate the effect of any potential future devaluation, further actions of the Venezuelan government, economic conditions in Venezuela, such as inflation and consumer spending, the availability of raw materials, utilities and energy and the future state of exchange controls in Venezuela including the availability of U.S. dollars at the official foreign exchange rate. BUSINESS SEGMENT DISCUSSION  Three and Nine Months Ended March 31, 2011 The following discussion provides a review of results by business segment. Analyses of the results for the three and nine months ended March 31, 2011 are provided compared to the same three and nine month periods ended March 31, 2010. The primary financial measures used to evaluate segment performance are net sales and net earnings from continuing operations. The table below provides supplemental information on net sales and net earnings from continuing operations by business segment for the three and nine months ended March 31, 2011 versus the comparable prior year period (amounts in millions): Three Months Ended March 31, 2011 Earnings From Continuing Operations Before Income Taxes Fabric Care and Home Care Baby Care and Family Care Nine Months Ended March 31, 2011 Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Fabric Care and Home Care Baby Care and Family Care Net sales increased 5% to $4.9 billion during the third fiscal quarter. Organic sales grew 4%. Volume grew 5%, while organic volume, which excludes the net impact of acquisitions and divestitures, increased 6%. Volume growth was driven by double-digit growth in developing regions, while volume in the developed regions was in line with the prior year. Higher pricing in Latin America and Prestige increased net sales by 1%. Favorable foreign exchange increased net sales by 2%. Mix negatively impacted net sales by 3% due to disproportionate growth in developing regions, which have lower than segment average selling prices, and a decrease in Salon Professional volume, which has higher than segment average selling prices. Volume in Retail Hair Care grew high single digits behind double-digit growth in developing regions due to initiative activity and distribution expansions in Asia and Latin America. Global market share of the hair care category was up nearly half a point. Volume in Female Beauty was in line with the prior period as Olay skin care distribution expansion in Asia and Latin America and deodorants growth in North America were offset by a mid-single digit decline in developed regions driven by the Zest divestiture, competitive activity in cosmetics, and decreased shipments in skin due to an Olay UV reformulation and restage. Volume in Salon Professional declined high single digits due to the exit of non-strategic businesses and market contraction in Western Europe. Volume in Prestige Products was up high single digits behind the continued impact of fragrance initiatives, partially offset by minor brand divestitures. Excluding the minor brand divestitures, volume increased double digits. Net earnings decreased 3% to $547 million as sales growth was more than offset by a lower operating margin. Operating margin contracted primarily behind higher SG&A as a percentage of net sales. SG&A as a percentage of net sales increased mainly due to increased marketing spending, partially offset by a decrease in overhead spending as a percentage of sales. Net sales increased 2% to $15.1 billion fiscal year to date on unit volume growth of 5%. Organic sales grew 3%. Mix negatively impacted net sales growth by 2% behind disproportionate growth in developing regions, which have lower than segment average selling prices, and declines in the premium-priced categories of Prestige Products and Salon Professional. Unfavorable foreign exchange reduced net sales by 1%. Volume in developing regions increased double digits, while volume in developed regions declined low single digits. Volume in Retail Hair Care grew high single digits due to double-digit growth in developing regions behind initiative activity, price reductions, distribution expansions and market growth. Global market share of the hair care category was up slightly. Volume in Female Beauty was up low single digits primarily due to higher shipments of Olay, Safeguard and Venus behind initiative activity, distribution expansion and market growth. Volume in Salon Professional was down high single digits mainly due to the exit of non-strategic businesses and market size contractions in developed regions. Volume in Prestige Products declined low single digits primarily due to the divestiture of minor brands and lower shipments in Western Europe. Excluding the minor brand divestitures, volume increased low single digits. Net earnings increased 3% to $2.3 billion, consistent with sales growth. Operating margin was comparable with the prior year, as higher marketing spending was largely offset by lower overhead spending and reduced foreign currency exchange costs. The effective tax rate decreased due to favorable geographic mix of earnings. Grooming Net sales increased 8% to $1.9 billion for the quarter on a 2% increase in unit volume. Organic sales were up 7%. Price increases taken primarily across blades and razors in Latin America and developed regions, added 5% to net sales growth. Favorable foreign exchange increased net sales growth by 1%. Volume growth was driven by high single-digit growth in developing regions, which was partially offset by a mid-single-digit decrease in developed regions. Volume in Male Grooming increased low single digits primarily due to high-single-digit growth of blades and razors in developing regions, particularly Latin America and Asia, as well as deodorants in North America, partially offset by a mid-single-digit decline in blades and razors in the developed regions. In the developed regions, double-digit growth of Fusion was more than offset by declines of Mach 3 and other legacy blades and razors. Global market share of the blades and razors category was down 1 point. Volume in Appliances decreased high single digits due to continuing economic difficulties in Western Europe as well as a high base period behind Hair Care appliances initiatives. Global market share of the dry shaving category was down more than half a point. Net earnings increased 1% to $379 million driven by net sales growth and operating margin expansion, partially offset by a higher effective tax rate. Operating margin grew due to improved gross margin, driven primarily by higher prices. SG&A as a percentage of net sales was comparable to the prior year as higher marketing spending was largely offset by reduced overhead as a percentage of sales driven by scale efficiencies. The effective tax rate was higher due to unfavorable geographic mix of earnings. Net sales increased 4% to $6.0 billion fiscal year to date on volume growth of 4%. Organic sales were up 6%. Price increases, taken primarily across blades and razors in Latin America and developed regions, contributed 2% to net sales growth. Unfavorable foreign exchange reduced net sales by 2%. Volume grew high single digits in developing regions and was in line with the prior year period in developed regions. Volume in Male Grooming was up mid-single digits due to higher shipments of blades and razors, mainly in developing regions driven by market growth, and deodorants in North America, partially offset by softness in blades and razors in the developed regions. Global market share of the blades and razors category was down more than half a point. Volume in Appliances decreased low single digits due to continuing economic difficulties in Western Europe as well as a high base period behind Hair Care appliances initiatives. Global market share of the dry shave category was in line with the prior year period. Net earnings increased 8% to $1.3 billion behind higher net sales and increased operating margin. Operating margin expanded due to higher gross margin and lower SG&A as a percentage of net sales. Gross margin increased due to price increases and the favorable impact of volume scale leverage. SG&A as a percentage of net sales was down due to lower foreign currency exchange costs and reduced overhead spending, partially offset by higher marketing spending. Health Care Net sales increased 6% during the third fiscal quarter to $3.0 billion on unit volume growth of 4%. Organic sales grew 5%. Price increases in developing regions contributed 1% to net sales. Favorable foreign exchange increased net sales by 1%. Volume was up mid-single digits in both developed and developing regions. Volume in Oral Care was up mid-single digits due to the continued strength and incremental merchandising support behind Crest 3D White in North America, Oral-B toothpaste expansions in Brazil, Belgium and Holland and toothbrush initiatives in Asia. Global market share of the oral care category was up over a point. Volume in Personal Health Care was up high single digits primarily due to double-digit growth in North America behind initiative activity and a strong cold and cough season. Volume in Feminine Care grew low single digits due to the expansion of Naturella into China and Always initiatives in Asia and Western Europe. Net earnings declined 2% to $427 million, as higher net sales were more than offset by lower operating margin. Operating margin declined due to lower gross margin driven mainly by higher commodity costs. Net sales increased 3% to $9.1 billion fiscal year to date on 5% growth in unit volume. Organic sales were up 4%. Price decreases in developed regions reduced net sales by 1%. Unfavorable foreign exchange negatively impacted net sales growth by 1%. Volume increased high single digits in developing regions and low single digits in developed regions. Volume in Oral Care grew high single digits behind initiative activity and incremental merchandising support of Crest and Oral-B. Global market share of the oral care category was up nearly a point. Volume in Personal Health Care grew mid-single digits behind higher shipments of Vicks and increased distribution of PuR in CEEMEA, partially offset by lower shipments of Prilosec OTC in North America. Volume in Feminine Care was up mid-single digits mainly due to higher shipments of Naturella, behind expansion into developing regions, and Always, behind initiative activity in developing regions. Global market share of the feminine care category was down less than half a point. Net earnings decreased 4% to $1.5 billion as higher net sales were more than offset by lower operating margins. Operating margin contracted due to lower gross margin and higher SG&A as a percentage of net sales. Gross margin declined mainly due to higher commodity costs. SG&A as a percentage of net sales increased behind higher marketing spending, partially offset by lower foreign currency exchange costs. In March 2011, P&G and Teva Pharmaceutical Industries announced that the companies have reached an agreement to create a partnership in consumer health care by bringing together both companies existing over-the-counter medicines and complementary capabilities. The partnership is expected to have over $1 billion in sales, only a portion of which will be incremental to our consolidated financial statements. The Company expects the transaction to close by the end of the 2011 calendar year, pending necessary regulatory approvals. Snacks and Pet Care Net sales increased 7% to $799 million for the quarter on a 7% increase in unit volume. Organic sales, which exclude the impacts of foreign exchange and the Natura Pet Products acquisition, were in line with prior year on a 4% increase in organic volume. Mix lowered net sales by 2% primarily due to the disproportionate growth of developing regions and Snacks, both of which have lower than segment average selling prices. Favorable foreign exchange increased net sales by 2%. Snacks volume increased double digits behind increased distribution in the developing regions and incremental merchandising activity in the developed regions. Pet Care volume was up low single digits due to the impact of the Natura acquisition in June 2010, partially offset by the impacts of supply constraints following the pet food recall. Excluding the Natura acquisition, Pet Care volume decreased mid-single digits. Net earnings decreased 21% to $61 million as net sales growth was more than offset by a lower operating margin. Operating margin decreased mainly due to a lower gross margin driven by increased product costs resulting from the pet food supply disruptions and negative product mix. SG&A as a percentage of net sales decreased marginally behind lower marketing spending primarily in Pet Care, which was largely offset by increased overhead spending. Net sales decreased 1% to $2.3 billion fiscal year to date on a 1% increase in unit volume. Organic sales, which exclude the impacts of foreign exchange and the Natura acquisition, were down 6% on a 2% decline in organic volume. Lower pricing in developed regions reduced net sales by 1%. Mix reduced net sales by 1% due to the disproportionate growth of Snacks and developing regions, both of which have lower than segment average selling prices. Snacks volume increased high single digits mainly due to increased distribution in CEEMEA and Latin America, as well as initiatives and incremental merchandising activity. Pet Care volume was down mid-single digits mainly due to the impacts of the supply constraints resulting from a restructuring of the supply chain following the voluntary pet food recalls, partially offset by the impact of the Natura acquisition in June 2010. Excluding the Natura acquisition, Pet Care volume decreased double digits. Net earnings decreased 27% to $182 million mainly due to lower net sales and a reduced operating margin driven by incremental costs and reduced scale leverage related to the pet food recall and supply chain restructuring efforts. In April 2011, we announced plans to divest the Companys Snacks business through a merger with Diamond Foods, Inc in an all-stock reverse Morris Trust transaction. The Snacks business had net sales of approximately $1.4 billion and operating income of about $170 million in fiscal 2010. The Company expects the transaction to close by the end of the 2011 calendar year, pending necessary regulatory approvals. Fabric Care and Home Care Net sales increased 5% to $6.1 billion for the quarter on a 6% increase in unit volume. Organic sales, which excludes the impact of the Ambi Pur acquisition and foreign exchange, increased 3% on 5% organic volume growth. Mix negatively impacted net sales by 2% primarily due to disproportionate growth of low and mid-tier product lines, which have lower than segment average selling prices. Favorable foreign exchange increased net sales by 1%. Volume increased high single digits in developing regions and mid-single digits in developed regions. Fabric Care volume was up mid-single digits due to the strength of prior period initiative launches such as liquitabs in Western Europe and laundry additives, as well as market growth in developing regions. Global market share of the fabric care category increased about half a point. Home Care volume increased double digits driven by initiatives, geographic expansion of dish and air care product lines, and the Ambi Pur acquisition. Excluding the Ambi Pur acquisition, Home Care volume increased high single digits. Global market share of the home care category was up nearly a point. Batteries volume was consistent with the prior year period as initiatives and distribution expansion in the current year period were offset by a spike in shipments in the base period following consumer value corrections in North America. Net earnings were in line with the prior year period at $754 million as sales growth was offset by operating margin contraction. Operating margin declined behind reduced gross margin, partially offset by reduced SG&A as a percentage of sales. Gross margin was down due to higher commodity costs, partially offset by manufacturing cost savings. SG&A as a percentage of net sales was down due to a reduction in marketing spending, partially offset by increased overhead spending. Net sales increased 2% to $18.7 billion fiscal year to date. Organic sales were up 3%. Volume grew 7%, while organic volume, which excludes the impact of the Ambi Pur acquisition, increased 6%. Lower pricing, mainly in developed regions, reduced net sales by 1%. Mix negatively impacted net sales growth by 2% mainly due to disproportionate growth of low and mid-tier product lines and powdered laundry detergents, which have lower than segment average selling prices. Unfavorable foreign exchange reduced net sales growth by 2%. Volume in developing regions was up double digits, while volume in developed regions grew mid-single digits. Fabric Care volume increased mid-single digits mainly due to growth in developing regions behind initiative activity, increased distribution and market growth. Global market share of the fabric care category increased about half a point. Home Care volume increased double digits due, in part, to the Ambi Pur acquisition. Organic volume in Home Care was also up double digits driven mainly by initiative activity, including the prior-period launches of Gain hand dishwashing liquid and Febreze Set & Refresh in North America, and geographic expansion of dish and air care product lines. Global market share of the home care category was up over 1 point. Batteries volume grew mid-single digits primarily due to price reductions executed through pack count increases in North America, which were implemented in January 2010, initiative activity in Western Europe and market growth and distribution expansion in Asia. Global market share of the batteries category increased about 1 point. Net earnings decreased 10% to $2.4 billion as net sales growth was more than offset by operating margin contraction. Operating margin declined primarily due to lower gross margin, mainly due to higher commodity costs and unfavorable product mix behind disproportionate growth of developing regions and low and mid-tier value products. SG&A as a percentage of net sales increased marginally behind higher marketing spending. Baby Care and Family Care Net sales increased 5% to $4.0 billion for the quarter on 7% volume growth. Organic sales were up 5%. Price increases primarily in developing regions improved net sales by 1%. Mix reduced net sales by 2% driven by disproportionate growth of mid-tier and value product lines, larger package sizes and developing regions, all of which have lower than segment average selling prices. Unfavorable foreign exchange reduced net sales by 1%. Volume in developing regions was up double digits and volume in developed regions increased low single digits. Volume in Baby Care grew high single digits due to initiative activity, distribution expansion and market growth in Europe and developing regions; partially offset by the impact of the North American launch of Pampers Dry Max in the base period. Global market share of the baby care category increased nearly 1 point. Volume in Family Care was up mid-single digits behind the continued impact of prior-period initiative launches across Charmin and Bounty, and growth of Charmin Basic in North America. Net earnings declined 5% to $528 million as sales growth was more than offset by a lower operating margin. Operating margin decreased mainly due to a lower gross margin driven by higher commodity costs and unfavorable product mix due to disproportionate growth of mid-tier product lines, larger package sizes and developing regions. Net sales increased 3% to $11.5 billion fiscal year to date on 9% volume growth. Organic sales were up 5%. Price reductions executed in prior periods lowered net sales by 1%. Mix reduced net sales by 3% driven mainly by disproportionate growth of mid-tier product lines, larger package sizes and developing regions, all of which have lower than segment average selling prices. Unfavorable foreign exchange negatively impacted net sales growth by 2%. Volume grew double digits in developing regions and mid-single digits in developed regions. Volume in Baby Care was up high single digits primarily due to growth in developing regions behind initiative activity, market size growth and distribution expansion. Global market share of the baby care category increased over 1 point. Volume in Family Care increased high single digits driven by the continued impact of initiative launches from prior periods, growth of Charmin Basic in North America and lower price gaps versus competition in Latin America. U.S. all outlet share of the family care category increased over half a point. Net earnings decreased 11% to $1.5 billion as sales growth was more than offset by a lower operating margin. Operating margin declined mainly due to a lower gross margin. Gross margin decreased as higher commodity costs and unfavorable product mix, behind disproportionate growth of mid-tier product lines, larger package sizes and developing regions, were only partially offset by the favorable impact of volume scale leverage and manufacturing cost savings. SG&A as a percentage of net sales was in line with the prior year period as increased marketing spending was largely offset by lower foreign currency exchange costs. CORPORATE Corporate includes certain operating and non-operating activities not allocated to specific business units. These include: the incidental businesses managed at the corporate level; financing and investing activities; other general corporate items; the historical results of certain divested brands and categories; and certain restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization. Corporate also includes reconciling items to adjust the accounting policies used in the segments to U.S. GAAP. The most significant reconciling items include income taxes (to adjust from statutory rates that are reflected in the segments to the overall Company effective tax rate), adjustments for unconsolidated entities (to eliminate net sales, cost of products sold and SG&A for entities that are consolidated in the segments but accounted for using the equity method for U.S. GAAP) and noncontrolling interest adjustments for subsidiaries where we do not have 100% ownership. Since certain unconsolidated entities and less than 100%-owned subsidiaries are managed as integral parts of the Company, they are accounted for similar to a wholly-owned subsidiary for management and segment purposes. This means our segment results recognize 100% of each income statement component through before-tax earnings in the segments, with eliminations for unconsolidated entities and noncontrolling interests in Corporate. In determining segment after-tax net earnings, we apply the statutory tax rates (with adjustments to arrive at the Companys effective tax rate in Corporate) and eliminate the share of earnings applicable to other ownership interests, in a manner similar to noncontrolling interest. Net sales in the Corporate segment primarily reflect the adjustment to eliminate the sales of unconsolidated entities included in business segment results. Accordingly, Corporate net sales are generally a negative balance. Negative net sales were up $28 million in the third fiscal quarter and down $88 million fiscal year to date primarily due to adjustments required to eliminate the sales of unconsolidated entities. Corporate had net earnings of $177 million in the quarter versus net expenses of $176 million in the prior year period. This $353 million change was due to a base period charge of $152 million for legislation, which changed the taxation of certain future retiree prescription drug subsidy payments, as well as a more favorable current year effective tax rate due to a favorable mix of earnings. Net earnings fiscal year to date increased $975 million due to the net impact of discrete adjustments to reserves for uncertain income tax positions, favorable settlement of a value added tax audit, lower current period restructuring-type spending and a more favorable current year effective tax rate due to a more favorable mix of earnings. Net discrete adjustments to reserves for uncertain tax positions benefited current year by $424 million, while prior year adjustments reduced earnings by $86 million, including the aforementioned base period charge of $152 million. FINANCIAL CONDITION Operating Activities We generated $9.4 billion from operating activities during the fiscal year to date period. This represents a 26% decline versus the prior year period primarily due to higher levels of cash invested in working capital. On a year-to-date basis, working capital consumed $1.5 billion primarily behind higher accounts receivable and inventory balances. Accounts receivable used $495 million to support business growth and as a result of disproportionately higher sales in the last month of the quarter. Inventory consumed $817 million driven by higher commodity costs, initiative activity, business growth, and increased safety stock levels behind customer service improvement efforts. Accounts payable, accrued and other liabilities used $223 million primarily to satisfy marketing and capital commitments accrued for at the end of the 2010 fiscal year. Other operating assets and liabilities resulted in a reconciling use of $797 million mainly due to favorable adjustments of net liabilities for unrecognized tax positions, which did not provide cash. Investing Activities We invested $2.4 billion to support capital expenditures and our net acquisition and divestiture activities in the current period. Capital expenditures were $2.1 billion or 3.3% of net sales. We expect capital expenditures of approximately 4% of net sales for the fiscal year. Acquisitions consumed $489 million mainly due to the purchase of Ambi Pur, while proceeds from asset sales were primarily driven by the Zest divestiture in North America. Prior-year cash generated from investing activities was $1.0 billion, as normal ongoing capital investments was more than offset by proceeds from divestitures driven by the sale of the global pharmaceuticals business in October 2009. Financing Activities We utilized $7.1 billion for financing activities. We continued to return cash to shareholders by purchasing $4.5 billion of treasury stock and paying $4.2 billion in dividends. We received $928 million primarily behind the proceeds from additional debt issuances. We expect to repurchase a total of $6 - $8 billion of treasury stock during fiscal 2011. In the prior year period, we consumed $13.5 billion to fund financing activities, primarily due to debt repayments, dividends and share repurchases. As of March 31, 2011, our current liabilities exceeded current assets by $4.4 billion. We have short- and long-term debt to fund discretionary items such as acquisitions and share repurchase programs. We anticipate being able to support our short-term liquidity and operating needs largely through cash generated from operations. We have strong short- and long-term debt ratings which have enabled and should continue to enable us to refinance our debt as it becomes due at favorable rates in commercial paper and bond markets. In addition, we have agreements with a diverse group of financial institutions that, if needed, should provide sufficient credit funding to meet short-term financing requirements. RECONCILIATION OF NON-GAAP MEASURES Our discussion of financial results includes several measures not defined by U.S. GAAP. We believe these measures provide our investors with additional information about the underlying results and trends of the Company, as well as insight to some of the metrics used to evaluate management. When used in MD&A, we have provided the comparable GAAP measure in the discussion. Organic Sales Growth: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions, divestitures and foreign exchange from year-over-year comparisons. We believe this provides investors with a more complete understanding of underlying sales trends by providing sales growth on a consistent basis. Organic sales is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation. The reconciliation of reported sales growth to organic sales for the January - March quarter: Acquisition/ Divestiture Impact* Fabric Care and Home Care Baby Care and Family Care Acquisition/Divestiture Impacts includes rounding impacts necessary to reconcile net sales to organic sales. The reconciliation of reported sales growth to organic sales for the fiscal year to date period: Acquisition/ Divestiture Impact* Fabric Care and Home Care Baby Care and Family Care Acquisition/Divestiture Impacts includes rounding impacts necessary to reconcile net sales to organic sales. Core EPS: This is a measure of the Companys diluted net earnings per share from continuing operations excluding a charge related to a tax provision for retiree healthcare subsidy payments in the U.S. healthcare reform legislation in the prior year period, charges related to pending European legal matters for current and prior years, and a significant adjustment to an income tax reserve related to the deductibility of technology donations in prior years. We do not view these items to be part of our sustainable results. We believe the Core EPS measure provides an important perspective of underlying business trends and results and provides a more comparable measure of year-on-year earnings per share growth. Core EPS is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation. The table below provides a reconciliation of reported diluted net earnings per share from continuing operations to Core EPS: Diluted Net Earnings Per Share - Continuing Operations Charge for Taxation of Retiree Healthcare Subsidy Diluted Net Earnings Per Share - Continuing Operations Significant Adjustment to Income Tax Reserve Charges for Pending European Legal Matters Charge for Taxation of Retiree Healthcare Subsidy Note  All reconciling items are presented net of tax. Tax effects are calculated consistent with the nature of the underlying transaction. The significant adjustment to an income tax reserve was tax expense. There was no tax impact on EPS due to the charges for pending European legal matters. Free Cash Flow: Free cash flow is defined as operating cash flow less capital spending. We view free cash flow as an important measure because it is one factor in determining the amount of cash available for dividends and discretionary investment. Free cash flow is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation. Free Cash Flow Productivity: Free cash flow productivity is defined as the ratio of free cash flow to net earnings. The Companys long-term target is to generate free cash at or above 90 percent of net earnings. Free cash flow is also one of the measures used to evaluate senior management. The reconciliation of free cash flow and free cash flow productivity is provided below (amounts in millions): Free Cash Flow Productivity Quantitative and Qualitative Disclosures About Market Risk. There have been no material changes in the Companys exposure to market risk since June 30, 2010. Additional information can be found in the section entitled Other Information, which appears on pages 48-49, and Note 5, Risk Management Activities and Fair Value Measurements, which appears on pages 59-62 of the Annual Report to Shareholders for the fiscal year ended June 30, 2010 which can be found by reference to Exhibit 13 of the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2010. Controls and Procedures. Evaluation of Disclosure Controls and Procedures. The Companys Chairman of the Board, President and Chief Executive Officer, Robert A. McDonald, and the Companys Chief Financial Officer, Jon R. Moeller, performed an evaluation of the Companys disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (Exchange Act)) as of the end of the period covered by this report. Messrs. McDonald and Moeller have concluded that the Companys disclosure controls and procedures were effective to ensure that information required to be disclosed in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) accumulated and communicated to our management, including Messrs. McDonald and Moeller, to allow their timely decisions regarding required disclosure. Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting that occurred during the Companys fiscal quarter ended March 31, 2011 that have materially affected, or are reasonably likely to materially affect, the Companys internal control over financial reporting. PART II. OTHER INFORMATION Legal Proceedings. The Company is subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental issues, patent and trademark matters, labor and employment matters and taxes. As previously reported, the Company has been subject to a number of investigations into potential competition law violations in Europe. Those that are pending include investigations by national authorities in Belgium, France, Germany, Greece, and Romania. We believe that all of these matters involve a number of other consumer products companies and/or retail customers. Although non-monetary sanctions are not being sought in any of these matters, competition and antitrust law investigations often continue for several years and, if violations are found, can result in substantial fines. In cases in other industries, fines have amounted to hundreds of millions of dollars. The Companys policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with investigations by relevant regulatory authorities, which the Company is doing. In response to the actions of the European Commission and national authorities, the Company launched its own internal investigations into potential violations of competition laws. The Company identified violations in certain European countries and appropriate actions were taken. As a result of certain investigations that were previously disclosed, several authorities issued separate complaints alleging that the Company, along with several other companies, engaged in violations of competition laws in the past. During the most recent quarter, authorities in Spain and the Czech Republic issued final decisions, and in April 2011, the European Commission also issued a final decision. All of these decisions resulted in monetary penalties, for which the Company had previously accrued sufficient financial reserves. The ultimate resolution of the remaining matters listed above may result in fines or costs in excess of the amounts reserved that could materially impact our income statement and cash flows in the period in which they are accrued and paid, respectively. Please refer to the Companys Risk Factors in Item 1A of this Form 10-Q for additional information. In December 2008, the Company became aware of an investigation by Italian authorities into an environmental accident at the site of a contractor which provides services to one or more of the Companys European affiliates. The accident involved the explosion of certain pressurized cans and resulted in the death of one worker and serious injuries to another. Italian authorities have commenced a formal criminal proceeding regarding whether the Companys local affiliate and certain of its employees complied with Italian laws related to the proper classification and disposal of their products. Should they find that these entities violated the law, the Italian authorities could levy fines in excess of $100 thousand against the Companys European affiliate(s). Risk Factors. For a discussion of the Companys risk factors, please refer to Part 1, Item 1A. Risk Factors in the Companys Form 10-Q for the quarter ended December 31, 2010. Unregistered Sales of Equity Securities and Use of Proceeds. ISSUER PURCHASES OF EQUITY SECURITIES Total Number of Shares Purchased (1) Average Price Paid per Share (2) Purchased as Part of Publicly Announced Plans or Programs (3) Approximate Dollar Value of Shares That May Yet Be Purchased Under our Share Repurchase Program ($ in billions) (3) (4) The total number of shares purchased was 16,076,119 for the quarter. This includes 64,213 shares acquired by the Company under various compensation and benefit plans. All transactions were made in the open market or pursuant to prepaid forward agreements with large financial institutions. Under these agreements, the Company prepays large financial institutions to deliver shares at future dates in exchange for a discount. This table excludes shares withheld from employees to satisfy minimum tax withholding requirements on option exercises and other equity-based transactions. The Company administers cashless exercises through an independent third party and does not repurchase stock in connection with a cashless exercise. Average price paid per share is calculated on a settlement basis and excludes commission. On August 3, 2010, the Company announced a share repurchase plan to acquire $6 to $8 billion of Company common stock during the fiscal year ending June 30, 2011 in open market and/or private transactions. This repurchase plan was authorized pursuant to a resolution issued by the Companys Board of Directors and is expected to be financed by issuing a combination of long-term and short-term debt. Certain purchases were made prior to the announcement of the plan but are considered purchases against the plan. The dollar values listed in this column include commissions to be paid to brokers to execute the transactions. Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October 14, 2008) (Incorporated by reference to Exhibit (3-1) of the Companys Form 10-Q for the quarter ended December 31, 2008). Regulations (as amended by the Board of Directors on April 18, 2010 pursuant to authority granted by shareholders at the annual meeting on October 13, 2009). (Incorporated by reference to Exhibit 3.ii of the Companys Form 8-K filed on April 18, 2010). The Procter & Gamble 2009 Stock and Incentive Compensation Plan (Incorporated by reference to Exhibit (10-1) of the Companys Form 10-Q for the quarter ended December 31, 2009) and the Regulations of the Compensation and Leadership Development Committee for The Procter & Gamble 2009 Stock and Incentive Compensation Plan, The Procter & Gamble 2001 Stock and Incentive Compensation Plan, The Procter & Gamble 1992 Stock Plan, The Procter & Gamble 1992 Stock Plan (Belgian Version), The Gillette Company 2004 Long-Term Incentive Plan, and The Gillette Company 1971 Stock Option Plan.* The Procter & Gamble 2009 Stock and Incentive Compensation Plan - Additional terms and conditions (Incorporated by reference to Exhibit (10-1) of the Companys Form 10-Q for the quarter ended December 31, 2009) and related correspondence. * The Procter & Gamble Performance Stock Program Summary and related terms and conditions* Computation of Earnings per Share Computation of Ratio of Earnings to Fixed Charges.",13159
2011-05-04,8-K,0000735244-11-000022,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) DEPARTURE OF CERTAIN OFFICERS On May 4, 2011, The Procter & Gamble Company (the Company) announced that Edward D. Shirley will leave his current position as Vice Chairman- Beauty & Grooming effective July 1, 2011, in anticipation of retiring from the Company on January 1, 2012. The Company is filing this 8-K pursuant to Item 5.02(b), ""Departure of Certain Officers.""",173
2011-07-12,8-K,0000080424-11-000008,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On July 12, 2011, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of fifty two point five cents ($0.525) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after August 15, 2011 to Common Stock shareholders of record at the close of business on July 22, 2011, and payable on the dividend payment date for the Common Stock to Series A and Series B Preferred Stock shareholders of record at the start of business on that date. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",233
2011-08-05,8-K,0000735244-11-000030,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) ( Registrant's telephone number, including area code ) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On August 5, 2011, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended June 30, 2011. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",165
2011-08-10,10-K,0000080424-11-000014,"THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES _________________________________________________ ANNUAL REPORT ON FORM 10-K TO THE SECURITIES AND EXCHANGE COMMISSION FOR THE YEAR ENDED JUNE 30, 2011 ****************************************** UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark one) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended June 30, 2011 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-434 THE PROCTER & GAMBLE COMPANY One Procter & Gamble Plaza, Cincinnati, Ohio 45202 Telephone (513) 983-1100 IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered Common Stock, without Par Value New York Stock Exchange, NYSE Euronext-Paris Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.Yes  No o Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes o No  Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No o Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No o Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act). Large accelerated filer  Accelerated filer o Non-accelerated filer o Smaller reporting company o Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No  The aggregate market value of the voting stock held by non-affiliates amounted to $181 billion on December 31, 2010. There were 2,747,768,202 shares of Common Stock outstanding as of July 31, 2011. Documents Incorporated by Reference Portions of the Annual Report to Shareholders for the fiscal year ended June 30, 2011, (2011 Annual Report) are incorporated by reference into Part I, Part II and Part IV of this report to the extent described herein. Portions of the Proxy Statement for the 2011 Annual Meeting of Shareholders which will be filed within one hundred and twenty days of the fiscal year ended June 30, 2011, (2011 Proxy Statement) are incorporated by reference into Part III of this report to the extent described herein. 1 PART I Item 1. Business . Additional information required by this item is",588
2011-08-15,8-K,0000735244-11-000032,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Item 8.01 Other Events. On August 15, 2011, The Procter & Gamble Company (the Company) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 0.700% Notes due 2014 and $1,000,000,000 aggregate principal amount of 1.450% Notes due 2016 under the Companys Registration Statement on Form S-3 (Registration No. 333-161767). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are",180
2011-10-11,8-K,0000080424-11-000022,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD On October 11, 2011, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of fifty-two point five cents ($0.525) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after November 15, 2011 to Common Stock and Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the close of business on October 21, 2011. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",213
2011-10-11,8-K,0000080424-11-000020,"shareholdermeeting2011.htm SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 7.01 REGULATION FD DISCLOSURE On October 11, 2011, The Procter & Gamble Company (the ""Company"") issued a news release with respect to Chairman of the Board, President and Chief Executive Officer Robert A. McDonald's address to the shareholders at the Company's annual meeting. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",151
2011-10-14,8-K,0000080424-11-000025,"annualshareholdermtgresults.htm SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act Submission of Matters to a Vote of Security Holders The Procter & Gamble Company (the Company) held its Annual Meeting of Shareholders on October 11, 2011. Set forth below are the final voting results for each of the proposals submitted to a vote of the shareholders. Ratify Appointment of Independent Registered Public Accounting Firm Advisory Vote on Executive Compensation (The Say-on-Pay Vote) Frequency on an Advisory Vote on Say-on-Pay Amend the Articles of Incorporation Shareholder Proposal - Adopt Cumulative Voting in the Election of Directors Shareholder Proposal - Plan to Phase Out Animal Testing Shareholder Proposal - Annual Proposal Describing Electioneering Contributions A majority of the votes cast by shareholders, on an advisory basis, were in favor of holding an advisory vote on the Company's executive compensation every year. In accordance with this shareholder vote, the Board of Directors approved an annual shareholder advisory vote on the Company's executive compensation as reported in its annual proxy statement. Annual votes will be held until the next shareholder vote on the frequency of such advisory vote, to occur no later than our Annual Meeting of Shareholders in 2017.",280
2011-10-27,8-K,0000080424-11-000036,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) ( Registrant's telephone number, including area code ) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On October 27, 2011, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended September 30, 2011. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",165
2011-10-27,8-K,0000080424-11-000040,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On October 27, 2011, The Procter & Gamble Company (the ""Company"") issued a press release announcing its first quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",183
2011-10-27,10-Q,0000080424-11-000043,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-434 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 31-0411980 (State of Incorporation) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) (513) 983-1100 (Registrants telephone number, including area code) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No o Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Large accelerated filer  Accelerated filer o Non-accelerated filer o Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No  There were 2,751,320,136 shares of Common Stock outstanding as of September 30, 2011. PART I. FINANCIAL INFORMATION Item I. Financial Statements. The Consolidated Statements of Earnings of The Procter & Gamble Company and subsidiaries (the Company, we or our) for the three months ended September 30, 2011 and 2010, the Consolidated Balance Sheets as of September 30, 2011 and June 30, 2011, and the Consolidated Statements of Cash Flows for the three months ended September 30, 2011 and 2010 follow. In the opinion of management, these unaudited Consolidated Financial Statements contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, such financial statements may not necessarily be indicative of annual results. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS Three Months Ended September 30 Amounts in millions except per share amounts 2011 2010 Net Sales $ 21,917 $ 20,122 Cost of products sold 11,061 9,689 Selling, general and administrative expense 6,522 5,932 Operating Income 4,334 4,501 Interest expense 207 208 Other non-operating income/(expense), net (32 ) (11 ) Earnings Before Income Taxes 4,095 4,282 Income taxes 1,071 1,201 Net Earnings $ 3,024 $ 3,081 Per Common Share Basic net earnings $ 1.08 $ 1.07 Diluted net earnings 1.03 1.02 Dividends $ 0.5250 $ 0.4818 Diluted Weighted Average Common Shares Outstanding 2,945.8 3,025.6 See accompanying Notes to Consolidated Financial Statements 2 THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS Amounts in millions September 30, 2011 June 30, 2011 ASSETS CURRENT ASSETS Cash and cash equivalents $ 3,582 $ 2,768 Accounts receivable 6,584 6,275 Inventories Materials and supplies 2,137 2,153 Work in process 744 717 Finished goods 5,120 4,509 Total inventories 8,001 7,379 Deferred income taxes 1,048 1,140 Prepaid expenses and other current assets 3,910 4,408 TOTAL CURRENT ASSETS 23,125 21,970 PROPERTY, PLANT AND EQUIPMENT Buildings 7,507 7,753 Machinery and equipment 32,321 32,820 Land 919 934 Total property, plant and equipment 40,747 41,507 Accumulated depreciation (19,982 ) (20,214 ) NET PROPERTY, PLANT AND EQUIPMENT 20,765 21,293 GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill 56,079 57,562 Trademarks and other intangible assets, net 31,858 32,620 NET GOODWILL AND OTHER INTANGIBLE ASSETS 87,937 90,182 OTHER NONCURRENT ASSETS 4,790 4,909 TOTAL ASSETS $ 136,617 $ 138,354 LIABILITIES AND SHAREHOLDERS EQUITY CURRENT LIABILITIES Accounts payable $ 7,290 $ 8,022 Accrued and other liabilities 9,202 9,290 Debt due within one year 11,476 9,981 TOTAL CURRENT LIABILITIES 27,968 27,293 LONG-TERM DEBT 22,372 22,033 DEFERRED INCOME TAXES 11,070 11,070 OTHER NONCURRENT LIABILITIES 9,573 9,957 TOTAL LIABILITIES 70,983 70,353 SHAREHOLDERS EQUITY Preferred stock 1,221 1,234 Common stock  shares issued  30-Sep 4,007.9 4,008 30-Jun 4,007.9 4,008 Additional paid-in capital 62,535 62,405 Reserve for ESOP debt retirement (1,357 ) (1,357 ) Accumulated other comprehensive income (loss) (4,995 ) (2,054 ) Treasury stock (68,383 ) (67,278 ) Retained earnings 72,215 70,682 Noncontrolling interest 390 361 TOTAL SHAREHOLDERS EQUITY 65,634 68,001 TOTAL LIABILITIES AND SHAREHOLDERS EQUITY $ 136,617 $ 138,354 See accompanying Notes to Consolidated Financial Statements 3 THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS Three Months Ended September 30 Amounts in millions 2011 2010 CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD $ 2,768 $ 2,879 OPERATING ACTIVITIES Net earnings 3,024 3,081 Depreciation and amortization 743 689 Share-based compensation expense 80 87 Deferred income taxes 126 48 (Gain)/loss on sale of businesses (2 ) 2 Changes in: Accounts receivable (639 ) (434 ) Inventories (927 ) (604 ) Accounts payable, accrued and other liabilities (479 ) (303 ) Other operating assets and liabilities 199 19 Other 42 (133 ) TOTAL OPERATING ACTIVITIES 2,167 2,452 INVESTING ACTIVITIES Capital expenditures (833 ) (519 ) Proceeds from asset sales 5 14 Acquisitions, net of cash acquired (6 ) (398 ) Change in investments (25 ) (25 ) TOTAL INVESTING ACTIVITIES (859 ) (928 ) FINANCING ACTIVITIES Dividends to shareholders (1,503 ) (1,422 ) Change in short-term debt 1,217 2,412 Additions to long-term debt 1,988 1 Reductions of long-term debt (1,013 ) (18 ) Treasury stock purchases (1,261 ) (3,010 ) Impact of stock options and other 153 136 TOTAL FINANCING ACTIVITIES (419 ) (1,901 ) EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS (75 ) 101 CHANGE IN CASH AND CASH EQUIVALENTS 814 (276 ) CASH AND CASH EQUIVALENTS, END OF PERIOD $ 3,582 $ 2,603 See accompanying Notes to Consolidated Financial Statements 4 THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 1. These statements should be read in conjunction with the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2011. The results of operations for the three-month period ended September 30, 2011 are not necessarily indicative of annual results. 2. Comprehensive Income - Total comprehensive income is comprised primarily of net earnings, net currency translation gains and losses, impacts of net investment and cash flow hedges, net unrealized gains and losses on investment securities and defined benefit and other retiree benefit plan activities. Total comprehensive income for the three months ended September 30, 2011 and 2010 was $83 million and $5,896 million , respectively. 3. Segment Information - Following is a summary of segment results. Three Months Ended September 30 Amounts in millions Net Sales Earnings Before Income Taxes Net Earnings Beauty 2011 $ 5,390 $ 991 $ 731 2010 4,929 1,081 829 Grooming 2011 2,093 576 438 2010 1,898 524 398 Health Care 2011 3,291 800 542 2010 2,984 741 495 Snacks and Pet Care 2011 776 90 62 2010 709 77 54 Fabric Care and Home Care 2011 6,681 1,263 805 2010 6,297 1,417 937 Baby Care and Family Care 2011 4,079 792 494 2010 3,652 749 470 Corporate 2011 (393 ) (417 ) (48 ) 2010 (347 ) (307 ) (102 ) Total 2011 21,917 4,095 3,024 2010 20,122 4,282 3,081 4. Goodwill and Other Intangible Assets - Goodwill as of September 30, 2011 is allocated by reportable segment as follows (amounts in millions): Beauty Grooming Health Care Snacks and Pet Care Fabric Care and Home Care Baby Care and Family Care Corporate Total Company GOODWILL at JUNE 30, 2011 19,068 21,621 8,179 2,243 4,589 1,553 309 57,562 Acquisitions and divestitures  (1 )      (1 ) Translation and other (628 ) (532 ) (145 ) (9 ) (111 ) (57 )  (1,482 ) GOODWILL at SEPTEMBER 30, 2011 18,440 21,088 8,034 2,234 4,478 1,496 309 56,079 The decrease in goodwill from June 30, 2011 is primarily due to currency translation across reportable segments. Identifiable intangible assets as of September 30, 2011 are comprised of (amounts in millions): Gross Carrying Amount Accumulated Amortization Amortizable intangible assets with determinable lives $ 8,894 $ 4,267 Intangible assets with indefinite lives 27,231  Total identifiable intangible assets $ 36,125 $ 4,267 5 Amortizable intangible assets consist principally of brands, patents, technology and customer relationships. The intangible assets with indefinite lives consist primarily of brands. The amortization of intangible assets for the three months ended September 30, 2011 and 2010 was $128 million and $140 million , respectively. 5. Share-Based Compensation - Pursuant to applicable accounting guidance for share-based payments, companies must recognize the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of those awards. Total share-based compensation for the three months ended September 30, 2011 and 2010 are summarized in the following table (amounts in millions): Three Months Ended September 30 2011 2010 Share-Based Compensation Stock options $ 62 $ 68 Other share-based awards 18 19 Total share-based compensation $ 80 $ 87 Assumptions utilized in the model are evaluated and revised, as necessary, to reflect market conditions and experience. 6. Postretirement Benefits - The Company offers various postretirement benefits to its employees. The components of net periodic benefit cost for defined benefit plans are as follows: Pension Benefits Other Retiree Benefits Three Months Ended September 30 Three Months Ended September 30 Amounts in millions 2011 2010 2011 2010 Service cost $ 67 $ 62 $ 36 $ 35 Interest cost 157 140 69 65 Expected return on plan assets (146 ) (119 ) (108 ) (108 ) Amortization of deferred amounts 6 4 (5 ) (5 ) Recognized net actuarial loss 26 37 25 24 Gross benefit cost (credit) 110 124 17 11 Dividends on ESOP preferred stock   (19 ) (20 ) Net periodic benefit cost (credit) $ 110 $ 124 $ (2 ) $ (9 ) For the year ending June 30, 2012, the expected return on plan assets is 7.4% and 9.2% for defined benefit and other retiree benefit plans, respectively. 7. Risk Management Activities and Fair Value Measurements As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. For details on the Companys risk management activities and fair value measurement policies under the fair value hierarchy, refer to the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2011. Fair Value Hierarchy The Company has not changed its valuation techniques in measuring the fair value of any financial assets and liabilities during the period. The following table sets forth the Companys financial assets and liabilities as of September 30 and June 30, 2011 that are measured at fair value on a recurring basis during the period, segregated by level within the fair value hierarchy: 6 Level 1 Level 2 Level 3 Total Amounts in millions September 30, 2011 June 30, 2011 September 30, 2011 June 30, 2011 September 30, 2011 June 30, 2011 September 30, 2011 June 30, 2011 Assets at fair value: Investment securities $ 10 $ 16 $  $  $ 23 $ 23 $ 33 $ 39 Derivatives relating to: Foreign currency hedges    1    1 Other foreign currency instruments (1)   49 182   49 182 Interest rates   295 163   295 163 Net investment hedges   5    5  Commodities   3 4   3 4 Total assets at fair value (2) 10 16 352 350 23 23 385 389 Liabilities at fair value: Derivatives relating to: Foreign currency hedges   174 119   174 119 Other foreign currency instruments (1)   361 43   361 43 Net investment hedges   182 138   182 138 Commodities   3 1   3 1 Total liabilities at fair value (3)   720 301   720 301 (1) Other foreign currency instruments are comprised of foreign currency financial instruments that do not qualify as hedges. (2) Investment securities are presented in other noncurrent assets and all derivative assets are presented in prepaid expenses and other current assets or other noncurrent assets. (3) All liabilities are presented in accrued and other liabilities or other noncurrent liabilities. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each quarter. There was no significant activity within the Level 3 assets and liabilities during the periods presented. There were no assets or liabilities that were re-measured at fair value on a non-recurring basis during the periods presented. Certain of the Companys financial instruments used in hedging transactions are governed by industry standard netting agreements with counterparties. If the Companys credit rating were to fall below the levels stipulated in the agreements, the counterparties could demand either collateralization or termination of the arrangement. The aggregate fair value of the instruments covered by these contractual features that are in a net liability position as of September 30, 2011 was $504 million . The Company has never been required to post any collateral as a result of these contractual features. Fair Values of Other Financial Instruments Other financial instruments, including cash equivalents, other investments and short-term debt, are recorded at cost, which approximates fair value. The fair value of the long-term debt was $24,807 million and $23,418 million at September 30 and June 30, 2011, respectively. Disclosures about Derivative Instruments The notional amounts and fair values of qualifying and non-qualifying financial instruments used in hedging transactions as of September 30 and June 30, 2011 are as follows: 7 Notional Amount Fair Value Asset (Liability) Amounts in Millions September 30, 2011 June 30, 2011 September 30, 2011 June 30, 2011 Derivatives in Cash Flow Hedging Relationships Interest rate contracts $  $  $  $  Foreign currency contracts 831 831 (174 ) (118 ) Commodity contracts 10 16 2 4 Total 841 847 (172 ) (114 ) Derivatives in Fair Value Hedging Relationships Interest rate contracts 9,025 10,308 295 163 Derivatives in Net Investment Hedging Relationships Net investment hedges 1,413 1,540 (177 ) (138 ) Derivatives Not Designated as Hedging Instruments Foreign currency contracts 14,652 14,957 (312 ) 139 Commodity contracts 33 39 (2 ) (1 ) Total 14,685 14,996 (314 ) 138 The total notional amount of contracts outstanding at the end of the period is indicative of the level of the Companys derivative activity during the period. Amount of Gain (Loss) Recognized in Accumulated OCI on Derivatives (Effective Portion) Amounts in Millions September 30, 2011 June 30, 2011 Derivatives in Cash Flow Hedging Relationships Interest rate contracts $ 14 $ 15 Foreign currency contracts 25 32 Commodity contracts 1 3 Total 40 50 Derivatives in Net Investment Hedging Relationships Net investment hedges (111 ) (88 ) The effective portion of gains and losses on derivative instruments that was recognized in other comprehensive income (OCI) during the three months ended September 30, 2011 and 2010 was not material. During the next 12 months, the amount of the September 30, 2011 accumulated OCI balance that will be reclassified to earnings is expected to be immaterial. The amounts of gains and losses on qualifying and non-qualifying financial instruments used in hedging transactions for the three months ended September 30, 2011 and 2010 are as follows: 8 Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (1) Three Months Ended September 30 Amounts in Millions 2011 2010 Derivatives in Cash Flow Hedging Relationships Interest rate contracts $ 2 $ 2 Foreign currency contracts (45 ) (49 ) Commodity contracts 1 14 Total (42 ) (33 ) Amount of Gain (Loss) Recognized in Income Three Months Ended September 30 Amounts in Millions 2011 2010 Derivatives in Fair Value Hedging Relationships (2) Interest rate contracts 131 62 Debt (133 ) (63 ) Total (2 ) (1 ) Derivatives in Net Investment Hedging Relationships (2) Net investment hedges (3 )  Derivatives Not Designated as Hedging Instruments (3) Foreign currency contracts (581 ) 736 Commodity contracts (1 ) 2 Total (582 ) 738 (1) The gain or loss on the effective portion of cash flow hedging relationships is reclassified from accumulated OCI into net income in the same period during which the related item affects earnings. Such amounts are included in the Consolidated Statements of Earnings as follows: interest rate contracts in interest expense, foreign currency contracts in selling, general and administrative expense and interest expense and commodity contracts in cost of products sold. (2) The gain or loss on the ineffective portion of interest rate contracts and net investment hedges, if any, is included in the Consolidated Statements of Earnings in interest expense. (3) The gain or loss on contracts not designated as hedging instruments is included in the Consolidated Statements of Earnings as follows: foreign currency contracts in selling, general and administrative expense and commodity contracts in cost of products sold. 8. New Accounting Pronouncements and Policies No new accounting pronouncement issued or effective during the fiscal year has had or is expected to have a material impact on the Consolidated Financial Statements. 9. Commitments and Contingencies Litigation We are subject to various legal proceedings and claims arising out of our business which cover a wide range of matters such as antitrust, trade and other governmental regulations, product liability, patent and trademark matters, income taxes and other actions. As previously disclosed, the Company is and has been subject to a variety of investigations into potential competition law violations in Europe. These matters involve a number of other consumer products companies and/or retail customers. The Companys policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with investigations by relevant regulatory authorities, which the Company is doing. Competition and antitrust law inquiries often continue for several years and, if violations are found, can result in substantial fines. In response to the actions of the regulatory authorities, the Company launched its own internal investigations into potential violations of competition laws. The Company has identified violations in certain European countries and appropriate actions 9 were taken. Several regulatory authorities in Europe have issued separate complaints pursuant to their investigations alleging that the Company, along with several other companies, engaged in violations of competition laws in those countries. The remaining authorities' investigations are in various stages of the regulatory process. As a result of our initial and on-going analyses of the complaints, as well as final decisions issued by authorities in a number of countries, the Company has accrued liabilities for competition law violations totaling $283 million as of September 30, 2011. While the ultimate resolution of the matters for which we have accrued liabilities may result in fines or costs in excess of the amounts reserved, we do not expect any such incremental losses to materially impact our financial statements in the period in which they are accrued and paid, respectively. For our other remaining competition law matters, at this time, there are none that we consider reasonably possible to result in fines that are probable and estimable and we cannot reasonably estimate any additional fines to which the Company may be subject. We will continue to monitor developments for all of these investigations and will record additional charges as appropriate. With respect to other litigation and claims, while considerable uncertainty exists, in the opinion of management and our counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows. We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will have a material adverse effect on our financial position, results of operations or cash flows. Income Tax Uncertainties The Company is present in over 150 taxable jurisdictions and, at any point in time, has 50  60 audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law and closing of statute of limitations. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 2002 and forward. We are generally not able to reliably estimate the ultimate settlement amounts or timing until the close of the audit. While we do not expect material changes, it is possible that the amount of unrecognized benefit with respect to our uncertain tax positions will significantly increase or decrease within the next 12 months related to audits described above. At this time, we are not able to make a reasonable estimate of the range of impact on the balance of uncertain tax positions or the impact on the effective tax rate related to these items. Additional information on the Commitments and Contingencies of the Company can be found in Note 10, Commitments and Contingencies, which appears in the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2011. Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations The purpose of this discussion is to provide an understanding of P&Gs financial results and condition by focusing on changes in certain key measures from year to year. Managements Discussion and Analysis (MD&A) is organized in the following sections:  Overview  Summary of Results  Forward-Looking Statements  Results of Operations  Three Months Ended September 30, 2011  Business Segment Discussion  Three Months Ended September 30, 2011  Financial Condition  Reconciliation of Non-GAAP Measures Throughout MD&A, we refer to measures used by management to evaluate performance, including unit volume growth, net sales and net earnings. We also refer to a number of financial measures that are not defined under accounting principles generally accepted in the United States of America (U.S. GAAP), including organic sales growth, free cash flow and free cash flow productivity. Organic sales growth is net sales growth excluding the impacts of foreign exchange, acquisitions and divestitures. Free cash flow is operating cash flow less capital spending. Free cash flow productivity is the ratio of free cash 10 flow to net earnings. We believe these measures provide investors with important information that is useful in understanding our business results and trends. The explanation at the end of MD&A provides more details on the use and the derivation of these measures. Management also uses certain market share and market consumption estimates to evaluate performance relative to competition despite some limitations on the availability and comparability of share and consumption information. References to market share and market consumption in MD&A are based on a combination of vendor-reported consumption and market size data, as well as internal estimates. All market share references represent the percentage of sales in dollar terms on a constant currency basis of our products, relative to all product sales in the category. OVERVIEW The purpose of our business is to provide branded consumer packaged goods of superior quality and value to our consumers around the world. This will enable us to execute our Purpose-inspired growth strategy: to touch and improve more consumers' lives, in more parts of the world, more completely. We believe this will result in leadership sales, earnings and value creation, allowing employees, shareholders and the communities in which we operate to prosper. Our products are sold in more than 180 countries primarily through mass merchandisers, grocery stores, membership club stores, drug stores and high-frequency stores, the neighborhood stores which serve many consumers in developing markets. We continue to expand our presence in other channels, including department stores, perfumeries, pharmacies, salons and e-commerce. We have on-the-ground operations in approximately 80 countries. Our market environment is highly competitive with global, regional and local competitors. In many of the markets and industry segments in which we sell our products, we compete against other branded products as well as retailers' private-label brands. Additionally, many of the product segments in which we compete are differentiated by price (referred to as super-premium, premium, mid-tier and value-tier products). We are well positioned in the industry segments and markets in which we operate-often holding a leadership or significant market share position. The table below provides more information about the components of our reportable business segment structure. Reportable Segment Categories Billion Dollar Brands Beauty Cosmetics, Female Antiperspirant and Deodorant, Female Personal Cleansing, Female Shave Care, Hair Care, Hair Color, Hair Styling, Pharmacy Channel, Prestige Products, Salon Professional, Skin Care Head & Shoulders, Olay, Pantene, Wella Grooming Electronic Hair Removal Devices, Small Home Appliances, Male Blades and Razors, Male Personal Care Braun, Fusion, Gillette, Mach3 Health Care Feminine Care, Gastrointestinal, Incontinence, Rapid Diagnostics, Respiratory, Toothbrush, Toothpaste, Water Filtration, Other Oral Care Always, Crest, Oral-B Snacks and Pet Care Pet Care, Snacks Iams, Pringles Fabric Care and Home Care Air Care, Batteries, Dish Care, Fabric Enhancers, Laundry Additives, Laundry Detergents, Surface Care Ace, Ariel, Dawn, Downy, Duracell, Gain, Tide, Febreze Baby Care and Family Care Baby Wipes, Diapers, Paper Towels, Tissues, Toilet Paper Bounty, Charmin, Pampers The following table provides the percentage of net sales and net earnings by reportable business segment for the three months ended September 30, 2011 (excludes net sales and net earnings in Corporate): 11 Three Months Ended September 30 Net Sales Net Earnings Beauty 24 % 24 % Grooming 9 % 14 % Health Care 15 % 18 % Snacks and Pet Care 4 % 2 % Fabric Care and Home Care 30 % 26 % Baby Care and Family Care 18 % 16 % Total 100 % 100 % SUMMARY OF RESULTS Following are highlights of results for the three months ended September 30, 2011:  Net sales increased 9% to $21.9 billion. Organic sales, which exclude the impacts of acquisitions, divestitures and foreign exchange, were up 4%.  Unit volume grew 1%, led by mid-single-digit growth in the developing regions and the Beauty Care segment.  Net earnings were $3.0 billion, a decrease of 2% versus the prior year period as sales growth was more than offset by gross margin contraction driven primarily by higher commodity costs.  Diluted net earnings per share increased 1% to $1.03. Earnings per share growth exceeded net earnings growth due to the impact of share repurchase activity.  Operating cash flow decreased 12% versus the prior year period to $2.2 billion mainly due to an increase in working capital. Free cash flow, which is operating cash flow less capital expenditures, was $1.3 billion. Free cash flow productivity, which is the ratio of free cash flow to net earnings, was 44%. FORWARD-LOOKING STATEMENTS We discuss expectations regarding future performance, events and outcomes, such as our business outlook and objectives, in annual and quarterly reports, press releases and other written and oral communications. All such statements, except for historical and present factual information, are ""forward-looking statements,"" and are based on financial data and our business plans available only as of the time the statements are made, which may become out-of-date or incomplete. We assume no obligation to update any forward-looking statements as a result of new information, future events or other factors. Forward-looking statements are inherently uncertain and investors must recognize that events could be significantly different from our expectations. For more information on risks that could impact our results, refer to Part II, Item 1A Risk Factors in this Form 10-Q. Ability to Achieve Business Plans . We are a consumer products company and rely on continued demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers and retail trade customers. Our continued success is dependent on leading-edge innovation with respect to both products and operations, on the continued positive reputations of our brands and our ability to successfully maintain trademark protection. This means we must be able to obtain patents and trademarks, and respond to technological advances and patents granted to competition. Our success is also dependent on effective sales, advertising and marketing programs. Our ability to innovate and execute in these areas will determine the extent to which we are able to grow existing sales and volume profitably, especially with respect to the product categories and geographic markets (including developing markets) in which we have chosen to focus. There are high levels of competitive activity in the environments in which we operate. To address these challenges, we must respond to competitive factors, including pricing, promotional incentives, trade terms and product initiatives. We must manage each of these factors, as well as maintain mutually beneficial relationships with our key customers, in order to effectively compete and achieve our business plans. As a company that manages a portfolio of consumer brands, our ongoing business model involves a certain level of ongoing acquisition and divestiture activities. We must be able to successfully manage the impacts of these activities, while at the same time delivering against base business objectives. Daily conduct of our business also depends on our ability to maintain key information technology systems, including systems operated by third-party suppliers, and to maintain security over our data. Cost Pressures . Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, labor costs, foreign exchange and interest rates. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects, sourcing decisions and certain hedging transactions. We also must 12 manage our debt and currency exposure, especially in certain countries with currency exchange controls, such as Venezuela, China and India. We need to maintain key manufacturing and supply arrangements, including sole supplier and sole manufacturing plant arrangements, and successfully manage any disruptions at Company manufacturing sites. We must implement, achieve and sustain cost improvement plans, including our outsourcing projects and those related to general overhead and workforce optimization. Successfully managing these changes, including identifying, developing and retaining key employees, is critical to our success. Global Economic Conditions . Economic changes, terrorist activity, political unrest and natural disasters, such as the civil unrest in the Middle East and the impacts of the Japan earthquake and tsunami, may result in business interruption, inflation, deflation or decreased demand for our products. Our success will depend, in part, on our ability to manage continued global political and/or economic uncertainty, especially in our significant geographic markets, due to terrorist and other hostile activities or natural disasters. We could also be negatively impacted by a global, regional or national economic crisis, including sovereign risk in the event of a deterioration in the credit worthiness of or a default by local governments, resulting in a disruption of credit markets. Such events could negatively impact our ability to collect receipts due from governments, including refunds of value added taxes, create significant credit risks relative to our local customers and depository institutions, and/or negatively impact our overall liquidity. Regulatory Environment . Changes in laws, regulations and the related interpretations may alter the environment in which we do business. This includes changes in environmental, competitive and product-related laws, as well as changes in accounting standards and taxation requirements. Our ability to manage regulatory, tax and legal matters (including product liability, patent, intellectual property, competition law matters and tax policy) and to resolve pending legal matters within current estimates may impact our results. RESULTS OF OPERATIONS  Three Months Ended September 30, 2011 The following discussion provides a review of results for the three months ended September 30, 2011 versus the three months ended September 30, 2010. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information 13 Three Months Ended September 30 2011 2010 % CHG NET SALES $ 21,917 $ 20,122 9% COST OF PRODUCTS SOLD 11,061 9,689 14% GROSS MARGIN 10,856 10,433 4% SELLING GENERAL & ADMINISTRATIVE EXPENSE 6,522 5,932 10% OPERATING INCOME 4,334 4,501 (4)% TOTAL INTEREST EXPENSE 207 208 OTHER NON-OPERATING INCOME/(EXPENSE), NET (32 ) (11 ) EARNINGS BEFORE INCOME TAXES 4,095 4,282 (4)% INCOME TAXES 1,071 1,201 NET EARNINGS 3,024 3,081 (2)% EFFECTIVE TAX RATE 26.2 % 28.0 % PER COMMON SHARE: BASIC NET EARNINGS $ 1.08 $ 1.07 1% DILUTED NET EARNINGS $ 1.03 $ 1.02 1% DIVIDENDS $ 0.525 $ 0.4818 9% AVERAGE DILUTED SHARES OUTSTANDING 2,945.8 3,025.6 COMPARISONS AS A % OF NET SALES Basis Pt Chg GROSS MARGIN 49.5 % 51.9 % (240 ) SELLING, GENERAL & ADMINISTRATIVE EXPENSE 29.7 % 29.5 % 20 OPERATING MARGIN 19.8 % 22.4 % (260 ) EARNINGS BEFORE INCOME TAXES 18.7 % 21.3 % (260 ) NET EARNINGS 13.8 % 15.3 % (150 ) Net sales increased 9% to $21.9 billion for the July - September quarter on a 1% increase in unit volume. Volume grew across four of the six business segments. Beauty Care grew mid-single digits, with Health Care, Snacks and Pet Care, and Baby Care and Family Care growing low single digits. Grooming volume was in line with the prior year period, while Fabric Care and Home Care volume was down low single digits. Volume grew mid-single digits in developing regions and was down low single digits in developed regions. Organic volume, which excludes acquisitions and divestitures, increased 2%. Price increases added 4% to net sales, driven by price increases across all business segments and regions to offset commodity costs. Negative mix reduced net sales by 1% due mainly to disproportionate growth in developing regions and mid-tier value products, both of which have lower than Company average selling prices. Favorable foreign exchange increased net sales by 5% as key foreign currencies strengthened versus the U.S. dollar. Organic sales growth was 4% driven by unit volume growth and price increases, partially offset by the impact of unfavorable mix. Net Sales Change Drivers 2011 vs. 2010 (Three Months Ended Sep.30) Volume with Acquisitions & Divestitures Volume Excluding Acquisitions & Divestitures Foreign Exchange Price Mix/Other Net Sales Growth Beauty 4 % 5 % 6 % 2 % -3 % 9 % Grooming 0 % 0 % 7 % 2 % 1 % 10 % Health Care 3 % 3 % 6 % 3 % -2 % 10 % Snacks and Pet Care 2 % 2 % 5 % 2 % 0 % 9 % Fabric Care and Home Care -1 % -1 % 5 % 5 % -3 % 6 % Baby Care and Family Care 2 % 2 % 5 % 4 % 1 % 12 % TOTAL COMPANY 1 % 2 % 5 % 4 % -1 % 9 % Net sales percentage changes are approximations based on quantitative formulas that are consistently applied. 14 Gross margin contracted 240 basis points to 49.5% of net sales in the first fiscal quarter. The reduction in gross margin was driven mainly by a 340 basis point impact from higher commodity and energy costs, along with negative product mix from disproportionate growth in developing regions and mid-tier products. These impacts were partially offset by a 140 basis point impact from pricing, as well as manufacturing cost savings, and the favorable impact of volume scale leverage. Total selling, general and administrative expenses (SG&A) increased 10% to $6.5 billion, driven by higher marketing and overhead spending to support growth, as well as the impact of foreign exchange. SG&A as a percentage of net sales increased 20 basis points in the first quarter to 29.7% driven by higher marketing spending, partially offset by overhead scale leverage from increased sales. Interest expense was $207 million for the quarter, down $1 million versus the prior year period due to lower interest rates on floating rate debt partially offset by an increase in debt outstanding. Other non-operating income/(expense) declined $21 million mainly behind lower interest and investment income and higher provisions for minority interests due to increased earnings in less than fully-owned subsidiaries. The effective tax rate on continuing operations decreased 180 basis points to 26.2% primarily due to the geographic mix of earnings, as an increased proportion of current year earnings were generated in foreign markets with lower tax rates versus the U.S. Net earnings decreased 2% to $3.0 billion for the quarter as the net sales increase was more than offset by operating margin contraction. Operating margin declined 260 basis points due to gross margin contraction and an increase in SG&A as a percentage of net sales. Diluted net earnings per share increased 1% to $1.03. Earnings per share growth exceeded net earnings growth due to the impact of share repurchase activity. Foreign Currency Translation  Venezuela Impacts Venezuela is a highly inflationary economy under U.S. GAAP. As a result, the U.S. dollar is now the functional currency for our subsidiaries in Venezuela. Any currency remeasurement adjustments for non-dollar denominated monetary assets and liabilities held by these subsidiaries and other transactional foreign exchange gains and losses are reflected in earnings. The Venezuelan government has a number of currency controls for companies operating in Venezuela. There is one official exchange rate for imported goods, equal to 4.3 bolivars to the U.S. dollar. Our overall results in Venezuela are reflected in our Consolidated Financial Statements at the 4.3 rate, which is also expected to be applicable to dividend repatriations. There are also exchange controls over securities transactions in what was the parallel market, which has historically been used to pay for imported goods and services that do not qualify for exchange in the official market and is now controlled by authorities. The Central Bank of Venezuela is currently the only legal intermediary to execute foreign exchange transactions outside of CADIVI (4.3 rate) through the SITME rate which was approximately 5.3 as of September 30, 2011. The notional amount of transactions that run through this foreign exchange rate for non-essential goods is restrictive, which for us has essentially eliminated our ability to access any foreign exchange rate other than the CADIVI (4.3) rate to pay for imported goods and/or manage our local monetary asset balances. As of September 30, 2011, we had net monetary assets denominated in local currency of approximately $782 million. Approximately $325 million of this balance has been remeasured using the SITME rate because we plan to use that amount of the net assets (largely cash) to satisfy U.S. dollar denominated liabilities that do not qualify for official rate dollars. The availability of the parallel market to settle these transactions is uncertain. The remaining net monetary asset balances are currently reflected within our Consolidated Financial Statements at the 4.3 official exchange rate. Depending on the future availability of U.S. dollars at the official rate, our local U.S. dollar needs, our overall repatriation plans and the creditworthiness of the local depository institutions and other creditors, we have exposure for our local monetary assets. We also have devaluation exposure for the differential between the current and potential future official and parallel exchange rates on the portion of our local monetary assets reflected at the 4.3 official exchange rate. Our ability to effectively manage sales and profit levels in Venezuela will be impacted by several factors, including the Company's ability to mitigate the effect of any potential future devaluation, further actions of the Venezuelan government, economic conditions in Venezuela, such as inflation and consumer spending, the availability of raw materials, utilities and energy and the future state of exchange controls in Venezuela including the availability of U.S. dollars at the official foreign exchange rate. BUSINESS SEGMENT DISCUSSION  Three Months Ended September 30, 2011 15 The following discussion provides a review of results by business segment. Analyses of the results for the three months ended September 30, 2011 are provided compared to the same three month period ended September 30, 2010. The primary financial measures used to evaluate segment performance are net sales and net earnings from continuing operations. The table below provides supplemental information on net sales and net earnings by business segment for the three months ended September 30, 2011 versus the comparable prior year period (amounts in millions): Three Months Ended September 30, 2011 Net Sales % Change Versus Year Ago Earnings Before Income Taxes % Change Versus Year Ago Net Earnings % Change Versus Year Ago Beauty $ 5,390 9 % $ 991 (8 )% $ 731 (12 )% Grooming 2,093 10 % 576 10 % 438 10 % Health Care 3,291 10 % 800 8 % 542 9 % Snacks and Pet Care 776 9 % 90 17 % 62 15 % Fabric Care and Home Care 6,681 6 % 1,263 (11 )% 805 (14 )% Baby Care and Family Care 4,079 12 % 792 6 % 494 5 % Corporate (393 ) N/A (417 ) N/A (48 ) N/A Total Company 21,917 9 % 4,095 (4 )% 3,024 (2 )% Beauty Beauty net sales increased 9% to $5.4 billion on unit volume growth of 4%. Organic sales grew 4% on 5% organic volume growth. Price increases contributed 2% to net sales growth. Mix negatively impacted net sales by 3% behind disproportionate growth in developing regions, which have lower than segment average selling prices, and a decrease in the premium-priced Salon Professional category. Favorable foreign exchange added 6% to net sales growth. Volume increased high single digits in developing regions and low single digits in developed regions. Volume in Retail Hair Care grew high single digits behind double-digit growth in developing regions led by Pantene initiatives and Head & Shoulders geographic expansion. Global market share of the hair care category was up over half a point. Volume in Female Beauty decreased mid-single digits due to the Zest and Infasil divestitures, as well as a decrease in Olay due to share loss from competitive activity in North America, and a decrease in the CEEMEA region due to a reduction in customer inventories following relatively high shipments in the June quarter and comparing against a high base period. Volume in Salon Professional was down high single digits mainly due to market size contractions and competitive activity. Volume in Prestige Products increased double digits driven by initiatives across Gucci, Hugo, and Lacoste. Net earnings decreased 12% to $731 million, as higher net sales were more than offset by a 320-basis point decrease in net earnings margin. Net earnings margin decreased due to gross margin contraction and higher SG&A as a percentage of net sales. Gross margin decreased primarily due to an increase in commodity costs, partially offset by manufacturing cost savings and higher pricing. SG&A as a percentage of net sales increased due to higher marketing and overhead spending to support growth. Grooming Grooming net sales increased 10% to $2.1 billion. Volume was in line with prior year. Organic sales were up 3%. Price increases contributed 2% to net sales growth. Positive product mix increased net sales by 1% mainly due to ProGlide and premium appliances initiatives, which have higher than segment average selling prices. Favorable foreign exchange increased net sales growth by 7%. Volume grew low single digits in developing regions and decreased low single digits in developed regions. Volume in Male Grooming was up low single digits due to growth of blades and razors in Asia and Latin America, as well as growth behind male personal care products in North America, partially offset by a decrease in Western Europe blades and razors due to market softness. Global market share of the blades and razors category was unchanged. Volume in Appliances decreased high single digits due to market contraction in Western Europe and a strong base period for shavers, epilators, and hair care appliances. Global market share of the dry shave category was down over 3 points. Net earnings increased 10% to $438 million behind higher net sales. Net earnings margin was in line with the prior year period, with gross margin contraction offset by a decrease in SG&A as a percentage of net sales. Gross margin decreased primarily due to an increase in commodity costs, partially offset by price increases. SG&A as a percentage of net sales decreased primarily due to scale leverage from increased sales. Health Care 16 Health Care net sales increased 10% to $3.3 billion on 3% growth in unit volume. Organic sales were up 4%. Price increases contributed 3% to net sales growth. Mix negatively impacted net sales by 2% behind geographic and product mix, due to disproportionate growth in countries and products with lower than segment average selling prices. Favorable foreign exchange increased net sales growth by 6%. Volume increased low single digits in both developing and developed regions. Volume in Oral Care increased mid-single digits behind the expansion of Oral-B toothpaste in Western Europe and Latin America, and toothbrush initiatives in Asia. Global market share of the oral care category was up nearly half a point. Volume in Personal Health Care increased low single digits behind higher shipments of Vicks, primarily in North America and Asia, due to initiative activity, partially offset by lower shipments of Prilosec OTC in North America due to non-branded competitive activity. All-outlet value share of the U.S. personal health care market increased about half a point. Volume in Feminine Care was up low single digits primarily due to new products in China and strong growth in India. Global market share of the feminine care category was down less than half a point. Net earnings increased 9% to $542 million as higher net sales were partially offset by a 10-basis point decrease in net earnings margin. Net earnings margin decreased due to gross margin contraction, partially offset by lower SG&A as a percentage of net sales. Gross margin declined due to higher commodity costs, partially offset by manufacturing cost savings and price increases. SG&A as a percentage of net sales decreased primarily due to scale leverage from increased sales. Snacks and Pet Care Snacks and Pet Care net sales increased 9% to $776 million on a 2% increase in unit volume. Organic sales, which exclude the impacts of foreign exchange increased 4%. Price increases added 2% to net sales growth. Favorable foreign exchange positively impacted net sales growth by 5%. Snacks volume increased high single digits mainly due to increased distribution and market growth in developing regions, as well as share growth and market growth in North America. Global market share of the snacks category was up slightly. Pet Care volume was down mid-single digits due mainly to customer inventory adjustments in North America related to the June price increase. Global market share of the pet care category was down approximately half a point. Net earnings increased 15% to $62 million due to sales growth and a 30-basis point increase in net earnings margin. Net earnings margin increased as a lower gross margin was more than fully offset by a decrease in SG&A as a percentage of net sales. Gross margin declined behind higher commodity costs, partially offset by manufacturing cost savings and pricing. SG&A as a percentage of net sales decreased primarily due to scale leverage from increased sales. In April 2011, we announced plans to divest the Company's Snacks business through a merger with Diamond Foods, Inc. in an all-stock Reverse Morris Trust transaction. The Snacks business had net sales of approximately $1.5 billion and operating income of approximately $200 million in fiscal 2011. The Company expects the transaction to close by the end of the 2011 calendar year, pending necessary regulatory approvals. Fabric Care and Home Care Fabric Care and Home Care net sales increased 6% to $6.7 billion, despite a 1% decrease in unit volume. Organic sales were up 1%. Price increases contributed 5% to net sales growth. Mix negatively impacted net sales growth by 3% due to disproportionate growth of mid-tier product lines and developing regions, which have lower than segment average selling prices. Favorable foreign exchange increased net sales by 5%. Volume in developing regions grew mid-single digits, while volume in developed regions decreased mid-single digits. Fabric Care volume decreased low single digits mainly due to initiative activity in the base period and the impact of the forward buy in the previous quarter ahead of the price increases in North America, partially offset by growth in Asia. Global market share of the fabric care category decreased half a point. Home Care volume decreased low single digits driven by the impact of the forward buy in the previous quarter ahead of the price increases in North America, partially offset by initiative activity and distribution expansion in developing regions. Global market share of the home care category was unchanged. Batteries volume grew low single digits primarily due to market growth in developing regions and increased demand following the hurricane in North America. Global market share of the batteries category increased more than half a point. Net earnings decreased 14% to $805 million as net sales growth was more than offset by a 280-basis point decrease in net earnings margin. Net earnings margin decreased mainly due to gross margin contraction and a higher effective tax rate. Gross margin decreased mainly due to higher commodity costs, partially offset by manufacturing cost savings and pricing. The tax rate increased due to a shift in the geographic mix of earnings to countries with higher statutory tax rates. Baby Care and Family Care Baby Care and Family Care net sales increased 12% to $4.1 billion on 2% volume growth. Organic sales were up 7%. Pricing added 4% to net sales growth. Mix increased net sales by 1% due to disproportionate growth of Baby Care, which has higher than segment average selling prices. Favorable foreign exchange increased net sales growth by 5%. Volume grew double 17 digits in developing regions and decreased low single digits in developed regions. Volume in Baby Care was up high single digits behind market size growth and distribution expansion in developing regions, partially offset by diaper market softness in North America and Western Europe. Global market share of the baby care category increased over 1 point. Volume in Family Care decreased mid-single digits primarily due to the impact of the forward buy in the previous quarter ahead of the price increases in North America. In the U.S., all-outlet share of the family care category increased slightly. Net earnings increased 5% to $494 million as sales growth was partially offset by an 80-basis point reduction in net earnings margin. Net earnings margin declined mainly due to a lower gross margin. The reduction in gross margin was driven by higher commodity costs, partially offset by the impact of higher pricing. CORPORATE Corporate includes certain operating and non-operating activities not allocated to specific business units. These include: the incidental businesses managed at the corporate level; financing and investing activities; other general corporate items; the historical results of certain divested brands and categories; and certain restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization. Corporate also includes reconciling items to adjust the accounting policies used in the segments to U.S. GAAP. The most significant reconciling items include income taxes (to adjust from statutory rates that are reflected in the segments to the overall Company effective tax rate), adjustments for unconsolidated entities (to eliminate net sales, cost of products sold and SG&A for entities that are consolidated in the segments but accounted for using the equity method for U.S. GAAP) and noncontrolling interest adjustments for subsidiaries where we do not have 100% ownership. Since certain unconsolidated entities and less than 100%-owned subsidiaries are managed as integral parts of the Company, they are accounted for similar to a wholly-owned subsidiary for management and segment purposes. This means our segment results recognize 100% of each income statement component through before-tax earnings in the segments, with eliminations for unconsolidated entities and noncontrolling interests in Corporate. In determining segment net earnings, we apply the statutory tax rates (with adjustments to arrive at the Company's effective tax rate in Corporate) and eliminate the share of earnings applicable to other ownership interests, in a manner similar to noncontrolling interest. Corporate net sales primarily reflect the adjustment to eliminate the sales of unconsolidated entities included in business segment results. Accordingly, Corporate net sales are generally a negative balance. In 2011, negative net sales in Corporate increased by $46 million due to increased adjustments required to eliminate higher sales of unconsolidated entities. Net Corporate expenses decreased $54 million, primarily due to net tax impacts. Additional discussion of the items impacting net income in Corporate are included in the Results of Operations section. FINANCIAL CONDITION Operating Activities We generated $2.2 billion of cash from operating activities in our first fiscal quarter. This represents a decline of 12% versus the prior year period primarily due to higher levels of working capital. On a year-to-date basis, the net of accounts receivable, inventory, and accounts payable consumed $2.0 billion of cash. Accounts receivable used $639 million of cash primarily due to increased sales later in the quarter, growth in regions and categories with longer average payment terms, extension of trade terms in the Respiratory business and to support overall business growth. Inventory consumed $927 million of cash, mainly to support product initiatives, holiday-related shipments in some of our seasonal businesses, and to build stock to support capacity expansions and manufacturing sourcing changes. Accounts payable, accrued and other liabilities used $479 million of cash, primarily related to the payment of prior-year marketing accruals and the payment of fines related to violations of the European competition laws. Investing Activities Our investing activities consumed cash of $859 million mainly to fund capital expenditures. Capital expenditures were $833 million or 3.8% of net sales. Cash used for investing activities decreased $69 million versus the prior year period mainly due to reduced net cash used for acquisitions, partially offset by an increase in capital expenditures. Financing Activities Our financing activities consumed net cash of $419 million. We used $1.3 billion for treasury stock purchases and $1.5 billion for dividends and partially funded these cash outlays through the issuance of $2.0 billion of long-term debt. Cash consumed by financing activities declined $1.5 billion versus the prior year period due to increased levels of debt and a decrease in the treasury stock purchases. 18 As of September 30, 2011, our current liabilities exceeded current assets by $4.8 billion. We have short- and long-term debt to fund discretionary items such as acquisitions and share repurchase programs. We anticipate being able to support our short-term liquidity and operating needs largely through cash generated from operations. We have strong short- and long-term debt ratings which have enabled and should continue to enable us to refinance our debt as it becomes due at favorable rates in commercial paper and bond markets. In addition, we have agreements with a diverse group of financial institutions that, if needed, should provide sufficient credit funding to meet short-term financing requirements. RECONCILIATION OF NON-GAAP MEASURES Our discussion of financial results includes several measures not defined by U.S. GAAP. We believe these measures provide our investors with additional information about the underlying results and trends of the Company, as well as insight to some of the metrics used to evaluate management. When used in MD&A, we have provided the comparable GAAP measure in the discussion. Organic Sales Growth: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions, divestitures and foreign exchange from year-over-year comparisons. We believe this provides investors with a more complete understanding of underlying sales trends by providing sales growth on a consistent basis. Organic sales is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation. The reconciliation of reported sales growth to organic sales for the July - September quarter: Jul - Sep 2011 Net Sales Growth Foreign Exchange Impact Acquisition/ Divestiture Impact* Organic Sales Growth Beauty 9 % (6 )% 1 % 4 % Grooming 10 % (7 )%  % 3 % Health Care 10 % (6 )%  % 4 % Snacks and Pet Care 9 % (5 )%  % 4 % Fabric Care and Home Care 6 % (5 )%  % 1 % Baby Care and Family Care 12 % (5 )%  % 7 % Total P&G 9 % (5 )%  % 4 % * Acquisition/Divestiture Impacts includes rounding impacts necessary to reconcile net sales to organic sales. Free Cash Flow: Free cash flow is defined as operating cash flow less capital spending. We view free cash flow as an important measure because it is one factor in determining the amount of cash available for dividends and discretionary investment. Free cash flow is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation. Free Cash Flow Productivity: Free cash flow productivity is defined as the ratio of free cash flow to net earnings. The Companys long-term target is to generate free cash at or above 90% of net earnings. Free cash flow productivity is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation. The reconciliation of free cash flow and free cash flow productivity is provided below (amounts in millions): Operating Cash Flow Capital Spending Free Cash Flow Net Earnings Free Cash Flow Productivity Jul - Sept 11 $2,167 $(833) $1,334 $3,024 44% 19 Item 3. Quantitative and Qualitative Disclosures About Market Risk. There have been no material changes in the Companys exposure to market risk since June 30, 2011. Additional information can be found in the section entitled Other Information, which appears on page 50, and Note 5, Risk Management Activities and Fair Value Measurements, which appears on pages 60-62 of the Annual Report to Shareholders for the fiscal year ended June 30, 2011 which can be found by reference to Exhibit 13 of the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2011. Item 4. Controls and Procedures. Evaluation of Disclosure Controls and Procedures. The Companys Chairman of the Board, President and Chief Executive Officer, Robert A. McDonald, and the Companys Chief Financial Officer, Jon R. Moeller, performed an evaluation of the Companys disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (Exchange Act)) as of the end of the period covered by this report. Messrs. McDonald and Moeller have concluded that the Companys disclosure controls and procedures were effective to ensure that information required to be disclosed in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) accumulated and communicated to our management, including Messrs. McDonald and Moeller, to allow their timely decisions regarding required disclosure. Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting that occurred during the Companys fiscal quarter ended September 30, 2011 that have materially affected, or are reasonably likely to materially affect, the Companys internal control over financial reporting. PART II. OTHER INFORMATION Item 1. Legal Proceedings. The Company is subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental issues, patent and trademark matters, labor and employment matters and tax. As previously reported, the Company has been subject to a number of investigations into potential competition law violations in Europe. The Companys policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with investigations by relevant regulatory authorities, which the Company is doing. In response to the actions of the regulatory authorities, the Company launched its own internal investigations into potential violations of competition laws. The Company identified violations in certain European countries and appropriate actions were taken. As a result of certain investigations that were previously disclosed, several authorities issued separate complaints alleging that the Company, along with several other companies, engaged in violations of competition laws in the past. The Company resolved several of these matters prior to the most recent quarter. Those that remain open include investigations by national authorities in Belgium, France, Germany and Greece. We believe that all of these matters involve a number of other consumer products companies and/or retail customers. Competition and antitrust violations often continue for several years and, if violations are found, can result in substantial fines. No non-monetary sanctions are being sought in these matters. There were no new developments on those remaining investigations during the most recent quarter. For certain of the remaining matters listed above, we have established accruals for potential fines. We do not expect any significant incremental fines or costs in excess of amounts accrued for these matters. For other remaining matters, we cannot reasonably estimate any fines to which the Company may be subject as a result of these competition law matters. Please refer to the Company's Risk Factors in Item 1A of this Form 10-Q for additional information. In December 2008, the Company became aware of an investigation by Italian authorities into an environmental accident at the site of a contractor which provides services to one or more of the Companys European affiliates. The accident involved the explosion of certain pressurized cans and resulted in the death of one worker and serious injuries to another. Italian authorities have commenced a formal criminal proceeding regarding whether the Companys local affiliate and certain of its employees complied with Italian laws related to the proper classification and disposal of their products. Should they find that these entities violated the law, the Italian authorities could levy fines in excess of $100 thousand against the Companys European affiliate(s). Item 1A. Risk Factors. 20 We discuss our expectations regarding future performance, events and outcomes, such as our business outlook and objectives in this Form 10-Q, the Annual Report to Shareholders, other quarterly reports, press releases and other written and oral communications. All statements, except for historical and present factual information, are forward-looking statements and are based on financial data and business plans available only as of the time the statements are made, which may become out of date or incomplete. We assume no obligation to update any forward-looking statements as a result of new information, future events, or other factors. Forward-looking statements are inherently uncertain, and investors must recognize that events could significantly differ from our expectations. The following discussion of risk factors identifies the most significant factors that may adversely affect our business, operations, financial position or future financial performance. This information should be read in conjunction with MD&A and the consolidated financial statements and related notes incorporated by reference into this report. The following discussion of risks is not all inclusive but is designed to highlight what we believe are important factors to consider when evaluating our expectations. These factors could cause our future results to differ from those in the forward-looking statements and from historical trends. A material change in consumer demand for our products could have a significant impact on our business. We are a consumer products company and rely on continued global demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers. This is dependent on a number of factors including our ability to develop effective sales, advertising and marketing programs. We expect to achieve our financial targets, in part, by shifting our portfolio towards faster growing, higher margin businesses. If demand and growth rates fall substantially below expected levels or our market share declines significantly in these businesses, our results could be negatively impacted. This could occur due to unforeseen negative economic or political events or to changes in consumer trends and habits. In addition, our continued success is dependent on leading-edge innovation, with respect to both products and operations. This means we must be able to obtain patents that lead to the development of products that appeal to our consumers across the world. The ability to achieve our business objectives is dependent on how well we can respond to our local and global competitors. Across all of our categories, we compete against a wide variety of global and local competitors. As a result, there are ongoing competitive product and pricing pressures in the environments in which we operate, as well as challenges in maintaining profit margins. To address these challenges, we must be able to successfully respond to competitive factors, including pricing, promotional incentives and trade terms, as well as technological advances and patents granted to competition. Our businesses face cost pressures and risks inherent in global manufacturing which could affect our business results. Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, labor costs, foreign exchange and interest rates. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects (including outsourcing projects), sourcing decisions and certain hedging transactions. In the manufacturing and general overhead areas, we need to maintain key manufacturing and supply arrangements, including any key sole supplier and sole manufacturing plant arrangements. In addition, we are subject to risks inherent in global manufacturing, such as environmental events, labor disputes, disruption in logistics, loss or impairment of key manufacturing sites, natural disasters, acts of war or terrorism and other external factors over which we have no control. While we have business continuity and contingency plans for key manufacturing sites and the supply of raw materials, significant disruption of manufacturing could interrupt product supply and, if not remedied, have an adverse impact on our business. We face risks associated with significant international operations. We conduct business across the globe with a significant portion of our sales outside the United States. As a result, we are subject to a number of risks, including, but not limited to, changes in exchange rates for foreign currencies, which may reduce the U.S. dollar value of revenues and earnings received and/or balances held by or invested in our foreign subsidiaries, as well as exchange controls and other limits on our ability to repatriate earnings from outside the U.S. that can increase our exposure. We have sizable businesses and maintain local currency cash balances in a number of foreign countries with exchange controls, including, but not limited to, Venezuela, China and India. Our results of operations and/or financial condition could be adversely impacted if we are unable to successfully manage these risks in an increasingly volatile environment. Further, we expect to achieve our financial targets, in part, by achieving disproportionate growth in developing regions. Should growth rates or our market share fall substantially below expected levels in these regions, our results could be negatively impacted. In addition, economic changes, terrorist activity and political unrest may result in business interruption, inflation, deflation or decreased demand for our products. Our success will depend, in part, on our ability to manage continued 21 global political and/or economic uncertainty, especially in our significant geographical markets, as well as any political or economic disruption due to terrorist and other hostile activities. If the reputation of the Company or one or more of our leading brands erodes significantly, it could have a material impact on our financial results. The Company's reputation is the foundation of our relationships with key stakeholders and other constituencies. If we are unable to effectively manage real or perceived issues, which could negatively impact sentiments toward the Company, our ability to operate freely could be impaired and our financial results could suffer. Our financial success is directly dependent on the success of our brands, particularly our billion-dollar brands. The success of these brands can suffer if our marketing plans or product initiatives do not have the desired impact on a brand's image or its ability to attract consumers, or we are unable to maintain trademark protection. Further, our results could be negatively impacted if one of our leading brands suffers a substantial impediment to its reputation due to real or perceived quality issues or the distribution and sale of counterfeit products. Our ability to successfully adapt to ongoing organizational change could impact our business results. We have executed a number of significant business and organizational changes including acquisitions, divestitures and workforce optimization projects to support our growth strategies. We expect these types of changes to continue for the foreseeable future. Successfully managing these changes, including retention of key employees, is critical to our business success. In addition, we are generally a build-from-within company, and our success is dependent on identifying, developing and retaining key employees to provide uninterrupted leadership and direction for our business. This includes developing organization capabilities in key growth markets where the depth of skilled employees is limited and competition for these resources is intense. Further, business and organizational changes may result in more reliance on third parties for various services, and that reliance may increase reputational, operational and compliance risks, including the risk of corruption. Finally, our financial targets assume a consistent level of productivity improvement. If we are unable to deliver expected productivity improvements, while continuing to invest in business growth, our financial results could be adversely impacted. Our ability to successfully manage ongoing acquisition and divestiture activities could impact our business results. As a company that manages a portfolio of consumer brands, our ongoing business model involves a certain level of acquisition and divestiture activities. We must be able to successfully manage the impacts of these activities, while at the same time delivering against base business objectives. Specifically, our financial results could be adversely impacted if: 1) we are not able to deliver the expected cost and growth synergies associated with our acquisitions, 2) changes in the cash flows or other market-based assumptions cause the value of acquired assets to fall below book value or 3) we are unable to offset the dilutive impacts from the loss of revenue streams associated with divested brands. Our business is subject to legislation, regulation and enforcement in the U.S. and abroad. Changes in laws, regulations and the related interpretations, as well as changes in accounting standards, taxation requirements and increased enforcement actions and penalties may alter the environment in which we do business. Accordingly, our ability to manage regulatory, tax and legal matters (including product liability, patent, and other intellectual property matters), and to resolve pending legal matters without significant liability may materially impact our results of operations and financial position. Furthermore, the competition law and antitrust investigations described in Part II, Item 1 of this Form 10-Q, in total, may result in fines or costs in excess of the amounts accrued to date that could materially impact our results of operations and financial position. Moreover, as a U.S. based multinational company we are subject to tax regulations in the U.S. and multiple foreign jurisdictions, some of which are interdependent. For example, certain income that is earned and taxed in countries outside the U.S. is not taxed in the U.S., provided those earnings are indefinitely reinvested outside the U.S. If these or other tax regulations should change, our financial results could be impacted. A material change in customer relationships or in customer demand for our products could have a significant impact on our business. Our success is dependent on our ability to successfully manage relationships with our retail trade customers. This includes our ability to offer trade terms that are acceptable to our customers and are aligned with our pricing and profitability targets. Our business could suffer if we cannot reach agreement with a key customer based on our trade terms and principles. Further, retail trade consolidation could create significant cost and margin pressure and lead to more complex work across broader geographic boundaries for both us and key retailers. This can be particularly difficult when major customers are addressing local trade pressures or local law and regulation changes. In addition, our business would be negatively impacted if a key customer were to significantly reduce the range or inventory level of our products. We face risks related to changes in the global economic environment. 22 Our business is impacted by global economic conditions, which are increasingly volatile. If the global economy experiences significant disruptions, our business could be negatively impacted by reduced demand for our products related to a slow-down in the general economy, supplier or customer disruptions resulting from tighter credit markets, temporary interruptions in our ability to conduct day-to-day transactions through our financial intermediaries involving the payment to or collection of funds from our customers, vendors and suppliers and/or liquidity issues resulting from an inability to access credit markets to obtain cash to support operations. We could also be negatively impacted by an economic crisis in individual countries or regions, including sovereign risk related to a deterioration in the credit worthiness or a default by local governments. Such events could negatively impact our overall liquidity, as well as our ability to collect receipts due from governments, including refunds of value added taxes, and/or create significant credit risks relative to our local customers and depository institutions. A failure of a key information technology system, process or site could have a material adverse impact on our business or reputation. We rely extensively on information technology systems, including email and internet sites, as well as hardware, software and other applications, some of which are managed, hosted, or used by third-parties, to conduct our business. The various uses of these systems include, but are not limited to, ordering and managing materials from suppliers, converting materials to finished products, shipping product to customers, marketing and selling products to consumers, collecting and storing customer, consumer, employee, and research information, processing transactions, summarizing and reporting results of operations, sharing confidential information, complying with regulatory, legal or tax requirements, providing data security, and other processes necessary to manage our business. If our systems are damaged or cease to function properly, or if we suffer a loss or disclosure of business or stakeholder information, due to any number of causes, ranging from catastrophic events to power outages to security breaches, and our business continuity plans do not effectively compensate on a timely basis, we may suffer interruptions in our ability to manage operations and reputational, competitive and/or business harm, which may adversely impact our results of operations and/or financial condition. Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. ISSUER PURCHASES OF EQUITY SECURITIES Period Total Number of Shares Purchased (1) Average Price Paid per Share (2) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (3) Approximate Dollar Value of Shares That May Yet Be Purchased Under our Share Repurchase Program ($ in billions) 7/1/2011 - 7/31/2011 24,017,466 $64.52 19,386,127 8/1/2011 - 8/31/2011 24,654 $61.54  See Note 3 9/1/2011 - 9/30/2011 1,118 $61.46  (1) The total number of shares purchased was 24,043,238 for the quarter. This includes 25,772 shares acquired by the Company under various compensation and benefit plans and 4,631,339 shares acquired by the Profit Sharing Trust. All transactions were made in the open market or pursuant to prepaid forward agreements with large financial institutions. Under these agreements, the Company prepays large financial institutions to deliver shares at future dates in exchange for a discount. This table excludes shares withheld from employees to satisfy minimum tax withholding requirements on option exercises and other equity-based transactions. The Company administers cashless exercises through an independent, third party and does not repurchase stock in connection with cashless exercise. (2) Average price paid per share is calculated on a settlement basis and excludes commission. (3) On October 27, 2011, the Company stated that fiscal year 2011-12 share repurchases to reduce Company shares outstanding are estimated to be approximately $4 billion to $6 billion, notwithstanding any purchases under the Company's compensation and benefit plans. Purchases may be made in the open market and/or private transactions and purchases may be increased, decreased or discontinued at any time without prior notice. The share repurchases are authorized pursuant to a resolution issued by the Company's Board of Directors and is expected to be financed by issuing a combination of long-term and short-term debt. Item 6. Exhibits 23 3-1 Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October 11, 2011). 3-2 Regulations (as amended by the Board of Directors on April 18, 2010 pursuant to authority granted by shareholders at the annual meeting on October 13, 2009). (Incorporated by reference to Exhibit 3.ii of the Companys Form 8-K filed on April 22, 2010). 10-1 Summary of the Company's Short Term Achievement Reward Program.* 10-2 Summary of Personal Benefits Available to Certain Officers and Non-employee Directors.* 11 Computation of Earnings per Share. 12 Computation of Ratio of Earnings to Fixed Charges. 31.1",12902
2011-11-01,8-K,0000080424-11-000045,"pringlestransactiontiming.htm SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On November 1, 2011, The Procter & Gamble Company (the ""Company"") issued a press release announcing that the timing of the Pringles transaction with Diamond Foods, Inc. has moved from the front half to the back half of its fiscal year. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",173
2011-11-03,8-K,0000080424-11-000047,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4)) ITEM 7.01 REGULATION FD DISCLOSURE On November 3, 2011, The Procter & Gamble Company (the ""Company"") issued a press release updating the Company's guidance. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",150
2012-01-10,8-K,0000080424-12-000002,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On January 10, 2012, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of fifty-two point five cents ($0.525) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after February 15, 2012 to Common Stock and Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the close of business on January 20, 2012. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",214
2012-01-17,8-K,0000080424-12-000004,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE The Procter & Gamble Company (the ""Company"") changed its segment reporting structure during the quarter ended December 31, 2011. This Form 8-K provides pro forma historical segment results for the three months ended September 30, 2011, December 31, 2010, and September 30, 2010, as well as for the six months ended December 31, 2010 reflecting the change in the reporting structure of the Company. This information in no way revises or restates the Consolidated Statement of Earnings, Consolidated Balance Sheet, Consolidated Statement of Shareholders' Equity or Consolidated Statements of Cash Flows for the Company and consolidated subsidiaries for any period. Fiscal Year 2012 Changes to Global Business Unit (GBU) Structure Effective during the quarter ended December 31, 2011, we implemented a number of changes to our organization structure within the Beauty & Grooming GBU, which resulted in changes to the components of the Beauty reportable segment and the Grooming reportable segment. These two segments transitioned from consumer-oriented to product-oriented segment breakouts. As a result, female blades and razors transitioned from Beauty to Grooming, while Old Spice and Gillette male personal care products moved from Grooming to Beauty. The above changes will be reflected in the consolidated financial statements and segment reporting beginning in fiscal year 2012, starting with the Form 10-Q for the three months ended December 31, 2011. In advance of the Form 10-Q filing, this document provides pro forma consolidated earnings information and quarterly sales and profit information for the affected segments for the three months ended September 30, 2011, December 31, 2010, and September 30, 2010, as well as for the six months ended December 31, 2010. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Consolidated Earnings Information Three Months Ended September 30, 2010 Fabric Care and Home Care Baby Care and Family Care THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Consolidated Earnings Information Three Months Ended December 31, 2010 Fabric Care and Home Care Baby Care and Family Care THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Consolidated Earnings Information Six Months Ended December 31, 2010 Fabric Care and Home Care Baby Care and Family Care THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Consolidated Earnings Information Three Months Ended September 30, 2011 Fabric Care and Home Care Baby Care and Family Care This 8-K is furnished pursuant to Item 7.01 ""Regulation FD Disclosure"".",503
2012-01-27,8-K,0000080424-12-000011,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On January 27, 2012, The Procter & Gamble Company (the ""Company"") issued a press release announcing its second quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",183
2012-01-27,8-K,0000080424-12-000009,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) ( Registrant's telephone number, including area code ) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 27, 2012, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended December 31, 2011. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",159
2012-01-27,10-Q,0000080424-12-000015,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark one) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 31, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-434 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 31-0411980 (State of Incorporation) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) (513) 983-1100 (Registrants telephone number, including area code) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No o Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Large accelerated filer  Accelerated filer o Non-accelerated filer o Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No  There were 2,754,399,314 shares of Common Stock outstanding as of December 31, 2011. PART I. FINANCIAL INFORMATION Item I. Financial Statements. The Consolidated Statements of Earnings of The Procter & Gamble Company and subsidiaries (the Company, ""Procter & Gamble"", we or our) for the three months and six months ended December 31, 2011 and 2010, the Consolidated Balance Sheets as of December 31, 2011 and June 30, 2011, and the Consolidated Statements of Cash Flows for the six months ended December 31, 2011 and 2010 follow. In the opinion of management, these unaudited Consolidated Financial Statements contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, such financial statements may not necessarily be indicative of annual results. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS Three Months Ended December 31 Six Months Ended December 31 Amounts in millions except per share amounts 2011 2010 2011 2010 Net Sales $ 22,135 $ 21,347 $ 44,052 $ 41,469 Cost of products sold 11,125 10,287 22,186 19,976 Selling, general and administrative expense 6,717 6,800 13,239 12,732 Goodwill and indefinite lived intangibles impairment charges 1,554  1,554  Operating Income 2,739 4,260 7,073 8,761 Interest expense 201 209 408 417 Other non-operating income/(expense), net 170 39 171 67 Earnings Before Income Taxes 2,708 4,090 6,836 8,411 Income taxes 995 728 2,066 1,929 Net Earnings $ 1,713 $ 3,362 $ 4,770 $ 6,482 Less: Net earnings attributable to noncontrolling interests $ 23 $ 29 $ 56 $ 68 Net Earnings Attributable to Procter & Gamble $ 1,690 $ 3,333 $ 4,714 $ 6,414 Per Common Share Basic net earnings (1) $ 0.59 $ 1.17 $ 1.67 $ 2.24 Diluted net earnings (1) 0.57 1.11 1.60 2.13 Dividends $ 0.5250 $ 0.4818 $ 1.0500 $ 0.9636 Diluted Weighted Average Common Shares Outstanding 2,949.7 3,000.2 2,946.5 3,013.0 (1) Basic net earnings per share and diluted net earnings per share are calculated on net earnings attributable to Procter & Gamble See accompanying Notes to Consolidated Financial Statements 2 THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS Amounts in millions December 31, 2011 June 30, 2011 ASSETS CURRENT ASSETS Cash and cash equivalents $ 4,414 $ 2,768 Accounts receivable 6,905 6,275 Inventories Materials and supplies 2,053 2,153 Work in process 709 717 Finished goods 4,682 4,509 Total inventories 7,444 7,379 Deferred income taxes 1,096 1,140 Prepaid expenses and other current assets 3,792 4,408 TOTAL CURRENT ASSETS 23,651 21,970 PROPERTY, PLANT AND EQUIPMENT Buildings 7,430 7,753 Machinery and equipment 32,042 32,820 Land 899 934 Total property, plant and equipment 40,371 41,507 Accumulated depreciation (19,999 ) (20,214 ) NET PROPERTY, PLANT AND EQUIPMENT 20,372 21,293 GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill 54,307 57,562 Trademarks and other intangible assets, net 31,325 32,620 NET GOODWILL AND OTHER INTANGIBLE ASSETS 85,632 90,182 OTHER NONCURRENT ASSETS 4,656 4,909 TOTAL ASSETS $ 134,311 $ 138,354 LIABILITIES AND SHAREHOLDERS EQUITY CURRENT LIABILITIES Accounts payable $ 6,735 $ 8,022 Accrued and other liabilities 8,939 9,290 Debt due within one year 14,118 9,981 TOTAL CURRENT LIABILITIES 29,792 27,293 LONG-TERM DEBT 19,270 22,033 DEFERRED INCOME TAXES 11,133 11,070 OTHER NONCURRENT LIABILITIES 9,216 9,957 TOTAL LIABILITIES 69,411 70,353 SHAREHOLDERS EQUITY Preferred stock 1,217 1,234 Common stock  shares issued  31-Dec 4,008.2 4,008 30-Jun 4,007.9 4,008 Additional paid-in capital 62,879 62,405 Reserve for ESOP debt retirement (1,359 ) (1,357 ) Accumulated other comprehensive income (loss) (6,374 ) (2,054 ) Treasury stock (68,481 ) (67,278 ) Retained earnings 72,407 70,682 Noncontrolling interest 603 361 TOTAL SHAREHOLDERS EQUITY 64,900 68,001 TOTAL LIABILITIES AND SHAREHOLDERS EQUITY $ 134,311 $ 138,354 See accompanying Notes to Consolidated Financial Statements 3 THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS Six Months Ended December 31 Amounts in millions 2011 2010 CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD $ 2,768 $ 2,879 OPERATING ACTIVITIES Net earnings 4,770 6,482 Depreciation and amortization 1,456 1,400 Share-based compensation expense 168 180 Deferred income taxes 32 142 (Gain)/loss on sale of businesses (187 ) (3 ) Goodwill and indefinite lived intangibles impairment charges 1,554  Changes in: Accounts receivable (1,079 ) (931 ) Inventories (497 ) (779 ) Accounts payable, accrued and other liabilities (1,009 ) (377 ) Other operating assets and liabilities 230 (671 ) Other 57 (67 ) TOTAL OPERATING ACTIVITIES 5,495 5,376 INVESTING ACTIVITIES Capital expenditures (1,780 ) (1,256 ) Proceeds from asset sales 238 22 Acquisitions, net of cash acquired 2 (435 ) Change in investments 71 128 TOTAL INVESTING ACTIVITIES (1,469 ) (1,541 ) FINANCING ACTIVITIES Dividends to shareholders (3,013 ) (2,834 ) Change in short-term debt 2,416 948 Additions to long-term debt 1,990 1,536 Reductions of long-term debt (2,514 ) (160 ) Treasury stock purchases (1,764 ) (3,528 ) Impact of stock options and other 589 463 TOTAL FINANCING ACTIVITIES (2,296 ) (3,575 ) EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS (84 ) 110 CHANGE IN CASH AND CASH EQUIVALENTS 1,646 370 CASH AND CASH EQUIVALENTS, END OF PERIOD $ 4,414 $ 3,249 See accompanying Notes to Consolidated Financial Statements 4 THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 1. These statements should be read in conjunction with the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2011. The results of operations for the three-month and six-month periods ended December 31, 2011 are not necessarily indicative of annual results. 2. Comprehensive Income - Total comprehensive income is comprised primarily of net earnings, net currency translation gains and losses, impacts of net investment and cash flow hedges, net unrealized gains and losses on investment securities and defined benefit and other retiree benefit plan activities. Total comprehensive income for the three months ended December 31, 2011 and 2010 was $334 million and $3,013 million , respectively. For the six months ended December 31, 2011 and 2010, total comprehensive income was $450 million and $8,948 million , respectively. 3. Segment Information - Effective during the quarter ended December 31, 2011, we implemented a number of changes to the organization structure of the Beauty and Grooming GBU, which resulted in changes to the components of our reportable segment structure. Female blades and razors were formerly included in the Beauty reportable segment and are now included in the Grooming reportable segment. Certain male-focused brands and businesses, such as Old Spice and Gillette personal care, moved from the Grooming reportable segment to the Beauty reportable segment. These changes have been reflected in our segment reporting for all periods presented. Following is a summary of segment results. Three Months Ended December 31 Six Months Ended December 31 Amounts in millions Net Sales Earnings Before Income Taxes Net Earnings attributable to Procter & Gamble Net Sales Earnings Before Income Taxes Net Earnings attributable to Procter & Gamble Beauty 2011 $ 5,353 $ 1,014 $ 802 $ 10,668 $ 1,942 $ 1,485 2010 5,279 1,112 872 10,141 2,130 1,651 Grooming 2011 2,202 692 517 4,370 1,331 1,003 2010 2,175 664 506 4,140 1,251 954 Health Care 2011 3,183 784 537 6,474 1,584 1,079 2010 3,138 779 531 6,122 1,520 1,026 Snacks and Pet Care 2011 824 95 61 1,600 185 123 2010 798 93 67 1,507 170 121 Fabric Care and Home Care 2011 6,605 1,151 717 13,286 2,414 1,522 2010 6,308 1,165 758 12,605 2,582 1,695 Baby Care and Family Care 2011 4,162 816 516 8,241 1,608 1,010 2010 3,930 802 502 7,582 1,551 972 Corporate 2011 (194 ) (1,844 ) (1,460 ) (587 ) (2,228 ) (1,508 ) 2010 (281 ) (525 ) 97 (628 ) (793 ) (5 ) Total 2011 22,135 2,708 1,690 44,052 6,836 4,714 2010 21,347 4,090 3,333 41,469 8,411 6,414 4. Goodwill and Other Intangible Assets - Goodwill as of December 31, 2011, is allocated by reportable segment as follows (amounts in millions): Beauty Grooming Health Care Snacks and Pet Care Fabric Care and Home Care Baby Care and Family Care Corporate Total Company GOODWILL at JUNE 30, 2011 $ 18,039 $ 22,650 $ 8,179 $ 2,243 $ 4,589 $ 1,553 $ 309 $ 57,562 Acquisitions and divestitures (1 ) (4 ) 417  (1 )   411 Goodwill Impairment charges (433 ) (875 )      (1,308 ) Translation and other (959 ) (877 ) (257 ) (14 ) (169 ) (82 )  (2,358 ) GOODWILL at DECEMBER 31, 2011 $ 16,646 $ 20,894 $ 8,339 $ 2,229 $ 4,419 $ 1,471 $ 309 $ 54,307 During the second quarter of fiscal 2012, we changed our annual goodwill impairment testing date from July 1 to October 1 of 5 each year. This change was made to better align the timing of our annual impairment testing with the timing of the Company's annual strategic planning process. We believe this change is preferable because it allows us to more efficiently utilize the reporting units' long-term financial projections, which are generated from the annual strategic planning process, as the basis for performing our annual impairment testing. This change does not result in any delay, acceleration or avoidance of impairment, nor does this change result in adjustments to previously issued financial statements. This change was applied prospectively beginning on October 1, 2011; retrospective application to prior periods is impracticable as the Company is unable to objectively determine, without the use of hindsight, the assumptions that would have been used in those earlier periods. We also test our indefinite lived intangibles for impairment during the second fiscal quarter of each year, and accordingly performed this testing during the quarter ended December 31, 2011. We tested goodwill for impairment as of July 1, 2011 (the testing date under our previous policy) and no impairments were indicated. Our goodwill impairment testing as of October 1, 2011 (the testing date under our new policy) determined that certain goodwill amounts were impaired. Specifically, the results of our annual impairment testing during the quarter ended December 31, 2011, indicated that the estimated fair values of our Appliances and Salon Professional reporting units were less than their respective carrying amounts. The test to evaluate goodwill for impairment is a two step process. In the first step, we compare the fair value of each reporting unit to its carrying value. If the fair value of any reporting unit is less than its carrying value, we perform a second step to determine the implied fair value of the reporting unit's goodwill. The second step of the impairment analysis requires a valuation of a reporting unit's tangible and intangible assets and liabilities in a manner similar to the allocation of purchase price in a business combination. If the resulting implied fair value of the reporting unit's goodwill is less than its carrying value, that difference represents an impairment. As a result of our impairment testing, we recorded an estimated noncash before and after tax impairment charge of $1,308 million to reduce the carrying amount of goodwill for these units to estimated fair value- $875 million related to Appliances and $433 million related to Salon Professional. Following the impairment charges, the carrying values of the goodwill of Appliances and Salon Professional were $638 million and $420 million , respectively. Our impairment testing for indefinite lived intangible assets during the quarter ended December 31, 2011, also indicated a decline in the fair value of our Koleston Perfect and Wella trade name intangible assets below their respective carrying values. This resulted in a noncash before tax impairment charge of $246 million ( $173 million after tax) to reduce the carrying amounts of these assets to their respective fair values. Following the impairment charges, the carrying values of the Koleston Perfect and Wella trade names were $308 million and $605 million , respectively. To determine the fair value of our reporting units and indefinite lived intangibles, we use a discounted cash flow (DCF) approach, which we believe is the most reliable indicator of fair value of the business, and is most consistent with the approach a market-place participant would use. Under this approach, we estimate the future cash flows of the respective reporting units and indefinite lived intangible assets and discount those cash flows at a rate of return that reflects the relative risk of each business. The declines in the fair value of the Appliances and Salon Professional reporting units and the underlying Koleston Perfect and Wella trade name intangibles were driven by a combination of similar competitive and economic factors, which are resulting in a reduction in the forecasted growth rates and cash flows used to estimate fair value. These factors include; (1) A more prolonged and deeper deterioration of the macroeconomic environment than was previously expected which, due to the more discretionary nature of the Appliances and Salon Professional businesses, is leading to a reduction in the overall market size in the short term and a more significant and prolonged reduction in the expected underlying market growth rates and resulting sales levels in the longer term. This is particularly evident in Europe, which is where we have historically generated a majority of the Appliances and Salon Professional sales. (2) Increasing competitive levels of innovation in Salon Professional is negatively impacting our current and nearer-term projected market share progress. (3) An increasing level of competitive pricing activities is negatively impacting pricing levels and lowering overall category profitability. As a result of these factors, we have recently reduced our current and longer-term sales and earnings forecasts for these businesses. All of the impairment charges are included in Corporate for segment reporting. The second step of the goodwill impairment evaluations have not yet been finalized. Accordingly, the impairments recorded during the quarter ended December 31, 2011, are based on preliminary estimates. We expect to finalize these impairment evaluations during the quarter ended March 31, 2012. Any potential adjustments to the Company's preliminary estimates as a result of completing these evaluations, which could be significant, will be recorded in our consolidated financial statements when finalized. The goodwill and intangible asset valuations are dependent on a number of significant estimates and assumptions, including macroeconomic conditions, overall category growth rates, competitive activities, cost containment and margin expansion, and Company business plans. We believe these estimates and assumptions are reasonable. However, actual events and results could differ substantially from those used in our valuation. To the extent such factors result in a failure to achieve the level of projected cash flows used in our valuations, we may need to record additional non cash impairment charges in the future. 6 In addition to the impairment charges, goodwill also decreased from June 30, 2011, due to currency translation across reportable segments and the divestiture of PUR, the water filtration brand, in our Health Care reportable segment. These decreases were partially offset by the establishment of goodwill related to the previously disclosed business combination with Teva Pharmaceuticals Industries in our Health Care reportable segment. Identifiable intangible assets as of December 31, 2011, are comprised of (amounts in millions): Gross Carrying Amount Accumulated Amortization Amortizable intangible assets with determinable lives $ 8,836 $ 4,351 Intangible assets with indefinite lives 26,840  Total identifiable intangible assets $ 35,676 $ 4,351 Amortizable intangible assets consist principally of brands, patents, technology and customer relationships. The intangible assets with indefinite lives consist primarily of brands. The amortization of intangible assets for the three months ended December 31, 2011 and 2010 was $123 million and $132 million , respectively. For the six months ended December 31, 2011 and 2010, the amortization of intangible assets was $251 million and $272 million , respectively. 5. Share-Based Compensation - Pursuant to applicable accounting guidance for share-based payments, companies must recognize the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of those awards. Total share-based compensation for the three months and six months ended December 31, 2011 and 2010 are summarized in the following table (amounts in millions): Three Months Ended December 31 Six Months Ended December 31 2011 2010 2011 2010 Share-Based Compensation Stock options $ 76 $ 85 $ 138 $ 153 Other share-based awards 12 8 30 27 Total share-based compensation $ 88 $ 93 $ 168 $ 180 Assumptions utilized in the model are evaluated and revised, as necessary, to reflect market conditions and experience. 6. Postretirement Benefits - The Company offers various postretirement benefits to its employees. The components of net periodic benefit cost for defined benefit plans are as follows: Pension Benefits Other Retiree Benefits Three Months Ended December 31 Three Months Ended December 31 Amounts in millions 2011 2010 2011 2010 Service cost $ 63 $ 64 $ 35 $ 35 Interest cost 152 144 69 66 Expected return on plan assets (142 ) (122 ) (108 ) (107 ) Amortization of deferred amounts 5 5 (5 ) (5 ) Recognized net actuarial loss 26 38 24 23 Gross benefit cost (credit) 104 129 15 12 Dividends on ESOP preferred stock   (18 ) (19 ) Net periodic benefit cost (credit) $ 104 $ 129 $ (3 ) $ (7 ) 7 Pension Benefits Other Retiree Benefits Six Months Ended December 31 Six Months Ended December 31 Amounts in millions 2011 2010 2011 2010 Service cost $ 130 $ 126 $ 71 $ 70 Interest cost 309 284 138 131 Expected return on plan assets (288 ) (241 ) (216 ) (215 ) Amortization of deferred amounts 11 9 (10 ) (10 ) Recognized net actuarial loss 52 75 49 47 Gross benefit cost (credit) 214 253 32 23 Dividends on ESOP preferred stock   (37 ) (39 ) Net periodic benefit cost (credit) $ 214 $ 253 $ (5 ) $ (16 ) For the year ending June 30, 2012, the expected return on plan assets is 7.4% and 9.2% for defined benefit and other retiree benefit plans, respectively. 7. Risk Management Activities and Fair Value Measurements As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. For details on the Companys risk management activities and fair value measurement policies under the fair value hierarchy, refer to the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2011. Fair Value Hierarchy The Company has not changed its valuation techniques in measuring the fair value of any financial assets and liabilities during the period. The following table sets forth the Companys financial assets and liabilities as of December 31 and June 30, 2011 that are measured at fair value on a recurring basis during the period, segregated by level within the fair value hierarchy: Level 1 Level 2 Level 3 Total Amounts in millions December 31, 2011 June 30, 2011 December 31, 2011 June 30, 2011 December 31, 2011 June 30, 2011 December 31, 2011 June 30, 2011 Assets at fair value: Investment securities $ 7 $ 16 $  $  $ 22 $ 23 $ 29 $ 39 Derivatives relating to: Foreign currency hedges    1    1 Other foreign currency instruments (1)   30 182   30 182 Interest rates   275 163   275 163 Net investment hedges   6    6  Commodities   1 4   1 4 Total assets at fair value (2) 7 16 312 350 22 23 341 389 Liabilities at fair value: Derivatives relating to: Foreign currency hedges   169 119   169 119 Other foreign currency instruments (1)   272 43   272 43 Net investment hedges   70 138   70 138 Commodities    1    1 Total liabilities at fair value (3)   511 301   511 301 (1) Other foreign currency instruments are comprised of foreign currency financial instruments that do not qualify as hedges. (2) Investment securities are presented in other noncurrent assets and all derivative assets are presented in prepaid 8 expenses and other current assets or other noncurrent assets. (3) All liabilities are presented in accrued and other liabilities or other noncurrent liabilities. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each quarter. There was no significant activity within the Level 3 assets and liabilities during the periods presented. Except for the goodwill and intangible assets discussed in Note 4, there were no assets or liabilities that were re-measured at fair value on a non-recurring basis during the periods presented. Certain of the Companys financial instruments used in hedging transactions are governed by industry standard netting agreements with counterparties. If the Companys credit rating were to fall below the levels stipulated in the agreements, the counterparties could demand either collateralization or termination of the arrangement. The aggregate fair value of the instruments covered by these contractual features that are in a net liability position as of December 31, 2011 was $377 million . The Company has never been required to post any collateral as a result of these contractual features. Fair Values of Other Financial Instruments Other financial instruments, including cash equivalents, other investments and short-term debt, are recorded at cost, which approximates fair value. The fair value of the long-term debt was $21,950 million and $23,418 million at December 31 and June 30, 2011, respectively. Disclosures about Derivative Instruments The notional amounts and fair values of qualifying and non-qualifying financial instruments used in hedging transactions as of December 31 and June 30, 2011 are as follows: Notional Amount Fair Value Asset (Liability) Amounts in Millions December 31, 2011 June 30, 2011 December 31, 2011 June 30, 2011 Derivatives in Cash Flow Hedging Relationships Interest rate contracts $  $  $  $  Foreign currency contracts 831 831 (169 ) (118 ) Commodity contracts 27 16 1 4 Total 858 847 (168 ) (114 ) Derivatives in Fair Value Hedging Relationships Interest rate contracts 8,852 10,308 275 163 Derivatives in Net Investment Hedging Relationships Net investment hedges 1,809 1,540 (64 ) (138 ) Derivatives Not Designated as Hedging Instruments Foreign currency contracts 13,811 14,957 (242 ) 139 Commodity contracts 16 39  (1 ) Total 13,827 14,996 (242 ) 138 The total notional amount of contracts outstanding at the end of the period is indicative of the level of the Companys derivative activity during the period. Amount of Gain (Loss) Recognized in Accumulated OCI on Derivatives (Effective Portion) Amounts in Millions December 31, 2011 June 30, 2011 Derivatives in Cash Flow Hedging Relationships Interest rate contracts $ 13 $ 15 Foreign currency contracts 17 32 Commodity contracts 1 3 Total 31 50 Derivatives in Net Investment Hedging Relationships Net investment hedges (37 ) (88 ) 9 The effective portion of gains and losses on derivative instruments that was recognized in other comprehensive income (OCI) during the three and six months ended December 31, 2011 and 2010 was not material. During the next 12 months, the amount of the December 31, 2011 accumulated OCI balance that will be reclassified to earnings is expected to be immaterial. The amounts of gains and losses on qualifying and non-qualifying financial instruments used in hedging transactions for the three and six months ended December 31, 2011 and 2010 are as follows: Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (1) Three Months Ended December 31 Six Months Ended December 31 Amounts in Millions 2011 2010 2011 2010 Derivatives in Cash Flow Hedging Relationships Interest rate contracts $ 1 $ 2 $ 3 $ 4 Foreign currency contracts 18 (19 ) (27 ) (68 ) Commodity contracts  4 1 18 Total 19 (13 ) (23 ) (46 ) Amount of Gain (Loss) Recognized in Income Three Months Ended December 31 Six Months Ended December 31 Amounts in Millions 2011 2010 2011 2010 Derivatives in Fair Value Hedging Relationships (2) Interest rate contracts (19 ) (87 ) 112 (25 ) Debt 19 89 (114 ) 26 Total  2 (2 ) 1 Derivatives in Net Investment Hedging Relationships (2) Net investment hedges (5 ) (1 ) (8 ) (1 ) Derivatives Not Designated as Hedging Instruments (3) Foreign currency contracts (4) (410 ) (110 ) (991 ) 626 Commodity contracts  2 (1 ) 4 Total (410 ) (108 ) (992 ) 630 (1) The gain or loss on the effective portion of cash flow hedging relationships is reclassified from accumulated OCI into net income in the same period during which the related item affects earnings. Such amounts are included in the Consolidated Statements of Earnings as follows: interest rate contracts in interest expense, foreign currency contracts in selling, general and administrative expense and interest expense and commodity contracts in cost of products sold. (2) The gain or loss on the ineffective portion of interest rate contracts and net investment hedges, if any, is included in the Consolidated Statements of Earnings in interest expense. (3) The gain or loss on contracts not designated as hedging instruments is included in the Consolidated Statements of Earnings as follows: foreign currency contracts in selling, general and administrative expense and commodity contracts in cost of products sold. (4) The gain or loss on non-qualifying foreign currency contracts substantially offsets the foreign currency mark-to-market impact of the related exposure. 8. New Accounting Pronouncements and Policies Beginning with the quarter ended December 31, 2011, we elected to revise our Consolidated Statements of Earnings to present separately the net expense for earnings attributable to noncontrolling interests. As previously disclosed, this net expense has not historically been presented separately in the Consolidated Statements of Earnings due to immateriality, but has been reflected within other non-operating income/(expense). The historical Consolidated Statements of Earnings has been revised to conform to the new presentation, with a corresponding change to the ""net earnings"" line item in the Consolidated Statements of Cash Flows. This change did not impact our historically reported net earnings attributable to Procter & Gamble or the historical basic or diluted net earnings per share balances, nor did it impact total operating cash flows. However, it did impact certain amounts within those statements. The amount reclassified to net earnings attributable to noncontrolling interests for the 10 six months ended December 31, 2010, totaling $68 million , had an offsetting impact on other non-operating income/(expense) within the Consolidated Statement of Earnings and on ""changes in other operating assets and liabilitites"" within Operating Activities of the Consolidated Statement of Cash Flows. In connection with this change, we also made a change to prior year Consolidated Statement of Cash Flow amounts to appropriately classify dividends paid to noncontrolling interests. Such dividends had historically been included in ""changes in other operating assets and liabilities"" within Operating Activities of the Consolidated Statement of Cash Flows. These dividend payments ( $47 million for the six months ended December 31, 2010) were reclassified to ""impact of stock options and other"" within Financing Activities of the Consolidated Statement of Cash Flows. The above changes were made in order to provide additional transparency related to noncontrolling interests by segregating them from the ongoing operating activities attributable to shareholders of the company. No new accounting pronouncement issued or effective during the fiscal year had or is expected to have a material impact on the Consolidated Financial Statements. 9. Commitments and Contingencies Litigation We are subject to various legal proceedings and claims arising out of our business which cover a wide range of matters such as antitrust, trade and other governmental regulations, product liability, patent and trademark matters, income taxes and other actions. As previously disclosed, the Company is and has been subject to a variety of investigations into potential competition law violations in Europe. These matters involve a number of other consumer products companies and/or retail customers. The Companys policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with investigations by relevant regulatory authorities, which the Company is doing. Competition and antitrust law inquiries often continue for several years and, if violations are found, can result in substantial fines. In response to the actions of the regulatory authorities, the Company launched its own internal investigations into potential violations of competition laws. The Company has identified violations in certain European countries and appropriate actions were taken. Several regulatory authorities in Europe have issued separate complaints pursuant to their investigations alleging that the Company, along with several other companies, engaged in violations of competition laws in those countries. The remaining authorities' investigations are in various stages of the regulatory process. As a result of our initial and on-going analyses of the complaints, as well as a final decision issued during the quarter by authorities in France for a laundry detergent investigation, the Company has accrued liabilities for competition law violations totaling $335 million as of December 31, 2011. While the ultimate resolution of the matters for which we have accrued liabilities may result in fines or costs in excess of the amounts reserved, we do not expect any such incremental losses to materially impact our financial statements in the period in which they are accrued and paid, respectively. For our other remaining competition law matters, we cannot reasonably estimate any additional fines to which the Company may be subject as a result of the investigations. We will continue to monitor developments for all of these investigations and will record additional charges as appropriate. With respect to other litigation and claims, while considerable uncertainty exists, in the opinion of management and our counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows. We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will have a material adverse effect on our financial position, results of operations or cash flows. Income Tax Uncertainties The Company is present in over 150 taxable jurisdictions and, at any point in time, has 50  60 audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, 11 including progress of tax audits, developments in case law and closing of statute of limitations. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 2002 and forward. We are generally not able to reliably estimate the ultimate settlement amounts or timing until the close of the audit. While we do not expect material changes, it is possible that the amount of unrecognized benefit with respect to our uncertain tax positions will significantly increase or decrease within the next 12 months related to audits described above. At this time, we are not able to make a reasonable estimate of the range of impact on the balance of uncertain tax positions or the impact on the effective tax rate related to these items. Additional information on the Commitments and Contingencies of the Company can be found in Note 10, Commitments and Contingencies, which appears in the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2011. Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations The purpose of this discussion is to provide an understanding of Procter & Gambles financial results and condition by focusing on changes in certain key measures from year to year. Managements Discussion and Analysis (MD&A) is organized in the following sections:  Overview  Summary of Results  Forward-Looking Statements  Results of Operations  Three Months Ended December 31, 2011  Results of Operations  Six Months Ended December 31, 2011  Business Segment Discussion  Three and Six Months Ended December 31, 2011  Financial Condition  Reconciliation of Non-GAAP Measures Throughout MD&A, we refer to measures used by management to evaluate performance, including unit volume growth, net sales and net earnings. We also refer to a number of financial measures that are not defined under accounting principles generally accepted in the United States of America (U.S. GAAP), including organic sales growth, free cash flow and free cash flow productivity. Organic sales growth is net sales growth excluding the impacts of foreign exchange, acquisitions and divestitures. Free cash flow is operating cash flow less capital spending. Free cash flow productivity is the ratio of free cash flow to net earnings. We believe these measures provide investors with important information that is useful in understanding our business results and trends. The explanation at the end of MD&A provides more details on the use and the derivation of these measures. Management also uses certain market share and market consumption estimates to evaluate performance relative to competition despite some limitations on the availability and comparability of share and consumption information. References to market share and market consumption in MD&A are based on a combination of vendor-reported consumption and market size data, as well as internal estimates. All market share references represent the percentage of sales in dollar terms on a constant currency basis of our products, relative to all product sales in the category. OVERVIEW The purpose of our business is to provide branded consumer packaged goods of superior quality and value to our consumers around the world. This will enable us to execute our Purpose-inspired growth strategy: to touch and improve more consumers' lives, in more parts of the world, more completely. We believe this will result in leadership sales, earnings and value creation, allowing employees, shareholders and the communities in which we operate to prosper. Our products are sold in more than 180 countries primarily through mass merchandisers, grocery stores, membership club stores, drug stores and high-frequency stores, the neighborhood stores which serve many consumers in developing markets. We continue to expand our presence in other channels, including department stores, perfumeries, pharmacies, salons and e-commerce. We have on-the-ground operations in approximately 80 countries. Our market environment is highly competitive with global, regional and local competitors. In many of the markets and industry segments in which we sell our products, we compete against other branded products as well as retailers' private-label brands. Additionally, many of the product segments in which we compete are differentiated by price (referred to as super-premium, premium, mid-tier and value-tier products). We are well positioned in the industry segments and markets in which we operate-often holding a leadership or significant market share position. Effective during the quarter ended December 31, 2011, we implemented a number of changes to the organization structure of 12 the Beauty GBU, which resulted in changes to the components of our reportable segment structure. Female blades and razors were formerly included in the Beauty reportable segment and are now included in the Grooming reportable segment. Certain male-focused brands and businesses, such as Old Spice and Gillette personal care, moved from the Grooming reportable segment to the Beauty reportable segment. These changes have been reflected in our segment reporting for all periods presented. The table below provides more information about the components of our reportable business segment structure. Reportable Segment Categories Billion Dollar Brands Beauty Antiperspirant and Deodorant, Cosmetics, Hair Care, Hair Color, Hair Styling, Personal Cleansing, Prestige Products, Salon Professional, Skin Care Head & Shoulders, Olay, Pantene, Wella Grooming Blades and Razors, Electronic Hair Removal Devices, Shave Products, Home Small Appliances Braun, Fusion, Gillette, Mach3 Health Care Feminine Care, Gastrointestinal, Incontinence, Rapid Diagnostics, Respiratory, Toothbrush, Toothpaste, Other Oral Care Always, Crest, Oral-B Snacks and Pet Care Pet Care, Snacks Iams, Pringles Fabric Care and Home Care Air Care, Batteries, Dish Care, Fabric Enhancers, Laundry Additives, Laundry Detergents, Surface Care Ace, Ariel, Dawn, Downy, Duracell, Gain, Tide, Febreze Baby Care and Family Care Baby Wipes, Diapers, Paper Towels, Tissues, Toilet Paper Bounty, Charmin, Pampers The following table provides the percentage of net sales and net earnings by reportable business segment for the three months ended December 31, 2011 (excludes net sales and net earnings in Corporate): Three Months Ended December 31 Net Sales Net Earnings Beauty 24 % 26 % Grooming 10 % 16 % Health Care 14 % 17 % Snacks and Pet Care 4 % 2 % Fabric Care and Home Care 29 % 23 % Baby Care and Family Care 19 % 16 % Total 100 % 100 % The following table provides the percentage of net sales and net earnings by reportable business segment for the six months ended December 31, 2011 (excludes net sales and net earnings in Corporate): Six Months Ended December 31 Net Sales Net Earnings Beauty 24 % 24 % Grooming 10 % 16 % Health Care 14 % 17 % Snacks and Pet Care 4 % 2 % Fabric Care and Home Care 30 % 25 % Baby Care and Family Care 18 % 16 % Total 100 % 100 % SUMMARY OF RESULTS 13 Following are highlights of results for the six months ended December 31, 2011 versus the six months ended December 31, 2010:  Net sales increased 6% to $44.1 billion. Organic sales, which exclude the impacts of acquisitions, divestitures and foreign exchange, were up 4%.  Unit volume grew 1%, with low single digit growth for Beauty, Health, Grooming, Snacks and Pet Care, and Baby Care and Family Care.  Net earnings attributable to Procter & Gamble were $4.7 billion, a decrease of 27% versus the prior year period as sales growth was more than offset by non-core charges and gross margin contraction. The non-core charges included $1.6 billion of before tax non-cash goodwill and intangible assets impairment charges associated with the Appliances and Salon Professional businesses. The decline in gross margin was driven primarily by higher commodity costs.  Diluted net earnings per share decreased 25% to $1.60. Earnings per share decline is different from net earnings decline due to the impact of share repurchase activity.  Operating cash flow for fiscal year to date increased 2% to $5.5 billion. Free cash flow, which is operating cash flow less capital expenditures, was $3.7 billion. Free cash flow productivity, which is the ratio of free cash flow to net earnings, was 78%. FORWARD-LOOKING STATEMENTS We discuss expectations regarding future performance, events and outcomes, such as our business outlook and objectives, in annual and quarterly reports, press releases and other written and oral communications. All such statements, except for historical and present factual information, are ""forward-looking statements,"" and are based on financial data and our business plans available only as of the time the statements are made, which may become out-of-date or incomplete. We assume no obligation to update any forward-looking statements as a result of new information, future events or other factors. Forward-looking statements are inherently uncertain and investors must recognize that events could be significantly different from our expectations. For more information on risks that could impact our results, refer to Part II, Item 1A Risk Factors in this Form 10-Q. Ability to Achieve Business Plans . We are a consumer products company and rely on continued demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers and retail trade customers. Our continued success is dependent on leading-edge innovation with respect to both products and operations, on the continued positive reputations of our brands and our ability to successfully maintain trademark protection. This means we must be able to obtain patents and trademarks, and respond to technological advances and patents granted to competition. Our success is also dependent on effective sales, advertising and marketing programs. Our ability to innovate and execute in these areas will determine the extent to which we are able to grow existing sales and volume profitably, especially with respect to the product categories and geographic markets (including developing markets) in which we have chosen to focus. There are high levels of competitive activity in the environments in which we operate. To address these challenges, we must respond to competitive factors, including pricing, promotional incentives, trade terms and product initiatives. We must manage each of these factors, as well as maintain mutually beneficial relationships with our key customers, in order to effectively compete and achieve our business plans. As a company that manages a portfolio of consumer brands, our ongoing business model involves a certain level of ongoing acquisition, divestiture and joint venture activities. We must be able to successfully manage the impacts of these activities, while at the same time delivering against base business objectives. Daily conduct of our business also depends on our ability to maintain key information technology systems, including systems operated by third-party suppliers, and to maintain security over our data. Cost Pressures . Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, labor costs, foreign exchange and interest rates. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects, sourcing decisions and certain hedging transactions. We also must manage our debt and currency exposure, especially in certain countries with currency exchange controls, such as Venezuela, China and India. We need to maintain key manufacturing and supply arrangements, including sole supplier and sole manufacturing plant arrangements, and successfully manage any disruptions at Company manufacturing sites. We must implement, achieve and sustain cost improvement plans, including our outsourcing projects and those related to general overhead and workforce optimization. Successfully managing these changes, including identifying, developing and retaining key employees, is critical to our success. Global Economic Conditions . Economic changes, terrorist activity, political unrest and natural disasters, such as the civil unrest in the Middle East and the impacts of the Japan earthquake and tsunami, may result in business interruption, inflation, deflation or decreased demand for our products. Our success will depend, in part, on our ability to manage continued global political and/or economic uncertainty, especially in our significant geographic markets, due to terrorist and other hostile activities or natural disasters. We could also be negatively impacted by a global, regional or national economic crisis, including 14 sovereign risk in the event of a deterioration in the credit worthiness of or a default by local governments, resulting in a disruption of credit markets. Such events could negatively impact our ability to collect receipts due from governments, including refunds of value added taxes, create significant credit risks relative to our local customers and depository institutions, and/or negatively impact our overall liquidity. Regulatory Environment . Changes in laws, regulations and the related interpretations may alter the environment in which we do business. This includes changes in environmental, competitive and product-related laws, as well as changes in accounting standards and taxation requirements. Our ability to manage regulatory, tax and legal matters (including product liability, patent, intellectual property, competition law matters and tax policy) and to resolve pending legal matters within current estimates may impact our results. RESULTS OF OPERATIONS  Three Months Ended December 31, 2011 The following discussion provides a review of results for the three months ended December 31, 2011 versus the three months ended December 31, 2010. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended December 31 2011 2010 % CHG NET SALES $ 22,135 $ 21,347 4 % COST OF PRODUCTS SOLD 11,125 10,287 8 % GROSS PROFIT 11,010 11,060  % SELLING GENERAL & ADMINISTRATIVE EXPENSE 6,717 6,800 (1 )% GOODWILL & INDEFINITE LIVED INTANGIBLE IMPAIRMENT CHARGES 1,554  OPERATING INCOME 2,739 4,260 (36 )% TOTAL INTEREST EXPENSE 201 209 OTHER NON-OPERATING INCOME/(EXPENSE), NET 170 39 EARNINGS BEFORE INCOME TAXES 2,708 4,090 (34 )% INCOME TAXES 995 728 NET EARNINGS 1,713 3,362 (49 )% LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS 23 29 (21 )% NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE 1,690 3,333 (49 )% EFFECTIVE TAX RATE 36.7 % 17.8 % PER COMMON SHARE: BASIC NET EARNINGS (1) $ 0.59 $ 1.17 (50 )% DILUTED NET EARNINGS (1) $ 0.57 $ 1.11 (49 )% DIVIDENDS $ 0.525 $ 0.4818 9 % AVERAGE DILUTED SHARES OUTSTANDING 2,949.7 3,000.2 (1) Basic net earnings per share and diluted net earnings per share are calculated on net earnings attributable to Procter & Gamble COMPARISONS AS A % OF NET SALES Basis Pt Chg GROSS MARGIN 49.7 % 51.8 % (210 ) SELLING, GENERAL & ADMINISTRATIVE EXPENSE 30.3 % 31.8 % (150 ) OPERATING MARGIN 12.4 % 20.0 % (760 ) EARNINGS BEFORE INCOME TAXES 12.2 % 19.2 % (700 ) NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE 7.6 % 15.6 % (800 ) 15 Net sales increased 4% to $22.1 billion for the October - December quarter on a 1% increase in unit volume. Volume was in line with the prior year or grew across all six of the business segments. Snacks and Pet Care, Beauty and Grooming grew volume low single digits. Health Care, Fabric Care and Home Care, and Baby Care and Family Care volume was in line with the prior year period. Volume grew high single digits in developing regions and was down mid-single digits in developed regions. Price increases added 4% to net sales, driven by price increases across all business segments and regions primarily to offset commodity cost increases and devaluing developing market currencies. Negative mix reduced net sales by 1% due mainly to disproportionate growth in developing regions and mid-tier value products, both of which have lower than Company average selling prices. Organic sales growth was 4% driven by unit volume growth and price increases, partially offset by the impact of unfavorable mix. Net Sales Change Drivers 2011 vs. 2010 (Three Months Ended Dec. 31) Volume with Acquisitions & Divestitures Volume Excluding Acquisitions & Divestitures Foreign Exchange Price Mix/Other Net Sales Growth Beauty 1 % 2 % 1 % 3 % -4 % 1 % Grooming 1 % 1 % 0 % 2 % -2 % 1 % Health Care 0 % 0 % 0 % 3 % -2 % 1 % Snacks and Pet Care 2 % 2 % 0 % 3 % -2 % 3 % Fabric Care and Home Care 0 % 0 % 0 % 6 % -1 % 5 % Baby Care and Family Care 0 % 0 % 0 % 6 % 0 % 6 % TOTAL COMPANY 1 % 1 % 0 % 4 % -1 % 4 % Net sales percentage changes are approximations based on quantitative formulas that are consistently applied. Gross margin contracted 210 basis points to 49.7% of net sales for the quarter. The reduction in gross margin was driven mainly by a 280 basis point impact from higher commodity and energy costs. Gross margin was also negatively impacted by over 200 basis points from negative product mix behind disproportionate growth in developing regions and mid-tier products. These impacts were partially offset by a 190 basis point impact from increased pricing, as well as manufacturing cost savings and the favorable impact of volume scale leverage. Total selling, general and administrative expenses (SG&A) decreased 1% to $6.7 billion, driven by a decrease in overhead spending, partially offset by an increase in marketing spending. Overhead spending decreased due to lower competition law fines, which declined from $305 million in the prior period to $66 million in the current period. Marketing spending increased primarily due to increased investments to support innovation and expansion plans. SG&A as a percentage of net sales decreased 150 basis points to 30.3%. Both overhead spending and marketing spending declined as a percentage of net sales due to scale leverage from an increase in net sales. During the quarter we recorded a total of $1,554 million ($1,481 million after tax), in non-cash impairment charges for goodwill and indefinite lived intangible assets. The charges related to the carrying values of goodwill in our Appliances and Salon Professional businesses and our Koleston Perfect and Wella indefinite lived intangible assets, which are part of our Salon Professional business. See Note 4 to our Consolidated Financial Statements for more details, including factors leading to the impairment charges. Since goodwill is included in Corporate for internal management and segment reporting, the goodwill impairment charges are included in the Corporate segment. With respect to the indefinite lived intangible assets, for management reporting purposes, the underlying impairment charges were excluded from business unit earnings and included in Corporate. Accordingly, these charges were also included in Corporate for segment reporting. Interest expense was $201 million for the quarter, down $8 million versus the prior year period due to lower interest rates on floating rate debt partially offset by an increase in debt outstanding. Other non-operating income/(expense) increased $131 million mainly behind the divestiture gain from our PUR business. The effective tax rate on continuing operations increased 1,890 basis points to 36.7% primarily as a result of 1) a 1,170 basis points impact from non-deductibility of the impairment charges in the current year period and 2) the net impact of favorable discrete adjustments related to uncertain income tax positions (which netted to 930 basis points in the prior year and 170 basis points in the current year). These impacts were partially offset by an 80 basis point benefit from non-taxable divestiture gains in the current year period. Net earnings attributable to Procter & Gamble decreased 49% to $1.7 billion for the quarter as the net sales increase was more than offset by operating margin contraction. Operating margin declined 760 basis points due to a 700 basis point impact from 16 goodwill and intangible impairment charges and the 210 basis point gross margin contraction, partially offset by a 150 basis point decrease in SG&A as a percentage of net sales. Diluted net earnings per share decreased 49% to $0.57. Foreign Currency Translation  Venezuela Impacts Venezuela is a highly inflationary economy under U.S. GAAP. As a result, the U.S. dollar is now the functional currency for our subsidiaries in Venezuela. Any currency remeasurement adjustments for non-dollar denominated monetary assets and liabilities held by these subsidiaries and other transactional foreign exchange gains and losses are reflected in earnings. The Venezuelan government has a number of currency controls for companies operating in Venezuela. There is one official exchange rate for imported goods, equal to 4.3 bolivars to one U.S. dollar. Our overall results in Venezuela are reflected in our Consolidated Financial Statements at the 4.3 rate, which is also expected to be applicable to dividend repatriations. There are also exchange controls over securities transactions in what was the parallel market, which has historically been used to pay for imported goods and services that do not qualify for exchange in the official market and is now controlled by authorities. The Central Bank of Venezuela is currently the only legal intermediary to execute foreign exchange transactions outside of CADIVI (4.3 rate) through the SITME rate which was approximately 5.3 as of December 31, 2011. The notional amount of transactions that run through this foreign exchange rate for non-essential goods is restrictive, which for us has essentially eliminated our ability to access any foreign exchange rate other than the CADIVI (4.3) rate to pay for imported goods and/or manage our local monetary asset balances. As of December 31, 2011, we had net monetary assets denominated in local currency of approximately $827 million. Approximately $352 million of this balance has been remeasured using the SITME rate because we plan to use that amount of the net assets (largely cash) to satisfy U.S. dollar denominated liabilities that do not qualify for official rate dollars. The availability of the parallel market to settle these transactions is uncertain. The remaining net monetary asset balances are currently reflected within our Consolidated Financial Statements at the 4.3 official exchange rate. Depending on the future availability of U.S. dollars at the official rate, our local U.S. dollar needs, our overall repatriation plans and the creditworthiness of the local depository institutions and other creditors, we have exposure for our local monetary assets. We also have devaluation exposure for the differential between the current and potential future official and parallel exchange rates on the portion of our local monetary assets reflected at the 4.3 official exchange rate. Our ability to effectively manage sales and profit levels in Venezuela will be impacted by several factors, including the Company's ability to mitigate the effect of any potential future devaluation, further actions of the Venezuelan government, economic conditions in Venezuela, such as inflation and consumer spending, the availability of raw materials, utilities and energy and the future state of exchange controls in Venezuela including the availability of U.S. dollars at the official foreign exchange rate. Sales and profit levels in Venezuela could also be impacted by any actions taken by the government under the recently passed law aimed at controlling market prices, which could restrict our ability to take future pricing or force us to freeze or even reduce current pricing levels. RESULTS OF OPERATIONS  Six Months Ended December 31, 2011 The following discussion provides a review of results for the six months ended December 31, 2011 versus the six months ended December 31, 2010. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information 17 Six Months Ended December 31 2011 2010 % CHG NET SALES $ 44,052 $ 41,469 6 % COST OF PRODUCTS SOLD 22,186 19,976 11 % GROSS PROFIT 21,866 21,493 2 % SELLING GENERAL & ADMINISTRATIVE EXPENSE 13,239 12,732 4 % GOODWILL & INDEFINITE LIVED INTANGIBLE IMPAIRMENT CHARGES 1,554  OPERATING INCOME 7,073 8,761 (19 )% TOTAL INTEREST EXPENSE 408 417 OTHER NON-OPERATING INCOME/(EXPENSE), NET 171 67 EARNINGS BEFORE INCOME TAXES 6,836 8,411 (19 )% INCOME TAXES 2,066 1,929 NET EARNINGS 4,770 6,482 (26 )% LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS 56 68 (18 )% NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE 4,714 6,414 (27 )% EFFECTIVE TAX RATE 30.2 % 22.9 % PER COMMON SHARE: BASIC NET EARNINGS (1) $ 1.67 $ 2.24 (25 )% DILUTED NET EARNINGS (1) $ 1.60 $ 2.13 (25 )% DIVIDENDS $ 1.0500 $ 0.9636 9 % AVERAGE DILUTED SHARES OUTSTANDING 2,946.5 3,013.0 (1) Basic net earnings per share and diluted net earnings per share are calculated on net earnings attributable to Procter & Gamble COMPARISONS AS A % OF NET SALES Basis Pt Chg GROSS MARGIN 49.6 % 51.8 % (220 ) SELLING, GENERAL & ADMINISTRATIVE EXPENSE 30.0 % 30.7 % (70 ) OPERATING MARGIN 16.1 % 21.1 % (500 ) EARNINGS BEFORE INCOME TAXES 15.5 % 20.3 % (480 ) NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE 10.7 % 15.5 % (480 ) Net sales increased 6% to $44.1 billion fiscal year to date on a 1% increase in unit volume. Volume grew or was in line with the prior period across all six business segments. Beauty Care, Health Care, Grooming, Snacks and Pet Care, and Baby Care and Family Care volume grew low single digits. Fabric Care and Home Care volume was in line with the prior year period. Volume grew high single digits in developing regions and was down low single digits in developed regions. Price increases added 4% to net sales, driven by price increases across all business segments and regions to primarily offset commodity costs and devaluing developing market currencies. Negative mix reduced net sales by 2% due mainly to disproportionate growth in developing regions and mid-tier value products, both of which have lower than Company average selling prices. Favorable foreign exchange increased net sales by 3% as key foreign currencies strengthened versus the U.S. dollar. Organic sales growth was 4% driven by unit volume growth and price increases, partially offset by the impact of unfavorable mix. 18 Net Sales Change Drivers 2011 vs. 2010 (Six Months Ended Dec. 31) Volume with Acquisitions & Divestitures Volume Excluding Acquisitions & Divestitures Foreign Exchange Price Mix/Other Net Sales Growth Beauty 3 % 4 % 3 % 2 % -3 % 5 % Grooming 1 % 1 % 3 % 2 % 0 % 6 % Health Care 2 % 1 % 3 % 3 % -2 % 6 % Snacks and Pet Care 2 % 2 % 3 % 2 % -1 % 6 % Fabric Care and Home Care 0 % 0 % 2 % 5 % -2 % 5 % Baby Care and Family Care 1 % 1 % 2 % 5 % 1 % 9 % TOTAL COMPANY 1 % 1 % 3 % 4 % -2 % 6 % Net sales percentage changes are approximations based on quantitative formulas that are consistently applied. Gross margin contracted 220 basis points to 49.6% of net sales. The reduction in gross margin was driven mainly by a 270 basis point impact from higher commodity and energy costs. Gross margin was also negatively impacted by 240 basis points from negative product mix behind disproportionate growth in developing regions and mid-tier products. These impacts were partially offset by a 160 basis point impact from increased pricing, as well as manufacturing cost savings and the favorable impact of volume scale leverage. Total SG&A increased 4% to $13.2 billion, driven by higher marketing and overhead spending to support growth, partially offset by a reduction in competition law fines (which were $306 million in the prior period compared to $65 million in the current period). SG&A as a percentage of net sales decreased 70 basis points to 30.0% driven by scale leverage on overhead costs from increased sales. Interest expense was $408 million for the period, down $9 million versus the prior year period due to lower interest rates on floating rate debt partially offset by an increase in debt outstanding. Other non-operating income/(expense) increased $104 million mainly behind divestiture gains. The effective tax rate on continuing operations increased 730 basis points to 30.2% primarily due to a 470 basis points impact from non-deductibility of impairment charges in the current year period and the net impact of favorable discrete adjustments related to uncertain income tax positions (which netted to 450 basis points in the prior year and 130 basis points in the current year). Net earnings attributable to Procter & Gamble decreased 27% to $4.7 billion as the net sales increase was more than offset by operating margin contraction. Operating margin declined 500 basis points due to a 350 basis point impact from goodwill and intangible impairment charges and the 220 basis point gross margin contraction, partially offset by a 70 basis point reduction in SG&A as a percentage of net sales. Diluted net earnings per share decreased 25% to $1.60. The earnings per share decline is different from the net earnings decline due to the impact of share repurchase activity. BUSINESS SEGMENT DISCUSSION  Three and Six Months Ended December 31, 2011 The following discussion provides a review of results by business segment. Analyses of the results for the three and six months ended December 31, 2011, are provided compared to the same three and six month periods ended December 31, 2010. The primary financial measures used to evaluate segment performance are net sales and net earnings. The table below provides supplemental information on net sales and net earnings by business segment for the three and six months ended December 31, 2011, versus the comparable prior year period (amounts in millions): 19 Three Months Ended December 31, 2011 Net Sales % Change Versus Year Ago Earnings Before Income Taxes % Change Versus Year Ago Net Earnings Attributable to Procter & Gamble % Change Versus Year Ago Beauty $ 5,353 1 % $ 1,014 (9 )% $ 802 (8 )% Grooming 2,202 1 % 692 4 % 517 2 % Health Care 3,183 1 % 784 1 % 537 1 % Snacks and Pet Care 824 3 % 95 2 % 61 (9 )% Fabric Care and Home Care 6,605 5 % 1,151 (1 )% 717 (5 )% Baby Care and Family Care 4,162 6 % 816 2 % 516 3 % Corporate (194 ) N/A (1,844 ) N/A (1,460 ) N/A Total Company 22,135 4 % 2,708 (34 )% 1,690 (49 )% Six Months Ended December 31, 2011 Net Sales % Change Versus Year Ago Earnings Before Income Taxes % Change Versus Year Ago Net Earnings Attributable to Procter & Gamble % Change Versus Year Ago Beauty $ 10,668 5 % $ 1,942 (9 )% $ 1,485 (10 )% Grooming 4,370 6 % 1,331 6 % 1,003 5 % Health Care 6,474 6 % 1,584 4 % 1,079 5 % Snacks and Pet Care 1,600 6 % 185 9 % 123 2 % Fabric Care and Home Care 13,286 5 % 2,414 (7 )% 1,522 (10 )% Baby Care and Family Care 8,241 9 % 1,608 4 % 1,010 4 % Corporate (587 ) N/A (2,228 ) N/A (1,508 ) N/A Total Company 44,052 6 % 6,836 (19 )% 4,714 (27 )% Beauty Beauty net sales increased 1% to $5.4 billion during the second fiscal quarter on unit volume growth of 1%. Organic sales grew 2% on 2% organic volume growth. Price increases contributed 3% to net sales growth. Mix negatively impacted net sales by 4% behind disproportionate growth in developing regions, which have lower than segment average selling prices, and a decrease in the premium-priced product categories. Favorable foreign exchange added 1% to net sales growth. Volume grew high single digits in developing markets behind investments to support initiatives and expansions, and decreased mid-single digits in developed regions. Volume in Hair Care increased mid-single digits behind high-single-digit growth in developing regions due to product innovations and distribution expansions in Asia, while developed regions decreased mid-single digits. Global market share of the hair care category was up slightly. Volume in Skin Care, Personal Care and Cosmetics decreased low single digits due to the Zest and Infasil divestitures, Olay share loss in developed markets and the volume impact of price increases due to consumer value differences relative to competitive products in North America. Volume in Salon Professional declined high single digits due to market contraction in Europe, distribution share losses and non-strategic brand discontinuations. Volume in Prestige Products decreased low single digits driven by minor brand divestitures and initiative activities in the base period, offset by current year market growth and initiatives for SKII. Net earnings decreased 8% to $802 million, as higher net sales were more than offset by a 150-basis point decrease in net earnings margin. Net earnings margin decreased due to gross margin contraction and higher SG&A as a percentage of net sales. Gross margin decreased primarily due to an increase in commodity costs, partially offset by manufacturing cost savings and higher pricing. SG&A as a percentage of net sales increased slightly due to higher marketing spending. Beauty net sales increased 5% to $10.7 billion fiscal year to date on unit volume growth of 3%. Organic sales grew 3% on 4% organic volume growth. Price increases contributed 2% to net sales growth. Mix negatively impacted net sales by 3% behind disproportionate growth in developing regions, which have lower than segment average selling prices, and a decrease in the premium-priced product categories. Favorable foreign exchange added 3% to net sales growth. Volume increased high single digits in developing regions while developed regions decreased low single digits. Volume in Retail Hair Care grew mid-single digits behind double-digit growth in developing regions led by Pantene initiatives and Head & Shoulders geographic expansion. Global market share of the hair care category was up slightly. Volume in Skin Care, Personal Care and Cosmetics 20 decreased low single digits due to the Zest and Infasil divestitures, a decrease in Olay due to share loss from competitive activity in North America, and a decrease in the CEEMEA region due to a reduction in customer inventories following relatively high shipments in the June quarter and comparing against a high base period. Volume in Salon Professional was down high single digits mainly due to market contraction in Europe, distribution share losses and competitive activity. Volume in Prestige Products increased mid-single digits driven by initiatives across SKII, Gucci, Hugo, and Lacoste, partially offset by minor brand divestitures. Net earnings decreased 10% to $1.5 billion, as higher net sales were more than offset by a 240-basis point decrease in net earnings margin. Net earnings margin decreased due to gross margin contraction and higher SG&A as a percentage of net sales. Gross margin decreased primarily due to an increase in commodity costs, partially offset by manufacturing cost savings and higher pricing. SG&A as a percentage of net sales increased due to higher marketing and overhead spending. Grooming Grooming net sales increased 1% to $2.2 billion during the second fiscal quarter on a 1% increase in unit volume. Organic sales were up 2%. Price increases contributed 2% to net sales growth. Negative product and geographic mix decreased net sales by 2% mainly due to a reduction in premium appliances, which have higher than segment average selling prices. Volume grew high single digits in developing regions and decreased mid-single digits in developed regions. Shave Care volume grew low single digits due to high single-digit growth in developing regions behind product and commercial innovation, Fusion ProGlide geographic expansion and market growth, partially offset by a mid-single-digit decrease in developed regions due to market contraction and competitive activity. Global market share of the blades and razors category was down slightly. Volume in Appliances decreased double digits primarily due to a decrease in Western Europe as a result of market contraction and competitive activity. Global market share of the dry shave category was down over 2 points. Net earnings increased 2% to $517 million, due to net sales growth and a 20-basis point improvement in net earnings margin. Net earnings margin increased due to a reduction in marketing and overhead spending, partially offset by a decline in gross margin due primarily to unfavorable geographic and product mix. Grooming net sales increased 6% to $4.4 billion fiscal year to date on a 1% increase in unit volume. Organic sales were up 2%. Price increases contributed 2% to net sales growth. Favorable foreign exchange increased net sales growth by 3%. Volume grew mid-single digits in developing regions and decreased mid-single digits in developed regions. Volume in Shave Care was up low single digits due to mid-single-digit growth in developing regions behind initiatives, Fusion ProGlide geographic expansion and market growth, partially offset by a low single-digit decrease in developed regions due to market contraction and competitive activity. Global market share of the blades and razors category was down slightly. Volume in Appliances decreased high single digits due to market contraction in Western Europe and competitive activity. Global market share of the dry shave category was down over 3 points. Net earnings increased 5% to $1.0 billion, largely in line with net sales growth. Net earnings margin decreased 10 basis points due to gross margin contraction and a higher effective tax rate, largely offset by a decrease in SG&A as a percentage of net sales. Gross margin decreased primarily due to an increase in commodity costs and unfavorable geographic and product mix, partially offset by price increases. SG&A as a percentage of net sales decreased primarily due to scale leverage from increased sales. The tax rate increased due to a shift in the geographic mix of earnings to countries with higher statutory tax rates. Health Care Health Care net sales increased 1% to $3.2 billion during the second fiscal quarter on unit volume that was in-line with the prior year period. Organic sales were up 1%. Price increases contributed 3% to net sales growth. Mix negatively impacted net sales by 2% behind geographic and product mix, due to disproportionate growth in countries and products with lower than segment average selling prices. Volume increased low single digits across developing regions, while developed regions decreased low single digits. Oral Care volume decreased low single digits due to initiative activity in the base period in North America behind Crest 3D White and current period competitive activity in developed markets and Asia. Global market share of the oral care category was down slightly. Volume in Personal Health Care increased mid-single digits primarily due to the addition of Teva partnership, with organic volume increasing low single digits behind market growth and Vicks initiative activity, partially offset by lower shipments of Prilosec OTC in North America. All-outlet value share of the U.S. personal health care market was down slightly. Volume in Feminine Care grew low single digits driven by mid-single digit growth in developing markets behind a new distributor start-up in CEEMEA and market growth and product innovation in India, partially offset by a mid-single digit decrease in developed regions due to competitive activity in North America. Global market share of the feminine care category was down about a half a point. Net earnings increased 1% to $537 million, consistent with sales growth. Gross margin declined driven by commodity costs, partially offset by pricing. This was offset by reduced levels of SG&A costs. Health Care net sales increased 6% to $6.5 billion fiscal year to date on 2% growth in unit volume. Organic sales were up 2%. 21 Price increases contributed 3% to net sales growth. Mix negatively impacted net sales by 2% due to disproportionate growth in countries and products with lower than segment average selling prices. Favorable foreign exchange increased net sales growth by 3%. Volume increased low single digits in developing regions and was in line with the prior period in developed regions. Oral Care volume increased low single digits behind the expansion of Oral-B toothpaste in Western Europe and Latin America, and toothbrush initiatives in Asia. Global market share of the oral care category was unchanged. Volume in Personal Health Care increased low single digits behind market growth and Vicks initiative activity, partially offset by lower shipments of Prilosec OTC in North America due to competitive activity. All-outlet value share of the U.S. personal health care market was unchanged. Volume in Feminine Care was up low single digits driven by mid-single digit growth in developing markets due to distribution expansions in CEEMEA and initiative activity in India, partially offset by a low single digit decrease in developed regions due to competitive activity in North America Net earnings increased 5% to $1.1 billion, largely in line with net sales growth. Net earnings margin decreased 10 basis points due to gross margin contraction, partially offset by lower SG&A as a percentage of net sales. Gross margin declined due to higher commodity costs, partially offset by manufacturing cost savings and price increases. SG&A as a percentage of net sales decreased primarily due to scale leverage from increased sales. Snacks and Pet Care Snacks and Pet Care net sales increased 3% to $824 million during the second fiscal quarter on a 2% increase in unit volume. Organic sales were up 3%. Price increases added 3% to net sales growth. Mix negatively impacted net sales by 2% due to disproportionate growth in countries and products with lower than segment average selling prices. Snacks volume increased mid-single digits mainly due to increased distribution and market growth in developing regions. Global market share of the snacks category was unchanged. Pet Care volume decreased low single digits due to customer inventory adjustments and market contraction. Global market share of the pet care category was down slightly. Net earnings decreased 9% to $61 million as sales growth was more than offset by a 100-basis point decrease in net earnings margin. Net earnings margin decreased primarily due to a decline in gross margin and a higher effective tax rate, partially offset by a decrease in overhead spending. Gross margin decreased behind an increase in commodity costs, partially offset by price increases and manufacturing cost savings. The tax rate increased due to a shift in the geographic mix of earnings to countries with higher statutory tax rates. Overhead spending decreased due to incremental costs in the prior year period resulting from the pet food recalls and related supply constraints and lower current year allocations of overhead spending due to the pending divestiture. Snacks and Pet Care net sales increased 6% to $1.6 billion fiscal year to date on a 2% increase in unit volume. Organic sales increased 4%. Price increases added 2% to net sales growth. Mix negatively impacted net sales by 1% due to disproportionate growth in countries and products with lower than segment average selling prices. Favorable foreign exchange positively impacted net sales growth by 3%. Snacks volume increased mid-single digits mainly due to increased distribution and market growth in developing regions, as well as share growth and market growth in North America. Global market share of the snacks category was up slightly. Pet Care volume was down low single digits due to customer inventory adjustments and market contraction. Global market share of the pet care category was down slightly. Net earnings increased 2% to $123 million due to sales growth, partially offset by a 40-basis point decrease in net earnings margin. Net earnings margin decreased due to a lower gross margin and a higher effective tax rate, partially offset by a decrease in SG&A as a percentage of net sales. Gross margin declined behind higher commodity costs, partially offset by manufacturing cost savings and pricing. The tax rate increased due to a shift in the geographic mix of earnings to countries with higher statutory tax rates. SG&A as a percentage of net sales decreased due to scale leverage from increased sales and a reduction in overhead spending due to incremental costs in the prior year period resulting from the pet food recalls and related supply constraints and lower current year allocations of overhead spending due to the pending divestiture. In April 2011, we announced plans to divest the Company's Snacks business through a merger with Diamond Foods, Inc. in an all-stock Reverse Morris Trust transaction. The Company expects the transaction to close by the end of the 2012 fiscal year, pending the satisfactory resolution of the Diamond Foods investigations. The Snacks business had net sales of approximately $1.5 billion and operating income of approximately $200 million in fiscal 2011. Fabric Care and Home Care Fabric Care and Home Care net sales increased 5% to $6.6 billion during the second fiscal quarter. Unit volume was in line with the prior year period. Organic sales were up 5%. Price increases contributed 6% to net sales growth. Mix negatively impacted net sales growth by 1% due to disproportionate growth of mid-tier product lines and developing regions, which have lower than segment average selling prices. A high single digits increase in volume in developing regions was offset by a low single digit decrease in developed regions. Fabric Care volume was in line with the prior year as a mid-single digit increase in developing regions driven by initiative activity and market growth was offset by a mid-single digit decrease in developed regions due to competitive activity and the impact of price increases taken in previous quarters. Global market share of the 22 fabric care category decreased more than half a point. Home Care volume increased low single digits driven by initiative activity and distribution expansion in developing regions. Global market share of the home care category was unchanged. Batteries volume decreased low single digits due to market contraction and distribution losses in developed markets, partially offset by market growth and distribution expansion in developing regions. Global market share of the batteries category increased more than half a point. Net earnings decreased 5% to $717 million as net sales growth was more than offset by a 120-basis point decrease in net earnings margin. Net earnings margin decreased mainly due to gross margin contraction. Gross margin decreased mainly due to higher commodity costs, partially offset by manufacturing cost savings and pricing. Fabric Care and Home Care net sales increased 5% to $13.3 billion fiscal year to date. Unit volume was in line with the prior year period. Organic sales were up 3%. Price increases contributed 5% to net sales growth. Mix negatively impacted net sales growth by 2% due to disproportionate growth of mid-tier product lines and developing regions, which have lower than segment average selling prices. Favorable foreign exchange increased net sales by 2%. Volume in developing regions grew mid-single digits, while volume in developed regions decreased low single digits. Fabric Care volume decreased low single digits mainly due to the impact of the customer forward buy at the end of fiscal 2011 ahead of price increases in North America, partially offset by growth in Asia. Global market share of the fabric care category decreased more than half a point. Home Care volume was in line with the prior year period driven by the impact of the forward buy at the end of fiscal 2011 ahead of the price increases in North America, partially offset by initiative activity and distribution expansion in developing regions. Global market share of the home care category was unchanged. Batteries volume decreased low single digits due to market contraction and distribution losses in developed markets, partially offset by market growth and distribution expansion in developing regions. Global market share of the batteries category increased more than half a point. Net earnings decreased 10% to $1.5 billion as net sales growth was more than offset by a 200-basis point decrease in net earnings margin. Net earnings margin decreased mainly due to gross margin contraction and a higher effective tax rate. Gross margin decreased mainly due to higher commodity costs, partially offset by manufacturing cost savings and pricing. The tax rate increased due to a shift in the geographic mix of earnings to countries with higher statutory tax rates. Baby Care and Family Care Baby Care and Family Care net sales increased 6% to $4.2 billion during the second fiscal quarter on unit volume that was unchanged versus the prior year period. Organic sales were up 6%. Pricing added 6% to net sales growth. Volume in developing regions increased double digits, while volume in developed regions decreased mid-single digits. Volume in Baby Care increased mid-single digits as a double digit increase in developing regions behind market size growth and distribution expansion was partially offset by a low single digit decrease in developed regions due to market contraction. Global market share of the baby care category increased nearly 1 point. Volume in Family Care decreased mid-single digits primarily due to competitive activity in North America and price differential relative to competitive products following our price increases. In the U.S., all-outlet share of the family care category decreased more than half a point. Net earnings increased 3% to $516 million as sales growth was partially offset by a 40-basis point reduction in net earnings margin. Net earnings margin declined mainly due to a lower gross margin, partially offset by a reduction in SG&A as a percentage of net sales. The reduction in gross margin was driven by higher commodity costs, partially offset by the impact of higher pricing and manufacturing cost savings. The reduction in SG&A as a percentage of net sales was due primarily to scale benefits from increased net sales. Baby Care and Family Care net sales increased 9% to $8.2 billion fiscal year to date on 1% volume growth. Organic sales were up 7%. Pricing added 5% to net sales growth. Mix increased net sales by 1% due to disproportionate growth of Baby Care, which has higher than segment average selling prices. Favorable foreign exchange increased net sales growth by 2%. Volume grew double digits in developing regions and decreased mid-single digits in developed regions. Volume in Baby Care was up mid-single digits behind market size growth and distribution expansion in developing regions, partially offset by declines in North America and Western Europe from diaper market softness. Global market share of the baby care category increased 1 point. Volume in Family Care decreased mid-single digits primarily due to competitive activity and the impact of a forward buy at the end of fiscal 2011 ahead of price increases in North America. In the U.S., all-outlet share of the family care category decreased slightly. Net earnings increased 4% to $1.0 billion as sales growth was partially offset by a 60-basis point reduction in net earnings margin. Net earnings margin declined mainly due to a lower gross margin, partially offset by a decrease in SG&A as a percentage of net sales. The reduction in gross margin was driven by higher commodity costs, partially offset by the impact of higher pricing. SG&A as a percentage of net sales decreased due to scale leverage from increased sales. CORPORATE Corporate includes certain operating and non-operating activities not allocated to specific business units. These include: the incidental businesses managed at the corporate level; financing and investing activities; other general corporate items; the historical results of certain divested brands and categories; certain restructuring-type activities to maintain a competitive cost 23 structure, including manufacturing and workforce optimization; and certain significant impairment charges. Corporate also includes reconciling items to adjust the accounting policies used in the segments to U.S. GAAP. The most significant reconciling items include income taxes (to adjust from statutory rates that are reflected in the segments to the overall Company effective tax rate), adjustments for unconsolidated entities (to eliminate net sales, cost of products sold and SG&A for entities that are consolidated in the segments but accounted for using the equity method for U.S. GAAP) and noncontrolling interest adjustments for subsidiaries where we do not have 100% ownership. Since certain unconsolidated entities and less than 100%-owned subsidiaries are managed as integral parts of the Company, they are accounted for similar to a wholly-owned subsidiary for management and segment purposes. This means our segment results recognize 100% of each income statement component through before-tax earnings in the segments, with eliminations for unconsolidated entities and noncontrolling interests in Corporate. In determining segment net earnings, we apply the statutory tax rates (with adjustments to arrive at the Company's effective tax rate in Corporate). We also eliminate the share of earnings applicable to other ownership interests. Corporate net sales primarily reflect the adjustment to eliminate the sales of unconsolidated entities included in business segment results. Accordingly, Corporate net sales are generally a negative balance. Negative net sales in Corporate decreased by $87 million in the second fiscal quarter and decreased $41 million fiscal year to date due to adjustments required to eliminate the sales of unconsolidated entities. Net Corporate expenses increased $1.6 billion in the second fiscal quarter and increased $1.5 billion fiscal year to date primarily due to the net after tax goodwill and intangibles impairment charges of $1.5 billion. Additional discussion of the items impacting net earnings in Corporate are included in the Results of Operations section. FINANCIAL CONDITION Operating Activities We generated $5.5 billion of cash from operating activities during the fiscal year to date period. On a year-to-date basis, the net of accounts receivable, inventory, and accounts payable consumed $2.6 billion of cash. Accounts receivable used $1.1 billion of cash primarily due to increased sales at the end of the period. Inventory consumed $497 million of cash, mainly to support product initiatives and to build stock to support capacity expansions and manufacturing sourcing changes. Accounts payable, accrued and other liabilities used $1,009 million of cash, primarily related to the payment of prior-year marketing accruals and the payment of fines related to violations of the European competition laws. Investing Activities Cash used for investing activities was $1.5 billion fiscal year to date, a decline of $72 million versus the prior year period. Capital expenditures consumed $1.8 billion or 4.0% of net sales, as compared to $1.3 billion in the prior year period. Cash generated from asset sales was $238 million in the current year, an increase of $216 million mainly due to proceeds from the PUR divestiture. Financing Activities Our financing activities consumed net cash of $2.3 billion. We used $1.8 billion for treasury stock purchases and $3.0 billion for dividends and partially funded these cash outlays through the issuance of $1.9 billion of debt. Cash consumed by financing activities declined $1.3 billion versus the prior year period due to increased levels of debt and a decrease in the treasury stock purchases. As of December 31, 2011, our current liabilities exceeded current assets by $6.1 billion. We have short- and long-term debt to fund discretionary items such as acquisitions and share repurchase programs. We anticipate being able to support our short-term liquidity and operating needs largely through cash generated from operations. We have strong short- and long-term debt ratings which have enabled and should continue to enable us to refinance our debt as it becomes due at favorable rates in commercial paper and bond markets. In addition, we have agreements with a diverse group of financial institutions that, if needed, should provide sufficient credit funding to meet short-term financing requirements. RECONCILIATION OF NON-GAAP MEASURES Our discussion of financial results includes several measures not defined by U.S. GAAP. We believe these measures provide our investors with additional information about the underlying results and trends of the Company, as well as insight to some of the metrics used to evaluate management. When used in MD&A, we have provided the comparable GAAP measure in the discussion. 24 Organic Sales Growth: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions, divestitures and foreign exchange from year-over-year comparisons. We believe this provides investors with a more complete understanding of underlying sales trends by providing sales growth on a consistent basis. Organic sales is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation. The reconciliation of reported sales growth to organic sales for the October - December quarter: Oct - Dec 2011 Net Sales Growth Foreign Exchange Impact Acquisition/ Divestiture Impact* Organic Sales Growth Beauty 1 % (1 )% 2 % 2 % Grooming 1 %  % 1 % 2 % Health Care 1 %  %  % 1 % Snacks and Pet Care 3 %  %  % 3 % Fabric Care and Home Care 5 %  %  % 5 % Baby Care and Family Care 6 %  %  % 6 % Total P&G 4 %  %  % 4 % * Acquisition/Divestiture Impacts includes rounding impacts necessary to reconcile net sales to organic sales. The reconciliation of reported sales growth to organic sales for the fiscal year to date period: Jul - Dec 2011 Net Sales Growth Foreign Exchange Impact Acquisition/ Divestiture Impact* Organic Sales Growth Beauty 5 % (3 )% 1 % 3 % Grooming 6 % (3 )% (1 )% 2 % Health Care 6 % (3 )% (1 )% 2 % Snacks and Pet Care 6 % (3 )% 1 % 4 % Fabric Care and Home Care 5 % (2 )%  % 3 % Baby Care and Family Care 9 % (2 )%  % 7 % Total P&G 6 % (3 )% 1 % 4 % * Acquisition/Divestiture Impacts includes rounding impacts necessary to reconcile net sales to organic sales. Free Cash Flow: Free cash flow is defined as operating cash flow less capital spending. We view free cash flow as an important measure because it is one factor in determining the amount of cash available for dividends and discretionary investment. Free cash flow is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation. Free Cash Flow Productivity: Free cash flow productivity is defined as the ratio of free cash flow to net earnings. The Companys long-term target is to generate free cash at or above 90% of net earnings. Free cash flow productivity is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation. The reconciliation of free cash flow and free cash flow productivity is provided below (amounts in millions): Operating Cash Flow Capital Spending Free Cash Flow Net Earnings Free Cash Flow Productivity Jul - Dec 11 $5,495 $(1,780) $3,715 $4,770 78% 25 Item 3. Quantitative and Qualitative Disclosures About Market Risk. There have been no material changes in the Companys exposure to market risk since June 30, 2011. Additional information can be found in the section entitled Other Information, which appears on page 50, and Note 5, Risk Management Activities and Fair Value Measurements, which appears on pages 60-62 of the Annual Report to Shareholders for the fiscal year ended June 30, 2011 which can be found by reference to Exhibit 13 of the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2011. Item 4. Controls and Procedures. Evaluation of Disclosure Controls and Procedures. The Companys Chairman of the Board, President and Chief Executive Officer, Robert A. McDonald, and the Companys Chief Financial Officer, Jon R. Moeller, performed an evaluation of the Companys disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (Exchange Act)) as of the end of the period covered by this report. Messrs. McDonald and Moeller have concluded that the Companys disclosure controls and procedures were effective to ensure that information required to be disclosed in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) accumulated and communicated to our management, including Messrs. McDonald and Moeller, to allow their timely decisions regarding required disclosure. Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting that occurred during the Companys fiscal quarter ended December 31, 2011 that have materially affected, or are reasonably likely to materially affect, the Companys internal control over financial reporting. PART II. OTHER INFORMATION Item 1. Legal Proceedings. The Company is subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental issues, patent and trademark matters, labor and employment matters and tax. As previously reported, the Company has been subject to a number of investigations into potential competition law violations in Europe. The Companys policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with investigations by relevant regulatory authorities, which the Company is doing. In response to the actions of the regulatory authorities, the Company launched its own internal investigations into potential violations of competition laws. The Company identified violations in certain European countries and appropriate actions were taken. As a result of certain investigations that were previously disclosed, several authorities issued separate complaints alleging that the Company, along with several other companies, engaged in violations of competition laws in the past. The Company resolved several of these matters prior to the most recent quarter. During the most recent quarter, authorities in France issued a final decision for its investigation into laundry detergents, which resulted in a monetary penalty. As a result, the Company adjusted its previously established accrual for this matter. The remaining matters include investigations by national authorities in Belgium, France, Germany and Greece. We believe that all of these matters involve a number of other consumer products companies and/or retail customers. Competition and antitrust violations often continue for several years and, if violations are found, can result in substantial fines. No non-monetary sanctions are being sought in these matters. For certain of the remaining matters listed above, we have established accruals for potential fines and we do not expect any significant incremental fines or costs in excess of amounts accrued for these matters. For other remaining matters, we cannot reasonably estimate any fines to which the Company may be subject as a result of the investigations. Please refer to the Company's Risk Factors in Item 1A of this Form 10-Q for additional information. In December 2008, the Company became aware of an investigation by Italian authorities into an environmental accident at the site of a contractor which provides services to one or more of the Company's European affiliates. The accident involved the explosion of certain pressurized cans and resulted in the death of one worker and serious injuries to another. Italian authorities have commenced a formal criminal proceeding regarding whether the Company's local affiliate and certain of its employees complied with Italian laws related to the proper classification and disposal of their products. The Company's European affiliate 26 (s) could be levied fines in excess of $100 thousand for this accident. Item 1A. Risk Factors. We discuss our expectations regarding future performance, events and outcomes, such as our business outlook and objectives in this Form 10-Q, the Annual Report to Shareholders, other quarterly reports, press releases and other written and oral communications. All statements, except for historical and present factual information, are forward-looking statements and are based on financial data and business plans available only as of the time the statements are made, which may become out of date or incomplete. We assume no obligation to update any forward-looking statements as a result of new information, future events, or other factors. Forward-looking statements are inherently uncertain, and investors must recognize that events could significantly differ from our expectations. The following discussion of risk factors identifies the most significant factors that may adversely affect our business, operations, financial position or future financial performance. This information should be read in conjunction with MD&A and the consolidated financial statements and related notes incorporated by reference into this report. The following discussion of risks is not all inclusive but is designed to highlight what we believe are important factors to consider when evaluating our expectations. These factors could cause our future results to differ from those in the forward-looking statements and from historical trends. A material change in consumer demand for our products could have a significant impact on our business. We are a consumer products company and rely on continued global demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers. This is dependent on a number of factors including our ability to develop effective sales, advertising and marketing programs. We expect to achieve our financial targets, in part, by shifting our portfolio towards faster growing, higher margin businesses. If demand and growth rates fall substantially below expected levels or our market share declines significantly in these businesses, our results could be negatively impacted. This could occur due to unforeseen negative economic or political events or to changes in consumer trends and habits. In addition, our continued success is dependent on leading-edge innovation, with respect to both products and operations. This means we must be able to obtain patents that lead to the development of products that appeal to our consumers across the world. The ability to achieve our business objectives is dependent on how well we can respond to our local and global competitors. Across all of our categories, we compete against a wide variety of global and local competitors. As a result, there are ongoing competitive product and pricing pressures in the environments in which we operate, as well as challenges in maintaining profit margins. To address these challenges, we must be able to successfully respond to competitive factors, including pricing, promotional incentives and trade terms, as well as technological advances and patents granted to competition. Our businesses face cost pressures and risks inherent in global manufacturing which could affect our business results. Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, labor costs, foreign exchange and interest rates. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects (including outsourcing projects), sourcing decisions and certain hedging transactions. In the manufacturing and general overhead areas, we need to maintain key manufacturing and supply arrangements, including any key sole supplier and sole manufacturing plant arrangements. In addition, we are subject to risks inherent in global manufacturing, such as environmental events, labor disputes, disruption in logistics, loss or impairment of key manufacturing sites, natural disasters, acts of war or terrorism and other external factors over which we have no control. While we have business continuity and contingency plans for key manufacturing sites and the supply of raw materials, significant disruption of manufacturing could interrupt product supply and, if not remedied, have an adverse impact on our business. We face risks associated with significant international operations. We conduct business across the globe with a significant portion of our sales outside the United States. As a result, we are subject to a number of risks, including, but not limited to, changes in exchange rates for foreign currencies, which may reduce the U.S. dollar value of revenues and earnings received and/or balances held by or invested in our foreign subsidiaries, as well as exchange controls and other limits on our ability to repatriate earnings from outside the U.S. that can increase our exposure. We have sizable businesses and maintain local currency cash balances in a number of foreign countries with exchange controls, including, but not limited to, Venezuela, China and India. Our results of operations and/or financial condition could be adversely impacted if we are unable to successfully manage these risks in an increasingly volatile environment. Further, we expect to achieve our financial targets, in part, by achieving disproportionate growth in developing 27 regions. Growth rates in these regions may be impacted by the enactment of laws or governmental actions aimed at controlling prices. Should growth rates or our market share fall substantially below expected levels in these regions, our results could be negatively impacted. In addition, economic changes, terrorist activity and political unrest may result in business interruption, inflation, deflation or decreased demand for our products. Our success will depend, in part, on our ability to manage continued global political and/or economic uncertainty, especially in our significant geographical markets, as well as any political or economic disruption due to terrorist and other hostile activities. If the reputation of the Company or one or more of our leading brands erodes significantly, it could have a material impact on our financial results. The Company's reputation is the foundation of our relationships with key stakeholders and other constituencies. If we are unable to effectively manage real or perceived issues, which could negatively impact sentiments toward the Company, our ability to operate freely could be impaired and our financial results could suffer. Our financial success is directly dependent on the success of our brands, particularly our billion-dollar brands. The success of these brands can suffer if our marketing plans or product initiatives do not have the desired impact on a brand's image or its ability to attract consumers, or we are unable to maintain trademark protection. Further, our results could be negatively impacted if one of our leading brands suffers a substantial impediment to its reputation due to real or perceived quality issues or the distribution and sale of counterfeit products. Our ability to successfully adapt to ongoing organizational change could impact our business results. We have executed a number of significant business and organizational changes including acquisitions, divestitures and workforce optimization projects to support our growth strategies. We expect these types of changes to continue for the foreseeable future. Successfully managing these changes, including retention of key employees, is critical to our business success. In addition, we are generally a build-from-within company, and our success is dependent on identifying, developing and retaining key employees to provide uninterrupted leadership and direction for our business. This includes developing organization capabilities in key growth markets where the depth of skilled employees is limited and competition for these resources is intense. Further, business and organizational changes may result in more reliance on third parties for various services, and that reliance may increase reputational, operational and compliance risks, including the risk of corruption. Finally, our financial targets assume a consistent level of productivity improvement. If we are unable to deliver expected productivity improvements, while continuing to invest in business growth, our financial results could be adversely impacted. Our ability to successfully manage ongoing acquisition and divestiture activities could impact our business results. As a company that manages a portfolio of consumer brands, our ongoing business model involves a certain level of acquisition and divestiture activities. We must be able to successfully manage the impacts of these activities, while at the same time delivering against base business objectives. Specifically, our financial results could be adversely impacted if: 1) we are not able to deliver the expected cost and growth synergies associated with our acquisitions, 2) changes in the cash flows or other market-based assumptions cause the value of acquired assets to fall below book value or 3) we are unable to offset the dilutive impacts from the loss of revenue streams associated with divested brands. Our business is subject to legislation, regulation and enforcement in the U.S. and abroad. Changes in laws, regulations and the related interpretations, as well as changes in accounting standards, taxation requirements and increased enforcement actions and penalties may alter the environment in which we do business. Accordingly, our ability to manage regulatory, tax and legal matters (including product liability, patent, and other intellectual property matters), and to resolve pending legal matters without significant liability may materially impact our results of operations and financial position. Furthermore, the competition law and antitrust investigations described in Part II, Item 1 of this Form 10-Q, in total, may result in fines or costs in excess of the amounts accrued to date that could materially impact our results of operations and financial position. Moreover, as a U.S. based multinational company we are subject to tax regulations in the U.S. and multiple foreign jurisdictions, some of which are interdependent. For example, certain income that is earned and taxed in countries outside the U.S. is not taxed in the U.S., provided those earnings are indefinitely reinvested outside the U.S. If these or other tax regulations should change, our financial results could be impacted. A material change in customer relationships or in customer demand for our products could have a significant impact on our business. Our success is dependent on our ability to successfully manage relationships with our retail trade customers. This includes our ability to offer trade terms that are acceptable to our customers and are aligned with our pricing and profitability targets. Our business could suffer if we cannot reach agreement with a key customer based on our trade terms and principles. Further, retail trade consolidation could create significant cost and margin pressure and lead to more complex work across 28 broader geographic boundaries for both us and key retailers. This can be particularly difficult when major customers are addressing local trade pressures or local law and regulation changes. In addition, our business would be negatively impacted if a key customer were to significantly reduce the range or inventory level of our products. We face risks related to changes in the global economic environment. Our business is impacted by global economic conditions, which are increasingly volatile. If the global economy experiences significant disruptions, our business could be negatively impacted by reduced demand for our products related to a slow-down in the general economy, supplier or customer disruptions resulting from tighter credit markets, temporary interruptions in our ability to conduct day-to-day transactions through our financial intermediaries involving the payment to or collection of funds from our customers, vendors and suppliers and/or liquidity issues resulting from an inability to access credit markets to obtain cash to support operations. We could also be negatively impacted by an economic crisis in individual countries or regions, including sovereign risk related to a deterioration in the credit worthiness or a default by local governments. Such events could negatively impact our overall liquidity, as well as our ability to collect receipts due from governments, including refunds of value added taxes, and/or create significant credit risks relative to our local customers and depository institutions. A failure of a key information technology system, process, site or service provider could have a material adverse impact on our business or reputation. We rely extensively on information technology systems, including email and internet sites, as well as hardware, software and other applications, some of which are managed, hosted, provided or used by third-parties or their vendors, to conduct our business. The various uses of these systems and services include, but are not limited to, ordering and managing materials from suppliers, converting materials to finished products, shipping product to customers, marketing and selling products to consumers, collecting and storing customer, consumer, employee, investor and research information, processing transactions, summarizing and reporting results of operations, sharing confidential information, complying with regulatory, legal or tax requirements, providing data security, and other processes necessary to manage our business. If the systems or service providers we rely upon fail to function properly, or if we suffer a loss or disclosure of business or stakeholder information, due to any number of causes, ranging from catastrophic events to power outages to security breaches, and our business continuity plans do not effectively compensate on a timely basis, we may suffer interruptions in our ability to manage operations and reputational, competitive and/or business harm, which may adversely impact our results of operations and/or financial condition. Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. ISSUER PURCHASES OF EQUITY SECURITIES Period Total Number of Shares Purchased (1) Average Price Paid per Share (2) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (3) Approximate Dollar Value of Shares That May Yet Be Purchased Under our Share Repurchase Program ($ in billions) 10/1/2011 - 10/31/2011 2,080 $65.89  11/1/2011 - 11/30/2011    See Note 3 12/1/2011 - 12/31/2011 7,682,281 $65.09 7,682,142 (1) The total number of shares purchased was 7,684,361 for the quarter. This includes 2,219 shares acquired by the Company under various compensation and benefit plans. All transactions were made in the open market or pursuant to prepaid forward agreements with large financial institutions. Under these agreements, the Company prepays large financial institutions to deliver shares at future dates in exchange for a discount. This table excludes shares withheld from employees to satisfy minimum tax withholding requirements on option exercises and other equity-based transactions. The Company administers cashless exercises through an independent, third party and does not repurchase stock in connection with cashless exercises. (2) Average price paid per share is calculated on a settlement basis and excludes commission. 29 (3) On January 27, 2012, the Company stated that fiscal year 2011-12 share repurchases to reduce Company shares outstanding are estimated to be approximately $4 billion to $5 billion, notwithstanding any purchases under the Company's compensation and benefit plans. Purchases may be made in the open market and/or private transactions and purchases may be increased, decreased or discontinued at any time without prior notice. The share repurchases are authorized pursuant to a resolution issued by the Company's Board of Directors and is expected to be financed by issuing a combination of long-term and short-term debt. Item 6. Exhibits 3-1 Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October 11, 2011) (Incorporated by reference to Exhibit (3-1) of the Company's Form 10-Q for the quarter ended September 30, 2011). . 3-2 Regulations (as amended by the Board of Directors effective January 16, 2012 pursuant to authority granted by shareholders at the annual meeting on October 13, 2009). 10-1 Summary of the Company's Short Term Achievement Reward Program's related correspondence and terms and conditions.* 10-2 Company's Form of Separation Agreement and Release.* 10-3 The Procter & Gamble 2009 Stock and Incentive Compensation Plan which was originally adopted by shareholders at the annual meeting on October 13, 2009.* 11 Computation of Earnings per Share. 12 Computation of Ratio of Earnings to Fixed Charges. 18 Preferability Letter Regarding Change in Accounting Policy relating to Goodwill. 31.1",18326
2012-02-06,8-K,0001193125-12-041398,"SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) February 6, 2012 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) February 6, 2012, The Procter & Gamble Company (the Company) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 2.300% Notes due 2022 and $1,000,000,000 aggregate principal amount of Floating Rate Notes due 2014 under the Companys Registration Statement on Form S-3 (Registration No. 333-177762). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are incorporated Financial Statements and Exhibits. (d) The following exhibits are being filed with this Current Report on Form 8-K. Opinion of Kenneth L. Blackburn, Esq., Senior Counsel of the Company. Opinion of Fried, Frank, Harris, Shriver & Jacobson LLP, which is referred to in the opinion filed as Exhibit (5)(a). Consent of Kenneth L. Blackburn, Esq., which is contained in his opinion filed as Exhibit (5)(a). Consent of Fried, Frank, Harris, Shriver & Jacobson LLP, which is referred to in the opinion filed as Exhibit (5)(c).",279
2012-02-10,8-K,0000080424-12-000020,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) February 10, 2012 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) Zip Code (513) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 8.01 OTHER EVENTS Effective during the quarter ended December 31, 2011, The Procter & Gamble Company (the Company) implemented a number of changes to our organization structure for the Beauty & Grooming Global Business Unit (GBU), which resulted in changes to the components of the Beauty reportable segment and the Grooming reportable segment. These two segments transitioned from consumer-oriented to product-oriented segment breakouts. As a result, female blades and razors transitioned from Beauty to Grooming, while Old Spice and Gillette male personal care products moved from Grooming to Beauty. These changes have been reflected in our segment reporting beginning in the second quarter of fiscal year 2012. In addition, the Company changed how it presents noncontrolling interests in its consolidated financial statements beginning in the second quarter of fiscal year 2012. Our Consolidated Statements of Earnings have been changed to present separately the net expense for earnings attributable to noncontrolling interests. As previously disclosed, this net expense was not historically presented separately in the Consolidated Statements of Earnings due to immateriality, but was reflected within other non-operating income/(expense). To provide additional transparency related to noncontrolling interests, the historical Consolidated Statements of Earnings have been revised to conform to the new presentation, with a corresponding change to the ""net earnings"" line item in the Consolidated Statements of Cash Flows. This change does not impact our historically reported net earnings attributable to Procter & Gamble or the historical basic or diluted net earnings per share balances, nor does it impact total operating cash flows. However, it does impact certain amounts within those statements, which is further detailed in Note 1 - Summary of Significant Accounting Policies of the notes to the Consolidated Financial Statements. In this Form 8-K, the Company is providing a revised Management's Discussion and Analysis (MD&A) and consolidated financial statements and notes thereto for the years ended June 30, 2011, 2010 and 2009, to revise the segment disclosures for those periods to conform to its new organization structure and to present separately the net expense for earnings attributable to noncontrolling interests. The revised MD&A and consolidated financial statements otherwise continue to speak as the date of the filing of the Form 10-K for the fiscal year ended June 30, 2011 (the 2011 10-K) with the Securities and Exchange Commission (SEC) and have not been updated for events or developments that occurred subsequent to such filing. For developments since the filing of the 2011 10-K, please refer to the Company's Form 10-Q for the quarter ended December 31, 2011 and the Company's Forms 8-K filed since August 10, 2011, the filing date of the 2011 10-K.",610
2012-02-15,8-K,0000080424-12-000022,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On February 15, 2012, The Procter & Gamble Company (""Company"") issued a news release announcing that it has reached an agreement to divest the Company's Snacks business to The Kellogg Company in a $2.7 billion all-cash transaction. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",168
2012-02-23,8-K,0000080424-12-000026,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4)) ITEM 7.01 REGULATION FD DISCLOSURE On February 23, 2012, The Procter & Gamble Company (the ""Company"") participated in the Consumer Analyst Group of New York annual conference. Pursuant to Item 7.01, ""Regulation FD Disclosure,"" the Company is furnishing on this Form 8-K a series of slides referenced in the Company's remarks at the conference. Presentation slides are also posted on the Company's website.",176
2012-04-13,8-K,0000080424-12-000032,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On April 13, 2012, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of fifty six point two cents ($0.562) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after May 15, 2012 to shareholders of record at the close of business on April 27, 2012. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",201
2012-04-27,8-K,0000080424-12-000038,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On April 27, 2012, The Procter & Gamble Company (the ""Company"") issued a press release announcing its third quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",183
2012-04-27,10-Q,0000080424-12-000040,", and Risk Factors. These forward-looking statements generally are identified by the words believe, project, expect, anticipate, estimate, intend, strategy, future, opportunity, plan, may, should, will, would, will be, will continue, will likely result, and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in this section titled ""Economic Conditions, Challenges and Risks"" and the section titled ",102
2012-04-27,8-K,0000080424-12-000036,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) ( Registrant's telephone number, including area code ) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On April 27, 2012, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended March 31, 2012. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",159
2012-05-04,8-K,0000080424-12-000042,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE During the quarter ended March 31, 2012, the Procter & Gamble Company (the Company) began presenting its Snacks business as a discontinued operation. During the quarter ended December 31, 2011, the Company changed its segment reporting structure and presentation of the Consolidated Statement of Earnings. This Form 8-K provides pro forma historical Consolidated Statements of Earnings and segment results for the three months ended September 30, 2011, December 31, 2011, and June 30, 2011, as well as for the twelve months ended June 30, 2011. This information in no way revises or restates the Consolidated Statement of Earnings, Consolidated Balance Sheet, Consolidated Statement of Shareholders Equity or Consolidated Statements of Cash Flows for the Company and consolidated subsidiaries for any period. Presentation of the Snacks Business as Discontinued Operations Effective during the quarter ended March 31, 2012, we reported the Snacks business as discontinued operations due to the agreement that was announced in February 2012 to divest the Snacks business to The Kellogg Company. Therefore, Snacks sales and earnings are no longer included in the results of the continuing operations of the Company. The transaction is expected to close by the end of the current fiscal year, subject to necessary regulatory approvals. Additionally, as a result of this change the Pet Care business is now included in the Fabric Care and Home Care segment effective in the January  March 2012 quarter. Fiscal Year 2012 Changes to Global Business Unit (GBU) Structure Effective during the quarter ended December 31, 2011, we implemented a number of changes to our organization structure within the Beauty & Grooming GBU, which resulted in changes to the components of the Beauty reportable segment and Grooming reportable segment. These two segments transitioned from consumer-oriented to product-oriented segment breakouts. As a result, female blades and razors transitioned from the Beauty reporting segment to the Grooming reporting segment, while male personal care products such as Old Spice and Gillette, moved from the Grooming reporting segment to the Beauty reporting segment. Presentation of the Consolidated Statements of Earnings Effective during the quarter ended December 31, 2011, we elected to revise our Consolidated Statements of Earnings to present separately the expense for net earnings attributable to noncontrolling interests. As previously disclosed, this expense has not historically been presented separately in the Consolidated Statements of Earnings due to immateriality, but has been reflected within other non-operating income/(expense). The historical Consolidated Statements of Earnings have been revised to conform to the new presentation. This document provides pro forma historical segment and consolidated earnings information reflecting these changes for the three months ended September 30, 2011, December 31, 2011, and June 30, 2011, as well as for the twelve months ended June 30, 2011. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Segment Earnings Information Three Months Ended September 30, 2011 Fabric Care and Home Care Baby Care and Family Care THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Segment Earnings Information Three Months Ended December 31, 2011 Fabric Care and Home Care Baby Care and Family Care THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Segment Earnings Information Three Months Ended June 30, 2011 Fabric Care and Home Care Baby Care and Family Care THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Segment Earnings Information Twelve Months Ended June 30, 2011 Fabric Care and Home Care Baby Care and Family Care THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended September 30, 2011 SELLING, GENERAL & ADMINISTRATIVE EXPENSE OTHER NON-OPERATING INCOME/(EXPENSE), NET EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES INCOME TAXES ON CONTINUING OPERATIONS NET EARNINGS FROM CONTINUING OPERATIONS NET EARNINGS FROM DISCONTINUED OPERATIONS LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE BASIC NET EARNINGS PER COMMON SHARE (1): EARNINGS FROM CONTINUING OPERATIONS EARNINGS FROM DISCONTINUED OPERATIONS BASIC NET EARNINGS PER COMMON SHARE DILUTED NET EARNINGS PER COMMON SHARE (1): EARNINGS FROM CONTINUING OPERATIONS EARNINGS FROM DISCONTINUED OPERATIONS DILUTED NET EARNINGS PER COMMON SHARE DIVIDENDS PER COMMON SHARE AVERAGE DILUTED SHARES OUTSTANDING (1) Basic net earnings per share and diluted net earnings per share are calculated on net earnings attributable to Procter & Gamble THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended December 31, 2011 SELLING, GENERAL & ADMINISTRATIVE EXPENSE GOODWILL & INDEFINITE LIVED INTANGIBLE IMPAIRMENT CHARGES OTHER NON-OPERATING INCOME/(EXPENSE), NET EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES INCOME TAXES ON CONTINUING OPERATIONS NET EARNINGS FROM CONTINUING OPERATIONS NET EARNINGS FROM DISCONTINUED OPERATIONS LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE BASIC NET EARNINGS PER COMMON SHARE (1): EARNINGS FROM CONTINUING OPERATIONS EARNINGS FROM DISCONTINUED OPERATIONS BASIC NET EARNINGS PER COMMON SHARE DILUTED NET EARNINGS PER COMMON SHARE (1): EARNINGS FROM CONTINUING OPERATIONS EARNINGS FROM DISCONTINUED OPERATIONS DILUTED NET EARNINGS PER COMMON SHARE DIVIDENDS PER COMMON SHARE AVERAGE DILUTED SHARES OUTSTANDING (1) Basic net earnings per share and diluted net earnings per share are calculated on net earnings attributable to Procter & Gamble THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended June 30, 2011 SELLING, GENERAL & ADMINISTRATIVE EXPENSE OTHER NON-OPERATING INCOME/(EXPENSE), NET EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES INCOME TAXES ON CONTINUING OPERATIONS NET EARNINGS FROM CONTINUING OPERATIONS NET EARNINGS FROM DISCONTINUED OPERATIONS LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE BASIC NET EARNINGS PER COMMON SHARE (1): EARNINGS FROM CONTINUING OPERATIONS EARNINGS FROM DISCONTINUED OPERATIONS BASIC NET EARNINGS PER COMMON SHARE DILUTED NET EARNINGS PER COMMON SHARE (1): EARNINGS FROM CONTINUING OPERATIONS EARNINGS FROM DISCONTINUED OPERATIONS DILUTED NET EARNINGS PER COMMON SHARE DIVIDENDS PER COMMON SHARE AVERAGE DILUTED SHARES OUTSTANDING (1) Basic net earnings per share and diluted net earnings per share are calculated on net earnings attributable to Procter & Gamble THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Twelve Months Ended June 30, 2011 SELLING, GENERAL & ADMINISTRATIVE EXPENSE OTHER NON-OPERATING INCOME/(EXPENSE), NET EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES INCOME TAXES ON CONTINUING OPERATIONS NET EARNINGS FROM CONTINUING OPERATIONS NET EARNINGS FROM DISCONTINUED OPERATIONS LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE BASIC NET EARNINGS PER COMMON SHARE (1): EARNINGS FROM CONTINUING OPERATIONS EARNINGS FROM DISCONTINUED OPERATIONS BASIC NET EARNINGS PER COMMON SHARE DILUTED NET EARNINGS PER COMMON SHARE (1): EARNINGS FROM CONTINUING OPERATIONS EARNINGS FROM DISCONTINUED OPERATIONS DILUTED NET EARNINGS PER COMMON SHARE DIVIDENDS PER COMMON SHARE AVERAGE DILUTED SHARES OUTSTANDING (1) Basic net earnings per share and diluted net earnings per share are calculated on net earnings attributable to Procter & Gamble This 8-K is furnished pursuant to Item 7.01 Regulation FD Disclosure.",1251
2012-05-23,8-K,0000080424-12-000044,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4)) ITEM 7.01 REGULATION FD DISCLOSURE On May 23, 2012, The Procter & Gamble Company (the ""Company"") participated in the Citi Global Consumer Conference. Pursuant to Item 7.01, ""Regulation FD Disclosure,"" the Company is furnishing on this Form 8-K a series of slides referenced in the Company's remarks at the conference. Presentation slides and an audio replay of the remarks are also posted on the Company's website.",179
2012-06-20,8-K,0000080424-12-000046,"deutschebankconfernce.htm SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4)) ITEM 7.01 REGULATION FD DISCLOSURE On June 20, 2012, The Procter & Gamble Company (the ""Company"") issued a news release with respect to their participation in the Deutsche Bank Global Consumer Conference. Pursuant to Item 7.01, ""Regulation FD Disclosure,"" the Company is furnishing on this Form 8-K the news release, along with presentation slides and a script of the remarks from the conference. Presentation slides and a link to the audio replay are also posted on the Company's website.",193
2012-07-10,8-K,0000080424-12-000051,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On July 10, 2012, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of fifty-six point two cents ($0.562) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after August 15, 2012 to Common Stock and Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the close of business on July 20, 2012. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",214
2012-07-18,8-K,0000080424-12-000053,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On July 18, 2012 , i n response to recent erroneous media reports, the independent directors of the Board of The Procter & Gamble Company make the following statement: The Board is overseeing a plan to return P&G results to levels that produce the best long term value for shareholders; unanimously supports the plan and Chief Executive Officer, Bob McDonald, as he leads its implementation; and is monitoring its effectiveness. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",201
2012-08-03,8-K,0000080424-12-000058,"amj12earningsreleaseslides.htm SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On August 3, 2012, The Procter & Gamble Company (the ""Company"") issued a press release announcing its fourth quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",184
2012-08-03,8-K,0000080424-12-000057,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) ( Registrant's telephone number, including area code ) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On August 3, 2012, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended June 30, 2012. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",159
2012-08-08,10-K,0000080424-12-000063,"FY 2012 Financial Statements Footnotes UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark one) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended June 30, 2012 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-434 THE PROCTER & GAMBLE COMPANY One Procter & Gamble Plaza, Cincinnati, Ohio 45202 Telephone (513) 983-1100 IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered Common Stock, without Par Value New York Stock Exchange, NYSE Euronext-Paris Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  No o Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes o No  Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No o Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No o Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act). Large accelerated filer  Accelerated filer o Non-accelerated filer o Smaller reporting company o Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No  The aggregate market value of the voting stock held by non-affiliates amounted to $184 billion on December 31, 2011. There were 2,754,274,536 shares of Common Stock outstanding as of July 31, 2012. Documents Incorporated by Reference Portions of the Proxy Statement for the 2012 Annual Meeting of Shareholders which will be filed within one hundred and twenty days of the fiscal year ended June 30, 2012 (2012 Proxy Statement) are incorporated by reference into Part III of this report to the extent described herein. The Procter & Gamble Company 2 PART I Item 1. Business . Additional information required by this item is",534
2012-08-14,8-K,0001193125-12-355664,"SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) August 14, 2012 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (513) 983-1100 (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Item 8.01 Other Events. On August 14, 2012, The Procter & Gamble Company (the Company) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of Floating Rate Notes due 2014 under the Companys Registration Statement on Form S-3 (Registration No. 333-177762). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are",190
2012-08-16,8-K,0001193125-12-358849,"SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) August 16, 2012 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (513) 983-1100 (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) August 16, 2012, The Procter & Gamble Company (the Company) closed an underwritten public offering of 1,000,000,000 aggregate principal amount of 2.000% Notes due 2022 under the Companys Registration Statement on Form S-3 (Registration No. 333-177762). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are",184
2012-09-06,8-K,0001140361-12-039572,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation) (IRS Employer Identification No.) One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) Registrant's telephone number, including area code Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4)) On September 6, 2012, The Procter & Gamble Company (the Company) participated in the Barclays Back to School Consumer Conference. Pursuant to Item 7.01, Regulation FD Disclosure, the Company is furnishing on this Form 8-K a series of slides referenced in the Companys remarks at the conference. Presentation slides are also posted on the Companys website.",175
2012-10-09,8-K,0000080424-12-000080,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On October 9, 2012, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of fifty-six point two cents ($0.562) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after November 15, 2012 to Common Stock shareholders of record at the close of business on October 19, 2012, and to Series A and Series B Preferred Stock shareholders of record at the start of business on October 19, 2012. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",223
2012-10-09,8-K,0000080424-12-000078,"shareholdermeeting2012.htm SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 7.01 REGULATION FD DISCLOSURE On October 9, 2012, The Procter & Gamble Company (the ""Company"") issued a news release with respect to Chairman of the Board, President and Chief Executive Officer Robert A. McDonald's address to the shareholders at the Company's annual meeting. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",151
2012-10-12,8-K,0000080424-12-000082,"annualshareholdermtgresults.htm SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act Submission of Matters to a Vote of Security Holders The Procter & Gamble Company (the Company) held its Annual Meeting of Shareholders on October 9, 2012. Set forth below are the final voting results for each of the proposals submitted to a vote of the shareholders. Ratify Appointment of Independent Registered Public Accounting Firm Advisory Vote on Executive Compensation (The Say-on-Pay Vote) Shareholder Proposal - Say on Political Contributions Shareholder Proposal - Producer Responsibility for Packaging Shareholder Proposal - Adopt Simple Majority Vote",177
2012-10-25,10-Q,0000080424-12-000092,", and Risk Factors. These forward-looking statements generally are identified by the words believe, project, expect, anticipate, estimate, intend, strategy, future, opportunity, plan, may, should, will, would, will be, will continue, will likely result, and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in this section titled ""Economic Conditions, Challenges and Risks"" and the section titled ",102
2012-10-25,8-K,0000080424-12-000089,"jas2012earningsslides.htm SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On October 25, 2012, The Procter & Gamble Company (the ""Company"") issued a press release announcing its first quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",184
2012-10-25,8-K,0000080424-12-000088,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) ( Registrant's telephone number, including area code ) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On October 25, 2012, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended September 30, 2012. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",159
2012-11-15,8-K,0000080424-12-000094,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 7.01 REGULATION FD DISCLOSURE On November 15, 2012, The Procter & Gamble Company (the ""Company"") issued the attached news release. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",141
2013-01-08,8-K,0000080424-13-000003,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 5.02 (b) DEPARTURE OF DIRECTORS and 5.02 (d) ELECTION OF DIRECTORS On January 8, 2013, The Procter & Gamble Company (the ""Company"") issued a news release announcing that current Director Johnathan Rodgers notified Robert A. McDonald, Chairman of the Board, President and Chief Executive Officer, of his intention not to stand for re-election at the Companys Annual Shareholder Meeting in October 2013. The Company also announced that Terry Lundgren, Chairman of the Board, President and Chief Executive Officer of Macys Inc. was appointed to the Board of Directors effective immediately. Mr. Lundgren will serve on the Governance & Public Responsibility and Innovation & Technology Committees. The Company is filing this 8-K pursuant to Item 5.02(b), ""Departure of Directors"" and 5.02(d), ""Election of Directors."" A copy of the Company's press release relating to this announcement is being furnished as Exhibit 99 to this 8-K.",257
2013-01-08,8-K,0000080424-13-000004,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On January 8, 2013, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of fifty-six point twenty cents ($0.562) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after February 15, 2013, to Common Stock shareholders of record at the close of business on January 18, 2013, and to Series A and Series B Preferred Stock shareholders of record at the start of business on January 18, 2013. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",223
2013-01-25,10-Q,0000080424-13-000012,", and Risk Factors. These forward-looking statements generally are identified by the words believe, project, expect, anticipate, estimate, intend, strategy, future, opportunity, plan, may, should, will, would, will be, will continue, will likely result, and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in the section titled ""Economic Conditions, Challenges and Risks"" and the section titled ",102
2013-01-25,8-K,0000080424-13-000008,"ond2012earningsslides.htm SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On January 25, 2013, The Procter & Gamble Company (the ""Company"") issued a press release announcing its second quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",184
2013-01-25,8-K,0000080424-13-000006,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) ( Registrant's telephone number, including area code ) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 25, 2013, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended December 31, 2012. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",159
2013-02-14,8-K,0000080424-13-000014,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4)) ITEM 7.01 REGULATION FD DISCLOSURE On February 14, 2013, The Procter & Gamble Company (the ""Company"") issued a press release updating the Company's guidance. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",150
2013-02-21,8-K,0000080424-13-000017,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4)) ITEM 7.01 REGULATION FD DISCLOSURE On February 21, 2013 The Procter & Gamble Company (the ""Company"") participated in the Consumer Analyst Group of New York annual conference. Pursuant to Item 7.01, ""Regulation FD Disclosure,"" the Company is furnishing on this Form 8-K a series of slides referenced in the Company's remarks at the conference. Presentation slides are also posted on the Company's website.",176
2013-04-15,8-K,0000080424-13-000023,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On April 15, 2013, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of sixty point fifteen cents ($0.6015) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after May 15, 2013, to Common Stock shareholders of record at the close of business on April 26, 2013, and to Series A and Series B Preferred Stock shareholders of record at the start of business on April 26, 2013. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",223
2013-04-24,8-K,0000080424-13-000029,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On April 24, 2013, The Procter & Gamble Company (the ""Company"") issued a press release announcing its third quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",183
2013-04-24,8-K,0000080424-13-000026,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) ( Registrant's telephone number, including area code ) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On April 24, 2013, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended March 31, 2013. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",159
2013-04-24,10-Q,0000080424-13-000033,", and Risk Factors. These forward-looking statements generally are identified by the words believe, project, expect, anticipate, estimate, intend, strategy, future, opportunity, plan, may, should, will, would, will be, will continue, will likely result, and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in the section titled ""Economic Conditions, Challenges and Risks"" and the section titled ",102
2013-05-14,8-K,0000080424-13-000037,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4)) ITEM 7.01 REGULATION FD DISCLOSURE On May 14, 2013, The Procter & Gamble Company (the ""Company"") participated in the Goldman Sachs Consumer Products Symposium. Pursuant to Item 7.01, ""Regulation FD Disclosure,"" the Company is furnishing on this Form 8-K a series of slides referenced in the Company's remarks at the conference. Presentation slides are also posted on the Company's website.",173
2013-05-24,8-K,0000080424-13-000039,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS On May 23, 2013, The Procter & Gamble Company (the Company) announced that, effective June 30, 2013, Robert A. McDonald will retire from the Company after 33 years of service and, effective immediately, has stepped down from his position of Chairman of the Board, President and Chief Executive Officer and resigned from the Board of Directors. During the weeks leading up to his retirement date, Mr. McDonald will serve in an advisory capacity on transition issues as Retired Chairman, President and Chief Executive Officer. The Company does not have employment contracts with its executive officers and Mr. McDonald will not receive any severance payments upon his retirement. The treatment of his compensation upon retirement will be consistent with the Companys past practices, and its programs as described on pages 56-59 of the Companys 2012 Proxy Statement. On May 23, 2013, the Company also announced that, effective immediately, A.G. Lafley (age 65) has been appointed to the Board of Directors, and elected Chairman of the Board, President and Chief Executive Officer, to serve at the pleasure of the Board. Mr. Lafley originally joined the Company in 1977 and was named Group Vice President in 1992, an Executive Vice President in 1995, and President and Chief Executive Officer in 2000, a position he held until June 30, 2009. On July 1, 2002, Mr. Lafley was elected Chairman of the Board, a position he held until January 2010. During the past five years, in addition to his roles as a Company employee, Mr. Lafley served as a consultant to the Company and as a member of the boards of directors of public companies Dell, Inc. and General Electric Company. Since his retirement from the Company he also has been involved in consulting on business and innovation strategy, advising on CEO succession and executive leadership development, and coaching experienced, new and potential CEOs. He currently serves as Senior Advisor at Clayton, Dubilier & Rice, LLC, a private equity partnership, and on the board of directors of Legend Pictures, LLC, a film production company. Effective immediately, Mr. Lafley will receive an annual base salary of U.S. $2,000,000. Starting on July 1, 2013 (the first day of the Companys new fiscal year), he will participate in the Companys annual performance-based bonus program with a target award equal to 250% of base salary. Starting in the Companys new fiscal year, he will receive equity grants under the Companys long-term incentive program commensurate with his position and on the same timing as other executive officers. In addition, on June 30, 2013, as compensation for his service in the current fiscal year, he will receive a cash payment of $1,632,000 equal to a prorated portion of his target annual bonus and estimated competitive annual long-term incentive grant value. Mr. Lafley will participate in all other elements of the Companys executive compensation and benefit programs (including as a vested participant in the Companys retirement program). Those programs are outlined in the Companys 2012 Proxy Statement. Mr. Lafley will not receive any fees for his service on the Board of Directors. The Company is filing this 8-K pursuant to Items 5.02(b), (c) & (d), Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. ITEM 7.01 REGULATION FD DISCLOSURE The Company issued a news release on May 23, 2013 announcing the election and appointment of Mr. Lafley and the changes to Mr. McDonalds role. A copy of this news release is furnished as Exhibit 99 to this report. The Companys Chief Financial Officer, Jon Moeller, will host a brief conference call on Friday, May 24, 2013 at 8:00 am EDT to provide additional perspective on the points noted in the press release. You may access the call by dialing: 1-800-299-9630 for domestic calls 1-617-786-2904 for international calls Confirmation code: 4662706 The Company will also webcast the conference call. You may access the webcast by going to: The Company is furnishing the information under this item pursuant to Item 7.01, Regulation FD Disclosure. The information in Exhibit 99 shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934 or incorporated by reference into any filing under the Securities Act of 1933.",839
2013-06-05,8-K,0000080424-13-000043,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4)) ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS On June 5, 2013, The Procter & Gamble Company (the Company) announced the grouping of its Global Business Units into four industry-based sectors. In connection with the organizational changes associated with that grouping, E. Dimitri Panayotopoulos, currently Vice Chairman, Global Business Units, will leave that position and has been elected Vice Chairman and Advisor to the Chairman and CEO, effective July 1, 2013. The Company is filing this 8-K pursuant to Item 5.02(b), Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. ITEM 7.01 REGULATION FD DISCLOSURE The Company issued a news release on June 5, 2013 announcing the changes to E. Dimitri Panayotopoulos role in addition to other organizational changes. A copy of this news release is furnished as Exhibit 99 to this report. The Company is furnishing the information under this item pursuant to Item 7.01, Regulation FD Disclosure. The information in Exhibit 99 shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934 or incorporated by reference into any filing under the Securities Act of 1933.",320
2013-06-12,8-K,0000080424-13-000045,"deutschbank2013conference.htm SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4)) ITEM 7.01 REGULATION FD DISCLOSURE On June 12, 2013, The Procter & Gamble Company (the ""Company"") participated in the Deutsche Bank Global Consumer Conference. Pursuant to Item 7.01, ""Regulation FD Disclosure,"" the Company is furnishing on this Form 8-K the presentation slides from the conference. Presentation slides and a link to the audio replay are also posted on the Company's website.",175
2013-07-09,8-K,0000080424-13-000049,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On July 9, 2013, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of sixty point fifteen cents ($0.6015) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after August 15, 2013, to Common Stock shareholders of record at the close of business on July 19, 2013, and to Series A and Series B Preferred Stock shareholders of record at the start of business on July 19, 2013. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",223
2013-08-01,8-K,0000080424-13-000054,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) ( Registrant's telephone number, including area code ) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On August 1, 2013, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended June 30, 2013. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",159
2013-08-01,8-K,0000080424-13-000057,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On August 1, 2013, The Procter & Gamble Company (the ""Company"") issued a press release announcing its fourth quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",183
2013-08-08,10-K,0000080424-13-000063,"FY 2013 10K Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark one) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended June 30, 2013 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-434 THE PROCTER & GAMBLE COMPANY One Procter & Gamble Plaza, Cincinnati, Ohio 45202 Telephone (513) 983-1100 IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered Common Stock, without Par Value New York Stock Exchange, NYSE Euronext-Paris Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  No o Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes o No  Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No o Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No o Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act). Large accelerated filer  Accelerated filer o Non-accelerated filer o Smaller reporting company o Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No  The aggregate market value of the voting stock held by non-affiliates amounted to $185 billion on December 31, 2012 . There were 2,738,760,542 shares of Common Stock outstanding as of July 31, 2013 . Documents Incorporated by Reference Portions of the Proxy Statement for the 2013 Annual Meeting of Shareholders which will be filed within one hundred and twenty days of the fiscal year ended June 30, 2013 ( 2013 Proxy Statement) are incorporated by reference into Part III of this report to the extent described herein. The Procter & Gamble Company 13 PART I Item 1. Business . Additional information required by this item is",537
2013-08-13,8-K,0001193125-13-332797,"SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) August 13, 2013 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (513) 983-1100 (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Item 8.01 Other Events. On August 13, 2013, The Procter & Gamble Company (the Company) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 3.100% Notes due 2023 under the Companys Registration Statement on Form S-3 (Registration No. 333-177762). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are",189
2013-08-15,8-K,0001193125-13-336252,"SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) August 15, 2013 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number) One Procter & Gamble Plaza, (Address of principal executive offices) (513) 983-1100 (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) August 15, 2013, The Procter & Gamble Company (the Company) closed an underwritten public offering of $69,838,000 aggregate principal amount of Floating Rate Notes due 2063 under the Companys Registration Statement on Form S-3 (Registration No. 333-177762). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are",183
2013-09-04,8-K,0000080424-13-000065,"barclay2013conference.htm SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4)) ITEM 7.01 REGULATION FD DISCLOSURE On September 4, 2013, The Procter & Gamble Company (the ""Company"") participated in the Barclays Back to School Conference. Pursuant to Item 7.01, ""Regulation FD Disclosure,"" the Company is furnishing on this Form 8-K a series of slides referenced in the Company's remarks at the conference. Presentation slides are also posted on the Company's website.",174
2013-09-16,8-K,0000080424-13-000067,"gbu2014structurechange.htm SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE The Procter & Gamble Company (the ""Company"") changed our segment reporting structure effective July 1, 2013. This Form 8-K provides pro forma historical segment earnings information for the three months ended June 30, 2013, March 31, 2013, December 31, 2012, September 30, 2012, June 30, 2012, March 31, 2012, December 31, 2011 and September 30, 2011, as well as for the twelve months ended June 30, 2013 and June 30, 2012, reflecting the change in the reporting structure of the Company. This information in no way revises or restates the Consolidated Statement of Earnings, Consolidated Statement of Comprehensive Income, Consolidated Balance Sheets, Consolidated Statement of Shareholders' Equity or Consolidated Statements of Cash Flows for the Company and consolidated subsidiaries for any period. Fiscal Year 2014 Changes to Global Business Unit (""GBU"") Structure Effective July 1, 2013, the Company implemented a number of changes to our GBU structure, which resulted in changes to our reportable segments. We organized our GBUs into four industry-based sectors, comprised of 1) Beauty, 2) Health and Grooming, 3) Fabric and Home Care, and 4) Baby, Feminine and Family Care. Under U.S. GAAP, the GBUs underlying these sectors will be aggregated into five reportable segments: 1) Beauty, 2) Grooming, 3) Health Care, 4) Fabric Care and Home Care, and 5) Baby, Feminine and Family Care. As a result, Feminine Care transitioned from Health Care to Baby, Feminine and Family Care. Additionally, Pet Care transitioned from Fabric Care and Home Care to Health Care. The above changes will be reflected in the consolidated financial statements and segment reporting beginning in fiscal year 2014, starting with the Form 10-Q for the three months ended September 30, 2013. In advance of the Form 10-Q filing, this document provides pro forma sales and earnings information for the affected segments for the three months ended June 30, 2013, March 31, 2013, and December 31, 2012, September 30, 2012, June 30, 2012, March 31, 2012, December 31, 2011, and September 30, 2011, as well as for the twelve months ended June 30, 2013 and June 30, 2012. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Segment Earnings Information Three Months Ended June 30, 2013 Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Fabric Care and Home Care Baby, Feminine, and Family Care 1 (1) Previously referred to as the Baby Care and Family Care segment THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Segment Earnings Information Three Months Ended March 31, 2013 Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Fabric Care and Home Care Baby, Feminine, and Family Care 1 (1) Previously referred to as the Baby Care and Family Care segment THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Segment Earnings Information Three Months Ended December 31, 2012 Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Fabric Care and Home Care Baby, Feminine, and Family Care 1 (1) Previously referred to as the Baby Care and Family Care segment THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Segment Earnings Information Three Months Ended September 30, 2012 Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Fabric Care and Home Care Baby, Feminine, and Family Care 1 (1) Previously referred to as the Baby Care and Family Care segment THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Segment Earnings Information Three Months Ended June 30, 2012 Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Fabric Care and Home Care Baby, Feminine, and Family Care 1 (1) Previously referred to as the Baby Care and Family Care segment THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Segment Earnings Information Three Months Ended March 31, 2012 Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Fabric Care and Home Care Baby, Feminine, and Family Care 1 (1) Previously referred to as the Baby Care and Family Care segment THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Segment Earnings Information Three Months Ended December 31, 2011 Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Fabric Care and Home Care Baby, Feminine, and Family Care 1 (1) Previously referred to as the Baby Care and Family Care segment THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Segment Earnings Information Three Months Ended September 30, 2011 Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Fabric Care and Home Care Baby, Feminine, and Family Care 1 (1) Previously referred to as the Baby Care and Family Care segment THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Segment Earnings Information Twelve Months Ended June 30, 2013 Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Fabric Care and Home Care Baby, Feminine, and Family Care 1 (1) Previously referred to as the Baby Care and Family Care segment THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Segment Earnings Information Twelve Months Ended June 30, 2012 Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Earnings From Continuing Operations Before Income Taxes Net Earnings From Continuing Operations Fabric Care and Home Care Baby, Feminine, and Family Care 1 (1) Previously referred to as the Baby Care and Family Care segment This 8-K is furnished pursuant to Item 7.01 Regulation FD Disclosure.",1104
2013-10-08,8-K,0000080424-13-000077,"shareholdermeeting2013.htm SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 7.01 REGULATION FD DISCLOSURE On October 8, 2013, The Procter & Gamble Company (NYSE:PG)(the ""Company"") issued a news release with respect to Chairman of the Board, President and Chief Executive Officer A.G. Lafley's address to the shareholders at the Company's annual meeting. In addition, t he Board of Directors of the Company declared a quarterly dividend of $0.6015 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after November 15, 2013, to Common Stock shareholders of record at the close of business on October 18, 2013, and to Series A and Series B Preferred Stock shareholders of record at the start of business on October 18, 2013. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",232
2013-10-11,8-K,0000080424-13-000079,"meeting2013voteresults.htm SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act Submission of Matters to a Vote of Security Holders The Procter & Gamble Company (the Company) held its Annual Meeting of Shareholders on October 8, 2013. Set forth below are the final voting results for each of the proposals submitted to a vote of the shareholders. Ratify Appointment of Independent Registered Public Accounting Firm Amend the Company's Regulations to Reduce Certain Supermajority Voting Requirements Adopt The Procter & Gamble 2013 Non-Employee Directors' Stock Plan Provide an Advisory Vote on the Company's Executive Compensation (the ""Say on Pay"" Vote)",182
2013-10-25,8-K,0000080424-13-000082,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) ( Registrant's telephone number, including area code ) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On October 25, 2013, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended September 30, 2013. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",165
2013-10-25,8-K,0000080424-13-000086,"q1fy2014earningsslides.htm SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On October 25, 2013, The Procter & Gamble Company (the ""Company"") issued a press release announcing its first quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",184
2013-10-25,10-Q,0000080424-13-000089,", and Risk Factors. These forward-looking statements generally are identified by the words believe, project, expect, anticipate, estimate, intend, strategy, future, opportunity, plan, may, should, will, would, will be, will continue, will likely result, and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in the section titled ""Economic Conditions, Challenges and Risks"" and the section titled ",102
2013-10-28,8-K,0000080424-13-000094,"FY2013 Form 8-K Cover Page UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) October 28, 2013 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) Zip Code (513) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 8.01 OTHER EVENTS Effective July 1, 2013, we implemented a number of changes to our Global Business Unit (GBU) structure, which resulted in changes to our reportable segments. We organized our GBUs into four industry-based sectors, comprised of 1) Global Beauty, 2) Global Health and Grooming, 3) Global Fabric and Home Care, and 4) Global Baby, Feminine and Family Care. Under U.S. GAAP, the GBUs underlying these sectors will be aggregated into five reportable segments: 1) Beauty, 2) Grooming, 3) Health Care, 4) Fabric Care and Home Care, and 5) Baby, Feminine and Family Care. As a result of the organizational changes, Feminine Care transitioned from Health Care to Baby, Feminine and Family Care, and Pet Care transitioned from Fabric Care and Home Care to Health Care. In this Form 8-K, the Company is providing a revised Management's Discussion and Analysis (MD&A) and consolidated financial statements and notes thereto for the years ended June 30, 2013, 2012 and 2011, to revise the segment disclosures for those periods to conform to its new organization structure. The revised MD&A and consolidated financial statements otherwise continue to speak as the date of the filing of the Form 10-K for the fiscal year ended June 30, 2013 (the 2013 10-K) with the Securities and Exchange Commission (SEC) and have not been updated for events or developments that occurred subsequent to such filing. For developments since the filing of the 2013 10-K, please refer to the Company's Form 10-Q for the quarter ended September 30, 2013 and the Company's Forms 8-K filed since August 8, 2013, the filing date of the 2013 10-K.",447
2013-11-04,8-K,0001193125-13-425198,"SECURITIES AND EXCHANGE COMMISSION CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) November 4, 2013 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) On November 4, 2013, The Procter & Gamble Company (the Company) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.600% Notes due 2018, $500,000,000 aggregate principal amount of 0.750% Notes due 2016 and $500,000,000 aggregate principal amount of Floating Rate Notes due 2016 under the Companys Registration Statement on Form S-3 (Registration No. 333-177762). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are",191
2013-11-05,8-K,0001193125-13-426591,"SECURITIES AND EXCHANGE COMMISSION CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) November 5, 2013 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) On November 5, 2013, The Procter & Gamble Company (the Company) closed an underwritten public offering of 750,000,000 aggregate principal amount of 2.000% Notes due 2021 under the Companys Registration Statement on Form S-3 (Registration No. 333-177762). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are",171
2013-12-13,8-K,0000080424-13-000101,"pgregulation2013change.htm SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGES IN FISCAL YEAR. On December 10, 2013, the Board of Directors of The Procter & Gamble Company (the Company) approved and adopted an amendment to the Companys Code of Regulations (the Regulations) effective immediately. The Board approved this amendment pursuant to authority granted by shareholders at the Annual Meeting of Shareholders held on October 13, 2009. The Board amended the provision of the Regulations that addresses indemnification of directors, officers and employees, including clarification of the language and improved readability. To simplify the structure of the Regulations, the indemnification provision (formerly Article III, Section 8) was made into a standalone Article of the Regulations (Article V), and the subsequent Articles were renumbered accordingly. The foregoing description of the Regulations is qualified in its entirety by reference to the full text of the Code of Regulations of The Procter & Gamble Company, which is filed as Exhibit 3(ii) to this Form 8-K and is hereby incorporated by reference. The Company is filing this 8-K pursuant to Item 5.03, "" Amendments to Articles of Incorporation or Bylaws; Changes in Fiscal Year .""",302
2014-01-14,8-K,0000080424-14-000002,"jan2014quarterlydividend.htm SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On January 14, 2014, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of sixty point fifteen cents ($0.6015) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after February 18, 2014, to Common Stock shareholders of record at the close of business on January 24, 2014, and to Series A and Series B Preferred Stock shareholders of record at the start of business on January 24, 2014. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",224
2014-01-24,10-Q,0000080424-14-000012,", and Risk Factors. These forward-looking statements generally are identified by the words believe, project, expect, anticipate, estimate, intend, strategy, future, opportunity, plan, may, should, will, would, will be, will continue, will likely result, and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in the section titled ""Economic Conditions, Challenges and Risks"" and the section titled ",102
2014-01-24,8-K,0000080424-14-000008,"ond2013earningsreleaseslides.htm SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On January 24, 2014, The Procter & Gamble Company (the ""Company"") issued a press release announcing its second quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",184
2014-01-24,8-K,0000080424-14-000006,"ond2013earningsrelease.htm SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) ( Registrant's telephone number, including area code ) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 24, 2014, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended December 31, 2013. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",166
2014-02-11,8-K,0000080424-14-000016,"earningsupdatefeb2014.htm SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4)) ITEM 7.01 REGULATION FD DISCLOSURE On February 11, 2014, The Procter & Gamble Company (the ""Company"") issued a press release updating the Company's guidance. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",151
2014-02-14,8-K,0000080424-14-000020,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 8.01 OTHER EVENTS On February 14, 2014, The Procter & Gamble Companys (the ""Company"") Chairman of the Board, President and Chief Executive Officer, A.G. Lafley, exercised stock options for 92,896 shares of P&G common stock. A portion of the shares were sold to cover the option cost and tax liability for the exercise, and the remaining shares were added to Mr. Lafleys current holdings, which now total 779,619 shares. These options, which were granted to Mr. Lafley during his prior tenure as CEO in 2004, were due to expire later this year. As part of his financial planning, Mr. Lafley exercised these options in order to ensure that they would not expire, given that he is subject to limited trading windows under the Companys trading policy. Mr. Lafley will have a sale of approximately 90,000 shares later this month to cover the tax obligations resulting from the settlement of a Restricted Stock Unit grant and an annual distribution of deferred compensation, each awarded during his prior tenure as CEO. Mr. Lafley has additional options that will expire in February 2015, and he will look at opportunities to exercise those options in the coming months, prior to expiration. Each of these transactions will be reported on Form 4s, in compliance with SEC rules. Additional detail regarding Mr. Lafleys holdings, including his outstanding stock option grants, Restricted Stock Units, and deferred compensation, are provided in the Companys 2013 Proxy Statement.",352
2014-02-28,8-K,0000080424-14-000022,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 8.01 OTHER EVENTS The Procter & Gamble Company (the Company) has been advised that A.G. Lafley, Chairman of the Board, President and Chief Executive Officer of the Company, has entered into a stock trading plan designed to comply with Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. Under Rule 10b5-1(c), directors and officers may adopt a prearranged plan or contract for the sale of Company securities under specified conditions and at specified times. Mr. Lafleys plan is designed to manage the exercise of options for 573,229 shares of common stock that were granted to him in February 2005, during his prior tenure as Chief Executive Officer, and will expire on February 28, 2015. The plan allows for the sale of the shares acquired upon the exercise of these options, subject to certain limit orders. Sales pursuant to this plan may begin on April 24, 2014. The plan, which was established during the Companys current open trading window, will terminate on February 28, 2015, when the options expire, unless terminated sooner in accordance with its terms. Mr. Lafley and the Company will report transactions effected under the plan as required, through Form 4 filings made with the Securities and Exchange Commission. Except as may be required by law, the Company does not undertake to report other Rule 10b5-1 plans that may be adopted by any officers or directors of the registrant in the future, or to report any modifications or termination of any publicly announced plan.",362
2014-04-07,8-K,0000080424-14-000026,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On April 7, 2014, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of sixty-four point thirty-six cents ($0.6436) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after May 15, 2014, to Common Stock shareholders of record at the close of business on April 25, 2014, and to Series A and Series B Preferred Stock shareholders of record at the start of business on April 25, 2014. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",223
2014-04-09,8-K,0000080424-14-000029,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On April 9, 2014, The Procter & Gamble Company (Company) and Mars, Incorporated (Mars) issued a news release announcing that the companies have reached an agreement for the sale of a significant portion of the Companys pet food business to Mars. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",172
2014-04-23,8-K,0000080424-14-000035,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On April 23, 2014, The Procter & Gamble Company (the ""Company"") issued a press release announcing its third quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",183
2014-04-23,8-K,0000080424-14-000033,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) ( Registrant's telephone number, including area code ) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On April 23, 2014, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended March 31, 2014. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",159
2014-04-23,10-Q,0000080424-14-000038,", and Risk Factors. These forward-looking statements generally are identified by the words believe, project, expect, anticipate, estimate, intend, strategy, future, opportunity, plan, may, should, will, would, will be, will continue, will likely result, and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in the section titled ""Economic Conditions, Challenges and Risks"" and the section titled ",102
2014-06-11,8-K,0000080424-14-000040,"informationalproforma2014.htm SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE As discussed in the following paragraph, due to the The Procter & Gamble Company's (the Company) planned exit from the pet care business, effective in April 2014 the Company is reporting the results of the pet care business as discontinued operations and, as such, these results have been excluded from both continuing operations and segment results. Additionally, as discussed below, the Company changed its management accounting during the final quarter of fiscal 2014 for unconsolidated investees, which impacted its segment reporting. This Form 8-K provides revised historical segment earnings and Consolidated Statements of Earnings information for the three months ended March 31, 2014, December 31, 2013, September 30, 2013, June 30, 2013, March 31, 2013, December 31, 2012 and September 30, 2012, as well as for the twelve months ended June 30, 2013 reflecting the above changes. This information in no way revises or restates the Consolidated Statements of Comprehensive Income, Consolidated Balance Sheets, Consolidated Statements of Shareholders Equity or Consolidated Statements of Cash Flows for the Company and consolidated subsidiaries for any period. In April 2014, the Company announced its intent to exit the pet care business. As part of the exit plan, the Company announced an agreement to sell its pet care operations in North America, Latin America, and other selected countries to Mars, Incorporated (Mars) for $2.9 billion in an all-cash transaction. Under the terms of the agreement, Mars will acquire our branded pet care products, our manufacturing facilities in the United States and the majority of the employees working in the pet care business. The agreement includes an option for Mars to acquire the pet care business in several additional countries. The Company expects to complete the transaction in the first half of fiscal 2015, pending the receipt of necessary regulatory approvals. The European Union countries are not included in the agreement with Mars. The Company is pursuing alternate plans to sell its pet care business in these markets. The pet care business had historically been part of the Companys Health Care reportable segment. In accordance with applicable accounting guidance for the disposal of long-lived assets, the results of the pet care business are presented as discontinued operations and, as such, will be excluded from both continuing operations and segment results. Additionally, the pet care balance sheet positions as of June 30, 2014 will be presented as held for sale in the Consolidated Balance Sheet. During the final quarter of fiscal 2014, we changed our management accounting for unconsolidated investees. Previously, certain unconsolidated investees that are managed as integral parts of our businesses for management reporting purposes were reflected as consolidated subsidiaries in segment results, with full recognition of the individual income statement line items through before-tax earnings. Eliminations to adjust these line items to the equity method of accounting under U.S. GAAP were included in Corporate. Pursuant to this change, segment results will no longer include full recognition of the individual income statement line items of unconsolidated investees, and resulting eliminations of such amounts will no longer be included in the corporate reportable segment. The change will not impact the net earnings of the segments or total Company. The above changes are being reflected in the consolidated financial statements and segment reporting beginning in fiscal year 2014, starting with the Form 10-K that will be issued for the twelve months ending June 30, 2014. Reporting changes for both of the above items will be reflected for all historical periods presented. In advance of the Form 10-K filing, this document provides revised sales and earnings information for the affected segments and Consolidated Statements of Earnings for the three months ended March 31, 2014, December 31, 2013, September 30, 2013, June 30, 2013, March 31, 2013, December 31, 2012 and September 30, 2012, as well as for the twelve months ended June 30, 2013. This 8-K is furnished pursuant to Item 7.01 Regulation FD Disclosure. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Segment Earnings Information Three Months Ended March 31, 2014 Fabric Care and Home Care Baby, Feminine, and Family Care THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Segment Earnings Information Three Months Ended December 31, 2013 Fabric Care and Home Care Baby, Feminine, and Family Care THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Segment Earnings Information Three Months Ended September 30, 2013 Fabric Care and Home Care Baby, Feminine, and Family Care THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Segment Earnings Information Three Months Ended June 30, 2013 Fabric Care and Home Care Baby, Feminine, and Family Care THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Segment Earnings Information Three Months Ended March 31, 2013 Fabric Care and Home Care Baby, Feminine, and Family Care THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Segment Earnings Information Three Months Ended December 31, 2012 Fabric Care and Home Care Baby, Feminine, and Family Care THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Segment Earnings Information Three Months Ended September 30, 2012 Fabric Care and Home Care Baby, Feminine, and Family Care THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES Segment Earnings Information Twelve Months Ended June 30, 2013 Fabric Care and Home Care Baby, Feminine, and Family Care THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended March 31, 2014 SELLING, GENERAL AND ADMINISTRATIVE EXPENSE GOODWILL AND INTANGIBLES IMPAIRMENT CHARGES OTHER NON-OPERATING INCOME, NET EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES NET EARNINGS FROM CONTINUING OPERATIONS NET EARNINGS FROM DISCONTINUED OPERATIONS LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE NET EARNINGS PER COMMON SHARE: EARNINGS FROM CONTINUING OPERATIONS EARNINGS FROM DISCONTINUED OPERATIONS BASIC NET EARNINGS PER COMMON SHARE DILUTED NET EARNINGS PER COMMON SHARE: EARNINGS FROM CONTINUING OPERATIONS EARNINGS FROM DISCONTINUED OPERATIONS DILUTED NET EARNINGS PER COMMON SHARE DIVIDENDS PER COMMON SHARE DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended December 31, 2013 SELLING, GENERAL AND ADMINISTRATIVE EXPENSE GOODWILL AND INTANGIBLES IMPAIRMENT CHARGES OTHER NON-OPERATING INCOME, NET EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES NET EARNINGS FROM CONTINUING OPERATIONS NET EARNINGS FROM DISCONTINUED OPERATIONS LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE NET EARNINGS PER COMMON SHARE: EARNINGS FROM CONTINUING OPERATIONS EARNINGS FROM DISCONTINUED OPERATIONS BASIC NET EARNINGS PER COMMON SHARE DILUTED NET EARNINGS PER COMMON SHARE: EARNINGS FROM CONTINUING OPERATIONS EARNINGS FROM DISCONTINUED OPERATIONS DILUTED NET EARNINGS PER COMMON SHARE DIVIDENDS PER COMMON SHARE DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended September 30, 2013 SELLING, GENERAL AND ADMINISTRATIVE EXPENSE GOODWILL AND INTANGIBLES IMPAIRMENT CHARGES OTHER NON-OPERATING INCOME, NET EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES NET EARNINGS FROM CONTINUING OPERATIONS NET EARNINGS FROM DISCONTINUED OPERATIONS LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE NET EARNINGS PER COMMON SHARE: EARNINGS FROM CONTINUING OPERATIONS EARNINGS FROM DISCONTINUED OPERATIONS BASIC NET EARNINGS PER COMMON SHARE DILUTED NET EARNINGS PER COMMON SHARE: EARNINGS FROM CONTINUING OPERATIONS EARNINGS FROM DISCONTINUED OPERATIONS DILUTED NET EARNINGS PER COMMON SHARE DIVIDENDS PER COMMON SHARE DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended June 30, 2013 SELLING, GENERAL AND ADMINISTRATIVE EXPENSE GOODWILL AND INTANGIBLES IMPAIRMENT CHARGES OTHER NON-OPERATING INCOME, NET EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES NET EARNINGS FROM CONTINUING OPERATIONS NET EARNINGS/(LOSS) FROM DISCONTINUED OPERATIONS LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE NET EARNINGS PER COMMON SHARE: EARNINGS FROM CONTINUING OPERATIONS EARNINGS FROM DISCONTINUED OPERATIONS BASIC NET EARNINGS PER COMMON SHARE DILUTED NET EARNINGS PER COMMON SHARE: EARNINGS FROM CONTINUING OPERATIONS EARNINGS FROM DISCONTINUED OPERATIONS DILUTED NET EARNINGS PER COMMON SHARE DIVIDENDS PER COMMON SHARE DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended March 31, 2013 SELLING, GENERAL AND ADMINISTRATIVE EXPENSE GOODWILL AND INTANGIBLES IMPAIRMENT CHARGES OTHER NON-OPERATING INCOME, NET EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES NET EARNINGS FROM CONTINUING OPERATIONS NET EARNINGS FROM DISCONTINUED OPERATIONS LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE NET EARNINGS PER COMMON SHARE: EARNINGS FROM CONTINUING OPERATIONS EARNINGS FROM DISCONTINUED OPERATIONS BASIC NET EARNINGS PER COMMON SHARE DILUTED NET EARNINGS PER COMMON SHARE: EARNINGS FROM CONTINUING OPERATIONS EARNINGS FROM DISCONTINUED OPERATIONS DILUTED NET EARNINGS PER COMMON SHARE DIVIDENDS PER COMMON SHARE DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended December 31, 2012 SELLING, GENERAL AND ADMINISTRATIVE EXPENSE GOODWILL AND INTANGIBLES IMPAIRMENT CHARGES OTHER NON-OPERATING INCOME, NET EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES NET EARNINGS FROM CONTINUING OPERATIONS NET EARNINGS FROM DISCONTINUED OPERATIONS LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE NET EARNINGS PER COMMON SHARE: EARNINGS FROM CONTINUING OPERATIONS EARNINGS FROM DISCONTINUED OPERATIONS BASIC NET EARNINGS PER COMMON SHARE DILUTED NET EARNINGS PER COMMON SHARE: EARNINGS FROM CONTINUING OPERATIONS EARNINGS FROM DISCONTINUED OPERATIONS DILUTED NET EARNINGS PER COMMON SHARE DIVIDENDS PER COMMON SHARE DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended September 30, 2012 SELLING, GENERAL AND ADMINISTRATIVE EXPENSE GOODWILL AND INTANGIBLES IMPAIRMENT CHARGES OTHER NON-OPERATING INCOME, NET EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES NET EARNINGS FROM CONTINUING OPERATIONS NET EARNINGS FROM DISCONTINUED OPERATIONS LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE NET EARNINGS PER COMMON SHARE: EARNINGS FROM CONTINUING OPERATIONS EARNINGS FROM DISCONTINUED OPERATIONS BASIC NET EARNINGS PER COMMON SHARE DILUTED NET EARNINGS PER COMMON SHARE: EARNINGS FROM CONTINUING OPERATIONS EARNINGS FROM DISCONTINUED OPERATIONS DILUTED NET EARNINGS PER COMMON SHARE DIVIDENDS PER COMMON SHARE DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Twelve Months Ended June 30, 2013 SELLING, GENERAL AND ADMINISTRATIVE EXPENSE GOODWILL AND INTANGIBLES IMPAIRMENT CHARGES OTHER NON-OPERATING INCOME, NET EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES NET EARNINGS FROM CONTINUING OPERATIONS NET EARNINGS FROM DISCONTINUED OPERATIONS LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE NET EARNINGS PER COMMON SHARE: EARNINGS FROM CONTINUING OPERATIONS EARNINGS FROM DISCONTINUED OPERATIONS BASIC NET EARNINGS PER COMMON SHARE DILUTED NET EARNINGS PER COMMON SHARE: EARNINGS FROM CONTINUING OPERATIONS EARNINGS FROM DISCONTINUED OPERATIONS DILUTED NET EARNINGS PER COMMON SHARE DIVIDENDS PER COMMON SHARE DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING",1911
2014-06-25,8-K,0000080424-14-000043,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS On June 25, 2014, The Procter & Gamble Company announced that Werner Geissler, currently Vice ChairmanGlobal Operations, will leave that position and has been elected Vice Chairman and Advisor to the Chairman and Chief Executive Officer, effective July 1, 2014. In that capacity, Mr. Geissler will report to A.G. Lafley and will lead the reorganization of the Companys Global Operations organization and support the previously announced Selling & Market Operations (SMO) transition in Europe; India, Middle East and Africa; and Asia. The Company is filing this 8-K pursuant to Items 5.02(b), Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.",242
2014-07-08,8-K,0000080424-14-000048,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On July 8, 2014, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of sixty-four point thirty-six cents ($0.6436) per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after August 15, 2014, to Common Stock shareholders of record at the close of business on July 18, 2014, and to Series A and Series B Preferred Stock shareholders of record at the start of business on July 18, 2014. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",223
2014-08-01,8-K,0000080424-14-000052,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On August 1, 2014, The Procter & Gamble Company (the ""Company"") issued a press release announcing its fourth quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",183
2014-08-01,8-K,0000080424-14-000050,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) ( Registrant's telephone number, including area code ) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On August 1, 2014, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended June 30, 2014. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",159
2014-08-08,10-K,0000080424-14-000057,"FY 2014 10K Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark one) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended June 30, 2014 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-434 THE PROCTER & GAMBLE COMPANY One Procter & Gamble Plaza, Cincinnati, Ohio 45202 Telephone (513) 983-1100 IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered Common Stock, without Par Value New York Stock Exchange, NYSE Euronext-Paris Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  No o Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes o No  Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No o Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No o Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act). Large accelerated filer  Accelerated filer o Non-accelerated filer o Smaller reporting company o Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No  The aggregate market value of the voting stock held by non-affiliates amounted to $221 billion on December 31, 2013 . There were 2,707,652,337 shares of Common Stock outstanding as of July 31, 2014 . Documents Incorporated by Reference Portions of the Proxy Statement for the 2014 Annual Meeting of Shareholders which will be filed within one hundred and twenty days of the fiscal year ended June 30, 2014 ( 2014 Proxy Statement) are incorporated by reference into Part III of this report to the extent described herein. The Procter & Gamble Company 11 PART I Item 1. Business . Additional information required by this item is",537
2014-10-14,8-K,0000080424-14-000069,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 7.01 REGULATION FD DISCLOSURE On October 14, 2014, The Procter & Gamble Company (NYSE:PG)(the ""Company"") announced that its Board of Directors declared a quarterly dividend of $0.6436 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after November 17, 2014, to Common Stock shareholders of record at the close of business on October 24, 2014, and to Series A and Series B Preferred Stock shareholders of record at the start of business on October 24, 2014. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",200
2014-10-20,8-K,0000080424-14-000072,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act Submission of Matters to a Vote of Security Holders The Procter & Gamble Company (the Company) held its Annual Meeting of Shareholders on October 14, 2014. Set forth below are the final voting results for each of the proposals submitted to a vote of the shareholders. Ratify Appointment of Independent Registered Public Accounting Firm Adopt The Procter & Gamble 2014 Stock and Incentive Compensation Plan Provide an Advisory Vote on the Company's Executive Compensation (the ""Say on Pay"" Vote) Shareholder Proposal - Report on Unrecycled Packaging Shareholder Proposal - Report on Alignment Between Corporate Values and Political Contributions AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGES IN FISCAL YEAR. On October 14, 2014, the Board of Directors of The Procter & Gamble Company (the Company) approved and adopted an amendment to the Companys Code of Regulations (the Regulations), effective immediately. The Board approved this amendment pursuant to authority granted by shareholders at the Annual Meeting of Shareholders held on October 13, 2009. The Board amended Article V, Section 1, to clarify the provision regarding the indemnification of directors, officers and employees. The foregoing description of the Regulations is qualified in its entirety by reference to the full text of the Code of Regulations of The Procter & Gamble Company, which is filed as Exhibit 3(ii) to this Form 8-K and is hereby incorporated by reference. The Company is filing this 8-K pursuant to Item 5.07, ""Submission of Matters to a Vote of Security Holders,"" and 5.03, "" Amendments to Articles of Incorporation or Bylaws; Changes in Fiscal Year .""",352
2014-10-24,10-Q,0000080424-14-000077,", Risk Factors, and Note 4 to the Consolidated Financial Statements. These forward-looking statements generally are identified by the words believe, project, expect, anticipate, estimate, intend, strategy, future, opportunity, plan, may, should, will, would, will be, will continue, will likely result, and similar expressions. Forward-looking statements are based on current Amounts in millions of dollars unless otherwise specified. expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in the section titled ""Economic Conditions, Challenges and Risks"" and the section titled ",117
2014-10-24,8-K,0000862335-14-000003,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) ( Registrant's telephone number, including area code ) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On October 24, 2014, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended September 30, 2014. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",165
2014-10-24,8-K,0000862335-14-000005,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On October 24, 2014, The Procter & Gamble Company (the ""Company"") issued a press release announcing its first quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",183
2014-11-03,8-K,0001193125-14-394027,"SECURITIES AND EXCHANGE COMMISSION CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) November 3, 2014 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) On November 3, 2014, The Procter & Gamble Company (the Company) closed an underwritten public offering of $550,000,000 aggregate principal amount of 1.900% Notes due 2019 and $450,000,000 aggregate principal amount of Floating Rate Notes due 2019 under the Companys Registration Statement on Form S-3 (Registration No. 333-199594). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are",182
2014-11-03,8-K,0000080424-14-000079,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE Procter & Gamble has been made aware of concerns relating to its operations in Argentina. In response to press inquiries in Argentina about these concerns, P&G responded: P&G pays all the taxes we owe in every country and jurisdiction, worldwide. P&G takes very seriously our responsibility to abide by the laws of every country we operate in, and to contribute to the countries and communities in which we live and work. We value our relationship with the country of Argentina and with Argentinian consumers. We have served Argentinian consumers with our brands and products since 1991. We are working to more fully understand the concerns and to constructively resolve them. P&G's Argentina business accounts for about 1 percent of total Company sales, and a smaller percent of profit. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",258
2014-11-04,8-K,0001193125-14-396206,"SECURITIES AND EXCHANGE COMMISSION CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) November 4, 2014 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) On November 4, 2014, The Procter & Gamble Company (the Company) closed an underwritten public offering of $112,589,000 aggregate principal amount of Floating Rate Notes due 2064 under the Companys Registration Statement on Form S-3 (Registration No. 333-199594). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are",172
2014-11-13,8-K,0000080424-14-000082,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On November 13, 2014, The Procter & Gamble Company (the ""Company"") issued a news release with respect to the Company's 2014 Analyst Meeting and the Company's agreement with Berkshire Hathaway regarding the Duracell business. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",164
2014-11-21,8-K,0000080424-14-000086,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 8.01 OTHER EVENTS The Procter & Gamble Company (the ""Company"") has been advised that A.G. Lafley, Chairman of the Board, President and Chief Executive Officer of the Company, has entered into a stock trading plan designed to comply with Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. Under Rule 10b5-1(c), directors and officers may adopt a prearranged plan or contract for the sale of Company securities under specified conditions and at specified times. Mr. Lafley's plan is designed to manage the exercise of options for 430,441 shares of common stock that were granted to him in February 2006, during his prior tenure as Chief Executive Officer, and will expire on February 28, 2016. The plan allows for the sale of the shares acquired upon the exercise of these options, subject to certain limit orders. Sales pursuant to this plan may begin on January 28, 2015. The plan, which was established during the Company's current open trading window, will terminate on February 28, 2016, when the options expire, unless terminated sooner in accordance with its terms. Mr. Lafley and the Company will report transactions effected under the plan as required, through Form 4 filings made with the Securities and Exchange Commission . Except as may be required by law, the Company does not undertake to report other Rule 10b5-1 plans that may be adopted by any officers or directors of the registrant in the future, or to report any modifications or termination of any publicly announced plan.",363
2014-12-22,8-K,0000080424-14-000089,"informationalproforma2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) December 22, 2014 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) Zip Code (513) 983-1100 45202 (Registrant's telephone number, including area code) Zip Code o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE As discussed in the following paragraph, due to The Procter & Gamble Company's (the Company) planned exit from the Batteries business, the Company is reporting the results of the Batteries business, including the previously reported impairment charge in the three months ended September 30, 2014, as discontinued operations. This informational Form 8-K provides revised historical Segment and Consolidated earnings information for the three months ended September 30, 2014, June 30, 2014, March 31, 2014, December 31, 2013, and September 30, 2013, as well as for the fiscal year ended June 30, 2014, reflecting the above changes. This informational Form 8-K in no way revises or restates the previously filed Consolidated Statements of Comprehensive Income, Consolidated Balance Sheets, Consolidated Statements of Shareholders' Equity or Consolidated Statements of Cash Flows for the Company and consolidated subsidiaries for any period. Fiscal Year 2015 Changes On November 13, 2014, the Company announced that it plans to divest the Duracell business via a split transaction with Berkshire Hathaway, in which it will exchange a recapitalized Duracell Company for Berkshire Hathaways shares of Procter & Gamble stock. The Company had previously announced an agreement to divest its controlling interest in a Chinese batteries venture, which represents the balance of the Companys Batteries business. The Company expects to complete the Duracell transaction in the second half of calendar year 2015, pending necessary regulatory approvals. The Batteries business had historically been part of the Companys Fabric Care and Home Care reportable segment. In accordance with applicable accounting guidance for the disposal of long-lived assets, the results of the Batteries business will be presented as discontinued operations and, as such, will be excluded from both continuing operations and segment results. Additionally, the Batteries balance sheet positions as of December 31, 2014 will be presented as held for sale in the Consolidated Balance Sheet. The above changes will be reflected in the consolidated financial statements and segment reporting beginning in the second quarter (October - December period) of fiscal year 2015, starting with the Form 10-Q that will be issued for the three and six month periods ending December 31, 2014. Reporting changes for the above items will be reflected for all historical periods presented. In advance of the Form 10-Q filing, this document provides revised sales and earnings information for the affected segments and Consolidated Earnings information for the three months ended September 30, 2014, June 30, 2014, March 31, 2014, December 31, 2013, and September 30, 2013, as well as for the twelve months ended June 30, 2014. This 8-K is furnished pursuant to Item 7.01 Regulation FD Disclosure. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions) Segment Earnings Information Three Months Ended September 30, 2014 As Reported Revised Net Sales Earnings/(Loss) From Continuing Operations Before Income Taxes Net Earnings/(Loss) From Continuing Operations Net Sales Earnings/(Loss) From Continuing Operations Before Income Taxes Net Earnings/(Loss) From Continuing Operations Beauty, Hair and Personal Care $ 4,857 $ 926 $ 710 $ 4,857 $ 926 $ 710 Grooming 1,941 621 466 1,941 621 466 Health Care 2,011 459 322 2,011 459 322 Fabric Care and Home Care 6,538 1,180 783 5,933 1,081 719 Baby, Feminine and Family Care 5,322 1,202 825 5,322 1,202 825 Corporate 123 (1,565 ) (1,103 ) 122 (629 ) (202 ) Total Company $ 20,792 $ 2,823 $ 2,003 $ 20,186 $ 3,660 $ 2,840 THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions) Segment Earnings Information Three Months Ended June 30, 2014 As Reported Revised Net Sales Earnings/(Loss) From Continuing Operations Before Income Taxes Net Earnings/(Loss) From Continuing Operations Net Sales Earnings/(Loss) From Continuing Operations Before Income Taxes Net Earnings/(Loss) From Continuing Operations Beauty, Hair and Personal Care $ 4,629 $ 661 $ 498 $ 4,629 $ 661 $ 498 Grooming 2,072 645 485 2,072 645 485 Health Care 1,813 290 174 1,813 290 174 Fabric Care and Home Care 6,262 1,019 647 5,702 971 618 Baby, Feminine and Family Care 5,203 1,064 725 5,203 1,064 725 Corporate 178 (452 ) 82 177 (482 ) 56 Total Company $ 20,157 $ 3,227 $ 2,611 $ 19,596 $ 3,149 $ 2,556 THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions) Segment Earnings Information Three Months Ended March 31, 2014 As Reported Revised Net Sales Earnings/(Loss) From Continuing Operations Before Income Taxes Net Earnings/(Loss) From Continuing Operations Net Sales Earnings/(Loss) From Continuing Operations Before Income Taxes Net Earnings/(Loss) From Continuing Operations Beauty, Hair and Personal Care $ 4,691 $ 800 $ 624 $ 4,691 $ 800 $ 624 Grooming 1,863 613 463 1,863 613 463 Health Care 1,938 398 270 1,938 398 270 Fabric Care and Home Care 6,312 1,029 658 5,775 964 619 Baby, Feminine and Family Care 5,177 1,065 725 5,177 1,065 725 Corporate 197 (630 ) (137 ) 197 (665 ) (170 ) Total Company $ 20,178 $ 3,275 $ 2,603 $ 19,641 $ 3,175 $ 2,531 THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions) Segment Earnings Information Three Months Ended December 31, 2013 As Reported Revised Net Sales Earnings/(Loss) From Continuing Operations Before Income Taxes Net Earnings/(Loss) From Continuing Operations Net Sales Earnings/(Loss) From Continuing Operations Before Income Taxes Net Earnings/(Loss) From Continuing Operations Beauty, Hair and Personal Care $ 5,284 $ 1,160 $ 927 $ 5,284 $ 1,160 $ 927 Grooming 2,118 730 553 2,118 730 553 Health Care 2,153 525 374 2,153 525 374 Fabric Care and Home Care 6,820 1,334 877 6,022 1,149 751 Baby, Feminine and Family Care 5,323 1,099 765 5,323 1,099 765 Corporate 199 (446 ) (42 ) 199 (481 ) (73 ) Total Company $ 21,897 $ 4,402 $ 3,454 $ 21,099 $ 4,182 $ 3,297 THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions) Segment Earnings Information Three Months Ended September 30, 2013 As Reported Revised Net Sales Earnings/(Loss) From Continuing Operations Before Income Taxes Net Earnings/(Loss) From Continuing Operations Net Sales Earnings/(Loss) From Continuing Operations Before Income Taxes Net Earnings/(Loss) From Continuing Operations Beauty, Hair and Personal Care $ 4,903 $ 909 $ 690 $ 4,903 $ 909 $ 690 Grooming 1,956 601 453 1,956 601 453 Health Care 1,894 384 265 1,894 384 265 Fabric Care and Home Care 6,666 1,296 857 6,010 1,182 783 Baby, Feminine and Family Care 5,247 1,082 725 5,247 1,082 725 Corporate 164 (291 ) 49 164 (327 ) 18 Total Company $ 20,830 $ 3,981 $ 3,039 $ 20,174 $ 3,831 $ 2,934 THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions) Segment Earnings Information Twelve Months Ended June 30, 2014 As Reported Revised Net Sales Earnings/(Loss) From Continuing Operations Before Income Taxes Net Earnings/(Loss) From Continuing Operations Net Sales Earnings/(Loss) From Continuing Operations Before Income Taxes Net Earnings/(Loss) From Continuing Operations Beauty, Hair and Personal Care $ 19,507 $ 3,530 $ 2,739 $ 19,507 $ 3,530 $ 2,739 Grooming 8,009 2,589 1,954 8,009 2,589 1,954 Health Care 7,798 1,597 1,083 7,798 1,597 1,083 Fabric Care and Home Care 26,060 4,678 3,039 23,509 4,266 2,771 Baby, Feminine and Family Care 20,950 4,310 2,940 20,950 4,310 2,940 Corporate 738 (1,819 ) (48 ) 737 (1,955 ) (169 ) Total Company $ 83,062 $ 14,885 $ 11,707 $ 80,510 $ 14,337 $ 11,318 THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended September 30, 2014 As Reported Revised NET SALES $ 20,792 $ 20,186 COST OF PRODUCTS SOLD 10,552 10,209 GROSS PROFIT 10,240 9,977 SELLING, GENERAL AND ADMINISTRATIVE EXPENSE 6,327 6,199 GOODWILL AND INDEFINITE-LIVED INTANGIBLE ASSET IMPAIRMENT CHARGES 973  OPERATING INCOME 2,940 3,778 INTEREST EXPENSE 169 170 INTEREST INCOME 31 31 OTHER NON-OPERATING INCOME, NET 21 21 EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 2,823 3,660 INCOME TAXES 820 820 NET EARNINGS FROM CONTINUING OPERATIONS 2,003 2,840 NET EARNINGS/(LOSS) FROM DISCONTINUED OPERATIONS 17 (820 ) NET EARNINGS 2,020 2,020 LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS 30 30 NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 1,990 $ 1,990 EFFECTIVE TAX RATE 29.0 % 22.4 % BASIC NET EARNINGS PER COMMON SHARE*: EARNINGS FROM CONTINUING OPERATIONS $ 0.70 $ 1.01 EARNINGS FROM DISCONTINUED OPERATIONS $ 0.01 $ (0.30 ) BASIC NET EARNINGS PER COMMON SHARE $ 0.71 $ 0.71 DILUTED NET EARNINGS PER COMMON SHARE*: EARNINGS FROM CONTINUING OPERATIONS $ 0.68 $ 0.97 EARNINGS FROM DISCONTINUED OPERATIONS $ 0.01 $ (0.28 ) DILUTED NET EARNINGS PER COMMON SHARE $ 0.69 $ 0.69 DIVIDENDS PER COMMON SHARE $ 0.644 $ 0.644 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,888.0 2,888.0 *Basic net earnings per common share and diluted net earnings per common share are calculated on net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended June 30, 2014 As Reported Revised NET SALES $ 20,157 $ 19,596 COST OF PRODUCTS SOLD 10,636 10,288 GROSS PROFIT 9,521 9,308 SELLING, GENERAL AND ADMINISTRATIVE EXPENSE 6,281 6,146 OPERATING INCOME 3,240 3,162 INTEREST EXPENSE 178 179 INTEREST INCOME 27 28 OTHER NON-OPERATING INCOME, NET 138 138 EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 3,227 3,149 INCOME TAXES 616 593 NET EARNINGS FROM CONTINUING OPERATIONS 2,611 2,556 NET EARNINGS FROM DISCONTINUED OPERATIONS 9 64 NET EARNINGS 2,620 2,620 LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS 41 41 NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 2,579 $ 2,579 EFFECTIVE TAX RATE 19.1 % 18.8 % BASIC NET EARNINGS PER COMMON SHARE*: EARNINGS FROM CONTINUING OPERATIONS $ 0.92 $ 0.90 EARNINGS FROM DISCONTINUED OPERATIONS $  $ 0.02 BASIC NET EARNINGS PER COMMON SHARE $ 0.92 $ 0.92 DILUTED NET EARNINGS PER COMMON SHARE*: EARNINGS FROM CONTINUING OPERATIONS $ 0.89 $ 0.87 EARNINGS FROM DISCONTINUED OPERATIONS $  $ 0.02 DILUTED NET EARNINGS PER COMMON SHARE $ 0.89 $ 0.89 DIVIDENDS PER COMMON SHARE $ 0.643 $ 0.643 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,891.9 2,891.9 *Basic net earnings per common share and diluted net earnings per common share are calculated on net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended March 31, 2014 As Reported Revised NET SALES $ 20,178 $ 19,641 COST OF PRODUCTS SOLD 10,366 10,040 GROSS PROFIT 9,812 9,601 SELLING, GENERAL AND ADMINISTRATIVE EXPENSE 6,407 6,295 OPERATING INCOME 3,405 3,306 INTEREST EXPENSE 179 180 INTEREST INCOME 29 29 OTHER NON-OPERATING INCOME, NET 20 20 EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 3,275 3,175 INCOME TAXES 672 644 NET EARNINGS FROM CONTINUING OPERATIONS 2,603 2,531 NET EARNINGS FROM DISCONTINUED OPERATIONS 33 105 NET EARNINGS 2,636 2,636 LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS 27 27 NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 2,609 $ 2,609 EFFECTIVE TAX RATE 20.5 % 20.3 % BASIC NET EARNINGS PER COMMON SHARE*: EARNINGS FROM CONTINUING OPERATIONS $ 0.93 $ 0.90 EARNINGS FROM DISCONTINUED OPERATIONS $ 0.01 $ 0.04 BASIC NET EARNINGS PER COMMON SHARE $ 0.94 $ 0.94 DILUTED NET EARNINGS PER COMMON SHARE*: EARNINGS FROM CONTINUING OPERATIONS $ 0.89 $ 0.87 EARNINGS FROM DISCONTINUED OPERATIONS $ 0.01 $ 0.03 DILUTED NET EARNINGS PER COMMON SHARE $ 0.90 $ 0.90 DIVIDENDS PER COMMON SHARE $ 0.602 $ 0.602 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,894.1 2,894.1 *Basic net earnings per common share and diluted net earnings per common share are calculated on net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended December 31, 2013 As Reported Revised NET SALES $ 21,897 $ 21,099 COST OF PRODUCTS SOLD 10,884 10,474 GROSS PROFIT 11,013 10,625 SELLING, GENERAL AND ADMINISTRATIVE EXPENSE 6,490 6,323 OPERATING INCOME 4,523 4,302 INTEREST EXPENSE 187 185 INTEREST INCOME 23 22 OTHER NON-OPERATING INCOME, NET 43 43 EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 4,402 4,182 INCOME TAXES 948 885 NET EARNINGS FROM CONTINUING OPERATIONS 3,454 3,297 NET EARNINGS FROM DISCONTINUED OPERATIONS 18 175 NET EARNINGS 3,472 3,472 LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS 44 44 NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 3,428 $ 3,428 EFFECTIVE TAX RATE 21.5 % 21.2 % BASIC NET EARNINGS PER COMMON SHARE*: EARNINGS FROM CONTINUING OPERATIONS $ 1.23 $ 1.18 EARNINGS FROM DISCONTINUED OPERATIONS $ 0.01 $ 0.06 BASIC NET EARNINGS PER COMMON SHARE $ 1.24 $ 1.24 DILUTED NET EARNINGS PER COMMON SHARE*: EARNINGS FROM CONTINUING OPERATIONS $ 1.17 $ 1.12 EARNINGS FROM DISCONTINUED OPERATIONS $ 0.01 $ 0.06 DILUTED NET EARNINGS PER COMMON SHARE $ 1.18 $ 1.18 DIVIDENDS PER COMMON SHARE $ 0.602 $ 0.602 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,908.5 2,908.5 *Basic net earnings per common share and diluted net earnings per common share are calculated on net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended September 30, 2013 As Reported Revised NET SALES $ 20,830 $ 20,174 COST OF PRODUCTS SOLD 10,574 10,208 GROSS PROFIT 10,256 9,966 SELLING, GENERAL AND ADMINISTRATIVE EXPENSE 6,136 5,996 OPERATING INCOME 4,120 3,970 INTEREST EXPENSE 165 166 INTEREST INCOME 21 22 OTHER NON-OPERATING INCOME, NET 5 5 EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 3,981 3,831 INCOME TAXES 942 897 NET EARNINGS FROM CONTINUING OPERATIONS 3,039 2,934 NET EARNINGS FROM DISCONTINUED OPERATIONS 18 123 NET EARNINGS 3,057 3,057 LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS 30 30 NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 3,027 $ 3,027 EFFECTIVE TAX RATE 23.7 % 23.4 % BASIC NET EARNINGS PER COMMON SHARE*: EARNINGS FROM CONTINUING OPERATIONS $ 1.08 $ 1.04 EARNINGS FROM DISCONTINUED OPERATIONS $ 0.01 $ 0.05 BASIC NET EARNINGS PER COMMON SHARE $ 1.09 $ 1.09 DILUTED NET EARNINGS PER COMMON SHARE*: EARNINGS FROM CONTINUING OPERATIONS $ 1.03 $ 1.00 EARNINGS FROM DISCONTINUED OPERATIONS $ 0.01 $ 0.04 DILUTED NET EARNINGS PER COMMON SHARE $ 1.04 $ 1.04 DIVIDENDS PER COMMON SHARE $ 0.602 $ 0.602 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,924.3 2,924.3 *Basic net earnings per common share and diluted net earnings per common share are calculated on net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Twelve Months Ended June 30, 2014 As Reported Revised NET SALES $ 83,062 $ 80,510 COST OF PRODUCTS SOLD 42,460 41,010 GROSS PROFIT 40,602 39,500 SELLING, GENERAL AND ADMINISTRATIVE EXPENSE 25,314 24,760 OPERATING INCOME 15,288 14,740 INTEREST EXPENSE 709 710 INTEREST INCOME 100 101 OTHER NON-OPERATING INCOME, NET 206 206 EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 14,885 14,337 INCOME TAXES 3,178 3,019 NET EARNINGS FROM CONTINUING OPERATIONS 11,707 11,318 NET EARNINGS FROM DISCONTINUED OPERATIONS 78 467 NET EARNINGS 11,785 11,785 LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS 142 142 NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 11,643 $ 11,643 EFFECTIVE TAX RATE 21.4 % 21.1 % BASIC NET EARNINGS PER COMMON SHARE*: EARNINGS FROM CONTINUING OPERATIONS $ 4.16 $ 4.03 EARNINGS FROM DISCONTINUED OPERATIONS $ 0.03 $ 0.16 BASIC NET EARNINGS PER COMMON SHARE $ 4.19 $ 4.19 DILUTED NET EARNINGS PER COMMON SHARE*: EARNINGS FROM CONTINUING OPERATIONS $ 3.98 $ 3.86 EARNINGS FROM DISCONTINUED OPERATIONS $ 0.03 $ 0.15 DILUTED NET EARNINGS PER COMMON SHARE $ 4.01 $ 4.01 DIVIDENDS PER COMMON SHARE $ 2.448 $ 2.448 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,904.7 2,904.7 *Basic net earnings per common share and diluted net earnings per common share are calculated on net earnings attributable to Procter & Gamble. Supplemental Core Earnings per Share Information Core earnings per share is a measure of the Company's diluted net earnings per share from continuing operations excluding certain items that are not judged to be part of the Company's sustainable results or trends. This includes charges in fiscal years 2015 and 2014 for incremental restructuring due to increased focus on productivity and cost savings, charges in fiscal years 2015 and 2014 for the balance sheet impacts from foreign exchange policy changes and the devaluations of the official foreign currency exchange rate in Venezuela, and charges in fiscal year 2014 related to pending European legal matters. We do not view these items to be part of our sustainable results. We believe the Core EPS measure provides an important perspective of underlying business trends and results and provides a more comparable measure of year-on year earnings per share growth. Core EPS is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation. The table below provides a reconciliation of reported diluted net earnings per share from continuing operations to Core EPS: JAS 13 OND 13 JFM 14 AMJ 14 FY 14 JAS 14 Diluted Net Earnings Per Share from Continuing Operations $ 1.00 $ 1.12 $ 0.87 $ 0.87 $ 3.86 $ 0.97 Incremental Restructuring 1 0.02 0.03 0.04 0.04 0.12 0.03 Venezuela Balance Sheet Remeasurement and Devaluation Impacts   0.10  0.09 0.04 Charges for European Legal Matters    0.02 0.02  Goodwill and Intangible Impairment 2       Rounding (0.01 )  (0.01 )    CORE EPS $ 1.01 $ 1.15 $ 1.00 $ 0.93 $ 4.09 $ 1.04 1 Excludes incremental restructuring for the Batteries business, which is included in discontinued operations. 2 Excludes a charge in JAS 14 for Batteries goodwill and indefinite-lived intangible asset impairment, which is reflected in discontinued operations.",3056
2015-01-13,8-K,0000080424-15-000003,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 7.01 REGULATION FD DISCLOSURE On January 13, 2015, The Procter & Gamble Company (NYSE:PG)(the ""Company"") announced that its Board of Directors declared a quarterly dividend of $0.6436 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after February 17, 2015, to Common Stock shareholders of record at the close of business on January 23, 2015, and to Series A and Series B Preferred Stock shareholders of record at the start of business on January 23, 2015. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",200
2015-01-27,8-K,0000080424-15-000010,"PG Press Releas Form 8K - OND 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) January 27, 2015 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) Zip Code (513) 983-1100 45202 (Registrant's telephone number, including area code) Zip Code  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 2.02 ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 27, 2015, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended December 31, 2014. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",209
2015-01-27,8-K,0000080424-15-000012,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On January 27, 2015, The Procter & Gamble Company (the ""Company"") issued a press release announcing its second quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",183
2015-01-27,10-Q,0000080424-15-000014,", Risk Factors, and Note 4 to the Consolidated Financial Statements. These forward-looking statements generally are identified by the words believe, project, expect, anticipate, estimate, intend, strategy, future, opportunity, plan, may, should, will, would, will be, will continue, will likely result, and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from those expressed or implied in the forward-looking statements. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in the section titled ""Economic Conditions, Challenges and Risks"" and the section titled ",114
2015-02-10,8-K,0000080424-15-000017,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 5.02(d) ELECTION OF DIRECTORS On February 10, 2015, The Procter & Gamble Company (the ""Company"") issued a news release announcing that Francis S. Blake was appointed to the Board of Directors, effective immediately. Mr. Blake's will serve on the Audit and Governance & Public Responsibility Committees. The Company is filing this 8-K pursuant to item 5.05(d), ""Election of Directors."" A copy of the Company's press release relating to this announcement is being furnished as Exhibit 99 to this 8-K.",193
2015-02-19,8-K,0000080424-15-000019,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On February 19, 2015, The Procter & Gamble Company (the ""Company"") participated in the Consumer Analyst Group of New York annual conference. Pursuant to Item 7.01, ""Regulation FD Disclosure,"" the Company is furnishing on this Form 8-K a series of slides referenced in the Company's remarks at the conference. Presentation slides are also posted on the Company's website.",176
2015-04-17,8-K,0000080424-15-000024,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 7.01 REGULATION FD DISCLOSURE On April 17, 2015, The Procter & Gamble Company (NYSE:PG)(the ""Company"") announced that its Board of Directors declared a quarterly dividend of $0.6629 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after May 15, 2015, to Common Stock shareholders of record at the close of business on April 27, 2015, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on April 27, 2015. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",204
2015-04-23,10-Q,0000080424-15-000039,"and Analysis of Financial Condition and Results of Operations. Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: Management's Discussion and Analysis, ",95
2015-04-23,8-K,0000080424-15-000032,"FY1415 Q3 JFM 8-K Press Release UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) April 23, 2015 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) Zip Code (513) 983-1100 45202 (Registrant's telephone number, including area code) Zip Code  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 2.02 ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On April 23, 2015 , The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended March 31, 2015 . The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",209
2015-04-23,8-K,0000080424-15-000036,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On April 23, 2015, The Procter & Gamble Company (the ""Company"") issued a press release announcing its third quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",183
2015-05-07,8-K,0001193125-15-176018,"SECURITIES AND EXCHANGE COMMISSION CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) May 7, 2015 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) On May 7, 2015, The Procter & Gamble Company (the Company) closed an underwritten public offering of 100,000,000,000 aggregate principal amount of 0.275% Notes due 2020 under the Companys Registration Statement on Form S-3 (Registration No. 333-199594). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are",171
2015-06-12,8-K,0000080424-15-000047,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGES IN FISCAL YEAR. On June 9, 2015, the Board of Directors of The Procter & Gamble Company (the Company) approved an amendment to the Companys Code of Regulations (the Regulations), effective immediately. The Board approved this amendment pursuant to authority granted by shareholders at the Annual Meeting of Shareholders held on October 13, 2009. The Board amended the Regulations to add Article X addressing choice of forum and also approved other minor changes to the Regulations. The foregoing description of the Regulations is qualified in its entirety by reference to the full text of the Code of Regulations of The Procter & Gamble Company, which is filed as Exhibit 3(ii) to this Form 8-K and is hereby incorporated by reference. The Company is filing this 8-K pursuant to Item 5.03, "" Amendments to Articles of Incorporation or Bylaws; Changes in Fiscal Year .""",244
2015-07-09,8-K,0000080424-15-000052,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT On July 8, 2015, The Procter & Gamble Company (NYSE:PG) (the ""Company""), Galleria Co., a wholly-owned subsidiary of the Company, Coty, Inc. (""Coty"") and Green Acquisition Sub Inc. (""Coty Sub""), a wholly-owned subsidiary of Coty, announced the signing of a definitive agreement (the ""Transaction Agreement"") to merge 43 of the Company's beauty brands (""RMT Brands"") with Coty Sub in a Reverse Morris Trust transaction. The transaction includes the Company's global salon professional hair care and color, retail hair color, cosmetics and fine fragrance businesses, along with select hair styling brands. Although a final decision has not been made on the form of deal, the Company expects to do a split-off or spin-off transaction. The Company's current preference is for a Reverse Morris Trust split-off transaction in which Company shareholders could elect to participate in an exchange offer to exchange Company shares for shares of Coty. If executed as a split-merge, the Company would establish a separate entity to hold the RMT Brands, which would be transferred to electing P&G shareholders in a tax-efficient transaction with a simultaneous merger of the new entity with Coty. Company shareholders would have the option of exchanging all, some or none of their Company shares. The Company expects to finalize the details of the transaction in the coming months and to close the transaction in the second half of calendar year 2016, pending regulatory approvals. The transaction is based on a proposal by Coty valuing the P&G Beauty Business at approximately $12.5 billion at the time the proposal was made. Based on Coty's current stock price and outstanding shares and equity grants, the value of the transaction is approximately $15 billion. The value is comprised of approximately 411 million shares, or 52% of the fully diluted equity of the newly combined company, valued at $13.3 billion and the assumption of $1.9 billion of debt by the entity holding RMT Brands. The assumed debt is expected to vary between $3.9 billion and $1.9 billion, subject to other contractual valuation adjustments, within a $22.06 to $27.06 per share collar based on the trading price of Coty's stock prior to the close of the transaction. The final value of the transaction will be known at closing based on Coty's stock price, Coty's outstanding shares and equity grants, and the amount of assumed debt. JAB Cosmetics B.V. is the owner of all of the outstanding shares of Coty's Class B common stock. In order to facilitate the transaction, JAB has agreed to convert all such shares into Class A common stock, subject to the completion of the transaction. The brands included in the transaction are Wella Professionals (and its sub-brands), Sebastian Professional, Clairol Professional, Sassoon Professional, Nioxin, SP (System Professional), Koleston, Soft Color, Color Charm, Wellaton, Natural Instincts, Nice & Easy, VS Salonist, VS ProSeries Color, Londa, Miss Clairol, L'image, Bellady, Blondor, Welloxon, Shockwaves, New Wave, Design, Silvikrin, Wellaflex, Forte, Wella Styling, Wella Trend, Hugo Boss, Dolce & Gabbana, Gucci, Lacoste, bruno banani, Christina Aguilera, Escada, Gabriela Sabatini, James Bond 007, Mexx, Stella McCartney, Alexander McQueen, Max Factor and Covergirl. Transfer of certain fragrance brand licenses in the transaction are subject to licensor consent. In the Transaction Agreement, the Company and Coty have agreed to certain customary representations, warranties and covenants, including, but not limited to, certain representations as to the financial statements, contracts, liabilities, and other attributes of the respective businesses, certain business conduct restrictions, certain covenants requiring efforts to complete the transaction and certain limited covenants of the Company not to compete and not to solicit employees following the closing of the transactions. The foregoing description of the Transaction Agreement is qualified in its entirety by reference to the Transaction Agreement itself. A copy of the Transaction Agreement will be filed as an exhibit to the Company's Annual Report on Form 10-K for the fiscal year ending June 30, 2015. ITEM 7.01 REGULATION FD DISCLOSURE On July 9, 2015, the Company issued a news release announcing the transaction. A copy of the news release is attached hereto as Exhibit 99.1. The information being furnished pursuant to Item 7.01, including Exhibit 99.1, shall not be deemed ""filed"" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the ""Exchange Act""), nor shall they be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by reference in such filing. ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS News release dated July 9, 2015",858
2015-07-14,8-K,0000080424-15-000057,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 7.01 REGULATION FD DISCLOSURE On July 14, 2015, The Procter & Gamble Company (NYSE:PG)(the ""Company"") announced that its Board of Directors declared a quarterly dividend of $0.6629 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after August 17, 2015, to Common Stock shareholders of record at the close of business on July 24, 2015, and to Series A and Series B Preferred Stock shareholders of record at the start of business on July 24, 2015. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",200
2015-07-29,8-K,0000080424-15-000060,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other juris diction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS On July 28, 2015, The Procter & Gamble Company (the ""Company"") announced that A.G. Lafley, Chairman of the Board, President and Chief Executive Officer, will step down from his position as President and Chief Executive Officer and has been elected Executive Chairman of the Board, effective November 1, 2015. On July 28, 2015, the Company also announced that David Taylor (age 57), currently Group President  Global Beauty, Grooming and Health Care, has been elected President and Chief Executive Officer, effective November 1, 2015, to serve at the pleasure of the Board of Directors. Mr. Taylor has also been appointed as a member of the Company's Board of Directors, effective immediately. As an employee of the Company, Mr. Taylor will not serve on any Board committees. Mr. Taylor joined the Company in 1980 and has held officer positions of increasing responsibility at the Company since that time, including: Group President  Global Beauty, Grooming and Health Care (February 2015  present); Group President  Global Health & Grooming (July 2013 through January 2015); President  Global Home Care (July 2007 through June 2013); President  Global Family Care (July 2005 through June 2007); Vice President  North America Family Care (September 2003 through June 2005); Vice President  Western European Family Care (October 2001 through August 2003); and Vice President  Greater China Hair Care and Anti-Counterfeiting (April 2001 through September 2001). Mr. Taylor also served as a member of the Board of Directors of TRW Automotive Holdings Corporation from 2010 until May 2015. Effective November 1, 2015 , Mr. Taylor will receive an annual base salary of U.S. $1,600,000. He will participate in the Company's annual performance-based bonus program with a target award equal to 200% of base salary, and he will receive equity grants under the Company's long-term incentive program commensurate with his position and on the same timing as other executive officers. Mr. Taylor will participate in all other elements of the Company's executive compensation and benefit programs (including as a vested participant in the Company's retirement program). Those programs are outlined in the Company's 2014 Proxy Statement. Mr. Taylor will not receive any fees for his service on the Board of Directors. Also effective November 1, 2015, Mr. Lafley will receive an annual base salary of U.S. $1,250,000. He will participate in the Company's annual performance-based bonus program with a target award equal to 150% of base salary, and he will receive equity grants under the Company's long-term incentive program commensurate with his position and on the same timing as other executive officers. Mr. Lafley will participate in all other elements of the Company's executive compensation and benefit programs (including as a vested participant in the Company's retirement program). The Company is filing this 8-K pursuant to Items 5.02(b), (c) & (d), ""Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers."" ITEM 7.01 REGULATION FD DISCLOSURE The Company issued a news release on July 28 , 2015 announcing the election and appointment of Mr. Taylor and the changes to Mr. Lafley's role. A copy of this news release is furnished as Exhibit 99 to this report. The Company's previously scheduled earnings webcast will take place Thursday, July 30th at 8:30 am EDT. Mr. Lafley and Jon Moeller, the Company's Chief Financial Officer, will host the webcast. You may access the call by dialing: 1-877-741-4248 for Domestic Calls 1-719-325-4810 for International Calls Confirmation code: 6097936 The Company will also webcast this conference call. You may access the webcast by going to: The Company is furnishing the information under this item pursuant to Item 7.01, ""Regulation FD Disclosure."" The information in Exhibit 99 shall not be deemed to be ""filed"" for purposes of Section 18 of the Securities Exchange Act of 1934 or incorporated by reference into any filing under the Securities Act of 1933.",780
2015-07-30,8-K,0000080424-15-000063,"FY1415 Q4 AMJ 8-K Press Release UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) July 30, 2015 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) Zip Code (513) 983-1100 45202 (Registrant's telephone number, including area code) Zip Code  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 2.02 ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On July 30, 2015 , The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter and fiscal year ended June 30, 2015 . The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",212
2015-07-30,8-K,0000080424-15-000066,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On July 30, 2015, The Procter & Gamble Company (the ""Company"") issued a press release announcing its fourth quarter and fiscal year results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",186
2015-08-07,10-K,0000080424-15-000070,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark one) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended June 30, 2015 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-434 THE PROCTER & GAMBLE COMPANY One Procter & Gamble Plaza, Cincinnati, Ohio 45202 Telephone (513) 983-1100 IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered Common Stock, without Par Value New York Stock Exchange, NYSE Euronext-Paris Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  No o Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes o No  Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No o Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No o Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act). Large accelerated filer  Accelerated filer o Non-accelerated filer o Smaller reporting company o Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No  The aggregate market value of the voting stock held by non-affiliates amounted to $246 billion on December 31, 2014 . There were 2,712,561,733 shares of Common Stock outstanding as of July 31, 2015 . Documents Incorporated by Reference Portions of the Proxy Statement for the 2015 Annual Meeting of Shareholders which will be filed within one hundred and twenty days of the fiscal year ended June 30, 2015 ( 2015 Proxy Statement) are incorporated by reference into Part III of this report to the extent described herein. The Procter & Gamble Company 12 PART I Item 1. Business. Additional information required by this item is",531
2015-09-08,8-K,0000080424-15-000074,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) September 8, 2015 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) Zip Code (513) 983-1100 45202 (Registrant's telephone number, including area code) Zip Code o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE Due to The Procter & Gamble Company's (the Company or ""P&G"") planned exit from certain Beauty businesses including the salon professional, fine fragrances, cosmetics and retail hair colorants categories, along with select hairstyling brands, effective July 1, 2015, the Company is reporting the results of these businesses as discontinued operations. This informational Form 8-K provides revised historical Segment and Consolidated earnings information, along with selected financial information tables, for the three months ended June 30, 2015, March 31, 2015, December 31, 2014, and September 30, 2014, as well as for the fiscal year ended June 30, 2015, reflecting the above changes. This informational Form 8-K in no way revises or restates the previously filed Consolidated Statements of Comprehensive Income, Consolidated Balance Sheets, Consolidated Statements of Shareholders' Equity or Consolidated Statements of Cash Flows for the Company and consolidated subsidiaries for any period. Fiscal Year 2016 Changes On July 9, 2015, the Company announced the signing of a definitive agreement with Coty, Inc. to divest four product categories, along with select hairstyling brands. While the ultimate form of the transaction has not yet been decided, the Companys current preference is for a Reverse Morris Trust split-off transaction in which P&G shareholders could elect to participate in an exchange offer to exchange P&G shares for Coty shares. The transaction includes P&Gs global salon professional hair care and color, retail hair color, cosmetics and fine fragrance categories, along with select hair styling brands, all of which have historically been part of the Company's Beauty, Hair and Personal Care reportable segment. The Company expects to complete this transaction by the end of calendar year 2016. In accordance with applicable accounting guidance for the disposal of long-lived assets, the results of the affected businesses will be reported as discontinued operations beginning with fiscal year 2015-2016 reported results and, as such, will be excluded from both continuing operations and segment results. Additionally, the balance sheet positions for the affected businesses as of September 30, 2015 will be presented as held for sale in the Consolidated Balance Sheet. The above changes will be reflected in the consolidated financial statements and segment reporting beginning in the first quarter (July - September period) of fiscal year 2015-2016, starting with the Form 10-Q that will be issued for the three-month period ending September 30, 2015. Reporting changes for the above items will be reflected for all historical periods presented. In advance of the Form 10-Q filing, this document provides revised sales and earnings information for the affected segments and Consolidated Earnings information for the three months ended June 30, 2015, March 31, 2015, December 31, 2014, and September 30, 2014, as well as for the fiscal year ended June 30, 2015. This 8-K is furnished pursuant to Item 7.01 Regulation FD Disclosure. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions) Segment Earnings Information Fiscal Year Ended June 30, 2015 As Reported Revised Net Sales Earnings/(Loss) From Continuing Operations Before Income Taxes Net Earnings/(Loss) From Continuing Operations Net Sales Earnings/(Loss) From Continuing Operations Before Income Taxes Net Earnings/(Loss) From Continuing Operations Beauty, Hair and Personal Care $ 18,135 $ 3,379 $ 2,584 $ 12,608 $ 2,895 $ 2,181 Grooming 7,441 2,374 1,787 7,441 2,374 1,787 Health Care 7,713 1,700 1,167 7,713 1,700 1,167 Fabric Care and Home Care 22,277 4,061 2,635 22,274 4,059 2,634 Baby, Feminine and Family Care 20,247 4,317 2,938 20,247 4,317 2,938 Corporate 466 (3,985 ) (2,181 ) 466 (4,333 ) (2,420 ) Total Company $ 76,279 $ 11,846 $ 8,930 $ 70,749 $ 11,012 $ 8,287 THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions) Segment Earnings Information Three Months Ended June 30, 2015 As Reported Revised Net Sales Earnings/(Loss) From Continuing Operations Before Income Taxes Net Earnings/(Loss) From Continuing Operations Net Sales Earnings/(Loss) From Continuing Operations Before Income Taxes Net Earnings/(Loss) From Continuing Operations Beauty, Hair and Personal Care $ 4,144 $ 670 $ 495 $ 2,907 $ 611 $ 454 Grooming 1,692 437 321 1,692 437 321 Health Care 1,705 265 173 1,705 265 173 Fabric Care and Home Care 5,321 960 616 5,321 960 616 Baby, Feminine and Family Care 4,818 987 662 4,818 987 662 Corporate 110 (2,050 ) (1,627 ) 110 (2,195 ) (1,730 ) Total Company $ 17,790 $ 1,269 $ 640 $ 16,553 $ 1,065 $ 496 THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions) Segment Earnings Information Three Months Ended March 31, 2015 As Reported Revised Net Sales Earnings/(Loss) From Continuing Operations Before Income Taxes Net Earnings/(Loss) From Continuing Operations Net Sales Earnings/(Loss) From Continuing Operations Before Income Taxes Net Earnings/(Loss) From Continuing Operations Beauty, Hair and Personal Care $ 4,172 $ 694 $ 516 $ 2,961 $ 642 $ 481 Grooming 1,801 603 456 1,801 603 456 Health Care 1,909 462 303 1,909 462 303 Fabric Care and Home Care 5,248 937 594 5,248 937 594 Baby, Feminine and Family Care 4,890 1,011 691 4,890 1,011 691 Corporate 122 (630 ) (85 ) 121 (687 ) (124 ) Total Company $ 18,142 $ 3,077 $ 2,475 $ 16,930 $ 2,968 $ 2,401 THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions) Segment Earnings Information Three Months Ended December 31, 2014 As Reported Revised Net Sales Earnings/(Loss) From Continuing Operations Before Income Taxes Net Earnings/(Loss) From Continuing Operations Net Sales Earnings/(Loss) From Continuing Operations Before Income Taxes Net Earnings/(Loss) From Continuing Operations Beauty, Hair and Personal Care $ 4,962 $ 1,089 $ 863 $ 3,297 $ 792 $ 607 Grooming 2,007 713 544 2,007 713 544 Health Care 2,088 514 369 2,088 514 369 Fabric Care and Home Care 5,775 1,083 706 5,773 1,081 705 Baby, Feminine and Family Care 5,217 1,117 760 5,217 1,117 760 Corporate 112 (676 ) (267 ) 113 (745 ) (311 ) Total Company $ 20,161 $ 3,840 $ 2,975 $ 18,495 $ 3,472 $ 2,674 THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions) Segment Earnings Information Three Months Ended September 30, 2014 As Reported* Revised Net Sales Earnings/(Loss) From Continuing Operations Before Income Taxes Net Earnings/(Loss) From Continuing Operations Net Sales Earnings/(Loss) From Continuing Operations Before Income Taxes Net Earnings/(Loss) From Continuing Operations Beauty, Hair and Personal Care $ 4,857 $ 926 $ 710 $ 3,443 $ 850 $ 639 Grooming 1,941 621 466 1,941 621 466 Health Care 2,011 459 322 2,011 459 322 Fabric Care and Home Care 5,933 1,081 719 5,932 1,081 719 Baby, Feminine and Family Care 5,322 1,202 825 5,322 1,202 825 Corporate 122 (629 ) (202 ) 122 (706 ) (255 ) Total Company $ 20,186 $ 3,660 $ 2,840 $ 18,771 $ 3,507 $ 2,716 *On form 8-K, furnished December 22, 2014. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Fiscal Year Ended June 30, 2015 As Reported Revised NET SALES $ 76,279 $ 70,749 COST OF PRODUCTS SOLD 38,876 37,056 GROSS PROFIT 37,403 33,693 SELLING, GENERAL AND ADMINISTRATIVE EXPENSE 23,585 20,616 VENEZUELA DECONSOLIDATION CHARGE 2,028 2,028 OPERATING INCOME 11,790 11,049 INTEREST EXPENSE 626 626 INTEREST INCOME 151 149 OTHER NON-OPERATING INCOME, NET 531 440 EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 11,846 11,012 INCOME TAXES 2,916 2,725 NET EARNINGS FROM CONTINUING OPERATIONS 8,930 8,287 NET EARNINGS/(LOSS) FROM DISCONTINUED OPERATIONS (1,786 ) (1,143 ) NET EARNINGS 7,144 7,144 LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS 108 108 NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 7,036 $ 7,036 EFFECTIVE TAX RATE 24.6 % 24.7 % BASIC NET EARNINGS PER COMMON SHARE*: EARNINGS FROM CONTINUING OPERATIONS $ 3.16 $ 2.92 EARNINGS/(LOSS) FROM DISCONTINUED OPERATIONS $ (0.66 ) $ (0.42 ) BASIC NET EARNINGS PER COMMON SHARE $ 2.50 $ 2.50 DILUTED NET EARNINGS PER COMMON SHARE*: EARNINGS FROM CONTINUING OPERATIONS $ 3.06 $ 2.84 EARNINGS/(LOSS) FROM DISCONTINUED OPERATIONS $ (0.62 ) $ (0.40 ) DILUTED NET EARNINGS PER COMMON SHARE $ 2.44 $ 2.44 DIVIDENDS PER COMMON SHARE $ 2.590 $ 2.590 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,883.6 2,833.6 *Basic net earnings per common share and diluted net earnings per common share are calculated on net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended June 30, 2015 As Reported Revised NET SALES $ 17,790 $ 16,553 COST OF PRODUCTS SOLD 9,257 8,837 GROSS PROFIT 8,533 7,716 SELLING, GENERAL AND ADMINISTRATIVE EXPENSE 5,575 4,876 VENEZUELA DECONSOLIDATION CHARGE 2,028 2,028 OPERATING INCOME 930 812 INTEREST EXPENSE 147 148 INTEREST INCOME 48 46 OTHER NON-OPERATING INCOME, NET 438 355 EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 1,269 1,065 INCOME TAXES 629 569 NET EARNINGS FROM CONTINUING OPERATIONS 640 496 NET EARNINGS/(LOSS) FROM DISCONTINUED OPERATIONS (102 ) 42 NET EARNINGS 538 538 LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS 17 17 NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 521 $ 521 EFFECTIVE TAX RATE 49.6 % 53.4 % BASIC NET EARNINGS PER COMMON SHARE*: EARNINGS FROM CONTINUING OPERATIONS $ 0.21 $ 0.15 EARNINGS/(LOSS) FROM DISCONTINUED OPERATIONS $ (0.04 ) $ 0.02 BASIC NET EARNINGS PER COMMON SHARE $ 0.17 $ 0.17 DILUTED NET EARNINGS PER COMMON SHARE*: EARNINGS FROM CONTINUING OPERATIONS $ 0.22 $ 0.17 EARNINGS/(LOSS) FROM DISCONTINUED OPERATIONS $ (0.04 ) $ 0.01 DILUTED NET EARNINGS PER COMMON SHARE $ 0.18 $ 0.18 DIVIDENDS PER COMMON SHARE $ 0.663 $ 0.663 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,878.5 2,878.5 *Basic net earnings per common share and diluted net earnings per common share are calculated on net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended March 31, 2015 As Reported Revised NET SALES $ 18,142 $ 16,930 COST OF PRODUCTS SOLD 9,327 8,927 GROSS PROFIT 8,815 8,003 SELLING, GENERAL AND ADMINISTRATIVE EXPENSE 5,680 4,978 OPERATING INCOME 3,135 3,025 INTEREST EXPENSE 149 148 INTEREST INCOME 38 38 OTHER NON-OPERATING INCOME, NET 53 53 EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 3,077 2,968 INCOME TAXES 602 567 NET EARNINGS FROM CONTINUING OPERATIONS 2,475 2,401 NET EARNINGS/(LOSS) FROM DISCONTINUED OPERATIONS (287 ) (213 ) NET EARNINGS 2,188 2,188 LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS 35 35 NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 2,153 $ 2,153 EFFECTIVE TAX RATE 19.6 % 19.1 % BASIC NET EARNINGS PER COMMON SHARE*: EARNINGS FROM CONTINUING OPERATIONS $ 0.88 $ 0.85 EARNINGS/(LOSS) FROM DISCONTINUED OPERATIONS $ (0.11 ) $ (0.08 ) BASIC NET EARNINGS PER COMMON SHARE $ 0.77 $ 0.77 DILUTED NET EARNINGS PER COMMON SHARE*: EARNINGS FROM CONTINUING OPERATIONS $ 0.85 $ 0.82 EARNINGS/(LOSS) FROM DISCONTINUED OPERATIONS $ (0.10 ) $ (0.07 ) DILUTED NET EARNINGS PER COMMON SHARE $ 0.75 $ 0.75 DIVIDENDS PER COMMON SHARE $ 0.644 $ 0.644 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,882.5 2,882.5 *Basic net earnings per common share and diluted net earnings per common share are calculated on net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended December 31, 2014 As Reported Revised NET SALES $ 20,161 $ 18,495 COST OF PRODUCTS SOLD 10,083 9,558 GROSS PROFIT 10,078 8,937 SELLING, GENERAL AND ADMINISTRATIVE EXPENSE 6,131 5,358 OPERATING INCOME 3,947 3,579 INTEREST EXPENSE 160 160 INTEREST INCOME 34 34 OTHER NON-OPERATING INCOME, NET 19 19 EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 3,840 3,472 INCOME TAXES 865 798 NET EARNINGS FROM CONTINUING OPERATIONS 2,975 2,674 NET EARNINGS/(LOSS) FROM DISCONTINUED OPERATIONS (577 ) (276 ) NET EARNINGS 2,398 2,398 LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS 26 26 NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 2,372 $ 2,372 EFFECTIVE TAX RATE 22.5 % 23.0 % BASIC NET EARNINGS PER COMMON SHARE*: EARNINGS FROM CONTINUING OPERATIONS $ 1.06 $ 0.95 EARNINGS/(LOSS) FROM DISCONTINUED OPERATIONS $ (0.21 ) $ (0.10 ) BASIC NET EARNINGS PER COMMON SHARE $ 0.85 $ 0.85 DILUTED NET EARNINGS PER COMMON SHARE*: EARNINGS FROM CONTINUING OPERATIONS $ 1.02 $ 0.92 EARNINGS/(LOSS) FROM DISCONTINUED OPERATIONS $ (0.20 ) $ (0.10 ) DILUTED NET EARNINGS PER COMMON SHARE $ 0.82 $ 0.82 DIVIDENDS PER COMMON SHARE $ 0.644 $ 0.644 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,885.2 2,885.2 *Basic net earnings per common share and diluted net earnings per common share are calculated on net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended September 30, 2014 As Reported* Revised NET SALES $ 20,186 $ 18,771 COST OF PRODUCTS SOLD 10,209 9,734 GROSS PROFIT 9,977 9,037 SELLING, GENERAL AND ADMINISTRATIVE EXPENSE 6,199 5,404 OPERATING INCOME 3,778 3,633 INTEREST EXPENSE 170 170 INTEREST INCOME 31 31 OTHER NON-OPERATING INCOME, NET 21 13 EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 3,660 3,507 INCOME TAXES 820 791 NET EARNINGS FROM CONTINUING OPERATIONS 2,840 2,716 NET EARNINGS/(LOSS) FROM DISCONTINUED OPERATIONS (820 ) (696 ) NET EARNINGS 2,020 2,020 LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS 30 30 NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 1,990 $ 1,990 EFFECTIVE TAX RATE 22.4 % 22.6 % BASIC NET EARNINGS PER COMMON SHARE**: EARNINGS FROM CONTINUING OPERATIONS $ 1.01 $ 0.97 EARNINGS/(LOSS) FROM DISCONTINUED OPERATIONS $ (0.30 ) $ (0.26 ) BASIC NET EARNINGS PER COMMON SHARE $ 0.71 $ 0.71 DILUTED NET EARNINGS PER COMMON SHARE*: EARNINGS FROM CONTINUING OPERATIONS $ 0.97 $ 0.93 EARNINGS/(LOSS) FROM DISCONTINUED OPERATIONS $ (0.28 ) $ (0.24 ) DILUTED NET EARNINGS PER COMMON SHARE $ 0.69 $ 0.69 DIVIDENDS PER COMMON SHARE $ 0.644 $ 0.644 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,888.0 2,888.0 *On form 8-K, furnished December 22, 2014. **Basic net earnings per common share and diluted net earnings per common share are calculated on net earnings attributable to Procter & Gamble. Exhibit 1: Selected Revised Financial Information and Non-GAAP Measures The following tables provide selected non-GAAP financial information revised for the impact of accounting for the affected Beauty businesses as discontinued operations. In accordance with the SEC's Regulation G, definitions of the non-GAAP measures presented with the selected revised financial information are provided below and the reconciliation to the most closely related revised GAAP measure are provided within the following tables. The Core earnings measures included in the following reconciliation tables refer to the equivalent revised GAAP measures adjusted as applicable for the following items:  charge in 2015 related to the deconsolidation of our Venezuelan subsidiaries,  charges for incremental restructuring due to increased focus on productivity and cost savings,  charges for balance sheet impacts from the devaluation of the foreign currency exchange rate in Venezuela prior to deconsolidation, and  charges for certain European legal matters. We do not view these items to be part of our sustainable results. We believe that these Core measures provide an important perspective of underlying business trends and results and provide a more comparable measure of year-on-year earnings per share growth. Core EPS is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation. Core EPS and Currency-neutral Core EPS: Core EPS is a measure of the Company's revised diluted net earnings per share from continuing operations adjusted as indicated. Currency-neutral Core EPS is a measure of the Company's Core EPS excluding the incremental current year impact of foreign exchange. We believe the Currency-neutral Core EPS measure provides a more comparable view of year-on-year earnings per share growth. The tables below provide a reconciliation of revised diluted net earnings per share to Core EPS and of Core EPS to Currency-neutral Core EPS. Core Operating Profit Margin: This is a measure of the Company's revised operating margin adjusted for items as indicated. Core Gross Margin: This is a measure of the Company's revised gross margin adjusted for items as indicated. Core Selling, General and Administrative Expense (SG&A) as a percentage of sales: This is a measure of the Company's revised SG&A as a percentage of sales adjusted for items as indicated. Core Tax Rate: This is a measure of the Company's revised tax rate on continuing operations adjusted for items as indicated. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Selected Financial Information & Non-GAAP Measures, Revised for Beauty Discontinued Operations Fiscal Year Ended June 30, 2015 AS REVISED (GAAP) DISCONTINUED OPERATIONS INCREMENTAL RESTRUCTURING VENEZUELA B/S REMEASUREMENT & DEVALUATION VENEZUELA DECONSOLIDATION CHARGES FOR EUROPEAN LEGAL MATTERS ROUNDING NON-GAAP (CORE*) NET SALES 70,749       70,749 COST OF PRODUCTS SOLD 37,056  (518 )    (1 ) 36,537 GROSS PROFIT 33,693  518    1 34,212 SELLING, GENERAL, & ADMINISTRATIVE EXPENSE 20,616  (103 ) (138 ) (28 ) 1 20,348 VENEZUELA DECONSOLIDATION CHARGE 2,028    (2,028 )    OPERATING INCOME 11,049  621 138 2,028 28  13,864 EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAX 11,012  621 138 2,028 28  13,827 INCOME TAX ON CONTINUING OPERATIONS 2,725  145 34 (24 )  (1 ) 2,879 NET EARNINGS FROM CONTINUING OPERATIONS 8,287  476 104 2,052 28 1 10,948 NET EARNINGS/(LOSS) FROM DISCONTINUED OPERATIONS (1,143 ) 1,143       NET EARNINGS ATTRIBUTABLE TO NON-CONTROLLING INTEREST 108       108 NET EARNINGS ATTRIBUTABLE TO P&G 7,036 1,143 476 104 2,052 28 1 10,840 GROSS MARGIN 47.6 %  % 0.7 %  %  %  % 0.1 % 48.4 % SELLING, GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 29.1 %  % (0.1 )% (0.2 )%  %  %  % 28.8 % OPERATING PROFIT MARGIN 15.6 %  % 0.9 % 0.2 % 2.9 %  %  % 19.6 % EFFECTIVE TAX RATE 24.7 %  % 0.1 %  % (4.0 )%  %  % 20.8 % Core EPS: DILUTED NET EARNINGS PER COMMON SHARE FROM CONTINUING OPERATIONS** 2.84  0.17 0.04 0.71 0.01 (0.01 ) 3.76 LESS: CURRENCY IMPACT TO EARNINGS 0.52 CURRENCY-NEUTRAL CORE EPS 4.28 FY 15 CHANGE VERSUS YEAR AGO CORE GROSS MARGIN 50 BPS CORE SELLING GENRAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 60 BPS CORE OPERATING PROFIT MARGIN (10) BPS CORE EFFECTIVE TAX RATE 10 BPS CORE EPS (2)% CURRENCY-NEUTRAL CORE EPS 11% *Core excludes incremental restructuring charges, certain legal reserves, Venezuela deconsolidation charge, and balance sheet remeasurement impact from Venezuela. **Diluted net earnings per common share from continuing operations are calculated on net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Selected Financial Information & Non-GAAP Measures, Revised for Beauty Discontinued Operations Fiscal Year Ended June 30, 2014 AS REVISED (GAAP) DISCONTINUED OPERATIONS INCREMENTAL RESTRUCTURING VENEZUELA B/S REMEASUREMENT & DEVALUATION VENEZUELA DECONSOLIDATION CHARGES FOR EUROPEAN LEGAL MATTERS ROUNDING NON-GAAP (CORE*) NET SALES 74,401       74,401 COST OF PRODUCTS SOLD 39,030  (301 )     38,729 GROSS PROFIT 35,371  301     35,672 SELLING, GENERAL, & ADMINISTRATIVE EXPENSE 21,461  (87 ) (298 )  (63 ) (1 ) 21,012 VENEZUELA DECONSOLIDATION CHARGE         OPERATING INCOME 13,910  388 298  63 1 14,660 EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAX 13,509  388 298  63  14,258 INCOME TAX ON CONTINUING OPERATIONS 2,851  76 23   (1 ) 2,949 NET EARNINGS FROM CONTINUING OPERATIONS 10,658  312 275  63 1 11,309 NET EARNINGS FROM DISCONTINUED OPERATIONS 1,127 (1,127 )       NET EARNINGS ATTRIBUTABLE TO NON-CONTROLLING INTEREST 142       142 NET EARNINGS ATTRIBUTABLE TO P&G 11,643 (1,127 ) 312 275  63 1 11,167 GROSS MARGIN 47.5 %  % 0.4 %  %  %  %  % 47.9 % SELLING, GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 28.8 %  % (0.1 )% (0.4 )%  % (0.1 )%  % 28.2 % OPERATING PROFIT MARGIN 18.7 %  % 0.5 % 0.4 %  % 0.1 %  % 19.7 % EFFECTIVE TAX RATE 21.1 %  %  % (0.3 )%  % (0.1 )%  % 20.7 % Core EPS: DILUTED NET EARNINGS PER COMMON SHARE FROM CONTINUING OPERATIONS** 3.63  0.11 0.09  0.02  3.85 *Core excludes incremental restructuring charges, certain legal reserves, Venezuela deconsolidation charge, and balance sheet remeasurement impact from Venezuela. **Diluted net earnings per common share from continuing operations are calculated on net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Selected Financial Information & Non-GAAP Measures, Revised for Beauty Discontinued Operations Three Months Ended June 30, 2015 AS REVISED (GAAP) DISCONTINUED OPERATIONS INCREMENTAL RESTRUCTURING VENEZUELA B/S REMEASUREMENT & DEVALUATION VENEZUELA DECONSOLIDATION CHARGES FOR EUROPEAN LEGAL MATTERS ROUNDING NON-GAAP (CORE*) NET SALES 16,553       16,553 COST OF PRODUCTS SOLD 8,837  (199 )     8,638 GROSS PROFIT 7,716  199     7,915 SELLING, GENERAL, & ADMINISTRATIVE EXPENSE 4,876  (37 )  16  4,855 VENEZUELA DECONSOLIDATION CHARGE 2,028    (2,028 )    OPERATING INCOME 812  236  2,028 (16 )  3,060 EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAX 1,065  236  2,028 (16 ) 1 3,314 INCOME TAX ON CONTINUING OPERATIONS 569  63  (24 )  1 609 NET EARNINGS FROM CONTINUING OPERATIONS 496  173  2,052 (16 )  2,705 NET EARNINGS FROM DISCONTINUED OPERATIONS 42 (42 )       NET EARNINGS ATTRIBUTABLE TO NON-CONTROLLING INTEREST 17       17 NET EARNINGS ATTRIBUTABLE TO P&G 521 (42 ) 173  2,052 (16 )  2,688 GROSS MARGIN 46.6 %  % 1.2 %  %  %  %  % 47.8 % SELLING, GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 29.5 %  % (0.2 )%  %  % 0.1 % (0.1 )% 29.3 % OPERATING PROFIT MARGIN 4.9 %  % 1.4 %  % 12.3 % (0.1 )%  % 18.5 % EFFECTIVE TAX RATE 53.4 %  % 0.6 %  % (35.8 )% 0.1 % 0.1 % 18.4 % Core EPS: DILUTED NET EARNINGS PER COMMON SHARE FROM CONTINUING OPERATIONS** 0.17  0.06  0.71 (0.01 )  0.93 LESS: CURRENCY IMPACT TO EARNINGS 0.13 CURRENCY-NEUTRAL CORE EPS 1.06 FY 15 CHANGE VERSUS YEAR AGO CORE GROSS MARGIN 130 BPS CORE SELLING GENRAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 40 BPS CORE OPERATING PROFIT MARGIN 80 BPS CORE EFFECTIVE TAX RATE (10) BPS CORE EPS 4% CURRENCY-NEUTRAL CORE EPS 19% *Core excludes incremental restructuring charges, certain legal reserves, Venezuela deconsolidation charge, and balance sheet remeasurement impact from Venezuela. **Diluted net earnings per common share from continuing operations are calculated on net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Selected Financial Information & Non-GAAP Measures, Revised for Beauty Discontinued Operations Three Months Ended June 30, 2014 AS REVISED (GAAP) DISCONTINUED OPERATIONS INCREMENTAL RESTRUCTURING VENEZUELA B/S REMEASUREMENT & DEVALUATION VENEZUELA DECONSOLIDATION CHARGES FOR EUROPEAN LEGAL MATTERS ROUNDING NON-GAAP (CORE*) NET SALES 18,115       18,115 COST OF PRODUCTS SOLD 9,785  (100 )     9,685 GROSS PROFIT 8,330  100     8,430 SELLING, GENERAL, & ADMINISTRATIVE EXPENSE 5,310  (27 )  (55 )  5,228 VENEZUELA DECONSOLIDATION CHARGE         OPERATING INCOME 3,020  127   55  3,202 EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAX 3,009  127   55  3,191 INCOME TAX ON CONTINUING OPERATIONS 559  30     589 NET EARNINGS FROM CONTINUING OPERATIONS 2,450  97   55  2,602 NET EARNINGS FROM DISCONTINUED OPERATIONS 170 (170 )       NET EARNINGS ATTRIBUTABLE TO NON-CONTROLLING INTEREST 41       41 NET EARNINGS ATTRIBUTABLE TO P&G 2,579 (170 ) 97   55  2,561 GROSS MARGIN 46.0 %  % 0.6 %  %  %  % (0.1 )% 46.5 % SELLING, GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 29.3 %  % (0.1 )%  %  % (0.3 )%  % 28.9 % OPERATING PROFIT MARGIN 16.7 %  % 0.7 %  %  % 0.3 %  % 17.7 % EFFECTIVE TAX RATE 18.6 %  % 0.2 %  %  % (0.3 )%  % 18.5 % Core EPS: DILUTED NET EARNINGS PER COMMON SHARE FROM CONTINUING OPERATIONS** 0.83  0.03   0.02 0.01 0.89 *Core excludes incremental restructuring charges, certain legal reserves, Venezuela deconsolidation charge, and balance sheet remeasurement impact from Venezuela. **Diluted net earnings per common share from continuing operations are calculated on net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Selected Financial Information & Non-GAAP Measures, Revised for Beauty Discontinued Operations Three Months Ended March 31, 2015 AS REVISED (GAAP) DISCONTINUED OPERATIONS INCREMENTAL RESTRUCTURING VENEZUELA B/S REMEASUREMENT & DEVALUATION VENEZUELA DECONSOLIDATION CHARGES FOR EUROPEAN LEGAL MATTERS ROUNDING NON-GAAP (CORE*) NET SALES 16,930       16,930 COST OF PRODUCTS SOLD 8,927  (156 )     8,771 GROSS PROFIT 8,003  156     8,159 SELLING, GENERAL, & ADMINISTRATIVE EXPENSE 4,978  (73 )   (5 )  4,900 OPERATING INCOME 3,025  229   5  3,259 EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAX 2,968  229   5  3,202 INCOME TAX ON CONTINUING OPERATIONS 567  49    (1 ) 615 NET EARNINGS FROM CONTINUING OPERATIONS 2,401  180   5 1 2,587 NET EARNINGS/(LOSS) FROM DISCONTINUED OPERATIONS (213 ) 213       NET EARNINGS ATTRIBUTABLE TO NON-CONTROLLING INTEREST 35       35 NET EARNINGS ATTRIBUTABLE TO P&G 2,153 213 180   5 1 2,552 GROSS MARGIN 47.3 %  % 0.9 %  %  %  %  % 48.2 % SELLING, GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 29.4 %  % (0.4 )%  %  %  % (0.1 )% 28.9 % OPERATING PROFIT MARGIN 17.9 %  % 1.4 %  %  %  % (0.1 )% 19.2 % EFFECTIVE TAX RATE 19.1 %  % 0.2 %  %  %  % (0.1 )% 19.2 % Core EPS: DILUTED NET EARNINGS PER COMMON SHARE FROM CONTINUING OPERATIONS** 0.82  0.06    0.01 0.89 LESS: CURRENCY IMPACT TO EARNINGS 0.18 CURRENCY-NEUTRAL CORE EPS 1.07 FY 15 CHANGE VERSUS YEAR AGO CORE GROSS MARGIN 30 BPS CORE SELLING GENRAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 70 BPS CORE OPERATING PROFIT MARGIN (50) BPS CORE EFFECTIVE TAX RATE 20 BPS CORE EPS (7)% CURRENCY-NEUTRAL CORE EPS 11% *Core excludes incremental restructuring charges, certain legal reserves, Venezuela deconsolidation charge, and balance sheet remeasurement impact from Venezuela. **Diluted net earnings per common share from continuing operations are calculated on net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Selected Financial Information & Non-GAAP Measures, Revised for Beauty Discontinued Operations Three Months Ended March 31, 2014 AS REVISED (GAAP) DISCONTINUED OPERATIONS INCREMENTAL RESTRUCTURING VENEZUELA B/S REMEASUREMENT & DEVALUATION VENEZUELA DECONSOLIDATION CHARGES FOR EUROPEAN LEGAL MATTERS ROUNDING NON-GAAP (CORE*) NET SALES 18,231       18,231 COST OF PRODUCTS SOLD 9,584  (87 )    (1 ) 9,496 GROSS PROFIT 8,647  87    1 8,735 SELLING, GENERAL, & ADMINISTRATIVE EXPENSE 5,475  (39 ) (298 )   1 5,139 OPERATING INCOME 3,172  126 298    3,596 EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAX 3,042  126 298   (1 ) 3,465 INCOME TAX ON CONTINUING OPERATIONS 613  23 23   (1 ) 658 NET EARNINGS FROM CONTINUING OPERATIONS 2,429  103 275    2,807 NET EARNINGS FROM DISCONTINUED OPERATIONS 207 (207 )       NET EARNINGS ATTRIBUTABLE TO NON-CONTROLLING INTEREST 27       27 NET EARNINGS ATTRIBUTABLE TO P&G 2,609 (207 ) 103 275    2,780 GROSS MARGIN 47.4 %  % 0.5 %  %  %  %  % 47.9 % SELLING, GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 30.0 %  % (0.2 )% (1.6 )%  %  %  % 28.2 % OPERATING PROFIT MARGIN 17.4 %  % 0.7 % 1.6 %  %  %  % 19.7 % EFFECTIVE TAX RATE 20.2 %  %  % (1.1 )%  %  % (0.1 )% 19 % Core EPS: DILUTED NET EARNINGS PER COMMON SHARE FROM CONTINUING OPERATIONS** 0.83  0.04 0.1   (0.01 ) 0.96 *Core excludes incremental restructuring charges, certain legal reserves, Venezuela deconsolidation charge, and balance sheet remeasurement impact from Venezuela. **Diluted net earnings per common share from continuing operations are calculated on net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Selected Financial Information & Non-GAAP Measures, Revised for Beauty Discontinued Operations Three Months Ended December 31, 2014 AS REVISED (GAAP) DISCONTINUED OPERATIONS INCREMENTAL RESTRUCTURING VENEZUELA B/S REMEASUREMENT & DEVALUATION VENEZUELA DECONSOLIDATION CHARGES FOR EUROPEAN LEGAL MATTERS ROUNDING NON-GAAP (CORE*) NET SALES 18,495       18,495 COST OF PRODUCTS SOLD 9,558  (72 )    (1 ) 9,485 GROSS PROFIT 8,937  72    1 9,010 SELLING, GENERAL, & ADMINISTRATIVE EXPENSE 5,358  (2 )   (39 )  5,317 OPERATING INCOME 3,579  74   39 1 3,693 EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAX 3,472  74   39 (1 ) 3,584 INCOME TAX ON CONTINUING OPERATIONS 798  18    (1 ) 815 NET EARNINGS FROM CONTINUING OPERATIONS 2,674  56   39  2,769 NET EARNINGS/(LOSS) FROM DISCONTINUED OPERATIONS (276 ) 276       NET EARNINGS ATTRIBUTABLE TO NON-CONTROLLING INTEREST 26       26 NET EARNINGS ATTRIBUTABLE TO P&G 2,372 276 56   39  2,743 GROSS MARGIN 48.3 %  % 0.4 %  %  %  %  % 48.7 % SELLING, GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 29.0 %  %  %  %  % (0.2 )% (0.1 )% 28.7 % OPERATING PROFIT MARGIN 19.4 %  % 0.4 %  %  % 0.2 %  % 20 % EFFECTIVE TAX RATE 23.0 %  %  %  %  % (0.3 )%  % 22.7 % Core EPS: DILUTED NET EARNINGS PER COMMON SHARE FROM CONTINUING OPERATIONS** 0.92  0.02   0.01  0.95 LESS: CURRENCY IMPACT TO EARNINGS 0.15 CURRENCY-NEUTRAL CORE EPS 1.10 FY 15 CHANGE VERSUS YEAR AGO CORE GROSS MARGIN (10) BPS CORE SELLING GENRAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 50 BPS CORE OPERATING PROFIT MARGIN (60) BPS CORE EFFECTIVE TAX RATE 130 BPS CORE EPS (8)% CURRENCY-NEUTRAL CORE EPS 7% *Core excludes incremental restructuring charges, certain legal reserves, Venezuela deconsolidation charge, and balance sheet remeasurement impact from Venezuela. **Diluted net earnings per common share from continuing operations are calculated on net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Selected Financial Information & Non-GAAP Measures, Revised for Beauty Discontinued Operations Three Months Ended December 31, 2013 AS REVISED (GAAP) DISCONTINUED OPERATIONS INCREMENTAL RESTRUCTURING VENEZUELA B/S REMEASUREMENT & DEVALUATION VENEZUELA DECONSOLIDATION CHARGES FOR EUROPEAN LEGAL MATTERS ROUNDING NON-GAAP (CORE*) NET SALES 19,299       19,299 COST OF PRODUCTS SOLD 9,924  (51 )     9,873 GROSS PROFIT 9,375  51     9,426 SELLING, GENERAL, & ADMINISTRATIVE EXPENSE 5,483  (23 )   (8 ) (1 ) 5,451 OPERATING INCOME 3,892  74   8 1 3,975 EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAX 3,770  74   8 1 3,853 INCOME TAX ON CONTINUING OPERATIONS 815  10     825 NET EARNINGS FROM CONTINUING OPERATIONS 2,955  64   8 1 3,028 NET EARNINGS FROM DISCONTINUED OPERATIONS 517 (517 )       NET EARNINGS ATTRIBUTABLE TO NON-CONTROLLING INTEREST 44       44 NET EARNINGS ATTRIBUTABLE TO P&G 3,428 (517 ) 64   8 1 2,984 GROSS MARGIN 48.6 %  % 0.3 %  %  %  % (0.1 )% 48.8 % SELLING, GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 28.4 %  % (0.1 )%  %  %  % (0.1 )% 28.2 % OPERATING PROFIT MARGIN 20.2 %  % 0.4 %  %  %  %  % 20.6 % EFFECTIVE TAX RATE 21.6 %  % (0.2 )%  %  %  %  % 21.4 % Core EPS: DILUTED NET EARNINGS PER COMMON SHARE FROM CONTINUING OPERATIONS** 1.00  0.02    0.01 1.03 *Core excludes incremental restructuring charges, certain legal reserves, Venezuela deconsolidation charge, and balance sheet remeasurement impact from Venezuela. **Diluted net earnings per common share from continuing operations are calculated on net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Selected Financial Information & Non-GAAP Measures, Revised for Beauty Discontinued Operations Three Months Ended September 30, 2014 AS REVISED (GAAP) DISCONTINUED OPERATIONS INCREMENTAL RESTRUCTURING VENEZUELA B/S REMEASUREMENT & DEVALUATION VENEZUELA DECONSOLIDATION CHARGES FOR EUROPEAN LEGAL MATTERS ROUNDING NON-GAAP (CORE*) NET SALES 18,771       18,771 COST OF PRODUCTS SOLD 9,734  (91 )     9,643 GROSS PROFIT 9,037  91     9,128 SELLING, GENERAL, & ADMINISTRATIVE EXPENSE 5,404  9 (138 )   1 5,276 OPERATING INCOME 3,633  82 138   (1 ) 3,852 EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAX 3,507  82 138    3,727 INCOME TAX ON CONTINUING OPERATIONS 791  15 34    840 NET EARNINGS FROM CONTINUING OPERATIONS 2,716  67 104    2,887 NET EARNINGS/(LOSS) FROM DISCONTINUED OPERATIONS (696 ) 696       NET EARNINGS ATTRIBUTABLE TO NON-CONTROLLING INTEREST 30       30 NET EARNINGS ATTRIBUTABLE TO P&G 1,990 696 67 104    2,857 GROSS MARGIN 48.1 %  % 0.5 %  %  %  %  % 48.6 % SELLING, GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 28.8 %  %  % (0.7 )%  %  %  % 28.1 % OPERATING PROFIT MARGIN 19.4 %  % 0.4 % 0.7 %  %  %  % 20.5 % EFFECTIVE TAX RATE 22.6 %  % (0.1 )% 0.1 %  %  % (0.1 )% 22.5 % Core EPS: DILUTED NET EARNINGS PER COMMON SHARE FROM CONTINUING OPERATIONS** 0.93  0.02 0.04    0.99 LESS: CURRENCY IMPACT TO EARNINGS 0.07 CURRENCY-NEUTRAL CORE EPS 1.06 FY 15 CHANGE VERSUS YEAR AGO CORE GROSS MARGIN 20 BPS CORE SELLING GENRAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 40 BPS CORE OPERATING PROFIT MARGIN (20) BPS CORE EFFECTIVE TAX RATE (90) BPS CORE EPS 2% CURRENCY-NEUTRAL CORE EPS 9% *Core excludes incremental restructuring charges, certain legal reserves, Venezuela deconsolidation charge, and balance sheet remeasurement impact from Venezuela. **Diluted net earnings per common share from continuing operations are calculated on net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Selected Financial Information & Non-GAAP Measures, Revised for Beauty Discontinued Operations Three Months Ended September 30, 2013 AS REVISED (GAAP) DISCONTINUED OPERATIONS INCREMENTAL RESTRUCTURING VENEZUELA B/S REMEASUREMENT & DEVALUATION VENEZUELA DECONSOLIDATION CHARGES FOR EUROPEAN LEGAL MATTERS ROUNDING NON-GAAP (CORE*) NET SALES 18,756       18,756 COST OF PRODUCTS SOLD 9,737  (62 )     9,675 GROSS PROFIT 9,019  62     9,081 SELLING, GENERAL, & ADMINISTRATIVE EXPENSE 5,193  1     5,194 OPERATING INCOME 3,826  61     3,887 EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAX 3,688  61     3,749 INCOME TAX ON CONTINUING OPERATIONS 864  13     877 NET EARNINGS FROM CONTINUING OPERATIONS 2,824  48     2,872 NET EARNINGS FROM DISCONTINUED OPERATIONS 233 (233 )       NET EARNINGS ATTRIBUTABLE TO NON-CONTROLLING INTEREST 30       30 NET EARNINGS ATTRIBUTABLE TO P&G 3,027 (233 ) 48     2,842 GROSS MARGIN 48.1 %  % 0.3 %  %  %  %  % 48.4 % SELLING, GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 27.7 %  %  %  %  %  %  % 27.7 % OPERATING PROFIT MARGIN 20.4 %  % 0.3 %  %  %  %  % 20.7 % EFFECTIVE TAX RATE 23.4 %  %  %  %  %  %  % 23.4 % Core EPS: DILUTED NET EARNINGS PER COMMON SHARE FROM CONTINUING OPERATIONS** 0.96  0.02    (0.01 ) 0.97 *Core excludes incremental restructuring charges, certain legal reserves, Venezuela deconsolidation charge, and balance sheet remeasurement impact from Venezuela. **Diluted net earnings per common share from continuing operations are calculated on net earnings attributable to Procter & Gamble.",6500
2015-09-11,8-K,0000080424-15-000076,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS On September 9, 2015, The Procter & Gamble Company (the ""Company"") announced that Martin Riant, currently Group President-Global Baby, Feminine & Family Care, will retire from the Company effective June 30, 2016, after more than 35 years of service. Effective October 1, Mr. Riant will serve as an advisor to the CEO and continue his executive sponsorship of Global Sustainability. The Company is filing this 8-K pursuant to Items 5.02(b), ""Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.""",221
2015-09-25,8-K,0000080424-15-000084,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other juris diction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 5.02(b) DEPARTURE OF DIRECTORS On September 22, 2015, Mary Agnes Wilderotter notified The Procter & Gamble Company (the ""Company"") of her decision not to stand for re-election to the Company's Board of Directors at the October 13, 2015 annual meeting of shareholders. This decision was made in connection with Ms. Wilderotter's transition to Executive Chairman of Frontier Communications earlier this year and her desire to pursue other interests. In light of this decision and consistent with the terms of the Company's Code of Regulations, the Board has decreased the size of the Board from thirteen to twelve members, effective with commencement of the Company's annual meeting of shareholders, and therefore no other nominee for election at the annual meeting will be named in Ms. Wilderotter's place. The Company is filing this 8-K pursuant to Item 5.02(b), ""Departure of Certain Officers and Directors.""",257
2015-10-13,8-K,0000080424-15-000086,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 7.01 REGULATION FD DISCLOSURE On October 13, 2015, The Procter & Gamble Company (NYSE:PG)(the ""Company"") announced that its Board of Directors declared a quarterly dividend of $0.6629 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after November 16, 2015, to Common Stock shareholders of record at the close of business on October 23, 2015, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on October 23, 2015. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",204
2015-10-16,8-K,0000080424-15-000088,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act Item 5.07. Submission of Matters to a Vote of Security Holders The Procter & Gamble Company (the ""Company"") held its Annual Meeting of Shareholders on October 13, 2015. Set forth below are the final voting results for each of the proposals submitted to a vote of the shareholders. 1 . Election of Directors 2. Ratify Appointment of the Independent Registered Public 3. Advisory vote in the Company's Executive Compensation The Company's proxy materials also included a shareholder proposal regarding proxy access. This proposal was not voted upon at the Annual Meeting because neither the proponents, nor a qualified representative of the proponents, appeared at the Annual Meeting to present the proposal. The Company is filing this 8-K pursuant to item 5.07, ""Submission of Matters to a Vote of Security Holders.""",223
2015-10-23,10-Q,0000080424-15-000098,"and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: Management's Discussion and Analysis, ",95
2015-10-23,8-K,0000080424-15-000095,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) October 23, 2015 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) Zip Code (513) 983-1100 45202 (Registrant's telephone number, including area code) Zip Code  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 2.02 ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On October 23, 2015 , The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended September 30, 2015 . The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",203
2015-10-23,8-K,0000080424-15-000097,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On October 23, 2015, The Procter & Gamble Company (the ""Company"") issued a press release announcing its first quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulaton FD Disclosure.""",184
2015-10-26,8-K,0000080424-15-000101,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) October 26, 2015 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) Zip Code (513) 983-1100 45202 (Registrant's telephone number, including area code) Zip Code o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 8.01 OTHER EVENTS On July 9, 2015, The Procter & Gamble Company (the ""Company"" or ""P&G"") announced the signing of a definitive agreement with Coty, Inc. to divest four product categories, along with select hairstyling brands. The transaction includes P&Gs global salon professional hair care and color, retail hair color, cosmetics and fine fragrance categories, along with select hair styling brands, all of which have historically been part of the Company's Beauty reportable segment (previously named Beauty, Hair and Personal Care). The Company expects to complete this transaction in the second half of calendar year 2016, pending regulatory approvals. In accordance with applicable accounting guidance for the disposal of long-lived assets, the results of the affected businesses are reported as discontinued operations beginning with fiscal year 2015-2016 reported results and, as such, are excluded from both continuing operations and segment results. Additionally, the balance sheet positions for the affected businesses as of September 30, 2015 are presented as held for sale in the Consolidated Balance Sheets. The above changes are reflected in the consolidated financial statements and segment reporting beginning in the first quarter (July - September period) of fiscal year 2015-2016, starting with the Form 10-Q filed on October 23, 2015 for the three-month period ending September 30, 2015. Reporting changes for the above items have been reflected for all historical periods presented. In this Form 8-K, the Company is providing revised Selected Financial Data, a revised Management's Discussion and Analysis (MD&A) and consolidated financial statements and notes thereto for the years ended June 30, 2015, 2014 and 2013 to revise the disclosures for those periods to reflect the discontinued operations reporting for the affected Beauty businesses. The revised Selected Financial Data, MD&A and consolidated financial statements otherwise continue to speak as of the date of the filing of the Form 10-K for the fiscal year ended June 30, 2015 (the 2015 10-K) with the Securities and Exchange Commission (SEC) and have not been updated for events or developments that occurred subsequent to such filing. For developments since the filing of the 2015 10-K, please refer to the Company's Form 10-Q for the quarter ended September 30, 2015 and the Company's Forms 8-K filed since August 7, 2015, the filing date of the 2015 10-K.",526
2015-11-02,8-K,0001193125-15-361279,"SECURITIES AND EXCHANGE COMMISSION CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) November 2, 2015 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) On November 2, 2015, The Procter & Gamble Company (the Company) closed an underwritten public offering of 1,250,000,000 aggregate principal amount of 1.125% Notes due 2023 under the Companys Registration Statement on Form S-3 (Registration No. 333-199594). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are",171
2015-11-13,8-K,0001193125-15-377186,"SECURITIES AND EXCHANGE COMMISSION CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) November 13, 2015 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) On November 13, 2015, The Procter & Gamble Company (the Company) closed an underwritten public offering of $132,764,000 aggregate principal amount of Floating Rate Notes due 2065 under the Companys Registration Statement on Form S-3 (Registration No. 333-199594). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are",172
2016-01-12,8-K,0000080424-16-000154,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ITEM 7.01 REGULATION FD DISCLOSURE On January 12, 2016, The Procter & Gamble Company (NYSE:PG)(the ""Company"") announced that its Board of Directors declared a quarterly dividend of $0.6629 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after February 16, 2016, to Common Stock shareholders of record at the close of business on January 22, 2016, and to Series A and Series B Preferred Stock shareholders of record at the start of business on January 22, 2016. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",200
2016-01-26,10-Q,0000080424-16-000166,"and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: Management's Discussion and Analysis, ",95
2016-01-26,8-K,0000080424-16-000161,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) January 26, 2016 Commission file number 1-434 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 31-0411980 (State of Incorporation) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) Zip Code (513) 983-1100 (Registrant's telephone number, including area code)  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 2.02 ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 26, 2016 , The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended December 31, 2015 . The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",197
2016-01-26,8-K,0000080424-16-000164,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On January 26, 2016, The Procter & Gamble Company (the ""Company"") issued a press release announcing its second quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulaton FD Disclosure.""",184
2016-02-02,8-K,0001193125-16-447752,"SECURITIES AND EXCHANGE COMMISSION CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) February 2, 2016 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Other Events. On February 2, 2016, The Procter & Gamble Company (the Company) closed an underwritten public offering of $600,000,000 aggregate principal amount of 1.850% Notes due 2021 and $600,000,000 aggregate principal amount of 2.700% Notes due 2026 under the Companys Registration Statement on Form S-3 (Registration No. 333-199594). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are",183
2016-02-29,8-K,0000080424-16-000171,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On February 29, 2016, The Procter & Gamble Company (the ""Company"") issued a news release with respect to the Company's completion of the transfer of the Duracell business to Berkshire Hathaway. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",161
2016-04-08,8-K,0000080424-16-000174,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On April 8, 2016, The Procter & Gamble Company (NYSE:PG) (the ""Company"") announced that its Board of Directors declared a quarterly dividend of $0.6695 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after May 16, 2016, to Common Stock shareholders of record at the close of business on April 18, 2016, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on April 18, 2016. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure.""",211
2016-04-12,8-K,0000080424-16-000175,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGES IN FISCAL YEAR. On April 8, 2016, the Board of Directors of The Procter & Gamble Company (the Company) approved an amendment to the Companys Code of Regulations (the Regulations), effective immediately. The Board approved this amendment pursuant to authority granted by shareholders at the Annual Meeting of Shareholders held on October 13, 2009. The Board amended the Regulations to add Article I, Section 9 implementing proxy access, which permits a shareholder, or group of up to 20 shareholders, owning 3% or more of the Company's outstanding stock continously for at least three years, to nominate and include in the Company's proxy materials director nominees constituting up to the greater of 20% of the Board or two directors, provided that the requirements set forth in the Regulations are satisfied. The Regulations were also amended to clarify and revise the notice provisions in Article I, Section 8 and implement certain other minor changes. The foregoing description of the Regulations is qualified in its entirety by reference to the full text of the Code of Regulations of The Procter & Gamble Company, which is filed as Exhibit 3(ii) to this Form 8-K and is hereby incorporated by reference. The Company is filing this 8-K pursuant to Item 5.03, "" Amendments to Articles of Incorporation or Bylaws; Changes in Fiscal Year .""",326
2016-04-26,8-K,0000080424-16-000180,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) April 26, 2016 Commission file number 1-434 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 31-0411980 (State of Incorporation) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) Zip Code (513) 983-1100 (Registrant's telephone number, including area code)  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 2.02 ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On April 26, 2016 , The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended March 31, 2016 . The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition.""",197
2016-04-26,10-Q,0000080424-16-000183,"and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: Management's Discussion and Analysis, ",95
2016-04-26,8-K,0000080424-16-000181,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On April 26, 2016, The Procter & Gamble Company (the ""Company"") issued a press release announcing its third quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure.""",183
2016-06-01,8-K,0000080424-16-000192,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS On June 1, 2016, The Procter & Gamble Company (the ""Company"") announced that A.G. Lafley, Executive Chairman of the Board, will retire from the Company, effective June 30, 2016. The Company also announced that David Taylor, currently President and Chief Executive Officer and a member of the Board, has been appointed Chairman of the Board, in addition to his current responsibilities, effective July 1, 2016, to serve at the pleasure of the Board of Directors (the ""Board""). A copy of the Company's press release announcing these changes is attached hereto as Exhibit 99.1 and is",228
2016-07-12,8-K,0000080424-16-000197,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On July 12, 2016, The Procter & Gamble Company (NYSE:PG)(the ""Company"") announced that its Board of Directors declared a quarterly dividend of $0.6695 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after August 15, 2016, to Common Stock shareholders of record at the close of business on July 22, 2016, and to Series A and Series B Preferred Stock shareholders of record at the start of business on July 22, 2016. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS. News Release by The Procter & Gamble Company dated July 12, 2016",224
2016-08-02,8-K,0000080424-16-000204,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On August 2, 2016, The Procter & Gamble Company (the ""Company"") issued a press release announcing its fourth quarter and fiscal year results, and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated August 2, 2016",205
2016-08-02,8-K,0000080424-16-000202,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) August 2, 2016 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) Zip Code (513) 983-1100 45202 (Registrant's telephone number, including area code) Zip Code  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On August 2, 2016, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter and fiscal year ended June 30, 2016. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated August 2, 2016.",224
2016-08-09,8-K,0000080424-16-000211,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other juris diction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 5.02(b) DEPARTURE OF DIRECTORS On August 3, 2016, Dr. Susan Desmond-Hellmann notified The Procter & Gamble Company (the ""Company"") of her decision not to stand for re-election to the Company's Board of Directors at the October 11, 2016 annual shareholder meeting. Dr. Desmond-Hellmann made this decision in order to focus on her role as Chief Executive Officer of the Bill and Melinda Gates Foundation and Lead Independent Director of Facebook, Inc. In light of this decision and consistent with the terms of the Company's Code of Regulations, the Board has decreased the size of the Board from 11 to 10 members, effective with commencement of the Company's annual shareholder meeting. The Company is filing this 8-K pursuant to Item 5.02(b), ""Departure of Certain Officers and Directors.""",241
2016-08-09,10-K,0000080424-16-000212,and Analysis of Financial Condition and Results of Operations 11 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 30 Item 8. Financial Statements and Supplementary Data 31 Management's Report and Reports of Independent Registered Public Accounting Firm 31 Consolidated Statements of Earnings 34 Consolidated Statements of Comprehensive Income 35 Consolidated Balance Sheets 36 Consolidated Statements of Shareholders' Equity 37 Consolidated Statements of Cash Flows 38 Notes to Consolidated Financial Statements 39 Note 1: Summary of Significant Accounting Policies 39 Note 2: Segment Information 41 Note 3: Supplemental Financial Information 43 Note 4: Goodwill and Intangible Assets 44 Note 5: Income Taxes 46 Note 6: Earnings Per Share 48 Note 7: Stock-based Compensation 48 Note 8: Postretirement Benefits and Employee Stock Ownership Plan 50 Note 9: Risk Management Activities and Fair Value Measurements 54 Note 10: Short-term and Long-term Debt 57 Note 11: Accumulated Other Comprehensive Income/(Loss) 58 Note 12: Commitments and Contingencies 59 Note 13: Discontinued Operations 59 Note 14: Quarterly Results (Unaudited) 64,165
2016-09-01,8-K,0001193125-16-699474,"SECURITIES AND EXCHANGE COMMISSION CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 1, 2016 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of Principal Executive Offices) Registrants telephone number, including area code: (513) 983-1100 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) On September 1, 2016, The Procter & Gamble Company (P&G) issued a press release announcing the commencement of an exchange offer for the separation of its global fine fragrances, salon professional, cosmetics and retail hair color businesses, along with select hair styling brands (referred to as P&G Beauty Brands). The exchange offer represents the next step in the proposed tax-efficient Reverse Morris Trust transaction with Coty Inc. (Coty) announced on July 8, 2015. In the proposed transaction, P&G will transfer the assets and liabilities of P&G Beauty Brands, other than specified excluded brands, to Galleria Co., a wholly owned subsidiary of P&G created to facilitate the transaction. Following completion of the exchange offer, Galleria Co. will merge with a subsidiary of Coty and become a wholly owned subsidiary of Coty. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is",307
2016-09-28,8-K,0001193125-16-723546,"SECURITIES AND EXCHANGE COMMISSION CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 28, 2016 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of Principal Executive Offices) Registrants telephone number, including area code: (513) 983-1100 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Other Events. On September 28, 2016, The Procter & Gamble Company (P&G) issued a press release announcing the final exchange ratio for its exchange offer in connection with the separation of its global fine fragrances, salon professional, cosmetics and retail hair color businesses, along with select hair styling brands (collectively, P&G Specialty Beauty Brands). The exchange offer represents the next step in the proposed tax-efficient Reverse Morris Trust transaction with Coty Inc. (Coty) announced on July 8, 2015. In the proposed transaction, P&G will transfer the assets and liabilities of P&G Specialty Beauty Brands, other than specified excluded brands, to Galleria Co., a wholly owned subsidiary of P&G created to facilitate the transaction. Following completion of the exchange offer, Galleria Co. will merge with a subsidiary of Coty and become a wholly owned subsidiary of Coty. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is",313
2016-09-30,8-K,0001193125-16-726791,"SECURITIES AND EXCHANGE COMMISSION CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 30, 2016 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of Principal Executive Offices) Registrants telephone number, including area code: (513) 983-1100 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Other Events. On September 30, 2016, The Procter & Gamble Company (P&G) issued a press release announcing the preliminary results of its exchange offer in connection with the separation of its global fine fragrances, salon professional, cosmetics and retail hair color businesses, along with select hair styling brands (collectively, P&G Beauty Brands). P&G transferred the assets and liabilities of P&G Beauty Brands, other than specified excluded brands, to Galleria Co. Following completion of the exchange offer, Galleria Co. will merge with a subsidiary of Coty and become a wholly owned subsidiary of Coty. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is",270
2016-10-03,8-K,0001193125-16-729227,"SECURITIES AND EXCHANGE COMMISSION CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 1, 2016 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of Principal Executive Offices) Registrants telephone number, including area code: (513) 983-1100 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Other Events. On October 3, 2016, The Procter & Gamble Company, an Ohio corporation, issued a press release announcing the successful closing of the previously announced tax-efficient Reverse Morris Trust transaction with Coty Inc. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K. Financial Statements and Exhibits. The following exhibit is being filed with this Current Report on Form 8-K. Press Release by The Procter & Gamble Company dated October 3, 2016.",238
2016-10-05,8-K,0001193125-16-731519,"SECURITIES AND EXCHANGE COMMISSION CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 5, 2016 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of Principal Executive Offices) Registrants telephone number, including area code: (513) 983-1100 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Other Events. On October 5, 2016, The Procter & Gamble Company (P&G), an Ohio corporation, issued a press release announcing the final proration factor of 15.0123% for its exchange offer in connection with the separation of P&Gs global fine fragrances, salon professional, cosmetics and retail hair color businesses, along with select hair styling brands (collectively, P&G Beauty Brands). A total of 690,798,524 shares of P&G common stock were validly tendered in exchange for 409,726,299 shares of common stock of Galleria Co., the corporation formed to hold P&G Beauty Brands, other than specified excluded brands. The exchange offer successfully closed on September 30, 2016. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K. Item 9.01 Financial Statements and Exhibits. The following exhibit is being filed with this Current Report on Form 8-K. Press Release by The Procter & Gamble Company dated October 5, 2016.",309
2016-10-11,8-K,0000080424-16-000228,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On October 11, 2016, The Procter & Gamble Company (NYSE:PG)(the ""Company"") announced that its Board of Directors declared a quarterly dividend of $0.6695 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after November 15, 2016, to Common Stock shareholders of record at the close of business on October 21, 2016, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on October 21, 2016. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS. News Release by The Procter & Gamble Company dated October 11, 2016",228
2016-10-14,8-K,0000080424-16-000231,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Item 5.07. Submission of Matters to a Vote of Security Holders The Procter & Gamble Company (the ""Company"") held its Annual Meeting of Shareholders on October 11, 2016. Set forth below are the final voting results for each of the proposals submitted to a vote of the shareholders. 1 . Election of Directors 4. Shareholder Proposal Report on Lobbying Policies of 5. Shareholder Proposal Report on Application of Company Non-Discrimination Policies The Company is filing this 8-K pursuant to item 5.07, ""Submission of Matters to a Vote of Security Holders.""",189
2016-10-17,8-K,0000080424-16-000233,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 17, 2016 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of Principal Executive Offices) Registrant's telephone number, including area code: (513) 983-1100 (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) On October 17, 2016, The Procter & Gamble Company (""P&G"") issued a press release announcing the launch of a $1.25 billion cash tender offer for outstanding debt securities. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is",201
2016-10-25,8-K,0000080424-16-000240,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On October 25, 2016, The Procter & Gamble Company (the ""Company"") issued a press release announcing its first quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated October 25, 2016",202
2016-10-25,10-Q,0000080424-16-000244,"and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: Management's Discussion and Analysis, ",95
2016-10-25,8-K,0000080424-16-000238,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) October 25, 2016 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) (513) 983-1100 (Registrants telephone number, including area code)  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On October 25, 2016, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended September 30, 2016. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated October 25, 2016.",215
2016-10-31,8-K,0000080424-16-000246,"SECURITIES AND EXCHANGE COMMISSION PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 31, 2016 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of Principal Executive Offices) Registrant's telephone number, including area code: (513) 983-1100 (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) On October 31, 2016, The Procter & Gamble Company (""P&G"") issued a press release announcing the early tender results and pricing of a $1.65 billion cash tender offer for outstanding debt securities. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is",205
2016-11-03,8-K,0001193125-16-759020,"SECURITIES AND EXCHANGE COMMISSION CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) November 3, 2016 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Other Events. On November 3, 2016, The Procter & Gamble Company (the Company) closed an underwritten public offering of $875,000,000 aggregate principal amount of 1.700% Notes due 2021 and $875,000,000 aggregate principal amount of 2.450% Notes due 2026 under the Companys Registration Statement on Form S-3 (Registration No. 333-199594). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are",183
2017-01-10,8-K,0000918866-17-000002,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On January 10, 2017, The Procter & Gamble Company (NYSE:PG)(the ""Company"") announced that its Board of Directors declared a quarterly dividend of $0.6695 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after February 15, 2017, to Common Stock shareholders of record at the close of business on January 20, 2017, and to Series A and Series B Preferred Stock shareholders of record at the start of business on January 20, 2017. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS. News Release by The Procter & Gamble Company dated January 10, 2017",224
2017-01-20,10-Q,0000080424-17-000011,"and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: Management's Discussion and Analysis, ",95
2017-01-20,8-K,0000080424-17-000008,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) January 20, 2017 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) (513) 983-1100 (Registrants telephone number, including area code)  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 20, 2017, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended December 31, 2016. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated January 20, 2017.",215
2017-01-20,8-K,0000080424-17-000010,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On January 20, 2017, The Procter & Gamble Company (the ""Company"") issued a press release announcing its second quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated January 20, 2017",202
2017-04-11,8-K,0000918866-17-000004,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On April 11, 2017, the Company announced that its Board of Directors declared a quarterly dividend of $0.6896 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after May 15, 2017, to Common Stock shareholders of record at the close of business on April 21, 2017, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on April 21, 2017. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Dividend News Release by The Procter & Gamble Company dated April 11, 2017.",224
2017-04-12,8-K,0000080424-17-000018,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 5.02(d) ELECTION OF DIRECTORS On April 11, 2017, the Board of Directors of The Procter & Gamble Company (the ""Company"") appointed Amy L. Chang, founder and Chief Executive Officer of Accompany, Inc., as a Director of the Company, effective June 1, 2017. Ms. Chang will serve on the Audit and Innovation & Technology Committees. The Company is filing this 8-K pursuant to Item 5.02(d), ""Election of Directors."" ITEM 7.01 REGULATION FD DISCLOSURE The Company issued a news release on April 12 , 2017, announcing the appointment of Ms. Chang. A copy of this news release is furnished as Exhibit 99.1. The Company is furnishing the information under this item, including Exhibit 99.1, pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Director Announcement News Release by The Procter & Gamble Company dated April 12 , 2017.",240
2017-04-26,10-Q,0000080424-17-000026,"and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: Management's Discussion and Analysis, ",95
2017-04-26,8-K,0000080424-17-000023,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) April 26, 2017 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) (513) 983-1100 (Registrants telephone number, including area code)  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On April 26, 2017, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended March 31, 2017. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated April 26, 2017.",301
2017-04-26,8-K,0000080424-17-000025,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On April 26, 2017, The Procter & Gamble Company (the ""Company"") issued a press release announcing its third quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated April 26, 2017",283
2017-05-03,8-K,0001193125-17-156299,"SECURITIES AND EXCHANGE COMMISSION CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) May 3, 2017 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Schedule 13(a) Other Events. On May 3, 2017, The Procter & Gamble Company (the Company) closed an underwritten public offering of 375,000,000 aggregate principal amount of 1.375% Notes due May 3, 2025 and 375,000,000 aggregate principal amount of 1.800% Notes due May 3, 2029 under the Companys Registration Statement on Form S-3 (Registration No. 333-199594). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are",264
2017-05-17,8-K,0000080424-17-000030,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS On May 15, 2017, Patrice Louvet, currently Group President-Global Beauty, notified The Procter & Gamble Company (the ""Company"") that he is resigning from the Company effective June 30, 2017. The Company is filing this 8-K pursuant to Items 5.02(b), ""Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.""",190
2017-07-11,8-K,0000080424-17-000036,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On July 11, 2017, the Company announced that its Board of Directors declared a quarterly dividend of $0.6896 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after August 15, 2017, to Common Stock shareholders of record at the close of business on July 21, 2017, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on July 21, 2017. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Dividend News Release by The Procter & Gamble Company dated July 11, 2017.",224
2017-07-27,8-K,0000080424-17-000039,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) July 27, 2017 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) (513) 983-1100 (Registrants telephone number, including area code)  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On July 27, 2017, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter and fiscal year ended June 30, 2017. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated July 27, 2017.",304
2017-07-27,8-K,0000080424-17-000044,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On July 27, 2017, The Procter & Gamble Company (the ""Company"") issued a press release announcing its fourth quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated July 27, 2017",283
2017-08-07,10-K,0000080424-17-000047,and Analysis of Financial Condition and Results of Operations 11 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 32 Item 8. Financial Statements and Supplementary Data 33 Management's Report and Reports of Independent Registered Public Accounting Firm 33 Consolidated Statements of Earnings 36 Consolidated Statements of Comprehensive Income 37 Consolidated Balance Sheets 38 Consolidated Statements of Shareholders' Equity 39 Consolidated Statements of Cash Flows 40 Notes to Consolidated Financial Statements 41 Note 1: Summary of Significant Accounting Policies 41 Note 2: Segment Information 44 Note 3: Supplemental Financial Information 46 Note 4: Goodwill and Intangible Assets 48 Note 5: Income Taxes 49 Note 6: Earnings Per Share 51 Note 7: Stock-based Compensation 52 Note 8: Postretirement Benefits and Employee Stock Ownership Plan 53 Note 9: Risk Management Activities and Fair Value Measurements 58 Note 10: Short-term and Long-term Debt 61 Note 11: Accumulated Other Comprehensive Income/(Loss) 62 Note 12: Commitments and Contingencies 62 Note 13: Discontinued Operations 63 Note 14: Quarterly Results (Unaudited) 66,165
2017-08-11,8-K,0001193125-17-255939,"SECURITIES AND EXCHANGE COMMISSION CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) August 11, 2017 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Schedule 13(a) of the Exchange Act.  On August 11, 2017, The Procter & Gamble Company (the Company) closed an underwritten public offering of $1,250,000,000 aggregate principal amount of 2.150% Notes due August 11, 2022 and $750,000,000 aggregate principal amount of 2.850% Notes due August 11, 2027 under the Companys Registration Statement on Form S-3 (Registration No. 333-199594). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are",271
2017-08-22,8-K,0001193125-17-264573,"SECURITIES AND EXCHANGE COMMISSION CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) August 22, 2017 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Schedule 13(a) of the Exchange Act.  On August 22, 2017, The Procter & Gamble Company (the Company) closed an underwritten public offering of $136,861,000 aggregate principal amount of Floating Rate Notes due 2067 under the Companys Registration Statement on Form S-3 (Registration No. 333-199594). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are",258
2017-10-10,8-K,0000080424-17-000055,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On October 10, 2017, the Company announced that its Board of Directors declared a quarterly dividend of $0.6896 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after November 15, 2017, to Common Stock shareholders of record at the close of business on October 20, 2017, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on October 20, 2017. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Dividend News Release by The Procter & Gamble Company dated October 10, 2017.",224
2017-10-16,8-K,0001193125-17-311028,"SECURITIES AND EXCHANGE COMMISSION CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 October 16, 2017 (October 10, 2017) Date of Report (Date of Earliest Event Reported) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Item 5.07 Submission of Matters to a Vote of Security Holders On October 10, 2017, The Procter & Gamble Company (the Company) held its 2017 Annual Meeting of Shareholders (the Annual Meeting). Set forth below are the proposals voted upon at the Annual Meeting, and the estimated preliminary voting results reported by the Companys proxy solicitors, D.F. King & Co., Inc. and MacKenzie Partners, Inc. (the Solicitors) based on the information available to the Solicitors. These results are preliminary estimates only and are subject to change based on the certification of the voting results by the independent inspector of elections, IVS Associates, Inc. (IVS). The Company will file an amendment to this Current Report on Form 8-K to disclose the final voting results after receiving IVSs final certified report. As of the close of business on August 11, 2017, the record date for the Annual Meeting, 2,548,109,787 shares of the Companys common stock, without par value (Common Stock), 41,379,583 shares of Series A ESOP Convertible Class A Preferred Stock (Series A Preferred Stock) and 55,789,846 shares of Series B ESOP Convertible Class A Preferred Stock (Series B Preferred Stock), were outstanding and entitled to vote. Based on the estimated preliminary results from the Solicitors and subject to the qualifications set forth herein, at least 1,906,405,454 shares of Common Stock, 41,379,583 shares of Series A Preferred Stock and 55,789,846 shares of Series B Preferred Stock were voted in person or by proxy at the Annual Meeting, representing more than 75 percent of the shares entitled to be voted. The estimated preliminary tabulation of the voting results (subject to the caveats noted herein) from the Solicitors for the proposals presented at the Annual Meeting are as follows: 1 Proposal 1 - Election of Directors The Companys Board of Director Nominees 1 The estimated preliminary vote results set forth in this 8-K have been prepared by the Solicitors based on their work performed in connection with the Annual Meeting. These estimated preliminary vote results reflect our Solicitors estimates of each of the following: (i) blue proxy cards received from registered holders by the Company netted to reflect revocations received by Trian Partners, L.P. and certain of its affiliates (together, Trian) on white proxy cards from registered holders; (ii) white proxy cards from registered holders received by Trian netted to reflect revocations received by the Company on blue proxy cards from registered holders; (iii) blue proxy cards and white proxy cards voted by Broadridge Financial Solutions (Broadridge) on behalf of custodian bank and broker clients; (iv) proxy cards voted by intermediaries for banks and brokers outside of the Broadridge system; (v) the net effect of legal proxies and other ballots or proxy cards voted at the Annual Meeting prior to the closing of the polls; and (vi) the number of votes cast on behalf of the beneficiaries of the Series A Preferred Stock and the Series B Preferred Stock. The total estimated number of broker non-votes with respect to Proposal 1 was 22,466,983. Based on the estimated preliminary results, the eleven directors elected at the meeting would be: Francis S. Blake, Angela F. Braly, Amy L. Chang, Kenneth I. Chenault, Scott D. Cook, Terry J. Lundgren, W. James McNerney Jr., David S. Taylor, Margaret C. Whitman, Patricia A. Woertz and Ernesto Zedillo. Proposal 2 - Ratify the appointment of the Independent Registered Public Accounting Firm . The proposal was approved based on the following estimated preliminary vote: Proposal 3 - Advisory vote on Companys Executive Compensation (the Say on Pay vote) . The proposal to approve, on an advisory basis, executive compensation was approved based upon the following estimated preliminary vote: Proposal 4 - Advisory vote on Frequency of Executive Compensation vote . The advisory vote on the frequency of future advisory votes on executive compensation received the following estimated preliminary vote, with the one year frequency receiving the highest number of estimated preliminary votes: The Company will disclose its decision on the frequency of the Say on Pay vote in a further amendment to this Current Report on Form 8-K. Proposal 5  Shareholder Proposal  Adopt Holy Land Principles . The shareholder proposal related to the adoption of the Holy Land Principles was withdrawn by the proponent and, consequently, not presented at the 2017 Annual Meeting. Proposal 6 - Shareholder Proposal - Report on Application of Company Non-Discrimination Policies in States with Pro-Discrimination Laws . The shareholder proposal did not obtain approval based on the following estimated preliminary vote: Proposal 7  Shareholder Proposal - Report on Mitigating Risks of Activities in Conflict-Affected Areas . The shareholder proposal did not obtain approval based on the following estimated preliminary vote: Proposal 8 - Shareholder Proposal - Repeal Certain Amendments to Regulations . The shareholder proposal did not obtain approval because it did not receive the affirmative vote of a majority of the outstanding shares entitled to vote on the proposal based on the following estimated preliminary vote:",1016
2017-10-20,8-K,0000080424-17-000066,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On October 20, 2017, The Procter & Gamble Company (the ""Company"") issued a press release announcing its first quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated October 20, 2017",283
2017-10-20,8-K,0000080424-17-000064,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) October 20, 2017 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) (513) 983-1100 (Registrants telephone number, including area code)  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On October 20, 2017, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended September 30, 2017. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated October 20, 2017.",301
2017-10-20,10-Q,0000080424-17-000078,"and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: Management's Discussion and Analysis, ",95
2017-10-25,8-K,0001193125-17-319343,"SECURITIES AND EXCHANGE COMMISSION REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) October 25, 2017 The Procter & Gamble Company (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Schedule 13(a) of the Exchange On October 25, 2017, The Procter & Gamble Company (the Company) closed an underwritten public offering of $600,000,000 aggregate principal amount of 1.750% Notes due October 25, 2019, $600,000,000 aggregate principal amount of 1.900% Notes due October 23, 2020 and $600,000,000 aggregate principal amount of 3.500% Notes due October 25, 2047 under the Companys Registration Statement on Form S-3 (Registration No. 333-221035). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are",278
2017-10-25,8-K,0001193125-17-319276,"SECURITIES AND EXCHANGE COMMISSION REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) October 25, 2017 The Procter & Gamble Company (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Schedule 13(a) of the Exchange On October 25, 2017, The Procter & Gamble Company (the Company) closed an underwritten public offering of 500,000,000 aggregate principal amount of 0.500% Notes due October 25, 2024 and 500,000,000 aggregate principal amount of 1.250% Notes due October 25, 2029 under the Companys Registration Statement on Form S-3 (Registration No. 333-221035). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are",267
2017-11-15,8-K,0001193125-17-344275,"SECURITIES AND EXCHANGE COMMISSION REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of Earliest Event Reported) PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange REGULATION FD DISCLOSURE On November 15, 2017, The Procter & Gamble Company (the Company) issued a press release announcing the preliminary voting results received from IVS Associates, Inc., the independent inspector of elections, for the Companys 2017 Annual Meeting of Stockholders held on October 10, 2017. This 8-K is being furnished pursuant to Item 7.01, Regulation FD Disclosure. FINANCIAL STATEMENTS AND EXHIBITS (d) Exhibits Press Release by The Procter & Gamble Company dated November 15, 2017",272
2017-12-15,8-K,0001193125-17-370870,"SECURITIES AND EXCHANGE COMMISSION REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of Earliest Event Reported) PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS (d) On December 15, 2017, the Board of Directors of The Procter & Gamble Company (the Company) increased the size of the Board from eleven to thirteen Directors and appointed Joseph Jimenez, Chief Executive Officer of Novartis AG, as a Director of the Company, effective March 1, 2018. The Board also appointed Nelson Peltz, Chief Executive Officer of Trian Fund Management, L.P., as a Director, effective March 1, 2018. The Company has agreed that Mr. Peltz will be included in the Companys slate of nominees for election to the Board of Directors at the 2018 annual meeting of shareholders. Committee assignments for Mr. Jimenez and Mr. Peltz will be determined at a later date. Mr. Jimenez and Mr. Peltz will each receive the same compensation from the Company as the other non-employee members of the Board of Directors. The Companys Director compensation program is described in the Companys definitive proxy statement filed with the Securities and Exchange Commission on August 1, 2017. The Company is filing this 8-K pursuant to Item 5.02(d), Election of Directors. REGULATION FD DISCLOSURE The Company issued a shareholder letter on December 15, 2017, announcing certified Director election results and certain actions taken by the Board of Directors based on shareholder input. A copy of this shareholder letter is furnished as Exhibit 99.1. The Company also issued two news releases on December 15, 2017, announcing the appointments of Mr. Jimenez and Mr. Peltz. Copies of these news releases are furnished as Exhibits 99.2 and 99.3. The Company is furnishing the information under this item, including Exhibits 99.1, 99.2, and 99.3, pursuant to Item 7.01, Regulation FD Disclosure. FINANCIAL STATEMENTS AND EXHIBITS (d) Exhibits Shareholder Letter dated December 15, 2017 Jimenez Announcement News Release dated December 15, 2017 Peltz Announcement News Release dated December 15, 2017",513
2018-01-09,8-K,0000080424-18-000002,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On January 9, 2018, the Company announced that its Board of Directors declared a quarterly dividend of $0.6896 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after February 15, 2018, to Common Stock shareholders of record at the close of business on January 19, 2018, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on January 19, 2018. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Dividend News Release by The Procter & Gamble Company dated January 9, 2018.",238
2018-01-23,10-Q,0000080424-18-000013,"and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: Management's Discussion and Analysis and ",96
2018-01-23,8-K,0000080424-18-000011,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On January 23, 2018, The Procter & Gamble Company (the ""Company"") issued a press release announcing its second quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated January 23, 2018",283
2018-01-23,8-K,0000080424-18-000009,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) January 23, 2018 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) (513) 983-1100 (Registrants telephone number, including area code)  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 23, 2018, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended December 31, 2017. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated January 23, 2018.",301
2018-04-10,8-K,0000080424-18-000021,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ITEM 7.01 REGULATION FD DISCLOSURE On April 10, 2018, the Company announced that its Board of Directors declared a quarterly dividend of $0.7172 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after May 15, 2018, to Common Stock shareholders of record at the close of business on April 20, 2018, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on April 20, 2018. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Dividend News Release by The Procter & Gamble Company dated April 10, 2018.",238
2018-04-19,10-Q,0000080424-18-000034,"and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: Management's Discussion and Analysis, ",95
2018-04-19,8-K,0000080424-18-000030,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) April 19, 2018 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) (513) 983-1100 (Registrants telephone number, including area code)  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On April 19, 2018, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended March 31, 2018. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated April 19, 2018.",301
2018-04-19,8-K,0000080424-18-000033,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On April 19, 2018, The Procter & Gamble Company (the ""Company"") issued a press release announcing its third quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated April 19, 2018",283
2018-04-19,8-K,0000080424-18-000029,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On April 19, 2018, The Procter & Gamble Company (the ""Company"") issued a press release with respect to the Company's agreement to acquire Merck KGaA's Consumer Health business. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS News Release by The Procter & Gamble Company dated April 19, 2018.",257
2018-05-09,8-K,0001193125-18-156876,"SECURITIES AND EXCHANGE COMMISSION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 9, 2018 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of Principal Executive Offices) Registrants telephone number, including area code: (513) 983-1100 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17CFR 240.12b-2). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  On May 9, 2018, The Procter & Gamble Company (P&G) issued a press release announcing the launch of a $1.25 billion cash tender offer for outstanding debt securities. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is",285
2018-05-23,8-K,0001193125-18-171879,"SECURITIES AND EXCHANGE COMMISSION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 23, 2018 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of Principal Executive Offices) Registrants telephone number, including area code: (513) 983-1100 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17CFR 240.12b-2). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Other Events. On May 23, 2018, The Procter & Gamble Company issued a press release announcing the pricing of its cash tender offer for outstanding debt securities. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is",282
2018-05-23,8-K,0001193125-18-171169,"SECURITIES AND EXCHANGE COMMISSION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 22, 2018 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of Principal Executive Offices) Registrants telephone number, including area code: (513) 983-1100 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17CFR 240.12b-2). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Other Events. On May 22, 2018, The Procter & Gamble Company issued a press release announcing the early tender results of its cash tender offer for outstanding debt securities. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is",284
2018-06-13,8-K,0000080424-18-000040,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS On June 12, 2018, the Compensation & Leadership Development Committee of the Board of Directors of The Procter & Gamble Company (the ""Company"") approved the amendment and restatement of the Summary of the Company's Short Term Achievement Reward Program (""STAR""), effective July 1, 2018. STAR is the Company's annual cash bonus program. Among other things, STAR was modified to expand the potential ranges for both the Company Factor and the Business Unit Factor to 0% - 200% from 70% - 130% and 50% - 150%, respectively; move from a multiplicative model for the Company Factor and the Business Unit Factor to an additive model for the two factors; and change from an equal weighting of the Company Factor and the Business Unit Factor in determining awards to a 30% / 70% weighting of the Company Factor and the Business Unit Factor, respectively. These modifications are designed to better align individual employee bonus awards with the results they deliver. The foregoing description of the modifications to STAR does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the amended and restated Summary of the Company's Short Term Achievement Reward Program. A copy of the amended and restated Summary of the Company's Short Term Achievement Reward Program is attached hereto as Exhibit 10.1 and is",437
2018-06-20,8-K,0000080424-18-000041,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS On June 19, 2018, Giovanni Ciserani, currently Group PresidentGlobal Fabric & Home Care and Global Baby & Feminine Care, notified The Procter & Gamble Company (the ""Company"") that he will retire from the Company effective November 30, 2018. The Company is filing this 8-K pursuant to Item 5.02(b), ""Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.""",280
2018-07-10,8-K,0000080424-18-000045,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On July 10, 2018, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of $0.7172 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after August 15, 2018, to Common Stock shareholders of record at the close of business on July 20, 2018, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on July 20, 2018. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Dividend News Release by The Procter & Gamble Company dated July 10, 2018.",324
2018-07-31,8-K,0000080424-18-000050,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) July 31, 2018 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) (513) 983-1100 (Registrants telephone number, including area code)  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On July 31, 2018, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended June 30, 2018. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated July 31, 2018.",301
2018-07-31,8-K,0000080424-18-000052,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On July 31, 2018, The Procter & Gamble Company (the ""Company"") issued a press release announcing its fourth quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated July 31, 2018",283
2018-08-07,10-K,0000080424-18-000055,and Analysis of Financial Condition and Results of Operations 12 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 33 Item 8. Financial Statements and Supplementary Data 34 Management's Report and Reports of Independent Registered Public Accounting Firm 34 Consolidated Statements of Earnings 37 Consolidated Statements of Comprehensive Income 38 Consolidated Balance Sheets 39 Consolidated Statements of Shareholders' Equity 40 Consolidated Statements of Cash Flows 41 Notes to Consolidated Financial Statements 42 Note 1: Summary of Significant Accounting Policies 42 Note 2: Segment Information 44 Note 3: Supplemental Financial Information 46 Note 4: Goodwill and Intangible Assets 48 Note 5: Income Taxes 49 Note 6: Earnings Per Share 51 Note 7: Stock-based Compensation 52 Note 8: Postretirement Benefits and Employee Stock Ownership Plan 53 Note 9: Risk Management Activities and Fair Value Measurements 58 Note 10: Short-term and Long-term Debt 62 Note 11: Accumulated Other Comprehensive Income/(Loss) 63 Note 12: Commitments and Contingencies 63 Note 13: Discontinued Operations 64 Note 14: Quarterly Results (Unaudited) 66,165
2018-10-09,8-K,0000080424-18-000084,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On October 9, 2018, the Company announced that its Board of Directors declared a quarterly dividend of $0.7172 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after November 15, 2018, to Common Stock shareholders of record at the close of business on October 19, 2018, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on October 19, 2018. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Dividend News Release by The Procter & Gamble Company dated October 9, 2018.",319
2018-10-10,8-K,0000080424-18-000087,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) October 10, 2018 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) Zip Code (513) 983-1100 45202 (Registrant's telephone number, including area code) Zip Code o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 7.01 REGULATION FD DISCLOSURE As disclosed in its Annual Report on Form 10-K for the year ended June 30, 2018, The Procter and Gamble Company (the Company, we) adopted the Financial Accounting Standards Board (FASB) ASU 2017-07, Compensation-Retirement Benefits: Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost (Topic 715) effective July 1, 2018. This informational Form 8-K provides revised historical Consolidated earnings information, along with selected financial information tables, for the three months ended June 30, March 31, December 31 and September 30 for the fiscal years ended 2018 and 2017, as well as for the fiscal years ended June 30, 2018 and June 30, 2017, reflecting the changes as described below. This informational Form 8-K in no way revises or restates the previously filed Consolidated Statements of Comprehensive Income, Consolidated Balance Sheets, Consolidated Statements of Shareholders' Equity or Consolidated Statements of Cash Flows for the Company and consolidated subsidiaries for any period. Fiscal Year 2018 and 2017 Changes Topic 715 requires an entity to disaggregate the current service cost component from the other components of net defined benefit costs on the face of the income statement. It requires the service cost component to be presented with other current compensation costs for the related employees in the operating section of the income statement. Other components of net benefit costs are required to be presented outside of income from operations. The Company has adopted ASU 2017-07 retrospectively. As such, prior periods results have been revised to report the other components of net benefit costs, previously reported in Cost of products sold and Selling, general, and administrative expense (SG&A), within Other non-operating income/(expense), net. The other components of net benefit costs for the periods presented are a net credit/income. As a result, the movement of these components increases Cost of products sold and SG&A, with an offsetting benefit in Other non-operating income/(expense), net. The above changes will be reflected in the consolidated financial statements beginning in the first quarter (July - September period) of fiscal year 2018-2019, starting with the Form 10-Q that will be issued for the three-month period ending September 30, 2018. Reporting changes for the above items will be reflected for all historical periods presented. In advance of the Form 10-Q filing, this document provides revised gross margin and operating income information for the Consolidated Earnings information for the three months ended June 30, March 31, December 31 and September 30 for the fiscal years ended 2018 and 2017, as well as for the fiscal years ended June 30, 2018 and June 30, 2017. This 8-K is furnished pursuant to Item 7.01 Regulation FD Disclosure. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Fiscal Year Ended June 30, 2018 Fiscal Year Ended June 30, 2017 As Reported Revised As Reported Revised NET SALES $ 66,832 $ 66,832 $ 65,058 $ 65,058 COST OF PRODUCTS SOLD 34,268 34,432 32,535 32,638 GROSS PROFIT 32,564 32,400 32,523 32,420 SELLING, GENERAL AND ADMINISTRATIVE EXPENSE 18,853 19,037 18,568 18,654 OPERATING INCOME 13,711 13,363 13,955 13,766 INTEREST EXPENSE 506 506 465 465 INTEREST INCOME 247 247 171 171 OTHER NON-OPERATING INCOME/(EXPENSE), NET (126 ) 222 (404 ) (215 ) EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 13,326 13,326 13,257 13,257 INCOME TAXES 3,465 3,465 3,063 3,063 NET EARNINGS FROM CONTINUING OPERATIONS 9,861 9,861 10,194 10,194 NET EARNINGS FROM DISCONTINUED OPERATIONS   5,217 5,217 NET EARNINGS 9,861 9,861 15,411 15,411 LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS 111 111 85 85 NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 9,750 $ 9,750 $ 15,326 $ 15,326 EFFECTIVE TAX RATE 26.0 % 26.0 % 23.1 % 23.1 % BASIC NET EARNINGS PER COMMON SHARE: (1) EARNINGS FROM CONTINUING OPERATIONS $ 3.75 $ 3.75 $ 3.79 $ 3.79 EARNINGS FROM DISCONTINUED OPERATIONS $  $  $ 2.01 $ 2.01 BASIC NET EARNINGS PER COMMON SHARE $ 3.75 $ 3.75 $ 5.80 $ 5.80 DILUTED NET EARNINGS PER COMMON SHARE: (1) EARNINGS FROM CONTINUING OPERATIONS $ 3.67 $ 3.67 $ 3.69 $ 3.69 EARNINGS FROM DISCONTINUED OPERATIONS $  $  $ 1.90 $ 1.90 DILUTED NET EARNINGS PER COMMON SHARE $ 3.67 $ 3.67 $ 5.59 $ 5.59 DIVIDENDS PER COMMON SHARE $ 2.7860 $ 2.7860 $ 2.6981 $ 2.6981 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,656.7 2,656.7 2,740.4 2,740.4 (1) Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended June 30, 2018 Three Months Ended June 30, 2017 As Reported Revised As Reported Revised NET SALES $ 16,503 $ 16,503 $ 16,079 $ 16,079 COST OF PRODUCTS SOLD 9,029 9,070 8,299 8,325 GROSS PROFIT 7,474 7,433 7,780 7,754 SELLING, GENERAL AND ADMINISTRATIVE EXPENSE 4,797 4,846 4,831 4,854 OPERATING INCOME 2,677 2,587 2,949 2,900 INTEREST EXPENSE 136 136 116 116 INTEREST INCOME 63 63 48 48 OTHER NON-OPERATING INCOME/(EXPENSE), NET (315 ) (225 ) 46 95 EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 2,289 2,289 2,927 2,927 INCOME TAXES 399 399 725 725 NET EARNINGS FROM CONTINUING OPERATIONS 1,890 1,890 2,202 2,202 NET EARNINGS FROM DISCONTINUED OPERATIONS     NET EARNINGS 1,890 1,890 2,202 2,202 LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS (1 ) (1 ) (13 ) (13 ) NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 1,891 $ 1,891 $ 2,215 $ 2,215 EFFECTIVE TAX RATE 17.4 % 17.4 % 24.8 % 24.8 % BASIC NET EARNINGS PER COMMON SHARE: (1) EARNINGS FROM CONTINUING OPERATIONS $ 0.73 $ 0.73 $ 0.84 $ 0.84 EARNINGS FROM DISCONTINUED OPERATIONS $  $  $  $  BASIC NET EARNINGS PER COMMON SHARE $ 0.73 $ 0.73 $ 0.84 $ 0.84 DILUTED NET EARNINGS PER COMMON SHARE: (1) EARNINGS FROM CONTINUING OPERATIONS $ 0.72 $ 0.72 $ 0.82 $ 0.82 EARNINGS FROM DISCONTINUED OPERATIONS $  $  $  $  DILUTED NET EARNINGS PER COMMON SHARE $ 0.72 $ 0.72 $ 0.82 $ 0.82 DIVIDENDS PER COMMON SHARE $ 0.7172 $ 0.7172 $ 0.6896 $ 0.6896 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,620.9 2,620.9 2,695.6 2,695.6 (1) Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended March 31, 2018 Three Months Ended March 31, 2017 As Reported Revised As Reported Revised NET SALES $ 16,281 $ 16,281 $ 15,605 $ 15,605 COST OF PRODUCTS SOLD 8,343 8,384 7,836 7,862 GROSS PROFIT 7,938 7,897 7,769 7,743 SELLING, GENERAL AND ADMINISTRATIVE EXPENSE 4,642 4,688 4,409 4,432 OPERATING INCOME 3,296 3,209 3,360 3,311 INTEREST EXPENSE 133 133 96 96 INTEREST INCOME 69 69 46 46 OTHER NON-OPERATING INCOME, NET 21 108 26 75 EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 3,253 3,253 3,336 3,336 INCOME TAXES 713 713 780 780 NET EARNINGS FROM CONTINUING OPERATIONS 2,540 2,540 2,556 2,556 NET EARNINGS FROM DISCONTINUED OPERATIONS     NET EARNINGS 2,540 2,540 2,556 2,556 LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS 29 29 34 34 NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 2,511 $ 2,511 $ 2,522 $ 2,522 EFFECTIVE TAX RATE 21.9 % 21.9 % 23.4 % 23.4 % BASIC NET EARNINGS PER COMMON SHARE: (1) EARNINGS FROM CONTINUING OPERATIONS $ 0.97 $ 0.97 $ 0.96 $ 0.96 EARNINGS FROM DISCONTINUED OPERATIONS $  $  $  $  BASIC NET EARNINGS PER COMMON SHARE $ 0.97 $ 0.97 $ 0.96 $ 0.96 DILUTED NET EARNINGS PER COMMON SHARE: (1) EARNINGS FROM CONTINUING OPERATIONS $ 0.95 $ 0.95 $ 0.93 $ 0.93 EARNINGS FROM DISCONTINUED OPERATIONS $  $  $  $  DILUTED NET EARNINGS PER COMMON SHARE $ 0.95 $ 0.95 $ 0.93 $ 0.93 DIVIDENDS PER COMMON SHARE $ 0.6896 $ 0.6896 $ 0.6695 $ 0.6695 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,645.6 2,645.6 2,705.5 2,705.5 (1) Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended December 31, 2017 Three Months Ended December 31, 2016 As Reported Revised As Reported Revised NET SALES $ 17,395 $ 17,395 $ 16,856 $ 16,856 COST OF PRODUCTS SOLD 8,667 8,709 8,298 8,323 GROSS PROFIT 8,728 8,686 8,558 8,533 SELLING, GENERAL AND ADMINISTRATIVE EXPENSE 4,725 4,767 4,683 4,706 OPERATING INCOME 4,003 3,919 3,875 3,827 INTEREST EXPENSE 122 122 122 122 INTEREST INCOME 66 66 42 42 OTHER NON-OPERATING INCOME/(EXPENSE), NET 86 170 (539 ) (491 ) EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 4,033 4,033 3,256 3,256 INCOME TAXES 1,472 1,472 695 695 NET EARNINGS FROM CONTINUING OPERATIONS 2,561 2,561 2,561 2,561 NET EARNINGS FROM DISCONTINUED OPERATIONS   5,335 5,335 NET EARNINGS 2,561 2,561 7,896 7,896 LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS 66 66 21 21 NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 2,495 $ 2,495 $ 7,875 $ 7,875 EFFECTIVE TAX RATE 36.5 % 36.5 % 21.3 % 21.3 % BASIC NET EARNINGS PER COMMON SHARE: (1) EARNINGS FROM CONTINUING OPERATIONS $ 0.96 $ 0.96 $ 0.96 $ 0.96 EARNINGS FROM DISCONTINUED OPERATIONS $  $  $ 2.05 $ 2.05 BASIC NET EARNINGS PER COMMON SHARE $ 0.96 $ 0.96 $ 3.01 $ 3.01 DILUTED NET EARNINGS PER COMMON SHARE: (1) EARNINGS FROM CONTINUING OPERATIONS $ 0.93 $ 0.93 $ 0.93 $ 0.93 EARNINGS FROM DISCONTINUED OPERATIONS $  $  $ 1.95 $ 1.95 DILUTED NET EARNINGS PER COMMON SHARE $ 0.93 $ 0.93 $ 2.88 $ 2.88 DIVIDENDS PER COMMON SHARE $ 0.6896 $ 0.6896 $ 0.6695 $ 0.6695 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,669.6 2,669.6 2,737.6 2,737.6 (1) Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Consolidated Earnings Information Three Months Ended September 30, 2017 Three Months Ended September 30, 2016 As Reported Revised As Reported Revised NET SALES $ 16,653 $ 16,653 $ 16,518 $ 16,518 COST OF PRODUCTS SOLD 8,229 8,269 8,102 8,128 GROSS PROFIT 8,424 8,384 8,416 8,390 SELLING, GENERAL AND ADMINISTRATIVE EXPENSE 4,689 4,736 4,645 4,662 OPERATING INCOME 3,735 3,648 3,771 3,728 INTEREST EXPENSE 115 115 131 131 INTEREST INCOME 49 49 35 35 OTHER NON-OPERATING INCOME, NET 82 169 63 106 EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES 3,751 3,751 3,738 3,738 INCOME TAXES 881 881 863 863 NET EARNINGS FROM CONTINUING OPERATIONS 2,870 2,870 2,875 2,875 NET EARNINGS/(LOSS) FROM DISCONTINUED OPERATIONS   (118 ) (118 ) NET EARNINGS 2,870 2,870 2,757 2,757 LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS 17 17 43 43 NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE $ 2,853 $ 2,853 $ 2,714 $ 2,714 EFFECTIVE TAX RATE 23.5 % 23.5 % 23.1 % 23.1 % BASIC NET EARNINGS PER COMMON SHARE: (1) EARNINGS FROM CONTINUING OPERATIONS $ 1.09 $ 1.09 $ 1.03 $ 1.03 EARNINGS/(LOSS) FROM DISCONTINUED OPERATIONS $  $  $ (0.04 ) $ (0.04 ) BASIC NET EARNINGS PER COMMON SHARE $ 1.09 $ 1.09 $ 0.99 $ 0.99 DILUTED NET EARNINGS PER COMMON SHARE: (1) EARNINGS FROM CONTINUING OPERATIONS $ 1.06 $ 1.06 $ 1.00 $ 1.00 EARNINGS/(LOSS) FROM DISCONTINUED OPERATIONS $  $  $ (0.04 ) $ (0.04 ) DILUTED NET EARNINGS PER COMMON SHARE $ 1.06 $ 1.06 $ 0.96 $ 0.96 DIVIDENDS PER COMMON SHARE $ 0.6896 $ 0.6896 $ 0.6695 $ 0.6695 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,690.6 2,690.6 2,822.9 2,822.9 (1) Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble. Exhibit 1: Selected Revised Financial Information and Non-GAAP Measures The following tables provide selected non-GAAP financial information revised for the impact of the adoption of ASU 2017-07, ""Compensation-Retirement Benefits: Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost"" (""Retirement Benefits Accounting Change""). In accordance with the SEC's Regulation G, definitions of the non-GAAP measures presented with the selected revised financial information are provided below and the reconciliation to the most closely related revised GAAP measure are provided within the following tables. The Core earnings from continuing operations measures included in the following reconciliation tables refer to the equivalent GAAP measures adjusted as applicable for the following items: Incremental Restructuring : The Company has had and continues to have an ongoing level of restructuring activities. Such activities have resulted in ongoing annual restructuring related charges of approximately $250 - $500 million before tax. In 2012, the Company began a $10 billion strategic productivity and cost savings initiative that includes incremental restructuring activities. In 2017, we communicated details of an additional multi-year productivity and cost savings plan. This results in incremental restructuring charges to accelerate productivity efforts and cost savings. The adjustment to Core earnings includes only the restructuring costs above what we believe are the normal recurring level of restructuring costs. Transitional Impacts of the U.S. Tax Act: In December 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the ""U.S. Tax Act""). This resulted in a net charge of $602 million for the fiscal year 2018. The adjustment to Core earnings only includes this transitional impact. It does not include the ongoing impacts of the lower U.S. statutory rate on current year earnings. Early debt extinguishment charges : In fiscal 2018 and 2017, the Company recorded after-tax charges of $243 million and $345 million, respectively, due to the early extinguishment of certain long-term debt. These charges represent the difference between the reacquisition price and the par value of the debt extinguished. We do not view the above items to be part of our sustainable results and their exclusion from Core earnings from continuing operations measures provides a more comparable measure of year-on-year results. These items are also excluded when evaluating senior management in determining their at-risk compensation. Core operating profit margin: Core operating profit margin is a measure of the Company's operating margin adjusted for items as indicated. Management believes this non-GAAP measure provides a supplemental perspective to the Companys operating efficiency over time. Core gross margin : Core gross margin is a measure of the Company's gross margin adjusted for items as indicated. Management believes this non-GAAP measure provides a supplemental perspective to the Companys operating efficiency over time. Core selling, general and administrative (SG&A) expense as a percentage of net sales : Core SG&A expense as a percentage of net sales is a measure of the Company's selling, general and administrative expenses adjusted for items as indicated. Management believes this non-GAAP measure provides a supplemental perspective to the Company's operating efficiency over time. Core EPS and currency-neutral Core EPS : Core earnings per share, or Core EPS, is a measure of the Company's diluted net earnings per share from continuing operations adjusted as indicated. Currency-neutral Core EPS is a measure of the Company's Core EPS excluding the incremental current year impact of foreign exchange. Management views these non-GAAP measures as a useful supplemental measure of Company performance over time. These measures are also used when evaluating senior management in determining their at-risk compensation. Core Tax Rate: This is a measure of the Company's revised tax rate on continuing operations adjusted for items as indicated. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Selected Financial Information & Non-GAAP Measures, Revised for the Retirement Benefits Accounting Change Fiscal Year Ended June 30, 2018 AS REVISED (GAAP) INCREMENTAL RESTRUCTURING TRANSITIONAL IMPACTS OF US TAX ACT EARLY DEBT EXTINGUISHMENT ROUNDING NON-GAAP (CORE) COST OF PRODUCTS SOLD 34,432 (724 )   (1 ) 33,707 GROSS PROFIT 32,400 724   1 33,125 GROSS MARGIN 48.5 % 1.1 %  %  %  % 49.6 % SELLING, GENERAL, & ADMINISTRATIVE EXPENSE 19,037 (1 )   1 19,037 SELLING, GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 28.5 %  %  %  %  % 28.5 % OPERATING INCOME 13,363 725    14,088 OPERATING PROFIT MARGIN 20.0 % 1.1 %  %  %  % 21.1 % INCOME TAX ON CONTINUING OPERATIONS 3,465 129 (602 ) 103  3,095 NET EARNINGS ATTRIBUTABLE TO P&G 9,750 610 602 243 (1 ) 11,204 EFFECTIVE TAX RATE 26.0 % (0.4 )% (4.2 )% 0.1 %  % 21.5 % Core EPS: DILUTED NET EARNINGS PER COMMON SHARE* 3.67 0.23 0.23 0.09  4.22 LESS: CURRENCY IMPACT TO EARNINGS (0.05 ) CURRENCY-NEUTRAL CORE EPS 4.17 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,656.7 *Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble. FY 18 CHANGE VERSUS YEAR AGO CORE GROSS MARGIN (100) BPS CORE SELLING GENRAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES (30) BPS CORE OPERATING PROFIT MARGIN (70) BPS CORE EPS 8% CURRENCY-NEUTRAL CORE EPS 6% THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Selected Financial Information & Non-GAAP Measures, Revised for the Retirement Benefits Accounting Change Fiscal Year Ended June 30, 2017 AS REVISED (GAAP) DISCONTINUED OPERATIONS INCREMENTAL RESTRUCTURING EARLY DEBT EXTINGUISHMENT ROUNDING NON-GAAP (CORE) COST OF PRODUCTS SOLD 32,638  (498 )   32,140 GROSS PROFIT 32,420  498   32,918 GROSS MARGIN 49.8 %  % 0.8 %  %  % 50.6 % SELLING, GENERAL, & ADMINISTRATIVE EXPENSE 18,654  107   18,761 SELLING, GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 28.7 %  % 0.2 %  % (0.1 )% 28.8 % OPERATING INCOME 13,766  391   14,157 OPERATING PROFIT MARGIN 21.2 %  % 0.6 %  %  % 21.8 % INCOME TAX ON CONTINUING OPERATIONS 3,063  120 198  3,381 NET EARNINGS ATTRIBUTABLE TO P&G 15,326 (5,217 ) 279 345 (1 ) 10,732 EFFECTIVE TAX RATE 23.1 %  % 0.2 % 0.5 %  % 23.8 % Core EPS: DILUTED NET EARNINGS PER COMMON SHARE* 5.59 (1.90 ) 0.10 0.13  3.92 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,740.4 *Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Selected Financial Information & Non-GAAP Measures, Revised for the Retirement Benefits Accounting Change Three Months Ended June 30, 2018 AS REVISED (GAAP) INCREMENTAL RESTRUCTURING TRANSITIONAL IMPACTS OF US TAX ACT EARLY DEBT EXTINGUISHMENT ROUNDING NON-GAAP (CORE) COST OF PRODUCTS SOLD 9,070 (428 )   (1 ) 8,641 GROSS PROFIT 7,433 428   1 7,862 GROSS MARGIN 45.0 % 2.6 %  %  %  % 47.6 % SELLING, GENERAL, & ADMINISTRATIVE EXPENSE 4,846 (3 )   2 4,845 SELLING, GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 29.4 %  %  %  %  % 29.4 % OPERATING INCOME 2,587 431   (1 ) 3,017 OPERATING PROFIT MARGIN 15.7 % 2.6 %  %  %  % 18.3 % INCOME TAX ON CONTINUING OPERATIONS 399 66 48 103 1 617 NET EARNINGS ATTRIBUTABLE TO P&G 1,891 368 (48 ) 243 (1 ) 2,453 EFFECTIVE TAX RATE 17.4 % (0.4 )% 1.6 % 1.4 % 0.1 % 20.1 % Core EPS: DILUTED NET EARNINGS PER COMMON SHARE* 0.72 0.14 (0.02 ) 0.09 0.01 0.94 LESS: CURRENCY IMPACT TO EARNINGS 0.01 CURRENCY-NEUTRAL CORE EPS 0.95 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,620.9 *Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble. FY 18 CHANGE VERSUS YEAR AGO CORE GROSS MARGIN (150) BPS CORE SELLING GENRAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES (90) BPS CORE OPERATING PROFIT MARGIN (50) BPS CORE EPS 11% CURRENCY-NEUTRAL CORE EPS 12% THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Selected Financial Information & Non-GAAP Measures, Revised for the Retirement Benefits Accounting Change Three Months Ended June 30, 2017 AS REVISED (GAAP) INCREMENTAL RESTRUCTURING ROUNDING NON-GAAP (CORE) COST OF PRODUCTS SOLD 8,325 (146 ) (1 ) 8,178 GROSS PROFIT 7,754 146 1 7,901 GROSS MARGIN 48.2 % 0.9 %  % 49.1 % SELLING, GENERAL, & ADMINISTRATIVE EXPENSE 4,854 20 1 4,875 SELLING, GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 30.2 % 0.1 %  % 30.3 % OPERATING INCOME 2,900 126  3,026 OPERATING PROFIT MARGIN 18.0 % 0.8 %  % 18.8 % INCOME TAX ON CONTINUING OPERATIONS 725 63 1 789 NET EARNINGS ATTRIBUTABLE TO P&G 2,215 65 (1 ) 2,279 EFFECTIVE TAX RATE 24.8 % 1.0 %  % 25.8 % Core EPS: DILUTED NET EARNINGS PER COMMON SHARE* 0.82 0.02 0.01 0.85 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,695.6 *Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Selected Financial Information & Non-GAAP Measures, Revised for the Retirement Benefits Accounting Change Three Months Ended March 31, 2018 AS REVISED (GAAP) INCREMENTAL RESTRUCTURING TRANSITIONAL IMPACTS OF US TAX ACT ROUNDING NON-GAAP (CORE) COST OF PRODUCTS SOLD 8,384 (110 )  (1 ) 8,273 GROSS PROFIT 7,897 110  1 8,008 GROSS MARGIN 48.5 % 0.7 %  %  % 49.2 % SELLING, GENERAL, & ADMINISTRATIVE EXPENSE 4,688 (24 )   4,664 SELLING, GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 28.8 % (0.1 )%  % (0.1 )% 28.6 % OPERATING INCOME 3,209 134  1 3,344 OPERATING PROFIT MARGIN 19.7 % 0.8 %  %  % 20.5 % INCOME TAX ON CONTINUING OPERATIONS 713 22 (22 ) (1 ) 712 NET EARNINGS ATTRIBUTABLE TO P&G 2,511 116 22  2,649 EFFECTIVE TAX RATE 21.9 % (0.2 )% (0.7 )%  % 21 % Core EPS: DILUTED NET EARNINGS PER COMMON SHARE* 0.95 0.04 0.01  1.00 LESS: CURRENCY IMPACT TO EARNINGS (0.03 ) CURRENCY-NEUTRAL CORE EPS 0.97 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,645.6 *Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble. FY 18 CHANGE VERSUS YEAR AGO CORE GROSS MARGIN (110) BPS CORE SELLING GENRAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 10 BPS CORE OPERATING PROFIT MARGIN (130) BPS CORE EPS 4% CURRENCY-NEUTRAL CORE EPS 1% THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Selected Financial Information & Non-GAAP Measures, Revised for the Retirement Benefits Accounting Change Three Months Ended March 31, 2017 AS REVISED (GAAP) INCREMENTAL RESTRUCTURING ROUNDING NON-GAAP (CORE) COST OF PRODUCTS SOLD 7,862 (113 ) 1 7,750 GROSS PROFIT 7,743 113 (1 ) 7,855 GROSS MARGIN 49.6 % 0.7 %  % 50.3 % SELLING, GENERAL, & ADMINISTRATIVE EXPENSE 4,432 24 (1 ) 4,455 SELLING, GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 28.4 % 0.2 % (0.1 )% 28.5 % OPERATING INCOME 3,311 89  3,400 OPERATING PROFIT MARGIN 21.2 % 0.6 %  % 21.8 % INCOME TAX ON CONTINUING OPERATIONS 780 21 (1 ) 800 NET EARNINGS ATTRIBUTABLE TO P&G 2,522 70  2,592 EFFECTIVE TAX RATE 23.4 %  %  % 23.4 % Core EPS: DILUTED NET EARNINGS PER COMMON SHARE* 0.93 0.03  0.96 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,705.5 *Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Selected Financial Information & Non-GAAP Measures, Revised for the Retirement Benefits Accounting Change Three Months Ended December 31, 2017 AS REVISED (GAAP) INCREMENTAL RESTRUCTURING TRANSITIONAL IMPACTS OF US TAX ACT ROUNDING NON-GAAP (CORE) COST OF PRODUCTS SOLD 8,709 (86 )  1 8,624 GROSS PROFIT 8,686 86  (1 ) 8,771 GROSS MARGIN 49.9 % 0.5 %  %  % 50.4 % SELLING, GENERAL, & ADMINISTRATIVE EXPENSE 4,767 19  (1 ) 4,785 SELLING, GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 27.4 % 0.1 %  %  % 27.5 % OPERATING INCOME 3,919 67   3,986 OPERATING PROFIT MARGIN 22.5 % 0.4 %  %  % 22.9 % INCOME TAX ON CONTINUING OPERATIONS 1,472 21 (628 )  865 NET EARNINGS ATTRIBUTABLE TO P&G 2,495 51 628  3,174 EFFECTIVE TAX RATE 36.5 % (0.1 )% (15.3 )%  % 21.1 % Core EPS: DILUTED NET EARNINGS PER COMMON SHARE* 0.93 0.02 0.24  1.19 LESS: CURRENCY IMPACT TO EARNINGS (0.04 ) CURRENCY-NEUTRAL CORE EPS 1.15 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,669.6 *Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble. FY 18 CHANGE VERSUS YEAR AGO CORE GROSS MARGIN (100) BPS CORE SELLING GENRAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES (70) BPS CORE OPERATING PROFIT MARGIN (30) BPS CORE EPS 10% CURRENCY-NEUTRAL CORE EPS 6% THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Selected Financial Information & Non-GAAP Measures, Revised for the Retirement Benefits Accounting Change Three Months Ended December 31, 2016 AS REVISED (GAAP) DISCONTINUED OPERATIONS INCREMENTAL RESTRUCTURING EARLY DEBT EXTINGUISHMENT ROUNDING NON-GAAP (CORE) COST OF PRODUCTS SOLD 8,323  (128 )   8,195 GROSS PROFIT 8,533  128   8,661 GROSS MARGIN 50.6 %  % 0.8 %  %  % 51.4 % SELLING, GENERAL, & ADMINISTRATIVE EXPENSE 4,706  38  1 4,745 SELLING, GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 27.9 %  % 0.2 %  % 0.1 % 28.2 % OPERATING INCOME 3,827  90  (1 ) 3,916 OPERATING PROFIT MARGIN 22.7 %  % 0.5 %  %  % 23.2 % INCOME TAX ON CONTINUING OPERATIONS 695  21 198 (1 ) 913 NET EARNINGS ATTRIBUTABLE TO P&G 7,875 (5,335 ) 71 345 2,956 EFFECTIVE TAX RATE 21.3 %  %  % 2.2 %  % 23.5 % Core EPS: DILUTED NET EARNINGS PER COMMON SHARE* 2.88 (1.95 ) 0.03 0.13 (0.01 ) 1.08 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,737.6 *Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble. THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Selected Financial Information & Non-GAAP Measures, Revised for the Retirement Benefits Accounting Change Three Months Ended September 30, 2017 AS REVISED (GAAP) INCREMENTAL RESTRUCTURING ROUNDING NON-GAAP (CORE) COST OF PRODUCTS SOLD 8,269 (100 )  8,169 GROSS PROFIT 8,384 100  8,484 GROSS MARGIN 50.3 % 0.6 %  % 50.9 % SELLING, GENERAL, & ADMINISTRATIVE EXPENSE 4,736 7  4,743 SELLING, GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 28.4 %  % 0.1 % 28.5 % OPERATING INCOME 3,648 93  3,741 OPERATING PROFIT MARGIN 21.9 % 0.6 %  % 22.5 % INCOME TAX ON CONTINUING OPERATIONS 881 20  901 NET EARNINGS ATTRIBUTABLE TO P&G 2,853 75  2,928 EFFECTIVE TAX RATE 23.5 % (0.1 )%  % 23.4 % Core EPS: DILUTED NET EARNINGS PER COMMON SHARE* 1.06 0.03  1.09 LESS: CURRENCY IMPACT TO EARNINGS  CURRENCY-NEUTRAL CORE EPS 1.09 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,690.6 *Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble. FY 18 CHANGE VERSUS YEAR AGO CORE GROSS MARGIN (60) BPS CORE SELLING GENRAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 10 BPS CORE OPERATING PROFIT MARGIN (60) BPS CORE EPS 6% CURRENCY-NEUTRAL CORE EPS 6% THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Selected Financial Information & Non-GAAP Measures, Revised for the Retirement Benefits Accounting Change Three Months Ended September 30, 2016 AS REVISED (GAAP) DISCONTINUED OPERATIONS INCREMENTAL RESTRUCTURING ROUNDING NON-GAAP (CORE) COST OF PRODUCTS SOLD 8,128  (111 )  8,017 GROSS PROFIT 8,390  111  8,501 GROSS MARGIN 50.8 %  % 0.7 %  % 51.5 % SELLING, GENERAL, & ADMINISTRATIVE EXPENSE 4,662  25 (1 ) 4,686 SELLING, GENERAL & ADMINISTRATIVE EXPENSE AS A % OF NET SALES 28.2 %  % 0.2 %  % 28.4 % OPERATING INCOME 3,728  86 1 3,815 OPERATING PROFIT MARGIN 22.6 %  % 0.5 %  % 23.1 % INCOME TAX ON CONTINUING OPERATIONS 863  15 1 879 NET EARNINGS ATTRIBUTABLE TO P&G 2,714 118 73  2,905 EFFECTIVE TAX RATE 23.1 %  % (0.1 )%  % 23 % Core EPS: DILUTED NET EARNINGS PER COMMON SHARE FROM CONTINUING OPERATIONS* 0.96 0.04 0.03  1.03 DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING 2,822.9 *Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.",5068
2018-10-11,8-K,0000080424-18-000090,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.07. Submission of Matters to a Vote of Security Holders The Procter & Gamble Company (the ""Company"") held its Annual Meeting of Shareholders on October 9, 2018. Set forth below are the final voting results for each of the proposals submitted to a vote of the shareholders. 1 . Election of Directors 2. Ratification of the Independent Registered Public Accounting Firm 3. Advisory vote on Company's Executive Compensation (the ""Say on Pay"" vote) The Company is filing this 8-K pursuant to item 5.07, ""Submission of Matters to a Vote of Security Holders.""",287
2018-10-19,8-K,0000080424-18-000098,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On October 19, 2018, The Procter & Gamble Company (the ""Company"") issued a press release announcing its first quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated October 19, 2018",283
2018-10-19,10-Q,0000080424-18-000100,"and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: Management's Discussion and Analysis, ",95
2018-10-19,8-K,0000080424-18-000095,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) October 19, 2018 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) (513) 983-1100 (Registrants telephone number, including area code)  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On October 19, 2018, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended September 30, 2018. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated October 19, 2018.",301
2018-10-22,8-K,0000080424-18-000106,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) October 22, 2018 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) Zip Code (513) 983-1100 45202 (Registrant's telephone number, including area code) Zip Code o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 8.01 OTHER EVENTS As disclosed in its Annual Report on Form 10-K for the year ended June 30, 2018 and the Quarterly Report on Form 10-Q for the three months ended September 30, 2018, The Procter and Gamble Company (the Company, we) adopted the Financial Accounting Standards Board (FASB) ASU 2017-07, Compensation-Retirement Benefits: Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost (Topic 715) effective July 1, 2018. Topic 715 requires an entity to disaggregate the current service cost component from the other components of net defined benefit costs on the face of the income statement. It requires the service cost component to be presented with other current compensation costs for the related employees in the operating section of the income statement. Other components of net benefit costs are required to be presented outside of income from operations. The Company has adopted ASU 2017-07 retrospectively. As such, prior periods results have been revised to report the other components of net benefit costs, previously reported in Cost of products sold and Selling, general, and administrative expense (SG&A), within Other non-operating income/(expense), net. In addition, as disclosed in its Quarterly Report on Form 10-Q for the three months ended September 30, 2018, the Company adopted ASU 2016-18, Statement of Cash Flows: Restricted Cash (Topic 230) effective July 1, 2018. Topic 230 requires the Statement of Cash Flows to present changes in the total of cash, cash equivalents and restricted cash. Prior to the adoption of this ASU, the relevant accounting guidance did not require the Statement of Cash Flows to include changes in restricted cash. We adopted this change retrospectively. We currently have no significant restricted cash balances. Historically, we had restricted cash balances and changes related to divestiture activity. Such balances were presented as Current assets held for sale on the balance sheets, with changes presented as investing activities on the statements of cash flow. Under Topic 230, such balances are included in the beginning and ending balances of cash, cash equivalents and restricted cash on the statement of cash flows for all periods presented. In this Form 8-K, the Company is providing revised Selected Financial Data, a revised Management's Discussion and Analysis (MD&A) and revised Consolidated Financial Statements and notes thereto for the years ended June 30, 2018, 2017 and 2016 to revise the disclosures for those periods to reflect the accounting changes described above. The revised Selected Financial Data, MD&A and Consolidated Financial Statements otherwise continue to speak as of the date of the filing of the Form 10-K for the fiscal year ended June 30, 2018 (the 2018 10-K) with the Securities and Exchange Commission (SEC) and have not been updated for events or developments that occurred subsequent to such filing. For developments since the filing of the 2018 10-K, please refer to the Company's Form 10-Q for the quarter ended September 30, 2018 and the Company's Forms 8-K filed since August 7, 2018, the filing date of the 2018 Form 10-K. ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS (d) Exhibits Exhibit Number Description 99.1 Revised Selected Financial Data 99.2 Revised Management's Discussion and Analysis 99.3 Revised Consolidated Financial Statements and Accompanying Footnotes 99.4 Report of Independent Registered Public Accounting Firm 23",774
2018-10-30,8-K,0001193125-18-312390,"SECURITIES AND EXCHANGE COMMISSION REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) October 30, 2018 The Procter & Gamble Company (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrants telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Schedule 13(a) of the Exchange On October 30, 2018, The Procter & Gamble Company (the Company) closed an underwritten public offering of 800,000,000 aggregate principal amount of 0.625% Notes due October 30, 2024, 800,000,000 aggregate principal amount of 1.200% Notes due October 30, 2028 and 500,000,000 aggregate principal amount of 1.875% Notes due October 30, 2038 under the Companys Registration Statement on Form S-3 (Registration No. 333-221035). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(c) and are",277
2018-11-08,8-K,0000080424-18-000109,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On November 8, 2018, The Procter & Gamble Company (the ""Company"") issued the attached news release. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS News Release Provided by The Procter & Gamble Company dated November 8, 2018",246
2018-12-27,8-K,0000080424-18-000112,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other juris diction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS On December 26, 2018, Kenneth I. Chenault notified The Procter & Gamble Company (the ""Company"") of his decision to retire from the Company's Board of Directors effective February 13, 2019. Mr. Chenault made this decision in order to allow more time to focus on a range of activities in the next phase of his life. The Company is filing this 8-K pursuant to Item 5.02(b), ""Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.""",298
2019-01-08,8-K,0000080424-19-000002,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On January 8, 2019, the Company announced that its Board of Directors declared a quarterly dividend of $0.7172 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after February 15, 2019, to Common Stock shareholders of record at the close of business on January 18, 2019, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on January 18, 2019. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Dividend News Release by The Procter & Gamble Company dated January 8, 2019.",319
2019-01-23,8-K,0000080424-19-000008,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) January 23, 2019 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) (513) 983-1100 (Registrants telephone number, including area code)  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 23, 2019, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended December 31, 2018. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated January 23, 2019.",301
2019-01-23,8-K,0000080424-19-000011,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 7.01 REGULATION FD DISCLOSURE On January 23, 2019, The Procter & Gamble Company (the ""Company"") issued a press release announcing its second quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated January 23, 2019",280
2019-01-23,10-Q,0000080424-19-000014,"and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: Management's Discussion and Analysis, ",95
2019-02-13,8-K,0000080424-19-000016,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other juris diction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN Effective February 13, 2019, Dr. Ernesto Zedillo retired from the Board of Directors of The Procter & Gamble Company (the ""Company"") after 18 years of service, in accordance with the term limits set forth in the Company's Corporate Governance Guidelines. The Company is filing this 8-K pursuant to Item 5.02(b), ""Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain",280
2019-04-09,8-K,0000080424-19-000023,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On April 9, 2019, the Company announced that its Board of Directors declared a quarterly dividend of $0.7459 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after May 15, 2019, to Common Stock shareholders of record at the close of business on April 19, 2019, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on April 19, 2019. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Dividend News Release by The Procter & Gamble Company dated April 9, 2019.",318
2019-04-23,8-K,0000080424-19-000030,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) (State or other jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio (Address of principal executive offices) (Registrant's telephone number, including area code) Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 7.01 REGULATION FD DISCLOSURE On April 23, 2019, The Procter & Gamble Company (the ""Company"") issued a press release announcing its third quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated April 23, 2019",281
2019-04-23,10-Q,0000080424-19-000031,"and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: Management's Discussion and Analysis, ",95
2019-04-23,8-K,0000080424-19-000028,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) April 23, 2019 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) (513) 983-1100 (Registrants telephone number, including area code)  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On April 23, 2019, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended March 31, 2019. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated April 23, 2019.",301
2019-06-13,8-K,0000080424-19-000036,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 of earliest event reported): June 13, 2019 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 7.01 REGULATION FD DISCLOSURE On June 13, 2019, The Procter & Gamble Company (the ""Company"") participated in the Deutsche Bank dbAccess Global Consumer Conference. The Company is furnishing on this Form 8-K a slide referenced in the Company's remarks at the conference. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slide Provided by The Procter & Gamble Company dated June 13, 2019",333
2019-07-09,8-K,0000080424-19-000040,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 9, 2019 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 7.01 REGULATION FD DISCLOSURE On July 9, 2019, the Company announced that its Board of Directors declared a quarterly dividend of $0.7459 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after August 15, 2019, to Common Stock shareholders of record at the close of business on July 19, 2019, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on July 19, 2019. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Dividend News Release by The Procter & Gamble Company dated July 9, 2019",394
2019-07-30,8-K,0000080424-19-000044,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) July 30, 2019 THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) (513) 983-1100 (Registrants telephone number, including area code)  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG New York Stock Exchange 4.125% EUR notes due December 2020 PG20A New York Stock Exchange 0.275% Notes due 2020 PG20 New York Stock Exchange 2.000% Notes due 2021 PG21 New York Stock Exchange 2.000% Notes due 2022 PG22B New York Stock Exchange 1.125% Notes due 2023 PG23A New York Stock Exchange 0.500% Notes due 2024 PG24A New York Stock Exchange 0.625% Notes due 2024 PG24B New York Stock Exchange 1.375% Notes due 2025 PG25 New York Stock Exchange 4.875% EUR notes due May 2027 PG27A New York Stock Exchange 1.200% Notes due 2028 PG28 New York Stock Exchange 1.250% Notes due 2029 PG29B New York Stock Exchange 1.800% Notes due 2029 PG29A New York Stock Exchange 6.250% GBP notes due January 2030 PG30 New York Stock Exchange 5.250% GBP notes due January 2033 PG33 New York Stock Exchange 1.875% Notes due 2038 PG38 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On July 30, 2019, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended June 30, 2019. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated July 30, 2019.",476
2019-07-30,8-K,0000080424-19-000046,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 30, 2019 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) ONE PROCTER & GAMBLE PLAZA, CINCINNATI , OHIO 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.125% EUR notes due December 2020 GBP notes due January 2030 GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On July 30, 2019, The Procter & Gamble Company (the ""Company"") issued a press release announcing its fourth quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated July 30, 2019",371
2019-08-06,10-K,0000080424-19-000050,and Analysis of Financial Condition and Results of Operations 11 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 29 Item 8. Financial Statements and Supplementary Data 30 Management's Report and Reports of Independent Registered Public Accounting Firm 30 Consolidated Statements of Earnings 35 Consolidated Statements of Comprehensive Income 36 Consolidated Balance Sheets 37 Consolidated Statements of Shareholders' Equity 38 Consolidated Statements of Cash Flows 39 Notes to Consolidated Financial Statements 40 Note 1: Summary of Significant Accounting Policies 40 Note 2: Segment Information 43 Note 3: Supplemental Financial Information 44 Note 4: Goodwill and Intangible Assets 46 Note 5: Income Taxes 47 Note 6: Earnings Per Share 49 Note 7: Stock-based Compensation 50 Note 8: Postretirement Benefits and Employee Stock Ownership Plan 51 Note 9: Risk Management Activities and Fair Value Measurements 56 Note 10: Short-term and Long-term Debt 59 Note 11: Accumulated Other Comprehensive Income/(Loss) 60 Note 12: Commitments and Contingencies 60 Note 13: Discontinued Operations 61 Note 14: Merck Acquisition 62 Note 15: Quarterly Results (Unaudited) 62,170
2019-10-08,8-K,0000080424-19-000063,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 8, 2019 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value EUR notes due December 2020 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On October 8, 2019, the Company announced that its Board of Directors declared a quarterly dividend of $0.7459 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after November 15, 2019, to Common Stock shareholders of record at the close of business on October 18, 2019, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on October 18, 2019. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Dividend News Release by The Procter & Gamble Company dated October 8, 2019",396
2019-10-08,8-K,0000080424-19-000064,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 8, 2019 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value EUR notes due December 2020 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On October 8, 2019, The Procter & Gamble Company (the Company) issued a news release announcing that, according to preliminary voting results, Christine M. McCarthy, Senior Executive Vice President and Chief Financial Officer of The Walt Disney Company, and the Companys eleven incumbent Directors, were elected to the Companys Board of Directors at the Annual Meeting of Shareholders. A copy of this news release is furnished The Company is furnishing the information under this item, including Exhibit 99.1, pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Director Election News Release by The Procter & Gamble Company dated October 8, 2019",381
2019-10-11,8-K,0000080424-19-000077,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 11, 2019 (October 8, 2019) THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value EUR notes due December 2020 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. At the Annual Meeting of Shareholders of The Procter & Gamble Company (the Company), held on October 8, 2019, the Companys shareholders approved The Procter & Gamble 2019 Stock and Incentive Compensation Plan (the 2019 Stock Plan). The 2019 Stock Plan authorizes the award of up to 150,000,000 shares of the Company's common stock. Types of awards authorized under the 2019 Stock Plan include common stock, restricted stock units, performance stock units, stock options, and stock appreciation rights. In addition, the 2019 Stock Plan permits the award of any shares that remain available under The Procter & Gamble 2014 Stock and Incentive Compensation Plan, approved by shareholders on October 14, 2014. The Board of Directors approved the 2019 Stock Plan for submission to shareholders on August 13, 2019. In addition to the above description, a summary of the 2019 Stock Plan is provided in the Companys definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on August 23, 2019. These descriptions are qualified in their entirety by reference to the 2019 Stock Plan, a copy of which is filed as Exhibit 10.1 to this Form 8-K. Submission of Matters to a Vote of Security Holders Set forth below are the final voting results for each of the proposals submitted to a vote of the shareholders at the Companys Annual Meeting of Shareholders, held on October 8, 2019. 1 . Election of Directors 2. Ratification of the Independent Registered Public Accounting Firm 3. Advisory vote on Company's Executive Compensation (the ""Say on Pay"" vote) 4. Approval of The Procter & Gamble 2019 Stock & Incentive Compensation Plan The Company is filing this 8-K pursuant to item 5.02(e), Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, and Item 5.07, ""Submission of Matters to a Vote of Security Holders."" Item 9.01. Financial Statements and Exhibits The Procter & Gamble 2019 Stock & Incentive Compensation Plan",619
2019-10-22,8-K,0000080424-19-000084,"SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 22, 2019 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value The New York Stock Exchange 4.125% EUR notes due December 2020 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On October 22, 2019, The Procter & Gamble Company (the ""Company"") issued a press release announcing its first quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated October 22, 2019. Cover Page Interactive Data File (embedded within the Inline XBRL document)",379
2019-10-22,8-K,0000080424-19-000080,"pg:A4.875EURdueMay2027Domain pg:A6.250GBPdueJanuary2030Domain pg:A5.250GBPdueJanuary2033Domain pg:A4.125EURdueDecember2020Domain UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) October 22, 2019 PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio OH 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza , Cincinnati OH One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 4.125% EUR notes due December 2020 PG20A NYSE 0.275% Notes due 2020 PG20 NYSE 2.000% Notes due 2021 PG21 NYSE 2.000% Notes due 2022 PG22B NYSE 1.125% Notes due 2023 PG23A NYSE 0.500% Notes due 2024 PG24A NYSE 0.625% Notes due 2024 PG24B NYSE 1.375% Notes due 2025 PG25 NYSE 4.875% EUR notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP notes due January 2030 PG30 NYSE 5.250% GBP notes due January 2033 PG33 NYSE 1.875% Notes due 2038 PG38 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On October 22, 2019, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended September 30, 2019. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated October 22, 2019. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",492
2019-10-22,10-Q,0000080424-19-000086,"and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: Management's Discussion and Analysis, ",95
2020-01-14,8-K,0000080424-20-000007,"false 0000080424 0000080424 2020-01-14 2020-01-14 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2020-01-14 2020-01-14 0000080424 pg:One800NotesDue2029Member 2020-01-14 2020-01-14 0000080424 pg:One875NotesDue2038Member 2020-01-14 2020-01-14 0000080424 pg:Zero625NotesDue2024Member 2020-01-14 2020-01-14 0000080424 pg:Zero275NotesDue2020Member 2020-01-14 2020-01-14 0000080424 pg:Zero500NotesDue2023Member 2020-01-14 2020-01-14 0000080424 pg:Four125EURNotesDueDecember2020Member 2020-01-14 2020-01-14 0000080424 pg:One250NotesDue2029Member 2020-01-14 2020-01-14 0000080424 pg:One200NotesDue2028Member 2020-01-14 2020-01-14 0000080424 pg:Two000NotesDue2021Member 2020-01-14 2020-01-14 0000080424 pg:Four875EURNotesDueMay2027Member 2020-01-14 2020-01-14 0000080424 pg:Two000NotesDue2022Member 2020-01-14 2020-01-14 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2020-01-14 2020-01-14 0000080424 pg:One125NotesDue2023Member 2020-01-14 2020-01-14 0000080424 pg:One375NotesDue2025Member 2020-01-14 2020-01-14 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 14, 2020 THE PROCTER & GAMBLE COMPANY PROCTERPROCTER & GAMBLE Co o (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock , without Par Value 4.125% EUR notes due December 2020 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On January 14, 2020, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of $0.7459 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after February 18, 2020 to Common Stock shareholders of record at the close of business on January 24, 2020, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on January 24, 2020. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Dividend News Release by The Procter & Gamble Company dated January 14, 2020. Cover Page Interactive Data File (embedded within the Inline XBRL document)",502
2020-01-23,10-Q,0000080424-20-000017,"and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including, without limitation, the following sections: Management's Discussion and Analysis, ",95
2020-01-23,8-K,0000080424-20-000010,"pg-20200123 PROCTER & GAMBLE CO 8-K 0000080424 1/23/2020 OH 1-434 31-0411980 One Procter & Gamble Plaza Cincinnati OH 45202 513 983-1100 False False False False False False 0000080424 2020-01-23 2020-01-23 0000080424 2020-01-23 2020-01-23 0000080424 exch:XNYS 2020-01-23 2020-01-23 0000080424 pg:A4.125EURdueDecember2020Domain 2020-01-23 2020-01-23 0000080424 pg:A0.275due2020Domain 2020-01-23 2020-01-23 0000080424 pg:A2.000due2021Domain 2020-01-23 2020-01-23 0000080424 pg:A2.000due2022Domain 2020-01-23 2020-01-23 0000080424 pg:A1.125due2023Domain 2020-01-23 2020-01-23 0000080424 pg:A0.500due2024Domain 2020-01-23 2020-01-23 0000080424 pg:A0.625due2024Domain 2020-01-23 2020-01-23 0000080424 pg:A1.375due2025Domain 2020-01-23 2020-01-23 0000080424 pg:A4.875EURdueMay2027Domain 2020-01-23 2020-01-23 0000080424 pg:A1.200due2028Domain 2020-01-23 2020-01-23 0000080424 pg:A1.250due2029Domain 2020-01-23 2020-01-23 0000080424 pg:A1.800due2029Domain 2020-01-23 2020-01-23 0000080424 pg:A6.250GBPdueJanuary2030Domain 2020-01-23 2020-01-23 0000080424 pg:A5.250GBPdueJanuary2033Domain 2020-01-23 2020-01-23 0000080424 pg:A1.875due2038Domain 2020-01-23 2020-01-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) January 23, 2020 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio OH 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza , Cincinnati OH One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 4.125% EUR notes due December 2020 PG20A NYSE 0.275% Notes due 2020 PG20 NYSE 2.000% Notes due 2021 PG21 NYSE 2.000% Notes due 2022 PG22B NYSE 1.125% Notes due 2023 PG23A NYSE 0.500% Notes due 2024 PG24A NYSE 0.625% Notes due 2024 PG24B NYSE 1.375% Notes due 2025 PG25 NYSE 4.875% EUR notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP notes due January 2030 PG30 NYSE 5.250% GBP notes due January 2033 PG33 NYSE 1.875% Notes due 2038 PG38 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 23, 2020, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended December 31, 2019. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated January 23, 2020. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",586
2020-01-23,8-K,0000080424-20-000012,"false 0000080424 0000080424 2020-01-23 2020-01-23 0000080424 pg:Zero500NotesDue2023Member 2020-01-23 2020-01-23 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2020-01-23 2020-01-23 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2020-01-23 2020-01-23 0000080424 pg:Four875EURNotesDueMay2027Member 2020-01-23 2020-01-23 0000080424 pg:One800NotesDue2029Member 2020-01-23 2020-01-23 0000080424 pg:One875NotesDue2038Member 2020-01-23 2020-01-23 0000080424 pg:Zero275NotesDue2020Member 2020-01-23 2020-01-23 0000080424 pg:One375NotesDue2025Member 2020-01-23 2020-01-23 0000080424 pg:Two000NotesDue2021Member 2020-01-23 2020-01-23 0000080424 pg:One200NotesDue2028Member 2020-01-23 2020-01-23 0000080424 pg:One125NotesDue2023Member 2020-01-23 2020-01-23 0000080424 pg:Zero625NotesDue2024Member 2020-01-23 2020-01-23 0000080424 pg:Four125EURNotesDueDecember2020Member 2020-01-23 2020-01-23 0000080424 pg:One250NotesDue2029Member 2020-01-23 2020-01-23 0000080424 pg:Two000NotesDue2022Member 2020-01-23 2020-01-23 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 23, 2020 THE PROCTER & GAMBLE COMPANY PROCTERPROCTER & GAMBLE Co o (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.125% EUR notes due December 2020 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On January 23, 2020, The Procter & Gamble Company (the ""Company"") issued a press release announcing its second quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated January 23, 2020. Cover Page Interactive Data File (embedded within the Inline XBRL document)",463
2020-02-20,8-K,0000080424-20-000021,"false 0000080424 0000080424 2020-02-20 2020-02-20 0000080424 pg:One125NotesDue2023Member 2020-02-20 2020-02-20 0000080424 pg:Zero625NotesDue2024Member 2020-02-20 2020-02-20 0000080424 pg:One875NotesDue2038Member 2020-02-20 2020-02-20 0000080424 pg:Four875EURNotesDueMay2027Member 2020-02-20 2020-02-20 0000080424 pg:One375NotesDue2025Member 2020-02-20 2020-02-20 0000080424 pg:Two000NotesDue2021Member 2020-02-20 2020-02-20 0000080424 pg:Two000NotesDue2022Member 2020-02-20 2020-02-20 0000080424 pg:One250NotesDue2029Member 2020-02-20 2020-02-20 0000080424 pg:Four125EURNotesDueDecember2020Member 2020-02-20 2020-02-20 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2020-02-20 2020-02-20 0000080424 pg:One200NotesDue2028Member 2020-02-20 2020-02-20 0000080424 pg:Zero275NotesDue2020Member 2020-02-20 2020-02-20 0000080424 pg:Zero500NotesDue2023Member 2020-02-20 2020-02-20 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2020-02-20 2020-02-20 0000080424 pg:One800NotesDue2029Member 2020-02-20 2020-02-20 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 20, 2020 THE PROCTER & GAMBLE COMPANY PROCTERPROCTER & GAMBLE Co o (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.125% EUR notes due December 2020 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On February 20, 2020, Jon Moeller, Vice Chairman, Chief Operating Officer and Chief Financial Officer of The Procter & Gamble Company (The Company), provided remarks at the Consumer Analyst Group of New York (CAGNY) 2020 Conference, including the following comments: We face the demand and supply challenges associated with the coronavirus outbreak. China is our second largest marketsales and profit. Store traffic is down considerably, with many stores closed or operating with reduced hours. Some of the demand has shifted online but supply of delivery operators and labor is limited. There are also impacts outside of China: travel retail, a significant reduction in department store traffic in many Asian metro areas, and global supply. We access 387 suppliers in China that ship to us globally more than 9,000 different materials, impacting approximately 17,600 different finished product items. Each of these suppliers faces their own challenges in resuming operations. The operating challenges change with the hour, and of course the path of the virus is unknown, making it very difficult to provide precise estimates of impact. Results for the January to March quarter in China and for the total Company will be materially impacted on both the top and bottom line by these dynamics. We continue to believe, based on what we know today, that our fiscal year top and bottom line guidance rangesand I emphasize rangesremain the right ones. We will continue to monitor the situation and obviously update you if and when a different reality becomes apparent. The Company is furnishing this 8-K pursuant to Item 7.01, Regulation FD Disclosure. Forward-Looking Statements Certain statements in this current report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words believe, project, expect, anticipate, estimate, intend, strategy, future, opportunity, plan, may, should, will, would, will be, will continue, will likely result, and similar expressions. Forward-looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, except to the extent required by law. Risks and uncertainties to which our forward-looking statements are subject include, without limitation: (1) the ability to successfully manage global financial risks, including foreign currency fluctuations, currency exchange or pricing controls and localized volatility; (2) the ability to successfully manage local, regional or global economic volatility, including, for example, reduced market growth rates and other business disruptions related to the coronavirus outbreak, and to generate sufficient income and cash flow to allow the Company to affect the expected share repurchases and dividend payments; (3) the ability to manage disruptions in credit markets or changes to our credit rating; (4) the ability to maintain key manufacturing and supply arrangements (including execution of supply chain optimizations and sole supplier and sole manufacturing plant arrangements) and to manage disruption of business due to factors outside of our control, such as natural disasters, acts of war or terrorism, or epidemics; (5) the ability to successfully manage cost fluctuations and pressures, including prices of commodities and raw materials, and costs of labor, transportation, energy, pension and healthcare; (6) the ability to stay on the leading edge of innovation, obtain necessary intellectual property protections and successfully respond to changing consumer habits and technological advances attained by, and patents granted to, competitors; (7) the ability to compete with our local and global competitors in new and existing sales channels, including by successfully responding to competitive factors such as prices, promotional incentives and trade terms for products; (8) the ability to manage and maintain key customer relationships; (9) the ability to protect our reputation and brand equity by successfully managing real or perceived issues, including concerns about safety, quality, ingredients, efficacy or similar matters that may arise; (10) the ability to successfully manage the financial, legal, reputational and operational risk associated with third-party relationships, such as our suppliers, contract manufacturers, distributors, contractors and external business partners; (11) the ability to rely on and maintain key company and third party information technology systems, networks and services, and maintain the security and functionality of such systems, networks and services and the data contained therein; (12) the ability to successfully manage uncertainties related to changing political conditions (including the United Kingdoms decision to leave the European Union) and potential implications such as exchange rate fluctuations and market contraction; (13) the ability to successfully manage regulatory and legal requirements and matters (including, without limitation, those laws and regulations involving product liability, product and packaging composition, intellectual property, antitrust, data protection, tax, environmental, and accounting and financial reporting) and to resolve pending matters within current estimates; (14) the ability to manage changes in applicable tax laws and regulations including maintaining our intended tax treatment of divestiture transactions; (15) the ability to successfully manage our ongoing acquisition, divestiture and joint venture activities, in each case to achieve the Companys overall business strategy and financial objectives, without impacting the delivery of base business objectives; and (16) the ability to successfully achieve productivity improvements and cost savings and manage ongoing organizational changes, while successfully identifying, developing and retaining key employees, including in key growth markets where the availability of skilled or experienced employees may be limited. For additional information concerning factors that could cause actual results and events to differ materially from those projected herein, please refer to our most recent 10-K, 10-Q and 8-K reports.",1341
2020-03-23,8-K,0001193125-20-081692,"THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) 513 - 983-1100 Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.125% EUR notes due December 2020 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Other Events. The Procter & Gamble Company (the Company) is filing this Current Report on Form 8-K to supplement the risk factors described in Item 1A of the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2019. The following risk factor disclosure should be read in conjunction with the risk factors described in the Annual Report on Form 10-K. We must successfully manage the demand, supply, and operational challenges associated with the actual or perceived effects of a disease outbreak, including epidemics, pandemics, or similar widespread public health concerns. Our business may be negatively impacted by the fear of exposure to or actual effects of a disease outbreak, epidemic, pandemic, or similar widespread public health concern, such as reduced travel or recommendations or mandates from governmental authorities to avoid large gatherings or to self-quarantine as a result of the novel coronavirus (COVID-19) pandemic. These impacts include, but are not limited to: Significant reductions in demand or significant volatility in demand for one or more of our products, which may be caused by, among other things: the temporary inability of consumers to purchase our products due to illness, quarantine or other travel restrictions, or financial hardship, shifts in demand away from one or more of our more discretionary or higher priced products to lower priced products, or stockpiling or similar pantry-loading activity; if prolonged such impacts can further increase the difficulty of planning for operations and may adversely impact our results; Inability to meet our customers needs and achieve costs targets due to disruptions in our manufacturing and supply arrangements caused by the loss or disruption of essential manufacturing and supply elements such as raw materials or other finished product components, transportation, workforce, or other manufacturing and distribution capability; Failure of third parties on which we rely, including our suppliers, contract manufacturers, distributors, contractors, commercial banks, joint venture partners and external business partners, to meet their obligations to the Company, or significant disruptions in their ability to do so, which may be caused by their own financial or operational difficulties and may adversely impact our operations; or Significant changes in the political conditions in markets in which we manufacture, sell or distribute our products, including quarantines, governmental or regulatory actions, closures or other restrictions that limit or close our operating and manufacturing facilities, restrict our employees ability to travel or perform necessary business functions, or otherwise prevent our third-party partners, suppliers, or customers from sufficiently staffing operations, including operations necessary for the production, distribution, sale, and support of our products, which could adversely impact our results. Despite our efforts to manage and remedy these impacts to the Company, their ultimate impact also depends on factors beyond our knowledge or control, including the duration and severity of any such outbreak as well as third-party actions taken to contain its spread and mitigate its public health effects.",762
2020-03-26,8-K,0001193125-20-085533,"THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) 513 - 983-1100 Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.125% EUR notes due December 2020 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Other Events. On March 25, 2020, The Procter & Gamble Company (the Company) closed an underwritten public offering of $750,000,000 aggregate principal amount of 2.450% Notes due March 25, 2025, $500,000,000 aggregate principal amount of 2.800% Notes due March 25, 2027, $1,500,000,000 aggregate principal amount of 3.000% Notes due March 25, 2030, $1,000,000,000 aggregate principal amount of 3.550% Notes due March 25, 2040 and $1,250,000,000 aggregate principal amount of 3.600% Notes due March 25, 2050 under the Companys Registration Statement on Form S-3 (Registration No. 333-221035). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are",385
2020-04-14,8-K,0000080424-20-000026,"false 0000080424 0000080424 2020-04-14 2020-04-14 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2020-04-14 2020-04-14 0000080424 pg:One800NotesDue2029Member 2020-04-14 2020-04-14 0000080424 pg:One875NotesDue2038Member 2020-04-14 2020-04-14 0000080424 pg:Zero625NotesDue2024Member 2020-04-14 2020-04-14 0000080424 pg:Zero275NotesDue2020Member 2020-04-14 2020-04-14 0000080424 pg:Zero500NotesDue2023Member 2020-04-14 2020-04-14 0000080424 pg:Four125EURNotesDueDecember2020Member 2020-04-14 2020-04-14 0000080424 pg:One250NotesDue2029Member 2020-04-14 2020-04-14 0000080424 pg:One200NotesDue2028Member 2020-04-14 2020-04-14 0000080424 pg:Two000NotesDue2021Member 2020-04-14 2020-04-14 0000080424 pg:Four875EURNotesDueMay2027Member 2020-04-14 2020-04-14 0000080424 pg:Two000NotesDue2022Member 2020-04-14 2020-04-14 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2020-04-14 2020-04-14 0000080424 pg:One125NotesDue2023Member 2020-04-14 2020-04-14 0000080424 pg:One375NotesDue2025Member 2020-04-14 2020-04-14 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 14, 2020 THE PROCTER & GAMBLE COMPANY PROCTERPROCTER & GAMBLE Co o (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock , without Par Value 4.125% EUR notes due December 2020 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On April 14, 2020, the Company announced that its Board of Directors declared a quarterly dividend of $0.7907 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after May 15, 2020, to Common Stock shareholders of record at the close of business on April 24, 2020, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on April 24, 2020. The Company also announced it is advancing the date for its third quarter earnings release to Friday, April 17, 2020, from the previously announced date of Tuesday, April 21. The Company noted the objective of advancing the release is simply to provide shareholders information as quickly and transparently as possible and should not be construed as an indication of either positive or negative The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Dividend News Release by The Procter & Gamble Company dated April 14, 2020. Cover Page Interactive Data File (embedded within the Inline XBRL document)",561
2020-04-17,8-K,0000080424-20-000029,"pg-20200417 PROCTER & GAMBLE CO 8-K 0000080424 4/17/2020 OH 1-434 31-0411980 One Procter & Gamble Plaza Cincinnati OH 45202 513 983-1100 False False False False False False 0000080424 2020-04-17 2020-04-17 0000080424 2020-04-17 2020-04-17 0000080424 exch:XNYS 2020-04-17 2020-04-17 0000080424 pg:A4.125EURdueDecember2020Domain 2020-04-17 2020-04-17 0000080424 pg:A0.275due2020Domain 2020-04-17 2020-04-17 0000080424 pg:A2.000due2021Domain 2020-04-17 2020-04-17 0000080424 pg:A2.000due2022Domain 2020-04-17 2020-04-17 0000080424 pg:A1.125due2023Domain 2020-04-17 2020-04-17 0000080424 pg:A0.500due2024Domain 2020-04-17 2020-04-17 0000080424 pg:A0.625due2024Domain 2020-04-17 2020-04-17 0000080424 pg:A1.375due2025Domain 2020-04-17 2020-04-17 0000080424 pg:A4.875EURdueMay2027Domain 2020-04-17 2020-04-17 0000080424 pg:A1.200due2028Domain 2020-04-17 2020-04-17 0000080424 pg:A1.250due2029Domain 2020-04-17 2020-04-17 0000080424 pg:A1.800due2029Domain 2020-04-17 2020-04-17 0000080424 pg:A6.250GBPdueJanuary2030Domain 2020-04-17 2020-04-17 0000080424 pg:A5.250GBPdueJanuary2033Domain 2020-04-17 2020-04-17 0000080424 pg:A1.875due2038Domain 2020-04-17 2020-04-17 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) April 17, 2020 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio OH 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza , Cincinnati OH One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 4.125% EUR notes due December 2020 PG20A NYSE 0.275% Notes due 2020 PG20 NYSE 2.000% Notes due 2021 PG21 NYSE 2.000% Notes due 2022 PG22B NYSE 1.125% Notes due 2023 PG23A NYSE 0.500% Notes due 2024 PG24A NYSE 0.625% Notes due 2024 PG24B NYSE 1.375% Notes due 2025 PG25 NYSE 4.875% EUR notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP notes due January 2030 PG30 NYSE 5.250% GBP notes due January 2033 PG33 NYSE 1.875% Notes due 2038 PG38 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On April 17, 2020, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended March 31, 2020. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated April 17, 2020. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",586
2020-04-17,8-K,0000080424-20-000031,"false 0000080424 0000080424 2020-04-17 2020-04-17 0000080424 pg:Zero500NotesDue2023Member 2020-04-17 2020-04-17 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2020-04-17 2020-04-17 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2020-04-17 2020-04-17 0000080424 pg:Four875EURNotesDueMay2027Member 2020-04-17 2020-04-17 0000080424 pg:One800NotesDue2029Member 2020-04-17 2020-04-17 0000080424 pg:One875NotesDue2038Member 2020-04-17 2020-04-17 0000080424 pg:Zero275NotesDue2020Member 2020-04-17 2020-04-17 0000080424 pg:One375NotesDue2025Member 2020-04-17 2020-04-17 0000080424 pg:Two000NotesDue2021Member 2020-04-17 2020-04-17 0000080424 pg:One200NotesDue2028Member 2020-04-17 2020-04-17 0000080424 pg:One125NotesDue2023Member 2020-04-17 2020-04-17 0000080424 pg:Zero625NotesDue2024Member 2020-04-17 2020-04-17 0000080424 pg:Four125EURNotesDueDecember2020Member 2020-04-17 2020-04-17 0000080424 pg:One250NotesDue2029Member 2020-04-17 2020-04-17 0000080424 pg:Two000NotesDue2022Member 2020-04-17 2020-04-17 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 17, 2020 THE PROCTER & GAMBLE COMPANY PROCTERPROCTER & GAMBLE Co o (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.125% EUR notes due December 2020 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On April 17, 2020, The Procter & Gamble Company (the ""Company"") issued a press release announcing its third quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated April 17, 2020. Cover Page Interactive Data File (embedded within the Inline XBRL document)",463
2020-04-20,10-Q,0000080424-20-000038,"and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including, without limitation, the following sections: Management's Discussion and Analysis, ",95
2020-07-14,8-K,0000080424-20-000043,"false 0000080424 0000080424 2020-07-14 2020-07-14 0000080424 pg:Four125EURNotesDueDecember2020Member 2020-07-14 2020-07-14 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2020-07-14 2020-07-14 0000080424 pg:Two00NotesDue2021Member 2020-07-14 2020-07-14 0000080424 pg:One800NotesDue2029Member 2020-07-14 2020-07-14 0000080424 pg:Zero625NotesDue2024Member 2020-07-14 2020-07-14 0000080424 pg:Four875EURNotesDueMay2027Member 2020-07-14 2020-07-14 0000080424 pg:One125NotesDue2023Member 2020-07-14 2020-07-14 0000080424 pg:Two000NotesDue2022Member 2020-07-14 2020-07-14 0000080424 pg:One200NotesDue2028Member 2020-07-14 2020-07-14 0000080424 pg:One875NotesDue2038Member 2020-07-14 2020-07-14 0000080424 pg:One250NotesDue2029Member 2020-07-14 2020-07-14 0000080424 pg:One375NotesDue2025Member 2020-07-14 2020-07-14 0000080424 pg:Zero500NotesDue2023Member 2020-07-14 2020-07-14 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2020-07-14 2020-07-14 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 14, 2020 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered 4.125% EUR notes due December 2020 4.875% EUR notes due May 2027 5.250% GBP notes due January 2033 6,250% GBP notes due January 2030 Common Stock, without Par Value Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On July 14, 2020, the Company announced that its Board of Directors declared a quarterly dividend of $0.7907 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after August 17, 2020, to Common Stock shareholders of record at the close of business on July 24, 2020, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on July 24, 2020. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Dividend News Release by The Procter & Gamble Company dated July 14, 2020. Cover Page Interactive Data File (embedded within the Inline XBRL document)",488
2020-07-30,8-K,0000080424-20-000048,"pg-20200730 PROCTER & GAMBLE CO 8-K 0000080424 7/30/2020 OH 1-434 31-0411980 One Procter & Gamble Plaza Cincinnati OH 45202 513 983-1100 False False False False False False 0000080424 2020-07-30 2020-07-30 0000080424 2020-07-30 2020-07-30 0000080424 exch:XNYS 2020-07-30 2020-07-30 0000080424 pg:A4.125EURdueDecember2020Domain 2020-07-30 2020-07-30 0000080424 pg:A2.000due2021Domain 2020-07-30 2020-07-30 0000080424 pg:A2.000due2022Domain 2020-07-30 2020-07-30 0000080424 pg:A1.125due2023Domain 2020-07-30 2020-07-30 0000080424 pg:A0.500due2024Domain 2020-07-30 2020-07-30 0000080424 pg:A0.625due2024Domain 2020-07-30 2020-07-30 0000080424 pg:A1.375due2025Domain 2020-07-30 2020-07-30 0000080424 pg:A4.875EURdueMay2027Domain 2020-07-30 2020-07-30 0000080424 pg:A1.200due2028Domain 2020-07-30 2020-07-30 0000080424 pg:A1.250due2029Domain 2020-07-30 2020-07-30 0000080424 pg:A1.800due2029Domain 2020-07-30 2020-07-30 0000080424 pg:A6.250GBPdueJanuary2030Domain 2020-07-30 2020-07-30 0000080424 pg:A5.250GBPdueJanuary2033Domain 2020-07-30 2020-07-30 0000080424 pg:A1.875due2038Domain 2020-07-30 2020-07-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) July 30, 2020 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio OH 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza , Cincinnati OH One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 4.125% EUR notes due December 2020 PG20A NYSE 2.000% Notes due 2021 PG21 NYSE 2.000% Notes due 2022 PG22B NYSE 1.125% Notes due 2023 PG23A NYSE 0.500% Notes due 2024 PG24A NYSE 0.625% Notes due 2024 PG24B NYSE 1.375% Notes due 2025 PG25 NYSE 4.875% EUR notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP notes due January 2030 PG30 NYSE 5.250% GBP notes due January 2033 PG33 NYSE 1.875% Notes due 2038 PG38 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On July 30, 2020, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended June 30, 2020. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated July 30, 2020. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",576
2020-07-30,8-K,0000080424-20-000050,"false 0000080424 0000080424 2020-07-30 2020-07-30 0000080424 pg:NewYorkStockExchangeMember pg:One250NotesDue2029Member 2020-07-30 2020-07-30 0000080424 pg:Four125EURNotesDueDecember2020Member pg:NewYorkStockExchangeMember 2020-07-30 2020-07-30 0000080424 pg:Six250GBPNotesDueJanuary2030Member pg:NewYorkStockExchangeMember 2020-07-30 2020-07-30 0000080424 pg:NewYorkStockExchangeMember pg:Zero500NotesDue2023Member 2020-07-30 2020-07-30 0000080424 pg:One800NotesDue2029Member pg:NewYorkStockExchangeMember 2020-07-30 2020-07-30 0000080424 pg:NewYorkStockExchangeLLCMember 2020-07-30 2020-07-30 0000080424 pg:One200NotesDue2028Member pg:NewYorkStockExchangeMember 2020-07-30 2020-07-30 0000080424 pg:One875NotesDue2038Member pg:NewYorkStockExchangeMember 2020-07-30 2020-07-30 0000080424 pg:One375NotesDue2025Member pg:NewYorkStockExchangeMember 2020-07-30 2020-07-30 0000080424 pg:Five250GBPNotesDueJanuary2033Member pg:NewYorkStockExchangeMember 2020-07-30 2020-07-30 0000080424 pg:NewYorkStockExchangeMember pg:Two00NotesDue2022Member 2020-07-30 2020-07-30 0000080424 pg:NewYorkStockExchangeMember pg:Two00NotesDue2021Member 2020-07-30 2020-07-30 0000080424 pg:Four875EURNotesDueMay2027Member pg:NewYorkStockExchangeMember 2020-07-30 2020-07-30 0000080424 pg:Zero625NotesDue2024Member pg:NewYorkStockExchangeMember 2020-07-30 2020-07-30 0000080424 pg:NewYorkStockExchangeMember pg:One125NotesDue2023Member 2020-07-30 2020-07-30 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 30, 2020 THE PROCTER & GAMBLE COMPANY PROCTERPROCTER & GAMBLE Co o (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value New York Stock Exchange LLC 4.125% EUR notes due December 2020 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On July 30, 2020, The Procter & Gamble Company (the ""Company"") issued a press release announcing its fourth quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated July 30, 2020. Cover Page Interactive Data File (embedded within the Inline XBRL document)",482
2020-08-06,10-K,0000080424-20-000053,"pg-20200630 PROCTER & GAMBLE CO 0000080424 Large Accelerated Filer 10-K 6/30 2020 FY false PG Yes Yes No 2,486,086,692 304 False TRUE FALSE 1-434 Yes FALSE FALSE TRUE 59 78 279 1   42 22 68 1 1 600 600 1 1 200 200 1 1 10,000 10,000 4,009.2 4,009.2 1,529.5 1,504.5 3.0284 2.8975 2.7860 15 15 7.9 0.9 14 14 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 exch:XNYS 2019-07-01 2020-06-30 0000080424 pg:A4125EURNotesDueDecember2020Domain 2019-07-01 2020-06-30 0000080424 exch:XNYS 2019-07-01 2020-06-30 0000080424 pg:A2000NotesDue2021Domain 2019-07-01 2020-06-30 0000080424 pg:A2000NotesDue2022Domain 2019-07-01 2020-06-30 0000080424 pg:A1125NotesDue2023Domain 2019-07-01 2020-06-30 0000080424 pg:A0500NotesDue2024Domain 2019-07-01 2020-06-30 0000080424 pg:A0625NotesDue2024Domain 2019-07-01 2020-06-30 0000080424 pg:A1375NotesDue2025Domain 2019-07-01 2020-06-30 0000080424 pg:A4875EURNotesDueMay2027Domain 2019-07-01 2020-06-30 0000080424 pg:A1200NotesDue2028Domain 2019-07-01 2020-06-30 0000080424 pg:A1250NotesDue2029Domain 2019-07-01 2020-06-30 0000080424 pg:A1800NotesDue2029Domain 2019-07-01 2020-06-30 0000080424 pg:A6250GBPNotesDueJanuary2030Domain 2019-07-01 2020-06-30 0000080424 pg:A5250GBPNotesDueJanuary2033Domain 2019-07-01 2020-06-30 0000080424 pg:A1875NotesDue2038Domain 2019-07-01 2020-06-30 iso4217:USD 0000080424 2019-12-31 xbrli:shares 0000080424 2020-07-31 0000080424 2018-07-01 2019-06-30 0000080424 2017-07-01 2018-06-30 iso4217:USD xbrli:shares 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2017-06-30 0000080424 2017-06-30 0000080424 2017-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2017-06-30 0000080424 2017-06-30 0000080424 2017-06-30 0000080424 2017-06-30 0000080424 2017-06-30 0000080424 2017-06-30 0000080424 2017-07-01 2018-06-30 0000080424 2017-07-01 2018-06-30 0000080424 2017-07-01 2018-06-30 0000080424 2017-07-01 2018-06-30 0000080424 2017-07-01 2018-06-30 0000080424 2017-07-01 2018-06-30 0000080424 2017-07-01 2018-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2017-07-01 2018-06-30 0000080424 2018-06-30 0000080424 2018-06-30 0000080424 2018-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2018-06-30 0000080424 2018-06-30 0000080424 2018-06-30 0000080424 2018-06-30 0000080424 2018-06-30 0000080424 2018-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2018-07-01 2019-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2018-07-01 2019-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2019-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2019-07-01 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 pg:countries 0000080424 2019-07-01 2020-06-30 0000080424 srt:MinimumMember 2019-07-01 2020-06-30 0000080424 srt:MaximumMember 2019-07-01 2020-06-30 0000080424 srt:MinimumMember 2019-07-01 2020-06-30 0000080424 srt:MaximumMember 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 pg:CustomerRelationshipsBrandsandOtherNonContractualIntangibleAssetsMember srt:MinimumMember 2019-07-01 2020-06-30 0000080424 srt:MaximumMember pg:CustomerRelationshipsBrandsandOtherNonContractualIntangibleAssetsMember 2019-07-01 2020-06-30 xbrli:pure 0000080424 pg:LeaseArrangementMember 2018-07-01 2019-06-30 pg:segment 0000080424 pg:FabricCareMember 2019-07-01 2020-06-30 0000080424 pg:FabricCareMember 2018-07-01 2019-06-30 0000080424 pg:FabricCareMember 2017-07-01 2018-06-30 0000080424 pg:BabyCareMember 2019-07-01 2020-06-30 0000080424 pg:BabyCareMember 2018-07-01 2019-06-30 0000080424 pg:BabyCareMember 2017-07-01 2018-06-30 0000080424 pg:HomeCareMember 2019-07-01 2020-06-30 0000080424 pg:HomeCareMember 2018-07-01 2019-06-30 0000080424 pg:HomeCareMember 2017-07-01 2018-06-30 0000080424 pg:SkinandPersonalCareMember 2019-07-01 2020-06-30 0000080424 pg:SkinandPersonalCareMember 2018-07-01 2019-06-30 0000080424 pg:SkinandPersonalCareMember 2017-07-01 2018-06-30 0000080424 pg:HairCareMember 2019-07-01 2020-06-30 0000080424 pg:HairCareMember 2018-07-01 2019-06-30 0000080424 pg:HairCareMember 2017-07-01 2018-06-30 0000080424 pg:FamilyCareMember 2019-07-01 2020-06-30 0000080424 pg:FamilyCareMember 2018-07-01 2019-06-30 0000080424 pg:FamilyCareMember 2017-07-01 2018-06-30 0000080424 pg:OralCareMember 2019-07-01 2020-06-30 0000080424 pg:OralCareMember 2018-07-01 2019-06-30 0000080424 pg:OralCareMember 2017-07-01 2018-06-30 0000080424 pg:ShaveCareMember 2019-07-01 2020-06-30 0000080424 pg:ShaveCareMember 2018-07-01 2019-06-30 0000080424 pg:ShaveCareMember 2017-07-01 2018-06-30 0000080424 pg:FeminineCareMember 2019-07-01 2020-06-30 0000080424 pg:FeminineCareMember 2018-07-01 2019-06-30 0000080424 pg:FeminineCareMember 2017-07-01 2018-06-30 0000080424 pg:PersonalHealthCareMember 2019-07-01 2020-06-30 0000080424 pg:PersonalHealthCareMember 2018-07-01 2019-06-30 0000080424 pg:PersonalHealthCareMember 2017-07-01 2018-06-30 0000080424 pg:AllOtherMember 2019-07-01 2020-06-30 0000080424 pg:AllOtherMember 2018-07-01 2019-06-30 0000080424 pg:AllOtherMember 2017-07-01 2018-06-30 0000080424 country:US 2019-07-01 2020-06-30 0000080424 country:US 2018-07-01 2019-06-30 0000080424 country:US 2017-07-01 2018-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2017-07-01 2018-06-30 0000080424 country:US 2020-06-30 0000080424 country:US 2019-06-30 0000080424 country:US 2018-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2018-06-30 0000080424 pg:WalMartStoresIncAndAffiliatesMember 2019-07-01 2020-06-30 0000080424 pg:WalMartStoresIncAndAffiliatesMember 2018-07-01 2019-06-30 0000080424 pg:WalMartStoresIncAndAffiliatesMember 2017-07-01 2018-06-30 0000080424 pg:BeautySegmentMember 2019-07-01 2020-06-30 0000080424 pg:BeautySegmentMember 2020-06-30 0000080424 pg:BeautySegmentMember 2018-07-01 2019-06-30 0000080424 pg:BeautySegmentMember 2019-06-30 0000080424 pg:BeautySegmentMember 2017-07-01 2018-06-30 0000080424 pg:BeautySegmentMember 2018-06-30 0000080424 pg:GroomingSegmentMember 2019-07-01 2020-06-30 0000080424 pg:GroomingSegmentMember 2020-06-30 0000080424 pg:GroomingSegmentMember 2018-07-01 2019-06-30 0000080424 pg:GroomingSegmentMember 2019-06-30 0000080424 pg:GroomingSegmentMember 2017-07-01 2018-06-30 0000080424 pg:GroomingSegmentMember 2018-06-30 0000080424 pg:HealthCareSegmentMember 2019-07-01 2020-06-30 0000080424 pg:HealthCareSegmentMember 2020-06-30 0000080424 pg:HealthCareSegmentMember 2018-07-01 2019-06-30 0000080424 pg:HealthCareSegmentMember 2019-06-30 0000080424 pg:HealthCareSegmentMember 2017-07-01 2018-06-30 0000080424 pg:HealthCareSegmentMember 2018-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2019-07-01 2020-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2020-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2018-07-01 2019-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2019-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2017-07-01 2018-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2018-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2019-07-01 2020-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2020-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2018-07-01 2019-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2019-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2017-07-01 2018-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2018-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2020-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2019-06-30 0000080424 2017-07-01 2018-06-30 0000080424 2018-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 srt:MinimumMember 2020-06-30 0000080424 srt:MaximumMember 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2018-06-30 0000080424 2018-06-30 0000080424 2018-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 pg:employees 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 pg:PatentsandDevelopedTechnologyMember 2020-06-30 0000080424 pg:PatentsandDevelopedTechnologyMember 2019-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 pg:U.S.TaxCutsandJobsActEffective2018Member 2017-07-01 2018-06-30 0000080424 pg:U.S.TaxCutsandJobsActEffective2018Member 2019-07-01 2020-06-30 0000080424 pg:U.S.TaxCutsandJobsActEffective2018Member 2018-01-01 utr:Rate pg:audit 0000080424 srt:MinimumMember 2019-07-01 2020-06-30 0000080424 srt:MaximumMember 2019-07-01 2020-06-30 0000080424 pg:NetOperatingLossExpiringWithin20YearsMember srt:MinimumMember 2020-06-30 0000080424 pg:NetOperatingLossIndefiniteLifeMember srt:MaximumMember 2020-06-30 0000080424 pg:NetOperatingLossExpiringWithin20YearsMember srt:MaximumMember 2037-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2017-07-01 2018-06-30 0000080424 2018-07-01 2019-06-30 0000080424 pg:ContinuingandDiscontinuedOperationsMember 2019-07-01 2020-06-30 0000080424 pg:ContinuingandDiscontinuedOperationsMember 2018-07-01 2019-06-30 0000080424 pg:ContinuingandDiscontinuedOperationsMember 2017-07-01 2018-06-30 0000080424 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 pg:RestrictedStockRsusAndPsusMember 2020-06-30 0000080424 pg:RestrictedStockRsusAndPsusMember 2019-07-01 2020-06-30 0000080424 country:US 2019-07-01 2020-06-30 0000080424 country:US 2018-07-01 2019-06-30 0000080424 country:US 2017-07-01 2018-06-30 0000080424 2019-06-30 0000080424 2018-06-30 0000080424 2019-06-30 0000080424 2018-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2017-07-01 2018-06-30 0000080424 2017-07-01 2018-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 pg:CompanyStockMember 2020-06-30 0000080424 pg:CompanyStockMember 2019-06-30 0000080424 pg:CompanyStockMember 2020-06-30 0000080424 pg:CompanyStockMember 2019-06-30 0000080424 pg:CompanyPreferredStockMember 2020-06-30 0000080424 pg:CompanyPreferredStockMember 2019-06-30 0000080424 pg:CompanyPreferredStockMember 2020-06-30 0000080424 pg:CompanyPreferredStockMember 2019-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 pg:InsuranceContractsDomain 2020-06-30 0000080424 pg:InsuranceContractsDomain 2019-06-30 0000080424 pg:InsuranceContractsDomain 2020-06-30 0000080424 pg:InsuranceContractsDomain 2019-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 1989-06-30 0000080424 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 1991-06-30 0000080424 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2018-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2018-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2018-07-01 2019-06-30 0000080424 pg:A1.90USDnotedueOctober2020Member 2020-06-30 0000080424 pg:A1.90USDnotedueOctober2020Member 2019-06-30 0000080424 pg:A4.13EURnotedueDecember2020Member 2020-06-30 0000080424 pg:A4.13EURnotedueDecember2020Member 2019-06-30 0000080424 pg:A9.36ESOPdebenturesdue20182021Member 2020-06-30 0000080424 pg:A9.36ESOPdebenturesdue20182021Member 2019-06-30 0000080424 pg:A1.85USDnotedueFebruary2021Member 2020-06-30 0000080424 pg:A1.85USDnotedueFebruary2021Member 2019-06-30 0000080424 pg:A1.70USDnotedueNovember2021Member 2020-06-30 0000080424 pg:A1.70USDnotedueNovember2021Member 2019-06-30 0000080424 pg:A2.00EURnotedueNovember2021Member 2020-06-30 0000080424 pg:A2.00EURnotedueNovember2021Member 2019-06-30 0000080424 pg:A230UsdNoteDueFeb2022Member 2020-06-30 0000080424 pg:A230UsdNoteDueFeb2022Member 2019-06-30 0000080424 pg:A2.15USDnotedueAug2022MemberMember 2020-06-30 0000080424 pg:A2.15USDnotedueAug2022MemberMember 2019-06-30 0000080424 pg:A2.00EURnotedueAug2022Member 2020-06-30 0000080424 pg:A2.00EURnotedueAug2022Member 2019-06-30 0000080424 pg:A3.10USDnotedueAugust2023Member 2020-06-30 0000080424 pg:A3.10USDnotedueAugust2023Member 2019-06-30 0000080424 pg:A1.13EURnotedueNovember2023Member 2020-06-30 0000080424 pg:A1.13EURnotedueNovember2023Member 2019-06-30 0000080424 pg:A0.50EURnotedueOctober2024Member 2020-06-30 0000080424 pg:A0.50EURnotedueOctober2024Member 2019-06-30 0000080424 pg:A0.63EURnotedueOctober2024Member 2020-06-30 0000080424 pg:A0.63EURnotedueOctober2024Member 2019-06-30 0000080424 pg:A245USDNoteDueMarch2025Member 2020-06-30 0000080424 pg:A245USDNoteDueMarch2025Member 2019-06-30 0000080424 pg:A2.70USDnotedueFebruary2026Member 2020-06-30 0000080424 pg:A2.70USDnotedueFebruary2026Member 2019-06-30 0000080424 pg:A2.45USDnotedueNovember2026Member 2020-06-30 0000080424 pg:A2.45USDnotedueNovember2026Member 2019-06-30 0000080424 pg:A280USDNoteDueMarch2027Member 2020-06-30 0000080424 pg:A280USDNoteDueMarch2027Member 2019-06-30 0000080424 pg:A4.88EURnotedueMay2027Member 2020-06-30 0000080424 pg:A4.88EURnotedueMay2027Member 2019-06-30 0000080424 pg:A2.85USDnotedueAugust2027Member 2020-06-30 0000080424 pg:A2.85USDnotedueAugust2027Member 2019-06-30 0000080424 pg:A1.20EURnotedueOctober2028Member 2020-06-30 0000080424 pg:A1.20EURnotedueOctober2028Member 2019-06-30 0000080424 pg:A1.25EURnotedueOctober2029Member 2020-06-30 0000080424 pg:A1.25EURnotedueOctober2029Member 2019-06-30 0000080424 pg:A300USDNoteDueMarch2030Member 2020-06-30 0000080424 pg:A300USDNoteDueMarch2030Member 2019-06-30 0000080424 pg:A5.55USDnotedueMarch2037Member 2020-06-30 0000080424 pg:A5.55USDnotedueMarch2037Member 2019-06-30 0000080424 pg:A1.88EURnotedueOctober2038Member 2020-06-30 0000080424 pg:A1.88EURnotedueOctober2038Member 2019-06-30 0000080424 pg:A355USDNoteDueMarch2040Member 2020-06-30 0000080424 pg:A355USDNoteDueMarch2040Member 2019-06-30 0000080424 pg:A3.50USDnotedueOctober2047Member 2020-06-30 0000080424 pg:A3.50USDnotedueOctober2047Member 2019-06-30 0000080424 pg:A360USDNoteDueMarch2050Member 2020-06-30 0000080424 pg:A360USDNoteDueMarch2050Member 2019-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2018-06-30 0000080424 2018-06-30 0000080424 2018-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 pg:PHCMERCKACQUISITIONMember 2018-11-01 2018-11-30 0000080424 pg:PHCMERCKACQUISITIONMember 2018-11-30 0000080424 pg:PHCMERCKACQUISITIONMember 2018-11-30 0000080424 pg:PHCMERCKACQUISITIONMember 2018-11-01 2018-11-30 0000080424 pg:PHCMERCKACQUISITIONMember pg:PatentsandDevelopedTechnologyMember 2018-11-30 0000080424 pg:PHCMERCKACQUISITIONMember pg:PatentsandDevelopedTechnologyMember 2018-11-01 2018-11-30 0000080424 pg:PHCMERCKACQUISITIONMember 2018-11-30 0000080424 pg:PHCMERCKACQUISITIONMember 2018-11-01 2018-11-30 0000080424 pg:PHCMERCKACQUISITIONMember 2018-11-30 0000080424 pg:PHCMERCKACQUISITIONMember srt:MinimumMember 2019-07-01 2020-06-30 0000080424 pg:PHCMERCKACQUISITIONMember srt:MaximumMember 2019-07-01 2020-06-30 0000080424 2019-07-01 2019-09-30 0000080424 2019-10-01 2019-12-31 0000080424 2020-01-01 2020-03-31 0000080424 2020-04-01 2020-06-30 0000080424 2018-07-01 2018-09-30 0000080424 2018-10-01 2018-12-31 0000080424 2019-01-01 2019-03-31 0000080424 2019-04-01 2019-06-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark one) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 TRUE For the Fiscal Year Ended June 30, 2020 OR [ ] ] FALSE TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 1-434 Cincinnati THE PROCTER & GAMBLE CO MPANY OH One Procter & Gamble Plaza One Procter & Gamble Plaza, Cincinnati, Ohio 45202 45202 513 Telephone (513) 983-1100 983-1100 IRS Employer Identification No. 31-0411980 31-0411980 State of Incorporation: Ohio OH Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG New York Stock Exchange 4.125% EUR notes due December 2020 PG20A New York Stock Exchange 2.000% notes due 2021 PG21 New York Stock Exchange 2.000% notes due 2022 PG22B New York Stock Exchange 1.125% notes due 2023 PG23A New York Stock Exchange 0.500% notes due 2024 PG24A New York Stock Exchange 0.625% notes due 2024 PG24B New York Stock Exchange 1.375% notes due 2025 PG25 New York Stock Exchange 4.875% EUR notes due May 2027 PG27A New York Stock Exchange 1.200% notes due 2028 PG28 New York Stock Exchange 1.250% notes due 2029 PG29B New York Stock Exchange 1.800% notes due 2029 PG29A New York Stock Exchange 6.250% GBP notes due January 2030 PG30 New York Stock Exchange 5.250% GBP notes due January 2033 PG33 New York Stock Exchange 1.875% notes due 2038 PG38 New York Stock Exchange Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  No o Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes o No  Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No o Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of ""large accelerated filed,"" ""accelerated filer,"" ""smaller reporting company,"" and ""emerging growth company"" in Rule 12b-2 of the Exchange Act. Large accelerated filer  Accelerated filer  Non-accelerated filer  Smaller reporting company  FALSE Emerging growth company  FALSE If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No  False Indicate by check mark whether the registrant has filed a report on and attestation to its managements assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the",1939
2020-08-12,8-K,0000080424-20-000061,"false 0000080424 0000080424 2020-08-12 2020-08-12 0000080424 pg:Two000NotesDue2022Member 2020-08-12 2020-08-12 0000080424 pg:One250NotesDue2029Member 2020-08-12 2020-08-12 0000080424 pg:Four125EURNotesDueDecember2020Member 2020-08-12 2020-08-12 0000080424 pg:One875NotesDue2038Member 2020-08-12 2020-08-12 0000080424 pg:One800NotesDue2029Member 2020-08-12 2020-08-12 0000080424 pg:One125NotesDue2023Member 2020-08-12 2020-08-12 0000080424 pg:Zero500NotesDue2024Member 2020-08-12 2020-08-12 0000080424 pg:Four875EURNotesDueMay2027Member 2020-08-12 2020-08-12 0000080424 pg:One200NotesDue2028Member 2020-08-12 2020-08-12 0000080424 pg:Zero625NotesDue2024Member 2020-08-12 2020-08-12 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2020-08-12 2020-08-12 0000080424 pg:Two000NotesDue2021Member 2020-08-12 2020-08-12 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2020-08-12 2020-08-12 0000080424 pg:One375NotesDue2025Member 2020-08-12 2020-08-12 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 12, 2020 (August 11, 2020) THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.125% EUR notes due December 2020 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENT OF CERTAIN OFFICERS. On August 11, 2020, the Board of Directors of The Procter & Gamble Company (the Company) appointed Debra L. Lee, Chief Executive Officer of Leading Women Defined, Inc., and former Chairman and Chief Executive Officer of BET Networks, as a Director of the Company, effective August 12, 2020. Ms. Lee will serve on the Compensation & Leadership Development and Governance & Public Responsibility Committees. The Board has determined that Ms. Lee is independent under the NYSE listing standards and the Companys Independence Guidelines. Ms. Lee will receive the same compensation as the other non-employee members of the Board of Directors. The Companys Director compensation program is described in the Companys definitive proxy statement dated August 23, 2019. The Company is filing the information under this item pursuant to Item 5.02(d), Election of Directors. ITEM 7.01 REGULATION FD DISCLOSURE A copy of the press release announcing the appointment of Ms. Lee is attached to this report as Exhibit 99.1. The Company is furnishing the information under this item, including Exhibit 99.1, pursuant to Item 7.01, Regulation FD Disclosure. ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Director Appointment Press Release by The Procter & Gamble Company dated August 12, 2020 Cover Page Interactive Data File (embedded within the Inline XBRL document)",584
2020-09-16,8-K,0000080424-20-000063,"false 0000080424 0000080424 2020-09-16 2020-09-16 0000080424 pg:Two000NotesDue2022Member 2020-09-16 2020-09-16 0000080424 pg:One250NotesDue2029Member 2020-09-16 2020-09-16 0000080424 pg:Four125EURNotesDueDecember2020Member 2020-09-16 2020-09-16 0000080424 pg:One875NotesDue2038Member 2020-09-16 2020-09-16 0000080424 pg:One800NotesDue2029Member 2020-09-16 2020-09-16 0000080424 pg:One125NotesDue2023Member 2020-09-16 2020-09-16 0000080424 pg:Zero500NotesDue2024Member 2020-09-16 2020-09-16 0000080424 pg:Four875EURNotesDueMay2027Member 2020-09-16 2020-09-16 0000080424 pg:One200NotesDue2028Member 2020-09-16 2020-09-16 0000080424 pg:Zero625NotesDue2024Member 2020-09-16 2020-09-16 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2020-09-16 2020-09-16 0000080424 pg:Two000NotesDue2021Member 2020-09-16 2020-09-16 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2020-09-16 2020-09-16 0000080424 pg:One375NotesDue2025Member 2020-09-16 2020-09-16 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 16, 2020 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.125% EUR notes due December 2020 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENT OF CERTAIN OFFICERS. On September 16, 2020, Valarie L. Sheppard, currently Controller and Treasurer and Group Vice President  Company Transition Leader and The Procter & Gamble Companys principal accounting officer, announced her intention to retire from the Company after 35 years of service, effective March 31, 2021. The Company is filing this 8-K pursuant to Item 5.02(b), ""Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.""",446
2020-10-13,8-K,0001193125-20-268528,"THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio (Address of Principal Executive Offices) (Zip Code) (513) 983-1100 Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.125% EUR notes due December 2020 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Other Events. On October 13, 2020, The Procter & Gamble Company (P&G) issued a press release announcing the launch of a $1.5 billion cash tender offer for outstanding debt securities. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is",322
2020-10-13,8-K,0000080424-20-000074,"false 0000080424 0000080424 2020-10-13 2020-10-13 0000080424 pg:One200NotesDue2028Member 2020-10-13 2020-10-13 0000080424 pg:Two000NotesDue2021Member 2020-10-13 2020-10-13 0000080424 pg:One875NotesDue2038Member 2020-10-13 2020-10-13 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2020-10-13 2020-10-13 0000080424 pg:One125NotesDue2023Member 2020-10-13 2020-10-13 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2020-10-13 2020-10-13 0000080424 pg:Zero625NotesDue2024Member 2020-10-13 2020-10-13 0000080424 pg:One375NotesDue2025Member 2020-10-13 2020-10-13 0000080424 pg:One250NotesDue2029Member 2020-10-13 2020-10-13 0000080424 pg:Zero500NotesDue2024Member 2020-10-13 2020-10-13 0000080424 pg:Four125NotesDueDecember2020Member 2020-10-13 2020-10-13 0000080424 pg:Four875EURNotesDueMay2027Member 2020-10-13 2020-10-13 0000080424 pg:Two000NotesDue2022Member 2020-10-13 2020-10-13 0000080424 pg:One800NotesDue2029Member 2020-10-13 2020-10-13 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 13, 2020 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.125% notes due December 2020 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On October 13, 2020, the Company announced that its Board of Directors declared a quarterly dividend of $0.7907 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after November 16, 2020, to Common Stock shareholders of record at the close of business on October 23, 2020, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on October 23, 2020. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Dividend News Release by The Procter & Gamble Company dated October 13, 2020. Cover Page Interactive Data File (embedded within the Inline XBRL document)",487
2020-10-15,8-K,0000080424-20-000076,"false 0000080424 0000080424 2020-10-13 2020-10-13 0000080424 pg:One875NotesDue2038Member 2020-10-13 2020-10-13 0000080424 pg:One800NotesDue2029Member 2020-10-13 2020-10-13 0000080424 pg:Two000NotesDue2022Member 2020-10-13 2020-10-13 0000080424 pg:One250NotesDue2029Member 2020-10-13 2020-10-13 0000080424 pg:Zero500NotesDue2024Member 2020-10-13 2020-10-13 0000080424 pg:Two000NotesDue2021Member 2020-10-13 2020-10-13 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2020-10-13 2020-10-13 0000080424 pg:One125NotesDue2023Member 2020-10-13 2020-10-13 0000080424 pg:One200NotesDue2028Member 2020-10-13 2020-10-13 0000080424 pg:Zero625NotesDue2024Member 2020-10-13 2020-10-13 0000080424 pg:Four875EURNotesDueMay2027Member 2020-10-13 2020-10-13 0000080424 pg:One375NotesDue2025Member 2020-10-13 2020-10-13 0000080424 pg:Five250GBPNotesDueJanuary2030Member 2020-10-13 2020-10-13 0000080424 pg:Four125NotesDueDecember2020Member 2020-10-13 2020-10-13 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 15, 2020 ( October 13, 2020 ) THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , OH 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.125% notes due December 2020 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2030 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Submission of Matters to a Vote of Security Holders On October 13, 2020, The Procter & Gamble Company (the Company), held its 2020 Annual Meeting of Shareholders. Set forth below are the final voting results for each of the proposals submitted to a vote of the shareholders. Proposal 1  Election of Directors . Each of the following nominees was elected to serve a one-year term on the Companys Board of Directors. Proposal 2- Ratify Appointment of the Independent Registered Public The proposal was approved. Proposal 3 - Advisory Vote to Approve the Companys Executive Compensation (the Say on Pay vote) . The proposal was approved. Proposal 4 - Approval of The Procter & Gamble Company International Stock Ownership Plan, As Amended and Restated . The proposal was approved. Proposal 5 - Shareholder Proposal - Report on Efforts to Eliminate The proposal was approved. Proposal 6 - Shareholder Proposal - Annual Report on Diversity . The proposal was not approved. The Company is filing this Form 8-K pursuant to Item 5.07, ""Submission of Matters to a Vote of Security Holders.""",536
2020-10-20,8-K,0000080424-20-000089,"pg-20201020 0000080424 False False False False False 0000080424 2020-07-01 2020-09-30 0000080424 2020-10-20 2020-10-20 0000080424 2020-10-20 2020-10-20 0000080424 exch:XNYS 2020-10-20 2020-10-20 0000080424 pg:A4.125EURdueDecember2020Domain 2020-10-20 2020-10-20 0000080424 pg:A2.000due2021Domain 2020-10-20 2020-10-20 0000080424 pg:A2.000due2022Domain 2020-10-20 2020-10-20 0000080424 pg:A1.125due2023Domain 2020-10-20 2020-10-20 0000080424 pg:A0.500due2024Domain 2020-10-20 2020-10-20 0000080424 pg:A0.625due2024Domain 2020-10-20 2020-10-20 0000080424 pg:A1.375due2025Domain 2020-10-20 2020-10-20 0000080424 pg:A4.875EURdueMay2027Domain 2020-10-20 2020-10-20 0000080424 pg:A1.200due2028Domain 2020-10-20 2020-10-20 0000080424 pg:A1.250due2029Domain 2020-10-20 2020-10-20 0000080424 pg:A1.800due2029Domain 2020-10-20 2020-10-20 0000080424 pg:A6.250GBPdueJanuary2030Domain 2020-10-20 2020-10-20 0000080424 pg:A5.250GBPdueJanuary2033Domain 2020-10-20 2020-10-20 0000080424 pg:A1.875due2038Domain 2020-10-20 2020-10-20 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) October 20, 2020 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio OH 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza , Cincinnati OH One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 4.125% EUR notes due December 2020 PG20A NYSE 2.000% Notes due 2021 PG21 NYSE 2.000% Notes due 2022 PG22B NYSE 1.125% Notes due 2023 PG23A NYSE 0.500% Notes due 2024 PG24A NYSE 0.625% Notes due 2024 PG24B NYSE 1.375% Notes due 2025 PG25 NYSE 4.875% EUR notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP notes due January 2030 PG30 NYSE 5.250% GBP notes due January 2033 PG33 NYSE 1.875% Notes due 2038 PG38 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On October 20, 2020, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended September 30, 2020. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated October 20, 2020. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",559
2020-10-20,8-K,0000080424-20-000091,"false 0000080424 0000080424 2020-10-20 2020-10-20 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2020-10-20 2020-10-20 0000080424 pg:Zero625NotesDue2024Member 2020-10-20 2020-10-20 0000080424 pg:One250NotesDue2029Member 2020-10-20 2020-10-20 0000080424 pg:One125NotesDue2023Member 2020-10-20 2020-10-20 0000080424 pg:One875NotesDue2038Member 2020-10-20 2020-10-20 0000080424 pg:One800NotesDue2029Member 2020-10-20 2020-10-20 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2020-10-20 2020-10-20 0000080424 pg:One375NotesDue2025Member 2020-10-20 2020-10-20 0000080424 pg:Two000NotesDue2022Member 2020-10-20 2020-10-20 0000080424 pg:One200NotesDue2028Member 2020-10-20 2020-10-20 0000080424 pg:Two000NotesDue2021Member 2020-10-20 2020-10-20 0000080424 pg:Zero500NotesDue2024Member 2020-10-20 2020-10-20 0000080424 pg:Four875EURNotesDueMay2027Member 2020-10-20 2020-10-20 0000080424 pg:Four125NotesDueDecember2020Member 2020-10-20 2020-10-20 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 20, 2020 THE PROCTER & GAMBLE COMPANY PROCTERPROCTER & GAMBLE Co o (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , OH 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.125% notes due December 2020 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On October 20, 2020, The Procter & Gamble Company (the ""Company"") issued a press release announcing its first quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated October 20, 2020. Cover Page Interactive Data File (embedded within the Inline XBRL document)",457
2020-10-20,10-Q,0000080424-20-000097,"and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including, without limitation, the following sections: Management's Discussion and Analysis, ",95
2020-10-27,8-K,0001193125-20-277446,"THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio (Address of Principal Executive Offices) (Zip Code) (513) 983-1100 Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.125% EUR notes due December 2020 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Other Events. On October 26, 2020, The Procter & Gamble Company issued a press release announcing the early tender results of its cash tender offer for outstanding debt securities. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is",321
2020-10-28,8-K,0001193125-20-278711,"THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio (Address of Principal Executive Offices) (Zip Code) (513) 983-1100 Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.125% EUR notes due December 2020 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Other Events. On October 27, 2020, The Procter & Gamble Company issued a press release announcing the pricing of its cash tender offer for outstanding debt securities. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is",319
2020-10-29,8-K,0001193125-20-281081,"THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) 513 - 983-1100 Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.125% EUR notes due December 2020 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Other Events. On October 29, 2020, The Procter & Gamble Company (the Company) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 0.550% Notes due October 29, 2025 and $1,250,000,000 aggregate principal amount of 1.200% Notes due October 29, 2030 under the Companys Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are",352
2020-11-16,8-K,0001193125-20-294832,"THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) 513 - 983-1100 Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.125% EUR notes due December 2020 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Other Events. On November 16, 2020, The Procter & Gamble Company (the Company) closed an underwritten public offering of $197,067,000 aggregate principal amount of Floating Rate Notes due November 16, 2070 under the Companys Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are",341
2020-12-09,8-K,0000080424-20-000105,"false 0000080424 0000080424 2020-12-09 2020-12-09 0000080424 pg:NewYorkStockExchangeMember 2020-12-09 2020-12-09 0000080424 pg:NewYorkStockExchangeMember pg:Four125EURNotesDueDecember2020Member 2020-12-09 2020-12-09 0000080424 pg:NewYorkStockExchangeMember pg:Zero500NotesDue2024Member 2020-12-09 2020-12-09 0000080424 pg:One125NotesDue2023Member pg:TheNewYorkStockExchangeMember 2020-12-09 2020-12-09 0000080424 pg:Two000NotesDue2021Member pg:NewYorkStockExchangeMember 2020-12-09 2020-12-09 0000080424 pg:NewYorkStockExchangeMember pg:Six250GBPNotesDueJanuary2030Member 2020-12-09 2020-12-09 0000080424 pg:One875NotesDue2038Member pg:NewYorkStockExchangeMember 2020-12-09 2020-12-09 0000080424 pg:NewYorkStockExchangeMember pg:Zero625NotesDue2024Member 2020-12-09 2020-12-09 0000080424 pg:One200NotesDue2028Member pg:NewYorkStockExchangeMember 2020-12-09 2020-12-09 0000080424 pg:Two000NotesDue2022Member pg:NewYorkStockExchangeMember 2020-12-09 2020-12-09 0000080424 pg:NewYorkStockExchangeMember pg:Four875EURNotesDueMay2027Member 2020-12-09 2020-12-09 0000080424 pg:NewYorkStockExchangeMember pg:One800NotesDue2029Member 2020-12-09 2020-12-09 0000080424 pg:NewYorkStockExchangeMember pg:One250NotesDue2029Member 2020-12-09 2020-12-09 0000080424 pg:NewYorkStockExchangeMember pg:Five250GBPNotesDueJanuary2033Member 2020-12-09 2020-12-09 0000080424 pg:NewYorkStockExchangeMember pg:One375NotesDue2025Member 2020-12-09 2020-12-09 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 9, 2020 (December 8, 2020) THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common stock, without Par Value 4.125% EUR notes due December 2020 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENT OF CERTAIN OFFICERS. On December 8, 2020, the Board of Directors of The Procter & Gamble Company (the ""Company"") elected Andre Schulten (age 50), currently Senior Vice PresidentBaby Care, North America, as the Companys Chief Financial Officer, effective March 1, 2021, to serve at the pleasure of the Board of Directors. Jon Moeller, currently Vice Chairman, Chief Operating Officer and Chief Financial Officer, will remain Vice Chairman and Chief Operating Officer. Mr. Schulten joined the Company in 1996 and has held positions of increasing responsibility at the Company since that time, including: Senior Vice President, Finance & Accounting, Western Europe (September 2010  June 2014); Senior Vice President, Finance & Accounting, Global Baby Care, Feminine Care, and Family Care (July 2014  April 2018), and most recently, Senior Vice PresidentBaby Care, North America (May 2018  present). Effective March 1, 2021, Mr. Schulten will receive an annual base salary of US $750,000 . He will participate in the Company's annual performance-based bonus program with a target award equal to 110% of base salary, and he will receive equity grants under the Company's long-term incentive program commensurate with his position and on the same timing as other executive officers. Mr. Schulten will participate in all other elements of the Company's executive compensation and benefit programs (including as a vested participant in the Company's retirement program). Those programs are outlined in the Company's definitive proxy statement dated August 28, 2020. The Company is filing the information under this item pursuant to Item 5.02, ""Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers."" ITEM 7.01 REGULATION FD DISCLOSURE The Company issued a news release on December 9, 2020, announcing the election of Mr. Schulten and the changes to Mr. Moellers role. A copy of this news release is furnished as Exhibit 99.1. The Company is furnishing the information under this item, including Exhibit 99.1, pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Officer Appointment Press Release by The Procter & Gamble Company dated December 9, 2020 Cover Page Interactive Data File (embedded within the Inline XBRL document)",749
2021-01-12,8-K,0000080424-21-000007,"false 0000080424 0000080424 2021-01-12 2021-01-12 0000080424 pg:Four875EURNotesDueMay2027Member 2021-01-12 2021-01-12 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2021-01-12 2021-01-12 0000080424 pg:One875NotesDue2038Member 2021-01-12 2021-01-12 0000080424 pg:Two000NotesDue2021Member 2021-01-12 2021-01-12 0000080424 pg:One125NotesDue2023Member 2021-01-12 2021-01-12 0000080424 pg:Zero500NotesDue2024Member 2021-01-12 2021-01-12 0000080424 pg:One800NotesDue2029Member 2021-01-12 2021-01-12 0000080424 pg:Zero625NotesDue2024Member 2021-01-12 2021-01-12 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2021-01-12 2021-01-12 0000080424 pg:One200NotesDue2028Member 2021-01-12 2021-01-12 0000080424 pg:One250NotesDue2029Member 2021-01-12 2021-01-12 0000080424 pg:One375NotesDue2025Member 2021-01-12 2021-01-12 0000080424 pg:Two000NotesDue2022Member 2021-01-12 2021-01-12 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 12, 2021 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On January 12, 2021, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of $0.7907 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after February 16, 2021, to Common Stock shareholders of record at the close of business on January 22, 2021, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on January 22, 2021. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Dividend News Release by The Procter & Gamble Company dated January 12, 2021. Cover Page Interactive Data File (embedded within the Inline XBRL document)",483
2021-01-20,8-K,0000080424-21-000023,"false 0000080424 0000080424 2021-01-20 2021-01-20 0000080424 pg:One800NotesDue2029Member 2021-01-20 2021-01-20 0000080424 pg:One375NotesDue2025Member 2021-01-20 2021-01-20 0000080424 pg:Two000NotesDue2022Member 2021-01-20 2021-01-20 0000080424 pg:Four875EURNotesDueMay2027Member 2021-01-20 2021-01-20 0000080424 pg:One125NotesDue2023Member 2021-01-20 2021-01-20 0000080424 pg:One200NotesDue2028Member 2021-01-20 2021-01-20 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2021-01-20 2021-01-20 0000080424 pg:Zero500NotesDue2024Member 2021-01-20 2021-01-20 0000080424 pg:Two000NotesDue2021Member 2021-01-20 2021-01-20 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2021-01-20 2021-01-20 0000080424 pg:Zero625NotesDue2024Member 2021-01-20 2021-01-20 0000080424 pg:One875NotesDue2038Member 2021-01-20 2021-01-20 0000080424 pg:One250NotesDue2029Member 2021-01-20 2021-01-20 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported) : January 20, 2021 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , OH 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On January 20, 2021, The Procter & Gamble Company (the ""Company"") issued a press release announcing its second quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated January 20, 2021. Cover Page Interactive Data File (embedded within the Inline XBRL document)",444
2021-01-20,10-Q,0000080424-21-000026,"and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including, without limitation, the following sections: Management's Discussion and Analysis, ",95
2021-01-20,8-K,0000080424-21-000021,"pg-20210120 0000080424 False False False False False 0000080424 2020-07-01 2020-12-31 0000080424 2020-07-01 2020-12-31 0000080424 exch:XNYS 2020-07-01 2020-12-31 0000080424 pg:A2.000due2021Domain 2020-07-01 2020-12-31 0000080424 pg:A2.000due2022Domain 2020-07-01 2020-12-31 0000080424 pg:A1.125due2023Domain 2020-07-01 2020-12-31 0000080424 pg:A0.500due2024Domain 2020-07-01 2020-12-31 0000080424 pg:A0.625due2024Domain 2020-07-01 2020-12-31 0000080424 pg:A1.375due2025Domain 2020-07-01 2020-12-31 0000080424 pg:A4.875EURdueMay2027Domain 2020-07-01 2020-12-31 0000080424 pg:A1.200due2028Domain 2020-07-01 2020-12-31 0000080424 pg:A1.250due2029Domain 2020-07-01 2020-12-31 0000080424 pg:A1.800due2029Domain 2020-07-01 2020-12-31 0000080424 pg:A6.250GBPdueJanuary2030Domain 2020-07-01 2020-12-31 0000080424 pg:A5.250GBPdueJanuary2033Domain 2020-07-01 2020-12-31 0000080424 pg:A1.875due2038Domain 2020-07-01 2020-12-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) January 20, 2021 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio OH 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza , Cincinnati OH One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 2.000% Notes due 2021 PG21 NYSE 2.000% Notes due 2022 PG22B NYSE 1.125% Notes due 2023 PG23A NYSE 0.500% Notes due 2024 PG24A NYSE 0.625% Notes due 2024 PG24B NYSE 1.375% Notes due 2025 PG25 NYSE 4.875% EUR notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP notes due January 2030 PG30 NYSE 5.250% GBP notes due January 2033 PG33 NYSE 1.875% Notes due 2038 PG38 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 20, 2021, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended December 31, 2020. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated January 20, 2021. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",544
2021-02-09,8-K,0000080424-21-000031,"false 0000080424 0000080424 2021-02-09 2021-02-09 0000080424 pg:One800NotesDue2029Member 2021-02-09 2021-02-09 0000080424 pg:One875NotesDue2038Member 2021-02-09 2021-02-09 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2021-02-09 2021-02-09 0000080424 pg:One125NotesDue2023Member 2021-02-09 2021-02-09 0000080424 pg:Zero500NotesDue2024Member 2021-02-09 2021-02-09 0000080424 pg:Four875EURNotesDueMay2027Member 2021-02-09 2021-02-09 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2021-02-09 2021-02-09 0000080424 pg:Zero625NotesDue2024Member 2021-02-09 2021-02-09 0000080424 pg:Two000NotesDue2021Member 2021-02-09 2021-02-09 0000080424 pg:One375NotesDue2025Member 2021-02-09 2021-02-09 0000080424 pg:One200NotesDue2028Member 2021-02-09 2021-02-09 0000080424 pg:Two000NotesDue2022Member 2021-02-09 2021-02-09 0000080424 pg:One250NotesDue2029Member 2021-02-09 2021-02-09 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 9, 2021 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENT OF CERTAIN OFFICERS. On February 9, 2021, the Board of Directors of The Procter & Gamble Company (the ""Company"") designated Michael (Mick) G. Homan (age 59), Senior Vice PresidentCorporate Accounting, as the Companys principal accounting officer, effective March 1, 2021. Mr. Homan will assume the principal accounting officer designation currently held by Valarie L. Sheppard, Controller and Treasurer and Group Vice President  Company Transition Leader. Ms. Sheppards retirement, effective March 31, 2021, was previously announced. Mr. Homan has served as the Companys Senior Vice President  Corporate Accounting since February 2006. He will continue to receive his current base salary and participate in the Companys performance-based incentive programs at levels commensurate with other similarly situated persons within the Company. Those programs are outlined in the Company's definitive proxy statement dated August 28, 2020. The Company is filing the information under this item pursuant to Item 5.02(c), Appointment of Certain Officers.""",511
2021-02-10,8-K,0000080424-21-000033,"false 0000080424 0000080424 2021-02-10 2021-02-10 0000080424 pg:Two000NotesDue2022Member 2021-02-10 2021-02-10 0000080424 pg:Two000NotesDue2021Member 2021-02-10 2021-02-10 0000080424 pg:One250NotesDue2029Member 2021-02-10 2021-02-10 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2021-02-10 2021-02-10 0000080424 pg:One875NotesDue2038Member 2021-02-10 2021-02-10 0000080424 pg:Zero625NotesDue2024Member 2021-02-10 2021-02-10 0000080424 pg:One200NotesDue2028Member 2021-02-10 2021-02-10 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2021-02-10 2021-02-10 0000080424 pg:Four875EURNotesDueMay2027Member 2021-02-10 2021-02-10 0000080424 pg:Zero500NotesDue2024Member 2021-02-10 2021-02-10 0000080424 pg:One800NotesDue2029Member 2021-02-10 2021-02-10 0000080424 pg:One125NotesDue2023Member 2021-02-10 2021-02-10 0000080424 pg:One375NotesDue2025Member 2021-02-10 2021-02-10 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 10, 2021 (February 9, 2021) THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. On February 9, 2021, the Board of Directors of The Procter & Gamble Company (the Company) appointed B. Marc Allen, chief strategy officer and senior vice president of Strategy and Corporate Development at The Boeing Company, as a Director of the Company, effective February 10, 2021. Mr. Allen will serve on the Audit and Innovation & Technology Committees. The Board has determined that Mr. Allen is independent under the NYSE listing standards and the Companys Independence Guidelines. Mr. Allen will receive the same compensation as the other non-employee members of the Board of Directors. The Companys Director compensation program is described in the Companys definitive proxy statement dated August 28, 2020. The Company is filing the information under this item pursuant to Item 5.02(d), Election of Directors. ITEM 7.01 REGULATION FD DISCLOSURE The Company issued a news release on February 10, 2021, announcing the appointment of Mr. Allen. A copy of this news release is furnished as Exhibit 99.1. The Company is furnishing the information under this item, including Exhibit 99.1, pursuant to Item 7.01, Regulation FD Disclosure. ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Director Appointment Press Release by The Procter & Gamble Company dated February 10, 2021 Cover Page Interactive Data File (embedded within the Inline XBRL document)",575
2021-03-26,8-K,0000080424-21-000040,"false 0000080424 0000080424 2021-03-26 2021-03-26 0000080424 pg:One875NotesDue2038Member 2021-03-26 2021-03-26 0000080424 pg:One125NotesDue2023Member 2021-03-26 2021-03-26 0000080424 pg:One200NotesDue2028Member 2021-03-26 2021-03-26 0000080424 pg:Two000NotesDue2021Member 2021-03-26 2021-03-26 0000080424 pg:Two000NotesDue2022Member 2021-03-26 2021-03-26 0000080424 pg:Four875EURNotesDueMay2027Member 2021-03-26 2021-03-26 0000080424 pg:Zero500NotesDue2024Member 2021-03-26 2021-03-26 0000080424 pg:One250NotesDue2029Member 2021-03-26 2021-03-26 0000080424 pg:One375NotesDue2025Member 2021-03-26 2021-03-26 0000080424 pg:Zero625NotesDue2024Member 2021-03-26 2021-03-26 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2021-03-26 2021-03-26 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2021-03-26 2021-03-26 0000080424 pg:One800NotesDue2029Member 2021-03-26 2021-03-26 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported) : March 26, 2021 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On March 26, 2021, The Procter & Gamble Company (the Company) issued a Forestry Practices Report, as requested by its shareholders. A copy of this report is furnished The Company is furnishing the information under this item, including Exhibit 99.1, pursuant to Item 7.01, Regulation FD Disclosure. ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS P&G Forestry Practices Report Cover Page Interactive Data File (embedded within the Inline XBRL document)",417
2021-04-13,8-K,0000080424-21-000046,"false 0000080424 0000080424 2021-04-13 2021-04-13 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2021-04-13 2021-04-13 0000080424 pg:One125NotesDue2023Member 2021-04-13 2021-04-13 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2021-04-13 2021-04-13 0000080424 pg:One250NotesDue2029Member 2021-04-13 2021-04-13 0000080424 pg:Four875EURNotesDueMay2027Member 2021-04-13 2021-04-13 0000080424 pg:One375NotesDue2025Member 2021-04-13 2021-04-13 0000080424 pg:Two000NotesDue2022Member 2021-04-13 2021-04-13 0000080424 pg:Zero500NotesDue2024Member 2021-04-13 2021-04-13 0000080424 pg:One200NotesDue2028Member 2021-04-13 2021-04-13 0000080424 pg:Two000NotesDue2021Member 2021-04-13 2021-04-13 0000080424 pg:One875NotesDue2038Member 2021-04-13 2021-04-13 0000080424 pg:One800NotesDue2029Member 2021-04-13 2021-04-13 0000080424 pg:Zero625NotesDue2024Member 2021-04-13 2021-04-13 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 13, 2021 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On April 13, 2021, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of $0.8698 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after May 17, 2021, to Common Stock shareholders of record at the close of business on April 23, 2021, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on April 23, 2021. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Dividend News Release by The Procter & Gamble Company dated April 13, 2021. Cover Page Interactive Data File (embedded within the Inline XBRL document)",483
2021-04-20,8-K,0000080424-21-000056,"pg-20210420 0000080424 False False False False False 0000080424 2020-07-01 2021-03-31 0000080424 2020-07-01 2021-03-31 0000080424 exch:XNYS 2020-07-01 2021-03-31 0000080424 pg:A2.000due2021Domain 2020-07-01 2021-03-31 0000080424 pg:A2.000due2022Domain 2020-07-01 2021-03-31 0000080424 pg:A1.125due2023Domain 2020-07-01 2021-03-31 0000080424 pg:A0.500due2024Domain 2020-07-01 2021-03-31 0000080424 pg:A0.625due2024Domain 2020-07-01 2021-03-31 0000080424 pg:A1.375due2025Domain 2020-07-01 2021-03-31 0000080424 pg:A4.875EURdueMay2027Domain 2020-07-01 2021-03-31 0000080424 pg:A1.200due2028Domain 2020-07-01 2021-03-31 0000080424 pg:A1.250due2029Domain 2020-07-01 2021-03-31 0000080424 pg:A1.800due2029Domain 2020-07-01 2021-03-31 0000080424 pg:A6.250GBPdueJanuary2030Domain 2020-07-01 2021-03-31 0000080424 pg:A5.250GBPdueJanuary2033Domain 2020-07-01 2021-03-31 0000080424 pg:A1.875due2038Domain 2020-07-01 2021-03-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) April 20, 2021 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio OH 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza , Cincinnati OH One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 2.000% Notes due 2021 PG21 NYSE 2.000% Notes due 2022 PG22B NYSE 1.125% Notes due 2023 PG23A NYSE 0.500% Notes due 2024 PG24A NYSE 0.625% Notes due 2024 PG24B NYSE 1.375% Notes due 2025 PG25 NYSE 4.875% EUR notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP notes due January 2030 PG30 NYSE 5.250% GBP notes due January 2033 PG33 NYSE 1.875% Notes due 2038 PG38 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On April 20, 2021, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended March 31, 2021. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated April 20, 2021. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",544
2021-04-20,8-K,0000080424-21-000059,"false 0000080424 0000080424 2021-04-20 2021-04-20 0000080424 pg:One375NotesDue2025Member 2021-04-20 2021-04-20 0000080424 pg:Zero500NotesDue2024Member 2021-04-20 2021-04-20 0000080424 pg:Four875EURNotesDueMay2027Member 2021-04-20 2021-04-20 0000080424 pg:One250NotesDue2029Member 2021-04-20 2021-04-20 0000080424 pg:One125NotesDue2023Member 2021-04-20 2021-04-20 0000080424 pg:One200NotesDue2028Member 2021-04-20 2021-04-20 0000080424 pg:Zero625NotesDue2024Member 2021-04-20 2021-04-20 0000080424 pg:Two000NotesDue2021Member 2021-04-20 2021-04-20 0000080424 pg:One800NotesDue2029Member 2021-04-20 2021-04-20 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2021-04-20 2021-04-20 0000080424 pg:Two000NotesDue2022Member 2021-04-20 2021-04-20 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2021-04-20 2021-04-20 0000080424 pg:One875NotesDue2038Member 2021-04-20 2021-04-20 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported) : April 20, 2021 THE PROCTER & GAMBLE COMPANY PROCTERPROCTER & GAMBLE Co o (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On April 20, 2021, The Procter & Gamble Company (the ""Company"") issued a press release announcing its second quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated April 20, 2021. Cover Page Interactive Data File (embedded within the Inline XBRL document)",449
2021-04-20,10-Q,0000080424-21-000062,"and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including, without limitation, the following sections: Management's Discussion and Analysis, ",95
2021-04-23,8-K,0001193125-21-129074,"THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) 513 - 983-1100 Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter).  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Item 8.01 Other Events. On April 23, 2021, The Procter & Gamble Company (the Company) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.000% Notes due April 23, 2026 and $1,000,000,000 aggregate principal amount of 1.950% Notes due April 23, 2031 under the Companys Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are",342
2021-06-11,8-K,0000080424-21-000070,"false 0000080424 0000080424 2021-06-11 2021-06-11 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2021-06-11 2021-06-11 0000080424 pg:One125NotesDue2023Member 2021-06-11 2021-06-11 0000080424 pg:Two000NotesDue2022Member 2021-06-11 2021-06-11 0000080424 pg:One800NotesDue2029Member 2021-06-11 2021-06-11 0000080424 pg:Two000NotesDue2021Member 2021-06-11 2021-06-11 0000080424 pg:One250NotesDue2029Member 2021-06-11 2021-06-11 0000080424 pg:Zero500NotesDue2024Member 2021-06-11 2021-06-11 0000080424 pg:One200NotesDue2028Member 2021-06-11 2021-06-11 0000080424 pg:One875NotesDue2038Member 2021-06-11 2021-06-11 0000080424 pg:One375NotesDue2025Member 2021-06-11 2021-06-11 0000080424 pg:Four875EURNotesDueMay2027Member 2021-06-11 2021-06-11 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2021-06-11 2021-06-11 0000080424 pg:Zero625NotesDue2024Member 2021-06-11 2021-06-11 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 11, 2021 (June 8, 2021) THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENT OF CERTAIN OFFICERS. On June 8, 2021, the following executives of The Procter & Gamble Company (the ""Company"") announced their intention to retire: Mary Lynn Ferguson-McHugh, currently Chief Executive Officer  Family Care and New Business, announced her intention to retire from the Company effective October 1, 2021, after more than 35 years of service. Steven D. Bishop, currently Chief Executive Officer  Health Care, announced his intention to retire from the Company effective February 18, 2022, after more than 35 years of The Company is filing this 8-K pursuant to Item 5.02(b), ""Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.""",474
2021-07-13,8-K,0000080424-21-000074,"false 0000080424 0000080424 2021-07-13 2021-07-13 0000080424 pg:Five250NotesDueJanuary2033Member 2021-07-13 2021-07-13 0000080424 pg:One800NotesDue2029Member 2021-07-13 2021-07-13 0000080424 pg:Four875EURNotesDueMay2027Member 2021-07-13 2021-07-13 0000080424 pg:Two000NotesDue2022Member 2021-07-13 2021-07-13 0000080424 pg:One200NotesDue2028Member 2021-07-13 2021-07-13 0000080424 pg:One250NotesDue2029Member 2021-07-13 2021-07-13 0000080424 pg:One875NotesDue2038Member 2021-07-13 2021-07-13 0000080424 pg:Zero625NotesDue2024Member 2021-07-13 2021-07-13 0000080424 pg:Zero500NotesDue2024Member 2021-07-13 2021-07-13 0000080424 pg:Two000NotesDue2021Member 2021-07-13 2021-07-13 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2021-07-13 2021-07-13 0000080424 pg:One125NotesDue2023Member 2021-07-13 2021-07-13 0000080424 pg:One375NotesDue2025Member 2021-07-13 2021-07-13 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 13, 2021 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On July 13, 2021, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of $0.8698 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after August 16, 2021, to Common Stock shareholders of record at the close of business on July 23, 2021, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on July 23, 2021. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Dividend News Release by The Procter & Gamble Company dated July 13, 2021. Cover Page Interactive Data File (embedded within the Inline XBRL document)",482
2021-07-29,8-K,0000080424-21-000078,"false 0000080424 0000080424 2021-07-29 2021-07-29 0000080424 pg:Two000NotesDue2022Member 2021-07-29 2021-07-29 0000080424 pg:Two000NotesDue2021Member 2021-07-29 2021-07-29 0000080424 pg:One200NotesDue2028Member 2021-07-29 2021-07-29 0000080424 pg:One250NotesDue2029Member 2021-07-29 2021-07-29 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2021-07-29 2021-07-29 0000080424 pg:Zero625NotesDue2024Member 2021-07-29 2021-07-29 0000080424 pg:One800NotesDue2029Member 2021-07-29 2021-07-29 0000080424 pg:One375NotesDue2025Member 2021-07-29 2021-07-29 0000080424 pg:One875NotesDue2038Member 2021-07-29 2021-07-29 0000080424 pg:One125NotesDue2023Member 2021-07-29 2021-07-29 0000080424 pg:Five250GBPNotessDueJanuary2033Member 2021-07-29 2021-07-29 0000080424 pg:Zero500NotesDue2024Member 2021-07-29 2021-07-29 0000080424 pg:Four875EURNotesDueMay2027Member 2021-07-29 2021-07-29 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 29, 2021 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notess due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. On July 29, 2021, The Procter & Gamble Company (the ""Company"") announced the following executive changes: David S. Taylor, Chairman of the Board, President and Chief Executive Officer, will transition into the role of Executive Chairman of the Board, effective November 1, 2021, to serve at the pleasure of the Board of Directors. Jon R. Moeller (age 57), currently Vice Chairman and Chief Operating Officer, has been elected President and Chief Executive Officer, effective November 1, 2021, to serve at the pleasure of the Board of Directors. Mr. Moeller has also been appointed as a member of the Companys Board of Directors, effective immediately. As an employee of the Company, Mr. Moeller will not serve on any Board committees. Shailesh Jejurikar (age 54), currently Chief Executive Officer  Fabric and Home Care, has been elected Chief Operating Officer, effective October 1, 2021, to serve at the pleasure of the Board of Directors. Mr. Moeller joined the Company in 1988 and has held positions of increasing responsibility since that time. Most recently, he has served as Vice Chairman and Chief Operating Officer (March 2021present). Previously, he served as Vice Chairman, Chief Operating Officer and Chief Financial Officer (2019-2021), Vice Chairman and Chief Financial Officer (20172019), and Chief Financial Officer (20092017). E ffective November 1, 2021, Mr. Moeller will receive an annual base salary of U.S. $1,600,000 and will participate in the Company's annual incentive program with a target award equal to 200% of base salary. In relation to his election and in connection with the Companys annual equity grant cycle, the Board of Directors approved a long-term incentive award valued at $11,200,000, with approximately 50% of the long-term incentive value in the Companys Performance Stock Program and 50% in the Long-Term Incentive Program. Going forward, Mr. Moeller will continue to receive equity grants under the Company's long-term incentive program commensurate with his position and on the same timing as other executive officers and will participate in all other elements of the Company's executive compensation and benefit programs (including as a vested participant in the Company's retirement program). Those programs are outlined in the Company's definitive proxy statement dated August 28, 2020. Mr. Moeller will not receive any fees for his service on the Board of Directors. In additio n, the Companys definitive proxy statement outlines a related person transaction between the Company and Mr. Moellers spouse, who retired from the Company in December 2020. Mr. Jejurikar joined the Company in 1989 and has held multiple positions of increasing responsibility since that time. Prior to his current service as Chief Executive Officer  Fabric and Home Care (2018present), Mr. Jejurikar served as President  Global Fabric Care and Brand-Building Officer Global Fabric & Home Care (2015-2018) and as President  Fabric Care, North America; Brand-Building Officer Fabric & Home Care New Business Creation (2014-2015). Effective October 1, 2021, Mr. Jejurikar will receive an annual base salary of U.S. $1,000,000 and will participate in the Company's annual incentive program with a target award equal to 120% of base salary. In relation to his election and in connection with the Companys annual equity grant cycle, the Board of Directors approved a long-term incentive award valued at $4,000,000, with approximately 50% of the long-term incentive value in the Companys Performance Stock Program and 50% in the Long-Term Incentive Program. Going forward, Mr. Jejurikar will continue to receive equity grants under the Company's long-term incentive program commensurate with his position and on the same timing as other executive officers and will participate in all other elements of the Company's executive compensation and benefit programs (including as a vested participant in the Company's retirement program). Those programs are outlined in the Company's definitive proxy statement dated August 28, 2020. Finally, effective November 1, 2021, Mr. Taylor will receive an annual base salary of U.S. $1,200,000 and will participate in the Company's annual incentive program with a target award equal to 150% of base salary. In relation to his election and in connection with the Companys annual equity grant cycle, the Board of Directors approved a long-term incentive award valued at $12,500,000, with approximately 50% of the long-term incentive value in the Companys Performance Stock Program and 50% in the Long-Term Incentive Program. Going forward, Mr. Taylor will continue to receive equity grants under the Company's long-term incentive program commensurate with his position and on the same timing as other executive officers and will participate in all other elements of the Company's executive compensation and benefit programs (including as a vested participant in the Company's retirement program). Those programs are outlined in the Company's definitive proxy statement dated August 28, 2020. The Company is filing the information under this item pursuant to Item 5.02, ""Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers."" ITEM 7.01 REGULATION FD DISCLOSURE The Company issued a news release on July 29, 2021, announcing the election and appointment of Mr. Moeller, the election of Mr. Jejurikar, and the changes to Mr. Taylors role. A copy of this news release is furnished as Exhibit 99.1 The Company is furnishing the information under this item, including Exhibit 99.1, pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Executive Changes Press Release by The Procter & Gamble Company dated July 29, 2021 Cover Page Interactive Data File (embedded within the Inline XBRL document)",1263
2021-07-30,8-K,0000080424-21-000083,"pg-20210730 0000080424 False 31-0411980 False 0000080424 2021-07-30 2021-07-30 0000080424 2021-07-30 2021-07-30 0000080424 exch:XNYS 2021-07-30 2021-07-30 0000080424 pg:A2.000due2021Domain 2021-07-30 2021-07-30 0000080424 pg:A2.000due2022Domain 2021-07-30 2021-07-30 0000080424 pg:A1.125due2023Domain 2021-07-30 2021-07-30 0000080424 pg:A0.500due2024Domain 2021-07-30 2021-07-30 0000080424 pg:A0.625due2024Domain 2021-07-30 2021-07-30 0000080424 pg:A1.375due2025Domain 2021-07-30 2021-07-30 0000080424 pg:A4.875EURdueMay2027Domain 2021-07-30 2021-07-30 0000080424 pg:A1.200due2028Domain 2021-07-30 2021-07-30 0000080424 pg:A1.250due2029Domain 2021-07-30 2021-07-30 0000080424 pg:A1.800due2029Domain 2021-07-30 2021-07-30 0000080424 pg:A6.250GBPdueJanuary2030Domain 2021-07-30 2021-07-30 0000080424 pg:A5.250GBPdueJanuary2033Domain 2021-07-30 2021-07-30 0000080424 pg:A1.875due2038Domain 2021-07-30 2021-07-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) July 30, 2021 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio OH 1-434 31-0411980 (State of Incorporation) OH (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza Cincinnati OH One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 2.000% Notes due 2021 PG21 NYSE 2.000% Notes due 2022 PG22B NYSE 1.125% Notes due 2023 PG23A NYSE 0.500% Notes due 2024 PG24A NYSE 0.625% Notes due 2024 PG24B NYSE 1.375% Notes due 2025 PG25 NYSE 4.875% EUR notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP notes due January 2030 PG30 NYSE 5.250% GBP notes due January 2033 PG33 NYSE 1.875% Notes due 2038 PG38 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On July 30, 2021, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter and fiscal year ended June 30, 2021. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated July 30, 2021. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",545
2021-07-30,8-K,0000080424-21-000091,"false 0000080424 0000080424 2021-07-30 2021-07-30 0000080424 pg:One375NotesDue2025Member 2021-07-30 2021-07-30 0000080424 pg:Zero500NotesDue2024Member 2021-07-30 2021-07-30 0000080424 pg:One800NotesDue2029Member 2021-07-30 2021-07-30 0000080424 pg:One125NotesDue2023Member 2021-07-30 2021-07-30 0000080424 pg:One200NotesDue2028Member 2021-07-30 2021-07-30 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2021-07-30 2021-07-30 0000080424 pg:One875NotesDue2038Member 2021-07-30 2021-07-30 0000080424 pg:Two000NotesDue2022Member 2021-07-30 2021-07-30 0000080424 pg:Two000NotesDue2021Member 2021-07-30 2021-07-30 0000080424 pg:Zero625NotesDue2024Member 2021-07-30 2021-07-30 0000080424 pg:Four875EURNotesDueMay2027Member 2021-07-30 2021-07-30 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2021-07-30 2021-07-30 0000080424 pg:One250NotesDue2029Member 2021-07-30 2021-07-30 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported) : July 30, 2021 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On July 30, 2021, The Procter & Gamble Company (the ""Company"") issued a press release announcing its fourth quarter and fiscal year results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated July 30, 2021. Cover Page Interactive Data File (embedded within the Inline XBRL document)",447
2021-08-05,8-K,0000080424-21-000096,"false 0000080424 0000080424 2021-08-05 2021-08-05 0000080424 pg:Zero625NotesDue2024Member 2021-08-05 2021-08-05 0000080424 pg:Two000NotesDue2021Member 2021-08-05 2021-08-05 0000080424 pg:One125NotesDue2023Member 2021-08-05 2021-08-05 0000080424 pg:Zero500NotesDue2024Member 2021-08-05 2021-08-05 0000080424 pg:One375NotesDue2025Member 2021-08-05 2021-08-05 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2021-08-05 2021-08-05 0000080424 pg:One875NotesDue2038Member 2021-08-05 2021-08-05 0000080424 pg:One200NotesDue2028Member 2021-08-05 2021-08-05 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2021-08-05 2021-08-05 0000080424 pg:One250NotesDue2029Member 2021-08-05 2021-08-05 0000080424 pg:One800NotesDue2029Member 2021-08-05 2021-08-05 0000080424 pg:Four875EURNotesDueMay2027Member 2021-08-05 2021-08-05 0000080424 pg:Two000NotesDue2022Member 2021-08-05 2021-08-05 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 5, 2021 (August 4, 2021) THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS On August 4, 2021, Nelson Peltz notified The Procter & Gamble Company (the ""Company"") of his intention to conclude his service on the Company's Board of Directors at the end of his current term, which expires at the Company's upcoming annual meeting of shareholders, expected to be held on October 12, 2021. The Company is filing this 8-K pursuant to Item 5.02(b), ""Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers."" ITEM 7.01 REGULATION FD DISCLOSURE The Company issued a news release on August 5, 2021, announcing Mr. Peltzs decision to retire from the Companys Board. A copy of this news release is furnished as Exhibit 99.1 The Company is furnishing the information under this item, including Exhibit 99.1, pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Director Press Release by The Procter & Gamble Company dated August 5, 2021 Cover Page Interactive Data File (embedded within the Inline XBRL document)",531
2021-08-06,10-K,0000080424-21-000100,"pg-20210630 0000080424 6/30 2021 FY False 2,427,424,874 341 10-K PROCTER & GAMBLE CO FALSE 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 exch:XNYS 2020-07-01 2021-06-30 0000080424 pg:A2000NotesDue2021Domain 2020-07-01 2021-06-30 0000080424 exch:XNYS 2020-07-01 2021-06-30 0000080424 pg:A2000NotesDue2022Domain 2020-07-01 2021-06-30 0000080424 pg:A1125NotesDue2023Domain 2020-07-01 2021-06-30 0000080424 pg:A0500NotesDue2024Domain 2020-07-01 2021-06-30 0000080424 pg:A0625NotesDue2024Domain 2020-07-01 2021-06-30 0000080424 pg:A1375NotesDue2025Domain 2020-07-01 2021-06-30 0000080424 pg:A4875EURNotesDueMay2027Domain 2020-07-01 2021-06-30 0000080424 pg:A1200NotesDue2028Domain 2020-07-01 2021-06-30 0000080424 pg:A1250NotesDue2029Domain 2020-07-01 2021-06-30 0000080424 pg:A1800NotesDue2029Domain 2020-07-01 2021-06-30 0000080424 pg:A6250GBPNotesDueJanuary2030Domain 2020-07-01 2021-06-30 0000080424 pg:A5250GBPNotesDueJanuary2033Domain 2020-07-01 2021-06-30 0000080424 pg:A1875NotesDue2038Domain 2020-07-01 2021-06-30 iso4217:USD 0000080424 2020-12-31 xbrli:shares 0000080424 2021-07-31 0000080424 2019-07-01 2020-06-30 0000080424 2018-07-01 2019-06-30 iso4217:USD xbrli:shares 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2021-06-30 0000080424 2018-06-30 0000080424 2018-06-30 0000080424 2018-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2018-06-30 0000080424 2018-06-30 0000080424 2018-06-30 0000080424 2018-06-30 0000080424 2018-06-30 0000080424 2018-06-30 0000080424 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-06-30 0000080424 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-06-30 0000080424 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-06-30 0000080424 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2018-07-01 2019-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2018-07-01 2019-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2019-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2019-07-01 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2020-07-01 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 pg:countries 0000080424 2020-07-01 2021-06-30 0000080424 srt:MinimumMember 2020-07-01 2021-06-30 0000080424 srt:MaximumMember 2020-07-01 2021-06-30 0000080424 srt:MinimumMember 2020-07-01 2021-06-30 0000080424 srt:MaximumMember 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 pg:CustomerRelationshipsBrandsandOtherNonContractualIntangibleAssetsMember srt:MinimumMember 2020-07-01 2021-06-30 0000080424 pg:CustomerRelationshipsBrandsandOtherNonContractualIntangibleAssetsMember srt:MaximumMember 2020-07-01 2021-06-30 pg:segment xbrli:pure 0000080424 pg:FabricCareMember 2020-07-01 2021-06-30 0000080424 pg:FabricCareMember 2019-07-01 2020-06-30 0000080424 pg:FabricCareMember 2018-07-01 2019-06-30 0000080424 pg:HomeCareMember 2020-07-01 2021-06-30 0000080424 pg:HomeCareMember 2019-07-01 2020-06-30 0000080424 pg:HomeCareMember 2018-07-01 2019-06-30 0000080424 pg:BabyCareMember 2020-07-01 2021-06-30 0000080424 pg:BabyCareMember 2019-07-01 2020-06-30 0000080424 pg:BabyCareMember 2018-07-01 2019-06-30 0000080424 pg:SkinandPersonalCareMember 2020-07-01 2021-06-30 0000080424 pg:SkinandPersonalCareMember 2019-07-01 2020-06-30 0000080424 pg:SkinandPersonalCareMember 2018-07-01 2019-06-30 0000080424 pg:HairCareMember 2020-07-01 2021-06-30 0000080424 pg:HairCareMember 2019-07-01 2020-06-30 0000080424 pg:HairCareMember 2018-07-01 2019-06-30 0000080424 pg:FamilyCareMember 2020-07-01 2021-06-30 0000080424 pg:FamilyCareMember 2019-07-01 2020-06-30 0000080424 pg:FamilyCareMember 2018-07-01 2019-06-30 0000080424 pg:OralCareMember 2020-07-01 2021-06-30 0000080424 pg:OralCareMember 2019-07-01 2020-06-30 0000080424 pg:OralCareMember 2018-07-01 2019-06-30 0000080424 pg:ShaveCareMember 2020-07-01 2021-06-30 0000080424 pg:ShaveCareMember 2019-07-01 2020-06-30 0000080424 pg:ShaveCareMember 2018-07-01 2019-06-30 0000080424 pg:FeminineCareMember 2020-07-01 2021-06-30 0000080424 pg:FeminineCareMember 2019-07-01 2020-06-30 0000080424 pg:FeminineCareMember 2018-07-01 2019-06-30 0000080424 pg:PersonalHealthCareMember 2020-07-01 2021-06-30 0000080424 pg:PersonalHealthCareMember 2019-07-01 2020-06-30 0000080424 pg:PersonalHealthCareMember 2018-07-01 2019-06-30 0000080424 pg:AllOtherMember 2020-07-01 2021-06-30 0000080424 pg:AllOtherMember 2019-07-01 2020-06-30 0000080424 pg:AllOtherMember 2018-07-01 2019-06-30 0000080424 country:US 2020-07-01 2021-06-30 0000080424 country:US 2019-07-01 2020-06-30 0000080424 country:US 2018-07-01 2019-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2018-07-01 2019-06-30 0000080424 country:US 2021-06-30 0000080424 country:US 2020-06-30 0000080424 country:US 2019-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 pg:WalMartStoresIncAndAffiliatesMember 2019-07-01 2020-06-30 0000080424 pg:WalMartStoresIncAndAffiliatesMember 2020-07-01 2021-06-30 0000080424 pg:WalMartStoresIncAndAffiliatesMember 2018-07-01 2019-06-30 0000080424 pg:BeautySegmentMember 2020-07-01 2021-06-30 0000080424 pg:BeautySegmentMember 2021-06-30 0000080424 pg:BeautySegmentMember 2019-07-01 2020-06-30 0000080424 pg:BeautySegmentMember 2020-06-30 0000080424 pg:BeautySegmentMember 2018-07-01 2019-06-30 0000080424 pg:BeautySegmentMember 2019-06-30 0000080424 pg:GroomingMember 2020-07-01 2021-06-30 0000080424 pg:GroomingMember 2021-06-30 0000080424 pg:GroomingMember 2019-07-01 2020-06-30 0000080424 pg:GroomingMember 2020-06-30 0000080424 pg:GroomingMember 2018-07-01 2019-06-30 0000080424 pg:GroomingMember 2019-06-30 0000080424 pg:HealthCareSegMember 2020-07-01 2021-06-30 0000080424 pg:HealthCareSegMember 2021-06-30 0000080424 pg:HealthCareSegMember 2019-07-01 2020-06-30 0000080424 pg:HealthCareSegMember 2020-06-30 0000080424 pg:HealthCareSegMember 2018-07-01 2019-06-30 0000080424 pg:HealthCareSegMember 2019-06-30 0000080424 pg:FabricHomeCareMember 2020-07-01 2021-06-30 0000080424 pg:FabricHomeCareMember 2021-06-30 0000080424 pg:FabricHomeCareMember 2019-07-01 2020-06-30 0000080424 pg:FabricHomeCareMember 2020-06-30 0000080424 pg:FabricHomeCareMember 2018-07-01 2019-06-30 0000080424 pg:FabricHomeCareMember 2019-06-30 0000080424 pg:BabyFeminineFamilyCareMember 2020-07-01 2021-06-30 0000080424 pg:BabyFeminineFamilyCareMember 2021-06-30 0000080424 pg:BabyFeminineFamilyCareMember 2019-07-01 2020-06-30 0000080424 pg:BabyFeminineFamilyCareMember 2020-06-30 0000080424 pg:BabyFeminineFamilyCareMember 2018-07-01 2019-06-30 0000080424 pg:BabyFeminineFamilyCareMember 2019-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2021-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2020-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2019-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 srt:MinimumMember 2021-06-30 0000080424 srt:MaximumMember 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 pg:GroomingSegmentMember 2020-07-01 2021-06-30 0000080424 pg:GroomingSegmentMember 2019-07-01 2020-06-30 0000080424 pg:GroomingSegmentMember 2018-07-01 2019-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2020-07-01 2021-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2019-07-01 2020-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2018-07-01 2019-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2020-07-01 2021-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2019-07-01 2020-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2018-07-01 2019-06-30 0000080424 pg:GroomingSegmentMember 2019-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2019-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2019-06-30 0000080424 pg:GroomingSegmentMember 2020-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2020-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2020-06-30 0000080424 pg:GroomingSegmentMember 2021-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2021-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2021-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 pg:PatentsandDevelopedTechnologyMember 2021-06-30 0000080424 pg:PatentsandDevelopedTechnologyMember 2020-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2021-06-30 0000080424 2020-06-30 utr:Rate pg:audit 0000080424 srt:MinimumMember 2020-07-01 2021-06-30 0000080424 srt:MaximumMember 2020-07-01 2021-06-30 0000080424 2021-07-01 2022-06-30 0000080424 pg:NetOperatingLossExpiringWithin20YearsMember srt:MinimumMember 2021-06-30 0000080424 pg:NetOperatingLossIndefiniteLifeMember srt:MaximumMember 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2018-07-01 2019-06-30 0000080424 pg:ContinuingandDiscontinuedOperationsMember 2020-07-01 2021-06-30 0000080424 pg:ContinuingandDiscontinuedOperationsMember 2019-07-01 2020-06-30 0000080424 pg:ContinuingandDiscontinuedOperationsMember 2018-07-01 2019-06-30 0000080424 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 pg:RestrictedStockRsusAndPsusMember 2021-06-30 0000080424 pg:RestrictedStockRsusAndPsusMember 2020-07-01 2021-06-30 0000080424 country:US 2018-07-01 2019-06-30 0000080424 country:US 2019-07-01 2020-06-30 0000080424 country:US 2020-07-01 2021-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2018-07-01 2019-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 pg:CompanyStockMember 2021-06-30 0000080424 pg:CompanyStockMember 2020-06-30 0000080424 pg:CompanyStockMember 2021-06-30 0000080424 pg:CompanyStockMember 2020-06-30 0000080424 pg:CompanyPreferredStockMember 2021-06-30 0000080424 pg:CompanyPreferredStockMember 2020-06-30 0000080424 pg:CompanyPreferredStockMember 2021-06-30 0000080424 pg:CompanyPreferredStockMember 2020-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 pg:InsuranceContractsDomain 2021-06-30 0000080424 pg:InsuranceContractsDomain 2020-06-30 0000080424 pg:InsuranceContractsDomain 2021-06-30 0000080424 pg:InsuranceContractsDomain 2020-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 1989-06-30 0000080424 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 1991-06-30 0000080424 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2019-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2019-07-01 2020-06-30 0000080424 pg:A1.70USDnotedueNovember2021Member 2021-06-30 0000080424 pg:A1.70USDnotedueNovember2021Member 2020-06-30 0000080424 pg:A2.00EURnotedueNovember2021Member 2021-06-30 0000080424 pg:A2.00EURnotedueNovember2021Member 2020-06-30 0000080424 pg:A230UsdNoteDueFeb2022Member 2021-06-30 0000080424 pg:A230UsdNoteDueFeb2022Member 2020-06-30 0000080424 pg:A2.15USDnotedueAug2022MemberMember 2021-06-30 0000080424 pg:A2.15USDnotedueAug2022MemberMember 2020-06-30 0000080424 pg:A2.00EURnotedueAug2022Member 2021-06-30 0000080424 pg:A2.00EURnotedueAug2022Member 2020-06-30 0000080424 pg:A3.10USDnotedueAugust2023Member 2021-06-30 0000080424 pg:A3.10USDnotedueAugust2023Member 2020-06-30 0000080424 pg:A1.13EURnotedueNovember2023Member 2021-06-30 0000080424 pg:A1.13EURnotedueNovember2023Member 2020-06-30 0000080424 pg:A0.50EURnotedueOctober2024Member 2021-06-30 0000080424 pg:A0.50EURnotedueOctober2024Member 2020-06-30 0000080424 pg:A0.63EURnotedueOctober2024Member 2021-06-30 0000080424 pg:A0.63EURnotedueOctober2024Member 2020-06-30 0000080424 pg:A138GBPNoteDueMay2025Member 2021-06-30 0000080424 pg:A138GBPNoteDueMay2025Member 2020-06-30 0000080424 pg:A055USDNoteDueOctober2025Member 2021-06-30 0000080424 pg:A055USDNoteDueOctober2025Member 2020-06-30 0000080424 pg:A2.70USDnotedueFebruary2026Member 2021-06-30 0000080424 pg:A2.70USDnotedueFebruary2026Member 2020-06-30 0000080424 pg:A100USDNoteDueApril2026Member 2021-06-30 0000080424 pg:A100USDNoteDueApril2026Member 2020-06-30 0000080424 pg:A2.45USDnotedueNovember2026Member 2021-06-30 0000080424 pg:A2.45USDnotedueNovember2026Member 2020-06-30 0000080424 pg:A280USDNoteDueMarch2027Member 2021-06-30 0000080424 pg:A280USDNoteDueMarch2027Member 2020-06-30 0000080424 pg:A4.88EURnotedueMay2027Member 2021-06-30 0000080424 pg:A4.88EURnotedueMay2027Member 2020-06-30 0000080424 pg:A2.85USDnotedueAugust2027Member 2021-06-30 0000080424 pg:A2.85USDnotedueAugust2027Member 2020-06-30 0000080424 pg:A1.20EURnotedueOctober2028Member 2021-06-30 0000080424 pg:A1.20EURnotedueOctober2028Member 2020-06-30 0000080424 pg:A18GBPNoteDueMay2029Member 2021-06-30 0000080424 pg:A18GBPNoteDueMay2029Member 2020-06-30 0000080424 pg:A1.25EURnotedueOctober2029Member 2021-06-30 0000080424 pg:A1.25EURnotedueOctober2029Member 2020-06-30 0000080424 pg:A300USDNoteDueMarch2030Member 2021-06-30 0000080424 pg:A300USDNoteDueMarch2030Member 2020-06-30 0000080424 pg:A120USDNoteDueOctober2030Member 2021-06-30 0000080424 pg:A120USDNoteDueOctober2030Member 2020-06-30 0000080424 pg:A195USDNoteDueApril2031Member 2021-06-30 0000080424 pg:A195USDNoteDueApril2031Member 2020-06-30 0000080424 pg:A5.55USDnotedueMarch2037Member 2021-06-30 0000080424 pg:A5.55USDnotedueMarch2037Member 2020-06-30 0000080424 pg:A1.88EURnotedueOctober2038Member 2021-06-30 0000080424 pg:A1.88EURnotedueOctober2038Member 2020-06-30 0000080424 pg:A355USDNoteDueMarch2040Member 2021-06-30 0000080424 pg:A355USDNoteDueMarch2040Member 2020-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 pg:PHCMERCKACQUISITIONMember 2018-11-01 2018-11-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark one) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 TRUE For the Fiscal Year Ended June 30, 2021 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 False For the transition period from to Commission File No. 1-434 Cincinnati THE PROCTER & GAMBLE CO MPANY OH One Procter & Gamble Plaza One Procter & Gamble Plaza, Cincinnati, Ohio 45202 45202 513 Telephone (513) 983-1100 983-1100 IRS Employer Identification No. 31-0411980 31-0411980 State of Incorporation: Ohio OH Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG New York Stock Exchange 2.000% notes due 2021 PG21 New York Stock Exchange 2.000% notes due 2022 PG22B New York Stock Exchange 1.125% notes due 2023 PG23A New York Stock Exchange 0.500% notes due 2024 PG24A New York Stock Exchange 0.625% notes due 2024 PG24B New York Stock Exchange 1.375% notes due 2025 PG25 New York Stock Exchange 4.875% EUR notes due May 2027 PG27A New York Stock Exchange 1.200% notes due 2028 PG28 New York Stock Exchange 1.250% notes due 2029 PG29B New York Stock Exchange 1.800% notes due 2029 PG29A New York Stock Exchange 6.250% GBP notes due January 2030 PG30 New York Stock Exchange 5.250% GBP notes due January 2033 PG33 New York Stock Exchange 1.875% notes due 2038 PG38 New York Stock Exchange Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  No o Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes o No  Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No o Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of ""large accelerated filed,"" ""accelerated filer,"" ""smaller reporting company,"" and ""emerging growth company"" in Rule 12b-2 of the Exchange Act. Large accelerated filer  Accelerated filer  Non-accelerated filer  Smaller reporting company  FALSE Emerging growth company  FALSE If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No  False Indicate by check mark whether the registrant has filed a report on and attestation to its managements assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the",1858
2021-10-12,8-K,0000080424-21-000114,"false 0000080424 0000080424 2021-10-12 2021-10-12 0000080424 pg:One125NotesDue2023Member 2021-10-12 2021-10-12 0000080424 pg:One200NotesDue2028Member 2021-10-12 2021-10-12 0000080424 pg:One250NotesDue2029Member 2021-10-12 2021-10-12 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2021-10-12 2021-10-12 0000080424 pg:One875NotesDue2038Member 2021-10-12 2021-10-12 0000080424 pg:Two000NotesDue2021Member 2021-10-12 2021-10-12 0000080424 pg:Two000NotesDue2022Member 2021-10-12 2021-10-12 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2021-10-12 2021-10-12 0000080424 pg:Zero625NotesDue2024Member 2021-10-12 2021-10-12 0000080424 pg:One375NotesDue2025Member 2021-10-12 2021-10-12 0000080424 pg:One800NotesDue2029Member 2021-10-12 2021-10-12 0000080424 pg:Zero500NotesDue2024Member 2021-10-12 2021-10-12 0000080424 pg:Four875EURNotesDueMay2027Member 2021-10-12 2021-10-12 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 12, 2021 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On October 12, 2021, The Procter & Gamble Company (the Company) issued a news release announcing that, according to preliminary voting results, Christopher Kempczinski, President and Chief Executive Officer of McDonalds Corporation, and the Companys eleven incumbent Director nominees were elected to the Companys Board of Directors at the Annual Meeting of Shareholders. In addition, the Company announced that its Board of Directors declared a quarterly dividend of $0.8698 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after November 15, 2021, to Common Stock shareholders of record at the close of business on October 22, 2021, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on October 22, 2021. A copy of this news release is furnished as Exhibit 99.1. The Company is furnishing the information under this item, including Exhibit 99.1, pursuant to Item 7.01, ""Regulation FD Disclosure. ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS News Release by The Procter & Gamble Company dated October 12, 2021. Cover Page Interactive Data File (embedded within the Inline XBRL document)",545
2021-10-15,8-K,0000080424-21-000116,"false 0000080424 0000080424 2021-10-15 2021-10-15 0000080424 pg:Two000NotesDue2021Member 2021-10-15 2021-10-15 0000080424 pg:One375NotesDue2025Member 2021-10-15 2021-10-15 0000080424 pg:Four875EURNotesDueMay2027Member 2021-10-15 2021-10-15 0000080424 pg:Two000NotesDue2022Member 2021-10-15 2021-10-15 0000080424 pg:One125NotesDue2023Member 2021-10-15 2021-10-15 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2021-10-15 2021-10-15 0000080424 pg:One200NotesDue2028Member 2021-10-15 2021-10-15 0000080424 pg:Zero625NotesDue2024Member 2021-10-15 2021-10-15 0000080424 pg:One250NotesDue2029Member 2021-10-15 2021-10-15 0000080424 pg:One800NotesDue2029Member 2021-10-15 2021-10-15 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2021-10-15 2021-10-15 0000080424 pg:Zero500NotesDue2024Member 2021-10-15 2021-10-15 0000080424 pg:One875NotesDue2038Member 2021-10-15 2021-10-15 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 15, 2021 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Submission of Matters to a Vote of Security Holders On October 12, 2021, The Procter & Gamble Company (the Company), held its 2021 Annual Meeting of Shareholders. Set forth below are the final voting results for each of the proposals submitted to a vote Proposal 1  Election of Directors . Each of the following nominees was elected to serve a one-year term on the Companys Board of Directors. Proposal 2- Ratify Appointment of the Independent Registered Public Accounting Firm . The proposal was approved. Proposal 3 - Advisory Vote to Approve the Companys Executive Compensation (the Say on Pay vote) . The proposal was approved. Proposal 4 - Inclusion of Non-Management Employees on Director Nominee Candidate List . The proposal was not approved. The Company is filing this Form 8-K pursuant to Item 5.07, ""Submission of Matters to a Vote of Security Holders.""",486
2021-10-19,10-Q,0000080424-21-000129,"and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: Management's Discussion and Analysis, ",95
2021-10-19,8-K,0000080424-21-000125,"false 0000080424 0000080424 2021-10-19 2021-10-19 0000080424 pg:One800NotesDue2029Member 2021-10-19 2021-10-19 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2021-10-19 2021-10-19 0000080424 pg:One125NotesDue2023Member 2021-10-19 2021-10-19 0000080424 pg:Zero500NotesDue2024Member 2021-10-19 2021-10-19 0000080424 pg:Two000NotesDue2022Member 2021-10-19 2021-10-19 0000080424 pg:Four875EURNotesDueMay2027Member 2021-10-19 2021-10-19 0000080424 pg:One875NotesDue2038Member 2021-10-19 2021-10-19 0000080424 pg:One200NotesDue2028Member 2021-10-19 2021-10-19 0000080424 pg:One250NotesDue2029Member 2021-10-19 2021-10-19 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2021-10-19 2021-10-19 0000080424 pg:Two000NotesDue2021Member 2021-10-19 2021-10-19 0000080424 pg:Zero625NotesDue2024Member 2021-10-19 2021-10-19 0000080424 pg:One375NotesDue2025Member 2021-10-19 2021-10-19 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported) : October 19, 2021 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On October 19, 2021, The Procter & Gamble Company (the ""Company"") issued a press release announcing its first quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated October 19, 2021. Cover Page Interactive Data File (embedded within the Inline XBRL document)",444
2021-10-19,8-K,0000080424-21-000123,"pg-20211019 0000080424 False False False False False 0000080424 2021-07-01 2021-09-30 0000080424 2021-07-01 2021-09-30 0000080424 exch:XNYS 2021-07-01 2021-09-30 0000080424 pg:A2.000due2021Domain 2021-07-01 2021-09-30 0000080424 pg:A2.000due2022Domain 2021-07-01 2021-09-30 0000080424 pg:A1.125due2023Domain 2021-07-01 2021-09-30 0000080424 pg:A0.500due2024Domain 2021-07-01 2021-09-30 0000080424 pg:A0.625due2024Domain 2021-07-01 2021-09-30 0000080424 pg:A1.375due2025Domain 2021-07-01 2021-09-30 0000080424 pg:A4.875EURdueMay2027Domain 2021-07-01 2021-09-30 0000080424 pg:A1.200due2028Domain 2021-07-01 2021-09-30 0000080424 pg:A1.250due2029Domain 2021-07-01 2021-09-30 0000080424 pg:A1.800due2029Domain 2021-07-01 2021-09-30 0000080424 pg:A6.250GBPdueJanuary2030Domain 2021-07-01 2021-09-30 0000080424 pg:A5.250GBPdueJanuary2033Domain 2021-07-01 2021-09-30 0000080424 pg:A1.875due2038Domain 2021-07-01 2021-09-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) October 19, 2021 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio OH 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza , Cincinnati OH One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 2.000% Notes due 2021 PG21 NYSE 2.000% Notes due 2022 PG22B NYSE 1.125% Notes due 2023 PG23A NYSE 0.500% Notes due 2024 PG24A NYSE 0.625% Notes due 2024 PG24B NYSE 1.375% Notes due 2025 PG25 NYSE 4.875% EUR notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP notes due January 2030 PG30 NYSE 5.250% GBP notes due January 2033 PG33 NYSE 1.875% Notes due 2038 PG38 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On October 19, 2021, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended September 30, 2021. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated October 19, 2021. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",544
2021-11-05,8-K,0001193125-21-321765,"THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) 513 - 983-1100 Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Item 8.01 Other Events. On November 5, 2021, The Procter & Gamble Company (the Company) closed an underwritten public offering of 500,000,000 aggregate principal amount of 0.350% Notes due May 5, 2030 and 600,000,000 aggregate principal amount of 0.900% Notes due November 4, 2041 under the Companys Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are",348
2021-11-08,8-K,0001193125-21-323196,"THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) 513 - 983-1100 Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 0.350% EUR notes due May 2030 5.250% GBP notes due January 2033 0.900% EUR notes due 2041 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Other Events. On November 8, 2021, The Procter & Gamble Company (the Company) closed an underwritten public offering of 50,000,000,000 aggregate principal amount of 0.110% Notes due November 6, 2026 and 50,000,000,000 aggregate principal amount of 0.230% Notes due November 6, 2031 under the Companys Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are",357
2021-12-10,8-K,0000080424-21-000138,"false 0000080424 0000080424 2021-12-10 2021-12-10 0000080424 pg:Two000NotesDue2022Member 2021-12-10 2021-12-10 0000080424 pg:One125NotesDue2023Member 2021-12-10 2021-12-10 0000080424 pg:Zero500NotesDue2024Member 2021-12-10 2021-12-10 0000080424 pg:Zero625NotesDue2024Member 2021-12-10 2021-12-10 0000080424 pg:One375NotesDue2025Member 2021-12-10 2021-12-10 0000080424 pg:Zero110NotesDue2026Member 2021-12-10 2021-12-10 0000080424 pg:Four875EURNotesDueMay2027Member 2021-12-10 2021-12-10 0000080424 pg:One200NotesDue2028Member 2021-12-10 2021-12-10 0000080424 pg:One250NotesDue2029Member 2021-12-10 2021-12-10 0000080424 pg:One800NotesDue2029Member 2021-12-10 2021-12-10 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2021-12-10 2021-12-10 0000080424 pg:Zero350NotesDue2030Member 2021-12-10 2021-12-10 0000080424 pg:Zero230NotesDue2031Member 2021-12-10 2021-12-10 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2021-12-10 2021-12-10 0000080424 pg:One875NotesDue2038Member 2021-12-10 2021-12-10 0000080424 pg:Zero900NotesDue2041Member 2021-12-10 2021-12-10 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 10, 2021 (December 8, 2021) THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP Notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. On December 8, 2021, President Joseph R. Biden, Jr., announced his intent to nominate Margaret C. Whitman, a Director of The Procter & Gamble Company (the Company), to serve as the United States Ambassador to Kenya. This nomination requires confirmation by the U.S. Senate. Ms. Whitman has notified the Company of her intent to resign from the Companys Board of Directors, effective upon Senate confirmation of The Company is filing this 8-K pursuant to Item 5.02(b), ""Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.""",472
2022-01-11,8-K,0000080424-22-000002,"false 0000080424 0000080424 2022-01-11 2022-01-11 0000080424 pg:Zero900NotesDue2041Member 2022-01-11 2022-01-11 0000080424 pg:Zero230NotesDue2031Member 2022-01-11 2022-01-11 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2022-01-11 2022-01-11 0000080424 pg:Zero110NotesDue2026Member 2022-01-11 2022-01-11 0000080424 pg:One125NotesDue2023Member 2022-01-11 2022-01-11 0000080424 pg:One200NotesDue2028Member 2022-01-11 2022-01-11 0000080424 pg:One250NotesDue2029Member 2022-01-11 2022-01-11 0000080424 pg:One800NotesDue2029Member 2022-01-11 2022-01-11 0000080424 pg:Zero625NotesDue2024Member 2022-01-11 2022-01-11 0000080424 pg:One875NotesDue2038Member 2022-01-11 2022-01-11 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2022-01-11 2022-01-11 0000080424 pg:Two000NotesDue2022Member 2022-01-11 2022-01-11 0000080424 pg:Zero500NotesDue2024Member 2022-01-11 2022-01-11 0000080424 pg:Four875EURNotesDueMay2027Member 2022-01-11 2022-01-11 0000080424 pg:Zero350NotesDue2030Member 2022-01-11 2022-01-11 0000080424 pg:One375NotesDue2025Member 2022-01-11 2022-01-11 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 11, 2022 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On January 11, 2022, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of $0.8698 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after February 15, 2022, to Common Stock shareholders of record at the close of business on January 21, 2022, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on January 21, 2022. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Dividend News Release by The Procter & Gamble Company dated January 11, 2022. Cover Page Interactive Data File (embedded within the Inline XBRL document)",500
2022-01-12,8-K,0000080424-22-000004,"false 0000080424 0000080424 2022-01-12 2022-01-12 0000080424 pg:Two000NotesDue2022Member 2022-01-12 2022-01-12 0000080424 pg:One800NotesDue2029Member 2022-01-12 2022-01-12 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2022-01-12 2022-01-12 0000080424 pg:One250NotesDue2029Member 2022-01-12 2022-01-12 0000080424 pg:One125NotesDue2023Member 2022-01-12 2022-01-12 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2022-01-12 2022-01-12 0000080424 pg:Four875EURNotesDueMay2027Member 2022-01-12 2022-01-12 0000080424 pg:Zero230NotesDue2031Member 2022-01-12 2022-01-12 0000080424 pg:Zero900NotesDue2041Member 2022-01-12 2022-01-12 0000080424 pg:Zero110NotesDue2026Member 2022-01-12 2022-01-12 0000080424 pg:Zero500NotesDue2024Member 2022-01-12 2022-01-12 0000080424 pg:Zero350NotesDue2030Member 2022-01-12 2022-01-12 0000080424 pg:Zero625NotesDue2024Member 2022-01-12 2022-01-12 0000080424 pg:One375NotesDue2025Member 2022-01-12 2022-01-12 0000080424 pg:One875NotesDue2038Member 2022-01-12 2022-01-12 0000080424 pg:One200NotesDue2028Member 2022-01-12 2022-01-12 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 12, 2022 (January 7, 2022) THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. On January 7, 2022, Michael G. Homan, currently Senior Vice President  Chief Accounting Officer, announced his intention to retire from The Procter & Gamble Company (the Company) after 24 years of service, Accordingly, on January 7, 2022, the Companys Board of Directors designated Matthew W. Janzaruk (age 48), currently Vice President  Finance & Accounting, Global Internal Audit, as the Companys principal accounting officer, effective March 1, 2022. Mr. Janzaruk has also been named Senior Vice President  Chief Accounting Officer, effective that same date. Mr. Janzaruk joined the Company in 2003 and has held positions of increasing responsibility since that time. He has served as Vice President  Finance & Accounting, Global Internal Audit since August 2016. Immediately prior to that role, he served as Vice President, Finance & Accounting  Corporate Accounting from July 2013 to July 2016. Mr. Janzaruk will continue to receive an annual base salary and equity grants under the Company's annual performance-based and long-term incentive programs commensurate with his position and on the same timing as other similarly situated persons within the Company. Those programs are outlined in the Company's definitive proxy statement dated August 27, 2021. The Company is filing this 8-K pursuant to Items 5.02(b) and 5.02(c), ""Departure of Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.""",604
2022-01-19,10-Q,0000080424-22-000016,"and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: Management's Discussion and Analysis, ",95
2022-01-19,8-K,0000080424-22-000011,"pg-20220119 0000080424 False False False False False 0000080424 2021-07-01 2021-12-31 0000080424 2021-07-01 2021-12-31 0000080424 exch:XNYS 2021-07-01 2021-12-31 0000080424 pg:A2.000due2022Domain 2021-07-01 2021-12-31 0000080424 pg:A1.125due2023Domain 2021-07-01 2021-12-31 0000080424 pg:A0.500due2024Domain 2021-07-01 2021-12-31 0000080424 pg:A0.625due2024Domain 2021-07-01 2021-12-31 0000080424 pg:A1.375due2025Domain 2021-07-01 2021-12-31 0000080424 pg:A0110Due2026Domain 2021-07-01 2021-12-31 0000080424 pg:A4.875EURdueMay2027Domain 2021-07-01 2021-12-31 0000080424 pg:A1.200due2028Domain 2021-07-01 2021-12-31 0000080424 pg:A1.250due2029Domain 2021-07-01 2021-12-31 0000080424 pg:A1.800due2029Domain 2021-07-01 2021-12-31 0000080424 pg:A6.250GBPdueJanuary2030Domain 2021-07-01 2021-12-31 0000080424 pg:A0350Due2030Domain 2021-07-01 2021-12-31 0000080424 pg:A0230Due2031Domain 2021-07-01 2021-12-31 0000080424 pg:A5.250GBPdueJanuary2033Domain 2021-07-01 2021-12-31 0000080424 pg:A1.875due2038Domain 2021-07-01 2021-12-31 0000080424 pg:A0900Due2041Domain 2021-07-01 2021-12-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) January 19, 2022 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio OH 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza , Cincinnati OH One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 2.000% Notes due 2022 PG22B NYSE 1.125% Notes due 2023 PG23A NYSE 0.500% Notes due 2024 PG24A NYSE 0.625% Notes due 2024 PG24B NYSE 1.375% Notes due 2025 PG25 NYSE 0.110% Notes due 2026 PG26D NYSE 4.875% EUR notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 5.250% GBP notes due January 2033 PG33 NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 19, 2022, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended December 31, 2021. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated January 19, 2022. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",574
2022-01-19,8-K,0000080424-22-000014,"false 0000080424 0000080424 2022-01-19 2022-01-19 0000080424 pg:One125NotesDue2023Member 2022-01-19 2022-01-19 0000080424 pg:Four875EURNotesDueMay2027Member 2022-01-19 2022-01-19 0000080424 pg:Zero110NotesDue2026Member 2022-01-19 2022-01-19 0000080424 pg:One375NotesDue2025Member 2022-01-19 2022-01-19 0000080424 pg:One800NotesDue2029Member 2022-01-19 2022-01-19 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2022-01-19 2022-01-19 0000080424 pg:One200NotesDue2028Member 2022-01-19 2022-01-19 0000080424 pg:One250NotesDue2029Member 2022-01-19 2022-01-19 0000080424 pg:Two000NotesDue2022Member 2022-01-19 2022-01-19 0000080424 pg:Zero350NotesDue2030Member 2022-01-19 2022-01-19 0000080424 pg:One875NotesDue2038Member 2022-01-19 2022-01-19 0000080424 pg:Zero625NotesDue2024Member 2022-01-19 2022-01-19 0000080424 pg:Zero900NotesDue2041Member 2022-01-19 2022-01-19 0000080424 pg:Zero500NotesDue2024Member 2022-01-19 2022-01-19 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2022-01-19 2022-01-19 0000080424 pg:Zero230NotesDue2031Member 2022-01-19 2022-01-19 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 19, 2022 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On January 19, 2022, The Procter & Gamble Company (the ""Company"") issued a press release announcing its second quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated January 19, 2022. Cover Page Interactive Data File (embedded within the Inline XBRL document)",459
2022-02-01,8-K,0001193125-22-024644,"THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) 513 - 983-1100 Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Other Events. On February 1, 2022, The Procter & Gamble Company (the Company) closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 1.900% Notes due February 1, 2027 and $850,000,000 aggregate principal amount of 2.300% Notes due February 1, 2032 under the Companys Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are",346
2022-02-08,8-K,0001193125-22-031163,"THE PROCTER & GAMBLE COMPANY PROCTERPROCTER & GAMBLE Coo (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) 513 - 983-1100 Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Other Events. On February 8, 2022, The Procter & Gamble Company (the Company) closed an underwritten public offering of $412,533,000 aggregate principal amount of Floating Rate Notes due February 8, 2072 under the Companys Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are",339
2022-04-12,8-K,0000080424-22-000022,"false 0000080424 0000080424 2022-04-12 2022-04-12 0000080424 pg:One200NotesDue2028Member 2022-04-12 2022-04-12 0000080424 pg:One125NotesDue2023Member 2022-04-12 2022-04-12 0000080424 pg:Zero900NotesDue2041Member 2022-04-12 2022-04-12 0000080424 pg:Zero625NotesDue2024Member 2022-04-12 2022-04-12 0000080424 pg:Zero110NotesDue2026Member 2022-04-12 2022-04-12 0000080424 pg:Four875EURNotesDueMay2027Member 2022-04-12 2022-04-12 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2022-04-12 2022-04-12 0000080424 pg:One375NotesDue2025Member 2022-04-12 2022-04-12 0000080424 pg:Zero230NotesDue2031Member 2022-04-12 2022-04-12 0000080424 pg:Zero350NotesDue2030Member 2022-04-12 2022-04-12 0000080424 pg:One875NotesDue2038Member 2022-04-12 2022-04-12 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2022-04-12 2022-04-12 0000080424 pg:One800NotesDue2029Member 2022-04-12 2022-04-12 0000080424 pg:Two000NotesDue2022Member 2022-04-12 2022-04-12 0000080424 pg:One250NotesDue2029Member 2022-04-12 2022-04-12 0000080424 pg:Zero500NotesDue2024Member 2022-04-12 2022-04-12 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 12, 2022 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On April 12, 2022, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of $0.9133 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after May 16, 2022, to Common Stock shareholders of record at the close of business on April 22, 2022, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on April 22, 2022. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Dividend News Release by The Procter & Gamble Company dated April 12, 2022. Cover Page Interactive Data File (embedded within the Inline XBRL document)",500
2022-04-14,8-K,0000080424-22-000025,"false 0000080424 0000080424 2022-04-14 2022-04-14 0000080424 pg:One250NotesDue2029Member 2022-04-14 2022-04-14 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2022-04-14 2022-04-14 0000080424 pg:Zero625NotesDue2024Member 2022-04-14 2022-04-14 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2022-04-14 2022-04-14 0000080424 pg:One875NotesDue2038Member 2022-04-14 2022-04-14 0000080424 pg:One200NotesDue2028Member 2022-04-14 2022-04-14 0000080424 pg:One800NotesDue2029Member 2022-04-14 2022-04-14 0000080424 pg:Zero900NotesDue2041Member 2022-04-14 2022-04-14 0000080424 pg:Zero230NotesDue2031Member 2022-04-14 2022-04-14 0000080424 pg:One375NotesDue2025Member 2022-04-14 2022-04-14 0000080424 pg:Zero350NotesDue2030Member 2022-04-14 2022-04-14 0000080424 pg:One125NotesDue2023Member 2022-04-14 2022-04-14 0000080424 pg:Two000NotesDue2022Member 2022-04-14 2022-04-14 0000080424 pg:Zero500NotesDue2024Member 2022-04-14 2022-04-14 0000080424 pg:Four875EURNotesDueMay2027Member 2022-04-14 2022-04-14 0000080424 pg:Zero110NotesDue2026Member 2022-04-14 2022-04-14 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 14, 2022 (April 12, 2022) THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS On April 14, 2022, The Procter & Gamble Company (the ""Company"") announced that David S. Taylor, Executive Chairman of the Board, will retire from the Company, effective June 30, 2022. The Company also announced that Jon R. Moeller, currently President and Chief Executive Officer and a member of the Board of Directors (the Board), has been appointed Chairman of the Board, in addition to his current responsibilities, effective July 1, 2022, to serve at the pleasure of the Board. In addition, the non-employee Directors of the Board reappointed Joseph Jimenez as the Boards independent Lead Director. The Company is filing the information under this item pursuant to Item 5.02, ""Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers."" ITEM 7.01 REGULATION FD DISCLOSURE The Company issued a news release on April 14, 2022, announcing Mr. Taylors retirement and Mr. Moellers appointment. A copy of this news release is furnished as Exhibit 99.1 The Company is furnishing the information under this item, including Exhibit 99.1, pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS News Release by The Procter & Gamble Company dated April 14, 2022. Cover Page Interactive Data File (embedded within the Inline XBRL document)",591
2022-04-20,8-K,0000080424-22-000032,"false 0000080424 0000080424 2022-04-20 2022-04-20 0000080424 pg:Four875EURNotesDueMay2027Member 2022-04-20 2022-04-20 0000080424 pg:Zero500NotesDue2024Member 2022-04-20 2022-04-20 0000080424 pg:One875NotesDue2038Member 2022-04-20 2022-04-20 0000080424 pg:One375NotesDue2025Member 2022-04-20 2022-04-20 0000080424 pg:Zero900NotesDue2041Member 2022-04-20 2022-04-20 0000080424 pg:Two000NotesDue2022Member 2022-04-20 2022-04-20 0000080424 pg:One125NotesDue2023Member 2022-04-20 2022-04-20 0000080424 pg:Zero625NotesDue2024Member 2022-04-20 2022-04-20 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2022-04-20 2022-04-20 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2022-04-20 2022-04-20 0000080424 pg:Zero230NotesDue2031Member 2022-04-20 2022-04-20 0000080424 pg:Zero110NotesDue2026Member 2022-04-20 2022-04-20 0000080424 pg:One200NotesDue2028Member 2022-04-20 2022-04-20 0000080424 pg:Zero350NotesDue2030Member 2022-04-20 2022-04-20 0000080424 pg:One800NotesDue2029Member 2022-04-20 2022-04-20 0000080424 pg:One250NotesDue2029Member 2022-04-20 2022-04-20 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 20, 2022 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP Notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On April 20, 2022, The Procter & Gamble Company (the ""Company"") issued a press release announcing its third quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated April 20, 2022. Cover Page Interactive Data File (embedded within the Inline XBRL document)",459
2022-04-20,8-K,0000080424-22-000029,"pg-20220420 0000080424 False False False False False 0000080424 2022-04-20 2022-04-20 0000080424 2022-04-20 2022-04-20 0000080424 exch:XNYS 2022-04-20 2022-04-20 0000080424 pg:A2.000due2022Domain 2022-04-20 2022-04-20 0000080424 pg:A1.125due2023Domain 2022-04-20 2022-04-20 0000080424 pg:A0.500due2024Domain 2022-04-20 2022-04-20 0000080424 pg:A0.625due2024Domain 2022-04-20 2022-04-20 0000080424 pg:A1.375due2025Domain 2022-04-20 2022-04-20 0000080424 pg:A0110Due2026Domain 2022-04-20 2022-04-20 0000080424 pg:A4.875EURdueMay2027Domain 2022-04-20 2022-04-20 0000080424 pg:A1.200due2028Domain 2022-04-20 2022-04-20 0000080424 pg:A1.250due2029Domain 2022-04-20 2022-04-20 0000080424 pg:A1.800due2029Domain 2022-04-20 2022-04-20 0000080424 pg:A6.250GBPdueJanuary2030Domain 2022-04-20 2022-04-20 0000080424 pg:A0350Due2030Domain 2022-04-20 2022-04-20 0000080424 pg:A0230Due2031Domain 2022-04-20 2022-04-20 0000080424 pg:A5.250GBPdueJanuary2033Domain 2022-04-20 2022-04-20 0000080424 pg:A1.875due2038Domain 2022-04-20 2022-04-20 0000080424 pg:A0900Due2041Domain 2022-04-20 2022-04-20 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) April 20, 2022 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio OH 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza , Cincinnati OH One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 2.000% Notes due 2022 PG22B NYSE 1.125% Notes due 2023 PG23A NYSE 0.500% Notes due 2024 PG24A NYSE 0.625% Notes due 2024 PG24B NYSE 1.375% Notes due 2025 PG25 NYSE 0.110% Notes due 2026 PG26D NYSE 4.875% EUR notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 5.250% GBP notes due January 2033 PG33 NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On April 20, 2022, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended March 31, 2022. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated April 20, 2022. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",574
2022-04-20,10-Q,0000080424-22-000035,"and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: Management's Discussion and Analysis, ",95
2022-07-12,8-K,0000080424-22-000044,"false 0000080424 0000080424 2022-07-12 2022-07-12 0000080424 pg:One250NotesDue2029Member 2022-07-12 2022-07-12 0000080424 pg:Two000NotesDue2022Member 2022-07-12 2022-07-12 0000080424 pg:Zero230NotesDue2031Member 2022-07-12 2022-07-12 0000080424 pg:Zero625NotesDue2024Member 2022-07-12 2022-07-12 0000080424 pg:Four875EURNotesDueMay2027Member 2022-07-12 2022-07-12 0000080424 pg:One200NotesDue2028Member 2022-07-12 2022-07-12 0000080424 pg:Zero900NotesDue2041Member 2022-07-12 2022-07-12 0000080424 pg:One375NotesDue2025Member 2022-07-12 2022-07-12 0000080424 pg:One875NotesDue2038Member 2022-07-12 2022-07-12 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2022-07-12 2022-07-12 0000080424 pg:Zero500NotesDue2024Member 2022-07-12 2022-07-12 0000080424 pg:Zero350NotesDue2030Member 2022-07-12 2022-07-12 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2022-07-12 2022-07-12 0000080424 pg:Zero110NotesDue2026Member 2022-07-12 2022-07-12 0000080424 pg:One800NotesDue2029Member 2022-07-12 2022-07-12 0000080424 pg:One125NotesDue2023Member 2022-07-12 2022-07-12 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 12, 2022 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR Notes due May 2027 6.250% GBP Notes due January 2030 5.250% GBP Notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On July 12, 2022, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of $0.9133 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after August 15, 2022, to Common Stock shareholders of record at the close of business on July 22, 2022, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on July 22, 2022. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Dividend News Release by The Procter & Gamble Company dated July 12, 2022. Cover Page Interactive Data File (embedded within the Inline XBRL document)",495
2022-07-29,8-K,0000080424-22-000053,"false 0000080424 0000080424 2022-07-29 2022-07-29 0000080424 pg:Zero110NotesDue2026Member 2022-07-29 2022-07-29 0000080424 pg:One875NotesDue2038Member 2022-07-29 2022-07-29 0000080424 pg:One250NotesDue2029Member 2022-07-29 2022-07-29 0000080424 pg:One200NotesDue2028Member 2022-07-29 2022-07-29 0000080424 pg:Zero625NotesDue2024Member 2022-07-29 2022-07-29 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2022-07-29 2022-07-29 0000080424 pg:Zero350NotesDue2030Member 2022-07-29 2022-07-29 0000080424 pg:Zero900NotesDue2041Member 2022-07-29 2022-07-29 0000080424 pg:One125NotesDue2023Member 2022-07-29 2022-07-29 0000080424 pg:Four875EURNotesDueMay2027Member 2022-07-29 2022-07-29 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2022-07-29 2022-07-29 0000080424 pg:One800NotesDue2029Member 2022-07-29 2022-07-29 0000080424 pg:Zero500NotesDue2024Member 2022-07-29 2022-07-29 0000080424 pg:One375NotesDue2025Member 2022-07-29 2022-07-29 0000080424 pg:Two000NotesDue2022Member 2022-07-29 2022-07-29 0000080424 pg:Zero230NotesDue2031Member 2022-07-29 2022-07-29 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 29, 2022 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On July 29, 2022, The Procter & Gamble Company (the ""Company"") issued a press release announcing its fourth quarter and fiscal year results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND Informational Slides Provided by The Procter & Gamble Company dated July 29, 2022. Cover Page Interactive Data File (embedded within the Inline XBRL document)",461
2022-07-29,8-K,0000080424-22-000051,"pg-20220729 0000080424 False 31-0411980 False 0000080424 2022-07-29 2022-07-29 0000080424 2022-07-29 2022-07-29 0000080424 exch:XNYS 2022-07-29 2022-07-29 0000080424 pg:A2.000due2022Domain 2022-07-29 2022-07-29 0000080424 pg:A1.125due2023Domain 2022-07-29 2022-07-29 0000080424 pg:A0.500due2024Domain 2022-07-29 2022-07-29 0000080424 pg:A0.625due2024Domain 2022-07-29 2022-07-29 0000080424 pg:A1.375due2025Domain 2022-07-29 2022-07-29 0000080424 pg:A0110Due2026Domain 2022-07-29 2022-07-29 0000080424 pg:A4.875EURdueMay2027Domain 2022-07-29 2022-07-29 0000080424 pg:A1.200due2028Domain 2022-07-29 2022-07-29 0000080424 pg:A1.250due2029Domain 2022-07-29 2022-07-29 0000080424 pg:A1.800due2029Domain 2022-07-29 2022-07-29 0000080424 pg:A6.250GBPdueJanuary2030Domain 2022-07-29 2022-07-29 0000080424 pg:A00350Due2030Domain 2022-07-29 2022-07-29 0000080424 pg:A00230Due2031Domain 2022-07-29 2022-07-29 0000080424 pg:A5.250GBPdueJanuary2033Domain 2022-07-29 2022-07-29 0000080424 pg:A1.875due2038Domain 2022-07-29 2022-07-29 0000080424 pg:A0900Due2041Domain 2022-07-29 2022-07-29 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) July 29, 2022 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio OH 1-434 31-0411980 (State of Incorporation) OH (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza Cincinnati OH One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 2.000% Notes due 2022 PG22B NYSE 1.125% Notes due 2023 PG23A NYSE 0.500% Notes due 2024 PG24A NYSE 0.625% Notes due 2024 PG24B NYSE 1.375% Notes due 2025 PG25 NYSE 0.110% Notes due 2026 PG26D NYSE 4.875% EUR Notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP Notes due January 2030 PG30 NYSE 0.0350% Notes due 2030 PG30C NYSE 0.0230% Notes due 2031 PG31A NYSE 5.250% GBP Notes due January 2033 PG33 NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On July 29, 2022, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter and fiscal year ended June 30, 2022. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated July 29, 2022. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",575
2022-08-05,10-K,0000080424-22-000064,"pg-20220630 0000080424 6/30 2022 FY False 2,389,553,883 392 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 exch:XNYS 2021-07-01 2022-06-30 0000080424 pg:A2000NotesDue2022Domain 2021-07-01 2022-06-30 0000080424 exch:XNYS 2021-07-01 2022-06-30 0000080424 pg:A1125NotesDue2023Domain 2021-07-01 2022-06-30 0000080424 pg:A0500NotesDue2024Domain 2021-07-01 2022-06-30 0000080424 pg:A0625NotesDue2024Domain 2021-07-01 2022-06-30 0000080424 pg:A1375NotesDue2025Domain 2021-07-01 2022-06-30 0000080424 pg:A0110NotesDue2026Domain 2021-07-01 2022-06-30 0000080424 pg:A4875EURNotesDueMay2027Domain 2021-07-01 2022-06-30 0000080424 pg:A1200NotesDue2028Domain 2021-07-01 2022-06-30 0000080424 pg:A1250NotesDue2029Domain 2021-07-01 2022-06-30 0000080424 pg:A1800NotesDue2029Domain 2021-07-01 2022-06-30 0000080424 pg:A6250GBPNotesDueJanuary2030Domain 2021-07-01 2022-06-30 0000080424 pg:A0350NotesDue2030Domain 2021-07-01 2022-06-30 0000080424 pg:A0230NotesDue2031Domain 2021-07-01 2022-06-30 0000080424 pg:A5250GBPNotesDueJanuary2033Domain 2021-07-01 2022-06-30 0000080424 pg:A1875NotesDue2038Domain 2021-07-01 2022-06-30 0000080424 pg:A0900NotesDue2041Domain 2021-07-01 2022-06-30 0000080424 2021-12-31 iso4217:USD 0000080424 2022-07-31 xbrli:shares 0000080424 2020-07-01 2021-06-30 0000080424 2019-07-01 2020-06-30 iso4217:USD xbrli:shares 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2022-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2019-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2019-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2019-07-01 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2020-07-01 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2021-07-01 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 pg:countries 0000080424 2021-07-01 2022-06-30 0000080424 srt:MinimumMember 2021-07-01 2022-06-30 0000080424 srt:MaximumMember 2021-07-01 2022-06-30 0000080424 srt:MinimumMember 2021-07-01 2022-06-30 0000080424 srt:MaximumMember 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 pg:CustomerRelationshipsBrandsandOtherNonContractualIntangibleAssetsMember srt:MinimumMember 2021-07-01 2022-06-30 0000080424 pg:CustomerRelationshipsBrandsandOtherNonContractualIntangibleAssetsMember srt:MaximumMember 2021-07-01 2022-06-30 pg:segment 0000080424 pg:FabricCareMember 2021-07-01 2022-06-30 xbrli:pure 0000080424 pg:FabricCareMember 2020-07-01 2021-06-30 0000080424 pg:FabricCareMember 2019-07-01 2020-06-30 0000080424 pg:HomeCareMember 2021-07-01 2022-06-30 0000080424 pg:HomeCareMember 2020-07-01 2021-06-30 0000080424 pg:HomeCareMember 2019-07-01 2020-06-30 0000080424 pg:BabyCareMember 2021-07-01 2022-06-30 0000080424 pg:BabyCareMember 2020-07-01 2021-06-30 0000080424 pg:BabyCareMember 2019-07-01 2020-06-30 0000080424 pg:SkinandPersonalCareMember 2021-07-01 2022-06-30 0000080424 pg:SkinandPersonalCareMember 2020-07-01 2021-06-30 0000080424 pg:SkinandPersonalCareMember 2019-07-01 2020-06-30 0000080424 pg:HairCareMember 2021-07-01 2022-06-30 0000080424 pg:HairCareMember 2020-07-01 2021-06-30 0000080424 pg:HairCareMember 2019-07-01 2020-06-30 0000080424 pg:FamilyCareMember 2021-07-01 2022-06-30 0000080424 pg:FamilyCareMember 2020-07-01 2021-06-30 0000080424 pg:FamilyCareMember 2019-07-01 2020-06-30 0000080424 pg:OralCareMember 2021-07-01 2022-06-30 0000080424 pg:OralCareMember 2020-07-01 2021-06-30 0000080424 pg:OralCareMember 2019-07-01 2020-06-30 0000080424 pg:ShaveCareMember 2021-07-01 2022-06-30 0000080424 pg:ShaveCareMember 2020-07-01 2021-06-30 0000080424 pg:ShaveCareMember 2019-07-01 2020-06-30 0000080424 pg:FeminineCareMember 2021-07-01 2022-06-30 0000080424 pg:FeminineCareMember 2020-07-01 2021-06-30 0000080424 pg:FeminineCareMember 2019-07-01 2020-06-30 0000080424 pg:PersonalHealthCareMember 2021-07-01 2022-06-30 0000080424 pg:PersonalHealthCareMember 2020-07-01 2021-06-30 0000080424 pg:PersonalHealthCareMember 2019-07-01 2020-06-30 0000080424 pg:AllOtherMember 2021-07-01 2022-06-30 0000080424 pg:AllOtherMember 2020-07-01 2021-06-30 0000080424 pg:AllOtherMember 2019-07-01 2020-06-30 0000080424 country:US 2021-07-01 2022-06-30 0000080424 country:US 2020-07-01 2021-06-30 0000080424 country:US 2019-07-01 2020-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2019-07-01 2020-06-30 0000080424 country:US 2022-06-30 0000080424 country:US 2021-06-30 0000080424 country:US 2020-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 pg:WalMartStoresIncAndAffiliatesMember 2019-07-01 2020-06-30 0000080424 pg:WalMartStoresIncAndAffiliatesMember 2020-07-01 2021-06-30 0000080424 pg:WalMartStoresIncAndAffiliatesMember 2021-07-01 2022-06-30 0000080424 pg:BeautySegmentMember 2021-07-01 2022-06-30 0000080424 pg:BeautySegmentMember 2022-06-30 0000080424 pg:BeautySegmentMember 2020-07-01 2021-06-30 0000080424 pg:BeautySegmentMember 2021-06-30 0000080424 pg:BeautySegmentMember 2019-07-01 2020-06-30 0000080424 pg:BeautySegmentMember 2020-06-30 0000080424 pg:GroomingMember 2021-07-01 2022-06-30 0000080424 pg:GroomingMember 2022-06-30 0000080424 pg:GroomingMember 2020-07-01 2021-06-30 0000080424 pg:GroomingMember 2021-06-30 0000080424 pg:GroomingMember 2019-07-01 2020-06-30 0000080424 pg:GroomingMember 2020-06-30 0000080424 pg:HealthCareSegMember 2021-07-01 2022-06-30 0000080424 pg:HealthCareSegMember 2022-06-30 0000080424 pg:HealthCareSegMember 2020-07-01 2021-06-30 0000080424 pg:HealthCareSegMember 2021-06-30 0000080424 pg:HealthCareSegMember 2019-07-01 2020-06-30 0000080424 pg:HealthCareSegMember 2020-06-30 0000080424 pg:FabricHomeCareMember 2021-07-01 2022-06-30 0000080424 pg:FabricHomeCareMember 2022-06-30 0000080424 pg:FabricHomeCareMember 2020-07-01 2021-06-30 0000080424 pg:FabricHomeCareMember 2021-06-30 0000080424 pg:FabricHomeCareMember 2019-07-01 2020-06-30 0000080424 pg:FabricHomeCareMember 2020-06-30 0000080424 pg:BabyFeminineFamilyCareMember 2021-07-01 2022-06-30 0000080424 pg:BabyFeminineFamilyCareMember 2022-06-30 0000080424 pg:BabyFeminineFamilyCareMember 2020-07-01 2021-06-30 0000080424 pg:BabyFeminineFamilyCareMember 2021-06-30 0000080424 pg:BabyFeminineFamilyCareMember 2019-07-01 2020-06-30 0000080424 pg:BabyFeminineFamilyCareMember 2020-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2022-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2021-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2020-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 srt:MinimumMember 2022-06-30 0000080424 srt:MaximumMember 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 pg:GroomingSegmentMember 2021-07-01 2022-06-30 0000080424 pg:GroomingSegmentMember 2020-07-01 2021-06-30 0000080424 pg:GroomingSegmentMember 2019-07-01 2020-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2021-07-01 2022-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2020-07-01 2021-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2019-07-01 2020-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2021-07-01 2022-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2020-07-01 2021-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2019-07-01 2020-06-30 0000080424 pg:GroomingSegmentMember 2020-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2020-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2020-06-30 0000080424 pg:GroomingSegmentMember 2021-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2021-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2021-06-30 0000080424 pg:GroomingSegmentMember 2022-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2022-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2022-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 pg:PatentsandDevelopedTechnologyMember 2022-06-30 0000080424 pg:PatentsandDevelopedTechnologyMember 2021-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 srt:MinimumMember 2021-07-01 2022-06-30 pg:audit 0000080424 srt:MaximumMember 2021-07-01 2022-06-30 0000080424 2022-07-01 2023-06-30 0000080424 pg:NetOperatingLossExpiringWithin20YearsMember srt:MinimumMember 2022-06-30 0000080424 srt:MaximumMember pg:NetOperatingLossIndefiniteLifeMember 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2019-07-01 2020-06-30 0000080424 pg:ContinuingandDiscontinuedOperationsMember 2021-07-01 2022-06-30 0000080424 pg:ContinuingandDiscontinuedOperationsMember 2020-07-01 2021-06-30 0000080424 pg:ContinuingandDiscontinuedOperationsMember 2019-07-01 2020-06-30 0000080424 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 pg:RestrictedStockRsusAndPsusMember 2022-06-30 0000080424 pg:RestrictedStockRsusAndPsusMember 2021-07-01 2022-06-30 0000080424 country:US country:US 2019-07-01 2020-06-30 0000080424 country:US country:US 2020-07-01 2021-06-30 0000080424 country:US country:US 2021-07-01 2022-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2019-07-01 2020-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 pg:CompanyStockMember 2022-06-30 0000080424 pg:CompanyStockMember 2021-06-30 0000080424 pg:CompanyStockMember 2022-06-30 0000080424 pg:CompanyStockMember 2021-06-30 0000080424 pg:CompanyPreferredStockMember 2022-06-30 0000080424 pg:CompanyPreferredStockMember 2021-06-30 0000080424 pg:CompanyPreferredStockMember 2022-06-30 0000080424 pg:CompanyPreferredStockMember 2021-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 pg:InsuranceContractsDomain 2022-06-30 0000080424 pg:InsuranceContractsDomain 2021-06-30 0000080424 pg:InsuranceContractsDomain 2022-06-30 0000080424 pg:InsuranceContractsDomain 2021-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 1989-06-30 0000080424 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 1991-06-30 0000080424 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2020-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2020-07-01 2021-06-30 0000080424 pg:A2.15USDnotedueAug2022MemberMember 2022-06-30 0000080424 pg:A2.15USDnotedueAug2022MemberMember 2021-06-30 0000080424 pg:A2.00EURnotedueAug2022Member 2022-06-30 0000080424 pg:A2.00EURnotedueAug2022Member 2021-06-30 0000080424 pg:A3.10USDnotedueAugust2023Member 2022-06-30 0000080424 pg:A3.10USDnotedueAugust2023Member 2021-06-30 0000080424 pg:A1.13EURnotedueNovember2023Member 2022-06-30 0000080424 pg:A1.13EURnotedueNovember2023Member 2021-06-30 0000080424 pg:A0.50EURnotedueOctober2024Member 2022-06-30 0000080424 pg:A0.50EURnotedueOctober2024Member 2021-06-30 0000080424 pg:A0.63EURnotedueOctober2024Member 2022-06-30 0000080424 pg:A0.63EURnotedueOctober2024Member 2021-06-30 0000080424 pg:A055USDNoteDueOctober2025Member 2022-06-30 0000080424 pg:A055USDNoteDueOctober2025Member 2021-06-30 0000080424 pg:A2.70USDnotedueFebruary2026Member 2022-06-30 0000080424 pg:A2.70USDnotedueFebruary2026Member 2021-06-30 0000080424 pg:A100USDNoteDueApril2026Member 2022-06-30 0000080424 pg:A100USDNoteDueApril2026Member 2021-06-30 0000080424 pg:A2.45USDnotedueNovember2026Member 2022-06-30 0000080424 pg:A2.45USDnotedueNovember2026Member 2021-06-30 0000080424 pg:A190USDNoteDueFebruary2027Member 2022-06-30 0000080424 pg:A190USDNoteDueFebruary2027Member 2021-06-30 0000080424 pg:A280USDNoteDueMarch2027Member 2022-06-30 0000080424 pg:A280USDNoteDueMarch2027Member 2021-06-30 0000080424 pg:A4.88EURnotedueMay2027Member 2022-06-30 0000080424 pg:A4.88EURnotedueMay2027Member 2021-06-30 0000080424 pg:A2.85USDnotedueAugust2027Member 2022-06-30 0000080424 pg:A2.85USDnotedueAugust2027Member 2021-06-30 0000080424 pg:A1.20EURnotedueOctober2028Member 2022-06-30 0000080424 pg:A1.20EURnotedueOctober2028Member 2021-06-30 0000080424 pg:A1.25EURnotedueOctober2029Member 2022-06-30 0000080424 pg:A1.25EURnotedueOctober2029Member 2021-06-30 0000080424 pg:A300USDNoteDueMarch2030Member 2022-06-30 0000080424 pg:A300USDNoteDueMarch2030Member 2021-06-30 0000080424 pg:A035EURNoteDueMay2030Member 2022-06-30 0000080424 pg:A035EURNoteDueMay2030Member 2021-06-30 0000080424 pg:A120USDNoteDueOctober2030Member 2022-06-30 0000080424 pg:A120USDNoteDueOctober2030Member 2021-06-30 0000080424 pg:A195USDNoteDueApril2031Member 2022-06-30 0000080424 pg:A195USDNoteDueApril2031Member 2021-06-30 0000080424 pg:A230USDNoteDueFebruary2032Member 2022-06-30 0000080424 pg:A230USDNoteDueFebruary2032Member 2021-06-30 0000080424 pg:A5.55USDnotedueMarch2037Member 2022-06-30 0000080424 pg:A5.55USDnotedueMarch2037Member 2021-06-30 0000080424 pg:A1.88EURnotedueOctober2038Member 2022-06-30 0000080424 pg:A1.88EURnotedueOctober2038Member 2021-06-30 0000080424 pg:A355USDNoteDueMarch2040Member 2022-06-30 0000080424 pg:A355USDNoteDueMarch2040Member 2021-06-30 0000080424 pg:A090EURNoteDueNovember2041Member 2022-06-30 0000080424 pg:A090EURNoteDueNovember2041Member 2021-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2022-06-30 0000080424 2021-06-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark one) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 TRUE For the Fiscal Year Ended June 30, 2022 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 False For the transition period from to Commission File No. 1-434 Cincinnati THE PROCTER & GAMBLE CO MPANY OH One Procter & Gamble Plaza One Procter & Gamble Plaza, Cincinnati, Ohio 45202 45202 513 Telephone (513) 983-1100 983-1100 IRS Employer Identification No. 31-0411980 31-0411980 State of Incorporation: Ohio OH Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG New York Stock Exchange 2.000% Notes due 2022 PG22B New York Stock Exchange 1.125% Notes due 2023 PG23A New York Stock Exchange 0.500% Notes due 2024 PG24A New York Stock Exchange 0.625% Notes due 2024 PG24B New York Stock Exchange 1.375% Notes due 2025 PG25 New York Stock Exchange 0.110% Notes due 2026 PG26D New York Stock Exchange 4.875% EUR Notes due May 2027 PG27A New York Stock Exchange 1.200% Notes due 2028 PG28 New York Stock Exchange 1.250% Notes due 2029 PG29B New York Stock Exchange 1.800% Notes due 2029 PG29A New York Stock Exchange 6.250% GBP Notes due January 2030 PG30 New York Stock Exchange 0.350% Notes due 2030 PG30C New York Stock Exchange 0.230% Notes due 2031 PG31A New York Stock Exchange 5.250% GBP Notes due January 2033 PG33 New York Stock Exchange 1.875% Notes due 2038 PG38 New York Stock Exchange 0.900% Notes due 2041 PG41 New York Stock Exchange Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  No o Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes o No  Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No o Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of ""large accelerated filed,"" ""accelerated filer,"" ""smaller reporting company,"" and ""emerging growth company"" in Rule 12b-2 of the Exchange Act. Large accelerated filer  Accelerated filer  Non-accelerated filer  Smaller reporting company  FALSE Emerging growth company  FALSE If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No  False Indicate by check mark whether the registrant has filed a report on and attestation to its managements assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the",1872
2022-10-11,8-K,0000080424-22-000074,"false 0000080424 0000080424 2022-10-11 2022-10-11 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2022-10-11 2022-10-11 0000080424 pg:One125NotesDue2023Member 2022-10-11 2022-10-11 0000080424 pg:Zero900NotesDue2041Member 2022-10-11 2022-10-11 0000080424 pg:Zero230NotesDue2031Member 2022-10-11 2022-10-11 0000080424 pg:Four875EURNotesDueMay2027Member 2022-10-11 2022-10-11 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2022-10-11 2022-10-11 0000080424 pg:Zero625NotesDue2024Member 2022-10-11 2022-10-11 0000080424 pg:Zero110NotesDue2026Member 2022-10-11 2022-10-11 0000080424 pg:One250NotesDue2029Member 2022-10-11 2022-10-11 0000080424 pg:One375NotesDue2025Member 2022-10-11 2022-10-11 0000080424 pg:One800NotesDue2029Member 2022-10-11 2022-10-11 0000080424 pg:Zero350NotesDue2030Member 2022-10-11 2022-10-11 0000080424 pg:One875NotesDue2038Member 2022-10-11 2022-10-11 0000080424 pg:Zero500NotesDue2024Member 2022-10-11 2022-10-11 0000080424 pg:One200NotesDue2028Member 2022-10-11 2022-10-11 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 11, 2022 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock Without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On October 11, 2022, The Procter & Gamble Company (the Company) issued a news release announcing that, according to preliminary voting results, Rajesh Subramaniam, President and Chief Executive Officer of FedEx Corporation, and the Companys ten incumbent Director nominees were elected to the Companys Board of Directors at the Annual Meeting of Shareholders. In addition, the Company announced that its Board of Directors declared a quarterly dividend of $0.9133 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after November 15, 2022, to Common Stock shareholders of record at the close of business on October 21, 2022, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on October 21, 2022. A copy of this news release is furnished as Exhibit 99.1. The Company is furnishing the information under this item, including Exhibit 99.1, pursuant to Item 7.01, ""Regulation FD Disclosure. ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS News Release by The Procter & Gamble Company dated October 11, 2022. Cover Page Interactive Data File (embedded within the Inline XBRL document)",553
2022-10-14,8-K,0000080424-22-000086,"false 0000080424 0000080424 2022-10-14 2022-10-14 0000080424 pg:Zero350NotesDue2030Member 2022-10-14 2022-10-14 0000080424 pg:Zero900NotesDue2041Member 2022-10-14 2022-10-14 0000080424 pg:One200NotesDue2028Member 2022-10-14 2022-10-14 0000080424 pg:One125NotesDue2023Member 2022-10-14 2022-10-14 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2022-10-14 2022-10-14 0000080424 pg:Zero500NotesDue2024Member 2022-10-14 2022-10-14 0000080424 pg:Four875EURNotesDueMay2027Member 2022-10-14 2022-10-14 0000080424 pg:One875NotesDue2038Member 2022-10-14 2022-10-14 0000080424 pg:Zero230NotesDue2031Member 2022-10-14 2022-10-14 0000080424 pg:Zero625NotesDue2024Member 2022-10-14 2022-10-14 0000080424 pg:One375NotesDue2025Member 2022-10-14 2022-10-14 0000080424 pg:One800NotesDue2029Member 2022-10-14 2022-10-14 0000080424 pg:One250NotesDue2029Member 2022-10-14 2022-10-14 0000080424 pg:Zero110NotesDue2026Member 2022-10-14 2022-10-14 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2022-10-14 2022-10-14 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 14, 2022 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Submission of Matters to a Vote of Security Holders On October 11, 2022, The Procter & Gamble Company (the Company), held its 2022 Annual Meeting of Shareholders. Set forth below are the final voting results for each of the proposals submitted to a vote of the shareholders. Each of the following nominees was elected to serve a one-year term on the Companys Board of Directors. Proposal 2- Ratify Appointment of the Independent Registered Public Accounting Firm . The proposal was approved. Proposal 3 - Advisory Vote to Approve the Companys Executive Compensation (the Say on Pay vote) . The proposal was approved. The Company is filing this Form 8-K pursuant to Item 5.07, ""Submission of Matters to a Vote of Security Holders.""",472
2022-10-19,10-Q,0000080424-22-000102,"and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: Management's Discussion and Analysis, ",95
2022-10-19,8-K,0000080424-22-000099,"false 0000080424 0000080424 2022-10-19 2022-10-19 0000080424 pg:Zero110NotesDue2026Member 2022-10-19 2022-10-19 0000080424 pg:One200NotesDue2028Member 2022-10-19 2022-10-19 0000080424 pg:One375NotesDue2025Member 2022-10-19 2022-10-19 0000080424 pg:Zero350NotesDue2030Member 2022-10-19 2022-10-19 0000080424 pg:One250NotesDue2029Member 2022-10-19 2022-10-19 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2022-10-19 2022-10-19 0000080424 pg:One875NotesDue2038Member 2022-10-19 2022-10-19 0000080424 pg:Zero500NotesDue2024Member 2022-10-19 2022-10-19 0000080424 pg:Zero230NotesDue2031Member 2022-10-19 2022-10-19 0000080424 pg:One125NotesDue2023Member 2022-10-19 2022-10-19 0000080424 pg:One800NotesDue2029Member 2022-10-19 2022-10-19 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2022-10-19 2022-10-19 0000080424 pg:Zero625NotesDue2024Member 2022-10-19 2022-10-19 0000080424 pg:Four875EURNotesDueMay2027Member 2022-10-19 2022-10-19 0000080424 pg:Zero900NotesDue2041Member 2022-10-19 2022-10-19 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 19, 2022 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On October 19, 2022, The Procter & Gamble Company (the ""Company"") issued a press release announcing its first quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND Informational Slides Provided by The Procter & Gamble Company dated October 19, 2022. Cover Page Interactive Data File (embedded within the Inline XBRL document)",454
2022-10-19,8-K,0000080424-22-000097,"pg-20221019 0000080424 False False False False False 0000080424 2022-10-19 2022-10-19 0000080424 2022-10-19 2022-10-19 0000080424 exch:XNYS 2022-10-19 2022-10-19 0000080424 pg:A1.125due2023Domain 2022-10-19 2022-10-19 0000080424 pg:A0.500due2024Domain 2022-10-19 2022-10-19 0000080424 pg:A0.625due2024Domain 2022-10-19 2022-10-19 0000080424 pg:A1.375due2025Domain 2022-10-19 2022-10-19 0000080424 pg:A0110Due2026Domain 2022-10-19 2022-10-19 0000080424 pg:A4.875EURdueMay2027Domain 2022-10-19 2022-10-19 0000080424 pg:A1.200due2028Domain 2022-10-19 2022-10-19 0000080424 pg:A1.250due2029Domain 2022-10-19 2022-10-19 0000080424 pg:A1.800due2029Domain 2022-10-19 2022-10-19 0000080424 pg:A6.250GBPdueJanuary2030Domain 2022-10-19 2022-10-19 0000080424 pg:A0350Due2030Domain 2022-10-19 2022-10-19 0000080424 pg:A0230Due2031Domain 2022-10-19 2022-10-19 0000080424 pg:A5.250GBPdueJanuary2033Domain 2022-10-19 2022-10-19 0000080424 pg:A1.875due2038Domain 2022-10-19 2022-10-19 0000080424 pg:A0900Due2041Domain 2022-10-19 2022-10-19 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) October 19, 2022 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio OH 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza , Cincinnati OH One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 1.125% Notes due 2023 PG23A NYSE 0.500% Notes due 2024 PG24A NYSE 0.625% Notes due 2024 PG24B NYSE 1.375% Notes due 2025 PG25 NYSE 0.110% Notes due 2026 PG26D NYSE 4.875% EUR notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 5.250% GBP notes due January 2033 PG33 NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On October 19, 2022, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended September 30, 2022. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated October 19, 2022. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",564
2022-12-13,8-K,0000080424-22-000109,"false 06-30 0000080424 0000080424 2022-12-13 2022-12-13 0000080424 pg:Four875EURNotesDueMay2027Member 2022-12-13 2022-12-13 0000080424 pg:Zero230NotesDue2031Member 2022-12-13 2022-12-13 0000080424 pg:One200NotesDue2028Member 2022-12-13 2022-12-13 0000080424 pg:One875NotesDue2038Member 2022-12-13 2022-12-13 0000080424 pg:Zero500NotesDue2024Member 2022-12-13 2022-12-13 0000080424 pg:One125NotesDue2023Member 2022-12-13 2022-12-13 0000080424 pg:One800NotesDue2029Member 2022-12-13 2022-12-13 0000080424 pg:Zero350NotesDue2030Member 2022-12-13 2022-12-13 0000080424 pg:Zero110NotesDue2026Member 2022-12-13 2022-12-13 0000080424 pg:Zero900NotesDue2041Member 2022-12-13 2022-12-13 0000080424 pg:One250NotesDue2029Member 2022-12-13 2022-12-13 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2022-12-13 2022-12-13 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2022-12-13 2022-12-13 0000080424 pg:One375NotesDue2025Member 2022-12-13 2022-12-13 0000080424 pg:Zero625NotesDue2024Member 2022-12-13 2022-12-13 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 13, 2022 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.03 AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR On December 13, 2022, the Board of Directors of The Procter & Gamble Company (the Company) amended the Companys Code of Regulations (the Regulations), effective immediately. The amendments, which are included in Article I, Section 8, address certain procedural and disclosure requirements in connection with shareholder nominations of directors and solicitation of proxies, including compliance with Rule 14a-19 under the Securities Exchange Act of 1934, as amended. Specifically, the amendments require that any shareholder submitting a nomination notice make a representation as to whether such shareholder intends to solicit proxies in support of director nominees other than the Companys nominees in accordance with Rule 14a-19 and further require that such shareholder comply with the requirements of Rule 14a-19, including providing reasonable evidence of such compliance to the Company. The foregoing description of the Regulations is qualified in its entirety by reference to the full text of the Code of Regulations of The Procter & Gamble Company, which are filed as Exhibit 3.2 to this Form 8-K and hereby incorporated by reference. The Company is filing this 8-K pursuant to Item 5.03, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. ITEM 9.01 FINANCIAL STATEMENTS AND Regulations (as approved by the Board of Directors on December 13, 2022, pursuant to authority granted by shareholders at the annual meeting on October 13, 2009) Cover Page Interactive Data File (embedded within the Inline XBRL document)",603
2023-01-10,8-K,0000080424-23-000003,"false 0000080424 NYSE NYSE NYSE NYSE NYSE NYSE NYSE NYSE NYSE NYSE NYSE NYSE NYSE NYSE NYSE NYSE 0000080424 2023-01-10 2023-01-10 0000080424 pg:One250NotesDue2029Member 2023-01-10 2023-01-10 0000080424 pg:One200NotesDue2028Member 2023-01-10 2023-01-10 0000080424 pg:Zero110NotesDue2026Member 2023-01-10 2023-01-10 0000080424 pg:One375NotesDue2025Member 2023-01-10 2023-01-10 0000080424 pg:Zero350NotesDue2030Member 2023-01-10 2023-01-10 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2023-01-10 2023-01-10 0000080424 pg:One125NotesDue2023Member 2023-01-10 2023-01-10 0000080424 pg:Zero900NotesDue2041Member 2023-01-10 2023-01-10 0000080424 pg:Four875EURNotesDueMay2027Member 2023-01-10 2023-01-10 0000080424 pg:Zero625NotesDue2024Member 2023-01-10 2023-01-10 0000080424 pg:One800NotesDue2029Member 2023-01-10 2023-01-10 0000080424 pg:One875NotesDue2038Member 2023-01-10 2023-01-10 0000080424 pg:Zero500NotesDue2024Member 2023-01-10 2023-01-10 0000080424 pg:Zero230NotesDue2031Member 2023-01-10 2023-01-10 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2023-01-10 2023-01-10 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 10, 2023 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On January 10, 2023, The Procter & Gamble Company (the Company) announced that its Board of Directors declared a quarterly dividend of $0.9133 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after February 15, 2023, to Common Stock shareholders of record at the close of business on January 20, 2023, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on January 20, 2023. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure. ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS News Release by The Procter & Gamble Company dated January 10, 2023. Cover Page Interactive Data File (embedded within the Inline XBRL document)",502
2023-01-19,8-K,0000080424-23-000010,"false 0000080424 NYSE NYSE NYSE NYSE NYSE NYSE NYSE NYSE NYSE NYSE NYSE NYSE NYSE NYSE NYSE NYSE 0000080424 2023-01-19 2023-01-19 0000080424 pg:Zero350NotesDue2030Member 2023-01-19 2023-01-19 0000080424 pg:One875NotesDue2038Member 2023-01-19 2023-01-19 0000080424 pg:One375NotesDue2025Member 2023-01-19 2023-01-19 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2023-01-19 2023-01-19 0000080424 pg:Zero625NotesDue2024Member 2023-01-19 2023-01-19 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2023-01-19 2023-01-19 0000080424 pg:One800NotesDue2029Member 2023-01-19 2023-01-19 0000080424 pg:One200NotesDue2028Member 2023-01-19 2023-01-19 0000080424 pg:One250NotesDue2029Member 2023-01-19 2023-01-19 0000080424 pg:Zero500NotesDue2024Member 2023-01-19 2023-01-19 0000080424 pg:One125NotesDue2023Member 2023-01-19 2023-01-19 0000080424 pg:Zero230NotesDue2031Member 2023-01-19 2023-01-19 0000080424 pg:Zero110NotesDue2026Member 2023-01-19 2023-01-19 0000080424 pg:Zero900NotesDue2041Member 2023-01-19 2023-01-19 0000080424 pg:Four875EURNotesDueMay2027Member 2023-01-19 2023-01-19 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 19, 2023 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On January 19, 2023, The Procter & Gamble Company (the ""Company"") issued a press release announcing its second quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND Informational Slides Provided by The Procter & Gamble Company dated January 19, 2023. Cover Page Interactive Data File (embedded within the Inline XBRL document)",470
2023-01-19,8-K,0000080424-23-000008,"pg-20230119 0000080424 False False False False False 0000080424 2023-01-19 2023-01-19 0000080424 2023-01-19 2023-01-19 0000080424 exch:XNYS 2023-01-19 2023-01-19 0000080424 pg:A1.125due2023Domain 2023-01-19 2023-01-19 0000080424 pg:A0.500due2024Domain 2023-01-19 2023-01-19 0000080424 pg:A0.625due2024Domain 2023-01-19 2023-01-19 0000080424 pg:A1.375due2025Domain 2023-01-19 2023-01-19 0000080424 pg:A0110Due2026Domain 2023-01-19 2023-01-19 0000080424 pg:A4.875EURdueMay2027Domain 2023-01-19 2023-01-19 0000080424 pg:A1.200due2028Domain 2023-01-19 2023-01-19 0000080424 pg:A1.250due2029Domain 2023-01-19 2023-01-19 0000080424 pg:A1.800due2029Domain 2023-01-19 2023-01-19 0000080424 pg:A6.250GBPdueJanuary2030Domain 2023-01-19 2023-01-19 0000080424 pg:A0350Due2030Domain 2023-01-19 2023-01-19 0000080424 pg:A0230Due2031Domain 2023-01-19 2023-01-19 0000080424 pg:A5.250GBPdueJanuary2033Domain 2023-01-19 2023-01-19 0000080424 pg:A1.875due2038Domain 2023-01-19 2023-01-19 0000080424 pg:A0900Due2041Domain 2023-01-19 2023-01-19 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) January 19, 2023 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio OH 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza , Cincinnati OH One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 1.125% Notes due 2023 PG23A NYSE 0.500% Notes due 2024 PG24A NYSE 0.625% Notes due 2024 PG24B NYSE 1.375% Notes due 2025 PG25 NYSE 0.110% Notes due 2026 PG26D NYSE 4.875% EUR notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 5.250% GBP notes due January 2033 PG33 NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 19, 2023 , The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended December 31, 2022. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated January 19, 2023 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",566
2023-01-19,10-Q,0000080424-23-000014,"and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: Management's Discussion and Analysis, ",95
2023-01-26,8-K,0001193125-23-016270,"THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) 513 - 983-1100 Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Other Events. On January 26, 2023, The Procter & Gamble Company (the Company) closed an underwritten public offering of $650,000,000 aggregate principal amount of 4.100% Notes due January 26, 2026, $600,000,000 aggregate principal amount of 3.950% Notes due January 26, 2028 and $850,000,000 aggregate principal amount of 4.050% Notes due January 26, 2033 under the Companys Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are",357
2023-02-03,8-K,0001193125-23-024268,"THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) 513 - 983-1100 Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Other Events. On February 3, 2023, The Procter & Gamble Company (the Company) closed an underwritten public offering of $482,886,000 aggregate principal amount of Floating Rate Notes due February 3, 2073 under the Companys Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are",335
2023-04-11,8-K,0000080424-23-000027,"false 0000080424 0000080424 2023-04-11 2023-04-11 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2023-04-11 2023-04-11 0000080424 pg:One200NotesDue2028Member 2023-04-11 2023-04-11 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2023-04-11 2023-04-11 0000080424 pg:One250NotesDue2029Member 2023-04-11 2023-04-11 0000080424 pg:Zero350NotesDue2030Member 2023-04-11 2023-04-11 0000080424 pg:Zero230NotesDue2031Member 2023-04-11 2023-04-11 0000080424 pg:One375NotesDue2025Member 2023-04-11 2023-04-11 0000080424 pg:Zero500NotesDue2024Member 2023-04-11 2023-04-11 0000080424 pg:Zero110NotesDue2026Member 2023-04-11 2023-04-11 0000080424 pg:One125NotesDue2023Member 2023-04-11 2023-04-11 0000080424 pg:Zero900NotesDue2041Member 2023-04-11 2023-04-11 0000080424 pg:Four875EURNotesDueMay2027Member 2023-04-11 2023-04-11 0000080424 pg:Zero625NotesDue2024Member 2023-04-11 2023-04-11 0000080424 pg:One875NotesDue2038Member 2023-04-11 2023-04-11 0000080424 pg:One800NotesDue2029Member 2023-04-11 2023-04-11 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 11, 2023 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN On April 11, 2023, the Board of Directors of The Procter & Gamble Company (the Company) appointed Sheila Bonini, Senior Vice President  Private Sector Engagement for World Wildlife Fund, Inc., and Robert Portman, former United States Senator, as Directors of the Company, effective April 11, 2023. Ms. Bonini will serve on the Governance & Public Responsibility and Innovation & Technology Committees. Mr. Portman will serve on the Audit and Governance & Public Responsibility Committees. The Board has determined that Ms. Bonini and Mr. Portman are each independent under the NYSE listing standards and the Companys Independence Guidelines. Ms. Bonini and Mr. Portman will each receive the same compensation as the other non-employee members of the Board of Directors. The Companys Director compensation program is described in the Companys definitive proxy statement dated August 26, 2022. In connection with the appointment of Ms. Bonini, the Board of Directors reviewed and approved the Companys continued financial contributions to the World Wildlife Fund, Inc. (WWF-US) under the Companys Related Person Transactions Policy. By virtue of her role at WWF-US, prior to her appointment as a Director, Ms. Bonini was involved in the discussion of the Companys contributions to and partnership with WWF-US in support of various sustainability efforts and programs, although Ms. Bonini did not receive special benefits from the Companys contributions. The Company has worked with and contributed to WWF-US since 2013. In its current fiscal year, the Company expects to contribute a total of approximately $550,000 to WWF-US under several partnership agreements. Upon her appointment as a Director of the Company, Ms. Bonini is no longer involved in and no longer has direct or indirect responsibility for WWF-USs relationship with the Company, and she will not be involved in the negotiation of any future partnership terms or payments for as long as she remains a Director. In approving the Companys continued contributions and partnership, the Board considered the Companys long-standing support of WWF-US, the significant value to the Company of external partnerships with organizations focused on sustainability efforts, and the fact that, going forward, Ms. Bonini would not be involved in the Companys financial relationship with WWF-US. Ultimately, the Board concluded that the partnership contributions were not inconsistent with the best interests of the Company as a whole. The Company is filing the information under this item pursuant to Item 5.02(d), Election of Directors. ITEM 7.01 REGULATION FD DISCLOSURE The Company issued a news release on April 11, 2023, announcing the appointments of Ms. Bonini and Mr. Portman. A copy of this news release is furnished as Exhibit The Company is furnishing the information under this item, including Exhibit 99.1, pursuant to Item 7.01, Regulation FD Disclosure. ITEM 9.01 FINANCIAL STATEMENTS AND Director News Release by The Procter & Gamble Company dated April 11, 2023. Cover Page Interactive Data File (embedded within the Inline XBRL document)",841
2023-04-11,8-K,0000080424-23-000026,"false 0000080424 0000080424 2023-04-11 2023-04-11 0000080424 pg:One250NotesDue2029Member 2023-04-11 2023-04-11 0000080424 pg:Zero900NotesDue2041Member 2023-04-11 2023-04-11 0000080424 pg:Zero625NotesDue2024Member 2023-04-11 2023-04-11 0000080424 pg:One875NotesDue2038Member 2023-04-11 2023-04-11 0000080424 pg:Four875EURNotesDueMay2027Member 2023-04-11 2023-04-11 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2023-04-11 2023-04-11 0000080424 pg:One800NotesDue2029Member 2023-04-11 2023-04-11 0000080424 pg:Zero500NotesDue2024Member 2023-04-11 2023-04-11 0000080424 pg:One375NotesDue2025Member 2023-04-11 2023-04-11 0000080424 pg:One200NotesDue2028Member 2023-04-11 2023-04-11 0000080424 pg:One125NotesDue2023Member 2023-04-11 2023-04-11 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2023-04-11 2023-04-11 0000080424 pg:Zero350NotesDue2030Member 2023-04-11 2023-04-11 0000080424 pg:Zero110NotesDue2026Member 2023-04-11 2023-04-11 0000080424 pg:Zero230NotesDue2031Member 2023-04-11 2023-04-11 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 11, 2023 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On April 11, 2023, The Procter & Gamble Company (the Company) announced that its Board of Directors declared a quarterly dividend of $0.9407 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after May 15, 2023, to Common Stock shareholders of record at the close of business on April 21, 2023, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on April 21, 2023. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure. ITEM 9.01 FINANCIAL STATEMENTS AND Dividend News Release by The Procter & Gamble Company dated April 11, 2023. Cover Page Interactive Data File (embedded within the Inline XBRL document)",486
2023-04-21,10-Q,0000080424-23-000046,"and Analysis of Financial Condition and Results of Operations Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: Management's Discussion and Analysis, ",95
2023-04-21,8-K,0000080424-23-000039,"pg-20230421 0000080424 False False False False False 0000080424 2023-04-21 2023-04-21 0000080424 2023-04-21 2023-04-21 0000080424 exch:XNYS 2023-04-21 2023-04-21 0000080424 pg:A1.125due2023Domain 2023-04-21 2023-04-21 0000080424 pg:A0.500due2024Domain 2023-04-21 2023-04-21 0000080424 pg:A0.625due2024Domain 2023-04-21 2023-04-21 0000080424 pg:A1.375due2025Domain 2023-04-21 2023-04-21 0000080424 pg:A0110Due2026Domain 2023-04-21 2023-04-21 0000080424 pg:A4.875EURdueMay2027Domain 2023-04-21 2023-04-21 0000080424 pg:A1.200due2028Domain 2023-04-21 2023-04-21 0000080424 pg:A1.250due2029Domain 2023-04-21 2023-04-21 0000080424 pg:A1.800due2029Domain 2023-04-21 2023-04-21 0000080424 pg:A6.250GBPdueJanuary2030Domain 2023-04-21 2023-04-21 0000080424 pg:A0350Due2030Domain 2023-04-21 2023-04-21 0000080424 pg:A0230Due2031Domain 2023-04-21 2023-04-21 0000080424 pg:A5.250GBPdueJanuary2033Domain 2023-04-21 2023-04-21 0000080424 pg:A1.875due2038Domain 2023-04-21 2023-04-21 0000080424 pg:A0900Due2041Domain 2023-04-21 2023-04-21 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) April 21, 2023 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio OH 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza , Cincinnati OH One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 1.125% Notes due 2023 PG23A NYSE 0.500% Notes due 2024 PG24A NYSE 0.625% Notes due 2024 PG24B NYSE 1.375% Notes due 2025 PG25 NYSE 0.110% Notes due 2026 PG26D NYSE 4.875% EUR notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 5.250% GBP notes due January 2033 PG33 NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On April 21, 2023 , The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended March 31, 2023. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated April 21, 2023 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",566
2023-04-21,8-K,0000080424-23-000043,"false 0000080424 0000080424 2023-04-21 2023-04-21 0000080424 pg:One125NotesDue2023Member 2023-04-21 2023-04-21 0000080424 pg:One250NotesDue2029Member 2023-04-21 2023-04-21 0000080424 pg:One875NotesDue2038Member 2023-04-21 2023-04-21 0000080424 pg:Zero900NotesDue2041Member 2023-04-21 2023-04-21 0000080424 pg:Zero110NotesDue2026Member 2023-04-21 2023-04-21 0000080424 pg:One800NotesDue2029Member 2023-04-21 2023-04-21 0000080424 pg:One200NotesDue2028Member 2023-04-21 2023-04-21 0000080424 pg:One375NotesDue2025Member 2023-04-21 2023-04-21 0000080424 pg:Zero350NotesDue2030Member 2023-04-21 2023-04-21 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2023-04-21 2023-04-21 0000080424 pg:Zero230NotesDue2031Member 2023-04-21 2023-04-21 0000080424 pg:Zero625NotesDue2024Member 2023-04-21 2023-04-21 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2023-04-21 2023-04-21 0000080424 pg:Four875EURNotesDueMay2027Member 2023-04-21 2023-04-21 0000080424 pg:Zero500NotesDue2024Member 2023-04-21 2023-04-21 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 21, 2023 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On April 21, 2023, The Procter & Gamble Company (the ""Company"") issued a press release announcing its third quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND Informational Slides Provided by The Procter & Gamble Company dated April 21, 2023. Cover Page Interactive Data File (embedded within the Inline XBRL document)",454
2023-05-02,8-K,0001193125-23-132560,"THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) 513 - 983-1100 Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Other Events. On May 2, 2023, The Procter & Gamble Company (the Company) closed an underwritten public offering of 650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2026 and 650,000,000 aggregate principal amount of 3.250% Notes due August 2, 2031 under the Companys Registration Statement on Form S-3 (Registration No. 333-249545). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are",346
2023-07-11,8-K,0000080424-23-000056,"false 0000080424 0000080424 2023-07-11 2023-07-11 0000080424 pg:Zero110NotesDue2026Member 2023-07-11 2023-07-11 0000080424 pg:One200NotesDue2028Member 2023-07-11 2023-07-11 0000080424 pg:Zero625NotesDue2024Member 2023-07-11 2023-07-11 0000080424 pg:Zero500NotesDue2024Member 2023-07-11 2023-07-11 0000080424 pg:One250NotesDue2029Member 2023-07-11 2023-07-11 0000080424 pg:Zero230NotesDue2031Member 2023-07-11 2023-07-11 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2023-07-11 2023-07-11 0000080424 pg:One125NotesDue2023Member 2023-07-11 2023-07-11 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2023-07-11 2023-07-11 0000080424 pg:One875NotesDue2038Member 2023-07-11 2023-07-11 0000080424 pg:One375NotesDue2025Member 2023-07-11 2023-07-11 0000080424 pg:Four875EURNotesDueMay2027Member 2023-07-11 2023-07-11 0000080424 pg:Zero325NotesDue2031Member 2023-07-11 2023-07-11 0000080424 pg:Zero350NotesDue2030Member 2023-07-11 2023-07-11 0000080424 pg:Zero325NotesDue2026Member 2023-07-11 2023-07-11 0000080424 pg:Zero900NotesDue2041Member 2023-07-11 2023-07-11 0000080424 pg:One800NotesDue2029Member 2023-07-11 2023-07-11 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 11, 2023 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On July 11, 2023, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of $0.9407 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after August 15, 2023, to Common Stock shareholders of record at the close of business on July 21, 2023, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on July 21, 2023. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Dividend News Release by The Procter & Gamble Company dated July 11, 2023. Cover Page Interactive Data File (embedded within the Inline XBRL document)",497
2023-07-28,8-K,0000080424-23-000059,"pg-20230728 0000080424 False 31-0411980 False 0000080424 2023-07-28 2023-07-28 0000080424 2023-07-28 2023-07-28 0000080424 exch:XNYS 2023-07-28 2023-07-28 0000080424 pg:A1.125due2023Domain 2023-07-28 2023-07-28 0000080424 pg:A0.500due2024Domain 2023-07-28 2023-07-28 0000080424 pg:A0.625due2024Domain 2023-07-28 2023-07-28 0000080424 pg:A1.375due2025Domain 2023-07-28 2023-07-28 0000080424 pg:A0110Due2026Domain 2023-07-28 2023-07-28 0000080424 pg:A3250EURDue2026Domain 2023-07-28 2023-07-28 0000080424 pg:A4.875EURdueMay2027Domain 2023-07-28 2023-07-28 0000080424 pg:A1.200due2028Domain 2023-07-28 2023-07-28 0000080424 pg:A1.250due2029Domain 2023-07-28 2023-07-28 0000080424 pg:A1.800due2029Domain 2023-07-28 2023-07-28 0000080424 pg:A6.250GBPdueJanuary2030Domain 2023-07-28 2023-07-28 0000080424 pg:A0350Due2030Domain 2023-07-28 2023-07-28 0000080424 pg:A0230Due2031Domain 2023-07-28 2023-07-28 0000080424 pg:A3250EURDue2031Domain 2023-07-28 2023-07-28 0000080424 pg:A5.250GBPdueJanuary2033Domain 2023-07-28 2023-07-28 0000080424 pg:A1.875due2038Domain 2023-07-28 2023-07-28 0000080424 pg:A0900Due2041Domain 2023-07-28 2023-07-28 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) July 28, 2023 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio OH 1-434 31-0411980 (State of Incorporation) OH (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza Cincinnati OH One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 1.125% Notes due 2023 PG23A NYSE 0.500% Notes due 2024 PG24A NYSE 0.625% Notes due 2024 PG24B NYSE 1.375% Notes due 2025 PG25 NYSE 0.110% Notes due 2026 PG26D NYSE 3.250% EUR Notes due 2026 PG26E NYSE 4.875% EUR Notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP Notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 3.250% EUR Notes due 2031 PG31B NYSE 5.250% GBP Notes due January 2033 PG33 NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On July 28, 2023, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter and fiscal year ended June 30, 2023. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated July 28, 2023. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",587
2023-07-28,8-K,0000080424-23-000061,"false 0000080424 0000080424 2023-07-28 2023-07-28 0000080424 pg:Three25NotesDue2031Member 2023-07-28 2023-07-28 0000080424 pg:One800NotesDue2029Member 2023-07-28 2023-07-28 0000080424 pg:Three25NotesDue2026Member 2023-07-28 2023-07-28 0000080424 pg:One250NotesDue2029Member 2023-07-28 2023-07-28 0000080424 pg:Zero110NotesDue2026Member 2023-07-28 2023-07-28 0000080424 pg:Zero230NotesDue2031Member 2023-07-28 2023-07-28 0000080424 pg:One125NotesDue2023Member 2023-07-28 2023-07-28 0000080424 pg:One375NotesDue2025Member 2023-07-28 2023-07-28 0000080424 pg:Zero625NotesDue2024Member 2023-07-28 2023-07-28 0000080424 pg:One875NotesDue2038Member 2023-07-28 2023-07-28 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2023-07-28 2023-07-28 0000080424 pg:Zero900NotesDue2041Member 2023-07-28 2023-07-28 0000080424 pg:One200NotesDue2028Member 2023-07-28 2023-07-28 0000080424 pg:Zero350NotesDue2030Member 2023-07-28 2023-07-28 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2023-07-28 2023-07-28 0000080424 pg:Zero500NotesDue2024Member 2023-07-28 2023-07-28 0000080424 pg:Four875EURNotesDueMay2027Member 2023-07-28 2023-07-28 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 28, 2023 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On July 28, 2023, The Procter & Gamble Company (the ""Company"") issued a press release announcing its fourth quarter and fiscal year results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated July 28, 2023. Cover Page Interactive Data File (embedded within the Inline XBRL document)",459
2023-08-04,10-K,0000080424-23-000073,"pg-20230630 0000080424 6/30 2023 FY False 2,357,306,187 357 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 exch:XNYS 2022-07-01 2023-06-30 0000080424 pg:A1125NotesDue2023Domain 2022-07-01 2023-06-30 0000080424 exch:XNYS 2022-07-01 2023-06-30 0000080424 pg:A0500NotesDue2024Domain 2022-07-01 2023-06-30 0000080424 pg:A0625NotesDue2024Domain 2022-07-01 2023-06-30 0000080424 pg:A1375NotesDue2025Domain 2022-07-01 2023-06-30 0000080424 pg:A0110NotesDue2026Domain 2022-07-01 2023-06-30 0000080424 pg:A3250EURNotesDue2026Domain 2022-07-01 2023-06-30 0000080424 pg:A4875EURNotesDueMay2027Domain 2022-07-01 2023-06-30 0000080424 pg:A1200NotesDue2028Domain 2022-07-01 2023-06-30 0000080424 pg:A1250NotesDue2029Domain 2022-07-01 2023-06-30 0000080424 pg:A1800NotesDue2029Domain 2022-07-01 2023-06-30 0000080424 pg:A6250GBPNotesDueJanuary2030Domain 2022-07-01 2023-06-30 0000080424 pg:A0350NotesDue2030Domain 2022-07-01 2023-06-30 0000080424 pg:A0230NotesDue2031Domain 2022-07-01 2023-06-30 0000080424 pg:A3250EURNotesDue2031Domain 2022-07-01 2023-06-30 0000080424 pg:A5250GBPNotesDueJanuary2033Domain 2022-07-01 2023-06-30 0000080424 pg:A1875NotesDue2038Domain 2022-07-01 2023-06-30 0000080424 pg:A0900NotesDue2041Domain 2022-07-01 2023-06-30 0000080424 2022-12-31 iso4217:USD 0000080424 2023-07-31 xbrli:shares 0000080424 2021-07-01 2022-06-30 0000080424 2020-07-01 2021-06-30 iso4217:USD xbrli:shares 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2023-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2020-07-01 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2021-07-01 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2022-07-01 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 pg:countries 0000080424 2022-07-01 2023-06-30 0000080424 srt:MinimumMember 2022-07-01 2023-06-30 0000080424 srt:MaximumMember 2022-07-01 2023-06-30 0000080424 srt:MinimumMember 2022-07-01 2023-06-30 0000080424 srt:MaximumMember 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 pg:CustomerRelationshipsBrandsandOtherNonContractualIntangibleAssetsMember srt:MinimumMember 2022-07-01 2023-06-30 0000080424 srt:MaximumMember pg:CustomerRelationshipsBrandsandOtherNonContractualIntangibleAssetsMember 2022-07-01 2023-06-30 pg:segment 0000080424 pg:FabricCareMember 2022-07-01 2023-06-30 xbrli:pure 0000080424 pg:FabricCareMember 2021-07-01 2022-06-30 0000080424 pg:FabricCareMember 2020-07-01 2021-06-30 0000080424 pg:HomeCareMember 2022-07-01 2023-06-30 0000080424 pg:HomeCareMember 2021-07-01 2022-06-30 0000080424 pg:HomeCareMember 2020-07-01 2021-06-30 0000080424 pg:BabyCareMember 2022-07-01 2023-06-30 0000080424 pg:BabyCareMember 2021-07-01 2022-06-30 0000080424 pg:BabyCareMember 2020-07-01 2021-06-30 0000080424 pg:SkinandPersonalCareMember 2022-07-01 2023-06-30 0000080424 pg:SkinandPersonalCareMember 2021-07-01 2022-06-30 0000080424 pg:SkinandPersonalCareMember 2020-07-01 2021-06-30 0000080424 pg:HairCareMember 2022-07-01 2023-06-30 0000080424 pg:HairCareMember 2021-07-01 2022-06-30 0000080424 pg:HairCareMember 2020-07-01 2021-06-30 0000080424 pg:FamilyCareMember 2022-07-01 2023-06-30 0000080424 pg:FamilyCareMember 2021-07-01 2022-06-30 0000080424 pg:FamilyCareMember 2020-07-01 2021-06-30 0000080424 pg:GroomingMember 2022-07-01 2023-06-30 0000080424 pg:GroomingMember 2021-07-01 2022-06-30 0000080424 pg:GroomingMember 2020-07-01 2021-06-30 0000080424 pg:OralCareMember 2022-07-01 2023-06-30 0000080424 pg:OralCareMember 2021-07-01 2022-06-30 0000080424 pg:OralCareMember 2020-07-01 2021-06-30 0000080424 pg:FeminineCareMember 2022-07-01 2023-06-30 0000080424 pg:FeminineCareMember 2021-07-01 2022-06-30 0000080424 pg:FeminineCareMember 2020-07-01 2021-06-30 0000080424 pg:PersonalHealthCareMember 2022-07-01 2023-06-30 0000080424 pg:PersonalHealthCareMember 2021-07-01 2022-06-30 0000080424 pg:PersonalHealthCareMember 2020-07-01 2021-06-30 0000080424 pg:AllOtherMember 2022-07-01 2023-06-30 0000080424 pg:AllOtherMember 2021-07-01 2022-06-30 0000080424 pg:AllOtherMember 2020-07-01 2021-06-30 0000080424 country:US 2022-07-01 2023-06-30 0000080424 country:US 2021-07-01 2022-06-30 0000080424 country:US 2020-07-01 2021-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2020-07-01 2021-06-30 0000080424 country:US 2023-06-30 0000080424 country:US 2022-06-30 0000080424 country:US 2021-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 pg:WalMartStoresIncAndAffiliatesMember 2022-07-01 2023-06-30 0000080424 pg:WalMartStoresIncAndAffiliatesMember 2021-07-01 2022-06-30 0000080424 pg:WalMartStoresIncAndAffiliatesMember 2020-07-01 2021-06-30 0000080424 pg:BeautySegmentMember 2022-07-01 2023-06-30 0000080424 pg:BeautySegmentMember 2023-06-30 0000080424 pg:BeautySegmentMember 2021-07-01 2022-06-30 0000080424 pg:BeautySegmentMember 2022-06-30 0000080424 pg:BeautySegmentMember 2020-07-01 2021-06-30 0000080424 pg:BeautySegmentMember 2021-06-30 0000080424 pg:GroomingMember 2022-07-01 2023-06-30 0000080424 pg:GroomingMember 2023-06-30 0000080424 pg:GroomingMember 2021-07-01 2022-06-30 0000080424 pg:GroomingMember 2022-06-30 0000080424 pg:GroomingMember 2020-07-01 2021-06-30 0000080424 pg:GroomingMember 2021-06-30 0000080424 pg:HealthCareSegMember 2022-07-01 2023-06-30 0000080424 pg:HealthCareSegMember 2023-06-30 0000080424 pg:HealthCareSegMember 2021-07-01 2022-06-30 0000080424 pg:HealthCareSegMember 2022-06-30 0000080424 pg:HealthCareSegMember 2020-07-01 2021-06-30 0000080424 pg:HealthCareSegMember 2021-06-30 0000080424 pg:FabricHomeCareMember 2022-07-01 2023-06-30 0000080424 pg:FabricHomeCareMember 2023-06-30 0000080424 pg:FabricHomeCareMember 2021-07-01 2022-06-30 0000080424 pg:FabricHomeCareMember 2022-06-30 0000080424 pg:FabricHomeCareMember 2020-07-01 2021-06-30 0000080424 pg:FabricHomeCareMember 2021-06-30 0000080424 pg:BabyFeminineFamilyCareMember 2022-07-01 2023-06-30 0000080424 pg:BabyFeminineFamilyCareMember 2023-06-30 0000080424 pg:BabyFeminineFamilyCareMember 2021-07-01 2022-06-30 0000080424 pg:BabyFeminineFamilyCareMember 2022-06-30 0000080424 pg:BabyFeminineFamilyCareMember 2020-07-01 2021-06-30 0000080424 pg:BabyFeminineFamilyCareMember 2021-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2023-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2022-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2021-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 srt:MinimumMember 2023-06-30 0000080424 srt:MaximumMember 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 pg:GroomingSegmentMember 2022-07-01 2023-06-30 0000080424 pg:GroomingSegmentMember 2021-07-01 2022-06-30 0000080424 pg:GroomingSegmentMember 2020-07-01 2021-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2022-07-01 2023-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2021-07-01 2022-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2020-07-01 2021-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2022-07-01 2023-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2021-07-01 2022-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2020-07-01 2021-06-30 0000080424 pg:GroomingSegmentMember 2021-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2021-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2021-06-30 0000080424 pg:GroomingSegmentMember 2022-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2022-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2022-06-30 0000080424 pg:GroomingSegmentMember 2023-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2023-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2023-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 pg:PatentsandDevelopedTechnologyMember 2023-06-30 0000080424 pg:PatentsandDevelopedTechnologyMember 2022-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 srt:MinimumMember 2022-07-01 2023-06-30 pg:audit 0000080424 srt:MaximumMember 2022-07-01 2023-06-30 0000080424 2023-07-01 2024-06-30 0000080424 pg:NetOperatingLossExpiringWithin20YearsMember srt:MinimumMember 2023-06-30 0000080424 srt:MaximumMember pg:NetOperatingLossIndefiniteLifeMember 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2020-07-01 2021-06-30 0000080424 pg:ContinuingandDiscontinuedOperationsMember 2022-07-01 2023-06-30 0000080424 pg:ContinuingandDiscontinuedOperationsMember 2021-07-01 2022-06-30 0000080424 pg:ContinuingandDiscontinuedOperationsMember 2020-07-01 2021-06-30 0000080424 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 pg:RestrictedStockRsusAndPsusMember 2023-06-30 0000080424 pg:RestrictedStockRsusAndPsusMember 2022-07-01 2023-06-30 0000080424 country:US country:US 2022-07-01 2023-06-30 0000080424 country:US country:US 2021-07-01 2022-06-30 0000080424 country:US country:US 2020-07-01 2021-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2020-07-01 2021-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 pg:CompanyStockMember 2023-06-30 0000080424 pg:CompanyStockMember 2022-06-30 0000080424 pg:CompanyStockMember 2023-06-30 0000080424 pg:CompanyStockMember 2022-06-30 0000080424 pg:CompanyPreferredStockMember 2023-06-30 0000080424 pg:CompanyPreferredStockMember 2022-06-30 0000080424 pg:CompanyPreferredStockMember 2023-06-30 0000080424 pg:CompanyPreferredStockMember 2022-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 pg:InsuranceContractsDomain 2023-06-30 0000080424 pg:InsuranceContractsDomain 2022-06-30 0000080424 pg:InsuranceContractsDomain 2023-06-30 0000080424 pg:InsuranceContractsDomain 2022-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 1989-06-30 0000080424 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 1991-06-30 0000080424 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2021-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2021-07-01 2022-06-30 0000080424 pg:A3.10USDnotedueAugust2023Member 2023-06-30 0000080424 pg:A3.10USDnotedueAugust2023Member 2022-06-30 0000080424 pg:A1.13EURnotedueNovember2023Member 2023-06-30 0000080424 pg:A1.13EURnotedueNovember2023Member 2022-06-30 0000080424 pg:A0.50EURnotedueOctober2024Member 2023-06-30 0000080424 pg:A0.50EURnotedueOctober2024Member 2022-06-30 0000080424 pg:A063EURNoteDueOctober2024Member 2023-06-30 0000080424 pg:A063EURNoteDueOctober2024Member 2022-06-30 0000080424 pg:A055USDNoteDueOctober2025Member 2023-06-30 0000080424 pg:A055USDNoteDueOctober2025Member 2022-06-30 0000080424 pg:A410USDNoteDueJanuary2026Member 2023-06-30 0000080424 pg:A410USDNoteDueJanuary2026Member 2022-06-30 0000080424 pg:A270USDNoteDueFebruary2026Member 2023-06-30 0000080424 pg:A270USDNoteDueFebruary2026Member 2022-06-30 0000080424 pg:A100USDNoteDueApril2026Member 2023-06-30 0000080424 pg:A100USDNoteDueApril2026Member 2022-06-30 0000080424 pg:A325EURNoteDueAugust2026Member 2023-06-30 0000080424 pg:A325EURNoteDueAugust2026Member 2022-06-30 0000080424 pg:A2.45USDnotedueNovember2026Member 2023-06-30 0000080424 pg:A2.45USDnotedueNovember2026Member 2022-06-30 0000080424 pg:A190USDNoteDueFebruary2027Member 2023-06-30 0000080424 pg:A190USDNoteDueFebruary2027Member 2022-06-30 0000080424 pg:A280USDNoteDueMarch2027Member 2023-06-30 0000080424 pg:A280USDNoteDueMarch2027Member 2022-06-30 0000080424 pg:A4.88EURnotedueMay2027Member 2023-06-30 0000080424 pg:A4.88EURnotedueMay2027Member 2022-06-30 0000080424 pg:A2.85USDnotedueAugust2027Member 2023-06-30 0000080424 pg:A2.85USDnotedueAugust2027Member 2022-06-30 0000080424 pg:A395USDNoteDueJanuary2028Member 2023-06-30 0000080424 pg:A395USDNoteDueJanuary2028Member 2022-06-30 0000080424 pg:A1.20EURnotedueOctober2028Member 2023-06-30 0000080424 pg:A1.20EURnotedueOctober2028Member 2022-06-30 0000080424 pg:A1.25EURnotedueOctober2029Member 2023-06-30 0000080424 pg:A1.25EURnotedueOctober2029Member 2022-06-30 0000080424 pg:A300USDNoteDueMarch2030Member 2023-06-30 0000080424 pg:A300USDNoteDueMarch2030Member 2022-06-30 0000080424 pg:A035EURNoteDueMay2030Member 2023-06-30 0000080424 pg:A035EURNoteDueMay2030Member 2022-06-30 0000080424 pg:A120USDNoteDueOctober2030Member 2023-06-30 0000080424 pg:A120USDNoteDueOctober2030Member 2022-06-30 0000080424 pg:A195USDNoteDueApril2031Member 2023-06-30 0000080424 pg:A195USDNoteDueApril2031Member 2022-06-30 0000080424 pg:A325EURNoteDueAugust2031Member 2023-06-30 0000080424 pg:A325EURNoteDueAugust2031Member 2022-06-30 0000080424 pg:A230USDNoteDueFebruary2032Member 2023-06-30 0000080424 pg:A230USDNoteDueFebruary2032Member 2022-06-30 0000080424 pg:A405USDNoteDueJanuary2033Member 2023-06-30 0000080424 pg:A405USDNoteDueJanuary2033Member 2022-06-30 0000080424 pg:A5.55USDnotedueMarch2037Member 2023-06-30 0000080424 pg:A5.55USDnotedueMarch2037Member 2022-06-30 0000080424 pg:A1.88EURnotedueOctober2038Member 2023-06-30 0000080424 pg:A1.88EURnotedueOctober2038Member 2022-06-30 0000080424 pg:A355USDNoteDueMarch2040Member 2023-06-30 0000080424 pg:A355USDNoteDueMarch2040Member 2022-06-30 0000080424 pg:A090EURNoteDueNovember2041Member 2023-06-30 0000080424 pg:A090EURNoteDueNovember2041Member 2022-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2022-07-01 2023-06-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark one) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 TRUE For the Fiscal Year Ended June 30, 2023 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 False For the transition period from to Commission File No. 1-434 Cincinnati THE PROCTER & GAMBLE CO MPANY OH One Procter & Gamble Plaza One Procter & Gamble Plaza, Cincinnati, Ohio 45202 45202 513 Telephone (513) 983-1100 983-1100 IRS Employer Identification No. 31-0411980 31-0411980 State of Incorporation: Ohio OH Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG New York Stock Exchange 1.125% Notes due 2023 PG23A New York Stock Exchange 0.500% Notes due 2024 PG24A New York Stock Exchange 0.625% Notes due 2024 PG24B New York Stock Exchange 1.375% Notes due 2025 PG25 New York Stock Exchange 0.110% Notes due 2026 PG26D New York Stock Exchange 3.250% EUR Notes due 2026 PG26E New York Stock Exchange 4.875% EUR Notes due May 2027 PG27A New York Stock Exchange 1.200% Notes due 2028 PG28 New York Stock Exchange 1.250% Notes due 2029 PG29B New York Stock Exchange 1.800% Notes due 2029 PG29A New York Stock Exchange 6.250% GBP Notes due January 2030 PG30 New York Stock Exchange 0.350% Notes due 2030 PG30C New York Stock Exchange 0.230% Notes due 2031 PG31A New York Stock Exchange 3.250% EUR Notes due 2031 PG31B New York Stock Exchange 5.250% GBP Notes due January 2033 PG33 New York Stock Exchange 1.875% Notes due 2038 PG38 New York Stock Exchange 0.900% Notes due 2041 PG41 New York Stock Exchange Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  No o Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes o No  Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No o Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of ""large accelerated filed,"" ""accelerated filer,"" ""smaller reporting company,"" and ""emerging growth company"" in Rule 12b-2 of the Exchange Act. Large accelerated filer  Accelerated filer  Emerging growth company  Non-accelerated filer  Smaller reporting company  FALSE FALSE If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Indicate by check mark whether the registrant has filed a report on and attestation to its managements assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the",1864
2023-10-10,8-K,0000080424-23-000088,"false 0000080424 NYSE 0000080424 2023-10-10 2023-10-10 0000080424 pg:One125NotesDue2023Member 2023-10-10 2023-10-10 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2023-10-10 2023-10-10 0000080424 pg:One200NotesDue2028Member 2023-10-10 2023-10-10 0000080424 pg:Zero500NotesDue2024Member 2023-10-10 2023-10-10 0000080424 pg:One875NotesDue2038Member 2023-10-10 2023-10-10 0000080424 pg:One800NotesDue2029Member 2023-10-10 2023-10-10 0000080424 pg:Four875EURNotesDueMay2027Member 2023-10-10 2023-10-10 0000080424 pg:Three25NotesDue2031Member 2023-10-10 2023-10-10 0000080424 pg:Zero110NotesDue2026Member 2023-10-10 2023-10-10 0000080424 pg:One375NotesDue2025Member 2023-10-10 2023-10-10 0000080424 pg:Zero625NotesDue2024Member 2023-10-10 2023-10-10 0000080424 pg:Zero230NotesDue2031Member 2023-10-10 2023-10-10 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2023-10-10 2023-10-10 0000080424 pg:One250NotesDue2029Member 2023-10-10 2023-10-10 0000080424 pg:Zero350NotesDue2030Member 2023-10-10 2023-10-10 0000080424 pg:Zero900NotesDue2041Member 2023-10-10 2023-10-10 0000080424 pg:Three25EURNotesDue2026Member 2023-10-10 2023-10-10 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 10, 2023 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On October 10, 2023, The Procter & Gamble Company (the Company) issued a news release announcing that, according to preliminary voting results, Brett Biggs, former Executive Vice President and Chief Financial Officer of Walmart, Inc, and the Companys thirteen incumbent Director nominees were elected to the Companys Board of Directors at the Annual Meeting of Shareholders. In addition, the Company announced that its Board of Directors declared a quarterly dividend of $0.9407 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after November 15, 2023, to Common Stock shareholders of record at the close of business on October 20, 2023, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on October 20, 2023. A copy of this news release is furnished as Exhibit 99.1. The Company is furnishing the information under this item, including Exhibit 99.1, pursuant to Item 7.01, ""Regulation FD Disclosure. ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS News Release by The Procter & Gamble Company dated October 10, 2023. Cover Page Interactive Data File (embedded within the Inline XBRL document)",565
2023-10-13,8-K,0000080424-23-000090,"false 0000080424 0000080424 2023-10-13 2023-10-13 0000080424 pg:Zero350NotesDue2030Member 2023-10-13 2023-10-13 0000080424 pg:One250NotesDue2029Member 2023-10-13 2023-10-13 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2023-10-13 2023-10-13 0000080424 pg:Three25NotesDue2026Member 2023-10-13 2023-10-13 0000080424 pg:One800NotesDue2029Member 2023-10-13 2023-10-13 0000080424 pg:One125NotesDue2023Member 2023-10-13 2023-10-13 0000080424 pg:One200NotesDue2028Member 2023-10-13 2023-10-13 0000080424 pg:Three25NotesDue2031Member 2023-10-13 2023-10-13 0000080424 pg:Zero900NotesDue2041Member 2023-10-13 2023-10-13 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2023-10-13 2023-10-13 0000080424 pg:One375NotesDue2025Member 2023-10-13 2023-10-13 0000080424 pg:Zero230NotesDue2031Member 2023-10-13 2023-10-13 0000080424 pg:Four875EURNotesDueMay2027Member 2023-10-13 2023-10-13 0000080424 pg:One875NotesDue2038Member 2023-10-13 2023-10-13 0000080424 pg:Zero500NotesDue2024Member 2023-10-13 2023-10-13 0000080424 pg:Zero110NotesDue2026Member 2023-10-13 2023-10-13 0000080424 pg:Zero625NotesDue2024Member 2023-10-13 2023-10-13 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 13, 2023 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.07. Submission of Matters to a Vote of Security Holders On October 10, 2023, The Procter & Gamble Company (the Company), held its 2023 Annual Meeting of Shareholders. Set forth below are the final voting results for each of the proposals submitted to a vote of the shareholders. Proposal 1  Election of Directors. Each of the following nominees was elected to serve a one-year term on the Companys Board of Directors (the Board). Proposal 2- Ratify Appointment of the Independent Registered Public Accounting Firm. The proposal was approved. Proposal 3 - Advisory Vote to Approve the Companys Executive Compensation (the Say on Pay vote). The proposal was approved. Proposal 4 - Advisory Vote to Approve the Frequency of the Executive Compensation Vote (the Say on Frequency vote). The frequency 1 Year received the highest number of votes. The Board considered the results of the advisory vote and decided that, consistent with the Boards recommendation in the proxy statement for the 2023 Annual Meeting, the Company will continue to solicit an advisory vote on executive compensation annually until the next required advisory vote on the frequency of future advisory votes on executive compensation. Proposal 5 - Shareholder Proposal - Civil Rights Audit of Reverse Discrimination The proposal was not approved. Proposal 6 - Shareholder Proposal  Annual Report on Operations in China The proposal was not approved. Proposal 7 - Shareholder Proposal  Request to Require Shareholder Approval for Certain Future Amendments to Company Regulations The proposal was not approved. The Company is filing this Form 8-K pursuant to Item 5.07, ""Submission of Matters to a Vote of Security Holders.""",627
2023-10-18,10-Q,0000080424-23-000103,and Analysis of Financial Condition and Results of Operations 11 Item 3. Quantitative and Qualitative Disclosures About Market Risk 16 Item 4. Controls and Procedures 16 PART II Item 1. Legal Proceedings 16 Item 1A.,35
2023-10-18,8-K,0000080424-23-000094,"pg-20231018 0000080424 False False False False False 0000080424 2023-10-18 2023-10-18 0000080424 2023-10-18 2023-10-18 0000080424 exch:XNYS 2023-10-18 2023-10-18 0000080424 pg:A1.125due2023Domain 2023-10-18 2023-10-18 0000080424 pg:A0.500due2024Domain 2023-10-18 2023-10-18 0000080424 pg:A0.625due2024Domain 2023-10-18 2023-10-18 0000080424 pg:A1.375due2025Domain 2023-10-18 2023-10-18 0000080424 pg:A0110Due2026Domain 2023-10-18 2023-10-18 0000080424 pg:A3250EURNotesDue2026Domain 2023-10-18 2023-10-18 0000080424 pg:A4.875EURdueMay2027Domain 2023-10-18 2023-10-18 0000080424 pg:A1.200due2028Domain 2023-10-18 2023-10-18 0000080424 pg:A1.250due2029Domain 2023-10-18 2023-10-18 0000080424 pg:A1.800due2029Domain 2023-10-18 2023-10-18 0000080424 pg:A6.250GBPdueJanuary2030Domain 2023-10-18 2023-10-18 0000080424 pg:A0350Due2030Domain 2023-10-18 2023-10-18 0000080424 pg:A0230Due2031Domain 2023-10-18 2023-10-18 0000080424 pg:A3250EURNotesDue2031Domain 2023-10-18 2023-10-18 0000080424 pg:A5.250GBPdueJanuary2033Domain 2023-10-18 2023-10-18 0000080424 pg:A1.875due2038Domain 2023-10-18 2023-10-18 0000080424 pg:A0900Due2041Domain 2023-10-18 2023-10-18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) October 18, 2023 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio OH 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza , Cincinnati OH One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 1.125% Notes due 2023 PG23A NYSE 0.500% Notes due 2024 PG24A NYSE 0.625% Notes due 2024 PG24B NYSE 1.375% Notes due 2025 PG25 NYSE 0.110% Notes due 2026 PG26D NYSE 3.250% EUR Notes due 2026 PG26E NYSE 4.875% EUR notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 3.250% EUR Notes due 2031 PG31B NYSE 5.250% GBP notes due January 2033 PG33 NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On October 18, 2023 , The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended September 30, 2023. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated October 18, 2023 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",588
2023-10-18,8-K,0000080424-23-000096,"false 0000080424 0000080424 2023-10-18 2023-10-18 0000080424 pg:One250NotesDue2029Member 2023-10-18 2023-10-18 0000080424 pg:Four875EURNotesDueMay2027Member 2023-10-18 2023-10-18 0000080424 pg:Zero625NotesDue2024Member 2023-10-18 2023-10-18 0000080424 pg:Zero230NotesDue2031Member 2023-10-18 2023-10-18 0000080424 pg:One125NotesDue2023Member 2023-10-18 2023-10-18 0000080424 pg:One875NotesDue2038Member 2023-10-18 2023-10-18 0000080424 pg:Zero110NotesDue2026Member 2023-10-18 2023-10-18 0000080424 pg:Three25NotesDue2026Member 2023-10-18 2023-10-18 0000080424 pg:Zero500NotesDue2024Member 2023-10-18 2023-10-18 0000080424 pg:Three25NotesDue2031Member 2023-10-18 2023-10-18 0000080424 pg:Zero350NotesDue2030Member 2023-10-18 2023-10-18 0000080424 pg:Zero900NotesDue2041Member 2023-10-18 2023-10-18 0000080424 pg:One200NotesDue2028Member 2023-10-18 2023-10-18 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2023-10-18 2023-10-18 0000080424 pg:One375NotesDue2025Member 2023-10-18 2023-10-18 0000080424 pg:One800NotesDue2029Member 2023-10-18 2023-10-18 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2023-10-18 2023-10-18 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 18, 2023 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On October 18, 2023, The Procter & Gamble Company (the ""Company"") issued a press release announcing its first quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated October 18, 2023. Cover Page Interactive Data File (embedded within the Inline XBRL document)",456
2023-11-01,8-K,0001193125-23-268205,"THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) 513 - 983-1100 Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Other Events. On November 1, 2023, The Procter & Gamble Company (the Company) closed an underwritten public offering of $256,534,000 aggregate principal amount of Floating Rate Notes due November 1, 2073 under the Companys Registration Statement on Form S-3 (Registration No. 333-275071). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are",335
2023-12-05,8-K,0000080424-23-000107,"false 0000080424 0000080424 2023-12-05 2023-12-05 0000080424 pg:One375NotesDue2025Member 2023-12-05 2023-12-05 0000080424 pg:Three25NotesDue2026Member 2023-12-05 2023-12-05 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2023-12-05 2023-12-05 0000080424 pg:One200NotesDue2028Member 2023-12-05 2023-12-05 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2023-12-05 2023-12-05 0000080424 pg:Zero110NotesDue2026Member 2023-12-05 2023-12-05 0000080424 pg:One875NotesDue2038Member 2023-12-05 2023-12-05 0000080424 pg:Three25NotesDue2031Member 2023-12-05 2023-12-05 0000080424 pg:Zero625NotesDue2024Member 2023-12-05 2023-12-05 0000080424 pg:Zero230NotesDue2031Member 2023-12-05 2023-12-05 0000080424 pg:Four875EURNotesDueMay2027Member 2023-12-05 2023-12-05 0000080424 pg:One800NotesDue2029Member 2023-12-05 2023-12-05 0000080424 pg:One250NotesDue2029Member 2023-12-05 2023-12-05 0000080424 pg:Zero500NotesDue2024Member 2023-12-05 2023-12-05 0000080424 pg:Zero350NotesDue2030Member 2023-12-05 2023-12-05 0000080424 pg:Zero900NotesDue2041Member 2023-12-05 2023-12-05 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 5, 2023 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 7.01 Regulation FD Disclosure The Procter & Gamble Company (the Company) announced today a limited market portfolio restructuring of its business operations, primarily in certain Enterprise Markets, including Argentina and Nigeria, to address challenging macroeconomic and fiscal conditions. In connection with this announcement, the Company expects to record incremental restructuring charges of $1.0 to 1.5 billion after tax, including foreign currency translation losses to be recognized upon the substantial liquidation of operations in the affected markets. The Company estimates the large majority of these charges will be noncash. Although the timing of the completion of this restructuring program has yet to be determined, the Company currently anticipates that these restructuring charges will be recognized in the fiscal years ending June 30, 2024 and 2025, with initial charges recognized in the quarter ending December 31, 2023. Combining the restructuring program with an impairment charge described further below, the Company anticipates total charges of approximately $2.0 billion to $2.5 billion after tax over the periods described. The Company estimates a large majority of these charges will be noncash. These charges will be reported as non-core charges. The Company is furnishing the information under this item pursuant to Item 7.01, Regulation FD Disclosure. Item 2.06 Material Impairments In connection with the restructuring program discussed above, on December 1, 2023, the Company concluded it will record an approximately $1.3 billion before tax ($1.0 billion after tax) noncash impairment charge in the quarter ending December 31, 2023, on intangible assets acquired as part of the Companys 2005 acquisition of The Gillette Company. The impairment charge arises from a reduction in the estimated fair value of the Gillette indefinite-lived intangible asset due to a higher discount rate, weakening of several currencies relative to the U.S. dollar and the impact of the restructuring program described above. This impairment charge adjusts the carrying value of the Gillette indefinite-lived intangible asset to fair value. Underlying performance of the Gillette business remains strong. However, future adverse changes in the business or macroeconomic environment may trigger a further impairment charge. The Company is filing the information under this item pursuant to Item 2.06, Material Impairments. Forward-Looking Statements Certain statements in this current report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words believe, project, expect, anticipate, estimate, intend, strategy, future, opportunity, plan, may, should, will, would, will be, will continue, will likely result and similar expressions. Forward-looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, except to the extent required by law. Risks and uncertainties to which our forward-looking statements are subject include, without limitation: (1) the ability to successfully manage global financial risks, including foreign currency fluctuations, currency exchange or pricing controls and localized volatility; (2) the ability to successfully manage local, regional or global economic volatility, including reduced market growth rates, and to generate sufficient income and cash flow to allow the Company to effect the expected share repurchases and dividend payments; (3) the ability to manage disruptions in credit markets or to our banking partners or changes to our credit rating; (4) the ability to maintain key manufacturing and supply arrangements (including execution of supply chain optimizations and sole supplier and sole manufacturing plant arrangements) and to manage disruption of business due to various factors, including ones outside of our control, such as natural disasters, acts of war (including the Russia-Ukraine War) or terrorism or disease outbreaks; (5) the ability to successfully manage cost fluctuations and pressures, including prices of commodities and raw materials and costs of labor, transportation, energy, pension and healthcare; (6) the ability to stay on the leading edge of innovation, obtain necessary intellectual property protections and successfully respond to changing consumer habits, evolving digital marketing and selling platform requirements and technological advances attained by, and patents granted to, competitors; (7) the ability to compete with our local and global competitors in new and existing sales channels, including by successfully responding to competitive factors such as prices, promotional incentives and trade terms for products; (8) the ability to manage and maintain key customer relationships; (9) the ability to protect our reputation and brand equity by successfully managing real or perceived issues, including concerns about safety, quality, ingredients, efficacy, packaging content, supply chain practices or similar matters that may arise; (10) the ability to successfully manage the financial, legal, reputational and operational risk associated with third-party relationships, such as our suppliers, contract manufacturers, distributors, contractors and external business partners; (11) the ability to rely on and maintain key company and third-party information and operational technology systems, networks and services and maintain the security and functionality of such systems, networks and services and the data contained therein; (12) the ability to successfully manage uncertainties related to changing political and geopolitical conditions and potential implications such as exchange rate fluctuations and market contraction; (13) the ability to successfully manage current and expanding regulatory and legal requirements and matters (including, without limitation, those laws and regulations involving product liability, product and packaging composition, intellectual property, labor and employment, antitrust, privacy and data protection, tax, the environment, due diligence, risk oversight, accounting and financial reporting) and to resolve new and pending matters within current estimates; (14) the ability to manage changes in applicable tax laws and regulations; (15) the ability to successfully manage our ongoing acquisition, divestiture and joint venture activities, in each case to achieve the Companys overall business strategy and financial objectives, without impacting the delivery of base business objectives; (16) the ability to successfully achieve productivity improvements and cost savings and manage ongoing organizational changes while successfully identifying, developing and retaining key employees, including in key growth markets where the availability of skilled or experienced employees may be limited; (17) the ability to successfully manage the demand, supply and operational challenges, as well as governmental responses or mandates, associated with a disease outbreak, including epidemics, pandemics or similar widespread public health concerns; (18) the ability to manage the uncertainties, sanctions and economic effects from the war between Russia and Ukraine; and (19) the ability to successfully achieve our ambition of reducing our greenhouse gas emissions and delivering progress towards our environmental sustainability priorities. For additional information concerning factors that could cause actual results and events to differ materially from those projected herein, please refer to our most recent 10-K, 10-Q and 8-K reports.",1506
2023-12-13,8-K,0000080424-23-000114,"false 0000080424 0000080424 2023-12-13 2023-12-13 0000080424 pg:One375NotesDue2025Member 2023-12-13 2023-12-13 0000080424 pg:One200NotesDue2028Member 2023-12-13 2023-12-13 0000080424 pg:Zero500NotesDue2024Member 2023-12-13 2023-12-13 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2023-12-13 2023-12-13 0000080424 pg:Zero900NotesDue2041Member 2023-12-13 2023-12-13 0000080424 pg:Four875EURNotesDueMay2027Member 2023-12-13 2023-12-13 0000080424 pg:One800NotesDue2029Member 2023-12-13 2023-12-13 0000080424 pg:Three25EURNotesDue2026Member 2023-12-13 2023-12-13 0000080424 pg:Zero110NotesDue2026Member 2023-12-13 2023-12-13 0000080424 pg:Zero625NotesDue2024Member 2023-12-13 2023-12-13 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2023-12-13 2023-12-13 0000080424 pg:Zero230NotesDue2031Member 2023-12-13 2023-12-13 0000080424 pg:One250NotesDue2029Member 2023-12-13 2023-12-13 0000080424 pg:One875NotesDue2038Member 2023-12-13 2023-12-13 0000080424 pg:Three25EURNotesDue2031Member 2023-12-13 2023-12-13 0000080424 pg:Zero350NotesDue2030Member 2023-12-13 2023-12-13 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 13, 2023 (December 12, 2023) THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. On December 12, 2023, the Board of Directors of The Procter & Gamble Company (the Company) appointed Ashley McEvoy, former Executive Vice President, Worldwide Chairman of MedTech at Johnson & Johnson, as a Director of the Company, effective December 12. Ms. McEvoy will serve on the Compensation & Leadership Development and Innovation & Technology Committees. The Board has determined that Ms. McEvoy is independent under the NYSE listing standards and the Companys Independence Guidelines. Ms. McEvoy will receive the same compensation as the other non-employee members of the Board of Directors, including a pro-rated annual RSU grant that reflects her December appointment date. The Companys Director compensation program is described in the Companys definitive proxy statement dated August 25, 2023. The Company is filing the information under this item pursuant to Item 5.02(d), Election of Directors. ITEM 7.01 REGULATION FD DISCLOSURE The Company issued a news release on December 13, 2023, announcing the appointment of Ms. McEvoy. A copy of this news release is furnished as Exhibit 99.1. The Company is furnishing the information under this item, including Exhibit 99.1, pursuant to Item 7.01, Regulation FD Disclosure. ITEM 9.01 FINANCIAL STATEMENTS Director News Release by The Procter & Gamble Company dated December 13, 2023. Cover Page Interactive Data File (embedded within the Inline XBRL document)",592
2024-01-09,8-K,0000080424-24-000004,"false 0000080424 0000080424 2024-01-09 2024-01-09 0000080424 pg:Zero110NotesDue2026Member 2024-01-09 2024-01-09 0000080424 pg:One800NotesDue2029Member 2024-01-09 2024-01-09 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2024-01-09 2024-01-09 0000080424 pg:One875NotesDue2038Member 2024-01-09 2024-01-09 0000080424 pg:One200NotesDue2028Member 2024-01-09 2024-01-09 0000080424 pg:One375NotesDue2025Member 2024-01-09 2024-01-09 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2024-01-09 2024-01-09 0000080424 pg:Three25EURNotesDue2031Member 2024-01-09 2024-01-09 0000080424 pg:Zero230NotesDue2031Member 2024-01-09 2024-01-09 0000080424 pg:Zero500NotesDue2024Member 2024-01-09 2024-01-09 0000080424 pg:One250NotesDue2029Member 2024-01-09 2024-01-09 0000080424 pg:Three25EURNotesDue2026Member 2024-01-09 2024-01-09 0000080424 pg:Four875EURNotesDueMay2027Member 2024-01-09 2024-01-09 0000080424 pg:Zero625NotesDue2024Member 2024-01-09 2024-01-09 0000080424 pg:Zero350NotesDue2030Member 2024-01-09 2024-01-09 0000080424 pg:Zero900NotesDue2041Member 2024-01-09 2024-01-09 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 9, 2024 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On January 9, 2024, The Procter & Gamble Company (the Company) announced that its Board of Directors declared a quarterly dividend of $0.9407 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after February 15, 2024, to Common Stock shareholders of record at the close of business on January 19, 2024, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on January 19, 2024. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure. ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS News Release by The Procter & Gamble Company dated January 9, 2024. Cover Page Interactive Data File (embedded within the Inline XBRL document)",490
2024-01-23,10-Q,0000080424-24-000018,and Analysis of Financial Condition and Results of Operations 13 Item 3. Quantitative and Qualitative Disclosures About Market Risk 29 Item 4. Controls and Procedures 29 PART II Item 1. Legal Proceedings 29 Item 1A.,35
2024-01-23,8-K,0000080424-24-000015,"false 0000080424 0000080424 2024-01-23 2024-01-23 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2024-01-23 2024-01-23 0000080424 pg:Zero900NotesDue2041Member 2024-01-23 2024-01-23 0000080424 pg:Three25EURNotesDue2026Member 2024-01-23 2024-01-23 0000080424 pg:One800NotesDue2029Member 2024-01-23 2024-01-23 0000080424 pg:Zero500NotesDue2024Member 2024-01-23 2024-01-23 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2024-01-23 2024-01-23 0000080424 pg:Three25EURNotesDue2031Member 2024-01-23 2024-01-23 0000080424 pg:One200NotesDue2028Member 2024-01-23 2024-01-23 0000080424 pg:Zero230NotesDue2031Member 2024-01-23 2024-01-23 0000080424 pg:Four875EURNotesDueMay2027Member 2024-01-23 2024-01-23 0000080424 pg:Zero110NotesDue2026Member 2024-01-23 2024-01-23 0000080424 pg:Zero625NotesDue2024Member 2024-01-23 2024-01-23 0000080424 pg:One375NotesDue2025Member 2024-01-23 2024-01-23 0000080424 pg:One250NotesDue2029Member 2024-01-23 2024-01-23 0000080424 pg:Zero350NotesDue2030Member 2024-01-23 2024-01-23 0000080424 pg:One875NotesDue2038Member 2024-01-23 2024-01-23 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 23, 2024 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On January 23, 2024, The Procter & Gamble Company (the ""Company"") issued a press release announcing its second quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND Informational Slides Provided by The Procter & Gamble Company dated January 23, 2024 Cover Page Interactive Data File (embedded within the Inline XBRL document)",453
2024-01-23,8-K,0000080424-24-000013,"pg-20240123 0000080424 False False False False False 0000080424 2024-01-23 2024-01-23 0000080424 2024-01-23 2024-01-23 0000080424 exch:XNYS 2024-01-23 2024-01-23 0000080424 pg:A0.500due2024Domain 2024-01-23 2024-01-23 0000080424 pg:A0.625due2024Domain 2024-01-23 2024-01-23 0000080424 pg:A1.375due2025Domain 2024-01-23 2024-01-23 0000080424 pg:A0110Due2026Domain 2024-01-23 2024-01-23 0000080424 pg:A3250EURNotesDue2026Domain 2024-01-23 2024-01-23 0000080424 pg:A4.875EURdueMay2027Domain 2024-01-23 2024-01-23 0000080424 pg:A1.200due2028Domain 2024-01-23 2024-01-23 0000080424 pg:A1.250due2029Domain 2024-01-23 2024-01-23 0000080424 pg:A1.800due2029Domain 2024-01-23 2024-01-23 0000080424 pg:A6.250GBPdueJanuary2030Domain 2024-01-23 2024-01-23 0000080424 pg:A0350Due2030Domain 2024-01-23 2024-01-23 0000080424 pg:A0230Due2031Domain 2024-01-23 2024-01-23 0000080424 pg:A3250EURNotesDue2031Domain 2024-01-23 2024-01-23 0000080424 pg:A5.250GBPdueJanuary2033Domain 2024-01-23 2024-01-23 0000080424 pg:A1.875due2038Domain 2024-01-23 2024-01-23 0000080424 pg:A0900Due2041Domain 2024-01-23 2024-01-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) January 23, 2024 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio OH 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza , Cincinnati OH One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 0.500% Notes due 2024 PG24A NYSE 0.625% Notes due 2024 PG24B NYSE 1.375% Notes due 2025 PG25 NYSE 0.110% Notes due 2026 PG26D NYSE 3.250% EUR Notes due 2026 PG26E NYSE 4.875% EUR notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 3.250% EUR Notes due 2031 PG31B NYSE 5.250% GBP notes due January 2033 PG33 NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 23, 2024 , The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended December 31, 2023. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated January 23, 2024 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",578
2024-01-29,8-K,0001193125-24-018146,"THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) 513 - 983-1100 Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Other Events. On January 29, 2024, The Procter & Gamble Company (the Company) closed an underwritten public offering of $600,000,000 aggregate principal amount of 4.350% Notes due January 29, 2029 and $750,000,000 aggregate principal amount of 4.550% Notes due January 29, 2034 under the Companys Registration Statement on Form S-3 (Registration No. 333-275071). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are",346
2024-04-09,8-K,0000080424-24-000030,"false 0000080424 0000080424 2024-04-09 2024-04-09 0000080424 pg:Zero500NotesDue2024Member 2024-04-09 2024-04-09 0000080424 pg:Zero625NotesDue2024Member 2024-04-09 2024-04-09 0000080424 pg:One375NotesDue2025Member 2024-04-09 2024-04-09 0000080424 pg:Zero110NotesDue2026Member 2024-04-09 2024-04-09 0000080424 pg:Three25EURNotesDue2026Member 2024-04-09 2024-04-09 0000080424 pg:Four875EURNotesDueMay2027Member 2024-04-09 2024-04-09 0000080424 pg:One200NotesDue2028Member 2024-04-09 2024-04-09 0000080424 pg:One250NotesDue2029Member 2024-04-09 2024-04-09 0000080424 pg:One800NotesDue2029Member 2024-04-09 2024-04-09 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2024-04-09 2024-04-09 0000080424 pg:Zero350NotesDue2030Member 2024-04-09 2024-04-09 0000080424 pg:Zero230NotesDue2031Member 2024-04-09 2024-04-09 0000080424 pg:Three25EURNotesDue2031Member 2024-04-09 2024-04-09 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2024-04-09 2024-04-09 0000080424 pg:One875NotesDue2038Member 2024-04-09 2024-04-09 0000080424 pg:Zero900NotesDue2041Member 2024-04-09 2024-04-09 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 9, 2024 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN On April 9, 2024, Angela F. Braly notified The Procter & Gamble Company (the Company) of her decision to retire from the Companys Board of Directors effective June 11, 2024. Ms. Braly made the decision in order to provide more time for her to focus on a range of activities and personal pursuits. The Company is filing the information under this item pursuant to Item 5.02(b), Departure of Directors or Certain Officers.",445
2024-04-09,8-K,0000080424-24-000029,"false 0000080424 0000080424 2024-04-09 2024-04-09 0000080424 pg:Three25EURNotesDue2026Member 2024-04-09 2024-04-09 0000080424 pg:Zero350NotesDue2030Member 2024-04-09 2024-04-09 0000080424 pg:One875NotesDue2038Member 2024-04-09 2024-04-09 0000080424 pg:One200NotesDue2028Member 2024-04-09 2024-04-09 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2024-04-09 2024-04-09 0000080424 pg:Zero625NotesDue2024Member 2024-04-09 2024-04-09 0000080424 pg:One800NotesDue2029Member 2024-04-09 2024-04-09 0000080424 pg:Zero500NotesDue2024Member 2024-04-09 2024-04-09 0000080424 pg:Zero110NotesDue2026Member 2024-04-09 2024-04-09 0000080424 pg:Four875EURNotesDueMay2027Member 2024-04-09 2024-04-09 0000080424 pg:Zero230NotesDue2031Member 2024-04-09 2024-04-09 0000080424 pg:Zero900NotesDue2041Member 2024-04-09 2024-04-09 0000080424 pg:One375NotesDue2025Member 2024-04-09 2024-04-09 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2024-04-09 2024-04-09 0000080424 pg:One250NotesDue2029Member 2024-04-09 2024-04-09 0000080424 pg:Three25EURNotesDue2031Member 2024-04-09 2024-04-09 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 9, 2024 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On April 9, 2024, The Procter & Gamble Company (the Company) announced that its Board of Directors declared a quarterly dividend of $1.0065 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after May 15, 2024, to Common Stock shareholders of record at the close of business on April 19, 2024, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on April 19, 2024. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure. ITEM 9.01 FINANCIAL STATEMENTS AND News Release by The Procter & Gamble Company dated April 9, 2024. Cover Page Interactive Data File (embedded within the Inline XBRL document)",489
2024-04-19,8-K,0000080424-24-000046,"pg-20240419 0000080424 False False False False False 0000080424 2024-04-19 2024-04-19 0000080424 2024-04-19 2024-04-19 0000080424 exch:XNYS 2024-04-19 2024-04-19 0000080424 pg:A0.500due2024Domain 2024-04-19 2024-04-19 0000080424 pg:A0.625due2024Domain 2024-04-19 2024-04-19 0000080424 pg:A1.375due2025Domain 2024-04-19 2024-04-19 0000080424 pg:A0110Due2026Domain 2024-04-19 2024-04-19 0000080424 pg:A3250EURNotesDue2026Domain 2024-04-19 2024-04-19 0000080424 pg:A4.875EURdueMay2027Domain 2024-04-19 2024-04-19 0000080424 pg:A1.200due2028Domain 2024-04-19 2024-04-19 0000080424 pg:A1.250due2029Domain 2024-04-19 2024-04-19 0000080424 pg:A1.800due2029Domain 2024-04-19 2024-04-19 0000080424 pg:A6.250GBPdueJanuary2030Domain 2024-04-19 2024-04-19 0000080424 pg:A0350Due2030Domain 2024-04-19 2024-04-19 0000080424 pg:A0230Due2031Domain 2024-04-19 2024-04-19 0000080424 pg:A3250EURNotesDue2031Domain 2024-04-19 2024-04-19 0000080424 pg:A5.250GBPdueJanuary2033Domain 2024-04-19 2024-04-19 0000080424 pg:A1.875due2038Domain 2024-04-19 2024-04-19 0000080424 pg:A0900Due2041Domain 2024-04-19 2024-04-19 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) April 19, 2024 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio OH 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza , Cincinnati OH One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 0.500% Notes due 2024 PG24A NYSE 0.625% Notes due 2024 PG24B NYSE 1.375% Notes due 2025 PG25 NYSE 0.110% Notes due 2026 PG26D NYSE 3.250% EUR Notes due 2026 PG26E NYSE 4.875% EUR notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 3.250% EUR Notes due 2031 PG31B NYSE 5.250% GBP notes due January 2033 PG33 NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On April 19, 2024 , The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended March 31, 2024. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated April 19, 2024 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",578
2024-04-19,10-Q,0000080424-24-000051,and Analysis of Financial Condition and Results of Operations 13 Item 3. Quantitative and Qualitative Disclosures About Market Risk 29 Item 4. Controls and Procedures 29 PART II Item 1. Legal Proceedings 29 Item 1A.,35
2024-04-19,8-K,0000080424-24-000048,"false 0000080424 0000080424 2024-04-19 2024-04-19 0000080424 pg:Zero900NotesDue2041Member 2024-04-19 2024-04-19 0000080424 pg:Zero350NotesDue2030Member 2024-04-19 2024-04-19 0000080424 pg:One250NotesDue2029Member 2024-04-19 2024-04-19 0000080424 pg:One875NotesDue2038Member 2024-04-19 2024-04-19 0000080424 pg:Zero110NotesDue2026Member 2024-04-19 2024-04-19 0000080424 pg:Zero230NotesDue2031Member 2024-04-19 2024-04-19 0000080424 pg:One375NotesDue2025Member 2024-04-19 2024-04-19 0000080424 pg:Three25EURNotesDue2026Member 2024-04-19 2024-04-19 0000080424 pg:One200NotesDue2028Member 2024-04-19 2024-04-19 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2024-04-19 2024-04-19 0000080424 pg:Zero500NotesDue2024Member 2024-04-19 2024-04-19 0000080424 pg:Four875EURNotesDueMay2027Member 2024-04-19 2024-04-19 0000080424 pg:Three25EURNotesDue2031Member 2024-04-19 2024-04-19 0000080424 pg:One800NotesDue2029Member 2024-04-19 2024-04-19 0000080424 pg:Zero625NotesDue2024Member 2024-04-19 2024-04-19 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2024-04-19 2024-04-19 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 19, 2024 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On April 19, 2024, The Procter & Gamble Company (the ""Company"") issued a press release announcing its third quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND Informational Slides Provided by The Procter & Gamble Company dated April 19, 2024 Cover Page Interactive Data File (embedded within the Inline XBRL document)",453
2024-04-29,8-K,0001193125-24-122626,"THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Charter) (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of Principal Executive Offices, and Zip Code) 513 - 983-1100 Registrants Telephone Number, Including Area Code (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 3.250% EUR Notes due 2026 4.875% EUR Notes due May 2027 6.250% GBP Notes due January 2030 3.250% EUR Notes due 2031 5.250% GBP Notes due January 2033 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Other Events. On April 29, 2024, The Procter & Gamble Company (the Company) closed an underwritten public offering of 650,000,000 aggregate principal amount of 3.150% Notes due April 29, 2028 and 850,000,000 aggregate principal amount of 3.200% Notes due April 29, 2034 under the Companys Registration Statement on Form S-3 (Registration No. 333-275071). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are",356
2024-07-09,8-K,0000080424-24-000063,"false 0000080424 0000080424 2024-07-09 2024-07-09 0000080424 pg:Three25EURNotesDue2031Member 2024-07-09 2024-07-09 0000080424 pg:Three150EURNotesDue2028Member 2024-07-09 2024-07-09 0000080424 pg:Three25EURNotesDue2026Member 2024-07-09 2024-07-09 0000080424 pg:Zero230NotesDue2031Member 2024-07-09 2024-07-09 0000080424 pg:One375NotesDue2025Member 2024-07-09 2024-07-09 0000080424 pg:Zero110NotesDue2026Member 2024-07-09 2024-07-09 0000080424 pg:One800NotesDue2029Member 2024-07-09 2024-07-09 0000080424 pg:Three200EURNotesDue2034Member 2024-07-09 2024-07-09 0000080424 pg:Zero350NotesDue2030Member 2024-07-09 2024-07-09 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2024-07-09 2024-07-09 0000080424 pg:Four875EURNotesDueMay2027Member 2024-07-09 2024-07-09 0000080424 pg:Zero625NotesDue2024Member 2024-07-09 2024-07-09 0000080424 pg:One200NotesDue2028Member 2024-07-09 2024-07-09 0000080424 pg:One875NotesDue2038Member 2024-07-09 2024-07-09 0000080424 pg:One250NotesDue2029Member 2024-07-09 2024-07-09 0000080424 pg:Zero900NotesDue2041Member 2024-07-09 2024-07-09 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2024-07-09 2024-07-09 0000080424 pg:Zero500NotesDue2024Member 2024-07-09 2024-07-09 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 9, 2024 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 3.150% EUR Notes due 2028 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 3.200% EUR Notes due 2034 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On July 9, 2024, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of $1.0065 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after August 15, 2024, to Common Stock shareholders of record at the close of business on July 19, 2024, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on July 19, 2024. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Dividend News Release by The Procter & Gamble Company dated July 9, 2024. Cover Page Interactive Data File (embedded within the Inline XBRL document)",511
2024-07-30,8-K,0000080424-24-000073,"false 0000080424 0000080424 2024-07-30 2024-07-30 0000080424 pg:One200NotesDue2028Member 2024-07-30 2024-07-30 0000080424 pg:One250NotesDue2029Member 2024-07-30 2024-07-30 0000080424 pg:Three25EURNotesDue2031Member 2024-07-30 2024-07-30 0000080424 pg:Three200EURNotesDue2034Member 2024-07-30 2024-07-30 0000080424 pg:Zero230NotesDue2031Member 2024-07-30 2024-07-30 0000080424 pg:Zero350NotesDue2030Member 2024-07-30 2024-07-30 0000080424 pg:One875NotesDue2038Member 2024-07-30 2024-07-30 0000080424 pg:Four875EURNotesDueMay2027Member 2024-07-30 2024-07-30 0000080424 pg:One800NotesDue2029Member 2024-07-30 2024-07-30 0000080424 pg:Zero625NotesDue2024Member 2024-07-30 2024-07-30 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2024-07-30 2024-07-30 0000080424 pg:Zero500NotesDue2024Member 2024-07-30 2024-07-30 0000080424 pg:Zero900NotesDue2041Member 2024-07-30 2024-07-30 0000080424 pg:Three150EURNotesDue2028Member 2024-07-30 2024-07-30 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2024-07-30 2024-07-30 0000080424 pg:Three25EURNotesDue2026Member 2024-07-30 2024-07-30 0000080424 pg:Zero110NotesDue2026Member 2024-07-30 2024-07-30 0000080424 pg:One375NotesDue2025Member 2024-07-30 2024-07-30 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 30, 2024 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 3.150% EUR Notes due 2028 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 3.200% EUR Notes due 2034 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On July 30, 2024, The Procter & Gamble Company (the ""Company"") issued a press release announcing its fourth quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND Informational Slides Provided by The Procter & Gamble Company dated July 30, 2024. Cover Page Interactive Data File (embedded within the Inline XBRL document)",469
2024-07-30,8-K,0000080424-24-000071,"pg-20240730 0000080424 False False 0000080424 2024-07-30 2024-07-30 0000080424 2024-07-30 2024-07-30 0000080424 exch:XNYS 2024-07-30 2024-07-30 0000080424 pg:A0.500NotesDue2024Domain 2024-07-30 2024-07-30 0000080424 pg:A0.625NotesDue2024Domain 2024-07-30 2024-07-30 0000080424 pg:A1.375NotesDue2025Domain 2024-07-30 2024-07-30 0000080424 pg:A0.110NotesDue2026Domain 2024-07-30 2024-07-30 0000080424 pg:A3.250EURNotesDue2026Domain 2024-07-30 2024-07-30 0000080424 pg:A4.875EURNotesDueMay2027Domain 2024-07-30 2024-07-30 0000080424 pg:A1.200NotesDue2028Domain 2024-07-30 2024-07-30 0000080424 pg:A3.150EURNotesDue2028Domain 2024-07-30 2024-07-30 0000080424 pg:A1.250NotesDue2029Domain 2024-07-30 2024-07-30 0000080424 pg:A1.800NotesDue2029Domain 2024-07-30 2024-07-30 0000080424 pg:A6.250GBPNotesDueJanuary2030Domain 2024-07-30 2024-07-30 0000080424 pg:A0.350NotesDue2030Domain 2024-07-30 2024-07-30 0000080424 pg:A0.230NotesDue2031Domain 2024-07-30 2024-07-30 0000080424 pg:A3.250EURNotesDue2031Domain 2024-07-30 2024-07-30 0000080424 pg:A5.250GBPNotesDueJanuary2033Domain 2024-07-30 2024-07-30 0000080424 pg:A3.200EURNotesDue2034Domain 2024-07-30 2024-07-30 0000080424 pg:A1.875NotesDue2038Domain 2024-07-30 2024-07-30 0000080424 pg:A0900Due2041Domain 2024-07-30 2024-07-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) July 30, 2024 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 0.500% Notes due 2024 PG24A NYSE 0.625% Notes due 2024 PG24B NYSE 1.375% Notes due 2025 PG25 NYSE 0.110% Notes due 2026 PG26D NYSE 3.250% EUR Notes due 2026 PG26F NYSE 4.875% EUR Notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 3.150% EUR Notes due 2028 PG28B NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP Notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 3.250% EUR Notes due 2031 PG31B NYSE 5.250% GBP Notes due January 2033 PG33 NYSE 3.200% EUR Notes due 2034 PG34C NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On July 30, 2024, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter and fiscal year ended June 30, 2024. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated July 30, 2024 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",592
2024-08-05,10-K,0000080424-24-000083,"pg-20240630 0000080424 2024 FY False iso4217:USD xbrli:shares iso4217:USD xbrli:shares pg:country pg:segment xbrli:pure pg:audit 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 pg:A0.500NotesDue2024Member 2023-07-01 2024-06-30 0000080424 pg:A0.625NotesDue2024Member 2023-07-01 2024-06-30 0000080424 pg:A1.375NotesDue2025Member 2023-07-01 2024-06-30 0000080424 pg:A0.110NotesDue2026Member 2023-07-01 2024-06-30 0000080424 pg:A3.250EURNotesDue2026Member 2023-07-01 2024-06-30 0000080424 pg:A4.875EURNotesDueMay2027Member 2023-07-01 2024-06-30 0000080424 pg:A1.200NotesDue2028Member 2023-07-01 2024-06-30 0000080424 pg:A3.150EURNotesDue2028Member 2023-07-01 2024-06-30 0000080424 pg:A1.250NotesDue2029Member 2023-07-01 2024-06-30 0000080424 pg:A1.800NotesDue2029Member 2023-07-01 2024-06-30 0000080424 pg:A6.250GBPNotesDueJanuary2030Member 2023-07-01 2024-06-30 0000080424 pg:A0.350NotesDue2030Member 2023-07-01 2024-06-30 0000080424 pg:A0.230NotesDue2031Member 2023-07-01 2024-06-30 0000080424 pg:A3.250EURNotesDue2031Member 2023-07-01 2024-06-30 0000080424 pg:A5.250GBPNotesDueJanuary2033Member 2023-07-01 2024-06-30 0000080424 pg:A3.200EURNotesDue2034Member 2023-07-01 2024-06-30 0000080424 pg:A1.875NotesDue2038Member 2023-07-01 2024-06-30 0000080424 pg:A0.900NotesDue2041Member 2023-07-01 2024-06-30 0000080424 2023-12-31 0000080424 2024-07-31 0000080424 2022-07-01 2023-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2021-07-01 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2022-07-01 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2023-07-01 2024-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2024-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 srt:MinimumMember 2024-06-30 0000080424 srt:MaximumMember 2024-06-30 0000080424 srt:MinimumMember 2024-06-30 0000080424 srt:MaximumMember 2024-06-30 0000080424 2024-06-30 0000080424 srt:MinimumMember pg:CustomerRelationshipsBrandsandOtherNonContractualIntangibleAssetsMember 2024-06-30 0000080424 pg:CustomerRelationshipsBrandsandOtherNonContractualIntangibleAssetsMember srt:MaximumMember 2024-06-30 0000080424 pg:FabricHomeCareSegmentMember pg:FabricCareMember 2023-07-01 2024-06-30 0000080424 pg:FabricHomeCareSegmentMember pg:FabricCareMember 2022-07-01 2023-06-30 0000080424 pg:FabricHomeCareSegmentMember pg:FabricCareMember 2021-07-01 2022-06-30 0000080424 pg:FabricHomeCareSegmentMember pg:HomeCareMember 2023-07-01 2024-06-30 0000080424 pg:FabricHomeCareSegmentMember pg:HomeCareMember 2022-07-01 2023-06-30 0000080424 pg:FabricHomeCareSegmentMember pg:HomeCareMember 2021-07-01 2022-06-30 0000080424 pg:BabyCareMember pg:BabyFeminineFamilyCareSegmentMember 2023-07-01 2024-06-30 0000080424 pg:BabyCareMember pg:BabyFeminineFamilyCareSegmentMember 2022-07-01 2023-06-30 0000080424 pg:BabyCareMember pg:BabyFeminineFamilyCareSegmentMember 2021-07-01 2022-06-30 0000080424 pg:FamilyCareMember pg:BabyFeminineFamilyCareSegmentMember 2023-07-01 2024-06-30 0000080424 pg:FamilyCareMember pg:BabyFeminineFamilyCareSegmentMember 2022-07-01 2023-06-30 0000080424 pg:FamilyCareMember pg:BabyFeminineFamilyCareSegmentMember 2021-07-01 2022-06-30 0000080424 pg:HairCareMember pg:BeautySegmentMember 2023-07-01 2024-06-30 0000080424 pg:HairCareMember pg:BeautySegmentMember 2022-07-01 2023-06-30 0000080424 pg:HairCareMember pg:BeautySegmentMember 2021-07-01 2022-06-30 0000080424 pg:SkinandPersonalCareMember pg:BabyFeminineFamilyCareSegmentMember 2023-07-01 2024-06-30 0000080424 pg:SkinandPersonalCareMember pg:BabyFeminineFamilyCareSegmentMember 2022-07-01 2023-06-30 0000080424 pg:SkinandPersonalCareMember pg:BabyFeminineFamilyCareSegmentMember 2021-07-01 2022-06-30 0000080424 pg:GroomingSegmentMember pg:GroomingMember 2023-07-01 2024-06-30 0000080424 pg:GroomingSegmentMember pg:GroomingMember 2022-07-01 2023-06-30 0000080424 pg:GroomingSegmentMember pg:GroomingMember 2021-07-01 2022-06-30 0000080424 pg:OralCareMember pg:HealthCareSegmentMember 2023-07-01 2024-06-30 0000080424 pg:OralCareMember pg:HealthCareSegmentMember 2022-07-01 2023-06-30 0000080424 pg:OralCareMember pg:HealthCareSegmentMember 2021-07-01 2022-06-30 0000080424 pg:FeminineCareMember pg:BabyFeminineFamilyCareSegmentMember 2023-07-01 2024-06-30 0000080424 pg:FeminineCareMember pg:BabyFeminineFamilyCareSegmentMember 2022-07-01 2023-06-30 0000080424 pg:FeminineCareMember pg:BabyFeminineFamilyCareSegmentMember 2021-07-01 2022-06-30 0000080424 pg:HealthCareSegmentMember pg:PersonalHealthCareMember 2023-07-01 2024-06-30 0000080424 pg:HealthCareSegmentMember pg:PersonalHealthCareMember 2022-07-01 2023-06-30 0000080424 pg:HealthCareSegmentMember pg:PersonalHealthCareMember 2021-07-01 2022-06-30 0000080424 pg:GroomingSegmentMember pg:AllOtherMember 2023-07-01 2024-06-30 0000080424 pg:GroomingSegmentMember pg:AllOtherMember 2022-07-01 2023-06-30 0000080424 pg:GroomingSegmentMember pg:AllOtherMember 2021-07-01 2022-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2021-07-01 2022-06-30 0000080424 country:US 2023-07-01 2024-06-30 0000080424 country:US 2022-07-01 2023-06-30 0000080424 country:US 2021-07-01 2022-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2021-07-01 2022-06-30 0000080424 country:US 2024-06-30 0000080424 country:US 2023-06-30 0000080424 country:US 2022-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 pg:WalmartInc.AndAffiliatesMember 2023-07-01 2024-06-30 0000080424 pg:WalmartInc.AndAffiliatesMember 2021-07-01 2022-06-30 0000080424 pg:WalmartInc.AndAffiliatesMember 2022-07-01 2023-06-30 0000080424 pg:BeautySegmentMember 2023-07-01 2024-06-30 0000080424 pg:BeautySegmentMember 2024-06-30 0000080424 pg:BeautySegmentMember 2022-07-01 2023-06-30 0000080424 pg:BeautySegmentMember 2023-06-30 0000080424 pg:BeautySegmentMember 2021-07-01 2022-06-30 0000080424 pg:BeautySegmentMember 2022-06-30 0000080424 pg:GroomingSegmentMember 2023-07-01 2024-06-30 0000080424 pg:GroomingSegmentMember 2024-06-30 0000080424 pg:GroomingSegmentMember 2022-07-01 2023-06-30 0000080424 pg:GroomingSegmentMember 2023-06-30 0000080424 pg:GroomingSegmentMember 2021-07-01 2022-06-30 0000080424 pg:GroomingSegmentMember 2022-06-30 0000080424 pg:HealthCareSegmentMember 2023-07-01 2024-06-30 0000080424 pg:HealthCareSegmentMember 2024-06-30 0000080424 pg:HealthCareSegmentMember 2022-07-01 2023-06-30 0000080424 pg:HealthCareSegmentMember 2023-06-30 0000080424 pg:HealthCareSegmentMember 2021-07-01 2022-06-30 0000080424 pg:HealthCareSegmentMember 2022-06-30 0000080424 pg:FabricHomeCareSegmentMember 2023-07-01 2024-06-30 0000080424 pg:FabricHomeCareSegmentMember 2024-06-30 0000080424 pg:FabricHomeCareSegmentMember 2022-07-01 2023-06-30 0000080424 pg:FabricHomeCareSegmentMember 2023-06-30 0000080424 pg:FabricHomeCareSegmentMember 2021-07-01 2022-06-30 0000080424 pg:FabricHomeCareSegmentMember 2022-06-30 0000080424 pg:BabyFeminineFamilyCareSegmentMember 2023-07-01 2024-06-30 0000080424 pg:BabyFeminineFamilyCareSegmentMember 2024-06-30 0000080424 pg:BabyFeminineFamilyCareSegmentMember 2022-07-01 2023-06-30 0000080424 pg:BabyFeminineFamilyCareSegmentMember 2023-06-30 0000080424 pg:BabyFeminineFamilyCareSegmentMember 2021-07-01 2022-06-30 0000080424 pg:BabyFeminineFamilyCareSegmentMember 2022-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2024-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2023-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2022-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 srt:MinimumMember 2024-06-30 0000080424 srt:MaximumMember 2024-06-30 0000080424 srt:MinimumMember 2023-12-31 0000080424 srt:MaximumMember 2023-12-31 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 pg:GilletteMember 2023-07-01 2024-06-30 0000080424 pg:GilletteMember 2024-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 srt:MinimumMember 2023-07-01 2024-06-30 0000080424 srt:MaximumMember 2023-07-01 2024-06-30 0000080424 pg:SubjectToExpirationExpiringBetween2024And2043Member 2024-06-30 0000080424 pg:NotSubjectToExpirationMember 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2021-07-01 2022-06-30 0000080424 pg:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember 2023-07-01 2024-06-30 0000080424 pg:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember 2022-07-01 2023-06-30 0000080424 pg:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember 2021-07-01 2022-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 pg:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember 2024-06-30 0000080424 country:US 2022-07-01 2023-06-30 0000080424 country:US 2023-07-01 2024-06-30 0000080424 country:US 2021-07-01 2022-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 2021-07-01 2022-06-30 0000080424 2021-07-01 2022-06-30 0000080424 srt:MinimumMember 2023-07-01 2024-06-30 0000080424 srt:MaximumMember 2023-07-01 2024-06-30 0000080424 srt:MinimumMember 2023-07-01 2024-06-30 0000080424 srt:MaximumMember 2023-07-01 2024-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 pg:CompanyStockMember 2024-06-30 0000080424 pg:CompanyStockMember 2023-06-30 0000080424 pg:CompanyStockMember 2024-06-30 0000080424 pg:CompanyStockMember 2023-06-30 0000080424 pg:CompanyPreferredStockMember 2024-06-30 0000080424 pg:CompanyPreferredStockMember 2023-06-30 0000080424 pg:CompanyPreferredStockMember 2024-06-30 0000080424 pg:CompanyPreferredStockMember 2023-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 pg:InsuranceContractsMember 2024-06-30 0000080424 pg:InsuranceContractsMember 2023-06-30 0000080424 pg:InsuranceContractsMember 2024-06-30 0000080424 pg:InsuranceContractsMember 2023-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 1989-06-30 0000080424 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 1991-06-30 0000080424 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2022-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2022-07-01 2023-06-30 0000080424 pg:A3.10USDnotedueAugust2023Member 2024-06-30 0000080424 pg:A3.10USDnotedueAugust2023Member 2023-06-30 0000080424 pg:A1.13EURnotedueNovember2023Member 2024-06-30 0000080424 pg:A1.13EURnotedueNovember2023Member 2023-06-30 0000080424 pg:A0.50EURNoteDueOctober2024Member 2024-06-30 0000080424 pg:A0.50EURNoteDueOctober2024Member 2023-06-30 0000080424 pg:A063EURNoteDueOctober2024Member 2024-06-30 0000080424 pg:A063EURNoteDueOctober2024Member 2023-06-30 0000080424 pg:A055USDNoteDueOctober2025Member 2024-06-30 0000080424 pg:A055USDNoteDueOctober2025Member 2023-06-30 0000080424 pg:A410USDNoteDueJanuary2026Member 2024-06-30 0000080424 pg:A410USDNoteDueJanuary2026Member 2023-06-30 0000080424 pg:A270USDNoteDueFebruary2026Member 2024-06-30 0000080424 pg:A270USDNoteDueFebruary2026Member 2023-06-30 0000080424 pg:A100USDNoteDueApril2026Member 2024-06-30 0000080424 pg:A100USDNoteDueApril2026Member 2023-06-30 0000080424 pg:A325EURNoteDueAugust2026Member 2024-06-30 0000080424 pg:A325EURNoteDueAugust2026Member 2023-06-30 0000080424 pg:A2.45USDnotedueNovember2026Member 2024-06-30 0000080424 pg:A2.45USDnotedueNovember2026Member 2023-06-30 0000080424 pg:A190USDNoteDueFebruary2027Member 2024-06-30 0000080424 pg:A190USDNoteDueFebruary2027Member 2023-06-30 0000080424 pg:A280USDNoteDueMarch2027Member 2024-06-30 0000080424 pg:A280USDNoteDueMarch2027Member 2023-06-30 0000080424 pg:A4.88EURnotedueMay2027Member 2024-06-30 0000080424 pg:A4.88EURnotedueMay2027Member 2023-06-30 0000080424 pg:A2.85USDnotedueAugust2027Member 2024-06-30 0000080424 pg:A2.85USDnotedueAugust2027Member 2023-06-30 0000080424 pg:A395USDNoteDueJanuary2028Member 2024-06-30 0000080424 pg:A395USDNoteDueJanuary2028Member 2023-06-30 0000080424 pg:A3.15EURNoteDueApril2028Member 2024-06-30 0000080424 pg:A3.15EURNoteDueApril2028Member 2023-06-30 0000080424 pg:A1.20EURnotedueOctober2028Member 2024-06-30 0000080424 pg:A1.20EURnotedueOctober2028Member 2023-06-30 0000080424 pg:A4.35USDNoteDueJanuary2029Member 2024-06-30 0000080424 pg:A4.35USDNoteDueJanuary2029Member 2023-06-30 0000080424 pg:A1.25EURnotedueOctober2029Member 2024-06-30 0000080424 pg:A1.25EURnotedueOctober2029Member 2023-06-30 0000080424 pg:A300USDNoteDueMarch2030Member 2024-06-30 0000080424 pg:A300USDNoteDueMarch2030Member 2023-06-30 0000080424 pg:A035EURNoteDueMay2030Member 2024-06-30 0000080424 pg:A035EURNoteDueMay2030Member 2023-06-30 0000080424 pg:A120USDNoteDueOctober2030Member 2024-06-30 0000080424 pg:A120USDNoteDueOctober2030Member 2023-06-30 0000080424 pg:A195USDNoteDueApril2031Member 2024-06-30 0000080424 pg:A195USDNoteDueApril2031Member 2023-06-30 0000080424 pg:A325EURNoteDueAugust2031Member 2024-06-30 0000080424 pg:A325EURNoteDueAugust2031Member 2023-06-30 0000080424 pg:A230USDNoteDueFebruary2032Member 2024-06-30 0000080424 pg:A230USDNoteDueFebruary2032Member 2023-06-30 0000080424 pg:A405USDNoteDueJanuary2033Member 2024-06-30 0000080424 pg:A405USDNoteDueJanuary2033Member 2023-06-30 0000080424 pg:A4.55USDNoteDueJanuary2034Member 2024-06-30 0000080424 pg:A4.55USDNoteDueJanuary2034Member 2023-06-30 0000080424 pg:A3.20EURNoteDueApril2034Member 2024-06-30 0000080424 pg:A3.20EURNoteDueApril2034Member 2023-06-30 0000080424 pg:A5.55USDnotedueMarch2037Member 2024-06-30 0000080424 pg:A5.55USDnotedueMarch2037Member 2023-06-30 0000080424 pg:A1.88EURnotedueOctober2038Member 2024-06-30 0000080424 pg:A1.88EURnotedueOctober2038Member 2023-06-30 0000080424 pg:A355USDNoteDueMarch2040Member 2024-06-30 0000080424 pg:A355USDNoteDueMarch2040Member 2023-06-30 0000080424 pg:A090EURNoteDueNovember2041Member 2024-06-30 0000080424 pg:A090EURNoteDueNovember2041Member 2023-06-30 0000080424 2024-06-30 0000080424 pg:FiveYearCreditFacilityMember 2024-06-30 0000080424 pg:FiveYearCreditFacilityMember 2023-07-01 2024-06-30 0000080424 pg:A364DayCreditFacilityMember 2024-06-30 0000080424 pg:A364DayCreditFacilityMember 2023-07-01 2024-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 country:AR srt:ScenarioForecastMember 2024-07-01 2024-09-30 0000080424 2024-04-01 2024-06-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark one) [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 TRUE For the Fiscal Year Ended June 30 , 2024 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 False For the transition period from to Commission File No. 1-434 THE PROCTER & GAMBLE CO MPANY One Procter & Gamble Plaza , Cincinnati , Ohio 45202 Telephone ( 513 ) 983-1100 IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG New York Stock Exchange 0.500% Notes due 2024 PG24A New York Stock Exchange 0.625% Notes due 2024 PG24B New York Stock Exchange 1.375% Notes due 2025 PG25 New York Stock Exchange 0.110% Notes due 2026 PG26D New York Stock Exchange 3.250% EUR Notes due 2026 PG26F New York Stock Exchange 4.875% EUR Notes due May 2027 PG27A New York Stock Exchange 1.200% Notes due 2028 PG28 New York Stock Exchange 3.150% EUR Notes due 2028 PG28B New York Stock Exchange 1.250% Notes due 2029 PG29B New York Stock Exchange 1.800% Notes due 2029 PG29A New York Stock Exchange 6.250% GBP Notes due January 2030 PG30 New York Stock Exchange 0.350% Notes due 2030 PG30C New York Stock Exchange 0.230% Notes due 2031 PG31A New York Stock Exchange 3.250% EUR Notes due 2031 PG31B New York Stock Exchange 5.250% GBP Notes due January 2033 PG33 New York Stock Exchange 3.200% EUR Notes due 2034 PG34C New York Stock Exchange 1.875% Notes due 2038 PG38 New York Stock Exchange 0.900% Notes due 2041 PG41 New York Stock Exchange Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  No o Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes o No  Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No o Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of ""large accelerated filer,"" ""accelerated filer,"" ""smaller reporting company,"" and ""emerging growth company"" in Rule 12b-2 of the Exchange Act. Large accelerated filer  Accelerated filer  Emerging growth company  Non-accelerated filer  Smaller reporting company  FALSE FALSE If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Indicate by check mark whether the registrant has filed a report on and attestation to its managements assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the",1885
2024-10-08,8-K,0000080424-24-000098,"false 0000080424 0000080424 2024-10-08 2024-10-08 0000080424 pg:Zero350NotesDue2030Member 2024-10-08 2024-10-08 0000080424 pg:Four875EURNotesDueMay2027Member 2024-10-08 2024-10-08 0000080424 pg:Three200EURNotesDue2034Member 2024-10-08 2024-10-08 0000080424 pg:One200NotesDue2028Member 2024-10-08 2024-10-08 0000080424 pg:Zero500NotesDue2024Member 2024-10-08 2024-10-08 0000080424 pg:Zero110NotesDue2026Member 2024-10-08 2024-10-08 0000080424 pg:Zero625NotesDue2024Member 2024-10-08 2024-10-08 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2024-10-08 2024-10-08 0000080424 pg:Zero230NotesDue2031Member 2024-10-08 2024-10-08 0000080424 pg:Three25EURNotesDue2026Member 2024-10-08 2024-10-08 0000080424 pg:Zero900NotesDue2041Member 2024-10-08 2024-10-08 0000080424 pg:Three150EURNotesDue2028Member 2024-10-08 2024-10-08 0000080424 pg:One875NotesDue2038Member 2024-10-08 2024-10-08 0000080424 pg:Three25EURNotesDue2031Member 2024-10-08 2024-10-08 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2024-10-08 2024-10-08 0000080424 pg:One250NotesDue2029Member 2024-10-08 2024-10-08 0000080424 pg:One800NotesDue2029Member 2024-10-08 2024-10-08 0000080424 pg:One375NotesDue2025Member 2024-10-08 2024-10-08 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 8, 2024 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 3.150% EUR Notes due 2028 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 3.200% EUR Notes due 2034 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On October 8, 2024, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of $1.0065 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after November 15, 2024, to Common Stock shareholders of record at the close of business on October 18, 2024, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on October 18, 2024. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND Dividend News Release by The Procter & Gamble Company dated October 8, 2024. Cover Page Interactive Data File (embedded within the Inline XBRL document)",509
2024-10-10,8-K,0000080424-24-000100,"false 0000080424 0000080424 2024-10-10 2024-10-10 0000080424 pg:Zero110NotesDue2026Member 2024-10-10 2024-10-10 0000080424 pg:Three25EURNotesDue2026Member 2024-10-10 2024-10-10 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2024-10-10 2024-10-10 0000080424 pg:One375NotesDue2025Member 2024-10-10 2024-10-10 0000080424 pg:One200NotesDue2028Member 2024-10-10 2024-10-10 0000080424 pg:One875NotesDue2038Member 2024-10-10 2024-10-10 0000080424 pg:Zero500NotesDue2024Member 2024-10-10 2024-10-10 0000080424 pg:Zero625NotesDue2024Member 2024-10-10 2024-10-10 0000080424 pg:One250NotesDue2029Member 2024-10-10 2024-10-10 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2024-10-10 2024-10-10 0000080424 pg:Zero230NotesDue2031Member 2024-10-10 2024-10-10 0000080424 pg:Three150EURNotesDue2028Member 2024-10-10 2024-10-10 0000080424 pg:Three200EURNotesDue2034Member 2024-10-10 2024-10-10 0000080424 pg:Four875EURNotesDueMay2027Member 2024-10-10 2024-10-10 0000080424 pg:Zero350NotesDue2030Member 2024-10-10 2024-10-10 0000080424 pg:Zero900NotesDue2041Member 2024-10-10 2024-10-10 0000080424 pg:One800NotesDue2029Member 2024-10-10 2024-10-10 0000080424 pg:Three25EURNotesDue2031Member 2024-10-10 2024-10-10 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 10, 2024 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 3.150% EUR Notes due 2028 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 3.200% EUR Notes due 2034 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.07. Submission of Matters to a Vote of Security Holders On October 8, 2024, The Procter & Gamble Company (the Company), held its 2024 Annual Meeting of Shareholders. Set forth below are the final voting results for each of the proposals submitted to a vote of the shareholders. Proposal 1  Election of Directors. Each of the following nominees was elected to serve a one-year term on the Companys Board of Directors (the Board). Proposal 2- Ratify Appointment of the Independent Registered Public Accounting Firm. The proposal was approved. Proposal 3 - Advisory Vote to Approve the Companys Executive Compensation (the Say on Pay vote). The proposal was approved. Proposal 4 - Shareholder Proposal - Pay Gap Reporting. The proposal was not approved. The Company is filing this Form 8-K pursuant to Item 5.07, ""Submission of Matters to a Vote of Security Holders.""",514
2024-10-18,8-K,0000080424-24-000108,"pg-20241018 0000080424 False False False False False 0000080424 2024-10-18 2024-10-18 0000080424 2024-10-18 2024-10-18 0000080424 pg:A0.500due2024Domain 2024-10-18 2024-10-18 0000080424 pg:A0.625due2024Domain 2024-10-18 2024-10-18 0000080424 pg:A1.375due2025Domain 2024-10-18 2024-10-18 0000080424 pg:A0110Due2026Domain 2024-10-18 2024-10-18 0000080424 pg:A3250EURNotesDue2026Domain 2024-10-18 2024-10-18 0000080424 pg:A4.875EURdueMay2027Domain 2024-10-18 2024-10-18 0000080424 pg:A1.200due2028Domain 2024-10-18 2024-10-18 0000080424 pg:A3.150EURNotesDue2028Domain 2024-10-18 2024-10-18 0000080424 pg:A1.250due2029Domain 2024-10-18 2024-10-18 0000080424 pg:A1.800due2029Domain 2024-10-18 2024-10-18 0000080424 pg:A6.250GBPdueJanuary2030Domain 2024-10-18 2024-10-18 0000080424 pg:A0350Due2030Domain 2024-10-18 2024-10-18 0000080424 pg:A0230Due2031Domain 2024-10-18 2024-10-18 0000080424 pg:A3250EURNotesDue2031Domain 2024-10-18 2024-10-18 0000080424 pg:A5.250GBPdueJanuary2033Domain 2024-10-18 2024-10-18 0000080424 pg:A3.200EURNotesDue2034Domain 2024-10-18 2024-10-18 0000080424 pg:A1.875due2038Domain 2024-10-18 2024-10-18 0000080424 pg:A0900Due2041Domain 2024-10-18 2024-10-18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) October 18, 2024 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio OH 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza , Cincinnati OH One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 0.500% Notes due 2024 PG24A NYSE 0.625% Notes due 2024 PG24B NYSE 1.375% Notes due 2025 PG25 NYSE 0.110% Notes due 2026 PG26D NYSE 3.250% EUR Notes due 2026 PG26F NYSE 4.875% EUR notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 3.150% EUR Notes due 2028 PG28B NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 3.250% EUR Notes due 2031 PG31B NYSE 5.250% GBP notes due January 2033 PG33 NYSE 3.200% EUR Notes due 2034 PG34C NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On October 18, 2024 , The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended September 30, 2024. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated October 18, 2024 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",598
2024-10-18,8-K,0000080424-24-000110,"false 0000080424 0000080424 2024-10-18 2024-10-18 0000080424 pg:Zero500NotesDue2024Member 2024-10-18 2024-10-18 0000080424 pg:One800NotesDue2029Member 2024-10-18 2024-10-18 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2024-10-18 2024-10-18 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2024-10-18 2024-10-18 0000080424 pg:One875NotesDue2038Member 2024-10-18 2024-10-18 0000080424 pg:One200NotesDue2028Member 2024-10-18 2024-10-18 0000080424 pg:Three200EURNotesDue2034Member 2024-10-18 2024-10-18 0000080424 pg:Zero625NotesDue2024Member 2024-10-18 2024-10-18 0000080424 pg:Three25EURNotesDue2026Member 2024-10-18 2024-10-18 0000080424 pg:Four875EURNotesDueMay2027Member 2024-10-18 2024-10-18 0000080424 pg:Zero110NotesDue2026Member 2024-10-18 2024-10-18 0000080424 pg:Three150EURNotesDue2028Member 2024-10-18 2024-10-18 0000080424 pg:One250NotesDue2029Member 2024-10-18 2024-10-18 0000080424 pg:Three25EURNotesDue2031Member 2024-10-18 2024-10-18 0000080424 pg:One375NotesDue2025Member 2024-10-18 2024-10-18 0000080424 pg:Zero900NotesDue2041Member 2024-10-18 2024-10-18 0000080424 pg:Zero350NotesDue2030Member 2024-10-18 2024-10-18 0000080424 pg:Zero230NotesDue2031Member 2024-10-18 2024-10-18 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 18, 2024 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , OH 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 3.150% EUR Notes due 2028 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 3.200% EUR Notes due 2034 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On October 18, 2024, The Procter & Gamble Company (the ""Company"") issued a press release announcing its first quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated October 18, 2024. Cover Page Interactive Data File (embedded within the Inline XBRL document)",470
2024-10-18,10-Q,0000080424-24-000113,and Analysis of Financial Condition and Results of Operations 12 Item 3. Quantitative and Qualitative Disclosures About Market Risk 22 Item 4. Controls and Procedures 22 PART II Item 1. Legal Proceedings 23 Item 1A.,35
2024-10-24,8-K,0001193125-24-242887,"THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in charter) (State or other jurisdiction of incorporation) (IRS Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio (Address of principal executive offices) (Zip Code) 513 - 983-1100 Registrants telephone number, including area code (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.875% EUR notes due May 2027 3.150% EUR Notes due 2028 6.250% GBP notes due January 2030 3.250% EUR Notes due 2031 5.250% GBP notes due January 2033 3.200% EUR Notes due 2034 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Item 8.01 Other Events. On October 24, 2024, The Procter & Gamble Company (the Company) closed an underwritten public offering of $500,000,000 aggregate principal amount of 4.150% Notes due October 24, 2029 and $500,000,000 aggregate principal amount of 4.550% Notes due October 24, 2034 under the Companys Registration Statement on Form S-3 (Registration No. 333-275071). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are",357
2025-01-14,8-K,0000080424-25-000003,"false 0000080424 0000080424 2025-01-14 2025-01-14 0000080424 pg:One375NotesDue2025Member 2025-01-14 2025-01-14 0000080424 pg:Zero110NotesDue2026Member 2025-01-14 2025-01-14 0000080424 pg:Three25EURNotesDue2026Member 2025-01-14 2025-01-14 0000080424 pg:Four875EURNotesDueMay2027Member 2025-01-14 2025-01-14 0000080424 pg:One200NotesDue2028Member 2025-01-14 2025-01-14 0000080424 pg:Three15EURNotesDue2028Member 2025-01-14 2025-01-14 0000080424 pg:One250NotesDue2029Member 2025-01-14 2025-01-14 0000080424 pg:One800NotesDue2029Member 2025-01-14 2025-01-14 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2025-01-14 2025-01-14 0000080424 pg:Zero350NotesDue2030Member 2025-01-14 2025-01-14 0000080424 pg:Zero230NotesDue2031Member 2025-01-14 2025-01-14 0000080424 pg:Three25EURNotesDue2031Member 2025-01-14 2025-01-14 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2025-01-14 2025-01-14 0000080424 pg:Three200EURNotesDue2034Member 2025-01-14 2025-01-14 0000080424 pg:One875NotesDue2038Member 2025-01-14 2025-01-14 0000080424 pg:Zero900NotesDue2041Member 2025-01-14 2025-01-14 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 14, 2025 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 3.200% EUR Notes due 2034 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On January 14, 2025, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of $1.0065 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after February 18, 2025, to Common Stock shareholders of record at the close of business on January 24, 2025, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on January 24, 2025. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" Dividend News Release by The Procter & Gamble Company dated January 14, 2025. Cover Page Interactive Data File (embedded within the Inline XBRL document)",493
2025-01-22,10-Q,0000080424-25-000013,and Analysis of Financial Condition and Results of Operations 13 Item 3. Quantitative and Qualitative Disclosures About Market Risk 28 Item 4. Controls and Procedures 28 PART II Item 1. Legal Proceedings 29 Item 1A.,35
2025-01-22,8-K,0000080424-25-000009,"pg-20250122 0000080424 False False False False False 0000080424 2025-01-22 2025-01-22 0000080424 2025-01-22 2025-01-22 0000080424 pg:A1.375due2025Domain 2025-01-22 2025-01-22 0000080424 pg:A0110Due2026Domain 2025-01-22 2025-01-22 0000080424 pg:A3250EURNotesDue2026Domain 2025-01-22 2025-01-22 0000080424 pg:A4.875EURdueMay2027Domain 2025-01-22 2025-01-22 0000080424 pg:A1.200due2028Domain 2025-01-22 2025-01-22 0000080424 pg:A3.150EURNotesDue2028Domain 2025-01-22 2025-01-22 0000080424 pg:A1.250due2029Domain 2025-01-22 2025-01-22 0000080424 pg:A1.800due2029Domain 2025-01-22 2025-01-22 0000080424 pg:A6.250GBPdueJanuary2030Domain 2025-01-22 2025-01-22 0000080424 pg:A0350Due2030Domain 2025-01-22 2025-01-22 0000080424 pg:A0230Due2031Domain 2025-01-22 2025-01-22 0000080424 pg:A3250EURNotesDue2031Domain 2025-01-22 2025-01-22 0000080424 pg:A5.250GBPdueJanuary2033Domain 2025-01-22 2025-01-22 0000080424 pg:A3.200EURNotesDue2034Domain 2025-01-22 2025-01-22 0000080424 pg:A1.875due2038Domain 2025-01-22 2025-01-22 0000080424 pg:A0900Due2041Domain 2025-01-22 2025-01-22 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) January 22, 2025 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio OH 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza , Cincinnati OH One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 1.375% Notes due 2025 PG25 NYSE 0.110% Notes due 2026 PG26D NYSE 3.250% EUR Notes due 2026 PG26F NYSE 4.875% EUR notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 3.150% EUR Notes due 2028 PG28B NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 3.250% EUR Notes due 2031 PG31B NYSE 5.250% GBP notes due January 2033 PG33 NYSE 3.200% EUR Notes due 2034 PG34C NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 22, 2025 , The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended December 31, 2024. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated January 22, 2025 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",578
2025-01-22,8-K,0000080424-25-000011,"false 0000080424 0000080424 2025-01-22 2025-01-22 0000080424 pg:One375NotesDue2025Member 2025-01-22 2025-01-22 0000080424 pg:Zero110NotesDue2026Member 2025-01-22 2025-01-22 0000080424 pg:Three25EURNotesDue2026Member 2025-01-22 2025-01-22 0000080424 pg:Four875EURNotesDueMay2027Member 2025-01-22 2025-01-22 0000080424 pg:One200NotesDue2028Member 2025-01-22 2025-01-22 0000080424 pg:Three150EURNotesDue2028Member 2025-01-22 2025-01-22 0000080424 pg:One250NotesDue2029Member 2025-01-22 2025-01-22 0000080424 pg:One800NotesDue2029Member 2025-01-22 2025-01-22 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2025-01-22 2025-01-22 0000080424 pg:Zero350NotesDue2030Member 2025-01-22 2025-01-22 0000080424 pg:Zero230NotesDue2031Member 2025-01-22 2025-01-22 0000080424 pg:Three25EURNotesDue2031Member 2025-01-22 2025-01-22 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2025-01-22 2025-01-22 0000080424 pg:Three200EURNotesDue2034Member 2025-01-22 2025-01-22 0000080424 pg:One875NotesDue2038Member 2025-01-22 2025-01-22 0000080424 pg:Zero900NotesDue2041Member 2025-01-22 2025-01-22 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 22, 2025 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 3.150% EUR Notes due 2028 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 3.200% EUR Notes due 2034 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On January 22, 2025, The Procter & Gamble Company (the ""Company"") issued a press release announcing its second quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated January 22, 2025. Cover Page Interactive Data File (embedded within the Inline XBRL document)",459
2025-04-08,8-K,0000080424-25-000025,"false 0000080424 0000080424 2025-04-08 2025-04-08 0000080424 pg:Zero900NotesDue2041Member 2025-04-08 2025-04-08 0000080424 pg:Three200EURNotesDue2034Member 2025-04-08 2025-04-08 0000080424 pg:Zero110NotesDue2026Member 2025-04-08 2025-04-08 0000080424 pg:One200NotesDue2028Member 2025-04-08 2025-04-08 0000080424 pg:Three15EURNotesDue2028Member 2025-04-08 2025-04-08 0000080424 pg:Three25EURNotesDue2031Member 2025-04-08 2025-04-08 0000080424 pg:One250NotesDue2029Member 2025-04-08 2025-04-08 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2025-04-08 2025-04-08 0000080424 pg:Zero350NotesDue2030Member 2025-04-08 2025-04-08 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2025-04-08 2025-04-08 0000080424 pg:Zero230NotesDue2031Member 2025-04-08 2025-04-08 0000080424 pg:One375NotesDue2025Member 2025-04-08 2025-04-08 0000080424 pg:One875NotesDue2038Member 2025-04-08 2025-04-08 0000080424 pg:Three25EURNotesDue2026Member 2025-04-08 2025-04-08 0000080424 pg:Four875EURNotesDueMay2027Member 2025-04-08 2025-04-08 0000080424 pg:One800NotesDue2029Member 2025-04-08 2025-04-08 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 8, 2025 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 3.200% EUR Notes due 2034 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On April 8, 2025, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of $1.0568 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after May 15, 2025, to Common Stock shareholders of record at the close of business on April 21, 2025, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on April 21, 2025. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" 9.01 FINANCIAL STATEMENTS AND EXHIBITS Dividend News Release by The Procter & Gamble Company dated April 8, 2025. Cover Page Interactive Data File (embedded within the Inline XBRL document)",495
2025-04-24,10-Q,0000080424-25-000037,and Analysis of Financial Condition and Results of Operations 13 Item 3. Quantitative and Qualitative Disclosures About Market Risk 28 Item 4. Controls and Procedures 28 PART II Item 1. Legal Proceedings 28 Item 1A.,35
2025-04-24,8-K,0000080424-25-000032,"pg-20250424 0000080424 False False False False False 0000080424 2025-04-24 2025-04-24 0000080424 2025-04-24 2025-04-24 0000080424 pg:A1.375due2025Domain 2025-04-24 2025-04-24 0000080424 pg:A0110Due2026Domain 2025-04-24 2025-04-24 0000080424 pg:A3250EURNotesDue2026Domain 2025-04-24 2025-04-24 0000080424 pg:A4.875EURdueMay2027Domain 2025-04-24 2025-04-24 0000080424 pg:A1.200due2028Domain 2025-04-24 2025-04-24 0000080424 pg:A3.150EURNotesDue2028Domain 2025-04-24 2025-04-24 0000080424 pg:A1.250due2029Domain 2025-04-24 2025-04-24 0000080424 pg:A1.800due2029Domain 2025-04-24 2025-04-24 0000080424 pg:A6.250GBPdueJanuary2030Domain 2025-04-24 2025-04-24 0000080424 pg:A0350Due2030Domain 2025-04-24 2025-04-24 0000080424 pg:A0230Due2031Domain 2025-04-24 2025-04-24 0000080424 pg:A3250EURNotesDue2031Domain 2025-04-24 2025-04-24 0000080424 pg:A5.250GBPdueJanuary2033Domain 2025-04-24 2025-04-24 0000080424 pg:A3.200EURNotesDue2034Domain 2025-04-24 2025-04-24 0000080424 pg:A1.875due2038Domain 2025-04-24 2025-04-24 0000080424 pg:A0900Due2041Domain 2025-04-24 2025-04-24 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) April 24, 2025 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio OH 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza , Cincinnati OH One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 1.375% Notes due 2025 PG25 NYSE 0.110% Notes due 2026 PG26D NYSE 3.250% EUR Notes due 2026 PG26F NYSE 4.875% EUR notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 3.150% EUR Notes due 2028 PG28B NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 3.250% EUR Notes due 2031 PG31B NYSE 5.250% GBP notes due January 2033 PG33 NYSE 3.200% EUR Notes due 2034 PG34C NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On April 24, 2025 , The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended March 31, 2025. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated April 24, 2025 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",578
2025-04-24,8-K,0000080424-25-000035,"false 0000080424 0000080424 2025-04-24 2025-04-24 0000080424 pg:One375NotesDue2025Member 2025-04-24 2025-04-24 0000080424 pg:Zero110NotesDue2026Member 2025-04-24 2025-04-24 0000080424 pg:Three25EURNotesDue2026Member 2025-04-24 2025-04-24 0000080424 pg:Four875EURNotesDueMay2027Member 2025-04-24 2025-04-24 0000080424 pg:One200NotesDue2028Member 2025-04-24 2025-04-24 0000080424 pg:Three150EURNotesDue2028Member 2025-04-24 2025-04-24 0000080424 pg:One250NotesDue2029Member 2025-04-24 2025-04-24 0000080424 pg:One800NotesDue2029Member 2025-04-24 2025-04-24 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2025-04-24 2025-04-24 0000080424 pg:Zero350NotesDue2030Member 2025-04-24 2025-04-24 0000080424 pg:Zero230NotesDue2031Member 2025-04-24 2025-04-24 0000080424 pg:Three25EURNotesDue2031Member 2025-04-24 2025-04-24 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2025-04-24 2025-04-24 0000080424 pg:Three200EURNotesDue2034Member 2025-04-24 2025-04-24 0000080424 pg:One875NotesDue2038Member 2025-04-24 2025-04-24 0000080424 pg:Zero900NotesDue2041Member 2025-04-24 2025-04-24 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 24, 2025 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 3.150% EUR Notes due 2028 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 3.200% EUR Notes due 2034 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On April 24, 2025, The Procter & Gamble Company (the ""Company"") issued a press release announcing its third quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated April 24, 2025. Cover Page Interactive Data File (embedded within the Inline XBRL document)",459
2025-05-01,8-K,0001193125-25-110040,"THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in charter) (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio (Address of principal executive offices) (Zip Code) 513 - 983-1100 Registrants telephone number, including area code (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.875% EUR notes due May 2027 3.150% EUR Notes due 2028 6.250% GBP notes due January 2030 3.250% EUR Notes due 2031 5.250% GBP notes due January 2033 3.200% EUR Notes due 2034 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Other Events. On May 1, 2025, The Procter & Gamble Company (the Company) closed an underwritten public offering of $700,000,000 aggregate principal amount of 4.050% Notes due May 1, 2030 and $550,000,000 aggregate principal amount of 4.600% Notes due May 1, 2035 under the Companys Registration Statement on Form S-3 (Registration No. 333-275071). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are",358
2025-06-05,8-K,0000080424-25-000050,"false 0000080424 0000080424 2025-06-05 2025-06-05 0000080424 pg:Three150EURNotesDue2028Member 2025-06-05 2025-06-05 0000080424 pg:One800NotesDue2029Member 2025-06-05 2025-06-05 0000080424 pg:One250NotesDue2029Member 2025-06-05 2025-06-05 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2025-06-05 2025-06-05 0000080424 pg:Four875EURNotesDueMay2027Member 2025-06-05 2025-06-05 0000080424 pg:Zero900NotesDue2041Member 2025-06-05 2025-06-05 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2025-06-05 2025-06-05 0000080424 pg:Three25EURNotesDue2031Member 2025-06-05 2025-06-05 0000080424 pg:Zero350NotesDue2030Member 2025-06-05 2025-06-05 0000080424 pg:Zero110NotesDue2026Member 2025-06-05 2025-06-05 0000080424 pg:One875NotesDue2038Member 2025-06-05 2025-06-05 0000080424 pg:One200NotesDue2028Member 2025-06-05 2025-06-05 0000080424 pg:Zero230NotesDue2031Member 2025-06-05 2025-06-05 0000080424 pg:Three25EURNotesDue2026Member 2025-06-05 2025-06-05 0000080424 pg:Three200EURNotesDue2034Member 2025-06-05 2025-06-05 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 5, 2025 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 3.150% EUR Notes due 2028 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 3.200% EUR Notes due 2034 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE The Procter & Gamble Company (the Company) announced today a 2-year, non-core restructuring program while presenting at the Deutsche Banks dbAccess Global Consumer Conference. The program includes three elements: portfolio choices, supply chain optimization and organization design. The program will include brand exits in certain markets, the details of which will be announced at a later date. In addition, the portfolio choices will enable related interventions in the supply chain to drive various benefits, including efficiencies, faster innovation, and cost reduction. The Company also expects to reduce up to 7,000 roles, or approximately 15% of our current non-manufacturing workforce. In connection with this announcement, the Company expects to record a total non-core charge of $1.0 to $1.6 billion before tax over the course of the two-year program. The Company expects 25% of these charges to be non-cash. The slides referenced in connection with the announcement are attached hereto as Exhibit 99.1 and are incorporated by reference herein. The information contained in this 8-K, including Exhibit 99.1, is being furnished pursuant to Item 7.01, Regulation FD Disclosure. ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Informational Slides Provided by The Procter & Gamble Company dated June 5, 2025. Cover Page Interactive Data File (embedded within the Inline XBRL document) Forward-Looking Statements Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are ""forward-looking statements"" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words ""believe,"" ""project,"" ""expect,"" ""anticipate,"" ""estimate,"" ""intend,"" ""strategy,"" ""future,"" ""opportunity,"" ""plan,"" ""may,"" ""should,"" ""will,"" ""would,"" ""will be,"" ""will continue,"" ""will likely result"" and similar expressions. Forward-looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, except to the extent required by law. Risks and uncertainties to which our forward-looking statements are subject include, without limitation: (1) the ability to successfully manage global financial risks, including foreign currency fluctuations, currency exchange, pricing controls or tariffs; (2) the ability to successfully manage local, regional or global economic volatility, including reduced market growth rates, and to generate sufficient income and cash flow to allow the Company to effect the expected share repurchases and dividend payments; (3) the ability to successfully manage uncertainties related to changing political and geopolitical conditions and potential implications such as exchange rate fluctuations, market contraction, boycotts, sanctions, tariffs or other trade controls; (4) the ability to manage disruptions in credit markets or to our banking partners or changes to our credit rating; (5) the ability to maintain key manufacturing and supply arrangements (including execution of supply chain optimizations and sole supplier and sole manufacturing plant arrangements) and to manage disruption of business due to various factors, including ones outside of our control, such as natural disasters, acts of war or terrorism or disease outbreaks; (6) the ability to successfully manage cost fluctuations and pressures, including prices of commodities and raw materials and costs of labor, transportation, energy, pension and healthcare; (7) the ability to compete with our local and global competitors in new and existing sales channels, including by successfully responding to competitive factors such as prices, promotional incentives and trade terms for products; (8) the ability to manage and maintain key customer relationships; (9) the ability to protect our reputation and brand equity by successfully managing real or perceived issues, including concerns about safety, quality, ingredients, efficacy, packaging content, supply chain practices or similar matters that may arise; (10) the ability to successfully manage the financial, legal, reputational and operational risk associated with third-party relationships, such as our suppliers, contract manufacturers, distributors, contractors and external business partners; (11) the ability to rely on and maintain key company and third-party information and operational technology systems, networks and services and maintain the security and functionality of such systems, networks and services and the data contained therein; (12) the ability to successfully manage the demand, supply and operational challenges, as well as governmental responses or mandates, associated with a disease outbreak, including epidemics, pandemics or similar widespread public health concerns; (13) the ability to stay on the leading edge of innovation, obtain necessary intellectual property protections and successfully respond to changing consumer habits, evolving digital marketing and selling platform requirements and technological advances attained by, and patents granted to, competitors; (14) the ability to successfully manage our ongoing acquisition, divestiture and joint venture activities, in each case to achieve the Company's overall business strategy and financial objectives, without impacting the delivery of base business objectives; (15) the ability to successfully achieve productivity improvements and cost savings and manage ongoing organizational changes while successfully identifying, developing and retaining key employees, including in key growth markets where the availability of skilled or experienced employees may be limited; (16) the ability to successfully manage current and expanding regulatory and legal requirements and matters (including, without limitation, those laws and regulations involving product liability, product and packaging composition, manufacturing processes, intellectual property, labor and employment, antitrust, privacy, cybersecurity and data protection, artificial intelligence, tax, the environment, due diligence, risk oversight, accounting and financial reporting) and to resolve new and pending matters within current estimates; (17) the ability to manage changes in applicable tax laws and regulations; and (18) the ability to successfully achieve our ambition of reducing our greenhouse gas emissions and delivering progress towards our environmental sustainability priorities. For additional information concerning factors that could cause actual results and events to differ materially from those projected herein, please refer to our most recent 10-K, 10-Q and 8-K reports.",1351
2025-06-09,8-K,0000080424-25-000052,"false 0000080424 0000080424 2025-06-09 2025-06-09 0000080424 pg:Three25EURNotesDue2031Member 2025-06-09 2025-06-09 0000080424 pg:One875NotesDue2038Member 2025-06-09 2025-06-09 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2025-06-09 2025-06-09 0000080424 pg:Three200EURNotesDue2034Member 2025-06-09 2025-06-09 0000080424 pg:Four875EURNotesDueMay2027Member 2025-06-09 2025-06-09 0000080424 pg:One200NotesDue2028Member 2025-06-09 2025-06-09 0000080424 pg:Zero110NotesDue2026Member 2025-06-09 2025-06-09 0000080424 pg:Zero900NotesDue2041Member 2025-06-09 2025-06-09 0000080424 pg:One800NotesDue2029Member 2025-06-09 2025-06-09 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2025-06-09 2025-06-09 0000080424 pg:One250NotesDue2029Member 2025-06-09 2025-06-09 0000080424 pg:Zero230NotesDue2031Member 2025-06-09 2025-06-09 0000080424 pg:Zero350NotesDue2030Member 2025-06-09 2025-06-09 0000080424 pg:Three25EURNotesDue2026Member 2025-06-09 2025-06-09 0000080424 pg:Three150EURNotesDue2028Member 2025-06-09 2025-06-09 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 9, 2025 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 3.150% EUR Notes due 2028 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 3.200% EUR Notes due 2034 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. On June 9, 2025, the Board of Directors of The Procter & Gamble Company (the Company) appointed Craig Arnold, former Chairman and Chief Executive Officer of Eaton Corporation, as a Director of the Company, effective June 9. Mr. Arnold will serve on the Audit and Compensation & Leadership Development Committees. The Board has determined that Mr. Arnold is independent under the NYSE listing standards and the Companys Independence Guidelines. Mr. Arnold will receive the same compensation as the other non-employee members of the Board of Directors, including a pro-rated annual RSU grant that reflects his June appointment date. The Companys Director compensation program is described in the Companys definitive proxy statement dated August 23, 2024. The Company is filing the information under this item pursuant to Item 5.02(d), Election of Directors. ITEM 7.01 REGULATION FD DISCLOSURE The Company issued a news release on June 9, 2025, announcing the appointment of Mr. Arnold. A copy of this news release is furnished as Exhibit 99.1. The Company is furnishing the information under this item, including Exhibit 99.1, pursuant to Item 7.01, Regulation FD Disclosure. ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Director News Release by The Procter & Gamble Company dated June 9, 2025. Cover Page Interactive Data File (embedded within the Inline XBRL document)",588
2025-07-08,8-K,0000080424-25-000057,"false 0000080424 0000080424 2025-07-08 2025-07-08 0000080424 pg:One200NotesDue2028Member 2025-07-08 2025-07-08 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2025-07-08 2025-07-08 0000080424 pg:Zero350NotesDue2030Member 2025-07-08 2025-07-08 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2025-07-08 2025-07-08 0000080424 pg:Four875EURNotesDueMay2027Member 2025-07-08 2025-07-08 0000080424 pg:Zero110NotesDue2026Member 2025-07-08 2025-07-08 0000080424 pg:Zero230NotesDue2031Member 2025-07-08 2025-07-08 0000080424 pg:Three25EURNotesDue2026Member 2025-07-08 2025-07-08 0000080424 pg:One875NotesDue2038Member 2025-07-08 2025-07-08 0000080424 pg:One250NotesDue2029Member 2025-07-08 2025-07-08 0000080424 pg:Three25EURNotesDue2031Member 2025-07-08 2025-07-08 0000080424 pg:One800NotesDue2029Member 2025-07-08 2025-07-08 0000080424 pg:Three200EURNotesDue2034Member 2025-07-08 2025-07-08 0000080424 pg:Three15EURNotesDue2028Member 2025-07-08 2025-07-08 0000080424 pg:Zero900NotesDue2041Member 2025-07-08 2025-07-08 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 8, 2025 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 3.200% EUR Notes due 2034 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On July 8, 2025, The Procter & Gamble Company (the ""Company"") announced that its Board of Directors declared a quarterly dividend of $1.0568 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after August 15, 2025, to Common Stock shareholders of record at the close of business on July 18, 2025, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on July 18, 2025. The Company is furnishing this 8-K pursuant to Item 7.01, ""Regulation FD Disclosure."" Dividend News Release by The Procter & Gamble Company dated July 8, 2025. Cover Page Interactive Data File (embedded within the Inline XBRL document)",489
2025-07-28,8-K,0000080424-25-000061,"false 0000080424 0000080424 2025-07-28 2025-07-28 0000080424 pg:Three15EURNotesDue2028Member 2025-07-28 2025-07-28 0000080424 pg:Zero230NotesDue2031Member 2025-07-28 2025-07-28 0000080424 pg:Zero110NotesDue2026Member 2025-07-28 2025-07-28 0000080424 pg:Three25EURNotesDue2026Member 2025-07-28 2025-07-28 0000080424 pg:Three25EURNotesDue2031Member 2025-07-28 2025-07-28 0000080424 pg:One875NotesDue2038Member 2025-07-28 2025-07-28 0000080424 pg:Six250GBPNotesDueJanuary2030Member 2025-07-28 2025-07-28 0000080424 pg:Four875EURNotesDueMay2027Member 2025-07-28 2025-07-28 0000080424 pg:Three200EURNotesDue2034Member 2025-07-28 2025-07-28 0000080424 pg:Zero350NotesDue2030Member 2025-07-28 2025-07-28 0000080424 pg:Zero900NotesDue2041Member 2025-07-28 2025-07-28 0000080424 pg:One800NotesDue2029Member 2025-07-28 2025-07-28 0000080424 pg:Five250GBPNotesDueJanuary2033Member 2025-07-28 2025-07-28 0000080424 pg:One200NotesDue2028Member 2025-07-28 2025-07-28 0000080424 pg:One250NotesDue2029Member 2025-07-28 2025-07-28 SECURITIES AND EXCHANGE COMMISSION Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 28, 2025 THE PROCTER & GAMBLE COMPANY (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices, including zip code) (Registrants telephone number, including area code) address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock without Par Value 4.875% EUR notes due May 2027 6.250% GBP notes due January 2030 5.250% GBP notes due January 2033 3.200% EUR Notes due 2034 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS . On July 28, 2025, The Procter & Gamble Company (the ""Company"") announced the following executive changes: Jon Moeller, Chairman of the Board, President and Chief Executive Officer, will transition into the role of Executive Chairman of the Board, effective January 1, 2026, to serve at the pleasure of the Board of Directors. Shailesh Jejurikar (age 58), currently Chief Operating Officer, has been elected President and Chief Executive Officer, effective January 1, 2026, to serve at the pleasure of the Board of Directors. The Board has also nominated Mr. Jejurikar to stand for election to the Board at the Companys annual shareholder meeting in October 2025, to be effective upon conclusion of the annual Mr. Jejurikar joined the Company in 1989 and has held positions of increasing responsibility since that time. Most recently, he has served as Chief Operating Officer (2021  present). Previously, he served as Chief Executive Officer, Global Fabric and Home Care, and Executive Sponsor, Global Sustainability (2019  2021). Effective January 1, 2026, Mr. Jejurikar will receive an annual base salary of U.S. $1.6 million and will participate in the Company's annual incentive program with a target award equal to 200% of base salary. In relation to his election and in connection with the Companys annual equity grant cycle, the Board of Directors approved a long-term incentive award valued at $14 million, with approximately 50% of the long-term incentive value in the Companys Performance Stock Program and 50% in the Long-Term Incentive Program. Going forward, Mr. Jejurikar will continue to receive equity grants under the Company's long-term incentive program commensurate with his position and on the same timing as other executive officers and will participate in all other elements of the Company's executive compensation and benefit programs (including as a vested participant in the Company's retirement program). Those programs are outlined in the Company's definitive proxy statement dated August 23, 2024. If elected to the Board by shareholders in October 2025, Mr. Jejurikar will not receive any fees for his service on the Board of Directors. Effective January 1, 2026, Mr. Moeller will receive an annual base salary of U.S. $1.2 million and will participate in the Company's annual incentive program with a target award equal to 150% of base salary. In relation to his election and in connection with the Companys annual equity grant cycle, the Board of Directors approved a long-term incentive award valued at $15 million, with approximately 50% of the long-term incentive value in the Companys Performance Stock Program and 50% in the Long-Term Incentive Program. Going forward, Mr. Moeller will continue to receive equity grants under the Company's long-term incentive program commensurate with his position and on the same timing as other executive officers and will participate in all other elements of the Company's executive compensation and benefit programs (including as a vested participant in the Company's retirement program). Those programs are outlined in the Company's definitive proxy statement dated August 23, 2024. The Company is filing the information under this item pursuant to Item 5.02, ""Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers."" ITEM 7.01 REGULATION FD DISCLOSURE The Company issued a news release on July 28, 2025, announcing the election of Mr. Jejurikar and the changes to Mr. Moellers role. A copy of this news release is furnished as The Company is furnishing the information under this item, including Exhibit 99.1, pursuant to Item 7.01, ""Regulation FD Disclosure."" Executive Changes Press Release by The Procter & Gamble Company dated July 28, 2025 Cover Page Interactive Data File (embedded within the Inline XBRL document)",974
2025-07-29,8-K,0000080424-25-000067,"pg-20250729 0000080424 False False 0000080424 2025-07-29 2025-07-29 0000080424 2025-07-29 2025-07-29 0000080424 exch:XNYS 2025-07-29 2025-07-29 0000080424 pg:A0.110NotesDue2026Domain 2025-07-29 2025-07-29 0000080424 pg:A3.250EURNotesDue2026Domain 2025-07-29 2025-07-29 0000080424 pg:A4.875EURNotesDueMay2027Domain 2025-07-29 2025-07-29 0000080424 pg:A1.200NotesDue2028Domain 2025-07-29 2025-07-29 0000080424 pg:A3.150EURNotesDue2028Domain 2025-07-29 2025-07-29 0000080424 pg:A1.250NotesDue2029Domain 2025-07-29 2025-07-29 0000080424 pg:A1.800NotesDue2029Domain 2025-07-29 2025-07-29 0000080424 pg:A6.250GBPNotesDueJanuary2030Domain 2025-07-29 2025-07-29 0000080424 pg:A0.350NotesDue2030Domain 2025-07-29 2025-07-29 0000080424 pg:A0.230NotesDue2031Domain 2025-07-29 2025-07-29 0000080424 pg:A3.250EURNotesDue2031Domain 2025-07-29 2025-07-29 0000080424 pg:A5.250GBPNotesDueJanuary2033Domain 2025-07-29 2025-07-29 0000080424 pg:A3.200EURNotesDue2034Domain 2025-07-29 2025-07-29 0000080424 pg:A1.875NotesDue2038Domain 2025-07-29 2025-07-29 0000080424 pg:A0900Due2041Domain 2025-07-29 2025-07-29 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) July 29, 2025 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 0.110% Notes due 2026 PG26D NYSE 3.250% EUR Notes due 2026 PG26F NYSE 4.875% EUR Notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 3.150% EUR Notes due 2028 PG28B NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP Notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 3.250% EUR Notes due 2031 PG31B NYSE 5.250% GBP Notes due January 2033 PG33 NYSE 3.200% EUR Notes due 2034 PG34C NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On July 29, 2025, The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter and fiscal year ended June 30, 2025. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated July 29, 2025 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",562
2025-07-29,8-K,0000080424-25-000069,"pg-20250729 0000080424 False False 0000080424 2025-07-29 2025-07-29 0000080424 2025-07-29 2025-07-29 0000080424 exch:XNYS 2025-07-29 2025-07-29 0000080424 pg:A0.110NotesDue2026Domain 2025-07-29 2025-07-29 0000080424 pg:A3.25EURNotesDue2026Domain 2025-07-29 2025-07-29 0000080424 pg:A4.875EURNotesDueMay2027Domain 2025-07-29 2025-07-29 0000080424 pg:A1.200NotesDue2028Domain 2025-07-29 2025-07-29 0000080424 pg:A3.150EURNotesDue2028Domain 2025-07-29 2025-07-29 0000080424 pg:A1.250NotesDue2029Domain 2025-07-29 2025-07-29 0000080424 pg:A1.800NotesDue2029Domain 2025-07-29 2025-07-29 0000080424 pg:A6.250GBPNotesDueJanuary2030Domain 2025-07-29 2025-07-29 0000080424 pg:A0.350NotesDue2030Domain 2025-07-29 2025-07-29 0000080424 pg:A0.230NotesDue2031Domain 2025-07-29 2025-07-29 0000080424 pg:A3.250EURNotesDue2031Domain 2025-07-29 2025-07-29 0000080424 pg:A5.250GBPNotesDueJanuary2033Domain 2025-07-29 2025-07-29 0000080424 pg:A3.200EURNotesDue2034Domain 2025-07-29 2025-07-29 0000080424 pg:A1.875NotesDue2038Domain 2025-07-29 2025-07-29 0000080424 pg:A0.900NotesDue2041Domain 2025-07-29 2025-07-29 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 8-K ___________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): 7/29/2025 ___________________________________ The Procter & Gamble Company (Exact name of registrant as specified in its charter) ___________________________________ Ohio (State or other jurisdiction of incorporation or organization) 001-00434 (Commission File Number) 31-0411980 (I.R.S. Employer Identification Number) One Procter & Gamble Plaza Cincinnati , Ohio 45202 (Address of principal executive offices and zip code) ( 513 ) 983-1100 (Registrant's telephone number, including area code) ___________________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock without Par Value PG NYSE 0.110% Notes due 2026 PG26D NYSE 3.25% EUR Notes due 2026 PG26F NYSE 4.875% EUR Notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 3.150% EUR Notes due 2028 PG28B NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP Notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 3.250% EUR Notes due 2031 PG31B NYSE 5.250% GBP Notes due January 2033 PG33 NYSE 3.200% EUR Notes due 2034 PG34C NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act. Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 7.01 - Regulation FD Disclosure On July 29, 2025, The Procter & Gamble Company (the ""Company"") issued a press release announcing its fourth quarter and fiscal year 2025 results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" Item 9.01 - Financial Statements and Exhibits (d): The following exhibits are being filed herewith: Exhibit No. Description 99.1 Informational Slides Provided by The Procter & Gamble Company dated July 29, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)",569
2025-08-04,10-K,0000080424-25-000076,"pg-20250630 0000080424 2025 FY False iso4217:USD xbrli:shares iso4217:USD xbrli:shares pg:country pg:segment xbrli:pure pg:audit 0000080424 2024-07-01 2025-06-30 0000080424 2024-07-01 2025-06-30 0000080424 pg:A0.110NotesDue2026Member 2024-07-01 2025-06-30 0000080424 pg:A3.250EURNotesDue2026Member 2024-07-01 2025-06-30 0000080424 pg:A4.875EURNotesDueMay2027Member 2024-07-01 2025-06-30 0000080424 pg:A1.200NotesDue2028Member 2024-07-01 2025-06-30 0000080424 pg:A3.150EURONotesDue2028Member 2024-07-01 2025-06-30 0000080424 pg:A1.250NotesDue2029Member 2024-07-01 2025-06-30 0000080424 pg:A1.800NotesDue2029Member 2024-07-01 2025-06-30 0000080424 pg:A6.250GBPNotesDueJanuary2030Member 2024-07-01 2025-06-30 0000080424 pg:A0.350NotesDue2030Member 2024-07-01 2025-06-30 0000080424 pg:A0.230NotesDue2031Member 2024-07-01 2025-06-30 0000080424 pg:A3.250EURNotesDue2031Member 2024-07-01 2025-06-30 0000080424 pg:A5.250GBPNotesDueJanuary2033Member 2024-07-01 2025-06-30 0000080424 pg:A3.200EURNotesDue2034Member 2024-07-01 2025-06-30 0000080424 pg:A1.875NotesDue2038Member 2024-07-01 2025-06-30 0000080424 pg:A0.900NotesDue2041Member 2024-07-01 2025-06-30 0000080424 2024-12-31 0000080424 2025-07-31 0000080424 2023-07-01 2024-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 2025-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2022-07-01 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2023-07-01 2024-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2024-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2024-07-01 2025-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2024-07-01 2025-06-30 0000080424 2025-06-30 0000080424 2025-06-30 0000080424 2025-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2025-06-30 0000080424 2025-06-30 0000080424 2025-06-30 0000080424 2025-06-30 0000080424 2025-06-30 0000080424 2025-06-30 0000080424 srt:MinimumMember 2025-06-30 0000080424 srt:MaximumMember 2025-06-30 0000080424 srt:MinimumMember 2025-06-30 0000080424 srt:MaximumMember 2025-06-30 0000080424 2025-06-30 0000080424 srt:MinimumMember pg:CustomerRelationshipsBrandsandOtherNonContractualIntangibleAssetsMember 2025-06-30 0000080424 srt:MaximumMember pg:CustomerRelationshipsBrandsandOtherNonContractualIntangibleAssetsMember 2025-06-30 0000080424 pg:FabricCareMember pg:FabricHomeCareSegmentMember 2024-07-01 2025-06-30 0000080424 pg:FabricCareMember pg:FabricHomeCareSegmentMember 2023-07-01 2024-06-30 0000080424 pg:FabricCareMember pg:FabricHomeCareSegmentMember 2022-07-01 2023-06-30 0000080424 pg:HomeCareMember pg:FabricHomeCareSegmentMember 2024-07-01 2025-06-30 0000080424 pg:HomeCareMember pg:FabricHomeCareSegmentMember 2023-07-01 2024-06-30 0000080424 pg:HomeCareMember pg:FabricHomeCareSegmentMember 2022-07-01 2023-06-30 0000080424 pg:BabyCareMember pg:BabyFeminineFamilyCareSegmentMember 2024-07-01 2025-06-30 0000080424 pg:BabyCareMember pg:BabyFeminineFamilyCareSegmentMember 2023-07-01 2024-06-30 0000080424 pg:BabyCareMember pg:BabyFeminineFamilyCareSegmentMember 2022-07-01 2023-06-30 0000080424 pg:FamilyCareMember pg:BabyFeminineFamilyCareSegmentMember 2024-07-01 2025-06-30 0000080424 pg:FamilyCareMember pg:BabyFeminineFamilyCareSegmentMember 2023-07-01 2024-06-30 0000080424 pg:FamilyCareMember pg:BabyFeminineFamilyCareSegmentMember 2022-07-01 2023-06-30 0000080424 pg:HairCareMember pg:BeautySegmentMember 2024-07-01 2025-06-30 0000080424 pg:HairCareMember pg:BeautySegmentMember 2023-07-01 2024-06-30 0000080424 pg:HairCareMember pg:BeautySegmentMember 2022-07-01 2023-06-30 0000080424 pg:GroomingMember pg:GroomingSegmentMember 2024-07-01 2025-06-30 0000080424 pg:GroomingMember pg:GroomingSegmentMember 2023-07-01 2024-06-30 0000080424 pg:GroomingMember pg:GroomingSegmentMember 2022-07-01 2023-06-30 0000080424 pg:OralCareMember pg:HealthCareSegmentMember 2024-07-01 2025-06-30 0000080424 pg:OralCareMember pg:HealthCareSegmentMember 2023-07-01 2024-06-30 0000080424 pg:OralCareMember pg:HealthCareSegmentMember 2022-07-01 2023-06-30 0000080424 pg:FeminineCareMember pg:BabyFeminineFamilyCareSegmentMember 2024-07-01 2025-06-30 0000080424 pg:FeminineCareMember pg:BabyFeminineFamilyCareSegmentMember 2023-07-01 2024-06-30 0000080424 pg:FeminineCareMember pg:BabyFeminineFamilyCareSegmentMember 2022-07-01 2023-06-30 0000080424 pg:PersonalCareMember pg:BeautySegmentMember 2024-07-01 2025-06-30 0000080424 pg:PersonalCareMember pg:BeautySegmentMember 2023-07-01 2024-06-30 0000080424 pg:PersonalCareMember pg:BeautySegmentMember 2022-07-01 2023-06-30 0000080424 pg:PersonalHealthCareMember pg:HealthCareSegmentMember 2024-07-01 2025-06-30 0000080424 pg:PersonalHealthCareMember pg:HealthCareSegmentMember 2023-07-01 2024-06-30 0000080424 pg:PersonalHealthCareMember pg:HealthCareSegmentMember 2022-07-01 2023-06-30 0000080424 pg:SkinCareMember pg:BeautySegmentMember 2024-07-01 2025-06-30 0000080424 pg:SkinCareMember pg:BeautySegmentMember 2023-07-01 2024-06-30 0000080424 pg:SkinCareMember pg:BeautySegmentMember 2022-07-01 2023-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2022-07-01 2023-06-30 0000080424 country:US 2024-07-01 2025-06-30 0000080424 country:US 2023-07-01 2024-06-30 0000080424 country:US 2022-07-01 2023-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2022-07-01 2023-06-30 0000080424 country:US 2025-06-30 0000080424 country:US 2024-06-30 0000080424 country:US 2023-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 pg:WalmartInc.AndAffiliatesMember 2023-07-01 2024-06-30 0000080424 pg:WalmartInc.AndAffiliatesMember 2024-07-01 2025-06-30 0000080424 pg:WalmartInc.AndAffiliatesMember 2022-07-01 2023-06-30 0000080424 pg:BeautySegmentMember 2024-07-01 2025-06-30 0000080424 pg:GroomingSegmentMember 2024-07-01 2025-06-30 0000080424 pg:HealthCareSegmentMember 2024-07-01 2025-06-30 0000080424 pg:FabricHomeCareSegmentMember 2024-07-01 2025-06-30 0000080424 pg:BabyFeminineFamilyCareSegmentMember 2024-07-01 2025-06-30 0000080424 2024-07-01 2025-06-30 0000080424 pg:BeautySegmentMember 2023-07-01 2024-06-30 0000080424 pg:GroomingSegmentMember 2023-07-01 2024-06-30 0000080424 pg:HealthCareSegmentMember 2023-07-01 2024-06-30 0000080424 pg:FabricHomeCareSegmentMember 2023-07-01 2024-06-30 0000080424 pg:BabyFeminineFamilyCareSegmentMember 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 pg:GilletteMember 2023-07-01 2024-06-30 0000080424 pg:BeautySegmentMember 2022-07-01 2023-06-30 0000080424 pg:GroomingSegmentMember 2022-07-01 2023-06-30 0000080424 pg:HealthCareSegmentMember 2022-07-01 2023-06-30 0000080424 pg:FabricHomeCareSegmentMember 2022-07-01 2023-06-30 0000080424 pg:BabyFeminineFamilyCareSegmentMember 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 srt:MinimumMember 2025-06-30 0000080424 srt:MaximumMember 2025-06-30 0000080424 2024-07-01 2024-09-30 0000080424 2023-10-01 2024-09-30 0000080424 2024-07-01 2025-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2025-06-30 0000080424 2025-06-30 0000080424 2025-06-30 0000080424 pg:BeautySegmentMember 2023-06-30 0000080424 pg:GroomingSegmentMember 2023-06-30 0000080424 pg:HealthCareSegmentMember 2023-06-30 0000080424 pg:FabricHomeCareSegmentMember 2023-06-30 0000080424 pg:BabyFeminineFamilyCareSegmentMember 2023-06-30 0000080424 pg:BeautySegmentMember 2023-07-01 2024-06-30 0000080424 pg:GroomingSegmentMember 2023-07-01 2024-06-30 0000080424 pg:HealthCareSegmentMember 2023-07-01 2024-06-30 0000080424 pg:FabricHomeCareSegmentMember 2023-07-01 2024-06-30 0000080424 pg:BabyFeminineFamilyCareSegmentMember 2023-07-01 2024-06-30 0000080424 pg:BeautySegmentMember 2024-06-30 0000080424 pg:GroomingSegmentMember 2024-06-30 0000080424 pg:HealthCareSegmentMember 2024-06-30 0000080424 pg:FabricHomeCareSegmentMember 2024-06-30 0000080424 pg:BabyFeminineFamilyCareSegmentMember 2024-06-30 0000080424 pg:BeautySegmentMember 2024-07-01 2025-06-30 0000080424 pg:GroomingSegmentMember 2024-07-01 2025-06-30 0000080424 pg:HealthCareSegmentMember 2024-07-01 2025-06-30 0000080424 pg:FabricHomeCareSegmentMember 2024-07-01 2025-06-30 0000080424 pg:BabyFeminineFamilyCareSegmentMember 2024-07-01 2025-06-30 0000080424 pg:BeautySegmentMember 2025-06-30 0000080424 pg:GroomingSegmentMember 2025-06-30 0000080424 pg:HealthCareSegmentMember 2025-06-30 0000080424 pg:FabricHomeCareSegmentMember 2025-06-30 0000080424 pg:BabyFeminineFamilyCareSegmentMember 2025-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 srt:MinimumMember 2024-07-01 2025-06-30 0000080424 srt:MaximumMember 2024-07-01 2025-06-30 0000080424 pg:SubjectToExpirationExpiringBetween2025And2045Member 2025-06-30 0000080424 pg:NotSubjectToExpirationMember 2025-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2022-07-01 2023-06-30 0000080424 pg:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember 2024-07-01 2025-06-30 0000080424 pg:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember 2023-07-01 2024-06-30 0000080424 pg:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember 2022-07-01 2023-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 2025-06-30 0000080424 2025-06-30 0000080424 pg:RestrictedStockUnitsRSUsAndPerformanceStockUnitsPSUsMember 2025-06-30 0000080424 country:US 2024-07-01 2025-06-30 0000080424 country:US 2022-07-01 2023-06-30 0000080424 country:US 2023-07-01 2024-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2025-06-30 0000080424 2025-06-30 0000080424 2022-07-01 2023-06-30 0000080424 2022-07-01 2023-06-30 0000080424 srt:MinimumMember 2024-07-01 2025-06-30 0000080424 srt:MaximumMember 2024-07-01 2025-06-30 0000080424 srt:MinimumMember 2024-07-01 2025-06-30 0000080424 srt:MaximumMember 2024-07-01 2025-06-30 0000080424 2025-06-30 0000080424 2025-06-30 0000080424 2025-06-30 0000080424 2025-06-30 0000080424 2025-06-30 0000080424 2025-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 pg:CompanyStockMember 2025-06-30 0000080424 pg:CompanyStockMember 2024-06-30 0000080424 pg:CompanyStockMember 2025-06-30 0000080424 pg:CompanyStockMember 2024-06-30 0000080424 pg:CompanyPreferredStockMember 2025-06-30 0000080424 pg:CompanyPreferredStockMember 2024-06-30 0000080424 pg:CompanyPreferredStockMember 2025-06-30 0000080424 pg:CompanyPreferredStockMember 2024-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 pg:InsuranceContractsMember 2025-06-30 0000080424 pg:InsuranceContractsMember 2024-06-30 0000080424 pg:InsuranceContractsMember 2025-06-30 0000080424 pg:InsuranceContractsMember 2024-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 1989-06-30 0000080424 2025-06-30 0000080424 2024-07-01 2025-06-30 0000080424 1991-06-30 0000080424 2025-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 2023-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 2025-06-30 0000080424 2024-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2023-07-01 2024-06-30 0000080424 pg:A0.50EURNoteDueOctober2024Member 2025-06-30 0000080424 pg:A0.50EURNoteDueOctober2024Member 2024-06-30 0000080424 pg:A0.63EURNoteDueOctober2024Member 2025-06-30 0000080424 pg:A0.63EURNoteDueOctober2024Member 2024-06-30 0000080424 pg:A0.55USDNoteDueOctober2025Member 2025-06-30 0000080424 pg:A0.55USDNoteDueOctober2025Member 2024-06-30 0000080424 pg:A4.10USDNoteDueJanuary2026Member 2025-06-30 0000080424 pg:A4.10USDNoteDueJanuary2026Member 2024-06-30 0000080424 pg:A2.70USDNoteDueFebruary2026Member 2025-06-30 0000080424 pg:A2.70USDNoteDueFebruary2026Member 2024-06-30 0000080424 pg:A1.00USDNoteDueApril2026Member 2025-06-30 0000080424 pg:A1.00USDNoteDueApril2026Member 2024-06-30 0000080424 pg:A3.25EURNoteDueAugust2026Member 2025-06-30 0000080424 pg:A3.25EURNoteDueAugust2026Member 2024-06-30 0000080424 pg:A2.45USDNoteDueNovember2026Member 2025-06-30 0000080424 pg:A2.45USDNoteDueNovember2026Member 2024-06-30 0000080424 pg:A1.90USDNoteDueFebruary2027Member 2025-06-30 0000080424 pg:A1.90USDNoteDueFebruary2027Member 2024-06-30 0000080424 pg:A2.80USDNoteDueMarch2027Member 2025-06-30 0000080424 pg:A2.80USDNoteDueMarch2027Member 2024-06-30 0000080424 pg:A4.88EURNoteDueMay2027Member 2025-06-30 0000080424 pg:A4.88EURNoteDueMay2027Member 2024-06-30 0000080424 pg:A2.85USDNoteDueAugust2027Member 2025-06-30 0000080424 pg:A2.85USDNoteDueAugust2027Member 2024-06-30 0000080424 pg:A3.95USDNoteDueJanuary2028Member 2025-06-30 0000080424 pg:A3.95USDNoteDueJanuary2028Member 2024-06-30 0000080424 pg:A3.15EURNoteDueApril2028Member 2025-06-30 0000080424 pg:A3.15EURNoteDueApril2028Member 2024-06-30 0000080424 pg:A1.20EURNoteDueOctober2028Member 2025-06-30 0000080424 pg:A1.20EURNoteDueOctober2028Member 2024-06-30 0000080424 pg:A4.35USDNoteDueJanuary2029Member 2025-06-30 0000080424 pg:A4.35USDNoteDueJanuary2029Member 2024-06-30 0000080424 pg:A1.80GBPNoteDueMay2029Member 2025-06-30 0000080424 pg:A1.80GBPNoteDueMay2029Member 2024-06-30 0000080424 pg:A4.15USDNoteDueOctober2029Member 2025-06-30 0000080424 pg:A4.15USDNoteDueOctober2029Member 2024-06-30 0000080424 pg:A1.25EURNoteDueOctober2029Member 2025-06-30 0000080424 pg:A1.25EURNoteDueOctober2029Member 2024-06-30 0000080424 pg:A3.00USDNoteDueMarch2030Member 2025-06-30 0000080424 pg:A3.00USDNoteDueMarch2030Member 2024-06-30 0000080424 pg:A4.05USDNoteDueMay2030Member 2025-06-30 0000080424 pg:A4.05USDNoteDueMay2030Member 2024-06-30 0000080424 pg:A0.35EURNoteDueMay2030Member 2025-06-30 0000080424 pg:A0.35EURNoteDueMay2030Member 2024-06-30 0000080424 pg:A1.20USDNoteDueOctober2030Member 2025-06-30 0000080424 pg:A1.20USDNoteDueOctober2030Member 2024-06-30 0000080424 pg:A1.95USDNoteDueApril2031Member 2025-06-30 0000080424 pg:A1.95USDNoteDueApril2031Member 2024-06-30 0000080424 pg:A3.25EURNoteDueAugust2031Member 2025-06-30 0000080424 pg:A3.25EURNoteDueAugust2031Member 2024-06-30 0000080424 pg:A2.30USDNoteDueFebruary2032Member 2025-06-30 0000080424 pg:A2.30USDNoteDueFebruary2032Member 2024-06-30 0000080424 pg:A4.05USDNoteDueJanuary2033Member 2025-06-30 0000080424 pg:A4.05USDNoteDueJanuary2033Member 2024-06-30 0000080424 pg:A4.55USDNoteDueJanuary2034Member 2025-06-30 0000080424 pg:A4.55USDNoteDueJanuary2034Member 2024-06-30 0000080424 pg:A3.20EURNoteDueApril2034Member 2025-06-30 0000080424 pg:A3.20EURNoteDueApril2034Member 2024-06-30 0000080424 pg:A4.55USDNoteDueOctober2034Member 2025-06-30 0000080424 pg:A4.55USDNoteDueOctober2034Member 2024-06-30 0000080424 pg:A4.60USDNoteDueMay2035Member 2025-06-30 0000080424 pg:A4.60USDNoteDueMay2035Member 2024-06-30 0000080424 pg:A5.55USDNoteDueMarch2037Member 2025-06-30 0000080424 pg:A5.55USDNoteDueMarch2037Member 2024-06-30 0000080424 pg:A1.88EURNoteDueOctober2038Member 2025-06-30 0000080424 pg:A1.88EURNoteDueOctober2038Member 2024-06-30 0000080424 pg:A3.55USDNoteDueMarch2040Member 2025-06-30 0000080424 pg:A3.55USDNoteDueMarch2040Member 2024-06-30 0000080424 pg:A0.90EURNoteDueNovember2041Member 2025-06-30 0000080424 pg:A0.90EURNoteDueNovember2041Member 2024-06-30 0000080424 2025-06-30 0000080424 pg:FiveYearCreditFacilityMember 2025-06-30 0000080424 pg:FiveYearCreditFacilityMember 2024-07-01 2025-06-30 0000080424 pg:A364DayCreditFacilityMember 2025-06-30 0000080424 pg:A364DayCreditFacilityMember 2024-07-01 2025-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2023-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2023-07-01 2024-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 2024-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2024-07-01 2025-06-30 0000080424 2025-06-30 0000080424 2025-06-30 0000080424 2025-06-30 0000080424 2025-06-30 0000080424 2025-04-01 2025-06-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark one) [ x ] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 TRUE For the Fiscal Year Ended June 30 , 2025 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 False For the transition period from to Commission File No. 1-434 THE PROCTER & GAMBLE CO MPANY One Procter & Gamble Plaza , Cincinnati , Ohio 45202 Telephone ( 513 ) 983-1100 IRS Employer Identification No. 31-0411980 State of Incorporation: Ohio Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG New York Stock Exchange 0.110% Notes due 2026 PG26D New York Stock Exchange 3.250% EUR Notes due 2026 PG26F New York Stock Exchange 4.875% EUR Notes due May 2027 PG27A New York Stock Exchange 1.200% Notes due 2028 PG28 New York Stock Exchange 3.150% EUR Notes due 2028 PG28B New York Stock Exchange 1.250% Notes due 2029 PG29B New York Stock Exchange 1.800% Notes due 2029 PG29A New York Stock Exchange 6.250% GBP Notes due January 2030 PG30 New York Stock Exchange 0.350% Notes due 2030 PG30C New York Stock Exchange 0.230% Notes due 2031 PG31A New York Stock Exchange 3.250% EUR Notes due 2031 PG31B New York Stock Exchange 5.250% GBP Notes due January 2033 PG33 New York Stock Exchange 3.200% EUR Notes due 2034 PG34C New York Stock Exchange 1.875% Notes due 2038 PG38 New York Stock Exchange 0.900% Notes due 2041 PG41 New York Stock Exchange Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  No o Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes o No  Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No o Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  No o Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of ""large accelerated filer,"" ""accelerated filer,"" ""smaller reporting company,"" and ""emerging growth company"" in Rule 12b-2 of the Exchange Act. Large accelerated filer  Accelerated filer  Emerging growth company  Non-accelerated filer  Smaller reporting company  FALSE FALSE If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Indicate by check mark whether the registrant has filed a report on and attestation to its managements assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the",1886
2025-08-14,8-K,0000080424-25-000111,"pg-20250814 0000080424 False False 0000080424 2025-08-14 2025-08-14 0000080424 2025-08-14 2025-08-14 0000080424 exch:XNYS 2025-08-14 2025-08-14 0000080424 pg:A0.110NotesDue2026Domain 2025-08-14 2025-08-14 0000080424 pg:A3.25EURNotesDue2026Domain 2025-08-14 2025-08-14 0000080424 pg:A4.875EURNotesDueMay2027Domain 2025-08-14 2025-08-14 0000080424 pg:A1.200NotesDue2028Domain 2025-08-14 2025-08-14 0000080424 pg:A3.150EURNotesDue2028Domain 2025-08-14 2025-08-14 0000080424 pg:A1.250NotesDue2029Domain 2025-08-14 2025-08-14 0000080424 pg:A1.800NotesDue2029Domain 2025-08-14 2025-08-14 0000080424 pg:A6.250GBPNotesDueJanuary2030Domain 2025-08-14 2025-08-14 0000080424 pg:A0.350NotesDue2030Domain 2025-08-14 2025-08-14 0000080424 pg:A0.230NotesDue2031Domain 2025-08-14 2025-08-14 0000080424 pg:A3.250EURNotesDue2031Domain 2025-08-14 2025-08-14 0000080424 pg:A5.250GBPNotesDueJanuary2033Domain 2025-08-14 2025-08-14 0000080424 pg:A3.200EURNotesDue2034Domain 2025-08-14 2025-08-14 0000080424 pg:A1.875NotesDue2038Domain 2025-08-14 2025-08-14 0000080424 pg:A0.900NotesDue2041Domain 2025-08-14 2025-08-14 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 8-K ___________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 14, 2025 (August 12, 2025) ___________________________________ The Procter & Gamble Company (Exact name of registrant as specified in its charter) ___________________________________ Ohio (State or other jurisdiction of incorporation or organization) 001-00434 (Commission File Number) 31-0411980 (I.R.S. Employer Identification Number) One Procter & Gamble Plaza Cincinnati , Ohio 45202 (Address of principal executive offices and zip code) ( 513 ) 983-1100 (Registrant's telephone number, including area code) ___________________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock without Par Value PG NYSE 0.110% Notes due 2026 PG26D NYSE 3.25% EUR Notes due 2026 PG26F NYSE 4.875% EUR Notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 3.150% EUR Notes due 2028 PG28B NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP Notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 3.250% EUR Notes due 2031 PG31B NYSE 5.250% GBP Notes due January 2033 PG33 NYSE 3.200% EUR Notes due 2034 PG34C NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act. Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. On August 12, 2025, Alexandra Keith, currently Chief Executive Officer  Beauty, announced her intention to retire from the Company effective February 20, 2026, after more than 36 years of service. At the time of her retirement, Ms. Keith will enter into the Companys standard Written Separation Agreement, which will not provide any cash severance payment, but will allow her to retain the remainder of her special equity award scheduled to vest in August 2026. All other equity awards will be retained or pro-rated as described in the applicable Award Agreement.",566
2025-10-14,8-K,0000080424-25-000217,"pg-20251014 0000080424 False False 0000080424 2025-10-14 2025-10-14 0000080424 2025-10-14 2025-10-14 0000080424 exch:XNYS 2025-10-14 2025-10-14 0000080424 pg:A0.110NotesDue2026Domain 2025-10-14 2025-10-14 0000080424 pg:A3.25EURNotesDue2026Domain 2025-10-14 2025-10-14 0000080424 pg:A4.875EURNotesDueMay2027Domain 2025-10-14 2025-10-14 0000080424 pg:A1.200NotesDue2028Domain 2025-10-14 2025-10-14 0000080424 pg:A3.150EURNotesDue2028Domain 2025-10-14 2025-10-14 0000080424 pg:A1.250NotesDue2029Domain 2025-10-14 2025-10-14 0000080424 pg:A1.800NotesDue2029Domain 2025-10-14 2025-10-14 0000080424 pg:A6.250GBPNotesDueJanuary2030Domain 2025-10-14 2025-10-14 0000080424 pg:A0.350NotesDue2030Domain 2025-10-14 2025-10-14 0000080424 pg:A0.230NotesDue2031Domain 2025-10-14 2025-10-14 0000080424 pg:A3.250EURNotesDue2031Domain 2025-10-14 2025-10-14 0000080424 pg:A5.250GBPNotesDueJanuary2033Domain 2025-10-14 2025-10-14 0000080424 pg:A3.200EURNotesDue2034Domain 2025-10-14 2025-10-14 0000080424 pg:A1.875NotesDue2038Domain 2025-10-14 2025-10-14 0000080424 pg:A0.900NotesDue2041Domain 2025-10-14 2025-10-14 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 8-K ___________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 14, 2025 ___________________________________ The Procter & Gamble Company (Exact name of registrant as specified in its charter) ___________________________________ Ohio (State or other jurisdiction of incorporation or organization) 001-00434 (Commission File Number) 31-0411980 (I.R.S. Employer Identification Number) One Procter & Gamble Plaza Cincinnati , Ohio 45202 (Address of principal executive offices and zip code) ( 513 ) 983-1100 (Registrant's telephone number, including area code) ___________________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock without Par Value PG NYSE 0.110% Notes due 2026 PG26D NYSE 3.25% EUR Notes due 2026 PG26F NYSE 4.875% EUR Notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 3.150% EUR Notes due 2028 PG28B NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP Notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 3.250% EUR Notes due 2031 PG31B NYSE 5.250% GBP Notes due January 2033 PG33 NYSE 3.200% EUR Notes due 2034 PG34C NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act. Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 7.01 - Regulation FD Disclosure On October 14, 2025, The Procter & Gamble Company (the ""Company"") issued a news release announcing that its Board of Directors declared a quarterly dividend of $1.0568 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after November 17, 2025, to Common Stock shareholders of record at the close of business on October 24, 2025, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on October 24, 2025. In addition, the Company announced that, according to preliminary voting results, the Company's fourteen Director nominees were elected to the Company's Board of Directors at the Annual Meeting of Shareholders. The Company is furnishing this 8-K, including Exhibit 99.1, pursuant to Item 7.01, ""Regulation FD Disclosure."" Item 9.01 - Financial Statements and Exhibits Exhibit No. Description 99.1 Dividend News Release by The Procter & Gamble Company dated October 14, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)",637
2025-10-16,8-K,0000080424-25-000235,"pg-20251016 0000080424 False False 0000080424 2025-10-16 2025-10-16 0000080424 2025-10-16 2025-10-16 0000080424 exch:XNYS 2025-10-16 2025-10-16 0000080424 pg:A0.110NotesDue2026Domain 2025-10-16 2025-10-16 0000080424 pg:A3.25EURNotesDue2026Domain 2025-10-16 2025-10-16 0000080424 pg:A4.875EURNotesDueMay2027Domain 2025-10-16 2025-10-16 0000080424 pg:A1.200NotesDue2028Domain 2025-10-16 2025-10-16 0000080424 pg:A3.150EURNotesDue2028Domain 2025-10-16 2025-10-16 0000080424 pg:A1.250NotesDue2029Domain 2025-10-16 2025-10-16 0000080424 pg:A1.800NotesDue2029Domain 2025-10-16 2025-10-16 0000080424 pg:A6.250GBPNotesDueJanuary2030Domain 2025-10-16 2025-10-16 0000080424 pg:A0.350NotesDue2030Domain 2025-10-16 2025-10-16 0000080424 pg:A0.230NotesDue2031Domain 2025-10-16 2025-10-16 0000080424 pg:A3.250EURNotesDue2031Domain 2025-10-16 2025-10-16 0000080424 pg:A5.250GBPNotesDueJanuary2033Domain 2025-10-16 2025-10-16 0000080424 pg:A3.200EURNotesDue2034Domain 2025-10-16 2025-10-16 0000080424 pg:A1.875NotesDue2038Domain 2025-10-16 2025-10-16 0000080424 pg:A0.900NotesDue2041Domain 2025-10-16 2025-10-16 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 8-K ___________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 16, 2025 (October 14, 2025) ___________________________________ The Procter & Gamble Company (Exact name of registrant as specified in its charter) ___________________________________ Ohio (State or other jurisdiction of incorporation or organization) 001-00434 (Commission File Number) 31-0411980 (I.R.S. Employer Identification Number) One Procter & Gamble Plaza Cincinnati , Ohio 45202 (Address of principal executive offices and zip code) ( 513 ) 983-1100 (Registrant's telephone number, including area code) ___________________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock without Par Value PG NYSE 0.110% Notes due 2026 PG26D NYSE 3.25% EUR Notes due 2026 PG26F NYSE 4.875% EUR Notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 3.150% EUR Notes due 2028 PG28B NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP Notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 3.250% EUR Notes due 2031 PG31B NYSE 5.250% GBP Notes due January 2033 PG33 NYSE 3.200% EUR Notes due 2034 PG34C NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act. Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. At the Annual Meeting of Shareholders of The Procter & Gamble Company (the ""Company), held on October 14, 2025, the Companys shareholders approved The Procter & Gamble 2025 Stock and Incentive Compensation Plan (the 2025 Stock Plan). The 2025 Stock Plan authorizes the award of up to 175,000,000 shares of the Company's common stock. Types of awards authorized under the 2025 Stock Plan include common stock, restricted stock units, performance stock units, stock options, and stock appreciation rights. In addition, the 2025 Stock Plan permits the award of any shares that remain available under The Procter & Gamble 2019 Stock and Incentive Compensation Plan, approved by shareholders on October 8, 2019. The Board of Directors approved the 2025 Stock Plan for submission to shareholders on August 12, 2025. In addition to the above description, a summary of the 2025 Stock Plan is provided in the Companys definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on August 29, 2025. These descriptions are qualified in their entirety by reference to the 2025 Stock Plan, a copy of which is filed as Exhibit 10.1 to this Form 8-K. Item 5.07. Submission of Matters to a Vote of Security Holders On October 14, 2025, the Company held its 2025 Annual Meeting of Shareholders. Set forth below are the final voting results for each of the proposals submitted to a vote of the shareholders. Proposal 1  Election of Directors. Each of the following nominees was elected to serve a one-year term on the Companys Board of Directors. Votes For Votes Against Abstentions Broker Non-Votes Allen, B. Marc 1,641,593,836 30,733,501 6,052,004 353,456,701 Arnold, Craig 1,659,592,471 12,862,587 5,924,283 353,456,701 Biggs, Brett 1,644,255,917 27,864,284 6,259,140 353,456,701 Bonini, Sheila 1,645,914,558 26,767,428 5,697,355 353,456,701 Chang, Amy L. 1,646,845,751 25,231,395 6,302,195 353,456,701 Jejurikar, Shailesh 1,658,214,765 13,733,328 6,431,248 353,456,701 Jimenez, Joseph 1,632,774,150 39,321,857 6,283,334 353,456,701 Kempczinski, Christopher 1,609,309,726 62,825,032 6,244,583 353,456,701 Lee, Debra L. 1,641,187,922 30,904,430 6,286,989 353,456,701 McCarthy, Christine M. 1,612,379,591 60,308,803 5,690,947 353,456,701 McEvoy, Ashley 1,658,543,759 13,661,354 6,174,228 353,456,701 Moeller, Jon R. 1,601,057,047 64,196,316 13,125,978 353,456,701 Portman, Robert J. 1,639,611,111 32,755,390 6,012,840 353,456,701 Subramaniam, Rajesh 1,646,446,064 25,186,498 6,746,779 353,456,701 Proposal 2- Ratify Appointment of the Independent Registered Public Accounting Firm. The proposal was approved. Votes For Votes Against Abstentions Broker Non-Votes 1,894,297,538 126,992,854 10,545,650 0 Proposal 3 - Advisory Vote to Approve the Companys Executive Compensation (the Say on Pay Vote). The proposal was approved. Votes For Votes Against Abstentions Broker Non-Votes 1,534,984,603 129,176,624 14,218,114 353,456,701 Proposal 4 - Approval of The Procter & Gamble 2025 Stock and Incentive Compensation Plan. The proposal was approved. Votes For Votes Against Abstentions Broker Non-Votes 1,586,240,525 81,892,084 10,246,732 353,456,701 Proposal 5 - Shareholder Proposal Requesting Additional Reporting on Plastic Packaging. The proposal was not approved. Votes For Votes Against Abstentions Broker Non-Votes 230,471,871 1,423,774,151 24,133,319 353,456,701 The Company is filing this 8-K pursuant to item 5.02(e), Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, and Item 5.07, ""Submission of Matters to a Vote of Security Holders."" Item 9.01 - Financial Statements and Exhibits (d): The following exhibits are being filed herewith: Exhibit No. Description 10.1 The Procter & Gamble 2025 Stock and Incentive Compensation Plan 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)",1026
2025-10-24,8-K,0000080424-25-000243,"pg-20251024 0000080424 False False 0000080424 2025-10-24 2025-10-24 0000080424 2025-10-24 2025-10-24 0000080424 exch:XNYS 2025-10-24 2025-10-24 0000080424 pg:A0.110NotesDue2026Domain 2025-10-24 2025-10-24 0000080424 pg:A3.25EURNotesDue2026Domain 2025-10-24 2025-10-24 0000080424 pg:A4.875EURNotesDueMay2027Domain 2025-10-24 2025-10-24 0000080424 pg:A1.200NotesDue2028Domain 2025-10-24 2025-10-24 0000080424 pg:A3.150EURNotesDue2028Domain 2025-10-24 2025-10-24 0000080424 pg:A1.250NotesDue2029Domain 2025-10-24 2025-10-24 0000080424 pg:A1.800NotesDue2029Domain 2025-10-24 2025-10-24 0000080424 pg:A6.250GBPNotesDueJanuary2030Domain 2025-10-24 2025-10-24 0000080424 pg:A0.350NotesDue2030Domain 2025-10-24 2025-10-24 0000080424 pg:A0.230NotesDue2031Domain 2025-10-24 2025-10-24 0000080424 pg:A3.250EURNotesDue2031Domain 2025-10-24 2025-10-24 0000080424 pg:A5.250GBPNotesDueJanuary2033Domain 2025-10-24 2025-10-24 0000080424 pg:A3.200EURNotesDue2034Domain 2025-10-24 2025-10-24 0000080424 pg:A1.875NotesDue2038Domain 2025-10-24 2025-10-24 0000080424 pg:A0.900NotesDue2041Domain 2025-10-24 2025-10-24 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 8-K ___________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 24, 2025 ___________________________________ The Procter & Gamble Company (Exact name of registrant as specified in its charter) ___________________________________ Ohio (State or other jurisdiction of incorporation or organization) 001-00434 (Commission File Number) 31-0411980 (I.R.S. Employer Identification Number) One Procter & Gamble Plaza Cincinnati , Ohio 45202 (Address of principal executive offices and zip code) ( 513 ) 983-1100 (Registrant's telephone number, including area code) ___________________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock without Par Value PG NYSE 0.110% Notes due 2026 PG26D NYSE 3.25% EUR Notes due 2026 PG26F NYSE 4.875% EUR Notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 3.150% EUR Notes due 2028 PG28B NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP Notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 3.250% EUR Notes due 2031 PG31B NYSE 5.250% GBP Notes due January 2033 PG33 NYSE 3.200% EUR Notes due 2034 PG34C NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act. Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 7.01 - Regulation FD Disclosure On October 24, 2025, The Procter & Gamble Company (the ""Company"") issued a press release announcing its first quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" Item 9.01 - Financial Statements and Exhibits (d): The following exhibits are being filed herewith: Exhibit No. Description 99.1 Informational Slides Provided by The Procter & Gamble Company dated October 24, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)",567
2025-10-24,10-Q,0000080424-25-000245,and Analysis of Financial Condition and Results of Operations 13 Item 3. Quantitative and Qualitative Disclosures About Market Risk 24 Item 4. Controls and Procedures 24 PART II Item 1. Legal Proceedings 24 Item 1A.,35
2025-10-24,8-K,0000080424-25-000240,"pg-20251024 0000080424 False False False False False 0000080424 2025-10-24 2025-10-24 0000080424 2025-10-24 2025-10-24 0000080424 pg:A0.110Due2026Member 2025-10-24 2025-10-24 0000080424 pg:A3.250EURNotesDue2026Member 2025-10-24 2025-10-24 0000080424 pg:A4.875EURDueMay2027Member 2025-10-24 2025-10-24 0000080424 pg:A1.200Due2028Member 2025-10-24 2025-10-24 0000080424 pg:A3.150EURNotesDue2028Member 2025-10-24 2025-10-24 0000080424 pg:A1.250Due2029Member 2025-10-24 2025-10-24 0000080424 pg:A1.800Due2029Member 2025-10-24 2025-10-24 0000080424 pg:A6.250GBPDueJanuary2030Member 2025-10-24 2025-10-24 0000080424 pg:A0.350Due2030Member 2025-10-24 2025-10-24 0000080424 pg:A0.230Due2031Member 2025-10-24 2025-10-24 0000080424 pg:A3.250EURNotesDue2031Member 2025-10-24 2025-10-24 0000080424 pg:A5.250GBPDueJanuary2033Member 2025-10-24 2025-10-24 0000080424 pg:A3.200EURNotesDue2034Member 2025-10-24 2025-10-24 0000080424 pg:A1.875Due2038Member 2025-10-24 2025-10-24 0000080424 pg:A0.900Due2041Member 2025-10-24 2025-10-24 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) October 24, 2025 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio OH 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza , Cincinnati OH One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 0.110% Notes due 2026 PG26D NYSE 3.250% EUR Notes due 2026 PG26F NYSE 4.875% EUR notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 3.150% EUR Notes due 2028 PG28B NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 3.250% EUR Notes due 2031 PG31B NYSE 5.250% GBP notes due January 2033 PG33 NYSE 3.200% EUR Notes due 2034 PG34C NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On October 24, 2025 , The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended September 30, 2025. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated October 24, 2025 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",568
2025-11-03,8-K,0001193125-25-262609,"THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in charter) (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices and zip code) 513 - 983-1100 Registrants telephone number, including area code (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.875% EUR notes due May 2027 3.150% EUR Notes due 2028 6.250% GBP notes due January 2030 3.250% EUR Notes due 2031 5.250% GBP notes due January 2033 3.200% EUR Notes due 2034 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Item 8.01 Other Events. On November 3, 2025, The Procter & Gamble Company (the Company) closed an underwritten public offering of 500,000,000 aggregate principal amount of 2.900% Notes due November 3, 2033 and 500,000,000 aggregate principal amount of 3.650% Notes due November 3, 2045 under the Companys Registration Statement on Form S-3 (Registration No. 333-275071) (the Registration Statement). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are",365
2025-11-04,8-K,0001193125-25-264728,"THE PROCTER & GAMBLE COMPANY (Exact name of registrant as specified in charter) (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices and zip code) 513 - 983-1100 Registrants telephone number, including area code (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Common Stock, without Par Value 4.875% EUR notes due May 2027 3.150% EUR Notes due 2028 6.250% GBP notes due January 2030 3.250% EUR Notes due 2031 5.250% GBP notes due January 2033 2.900% EUR Notes due 2033 3.200% EUR Notes due 2034 3.650% EUR Notes due 2045 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  Other Events. On November 4, 2025, The Procter & Gamble Company (the Company) closed an underwritten public offering of $258,889,000 aggregate principal amount of Floating Rate Notes due November 4, 2075 under the Companys Registration Statement on Form S-3 (Registration No. 333-275071). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are",359
2025-12-15,8-K,0000080424-25-000287,"pg-20251215 0000080424 False False 0000080424 2025-12-15 2025-12-15 0000080424 2025-12-15 2025-12-15 0000080424 exch:XNYS 2025-12-15 2025-12-15 0000080424 pg:A0.110NotesDue2026Domain 2025-12-15 2025-12-15 0000080424 pg:A3.25EURNotesDue2026Domain 2025-12-15 2025-12-15 0000080424 pg:A4.875EURNotesDueMay2027Domain 2025-12-15 2025-12-15 0000080424 pg:A1.200NotesDue2028Domain 2025-12-15 2025-12-15 0000080424 pg:A3.150EURNotesDue2028Domain 2025-12-15 2025-12-15 0000080424 pg:A1.250NotesDue2029Domain 2025-12-15 2025-12-15 0000080424 pg:A1.800NotesDue2029Domain 2025-12-15 2025-12-15 0000080424 pg:A6.250GBPNotesDueJanuary2030Domain 2025-12-15 2025-12-15 0000080424 pg:A0.350NotesDue2030Domain 2025-12-15 2025-12-15 0000080424 pg:A0.230NotesDue2031Domain 2025-12-15 2025-12-15 0000080424 pg:A3.250EURNotesDue2031Domain 2025-12-15 2025-12-15 0000080424 pg:A5.250GBPNotesDueJanuary2033Domain 2025-12-15 2025-12-15 0000080424 pg:A2.900EURNotesDue2033Domain 2025-12-15 2025-12-15 0000080424 pg:A3.200EURNotesDue2034Domain 2025-12-15 2025-12-15 0000080424 pg:A1.875NotesDue2038Domain 2025-12-15 2025-12-15 0000080424 pg:A0.900NotesDue2041Domain 2025-12-15 2025-12-15 0000080424 pg:A3.650EURNotesDue2045Domain 2025-12-15 2025-12-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 8-K ___________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 15, 2025 ( December 9, 2025 ) ___________________________________ The Procter & Gamble Company (Exact name of registrant as specified in its charter) ___________________________________ Ohio (State or other jurisdiction of incorporation or organization) 001-00434 (Commission File Number) 31-0411980 (I.R.S. Employer Identification Number) One Procter & Gamble Plaza Cincinnati , Ohio 45202 (Address of principal executive offices and zip code) ( 513 ) 983-1100 (Registrant's telephone number, including area code) ___________________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock without Par Value PG NYSE 0.110% Notes due 2026 PG26D NYSE 3.25% EUR Notes due 2026 PG26F NYSE 4.875% EUR Notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 3.150% EUR Notes due 2028 PG28B NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP Notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 3.250% EUR Notes due 2031 PG31B NYSE 5.250% GBP Notes due January 2033 PG33 NYSE 2.900% EUR Notes due 2033 PG33B NYSE 3.200% EUR Notes due 2034 PG34C NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE 3.650% Notes due 2045 PG45 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act. Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. On December 9, 2025, Jennifer Davis, currently Chief Executive Officer - Health Care, notified the Company of her intent to retire effective June 30, 2026, after more than 33 years of service.",530
2026-01-13,8-K,0000080424-26-000002,"pg-20260113 0000080424 False False 0000080424 2026-01-13 2026-01-13 0000080424 2026-01-13 2026-01-13 0000080424 exch:XNYS 2026-01-13 2026-01-13 0000080424 pg:A0.110NotesDue2026Domain 2026-01-13 2026-01-13 0000080424 pg:A3.25EURNotesDue2026Domain 2026-01-13 2026-01-13 0000080424 pg:A4.875EURNotesDueMay2027Domain 2026-01-13 2026-01-13 0000080424 pg:A1.200NotesDue2028Domain 2026-01-13 2026-01-13 0000080424 pg:A3.150EURNotesDue2028Domain 2026-01-13 2026-01-13 0000080424 pg:A1.250NotesDue2029Domain 2026-01-13 2026-01-13 0000080424 pg:A1.800NotesDue2029Domain 2026-01-13 2026-01-13 0000080424 pg:A6.250GBPNotesDueJanuary2030Domain 2026-01-13 2026-01-13 0000080424 pg:A0.350NotesDue2030Domain 2026-01-13 2026-01-13 0000080424 pg:A0.230NotesDue2031Domain 2026-01-13 2026-01-13 0000080424 pg:A3.250EURNotesDue2031Domain 2026-01-13 2026-01-13 0000080424 pg:A5.250GBPNotesDueJanuary2033Domain 2026-01-13 2026-01-13 0000080424 pg:A2.900EURNotesDue2033Domain 2026-01-13 2026-01-13 0000080424 pg:A3.200EURNotesDue2034Domain 2026-01-13 2026-01-13 0000080424 pg:A1.875NotesDue2038Domain 2026-01-13 2026-01-13 0000080424 pg:A0.900NotesDue2041Domain 2026-01-13 2026-01-13 0000080424 pg:A3.650EURNotesDue2045Domain 2026-01-13 2026-01-13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 8-K ___________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 13, 2026 ___________________________________ The Procter & Gamble Company (Exact name of registrant as specified in its charter) ___________________________________ Ohio (State or other jurisdiction of incorporation or organization) 001-00434 (Commission File Number) 31-0411980 (I.R.S. Employer Identification Number) One Procter & Gamble Plaza Cincinnati , Ohio 45202 (Address of principal executive offices and zip code) ( 513 ) 983-1100 (Registrant's telephone number, including area code) ___________________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock without Par Value PG NYSE 0.110% Notes due 2026 PG26D NYSE 3.25% EUR Notes due 2026 PG26F NYSE 4.875% EUR Notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 3.150% EUR Notes due 2028 PG28B NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP Notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 3.250% EUR Notes due 2031 PG31B NYSE 5.250% GBP Notes due January 2033 PG33 NYSE 2.900% EUR Notes due 2033 PG33B NYSE 3.200% EUR Notes due 2034 PG34C NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE 3.650% Notes due 2045 PG45 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act. Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 7.01 REGULATION FD DISCLOSURE On January 13, 2026, The Procter & Gamble Company (the ""Company"") issued a news release announcing that its Board of Directors declared a quarterly dividend of $1.0568 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after February 17, 2026, to Common Stock shareholders of record at the close of business on January 23, 2026, and to Series A and Series B ESOP Convertible Class A Preferred Stock shareholders of record at the start of business on January 23, 2026. The Company is furnishing this 8-K, including Exhibit 99.1, pursuant to Item 7.01, ""Regulation FD Disclosure."" ITEM 9.01 - FINANCIAL STATEMENTS AND EXHIBITS Exhibit No. Description 99.1 Dividend News Release by The Procter & Gamble Company dated January 13, 2026. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)",627
2026-01-22,8-K,0000080424-26-000006,"pg-20260122 0000080424 False False False False False 0000080424 2026-01-22 2026-01-22 0000080424 2026-01-22 2026-01-22 0000080424 pg:A0.110Due2026Member 2026-01-22 2026-01-22 0000080424 pg:A3.250EURNotesDue2026Member 2026-01-22 2026-01-22 0000080424 pg:A4.875EURDueMay2027Member 2026-01-22 2026-01-22 0000080424 pg:A1.200Due2028Member 2026-01-22 2026-01-22 0000080424 pg:A3.150EURNotesDue2028Member 2026-01-22 2026-01-22 0000080424 pg:A1.250Due2029Member 2026-01-22 2026-01-22 0000080424 pg:A1.800Due2029Member 2026-01-22 2026-01-22 0000080424 pg:A6.250GBPDueJanuary2030Member 2026-01-22 2026-01-22 0000080424 pg:A0.350Due2030Member 2026-01-22 2026-01-22 0000080424 pg:A0.230Due2031Member 2026-01-22 2026-01-22 0000080424 pg:A3.250EURNotesDue2031Member 2026-01-22 2026-01-22 0000080424 pg:A5.250GBPDueJanuary2033Member 2026-01-22 2026-01-22 0000080424 pg:A2.900NotesDue2033Member 2026-01-22 2026-01-22 0000080424 pg:A3.200EURNotesDue2034Member 2026-01-22 2026-01-22 0000080424 pg:A1.875Due2038Member 2026-01-22 2026-01-22 0000080424 pg:A0.900Due2041Member 2026-01-22 2026-01-22 0000080424 pg:A3.650NotesDue2045Member 2026-01-22 2026-01-22 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934 Date of Report (Date of earliest event reported) January 22, 2026 THE PROCTER & GAMBLE CO MPANY (Exact name of registrant as specified in its charter) Ohio OH 1-434 31-0411980 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number) One Procter & Gamble Plaza , Cincinnati OH One Procter & Gamble Plaza , Cincinnati , Ohio 45202 (Address of principal executive offices) (Zip Code) ( 513 ) 983-1100 (Registrants telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):  False Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  False Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  False Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  False Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, without Par Value PG NYSE 0.110% Notes due 2026 PG26D NYSE 3.250% EUR Notes due 2026 PG26F NYSE 4.875% EUR notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 3.150% EUR Notes due 2028 PG28B NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 3.250% EUR Notes due 2031 PG31B NYSE 5.250% GBP notes due January 2033 PG33 NYSE 2.900% Notes due 2033 PG33B NYSE 3.200% EUR Notes due 2034 PG34C NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE 3.650% Notes due 2045 PG45 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company  False If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 22, 2026 , The Procter & Gamble Company (the ""Company"") issued a news release with respect to earnings for the quarter ended December 31, 2025. The Company is furnishing this 8-K pursuant to Item 2.02, ""Results of Operations and Financial Condition."" ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit Number Description 99.1 News Release by The Procter & Gamble Company dated January 22, 2026 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).",588
2026-01-22,8-K,0000080424-26-000009,"pg-20260122 0000080424 False False 0000080424 2026-01-22 2026-01-22 0000080424 2026-01-22 2026-01-22 0000080424 exch:XNYS 2026-01-22 2026-01-22 0000080424 pg:A0.110NotesDue2026Domain 2026-01-22 2026-01-22 0000080424 pg:A3.25EURNotesDue2026Domain 2026-01-22 2026-01-22 0000080424 pg:A4.875EURNotesDueMay2027Domain 2026-01-22 2026-01-22 0000080424 pg:A1.200NotesDue2028Domain 2026-01-22 2026-01-22 0000080424 pg:A3.150EURNotesDue2028Domain 2026-01-22 2026-01-22 0000080424 pg:A1.250NotesDue2029Domain 2026-01-22 2026-01-22 0000080424 pg:A1.800NotesDue2029Domain 2026-01-22 2026-01-22 0000080424 pg:A6.250GBPNotesDueJanuary2030Domain 2026-01-22 2026-01-22 0000080424 pg:A0.350NotesDue2030Domain 2026-01-22 2026-01-22 0000080424 pg:A0.230NotesDue2031Domain 2026-01-22 2026-01-22 0000080424 pg:A3.250EURNotesDue2031Domain 2026-01-22 2026-01-22 0000080424 pg:A5.250GBPNotesDueJanuary2033Domain 2026-01-22 2026-01-22 0000080424 pg:A2.900EURNotesDue2033Domain 2026-01-22 2026-01-22 0000080424 pg:A3.200EURNotesDue2034Domain 2026-01-22 2026-01-22 0000080424 pg:A1.875NotesDue2038Domain 2026-01-22 2026-01-22 0000080424 pg:A0.900NotesDue2041Domain 2026-01-22 2026-01-22 0000080424 pg:A3.650EURNotesDue2045Domain 2026-01-22 2026-01-22 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 8-K ___________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 22, 2026 ___________________________________ The Procter & Gamble Company (Exact name of registrant as specified in its charter) ___________________________________ Ohio (State or other jurisdiction of incorporation or organization) 001-00434 (Commission File Number) 31-0411980 (I.R.S. Employer Identification Number) One Procter & Gamble Plaza Cincinnati , Ohio 45202 (Address of principal executive offices and zip code) ( 513 ) 983-1100 (Registrant's telephone number, including area code) ___________________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock without Par Value PG NYSE 0.110% Notes due 2026 PG26D NYSE 3.25% EUR Notes due 2026 PG26F NYSE 4.875% EUR Notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 3.150% EUR Notes due 2028 PG28B NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP Notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 3.250% EUR Notes due 2031 PG31B NYSE 5.250% GBP Notes due January 2033 PG33 NYSE 2.900% EUR Notes due 2033 PG33B NYSE 3.200% EUR Notes due 2034 PG34C NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE 3.650% Notes due 2045 PG45 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act. Emerging growth company  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 7.01 - Regulation FD Disclosure On January 22, 2026, The Procter & Gamble Company (the ""Company"") issued a press release announcing its second quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, ""Regulation FD Disclosure."" Item 9.01 - Financial Statements and Exhibits (d): The following exhibits are being filed herewith: Exhibit No. Description 99.1 Informational Slides Provided by The Procter & Gamble Company dated January 22, 2026. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)",588
2026-01-23,10-Q,0000080424-26-000011,and Analysis of Financial Condition and Results of Operations 14 Item 3. Quantitative and Qualitative Disclosures About Market Risk 29 Item 4. Controls and Procedures 29 PART II Item 1. Legal Proceedings 30 Item 1A.,35
